PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"33865446","A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody","Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, Lannfelt L, Bradley H, Rabe M, Koyama A, Reyderman L, Berry DA, Berry S, Gordon R, Kramer LD, Cummings JL.","Alzheimers Res Ther. 2021 Apr 17;13(1):80. doi: 10.1186/s13195-021-00813-8.","Swanson CJ","Alzheimers Res Ther","2021","2021/04/18","PMC8053280","","10.1186/s13195-021-00813-8"
"29991131","The Effects of Music Therapy on Cognition, Psychiatric Symptoms, and Activities of Daily Living in Patients with Alzheimer's Disease","Lyu J, Zhang J, Mu H, Li W, Champ M, Xiong Q, Gao T, Xie L, Jin W, Yang W, Cui M, Gao M, Li M.","J Alzheimers Dis. 2018;64(4):1347-1358. doi: 10.3233/JAD-180183.","Lyu J","J Alzheimers Dis","2018","2018/07/12","","","10.3233/JAD-180183"
"31127076","Comparison between physical and cognitive treatment in patients with MCI and Alzheimer's disease","Fonte C, Smania N, Pedrinolla A, Munari D, Gandolfi M, Picelli A, Varalta V, Benetti MV, Brugnera A, Federico A, Muti E, Tamburin S, Schena F, Venturelli M.","Aging (Albany NY). 2019 May 24;11(10):3138-3155. doi: 10.18632/aging.101970.","Fonte C","Aging (Albany NY)","2019","2019/05/26","PMC6555450","","10.18632/aging.101970"
"30211001","The effect of physical exercise on cerebral blood flow in Alzheimer's disease","van der Kleij LA, Petersen ET, Siebner HR, Hendrikse J, Frederiksen KS, Sobol NA, Hasselbalch SG, Garde E.","Neuroimage Clin. 2018 Sep 4;20:650-654. doi: 10.1016/j.nicl.2018.09.003. eCollection 2018.","van der Kleij LA","Neuroimage Clin","2018","2018/09/14","PMC6129739","","10.1016/j.nicl.2018.09.003"
"26963387","Periodontitis and Cognitive Decline in Alzheimer's Disease","Ide M, Harris M, Stevens A, Sussams R, Hopkins V, Culliford D, Fuller J, Ibbett P, Raybould R, Thomas R, Puenter U, Teeling J, Perry VH, Holmes C.","PLoS One. 2016 Mar 10;11(3):e0151081. doi: 10.1371/journal.pone.0151081. eCollection 2016.","Ide M","PLoS One","2016","2016/03/11","PMC4786266","","10.1371/journal.pone.0151081"
"30446421","The clinical practice of risk reduction for Alzheimer's disease: A precision medicine approach","Isaacson RS, Ganzer CA, Hristov H, Hackett K, Caesar E, Cohen R, Kachko R, Meléndez-Cabrero J, Rahman A, Scheyer O, Hwang MJ, Berkowitz C, Hendrix S, Mureb M, Schelke MW, Mosconi L, Seifan A, Krikorian R.","Alzheimers Dement. 2018 Dec;14(12):1663-1673. doi: 10.1016/j.jalz.2018.08.004. Epub 2018 Nov 13.","Isaacson RS","Alzheimers Dement","2018","2018/11/18","PMC6373477","NIHMS1511801","10.1016/j.jalz.2018.08.004"
"30040719","Change in Fitness and the Relation to Change in Cognition and Neuropsychiatric Symptoms After Aerobic Exercise in Patients with Mild Alzheimer's Disease","Sobol NA, Dall CH, Høgh P, Hoffmann K, Frederiksen KS, Vogel A, Siersma V, Waldemar G, Hasselbalch SG, Beyer N.","J Alzheimers Dis. 2018;65(1):137-145. doi: 10.3233/JAD-180253.","Sobol NA","J Alzheimers Dis","2018","2018/07/25","PMC6087450","","10.3233/JAD-180253"
"35811518","Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project","Toups K, Hathaway A, Gordon D, Chung H, Raji C, Boyd A, Hill BD, Hausman-Cohen S, Attarha M, Chwa WJ, Jarrett M, Bredesen DE.","J Alzheimers Dis. 2022;88(4):1411-1421. doi: 10.3233/JAD-215707.","Toups K","J Alzheimers Dis","2022","2022/07/11","PMC9484109","","10.3233/JAD-215707"
"32690472","Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial","Arellanes IC, Choe N, Solomon V, He X, Kavin B, Martinez AE, Kono N, Buennagel DP, Hazra N, Kim G, D'Orazio LM, McCleary C, Sagare A, Zlokovic BV, Hodis HN, Mack WJ, Chui HC, Harrington MG, Braskie MN, Schneider LS, Yassine HN.","EBioMedicine. 2020 Sep;59:102883. doi: 10.1016/j.ebiom.2020.102883. Epub 2020 Jul 17.","Arellanes IC","EBioMedicine","2020","2020/07/22","PMC7502665","","10.1016/j.ebiom.2020.102883"
"33074237","Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial","Gibson GE, Luchsinger JA, Cirio R, Chen H, Franchino-Elder J, Hirsch JA, Bettendorff L, Chen Z, Flowers SA, Gerber LM, Grandville T, Schupf N, Xu H, Stern Y, Habeck C, Jordan B, Fonzetti P.","J Alzheimers Dis. 2020;78(3):989-1010. doi: 10.3233/JAD-200896.","Gibson GE","J Alzheimers Dis","2020","2020/10/19","PMC7880246","NIHMS1666597","10.3233/JAD-200896"
"24077434","A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease","Shinto L, Quinn J, Montine T, Dodge HH, Woodward W, Baldauf-Wagner S, Waichunas D, Bumgarner L, Bourdette D, Silbert L, Kaye J.","J Alzheimers Dis. 2014;38(1):111-20. doi: 10.3233/JAD-130722.","Shinto L","J Alzheimers Dis","2014","2013/10/01","PMC3886557","NIHMS539809","10.3233/JAD-130722"
"32920957","36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease","Soininen H, Solomon A, Visser PJ, Hendrix SB, Blennow K, Kivipelto M, Hartmann T; LipiDiDiet clinical study group.","Alzheimers Dement. 2021 Jan;17(1):29-40. doi: 10.1002/alz.12172. Epub 2020 Sep 13.","Soininen H","Alzheimers Dement","2021","2020/09/13","PMC7821311","","10.1002/alz.12172"
"25304364","Effects of aerobic exercise on cognition and hippocampal volume in Alzheimer's disease: study protocol of a randomized controlled trial (The FIT-AD trial)","Yu F, Bronas UG, Konety S, Nelson NW, Dysken M, Jack C Jr, Wyman JF, Vock D, Smith G.","Trials. 2014 Oct 11;15:394. doi: 10.1186/1745-6215-15-394.","Yu F","Trials","2014","2014/10/12","PMC4283145","","10.1186/1745-6215-15-394"
"35275541","Yoga Prevents Gray Matter Atrophy in Women at Risk for Alzheimer's Disease: A Randomized Controlled Trial","Krause-Sorio B, Siddarth P, Kilpatrick L, Milillo MM, Aguilar-Faustino Y, Ercoli L, Narr KL, Khalsa DS, Lavretsky H.","J Alzheimers Dis. 2022;87(2):569-581. doi: 10.3233/JAD-215563.","Krause-Sorio B","J Alzheimers Dis","2022","2022/03/11","PMC9198760","","10.3233/JAD-215563"
"30372680","A Randomized Controlled Trial of Adherence to a 24-Month Home-Based Physical Activity Program and the Health Benefits for Older Adults at Risk of Alzheimer's Disease: The AIBL Active-Study","Cox KL, Cyarto EV, Ellis KA, Ames D, Desmond P, Phal P, Sharman MJ, Szoeke C, Rowe CC, Masters CL, You E, Burrows S, Lai MMY, Lautenschlager NT.","J Alzheimers Dis. 2019;70(s1):S187-S205. doi: 10.3233/JAD-180521.","Cox KL","J Alzheimers Dis","2019","2018/10/30","PMC6700652","","10.3233/JAD-180521"
"21852281","Six-month walking program changes cognitive and ADL performance in patients with Alzheimer","Venturelli M, Scarsini R, Schena F.","Am J Alzheimers Dis Other Demen. 2011 Aug;26(5):381-8. doi: 10.1177/1533317511418956. Epub 2011 Aug 17.","Venturelli M","Am J Alzheimers Dis Other Demen","2011","2011/08/20","","","10.1177/1533317511418956"
"30056419","Improvement of Main Cognitive Functions in Patients with Alzheimer's Disease after Treatment with Coconut Oil Enriched Mediterranean Diet: A Pilot Study","de la Rubia Ortí JE, García-Pardo MP, Drehmer E, Sancho Cantus D, Julián Rochina M, Aguilar MA, Hu Yang I.","J Alzheimers Dis. 2018;65(2):577-587. doi: 10.3233/JAD-180184.","de la Rubia Ortí JE","J Alzheimers Dis","2018","2018/07/30","","","10.3233/JAD-180184"
"30367958","Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer's disease","Ota M, Matsuo J, Ishida I, Takano H, Yokoi Y, Hori H, Yoshida S, Ashida K, Nakamura K, Takahashi T, Kunugi H.","Neurosci Lett. 2019 Jan 18;690:232-236. doi: 10.1016/j.neulet.2018.10.048. Epub 2018 Oct 24.","Ota M","Neurosci Lett","2019","2018/10/28","","","10.1016/j.neulet.2018.10.048"
"28922159","Can Musical or Painting Interventions Improve Chronic Pain, Mood, Quality of Life, and Cognition in Patients with Mild Alzheimer's Disease? Evidence from a Randomized Controlled Trial","Pongan E, Tillmann B, Leveque Y, Trombert B, Getenet JC, Auguste N, Dauphinot V, El Haouari H, Navez M, Dorey JM, Krolak-Salmon P, Laurent B, Rouch I; LACMé Group.","J Alzheimers Dis. 2017;60(2):663-677. doi: 10.3233/JAD-170410.","Pongan E","J Alzheimers Dis","2017","2017/09/19","","","10.3233/JAD-170410"
"36329553","Genistein effect on cognition in prodromal Alzheimer's disease patients. The GENIAL clinical trial","Viña J, Escudero J, Baquero M, Cebrián M, Carbonell-Asíns JA, Muñoz JE, Satorres E, Meléndez JC, Ferrer-Rebolleda J, Cózar-Santiago MDP, Santabárbara-Gómez JM, Jové M, Pamplona R, Tarazona-Santabalbina FJ, Borrás C.","Alzheimers Res Ther. 2022 Nov 4;14(1):164. doi: 10.1186/s13195-022-01097-2.","Viña J","Alzheimers Res Ther","2022","2022/11/04","PMC9635167","","10.1186/s13195-022-01097-2"
"35272209","Effect of light therapy on delirium in older patients with Alzheimer's disease-related dementia","Zou C, Mei X, Li X, Hu J, Xu T, Zheng C.","J Psychiatr Res. 2022 May;149:124-127. doi: 10.1016/j.jpsychires.2022.03.003. Epub 2022 Mar 6.","Zou C","J Psychiatr Res","2022","2022/03/10","","","10.1016/j.jpsychires.2022.03.003"
"33444359","Effect of aerobic exercise on amyloid accumulation in preclinical Alzheimer's: A 1-year randomized controlled trial","Vidoni ED, Morris JK, Watts A, Perry M, Clutton J, Van Sciver A, Kamat AS, Mahnken J, Hunt SL, Townley R, Honea R, Shaw AR, Johnson DK, Vacek J, Burns JM.","PLoS One. 2021 Jan 14;16(1):e0244893. doi: 10.1371/journal.pone.0244893. eCollection 2021.","Vidoni ED","PLoS One","2021","2021/01/14","PMC7808620","","10.1371/journal.pone.0244893"
"33002645","Enhancing cognitive training effects in Alzheimer's disease: rTMS as an add-on treatment","Bagattini C, Zanni M, Barocco F, Caffarra P, Brignani D, Miniussi C, Defanti CA.","Brain Stimul. 2020 Nov-Dec;13(6):1655-1664. doi: 10.1016/j.brs.2020.09.010. Epub 2020 Sep 28.","Bagattini C","Brain Stimul","2020","2020/10/01","","","10.1016/j.brs.2020.09.010"
"2684293","P300 and Alzheimer's disease","Polich J.","Biomed Pharmacother. 1989;43(7):493-9. doi: 10.1016/0753-3322(89)90110-8.","Polich J","Biomed Pharmacother","1989","1989/01/01","","","10.1016/0753-3322(89)90110-8"
"3541049","Pharmacotherapy in Alzheimer's disease: basis and rationale","Narang PK, Cutler NR.","Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):519-31. doi: 10.1016/0278-5846(86)90022-9.","Narang PK","Prog Neuropsychopharmacol Biol Psychiatry","1986","1986/01/01","","","10.1016/0278-5846(86)90022-9"
"31062834","Treatment Effects of Vortioxetine on Cognitive Functions in Mild Alzheimer's Disease Patients with Depressive Symptoms: A 12 Month, Open-Label, Observational Study","Cumbo E, Cumbo S, Torregrossa S, Migliore D.","J Prev Alzheimers Dis. 2019;6(3):192-197. doi: 10.14283/jpad.2019.24.","Cumbo E","J Prev Alzheimers Dis","2019","2019/05/08","","","10.14283/jpad.2019.24"
"33780529","Recruitment and Screening Methods in Alzheimer's Disease Research: The FIT-AD Trial","Greimel S, Wyman JF, Zhang L, Yu F.","J Gerontol A Biol Sci Med Sci. 2022 Mar 3;77(3):547-553. doi: 10.1093/gerona/glab092.","Greimel S","J Gerontol A Biol Sci Med Sci","2022","2021/03/29","PMC8893175","","10.1093/gerona/glab092"
"23786793","Perceptual and response interference in Alzheimer's disease and mild cognitive impairment","Wang P, Zhang X, Liu Y, Liu S, Zhou B, Zhang Z, Yao H, Zhang X, Jiang T.","Clin Neurophysiol. 2013 Dec;124(12):2389-96. doi: 10.1016/j.clinph.2013.05.014. Epub 2013 Jun 17.","Wang P","Clin Neurophysiol","2013","2013/06/22","","","10.1016/j.clinph.2013.05.014"
"24479631","Butyrylcholinesterase K and apolipoprotein ε4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease","Yoo HB, Lee HW, Shin S, Park SW, Choi JS, Jung HY, Cha J, Lee JM, Lee JY.","Curr Alzheimer Res. 2014 Feb;11(2):137-44. doi: 10.2174/1567205011666140130152114.","Yoo HB","Curr Alzheimer Res","2014","2014/02/01","","","10.2174/1567205011666140130152114"
"25125457","Cognitive and functional decline and their relationship in patients with mild Alzheimer's dementia","Liu-Seifert H, Siemers E, Sundell K, Price K, Han B, Selzler K, Aisen P, Cummings J, Raskin J, Mohs R.","J Alzheimers Dis. 2015;43(3):949-55. doi: 10.3233/JAD-140792.","Liu-Seifert H","J Alzheimers Dis","2015","2014/08/16","","","10.3233/JAD-140792"
"10786501","[Therapeutic touch]","Giasson M, Leroux G, Tardif H, Bouchard L.","Infirm Que. 1999 Jul-Aug;6(6):38-47.","Giasson M","Infirm Que","1999","2000/04/29","","",""
"10447153","Defining meaningful change in Alzheimer's disease trials: the donepezil experience","McLendon BM, Doraiswamy PM.","J Geriatr Psychiatry Neurol. 1999 Spring;12(1):39-48. doi: 10.1177/089198879901200108.","McLendon BM","J Geriatr Psychiatry Neurol","1999","1999/08/14","","","10.1177/089198879901200108"
"2405484","NGF and Alzheimer's: hopes and fears","Marx J.","Science. 1990 Jan 26;247(4941):408-10. doi: 10.1126/science.2405484.","Marx J","Science","1990","1990/01/26","","","10.1126/science.2405484"
"2065522","Alternatives in the treatment of memory loss in patients with Alzheimer's disease","Volger BW.","Clin Pharm. 1991 Jun;10(6):447-56.","Volger BW","Clin Pharm","1991","1991/06/01","","",""
"33459713","The Fragility of Temporal Memory in Alzheimer's Disease","Park JH, Lee SA.","J Alzheimers Dis. 2021;79(4):1631-1646. doi: 10.3233/JAD-200892.","Park JH","J Alzheimers Dis","2021","2021/01/18","","","10.3233/JAD-200892"
"1357552","Treatment for Alzheimer's disease?","Growdon JH.","N Engl J Med. 1992 Oct 29;327(18):1306-8. doi: 10.1056/NEJM199210293271810.","Growdon JH","N Engl J Med","1992","1992/10/29","","","10.1056/NEJM199210293271810"
"33682705","Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET","Devous MD Sr, Fleisher AS, Pontecorvo MJ, Lu M, Siderowf A, Navitsky M, Kennedy I, Southekal S, Harris TS, Mintun MA.","J Alzheimers Dis. 2021;80(3):1091-1104. doi: 10.3233/JAD-200808.","Devous MD Sr","J Alzheimers Dis","2021","2021/03/08","","","10.3233/JAD-200808"
"30966759","Efficacy and Limitations of rCBF-SPECT in the Diagnosis of Alzheimer's Disease With Amyloid-PET","Takahashi M, Tada T, Nakamura T, Koyama K, Momose T.","Am J Alzheimers Dis Other Demen. 2019 Aug;34(5):314-321. doi: 10.1177/1533317519841192. Epub 2019 Apr 9.","Takahashi M","Am J Alzheimers Dis Other Demen","2019","2019/04/11","PMC6610554","","10.1177/1533317519841192"
"23780659","Effects of aging and Alzheimer's disease along the longitudinal axis of the hippocampus","Gordon BA, Blazey T, Benzinger TL, Head D.","J Alzheimers Dis. 2013;37(1):41-50. doi: 10.3233/JAD-130011.","Gordon BA","J Alzheimers Dis","2013","2013/06/20","PMC3883500","NIHMS529427","10.3233/JAD-130011"
"28372335","Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial","Craft S, Claxton A, Baker LD, Hanson AJ, Cholerton B, Trittschuh EH, Dahl D, Caulder E, Neth B, Montine TJ, Jung Y, Maldjian J, Whitlow C, Friedman S.","J Alzheimers Dis. 2017;57(4):1325-1334. doi: 10.3233/JAD-161256.","Craft S","J Alzheimers Dis","2017","2017/04/05","PMC5409050","","10.3233/JAD-161256"
"22672770","Safety and biomarker effects of solanezumab in patients with Alzheimer's disease","Farlow M, Arnold SE, van Dyck CH, Aisen PS, Snider BJ, Porsteinsson AP, Friedrich S, Dean RA, Gonzales C, Sethuraman G, DeMattos RB, Mohs R, Paul SM, Siemers ER.","Alzheimers Dement. 2012 Jul;8(4):261-71. doi: 10.1016/j.jalz.2011.09.224. Epub 2012 Jun 5.","Farlow M","Alzheimers Dement","2012","2012/06/08","","","10.1016/j.jalz.2011.09.224"
"23290333","Long-term observation of a multicomponent cognitive intervention in mild cognitive impairment","Buschert VC, Giegling I, Teipel SJ, Jolk S, Hampel H, Rujescu D, Buerger K.","J Clin Psychiatry. 2012 Dec;73(12):e1492-8. doi: 10.4088/JCP.11m07270.","Buschert VC","J Clin Psychiatry","2012","2013/01/08","","","10.4088/JCP.11m07270"
"32568205","The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer's Disease: The Okayama Depression and Apathy Project (ODAP)","Takemoto M, Ohta Y, Hishikawa N, Yamashita T, Nomura E, Tsunoda K, Sasaki R, Tadokoro K, Matsumoto N, Omote Y, Abe K.","J Alzheimers Dis. 2020;76(2):769-772. doi: 10.3233/JAD-200247.","Takemoto M","J Alzheimers Dis","2020","2020/06/23","","","10.3233/JAD-200247"
"32281303","Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study","Lopes Alves I, Collij LE, Altomare D, Frisoni GB, Saint-Aubert L, Payoux P, Kivipelto M, Jessen F, Drzezga A, Leeuwis A, Wink AM, Visser PJ, van Berckel BNM, Scheltens P, Gray KR, Wolz R, Stephens A, Gismondi R, Buckely C, Gispert JD, Schmidt M, Ford L, Ritchie C, Farrar G, Barkhof F, Molinuevo JL; AMYPAD Consortium.","Alzheimers Dement. 2020 May;16(5):750-758. doi: 10.1002/alz.12069. Epub 2020 Apr 12.","Lopes Alves I","Alzheimers Dement","2020","2020/04/14","PMC7984341","","10.1002/alz.12069"
"9566385","Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging","Baldereschi M, Di Carlo A, Lepore V, Bracco L, Maggi S, Grigoletto F, Scarlato G, Amaducci L.","Neurology. 1998 Apr;50(4):996-1002. doi: 10.1212/wnl.50.4.996.","Baldereschi M","Neurology","1998","1998/05/05","","","10.1212/wnl.50.4.996"
"29096697","Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers","Howell JC, Watts KD, Parker MW, Wu J, Kollhoff A, Wingo TS, Dorbin CD, Qiu D, Hu WT.","Alzheimers Res Ther. 2017 Nov 2;9(1):88. doi: 10.1186/s13195-017-0315-1.","Howell JC","Alzheimers Res Ther","2017","2017/11/04","PMC5668981","","10.1186/s13195-017-0315-1"
"23141383","Risk disclosure and preclinical Alzheimer's disease clinical trial enrollment","Grill JD, Karlawish J, Elashoff D, Vickrey BG.","Alzheimers Dement. 2013 May;9(3):356-359.e1. doi: 10.1016/j.jalz.2012.03.001. Epub 2012 Nov 8.","Grill JD","Alzheimers Dement","2013","2012/11/13","PMC3572336","NIHMS373844","10.1016/j.jalz.2012.03.001"
"26402769","Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease","Liu-Seifert H, Siemers E, Price K, Han B, Selzler KJ, Henley D, Sundell K, Aisen P, Cummings J, Raskin J, Mohs R; Alzheimer’s Disease Neuroimaging Initiative.","J Alzheimers Dis. 2015;47(1):205-14. doi: 10.3233/JAD-142508.","Liu-Seifert H","J Alzheimers Dis","2015","2015/09/25","PMC4923754","","10.3233/JAD-142508"
"9447496","Major and minor depression in Alzheimer's disease: prevalence and impact","Lyketsos CG, Steele C, Baker L, Galik E, Kopunek S, Steinberg M, Warren A.","J Neuropsychiatry Clin Neurosci. 1997 Fall;9(4):556-61. doi: 10.1176/jnp.9.4.556.","Lyketsos CG","J Neuropsychiatry Clin Neurosci","1997","1998/02/03","","","10.1176/jnp.9.4.556"
"34726348","Neuropsychological, neuropsychiatric, and quality-of-life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study","Boada M, López OL, Olazarán J, Núñez L, Pfeffer M, Puente O, Piñol-Ripoll G, Gámez JE, Anaya F, Kiprov D, Alegret M, Grifols C, Barceló M, Bozzo J, Szczepiorkowski ZM, Páez A; AMBAR Trial Group.","Alzheimers Dement. 2022 Jul;18(7):1314-1324. doi: 10.1002/alz.12477. Epub 2021 Nov 2.","Boada M","Alzheimers Dement","2022","2021/11/02","PMC9540900","","10.1002/alz.12477"
"1663715","First clinical impressions with an ACTH analog (HOE 427) in the treatment of Alzheimer's disease","Siegfried KR.","Ann N Y Acad Sci. 1991;640:280-3. doi: 10.1111/j.1749-6632.1991.tb00234.x.","Siegfried KR","Ann N Y Acad Sci","1991","1991/01/01","","","10.1111/j.1749-6632.1991.tb00234.x"
"25160273","Contrastive conversational analysis of language production by Alzheimer's and control people","Boyé M, Grabar N, Thi Tran M.","Stud Health Technol Inform. 2014;205:682-6.","Boyé M","Stud Health Technol Inform","2014","2014/08/28","","",""
"3280127","Glutamatergic abnormalities in Alzheimer's disease and a rationale for clinical trials with L-glutamate","Deutsch SI, Morihisa JM.","Clin Neuropharmacol. 1988 Feb;11(1):18-35. doi: 10.1097/00002826-198802000-00002.","Deutsch SI","Clin Neuropharmacol","1988","1988/02/01","","","10.1097/00002826-198802000-00002"
"2969232","Thiamine and Alzheimer's disease. A pilot study","Blass JP, Gleason P, Brush D, DiPonte P, Thaler H.","Arch Neurol. 1988 Aug;45(8):833-5. doi: 10.1001/archneur.1988.00520320019008.","Blass JP","Arch Neurol","1988","1988/08/01","","","10.1001/archneur.1988.00520320019008"
"21915490","Effects of a multidisciplinary cognitive rehabilitation program for patients with mild Alzheimer's disease","Viola LF, Nunes PV, Yassuda MS, Aprahamian I, Santos FS, Santos GD, Brum PS, Borges SM, Oliveira AM, Chaves GF, Ciasca EC, Ferreira RC, Paula VJ, Takeda OH, Mirandez RM, Watari R, Falcao DV, Cachioni M, Forlenza OV.","Clinics (Sao Paulo). 2011;66(8):1395-400. doi: 10.1590/s1807-59322011000800015.","Viola LF","Clinics (Sao Paulo)","2011","2011/09/15","PMC3161218","","10.1590/s1807-59322011000800015"
"22647256","Independent deficits of visual word and motion processing in aging and early Alzheimer's disease","Velarde C, Perelstein E, Ressmann W, Duffy CJ.","J Alzheimers Dis. 2012;31(3):613-21. doi: 10.3233/JAD-2012-112201.","Velarde C","J Alzheimers Dis","2012","2012/06/01","PMC3732794","NIHMS496953","10.3233/JAD-2012-112201"
"2872956","GABA-agonist therapy for Alzheimer's disease","Mohr E, Bruno G, Foster N, Gillespie M, Cox C, Hare TA, Tamminga C, Fedio P, Chase TN.","Clin Neuropharmacol. 1986;9(3):257-63. doi: 10.1097/00002826-198606000-00004.","Mohr E","Clin Neuropharmacol","1986","1986/01/01","","","10.1097/00002826-198606000-00004"
"26576633","Cognitive behavioural treatment for mild Alzheimer's patients and their caregivers (CBTAC): study protocol for a randomized controlled trial","Forstmeier S, Maercker A, Savaskan E, Roth T.","Trials. 2015 Nov 17;16:526. doi: 10.1186/s13063-015-1043-0.","Forstmeier S","Trials","2015","2015/11/19","PMC4650298","","10.1186/s13063-015-1043-0"
"15681627","Frontotemporal dementia, semantic dementia, and Alzheimer's disease: the contribution of standard neuropsychological tests to differential diagnosis","Diehl J, Monsch AU, Aebi C, Wagenpfeil S, Krapp S, Grimmer T, Seeley W, Förstl H, Kurz A.","J Geriatr Psychiatry Neurol. 2005 Mar;18(1):39-44. doi: 10.1177/0891988704272309.","Diehl J","J Geriatr Psychiatry Neurol","2005","2005/02/01","","","10.1177/0891988704272309"
"8167575","Alzheimer's residents' cognitive and functional measures: special and traditional care unit comparison","Swanson EA, Maas ML, Buckwalter KC.","Clin Nurs Res. 1994 Feb;3(1):27-41. doi: 10.1177/105477389400300104.","Swanson EA","Clin Nurs Res","1994","1994/02/01","","","10.1177/105477389400300104"
"28237746","Cognitive-behavioral treatment for depressed patients with Alzheimer's disease. An open trial","García-Alberca JM.","Arch Gerontol Geriatr. 2017 Jul;71:1-8. doi: 10.1016/j.archger.2017.02.008. Epub 2017 Feb 14.","García-Alberca JM","Arch Gerontol Geriatr","2017","2017/02/27","","","10.1016/j.archger.2017.02.008"
"30755255","Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease","Frölich L, Wunderlich G, Thamer C, Roehrle M, Garcia M Jr, Dubois B.","Alzheimers Res Ther. 2019 Feb 12;11(1):18. doi: 10.1186/s13195-019-0467-2.","Frölich L","Alzheimers Res Ther","2019","2019/02/14","PMC6371616","","10.1186/s13195-019-0467-2"
"24788581","Multistimulation group therapy in Alzheimer's disease promotes changes in brain functioning","Baglio F, Griffanti L, Saibene FL, Ricci C, Alberoni M, Critelli R, Villanelli F, Fioravanti R, Mantovani F, D'amico A, Cabinio M, Preti MG, Nemni R, Farina E.","Neurorehabil Neural Repair. 2015 Jan;29(1):13-24. doi: 10.1177/1545968314532833. Epub 2014 Apr 29.","Baglio F","Neurorehabil Neural Repair","2015","2014/05/03","","","10.1177/1545968314532833"
"32925060","Neuromodulation for Apathy in Alzheimer's Disease: A Double-Blind, Randomized, Sham-Controlled Pilot Study","Padala PR, Boozer EM, Lensing SY, Parkes CM, Hunter CR, Dennis RA, Caceda R, Padala KP.","J Alzheimers Dis. 2020;77(4):1483-1493. doi: 10.3233/JAD-200640.","Padala PR","J Alzheimers Dis","2020","2020/09/14","PMC7683089","","10.3233/JAD-200640"
"25537011","A phase II trial of tideglusib in Alzheimer's disease","Lovestone S, Boada M, Dubois B, Hüll M, Rinne JO, Huppertz HJ, Calero M, Andrés MV, Gómez-Carrillo B, León T, del Ser T; ARGO investigators.","J Alzheimers Dis. 2015;45(1):75-88. doi: 10.3233/JAD-141959.","Lovestone S","J Alzheimers Dis","2015","2014/12/25","","","10.3233/JAD-141959"
"28446028","Impact of Nutritional Supplementation and a Psychomotor Program on Patients With Alzheimer's Disease","Vicente de Sousa O, Soares Guerra R, Sousa AS, Pais Henriques B, Pereira Monteiro A, Amaral TF.","Am J Alzheimers Dis Other Demen. 2017 Sep;32(6):329-341. doi: 10.1177/1533317517705221. Epub 2017 Apr 26.","Vicente de Sousa O","Am J Alzheimers Dis Other Demen","2017","2017/04/28","","","10.1177/1533317517705221"
"7580197","Mania in Alzheimer's disease","Lyketsos CG, Corazzini K, Steele C.","J Neuropsychiatry Clin Neurosci. 1995 Summer;7(3):350-2. doi: 10.1176/jnp.7.3.350.","Lyketsos CG","J Neuropsychiatry Clin Neurosci","1995","1995/01/01","","","10.1176/jnp.7.3.350"
"2215842","Assessment of functional changes in Alzheimer's disease","Gauthier L, Gauthier S.","Neuroepidemiology. 1990;9(4):183-8. doi: 10.1159/000110771.","Gauthier L","Neuroepidemiology","1990","1990/01/01","","","10.1159/000110771"
"28571835","[Cataract surgery among 50 Alzheimer's patient (55 eyes)]","Girard B, Chouard B, Hardy F.","J Fr Ophtalmol. 2017 Jun;40(6):487-498. doi: 10.1016/j.jfo.2017.01.006. Epub 2017 May 29.","Girard B","J Fr Ophtalmol","2017","2017/06/03","","","10.1016/j.jfo.2017.01.006"
"25588408","The effectiveness of reality orientation in the treatment of Alzheimer's disease","Camargo CH, Justus FF, Retzlaff G.","Am J Alzheimers Dis Other Demen. 2015 Aug;30(5):527-32. doi: 10.1177/1533317514568004. Epub 2015 Jan 14.","Camargo CH","Am J Alzheimers Dis Other Demen","2015","2015/01/16","","","10.1177/1533317514568004"
"26402073","Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial","Di Stefano F, Epelbaum S, Coley N, Cantet C, Ousset PJ, Hampel H, Bakardjian H, Lista S, Vellas B, Dubois B, Andrieu S; GuidAge study group.","J Alzheimers Dis. 2015;48(3):793-804. doi: 10.3233/JAD-150013.","Di Stefano F","J Alzheimers Dis","2015","2015/09/25","","","10.3233/JAD-150013"
"23881834","Learning in Alzheimer's disease is facilitated by social interaction","Duff MC, Gallegos DR, Cohen NJ, Tranel D.","J Comp Neurol. 2013 Dec 15;521(18):4356-69. doi: 10.1002/cne.23433.","Duff MC","J Comp Neurol","2013","2013/07/25","PMC4038091","NIHMS578421","10.1002/cne.23433"
"29616706","The Integrated Alzheimer's Disease Rating Scale (iADRS) Findings from the EXPEDITION3 Trial","Wessels AM, Andersen SW, Dowsett SA, Siemers ER.","J Prev Alzheimers Dis. 2018;5(2):134-136. doi: 10.14283/jpad.2018.10.","Wessels AM","J Prev Alzheimers Dis","2018","2018/04/05","","","10.14283/jpad.2018.10"
"17712157","Impact of a multimodal rehabilitative intervention on demented patients and their caregivers","Onor ML, Trevisiol M, Negro C, Signorini A, Saina M, Aguglia E.","Am J Alzheimers Dis Other Demen. 2007 Aug-Sep;22(4):261-72. doi: 10.1177/1533317507302071.","Onor ML","Am J Alzheimers Dis Other Demen","2007","2007/08/23","","","10.1177/1533317507302071"
"8129637","Lack of difference in brain hyperintensities between patients with early Alzheimer's disease and control subjects","Erkinjuntti T, Gao F, Lee DH, Eliasziw M, Merskey H, Hachinski VC.","Arch Neurol. 1994 Mar;51(3):260-8. doi: 10.1001/archneur.1994.00540150054016.","Erkinjuntti T","Arch Neurol","1994","1994/03/01","","","10.1001/archneur.1994.00540150054016"
"16914835","Relationship of cognitive measures and gray and white matter in Alzheimer's disease","Baxter LC, Sparks DL, Johnson SC, Lenoski B, Lopez JE, Connor DJ, Sabbagh MN.","J Alzheimers Dis. 2006 Aug;9(3):253-60. doi: 10.3233/jad-2006-9304.","Baxter LC","J Alzheimers Dis","2006","2006/08/18","","","10.3233/jad-2006-9304"
"21915483","Attenuation of neuropsychiatric symptoms and caregiver burden in Alzheimer's disease by motor intervention: a controlled trial","Stella F, Canonici AP, Gobbi S, Galduroz RF, Cação Jde C, Gobbi LT.","Clinics (Sao Paulo). 2011;66(8):1353-60. doi: 10.1590/s1807-59322011000800008.","Stella F","Clinics (Sao Paulo)","2011","2011/09/15","PMC3161211","","10.1590/s1807-59322011000800008"
"35146847","Most families tend to realize progress of Alzheimer's disease when behavioural and psychological symptoms are obvious","Honjo Y, Ide K, Takechi H.","Psychogeriatrics. 2022 May;22(3):317-323. doi: 10.1111/psyg.12815. Epub 2022 Feb 10.","Honjo Y","Psychogeriatrics","2022","2022/02/11","","","10.1111/psyg.12815"
"28702899","Complex antioxidants in a randomized single-blinded study of memory in seniors","Summers WK, Martin RL, Liu Y, Peña B, Marsh GM.","Aging Clin Exp Res. 2018 Apr;30(4):395-405. doi: 10.1007/s40520-017-0788-6. Epub 2017 Jul 12.","Summers WK","Aging Clin Exp Res","2018","2017/07/14","","","10.1007/s40520-017-0788-6"
"26205305","Protecting cognition from aging and Alzheimer's disease: a computerized cognitive training combined with reminiscence therapy","Barban F, Annicchiarico R, Pantelopoulos S, Federici A, Perri R, Fadda L, Carlesimo GA, Ricci C, Giuli S, Scalici F, Turchetta CS, Adriano F, Lombardi MG, Zaccarelli C, Cirillo G, Passuti S, Mattarelli P, Lymperopoulou O, Sakka P, Ntanasi E, Moliner R, Garcia-Palacios A, Caltagirone C.","Int J Geriatr Psychiatry. 2016 Apr;31(4):340-8. doi: 10.1002/gps.4328. Epub 2015 Jul 23.","Barban F","Int J Geriatr Psychiatry","2016","2015/07/25","","","10.1002/gps.4328"
"16873967","Correlations of disability and biologic alterations in Alzheimer brain and test of significance by a therapeutic trial in humans","Blass JP, Gibson GE.","J Alzheimers Dis. 2006 Jul;9(2):207-18. doi: 10.3233/jad-2006-9212.","Blass JP","J Alzheimers Dis","2006","2006/07/29","","","10.3233/jad-2006-9212"
"22495338","Physical and cognitive stimulation in Alzheimer Disease. the GAIA Project: a pilot study","Maci T, Pira FL, Quattrocchi G, Nuovo SD, Perciavalle V, Zappia M.","Am J Alzheimers Dis Other Demen. 2012 Mar;27(2):107-13. doi: 10.1177/1533317512440493.","Maci T","Am J Alzheimers Dis Other Demen","2012","2012/04/13","","","10.1177/1533317512440493"
"25547632","Cognitive-motor intervention in Alzheimer's disease: long-term results from the Maria Wolff trial","Muñiz R, Serra CM, Reisberg B, Rojo JM, Del Ser T, Peña Casanova J, Olazarán J.","J Alzheimers Dis. 2015;45(1):295-304. doi: 10.3233/JAD-142364.","Muñiz R","J Alzheimers Dis","2015","2014/12/31","","","10.3233/JAD-142364"
"36189591","A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance","Blivet G, Relano-Gines A, Wachtel M, Touchon J.","J Alzheimers Dis. 2022;90(2):811-822. doi: 10.3233/JAD-220467.","Blivet G","J Alzheimers Dis","2022","2022/10/03","","","10.3233/JAD-220467"
"36278469","Machine-Based Learning Shifting to Prediction Model of Deteriorative MCI Due to Alzheimer's Disease - A Two-Year Follow-Up Investigation","Zhao X, Sui H, Yan C, Zhang M, Song H, Liu X, Yang J.","Curr Alzheimer Res. 2022;19(10):708-715. doi: 10.2174/1567205020666221019122049.","Zhao X","Curr Alzheimer Res","2022","2022/10/24","","","10.2174/1567205020666221019122049"
"33967047","Safety and Tolerability of GRF6019 Infusions in Severe Alzheimer's Disease: A Phase II Double-Blind Placebo-Controlled Trial","Hannestad J, Duclos T, Chao W, Koborsi K, Klutzaritz V, Beck B, Patel AK, Scott J, Thein SG, Cummings JL, Kay G, Braithwaite S, Nikolich K.","J Alzheimers Dis. 2021;81(4):1649-1662. doi: 10.3233/JAD-210011.","Hannestad J","J Alzheimers Dis","2021","2021/05/10","","","10.3233/JAD-210011"
"26238576","Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients","Siemers ER, Sundell KL, Carlson C, Case M, Sethuraman G, Liu-Seifert H, Dowsett SA, Pontecorvo MJ, Dean RA, Demattos R.","Alzheimers Dement. 2016 Feb;12(2):110-120. doi: 10.1016/j.jalz.2015.06.1893. Epub 2015 Aug 1.","Siemers ER","Alzheimers Dement","2016","2015/08/05","","","10.1016/j.jalz.2015.06.1893"
"12501480","Depression and Alzheimer's disease: symptom or comorbidity?","Moretti R, Torre P, Antonello RM, Cazzato G, Bava A.","Am J Alzheimers Dis Other Demen. 2002 Nov-Dec;17(6):338-44. doi: 10.1177/153331750201700607.","Moretti R","Am J Alzheimers Dis Other Demen","2002","2002/12/28","","","10.1177/153331750201700607"
"27567841","Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects","De Beaumont L, Pelleieux S, Lamarre-Théroux L, Dea D, Poirier J; Alzheimer’s Disease Cooperative Study.","J Alzheimers Dis. 2016 Oct 4;54(3):913-922. doi: 10.3233/JAD-160373.","De Beaumont L","J Alzheimers Dis","2016","2016/08/29","","","10.3233/JAD-160373"
"22737979","Alzheimer's disease multiple intervention trial (ADMIT): study protocol for a randomized controlled clinical trial","Callahan CM, Boustani MA, Schmid AA, Austrom MG, Miller DK, Gao S, Morris CS, Vogel M, Hendrie HC.","Trials. 2012 Jun 27;13:92. doi: 10.1186/1745-6215-13-92.","Callahan CM","Trials","2012","2012/06/29","PMC3518146","","10.1186/1745-6215-13-92"
"25516380","Clinical efficacy of lamotrigine and changes in the dosages of concomitantly used psychotropic drugs in Alzheimer's disease with behavioural and psychological symptoms of dementia: a preliminary open-label trial","Suzuki H, Gen K.","Psychogeriatrics. 2015 Mar;15(1):32-7. doi: 10.1111/psyg.12085. Epub 2014 Dec 17.","Suzuki H","Psychogeriatrics","2015","2014/12/18","","","10.1111/psyg.12085"
"32039840","Individual Differences in the Effects of Physical Activity on Cognitive Function in People with Mild to Moderate Dementia","Uijen IL, Aaronson JA, Karssemeijer EGA, Olde Rikkert MGM, Kessels RPC.","J Alzheimers Dis. 2020;74(2):435-439. doi: 10.3233/JAD-190606.","Uijen IL","J Alzheimers Dis","2020","2020/02/11","PMC7175929","","10.3233/JAD-190606"
"30569083","Pimavanserin in Alzheimer's Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms","Ballard C, Youakim JM, Coate B, Stankovic S.","J Prev Alzheimers Dis. 2019;6(1):27-33. doi: 10.14283/jpad.2018.30.","Ballard C","J Prev Alzheimers Dis","2019","2018/12/21","","","10.14283/jpad.2018.30"
"8638419","Discovering life quality in coping with dementia","Quayhagen MP, Quayhagen M.","West J Nurs Res. 1996 Apr;18(2):120-35. doi: 10.1177/019394599601800202.","Quayhagen MP","West J Nurs Res","1996","1996/04/01","","","10.1177/019394599601800202"
"31561360","Observation of Patient and Caregiver Burden Associated with Early Alzheimer's Disease in the United States: Design and Baseline Findings of the GERAS-US Cohort Study1","Robinson RL, Rentz DM, Bruemmer V, Scott Andrews J, Zagar A, Kim Y, Schwartz RL, Ye W, Fillit HM.","J Alzheimers Dis. 2019;72(1):279-292. doi: 10.3233/JAD-190430.","Robinson RL","J Alzheimers Dis","2019","2019/09/29","PMC6839598","","10.3233/JAD-190430"
"8780138","NSAIDs and cognition in Alzheimer's disease","Doraiswamy PM, Krishen A, Stallone F, Martin WL, Potts NL, Metz A, MRCPsych AM, DeVeaugh-Geiss J.","Neurology. 1996 Apr;46(4):1194. doi: 10.1212/wnl.46.4.1194.","Doraiswamy PM","Neurology","1996","1996/04/01","","","10.1212/wnl.46.4.1194"
"23178035","Amyloid positron emission tomography with (18)F-flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer's disease","Duara R, Loewenstein DA, Shen Q, Barker W, Potter E, Varon D, Heurlin K, Vandenberghe R, Buckley C.","Alzheimers Dement. 2013 May;9(3):295-301. doi: 10.1016/j.jalz.2012.01.006. Epub 2012 Nov 22.","Duara R","Alzheimers Dement","2013","2012/11/27","PMC5610964","NIHMS879171","10.1016/j.jalz.2012.01.006"
"23239554","Hemodynamic effects of cholinesterase inhibition in mild Alzheimer's disease","Chaudhary S, Scouten A, Schwindt G, Janik R, Lee W, Sled JG, Black SE, Stefanovic B.","J Magn Reson Imaging. 2013 Jul;38(1):26-35. doi: 10.1002/jmri.23967. Epub 2012 Dec 13.","Chaudhary S","J Magn Reson Imaging","2013","2012/12/15","","","10.1002/jmri.23967"
"24270207","Hyperphosphorylated tau is elevated in Alzheimer's disease with psychosis","Murray PS, Kirkwood CM, Gray MC, Fish KN, Ikonomovic MD, Hamilton RL, Kofler JK, Klunk WE, Lopez OL, Sweet RA.","J Alzheimers Dis. 2014;39(4):759-73. doi: 10.3233/JAD-131166.","Murray PS","J Alzheimers Dis","2014","2013/11/26","PMC4034758","NIHMS568716","10.3233/JAD-131166"
"29843238","Oxidative Stress in Elderly with Different Cognitive Status: My Mind Project","Fattoretti P, Malavolta M, Fabbietti P, Papa R, Giacconi R, Costarelli L, Galeazzi R, Paoloni C, Postacchini D, Lattanzio F, Giuli C.","J Alzheimers Dis. 2018;63(4):1405-1414. doi: 10.3233/JAD-171117.","Fattoretti P","J Alzheimers Dis","2018","2018/05/31","","","10.3233/JAD-171117"
"22976072","Silicon-rich mineral water as a non-invasive test of the 'aluminum hypothesis' in Alzheimer's disease","Davenward S, Bentham P, Wright J, Crome P, Job D, Polwart A, Exley C.","J Alzheimers Dis. 2013;33(2):423-30. doi: 10.3233/JAD-2012-121231.","Davenward S","J Alzheimers Dis","2013","2012/09/15","","","10.3233/JAD-2012-121231"
"28130589","Social network and cognitive functioning in old age : Self-efficacy as a mediator?","Fankhauser S, Maercker A, Forstmeier S.","Z Gerontol Geriatr. 2017 Feb;50(2):123-131. doi: 10.1007/s00391-016-1178-y. Epub 2017 Jan 27.","Fankhauser S","Z Gerontol Geriatr","2017","2017/01/29","","","10.1007/s00391-016-1178-y"
"32568198","Design and Rationale of the PACt-MD Randomized Clinical Trial: Prevention of Alzheimer's dementia with Cognitive remediation plus transcranial direct current stimulation in Mild cognitive impairment and Depression","Rajji TK, Bowie CR, Herrmann N, Pollock BG, Bikson M, Blumberger DM, Butters MA, Daskalakis ZJ, Fischer CE, Flint AJ, Golas AC, Graff-Guerrero A, Kumar S, Lourenco L, Mah L, Ovaysikia S, Thorpe KE, Voineskos AN, Mulsant BH; PACt-MD Study Group.","J Alzheimers Dis. 2020;76(2):733-751. doi: 10.3233/JAD-200141.","Rajji TK","J Alzheimers Dis","2020","2020/06/23","","","10.3233/JAD-200141"
"33935080","Interventional Study to Evaluate the Clinical Effects and Safety of the Nutraceutical Compound BrainUp-10® in a Cohort of Patients with Alzheimer's Disease: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial","Guzman-Martinez L, Farías GA, Tapia JP, Sánchez MP, Fuentes P, Gloger S, Maccioni RB.","J Alzheimers Dis. 2021;81(3):1231-1241. doi: 10.3233/JAD-201501.","Guzman-Martinez L","J Alzheimers Dis","2021","2021/05/03","","","10.3233/JAD-201501"
"9041856","Response of the pupil to tropicamide is not a reliable test for Alzheimer disease","FitzSimon JS, Waring SC, Kokmen E, McLaren JW, Brubaker RF.","Arch Neurol. 1997 Feb;54(2):155-9. doi: 10.1001/archneur.1997.00550140031009.","FitzSimon JS","Arch Neurol","1997","1997/02/01","","","10.1001/archneur.1997.00550140031009"
"33216026","Stressor-Oriented MUlticomponent Intervention and the WeLl-Being of Patients with Alzheimer's Disease: A Randomized Controlled Trial (SOUL-P)","Yang B, Yang S, Zhang Y, Liu W, Gan Y, Li Y, Jiang D, Luo Y, Zhao Q.","J Alzheimers Dis. 2021;79(1):141-152. doi: 10.3233/JAD-200652.","Yang B","J Alzheimers Dis","2021","2020/11/20","","","10.3233/JAD-200652"
"9236947","A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study","Ferris SH, Mackell JA, Mohs R, Schneider LS, Galasko D, Whitehouse PJ, Schmitt FA, Sano M, Thomas RG, Ernesto C, Grundman M, Schafer K, Thal LJ.","Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S1-12.","Ferris SH","Alzheimer Dis Assoc Disord","1997","1997/01/01","","",""
"7723928","Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease","Pettegrew JW, Klunk WE, Panchalingam K, Kanfer JN, McClure RJ.","Neurobiol Aging. 1995 Jan-Feb;16(1):1-4. doi: 10.1016/0197-4580(95)80001-8.","Pettegrew JW","Neurobiol Aging","1995","1995/01/01","","","10.1016/0197-4580(95)80001-8"
"10204751","Pain threshold and tolerance in Alzheimer's disease","Benedetti F, Vighetti S, Ricco C, Lagna E, Bergamasco B, Pinessi L, Rainero I.","Pain. 1999 Mar;80(1-2):377-82. doi: 10.1016/s0304-3959(98)00228-0.","Benedetti F","Pain","1999","1999/04/16","","","10.1016/s0304-3959(98)00228-0"
"20395684","Cognition and function in Alzheimer's disease: identifying the transitions from moderate to severe disease","Schwam E, Xu Y.","Dement Geriatr Cogn Disord. 2010;29(4):309-16. doi: 10.1159/000269837. Epub 2010 Apr 16.","Schwam E","Dement Geriatr Cogn Disord","2010","2010/04/17","","","10.1159/000269837"
"29972208","Commentary: Fatty acids and Alzheimer's disease: evidence on cognition and cortical β-amyloid from secondary analyses of the Multidomain Alzheimer Preventive Trial","Hooper C, Vellas B.","J Prev Alzheimers Dis. 2018;5(3):168-170. doi: 10.14283/jpad.2018.7.","Hooper C","J Prev Alzheimers Dis","2018","2018/07/05","","","10.14283/jpad.2018.7"
"16306249","Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study","Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Green RC; REVEAL (Risk Evaluation and Education for Alzheimer's Disease) Study Group.","J Geriatr Psychiatry Neurol. 2005 Dec;18(4):250-5. doi: 10.1177/0891988705281883.","Roberts JS","J Geriatr Psychiatry Neurol","2005","2005/11/25","","","10.1177/0891988705281883"
"21750046","Maintaining physical fitness and function in Alzheimer's disease: a pilot study","Yu F, Savik K, Wyman JF, Bronas UG.","Am J Alzheimers Dis Other Demen. 2011 Aug;26(5):406-12. doi: 10.1177/1533317511414861. Epub 2011 Jul 12.","Yu F","Am J Alzheimers Dis Other Demen","2011","2011/07/14","PMC5679098","NIHMS916973","10.1177/1533317511414861"
"11129744","A double-blind, placebo-controlled, multicenter study of Cerebrolysin for Alzheimer's disease","Bae CY, Cho CY, Cho K, Hoon Oh B, Choi KG, Lee HS, Jung SP, Kim DH, Lee S, Choi GD, Cho H, Lee H.","J Am Geriatr Soc. 2000 Dec;48(12):1566-71. doi: 10.1111/j.1532-5415.2000.tb03865.x.","Bae CY","J Am Geriatr Soc","2000","2000/12/29","","","10.1111/j.1532-5415.2000.tb03865.x"
"24898637","Motor effects of radio electric asymmetric conveyer in Alzheimer's disease: results from a cross-over trial","Olazarán J, González B, Osa-Ruiz E, Felipe-Ruiz S, Boyano I, Fontani V, Castagna A, Mendoza C, Zea MA, Frades B, Rinaldi S, Martínez-Martín P.","J Alzheimers Dis. 2014;42(1):325-32. doi: 10.3233/JAD-140417.","Olazarán J","J Alzheimers Dis","2014","2014/06/06","","","10.3233/JAD-140417"
"20353108","[Influence of acupuncture on isoprostane in patients with Alzheimer's disease]","Zhu H, Dong KL, Wu Y, Zhang T, Li RM, Dai SS, Wang HL.","Zhongguo Zhen Jiu. 2010 Jan;30(1):18-21.","Zhu H","Zhongguo Zhen Jiu","2010","2010/04/01","","",""
"16337870","The effect of Alzheimer's disease and aging on conceptual combination","Taler V, Chertkow H, Saumier D.","Brain Cogn. 2005 Dec;59(3):306-9. doi: 10.1016/j.bandc.2004.08.049.","Taler V","Brain Cogn","2005","2005/12/13","","","10.1016/j.bandc.2004.08.049"
"7870929","Age and sex differences of dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels in normal controls and Alzheimer's disease (AD)","Leblhuber F, Neubauer C, Peichl M, Reisecker F, Steinparz FX, Windhager E, Dienstl E.","Psychopharmacology (Berl). 1993;111(1):23-6. doi: 10.1007/BF02257402.","Leblhuber F","Psychopharmacology (Berl)","1993","1993/01/01","","","10.1007/BF02257402"
"8128836","Physostigmine and tetrahydroaminoacridine treatment of Alzheimer's disease","Gustafson L.","Acta Neurol Scand Suppl. 1993;149(Rand):39-41. doi: 10.1111/j.1600-0404.1993.tb04253.x.","Gustafson L","Acta Neurol Scand Suppl","1993","1993/01/01","","","10.1111/j.1600-0404.1993.tb04253.x"
"3080909","Thyrotropin-releasing hormone (TRH) and Alzheimer's disease","Peabody CA, Deblois TE, Tinklenberg JR.","Am J Psychiatry. 1986 Feb;143(2):262-3. doi: 10.1176/ajp.143.2.262b.","Peabody CA","Am J Psychiatry","1986","1986/02/01","","","10.1176/ajp.143.2.262b"
"32375872","The cholinergic system in subtypes of Alzheimer's disease: an in vivo longitudinal MRI study","Machado A, Ferreira D, Grothe MJ, Eyjolfsdottir H, Almqvist PM, Cavallin L, Lind G, Linderoth B, Seiger Å, Teipel S, Wahlberg LU, Wahlund LO, Westman E, Eriksdotter M; Alzheimer’s Disease Neuroimaging Initiative.","Alzheimers Res Ther. 2020 May 6;12(1):51. doi: 10.1186/s13195-020-00620-7.","Machado A","Alzheimers Res Ther","2020","2020/05/08","PMC7203806","","10.1186/s13195-020-00620-7"
"27662321","Alzheimer's Disease Severity is Not Significantly Associated with Short Sleep: Survey by Actigraphy on 208 Mild and Moderate Alzheimer's Disease Patients","Leger D, Elbaz M, Dubois A, Rio S, Mezghiche H, Carita P, Stemmelin J, Strauss M.","J Alzheimers Dis. 2017;55(1):321-331. doi: 10.3233/JAD-160754.","Leger D","J Alzheimers Dis","2017","2016/09/24","","","10.3233/JAD-160754"
"7594160","The neuropsychological differentiation of patients with very mild Alzheimer's disease and/or major depression","desRosiers G, Hodges JR, Berrios G.","J Am Geriatr Soc. 1995 Nov;43(11):1256-63. doi: 10.1111/j.1532-5415.1995.tb07402.x.","desRosiers G","J Am Geriatr Soc","1995","1995/11/01","","","10.1111/j.1532-5415.1995.tb07402.x"
"32804144","Exploration of Plasma Lipids in Mild Cognitive Impairment due to Alzheimer's Disease","Bergland AK, Proitsi P, Kirsebom BE, Soennesyn H, Hye A, Larsen AI, Xu J, Legido-Quigley C, Rajendran L, Fladby T, Aarsland D.","J Alzheimers Dis. 2020;77(3):1117-1127. doi: 10.3233/JAD-200441.","Bergland AK","J Alzheimers Dis","2020","2020/08/18","","","10.3233/JAD-200441"
"24938502","Rivastigmine transdermal patch and physical exercises for Alzheimer's disease: a randomized clinical trial","Aguiar P, Monteiro L, Feres A, Gomes I, Melo A.","Curr Alzheimer Res. 2014;11(6):532-7. doi: 10.2174/1567205011666140618102224.","Aguiar P","Curr Alzheimer Res","2014","2014/06/19","","","10.2174/1567205011666140618102224"
"23972540","Slowing progression of early stages of AD with alternative therapies: a feasibility study","Lu DF, Hart LK, Lutgendorf SK, Oh H, Schilling M.","Geriatr Nurs. 2013 Nov-Dec;34(6):457-64. doi: 10.1016/j.gerinurse.2013.07.003. Epub 2013 Aug 22.","Lu DF","Geriatr Nurs","2013","2013/08/27","","","10.1016/j.gerinurse.2013.07.003"
"30248052","Association between Neuropsychiatric Improvement and Neurocognitive Change in Alzheimer's Disease: Analysis of the CATIE-AD Study","Nagata T, Shinagawa S, Nakajima S, Mimura M, Shigeta M.","J Alzheimers Dis. 2018;66(1):139-148. doi: 10.3233/JAD-180304.","Nagata T","J Alzheimers Dis","2018","2018/09/25","","","10.3233/JAD-180304"
"32065800","18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease","Okafor M, Nye JA, Shokouhi M, Shaw LM, Goldstein F, Hajjar I.","J Alzheimers Dis. 2020;74(2):589-601. doi: 10.3233/JAD-191330.","Okafor M","J Alzheimers Dis","2020","2020/02/18","","","10.3233/JAD-191330"
"31686093","Randomized, Placebo Controlled Trial of NPT088, A Phage-Derived, Amyloid-Targeted Treatment for Alzheimer's Disease","Michelson D, Grundman M, Magnuson K, Fisher R, Levenson JM, Aisen P, Marek K, Gray M, Hefti F.","J Prev Alzheimers Dis. 2019;6(4):228-231. doi: 10.14283/jpad.2019.37.","Michelson D","J Prev Alzheimers Dis","2019","2019/11/06","","","10.14283/jpad.2019.37"
"1984813","Effect of tetrahydroaminoacridine on cognition, function and behaviour in Alzheimer's disease","Molloy DW, Guyatt GH, Wilson DB, Duke R, Rees L, Singer J.","CMAJ. 1991 Jan 1;144(1):29-34.","Molloy DW","CMAJ","1991","1991/01/01","PMC1452525","",""
"23687181","Video prompting versus other instruction strategies for persons with Alzheimer's disease","Perilli V, Lancioni GE, Hoogeveen F, Caffó A, Singh N, O'Reilly M, Sigafoos J, Cassano G, Oliva D.","Am J Alzheimers Dis Other Demen. 2013 Jun;28(4):393-402. doi: 10.1177/1533317513488913. Epub 2013 May 17.","Perilli V","Am J Alzheimers Dis Other Demen","2013","2013/05/21","","","10.1177/1533317513488913"
"31403948","A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer's Disease: Cognitive Enhancement and Associated Changes in Cerebrospinal Fluid, Blood, and Brain Imaging","Arendash G, Cao C, Abulaban H, Baranowski R, Wisniewski G, Becerra L, Andel R, Lin X, Zhang X, Wittwer D, Moulton J, Arrington J, Smith A.","J Alzheimers Dis. 2019;71(1):57-82. doi: 10.3233/JAD-190367.","Arendash G","J Alzheimers Dis","2019","2019/08/13","PMC6839500","","10.3233/JAD-190367"
"36946448","Longitudinal Exposure-Response Modeling of Multiple Indicators of Alzheimer's Disease Progression","Polhamus DG, Dolton MJ, Rogers JA, Honigberg L, Jin JY, Quartino A.","J Prev Alzheimers Dis. 2023;10(2):212-222. doi: 10.14283/jpad.2023.13.","Polhamus DG","J Prev Alzheimers Dis","2023","2023/03/22","","","10.14283/jpad.2023.13"
"26688817","Deep Assessment: A Novel Framework for Improving the Care of People with Very Advanced Alzheimer's Disease","Lyons G, Arthur-Kelly M, Eidels A, Mavratzakis A.","Biomed Res Int. 2015;2015:749451. doi: 10.1155/2015/749451. Epub 2015 Nov 24.","Lyons G","Biomed Res Int","2015","2015/12/22","PMC4672100","","10.1155/2015/749451"
"16042036","Alzheimer's disease and depression: preclinical comorbidity effects on cognitive functioning","Berger AK, Fratiglioni L, Winblad B, Bäckman L.","Cortex. 2005 Aug;41(4):603-12. doi: 10.1016/s0010-9452(08)70200-4.","Berger AK","Cortex","2005","2005/07/27","","","10.1016/s0010-9452(08)70200-4"
"1776746","Essential fatty acids in Alzheimer's disease","Corrigan FM, Van Rhijn A, Horrobin DF.","Ann N Y Acad Sci. 1991;640:250-2. doi: 10.1111/j.1749-6632.1991.tb00228.x.","Corrigan FM","Ann N Y Acad Sci","1991","1991/01/01","","","10.1111/j.1749-6632.1991.tb00228.x"
"22984089","From Alzheimer's disease retrogenesis: a new care strategy for patients with advanced dementia","Venturelli M, Magalini A, Scarsini R, Schena F.","Am J Alzheimers Dis Other Demen. 2012 Nov;27(7):483-9. doi: 10.1177/1533317512459794. Epub 2012 Sep 13.","Venturelli M","Am J Alzheimers Dis Other Demen","2012","2012/09/18","","","10.1177/1533317512459794"
"9309486","Alzheimer's Disease Assessment Scale: reliability and validity in a multicenter clinical trial","Weyer G, Erzigkeit H, Kanowski S, Ihl R, Hadler D.","Int Psychogeriatr. 1997 Jun;9(2):123-38. doi: 10.1017/s1041610297004298.","Weyer G","Int Psychogeriatr","1997","1997/06/01","","","10.1017/s1041610297004298"
"21774999","Balance, executive functions and falls in elderly with Alzheimer's disease (AD): a longitudinal study","Pedroso RV, Coelho FG, Santos-Galduróz RF, Costa JL, Gobbi S, Stella F.","Arch Gerontol Geriatr. 2012 Mar-Apr;54(2):348-51. doi: 10.1016/j.archger.2011.05.029. Epub 2011 Jul 20.","Pedroso RV","Arch Gerontol Geriatr","2012","2011/07/22","","","10.1016/j.archger.2011.05.029"
"27983552","Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease","Sabbagh MN, Schäuble B, Anand K, Richards D, Murayama S, Akatsu H, Takao M, Rowe CC, Masters CL, Barthel H, Gertz HJ, Peters O, Rasgon N, Jovalekic A, Sabri O, Schulz-Schaeffer WJ, Seibyl J.","J Alzheimers Dis. 2017;56(2):441-446. doi: 10.3233/JAD-160821.","Sabbagh MN","J Alzheimers Dis","2017","2016/12/17","","","10.3233/JAD-160821"
"10588430","Haloperidol an Alzheimer's disease","Frisoni GB, Bianchetti A, Pignatti F, Gozzetti A, Trabucchi M.","Am J Psychiatry. 1999 Dec;156(12):2019-20. doi: 10.1176/ajp.156.12.2019.","Frisoni GB","Am J Psychiatry","1999","1999/12/10","","","10.1176/ajp.156.12.2019"
"6682203","Amitriptyline in Alzheimer's disease","Reding MJ, Young R, DiPonte P.","Neurology. 1983 Apr;33(4):522-3. doi: 10.1212/wnl.33.4.522.","Reding MJ","Neurology","1983","1983/04/01","","","10.1212/wnl.33.4.522"
"23234880","Blood transcriptomic biomarkers of Alzheimer's disease patients treated with EHT 0202","Désiré L, Blondiaux E, Carrière J, Haddad R, Sol O, Fehlbaum-Beurdeley P, Einstein R, Zhou W, Pando MP.","J Alzheimers Dis. 2013;34(2):469-83. doi: 10.3233/JAD-121501.","Désiré L","J Alzheimers Dis","2013","2012/12/14","","","10.3233/JAD-121501"
"35260178","Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer's disease with an implantable ultrasound device","Epelbaum S, Burgos N, Canney M, Matthews D, Houot M, Santin MD, Desseaux C, Bouchoux G, Stroer S, Martin C, Habert MO, Levy M, Bah A, Martin K, Delatour B, Riche M, Dubois B, Belin L, Carpentier A.","Alzheimers Res Ther. 2022 Mar 8;14(1):40. doi: 10.1186/s13195-022-00981-1.","Epelbaum S","Alzheimers Res Ther","2022","2022/03/09","PMC8905724","","10.1186/s13195-022-00981-1"
"27176461","Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials","Vandenberghe R, Rinne JO, Boada M, Katayama S, Scheltens P, Vellas B, Tuchman M, Gass A, Fiebach JB, Hill D, Lobello K, Li D, McRae T, Lucas P, Evans I, Booth K, Luscan G, Wyman BT, Hua L, Yang L, Brashear HR, Black RS; Bapineuzumab 3000 and 3001 Clinical Study Investigators.","Alzheimers Res Ther. 2016 May 12;8(1):18. doi: 10.1186/s13195-016-0189-7.","Vandenberghe R","Alzheimers Res Ther","2016","2016/05/14","PMC4866415","","10.1186/s13195-016-0189-7"
"24717737","Latino Alzheimer's disease caregivers and depression: using the stress coping model to examine the effects of spirituality and religion","Sun F, Hodge DR.","J Appl Gerontol. 2014 Apr;33(3):291-315. doi: 10.1177/0733464812444462. Epub 2012 May 15.","Sun F","J Appl Gerontol","2014","2014/04/11","","","10.1177/0733464812444462"
"31884472","An Exploratory Phase IIa Study of the PPAR delta/gamma Agonist T3D-959 Assessing Metabolic and Cognitive Function in Subjects with Mild to Moderate Alzheimer's Disease","Chamberlain S, Gabriel H, Strittmatter W, Didsbury J.","J Alzheimers Dis. 2020;73(3):1085-1103. doi: 10.3233/JAD-190864.","Chamberlain S","J Alzheimers Dis","2020","2019/12/30","PMC7081093","","10.3233/JAD-190864"
"34585216","The Cost-Effectiveness of Three Prevention Strategies in Alzheimer's Disease: Results from the Multidomain Alzheimer Preventive Trial (MAPT)","Costa N, Mounié M, Pagès A, Derumeaux H, Rapp T, Guyonnet S, Coley N, Cantet C, Carrié I, Andrieu S, Molinier L.","J Prev Alzheimers Dis. 2021;8(4):425-435. doi: 10.14283/jpad.2021.47.","Costa N","J Prev Alzheimers Dis","2021","2021/09/29","","","10.14283/jpad.2021.47"
"9260731","Treatment of Alzheimer's disease with sabeluzole: functional and structural correlates","Mohr E, Nair NP, Sampson M, Murtha S, Belanger G, Pappas B, Mendis T.","Clin Neuropharmacol. 1997 Aug;20(4):338-45. doi: 10.1097/00002826-199708000-00005.","Mohr E","Clin Neuropharmacol","1997","1997/08/01","","","10.1097/00002826-199708000-00005"
"1572123","SPECT brain imaging in Alzheimer's disease during treatment with oral tetrahydroaminoacridine and lecithin","Cohen MB, Fitten LJ, Lake RR, Perryman KM, Graham LS, Sevrin R.","Clin Nucl Med. 1992 Apr;17(4):312-5. doi: 10.1097/00003072-199204000-00012.","Cohen MB","Clin Nucl Med","1992","1992/04/01","","","10.1097/00003072-199204000-00012"
"29181489","The Alzheimer's Prevention Initiative Generation Program: Evaluating CNP520 Efficacy in the Prevention of Alzheimer's Disease","Lopez Lopez C, Caputo A, Liu F, Riviere ME, Rouzade-Dominguez ML, Thomas RG, Langbaum JB, Lenz R, Reiman EM, Graf A, Tariot PN.","J Prev Alzheimers Dis. 2017;4(4):242-246. doi: 10.14283/jpad.2017.37.","Lopez Lopez C","J Prev Alzheimers Dis","2017","2017/11/29","","","10.14283/jpad.2017.37"
"36373323","A Pilot Study of Near-Infrared Light Treatment for Alzheimer's Disease","Chen L, Xue J, Zhao Q, Liang X, Zheng L, Fan Z, Souare ISJ, Suo Y, Wei X, Ding D, Mao Y.","J Alzheimers Dis. 2023;91(1):191-201. doi: 10.3233/JAD-220866.","Chen L","J Alzheimers Dis","2023","2022/11/14","","","10.3233/JAD-220866"
"32310169","A Placebo-Controlled, Parallel-Group, Randomized Clinical Trial of AC-1204 in Mild-to-Moderate Alzheimer's Disease","Henderson ST, Morimoto BH, Cummings JL, Farlow MR, Walker J.","J Alzheimers Dis. 2020;75(2):547-557. doi: 10.3233/JAD-191302.","Henderson ST","J Alzheimers Dis","2020","2020/04/21","","","10.3233/JAD-191302"
"11513014","Providing education about Alzheimer's disease","Sullivan K, O'Conor F.","Aging Ment Health. 2001 Feb;5(1):5-13. doi: 10.1080/13607860020020582.","Sullivan K","Aging Ment Health","2001","2001/08/22","","","10.1080/13607860020020582"
"35542997","A Polymorphism Cluster at the 2q12 locus May Predict Response to Piromelatine in Patients with Mild Alzheimer's Disease","Schneider LS, Laudon M, Nir T, Caceres J, Ianniciello G, Capulli M, Zisapel N.","J Prev Alzheimers Dis. 2022;9(2):247-254. doi: 10.14283/jpad.2021.61.","Schneider LS","J Prev Alzheimers Dis","2022","2022/05/11","","","10.14283/jpad.2021.61"
"31930518","Effects of the cognitive stimulation therapy based on Roy's adaptation model on Alzheimer's patients' cognitive functions, coping-adaptation skills, and quality of life: A randomized controlled trial","Lok N, Buldukoglu K, Barcin E.","Perspect Psychiatr Care. 2020 Jul;56(3):581-592. doi: 10.1111/ppc.12472. Epub 2020 Jan 12.","Lok N","Perspect Psychiatr Care","2020","2020/01/14","","","10.1111/ppc.12472"
"28222525","Effect of a Comprehensive Intervention on Plasma BDNF in Patients with Alzheimer's Disease","Balietti M, Giuli C, Fattoretti P, Fabbietti P, Papa R, Postacchini D, Conti F.","J Alzheimers Dis. 2017;57(1):37-43. doi: 10.3233/JAD-161168.","Balietti M","J Alzheimers Dis","2017","2017/02/23","PMC5345639","","10.3233/JAD-161168"
"30301358","Effects of Hand Exercise on Eating Action in Patients With Alzheimer's Disease","Chen LL, Li H, Chen XH, Jin S, Chen QH, Chen MR, Li N.","Am J Alzheimers Dis Other Demen. 2019 Feb;34(1):57-62. doi: 10.1177/1533317518803722. Epub 2018 Oct 9.","Chen LL","Am J Alzheimers Dis Other Demen","2019","2018/10/11","","","10.1177/1533317518803722"
"17897706","Metaphor comprehension in Alzheimer's disease: novelty matters","Amanzio M, Geminiani G, Leotta D, Cappa S.","Brain Lang. 2008 Oct;107(1):1-10. doi: 10.1016/j.bandl.2007.08.003. Epub 2007 Sep 25.","Amanzio M","Brain Lang","2008","2007/09/28","","","10.1016/j.bandl.2007.08.003"
"32925066","Can Alzheimer's Disease Be Prevented? First Evidence from Spinal Stimulation Efficacy on Executive Functions","Pisano F, Caltagirone C, Satriano F, Perri R, Fadda L, Marangolo P.","J Alzheimers Dis. 2020;77(4):1755-1764. doi: 10.3233/JAD-200695.","Pisano F","J Alzheimers Dis","2020","2020/09/14","","","10.3233/JAD-200695"
"7798973","White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: morphological and regional cerebral blood flow correlates","Waldemar G, Christiansen P, Larsson HB, Høgh P, Laursen H, Lassen NA, Paulson OB.","J Neurol Neurosurg Psychiatry. 1994 Dec;57(12):1458-65. doi: 10.1136/jnnp.57.12.1458.","Waldemar G","J Neurol Neurosurg Psychiatry","1994","1994/12/01","PMC1073224","","10.1136/jnnp.57.12.1458"
"32508323","Volume Analysis of Brain Cognitive Areas in Alzheimer's Disease: Interim 3-Year Results from the ASCOMALVA Trial","Traini E, Carotenuto A, Fasanaro AM, Amenta F.","J Alzheimers Dis. 2020;76(1):317-329. doi: 10.3233/JAD-190623.","Traini E","J Alzheimers Dis","2020","2020/06/09","PMC7369051","","10.3233/JAD-190623"
"3812449","Prevalence of Alzheimer's disease in a retirement community","Pfeffer RI, Afifi AA, Chance JM.","Am J Epidemiol. 1987 Mar;125(3):420-36. doi: 10.1093/oxfordjournals.aje.a114548.","Pfeffer RI","Am J Epidemiol","1987","1987/03/01","","","10.1093/oxfordjournals.aje.a114548"
"8997549","Intracerebroventricular administration of GM1 ganglioside to presenile Alzheimer patients","Augustinsson LE, Blennow K, Blomstrand C, Bråne G, Ekman R, Fredman P, Karlsson I, Kihlgren M, Lehmann W, Lekman A, Månsson JE, Ramström I, Wallin A, Wikkelsö C, Gottfries CG, Svennerholm L.","Dement Geriatr Cogn Disord. 1997 Jan-Feb;8(1):26-33. doi: 10.1159/000106597.","Augustinsson LE","Dement Geriatr Cogn Disord","1997","1997/01/01","","","10.1159/000106597"
"22886016","C145 as a short-latency electrophysiological index of cognitive compensation in Alzheimer's disease","Chapman RM, Porsteinsson AP, Gardner MN, Mapstone M, McCrary JW, Sandoval TC, Guillily MD, DeGrush E, Reilly LA.","J Alzheimers Dis. 2013;33(1):55-68. doi: 10.3233/JAD-2012-120646.","Chapman RM","J Alzheimers Dis","2013","2012/08/14","PMC3576817","NIHMS409260","10.3233/JAD-2012-120646"
"35839637","Parietal-hippocampal rTMS improves cognitive function in Alzheimer's disease and increases dynamic functional connectivity of default mode network","Wei L, Zhang Y, Wang J, Xu L, Yang K, Lv X, Zhu Z, Gong Q, Hu W, Li X, Qian M, Shen Y, Chen W.","Psychiatry Res. 2022 Sep;315:114721. doi: 10.1016/j.psychres.2022.114721. Epub 2022 Jul 8.","Wei L","Psychiatry Res","2022","2022/07/15","","","10.1016/j.psychres.2022.114721"
"20925948","Exercise rehabilitation on home-dwelling patients with Alzheimer's disease--a randomized, controlled trial. Study protocol","Pitkala KH, Raivio MM, Laakkonen ML, Tilvis RS, Kautiainen H, Strandberg TE.","Trials. 2010 Oct 6;11:92. doi: 10.1186/1745-6215-11-92.","Pitkala KH","Trials","2010","2010/10/08","PMC2978202","","10.1186/1745-6215-11-92"
"16055825","Brief psychotherapy in Alzheimer's disease: randomised controlled trial","Burns A, Guthrie E, Marino-Francis F, Busby C, Morris J, Russell E, Margison F, Lennon S, Byrne J.","Br J Psychiatry. 2005 Aug;187:143-7. doi: 10.1192/bjp.187.2.143.","Burns A","Br J Psychiatry","2005","2005/08/02","","","10.1192/bjp.187.2.143"
"24520910","German adaptation of the Resources for Enhancing Alzheimer's Caregiver Health II: study protocol of a single-centred, randomised controlled trial","Heinrich S, Berwig M, Simon A, Jänichen J, Hallensleben N, Nickel W, Hinz A, Brähler E, Gertz HJ.","BMC Geriatr. 2014 Feb 12;14:21. doi: 10.1186/1471-2318-14-21.","Heinrich S","BMC Geriatr","2014","2014/02/14","PMC3925255","","10.1186/1471-2318-14-21"
"26822146","Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease","Cummings JL, Zhong K, Kinney JW, Heaney C, Moll-Tudla J, Joshi A, Pontecorvo M, Devous M, Tang A, Bena J.","Alzheimers Res Ther. 2016 Jan 29;8:4. doi: 10.1186/s13195-016-0173-2.","Cummings JL","Alzheimers Res Ther","2016","2016/01/30","PMC4731943","","10.1186/s13195-016-0173-2"
"10026387","Behavioral syndromes in Alzheimer's disease: description and correlates","Frisoni GB, Rozzini L, Gozzetti A, Binetti G, Zanetti O, Bianchetti A, Trabucchi M, Cummings JL.","Dement Geriatr Cogn Disord. 1999 Mar-Apr;10(2):130-8. doi: 10.1159/000017113.","Frisoni GB","Dement Geriatr Cogn Disord","1999","1999/02/23","","","10.1159/000017113"
"19106276","Persons with mild or moderate Alzheimer's disease managing daily activities via verbal instruction technology","Lancioni GE, La Martire ML, Singh NN, O'Reilly MF, Sigafoos J, Pinto K, Minervini MG.","Am J Alzheimers Dis Other Demen. 2008 Dec-2009 Jan;23(6):552-62. doi: 10.1177/1533317508328181.","Lancioni GE","Am J Alzheimers Dis Other Demen","2008","2008/12/25","","","10.1177/1533317508328181"
"23645097","Screening by telephone in the Alzheimer's disease anti-inflammatory prevention trial","Reckess GZ, Brandt J, Luis CA, Zandi P, Martin B, Breitner JC; ADAPT Research Group.","J Alzheimers Dis. 2013;36(3):433-43. doi: 10.3233/JAD-130113.","Reckess GZ","J Alzheimers Dis","2013","2013/05/07","PMC3913728","NIHMS550225","10.3233/JAD-130113"
"31353860","Early alteration of the locus coeruleus in phenotypic variants of Alzheimer's disease","Olivieri P, Lagarde J, Lehericy S, Valabrègue R, Michel A, Macé P, Caillé F, Gervais P, Bottlaender M, Sarazin M.","Ann Clin Transl Neurol. 2019 Jul;6(7):1345-1351. doi: 10.1002/acn3.50818. Epub 2019 Jun 23.","Olivieri P","Ann Clin Transl Neurol","2019","2019/07/30","PMC6649639","","10.1002/acn3.50818"
"29370871","Data-driven identification of endophenotypes of Alzheimer's disease progression: implications for clinical trials and therapeutic interventions","Geifman N, Kennedy RE, Schneider LS, Buchan I, Brinton RD.","Alzheimers Res Ther. 2018 Jan 15;10(1):4. doi: 10.1186/s13195-017-0332-0.","Geifman N","Alzheimers Res Ther","2018","2018/01/27","PMC6389228","","10.1186/s13195-017-0332-0"
"19433891","White matter microstructure in relation to education in aging and Alzheimer's disease","Teipel SJ, Meindl T, Wagner M, Kohl T, Bürger K, Reiser MF, Herpertz S, Möller HJ, Hampel H.","J Alzheimers Dis. 2009;17(3):571-83. doi: 10.3233/JAD-2009-1077.","Teipel SJ","J Alzheimers Dis","2009","2009/05/13","","","10.3233/JAD-2009-1077"
"9562266","Cerebrospinal fluid carnitine levels in patients with Alzheimer's disease","Rubio JC, de Bustos F, Molina JA, Jiménez-Jiménez FJ, Benito-León J, Martín MA, Campos Y, Ortí-Pareja M, Cabrera-Valdivia F, Arenas J.","J Neurol Sci. 1998 Mar 5;155(2):192-5. doi: 10.1016/s0022-510x(97)00314-6.","Rubio JC","J Neurol Sci","1998","1998/04/30","","","10.1016/s0022-510x(97)00314-6"
"26639957","Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease","Novak G, Fox N, Clegg S, Nielsen C, Einstein S, Lu Y, Tudor IC, Gregg K, Di J, Collins P, Wyman BT, Yuen E, Grundman M, Brashear HR, Liu E.","J Alzheimers Dis. 2016;49(4):1123-34. doi: 10.3233/JAD-150448.","Novak G","J Alzheimers Dis","2016","2015/12/08","","","10.3233/JAD-150448"
"8938815","Conventional MRI volumetric measures of parietal and insular cortex in Alzheimer's disease","Foundas AL, Eure KF, Seltzer B.","Prog Neuropsychopharmacol Biol Psychiatry. 1996 Oct;20(7):1131-44. doi: 10.1016/s0278-5846(96)00101-7.","Foundas AL","Prog Neuropsychopharmacol Biol Psychiatry","1996","1996/10/01","","","10.1016/s0278-5846(96)00101-7"
"19001349","The first therapeutic game specifically designed and evaluated for Alzheimer's disease","Cohen GD, Firth KM, Biddle S, Lloyd Lewis MJ, Simmens S.","Am J Alzheimers Dis Other Demen. 2008 Dec-2009 Jan;23(6):540-51. doi: 10.1177/1533317508323570. Epub 2008 Nov 10.","Cohen GD","Am J Alzheimers Dis Other Demen","2008","2008/11/13","","","10.1177/1533317508323570"
"33814447","A Precision Medicine Approach to Treating Alzheimer's Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials","O'Bryant SE, Zhang F, Petersen M, Johnson L, Hall J, Rissman RA.","J Alzheimers Dis. 2021;81(2):557-568. doi: 10.3233/JAD-201610.","O'Bryant SE","J Alzheimers Dis","2021","2021/04/05","PMC8203239","","10.3233/JAD-201610"
"28035924","The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial","Carotenuto A, Rea R, Traini E, Fasanaro AM, Ricci G, Manzo V, Amenta F.","J Alzheimers Dis. 2017;56(2):805-815. doi: 10.3233/JAD-160675.","Carotenuto A","J Alzheimers Dis","2017","2016/12/31","","","10.3233/JAD-160675"
"28304290","The Efficacy of Emotion Recognition Rehabilitation for People with Alzheimer's Disease","García-Casal JA, Goñi-Imizcoz M, Perea-Bartolomé MV, Soto-Pérez F, Smith SJ, Calvo-Simal S, Franco-Martín M.","J Alzheimers Dis. 2017;57(3):937-951. doi: 10.3233/JAD-160940.","García-Casal JA","J Alzheimers Dis","2017","2017/03/18","","","10.3233/JAD-160940"
"23603397","Motor effects of REAC in advanced Alzheimer's disease: results from a pilot trial","Olazarán J, González B, López-Álvarez J, Castagna A, Osa-Ruiz E, Herrero-Cano V, Agüera-Ortiz L, Rinaldi S, Martínez-Martín P.","J Alzheimers Dis. 2013;36(2):297-302. doi: 10.3233/JAD-130077.","Olazarán J","J Alzheimers Dis","2013","2013/04/23","","","10.3233/JAD-130077"
"9813788","Executive dysfunction in Alzheimer's disease: association with neuropsychiatric symptoms and functional impairment","Chen ST, Sultzer DL, Hinkin CH, Mahler ME, Cummings JL.","J Neuropsychiatry Clin Neurosci. 1998 Fall;10(4):426-32. doi: 10.1176/jnp.10.4.426.","Chen ST","J Neuropsychiatry Clin Neurosci","1998","1998/11/14","","","10.1176/jnp.10.4.426"
"8835880","Atrophy of hippocampus in patients with Alzheimer's disease and other diseases with memory impairment","Horn R, Ostertun B, Fric M, Solymosi L, Steudel A, Möller HJ.","Dementia. 1996 Jul-Aug;7(4):182-6. doi: 10.1159/000106876.","Horn R","Dementia","1996","1996/07/01","","","10.1159/000106876"
"19056706","Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study","Remington R, Chan A, Paskavitz J, Shea TB.","Am J Alzheimers Dis Other Demen. 2009 Feb-Mar;24(1):27-33. doi: 10.1177/1533317508325094. Epub 2008 Dec 3.","Remington R","Am J Alzheimers Dis Other Demen","2009","2008/12/06","","","10.1177/1533317508325094"
"17267379","Clock drawing and frontal lobe behavioral effects of memantine in Alzheimer's disease: a rater-blinded study","Paskavitz JF, Gunstad JJ, Samuel JE.","Am J Alzheimers Dis Other Demen. 2006 Dec-2007 Jan;21(6):454-9. doi: 10.1177/1533317506294474.","Paskavitz JF","Am J Alzheimers Dis Other Demen","2006","2007/02/03","","","10.1177/1533317506294474"
"12124484","Relationship between cognitive function and regional cerebral blood flow in Alzheimer's disease","Ushijima Y, Okuyama C, Mori S, Nakamura T, Kubota T, Nishimura T.","Nucl Med Commun. 2002 Aug;23(8):779-84. doi: 10.1097/00006231-200208000-00012.","Ushijima Y","Nucl Med Commun","2002","2002/07/19","","","10.1097/00006231-200208000-00012"
"8425936","Factor structure and scoring of the SKT test battery","Kim YS, Nibbelink DW, Overall JE.","J Clin Psychol. 1993 Jan;49(1):61-71. doi: 10.1002/1097-4679(199301)49:1<61::aid-jclp2270490109>3.0.co;2-b.","Kim YS","J Clin Psychol","1993","1993/01/01","","","10.1002/1097-4679(199301)49:1<61::aid-jclp2270490109>3.0.co;2-b"
"27005937","Transcranial direct current stimulation as a memory enhancer in patients with Alzheimer's disease: a randomized, placebo-controlled trial","Bystad M, Grønli O, Rasmussen ID, Gundersen N, Nordvang L, Wang-Iversen H, Aslaksen PM.","Alzheimers Res Ther. 2016 Mar 23;8(1):13. doi: 10.1186/s13195-016-0180-3.","Bystad M","Alzheimers Res Ther","2016","2016/03/24","PMC4804486","","10.1186/s13195-016-0180-3"
"24359502","A comparison of emotional decoding abilities in patients with amnestic mild cognitive impairment, very mild and mild Alzheimer's disease","Klimkowicz-Mrowiec A, Krzywoszanski L, Spisak K, Donohue BE, Szczudlik A, Slowik A.","Curr Alzheimer Res. 2014 Feb;11(2):200-5. doi: 10.2174/1567205010666131212120020.","Klimkowicz-Mrowiec A","Curr Alzheimer Res","2014","2013/12/24","","","10.2174/1567205010666131212120020"
"27163805","Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer's Disease Trials of Bapineuzumab","Russu A, Samtani MN, Xu S, Adedokun OJ, Lu M, Ito K, Corrigan B, Raje S, Liu E, Brashear HR, Styren S, Hu C.","J Alzheimers Dis. 2016 May 3;53(2):535-46. doi: 10.3233/JAD-151065.","Russu A","J Alzheimers Dis","2016","2016/05/11","","","10.3233/JAD-151065"
"28583972","A Black Alzheimer's Patient Wants To Be Part Of The Cure","Gray K.","Health Aff (Millwood). 2017 Jun 1;36(6):1129-1132. doi: 10.1377/hlthaff.2017.0296.","Gray K","Health Aff (Millwood)","2017","2017/06/07","","","10.1377/hlthaff.2017.0296"
"27823981","Repetitive transcranial magnetic stimulation improves cognitive function of Alzheimer's disease patients","Zhao J, Li Z, Cong Y, Zhang J, Tan M, Zhang H, Geng N, Li M, Yu W, Shan P.","Oncotarget. 2017 May 16;8(20):33864-33871. doi: 10.18632/oncotarget.13060.","Zhao J","Oncotarget","2017","2016/11/09","PMC5464918","","10.18632/oncotarget.13060"
"36709275","Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer's dementia: a randomized controlled trial","Wunderlich G, Blahova Z, Garcia M, Jessen F.","Alzheimers Res Ther. 2023 Jan 28;15(1):24. doi: 10.1186/s13195-023-01163-3.","Wunderlich G","Alzheimers Res Ther","2023","2023/01/28","PMC9883916","","10.1186/s13195-023-01163-3"
"20570398","Subregions of the inferior parietal lobule are affected in the progression to Alzheimer's disease","Greene SJ, Killiany RJ; Alzheimer's Disease Neuroimaging Initiative.","Neurobiol Aging. 2010 Aug;31(8):1304-11. doi: 10.1016/j.neurobiolaging.2010.04.026. Epub 2010 Jun 8.","Greene SJ","Neurobiol Aging","2010","2010/06/24","PMC2907057","NIHMS206542","10.1016/j.neurobiolaging.2010.04.026"
"33720895","The Cognition and Flow Study: A Feasibility Randomized Controlled Trial of the Effects of Cognitive Training on Cerebral Blood Flow","Beishon LC, Panerai RB, Budgeon C, Subramaniam H, Mukaetova-Ladinska E, Robinson TG, Haunton VJ.","J Alzheimers Dis. 2021;80(4):1567-1581. doi: 10.3233/JAD-201444.","Beishon LC","J Alzheimers Dis","2021","2021/03/15","","","10.3233/JAD-201444"
"28222509","Galantamine Response Associates with Agitation and the Prefrontal Cortex in Patients with Alzheimer's Disease","Nakayama S, Suda A, Nakanishi A, Motoi Y, Hattori N.","J Alzheimers Dis. 2017;57(1):267-273. doi: 10.3233/JAD-160902.","Nakayama S","J Alzheimers Dis","2017","2017/02/23","","","10.3233/JAD-160902"
"34151817","Effect of Age on Clinical Trial Outcome in Participants with Probable Alzheimer's Disease","Targum SD, Fosdick L, Drake KE, Rosenberg PB, Burke AD, Wolk DA, Foote KD, Asaad WF, Sabbagh M, Smith GS, Lozano AM, Lyketsos CG.","J Alzheimers Dis. 2021;82(3):1243-1257. doi: 10.3233/JAD-210530.","Targum SD","J Alzheimers Dis","2021","2021/06/21","PMC8461716","","10.3233/JAD-210530"
"21646051","Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer's disease","Weiner MW, Sadowsky C, Saxton J, Hofbauer RK, Graham SM, Yu SY, Li S, Hsu HA, Suhy J, Fridman M, Perhach JL.","Alzheimers Dement. 2011 Jul;7(4):425-35. doi: 10.1016/j.jalz.2010.09.003. Epub 2011 Jun 8.","Weiner MW","Alzheimers Dement","2011","2011/06/08","","","10.1016/j.jalz.2010.09.003"
"11739614","Wheat germ agglutinin-binding glycoproteins are decreased in Alzheimer's disease cerebrospinal fluid","Fodero LR, Sáez-Valero J, Barquero MS, Marcos A, McLean CA, Small DH.","J Neurochem. 2001 Dec;79(5):1022-6. doi: 10.1046/j.1471-4159.2001.00640.x.","Fodero LR","J Neurochem","2001","2001/12/12","","","10.1046/j.1471-4159.2001.00640.x"
"8558158","Clinical application of electrophysiological markers in the differential diagnosis of depression and very mild Alzheimer's disease","Swanwick GR, Rowan M, Coen RF, O'Mahony D, Lee H, Lawlor BA, Walsh JB, Coakley D.","J Neurol Neurosurg Psychiatry. 1996 Jan;60(1):82-6. doi: 10.1136/jnnp.60.1.82.","Swanwick GR","J Neurol Neurosurg Psychiatry","1996","1996/01/01","PMC486195","","10.1136/jnnp.60.1.82"
"29439335","Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases","Babiloni C, Del Percio C, Lizio R, Noce G, Lopez S, Soricelli A, Ferri R, Pascarelli MT, Catania V, Nobili F, Arnaldi D, Famà F, Aarsland D, Orzi F, Buttinelli C, Giubilei F, Onofrj M, Stocchi F, Vacca L, Stirpe P, Fuhr P, Gschwandtner U, Ransmayr G, Garn H, Fraioli L, Pievani M, Frisoni GB, D'Antonio F, De Lena C, Güntekin B, Hanoğlu L, Başar E, Yener G, Emek-Savaş DD, Triggiani AI, Franciotti R, Taylor JP, De Pandis MF, Bonanni L.","J Alzheimers Dis. 2018;62(1):247-268. doi: 10.3233/JAD-170703.","Babiloni C","J Alzheimers Dis","2018","2018/02/15","","","10.3233/JAD-170703"
"36104179","A Pilot Study of Whole-Brain Low-Intensity Pulsed Ultrasound Therapy for Early Stage of Alzheimer's Disease (LIPUS-AD): A Randomized, Double-Blind, Placebo-Controlled Trial","Shimokawa H, Shindo T, Ishiki A, Tomita N, Ichijyo S, Watanabe T, Nakata T, Eguchi K, Kikuchi Y, Shiroto T, Takahashi J, Yasuda S, Arai H.","Tohoku J Exp Med. 2022 Oct 25;258(3):167-175. doi: 10.1620/tjem.2022.J078. Epub 2022 Sep 15.","Shimokawa H","Tohoku J Exp Med","2022","2022/09/14","","","10.1620/tjem.2022.J078"
"22751169","Pilot study of granulocyte-colony stimulating factor for treatment of Alzheimer's disease","Sanchez-Ramos J, Cimino C, Avila R, Rowe A, Chen R, Whelan G, Lin X, Cao C, Ashok R.","J Alzheimers Dis. 2012;31(4):843-55. doi: 10.3233/JAD-2012-120196.","Sanchez-Ramos J","J Alzheimers Dis","2012","2012/07/04","","","10.3233/JAD-2012-120196"
"28137552","Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease","Nestor SM, Mišić B, Ramirez J, Zhao J, Graham SJ, Verhoeff NPLG, Stuss DT, Masellis M, Black SE.","Alzheimers Dement. 2017 Jul;13(7):749-760. doi: 10.1016/j.jalz.2016.12.007. Epub 2017 Jan 27.","Nestor SM","Alzheimers Dement","2017","2017/02/01","","","10.1016/j.jalz.2016.12.007"
"24219193","Benefits of multimodal exercise intervention for postural control and frontal cognitive functions in individuals with Alzheimer's disease: a controlled trial","de Andrade LP, Gobbi LT, Coelho FG, Christofoletti G, Costa JL, Stella F.","J Am Geriatr Soc. 2013 Nov;61(11):1919-26. doi: 10.1111/jgs.12531. Epub 2013 Nov 5.","de Andrade LP","J Am Geriatr Soc","2013","2013/11/14","","","10.1111/jgs.12531"
"10396132","[Psychosocial risk factors for Alzheimer's disease]","Kropiunigg U, Sebek K, Leonhardsberger A, Schemper M, Dal-Bianco P.","Psychother Psychosom Med Psychol. 1999 May;49(5):153-9.","Kropiunigg U","Psychother Psychosom Med Psychol","1999","1999/07/09","","",""
"18297481","Exercise training for depressed older adults with Alzheimer's disease","Williams CL, Tappen RM.","Aging Ment Health. 2008 Jan;12(1):72-80. doi: 10.1080/13607860701529932.","Williams CL","Aging Ment Health","2008","2008/02/26","PMC2475651","NIHMS42964","10.1080/13607860701529932"
"21939611","Effect of second-generation antipsychotics on caregiver burden in Alzheimer's disease","Mohamed S, Rosenheck R, Lyketsos CG, Kaczynski R, Sultzer DL, Schneider LS.","J Clin Psychiatry. 2012 Jan;73(1):121-8. doi: 10.4088/JCP.10m06574. Epub 2011 Sep 6.","Mohamed S","J Clin Psychiatry","2012","2011/09/24","PMC4040971","NIHMS445643","10.4088/JCP.10m06574"
"24683126","Gait changes with anti-dementia drugs: a prospective, open-label study combining single and dual task assessments in patients with Alzheimer's disease","Beauchet O, Launay CP, Allali G, Herrmann FR, Annweiler C.","Drugs Aging. 2014 May;31(5):363-72. doi: 10.1007/s40266-014-0175-3.","Beauchet O","Drugs Aging","2014","2014/04/01","","","10.1007/s40266-014-0175-3"
"8122302","Desferrioxamine and Alzheimer's disease: video home behavior assessment of clinical course and measures of brain aluminum","McLachlan DR, Smith WL, Kruck TP.","Ther Drug Monit. 1993 Dec;15(6):602-7.","McLachlan DR","Ther Drug Monit","1993","1993/12/01","","",""
"29660937","Personality Modulates the Efficacy of Art Intervention on Chronic Pain in a Population of Patients with Alzheimer's Disease","Rouch I, Pongan E, Leveque Y, Tillmann B, Trombert B, Getenet JC, Auguste N, Krolak-Salmon P; LACMé group; Laurent B, Dorey JM.","J Alzheimers Dis. 2018;63(2):617-624. doi: 10.3233/JAD-170990.","Rouch I","J Alzheimers Dis","2018","2018/04/18","","","10.3233/JAD-170990"
"28629447","Transcranial direct current stimulation for depression in Alzheimer's disease: study protocol for a randomized controlled trial","Narita Z, Yokoi Y.","Trials. 2017 Jun 19;18(1):285. doi: 10.1186/s13063-017-2019-z.","Narita Z","Trials","2017","2017/06/21","PMC5477338","","10.1186/s13063-017-2019-z"
"26750717","Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability","Lim YY, Maruff P, Getter C, Snyder PJ.","Alzheimers Dement. 2016 Apr;12(4):454-8. doi: 10.1016/j.jalz.2015.09.005. Epub 2015 Dec 30.","Lim YY","Alzheimers Dement","2016","2016/01/12","","","10.1016/j.jalz.2015.09.005"
"2730278","Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. A controlled study","Lawlor BA, Sunderland T, Mellow AM, Hill JL, Molchan SE, Murphy DL.","Arch Gen Psychiatry. 1989 Jun;46(6):542-9. doi: 10.1001/archpsyc.1989.01810060064010.","Lawlor BA","Arch Gen Psychiatry","1989","1989/06/01","","","10.1001/archpsyc.1989.01810060064010"
"29378651","Safety, tolerability and immunogenicity of an active anti-Aβ(40) vaccine (ABvac40) in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase I trial","Lacosta AM, Pascual-Lucas M, Pesini P, Casabona D, Pérez-Grijalba V, Marcos-Campos I, Sarasa L, Canudas J, Badi H, Monleón I, San-José I, Munuera J, Rodríguez-Gómez O, Abdelnour C, Lafuente A, Buendía M, Boada M, Tárraga L, Ruiz A, Sarasa M.","Alzheimers Res Ther. 2018 Jan 29;10(1):12. doi: 10.1186/s13195-018-0340-8.","Lacosta AM","Alzheimers Res Ther","2018","2018/01/31","PMC5789644","","10.1186/s13195-018-0340-8"
"8845700","Apathy and loss of insight in Alzheimer's disease: a SPECT imaging study","Ott BR, Noto RB, Fogel BS.","J Neuropsychiatry Clin Neurosci. 1996 Winter;8(1):41-6. doi: 10.1176/jnp.8.1.41.","Ott BR","J Neuropsychiatry Clin Neurosci","1996","1996/01/01","","","10.1176/jnp.8.1.41"
"6228933","[Neuropsychological study of decline of attention and drug therapy of patients with Alzheimer's disease]","Tecce JJ, Cattanach L, Boehner-Davis MB, Branconnier RJ, Cole JO.","Presse Med. 1983 Dec 29;12(48):3155-62.","Tecce JJ","Presse Med","1983","1983/12/29","","",""
"16723320","Counting complex dot patterns in Alzheimer's disease","Delazer M, Karner E, Proell S, Benke T.","J Clin Exp Neuropsychol. 2006 Jul;28(5):721-31. doi: 10.1080/13803390591000819.","Delazer M","J Clin Exp Neuropsychol","2006","2006/05/26","","","10.1080/13803390591000819"
"10758259","Quantifying behavioral disturbance in Alzheimer's disease patients","Weiner MF, Tractenberg R, Teri L, Logsdon R, Thomas RG, Gamst A, Thal LJ.","J Psychiatr Res. 2000 Mar-Apr;34(2):163-7. doi: 10.1016/s0022-3956(99)00042-4.","Weiner MF","J Psychiatr Res","2000","2000/04/12","","","10.1016/s0022-3956(99)00042-4"
"23784727","One-year repeated cycles of cognitive training (CT) for Alzheimer's disease","Bergamaschi S, Arcara G, Calza A, Villani D, Orgeta V, Mondini S.","Aging Clin Exp Res. 2013 Aug;25(4):421-6. doi: 10.1007/s40520-013-0065-2. Epub 2013 Jun 20.","Bergamaschi S","Aging Clin Exp Res","2013","2013/06/21","","","10.1007/s40520-013-0065-2"
"27031491","Short-Term Effects of Rhythmic Sensory Stimulation in Alzheimer's Disease: An Exploratory Pilot Study","Clements-Cortes A, Ahonen H, Evans M, Freedman M, Bartel L.","J Alzheimers Dis. 2016 Mar 25;52(2):651-60. doi: 10.3233/JAD-160081.","Clements-Cortes A","J Alzheimers Dis","2016","2016/04/01","","","10.3233/JAD-160081"
"23771298","Model-based quantification of cerebral hemodynamics as a physiomarker for Alzheimer's disease?","Marmarelis VZ, Shin DC, Orme ME, Zhang R.","Ann Biomed Eng. 2013 Nov;41(11):2296-317. doi: 10.1007/s10439-013-0837-z. Epub 2013 Jun 15.","Marmarelis VZ","Ann Biomed Eng","2013","2013/06/18","PMC3992829","NIHMS494174","10.1007/s10439-013-0837-z"
"25876339","[Clinical observation of Alzheimer's disease treated with acupuncture]","Gu W, Jin XX, Zhang YJ, Li ZJ, Kong Y.","Zhongguo Zhen Jiu. 2014 Dec;34(12):1156-60.","Gu W","Zhongguo Zhen Jiu","2014","2015/04/17","","",""
"22713851","[Non pharmacological treatment for Alzheimer's disease: comparison between musical and non-musical interventions]","Narme P, Tonini A, Khatir F, Schiaratura L, Clément S, Samson S.","Geriatr Psychol Neuropsychiatr Vieil. 2012 Jun;10(2):215-24. doi: 10.1684/pnv.2012.0343.","Narme P","Geriatr Psychol Neuropsychiatr Vieil","2012","2012/06/21","","","10.1684/pnv.2012.0343"
"24411134","A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease","Rafii MS, Baumann TL, Bakay RA, Ostrove JM, Siffert J, Fleisher AS, Herzog CD, Barba D, Pay M, Salmon DP, Chu Y, Kordower JH, Bishop K, Keator D, Potkin S, Bartus RT.","Alzheimers Dement. 2014 Sep;10(5):571-81. doi: 10.1016/j.jalz.2013.09.004. Epub 2014 Jan 7.","Rafii MS","Alzheimers Dement","2014","2014/01/14","","","10.1016/j.jalz.2013.09.004"
"10574080","Delusions in Alzheimer's disease: spet evidence of right hemispheric dysfunction","Staff RT, Shanks MF, Macintosh L, Pestell SJ, Gemmell HG, Venneri A.","Cortex. 1999 Sep;35(4):549-60. doi: 10.1016/s0010-9452(08)70818-9.","Staff RT","Cortex","1999","1999/11/26","","","10.1016/s0010-9452(08)70818-9"
"10689035","Diagnosis of Alzheimer's disease: MRI of the hippocampus vs delayed recall","Laakso MP, Hallikainen M, Hänninen T, Partanen K, Soininen H.","Neuropsychologia. 2000;38(5):579-84. doi: 10.1016/s0028-3932(99)00111-6.","Laakso MP","Neuropsychologia","2000","2000/02/26","","","10.1016/s0028-3932(99)00111-6"
"8038871","Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer's disease. A neuropsychological, EEG, and PET investigation","Heiss WD, Kessler J, Mielke R, Szelies B, Herholz K.","Dementia. 1994 Mar-Apr;5(2):88-98. doi: 10.1159/000106702.","Heiss WD","Dementia","1994","1994/03/01","","","10.1159/000106702"
"1282416","[EEG-mapping in Alzheimer-type dementias]","Iznak AF, Chaianov NV, Gavrilova SI, Mikhaĭlova NM, Selezneva ND, Kalyn IaB, Kolykhalov IV.","Vestn Ross Akad Med Nauk. 1992;(8):39-41.","Iznak AF","Vestn Ross Akad Med Nauk","1992","1992/01/01","","",""
"21250762","Effect of memantine on resting state default mode network activity in Alzheimer's disease","Lorenzi M, Beltramello A, Mercuri NB, Canu E, Zoccatelli G, Pizzini FB, Alessandrini F, Cotelli M, Rosini S, Costardi D, Caltagirone C, Frisoni GB.","Drugs Aging. 2011 Mar 1;28(3):205-17. doi: 10.2165/11586440-000000000-00000.","Lorenzi M","Drugs Aging","2011","2011/01/22","","","10.2165/11586440-000000000-00000"
"7973660","A potential noninvasive neurobiological test for Alzheimer's disease","Scinto LF, Daffner KR, Dressler D, Ransil BI, Rentz D, Weintraub S, Mesulam M, Potter H.","Science. 1994 Nov 11;266(5187):1051-4. doi: 10.1126/science.7973660.","Scinto LF","Science","1994","1994/11/11","","","10.1126/science.7973660"
"30198872","A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease","O'Bryant SE, Zhang F, Johnson LA, Hall J, Edwards M, Grammas P, Oh E, Lyketsos CG, Rissman RA.","J Alzheimers Dis. 2018;66(1):97-104. doi: 10.3233/JAD-180619.","O'Bryant SE","J Alzheimers Dis","2018","2018/09/11","PMC6428063","NIHMS1013121","10.3233/JAD-180619"
"22944256","Assessing the impact and social perception of self-regulated music stimulation with patients with Alzheimer's disease","Lancioni GE, O'Reilly MF, Singh NN, Sigafoos J, Grumo G, Pinto K, Stasolla F, Signorino M, Groeneweg J.","Res Dev Disabil. 2013 Jan;34(1):139-46. doi: 10.1016/j.ridd.2012.07.026. Epub 2012 Sep 1.","Lancioni GE","Res Dev Disabil","2013","2012/09/05","","","10.1016/j.ridd.2012.07.026"
"31424399","An Indoor Therapeutic Garden for Behavioral Symptoms in Alzheimer's Disease: A Randomized Controlled Trial","Pedrinolla A, Tamburin S, Brasioli A, Sollima A, Fonte C, Muti E, Smania N, Schena F, Venturelli M.","J Alzheimers Dis. 2019;71(3):813-823. doi: 10.3233/JAD-190394.","Pedrinolla A","J Alzheimers Dis","2019","2019/08/20","","","10.3233/JAD-190394"
"3528889","Piracetam combined with lecithin in the treatment of Alzheimer's disease","Growdon JH, Corkin S, Huff FJ, Rosen TJ.","Neurobiol Aging. 1986 Jul-Aug;7(4):269-76. doi: 10.1016/0197-4580(86)90007-2.","Growdon JH","Neurobiol Aging","1986","1986/07/01","","","10.1016/0197-4580(86)90007-2"
"29405233","The Value of Pre-Screening in the Alzheimer's Prevention Initiative (API) Autosomal Dominant Alzheimer's Disease Trial","Rios-Romenets S, Giraldo-Chica M, López H, Piedrahita F, Ramos C, Acosta-Baena N, Muñoz C, Ospina P, Tobón C, Cho W, Ward M, Langbaum JB, Tariot PN, Reiman EM, Lopera F.","J Prev Alzheimers Dis. 2018;5(1):49-54. doi: 10.14283/jpad.2017.44.","Rios-Romenets S","J Prev Alzheimers Dis","2018","2018/02/07","PMC5987758","NIHMS952568","10.14283/jpad.2017.44"
"8716494","Floor patterns limit wandering of people with Alzheimer's","Hewawasam L.","Nurs Times. 1996 May 29-Jun 4;92(22):41-4.","Hewawasam L","Nurs Times","1996","1996/05/04","","",""
"9529820","Structural MRI correlates of recognition memory in Alzheimer's disease","Cahn DA, Sullivan EV, Shear PK, Marsh L, Fama R, Lim KO, Yesavage JA, Tinklenberg JR, Pfefferbaum A.","J Int Neuropsychol Soc. 1998 Mar;4(2):106-14. doi: 10.1017/s1355617798001064.","Cahn DA","J Int Neuropsychol Soc","1998","1998/04/08","","","10.1017/s1355617798001064"
"10403716","Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease","Bondi MW, Salmon DP, Galasko D, Thomas RG, Thal LJ.","Psychol Aging. 1999 Jun;14(2):295-303. doi: 10.1037//0882-7974.14.2.295.","Bondi MW","Psychol Aging","1999","1999/07/14","","","10.1037//0882-7974.14.2.295"
"28945120","Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer's Disease: A Double-Blind, Randomized, Placebo-Controlled Trial","Padala PR, Padala KP, Lensing SY, Ramirez D, Monga V, Bopp MM, Roberson PK, Dennis RA, Petty F, Sullivan DH, Burke WJ.","Am J Psychiatry. 2018 Feb 1;175(2):159-168. doi: 10.1176/appi.ajp.2017.17030316. Epub 2017 Sep 15.","Padala PR","Am J Psychiatry","2018","2017/09/26","","","10.1176/appi.ajp.2017.17030316"
"22395762","[Effects of a psychological group intervention on neuropsychiatric symptoms and communication in Alzheimer's dementia]","Fischer-Terworth C, Probst P.","Z Gerontol Geriatr. 2012 Jul;45(5):392-7. doi: 10.1007/s00391-012-0296-4.","Fischer-Terworth C","Z Gerontol Geriatr","2012","2012/03/08","","","10.1007/s00391-012-0296-4"
"7650534","P300 in Alzheimer's disease: relationships to dementia severity and glucose metabolism","Szelies B, Mielke R, Grond M, Heiss WD.","J Neurol Sci. 1995 May;130(1):77-81. doi: 10.1016/0022-510x(95)00006-n.","Szelies B","J Neurol Sci","1995","1995/05/01","","","10.1016/0022-510x(95)00006-n"
"28365320","Use of white matter reference regions for detection of change in florbetapir positron emission tomography from completed phase 3 solanezumab trials","Fleisher AS, Joshi AD, Sundell KL, Chen YF, Kollack-Walker S, Lu M, Chen S, Devous MD Sr, Seibyl J, Marek K, Siemers ER, Mintun MA.","Alzheimers Dement. 2017 Oct;13(10):1117-1124. doi: 10.1016/j.jalz.2017.02.009. Epub 2017 Mar 30.","Fleisher AS","Alzheimers Dement","2017","2017/04/03","","","10.1016/j.jalz.2017.02.009"
"29658441","Efficacy of Transcranial Direct Current Stimulation Combined with Cognitive Training in the Treatment of Apathy in Patients with Alzheimer's Disease: Study Protocol for a Randomized Trial","Nguyen JP, Boutoleau-Bretonniere C, Lefaucheur JP, Suarez A, Gaillard H, Chapelet G, Abad S, Van Langhenhove A, Nizard J, de Decker L.","Rev Recent Clin Trials. 2018;13(4):319-327. doi: 10.2174/1574887113666180416153316.","Nguyen JP","Rev Recent Clin Trials","2018","2018/04/17","","","10.2174/1574887113666180416153316"
"19785641","The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease","Wiig EH, Annas P, Basun H, Andreasen N, Lannfelt L, Zetterberg H, Blennow K, Minthon L.","Acta Neurol Scand. 2010 Mar;121(3):186-93. doi: 10.1111/j.1600-0404.2009.01160.x. Epub 2009 Sep 24.","Wiig EH","Acta Neurol Scand","2010","2009/09/30","","","10.1111/j.1600-0404.2009.01160.x"
"15359562","Evaluating the effect of therapeutic gardens","Heath Y.","Am J Alzheimers Dis Other Demen. 2004 Jul-Aug;19(4):239-42. doi: 10.1177/153331750401900410.","Heath Y","Am J Alzheimers Dis Other Demen","2004","2004/09/14","","","10.1177/153331750401900410"
"30958348","Extracellular Vesicle Biomarkers Track Cognitive Changes Following Intranasal Insulin in Alzheimer's Disease","Mustapic M, Tran J, Craft S, Kapogiannis D.","J Alzheimers Dis. 2019;69(2):489-498. doi: 10.3233/JAD-180578.","Mustapic M","J Alzheimers Dis","2019","2019/04/09","PMC6668911","NIHMS1037984","10.3233/JAD-180578"
"10818549","Investigating the natural course and treatment of vascular dementia and Alzheimer's disease. Parallel study populations in two randomized, placebo-controlled trials","Kittner B, De Deyn PP, Erkinjuntti T.","Ann N Y Acad Sci. 2000 Apr;903:535-41. doi: 10.1111/j.1749-6632.2000.tb06410.x.","Kittner B","Ann N Y Acad Sci","2000","2000/05/20","","","10.1111/j.1749-6632.2000.tb06410.x"
"25550228","Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease","Wischik CM, Staff RT, Wischik DJ, Bentham P, Murray AD, Storey JM, Kook KA, Harrington CR.","J Alzheimers Dis. 2015;44(2):705-20. doi: 10.3233/JAD-142874.","Wischik CM","J Alzheimers Dis","2015","2015/01/01","","","10.3233/JAD-142874"
"9164692","A randomized, controlled trial of linopirdine in the treatment of Alzheimer's disease","Rockwood K, Beattie BL, Eastwood MR, Feldman H, Mohr E, Pryse-Phillips W, Gauthier S.","Can J Neurol Sci. 1997 May;24(2):140-5. doi: 10.1017/s031716710002148x.","Rockwood K","Can J Neurol Sci","1997","1997/05/01","","","10.1017/s031716710002148x"
"16988476","Non-invasive therapy to reduce the body burden of aluminium in Alzheimer's disease","Exley C, Korchazhkina O, Job D, Strekopytov S, Polwart A, Crome P.","J Alzheimers Dis. 2006 Sep;10(1):17-24; discussion 29-31. doi: 10.3233/jad-2006-10103.","Exley C","J Alzheimers Dis","2006","2006/09/22","","","10.3233/jad-2006-10103"
"36442199","Mindfulness Prevents Depression and Psychopathology in Elderly People with Mild to Moderate Alzheimer's Disease: A Randomized Clinical Trial","Quintana-Hernández DJ, Rojas-Hernández J, Santana-Del Pino A, Céspedes Suárez C, Pellejero Silva M, Miró-Barrachina MT, Ibáñez Fernández I, Estupiñán López JA, Borkel LF.","J Alzheimers Dis. 2023;91(1):471-481. doi: 10.3233/JAD-220889.","Quintana-Hernández DJ","J Alzheimers Dis","2023","2022/11/28","PMC9881020","","10.3233/JAD-220889"
"9444495","A comparison of qEEG and HMPAO-SPECT in relation to the clinical severity of Alzheimer's disease","Müller TJ, Thome J, Chiaramonti R, Dierks T, Maurer K, Fallgatter AJ, Frölich L, Scheubeck M, Strik WK.","Eur Arch Psychiatry Clin Neurosci. 1997;247(5):259-63. doi: 10.1007/BF02900304.","Müller TJ","Eur Arch Psychiatry Clin Neurosci","1997","1997/01/01","","","10.1007/BF02900304"
"29154271","Does Fatty Acid Composition in Subcutaneous Adipose Tissue Differ between Patients with Alzheimer's Disease and Cohabiting Proxies?","Faxen-Irving G, Falahati F, Basun H, Eriksdotter M, Vedin I, Wahlund LO, Schultzberg M, Hjorth E, Palmblad J, Cederholm T, Freund-Levi Y.","J Alzheimers Dis. 2018;61(2):515-519. doi: 10.3233/JAD-170359.","Faxen-Irving G","J Alzheimers Dis","2018","2017/11/21","","","10.3233/JAD-170359"
"22272562","A new frontier in spaced retrieval memory training for persons with Alzheimer's disease","Small JA.","Neuropsychol Rehabil. 2012;22(3):329-61. doi: 10.1080/09602011.2011.640468. Epub 2012 Jan 24.","Small JA","Neuropsychol Rehabil","2012","2012/01/26","","","10.1080/09602011.2011.640468"
"25075811","Longitudinal changes in awareness over 36 months in patients with mild Alzheimer's disease","Vogel A, Waldorff FB, Waldemar G.","Int Psychogeriatr. 2015 Jan;27(1):95-102. doi: 10.1017/S1041610214001562. Epub 2014 Jul 30.","Vogel A","Int Psychogeriatr","2015","2014/07/31","","","10.1017/S1041610214001562"
"21955815","Memantine and functional communication in Alzheimer's disease: results of a 12-week, international, randomized clinical trial","Saxton J, Hofbauer RK, Woodward M, Gilchrist NL, Potocnik F, Hsu HA, Miller ML, Pejović V, Graham SM, Perhach JL.","J Alzheimers Dis. 2012;28(1):109-18. doi: 10.3233/JAD-2011-110947.","Saxton J","J Alzheimers Dis","2012","2011/09/30","","","10.3233/JAD-2011-110947"
"31292734","High-frequency repetitive transcranial magnetic stimulation combined with cognitive training improves cognitive function and cortical metabolic ratios in Alzheimer's disease","Zhang F, Qin Y, Xie L, Zheng C, Huang X, Zhang M.","J Neural Transm (Vienna). 2019 Aug;126(8):1081-1094. doi: 10.1007/s00702-019-02022-y. Epub 2019 Jul 10.","Zhang F","J Neural Transm (Vienna)","2019","2019/07/12","","","10.1007/s00702-019-02022-y"
"28157102","A 3-Month Aerobic Training Program Improves Brain Energy Metabolism in Mild Alzheimer's Disease: Preliminary Results from a Neuroimaging Study","Castellano CA, Paquet N, Dionne IJ, Imbeault H, Langlois F, Croteau E, Tremblay S, Fortier M, Matte JJ, Lacombe G, Fülöp T, Bocti C, Cunnane SC.","J Alzheimers Dis. 2017;56(4):1459-1468. doi: 10.3233/JAD-161163.","Castellano CA","J Alzheimers Dis","2017","2017/02/04","","","10.3233/JAD-161163"
"10380968","Alzheimer's disease may not be a spirochetosis","McLaughlin R, Kin NM, Chen MF, Nair NP, Chan EC.","Neuroreport. 1999 May 14;10(7):1489-91. doi: 10.1097/00001756-199905140-00018.","McLaughlin R","Neuroreport","1999","1999/06/25","","","10.1097/00001756-199905140-00018"
"10974962","Effectiveness of cognitive-behavioural family intervention in reducing the burden of care in carers of patients with Alzheimer's disease","Marriott A, Donaldson C, Tarrier N, Burns A.","Br J Psychiatry. 2000 Jun;176:557-62. doi: 10.1192/bjp.176.6.557.","Marriott A","Br J Psychiatry","2000","2000/09/07","","","10.1192/bjp.176.6.557"
"2049365","Clinical trials in dementia: learning effects with repeated testing","Claus JJ, Mohr E, Chase TN.","J Psychiatry Neurosci. 1991 Mar;16(1):1-4.","Claus JJ","J Psychiatry Neurosci","1991","1991/03/01","PMC1188280","",""
"26845282","Gray matter volumes and treatment response of psychotic symptoms to risperidone in antipsychotic-naïve Alzheimer's disease patients","Lee YM, Park JM, Lee BD, Moon E, Jeong HJ, Chung YI, Kim JH, Kim HJ, Mun CW, Kim TH, Kim YH.","J Clin Psychiatry. 2016 Jan;77(1):e8-13. doi: 10.4088/JCP.14m09740.","Lee YM","J Clin Psychiatry","2016","2016/02/05","","","10.4088/JCP.14m09740"
"33076983","The impact of a multi-domain intervention on cerebral glucose metabolism: analysis from the randomized ancillary FDG PET MAPT trial","Delrieu J, Voisin T, Saint-Aubert L, Carrie I, Cantet C, Vellas B, Payoux P, Andrieu S.","Alzheimers Res Ther. 2020 Oct 19;12(1):134. doi: 10.1186/s13195-020-00683-6.","Delrieu J","Alzheimers Res Ther","2020","2020/10/20","PMC7574215","","10.1186/s13195-020-00683-6"
"9547468","Olfactory dysfunction discriminates Alzheimer's dementia from major depression","Solomon GS, Petrie WM, Hart JR, Brackin HB Jr.","J Neuropsychiatry Clin Neurosci. 1998 Winter;10(1):64-7. doi: 10.1176/jnp.10.1.64.","Solomon GS","J Neuropsychiatry Clin Neurosci","1998","1998/04/21","","","10.1176/jnp.10.1.64"
"31282418","Can Adults with Mild Cognitive Impairment Build Cognitive Reserve and Learn Mindfulness Meditation? Qualitative Theme Analyses from a Small Pilot Study","Wells RE, Kerr C, Dossett ML, Danhauer SC, Sohl SJ, Sachs BC, Feeley JW, Wolkin J, Wall R, Kaptchuk T, Press DZ, Phillips RS, Yeh GY.","J Alzheimers Dis. 2019;70(3):825-842. doi: 10.3233/JAD-190191.","Wells RE","J Alzheimers Dis","2019","2019/07/09","PMC6753379","NIHMS1050903","10.3233/JAD-190191"
"31424389","Effects of Psychotropic Medication on Cognition, Caregiver Burden, and Neuropsychiatric Symptoms in Alzheimer's Disease over 12 Months: Results from a Prospective Registry of Dementia in Austria (PRODEM)","Pirker-Kees A, Dal-Bianco P, Schmidt R.","J Alzheimers Dis. 2019;71(2):623-630. doi: 10.3233/JAD-181102.","Pirker-Kees A","J Alzheimers Dis","2019","2019/08/20","","","10.3233/JAD-181102"
"27567810","A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease","Lozano AM, Fosdick L, Chakravarty MM, Leoutsakos JM, Munro C, Oh E, Drake KE, Lyman CH, Rosenberg PB, Anderson WS, Tang-Wai DF, Pendergrass JC, Salloway S, Asaad WF, Ponce FA, Burke A, Sabbagh M, Wolk DA, Baltuch G, Okun MS, Foote KD, McAndrews MP, Giacobbe P, Targum SD, Lyketsos CG, Smith GS.","J Alzheimers Dis. 2016 Sep 6;54(2):777-87. doi: 10.3233/JAD-160017.","Lozano AM","J Alzheimers Dis","2016","2016/08/29","PMC5026133","","10.3233/JAD-160017"
"16127110","A randomized, crossover trial of high-carbohydrate foods in nursing home residents with Alzheimer's disease: associations among intervention response, body mass index, and behavioral and cognitive function","Young KW, Greenwood CE, van Reekum R, Binns MA.","J Gerontol A Biol Sci Med Sci. 2005 Aug;60(8):1039-45. doi: 10.1093/gerona/60.8.1039.","Young KW","J Gerontol A Biol Sci Med Sci","2005","2005/08/30","","","10.1093/gerona/60.8.1039"
"22624652","Nutritional treatment of aged individuals with Alzheimer disease living at home with their spouses: study protocol for a randomized controlled trial","Jyvakorpi SK, Puranen T, Pitkala KH, Suominen MH.","Trials. 2012 May 24;13:66. doi: 10.1186/1745-6215-13-66.","Jyvakorpi SK","Trials","2012","2012/05/26","PMC3517368","","10.1186/1745-6215-13-66"
"23229078","Targeted recruitment using cerebrospinal fluid biomarkers: implications for Alzheimer's disease therapeutic trials","Barnes J, Bartlett JW, Fox NC, Schott JM.","J Alzheimers Dis. 2013;34(2):431-7. doi: 10.3233/JAD-121936.","Barnes J","J Alzheimers Dis","2013","2012/12/12","","","10.3233/JAD-121936"
"2650662","Clonidine treatment of Alzheimer's disease","Mohr E, Schlegel J, Fabbrini G, Williams J, Mouradian MM, Mann UM, Claus JJ, Fedio P, Chase TN.","Arch Neurol. 1989 Apr;46(4):376-8. doi: 10.1001/archneur.1989.00520400030015.","Mohr E","Arch Neurol","1989","1989/04/01","","","10.1001/archneur.1989.00520400030015"
"24187864","Effect of reinforcing kidney-essence, removing phlegm, and promoting mental therapy on treating Alzheimer's disease","Liu P, Kong M, Liu S, Chen G, Wang P.","J Tradit Chin Med. 2013 Aug;33(4):449-54. doi: 10.1016/s0254-6272(13)60147-8.","Liu P","J Tradit Chin Med","2013","2013/11/06","","","10.1016/s0254-6272(13)60147-8"
"11408339","Comprehension of metaphors and idioms in patients with Alzheimer's disease: a longitudinal study","Papagno C.","Brain. 2001 Jul;124(Pt 7):1450-60. doi: 10.1093/brain/124.7.1450.","Papagno C","Brain","2001","2001/06/16","","","10.1093/brain/124.7.1450"
"21282280","Impact of rivastigmine patch and capsules on activities of daily living in Alzheimer's disease","Grossberg G, Meng X, Olin JT.","Am J Alzheimers Dis Other Demen. 2011 Feb;26(1):65-71. doi: 10.1177/1533317510391240.","Grossberg G","Am J Alzheimers Dis Other Demen","2011","2011/02/02","","","10.1177/1533317510391240"
"21084721","Qualitative analysis of therapeutic light effects on global function in Alzheimer's disease","Nowak L, Davis J.","West J Nurs Res. 2011 Nov;33(7):933-52. doi: 10.1177/0193945910386248. Epub 2010 Nov 17.","Nowak L","West J Nurs Res","2011","2010/11/19","","","10.1177/0193945910386248"
"16544870","A home health care approach to exercise for persons with Alzheimer's disease","Logsdon RG, McCurry SM, Teri L.","Care Manag J. 2005 Summer;6(2):90-7. doi: 10.1891/cmaj.6.2.90.","Logsdon RG","Care Manag J","2005","2006/03/21","","","10.1891/cmaj.6.2.90"
"9660106","Cerebrospinal fluid levels of non-neurotransmitter amino acids in patients with Alzheimer's disease","Molina JA, Jiménez-Jiménez FJ, Vargas C, Gómez P, de Bustos F, Ortí-Pareja M, Tallón-Barranco A, Benito-León J, Arenas J, Enríquez-de-Salamanca R.","J Neural Transm (Vienna). 1998;105(2-3):279-86. doi: 10.1007/s007020050057.","Molina JA","J Neural Transm (Vienna)","1998","1998/07/11","","","10.1007/s007020050057"
"11552768","A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease","Ruether E, Husmann R, Kinzler E, Diabl E, Klingler D, Spatt J, Ritter R, Schmidt R, Taneri Z, Winterer W, Koper D, Kasper S, Rainer M, Moessler H.","Int Clin Psychopharmacol. 2001 Sep;16(5):253-63. doi: 10.1097/00004850-200109000-00002.","Ruether E","Int Clin Psychopharmacol","2001","2001/09/13","","","10.1097/00004850-200109000-00002"
"28747210","The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer's disease: results from a randomized controlled trial","Rijpma A, van der Graaf M, Lansbergen MM, Meulenbroek O, Cetinyurek-Yavuz A, Sijben JW, Heerschap A, Olde Rikkert MGM.","Alzheimers Res Ther. 2017 Jul 26;9(1):51. doi: 10.1186/s13195-017-0286-2.","Rijpma A","Alzheimers Res Ther","2017","2017/07/28","PMC5530581","","10.1186/s13195-017-0286-2"
"28387664","Efficacy of Hearing Aids on the Cognitive Status of Patients with Alzheimer's Disease and Hearing Loss: A Multicenter Controlled Randomized Trial","Nguyen MF, Bonnefoy M, Adrait A, Gueugnon M, Petitot C, Collet L, Roux A, Perrot X; ADPHA study group.","J Alzheimers Dis. 2017;58(1):123-137. doi: 10.3233/JAD-160793.","Nguyen MF","J Alzheimers Dis","2017","2017/04/08","","","10.3233/JAD-160793"
"19494439","Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental","Lloret A, Badía MC, Mora NJ, Pallardó FV, Alonso MD, Viña J.","J Alzheimers Dis. 2009;17(1):143-9. doi: 10.3233/JAD-2009-1033.","Lloret A","J Alzheimers Dis","2009","2009/06/05","","","10.3233/JAD-2009-1033"
"11884649","Estimating the prevalence of agitation in community-dwelling persons with Alzheimer's disease","Tractenberg RE, Weiner MF, Thal LJ.","J Neuropsychiatry Clin Neurosci. 2002 Winter;14(1):11-8. doi: 10.1176/jnp.14.1.11.","Tractenberg RE","J Neuropsychiatry Clin Neurosci","2002","2002/03/09","","","10.1176/jnp.14.1.11"
"3553166","Behavioral symptoms in Alzheimer's disease: phenomenology and treatment","Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A.","J Clin Psychiatry. 1987 May;48 Suppl:9-15.","Reisberg B","J Clin Psychiatry","1987","1987/05/01","","",""
"29405226","Delayed-Start Analyses in the Phase 3 Solanezumab EXPEDITION3 Study in Mild Alzheimer's Disease","Liu-Seifert H, Case MG, Andersen SW, Holdridge KC, Aisen PS, Kollack-Walker S, Siemers E.","J Prev Alzheimers Dis. 2018;5(1):8-14. doi: 10.14283/jpad.2018.1.","Liu-Seifert H","J Prev Alzheimers Dis","2018","2018/02/07","","","10.14283/jpad.2018.1"
"19460120","Correlation between a reduction in Frontal Assessment Battery scores and delusional thoughts in patients with Alzheimer's disease","Nagata T, Ishii K, Ito T, Aoki K, Ehara Y, Kada H, Furukawa H, Tsumura M, Shinagawa S, Kasahara H, Nakayama K.","Psychiatry Clin Neurosci. 2009 Aug;63(4):449-54. doi: 10.1111/j.1440-1819.2009.01968.x. Epub 2009 Apr 29.","Nagata T","Psychiatry Clin Neurosci","2009","2009/05/23","","","10.1111/j.1440-1819.2009.01968.x"
"1414271","Tacrine in Alzheimer's disease","Eagger SA, Levy R, Sahakian BJ.","Acta Neurol Scand Suppl. 1992;139:75-80. doi: 10.1111/j.1600-0404.1992.tb04459.x.","Eagger SA","Acta Neurol Scand Suppl","1992","1992/01/01","","","10.1111/j.1600-0404.1992.tb04459.x"
"12568834","Hormone replacement therapy in postmenopausal women with Alzheimer's disease: a randomized, prospective study","Yoon BK, Kim DK, Kang Y, Kim JW, Shin MH, Na DL.","Fertil Steril. 2003 Feb;79(2):274-80. doi: 10.1016/s0015-0282(02)04666-6.","Yoon BK","Fertil Steril","2003","2003/02/06","","","10.1016/s0015-0282(02)04666-6"
"22647254","Impaired LTP- but not LTD-like cortical plasticity in Alzheimer's disease patients","Koch G, Di Lorenzo F, Bonnì S, Ponzo V, Caltagirone C, Martorana A.","J Alzheimers Dis. 2012;31(3):593-9. doi: 10.3233/JAD-2012-120532.","Koch G","J Alzheimers Dis","2012","2012/06/01","","","10.3233/JAD-2012-120532"
"2501817","Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's disease","Mellow AM, Sunderland T, Cohen RM, Lawlor BA, Hill JL, Newhouse PA, Cohen MR, Murphy DL.","Psychopharmacology (Berl). 1989;98(3):403-7. doi: 10.1007/BF00451695.","Mellow AM","Psychopharmacology (Berl)","1989","1989/01/01","","","10.1007/BF00451695"
"33252075","Retinal Optical Coherence Tomography Metrics Are Unchanged in Verubecestat Alzheimer's Disease Clinical Trial but Correlate with Baseline Regional Brain Atrophy","Sergott RC, Raji A, Kost J, Sur C, Jackson S, Locco A, Patel A, Furtek C, Mattson B, Egan MF.","J Alzheimers Dis. 2021;79(1):275-287. doi: 10.3233/JAD-200735.","Sergott RC","J Alzheimers Dis","2021","2020/11/30","","","10.3233/JAD-200735"
"19047474","Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension","Chan A, Paskavitz J, Remington R, Rasmussen S, Shea TB.","Am J Alzheimers Dis Other Demen. 2008 Dec-2009 Jan;23(6):571-85. doi: 10.1177/1533317508325093. Epub 2008 Dec 1.","Chan A","Am J Alzheimers Dis Other Demen","2008","2008/12/03","","","10.1177/1533317508325093"
"31433930","Fornix-Region Deep Brain Stimulation-Induced Memory Flashbacks in Alzheimer's Disease","Deeb W, Salvato B, Almeida L, Foote KD, Amaral R, Germann J, Rosenberg PB, Tang-Wai DF, Wolk DA, Burke AD, Salloway S, Sabbagh MN, Chakravarty MM, Smith GS, Lyketsos CG, Lozano AM, Okun MS.","N Engl J Med. 2019 Aug 22;381(8):783-785. doi: 10.1056/NEJMc1905240.","Deeb W","N Engl J Med","2019","2019/08/22","PMC7313538","NIHMS1548717","10.1056/NEJMc1905240"
"9718229","Beyond the cholinergic hypothesis: the effect of metrifonate and other cholinesterase inhibitors on neuropsychiatric symptoms in Alzheimer's disease","Kaufer D.","Dement Geriatr Cogn Disord. 1998;9 Suppl 2:8-14. doi: 10.1159/000051193.","Kaufer D","Dement Geriatr Cogn Disord","1998","1998/08/26","","","10.1159/000051193"
"30391679","Insulin resistance in patients with Alzheimer's dementia: A controlled study from India","Thankappan S, Sen S, Subramanian S, Sinha P, Purushottam M, Bharath S.","Asian J Psychiatr. 2018 Dec;38:33-34. doi: 10.1016/j.ajp.2018.10.026. Epub 2018 Oct 28.","Thankappan S","Asian J Psychiatr","2018","2018/11/05","","","10.1016/j.ajp.2018.10.026"
"36641605","Establishing Clinically Meaningful Change on Outcome Assessments Frequently Used in Trials of Mild Cognitive Impairment Due to Alzheimer's Disease","Lansdall CJ, McDougall F, Butler LM, Delmar P, Pross N, Qin S, McLeod L, Zhou X, Kerchner GA, Doody RS.","J Prev Alzheimers Dis. 2023;10(1):9-18. doi: 10.14283/jpad.2022.102.","Lansdall CJ","J Prev Alzheimers Dis","2023","2023/01/15","","","10.14283/jpad.2022.102"
"23954029","Simulating effects of biomarker enrichment on Alzheimer's disease prevention trials: conceptual framework and example","Leoutsakos JM, Bartlett AL, Forrester SN, Lyketsos CG.","Alzheimers Dement. 2014 Mar;10(2):152-61. doi: 10.1016/j.jalz.2013.05.1776. Epub 2013 Aug 15.","Leoutsakos JM","Alzheimers Dement","2014","2013/08/20","PMC3925200","NIHMS516452","10.1016/j.jalz.2013.05.1776"
"21971472","MR spectroscopy for assessment of memantine treatment in mild to moderate Alzheimer dementia","Ashford JW, Adamson M, Beale T, La D, Hernandez B, Noda A, Rosen A, O'Hara R, Fairchild JK, Spielman D, Yesavage JA.","J Alzheimers Dis. 2011;26 Suppl 3(0 3):331-6. doi: 10.3233/JAD-2011-0021.","Ashford JW","J Alzheimers Dis","2011","2011/10/06","PMC3764646","NIHMS504005","10.3233/JAD-2011-0021"
"18999344","Implicit/explicit memory dissociation in Alzheimer's disease: the consequence of inappropriate processing?","Willems S, Salmon E, Van der Linden M.","Neuropsychology. 2008 Nov;22(6):710-7. doi: 10.1037/a0012986.","Willems S","Neuropsychology","2008","2008/11/13","","","10.1037/a0012986"
"19846683","The effect of multisensory stimulation on persons residing in an extended care facility","Ward-Smith P, Llanque SM, Curran D.","Am J Alzheimers Dis Other Demen. 2009 Dec-2010 Jan;24(6):450-5. doi: 10.1177/1533317509350153. Epub 2009 Oct 21.","Ward-Smith P","Am J Alzheimers Dis Other Demen","2009","2009/10/23","","","10.1177/1533317509350153"
"27846868","Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer's disease: post-hoc analysis of a randomized placebo-controlled study","Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM.","Alzheimers Res Ther. 2016 Nov 15;8(1):47. doi: 10.1186/s13195-016-0214-x.","Hager K","Alzheimers Res Ther","2016","2016/11/17","PMC5111338","","10.1186/s13195-016-0214-x"
"3674795","Effects of oral physostigmine in Alzheimer's disease","Stern Y, Sano M, Mayeux R.","Ann Neurol. 1987 Sep;22(3):306-10. doi: 10.1002/ana.410220305.","Stern Y","Ann Neurol","1987","1987/09/01","","","10.1002/ana.410220305"
"16420392","A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease","Alvarez XA, Cacabelos R, Laredo M, Couceiro V, Sampedro C, Varela M, Corzo L, Fernandez-Novoa L, Vargas M, Aleixandre M, Linares C, Granizo E, Muresanu D, Moessler H.","Eur J Neurol. 2006 Jan;13(1):43-54. doi: 10.1111/j.1468-1331.2006.01222.x.","Alvarez XA","Eur J Neurol","2006","2006/01/20","","","10.1111/j.1468-1331.2006.01222.x"
"10717900","Changes in the rCBF images of patients with Alzheimer's disease receiving Donepezil therapy","Staff RT, Gemmell HG, Shanks MF, Murray AD, Venneri A.","Nucl Med Commun. 2000 Jan;21(1):37-41. doi: 10.1097/00006231-200001000-00007.","Staff RT","Nucl Med Commun","2000","2000/03/16","","","10.1097/00006231-200001000-00007"
"20541837","Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer's disease","Koch W, Teipel S, Mueller S, Benninghoff J, Wagner M, Bokde AL, Hampel H, Coates U, Reiser M, Meindl T.","Neurobiol Aging. 2012 Mar;33(3):466-78. doi: 10.1016/j.neurobiolaging.2010.04.013. Epub 2010 Jun 11.","Koch W","Neurobiol Aging","2012","2010/06/15","","","10.1016/j.neurobiolaging.2010.04.013"
"23090007","Enhancing the salience of fluency improves recognition memory performance in mild Alzheimer's disease","Bastin C, Willems S, Genon S, Salmon E.","J Alzheimers Dis. 2013;33(4):1033-9. doi: 10.3233/JAD-2012-121678.","Bastin C","J Alzheimers Dis","2013","2012/10/24","","","10.3233/JAD-2012-121678"
"2643356","Double-blind trial of imipramine in Alzheimer's disease patients with and without depression","Reifler BV, Teri L, Raskind M, Veith R, Barnes R, White E, McLean P.","Am J Psychiatry. 1989 Jan;146(1):45-9. doi: 10.1176/ajp.146.1.45.","Reifler BV","Am J Psychiatry","1989","1989/01/01","","","10.1176/ajp.146.1.45"
"24496072","Effects of centrally acting angiotensin converting enzyme inhibitors on functional decline in patients with Alzheimer's disease","O'Caoimh R, Healy L, Gao Y, Svendrovski A, Kerins DM, Eustace J, Kehoe PG, Guyatt G, Molloy DW.","J Alzheimers Dis. 2014;40(3):595-603. doi: 10.3233/JAD-131694.","O'Caoimh R","J Alzheimers Dis","2014","2014/02/06","","","10.3233/JAD-131694"
"19494443","Delusion symptoms and response to antipsychotic treatment are associated with the 5-HT2A receptor polymorphism (102T/C) in Alzheimer's disease: a 3-year follow-up longitudinal study","Angelucci F, Bernardini S, Gravina P, Bellincampi L, Trequattrini A, Di Iulio F, Vanni D, Federici G, Caltagirone C, Bossù P, Spalletta G.","J Alzheimers Dis. 2009;17(1):203-11. doi: 10.3233/JAD-2009-1031.","Angelucci F","J Alzheimers Dis","2009","2009/06/05","","","10.3233/JAD-2009-1031"
"15896425","Effect of oral administration of a whole formula diet on nutritional and cognitive status in patients with Alzheimer's disease","Salas-Salvadó J, Torres M, Planas M, Altimir S, Pagan C, Gonzalez ME, Johnston S, Puiggros C, Bonada A, García-Lorda P.","Clin Nutr. 2005 Jun;24(3):390-7. doi: 10.1016/j.clnu.2004.12.006.","Salas-Salvadó J","Clin Nutr","2005","2005/05/18","","","10.1016/j.clnu.2004.12.006"
"9494702","No neuropathologic evidence for an increased frequency of Alzheimer's disease among elderly schizophrenics","Murphy GM Jr, Lim KO, Wieneke M, Ellis WG, Forno LS, Hoff AL, Nordahl T.","Biol Psychiatry. 1998 Feb 1;43(3):205-9. doi: 10.1016/S0006-3223(97)00031-0.","Murphy GM Jr","Biol Psychiatry","1998","1998/03/12","","","10.1016/S0006-3223(97)00031-0"
"9660108","Antiglutamatergic therapy in Alzheimer's disease--effects of lamotrigine. Short communication","Tekin S, Aykut-Bingöl C, Tanridağ T, Aktan S.","J Neural Transm (Vienna). 1998;105(2-3):295-303. doi: 10.1007/s007020050059.","Tekin S","J Neural Transm (Vienna)","1998","1998/07/11","","","10.1007/s007020050059"
"12574428","Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease","Grady CL, McIntosh AR, Beig S, Keightley ML, Burian H, Black SE.","J Neurosci. 2003 Feb 1;23(3):986-93. doi: 10.1523/JNEUROSCI.23-03-00986.2003.","Grady CL","J Neurosci","2003","2003/02/08","PMC6741917","","10.1523/JNEUROSCI.23-03-00986.2003"
"29295652","Long-Lasting Neuropsychological Effects of a Computerized Cognitive Training in Patients Affected by Early Stage Alzheimer's Disease: Are They Stable Over Time?","Cavallo M, Angilletta C.","J Appl Gerontol. 2019 Jul;38(7):1035-1044. doi: 10.1177/0733464817750276. Epub 2018 Jan 2.","Cavallo M","J Appl Gerontol","2019","2018/01/04","","","10.1177/0733464817750276"
"9660107","Abnormal amino acid metabolism in patients with early stage Alzheimer dementia","Fekkes D, van der Cammen TJ, van Loon CP, Verschoor C, van Harskamp F, de Koning I, Schudel WJ, Pepplinkhuizen L.","J Neural Transm (Vienna). 1998;105(2-3):287-94. doi: 10.1007/s007020050058.","Fekkes D","J Neural Transm (Vienna)","1998","1998/07/11","","","10.1007/s007020050058"
"24262299","Effects of a non-focal plasticity protocol on apathy in moderate Alzheimer's disease: a randomized, double-blind, sham-controlled trial","Suemoto CK, Apolinario D, Nakamura-Palacios EM, Lopes L, Leite RE, Sales MC, Nitrini R, Brucki SM, Morillo LS, Magaldi RM, Fregni F.","Brain Stimul. 2014 Mar-Apr;7(2):308-13. doi: 10.1016/j.brs.2013.10.003. Epub 2013 Oct 25.","Suemoto CK","Brain Stimul","2014","2013/11/23","","","10.1016/j.brs.2013.10.003"
"30298182","Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study","Harrison JE, Rentz DM, Brashear HR, Arrighi HM, Ropacki MT, Liu E.","J Prev Alzheimers Dis. 2018;5(4):236-244. doi: 10.14283/jpad.2018.31.","Harrison JE","J Prev Alzheimers Dis","2018","2018/10/10","","","10.14283/jpad.2018.31"
"2266510","Italian Multicentre Study on Dementia (SMID): a neuropsychological test battery for assessing Alzheimer's disease","Bracco L, Amaducci L, Pedone D, Bino G, Lazzaro MP, Carella F, D'Antona R, Gallato R, Denes G.","J Psychiatr Res. 1990;24(3):213-26. doi: 10.1016/0022-3956(90)90011-e.","Bracco L","J Psychiatr Res","1990","1990/01/01","","","10.1016/0022-3956(90)90011-e"
"15481783","Improving quality of life for persons with Alzheimer's disease and their family caregivers: brief occupational therapy intervention","Dooley NR, Hinojosa J.","Am J Occup Ther. 2004 Sep-Oct;58(5):561-9. doi: 10.5014/ajot.58.5.561.","Dooley NR","Am J Occup Ther","2004","2004/10/16","","","10.5014/ajot.58.5.561"
"1907964","The use of selegiline in Alzheimer's patients with behavior problems","Goad DL, Davis CM, Liem P, Fuselier CC, McCormack JR, Olsen KM.","J Clin Psychiatry. 1991 Aug;52(8):342-5.","Goad DL","J Clin Psychiatry","1991","1991/08/01","","",""
"29914022","Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study","Salloway SP, Sperling R, Fox NC, Sabbagh MN, Honig LS, Porsteinsson AP, Rofael H, Ketter N, Wang D, Liu E, Carr S, Black RS, Brashear HR.","J Alzheimers Dis. 2018;64(3):689-707. doi: 10.3233/JAD-171157.","Salloway SP","J Alzheimers Dis","2018","2018/06/20","","","10.3233/JAD-171157"
"27724156","[Formula: see text]Practice effects and longitudinal cognitive change in clinically normal older adults differ by Alzheimer imaging biomarker status","Machulda MM, Hagen CE, Wiste HJ, Mielke MM, Knopman DS, Roberts RO, Vemuri P, Lowe VJ, Jack CR Jr, Petersen RC.","Clin Neuropsychol. 2017 Jan;31(1):99-117. doi: 10.1080/13854046.2016.1241303. Epub 2016 Oct 11.","Machulda MM","Clin Neuropsychol","2017","2016/10/12","PMC5408356","NIHMS856242","10.1080/13854046.2016.1241303"
"26402079","Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study","Eriksdotter M, Vedin I, Falahati F, Freund-Levi Y, Hjorth E, Faxen-Irving G, Wahlund LO, Schultzberg M, Basun H, Cederholm T, Palmblad J.","J Alzheimers Dis. 2015;48(3):805-12. doi: 10.3233/JAD-150102.","Eriksdotter M","J Alzheimers Dis","2015","2015/09/25","","","10.3233/JAD-150102"
"9017530","Depression, delusions, and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype","Lyketsos CG, Baker L, Warren A, Steele C, Brandt J, Steinberg M, Kopunek S, Baker A.","J Neuropsychiatry Clin Neurosci. 1997 Winter;9(1):64-7. doi: 10.1176/jnp.9.1.64.","Lyketsos CG","J Neuropsychiatry Clin Neurosci","1997","1997/01/01","","","10.1176/jnp.9.1.64"
"11935419","Characterization of visuoconstructional disabilities in patients with probable dementia of Alzheimer's type","Guérin F, Belleville S, Ska B.","J Clin Exp Neuropsychol. 2002 Feb;24(1):1-17. doi: 10.1076/jcen.24.1.1.963.","Guérin F","J Clin Exp Neuropsychol","2002","2002/04/06","","","10.1076/jcen.24.1.1.963"
"24736801","Psychometric properties of the Dependence Scale in large randomized clinical trials of patients with mild and moderate Alzheimer's disease","Wyrwich KW, Auguste P, Buchanan J, Rudell K, Lacey L, Leibman C, Symonds T, Brashear HR.","Am J Alzheimers Dis Other Demen. 2014 Nov;29(7):620-9. doi: 10.1177/1533317514527336. Epub 2014 Apr 15.","Wyrwich KW","Am J Alzheimers Dis Other Demen","2014","2014/04/17","","","10.1177/1533317514527336"
"31658058","Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer's Disease","Schelter BO, Shiells H, Baddeley TC, Rubino CM, Ganesan H, Hammel J, Vuksanovic V, Staff RT, Murray AD, Bracoud L, Riedel G, Gauthier S, Jia J, Bentham P, Kook K, Storey JMD, Harrington CR, Wischik CM.","J Alzheimers Dis. 2019;72(3):931-946. doi: 10.3233/JAD-190772.","Schelter BO","J Alzheimers Dis","2019","2019/10/29","PMC6918900","","10.3233/JAD-190772"
"20338990","Apple juice improved behavioral but not cognitive symptoms in moderate-to-late stage Alzheimer's disease in an open-label pilot study","Remington R, Chan A, Lepore A, Kotlya E, Shea TB.","Am J Alzheimers Dis Other Demen. 2010 Jun;25(4):367-71. doi: 10.1177/1533317510363470. Epub 2010 Mar 25.","Remington R","Am J Alzheimers Dis Other Demen","2010","2010/03/27","","","10.1177/1533317510363470"
"7617154","Is semantic memory consistently impaired early in the course of Alzheimer's disease? Neuroanatomical and diagnostic implications","Hodges JR, Patterson K.","Neuropsychologia. 1995 Apr;33(4):441-59. doi: 10.1016/0028-3932(94)00127-b.","Hodges JR","Neuropsychologia","1995","1995/04/01","","","10.1016/0028-3932(94)00127-b"
"9777903","The association of weight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis","White H, Pieper C, Schmader K.","J Am Geriatr Soc. 1998 Oct;46(10):1223-7. doi: 10.1111/j.1532-5415.1998.tb04537.x.","White H","J Am Geriatr Soc","1998","1998/10/20","","","10.1111/j.1532-5415.1998.tb04537.x"
"32236402","Cortical β-Amyloid in Older Adults Is Associated with Multidomain Interventions with and without Omega 3 Polyunsaturated Fatty Acid Supplementation","Hooper C, Coley N, De Souto Barreto P, Payoux P, Salabert AS, Andrieu S, Weiner M, Vellas B.","J Prev Alzheimers Dis. 2020;7(2):128-134. doi: 10.14283/jpad.2020.4.","Hooper C","J Prev Alzheimers Dis","2020","2020/04/03","","","10.14283/jpad.2020.4"
"22531417","High prevalence of cerebral microbleeds at 7Tesla MRI in patients with early Alzheimer's disease","Brundel M, Heringa SM, de Bresser J, Koek HL, Zwanenburg JJ, Jaap Kappelle L, Luijten PR, Biessels GJ.","J Alzheimers Dis. 2012;31(2):259-63. doi: 10.3233/JAD-2012-120364.","Brundel M","J Alzheimers Dis","2012","2012/04/26","","","10.3233/JAD-2012-120364"
"15121650","Sustained benefit of supportive intervention for depressive symptoms in caregivers of patients with Alzheimer's disease","Mittelman MS, Roth DL, Coon DW, Haley WE.","Am J Psychiatry. 2004 May;161(5):850-6. doi: 10.1176/appi.ajp.161.5.850.","Mittelman MS","Am J Psychiatry","2004","2004/05/04","","","10.1176/appi.ajp.161.5.850"
"8018041","Impairment of spatially directed attention in patients with probable Alzheimer's disease as measured by eye movements","Scinto LF, Daffner KR, Castro L, Weintraub S, Vavrik M, Mesulam MM.","Arch Neurol. 1994 Jul;51(7):682-8. doi: 10.1001/archneur.1994.00540190062016.","Scinto LF","Arch Neurol","1994","1994/07/01","","","10.1001/archneur.1994.00540190062016"
"21741446","Changes in cerebral glucose metabolism in patients with mild-to-moderate Alzheimer's disease: a pilot study with the Chinese herbal medicine fuzhisan","Bi M, Tong S, Zhang Z, Ma Q, Zhang S, Luo Z, Zhang Y, Li X, Wang D.","Neurosci Lett. 2011 Aug 21;501(1):35-40. doi: 10.1016/j.neulet.2011.06.036. Epub 2011 Jun 29.","Bi M","Neurosci Lett","2011","2011/07/12","","","10.1016/j.neulet.2011.06.036"
"25079803","Donepezil improves gait performance in older adults with mild Alzheimer's disease: a phase II clinical trial","Montero-Odasso M, Muir-Hunter SW, Oteng-Amoako A, Gopaul K, Islam A, Borrie M, Wells J, Speechley M.","J Alzheimers Dis. 2015;43(1):193-9. doi: 10.3233/JAD-140759.","Montero-Odasso M","J Alzheimers Dis","2015","2014/08/01","","","10.3233/JAD-140759"
"12445840","Steroid-induced elevation of glucose in Alzheimer's disease: relationship to gender, apolipoprotein E genotype and cognition","Aisen PS, Berg JD, Craft S, Peskind ER, Sano M, Teri L, Mulnard RA, Thomas RG, Thal LJ.","Psychoneuroendocrinology. 2003 Jan;28(1):113-20. doi: 10.1016/s0306-4530(02)00015-x.","Aisen PS","Psychoneuroendocrinology","2003","2002/11/26","","","10.1016/s0306-4530(02)00015-x"
"11144935","[Effects of family-centered group therapy with demented patients and their caregivers]","Haupt M, Siebel U, Palm B, Kretschmar JH, Jänner M.","Fortschr Neurol Psychiatr. 2000 Nov;68(11):503-15. doi: 10.1055/s-2000-11789.","Haupt M","Fortschr Neurol Psychiatr","2000","2001/01/06","","","10.1055/s-2000-11789"
"30883357","Rationale and Design of a Clinical Trial of Adapted Tango to Improve Negative Health Impacts in Middle Aged African-American Female Caregivers of Persons with Alzheimer's Disease (ACT Trial)","Hackney ME, McCullough LE, Bay AA, Silverstein HA, Hart AR, Shin RJ, Wharton W.","J Alzheimers Dis. 2019;68(2):767-775. doi: 10.3233/JAD-181130.","Hackney ME","J Alzheimers Dis","2019","2019/03/19","","","10.3233/JAD-181130"
"9596021","Lack of relation between race and cognitive test performance in Alzheimer's disease","Carlson MC, Brandt J, Carson KA, Kawas CH.","Neurology. 1998 May;50(5):1499-501. doi: 10.1212/wnl.50.5.1499.","Carlson MC","Neurology","1998","1998/05/22","","","10.1212/wnl.50.5.1499"
"25022541","Follow-up evaluation of cognitive function in the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial and its Follow-up Study","ADAPT-FS Research Group.","Alzheimers Dement. 2015 Feb;11(2):216-25.e1. doi: 10.1016/j.jalz.2014.03.009. Epub 2014 Jul 9.","ADAPT-FS Research Group","Alzheimers Dement","2015","2014/07/16","PMC4287453","NIHMS612210","10.1016/j.jalz.2014.03.009"
"24934544","Effects of supplementation with omega-3 fatty acids on oxidative stress and inflammation in patients with Alzheimer's disease: the OmegAD study","Freund-Levi Y, Vedin I, Hjorth E, Basun H, Faxén Irving G, Schultzberg M, Eriksdotter M, Palmblad J, Vessby B, Wahlund LO, Cederholm T, Basu S.","J Alzheimers Dis. 2014;42(3):823-31. doi: 10.3233/JAD-132042.","Freund-Levi Y","J Alzheimers Dis","2014","2014/06/18","","","10.3233/JAD-132042"
"8239307","Activation PET as an instrument to determine therapeutic efficacy in Alzheimer's disease","Heiss WD, Kessler J, Slansky I, Mielke R, Szelies B, Herholz K.","Ann N Y Acad Sci. 1993 Sep 24;695:327-31. doi: 10.1111/j.1749-6632.1993.tb23078.x.","Heiss WD","Ann N Y Acad Sci","1993","1993/09/24","","","10.1111/j.1749-6632.1993.tb23078.x"
"30958356","Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study","Jernerén F, Cederholm T, Refsum H, Smith AD, Turner C, Palmblad J, Eriksdotter M, Hjorth E, Faxen-Irving G, Wahlund LO, Schultzberg M, Basun H, Freund-Levi Y.","J Alzheimers Dis. 2019;69(1):189-197. doi: 10.3233/JAD-181148.","Jernerén F","J Alzheimers Dis","2019","2019/04/09","","","10.3233/JAD-181148"
"1912105","A pilot placebo-controlled study of chronic m-CPP administration in Alzheimer's disease","Lawlor BA, Sunderland T, Mellow AM, Molchan SE, Martinez R, Murphy DL.","Biol Psychiatry. 1991 Jul 15;30(2):140-4. doi: 10.1016/0006-3223(91)90167-k.","Lawlor BA","Biol Psychiatry","1991","1991/07/15","","","10.1016/0006-3223(91)90167-k"
"9451579","ERP assessment of semantic memory in Alzheimer's disease","Castañeda M, Ostrosky-Solis F, Pérez M, Bobes MA, Rangel LE.","Int J Psychophysiol. 1997 Dec;27(3):201-14. doi: 10.1016/s0167-8760(97)00064-0.","Castañeda M","Int J Psychophysiol","1997","1998/02/06","","","10.1016/s0167-8760(97)00064-0"
"18928090","[Correlation analysis on changes between cognitive ability and brain fMRI after acupoint thread embedding in Alzheimer's disease patients]","Zhou YL, Han HY, Jia JP.","Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008 Aug;28(8):689-93.","Zhou YL","Zhongguo Zhong Xi Yi Jie He Za Zhi","2008","2008/10/22","","",""
"27567824","The Savvy Caregiver Program: A Probe Multicenter Randomized Controlled Pilot Trial in Caregivers of Patients Affected by Alzheimer's Disease","Sepe-Monti M, Vanacore N, Bartorelli L, Tognetti A, Giubilei F; Caregiver Study Group Savvy.","J Alzheimers Dis. 2016 Oct 4;54(3):1235-1246. doi: 10.3233/JAD-160235.","Sepe-Monti M","J Alzheimers Dis","2016","2016/08/29","","","10.3233/JAD-160235"
"1808500","[The significance of quantified EEG in Alzheimer's disease. Changes induced by piracetam]","Pierlovisi-Lavaivre M, Michel B, Sebban C, Tesolin B, Chave B, Sambuc R, Melac M, Gastaut JL, Poitrenaud J, Millet Y.","Neurophysiol Clin. 1991 Dec;21(5-6):411-23. doi: 10.1016/s0987-7053(05)80332-6.","Pierlovisi-Lavaivre M","Neurophysiol Clin","1991","1991/12/01","","","10.1016/s0987-7053(05)80332-6"
"11459677","Recurrent neural network-based approach for early recognition of Alzheimer's disease in EEG","Petrosian AA, Prokhorov DV, Lajara-Nanson W, Schiffer RB.","Clin Neurophysiol. 2001 Aug;112(8):1378-87. doi: 10.1016/s1388-2457(01)00579-x.","Petrosian AA","Clin Neurophysiol","2001","2001/07/19","","","10.1016/s1388-2457(01)00579-x"
"21157026","Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer's disease patients","Keller C, Kadir A, Forsberg A, Porras O, Nordberg A.","J Alzheimers Dis. 2011;24(1):109-23. doi: 10.3233/JAD-2010-101290.","Keller C","J Alzheimers Dis","2011","2010/12/16","","","10.3233/JAD-2010-101290"
"20517868","[Human Albumin Grifols 5% in plasmapheresis: a new therapy involving beta-amyloid mobilisation in Alzheimer's disease]","Boada-Rovira M.","Rev Neurol. 2010 Mar 16;50 Suppl 5:S9-18.","Boada-Rovira M","Rev Neurol","2010","2010/06/03","","",""
"7662176","Potential of cognitive plasticity as a diagnostic instrument: a cross-validation and extension","Baltes MM, Kühl KP, Gutzmann H, Sowarka D.","Psychol Aging. 1995 Jun;10(2):167-72. doi: 10.1037//0882-7974.10.2.167.","Baltes MM","Psychol Aging","1995","1995/06/01","","","10.1037//0882-7974.10.2.167"
"8351023","Clinical trial of indomethacin in Alzheimer's disease","Rogers J, Kirby LC, Hempelman SR, Berry DL, McGeer PL, Kaszniak AW, Zalinski J, Cofield M, Mansukhani L, Willson P, et al.","Neurology. 1993 Aug;43(8):1609-11. doi: 10.1212/wnl.43.8.1609.","Rogers J","Neurology","1993","1993/08/01","","","10.1212/wnl.43.8.1609"
"21498904","Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's disease","Förster S, Buschert VC, Buchholz HG, Teipel SJ, Friese U, Zach C, la Fougere C, Rominger A, Drzezga A, Hampel H, Bartenstein P, Buerger K.","J Alzheimers Dis. 2011;25(4):695-706. doi: 10.3233/JAD-2011-100996.","Förster S","J Alzheimers Dis","2011","2011/04/19","","","10.3233/JAD-2011-100996"
"24898653","A nutritional approach to ameliorate altered phospholipid metabolism in Alzheimer's disease","Hartmann T, van Wijk N, Wurtman RJ, Olde Rikkert MG, Sijben JW, Soininen H, Vellas B, Scheltens P.","J Alzheimers Dis. 2014;41(3):715-7. doi: 10.3233/JAD-141137.","Hartmann T","J Alzheimers Dis","2014","2014/06/06","","","10.3233/JAD-141137"
"11897170","No association between the lipoprotein lipase S447X polymorphism and Alzheimer's disease","Fidani L, Compton D, Hardy J, Petersen RC, Tangalos E, Mirtsou V, Goulas A, De Vrieze FW.","Neurosci Lett. 2002 Apr 12;322(3):192-4. doi: 10.1016/s0304-3940(02)00098-8.","Fidani L","Neurosci Lett","2002","2002/03/19","","","10.1016/s0304-3940(02)00098-8"
"1565229","Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease","Powers WJ, Perlmutter JS, Videen TO, Herscovitch P, Griffeth LK, Royal HD, Siegel BA, Morris JC, Berg L.","Neurology. 1992 Apr;42(4):765-70. doi: 10.1212/wnl.42.4.765.","Powers WJ","Neurology","1992","1992/04/01","","","10.1212/wnl.42.4.765"
"9213070","Distinguishing between patients with depression or very mild Alzheimer's disease using the Delayed-Word-Recall test","Coen RF, Kirby M, Swanwick GR, Maguire CP, Walsh JB, Coakley D, O'Neill D, Lawlor BA.","Dement Geriatr Cogn Disord. 1997 Jul-Aug;8(4):244-7. doi: 10.1159/000106638.","Coen RF","Dement Geriatr Cogn Disord","1997","1997/07/01","","","10.1159/000106638"
"26499250","Would transcranial direct current stimulation (tDCS) enhance the effects of working memory training in older adults with mild neurocognitive disorder due to Alzheimer's disease: study protocol for a randomized controlled trial","Cheng CP, Chan SS, Mak AD, Chan WC, Cheng ST, Shi L, Wang D, Lam LC.","Trials. 2015 Oct 24;16:479. doi: 10.1186/s13063-015-0999-0.","Cheng CP","Trials","2015","2015/10/27","PMC4619532","","10.1186/s13063-015-0999-0"
"26560146","New scoring methodology improves the sensitivity of the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials","Verma N, Beretvas SN, Pascual B, Masdeu JC, Markey MK; Alzheimer’s Disease Neuroimaging Initiative.","Alzheimers Res Ther. 2015 Nov 12;7(1):64. doi: 10.1186/s13195-015-0151-0.","Verma N","Alzheimers Res Ther","2015","2015/11/13","PMC4642693","","10.1186/s13195-015-0151-0"
"18684311","An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer's disease","Heo JH, Lee ST, Chu K, Oh MJ, Park HJ, Shim JY, Kim M.","Eur J Neurol. 2008 Aug;15(8):865-8. doi: 10.1111/j.1468-1331.2008.02157.x.","Heo JH","Eur J Neurol","2008","2008/08/08","","","10.1111/j.1468-1331.2008.02157.x"
"18640457","Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study","Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, Seely L, Hung D; dimebon investigators.","Lancet. 2008 Jul 19;372(9634):207-15. doi: 10.1016/S0140-6736(08)61074-0.","Doody RS","Lancet","2008","2008/07/22","","","10.1016/S0140-6736(08)61074-0"
"25122521","""The Castle of Remembrance"": New insights from a cognitive training programme for autobiographical memory in Alzheimer's disease","Lalanne J, Gallarda T, Piolino P.","Neuropsychol Rehabil. 2015;25(2):254-82. doi: 10.1080/09602011.2014.949276. Epub 2014 Aug 14.","Lalanne J","Neuropsychol Rehabil","2015","2014/08/15","","","10.1080/09602011.2014.949276"
"2405043","Biological and neuropsychological characterization of physostigmine responders and nonresponders in Alzheimer's disease","Harrell LE, Jope RS, Falgout J, Callaway R, Avery C, Spiers M, Leli D, Morere D, Halsey JH Jr.","J Am Geriatr Soc. 1990 Feb;38(2):113-22. doi: 10.1111/j.1532-5415.1990.tb03471.x.","Harrell LE","J Am Geriatr Soc","1990","1990/02/01","","","10.1111/j.1532-5415.1990.tb03471.x"
"8814420","Comparisons between SPECT and quantitative EEG measures of cortical impairment in mild to moderate Alzheimer's disease","Montplaisir J, Petit D, McNamara D, Gauthier S.","Eur Neurol. 1996;36(4):197-200. doi: 10.1159/000117247.","Montplaisir J","Eur Neurol","1996","1996/01/01","","","10.1159/000117247"
"26796681","Functional connectivity increase in the default-mode network of patients with Alzheimer's disease after long-term treatment with Galantamine","Blautzik J, Keeser D, Paolini M, Kirsch V, Berman A, Coates U, Reiser M, Teipel SJ, Meindl T.","Eur Neuropsychopharmacol. 2016 Mar;26(3):602-13. doi: 10.1016/j.euroneuro.2015.12.006. Epub 2015 Dec 10.","Blautzik J","Eur Neuropsychopharmacol","2016","2016/01/23","","","10.1016/j.euroneuro.2015.12.006"
"9532346","Effects of ""isolated"" transcutaneous electrical nerve stimulation on memory and affective behavior in patients with probable Alzheimer's disease","Scherder EJ, Bouma A, Steen LM.","Biol Psychiatry. 1998 Mar 15;43(6):417-24. doi: 10.1016/s0006-3223(97)00208-4.","Scherder EJ","Biol Psychiatry","1998","1998/04/09","","","10.1016/s0006-3223(97)00208-4"
"9653639","[The clinical picture and stability of non-cognitive symptoms in patients with Alzheimer's disease]","Haupt M, Jänner M, Stierstorfer A, Kretschmar C.","Fortschr Neurol Psychiatr. 1998 May;66(5):233-40. doi: 10.1055/s-2007-995259.","Haupt M","Fortschr Neurol Psychiatr","1998","1998/07/08","","","10.1055/s-2007-995259"
"1775604","Do blood pressure and age predict response to tacrine (THA) in Alzheimer's disease? A preliminary report","Schneider LS, Lyness SA, Pawluczyk S, Gleason RP, Sloane RB.","Psychopharmacol Bull. 1991;27(3):309-14.","Schneider LS","Psychopharmacol Bull","1991","1991/01/01","","",""
"23196404","Application of behavior-based ergonomics therapies to improve quality of life and reduce medication usage for Alzheimer's/dementia residents","Mowrey C, Parikh PJ, Bharwani G, Bharwani M.","Am J Alzheimers Dis Other Demen. 2013 Feb;28(1):35-41. doi: 10.1177/1533317512467678. Epub 2012 Nov 29.","Mowrey C","Am J Alzheimers Dis Other Demen","2013","2012/12/01","","","10.1177/1533317512467678"
"2653175","Multicenter trial of naloxone in Alzheimer's disease","Henderson VW, Roberts E, Wimer C, Bardolph EL, Chui HC, Damasio AR, Eslinger PJ, Folstein MF, Schneider LS, Teng EL, et al.","Ann Neurol. 1989 Apr;25(4):404-6. doi: 10.1002/ana.410250413.","Henderson VW","Ann Neurol","1989","1989/04/01","","","10.1002/ana.410250413"
"1444879","Treatment trial of oxiracetam in Alzheimer's disease","Green RC, Goldstein FC, Auchus AP, Presley R, Clark WS, Van Tuyl L, Green J, Hersch SM, Karp HR.","Arch Neurol. 1992 Nov;49(11):1135-6. doi: 10.1001/archneur.1992.00530350049018.","Green RC","Arch Neurol","1992","1992/11/01","","","10.1001/archneur.1992.00530350049018"
"7892366","Priming deficits in patients with dementia of the Alzheimer type","Burke J, Knight RG, Partridge FM.","Psychol Med. 1994 Nov;24(4):987-93. doi: 10.1017/s003329170002907x.","Burke J","Psychol Med","1994","1994/11/01","","","10.1017/s003329170002907x"
"21329501","Cognitive activity for the treatment of older adults with mild Alzheimer's disease (AD)--PACE AD: study protocol for a randomised controlled trial","Vidovich MR, Shaw J, Flicker L, Almeida OP.","Trials. 2011 Feb 17;12:47. doi: 10.1186/1745-6215-12-47.","Vidovich MR","Trials","2011","2011/02/19","PMC3052177","","10.1186/1745-6215-12-47"
"19324592","Ibuprofen treatment modifies cortical sources of EEG rhythms in mild Alzheimer's disease","Babiloni C, Frisoni GB, Del Percio C, Zanetti O, Bonomini C, Cassetta E, Pasqualetti P, Miniussi C, De Rosas M, Valenzano A, Cibelli G, Eusebi F, Rossini PM.","Clin Neurophysiol. 2009 Apr;120(4):709-18. doi: 10.1016/j.clinph.2009.02.005. Epub 2009 Mar 25.","Babiloni C","Clin Neurophysiol","2009","2009/03/28","","","10.1016/j.clinph.2009.02.005"
"10705165","Determinants of quantitative spectral electroencephalography in early Alzheimer's disease: cognitive function, regional cerebral blood flow, and computed tomography","Claus JJ, Ongerboer De Visser BW, Bour LJ, Walstra GJ, Hijdra A, Verbeeten B Jr, Van Royen EA, Kwa VI, van Gool WA.","Dement Geriatr Cogn Disord. 2000 Mar-Apr;11(2):81-9. doi: 10.1159/000017219.","Claus JJ","Dement Geriatr Cogn Disord","2000","2000/03/08","","","10.1159/000017219"
"9547470","Blood-brain barrier integrity in Alzheimer's disease patients and elderly control subjects","Caserta MT, Caccioppo D, Lapin GD, Ragin A, Groothuis DR.","J Neuropsychiatry Clin Neurosci. 1998 Winter;10(1):78-84. doi: 10.1176/jnp.10.1.78.","Caserta MT","J Neuropsychiatry Clin Neurosci","1998","1998/04/21","","","10.1176/jnp.10.1.78"
"11044780","Fate of patients with questionable (very mild) Alzheimer's disease: longitudinal profiles of individual subjects' decline","Perry RJ, Hodges JR.","Dement Geriatr Cogn Disord. 2000 Nov-Dec;11(6):342-9. doi: 10.1159/000017264.","Perry RJ","Dement Geriatr Cogn Disord","2000","2000/10/25","","","10.1159/000017264"
"16762429","Category-specific visual identification of filtered objects in Alzheimer's disease","Viggiano MP, Gori G, Zaccara G, Righi S, Vannucci M, Giovannelli F.","Arch Gerontol Geriatr. 2007 Mar-Apr;44(2):125-39. doi: 10.1016/j.archger.2006.04.003. Epub 2006 Jun 9.","Viggiano MP","Arch Gerontol Geriatr","2007","2006/06/10","","","10.1016/j.archger.2006.04.003"
"15004324","Colostrinin (a naturally occurring, proline-rich, polypeptide mixture) in the treatment of Alzheimer's disease","Bilikiewicz A, Gaus W.","J Alzheimers Dis. 2004 Feb;6(1):17-26. doi: 10.3233/jad-2004-6103.","Bilikiewicz A","J Alzheimers Dis","2004","2004/03/09","","","10.3233/jad-2004-6103"
"36442202","Impact of Computerized Cognitive Training on Default Mode Network Connectivity in Subjects at Risk for Alzheimer's Disease: A 78-week Randomized Controlled Trial","Petrella JR, Michael AM, Qian M, Nwosu A, Sneed J, Goldberg TE, Devanand DP, Doraiswamy PM.","J Alzheimers Dis. 2023;91(1):483-494. doi: 10.3233/JAD-220946.","Petrella JR","J Alzheimers Dis","2023","2022/11/28","PMC9881022","","10.3233/JAD-220946"
"16788393","High-frequency cranial electrostimulation (CES) in patients with probable Alzheimer's disease","Scherder EJ, van Tol MJ, Swaab DF.","Am J Phys Med Rehabil. 2006 Jul;85(7):614-8. doi: 10.1097/01.phm.0000223221.17301.50.","Scherder EJ","Am J Phys Med Rehabil","2006","2006/06/22","","","10.1097/01.phm.0000223221.17301.50"
"9232354","Postprandial hypotension in Alzheimer's disease","Idiaquez J, Rios L, Sandoval E.","Clin Auton Res. 1997 Jun;7(3):119-20. doi: 10.1007/BF02308837.","Idiaquez J","Clin Auton Res","1997","1997/06/01","","","10.1007/BF02308837"
"28269765","Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients","Ketter N, Brashear HR, Bogert J, Di J, Miaux Y, Gass A, Purcell DD, Barkhof F, Arrighi HM.","J Alzheimers Dis. 2017;57(2):557-573. doi: 10.3233/JAD-160216.","Ketter N","J Alzheimers Dis","2017","2017/03/09","","","10.3233/JAD-160216"
"9845166","Predictors of perceived memory impairment: do they differ in Alzheimer's disease versus normal aging?","Brustrom JE, Ober BA.","J Clin Exp Neuropsychol. 1998 Jun;20(3):402-12. doi: 10.1076/jcen.20.3.402.815.","Brustrom JE","J Clin Exp Neuropsychol","1998","1998/12/09","","","10.1076/jcen.20.3.402.815"
"8080392","Discrimination between stages of Alzheimer's disease with subsets of Mini-Mental State Examination items. An analysis of Consortium to Establish a Registry for Alzheimer's Disease data","Fillenbaum GG, Wilkinson WE, Welsh KA, Mohs RC.","Arch Neurol. 1994 Sep;51(9):916-21. doi: 10.1001/archneur.1994.00540210088017.","Fillenbaum GG","Arch Neurol","1994","1994/09/01","","","10.1001/archneur.1994.00540210088017"
"1513920","Low dose oral haloperidol and blood levels in Alzheimer's disease: a preliminary study","Devanand DP, Cooper T, Sackeim HA, Taurke E, Mayeux R.","Psychopharmacol Bull. 1992;28(2):169-73.","Devanand DP","Psychopharmacol Bull","1992","1992/01/01","","",""
"19328438","Commentary on ""A roadmap for the prevention of dementia II. Leon Thal Symposium 2008."" The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease","Gillette-Guyonnet S, Andrieu S, Dantoine T, Dartigues JF, Touchon J, Vellas B; MAPT Study Group.","Alzheimers Dement. 2009 Mar;5(2):114-21. doi: 10.1016/j.jalz.2009.01.008.","Gillette-Guyonnet S","Alzheimers Dement","2009","2009/03/31","","","10.1016/j.jalz.2009.01.008"
"12725765","A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry","Karas GB, Burton EJ, Rombouts SA, van Schijndel RA, O'Brien JT, Scheltens Ph, McKeith IG, Williams D, Ballard C, Barkhof F.","Neuroimage. 2003 Apr;18(4):895-907. doi: 10.1016/s1053-8119(03)00041-7.","Karas GB","Neuroimage","2003","2003/05/03","","","10.1016/s1053-8119(03)00041-7"
"2249050","Accuracy of clinical diagnosis of Alzheimer's disease","Burns A, Luthert P, Levy R, Jacoby R, Lantos P.","BMJ. 1990 Nov 3;301(6759):1026. doi: 10.1136/bmj.301.6759.1026.","Burns A","BMJ","1990","1990/11/03","PMC1664030","","10.1136/bmj.301.6759.1026"
"2898227","Intracerebroventricular bethanechol chloride administration in Alzheimer's disease","Harbaugh RE.","Ann N Y Acad Sci. 1988;531:174-9. doi: 10.1111/j.1749-6632.1988.tb31824.x.","Harbaugh RE","Ann N Y Acad Sci","1988","1988/01/01","","","10.1111/j.1749-6632.1988.tb31824.x"
"12112177","Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease","Lanctôt KL, Herrmann N, van Reekum R, Eryavec G, Naranjo CA.","Int J Geriatr Psychiatry. 2002 Jun;17(6):531-41. doi: 10.1002/gps.636.","Lanctôt KL","Int J Geriatr Psychiatry","2002","2002/07/12","","","10.1002/gps.636"
"29181493","Neflamapimod: Clinical Phase 2b-Ready Oral Small Molecule Inhibitor of p38α to Reverse Synaptic Dysfunction in Early Alzheimer's Disease","Alam J, Blackburn K, Patrick D.","J Prev Alzheimers Dis. 2017;4(4):273-278. doi: 10.14283/jpad.2017.41.","Alam J","J Prev Alzheimers Dis","2017","2017/11/29","","","10.14283/jpad.2017.41"
"29171296","The Support, Health, Activities, Resources, and Education program for early stage dementia: Results from a randomized controlled trial","Whitlatch CJ, Heid AR, Femia EE, Orsulic-Jeras S, Szabo S, Zarit SH.","Dementia (London). 2019 Aug;18(6):2122-2139. doi: 10.1177/1471301217743033. Epub 2017 Nov 24.","Whitlatch CJ","Dementia (London)","2019","2017/11/25","","","10.1177/1471301217743033"
"25922840","Diagnostic Value of Subjective Memory Complaints Assessed with a Single Item in Dominantly Inherited Alzheimer's Disease: Results of the DIAN Study","Laske C, Sohrabi HR, Jasielec MS, Müller S, Koehler NK, Gräber S, Förster S, Drzezga A, Mueller-Sarnowski F, Danek A, Jucker M, Bateman RJ, Buckles V, Saykin AJ, Martins RN, Morris JC, Dominantly Inherited Alzheimer Network Dian.","Biomed Res Int. 2015;2015:828120. doi: 10.1155/2015/828120. Epub 2015 Apr 2.","Laske C","Biomed Res Int","2015","2015/04/30","PMC4398930","","10.1155/2015/828120"
"8483354","[New studies on Alzheimer's disease. Promising therapeutic results with tacrine]","Nordberg A, Viitanen M, Winblad B.","Lakartidningen. 1993 Apr 21;90(16):1561-3.","Nordberg A","Lakartidningen","1993","1993/04/21","","",""
"7893851","Nonsteroidal antiinflammatory drug use in Alzheimer's disease","Lucca U, Tettamanti M, Forloni G, Spagnoli A.","Biol Psychiatry. 1994 Dec 15;36(12):854-6. doi: 10.1016/0006-3223(94)90598-3.","Lucca U","Biol Psychiatry","1994","1994/12/15","","","10.1016/0006-3223(94)90598-3"
"21069636","[The effect of donepezil in comparison with conventional treatment on cognitive functioning and the performance of the patient in a prospective cohort of patients with Alzheimer's disease treated in routine clinical practice in Spain]","López-Pousa S, Bermejo-Pareja F, Frank A, Hernández F, León T, Rejas-Gutiérrez J; ECO.","Rev Neurol. 2010 Nov 16;51(10):577-88.","López-Pousa S","Rev Neurol","2010","2010/11/12","","",""
"12188104","Impact of Alzheimer's disease and rivastigmine treatment on activities of daily living over the course of mild to moderately severe disease","Potki SG, Anand R, Hartman R, Veach J, Grossberg G.","Prog Neuropsychopharmacol Biol Psychiatry. 2002 May;26(4):713-20. doi: 10.1016/s0278-5846(02)00212-9.","Potki SG","Prog Neuropsychopharmacol Biol Psychiatry","2002","2002/08/22","","","10.1016/s0278-5846(02)00212-9"
"2687312","Alzheimer's dementia: performance on parallel forms of the dementia assessment battery","Teng EL, Wimer C, Roberts E, Damasio AR, Eslinger PJ, Folstein MF, Tune LE, Whitehouse PJ, Bardolph EL, Chui HC, et al.","J Clin Exp Neuropsychol. 1989 Dec;11(6):899-912. doi: 10.1080/01688638908400943.","Teng EL","J Clin Exp Neuropsychol","1989","1989/12/01","","","10.1080/01688638908400943"
"19949163","Item analysis of ADAS-Cog: effect of baseline cognitive impairment in a clinical AD trial","Sevigny JJ, Peng Y, Liu L, Lines CR.","Am J Alzheimers Dis Other Demen. 2010 Mar;25(2):119-24. doi: 10.1177/1533317509350298.","Sevigny JJ","Am J Alzheimers Dis Other Demen","2010","2009/12/02","","","10.1177/1533317509350298"
"9813789","Alteration of regional cerebral glucose utilization with delusions in Alzheimer's disease","Hirono N, Mori E, Ishii K, Kitagaki H, Sasaki M, Ikejiri Y, Imamura T, Shimomura T, Ikeda M, Yamashita H.","J Neuropsychiatry Clin Neurosci. 1998 Fall;10(4):433-9. doi: 10.1176/jnp.10.4.433.","Hirono N","J Neuropsychiatry Clin Neurosci","1998","1998/11/14","","","10.1176/jnp.10.4.433"
"21501948","Persons with mild or moderate Alzheimer's disease use a basic orientation technology to travel to different rooms within a day center","Lancioni GE, Perilli V, Singh NN, O'Reilly MF, Sigafoos J, Bosco A, De Caro MF, Cassano G, Pinto K, Minervini M.","Res Dev Disabil. 2011 Sep-Oct;32(5):1895-901. doi: 10.1016/j.ridd.2011.03.020. Epub 2011 Apr 17.","Lancioni GE","Res Dev Disabil","2011","2011/04/20","","","10.1016/j.ridd.2011.03.020"
"8707476","Response to tacrine in patients with dementia of the Alzheimer's type: cerebral perfusion change is related to change in mental status","Harkins SW, Taylor JR, Mattay VS.","Int J Neurosci. 1996 Feb;84(1-4):149-56. doi: 10.3109/00207459608987260.","Harkins SW","Int J Neurosci","1996","1996/02/01","","","10.3109/00207459608987260"
"11796166","Cranial electrostimulation (CES) in patients with probable Alzheimer's disease","Scherder EJ, Deijen JB, Vreeswijk SH, Sergeant JA, Swaab DF.","Behav Brain Res. 2002 Jan 22;128(2):215-7. doi: 10.1016/s0166-4328(01)00323-0.","Scherder EJ","Behav Brain Res","2002","2002/02/14","","","10.1016/s0166-4328(01)00323-0"
"10697060","Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study","Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ.","JAMA. 2000 Feb 23;283(8):1007-15. doi: 10.1001/jama.283.8.1007.","Mulnard RA","JAMA","2000","2000/03/04","","","10.1001/jama.283.8.1007"
"10559566","Impairment of neocortical metabolism predicts progression in Alzheimer's disease","Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, Halber M, Jelic V, Almkvist O, Collette F, Alberoni M, Kennedy A, Hasselbalch S, Fazio F, Heiss WD.","Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):494-504. doi: 10.1159/000017196.","Herholz K","Dement Geriatr Cogn Disord","1999","1999/11/24","","","10.1159/000017196"
"18599956","Predictors of placebo group decline in the Alzheimer's disease Assessment Scale-cognitive subscale (ADAS-Cog) in 24 week clinical trials of Alzheimer's disease","Irizarry MC, Webb DJ, Bains C, Barrett SJ, Lai RY, Laroche JP, Hosford D, Maher-Edwards G, Weil JG.","J Alzheimers Dis. 2008 Jul;14(3):301-11. doi: 10.3233/jad-2008-14304.","Irizarry MC","J Alzheimers Dis","2008","2008/07/05","","","10.3233/jad-2008-14304"
"21891871","Long-term effects of galantamine on cognitive function in Alzheimer's disease: a large-scale international retrospective study","Kavanagh S, Van Baelen B, Schäuble B.","J Alzheimers Dis. 2011;27(3):521-30. doi: 10.3233/JAD-2011-110417.","Kavanagh S","J Alzheimers Dis","2011","2011/09/06","","","10.3233/JAD-2011-110417"
"2571689","Intracerebroventricular bethanechol chloride infusion in Alzheimer's disease. Results of a collaborative double-blind study","Harbaugh RE, Reeder TM, Senter HJ, Knopman DS, Baskin DS, Pirozzolo F, Chui HC, Shetter AG, Bakay RA, Leblanc R, et al.","J Neurosurg. 1989 Oct;71(4):481-6. doi: 10.3171/jns.1989.71.4.0481.","Harbaugh RE","J Neurosurg","1989","1989/10/01","","","10.3171/jns.1989.71.4.0481"
"12735425","A study on the rehabilitation of cognitive function and short-term memory in patients with Alzheimer's disease using transcutaneous electrical nerve stimulation","Guo Y, Shi X, Uchiyama H, Hasegawa A, Nakagawa Y, Tanaka M, Fukumoto I.","Front Med Biol Eng. 2002;11(4):237-47. doi: 10.1163/156855701321138905.","Guo Y","Front Med Biol Eng","2002","2003/05/09","","","10.1163/156855701321138905"
"8204192","Factor structure and reliability of the Alzheimer's Disease Assessment Scale in a multicenter trial with linopirdine","Kim YS, Nibbelink DW, Overall JE.","J Geriatr Psychiatry Neurol. 1994 Apr-Jun;7(2):74-83. doi: 10.1177/089198879400700202.","Kim YS","J Geriatr Psychiatry Neurol","1994","1994/04/01","","","10.1177/089198879400700202"
"8437604","Tacrine in Alzheimer's disease","Levy R.","N Engl J Med. 1993 Mar 18;328(11):808; author reply 809-10.","Levy R","N Engl J Med","1993","1993/03/18","","",""
"20930300","A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease","Tzimopoulou S, Cunningham VJ, Nichols TE, Searle G, Bird NP, Mistry P, Dixon IJ, Hallett WA, Whitcher B, Brown AP, Zvartau-Hind M, Lotay N, Lai RY, Castiglia M, Jeter B, Matthews JC, Chen K, Bandy D, Reiman EM, Gold M, Rabiner EA, Matthews PM.","J Alzheimers Dis. 2010;22(4):1241-56. doi: 10.3233/JAD-2010-100939.","Tzimopoulou S","J Alzheimers Dis","2010","2010/10/09","","","10.3233/JAD-2010-100939"
"19170800","Pioglitazone improved cognition in a pilot study on patients with Alzheimer's disease and mild cognitive impairment with diabetes mellitus","Hanyu H, Sato T, Kiuchi A, Sakurai H, Iwamoto T.","J Am Geriatr Soc. 2009 Jan;57(1):177-9. doi: 10.1111/j.1532-5415.2009.02067.x.","Hanyu H","J Am Geriatr Soc","2009","2009/01/28","","","10.1111/j.1532-5415.2009.02067.x"
"18955723","The usefulness of cube copying for evaluating treatment of Alzheimer's disease","Palmqvist S, Hansson O, Minthon L, Londos E.","Am J Alzheimers Dis Other Demen. 2008 Oct-Nov;23(5):439-46. doi: 10.1177/1533317508320084.","Palmqvist S","Am J Alzheimers Dis Other Demen","2008","2008/10/29","","","10.1177/1533317508320084"
"3587619","Lecithin: absence of neurophysiologic effect in Alzheimer's disease by EEG topography","Duffy FH, McAnulty G, Albert M, Durwen H, Weintraub S.","Neurology. 1987 Jun;37(6):1015-9. doi: 10.1212/wnl.37.6.1015.","Duffy FH","Neurology","1987","1987/06/01","","","10.1212/wnl.37.6.1015"
"2667504","A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer's disease","Devanand DP, Sackeim HA, Brown RP, Mayeux R.","Arch Neurol. 1989 Aug;46(8):854-7. doi: 10.1001/archneur.1989.00520440036018.","Devanand DP","Arch Neurol","1989","1989/08/01","","","10.1001/archneur.1989.00520440036018"
"7824141","A large pedigree with early-onset Alzheimer's disease: clinical, neuropathologic, and genetic characterization","Campion D, Brice A, Hannequin D, Tardieu S, Dubois B, Calenda A, Brun E, Penet C, Tayot J, Martinez M, et al.","Neurology. 1995 Jan;45(1):80-5. doi: 10.1212/wnl.45.1.80.","Campion D","Neurology","1995","1995/01/01","","","10.1212/wnl.45.1.80"
"16035127","Effect of timed bright light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease","Dowling GA, Mastick J, Hubbard EM, Luxenberg JS, Burr RL.","Int J Geriatr Psychiatry. 2005 Aug;20(8):738-43. doi: 10.1002/gps.1352.","Dowling GA","Int J Geriatr Psychiatry","2005","2005/07/22","PMC2387133","NIHMS46908","10.1002/gps.1352"
"12186960","Detecting regional cerebral blood flow changes in Alzheimer's patients after milameline treatment: activation or baseline SPECT?","Zheng XM.","J Nucl Med Technol. 2002 Sep;30(3):118-22.","Zheng XM","J Nucl Med Technol","2002","2002/08/21","","",""
"8309570","Observations on the short-term 'natural history' of probable Alzheimer's disease in a controlled clinical trial","Knopman D, Gracon S.","Neurology. 1994 Feb;44(2):260-5. doi: 10.1212/wnl.44.2.260.","Knopman D","Neurology","1994","1994/02/01","","","10.1212/wnl.44.2.260"
"15931515","Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease","Rodriguez G, Morbelli S, Brugnolo A, Calvini P, Girtler N, Piccardo A, Dougall NJ, Ebmeier KP, Baron JC, Nobili F.","Eur J Nucl Med Mol Imaging. 2005 Oct;32(10):1186-92. doi: 10.1007/s00259-005-1831-y. Epub 2005 Jun 2.","Rodriguez G","Eur J Nucl Med Mol Imaging","2005","2005/06/03","","","10.1007/s00259-005-1831-y"
"27109039","Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort","Tosun D, Chen YF, Yu P, Sundell KL, Suhy J, Siemers E, Schwarz AJ, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.","Alzheimers Dement. 2016 Sep;12(9):977-986. doi: 10.1016/j.jalz.2016.03.009. Epub 2016 Apr 22.","Tosun D","Alzheimers Dement","2016","2016/04/26","","","10.1016/j.jalz.2016.03.009"
"3317822","Alzheimer's drug trial put on hold","Marx JL.","Science. 1987 Nov 20;238(4830):1041-2. doi: 10.1126/science.3317822.","Marx JL","Science","1987","1987/11/20","","","10.1126/science.3317822"
"18290848","How long can patients with mild or moderate Alzheimer's dementia maintain both the cognition and the therapy of cholinesterase inhibitors: a national population-based study","Sun Y, Lai MS, Lu CJ, Chen RC.","Eur J Neurol. 2008 Mar;15(3):278-83. doi: 10.1111/j.1468-1331.2007.02049.x.","Sun Y","Eur J Neurol","2008","2008/02/23","","","10.1111/j.1468-1331.2007.02049.x"
"8679062","Cardinal features of cognitive dysfunction in Alzheimer's disease: a factor-analytic study of the Alzheimer's Disease Assessment Scale","Talwalker S, Overall JE, Srirama MK, Gracon SI.","J Geriatr Psychiatry Neurol. 1996 Jan;9(1):39-46. doi: 10.1177/089198879600900107.","Talwalker S","J Geriatr Psychiatry Neurol","1996","1996/01/01","","","10.1177/089198879600900107"
"18257187","[Clinical observation on catgut implantation at acupoint for treatment of Alzheimer's disease]","Zhou YL, Jia JP.","Zhongguo Zhen Jiu. 2008 Jan;28(1):37-40.","Zhou YL","Zhongguo Zhen Jiu","2008","2008/02/09","","",""
"8579805","99mTc-HMPAO-SPECT in the diagnosis of senile dementia of Alzheimer's type--a study under clinical routine conditions","Stoppe G, Staedt J, Kögler A, Schütze R, Kunert HJ, Sandrock D, Munz DL, Emrich D, Rüther E.","J Neural Transm Gen Sect. 1995;99(1-3):195-211. doi: 10.1007/BF01271479.","Stoppe G","J Neural Transm Gen Sect","1995","1995/01/01","","","10.1007/BF01271479"
"28372326","Does Functional Connectivity Provide a Marker for Cognitive Rehabilitation Effects in Alzheimer's Disease? An Interventional Study","Ochmann S, Dyrba M, Grothe MJ, Kasper E, Webel S, Hauenstein K, Teipel SJ.","J Alzheimers Dis. 2017;57(4):1303-1313. doi: 10.3233/JAD-160773.","Ochmann S","J Alzheimers Dis","2017","2017/04/05","PMC5409049","","10.3233/JAD-160773"
"8341134","Delayed matching-to-sample performance during a double-blind trial of tacrine (THA) and lecithin in patients with Alzheimer's disease","Perryman KM, Fitten LJ.","Life Sci. 1993;53(6):479-86. doi: 10.1016/0024-3205(93)90699-4.","Perryman KM","Life Sci","1993","1993/01/01","","","10.1016/0024-3205(93)90699-4"
"7826495","The factor structure of the Brief Psychiatric Rating Scale in Alzheimer's disease","Ownby RL, Koss E, Smyth KA, Whitehouse PJ.","J Geriatr Psychiatry Neurol. 1994 Oct-Dec;7(4):245-50. doi: 10.1177/089198879400700410.","Ownby RL","J Geriatr Psychiatry Neurol","1994","1994/10/01","","","10.1177/089198879400700410"
"12814055","Effects of low-frequency cranial electrostimulation on the rest-activity rhythm and salivary cortisol in Alzheimer's disease","Scherder E, Knol D, van Someren E, Deijen JB, Binnekade R, Tilders F, Sergeant J.","Neurorehabil Neural Repair. 2003 Jun;17(2):101-8. doi: 10.1177/0888439003017002004.","Scherder E","Neurorehabil Neural Repair","2003","2003/06/20","","","10.1177/0888439003017002004"
"10218187","Using a therapy dog to alleviate the agitation and desocialization of people with Alzheimer's disease","Churchill M, Safaoui J, McCabe BW, Baun MM.","J Psychosoc Nurs Ment Health Serv. 1999 Apr;37(4):16-22. doi: 10.3928/0279-3695-19990401-12.","Churchill M","J Psychosoc Nurs Ment Health Serv","1999","1999/04/28","","","10.3928/0279-3695-19990401-12"
"1410128","Effects of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer's disease","Ebmeier KP, Hunter R, Curran SM, Dougal NJ, Murray CL, Wyper DJ, Patterson J, Hanson MT, Siegfried K, Goodwin GM.","Psychopharmacology (Berl). 1992;108(1-2):103-9. doi: 10.1007/BF02245293.","Ebmeier KP","Psychopharmacology (Berl)","1992","1992/01/01","","","10.1007/BF02245293"
"11302072","Bingo vs. physical intervention in stimulating short-term cognition in Alzheimer's disease patients","Sobel BP.","Am J Alzheimers Dis Other Demen. 2001 Mar-Apr;16(2):115-20. doi: 10.1177/153331750101600214.","Sobel BP","Am J Alzheimers Dis Other Demen","2001","2001/04/17","","","10.1177/153331750101600214"
"9342685","Criterion-related validity of the Geriatric Depression Scale in Alzheimer's disease","Gilley DW, Wilson RS.","J Clin Exp Neuropsychol. 1997 Aug;19(4):489-99. doi: 10.1080/01688639708403739.","Gilley DW","J Clin Exp Neuropsychol","1997","1997/08/01","","","10.1080/01688639708403739"
"15534055","Educational level influences regional cerebral blood flow in patients with Alzheimer's disease","Chiu NT, Lee BF, Hsiao S, Pai MC.","J Nucl Med. 2004 Nov;45(11):1860-3.","Chiu NT","J Nucl Med","2004","2004/11/10","","",""
"2011259","Nootropic drugs in Alzheimer's disease: symptomatic treatment with pramiracetam","Claus JJ, Ludwig C, Mohr E, Giuffra M, Blin J, Chase TN.","Neurology. 1991 Apr;41(4):570-4. doi: 10.1212/wnl.41.4.570.","Claus JJ","Neurology","1991","1991/04/01","","","10.1212/wnl.41.4.570"
"9065964","Pupil dilation response to tropicamide: a biological test for Alzheimer's disease?","Kurz A, Marquard R, Fremke S, Leipert KP.","Pharmacopsychiatry. 1997 Jan;30(1):12-5. doi: 10.1055/s-2007-979476.","Kurz A","Pharmacopsychiatry","1997","1997/01/01","","","10.1055/s-2007-979476"
"10026389","Alzheimer's disease in 22 twin pairs--13-year follow-up: hormonal, infectious and traumatic factors","Nee LE, Lippa CF.","Dement Geriatr Cogn Disord. 1999 Mar-Apr;10(2):148-51. doi: 10.1159/000017115.","Nee LE","Dement Geriatr Cogn Disord","1999","1999/02/23","","","10.1159/000017115"
"9218645","A polymorphism in the presenilin 1 gene does not modify risk for Alzheimer's disease in a cohort with sporadic early onset","Lendon CL, Myers A, Cumming A, Goate AM, St Clair D.","Neurosci Lett. 1997 Jun 13;228(3):212-4. doi: 10.1016/s0304-3940(97)00393-5.","Lendon CL","Neurosci Lett","1997","1997/06/13","","","10.1016/s0304-3940(97)00393-5"
"12212782","Nerve growth factor gene therapy for Alzheimer's disease","Tuszynski MH, Thal L, U HS, Pay MM, Blesch A, Conner J, Vahlsing HL.","J Mol Neurosci. 2002 Aug-Oct;19(1-2):207. doi: 10.1007/s12031-002-0034-2.","Tuszynski MH","J Mol Neurosci","2002","2002/09/06","","","10.1007/s12031-002-0034-2"
"9543326","Propentofylline enhances cerebral metabolic response to auditory memory stimulation in Alzheimer's disease","Mielke R, Ghaemi M, Kessler J, Kittner B, Szelies B, Herholz K, Heiss WD.","J Neurol Sci. 1998 Jan 21;154(1):76-82. doi: 10.1016/s0022-510x(97)00217-7.","Mielke R","J Neurol Sci","1998","1998/05/23","","","10.1016/s0022-510x(97)00217-7"
"8843494","Inositol treatment of Alzheimer's disease: a double blind, cross-over placebo controlled trial","Barak Y, Levine J, Glasman A, Elizur A, Belmaker RH.","Prog Neuropsychopharmacol Biol Psychiatry. 1996 May;20(4):729-35. doi: 10.1016/0278-5846(96)00043-7.","Barak Y","Prog Neuropsychopharmacol Biol Psychiatry","1996","1996/05/01","","","10.1016/0278-5846(96)00043-7"
"11394721","Abnormal semantic network for ""animals"" but not ""tools"" in patients with Alzheimer's disease","Chan AS, Salmon DP, De La Pena J.","Cortex. 2001 Apr;37(2):197-217. doi: 10.1016/s0010-9452(08)70568-9.","Chan AS","Cortex","2001","2001/06/08","","","10.1016/s0010-9452(08)70568-9"
"2878712","Transmitter-replacement therapy in Alzheimer's disease using intracerebroventricular infusions of receptor agonists","Gauthier S, Leblanc R, Robitaille Y, Quirion R, Carlsson G, Beaulieu M, Bouchard R, Dastoor D, Ervin F, Gauthier L, et al.","Can J Neurol Sci. 1986 Nov;13(4 Suppl):394-402. doi: 10.1017/s0317167100036969.","Gauthier S","Can J Neurol Sci","1986","1986/11/01","","","10.1017/s0317167100036969"
"19300981","Lithium treatment in Alzheimer's disease does not promote cognitive enhancement, but may exert long-term neuroprotective effects","Pomara N.","Psychopharmacology (Berl). 2009 Jul;205(1):169-70. doi: 10.1007/s00213-009-1510-y. Epub 2009 Mar 20.","Pomara N","Psychopharmacology (Berl)","2009","2009/03/21","","","10.1007/s00213-009-1510-y"
"1608494","Italian Multicenter Study on Dementia: a protocol for data collection and clinical diagnosis of Alzheimer's disease. The SMID Group","Bracco L, Amaducci L.","Neuroepidemiology. 1992;11(1):39-45. doi: 10.1159/000110906.","Bracco L","Neuroepidemiology","1992","1992/01/01","","","10.1159/000110906"
"19075297","Video programming for individuals with dementia: assessing cognitive congruence","Heller RB, Dobbs BM, Strain LA.","Am J Alzheimers Dis Other Demen. 2009 Apr-May;24(2):122-8. doi: 10.1177/1533317508328051. Epub 2008 Dec 15.","Heller RB","Am J Alzheimers Dis Other Demen","2009","2008/12/17","","","10.1177/1533317508328051"
"16912480","Effects of high-frequency cranial electrostimulation on the rest-activity rhythm and salivary cortisol in Alzheimer's disease: a pilot study","Scherder E, Knol D, van Tol MJ, van Someren E, Deijen JB, Swaab D, Scheltens P.","Dement Geriatr Cogn Disord. 2006;22(4):267-72. doi: 10.1159/000095108. Epub 2006 Aug 15.","Scherder E","Dement Geriatr Cogn Disord","2006","2006/08/17","","","10.1159/000095108"
"11585854","Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease","Nakano S, Asada T, Matsuda H, Uno M, Takasaki M.","J Nucl Med. 2001 Oct;42(10):1441-5.","Nakano S","J Nucl Med","2001","2001/10/05","","",""
"9754791","Entropy maps characterize drug effects on brain dynamics in Alzheimer's disease","Pezard L, Martinerie J, Varela FJ, Bouchet F, Guez D, Derouesné C, Renault B.","Neurosci Lett. 1998 Aug 28;253(1):5-8. doi: 10.1016/s0304-3940(98)00603-x.","Pezard L","Neurosci Lett","1998","1998/10/01","","","10.1016/s0304-3940(98)00603-x"
"1753253","Galanthamine treatment in Alzheimer's disease","Dal-Bianco P, Maly J, Wôber C, Lind C, Koch G, Hufgard J, Marschall I, Mraz M, Deecke L.","J Neural Transm Suppl. 1991;33:59-63. doi: 10.1007/978-3-7091-9135-4_10.","Dal-Bianco P","J Neural Transm Suppl","1991","1991/01/01","","","10.1007/978-3-7091-9135-4_10"
"11954675","Use of a false recognition paradigm in an Alzheimer's disease clinical trial: a pilot study","Budson AE, Michalska KJ, Rentz DM, Joubert CC, Daffner KR, Schacter DL, Sperling RA.","Am J Alzheimers Dis Other Demen. 2002 Mar-Apr;17(2):93-100. doi: 10.1177/153331750201700204.","Budson AE","Am J Alzheimers Dis Other Demen","2002","2002/04/17","","","10.1177/153331750201700204"
"10342404","Transcutaneous electrical nerve stimulation (TENS) improves the rest-activity rhythm in midstage Alzheimer's disease","Scherder EJ, Van Someren EJ, Swaab DF.","Behav Brain Res. 1999 May;101(1):105-7. doi: 10.1016/s0166-4328(98)00150-8.","Scherder EJ","Behav Brain Res","1999","1999/05/26","","","10.1016/s0166-4328(98)00150-8"
"11061280","A randomized controlled trial of prednisone in Alzheimer's disease","Koch HJ, Szecsey A.","Neurology. 2000 Oct 10;55(7):1067. doi: 10.1212/wnl.55.7.1067.","Koch HJ","Neurology","2000","2000/11/04","","","10.1212/wnl.55.7.1067"
"15324599","Memantine approved to treat moderate to severe Alzheimer's disease","Marder K.","Curr Neurol Neurosci Rep. 2004 Sep;4(5):349-50. doi: 10.1007/s11910-004-0080-y.","Marder K","Curr Neurol Neurosci Rep","2004","2004/08/25","","","10.1007/s11910-004-0080-y"
"15259400","Evaluation of prospective memory training for individuals with mild Alzheimer's disease","Kixmiller JS.","Brain Cogn. 2002 Jul;49(2):237-41.","Kixmiller JS","Brain Cogn","2002","2004/07/21","","",""
"11398568","Obtaining family consent for participation in Alzheimer's research in a Cuban-American population: strategies to overcome the barriers","Williams CL, Tappen R, Buscemi C, Rivera R, Lezcano J.","Am J Alzheimers Dis Other Demen. 2001 May-Jun;16(3):183-7. doi: 10.1177/153331750101600312.","Williams CL","Am J Alzheimers Dis Other Demen","2001","2001/06/12","PMC1959408","NIHMS25142","10.1177/153331750101600312"
"8527009","Regional cerebral blood flow measured by 99mTc-HMPAO SPECT differs in subgroups of Alzheimer's disease","Soininen H, Helkala EL, Kuikka J, Hartikainen P, Lehtovirta M, Riekkinen PJ Sr.","J Neural Transm Park Dis Dement Sect. 1995;9(2-3):95-109. doi: 10.1007/BF02259652.","Soininen H","J Neural Transm Park Dis Dement Sect","1995","1995/01/01","","","10.1007/BF02259652"
"1897377","Physostigmine in Alzheimer's disease: effects on cognitive functioning, cerebral glucose metabolism analyzed by positron emission tomography and cerebral blood flow analyzed by single photon emission tomography","Tune L, Brandt J, Frost JJ, Harris G, Mayberg H, Steele C, Burns A, Sapp J, Folstein MF, Wagner HN, et al.","Acta Psychiatr Scand Suppl. 1991;366:61-5. doi: 10.1111/j.1600-0447.1991.tb03111.x.","Tune L","Acta Psychiatr Scand Suppl","1991","1991/01/01","","","10.1111/j.1600-0447.1991.tb03111.x"
"7774824","Music as a nursing intervention for residents with Alzheimer's disease in long-term care","Sambandham M, Schirm V.","Geriatr Nurs. 1995 Mar-Apr;16(2):79-83. doi: 10.1016/s0197-4572(05)80011-4.","Sambandham M","Geriatr Nurs","1995","1995/03/01","","","10.1016/s0197-4572(05)80011-4"
"8267111","A double-blind, placebo-controlled crossover study of ganglioside GM1 treatment for Alzheimer's disease","Flicker C, Ferris SH, Kalkstein D, Serby M.","Am J Psychiatry. 1994 Jan;151(1):126-9. doi: 10.1176/ajp.151.1.126.","Flicker C","Am J Psychiatry","1994","1994/01/01","","","10.1176/ajp.151.1.126"
"1881606","Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's disease","Alhainen K, Partanen J, Reinikainen K, Laulumaa V, Soininen H, Airaksinen M, Riekkinen P.","Neurosci Lett. 1991 Jun 10;127(1):113-6. doi: 10.1016/0304-3940(91)90907-b.","Alhainen K","Neurosci Lett","1991","1991/06/10","","","10.1016/0304-3940(91)90907-b"
"14692868","WAIS-R factor structure in Alzheimer's disease patients: a comparison of alternative models and an assessment of their generalizability","Davis RN, Massman PJ, Doody RS.","Psychol Aging. 2003 Dec;18(4):836-43. doi: 10.1037/0882-7974.18.4.836.","Davis RN","Psychol Aging","2003","2003/12/25","","","10.1037/0882-7974.18.4.836"
"8845704","Guidelines for the use of tacrine in Alzheimer's disease: clinical application and effectiveness. Johns Hopkins Dementia Research Clinic","Lyketsos CG, Corazzini K, Steele CD, Kraus MF.","J Neuropsychiatry Clin Neurosci. 1996 Winter;8(1):67-73. doi: 10.1176/jnp.8.1.67.","Lyketsos CG","J Neuropsychiatry Clin Neurosci","1996","1996/01/01","","","10.1176/jnp.8.1.67"
"10171927","Effects of an intervention program on dementia patients & their caregivers","Ghatak R.","Caring. 1994 Aug;13(8):34-9.","Ghatak R","Caring","1994","1994/07/07","","",""
"18612874","A comparison of adjusted spaced retrieval versus a uniform expanded retrieval schedule for learning a name-face association in older adults with probable Alzheimer's disease","Hawley KS, Cherry KE, Boudreaux EO, Jackson EM.","J Clin Exp Neuropsychol. 2008 Aug;30(6):639-49. doi: 10.1080/13803390701595495.","Hawley KS","J Clin Exp Neuropsychol","2008","2008/07/10","","","10.1080/13803390701595495"
"17632234","Levetiracetam for manic behavior in hospitalized geriatric patients with dementia of the Alzheimer's type","Kyomen HH, Whitfield TH, Baldessarini RJ.","J Clin Psychopharmacol. 2007 Aug;27(4):408-10. doi: 10.1097/01.jcp.0000264996.08901.3c.","Kyomen HH","J Clin Psychopharmacol","2007","2007/07/17","","","10.1097/01.jcp.0000264996.08901.3c"
"8747165","MRI of amygdala fails to diagnose early Alzheimer's disease","Laakso MP, Partanen K, Lehtovirta M, Hallikainen M, Hänninen T, Vainio P, Riekkinen P Sr, Soininen H.","Neuroreport. 1995 Nov 27;6(17):2414-8. doi: 10.1097/00001756-199511270-00032.","Laakso MP","Neuroreport","1995","1995/11/27","","","10.1097/00001756-199511270-00032"
"11311039","Remote memory for public figures in Alzheimer's disease: relationships to regional cortical and limbic brain volumes","Fama R, Shear PK, Marsh L, Yesavage JA, Tinklenberg JR, Lim KO, Pfefferbaum A, Sullivan EV.","J Int Neuropsychol Soc. 2001 Mar;7(3):384-90. doi: 10.1017/s1355617701733127.","Fama R","J Int Neuropsychol Soc","2001","2001/04/20","","","10.1017/s1355617701733127"
"8437606","Tacrine in Alzheimer's disease","Lachs M.","N Engl J Med. 1993 Mar 18;328(11):809-10.","Lachs M","N Engl J Med","1993","1993/03/18","","",""
"9813787","Prevalence and correlates of aggressive behavior in Alzheimer's disease","Chemerinski E, Petracca G, Tesón A, Sabe L, Leiguarda R, Starkstein SE.","J Neuropsychiatry Clin Neurosci. 1998 Fall;10(4):421-5. doi: 10.1176/jnp.10.4.421.","Chemerinski E","J Neuropsychiatry Clin Neurosci","1998","1998/11/14","","","10.1176/jnp.10.4.421"
"9223063","Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease","Riekkinen P Jr, Riekkinen M, Soininen H, Kuikka J, Laakso M, Riekkinen P Sr.","Neuroreport. 1997 May 27;8(8):1845-9. doi: 10.1097/00001756-199705260-00011.","Riekkinen P Jr","Neuroreport","1997","1997/05/27","","","10.1097/00001756-199705260-00011"
"16510944","Study on a quantitative electroencephalography power spectrum typical of Chinese Han Alzheimer's disease patients by using wavelet transforms","Wan B, Ming D, Fu X, Yang C, Qi H, Chen B.","J Neural Eng. 2006 Mar;3(1):71-7. doi: 10.1088/1741-2560/3/1/008. Epub 2006 Mar 1.","Wan B","J Neural Eng","2006","2006/03/03","","","10.1088/1741-2560/3/1/008"
"3553285","Multiple nutrients in the treatment of Alzheimer's disease","Kushnir SL, Ratner JT, Gregoire PA.","J Am Geriatr Soc. 1987 May;35(5):476-7. doi: 10.1111/j.1532-5415.1987.tb04682.x.","Kushnir SL","J Am Geriatr Soc","1987","1987/05/01","","","10.1111/j.1532-5415.1987.tb04682.x"
"2565644","Early stages of late onset Alzheimer's disease. Diagnostic criteria, protein metabolism, precursor loading effects, neurochemical and neuropsychological applications","Forssell LG, Hellström A, Ericsson K, Winblad B.","Acta Neurol Scand Suppl. 1989;121:1-95.","Forssell LG","Acta Neurol Scand Suppl","1989","1989/01/01","","",""
"11096224","A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease","Farlow M, Anand R, Messina J Jr, Hartman R, Veach J.","Eur Neurol. 2000;44(4):236-41. doi: 10.1159/000008243.","Farlow M","Eur Neurol","2000","2000/11/30","","","10.1159/000008243"
"7783942","Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease","Kennedy AM, Frackowiak RS, Newman SK, Bloomfield PM, Seaward J, Roques P, Lewington G, Cunningham VJ, Rossor MN.","Neurosci Lett. 1995 Feb 15;186(1):17-20. doi: 10.1016/0304-3940(95)11270-7.","Kennedy AM","Neurosci Lett","1995","1995/02/15","","","10.1016/0304-3940(95)11270-7"
"11026134","[Akatinol memantin in Alzheimer's disease: clinico-immunological correlates]","Androsova LV, Selezneva ND.","Zh Nevrol Psikhiatr Im S S Korsakova. 2000;100(9):36-8.","Androsova LV","Zh Nevrol Psikhiatr Im S S Korsakova","2000","2000/10/12","","",""
"8513039","Physostigmine ameliorates the delusions of Alzheimer's disease","Cummings JL, Gorman DG, Shapira J.","Biol Psychiatry. 1993 Apr 1;33(7):536-41. doi: 10.1016/0006-3223(93)90009-3.","Cummings JL","Biol Psychiatry","1993","1993/04/01","","","10.1016/0006-3223(93)90009-3"
"15259392","Predictors of cognitive change from preclinical to clinical Alzheimer's disease","Jones S, Small BJ, Fratiglioni L, Backman L.","Brain Cogn. 2002 Jul;49(2):210-3.","Jones S","Brain Cogn","2002","2004/07/21","","",""
"3700343","Combination therapy with lecithin and ergoloid mesylates for Alzheimer's disease","Jenike MA, Albert MS, Heller H, LoCastro S, Gunther J.","J Clin Psychiatry. 1986 May;47(5):249-51.","Jenike MA","J Clin Psychiatry","1986","1986/05/01","","",""
"9805325","Evidence for an impaired ability to determine semantic relations in Alzheimer's disease patients","Sailor KM, Bramwell A, Griesing TA.","Neuropsychology. 1998 Oct;12(4):555-64. doi: 10.1037//0894-4105.12.4.555.","Sailor KM","Neuropsychology","1998","1998/11/07","","","10.1037//0894-4105.12.4.555"
"10486621","[Speech comprehension by patients with Alzheimer disease. Possibilities for improvement]","Boelen HJ, Veen C.","Tijdschr Gerontol Geriatr. 1999 Aug;30(4):164-7.","Boelen HJ","Tijdschr Gerontol Geriatr","1999","1999/09/16","","",""
"8563788","Electroencephalographic correlates of periventricular white matter lesions in probable Alzheimer's disease","Lopez OL, Brenner RP, Becker JT, Jungreis CA, Rezek D, DeKosky ST.","Dementia. 1995 Nov-Dec;6(6):343-7. doi: 10.1159/000106968.","Lopez OL","Dementia","1995","1995/11/01","","","10.1159/000106968"
"15055749","Cholinesterase inhibitors in Alzheimer's disease: efficacy in a non-selected population","Sinforiani E, Banchieri LM, Zucchella C, Bernasconi L, Nappi G.","Funct Neurol. 2003 Oct-Dec;18(4):233-7.","Sinforiani E","Funct Neurol","2003","2004/04/02","","",""
"1683967","Anomalous acetylcholinesterase in lumbar CSF in Alzheimer's disease","Smith AD, Jobst KA, Navaratnam DS, Shen ZX, Priddle JD, McDonald B, King E, Esiri MM.","Lancet. 1991 Dec 14;338(8781):1538. doi: 10.1016/0140-6736(91)92367-b.","Smith AD","Lancet","1991","1991/12/14","","","10.1016/0140-6736(91)92367-b"
"9386861","Electrophysiologic responses to varying mnemonic demand: a ""stress test"" is not diagnostic in very mild Alzheimer's disease","Swanwick GR, Rowan MJ, Coen RF, Lawlor BA, Walsh JB, Coakley D.","Biol Psychiatry. 1997 Dec 1;42(11):1073-5. doi: 10.1016/s0006-3223(97)00328-4.","Swanwick GR","Biol Psychiatry","1997","1997/12/05","","","10.1016/s0006-3223(97)00328-4"
"9260340","Application of an attribution-affect-action model of caregiving behavior","Fopma-Loy J, Austin JK.","Arch Psychiatr Nurs. 1997 Aug;11(4):210-7. doi: 10.1016/s0883-9417(97)80028-3.","Fopma-Loy J","Arch Psychiatr Nurs","1997","1997/08/01","","","10.1016/s0883-9417(97)80028-3"
"11388371","The angiotensin-converting enzyme gene as a possible risk or protective factor in Alzheimer's disease","Shcherbatykh TV, Kiryanov SA, Korovaitseva GI, Selezneva ND, Voskresenskaya NI, Golimbet VE, Farrer L, Gavrilova SI, Rogaev EI.","Neurosci Behav Physiol. 2001 Mar-Apr;31(2):179-81. doi: 10.1023/a:1005264324466.","Shcherbatykh TV","Neurosci Behav Physiol","2001","2001/06/05","","","10.1023/a:1005264324466"
"7951680","A pilot study of clonidine plus physostigmine in Alzheimer's disease","Bierer LM, Aisen PS, Davidson M, Ryan TM, Schmeidler J, Davis KL.","Dementia. 1994 Sep-Oct;5(5):243-6. doi: 10.1159/000106731.","Bierer LM","Dementia","1994","1994/09/01","","","10.1159/000106731"
"2692054","Normalization of rCBF pattern in senile dementia of the Alzheimer's type","Mubrin Z, Knezevic S, Spilich G, Risberg J, Gubarev N, Wannenmacher W, Vucinic G.","Psychiatry Res. 1989 Sep;29(3):303-6. doi: 10.1016/0165-1781(89)90072-3.","Mubrin Z","Psychiatry Res","1989","1989/09/01","","","10.1016/0165-1781(89)90072-3"
"3290935","A pilot study of serotonergic system responsivity in Alzheimer's disease","Lawlor BA, Mellow AM, Sunderland T, Hill JL, Murphy DL.","Psychopharmacol Bull. 1988;24(1):127-9.","Lawlor BA","Psychopharmacol Bull","1988","1988/01/01","","",""
"15704485","[Neuropsychological evaluation of long-term therapy of Alzheimer's disease using different cerebrolysin dosages]","Roshchina IF, Gavrilova SI, Zharikov GA, Kalyn IaB, Kolykhalov IV, Selezneva ND.","Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(1):52-5.","Roshchina IF","Zh Nevrol Psikhiatr Im S S Korsakova","2005","2005/02/12","","",""
"17691220","Plasma Abeta levels as predictors of response to rivastigmine treatment in Alzheimer's disease","Sobow T, Flirski M, Liberski P, Kloszewska I.","Acta Neurobiol Exp (Wars). 2007;67(2):131-9.","Sobow T","Acta Neurobiol Exp (Wars)","2007","2007/08/19","","",""
"9221556","[Peripheral nerve stimulation in Alzheimer's disease]","Scherder E, Bouma A, Steen L, van Someren E.","Tijdschr Gerontol Geriatr. 1997 Apr;28(2):59-68.","Scherder E","Tijdschr Gerontol Geriatr","1997","1997/04/01","","",""
"11900820","Acute nicotine effects on auditory sensory memory in tacrine-treated and nontreated patients with Alzheimer's disease: an event-related potential study","Engeland C, Mahoney C, Mohr E, Ilivitsky V, Knott VJ.","Pharmacol Biochem Behav. 2002 May;72(1-2):457-64. doi: 10.1016/s0091-3057(02)00711-6.","Engeland C","Pharmacol Biochem Behav","2002","2002/03/20","","","10.1016/s0091-3057(02)00711-6"
"16696770","Benefits of combining donepezil plus traditional Japanese herbal medicine on cognition and brain perfusion in Alzheimer's disease: a 12-week observer-blind, donepezil monotherapy controlled trial","Maruyama M, Tomita N, Iwasaki K, Ootsuki M, Matsui T, Nemoto M, Okamura N, Higuchi M, Tsutsui M, Suzuki T, Seki T, Kaneta T, Furukawa K, Arai H.","J Am Geriatr Soc. 2006 May;54(5):869-71. doi: 10.1111/j.1532-5415.2006.00722.x.","Maruyama M","J Am Geriatr Soc","2006","2006/05/16","","","10.1111/j.1532-5415.2006.00722.x"
"9745231","Cognitive brain activity in Alzheimer's disease: electrophysiological response during picture semantic categorization","Ostrosky-Solís F, Castañeda M, Pérez M, Castillo G, Bobes MA.","J Int Neuropsychol Soc. 1998 Sep;4(5):415-25. doi: 10.1017/s1355617798455012.","Ostrosky-Solís F","J Int Neuropsychol Soc","1998","1998/09/24","","","10.1017/s1355617798455012"
"15025054","Simple linear and area MR measurements can help distinguish between Alzheimer's disease, frontotemporal dementia, and normal aging: the Sunnybrook dementia study","Deshpande NA, Gao FQ, Bakshi SN, Leibovitch FS, Black SE; Sunnybrook Dementia Study.","Brain Cogn. 2004 Mar;54(2):165-6.","Deshpande NA","Brain Cogn","2004","2004/03/18","","",""
"26525623","[A comparison of the efficacy and safety of memantal and original memantine in the treatment of mild and moderate dementia in Alzheimer's disease]","Shiryaev OY, Shapovalov DL, Polozova TM, Goncharova OV, Kuznetsova NA, Cherenkova EV, Fedorova EY.","Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(10):56-61. doi: 10.17116/jnevro201511510156-61.","Shiryaev OY","Zh Nevrol Psikhiatr Im S S Korsakova","2015","2015/11/04","","","10.17116/jnevro201511510156-61"
"27587347","[Neuropsychological benefit of cataract surgery among sight impaired Alzheimer's patient]","Girard B, Chouard B, Levy P, Luquel L, Seux ML, Drunat O.","J Fr Ophtalmol. 2016 Oct;39(8):675-686. doi: 10.1016/j.jfo.2016.05.005. Epub 2016 Aug 29.","Girard B","J Fr Ophtalmol","2016","2016/09/03","","","10.1016/j.jfo.2016.05.005"
"2680009","Progress report on the Canadian Multicentre Trial of tetrahydroaminoacridine with lecithin in Alzheimer's disease","Gauthier S, Bouchard R, Bacher Y, Bailey P, Bergman H, Carrier L, Charbonneau R, Clarfield M, Collier B, Dastoor D, et al.","Can J Neurol Sci. 1989 Nov;16(4 Suppl):543-6. doi: 10.1017/s0317167100029899.","Gauthier S","Can J Neurol Sci","1989","1989/11/01","","","10.1017/s0317167100029899"
"7648773","Caregiver time use: an outcome measure in clinical trial research on Alzheimer's disease","Clipp EC, Moore MJ.","Clin Pharmacol Ther. 1995 Aug;58(2):228-36. doi: 10.1016/0009-9236(95)90201-5.","Clipp EC","Clin Pharmacol Ther","1995","1995/08/01","","","10.1016/0009-9236(95)90201-5"
"23760946","Evaluation of the efficacy of a cognitive rehabilitation treatment on a group of Alzheimer's patients with moderate cognitive impairment: a pilot study","Salotti P, De Sanctis B, Clementi A, Fernandez Ferreira M, De Silvestris T.","Aging Clin Exp Res. 2013 Aug;25(4):403-9. doi: 10.1007/s40520-013-0062-5. Epub 2013 Jun 13.","Salotti P","Aging Clin Exp Res","2013","2013/06/14","","","10.1007/s40520-013-0062-5"
"1544011","Tacrine in Alzheimer's disease. Time course of changes in cognitive function and practice effects","Eagger S, Morant N, Levy R, Sahakian B.","Br J Psychiatry. 1992 Jan;160:36-40. doi: 10.1192/bjp.160.1.36.","Eagger S","Br J Psychiatry","1992","1992/01/01","","","10.1192/bjp.160.1.36"
"24157706","Cost analysis of early psychosocial intervention in Alzheimer's disease","Søgaard R, Sørensen J, Waldorff FB, Eckermann A, Buss DV, Waldemar G.","Dement Geriatr Cogn Disord. 2014;37(3-4):141-53. doi: 10.1159/000355368. Epub 2013 Oct 19.","Søgaard R","Dement Geriatr Cogn Disord","2014","2013/10/26","","","10.1159/000355368"
"12505543","Relationship between blood pressure and Alzheimer's disease in Linxian County, China","Wu C, Zhou D, Wen C, Zhang L, Como P, Qiao Y.","Life Sci. 2003 Jan 24;72(10):1125-33. doi: 10.1016/s0024-3205(02)02367-6.","Wu C","Life Sci","2003","2002/12/31","","","10.1016/s0024-3205(02)02367-6"
"9116176","Utility of clinical trial batteries in the measurement of Alzheimer's and Huntington's dementia","Mohr E, Walker D, Randolph C, Sampson M, Mendis T.","Int Psychogeriatr. 1996 Fall;8(3):397-411. doi: 10.1017/s1041610296002761.","Mohr E","Int Psychogeriatr","1996","1996/10/01","","","10.1017/s1041610296002761"
"21481640","Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study","Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, Hiemeyer F, Wittemer-Rump SM, Seibyl J, Reininger C, Sabri O; Florbetaben Study Group.","Lancet Neurol. 2011 May;10(5):424-35. doi: 10.1016/S1474-4422(11)70077-1. Epub 2011 Apr 8.","Barthel H","Lancet Neurol","2011","2011/04/13","","","10.1016/S1474-4422(11)70077-1"
"18454755","Galantamine improves gait performance in patients with Alzheimer's disease","Assal F, Allali G, Kressig RW, Herrmann FR, Beauchet O.","J Am Geriatr Soc. 2008 May;56(5):946-7. doi: 10.1111/j.1532-5415.2008.01657.x.","Assal F","J Am Geriatr Soc","2008","2008/05/06","","","10.1111/j.1532-5415.2008.01657.x"
"15852458","Rivastigmine in the treatment of dementia in Alzheimer's disease in adults with Down syndrome","Prasher VP, Fung N, Adams C.","Int J Geriatr Psychiatry. 2005 May;20(5):496-7. doi: 10.1002/gps.1306.","Prasher VP","Int J Geriatr Psychiatry","2005","2005/04/27","","","10.1002/gps.1306"
"15686607","Retrograde amnesia for semantic information in Alzheimer's disease","Meeter M, Kollen A, Scheltens P.","J Int Neuropsychol Soc. 2005 Jan;11(1):40-8. doi: 10.1017/S135561770505006X.","Meeter M","J Int Neuropsychol Soc","2005","2005/02/03","","","10.1017/S135561770505006X"
"21971473","Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease","Förster S, Buschert VC, Teipel SJ, Friese U, Buchholz HG, Drzezga A, Hampel H, Bartenstein P, Buerger K.","J Alzheimers Dis. 2011;26 Suppl 3:337-48. doi: 10.3233/JAD-2011-0025.","Förster S","J Alzheimers Dis","2011","2011/10/06","","","10.3233/JAD-2011-0025"
"12088698","EEG harmonic responses to photic stimulation in normal aging and Alzheimer's disease: differences in interhemispheric coherence","Kikuchi M, Wada Y, Takeda T, Oe H, Hashimoto T, Koshino Y.","Clin Neurophysiol. 2002 Jul;113(7):1045-51. doi: 10.1016/s1388-2457(02)00129-3.","Kikuchi M","Clin Neurophysiol","2002","2002/06/29","","","10.1016/s1388-2457(02)00129-3"
"9152715","Selegiline in the treatment of behavioural disturbance in Alzheimer's disease","Lawlor BA, Aisen PS, Green C, Fine E, Schmeïdler J.","Int J Geriatr Psychiatry. 1997 Mar;12(3):319-22. doi: 10.1002/(sici)1099-1166(199703)12:3<319::aid-gps488>3.0.co;2-q.","Lawlor BA","Int J Geriatr Psychiatry","1997","1997/03/01","","","10.1002/(sici)1099-1166(199703)12:3<319::aid-gps488>3.0.co;2-q"
"7763332","Age-associated memory impairment and early Alzheimer's disease. Only time will tell the difference","Förstl H, Hentschel F, Sattel H, Geiger-Kabisch C, Besthorn C, Czech C, Mönning U, Beyreuther K.","Arzneimittelforschung. 1995 Mar;45(3A):394-7.","Förstl H","Arzneimittelforschung","1995","1995/03/01","","",""
"18280503","Alzheimer's disease and mild cognitive impairment deteriorate fine movement control","Yan JH, Rountree S, Massman P, Doody RS, Li H.","J Psychiatr Res. 2008 Oct;42(14):1203-12. doi: 10.1016/j.jpsychires.2008.01.006. Epub 2008 Feb 15.","Yan JH","J Psychiatr Res","2008","2008/02/19","","","10.1016/j.jpsychires.2008.01.006"
"15880838","[ApoE genotype and efficacy of neurotrophic and cholinergic therapy in Alzheimer's disease]","Gavrilova SI, Kolykhalov IV, Korovaĭtseva GI, Zharikov GA, Kalyn IaB, Selezneva ND.","Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(4):27-34.","Gavrilova SI","Zh Nevrol Psikhiatr Im S S Korsakova","2005","2005/05/10","","",""
"32126838","Postmortem Analysis in a Clinical Trial of AAV2-NGF Gene Therapy for Alzheimer's Disease Identifies a Need for Improved Vector Delivery","Castle MJ, Baltanás FC, Kovacs I, Nagahara AH, Barba D, Tuszynski MH.","Hum Gene Ther. 2020 Apr;31(7-8):415-422. doi: 10.1089/hum.2019.367. Epub 2020 Mar 30.","Castle MJ","Hum Gene Ther","2020","2020/03/05","PMC7194314","","10.1089/hum.2019.367"
"9584871","Cognitive correlates of leukoaraiosis in the early stages of Alzheimer's disease","Tsiskaridze A, Shakarishvili R, Janelidze M, Vashadze T, Chikhladze M.","Funct Neurol. 1998 Jan-Mar;13(1):17-25.","Tsiskaridze A","Funct Neurol","1998","1998/05/19","","",""
"26967214","Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study","Florian H, Meier A, Gauthier S, Lipschitz S, Lin Y, Tang Q, Othman AA, Robieson WZ, Gault LM.","J Alzheimers Dis. 2016;51(4):1237-47. doi: 10.3233/JAD-150978.","Florian H","J Alzheimers Dis","2016","2016/03/12","","","10.3233/JAD-150978"
"25312605","Impact of a cognitive rehabilitation intervention on neuropsychiatric symptoms in mild to moderate Alzheimer's disease","Brunelle-Hamann L, Thivierge S, Simard M.","Neuropsychol Rehabil. 2015;25(5):677-707. doi: 10.1080/09602011.2014.964731. Epub 2014 Oct 14.","Brunelle-Hamann L","Neuropsychol Rehabil","2015","2014/10/15","","","10.1080/09602011.2014.964731"
"10026383","Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer's disease and vascular dementia","Ballard CG, Ayre G, O'Brien J, Sahgal A, McKeith IG, Ince PG, Perry RH.","Dement Geriatr Cogn Disord. 1999 Mar-Apr;10(2):104-8. doi: 10.1159/000017109.","Ballard CG","Dement Geriatr Cogn Disord","1999","1999/02/23","","","10.1159/000017109"
"21518170","Controlled study on the cognitive and psychological effect of coloring and drawing in mild Alzheimer's disease patients","Hattori H, Hattori C, Hokao C, Mizushima K, Mase T.","Geriatr Gerontol Int. 2011 Oct;11(4):431-7. doi: 10.1111/j.1447-0594.2011.00698.x. Epub 2011 Apr 26.","Hattori H","Geriatr Gerontol Int","2011","2011/04/27","","","10.1111/j.1447-0594.2011.00698.x"
"12188103","Long-term effects of rivastigmine in moderately severe Alzheimer's disease: does early initiation of therapy offer sustained benefits?","Doraiswamy PM, Krishnan KR, Anand R, Sohn H, Danyluk J, Hartman RD, Veach J.","Prog Neuropsychopharmacol Biol Psychiatry. 2002 May;26(4):705-12. doi: 10.1016/s0278-5846(01)00326-8.","Doraiswamy PM","Prog Neuropsychopharmacol Biol Psychiatry","2002","2002/08/22","","","10.1016/s0278-5846(01)00326-8"
"20164585","Effects of rivastigmine in Alzheimer's disease patients with and without hallucinations","Cummings J, Emre M, Aarsland D, Tekin S, Dronamraju N, Lane R.","J Alzheimers Dis. 2010;20(1):301-11. doi: 10.3233/JAD-2010-1362.","Cummings J","J Alzheimers Dis","2010","2010/02/19","","","10.3233/JAD-2010-1362"
"3897460","A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease","Little A, Levy R, Chuaqui-Kidd P, Hand D.","J Neurol Neurosurg Psychiatry. 1985 Aug;48(8):736-42. doi: 10.1136/jnnp.48.8.736.","Little A","J Neurol Neurosurg Psychiatry","1985","1985/08/01","PMC1028443","","10.1136/jnnp.48.8.736"
"9787883","Magnetic resonance imaging correlates of depression in early- and late-onset Alzheimer's disease","Clark LM, McDonald WM, Welsh-Bohmer KA, Siegler IC, Dawson DV, Tupler LA, Krishnan KR.","Biol Psychiatry. 1998 Oct 1;44(7):592-9. doi: 10.1016/s0006-3223(98)00106-1.","Clark LM","Biol Psychiatry","1998","1998/10/27","","","10.1016/s0006-3223(98)00106-1"
"21968871","Efficacy of a medical food on cognition in Alzheimer's disease: results from secondary analyses of a randomized, controlled trial","Kamphuis PJ, Verhey FR, Olde Rikkert MG, Twisk JW, Swinkels SH, Scheltens P.","J Nutr Health Aging. 2011 Aug;15(8):720-4. doi: 10.1007/s12603-011-0105-6.","Kamphuis PJ","J Nutr Health Aging","2011","2011/10/05","","","10.1007/s12603-011-0105-6"
"27935239","Effect of galantamine on attention in patients with Alzheimer's disease combined with cerebrovascular disease","Park JJ, Choi SH, Kim S, Lee AY, Moon SY, Lee JH, Kwon JC, Park KW, Ku BD, Han HJ, Kim EJ, Shim YS.","Geriatr Gerontol Int. 2017 Oct;17(10):1661-1666. doi: 10.1111/ggi.12934. Epub 2016 Dec 9.","Park JJ","Geriatr Gerontol Int","2017","2016/12/10","","","10.1111/ggi.12934"
"15106393","Reducing anxiety in Alzheimer's disease family caregivers: the effectiveness of a nine-week cognitive-behavioral intervention","Akkerman RL, Ostwald SK.","Am J Alzheimers Dis Other Demen. 2004 Mar-Apr;19(2):117-23. doi: 10.1177/153331750401900202.","Akkerman RL","Am J Alzheimers Dis Other Demen","2004","2004/04/27","","","10.1177/153331750401900202"
"25952279","Cognitive and functional patterns of nondemented subjects with equivocal visual amyloid PET findings","Payoux P, Delrieu J, Gallini A, Adel D, Salabert AS, Hitzel A, Cantet C, Tafani M, De Verbizier D, Darcourt J, Fernandez P, Monteil J, Carrié I, Voisin T, Gillette-Guyonnet S, Pontecorvo M, Vellas B, Andrieu S.","Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1459-68. doi: 10.1007/s00259-015-3067-9. Epub 2015 May 8.","Payoux P","Eur J Nucl Med Mol Imaging","2015","2015/05/09","","","10.1007/s00259-015-3067-9"
"21784350","Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab","Carlson C, Estergard W, Oh J, Suhy J, Jack CR Jr, Siemers E, Barakos J.","Alzheimers Dement. 2011 Jul;7(4):396-401. doi: 10.1016/j.jalz.2011.05.2353.","Carlson C","Alzheimers Dement","2011","2011/07/26","","","10.1016/j.jalz.2011.05.2353"
"11885210","Continuum of care for Alzheimer's disease: a nurse education and counseling program","Wright LK, Litaker M, Laraia MT, DeAndrade S.","Issues Ment Health Nurs. 2001 Apr-May;22(3):231-52. doi: 10.1080/01612840152053084.","Wright LK","Issues Ment Health Nurs","2001","2002/03/12","","","10.1080/01612840152053084"
"14716732","A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging","Higdon R, Foster NL, Koeppe RA, DeCarli CS, Jagust WJ, Clark CM, Barbas NR, Arnold SE, Turner RS, Heidebrink JL, Minoshima S.","Stat Med. 2004 Jan 30;23(2):315-26. doi: 10.1002/sim.1719.","Higdon R","Stat Med","2004","2004/01/13","","","10.1002/sim.1719"
"11971046","Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer's disease","Doubleday EK, Snowden JS, Varma AR, Neary D.","J Neurol Neurosurg Psychiatry. 2002 May;72(5):602-7. doi: 10.1136/jnnp.72.5.602.","Doubleday EK","J Neurol Neurosurg Psychiatry","2002","2002/04/24","PMC1737879","","10.1136/jnnp.72.5.602"
"8251051","Preliminary findings of high-dose thiamine in dementia of Alzheimer's type","Meador K, Loring D, Nichols M, Zamrini E, Rivner M, Posas H, Thompson E, Moore E.","J Geriatr Psychiatry Neurol. 1993 Oct-Dec;6(4):222-9. doi: 10.1177/089198879300600408.","Meador K","J Geriatr Psychiatry Neurol","1993","1993/10/01","","","10.1177/089198879300600408"
"34101780","Effects of Folic Acid and Vitamin B12 Supplementation on Cognitive Impairment and Inflammation in Patients with Alzheimer's Disease: A Randomized, Single-Blinded, Placebo-Controlled Trial","Chen H, Liu S, Ge B, Zhou D, Li M, Li W, Ma F, Liu Z, Ji Y, Huang G.","J Prev Alzheimers Dis. 2021;8(3):249-256. doi: 10.14283/jpad.2021.22.","Chen H","J Prev Alzheimers Dis","2021","2021/06/08","","","10.14283/jpad.2021.22"
"23171483","Practice effects in a longitudinal, multi-center Alzheimer's disease prevention clinical trial","Abner EL, Dennis BC, Mathews MJ, Mendiondo MS, Caban-Holt A, Kryscio RJ, Schmitt FA; PREADViSE Investigators; Crowley JJ; SELECT Investigators.","Trials. 2012 Nov 20;13:217. doi: 10.1186/1745-6215-13-217.","Abner EL","Trials","2012","2012/11/23","PMC3543284","","10.1186/1745-6215-13-217"
"1420408","Clinical trials in cognitive impairment in the elderly","Forette F, Panisset M, Boller F.","Aging (Milano). 1992 Sep;4(3):239-50. doi: 10.1007/BF03324098.","Forette F","Aging (Milano)","1992","1992/09/01","","","10.1007/BF03324098"
"8437693","Long-term and high-dose piracetam treatment of Alzheimer's disease","Croisile B, Trillet M, Fondarai J, Laurent B, Mauguière F, Billardon M.","Neurology. 1993 Feb;43(2):301-5. doi: 10.1212/wnl.43.2.301.","Croisile B","Neurology","1993","1993/02/01","","","10.1212/wnl.43.2.301"
"15845094","Regional cortical blood flow changes following sodium lactate infusion in Alzheimer's disease","Kálmán J, Palotás A, Kis G, Boda K, Túri P, Bari F, Domoki F, Dóda I, Argyelán M, Vincze G, Séra T, Csernay L, Janka Z, Pávics L.","Eur J Neurosci. 2005 Mar;21(6):1671-8. doi: 10.1111/j.1460-9568.2005.03924.x.","Kálmán J","Eur J Neurosci","2005","2005/04/23","","","10.1111/j.1460-9568.2005.03924.x"
"2830918","4-Aminopyridine in the treatment of Alzheimer's disease","Davidson M, Zemishlany Z, Mohs RC, Horvath TB, Powchik P, Blass JP, Davis KL.","Biol Psychiatry. 1988 Mar 1;23(5):485-90. doi: 10.1016/0006-3223(88)90020-0.","Davidson M","Biol Psychiatry","1988","1988/03/01","","","10.1016/0006-3223(88)90020-0"
"16820420","A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer's disease","Tárraga L, Boada M, Modinos G, Espinosa A, Diego S, Morera A, Guitart M, Balcells J, López OL, Becker JT.","J Neurol Neurosurg Psychiatry. 2006 Oct;77(10):1116-21. doi: 10.1136/jnnp.2005.086074. Epub 2006 Jul 4.","Tárraga L","J Neurol Neurosurg Psychiatry","2006","2006/07/06","PMC2077529","","10.1136/jnnp.2005.086074"
"11804704","Association of CSF apolipoprotein E, Abeta42 and cognition in Alzheimer's disease","Riemenschneider M, Schmolke M, Lautenschlager N, Vanderstichele H, Vanmechelen E, Guder WG, Kurz A.","Neurobiol Aging. 2002 Mar-Apr;23(2):205-11. doi: 10.1016/s0197-4580(01)00272-x.","Riemenschneider M","Neurobiol Aging","2002","2002/01/24","","","10.1016/s0197-4580(01)00272-x"
"7591506","Dysfunction of visual cortex contributes to disturbed processing of visual information in Alzheimer's disease","Mielke R, Kessler J, Fink G, Herholz K, Heiss WD.","Int J Neurosci. 1995 May;82(1-2):1-9. doi: 10.3109/00207459508994285.","Mielke R","Int J Neurosci","1995","1995/05/01","","","10.3109/00207459508994285"
"8928167","[Should Alzheimer disease be treated with tacrine? Review of the literature]","Arsland D, Laake K.","Tidsskr Nor Laegeforen. 1996 Sep 30;116(23):2791-4.","Arsland D","Tidsskr Nor Laegeforen","1996","1996/09/30","","",""
"26376345","Circadian rhythm in Alzheimer disease after trazodone use","Grippe TC, Gonçalves BS, Louzada LL, Quintas JL, Naves JO, Camargos EF, Nóbrega OT.","Chronobiol Int. 2015;32(9):1311-4. doi: 10.3109/07420528.2015.1077855. Epub 2015 Sep 16.","Grippe TC","Chronobiol Int","2015","2015/09/17","","","10.3109/07420528.2015.1077855"
"7580189","A SPECT study of parkinsonism in Alzheimer's disease","Starkstein SE, Vazquez S, Merello M, Tesón A, Petracchi M, Leiguarda R.","J Neuropsychiatry Clin Neurosci. 1995 Summer;7(3):308-13. doi: 10.1176/jnp.7.3.308.","Starkstein SE","J Neuropsychiatry Clin Neurosci","1995","1995/01/01","","","10.1176/jnp.7.3.308"
"14530","[A serogenetic approach to the study of Alzheimer's disease (author's transl)]","Mehne P, Grünwald P, Gerner-Beuerle E.","Aktuelle Gerontol. 1976 Jun;6(6):259-66.","Mehne P","Aktuelle Gerontol","1976","1976/06/01","","",""
"19660834","Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI","Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.","Neurobiol Aging. 2011 Jul;32(7):1207-18. doi: 10.1016/j.neurobiolaging.2009.07.002. Epub 2009 Aug 5.","Landau SM","Neurobiol Aging","2011","2009/08/08","PMC2891865","NIHMS132130","10.1016/j.neurobiolaging.2009.07.002"
"18405399","Decreased initiation of usual activities in people with mild-to-moderate Alzheimer's disease: a descriptive analysis from the VISTA clinical trial","Cook C, Fay S, Rockwood K.","Int Psychogeriatr. 2008 Oct;20(5):952-63. doi: 10.1017/S1041610208007230. Epub 2008 Apr 11.","Cook C","Int Psychogeriatr","2008","2008/04/15","","","10.1017/S1041610208007230"
"27048170","Safety and tolerability of BAN2401--a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody","Logovinsky V, Satlin A, Lai R, Swanson C, Kaplow J, Osswald G, Basun H, Lannfelt L.","Alzheimers Res Ther. 2016 Apr 6;8(1):14. doi: 10.1186/s13195-016-0181-2.","Logovinsky V","Alzheimers Res Ther","2016","2016/04/07","PMC4822297","","10.1186/s13195-016-0181-2"
"15718041","Enhanced GM1 ganglioside catabolism in cultured fibroblasts from Alzheimer patients","Pitto M, Raimondo F, Zoia C, Brighina L, Ferrarese C, Masserini M.","Neurobiol Aging. 2005 Jun;26(6):833-8. doi: 10.1016/j.neurobiolaging.2004.07.006.","Pitto M","Neurobiol Aging","2005","2005/02/19","","","10.1016/j.neurobiolaging.2004.07.006"
"2684292","Alzheimer's disease and THA: a review of the cholinergic theory and of preliminary results","Boller F, Forette F.","Biomed Pharmacother. 1989;43(7):487-91. doi: 10.1016/0753-3322(89)90109-1.","Boller F","Biomed Pharmacother","1989","1989/01/01","","","10.1016/0753-3322(89)90109-1"
"8719608","The set test as a diagnostic tool in elderly outpatients with suspected dementia","Oeksengaard AR, Braekhus A, Laake K, Engedal K.","Aging (Milano). 1995 Oct;7(5):398-401. doi: 10.1007/BF03324352.","Oeksengaard AR","Aging (Milano)","1995","1995/10/01","","","10.1007/BF03324352"
"20160215","Impaired awareness of deficits and neuropsychiatric symptoms in early Alzheimer's disease: the Danish Alzheimer Intervention Study (DAISY)","Vogel A, Waldorff FB, Waldemar G.","J Neuropsychiatry Clin Neurosci. 2010 Winter;22(1):93-9. doi: 10.1176/jnp.2010.22.1.93.","Vogel A","J Neuropsychiatry Clin Neurosci","2010","2010/02/18","","","10.1176/jnp.2010.22.1.93"
"23278858","An MRI-based index to measure the severity of Alzheimer's disease-like structural pattern in subjects with mild cognitive impairment","Spulber G, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Lovestone S, Wahlund LO, Westman E; dNeuroMed consortium and for the Alzheimer Disease Neuroimaging Initiative.","J Intern Med. 2013 Apr;273(4):396-409. doi: 10.1111/joim.12028. Epub 2013 Jan 30.","Spulber G","J Intern Med","2013","2013/01/03","PMC3605230","NIHMS431726","10.1111/joim.12028"
"32808453","Unblinded by the light: amyloid-related imaging abnormalities in Alzheimer's clinical trials","Gleason A, Ayton S, Bush AI.","Eur J Neurol. 2021 Jan;28(1):e1. doi: 10.1111/ene.14484. Epub 2020 Sep 9.","Gleason A","Eur J Neurol","2021","2020/08/19","","","10.1111/ene.14484"
"30839402","Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease","Gul A, Bakht J, Mehmood F.","J Chin Med Assoc. 2019 Jan;82(1):40-43. doi: 10.1016/j.jcma.2018.07.004.","Gul A","J Chin Med Assoc","2019","2019/03/07","","","10.1016/j.jcma.2018.07.004"
"14599278","Neural basis for verb processing in Alzheimer's disease: an fMRI study","Grossman M, Koenig P, DeVita C, Glosser G, Moore P, Gee J, Detre J, Alsop D.","Neuropsychology. 2003 Oct;17(4):658-74. doi: 10.1037/0894-4105.17.4.658.","Grossman M","Neuropsychology","2003","2003/11/06","","","10.1037/0894-4105.17.4.658"
"11949704","Do neuropsychological tests detect preclinical Alzheimer's disease: individual-test versus cognitive-discrepancy score analyses","Jacobson MW, Delis DC, Bondi MW, Salmon DP.","Neuropsychology. 2002 Apr;16(2):132-9. doi: 10.1037//0894-4105.16.2.132.","Jacobson MW","Neuropsychology","2002","2002/04/13","","","10.1037//0894-4105.16.2.132"
"22936010","Comparison of two analytical platforms for the clinical qualification of Alzheimer's disease biomarkers in pathologically-confirmed dementia","Le Bastard N, Coart E, Vanderstichele H, Vanmechelen E, Martin JJ, Engelborghs S.","J Alzheimers Dis. 2013;33(1):117-31. doi: 10.3233/JAD-2012-121246.","Le Bastard N","J Alzheimers Dis","2013","2012/09/01","","","10.3233/JAD-2012-121246"
"3530130","Alzheimer's disease. Using direct drug infusion to the central nervous system","Reeder TM, Hohmann M.","AORN J. 1986 Aug;44(2):222, 224-30, 232.","Reeder TM","AORN J","1986","1986/08/01","","",""
"7696598","Auditory sensory memory impairment in Alzheimer's disease: an event-related potential study","Pekkonen E, Jousmäki V, Könönen M, Reinikainen K, Partanen J.","Neuroreport. 1994 Dec 20;5(18):2537-40. doi: 10.1097/00001756-199412000-00033.","Pekkonen E","Neuroreport","1994","1994/12/20","","","10.1097/00001756-199412000-00033"
"29154277","Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial","Wilcock GK, Gauthier S, Frisoni GB, Jia J, Hardlund JH, Moebius HJ, Bentham P, Kook KA, Schelter BO, Wischik DJ, Davis CS, Staff RT, Vuksanovic V, Ahearn T, Bracoud L, Shamsi K, Marek K, Seibyl J, Riedel G, Storey JMD, Harrington CR, Wischik CM.","J Alzheimers Dis. 2018;61(1):435-457. doi: 10.3233/JAD-170560.","Wilcock GK","J Alzheimers Dis","2018","2017/11/21","PMC5734125","","10.3233/JAD-170560"
"26682695","Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial","Hoffmann K, Sobol NA, Frederiksen KS, Beyer N, Vogel A, Vestergaard K, Brændgaard H, Gottrup H, Lolk A, Wermuth L, Jacobsen S, Laugesen LP, Gergelyffy RG, Høgh P, Bjerregaard E, Andersen BB, Siersma V, Johannsen P, Cotman CW, Waldemar G, Hasselbalch SG.","J Alzheimers Dis. 2016;50(2):443-53. doi: 10.3233/JAD-150817.","Hoffmann K","J Alzheimers Dis","2016","2015/12/20","","","10.3233/JAD-150817"
"30484408","One-year Outcome of Shanghai Mild Cognitive Impairment Cohort Study","Zhou B, Zhao Q, Kojima S, Ding D, Higashide S, Nagai Y, Guo Q, Kagimura T, Fukushima M, Hong Z.","Curr Alzheimer Res. 2019;16(2):156-165. doi: 10.2174/1567205016666181128151144.","Zhou B","Curr Alzheimer Res","2019","2018/11/29","","","10.2174/1567205016666181128151144"
"12025737","Differences in EEG harmonic driving responses to photic stimulation between normal aging and Alzheimer's disease","Kikuchi M, Wada Y, Koshino Y.","Clin Electroencephalogr. 2002 Apr;33(2):86-92. doi: 10.1177/155005940203300208.","Kikuchi M","Clin Electroencephalogr","2002","2002/05/25","","","10.1177/155005940203300208"
"15754423","Abnormal cortical functional connections in Alzheimer's disease: analysis of inter- and intra-hemispheric EEG coherence","Jiang ZY.","J Zhejiang Univ Sci B. 2005 Apr;6(4):259-64. doi: 10.1631/jzus.2005.B0259.","Jiang ZY","J Zhejiang Univ Sci B","2005","2005/03/09","PMC1389734","","10.1631/jzus.2005.B0259"
"15279662","Absence of macrocytic anaemia in Alzheimer's disease","McCaddon A, Tandy S, Hudson P, Gray R, Davies G, Hill D, Duguid J.","Clin Lab Haematol. 2004 Aug;26(4):259-63. doi: 10.1111/j.1365-2257.2004.00618.x.","McCaddon A","Clin Lab Haematol","2004","2004/07/29","","","10.1111/j.1365-2257.2004.00618.x"
"32037737","Examination of the influence of cedar fragrance on cognitive function and behavioral and psychological symptoms of dementia in Alzheimer type dementia","Takahashi Y, Shindo S, Kanbayashi T, Takeshima M, Imanishi A, Mishima K.","Neuropsychopharmacol Rep. 2020 Mar;40(1):10-15. doi: 10.1002/npr2.12096. Epub 2020 Feb 9.","Takahashi Y","Neuropsychopharmacol Rep","2020","2020/02/11","PMC7292212","","10.1002/npr2.12096"
"10436344","Synapse density related to cerebral blood flow and symptomatology in frontal lobe degeneration and Alzheimer's disease","Liu X, Passant U, Risberg J, Warkentin S, Brun A.","Dement Geriatr Cogn Disord. 1999;10 Suppl 1:64-70. doi: 10.1159/000051216.","Liu X","Dement Geriatr Cogn Disord","1999","1999/08/07","","","10.1159/000051216"
"26402762","APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease","Waring JF, Tang Q, Robieson WZ, King DP, Das U, Dubow J, Dutta S, Marek GJ, Gault LM.","J Alzheimers Dis. 2015;47(1):137-48. doi: 10.3233/JAD-142589.","Waring JF","J Alzheimers Dis","2015","2015/09/25","PMC4923746","","10.3233/JAD-142589"
"36281666","Adjudicating Mild Cognitive Impairment Due to Alzheimer's Disease as a Novel Endpoint Event in the TOMMORROW Prevention Clinical Trial","Schneider LS, Bennett DA, Farlow MR, Peskind ER, Raskind MA, Sano M, Stern Y, Haneline S, Welsh-Bohmer KA, O'Neil J, Walter R, Maresca S, Culp M, Alexander R, Saunders AM, Burns DK, Chiang C.","J Prev Alzheimers Dis. 2022;9(4):625-634. doi: 10.14283/jpad.2022.72.","Schneider LS","J Prev Alzheimers Dis","2022","2022/10/25","","","10.14283/jpad.2022.72"
"9923574","Assessment of the value of therapeutic monitoring of tacrine in Alzheimer's disease","Roberts CJ, Ford JM, Truman CA, Scott M, Mäkelä PM, Wilcock GK.","Eur J Clin Pharmacol. 1998 Nov-Dec;54(9-10):721-4. doi: 10.1007/s002280050541.","Roberts CJ","Eur J Clin Pharmacol","1998","1999/01/29","","","10.1007/s002280050541"
"21220675","Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative","Schneider LS, Insel PS, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.","Arch Neurol. 2011 Jan;68(1):58-66. doi: 10.1001/archneurol.2010.343.","Schneider LS","Arch Neurol","2011","2011/01/12","PMC3259850","NIHMS285043","10.1001/archneurol.2010.343"
"11924899","Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease","Venneri A, Shanks MF, Staff RT, Pestell SJ, Forbes KE, Gemmell HG, Murray AD.","Neuroreport. 2002 Jan 21;13(1):83-7. doi: 10.1097/00001756-200201210-00020.","Venneri A","Neuroreport","2002","2002/04/02","","","10.1097/00001756-200201210-00020"
"21483095","Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study","Buschert VC, Friese U, Teipel SJ, Schneider P, Merensky W, Rujescu D, Möller HJ, Hampel H, Buerger K.","J Alzheimers Dis. 2011;25(4):679-94. doi: 10.3233/JAD-2011-100999.","Buschert VC","J Alzheimers Dis","2011","2011/04/13","","","10.3233/JAD-2011-100999"
"15271118","Providing nutrition supplements to institutionalized seniors with probable Alzheimer's disease is least beneficial to those with low body weight status","Young KW, Greenwood CE, van Reekum R, Binns MA.","J Am Geriatr Soc. 2004 Aug;52(8):1305-12. doi: 10.1111/j.1532-5415.2004.52360.x.","Young KW","J Am Geriatr Soc","2004","2004/07/24","","","10.1111/j.1532-5415.2004.52360.x"
"31806172","[Alzheimer's disease and singing: an application in mediated therapy]","Hamm S, Sudres JL, Menouer L, Brandibas G.","Soins Gerontol. 2019 Nov-Dec;24(140):15-19. doi: 10.1016/j.sger.2019.09.004.","Hamm S","Soins Gerontol","2019","2019/12/07","","","10.1016/j.sger.2019.09.004"
"12227833","Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment","Huang C, Wahlund LO, Svensson L, Winblad B, Julin P.","BMC Neurol. 2002 Sep 12;2:9. doi: 10.1186/1471-2377-2-9.","Huang C","BMC Neurol","2002","2002/09/14","PMC128832","","10.1186/1471-2377-2-9"
"7477910","Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes","Lehtovirta M, Laakso MP, Soininen H, Helisalmi S, Mannermaa A, Helkala EL, Partanen K, Ryynänen M, Vainio P, Hartikainen P, et al.","Neuroscience. 1995 Jul;67(1):65-72. doi: 10.1016/0306-4522(95)00014-a.","Lehtovirta M","Neuroscience","1995","1995/07/01","","","10.1016/0306-4522(95)00014-a"
"14686563","Potential long-term effects of rivastigmine on disease progression may be linked to drug effects on vascular changes in Alzheimer brains","Erkinjuntti T, Skoog I, Lane R, Andrews C.","Int J Clin Pract. 2003 Nov;57(9):756-60.","Erkinjuntti T","Int J Clin Pract","2003","2003/12/23","","",""
"25322923","Tolerability and safety of Souvenaid in patients with mild Alzheimer's disease: results of multi-center, 24-week, open-label extension study","Olde Rikkert MG, Verhey FR, Blesa R, von Arnim CA, Bongers A, Harrison J, Sijben J, Scarpini E, Vandewoude MF, Vellas B, Witkamp R, Kamphuis PJ, Scheltens P.","J Alzheimers Dis. 2015;44(2):471-80. doi: 10.3233/JAD-141305.","Olde Rikkert MG","J Alzheimers Dis","2015","2014/10/18","","","10.3233/JAD-141305"
"19531281","Reduced TNF-α and increased IGF-I levels in the serum of Alzheimer's disease patients treated with the neurotrophic agent cerebrolysin","Alvarez XA, Sampedro C, Cacabelos R, Linares C, Aleixandre M, García-Fantini M, Moessler H.","Int J Neuropsychopharmacol. 2009 Aug;12(7):867-72. doi: 10.1017/S1461145709990101. Epub 2009 Jun 17.","Alvarez XA","Int J Neuropsychopharmacol","2009","2009/06/18","","","10.1017/S1461145709990101"
"11605215","[Evaluation of animal-assisted therapy for the elderly with senile dementia in a day care program]","Kanamori M, Suzuki M, Yamamoto K, Kanda M, Matsui Y, Kozima E, Takeuchi S, Oshiro H.","Nihon Ronen Igakkai Zasshi. 2001 Sep;38(5):659-64. doi: 10.3143/geriatrics.38.659.","Kanamori M","Nihon Ronen Igakkai Zasshi","2001","2001/10/19","","","10.3143/geriatrics.38.659"
"30958353","D-Cycloserine Improves Difficult Discriminations in a Pattern Separation Task in Alzheimer's Disease Patients with Dementia","Goetghebeur PJD, Wesnes KA, Targum SD.","J Alzheimers Dis. 2019;69(2):377-383. doi: 10.3233/JAD-181094.","Goetghebeur PJD","J Alzheimers Dis","2019","2019/04/09","","","10.3233/JAD-181094"
"9562499","MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects","Laakso MP, Soininen H, Partanen K, Lehtovirta M, Hallikainen M, Hänninen T, Helkala EL, Vainio P, Riekkinen PJ Sr.","Neurobiol Aging. 1998 Jan-Feb;19(1):23-31. doi: 10.1016/s0197-4580(98)00006-2.","Laakso MP","Neurobiol Aging","1998","1998/04/30","","","10.1016/s0197-4580(98)00006-2"
"8838387","Acquisition and long-term retention of a fine motor skill in Alzheimer's disease","Dick MB, Nielson KA, Beth RE, Shankle WR, Cotman CW.","Brain Cogn. 1995 Dec;29(3):294-306. doi: 10.1006/brcg.1995.1283.","Dick MB","Brain Cogn","1995","1995/12/01","","","10.1006/brcg.1995.1283"
"25833732","Latent change score modeling as a method for analyzing the antidepressant effect of a psychosocial intervention in Alzheimer's disease","Werheid K, Köhncke Y, Ziegler M, Kurz A.","Psychother Psychosom. 2015;84(3):159-66. doi: 10.1159/000376583. Epub 2015 Mar 28.","Werheid K","Psychother Psychosom","2015","2015/04/03","","","10.1159/000376583"
"28550255","Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)","Nave S, Doody RS, Boada M, Grimmer T, Savola JM, Delmar P, Pauly-Evers M, Nikolcheva T, Czech C, Borroni E, Ricci B, Dukart J, Mannino M, Carey T, Moran E, Gilaberte I, Muelhardt NM, Gerlach I, Santarelli L, Ostrowitzki S, Fontoura P.","J Alzheimers Dis. 2017;58(4):1217-1228. doi: 10.3233/JAD-161309.","Nave S","J Alzheimers Dis","2017","2017/05/28","PMC5523913","","10.3233/JAD-161309"
"24435893","Early psychosocial intervention in Alzheimer's disease: cost utility evaluation alongside the Danish Alzheimer's Intervention Study (DAISY)","Søgaard R, Sørensen J, Waldorff FB, Eckermann A, Buss DV, Phung KT, Waldemar G; DAISY Study Investigators.","BMJ Open. 2014 Jan 15;4(1):e004105. doi: 10.1136/bmjopen-2013-004105.","Søgaard R","BMJ Open","2014","2014/01/18","PMC3902512","","10.1136/bmjopen-2013-004105"
"35841243","Evaluation of the Feasibility, Safety and Efficacy of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in People Affected by Moderate to Severe Alzheimer's Disease: A Double-Blind Masked Clinical Trial for Dose Finding","Ruiz A, Sánchez D, Lafuente A, Ortega G, Buendía M, Papasey J, Jimeno SY, Badia FP, Palacio ME, Abdelnour C, Ramírez-Toraño F, Maestú F, Sáez ME, Tárraga L, Dagnelie PC, Boada M.","J Prev Alzheimers Dis. 2022;9(3):425-434. doi: 10.14283/jpad.2022.38.","Ruiz A","J Prev Alzheimers Dis","2022","2022/07/16","","","10.14283/jpad.2022.38"
"31122267","Early recognition and treatment of neuropsychiatric symptoms to improve quality of life in early Alzheimer's disease: protocol of the BEAT-IT study","Eikelboom WS, Singleton E, van den Berg E, Coesmans M, Mattace Raso F, van Bruchem RL, Goudzwaard JA, de Jong FJ, Koopmanschap M, den Heijer T, Driesen JJM, Vroegindeweij LJHM, Thomeer EC, Hoogers SE, Dijkstra AA, Zuidema SU, Pijnenburg YAL, Scheltens P, van Swieten JC, Ossenkoppele R, Papma JM.","Alzheimers Res Ther. 2019 May 24;11(1):48. doi: 10.1186/s13195-019-0503-2.","Eikelboom WS","Alzheimers Res Ther","2019","2019/05/25","PMC6533693","","10.1186/s13195-019-0503-2"
"11748790","Olanzapine in the treatment of anxiety symptoms due to Alzheimer's disease: a post hoc analysis","Mintzer J, Faison W, Street JS, Sutton VK, Breier A.","Int J Geriatr Psychiatry. 2001 Dec;16 Suppl 1:S71-7. doi: 10.1002/1099-1166(200112)16:1+<::aid-gps568>3.0.co;2-m.","Mintzer J","Int J Geriatr Psychiatry","2001","2001/12/19","","","10.1002/1099-1166(200112)16:1+<::aid-gps568>3.0.co;2-m"
"24026135","[Effect of a non-pharmacological intervention, Voix d'Or(®), on behavior disturbances in Alzheimer disease and associated disorders]","Delphin-Combe F, Rouch I, Martin-Gaujard G, Relland S, Krolak-Salmon P.","Geriatr Psychol Neuropsychiatr Vieil. 2013 Sep;11(3):323-30. doi: 10.1684/pnv.2013.0421.","Delphin-Combe F","Geriatr Psychol Neuropsychiatr Vieil","2013","2013/09/13","","","10.1684/pnv.2013.0421"
"11513909","Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study","Van Gool WA, Weinstein HC, Scheltens P, Walstra GJ.","Lancet. 2001 Aug 11;358(9280):455-60. doi: 10.1016/s0140-6736(01)05623-9.","Van Gool WA","Lancet","2001","2001/08/22","","","10.1016/s0140-6736(01)05623-9"
"33646146","Low Doses of Ionizing Radiation as a Treatment for Alzheimer's Disease: A Pilot Study","Cuttler JM, Abdellah E, Goldberg Y, Al-Shamaa S, Symons SP, Black SE, Freedman M.","J Alzheimers Dis. 2021;80(3):1119-1128. doi: 10.3233/JAD-200620.","Cuttler JM","J Alzheimers Dis","2021","2021/03/01","PMC8150498","","10.3233/JAD-200620"
"23442574","A 12-week multidomain intervention versus active control to reduce risk of Alzheimer's disease: study protocol for a randomized controlled trial","Anstey KJ, Bahar-Fuchs A, Herath P, Rebok GW, Cherbuin N.","Trials. 2013 Feb 27;14:60. doi: 10.1186/1745-6215-14-60.","Anstey KJ","Trials","2013","2013/02/28","PMC3598396","","10.1186/1745-6215-14-60"
"31345172","Using joint models to disentangle intervention effect types and baseline confounding: an application within an intervention study in prodromal Alzheimer's disease with Fortasyn Connect","van Oudenhoven FM, Swinkels SHN, Hartmann T, Soininen H, van Hees AMJ, Rizopoulos D.","BMC Med Res Methodol. 2019 Jul 25;19(1):163. doi: 10.1186/s12874-019-0791-z.","van Oudenhoven FM","BMC Med Res Methodol","2019","2019/07/27","PMC6659198","","10.1186/s12874-019-0791-z"
"15595714","The Frontal Assessment Battery (FAB): normative data from an Italian sample and performances of patients with Alzheimer's disease and frontotemporal dementia","Iavarone A, Ronga B, Pellegrino L, Loré E, Vitaliano S, Galeone F, Carlomagno S.","Funct Neurol. 2004 Jul-Sep;19(3):191-5.","Iavarone A","Funct Neurol","2004","2004/12/15","","",""
"24164733","Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial","Cumbo E, Ligori LD.","J Alzheimers Dis. 2014;39(3):477-85. doi: 10.3233/JAD-131190.","Cumbo E","J Alzheimers Dis","2014","2013/10/30","","","10.3233/JAD-131190"
"11255449","A method for estimating progression rates in Alzheimer disease","Doody RS, Massman P, Dunn JK.","Arch Neurol. 2001 Mar;58(3):449-54. doi: 10.1001/archneur.58.3.449.","Doody RS","Arch Neurol","2001","2001/03/20","","","10.1001/archneur.58.3.449"
"2222246","GM-1 treatment of Alzheimer's disease. A pilot study of safety and efficacy","Ala T, Romero S, Knight F, Feldt K, Frey WH 2nd.","Arch Neurol. 1990 Oct;47(10):1126-30. doi: 10.1001/archneur.1990.00530100096020.","Ala T","Arch Neurol","1990","1990/10/01","","","10.1001/archneur.1990.00530100096020"
"11382871","Sleep disturbances and eeg slowing in alzheimer's disease","Montplaisir J, Petit D, Gauthier S, Gaudreau H, Décary A.","Sleep Res Online. 1998;1(4):147-51.","Montplaisir J","Sleep Res Online","1998","2001/05/31","","",""
"26402001","Apathy Treatment in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial","Rea R, Carotenuto A, Traini E, Fasanaro AM, Manzo V, Amenta F.","J Alzheimers Dis. 2015;48(2):377-83. doi: 10.3233/JAD-141983.","Rea R","J Alzheimers Dis","2015","2015/09/25","","","10.3233/JAD-141983"
"17135810","ADCS Prevention Instrument Project: the Mail-In Cognitive Function Screening Instrument (MCFSI)","Walsh SP, Raman R, Jones KB, Aisen PS; Alzheimer's Disease Cooperative Study Group.","Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4 Suppl 3):S170-8. doi: 10.1097/01.wad.0000213879.55547.57.","Walsh SP","Alzheimer Dis Assoc Disord","2006","2006/12/01","","","10.1097/01.wad.0000213879.55547.57"
"14651356","Decreased striatal D2 receptor density associated with severe behavioral abnormality in Alzheimer's disease","Tanaka Y, Meguro K, Yamaguchi S, Ishii H, Watanuki S, Funaki Y, Yamaguchi K, Yamadori A, Iwata R, Itoh M.","Ann Nucl Med. 2003 Oct;17(7):567-73. doi: 10.1007/BF03006670.","Tanaka Y","Ann Nucl Med","2003","2003/12/04","","","10.1007/BF03006670"
"10791297","The recovery of cerebrospinal fluid acetylcholinesterase activity in Alzheimer's disease patients after treatment with metrifonate","Unni L, Vicari S, Moriearty P, Schaefer F, Becker R.","Methods Find Exp Clin Pharmacol. 2000 Jan-Feb;22(1):57-61. doi: 10.1358/mf.2000.22.1.795849.","Unni L","Methods Find Exp Clin Pharmacol","2000","2000/05/03","","","10.1358/mf.2000.22.1.795849"
"10353370","Regional cerebral volume loss associated with verbal learning and memory in dementia of the Alzheimer type","Stout JC, Bondi MW, Jernigan TL, Archibald SL, Delis DC, Salmon DP.","Neuropsychology. 1999 Apr;13(2):188-97. doi: 10.1037//0894-4105.13.2.188.","Stout JC","Neuropsychology","1999","1999/06/03","","","10.1037//0894-4105.13.2.188"
"22883691","Diagnostic and economic evaluation of new biomarkers for Alzheimer's disease: the research protocol of a prospective cohort study","Handels RL, Aalten P, Wolfs CA, OldeRikkert M, Scheltens P, Visser PJ, Joore MA, Severens JL, Verhey FR.","BMC Neurol. 2012 Aug 10;12:72. doi: 10.1186/1471-2377-12-72.","Handels RL","BMC Neurol","2012","2012/08/14","PMC3460756","","10.1186/1471-2377-12-72"
"36482412","Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer's disease","Dhadda S, Kanekiyo M, Li D, Swanson CJ, Irizarry M, Berry S, Kramer LD, Berry DA.","Alzheimers Res Ther. 2022 Dec 9;14(1):182. doi: 10.1186/s13195-022-01129-x.","Dhadda S","Alzheimers Res Ther","2022","2022/12/09","PMC9733166","","10.1186/s13195-022-01129-x"
"1837978","Milacemide and other drugs active at glutamate NMDA receptors as potential treatment for dementia","Herting RL.","Ann N Y Acad Sci. 1991;640:237-40. doi: 10.1111/j.1749-6632.1991.tb00225.x.","Herting RL","Ann N Y Acad Sci","1991","1991/01/01","","","10.1111/j.1749-6632.1991.tb00225.x"
"12151908","Donepezil versus vitamin E in Alzheimer's disease: Part 2: mild versus moderate-severe Alzheimer's disease","Onofrj M, Thomas A, Luciano AL, Iacono D, Di Rollo A, D'Andreamatteo G, Di Iorio A.","Clin Neuropharmacol. 2002 Jul-Aug;25(4):207-15. doi: 10.1097/00002826-200207000-00004.","Onofrj M","Clin Neuropharmacol","2002","2002/08/02","","","10.1097/00002826-200207000-00004"
"7580194","Anosognosia in Alzheimer's disease: a study of associated factors","Migliorelli R, Tesón A, Sabe L, Petracca G, Petracchi M, Leiguarda R, Starkstein SE.","J Neuropsychiatry Clin Neurosci. 1995 Summer;7(3):338-44. doi: 10.1176/jnp.7.3.338.","Migliorelli R","J Neuropsychiatry Clin Neurosci","1995","1995/01/01","","","10.1176/jnp.7.3.338"
"19713001","Staged decline of visual processing capacity in mild cognitive impairment and Alzheimer's disease","Bublak P, Redel P, Sorg C, Kurz A, Förstl H, Müller HJ, Schneider WX, Finke K.","Neurobiol Aging. 2011 Jul;32(7):1219-30. doi: 10.1016/j.neurobiolaging.2009.07.012. Epub 2009 Aug 26.","Bublak P","Neurobiol Aging","2011","2009/08/29","","","10.1016/j.neurobiolaging.2009.07.012"
"36544184","Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study","McDade E, Cummings JL, Dhadda S, Swanson CJ, Reyderman L, Kanekiyo M, Koyama A, Irizarry M, Kramer LD, Bateman RJ.","Alzheimers Res Ther. 2022 Dec 21;14(1):191. doi: 10.1186/s13195-022-01124-2.","McDade E","Alzheimers Res Ther","2022","2022/12/21","PMC9768996","","10.1186/s13195-022-01124-2"
"7871052","Memory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer's disease","Soncrant TT, Raffaele KC, Asthana S, Berardi A, Morris PP, Haxby JV.","Psychopharmacology (Berl). 1993;112(4):421-7. doi: 10.1007/BF02244889.","Soncrant TT","Psychopharmacology (Berl)","1993","1993/01/01","","","10.1007/BF02244889"
"2690098","An example of a clinical trial in patients with Alzheimer's disease: some methodological issues","Lucca U, Menasce G, Comelli M, Cizza G, Bressi S, Frattura L, Tiraboschi P, Spagnoli A.","Prog Clin Biol Res. 1989;317:1301-10.","Lucca U","Prog Clin Biol Res","1989","1989/01/01","","",""
"22936007","Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study","del Ser T, Steinwachs KC, Gertz HJ, Andrés MV, Gómez-Carrillo B, Medina M, Vericat JA, Redondo P, Fleet D, León T.","J Alzheimers Dis. 2013;33(1):205-15. doi: 10.3233/JAD-2012-120805.","del Ser T","J Alzheimers Dis","2013","2012/09/01","","","10.3233/JAD-2012-120805"
"25147108","Brain changes in Alzheimer's disease patients with implanted encapsulated cells releasing nerve growth factor","Ferreira D, Westman E, Eyjolfsdottir H, Almqvist P, Lind G, Linderoth B, Seiger A, Blennow K, Karami A, Darreh-Shori T, Wiberg M, Simmons A, Wahlund LO, Wahlberg L, Eriksdotter M.","J Alzheimers Dis. 2015;43(3):1059-72. doi: 10.3233/JAD-141068.","Ferreira D","J Alzheimers Dis","2015","2014/08/23","","","10.3233/JAD-141068"
"8422085","A double-blind crossover pilot study of l-deprenyl (selegiline) combined with cholinesterase inhibitor in Alzheimer's disease","Schneider LS, Olin JT, Pawluczyk S.","Am J Psychiatry. 1993 Feb;150(2):321-3. doi: 10.1176/ajp.150.2.321.","Schneider LS","Am J Psychiatry","1993","1993/02/01","","","10.1176/ajp.150.2.321"
"18761132","Clustering and switching processes in semantic verbal fluency in the course of Alzheimer's disease subjects: results from the PAQUID longitudinal study","Raoux N, Amieva H, Le Goff M, Auriacombe S, Carcaillon L, Letenneur L, Dartigues JF.","Cortex. 2008 Oct;44(9):1188-96. doi: 10.1016/j.cortex.2007.08.019. Epub 2007 Dec 27.","Raoux N","Cortex","2008","2008/09/02","","","10.1016/j.cortex.2007.08.019"
"14533127","The effects of galantamine treatment on caregiver time in Alzheimer's disease","Sano M, Wilcock GK, van Baelen B, Kavanagh S.","Int J Geriatr Psychiatry. 2003 Oct;18(10):942-50. doi: 10.1002/gps.1000.","Sano M","Int J Geriatr Psychiatry","2003","2003/10/09","","","10.1002/gps.1000"
"29284465","Acupuncture for patients with mild to moderate Alzheimer's disease: a randomized controlled trial","Jia Y, Zhang X, Yu J, Han J, Yu T, Shi J, Zhao L, Nie K.","BMC Complement Altern Med. 2017 Dec 29;17(1):556. doi: 10.1186/s12906-017-2064-x.","Jia Y","BMC Complement Altern Med","2017","2017/12/30","PMC5747102","","10.1186/s12906-017-2064-x"
"9069479","Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases","Gnanalingham KK, Byrne EJ, Thornton A, Sambrook MA, Bannister P.","J Neurol Neurosurg Psychiatry. 1997 Mar;62(3):243-52. doi: 10.1136/jnnp.62.3.243.","Gnanalingham KK","J Neurol Neurosurg Psychiatry","1997","1997/03/01","PMC1064153","","10.1136/jnnp.62.3.243"
"8064320","Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography","Blin J, Piercey MF, Giuffra ME, Mouradian MM, Chase TN.","J Neurol Sci. 1994 May;123(1-2):44-51. doi: 10.1016/0022-510x(94)90202-x.","Blin J","J Neurol Sci","1994","1994/05/01","","","10.1016/0022-510x(94)90202-x"
"9460755","Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease","Riekkinen M, Soininen H, Riekkinen P Sr, Kuikka J, Laakso M, Helkala EL, Partanen J, Riekkinen P Jr.","Neuroscience. 1998 Mar;83(2):471-9. doi: 10.1016/s0306-4522(97)00400-4.","Riekkinen M","Neuroscience","1998","1998/02/14","","","10.1016/s0306-4522(97)00400-4"
"20696547","Technology-aided verbal instructions to help persons with mild or moderate Alzheimer's disease perform daily activities","Lancioni GE, Singh NN, O'Reilly MF, Sigafoos J, Tatulli E, Rigante V, Zonno N, Perilli V, Pinto K, Minervini MG.","Res Dev Disabil. 2010 Nov-Dec;31(6):1240-50. doi: 10.1016/j.ridd.2010.07.021. Epub 2010 Aug 8.","Lancioni GE","Res Dev Disabil","2010","2010/08/11","","","10.1016/j.ridd.2010.07.021"
"20541286","Boosting power for clinical trials using classifiers based on multiple biomarkers","Kohannim O, Hua X, Hibar DP, Lee S, Chou YY, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.","Neurobiol Aging. 2010 Aug;31(8):1429-42. doi: 10.1016/j.neurobiolaging.2010.04.022. Epub 2010 Jun 11.","Kohannim O","Neurobiol Aging","2010","2010/06/15","PMC2903199","NIHMS200910","10.1016/j.neurobiolaging.2010.04.022"
"25373630","A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein E4 carriers with mild-moderate Alzheimer's disease","Rosenbloom MH, Barclay TR, Pyle M, Owens BL, Cagan AB, Anderson CP, Frey WH 2nd, Hanson LR.","CNS Drugs. 2014 Dec;28(12):1185-9. doi: 10.1007/s40263-014-0214-y.","Rosenbloom MH","CNS Drugs","2014","2014/11/07","","","10.1007/s40263-014-0214-y"
"17936382","Social participation in home-living patients with mild Alzheimer's disease","Sørensen LV, Waldorff FB, Waldemar G.","Arch Gerontol Geriatr. 2008 Nov-Dec;47(3):291-301. doi: 10.1016/j.archger.2007.08.011. Epub 2007 Oct 23.","Sørensen LV","Arch Gerontol Geriatr","2008","2007/10/16","","","10.1016/j.archger.2007.08.011"
"21744032","Measuring health-related quality-of-life for Alzheimer's disease using the general public","Xie F, Oremus M, Gaebel K.","Qual Life Res. 2012 May;21(4):593-601. doi: 10.1007/s11136-011-9966-8. Epub 2011 Jul 9.","Xie F","Qual Life Res","2012","2011/07/12","","","10.1007/s11136-011-9966-8"
"30627575","Altered Functional Network Affects Amyloid and Structural Covariance in Alzheimer's Disease","Chang YT, Huang CW, Chang WN, Lee JJ, Chang CC.","Biomed Res Int. 2018 Dec 2;2018:8565620. doi: 10.1155/2018/8565620. eCollection 2018.","Chang YT","Biomed Res Int","2018","2019/01/11","PMC6304529","","10.1155/2018/8565620"
"16462011","Entropy analysis of the EEG background activity in Alzheimer's disease patients","Abásolo D, Hornero R, Espino P, Alvarez D, Poza J.","Physiol Meas. 2006 Mar;27(3):241-53. doi: 10.1088/0967-3334/27/3/003. Epub 2006 Jan 13.","Abásolo D","Physiol Meas","2006","2006/02/08","","","10.1088/0967-3334/27/3/003"
"21811019","Genetic variation in the tau kinases pathway may modify the risk and age at onset of Alzheimer's disease","Vázquez-Higuera JL, Mateo I, Sánchez-Juan P, Rodríguez-Rodríguez E, Pozueta A, Calero M, Dobato JL, Frank-García A, Valdivieso F, Berciano J, Bullido MJ, Combarros O.","J Alzheimers Dis. 2011;27(2):291-7. doi: 10.3233/JAD-2011-110794.","Vázquez-Higuera JL","J Alzheimers Dis","2011","2011/08/04","","","10.3233/JAD-2011-110794"
"23375563","Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging","Johnson KA, Sperling RA, Gidicsin CM, Carmasin JS, Maye JE, Coleman RE, Reiman EM, Sabbagh MN, Sadowsky CH, Fleisher AS, Murali Doraiswamy P, Carpenter AP, Clark CM, Joshi AD, Lu M, Grundman M, Mintun MA, Pontecorvo MJ, Skovronsky DM; AV45-A11 study group.","Alzheimers Dement. 2013 Oct;9(5 Suppl):S72-83. doi: 10.1016/j.jalz.2012.10.007. Epub 2013 Jan 30.","Johnson KA","Alzheimers Dement","2013","2013/02/05","PMC3800236","NIHMS487433","10.1016/j.jalz.2012.10.007"
"12672860","Memantine in moderate-to-severe Alzheimer's disease","Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ; Memantine Study Group.","N Engl J Med. 2003 Apr 3;348(14):1333-41. doi: 10.1056/NEJMoa013128.","Reisberg B","N Engl J Med","2003","2003/04/04","","","10.1056/NEJMoa013128"
"30421454","Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies","Boyle PA, Yu L, Leurgans SE, Wilson RS, Brookmeyer R, Schneider JA, Bennett DA.","Ann Neurol. 2019 Jan;85(1):114-124. doi: 10.1002/ana.25380. Epub 2018 Dec 19.","Boyle PA","Ann Neurol","2019","2018/11/14","PMC10128614","NIHMS1875800","10.1002/ana.25380"
"26401704","Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment","Nordberg A, Kadir A, Andreasen N, Almkvist O, Wall A, Långström B, Zetterberg H.","J Alzheimers Dis. 2015;47(3):691-704. doi: 10.3233/JAD-132474.","Nordberg A","J Alzheimers Dis","2015","2015/09/25","","","10.3233/JAD-132474"
"1953964","Quantitative EEG during a double-blind trial of THA and lecithin in patients with Alzheimer's disease","Perryman KM, Fitten LJ.","J Geriatr Psychiatry Neurol. 1991 Jul-Sep;4(3):127-33. doi: 10.1177/089198879100400302.","Perryman KM","J Geriatr Psychiatry Neurol","1991","1991/07/01","","","10.1177/089198879100400302"
"6685840","Vasopressin in Alzheimer's disease","Reding MJ, DiPonte P.","Neurology. 1983 Dec;33(12):1634-5. doi: 10.1212/wnl.33.12.1634-a.","Reding MJ","Neurology","1983","1983/12/01","","","10.1212/wnl.33.12.1634-a"
"12205648","Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial","Simons M, Schwärzler F, Lütjohann D, von Bergmann K, Beyreuther K, Dichgans J, Wormstall H, Hartmann T, Schulz JB.","Ann Neurol. 2002 Sep;52(3):346-50. doi: 10.1002/ana.10292.","Simons M","Ann Neurol","2002","2002/09/03","","","10.1002/ana.10292"
"9844037","Neuroimaging findings in twins discordant for Alzheimer's disease","Pedersen NL, Miller BL, Wetherell JL, Vallo J, Toga AW, Knutson N, Mehringer CM, Small GW, Gatz M.","Dement Geriatr Cogn Disord. 1999 Jan-Feb;10(1):51-8. doi: 10.1159/000017097.","Pedersen NL","Dement Geriatr Cogn Disord","1999","1998/12/09","","","10.1159/000017097"
"24075291","The Quick Mild Cognitive Impairment screen correlated with the Standardized Alzheimer's Disease Assessment Scale-cognitive section in clinical trials","O'Caoimh R, Svendrovski A, Johnston BC, Gao Y, McGlade C, Eustace J, Timmons S, Guyatt G, Molloy DW.","J Clin Epidemiol. 2014 Jan;67(1):87-92. doi: 10.1016/j.jclinepi.2013.07.009. Epub 2013 Sep 25.","O'Caoimh R","J Clin Epidemiol","2014","2013/10/01","","","10.1016/j.jclinepi.2013.07.009"
"12102448","Association between neuropsychiatric and autonomic dysfunction in Alzheimer's disease","Idiaquez J, Sandoval E, Seguel A.","Clin Auton Res. 2002 Feb;12(1):43-6. doi: 10.1007/s102860200009.","Idiaquez J","Clin Auton Res","2002","2002/07/10","","","10.1007/s102860200009"
"1775603","Pretreatment postural blood pressure drop as a possible predictor of response to the cholinesterase inhibitor velnacrine (HP 029) in Alzheimer's disease","Pomara N, Deptula D, Singh R.","Psychopharmacol Bull. 1991;27(3):301-7.","Pomara N","Psychopharmacol Bull","1991","1991/01/01","","",""
"21592050","Left anterior temporal lobe sustains naming in Alzheimer's dementia and mild cognitive impairment","Frings L, Klöppel S, Teipel S, Peters O, Frölich L, Pantel J, Schröder J, Gertz HJ, Arlt S, Heuser I, Kornhuber J, Wiltfang J, Maier W, Jessen F, Hampel H, Hüll M.","Curr Alzheimer Res. 2011 Dec;8(8):893-901. doi: 10.2174/156720511798192673.","Frings L","Curr Alzheimer Res","2011","2011/05/20","","","10.2174/156720511798192673"
"10559555","No detected mutations in the genes for the amyloid precursor protein and presenilins 1 and 2 in a swiss early-onset Alzheimer's disease family with a dominant mode of inheritance","Savioz A, Leuba G, Forsell C, Lilius L, Rossier C, Saini K, Bouras C, Lannfelt L.","Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):431-6. doi: 10.1159/000017185.","Savioz A","Dement Geriatr Cogn Disord","1999","1999/11/24","","","10.1159/000017185"
"26371345","Cognitive Efficacy (SIB) of 13.3 Versus 4.6 mg/24 h Rivastigmine Patch in Severe Alzheimer's Disease","Isaacson RS, Ferris S, Velting DM, Meng X.","Am J Alzheimers Dis Other Demen. 2016 May;31(3):270-7. doi: 10.1177/1533317515603687. Epub 2015 Sep 14.","Isaacson RS","Am J Alzheimers Dis Other Demen","2016","2015/09/16","","","10.1177/1533317515603687"
"81959","Choline in Alzheimers disease","Levy R.","Lancet. 1978 Oct 28;2(8096):944-5. doi: 10.1016/s0140-6736(78)91663-x.","Levy R","Lancet","1978","1978/10/28","","","10.1016/s0140-6736(78)91663-x"
"19151906","Improvement of spontaneous speech in early stage Alzheimer's with rivastigmine","Visch Brink EG, Van Rhee Temme W, Rietveld T, Krulder JW, Van Harskamp F, Van der Cammen TJ.","J Nutr Health Aging. 2009 Jan;13(1):34-8. doi: 10.1007/s12603-009-0007-z.","Visch Brink EG","J Nutr Health Aging","2009","2009/01/20","","","10.1007/s12603-009-0007-z"
"29141548","Cognitive Training in Patients with Alzheimer's Disease: Findings of a 12-month Randomized Controlled Trial","Trebbastoni A, Imbriano L, Podda L, Rendace L, Sacchetti ML, Campanelli A, D'Antonio F, de Lena C.","Curr Alzheimer Res. 2018 Mar 14;15(5):452-461. doi: 10.2174/1567205014666171113105044.","Trebbastoni A","Curr Alzheimer Res","2018","2017/11/17","","","10.2174/1567205014666171113105044"
"36394721","Classification of Alzheimer's disease stage using machine learning for left and right oxygenation difference signals in the prefrontal cortex: a patient-level, single-group, diagnostic interventional trial","Kim J, Kim SC, Kang D, Yon DK, Kim JG.","Eur Rev Med Pharmacol Sci. 2022 Nov;26(21):7734-7741. doi: 10.26355/eurrev_202211_30122.","Kim J","Eur Rev Med Pharmacol Sci","2022","2022/11/17","","","10.26355/eurrev_202211_30122"
"23782591","Medication adherence and tolerability of Alzheimer's disease medications: study protocol for a randomized controlled trial","Campbell NL, Dexter P, Perkins AJ, Gao S, Li L, Skaar TC, Frame A, Hendrie HC, Callahan CM, Boustani MA.","Trials. 2013 May 4;14:125. doi: 10.1186/1745-6215-14-125.","Campbell NL","Trials","2013","2013/06/21","PMC3764973","","10.1186/1745-6215-14-125"
"31006684","Recruitment of Older Veterans with Diabetes Risk for Alzheimer's Disease for a Randomized Clinical Trial of Computerized Cognitive Training","Karran M, Guerrero-Berroa E, Schmeidler J, Lee PG, Alexander N, Nabozny M, West RK, Beeri MS, Sano M, Silverman JM.","J Alzheimers Dis. 2019;69(2):401-411. doi: 10.3233/JAD-180952.","Karran M","J Alzheimers Dis","2019","2019/04/23","","","10.3233/JAD-180952"
"16928344","Donepezil in patients with severe Alzheimer's disease: double-blind parallel-group, placebo controlled study","Marder K.","Curr Neurol Neurosci Rep. 2006 Sep;6(5):364-3. doi: 10.1007/s11910-996-0015-x.","Marder K","Curr Neurol Neurosci Rep","2006","2006/08/25","","","10.1007/s11910-996-0015-x"
"29221491","A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease","Ostrowitzki S, Lasser RA, Dorflinger E, Scheltens P, Barkhof F, Nikolcheva T, Ashford E, Retout S, Hofmann C, Delmar P, Klein G, Andjelkovic M, Dubois B, Boada M, Blennow K, Santarelli L, Fontoura P; SCarlet RoAD Investigators.","Alzheimers Res Ther. 2017 Dec 8;9(1):95. doi: 10.1186/s13195-017-0318-y.","Ostrowitzki S","Alzheimers Res Ther","2017","2017/12/10","PMC5723032","","10.1186/s13195-017-0318-y"
"12917745","Dementia and Nutrition. Intervention study in institutionalized patients with Alzheimer disease","Gil Gregorio P, Ramirez Diaz SP, Ribera Casado JM; DEMENU group.","J Nutr Health Aging. 2003;7(5):304-8.","Gil Gregorio P","J Nutr Health Aging","2003","2003/08/15","","",""
"33023920","Linking the Mini-Mental State Examination, the Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Severe Impairment Battery: evidence from individual participant data from five randomised clinical trials of donepezil","Levine SZ, Yoshida K, Goldberg Y, Samara M, Cipriani A, Efthimiou O, Iwatsubo T, Leucht S, Furukawa TA.","Evid Based Ment Health. 2021 May;24(2):56-61. doi: 10.1136/ebmental-2020-300184. Epub 2020 Oct 6.","Levine SZ","Evid Based Ment Health","2021","2020/10/07","","","10.1136/ebmental-2020-300184"
"2253892","Ergoloid mesylates vs. Alzheimer's: the latest round","Walker C.","Geriatrics. 1990 Dec;45(12):22, 24.","Walker C","Geriatrics","1990","1990/12/01","","",""
"10779840","Three words three shapes: A clinical test of memory","Weintraub S, Peavy GM, O'Connor M, Johnson NA, Acar D, Sweeney J, Janssen I.","J Clin Exp Neuropsychol. 2000 Apr;22(2):267-78. doi: 10.1076/1380-3395(200004)22:2;1-1;FT267.","Weintraub S","J Clin Exp Neuropsychol","2000","2000/04/26","","","10.1076/1380-3395(200004)22:2;1-1;FT267"
"30246408","The effect of reminiscence therapy on cognitive functions, depression, and quality of life in Alzheimer patients: Randomized controlled trial","Lök N, Bademli K, Selçuk-Tosun A.","Int J Geriatr Psychiatry. 2019 Jan;34(1):47-53. doi: 10.1002/gps.4980. Epub 2018 Sep 24.","Lök N","Int J Geriatr Psychiatry","2019","2018/09/25","","","10.1002/gps.4980"
"2229455","Multiple dose pharmacokinetics, safety, and tolerance of velnacrine (HP 029) in healthy elderly subjects: a potential therapeutic agent for Alzheimer's disease","Puri SK, Ho I, Hsu R, Lassman HB.","J Clin Pharmacol. 1990 Oct;30(10):948-55. doi: 10.1002/j.1552-4604.1990.tb03576.x.","Puri SK","J Clin Pharmacol","1990","1990/10/01","","","10.1002/j.1552-4604.1990.tb03576.x"
"17563191","Positive aspects of caregiving as a moderator of treatment outcome over 12 months","Hilgeman MM, Allen RS, DeCoster J, Burgio LD.","Psychol Aging. 2007 Jun;22(2):361-71. doi: 10.1037/0882-7974.22.2.361.","Hilgeman MM","Psychol Aging","2007","2007/06/15","PMC2579267","NIHMS72023","10.1037/0882-7974.22.2.361"
"9065538","Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease","Galasko D, Clark C, Chang L, Miller B, Green RC, Motter R, Seubert P.","Neurology. 1997 Mar;48(3):632-5. doi: 10.1212/wnl.48.3.632.","Galasko D","Neurology","1997","1997/03/01","","","10.1212/wnl.48.3.632"
"8673964","Prior intra-operative hypotension is not a risk factor for development of Alzheimer's disease","Bohnen NI, Wijdicks EF, Kokmen E, Warner MA, Kurland LT.","Can J Neurol Sci. 1996 Feb;23(1):57-8. doi: 10.1017/s0317167100039196.","Bohnen NI","Can J Neurol Sci","1996","1996/02/01","","","10.1017/s0317167100039196"
"21131672","Comparing responses to horticultural-based and traditional activities in dementia care programs","Jarrott SE, Gigliotti CM.","Am J Alzheimers Dis Other Demen. 2010 Dec;25(8):657-65. doi: 10.1177/1533317510385810.","Jarrott SE","Am J Alzheimers Dis Other Demen","2010","2010/12/07","","","10.1177/1533317510385810"
"8701750","Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease","Xu SS, Gao ZX, Weng Z, Du ZM, Xu WA, Yang JS, Zhang ML, Tong ZH, Fang YS, Chai XS, et al.","Zhongguo Yao Li Xue Bao. 1995 Sep;16(5):391-5.","Xu SS","Zhongguo Yao Li Xue Bao","1995","1995/09/01","","",""
"11748789","Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia","Street JS, Clark WS, Kadam DL, Mitan SJ, Juliar BE, Feldman PD, Breier A.","Int J Geriatr Psychiatry. 2001 Dec;16 Suppl 1:S62-70. doi: 10.1002/1099-1166(200112)16:1+<::aid-gps569>3.0.co;2-j.","Street JS","Int J Geriatr Psychiatry","2001","2001/12/19","","","10.1002/1099-1166(200112)16:1+<::aid-gps569>3.0.co;2-j"
"20056923","Vascular care in patients with Alzheimer disease with cerebrovascular lesions slows progression of white matter lesions on MRI: the evaluation of vascular care in Alzheimer's disease (EVA) study","Richard E, Gouw AA, Scheltens P, van Gool WA.","Stroke. 2010 Mar;41(3):554-6. doi: 10.1161/STROKEAHA.109.571281. Epub 2010 Jan 7.","Richard E","Stroke","2010","2010/01/09","","","10.1161/STROKEAHA.109.571281"
"16191248","Psychosocial intervention for dementia caregivers: what can it accomplish?","Mittelman MS.","Int Psychogeriatr. 2003;15 Suppl 1:247-9. doi: 10.1017/S104161020300927X.","Mittelman MS","Int Psychogeriatr","2003","2005/09/30","","","10.1017/S104161020300927X"
"19625744","Effects of insulin and octreotide on memory and growth hormone in Alzheimer's disease","Watson GS, Baker LD, Cholerton BA, Rhoads KW, Merriam GR, Schellenberg GD, Asthana S, Cherrier M, Craft S.","J Alzheimers Dis. 2009;18(3):595-602. doi: 10.3233/JAD-2009-1165.","Watson GS","J Alzheimers Dis","2009","2009/07/24","PMC2842464","NIHMS164641","10.3233/JAD-2009-1165"
"29782824","APOE-ε4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies","Saeed U, Mirza SS, MacIntosh BJ, Herrmann N, Keith J, Ramirez J, Nestor SM, Yu Q, Knight J, Swardfager W, Potkin SG, Rogaeva E, St George-Hyslop P, Black SE, Masellis M.","Alzheimers Dement. 2018 Sep;14(9):1137-1147. doi: 10.1016/j.jalz.2018.04.005. Epub 2018 May 18.","Saeed U","Alzheimers Dement","2018","2018/05/22","","","10.1016/j.jalz.2018.04.005"
"8614505","d-Cycloserine enhances implicit memory in Alzheimer patients","Schwartz BL, Hashtroudi S, Herting RL, Schwartz P, Deutsch SI.","Neurology. 1996 Feb;46(2):420-4. doi: 10.1212/wnl.46.2.420.","Schwartz BL","Neurology","1996","1996/02/01","","","10.1212/wnl.46.2.420"
"32152925","Relationships between amyloid levels, glucose metabolism, morphologic changes in the brain and clinical status of patients with Alzheimer's disease","Thientunyakit T, Sethanandha C, Muangpaisan W, Chawalparit O, Arunrungvichian K, Siriprapa T, Vichianin Y, Kamal S, Suppasilp C, Thongpraparn T, Chanachai R, Gelovani JG.","Ann Nucl Med. 2020 May;34(5):337-348. doi: 10.1007/s12149-020-01453-y. Epub 2020 Mar 9.","Thientunyakit T","Ann Nucl Med","2020","2020/03/11","","","10.1007/s12149-020-01453-y"
"31498121","A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Teprenone in Patients with Alzheimer's Disease","Yokoyama S, Yoshinaga T, Matsuzaki J, Suzuki H.","J Alzheimers Dis. 2019;71(4):1187-1199. doi: 10.3233/JAD-190305.","Yokoyama S","J Alzheimers Dis","2019","2019/09/10","","","10.3233/JAD-190305"
"1404819","A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group","Farlow M, Gracon SI, Hershey LA, Lewis KW, Sadowsky CH, Dolan-Ureno J.","JAMA. 1992 Nov 11;268(18):2523-9.","Farlow M","JAMA","1992","1992/11/11","","",""
"20436440","[Possibilities of preventive treatment of Alzheimer's disease: results of the 3-year open prospective comparative study on efficacy and safety of the course therapy with cerebrolysin and cavinton in elderly patients with the syndrome of mild cognitive impairment]","Gavrilova SI, Kolykhalov IV, Fedorova IaB, Selezneva ND, Kalyn IaB, Roshchina IF, Odinak MM, Emelin AIu, Kashin AV, Gustov AV, Antipenko EA, Korshunova IuA, Davydova TA, Messler G.","Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(1):62-9.","Gavrilova SI","Zh Nevrol Psikhiatr Im S S Korsakova","2010","2010/05/04","","",""
"17934053","Patients with dementia and their carers","Bridges-Webb C, Giles B, Speechly C, Zurynski Y, Hiramanek N.","Ann N Y Acad Sci. 2007 Oct;1114:130-6. doi: 10.1196/annals.1396.012. Epub 2007 Oct 12.","Bridges-Webb C","Ann N Y Acad Sci","2007","2007/10/16","","","10.1196/annals.1396.012"
"9444476","Dissociations between reading responses and semantic priming effects in a dyslexic patient","Nakamura H, Nakanishi M, Hamanaka T, Nakaaki S, Furukawa T, Masui T.","Cortex. 1997 Dec;33(4):753-61. doi: 10.1016/s0010-9452(08)70732-9.","Nakamura H","Cortex","1997","1998/01/28","","","10.1016/s0010-9452(08)70732-9"
"1776748","Potential clinical use of an adrenergic/cholinergic agent (HP 128) in the treatment of Alzheimer's disease","Huff FJ, Antuono P, Murphy M, Beyer J, Dobson C.","Ann N Y Acad Sci. 1991;640:263-7. doi: 10.1111/j.1749-6632.1991.tb00230.x.","Huff FJ","Ann N Y Acad Sci","1991","1991/01/01","","","10.1111/j.1749-6632.1991.tb00230.x"
"20116388","Learning to perceive structure from motion and neural plasticity in patients with Alzheimer's disease","Kim NG, Park JH.","Neuropsychologia. 2010 Apr;48(5):1464-71. doi: 10.1016/j.neuropsychologia.2010.01.016. Epub 2010 Jan 29.","Kim NG","Neuropsychologia","2010","2010/02/02","","","10.1016/j.neuropsychologia.2010.01.016"
"17545732","Heritability of magnetic resonance imaging (MRI) traits in Alzheimer disease cases and their siblings in the MIRAGE study","Lunetta KL, Erlich PM, Cuenco KT, Cupples LA, Green RC, Farrer LA, Decarli C; MIRAGE Study Group.","Alzheimer Dis Assoc Disord. 2007 Apr-Jun;21(2):85-91. doi: 10.1097/WAD.0b013e3180653bf7.","Lunetta KL","Alzheimer Dis Assoc Disord","2007","2007/06/05","","","10.1097/WAD.0b013e3180653bf7"
"19812871","Domain-specific cognitive effects of tramiprosate in patients with mild to moderate Alzheimer's disease: ADAS-cog subscale results from the Alphase Study","Saumier D, Duong A, Haine D, Garceau D, Sampalis J.","J Nutr Health Aging. 2009 Nov;13(9):808-12. doi: 10.1007/s12603-009-0217-4.","Saumier D","J Nutr Health Aging","2009","2009/10/09","","","10.1007/s12603-009-0217-4"
"30355322","FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's disease","Novak P, Schmidt R, Kontsekova E, Kovacech B, Smolek T, Katina S, Fialova L, Prcina M, Parrak V, Dal-Bianco P, Brunner M, Staffen W, Rainer M, Ondrus M, Ropele S, Smisek M, Sivak R, Zilka N, Winblad B, Novak M.","Alzheimers Res Ther. 2018 Oct 24;10(1):108. doi: 10.1186/s13195-018-0436-1.","Novak P","Alzheimers Res Ther","2018","2018/10/26","PMC6201586","","10.1186/s13195-018-0436-1"
"8139380","Scopolamine effects on the pressor response to thyrotropin-releasing hormone in humans","Molchan SE, Hill JL, Minichiello M, Vitiello B, Sunderland T.","Life Sci. 1994;54(13):933-8. doi: 10.1016/0024-3205(94)00629-6.","Molchan SE","Life Sci","1994","1994/01/01","","","10.1016/0024-3205(94)00629-6"
"18690839","Reduced risk of incident AD with elective statin use in a clinical trial cohort","Sparks DL, Kryscio RJ, Sabbagh MN, Connor DJ, Sparks LM, Liebsack C.","Curr Alzheimer Res. 2008 Aug;5(4):416-21. doi: 10.2174/156720508785132316.","Sparks DL","Curr Alzheimer Res","2008","2008/08/12","","","10.2174/156720508785132316"
"27106901","My Mind Project: the effects of cognitive training for elderly-the study protocol of a prospective randomized intervention study","Giuli C, Fattoretti P, Gagliardi C, Mocchegiani E, Venarucci D, Balietti M, Casoli T, Costarelli L, Giacconi R, Malavolta M, Papa R, Lattanzio F, Postacchini D.","Aging Clin Exp Res. 2017 Jun;29(3):353-360. doi: 10.1007/s40520-016-0570-1. Epub 2016 Apr 22.","Giuli C","Aging Clin Exp Res","2017","2016/04/24","PMC5445186","","10.1007/s40520-016-0570-1"
"17135808","ADCS Prevention Instrument Project: behavioral measures in primary prevention trials","Cummings JL, Raman R, Ernstrom K, Salmon D, Ferris SH; Alzheimer's Disease Cooperative Study Group.","Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4 Suppl 3):S147-51. doi: 10.1097/01.wad.0000213872.17429.0f.","Cummings JL","Alzheimer Dis Assoc Disord","2006","2006/12/01","","","10.1097/01.wad.0000213872.17429.0f"
"24021498","Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial","Rosenberg PB, Lanctôt KL, Drye LT, Herrmann N, Scherer RW, Bachman DL, Mintzer JE, ADMET Investigators.","J Clin Psychiatry. 2013 Aug;74(8):810-6. doi: 10.4088/JCP.12m08099.","Rosenberg PB","J Clin Psychiatry","2013","2013/09/12","PMC3902018","NIHMS547397","10.4088/JCP.12m08099"
"32928279","A phase II randomized trial of sodium oligomannate in Alzheimer's dementia","Wang T, Kuang W, Chen W, Xu W, Zhang L, Li Y, Li H, Peng Y, Chen Y, Wang B, Xiao J, Li H, Yan C, Du Y, Tang M, He Z, Chen H, Li W, Lin H, Shi S, Bi J, Zhou H, Cheng Y, Gao X, Guan Y, Huang Q, Chen K, Xin X, Ding J, Geng M, Xiao S.","Alzheimers Res Ther. 2020 Sep 14;12(1):110. doi: 10.1186/s13195-020-00678-3.","Wang T","Alzheimers Res Ther","2020","2020/09/15","PMC7489025","","10.1186/s13195-020-00678-3"
"9844031","Apolipoprotein E and alpha1-antichymotrypsin genotypes and age of onset of familial Alzheimer's disease","Axelman K, Basun H, Lannfelt L.","Dement Geriatr Cogn Disord. 1999 Jan-Feb;10(1):1-5. doi: 10.1159/000017090.","Axelman K","Dement Geriatr Cogn Disord","1999","1998/12/09","","","10.1159/000017090"
"24797360","Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology","Burgos K, Malenica I, Metpally R, Courtright A, Rakela B, Beach T, Shill H, Adler C, Sabbagh M, Villa S, Tembe W, Craig D, Van Keuren-Jensen K.","PLoS One. 2014 May 5;9(5):e94839. doi: 10.1371/journal.pone.0094839. eCollection 2014.","Burgos K","PLoS One","2014","2014/05/07","PMC4010405","","10.1371/journal.pone.0094839"
"12088699","A new EEG method for estimating cortical neuronal impairment that is sensitive to early stage Alzheimer's disease","Musha T, Asada T, Yamashita F, Kinoshita T, Chen Z, Matsuda H, Uno M, Shankle WR.","Clin Neurophysiol. 2002 Jul;113(7):1052-8. doi: 10.1016/s1388-2457(02)00128-1.","Musha T","Clin Neurophysiol","2002","2002/06/29","","","10.1016/s1388-2457(02)00128-1"
"1968457","Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics","Gleason RP, Schneider LS.","J Clin Psychiatry. 1990 Mar;51(3):115-8.","Gleason RP","J Clin Psychiatry","1990","1990/03/01","","",""
"7866482","Tacrine treatment modifies cerebrospinal fluid neuropeptide levels in Alzheimer's disease","Minthon L, Edvinsson L, Gustafson L.","Dementia. 1994 Nov-Dec;5(6):295-301. doi: 10.1159/000106738.","Minthon L","Dementia","1994","1994/11/01","","","10.1159/000106738"
"34340251","Pilot evaluation of a consumer wearable device to assess sleep in a clinical polysomnography trial of suvorexant for treating insomnia in patients with Alzheimer's disease","Svetnik V, Wang TC, Ceesay P, Snyder E, Ceren O, Bliwise D, Budd K, Hutzelmann J, Stevens J, Lines C, Michelson D, Herring WJ.","J Sleep Res. 2021 Dec;30(6):e13328. doi: 10.1111/jsr.13328. Epub 2021 Aug 2.","Svetnik V","J Sleep Res","2021","2021/08/02","","","10.1111/jsr.13328"
"19407728","Selective benefit of donepezil on oral naming in Alzheimer's disease in men compared to women","Davis ML, Barrett AM.","CNS Spectr. 2009 Apr;14(4):175-6. doi: 10.1017/s1092852900020174.","Davis ML","CNS Spectr","2009","2009/05/02","PMC2928142","NIHMS229422","10.1017/s1092852900020174"
"20130406","Neuropsychiatric symptoms in korean patients with Alzheimer's disease: exploratory factor analysis and confirmatory factor analysis of the neuropsychiatric inventory","Kang HS, Ahn IS, Kim JH, Kim DK.","Dement Geriatr Cogn Disord. 2010;29(1):82-7. doi: 10.1159/000264629. Epub 2010 Feb 3.","Kang HS","Dement Geriatr Cogn Disord","2010","2010/02/05","","","10.1159/000264629"
"15600135","Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer's disease patients","Ancoli-Israel S, Gehrman P, Martin JL, Shochat T, Marler M, Corey-Bloom J, Levi L.","Behav Sleep Med. 2003;1(1):22-36. doi: 10.1207/S15402010BSM0101_4.","Ancoli-Israel S","Behav Sleep Med","2003","2004/12/17","","","10.1207/S15402010BSM0101_4"
"16298239","Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease","Watson GS, Bernhardt T, Reger MA, Cholerton BA, Baker LD, Peskind ER, Asthana S, Plymate SR, Frölich L, Craft S.","Neurobiol Aging. 2006 Jan;27(1):38-41. doi: 10.1016/j.neurobiolaging.2004.11.011.","Watson GS","Neurobiol Aging","2006","2005/11/22","","","10.1016/j.neurobiolaging.2004.11.011"
"28673322","The effect of electroacupuncture combined with donepezil on cognitive function in Alzheimer's disease patients: study protocol for a randomized controlled trial","Peng W, Zhou J, Xu M, Feng Q, Bin L, Liu Z.","Trials. 2017 Jul 3;18(1):301. doi: 10.1186/s13063-017-2052-y.","Peng W","Trials","2017","2017/07/05","PMC5496421","","10.1186/s13063-017-2052-y"
"11954669","Caregiving appraisal and interventions based on the progressively lowered stress threshold model","Stolley JM, Reed D, Buckwalter KC.","Am J Alzheimers Dis Other Demen. 2002 Mar-Apr;17(2):110-20. doi: 10.1177/153331750201700211.","Stolley JM","Am J Alzheimers Dis Other Demen","2002","2002/04/17","","","10.1177/153331750201700211"
"22430032","A SNP site in pri-miR-124 changes mature miR-124 expression but no contribution to Alzheimer's disease in a Mongolian population","Qi L, Hu Y, Zhan Y, Wang J, Wang BB, Xia HF, Ma X.","Neurosci Lett. 2012 Apr 25;515(1):1-6. doi: 10.1016/j.neulet.2012.02.061. Epub 2012 Mar 10.","Qi L","Neurosci Lett","2012","2012/03/21","","","10.1016/j.neulet.2012.02.061"
"8969979","The cardinal features of cognitive and noncognitive dysfunction and the differential efficacy of tacrine in Alzheimer's disease patients","Talwalker S.","J Biopharm Stat. 1996 Nov;6(4):443-56. doi: 10.1080/10543409608835155.","Talwalker S","J Biopharm Stat","1996","1996/11/01","","","10.1080/10543409608835155"
"9513028","1997 IPA/Bayer Research Awards in Psychogeriatrics. Associations between dysfunctional behaviors, gender, and burden in spousal caregivers of cognitively impaired older adults","Bédard M, Molloy DW, Pedlar D, Lever JA, Stones MJ.","Int Psychogeriatr. 1997 Sep;9(3):277-90. doi: 10.1017/s1041610297004444.","Bédard M","Int Psychogeriatr","1997","1998/03/26","","","10.1017/s1041610297004444"
"31744005","Sixteen-Week Interventional Study to Evaluate the Clinical Effects and Safety of Rivastigmine Capsules in Chinese Patients with Alzheimer's Disease","Jia J, Ji Y, Feng T, Ye Q, Peng D, Kuang W, Ning Y, Liang Z, Fan D, Wei W, Li Y, Xiao S.","J Alzheimers Dis. 2019;72(4):1313-1322. doi: 10.3233/JAD-190791.","Jia J","J Alzheimers Dis","2019","2019/11/21","","","10.3233/JAD-190791"
"9677506","Acetyl L-carnitine slows decline in younger patients with Alzheimer's disease: a reanalysis of a double-blind, placebo-controlled study using the trilinear approach","Brooks JO 3rd, Yesavage JA, Carta A, Bravi D.","Int Psychogeriatr. 1998 Jun;10(2):193-203. doi: 10.1017/s1041610298005304.","Brooks JO 3rd","Int Psychogeriatr","1998","1998/07/25","","","10.1017/s1041610298005304"
"11315318","Lipid metabolism parameters in patients with Alzheimer's disease and their first degree relatives","Czyzewski K, Lalowski MM, Pfeffer A, Barcikowska M.","Acta Neurobiol Exp (Wars). 2001;61(1):21-6.","Czyzewski K","Acta Neurobiol Exp (Wars)","2001","2001/04/24","","",""
"7761291","A dyadic remediation program for care recipients with dementia","Quayhagen MP, Quayhagen M, Corbeil RR, Roth PA, Rodgers JA.","Nurs Res. 1995 May-Jun;44(3):153-9.","Quayhagen MP","Nurs Res","1995","1995/05/01","","",""
"28617831","Depression in dementia with Lewy bodies: A comparison with Alzheimer's disease","Chiu PY, Wang CW, Tsai CT, Li SH, Lin CL, Lai TJ.","PLoS One. 2017 Jun 15;12(6):e0179399. doi: 10.1371/journal.pone.0179399. eCollection 2017.","Chiu PY","PLoS One","2017","2017/06/16","PMC5472293","","10.1371/journal.pone.0179399"
"8128839","Clinical trials with velnacrine: (PROPP) the physician reference of predicted probabilities--a statistical model for the estimation of hepatotoxicity risk with velnacrine maleate","Hardiman S, Miller K, Murphy M.","Acta Neurol Scand Suppl. 1993;149:46-52. doi: 10.1111/j.1600-0404.1993.tb04255.x.","Hardiman S","Acta Neurol Scand Suppl","1993","1993/01/01","","","10.1111/j.1600-0404.1993.tb04255.x"
"12111130","Limbic system perfusion in Alzheimer's disease measured by MRI-coregistered HMPAO SPET","Callen DJ, Black SE, Caldwell CB.","Eur J Nucl Med Mol Imaging. 2002 Jul;29(7):899-906. doi: 10.1007/s00259-002-0816-3. Epub 2002 Apr 27.","Callen DJ","Eur J Nucl Med Mol Imaging","2002","2002/07/12","","","10.1007/s00259-002-0816-3"
"30231896","Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE)","Salloway S, Honigberg LA, Cho W, Ward M, Friesenhahn M, Brunstein F, Quartino A, Clayton D, Mortensen D, Bittner T, Ho C, Rabe C, Schauer SP, Wildsmith KR, Fuji RN, Suliman S, Reiman EM, Chen K, Paul R.","Alzheimers Res Ther. 2018 Sep 19;10(1):96. doi: 10.1186/s13195-018-0424-5.","Salloway S","Alzheimers Res Ther","2018","2018/09/21","PMC6146627","","10.1186/s13195-018-0424-5"
"26666876","Atorvastatin May Correct Dyslipidemia in Adult Patients at Risk for Alzheimer's Disease Through an Anti-Inflammatory Pathway","Zhao L, Zhao Q, Zhou Y, Zhao Y, Wan Q.","CNS Neurol Disord Drug Targets. 2016;15(1):80-5. doi: 10.2174/1871527315999160111160143.","Zhao L","CNS Neurol Disord Drug Targets","2016","2015/12/16","","","10.2174/1871527315999160111160143"
"25946191","Reduced CSF Water Influx in Alzheimer's Disease Supporting the β-Amyloid Clearance Hypothesis","Suzuki Y, Nakamura Y, Yamada K, Igarashi H, Kasuga K, Yokoyama Y, Ikeuchi T, Nishizawa M, Kwee IL, Nakada T.","PLoS One. 2015 May 6;10(5):e0123708. doi: 10.1371/journal.pone.0123708. eCollection 2015.","Suzuki Y","PLoS One","2015","2015/05/07","PMC4422624","","10.1371/journal.pone.0123708"
"9344406","Potential role for estrogen replacement in the treatment of Alzheimer's dementia","Schneider LS, Farlow MR, Pogoda JM.","Am J Med. 1997 Sep 22;103(3A):46S-50S. doi: 10.1016/s0002-9343(97)00257-x.","Schneider LS","Am J Med","1997","1997/10/31","","","10.1016/s0002-9343(97)00257-x"
"7028239","Double blind study of lecithin in patients with Alzheimer's disease","Fisman M, Merskey H, Helmes E, McCready J, Colhoun EH, Rylett BJ.","Can J Psychiatry. 1981 Oct;26(6):426-8. doi: 10.1177/070674378102600608.","Fisman M","Can J Psychiatry","1981","1981/10/01","","","10.1177/070674378102600608"
"16958947","Combined cerebral blood flow effects of a cholinergic agonist (milameline) and a verbal recognition task in early Alzheimer's disease","Trollor JN, Sachdev PS, Haindl W, Brodaty H, Wen W, Walker BM.","Psychiatry Clin Neurosci. 2006 Oct;60(5):616-25. doi: 10.1111/j.1440-1819.2006.01567.x.","Trollor JN","Psychiatry Clin Neurosci","2006","2006/09/09","","","10.1111/j.1440-1819.2006.01567.x"
"10373973","Bright light treatment for people with Alzheimer's disease","Dawson P.","Perspectives. 1999 Spring;23(1):25-6.","Dawson P","Perspectives","1999","1999/06/22","","",""
"28124633","It is not only memory: effects of sensecam on improving well-being in patients with mild alzheimer disease","Silva AR, Pinho MS, Macedo L, Moulin C, Caldeira S, Firmino H.","Int Psychogeriatr. 2017 May;29(5):741-754. doi: 10.1017/S104161021600243X. Epub 2017 Jan 26.","Silva AR","Int Psychogeriatr","2017","2017/01/27","","","10.1017/S104161021600243X"
"18515851","Comprehensive approach of donepezil and psychosocial interventions on cognitive function and quality of life for Alzheimer's disease: the Osaki-Tajiri Project","Meguro M, Kasai M, Akanuma K, Ishii H, Yamaguchi S, Meguro K.","Age Ageing. 2008 Jul;37(4):469-73. doi: 10.1093/ageing/afn107. Epub 2008 May 31.","Meguro M","Age Ageing","2008","2008/06/03","","","10.1093/ageing/afn107"
"19181399","Self-rated health in patients with mild Alzheimer's disease: baseline data from the Danish Alzheimer Intervention Study","Waldorff FB, Nielsen AB, Waldemar G.","Arch Gerontol Geriatr. 2010 Jan-Feb;50(1):1-5. doi: 10.1016/j.archger.2008.12.010. Epub 2009 Feb 1.","Waldorff FB","Arch Gerontol Geriatr","2010","2009/02/03","","","10.1016/j.archger.2008.12.010"
"1777531","Calcium channel blocker nimodipine for primary degenerative dementia","Jarvik LF.","Biol Psychiatry. 1991 Dec 1;30(11):1171-2. doi: 10.1016/0006-3223(91)90186-p.","Jarvik LF","Biol Psychiatry","1991","1991/12/01","","","10.1016/0006-3223(91)90186-p"
"20831681","Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial","Akhondzadeh S, Sabet MS, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi SSh, Yousefi MH, Alimardani R, Jamshidi A, Zare F, Moradi A.","J Clin Pharm Ther. 2010 Oct;35(5):581-8. doi: 10.1111/j.1365-2710.2009.01133.x.","Akhondzadeh S","J Clin Pharm Ther","2010","2010/09/14","","","10.1111/j.1365-2710.2009.01133.x"
"11833978","Lay person-based screening for early detection of Alzheimer's disease: development and validation of an instrument","Mundt JC, Freed DM, Greist JH.","J Gerontol B Psychol Sci Soc Sci. 2000 May;55(3):P163-70. doi: 10.1093/geronb/55.3.p163.","Mundt JC","J Gerontol B Psychol Sci Soc Sci","2000","2002/02/09","","","10.1093/geronb/55.3.p163"
"8986058","[Regional cerebral blood flow measurements using 99mTc-ECD SPECT in patients with Alzheimer's disease (ad) in the early stage]","Nakano S, Matsuda H, Uno M.","Kaku Igaku. 1996 Nov;33(11):1197-206.","Nakano S","Kaku Igaku","1996","1996/11/01","","",""
"21560164","Apolipoprotein E genotype-specific short-term cognitive benefits of treatment with the antihypertensive nilvadipine in Alzheimer's patients--an open-label trial","Kennelly S, Abdullah L, Kenny RA, Mathura V, Luis CA, Mouzon B, Crawford F, Mullan M, Lawlor B.","Int J Geriatr Psychiatry. 2012 Apr;27(4):415-22. doi: 10.1002/gps.2735. Epub 2011 May 10.","Kennelly S","Int J Geriatr Psychiatry","2012","2011/05/12","","","10.1002/gps.2735"
"11001599","Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer's disease","Mega MS, Dinov ID, Lee L, O'Connor SM, Masterman DM, Wilen B, Mishkin F, Toga AW, Cummings JL.","J Neuropsychiatry Clin Neurosci. 2000 Spring;12(2):209-18. doi: 10.1176/jnp.12.2.209.","Mega MS","J Neuropsychiatry Clin Neurosci","2000","2000/09/23","","","10.1176/jnp.12.2.209"
"27758836","Adaptive working memory strategy training in early Alzheimer's disease: randomised controlled trial","Huntley JD, Hampshire A, Bor D, Owen A, Howard RJ.","Br J Psychiatry. 2017 Jan;210(1):61-66. doi: 10.1192/bjp.bp.116.182048. Epub 2016 Oct 6.","Huntley JD","Br J Psychiatry","2017","2016/10/21","PMC5209631","","10.1192/bjp.bp.116.182048"
"22959217","Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial","Vellas B, Coley N, Ousset PJ, Berrut G, Dartigues JF, Dubois B, Grandjean H, Pasquier F, Piette F, Robert P, Touchon J, Garnier P, Mathiex-Fortunet H, Andrieu S; GuidAge Study Group.","Lancet Neurol. 2012 Oct;11(10):851-9. doi: 10.1016/S1474-4422(12)70206-5. Epub 2012 Sep 6.","Vellas B","Lancet Neurol","2012","2012/09/11","","","10.1016/S1474-4422(12)70206-5"
"10883717","Early detection of Alzheimer's disease using the Cambridge Cognitive Examination (CAMCOG)","Schmand B, Walstra G, Lindeboom J, Teunisse S, Jonker C.","Psychol Med. 2000 May;30(3):619-27. doi: 10.1017/s0033291799002068.","Schmand B","Psychol Med","2000","2000/07/07","","","10.1017/s0033291799002068"
"18845693","Galantamine for the treatment of BPSD in Thai patients with possible Alzheimer's disease with or without cerebrovascular disease","Tangwongchai S, Thavichachart N, Senanarong V, Poungvarin N, Phanthumchinda K, Praditsuwan R, Nidhinandana S, Chankrachang S.","Am J Alzheimers Dis Other Demen. 2008 Dec-2009 Jan;23(6):593-601. doi: 10.1177/1533317508320603. Epub 2008 Oct 9.","Tangwongchai S","Am J Alzheimers Dis Other Demen","2008","2008/10/11","","","10.1177/1533317508320603"
"28874525","Differential diagnosis of Alzheimer's disease using spectrochemical analysis of blood","Paraskevaidi M, Morais CLM, Lima KMG, Snowden JS, Saxon JA, Richardson AMT, Jones M, Mann DMA, Allsop D, Martin-Hirsch PL, Martin FL.","Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):E7929-E7938. doi: 10.1073/pnas.1701517114. Epub 2017 Sep 5.","Paraskevaidi M","Proc Natl Acad Sci U S A","2017","2017/09/07","PMC5617251","","10.1073/pnas.1701517114"
"19997085","ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease","Stone DJ, Molony C, Suver C, Schadt EE, Potter WZ.","Pharmacogenomics J. 2010 Jun;10(3):161-4. doi: 10.1038/tpj.2009.58. Epub 2009 Dec 8.","Stone DJ","Pharmacogenomics J","2010","2009/12/10","","","10.1038/tpj.2009.58"
"9057170","Alzheimer's disease and history of blood transfusion by apolipoprotein-E genotype","O'Meara ES, Kukull WA, Schellenberg GD, Bowen JD, McCormick WC, Teri L, Pfanschmidt M, Thompson JD, Larson EB.","Neuroepidemiology. 1997;16(2):86-93. doi: 10.1159/000109675.","O'Meara ES","Neuroepidemiology","1997","1997/01/01","","","10.1159/000109675"
"27447428","A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease","Malpas CB, Vivash L, Genc S, Saling MM, Desmond P, Steward C, Hicks RJ, Callahan J, Brodtmann A, Collins S, Macfarlane S, Corcoran NM, Hovens CM, Velakoulis D, O'Brien TJ.","J Alzheimers Dis. 2016 Jul 22;54(1):223-32. doi: 10.3233/JAD-160544.","Malpas CB","J Alzheimers Dis","2016","2016/07/23","","","10.3233/JAD-160544"
"8994895","The Empirical Behavioral Pathology in Alzheimer's Disease (E-BEHAVE-AD) Rating Scale","Auer SR, Monteiro IM, Reisberg B.","Int Psychogeriatr. 1996 Summer;8(2):247-66. doi: 10.1017/s1041610296002621.","Auer SR","Int Psychogeriatr","1996","1996/01/01","","","10.1017/s1041610296002621"
"30477432","Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study","Legdeur N, Badissi M, Carter SF, de Crom S, van de Kreeke A, Vreeswijk R, Trappenburg MC, Oudega ML, Koek HL, van Campen JP, Keijsers CJPW, Amadi C, Hinz R, Gordon MF, Novak G, Podhorna J, Serné E, Verbraak F, Yaqub M, Hillebrand A, Griffa A, Pendleton N, Kramer SE, Teunissen CE, Lammertsma A, Barkhof F, van Berckel BNM, Scheltens P, Muller M, Maier AB, Herholz K, Visser PJ.","BMC Geriatr. 2018 Nov 26;18(1):289. doi: 10.1186/s12877-018-0984-z.","Legdeur N","BMC Geriatr","2018","2018/11/28","PMC6258163","","10.1186/s12877-018-0984-z"
"2861263","Direct cerebrospinal fluid infusion of bethanechol chloride in Alzheimer's disease: use of an implantable continuous infusion device","Reeder TM, Harbaugh RE.","J Neurosurg Nurs. 1985 Jun;17(3):184-9. doi: 10.1097/01376517-198506000-00008.","Reeder TM","J Neurosurg Nurs","1985","1985/06/01","","","10.1097/01376517-198506000-00008"
"30958695","APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer's disease pathophysiology","Tran TTT, Corsini S, Kellingray L, Hegarty C, Le Gall G, Narbad A, Müller M, Tejera N, O'Toole PW, Minihane AM, Vauzour D.","FASEB J. 2019 Jul;33(7):8221-8231. doi: 10.1096/fj.201900071R. Epub 2019 Apr 8.","Tran TTT","FASEB J","2019","2019/04/09","PMC6593891","","10.1096/fj.201900071R"
"36879199","Psychometric properties of the Alzheimer's Disease Cooperative Study - Activities of Daily Living for Mild Cognitive Impairment (ADCS-MCI-ADL) scale: a post hoc analysis of the ADCS ADC-008 trial","Potashman M, Pang M, Tahir M, Shahraz S, Dichter S, Perneczky R, Nolte S.","BMC Geriatr. 2023 Mar 6;23(1):124. doi: 10.1186/s12877-022-03527-0.","Potashman M","BMC Geriatr","2023","2023/03/06","PMC9990271","","10.1186/s12877-022-03527-0"
"9595861","Screening for presenilin-1 gene mutations by PCR-SSCP analysis in patients with early-onset Alzheimer's disease","Kowalska A, Florczak J, Pruchnik-Wolińska D, Hertmanowska H, Wender M.","Folia Neuropathol. 1998;36(1):32-7.","Kowalska A","Folia Neuropathol","1998","1998/05/22","","",""
"10886308","The apolipoprotein E epsilon4 allele and the response to tacrine therapy in Alzheimer's disease","Rigaud AS, Traykov L, Caputo L, Guelfi MC, Latour F, Couderc R, Moulin F, de Rotrou J, Forette F, Boller F.","Eur J Neurol. 2000 May;7(3):255-8. doi: 10.1046/j.1468-1331.2000.00073.x.","Rigaud AS","Eur J Neurol","2000","2000/07/25","","","10.1046/j.1468-1331.2000.00073.x"
"19939249","Private costs almost equal health care costs when intervening in mild Alzheimer's: a cohort study alongside the DAISY trial","Søgaard R, Sørensen J, Waldorff FB, Eckermann A, Buss DV, Waldemar G.","BMC Health Serv Res. 2009 Nov 25;9:215. doi: 10.1186/1472-6963-9-215.","Søgaard R","BMC Health Serv Res","2009","2009/11/27","PMC2789065","","10.1186/1472-6963-9-215"
"9805326","The naming deficit in early Alzheimer's and vascular dementia","Lukatela K, Malloy P, Jenkins M, Cohen R.","Neuropsychology. 1998 Oct;12(4):565-72. doi: 10.1037//0894-4105.12.4.565.","Lukatela K","Neuropsychology","1998","1998/11/07","","","10.1037//0894-4105.12.4.565"
"33523004","Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial","Yu F, Vock DM, Zhang L, Salisbury D, Nelson NW, Chow LS, Smith G, Barclay TR, Dysken M, Wyman JF.","J Alzheimers Dis. 2021;80(1):233-244. doi: 10.3233/JAD-201100.","Yu F","J Alzheimers Dis","2021","2021/02/01","PMC8075384","","10.3233/JAD-201100"
"19320533","Carotid intima-media thickness as a predictor of response to cholinesterase inhibitors in Alzheimer's disease: an open-label trial","Modrego PJ, Rios C, Pérez Trullen JM, García-Gómara MJ, Errea JM.","CNS Drugs. 2009;23(3):253-60. doi: 10.2165/00023210-200923030-00006.","Modrego PJ","CNS Drugs","2009","2009/03/27","","","10.2165/00023210-200923030-00006"
"2178869","Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia","Rai G, Wright G, Scott L, Beston B, Rest J, Exton-Smith AN.","Curr Med Res Opin. 1990;11(10):638-47. doi: 10.1185/03007999009112690.","Rai G","Curr Med Res Opin","1990","1990/01/01","","","10.1185/03007999009112690"
"7777193","Increased cerebrospinal fluid tau in patients with Alzheimer's disease","Jensen M, Basun H, Lannfelt L.","Neurosci Lett. 1995 Feb 17;186(2-3):189-91. doi: 10.1016/0304-3940(95)11297-a.","Jensen M","Neurosci Lett","1995","1995/02/17","","","10.1016/0304-3940(95)11297-a"
"8969976","The use of survival analysis techniques in evaluating the effect of long-term tacrine (Cognex) treatment on nursing home placement and mortality in patients with Alzheimer's disease","Smith F, Talwalker S, Gracon S, Srirama M.","J Biopharm Stat. 1996 Nov;6(4):395-409. doi: 10.1080/10543409608835152.","Smith F","J Biopharm Stat","1996","1996/11/01","","","10.1080/10543409608835152"
"8358504","Oral tetrahydroaminoacridine treatment of Alzheimer's disease evaluated clinically and by regional cerebral blood flow and EEG","Minthon L, Gustafson L, Dalfelt G, Hagberg B, Nilsson K, Risberg J, Rosén I, Seiving B, Wendt PE.","Dementia. 1993 Jan-Feb;4(1):32-42. doi: 10.1159/000107293.","Minthon L","Dementia","1993","1993/01/01","","","10.1159/000107293"
"25188811","The UP-TECH project, an intervention to support caregivers of Alzheimer's disease patients in Italy: preliminary findings on recruitment and caregiving burden in the baseline population","Chiatti C, Rimland JM, Bonfranceschi F, Masera F, Bustacchini S, Cassetta L; Fabrizia Lattanzio; UP-TECH research group.","Aging Ment Health. 2015;19(6):517-25. doi: 10.1080/13607863.2014.954526. Epub 2014 Sep 4.","Chiatti C","Aging Ment Health","2015","2014/09/05","","","10.1080/13607863.2014.954526"
"7969715","Human corpus callosum in aging and Alzheimer's disease: a magnetic resonance imaging study","Biegon A, Eberling JL, Richardson BC, Roos MS, Wong ST, Reed BR, Jagust WJ.","Neurobiol Aging. 1994 Jul-Aug;15(4):393-7. doi: 10.1016/0197-4580(94)90070-1.","Biegon A","Neurobiol Aging","1994","1994/07/01","","","10.1016/0197-4580(94)90070-1"
"32565008","Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments","Lanctôt KL, Scherer RW, Li A, Vieira D, Coulibaly H, Rosenberg PB, Herrmann N, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, Mintzer JE.","Am J Geriatr Psychiatry. 2021 Jan;29(1):81-89. doi: 10.1016/j.jagp.2020.05.020. Epub 2020 May 27.","Lanctôt KL","Am J Geriatr Psychiatry","2021","2020/06/23","PMC7704818","NIHMS1605397","10.1016/j.jagp.2020.05.020"
"10994000","A 1-year controlled trial of acetyl-l-carnitine in early-onset AD","Thal LJ, Calvani M, Amato A, Carta A.","Neurology. 2000 Sep 26;55(6):805-10. doi: 10.1212/wnl.55.6.805.","Thal LJ","Neurology","2000","2000/09/20","","","10.1212/wnl.55.6.805"
"23411014","Genetic variation in clusterin gene and Alzheimer's disease risk in Han Chinese","Yu JT, Ma XY, Wang YL, Sun L, Tan L, Hu N, Tan L.","Neurobiol Aging. 2013 Jul;34(7):1921.e17-23. doi: 10.1016/j.neurobiolaging.2013.01.010. Epub 2013 Feb 12.","Yu JT","Neurobiol Aging","2013","2013/02/16","","","10.1016/j.neurobiolaging.2013.01.010"
"8844880","Cognitive skills associated with estrogen replacement in women with Alzheimer's disease","Henderson VW, Watt L, Buckwalter JG.","Psychoneuroendocrinology. 1996 May;21(4):421-30. doi: 10.1016/0306-4530(95)00060-7.","Henderson VW","Psychoneuroendocrinology","1996","1996/05/01","","","10.1016/0306-4530(95)00060-7"
"26572055","The effect of memantine on sleep architecture and psychiatric symptoms in patients with Alzheimer's disease","Ishikawa I, Shinno H, Ando N, Mori T, Nakamura Y.","Acta Neuropsychiatr. 2016 Jun;28(3):157-64. doi: 10.1017/neu.2015.61. Epub 2015 Nov 17.","Ishikawa I","Acta Neuropsychiatr","2016","2015/11/18","","","10.1017/neu.2015.61"
"25707009","Reversing Ribot: does regression hold in language of prodromal Alzheimer's disease?","Lust B, Flynn S, Cohen Sherman J, Gair J, Henderson CR Jr, Cordella C, Whitlock J, Mancuso S, Chen Z, Costigan A, Immerman A.","Brain Lang. 2015 Apr;143:1-10. doi: 10.1016/j.bandl.2015.01.013. Epub 2015 Feb 23.","Lust B","Brain Lang","2015","2015/02/24","","","10.1016/j.bandl.2015.01.013"
"19276559","Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease","Leyhe T, Eschweiler GW, Stransky E, Gasser T, Annas P, Basun H, Laske C.","J Alzheimers Dis. 2009;16(3):649-56. doi: 10.3233/JAD-2009-1004.","Leyhe T","J Alzheimers Dis","2009","2009/03/12","","","10.3233/JAD-2009-1004"
"26925577","First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheimer's disease","Delnomdedieu M, Duvvuri S, Li DJ, Atassi N, Lu M, Brashear HR, Liu E, Ness S, Kupiec JW.","Alzheimers Res Ther. 2016 Mar 1;8(1):12. doi: 10.1186/s13195-016-0177-y.","Delnomdedieu M","Alzheimers Res Ther","2016","2016/03/02","PMC4772335","","10.1186/s13195-016-0177-y"
"8848271","Apolipoprotein E polymorphism and susceptibility to early- and late-onset sporadic Alzheimer's disease in Hokkaido, the northern part of Japan","Nunomura A, Chiba S, Eto M, Saito M, Makino I, Miyagishi T.","Neurosci Lett. 1996 Mar 8;206(1):17-20. doi: 10.1016/0304-3940(96)12415-0.","Nunomura A","Neurosci Lett","1996","1996/03/08","","","10.1016/0304-3940(96)12415-0"
"12006735","Performance on the cognitive abilities screening instrument at different stages of Alzheimer's disease","Liu HC, Teng EL, Lin KN, Chuang YY, Wang PN, Fuh JL, Liu CY.","Dement Geriatr Cogn Disord. 2002;13(4):244-8. doi: 10.1159/000057703.","Liu HC","Dement Geriatr Cogn Disord","2002","2002/05/15","","","10.1159/000057703"
"30109588","Effect and Safety of Huannao Yicong Formula () in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Double-Blinded, Donepezil-Controlled Trial","Yang Y, Liu JP, Fang JY, Wang HC, Wei Y, Cao Y, Liu JG, Liu LT, Li H.","Chin J Integr Med. 2019 Aug;25(8):574-581. doi: 10.1007/s11655-018-3054-7. Epub 2018 Aug 14.","Yang Y","Chin J Integr Med","2019","2018/08/16","","","10.1007/s11655-018-3054-7"
"28585932","Plasma REST: a novel candidate biomarker of Alzheimer's disease is modified by psychological intervention in an at-risk population","Ashton NJ, Hye A, Leckey CA, Jones AR, Gardner A, Elliott C, Wetherell JL, Lenze EJ, Killick R, Marchant NL.","Transl Psychiatry. 2017 Jun 6;7(6):e1148. doi: 10.1038/tp.2017.113.","Ashton NJ","Transl Psychiatry","2017","2017/06/07","PMC5537638","","10.1038/tp.2017.113"
"15202541","Awareness in early-stage Alzheimer's disease: relationship to outcome of cognitive rehabilitation","Clare L, Wilson BA, Carter G, Roth I, Hodges JR.","J Clin Exp Neuropsychol. 2004 Apr;26(2):215-26. doi: 10.1076/jcen.26.2.215.28088.","Clare L","J Clin Exp Neuropsychol","2004","2004/06/19","","","10.1076/jcen.26.2.215.28088"
"30761509","Efficacy of Cilostazol Administration in Alzheimer's Disease Patients with White Matter Lesions: A Positron-Emission Tomography Study","Lee JY, Lee H, Yoo HB, Choi JS, Jung HY, Yoon EJ, Kim H, Jung YH, Lee HY, Kim YK.","Neurotherapeutics. 2019 Apr;16(2):394-403. doi: 10.1007/s13311-018-00708-x.","Lee JY","Neurotherapeutics","2019","2019/02/15","PMC6554387","","10.1007/s13311-018-00708-x"
"19081767","High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer's disease patients","Abdullah L, Luis C, Paris D, Ait-ghezala G, Mouzon B, Allen E, Parrish J, Mullan MA, Ferguson S, Wood M, Crawford F, Mullan M.","Mol Med. 2009 Mar-Apr;15(3-4):95-100. doi: 10.2119/molmed.2008.00118. Epub 2009 Dec 8.","Abdullah L","Mol Med","2009","2008/12/17","PMC2600489","","10.2119/molmed.2008.00118"
"17199235","Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease","Burns A, Gauthier S, Perdomo C.","Int J Geriatr Psychiatry. 2007 Aug;22(8):806-12. doi: 10.1002/gps.1746.","Burns A","Int J Geriatr Psychiatry","2007","2007/01/03","","","10.1002/gps.1746"
"8173365","Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial","Maltby N, Broe GA, Creasey H, Jorm AF, Christensen H, Brooks WS.","BMJ. 1994 Apr 2;308(6933):879-83. doi: 10.1136/bmj.308.6933.879.","Maltby N","BMJ","1994","1994/04/02","PMC2539871","","10.1136/bmj.308.6933.879"
"9521254","Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease","Farlow MR, Lahiri DK, Poirier J, Davignon J, Schneider L, Hui SL.","Neurology. 1998 Mar;50(3):669-77. doi: 10.1212/wnl.50.3.669.","Farlow MR","Neurology","1998","1998/04/01","","","10.1212/wnl.50.3.669"
"30530975","A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease","Farlow MR, Thompson RE, Wei LJ, Tuchman AJ, Grenier E, Crockford D, Wilke S, Benison J, Alkon DL.","J Alzheimers Dis. 2019;67(2):555-570. doi: 10.3233/JAD-180759.","Farlow MR","J Alzheimers Dis","2019","2018/12/12","PMC6398557","","10.3233/JAD-180759"
"15465097","Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease","Tanaka M, Namiki C, Thuy DH, Yoshida H, Kawasaki K, Hashikawa K, Fukuyama H, Kita T.","J Neurol Sci. 2004 Oct 15;225(1-2):135-41. doi: 10.1016/j.jns.2004.07.009.","Tanaka M","J Neurol Sci","2004","2004/10/07","","","10.1016/j.jns.2004.07.009"
"9623002","Prospective comparative study of the evolution of probable Alzheimer's disease and Parkinson's disease dementia","Stern Y, Tang MX, Jacobs DM, Sano M, Marder K, Bell K, Dooneief G, Schofield P, Côté L.","J Int Neuropsychol Soc. 1998 May;4(3):279-84.","Stern Y","J Int Neuropsychol Soc","1998","1998/06/12","","",""
"19484836","Vascular care in patients with Alzheimer's disease with cerebrovascular lesions-a randomized clinical trial","Richard E, Kuiper R, Dijkgraaf MG, Van Gool WA; Evaluation of Vascular care in Alzheimer's disease.","J Am Geriatr Soc. 2009 May;57(5):797-805. doi: 10.1111/j.1532-5415.2009.02217.x.","Richard E","J Am Geriatr Soc","2009","2009/06/02","","","10.1111/j.1532-5415.2009.02217.x"
"10753002","Metrifonate enhances the ability of Alzheimer's disease patients to initiate, organize, and execute instrumental and basic activities of daily living","Gélinas I, Gauthier S, Cyrus PA.","J Geriatr Psychiatry Neurol. 2000 Spring;13(1):9-16. doi: 10.1177/089198870001300102.","Gélinas I","J Geriatr Psychiatry Neurol","2000","2001/02/07","","","10.1177/089198870001300102"
"2189429","Oral physostigmine as treatment for primary degenerative dementia: a double-blind placebo-controlled inpatient trial","Jenike MA, Albert M, Baer L, Gunther J.","J Geriatr Psychiatry Neurol. 1990 Jan-Mar;3(1):13-6. doi: 10.1177/089198879000300104.","Jenike MA","J Geriatr Psychiatry Neurol","1990","1990/01/01","","","10.1177/089198879000300104"
"10899409","The genetic association between Cathepsin D and Alzheimer's disease","Crawford FC, Freeman MJ, Schinka J, Abdullah LI, Richards D, Sevush S, Duara R, Mullan MJ.","Neurosci Lett. 2000 Jul 28;289(1):61-5. doi: 10.1016/s0304-3940(00)01260-x.","Crawford FC","Neurosci Lett","2000","2000/07/19","","","10.1016/s0304-3940(00)01260-x"
"14992980","Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease","Cummings JL, Schneider L, Tariot PN, Kershaw PR, Yuan W.","Am J Psychiatry. 2004 Mar;161(3):532-8. doi: 10.1176/appi.ajp.161.3.532.","Cummings JL","Am J Psychiatry","2004","2004/03/03","","","10.1176/appi.ajp.161.3.532"
"10937606","Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients","Weiner MF, Martin-Cook K, Foster BM, Saine K, Fontaine CS, Svetlik DA.","J Clin Psychiatry. 2000 Jul;61(7):487-92. doi: 10.4088/jcp.v61n0705.","Weiner MF","J Clin Psychiatry","2000","2000/08/11","","","10.4088/jcp.v61n0705"
"8941851","Semantic memory impairment in Alzheimer's disease","Daum I, Riesch G, Sartori G, Birbaumer N.","J Clin Exp Neuropsychol. 1996 Oct;18(5):648-65. doi: 10.1080/01688639608408289.","Daum I","J Clin Exp Neuropsychol","1996","1996/10/01","","","10.1080/01688639608408289"
"21943331","A prospective study of nutrition education and oral nutritional supplementation in patients with Alzheimer's disease","Pivi GA, da Silva RV, Juliano Y, Novo NF, Okamoto IH, Brant CQ, Bertolucci PH.","Nutr J. 2011 Sep 26;10:98. doi: 10.1186/1475-2891-10-98.","Pivi GA","Nutr J","2011","2011/09/28","PMC3189102","","10.1186/1475-2891-10-98"
"22027664","[Acetyl-L-carnitine (carnicetine) in the treatment of early stages of Alzheimer's disease and vascular dementia]","Gavrilova SI, Kalyn IaB, Kolykhalov IV, Roshchina IF, Selezneva ND.","Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(9):16-22.","Gavrilova SI","Zh Nevrol Psikhiatr Im S S Korsakova","2011","2011/10/27","","",""
"2030370","Tetrahydroaminoacridine and lecithin in the treatment of Alzheimer's disease. Effect on cognition, functioning in daily life, behavioural disturbances and burden experienced by the carers","Weinstein HC, Teunisse S, van Gool WA.","J Neurol. 1991 Feb;238(1):34-8. doi: 10.1007/BF00319708.","Weinstein HC","J Neurol","1991","1991/02/01","","","10.1007/BF00319708"
"9209733","In vivo proton magnetic resonance spectroscopy of Alzheimer's disease in the parietal and temporal lobes","Frederick BB, Satlin A, Yurgelun-Todd DA, Renshaw PF.","Biol Psychiatry. 1997 Jul 15;42(2):147-50. doi: 10.1016/s0006-3223(97)00242-4.","Frederick BB","Biol Psychiatry","1997","1997/07/15","","","10.1016/s0006-3223(97)00242-4"
"1406817","A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group","Davis KL, Thal LJ, Gamzu ER, Davis CS, Woolson RF, Gracon SI, Drachman DA, Schneider LS, Whitehouse PJ, Hoover TM, et al.","N Engl J Med. 1992 Oct 29;327(18):1253-9. doi: 10.1056/NEJM199210293271801.","Davis KL","N Engl J Med","1992","1992/10/29","","","10.1056/NEJM199210293271801"
"10609669","Determinants of attrition in a natural history study of Alzheimer disease","Koss E, Peterson B, Fillenbaum GG.","Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13(4):209-15. doi: 10.1097/00002093-199910000-00006.","Koss E","Alzheimer Dis Assoc Disord","1999","1999/12/28","","","10.1097/00002093-199910000-00006"
"23742728","Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response","Sabbagh M, Cummings J, Christensen D, Doody R, Farlow M, Liu L, Mackell J, Fain R.","BMC Geriatr. 2013 Jun 6;13:56. doi: 10.1186/1471-2318-13-56.","Sabbagh M","BMC Geriatr","2013","2013/06/08","PMC3681558","","10.1186/1471-2318-13-56"
"7970216","Association of apolipoprotein E4 with sporadic Alzheimer's disease is more pronounced in early onset type","Dai XY, Nanko S, Hattori M, Fukuda R, Nagata K, Isse K, Ueki A, Kazamatsuri H.","Neurosci Lett. 1994 Jul 4;175(1-2):74-6. doi: 10.1016/0304-3940(94)91081-2.","Dai XY","Neurosci Lett","1994","1994/07/04","","","10.1016/0304-3940(94)91081-2"
"35715872","Autologous skin-derived neural precursor cell therapy reverses canine Alzheimer dementia-like syndrome in a proof of concept veterinary trial","Valenzuela M, Duncan T, Abey A, Johnson A, Boulamatsis C, Dalton MA, Jacobson E, Brunel L, Child G, Simpson D, Buckland M, Lowe A, Siette J, Westbrook F, McGreevy P.","Stem Cell Res Ther. 2022 Jun 17;13(1):261. doi: 10.1186/s13287-022-02933-w.","Valenzuela M","Stem Cell Res Ther","2022","2022/06/17","PMC9205057","","10.1186/s13287-022-02933-w"
"31518224","A Pilot Study of Exenatide Actions in Alzheimer's Disease","Mullins RJ, Mustapic M, Chia CW, Carlson O, Gulyani S, Tran J, Li Y, Mattson MP, Resnick S, Egan JM, Greig NH, Kapogiannis D.","Curr Alzheimer Res. 2019;16(8):741-752. doi: 10.2174/1567205016666190913155950.","Mullins RJ","Curr Alzheimer Res","2019","2019/09/14","PMC7476877","NIHMS1620777","10.2174/1567205016666190913155950"
"12359169","Identification of diagnostic evoked response potential segments in Alzheimer's disease","Benvenuto J, Jin Y, Casale M, Lynch G, Granger R.","Exp Neurol. 2002 Aug;176(2):269-76. doi: 10.1006/exnr.2002.7930.","Benvenuto J","Exp Neurol","2002","2002/10/03","","","10.1006/exnr.2002.7930"
"14663031","Idebenone treatment fails to slow cognitive decline in Alzheimer's disease","Thal LJ, Grundman M, Berg J, Ernstrom K, Margolin R, Pfeiffer E, Weiner MF, Zamrini E, Thomas RG.","Neurology. 2003 Dec 9;61(11):1498-502. doi: 10.1212/01.wnl.0000096376.03678.c1.","Thal LJ","Neurology","2003","2003/12/10","","","10.1212/01.wnl.0000096376.03678.c1"
"32821251","The Effects of a Recollection-Based Occupational Therapy Program of Alzheimer's Disease: A Randomized Controlled Trial","Kim D.","Occup Ther Int. 2020 Jul 30;2020:6305727. doi: 10.1155/2020/6305727. eCollection 2020.","Kim D","Occup Ther Int","2020","2020/08/22","PMC7416254","","10.1155/2020/6305727"
"15023581","Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease","Lewczuk P, Esselmann H, Groemer TW, Bibl M, Maler JM, Steinacker P, Otto M, Kornhuber J, Wiltfang J.","Biol Psychiatry. 2004 Mar 1;55(5):524-30. doi: 10.1016/j.biopsych.2003.10.014.","Lewczuk P","Biol Psychiatry","2004","2004/03/17","","","10.1016/j.biopsych.2003.10.014"
"10928742","Implicit memory for music in Alzheimer's disease","Halpern AR, O'Connor MG.","Neuropsychology. 2000 Jul;14(3):391-7. doi: 10.1037//0894-4105.14.3.391.","Halpern AR","Neuropsychology","2000","2000/08/06","","","10.1037//0894-4105.14.3.391"
"11602028","Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease","Potkin SG, Anand R, Fleming K, Alva G, Keator D, Carreon D, Messina J, Wu JC, Hartman R, Fallon JH.","Int J Neuropsychopharmacol. 2001 Sep;4(3):223-30. doi: 10.1017/S1461145701002528.","Potkin SG","Int J Neuropsychopharmacol","2001","2001/10/17","","","10.1017/S1461145701002528"
"31288544","Immediate Benefit of Art on Pain and Well-Being in Community-Dwelling Patients with Mild Alzheimer's","Pongan E, Delphin-Combe F, Krolak-Salmon P, Leveque Y, Tillmann B, Bachelet R, Getenet JC, Auguste N, Trombert B, Dorey JM, Laurent B, Rouch I.","Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317519859202. doi: 10.1177/1533317519859202. Epub 2019 Jul 9.","Pongan E","Am J Alzheimers Dis Other Demen","2020","2019/07/11","","","10.1177/1533317519859202"
"27589523","A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease","Brody M, Liu E, Di J, Lu M, Margolin RA, Werth JL, Booth K, Shadman A, Brashear HR, Novak G.","J Alzheimers Dis. 2016 Oct 18;54(4):1509-1519. doi: 10.3233/JAD-160369.","Brody M","J Alzheimers Dis","2016","2016/09/03","","","10.3233/JAD-160369"
"32715609","Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients","Vidoni ED, Choi IY, Lee P, Reed G, Zhang N, Pleen J, Mahnken JD, Clutton J, Becker A, Sherry E, Bothwell R, Anderson H, Harris RA, Brooks W, Wilkins HM, Mosconi L, Burns JM, Swerdlow RH.","Alzheimers Dement. 2021 Jan;17(1):7-17. doi: 10.1002/alz.12156. Epub 2020 Jul 27.","Vidoni ED","Alzheimers Dement","2021","2020/07/28","PMC8084114","NIHMS1693488","10.1002/alz.12156"
"18999345","Memory profiling with paired associate learning in Alzheimer's disease, mild cognitive impairment, and healthy aging","Pike KE, Rowe CC, Moss SA, Savage G.","Neuropsychology. 2008 Nov;22(6):718-728. doi: 10.1037/a0013050.","Pike KE","Neuropsychology","2008","2008/11/13","","","10.1037/a0013050"
"19948364","Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: implications for early diagnosis and treatment","Molinuevo JL, Berthier ML, Rami L.","Arch Gerontol Geriatr. 2011 Jan-Feb;52(1):18-22. doi: 10.1016/j.archger.2009.11.004. Epub 2009 Nov 30.","Molinuevo JL","Arch Gerontol Geriatr","2011","2009/12/02","","","10.1016/j.archger.2009.11.004"
"19266699","A new scale measuring psychologic impact of genetic susceptibility testing for Alzheimer disease","Chung WW, Chen CA, Cupples LA, Roberts JS, Hiraki SC, Nair AK, Green RC, Stern RA.","Alzheimer Dis Assoc Disord. 2009 Jan-Mar;23(1):50-6. doi: 10.1097/wad.0b013e318188429e.","Chung WW","Alzheimer Dis Assoc Disord","2009","2009/03/10","PMC2743905","NIHMS84738","10.1097/wad.0b013e318188429e"
"28482641","Bryostatin Effects on Cognitive Function and PKCɛ in Alzheimer's Disease Phase IIa and Expanded Access Trials","Nelson TJ, Sun MK, Lim C, Sen A, Khan T, Chirila FV, Alkon DL.","J Alzheimers Dis. 2017;58(2):521-535. doi: 10.3233/JAD-170161.","Nelson TJ","J Alzheimers Dis","2017","2017/05/10","PMC5438479","","10.3233/JAD-170161"
"8128834","Pharmacodynamic and early clinical studies with velnacrine","Siegfried KR.","Acta Neurol Scand Suppl. 1993;149:26-8. doi: 10.1111/j.1600-0404.1993.tb04250.x.","Siegfried KR","Acta Neurol Scand Suppl","1993","1993/01/01","","","10.1111/j.1600-0404.1993.tb04250.x"
"22982468","Technology-based orientation programs to support indoor travel by persons with moderate Alzheimer's disease: impact assessment and social validation","Lancioni GE, Perilli V, O'Reilly MF, Singh NN, Sigafoos J, Bosco A, Caffò AO, Picucci L, Cassano G, Groeneweg J.","Res Dev Disabil. 2013 Jan;34(1):286-93. doi: 10.1016/j.ridd.2012.08.016. Epub 2012 Sep 14.","Lancioni GE","Res Dev Disabil","2013","2012/09/18","","","10.1016/j.ridd.2012.08.016"
"8185877","Transdermal physostigmine in the treatment of Alzheimer's disease","Levy A, Brandeis R, Treves TA, Meshulam Y, Mawassi F, Feiler D, Wengier A, Glikfeld P, Grunwald J, Dachir S, et al.","Alzheimer Dis Assoc Disord. 1994 Spring;8(1):15-21. doi: 10.1097/00002093-199408010-00004.","Levy A","Alzheimer Dis Assoc Disord","1994","1994/01/01","","","10.1097/00002093-199408010-00004"
"27767993","Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease","Cummings J, Scheltens P, McKeith I, Blesa R, Harrison JE, Bertolucci PH, Rockwood K, Wilkinson D, Wijker W, Bennett DA, Shah RC.","J Alzheimers Dis. 2017;55(3):1131-1139. doi: 10.3233/JAD-160745.","Cummings J","J Alzheimers Dis","2017","2016/10/22","PMC5147481","","10.3233/JAD-160745"
"19519311","Safety of lumbar puncture procedures in patients with Alzheimer's disease","Peskind E, Nordberg A, Darreh-Shori T, Soininen H.","Curr Alzheimer Res. 2009 Jun;6(3):290-2. doi: 10.2174/156720509788486509.","Peskind E","Curr Alzheimer Res","2009","2009/06/13","PMC4035477","NIHMS586605","10.2174/156720509788486509"
"9213067","The disturbances of object vision and spatial vision in Alzheimer's disease","Fujimori M, Imamura T, Yamashita H, Hirono N, Mori E.","Dement Geriatr Cogn Disord. 1997 Jul-Aug;8(4):228-31. doi: 10.1159/000106635.","Fujimori M","Dement Geriatr Cogn Disord","1997","1997/07/01","","","10.1159/000106635"
"28039287","Vascular biomarkers to predict response to exercise in Alzheimer's disease: the study protocol","Li D, Thomas R, Tsai MY, Li L, Vock DM, Greimel S, Yu F.","BMJ Open. 2016 Dec 30;6(12):e011054. doi: 10.1136/bmjopen-2016-011054.","Li D","BMJ Open","2016","2017/01/01","PMC5223628","","10.1136/bmjopen-2016-011054"
"19571733","MRI substudy participation in Alzheimer disease (AD) clinical trials: baseline comparability of a substudy sample to entire study population","Raman R, Thomas RG, Weiner MW, Jack CR, Ernstrom K, Aisen PS, Tariot PN, Quinn JF.","Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):333-6. doi: 10.1097/WAD.0b013e3181aba588.","Raman R","Alzheimer Dis Assoc Disord","2009","2009/07/03","PMC2804922","NIHMS163601","10.1097/WAD.0b013e3181aba588"
"10933431","Presenile primary cognitive decline or Alzheimer's dementia: 7-year clinical and neuropsychological follow-up","Zappoli R, Paganini M, Arnetoli G, Bracco L, Battaglia A, Chiaramonti R, Arneodo MG.","Ital J Neurol Sci. 1999 Apr;20(2):109-17. doi: 10.1007/s100720050018.","Zappoli R","Ital J Neurol Sci","1999","2000/08/10","","","10.1007/s100720050018"
"3137593","Intravenous nicotine in Alzheimer's disease: a pilot study","Newhouse PA, Sunderland T, Tariot PN, Blumhardt CL, Weingartner H, Mellow A, Murphy DL.","Psychopharmacology (Berl). 1988;95(2):171-5. doi: 10.1007/BF00174504.","Newhouse PA","Psychopharmacology (Berl)","1988","1988/01/01","","","10.1007/BF00174504"
"15601392","Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep","Mizuno S, Kameda A, Inagaki T, Horiguchi J.","Psychiatry Clin Neurosci. 2004 Dec;58(6):660-5. doi: 10.1111/j.1440-1819.2004.01317.x.","Mizuno S","Psychiatry Clin Neurosci","2004","2004/12/17","","","10.1111/j.1440-1819.2004.01317.x"
"8577814","Triazolam in Alzheimer's disease: pilot study on sleep and memory effects","McCarten JR, Kovera C, Maddox MK, Cleary JP.","Pharmacol Biochem Behav. 1995 Oct;52(2):447-52. doi: 10.1016/0091-3057(95)00116-e.","McCarten JR","Pharmacol Biochem Behav","1995","1995/10/01","","","10.1016/0091-3057(95)00116-e"
"11884656","Learning and recall in subjects at genetic risk for Alzheimer's disease","Chen JG, Edwards CL, Vidyarthi S, Pitchumoni S, Tabrizi S, Barboriak D, Charles HC, Doraiswamy PM.","J Neuropsychiatry Clin Neurosci. 2002 Winter;14(1):58-63. doi: 10.1176/jnp.14.1.58.","Chen JG","J Neuropsychiatry Clin Neurosci","2002","2002/03/09","","","10.1176/jnp.14.1.58"
"15882786","Lack of genetic association of cholesteryl ester transfer protein polymorphisms with late onset Alzheimers disease","Zhu H, Gopalraj RK, Kelly JF, Bennett DA, Estus S.","Neurosci Lett. 2005 Jun 10-17;381(1-2):36-41. doi: 10.1016/j.neulet.2005.01.078. Epub 2005 Feb 17.","Zhu H","Neurosci Lett","2005","2005/05/11","","","10.1016/j.neulet.2005.01.078"
"23551354","Rivastigmine patch and massage for Alzheimer's disease patients","Satoh S, Kajiwara M, Kiyokawa E, Toukairin Y, Fujii M, Sasaki H.","Geriatr Gerontol Int. 2013 Apr;13(2):515-6. doi: 10.1111/ggi.12010.","Satoh S","Geriatr Gerontol Int","2013","2013/04/05","","","10.1111/ggi.12010"
"26297092","Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer's Disease: Determinants and Level of Changes Observed","Lacey L, Bobula J, Rüdell K, Alvir J, Leibman C.","Value Health. 2015 Jul;18(5):638-45. doi: 10.1016/j.jval.2015.03.1787. Epub 2015 Apr 10.","Lacey L","Value Health","2015","2015/08/23","","","10.1016/j.jval.2015.03.1787"
"33336218","Thirty-Six-Month Amyloid Positron Emission Tomography Results Show Continued Reduction in Amyloid Burden with Subcutaneous Gantenerumab","Klein G, Delmar P, Kerchner GA, Hofmann C, Abi-Saab D, Davis A, Voyle N, Baudler M, Fontoura P, Doody R.","J Prev Alzheimers Dis. 2021;8(1):3-6. doi: 10.14283/jpad.2020.68.","Klein G","J Prev Alzheimers Dis","2021","2020/12/18","","","10.14283/jpad.2020.68"
"24000874","Angiotensin-converting enzyme inhibitors and Alzheimer's disease progression in older adults: results from the Réseau sur la Maladie d'Alzheimer Français cohort","Soto ME, van Kan GA, Nourhashemi F, Gillette-Guyonnet S, Cesari M, Cantet C, Rolland Y, Vellas B.","J Am Geriatr Soc. 2013 Sep;61(9):1482-8. doi: 10.1111/jgs.12415. Epub 2013 Sep 3.","Soto ME","J Am Geriatr Soc","2013","2013/09/05","","","10.1111/jgs.12415"
"20214847","Predictors of nursing home admission among Alzheimer's disease patients with psychosis and/or agitation","Miller EA, Schneider LS, Rosenheck RA.","Int Psychogeriatr. 2011 Feb;23(1):44-53. doi: 10.1017/S1041610210000244. Epub 2010 Mar 10.","Miller EA","Int Psychogeriatr","2011","2010/03/11","PMC3951873","NIHMS235431","10.1017/S1041610210000244"
"16999455","Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy","Modrego PJ, Pina MA, Fayed N, Díaz M.","CNS Drugs. 2006;20(10):867-77. doi: 10.2165/00023210-200620100-00006.","Modrego PJ","CNS Drugs","2006","2006/09/27","","","10.2165/00023210-200620100-00006"
"15764869","Cognition, function, and caregiving time patterns in patients with mild-to-moderate Alzheimer disease: a 12-month analysis","Feldman HH, Van Baelen B, Kavanagh SM, Torfs KE.","Alzheimer Dis Assoc Disord. 2005 Jan-Mar;19(1):29-36. doi: 10.1097/01.wad.0000157065.43282.bc.","Feldman HH","Alzheimer Dis Assoc Disord","2005","2005/03/15","","","10.1097/01.wad.0000157065.43282.bc"
"26656463","Alcohol consumption and mortality in patients with mild Alzheimer's disease: a prospective cohort study","Berntsen S, Kragstrup J, Siersma V, Waldemar G, Waldorff FB.","BMJ Open. 2015 Dec 11;5(12):e007851. doi: 10.1136/bmjopen-2015-007851.","Berntsen S","BMJ Open","2015","2015/12/15","PMC4679998","","10.1136/bmjopen-2015-007851"
"23794320","Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross-sectional study","Laroche ML, Perault-Pochat MC, Ingrand I, Merle L, Kreft-Jais C, Castot-Villepelet A, Durrieu G, Gras V, Guy C, Jean-Pastor MJ, Jonville-Béra AP, Merlet-Chicoine I, Miremont-Salamé G, Nourhashemi F, Charmes JP; French Centres of Pharmacovigilance Network.","Pharmacoepidemiol Drug Saf. 2013 Sep;22(9):952-60. doi: 10.1002/pds.3471. Epub 2013 Jun 24.","Laroche ML","Pharmacoepidemiol Drug Saf","2013","2013/06/25","","","10.1002/pds.3471"
"12111446","Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent","Panisset M, Gauthier S, Moessler H, Windisch M; Cerebrolysin Study Group.","J Neural Transm (Vienna). 2002 Jul;109(7-8):1089-104. doi: 10.1007/s007020200092.","Panisset M","J Neural Transm (Vienna)","2002","2002/07/12","","","10.1007/s007020200092"
"19607686","Effectiveness of balance training exercise in people with mild to moderate severity Alzheimer's disease: protocol for a randomised trial","Hill KD, LoGiudice D, Lautenschlager NT, Said CM, Dodd KJ, Suttanon P.","BMC Geriatr. 2009 Jul 16;9:29. doi: 10.1186/1471-2318-9-29.","Hill KD","BMC Geriatr","2009","2009/07/18","PMC2722658","","10.1186/1471-2318-9-29"
"22807076","Efficacy of psychosocial intervention in patients with mild Alzheimer's disease: the multicentre, rater blinded, randomised Danish Alzheimer Intervention Study (DAISY)","Waldorff FB, Buss DV, Eckermann A, Rasmussen ML, Keiding N, Rishøj S, Siersma V, Sørensen J, Sørensen LV, Vogel A, Waldemar G.","BMJ. 2012 Jul 17;345:e4693. doi: 10.1136/bmj.e4693.","Waldorff FB","BMJ","2012","2012/07/19","PMC3398860","","10.1136/bmj.e4693"
"1789687","Somatostatin replacement therapy for Alzheimer dementia","Mouradian MM, Blin J, Giuffra M, Heuser IJ, Baronti F, Ownby J, Chase TN.","Ann Neurol. 1991 Oct;30(4):610-3. doi: 10.1002/ana.410300415.","Mouradian MM","Ann Neurol","1991","1991/10/01","","","10.1002/ana.410300415"
"8740998","Evaluation of tacrine hydrochloride (Cognex) in two parallel-group studies","Gracon SI.","Acta Neurol Scand Suppl. 1996;165:114-22. doi: 10.1111/j.1600-0404.1996.tb05881.x.","Gracon SI","Acta Neurol Scand Suppl","1996","1996/01/01","","","10.1111/j.1600-0404.1996.tb05881.x"
"2187540","Short-term effects of the calcium channel blocker nimodipine (Bay-e-9736) in the management of primary degenerative dementia","Tollefson GD.","Biol Psychiatry. 1990 May 15;27(10):1133-42. doi: 10.1016/0006-3223(90)90050-c.","Tollefson GD","Biol Psychiatry","1990","1990/05/15","","","10.1016/0006-3223(90)90050-c"
"17767812","Omentum transposition surgery for patients with Alzheimer's disease: a case series","Shankle WR, Hara J, Bjornsen L, Gade GF, Leport PC, Ali MB, Kim J, Raimo M, Reyes L, Amen D, Rudy L, O'Heany T.","Neurol Res. 2008 Apr;30(3):313-25. doi: 10.1179/016164107X230126. Epub 2007 Aug 31.","Shankle WR","Neurol Res","2008","2007/09/05","","","10.1179/016164107X230126"
"12855821","Cerebral atherosclerosis and mild Alzheimer's disease","Rafael H.","Stroke. 2003 Aug;34(8):e106. doi: 10.1161/01.STR.0000083464.56904.E5. Epub 2003 Jul 10.","Rafael H","Stroke","2003","2003/07/12","","","10.1161/01.STR.0000083464.56904.E5"
"7580193","Lack of postmenopausal estrogen replacement therapy and the risk of dementia","Mortel KF, Meyer JS.","J Neuropsychiatry Clin Neurosci. 1995 Summer;7(3):334-7. doi: 10.1176/jnp.7.3.334.","Mortel KF","J Neuropsychiatry Clin Neurosci","1995","1995/01/01","","","10.1176/jnp.7.3.334"
"15622018","Preliminary study of the relationship between thyroid status and cognitive and neuropsychiatric functioning in euthyroid patients with Alzheimer dementia","Stern RA, Davis JD, Rogers BL, Smith KE, Harrington CJ, Ott BR, Jackson IM, Prange AJ Jr.","Cogn Behav Neurol. 2004 Dec;17(4):219-23.","Stern RA","Cogn Behav Neurol","2004","2004/12/29","","",""
"7888107","Heterogeneity of Alzheimer's disease. An interpretive review","Fudenberg HH.","Mol Neurobiol. 1994 Aug-Dec;9(1-3):55-71. doi: 10.1007/BF02816105.","Fudenberg HH","Mol Neurobiol","1994","1994/08/01","","","10.1007/BF02816105"
"10849895","Pharmaco-EEG test dose response predicts cholinesterase inhibitor treatment outcome in Alzheimer's disease","Knott V, Mohr E, Mahoney C, Ilivitsky V.","Methods Find Exp Clin Pharmacol. 2000 Mar;22(2):115-22. doi: 10.1358/mf.2000.22.2.796074.","Knott V","Methods Find Exp Clin Pharmacol","2000","2000/06/13","","","10.1358/mf.2000.22.2.796074"
"25925312","The efficacy and safety of the Chinese herbal medicine Di-Tan decoction for treating Alzheimer's disease: protocol for a randomized controlled trial","Chua KK, Wong A, Kwan PW, Song JX, Chen LL, Chan AL, Lu JH, Mok V, Li M.","Trials. 2015 Apr 30;16:199. doi: 10.1186/s13063-015-0716-z.","Chua KK","Trials","2015","2015/05/01","PMC4426181","","10.1186/s13063-015-0716-z"
"12574429","Dynamics of gray matter loss in Alzheimer's disease","Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, Herman D, Hong MS, Dittmer SS, Doddrell DM, Toga AW.","J Neurosci. 2003 Feb 1;23(3):994-1005. doi: 10.1523/JNEUROSCI.23-03-00994.2003.","Thompson PM","J Neurosci","2003","2003/02/08","PMC6741905","","10.1523/JNEUROSCI.23-03-00994.2003"
"6661730","Effect of cholinergic and anticholinergic drugs on short-term memory in Alzheimer's dementia: a neuropsychological and computerized electroencephalographic study","Agnoli A, Martucci N, Manna V, Conti L, Fioravanti M.","Clin Neuropharmacol. 1983;6(4):311-23. doi: 10.1097/00002826-198312000-00005.","Agnoli A","Clin Neuropharmacol","1983","1983/01/01","","","10.1097/00002826-198312000-00005"
"20377818","Effect of aromatherapy on patients with Alzheimer's disease","Jimbo D, Kimura Y, Taniguchi M, Inoue M, Urakami K.","Psychogeriatrics. 2009 Dec;9(4):173-9. doi: 10.1111/j.1479-8301.2009.00299.x.","Jimbo D","Psychogeriatrics","2009","2010/04/10","","","10.1111/j.1479-8301.2009.00299.x"
"10739429","Cognitive deficit induced by acute tryptophan depletion in patients with Alzheimer's disease","Porter RJ, Lunn BS, Walker LL, Gray JM, Ballard CG, O'Brien JT.","Am J Psychiatry. 2000 Apr;157(4):638-40. doi: 10.1176/appi.ajp.157.4.638.","Porter RJ","Am J Psychiatry","2000","2000/03/30","","","10.1176/appi.ajp.157.4.638"
"19089875","Evaluation of a home-based exercise program in the treatment of Alzheimer's disease: the Maximizing Independence in Dementia (MIND) study","Steinberg M, Leoutsakos JM, Podewils LJ, Lyketsos CG.","Int J Geriatr Psychiatry. 2009 Jul;24(7):680-5. doi: 10.1002/gps.2175.","Steinberg M","Int J Geriatr Psychiatry","2009","2008/12/18","PMC5172460","NIHMS836649","10.1002/gps.2175"
"12510954","Rivastigmine in patients with Alzheimer's disease and concurrent hypertension","Erkinjuntti T, Skoog I, Lane R, Andrews C.","Int J Clin Pract. 2002 Dec;56(10):791-6.","Erkinjuntti T","Int J Clin Pract","2002","2003/01/04","","",""
"11404806","An evaluation of the NINCDS-ADRDA neuropsychological criteria for the assessment of Alzheimer's disease: a confirmatory factor analysis of single versus multi-factor models","Loewenstein DA, Ownby R, Schram L, Acevedo A, Rubert M, Argüelles T.","J Clin Exp Neuropsychol. 2001 Jun;23(3):274-84. doi: 10.1076/jcen.23.3.274.1191.","Loewenstein DA","J Clin Exp Neuropsychol","2001","2001/06/19","","","10.1076/jcen.23.3.274.1191"
"35249488","Sixteen Weeks of Aerobic Exercise does not Alter Resting-state Connectivity of the Precuneus in Patients with Alzheimer's Disease","Musaeus CS, Johansen LB, Hasselbalch S, Beyer N, Høgh P, Siebner HR, Frederiksen KS.","Curr Alzheimer Res. 2022;19(2):171-177. doi: 10.2174/1567205019666220304091241.","Musaeus CS","Curr Alzheimer Res","2022","2022/03/07","","","10.2174/1567205019666220304091241"
"15525293","Confabulation, but not executive dysfunction discriminate AD from frontotemporal dementia","Nedjam Z, Devouche E, Dalla Barba G.","Eur J Neurol. 2004 Nov;11(11):728-33. doi: 10.1111/j.1468-1331.2004.00981.x.","Nedjam Z","Eur J Neurol","2004","2004/11/05","","","10.1111/j.1468-1331.2004.00981.x"
"2109658","Neuropsychological effects of L-deprenyl in Alzheimer's type dementia","Piccinin GL, Finali G, Piccirilli M.","Clin Neuropharmacol. 1990 Apr;13(2):147-63. doi: 10.1097/00002826-199004000-00004.","Piccinin GL","Clin Neuropharmacol","1990","1990/04/01","","","10.1097/00002826-199004000-00004"
"19117641","Epigenetic changes in Alzheimer's disease: decrements in DNA methylation","Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J.","Neurobiol Aging. 2010 Dec;31(12):2025-37. doi: 10.1016/j.neurobiolaging.2008.12.005. Epub 2008 Dec 30.","Mastroeni D","Neurobiol Aging","2010","2009/01/02","PMC2962691","NIHMS244885","10.1016/j.neurobiolaging.2008.12.005"
"16042029","Coverbal gestures in Alzheimer's type dementia","Carlomagno S, Pandolfi M, Marini A, Di Iasi G, Cristilli C.","Cortex. 2005 Aug;41(4):535-46. doi: 10.1016/s0010-9452(08)70193-x.","Carlomagno S","Cortex","2005","2005/07/27","","","10.1016/s0010-9452(08)70193-x"
"25814404","Deep Brain Stimulation Influences Brain Structure in Alzheimer's Disease","Sankar T, Chakravarty MM, Bescos A, Lara M, Obuchi T, Laxton AW, McAndrews MP, Tang-Wai DF, Workman CI, Smith GS, Lozano AM.","Brain Stimul. 2015 May-Jun;8(3):645-54. doi: 10.1016/j.brs.2014.11.020. Epub 2014 Dec 3.","Sankar T","Brain Stimul","2015","2015/03/28","PMC5659851","NIHMS911980","10.1016/j.brs.2014.11.020"
"34296549","Effects of Electrical Automatic Massage on Cognition and Sleep Quality in Alzheimer's Disease Spectrum Patients: A Randomized Controlled Trial","Kim YJ, Kim HR, Jung YH, Park YH, Seo SW.","Yonsei Med J. 2021 Aug;62(8):717-725. doi: 10.3349/ymj.2021.62.8.717.","Kim YJ","Yonsei Med J","2021","2021/07/23","PMC8298867","","10.3349/ymj.2021.62.8.717"
"23543281","The mini-Kingston Standardized Cognitive Assessment","Hopkins RW, Kilik LA.","Am J Alzheimers Dis Other Demen. 2013 May;28(3):239-44. doi: 10.1177/1533317513481095. Epub 2013 Mar 28.","Hopkins RW","Am J Alzheimers Dis Other Demen","2013","2013/04/02","","","10.1177/1533317513481095"
"2655861","Canadian collaborative study of tetrahydroaminoacridine (THA) and lecithin treatment of Alzheimer's disease: effect on mood","Vida S, Gauthier L, Gauthier S.","Can J Psychiatry. 1989 Apr;34(3):165-70. doi: 10.1177/070674378903400301.","Vida S","Can J Psychiatry","1989","1989/04/01","","","10.1177/070674378903400301"
"26923256","Donepezil 23 mg in Asian patients with moderate-to-severe Alzheimer's disease","Han SH, Lee JH, Kim SY, Park KW, Chen C, Tripathi M, Dash A, Kubota N.","Acta Neurol Scand. 2017 Feb;135(2):252-256. doi: 10.1111/ane.12571. Epub 2016 Feb 29.","Han SH","Acta Neurol Scand","2017","2016/03/01","","","10.1111/ane.12571"
"18761139","The impact of dementia, age and sex on category fluency: greater deficits in women with Alzheimer's disease","Moreno-Martínez FJ, Laws KR, Schulz J.","Cortex. 2008 Oct;44(9):1256-64. doi: 10.1016/j.cortex.2007.11.008. Epub 2008 Jan 20.","Moreno-Martínez FJ","Cortex","2008","2008/09/02","","","10.1016/j.cortex.2007.11.008"
"3108930","Cognitive effects of L-deprenyl in Alzheimer's disease","Tariot PN, Sunderland T, Weingartner H, Murphy DL, Welkowitz JA, Thompson K, Cohen RM.","Psychopharmacology (Berl). 1987;91(4):489-95. doi: 10.1007/BF00216016.","Tariot PN","Psychopharmacology (Berl)","1987","1987/01/01","","","10.1007/BF00216016"
"16963137","Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: a placebo-controlled pilot study","Mahlberg R, Walther S, Eichmann U, Tracik F, Kunz D.","Arch Gerontol Geriatr. 2007 Jul-Aug;45(1):19-26. doi: 10.1016/j.archger.2006.07.006. Epub 2006 Sep 11.","Mahlberg R","Arch Gerontol Geriatr","2007","2006/09/12","","","10.1016/j.archger.2006.07.006"
"10440564","A randomized trial to implement practice recommendations: design and methods of the Dementia Care Study","Holloway RG, Gifford DR, Frankel MR, Vickrey BG.","Control Clin Trials. 1999 Aug;20(4):369-85. doi: 10.1016/s0197-2456(99)00006-9.","Holloway RG","Control Clin Trials","1999","1999/08/10","","","10.1016/s0197-2456(99)00006-9"
"17033629","Decreased circulating CD34+ stem cells in early Alzheimer's disease: Evidence for a deficient hematopoietic brain support?","Maler JM, Spitzer P, Lewczuk P, Kornhuber J, Herrmann M, Wiltfang J.","Mol Psychiatry. 2006 Dec;11(12):1113-5. doi: 10.1038/sj.mp.4001913. Epub 2006 Oct 10.","Maler JM","Mol Psychiatry","2006","2006/10/13","","","10.1038/sj.mp.4001913"
"20922772","Do patients diagnosed with Alzheimer's disease benefit from a psycho-educational programme for family caregivers? A randomised controlled study","de Rotrou J, Cantegreil I, Faucounau V, Wenisch E, Chausson C, Jegou D, Grabar S, Rigaud AS.","Int J Geriatr Psychiatry. 2011 Aug;26(8):833-42. doi: 10.1002/gps.2611. Epub 2010 Oct 4.","de Rotrou J","Int J Geriatr Psychiatry","2011","2010/10/06","","","10.1002/gps.2611"
"21715226","Region and frequency specific changes of spectral power in Alzheimer's disease and mild cognitive impairment","Roh JH, Park MH, Ko D, Park KW, Lee DH, Han C, Jo SA, Yang KS, Jung KY.","Clin Neurophysiol. 2011 Nov;122(11):2169-76. doi: 10.1016/j.clinph.2011.03.023. Epub 2011 Jun 28.","Roh JH","Clin Neurophysiol","2011","2011/07/01","","","10.1016/j.clinph.2011.03.023"
"20594284","Clinical psychological tests useful for differentiating depressive state with Alzheimer's disease from major depression of the elderly","Hattori H, Yoshiyama K, Miura R, Fujie S.","Psychogeriatrics. 2010 Mar;10(1):29-33. doi: 10.1111/j.1479-8301.2010.00308.x.","Hattori H","Psychogeriatrics","2010","2010/07/03","","","10.1111/j.1479-8301.2010.00308.x"
"35542991","Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease","Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, Dent G, Hansson O, Harrison K, von Hehn C, Iwatsubo T, Mallinckrodt C, Mummery CJ, Muralidharan KK, Nestorov I, Nisenbaum L, Rajagovindan R, Skordos L, Tian Y, van Dyck CH, Vellas B, Wu S, Zhu Y, Sandrock A.","J Prev Alzheimers Dis. 2022;9(2):197-210. doi: 10.14283/jpad.2022.30.","Budd Haeberlein S","J Prev Alzheimers Dis","2022","2022/05/11","","","10.14283/jpad.2022.30"
"21492498","Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study","Barak Y, Plopski I, Tadger S, Paleacu D.","Int Psychogeriatr. 2011 Nov;23(9):1515-9. doi: 10.1017/S1041610211000743. Epub 2011 Apr 15.","Barak Y","Int Psychogeriatr","2011","2011/04/16","","","10.1017/S1041610211000743"
"30755135","Longitudinal evaluation of surrogates of regional cerebral blood flow computed from dynamic amyloid PET imaging","Bilgel M, Beason-Held L, An Y, Zhou Y, Wong DF, Resnick SM.","J Cereb Blood Flow Metab. 2020 Feb;40(2):288-297. doi: 10.1177/0271678X19830537. Epub 2019 Feb 12.","Bilgel M","J Cereb Blood Flow Metab","2020","2019/02/14","PMC7370613","","10.1177/0271678X19830537"
"8854306","Apo-E genotype and verbal deficits in Alzheimer's disease","Rasmusson DX, Dal Forno G, Brandt J, Warren AC, Troncoso J, Lyketsos C.","J Neuropsychiatry Clin Neurosci. 1996 Summer;8(3):335-7. doi: 10.1176/jnp.8.3.335.","Rasmusson DX","J Neuropsychiatry Clin Neurosci","1996","1996/01/01","","","10.1176/jnp.8.3.335"
"16210226","Proper names in patients with early Alzheimer's disease","Semenza C, Mondini S, Borgo F, Pasini M, Sgaramella MT.","Neurocase. 2003;9(1):63-9. doi: 10.1076/neur.9.1.63.14370.","Semenza C","Neurocase","2003","2005/10/08","","","10.1076/neur.9.1.63.14370"
"35103388","Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial","Vila-Castelar C, Tariot PN, Sink KM, Clayton D, Langbaum JB, Thomas RG, Chen Y, Su Y, Chen K, Hu N, Giraldo-Chica M, Tobón C, Acosta-Baena N, Luna E, Londoño M, Ospina P, Tirado V, Muñoz C, Henao E, Bocanegra Y, Alvarez S, Rios-Romenets S, Ghisays V, Goradia D, Lee W, Luo J, Malek-Ahmadi MH, Protas HD, Lopera F, Reiman EM, Quiroz YT; API ADAD Colombia Trial Group.","Alzheimers Dement. 2022 Nov;18(11):2272-2282. doi: 10.1002/alz.12552. Epub 2022 Feb 1.","Vila-Castelar C","Alzheimers Dement","2022","2022/02/01","PMC9339586","NIHMS1783831","10.1002/alz.12552"
"9801526","Use of music to decrease aggressive behaviors in people with dementia","Clark ME, Lipe AW, Bilbrey M.","J Gerontol Nurs. 1998 Jul;24(7):10-7. doi: 10.3928/0098-9134-19980701-05.","Clark ME","J Gerontol Nurs","1998","1998/11/05","","","10.3928/0098-9134-19980701-05"
"15259399","rCBF/SPECT in the evaluation of inner-city minority patients with a history of impaired memory: a pilot blind read pre- and poststudy","Jonas S, Van Heertum R, Tikofsky R, Millman E, Singh D, Brust J, McCurtis H, Locko R.","Brain Cogn. 2002 Jul;49(2):234-7.","Jonas S","Brain Cogn","2002","2004/07/21","","",""
"19300884","Lessons learned in the use of volumetric MRI in therapeutic trials in Alzheimer's disease: the ALZHEMED (Tramiprosate) experience","Saumier D, Aisen PS, Gauthier S, Vellas B, Ferris SH, Duong A, Suhy J, Oh J, Lau W, Garceau D, Haine D, Sampalis J.","J Nutr Health Aging. 2009 Apr;13(4):370-2. doi: 10.1007/s12603-009-0047-4.","Saumier D","J Nutr Health Aging","2009","2009/03/21","","","10.1007/s12603-009-0047-4"
"10896691","Temporal lobe asymmetry in patients with Alzheimer's disease with delusions","Geroldi C, Akkawi NM, Galluzzi S, Ubezio M, Binetti G, Zanetti O, Trabucchi M, Frisoni GB.","J Neurol Neurosurg Psychiatry. 2000 Aug;69(2):187-91. doi: 10.1136/jnnp.69.2.187.","Geroldi C","J Neurol Neurosurg Psychiatry","2000","2000/07/15","PMC1737042","","10.1136/jnnp.69.2.187"
"8890677","Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease","Levy ML, Cummings JL, Fairbanks LA, Bravi D, Calvani M, Carta A.","Am J Psychiatry. 1996 Nov;153(11):1438-43. doi: 10.1176/ajp.153.11.1438.","Levy ML","Am J Psychiatry","1996","1996/11/01","","","10.1176/ajp.153.11.1438"
"2192301","DGAVP (Org 5667) in early Alzheimer's disease patients: an international double-blind, placebo-controlled, multicenter trial","Wolters EC, Riekkinen P, Lowenthal A, Van der Plaats JJ, Zwart JM, Sennef C.","Neurology. 1990 Jul;40(7):1099-101. doi: 10.1212/wnl.40.7.1099.","Wolters EC","Neurology","1990","1990/07/01","","","10.1212/wnl.40.7.1099"
"20844871","In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease","Yokokura M, Mori N, Yagi S, Yoshikawa E, Kikuchi M, Yoshihara Y, Wakuda T, Sugihara G, Takebayashi K, Suda S, Iwata Y, Ueki T, Tsuchiya KJ, Suzuki K, Nakamura K, Ouchi Y.","Eur J Nucl Med Mol Imaging. 2011 Feb;38(2):343-51. doi: 10.1007/s00259-010-1612-0. Epub 2010 Sep 16.","Yokokura M","Eur J Nucl Med Mol Imaging","2011","2010/09/17","","","10.1007/s00259-010-1612-0"
"23015654","Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer's disease","Duron E, Funalot B, Brunel N, Coste J, Quinquis L, Viollet C, Belmin J, Jouanny P, Pasquier F, Treluyer JM, Epelbaum J, le Bouc Y, Hanon O.","J Clin Endocrinol Metab. 2012 Dec;97(12):4673-81. doi: 10.1210/jc.2012-2063. Epub 2012 Sep 26.","Duron E","J Clin Endocrinol Metab","2012","2012/09/28","","","10.1210/jc.2012-2063"
"7675432","[Molecular genetic markers of Alzheimer dementia]","Németh A, Urbanics K, Tariska P, Kramer J, Füst G, Dinya E, Abel T, Romics L, Pados G, Manfred H, et al.","Orv Hetil. 1995 Sep 3;136(36):1931-5.","Németh A","Orv Hetil","1995","1995/09/03","","",""
"17109476","Identification of responders and reactive domains to rivastigmine in Alzheimer's disease","Frankfort SV, Appels BA, de Boer A, Tulner LR, van Campen JP, Koks CH, Beijnen JH, Schmand BA.","Pharmacoepidemiol Drug Saf. 2007 May;16(5):545-51. doi: 10.1002/pds.1345.","Frankfort SV","Pharmacoepidemiol Drug Saf","2007","2006/11/17","","","10.1002/pds.1345"
"26401779","Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease","Gleason CE, Fischer BL, Dowling NM, Setchell KD, Atwood CS, Carlsson CM, Asthana S.","J Alzheimers Dis. 2015;47(4):1009-19. doi: 10.3233/JAD-142958.","Gleason CE","J Alzheimers Dis","2015","2015/09/25","PMC4657545","NIHMS737170","10.3233/JAD-142958"
"25637921","Multiple feature extraction and classification of electroencephalograph signal for Alzheimers' with spectrum and bispectrum","Wang R, Wang J, Li S, Yu H, Deng B, Wei X.","Chaos. 2015 Jan;25(1):013110. doi: 10.1063/1.4906038.","Wang R","Chaos","2015","2015/02/02","","","10.1063/1.4906038"
"23158895","Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer´s disease - protocol for a controlled, randomized double-blinded trial","Egefjord L, Gejl M, Møller A, Brændgaard H, Gottrup H, Antropova O, Møller N, Poulsen HE, Gjedde A, Brock B, Rungby J.","Dan Med J. 2012 Oct;59(10):A4519.","Egefjord L","Dan Med J","2012","2012/11/20","","",""
"27010616","ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials","Wang J, Logovinsky V, Hendrix SB, Stanworth SH, Perdomo C, Xu L, Dhadda S, Do I, Rabe M, Luthman J, Cummings J, Satlin A.","J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):993-9. doi: 10.1136/jnnp-2015-312383. Epub 2016 Mar 23.","Wang J","J Neurol Neurosurg Psychiatry","2016","2016/03/25","PMC5013117","","10.1136/jnnp-2015-312383"
"25504466","A pilot randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer's disease","D'Onofrio G, Sancarlo D, Addante F, Ciccone F, Cascavilla L, Paris F, Elia AC, Nuzzaci C, Picoco M, Greco A, Panza F, Pilotto A.","Int J Geriatr Psychiatry. 2015 Sep;30(9):965-75. doi: 10.1002/gps.4247. Epub 2014 Dec 12.","D'Onofrio G","Int J Geriatr Psychiatry","2015","2014/12/16","","","10.1002/gps.4247"
"19015485","Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial","Sevigny JJ, Ryan JM, van Dyck CH, Peng Y, Lines CR, Nessly ML; MK-677 Protocol 30 Study Group.","Neurology. 2008 Nov 18;71(21):1702-8. doi: 10.1212/01.wnl.0000335163.88054.e7.","Sevigny JJ","Neurology","2008","2008/11/19","","","10.1212/01.wnl.0000335163.88054.e7"
"26771737","Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial","Schneider LS, Frangakis C, Drye LT, Devanand DP, Marano CM, Mintzer J, Mulsant BH, Munro CA, Newell JA, Pawluczyk S, Pelton G, Pollock BG, Porsteinsson AP, Rabins PV, Rein L, Rosenberg PB, Shade D, Weintraub D, Yesavage J, Lyketsos CG; CitAD Research Group.","Am J Psychiatry. 2016 May 1;173(5):465-72. doi: 10.1176/appi.ajp.2015.15050648. Epub 2016 Jan 15.","Schneider LS","Am J Psychiatry","2016","2016/01/16","PMC6419726","NIHMS1013260","10.1176/appi.ajp.2015.15050648"
"12142731","Presence or absence of at least one epsilon 4 allele and gender are not predictive for the response to donepezil treatment in Alzheimer's disease","Rigaud AS, Traykov L, Latour F, Couderc R, Moulin F, Forette F.","Pharmacogenetics. 2002 Jul;12(5):415-20. doi: 10.1097/00008571-200207000-00009.","Rigaud AS","Pharmacogenetics","2002","2002/07/27","","","10.1097/00008571-200207000-00009"
"16618375","Music therapy in moderate and severe dementia of Alzheimer's type: a case-control study","Svansdottir HB, Snaedal J.","Int Psychogeriatr. 2006 Dec;18(4):613-21. doi: 10.1017/S1041610206003206. Epub 2006 Apr 18.","Svansdottir HB","Int Psychogeriatr","2006","2006/04/19","","","10.1017/S1041610206003206"
"11087767","Treatment of agitation in AD: a randomized, placebo-controlled clinical trial","Teri L, Logsdon RG, Peskind E, Raskind M, Weiner MF, Tractenberg RE, Foster NL, Schneider LS, Sano M, Whitehouse P, Tariot P, Mellow AM, Auchus AP, Grundman M, Thomas RG, Schafer K, Thal LJ; Alzheimer's Disease Cooperative Study.","Neurology. 2000 Nov 14;55(9):1271-8. doi: 10.1212/wnl.55.9.1271.","Teri L","Neurology","2000","2000/11/23","","","10.1212/wnl.55.9.1271"
"10559570","A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation","Wahlund LO, Basun H, Almkvist O, Julin P, Axelman K, Shigeta M, Jelic V, Nordberg A, Lannfelt L.","Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):526-33. doi: 10.1159/000017200.","Wahlund LO","Dement Geriatr Cogn Disord","1999","1999/11/24","","","10.1159/000017200"
"9267856","A controlled study of 2 doses of idebenone in the treatment of Alzheimer's disease","Weyer G, Babej-Dölle RM, Hadler D, Hofmann S, Herrmann WM.","Neuropsychobiology. 1997;36(2):73-82. doi: 10.1159/000119366.","Weyer G","Neuropsychobiology","1997","1997/01/01","","","10.1159/000119366"
"17846273","A neuropsychological test battery for use in Alzheimer disease clinical trials","Harrison J, Minassian SL, Jenkins L, Black RS, Koller M, Grundman M.","Arch Neurol. 2007 Sep;64(9):1323-9. doi: 10.1001/archneur.64.9.1323.","Harrison J","Arch Neurol","2007","2007/09/12","","","10.1001/archneur.64.9.1323"
"8642166","Improved reliability of the Standardized Alzheimer's Disease Assessment Scale (SADAS) compared with the Alzheimer's Disease Assessment Scale (ADAS)","Standish TI, Molloy DW, Bédard M, Layne EC, Murray EA, Strang D.","J Am Geriatr Soc. 1996 Jun;44(6):712-6. doi: 10.1111/j.1532-5415.1996.tb01838.x.","Standish TI","J Am Geriatr Soc","1996","1996/06/01","","","10.1111/j.1532-5415.1996.tb01838.x"
"22677258","Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study","Winblad B, Andreasen N, Minthon L, Floesser A, Imbert G, Dumortier T, Maguire RP, Blennow K, Lundmark J, Staufenbiel M, Orgogozo JM, Graf A.","Lancet Neurol. 2012 Jul;11(7):597-604. doi: 10.1016/S1474-4422(12)70140-0. Epub 2012 Jun 6.","Winblad B","Lancet Neurol","2012","2012/06/09","","","10.1016/S1474-4422(12)70140-0"
"28527204","Levetiracetam Alters Oscillatory Connectivity in Alzheimer's Disease","Musaeus CS, Shafi MM, Santarnecchi E, Herman ST, Press DZ.","J Alzheimers Dis. 2017;58(4):1065-1076. doi: 10.3233/JAD-160742.","Musaeus CS","J Alzheimers Dis","2017","2017/05/21","","","10.3233/JAD-160742"
"1634705","Milacemide: a placebo-controlled study in senile dementia of the Alzheimer type","Dysken MW, Mendels J, LeWitt P, Reisberg B, Pomara N, Wood J, Skare S, Fakouhi JD, Herting RL.","J Am Geriatr Soc. 1992 May;40(5):503-6. doi: 10.1111/j.1532-5415.1992.tb02019.x.","Dysken MW","J Am Geriatr Soc","1992","1992/05/01","","","10.1111/j.1532-5415.1992.tb02019.x"
"16614789","White matter damage of patients with Alzheimer's disease correlated with the decreased cognitive function","Duan JH, Wang HQ, Xu J, Lin X, Chen SQ, Kang Z, Yao ZB.","Surg Radiol Anat. 2006 May;28(2):150-6. doi: 10.1007/s00276-006-0111-2. Epub 2006 Apr 14.","Duan JH","Surg Radiol Anat","2006","2006/04/15","","","10.1007/s00276-006-0111-2"
"21356158","Animal-assisted activity and emotional status of patients with Alzheimer's disease in day care","Mossello E, Ridolfi A, Mello AM, Lorenzini G, Mugnai F, Piccini C, Barone D, Peruzzi A, Masotti G, Marchionni N.","Int Psychogeriatr. 2011 Aug;23(6):899-905. doi: 10.1017/S1041610211000226. Epub 2011 Mar 1.","Mossello E","Int Psychogeriatr","2011","2011/03/02","","","10.1017/S1041610211000226"
"12111443","Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit","Giacobini E, Spiegel R, Enz A, Veroff AE, Cutler NR.","J Neural Transm (Vienna). 2002 Jul;109(7-8):1053-65. doi: 10.1007/s007020200089.","Giacobini E","J Neural Transm (Vienna)","2002","2002/07/12","","","10.1007/s007020200089"
"9403153","An evaluation of the Cambridge Contextual Reading Test (CCRT) in Alzheimer's disease","Conway SC, O'Carroll RE.","Br J Clin Psychol. 1997 Nov;36(4):623-5. doi: 10.1111/j.2044-8260.1997.tb01267.x.","Conway SC","Br J Clin Psychol","1997","1997/12/24","","","10.1111/j.2044-8260.1997.tb01267.x"
"12486280","Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease","Rinne JO, Kaasinen V, Järvenpää T, Någren K, Roivainen A, Yu M, Oikonen V, Kurki T.","J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):113-5. doi: 10.1136/jnnp.74.1.113.","Rinne JO","J Neurol Neurosurg Psychiatry","2003","2002/12/18","PMC1738186","","10.1136/jnnp.74.1.113"
"11859291","An open-label study to evaluate the safety, tolerability and efficacy of rivastigmine in patients with mild to moderate probable Alzheimer's disease in the community setting","Bilikiewicz A, Opala G, Podemski R, Puzyński S, Łapin J, Sołtys K, Ochudło S, Barcikowska M, Pfeffer A, Bilińska M, Paradowski B, Parnowski T, Gabryelewicz T.","Med Sci Monit. 2002 Feb;8(2):PI9-15.","Bilikiewicz A","Med Sci Monit","2002","2002/02/23","","",""
"18230972","Treatment of a whole population sample of Alzheimer's disease with donepezil over a 4-year period: lessons learned","Lyle S, Grizzell M, Willmott S, Benbow S, Clark M, Jolley D.","Dement Geriatr Cogn Disord. 2008;25(3):226-31. doi: 10.1159/000114450. Epub 2008 Jan 30.","Lyle S","Dement Geriatr Cogn Disord","2008","2008/01/31","","","10.1159/000114450"
"10599935","Neuropsychometric tests in cross sectional and longitudinal studies - a regression analysis of ADAS - cog, SKT and MMSE","Ihl R, Grass-Kapanke B, Jänner M, Weyer G.","Pharmacopsychiatry. 1999 Nov;32(6):248-54. doi: 10.1055/s-2007-991102.","Ihl R","Pharmacopsychiatry","1999","1999/12/22","","","10.1055/s-2007-991102"
"29705156","Value of testosterone in saliva in the diagnosis of Alzheimer's disease","de la Rubia Ortí JE, García-Pardo MP, Rochina MJ.","Med Clin (Barc). 2019 Jan 18;152(2):75-76. doi: 10.1016/j.medcli.2018.03.006. Epub 2018 Apr 25.","de la Rubia Ortí JE","Med Clin (Barc)","2019","2018/04/30","","","10.1016/j.medcli.2018.03.006"
"36155316","Effects of oral health intervention strategies on cognition and microbiota alterations in patients with mild Alzheimer's disease: A randomized controlled trial","Chen L, Cao H, Wu X, Xu X, Ji X, Wang B, Zhang P, Li H.","Geriatr Nurs. 2022 Nov-Dec;48:103-110. doi: 10.1016/j.gerinurse.2022.09.005. Epub 2022 Sep 22.","Chen L","Geriatr Nurs","2022","2022/09/26","","","10.1016/j.gerinurse.2022.09.005"
"3881051","Oral physostigmine treatment of patients with Alzheimer's disease","Mohs RC, Davis BM, Johns CA, Mathé AA, Greenwald BS, Horvath TB, Davis KL.","Am J Psychiatry. 1985 Jan;142(1):28-33. doi: 10.1176/ajp.142.1.28.","Mohs RC","Am J Psychiatry","1985","1985/01/01","","","10.1176/ajp.142.1.28"
"34233376","Investigation of the effects of interventions made according to the Progressively Lowered Stress Threshold Model on the care outcomes of Alzheimer patients and their families: a randomized clinical trial","Duru Aşiret G, Kütmeç Yılmaz C, Sayın Kasar K.","Psychogeriatrics. 2021 Sep;21(5):738-748. doi: 10.1111/psyg.12734. Epub 2021 Jul 7.","Duru Aşiret G","Psychogeriatrics","2021","2021/07/07","","","10.1111/psyg.12734"
"24643135","Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study","Gareri P, Putignano D, Castagna A, Cotroneo AM, De Palo G, Fabbo A, Forgione L, Giacummo A, Lacava R, Marino S, Simone M, Zurlo A, Putignano S.","J Alzheimers Dis. 2014;41(2):633-40. doi: 10.3233/JAD-132735.","Gareri P","J Alzheimers Dis","2014","2014/03/20","","","10.3233/JAD-132735"
"9521249","Is videopupillography useful in the diagnosis of Alzheimer's disease?","Ferrario E, Molaschi M, Villa L, Varetto O, Bogetto C, Nuzzi R.","Neurology. 1998 Mar;50(3):642-4. doi: 10.1212/wnl.50.3.642.","Ferrario E","Neurology","1998","1998/04/01","","","10.1212/wnl.50.3.642"
"15207413","Alzheimer's disease and acetylcholinesterase inhibitor agents: a two-year longitudinal study","Fuschillo C, Ascoli E, Franzese G, Campana F, Cello C, Galdi M, La Pia S, Cetrangolo C.","Arch Gerontol Geriatr Suppl. 2004;(9):187-94. doi: 10.1016/j.archger.2004.04.026.","Fuschillo C","Arch Gerontol Geriatr Suppl","2004","2004/06/23","","","10.1016/j.archger.2004.04.026"
"14594748","Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease","Krishnan KR, Charles HC, Doraiswamy PM, Mintzer J, Weisler R, Yu X, Perdomo C, Ieni JR, Rogers S.","Am J Psychiatry. 2003 Nov;160(11):2003-11. doi: 10.1176/appi.ajp.160.11.2003.","Krishnan KR","Am J Psychiatry","2003","2003/11/05","","","10.1176/appi.ajp.160.11.2003"
"21699607","Evaluation of the regional cerebral blood flow changes during long-term donepezil therapy in patients with Alzheimer's disease using 3DSRT","Kimura N, Kumamoto T, Masuda T, Hanaoka T, Okazaki T, Arakawa R.","J Neuroimaging. 2012 Jul;22(3):299-304. doi: 10.1111/j.1552-6569.2011.00612.x. Epub 2011 Jun 23.","Kimura N","J Neuroimaging","2012","2011/06/25","","","10.1111/j.1552-6569.2011.00612.x"
"24747504","[Tolerability and efficacy of the long-term administration of memantine hydrochloride (Memary®) in patients with moderate to severe Alzheimer's disease]","Kitamura S, Nakamura Y, Homma A, Kimura N, Asami Y.","Nihon Ronen Igakkai Zasshi. 2014;51(1):74-84. doi: 10.3143/geriatrics.51.74.","Kitamura S","Nihon Ronen Igakkai Zasshi","2014","2014/04/22","","","10.3143/geriatrics.51.74"
"10940679","Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio","Sjögren M, Gustafson L, Wikkelsö C, Wallin A.","Dement Geriatr Cogn Disord. 2000 Sep-Oct;11(5):275-85. doi: 10.1159/000017250.","Sjögren M","Dement Geriatr Cogn Disord","2000","2000/08/15","","","10.1159/000017250"
"30727947","Maintenance of occupational therapy (OT) for dementia: protocol of a multi-center, randomized controlled and pragmatic trial","Pimouguet C, Sitta R, Wittwer J, Hayes N, Petit-Monéger A, Dartigues JF, Helmer C.","BMC Geriatr. 2019 Feb 6;19(1):35. doi: 10.1186/s12877-019-1046-x.","Pimouguet C","BMC Geriatr","2019","2019/02/08","PMC6366025","","10.1186/s12877-019-1046-x"
"32074412","Early Improvements of Individual Symptoms With Antipsychotics Predict Subsequent Treatment Response of Neuropsychiatric Symptoms in Alzheimer's Disease: A Re-Analysis of the CATIE-AD Study","Nagata T, Shinagawa S, Yoshida K, Noda Y, Shigeta M, Mimura M, Nakajima S.","J Clin Psychiatry. 2020 Feb 11;81(2):19m12961. doi: 10.4088/JCP.19m12961.","Nagata T","J Clin Psychiatry","2020","2020/02/20","","","10.4088/JCP.19m12961"
"10794845","Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease","Merched A, Xia Y, Visvikis S, Serot JM, Siest G.","Neurobiol Aging. 2000 Jan-Feb;21(1):27-30. doi: 10.1016/s0197-4580(99)00103-7.","Merched A","Neurobiol Aging","2000","2000/05/05","","","10.1016/s0197-4580(99)00103-7"
"23257314","Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease","Trzepacz PT, Cummings J, Konechnik T, Forrester TD, Chang C, Dennehy EB, Willis BA, Shuler C, Tabas LB, Lyketsos C.","Int Psychogeriatr. 2013 May;25(5):707-19. doi: 10.1017/S1041610212002141. Epub 2012 Dec 21.","Trzepacz PT","Int Psychogeriatr","2013","2012/12/22","PMC3938603","NIHMS548490","10.1017/S1041610212002141"
"16049637","Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease","Stefanova E, Wall A, Almkvist O, Nilsson A, Forsberg A, Långström B, Nordberg A.","J Neural Transm (Vienna). 2006 Feb;113(2):205-18. doi: 10.1007/s00702-005-0312-6. Epub 2005 Jul 29.","Stefanova E","J Neural Transm (Vienna)","2006","2005/07/29","","","10.1007/s00702-005-0312-6"
"8916107","Rate of cognitive decline in Alzheimer's disease is not affected by the alpha-1-antichymotrypsin A allele or the CYP2D6 B mutant","Murphy GM Jr, Yang L, Yesavage J, Tinklenberg JR.","Neurosci Lett. 1996 Oct 18;217(2-3):200-2.","Murphy GM Jr","Neurosci Lett","1996","1996/10/18","","",""
"24931567","An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease","Shah RC, Matthews DC, Andrews RD, Capuano AW, Fleischman DA, VanderLugt JT, Colca JR.","Curr Alzheimer Res. 2014;11(6):564-73. doi: 10.2174/1567205011666140616113406.","Shah RC","Curr Alzheimer Res","2014","2014/06/17","PMC4153084","","10.2174/1567205011666140616113406"
"21045096","Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial","Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr, Weiner M, Shinto L, Aisen PS.","JAMA. 2010 Nov 3;304(17):1903-11. doi: 10.1001/jama.2010.1510.","Quinn JF","JAMA","2010","2010/11/04","PMC3259852","NIHMS292002","10.1001/jama.2010.1510"
"10805059","Selegiline treatment and the extent of degenerative changes in brain tissue of patients with Alzheimer's disease","Alafuzoff I, Helisalmi S, Heinonen EH, Reinikainen K, Hallikainen M, Soininen H, Koivisto K.","Eur J Clin Pharmacol. 2000 Feb-Mar;55(11-12):815-9. doi: 10.1007/s002280050702.","Alafuzoff I","Eur J Clin Pharmacol","2000","2000/05/11","","","10.1007/s002280050702"
"6125806","Lecithin in Alzheimer's disease","Levy R.","Lancet. 1982 Sep 18;2(8299):671-2. doi: 10.1016/s0140-6736(82)92777-5.","Levy R","Lancet","1982","1982/09/18","","","10.1016/s0140-6736(82)92777-5"
"3048224","Multiple-dose arecoline infusions in Alzheimer's disease","Tariot PN, Cohen RM, Welkowitz JA, Sunderland T, Newhouse PA, Murphy DL, Weingartner H.","Arch Gen Psychiatry. 1988 Oct;45(10):901-5. doi: 10.1001/archpsyc.1988.01800340023003.","Tariot PN","Arch Gen Psychiatry","1988","1988/10/01","","","10.1001/archpsyc.1988.01800340023003"
"7798991","Cholinergic supersensitivity of the iris in Alzheimer's disease","Idiaquez J, Alvarez G, Villagra R, San Martin RA.","J Neurol Neurosurg Psychiatry. 1994 Dec;57(12):1544-5. doi: 10.1136/jnnp.57.12.1544-a.","Idiaquez J","J Neurol Neurosurg Psychiatry","1994","1994/12/01","PMC1073243","","10.1136/jnnp.57.12.1544-a"
"22766770","Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial","Scheltens P, Twisk JW, Blesa R, Scarpini E, von Arnim CA, Bongers A, Harrison J, Swinkels SH, Stam CJ, de Waal H, Wurtman RJ, Wieggers RL, Vellas B, Kamphuis PJ.","J Alzheimers Dis. 2012;31(1):225-36. doi: 10.3233/JAD-2012-121189.","Scheltens P","J Alzheimers Dis","2012","2012/07/07","","","10.3233/JAD-2012-121189"
"24696507","Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease","Galasko D, Bell J, Mancuso JY, Kupiec JW, Sabbagh MN, van Dyck C, Thomas RG, Aisen PS; Alzheimer's Disease Cooperative Study.","Neurology. 2014 Apr 29;82(17):1536-42. doi: 10.1212/WNL.0000000000000364. Epub 2014 Apr 2.","Galasko D","Neurology","2014","2014/04/04","PMC4011464","","10.1212/WNL.0000000000000364"
"22976077","The effect of an aloe polymannose multinutrient complex on cognitive and immune functioning in Alzheimer's disease","Lewis JE, McDaniel HR, Agronin ME, Loewenstein DA, Riveros J, Mestre R, Martinez M, Colina N, Abreu D, Konefal J, Woolger JM, Ali KH.","J Alzheimers Dis. 2013;33(2):393-406. doi: 10.3233/JAD-2012-121381.","Lewis JE","J Alzheimers Dis","2013","2012/09/15","","","10.3233/JAD-2012-121381"
"31694759","Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4(-/-): A double-blind, randomized, placebo-controlled crossover trial","Xu Q, Zhang Y, Zhang X, Liu L, Zhou B, Mo R, Li Y, Li H, Li F, Tao Y, Liu Y, Xue C.","Clin Nutr. 2020 Jul;39(7):2092-2105. doi: 10.1016/j.clnu.2019.10.017. Epub 2019 Oct 22.","Xu Q","Clin Nutr","2020","2019/11/08","","","10.1016/j.clnu.2019.10.017"
"17380475","Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study","Holmes C, Wilkinson D, Dean C, Clare C, El-Okl M, Hensford C, Moghul S.","Int J Geriatr Psychiatry. 2007 Apr;22(4):380-1. doi: 10.1002/gps.1667.","Holmes C","Int J Geriatr Psychiatry","2007","2007/03/24","","","10.1002/gps.1667"
"7635851","Effect of carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics","Lemke MR.","J Clin Psychiatry. 1995 Aug;56(8):354-7.","Lemke MR","J Clin Psychiatry","1995","1995/08/01","","",""
"8437603","Tacrine in Alzheimer's disease","Cutler NR, Sramek JJ.","N Engl J Med. 1993 Mar 18;328(11):808; author reply 809-10. doi: 10.1056/NEJM199303183281114.","Cutler NR","N Engl J Med","1993","1993/03/18","","","10.1056/NEJM199303183281114"
"18308781","Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6)","Erkinjuntti T, Gauthier S, Bullock R, Kurz A, Hammond G, Schwalen S, Zhu Y, Brashear R.","J Psychopharmacol. 2008 Sep;22(7):761-8. doi: 10.1177/0269881107083028. Epub 2008 Feb 28.","Erkinjuntti T","J Psychopharmacol","2008","2008/03/01","","","10.1177/0269881107083028"
"12809076","A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease","Tan RS, Pu SJ.","Aging Male. 2003 Mar;6(1):13-7.","Tan RS","Aging Male","2003","2003/06/18","","",""
"7981574","Secretion of growth hormone and thyroid-stimulating hormone in patients with dementia","Gómez JM, Aguilar M, Navarro MA, Ortolá J, Soler J.","Clin Investig. 1994 Jul;72(7):489-93. doi: 10.1007/BF00207475.","Gómez JM","Clin Investig","1994","1994/07/01","","","10.1007/BF00207475"
"10848143","Intervention effects on dementia caregiving interaction: a stress-adaptation modeling approach","Corbeil RR, Quayhagen MP, Quayhagen M.","J Aging Health. 1999 Feb;11(1):79-95. doi: 10.1177/089826439901100105.","Corbeil RR","J Aging Health","1999","2000/06/10","","","10.1177/089826439901100105"
"36017827","Comparative Bioavailability Study of a Novel Multi-Day Patch Formulation of Rivastigmine (Twice Weekly) with Exelon® Transdermal Patch (Daily)- A Randomized Clinical Trial","Schurad B, Koch C, Schug B, Morte A, Vaqué A, De la Torre R, Iniesta M.","Curr Alzheimer Res. 2022;19(7):541-553. doi: 10.2174/1567205019666220823105059.","Schurad B","Curr Alzheimer Res","2022","2022/08/26","","","10.2174/1567205019666220823105059"
"15159498","Cholesterol and APOE genotype interact to influence Alzheimer disease progression","Evans RM, Hui S, Perkins A, Lahiri DK, Poirier J, Farlow MR.","Neurology. 2004 May 25;62(10):1869-71. doi: 10.1212/01.wnl.0000125323.15458.3f.","Evans RM","Neurology","2004","2004/05/26","","","10.1212/01.wnl.0000125323.15458.3f"
"9642019","Cognitive mechanisms for processing nonwords: evidence from Alzheimer's disease","Glosser G, Friedman RB, Kohn SE, Sands L, Grugan P.","Brain Lang. 1998 Jun 1;63(1):32-49. doi: 10.1006/brln.1997.1924.","Glosser G","Brain Lang","1998","1998/06/27","","","10.1006/brln.1997.1924"
"34668391","Serum aberrant expression of miR-24-3p and its diagnostic value in Alzheimer's disease","Liu L, Liu L, Lu Y, Zhang T, Zhao W.","Biomark Med. 2021 Nov;15(16):1499-1507. doi: 10.2217/bmm-2021-0098. Epub 2021 Oct 20.","Liu L","Biomark Med","2021","2021/10/20","","","10.2217/bmm-2021-0098"
"9162211","The predictive value of hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease","Swanwick GR, Coen RF, Walsh JB, Coakley D, Lawlor BA.","Biol Psychiatry. 1996 Jun 1;39(11):976-8. doi: 10.1016/0006-3223(95)00590-0.","Swanwick GR","Biol Psychiatry","1996","1996/06/01","","","10.1016/0006-3223(95)00590-0"
"16393758","Can episodic memory tasks differentiate semantic dementia from Alzheimer's disease?","Scahill VL, Hodges JR, Graham KS.","Neurocase. 2005 Dec;11(6):441-51. doi: 10.1080/13554790500287734.","Scahill VL","Neurocase","2005","2006/01/06","","","10.1080/13554790500287734"
"15232656","Diagnosis of suspected Alzheimer's disease is improved by automated analysis of regional cerebral blood flow","Tang BN, Minoshima S, George J, Robert A, Swine C, Laloux P, Borght TV.","Eur J Nucl Med Mol Imaging. 2004 Nov;31(11):1487-94. doi: 10.1007/s00259-004-1597-7. Epub 2004 Jul 1.","Tang BN","Eur J Nucl Med Mol Imaging","2004","2004/07/03","","","10.1007/s00259-004-1597-7"
"9617511","Lisuride treatment of Alzheimer's disease. A preliminary placebo-controlled clinical trial of safety and therapeutic efficacy","Claus JJ, de Koning I, van Harskamp F, Breteler MM, Voet B, Gutzmann H, Dahlke F, van der Cammen T, Hofman A.","Clin Neuropharmacol. 1998 May-Jun;21(3):190-5.","Claus JJ","Clin Neuropharmacol","1998","1998/06/09","","",""
"31404102","Cognition may link cortical IGFBP5 levels with motor function in older adults","Buchman AS, Yu L, Petyuk VA, Gaiteri C, Tasaki S, Blizinsky KD, Schneider JA, De Jager PL, Bennett DA.","PLoS One. 2019 Aug 12;14(8):e0220968. doi: 10.1371/journal.pone.0220968. eCollection 2019.","Buchman AS","PLoS One","2019","2019/08/13","PMC6690580","","10.1371/journal.pone.0220968"
"24688081","Benefit-finding intervention for Alzheimer caregivers: conceptual framework, implementation issues, and preliminary efficacy","Cheng ST, Lau RW, Mak EP, Ng NS, Lam LC.","Gerontologist. 2014 Dec;54(6):1049-58. doi: 10.1093/geront/gnu018. Epub 2014 Mar 31.","Cheng ST","Gerontologist","2014","2014/04/02","","","10.1093/geront/gnu018"
"10668686","Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial","Henderson VW, Paganini-Hill A, Miller BL, Elble RJ, Reyes PF, Shoupe D, McCleary CA, Klein RA, Hake AM, Farlow MR.","Neurology. 2000 Jan 25;54(2):295-301. doi: 10.1212/wnl.54.2.295.","Henderson VW","Neurology","2000","2000/02/11","","","10.1212/wnl.54.2.295"
"31727169","Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia","Thal DR, Ronisz A, Tousseyn T, Rijal Upadhaya A, Balakrishnan K, Vandenberghe R, Vandenbulcke M, von Arnim CAF, Otto M, Beach TG, Lilja J, Heurling K, Chakrabarty A, Ismail A, Buckley C, Smith APL, Kumar S, Farrar G, Walter J.","Acta Neuropathol Commun. 2019 Nov 14;7(1):178. doi: 10.1186/s40478-019-0837-9.","Thal DR","Acta Neuropathol Commun","2019","2019/11/16","PMC6854805","","10.1186/s40478-019-0837-9"
"7779292","Effects of short-term transcutaneous electrical nerve stimulation on memory and affective behaviour in patients with probable Alzheimer's disease","Scherder EJ, Bouma A, Steen AM.","Behav Brain Res. 1995 Mar;67(2):211-9. doi: 10.1016/0166-4328(94)00115-v.","Scherder EJ","Behav Brain Res","1995","1995/03/01","","","10.1016/0166-4328(94)00115-v"
"17135812","ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly","Sano M, Zhu CW, Whitehouse PJ, Edland S, Jin S, Ernstrom K, Thomas RG, Thal LJ, Ferris SH; Alzheimer Disease Cooperative Study Group.","Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4 Suppl 3):S191-202. doi: 10.1097/01.wad.0000213875.63171.87.","Sano M","Alzheimer Dis Assoc Disord","2006","2006/12/01","PMC3229195","NIHMS336641","10.1097/01.wad.0000213875.63171.87"
"3127432","Tranylcypromine compared with L-deprenyl in Alzheimer's disease","Tariot PN, Sunderland T, Cohen RM, Newhouse PA, Mueller EA, Murphy DL.","J Clin Psychopharmacol. 1988 Feb;8(1):23-7.","Tariot PN","J Clin Psychopharmacol","1988","1988/02/01","","",""
"12627986","Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease","Wimo A, Winblad B, Stöffler A, Wirth Y, Möbius HJ.","Pharmacoeconomics. 2003;21(5):327-40. doi: 10.2165/00019053-200321050-00004.","Wimo A","Pharmacoeconomics","2003","2003/03/12","","","10.2165/00019053-200321050-00004"
"17660172","Effect of rivastigmine on regional cerebral blood flow in Alzheimer's disease","Cerci SS, Tamam Y, Kaya H, Yildiz M, Arslan S.","Adv Ther. 2007 May-Jun;24(3):611-21. doi: 10.1007/BF02848786.","Cerci SS","Adv Ther","2007","2007/07/31","","","10.1007/BF02848786"
"34332638","An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study","Sen A, Akinola M, Tai XY, Symmonds M, Davis Jones G, Mura S, Galloway J, Hallam A, Chan JYC, Koychev I, Butler C, Geddes J, Van Der Putt R, Thompson S, Manohar SG, Frangou E, Love S, McShane R, Husain M.","Trials. 2021 Jul 31;22(1):508. doi: 10.1186/s13063-021-05404-4.","Sen A","Trials","2021","2021/08/01","PMC8325256","","10.1186/s13063-021-05404-4"
"7929709","Intact primary memory in mild to moderate Alzheimer disease: indices from the California Verbal Learning Test","Simon E, Leach L, Winocur G, Moscovitch M.","J Clin Exp Neuropsychol. 1994 Jun;16(3):414-22. doi: 10.1080/01688639408402652.","Simon E","J Clin Exp Neuropsychol","1994","1994/06/01","","","10.1080/01688639408402652"
"20555135","Cortical oxygen supply during postural hypotension is further decreased in Alzheimer's disease, but unrelated to cholinesterase-inhibitor use","van Beek AH, Sijbesma JC, Jansen RW, Rikkert MG, Claassen JA.","J Alzheimers Dis. 2010;21(2):519-26. doi: 10.3233/JAD-2010-100288.","van Beek AH","J Alzheimers Dis","2010","2010/06/18","","","10.3233/JAD-2010-100288"
"9109749","Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease","Bodick NC, Offen WW, Levey AI, Cutler NR, Gauthier SG, Satlin A, Shannon HE, Tollefson GD, Rasmussen K, Bymaster FP, Hurley DJ, Potter WZ, Paul SM.","Arch Neurol. 1997 Apr;54(4):465-73. doi: 10.1001/archneur.1997.00550160091022.","Bodick NC","Arch Neurol","1997","1997/04/01","","","10.1001/archneur.1997.00550160091022"
"27358067","The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease","Yassine HN, Rawat V, Mack WJ, Quinn JF, Yurko-Mauro K, Bailey-Hall E, Aisen PS, Chui HC, Schneider LS.","Alzheimers Res Ther. 2016 Jun 30;8:25. doi: 10.1186/s13195-016-0194-x.","Yassine HN","Alzheimers Res Ther","2016","2016/07/01","PMC4928349","","10.1186/s13195-016-0194-x"
"18430857","Potential role of diffusion tensor MRI in the differential diagnosis of mild cognitive impairment and Alzheimer's disease","Parente DB, Gasparetto EL, da Cruz LC Jr, Domingues RC, Baptista AC, Carvalho AC, Domingues RC.","AJR Am J Roentgenol. 2008 May;190(5):1369-74. doi: 10.2214/AJR.07.2617.","Parente DB","AJR Am J Roentgenol","2008","2008/04/24","","","10.2214/AJR.07.2617"
"15347711","Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer's disease from controls using brain perfusion SPECT","Imabayashi E, Matsuda H, Asada T, Ohnishi T, Sakamoto S, Nakano S, Inoue T.","J Nucl Med. 2004 Sep;45(9):1450-7.","Imabayashi E","J Nucl Med","2004","2004/09/07","","",""
"36281683","Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate","Wischik CM, Bentham P, Gauthier S, Miller S, Kook K, Schelter BO.","J Prev Alzheimers Dis. 2022;9(4):780-790. doi: 10.14283/jpad.2022.63.","Wischik CM","J Prev Alzheimers Dis","2022","2022/10/25","PMC9226274","","10.14283/jpad.2022.63"
"29695589","ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease","Cummings JL, Cohen S, van Dyck CH, Brody M, Curtis C, Cho W, Ward M, Friesenhahn M, Rabe C, Brunstein F, Quartino A, Honigberg LA, Fuji RN, Clayton D, Mortensen D, Ho C, Paul R.","Neurology. 2018 May 22;90(21):e1889-e1897. doi: 10.1212/WNL.0000000000005550. Epub 2018 Apr 25.","Cummings JL","Neurology","2018","2018/04/27","PMC5962917","","10.1212/WNL.0000000000005550"
"16537230","Name relearning in elderly patients with schizophrenia: episodic and temporary, not semantic and permanent","Kondel TK, Hirsch SR, Laws KR.","Cogn Neuropsychiatry. 2006 Jan;11(1):1-12. doi: 10.1080/13546800444000137.","Kondel TK","Cogn Neuropsychiatry","2006","2006/03/16","","","10.1080/13546800444000137"
"9494696","Apolipoprotein E: depressive illness, depressive symptoms, and Alzheimer's disease","Holmes C, Russ C, Kirov G, Aitchison KJ, Powell JF, Collier DA, Lovestone S.","Biol Psychiatry. 1998 Feb 1;43(3):159-64. doi: 10.1016/S0006-3223(97)00326-0.","Holmes C","Biol Psychiatry","1998","1998/03/12","","","10.1016/S0006-3223(97)00326-0"
"9581210","Short-term administration of selegiline for mild-to-moderate dementia of the Alzheimer's type","Tariot PN, Goldstein B, Podgorski CA, Cox C, Frambes N.","Am J Geriatr Psychiatry. 1998 Spring;6(2):145-54.","Tariot PN","Am J Geriatr Psychiatry","1998","1998/05/15","","",""
"9469263","Cerebral blood flow in white matter is correlated with systolic blood pressure and EEG in senile dementia of the Alzheimer type","Siennicki-Lantz A, Lilja B, Rosén I, Elmståhl S.","Dement Geriatr Cogn Disord. 1998 Jan-Feb;9(1):29-38. doi: 10.1159/000017019.","Siennicki-Lantz A","Dement Geriatr Cogn Disord","1998","1998/02/20","","","10.1159/000017019"
"30642737","Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: A randomized, double-blind, controlled trial","Tamtaji OR, Heidari-Soureshjani R, Mirhosseini N, Kouchaki E, Bahmani F, Aghadavod E, Tajabadi-Ebrahimi M, Asemi Z.","Clin Nutr. 2019 Dec;38(6):2569-2575. doi: 10.1016/j.clnu.2018.11.034. Epub 2018 Dec 10.","Tamtaji OR","Clin Nutr","2019","2019/01/16","","","10.1016/j.clnu.2018.11.034"
"31264051","Long Non-coding RNA BACE1-AS May Serve as an Alzheimer's Disease Blood-Based Biomarker","Fotuhi SN, Khalaj-Kondori M, Hoseinpour Feizi MA, Talebi M.","J Mol Neurosci. 2019 Nov;69(3):351-359. doi: 10.1007/s12031-019-01364-2. Epub 2019 Jul 1.","Fotuhi SN","J Mol Neurosci","2019","2019/07/03","","","10.1007/s12031-019-01364-2"
"21996001","Chronic treatment with rivastigmine in patients with Alzheimer's disease: a study on primary motor cortex excitability tested by 5 Hz-repetitive transcranial magnetic stimulation","Trebbastoni A, Gilio F, D'Antonio F, Cambieri C, Ceccanti M, de Lena C, Inghilleri M.","Clin Neurophysiol. 2012 May;123(5):902-9. doi: 10.1016/j.clinph.2011.09.010. Epub 2011 Oct 12.","Trebbastoni A","Clin Neurophysiol","2012","2011/10/15","","","10.1016/j.clinph.2011.09.010"
"18483726","Quantitative analysis of the effects of donepezil on regional cerebral blood flow in Alzheimer's disease by using an automated program, 3DSRT","Tateno M, Kobayashi S, Utsumi K, Morii H, Fujii K.","Neuroradiology. 2008 Aug;50(8):723-7. doi: 10.1007/s00234-008-0401-y. Epub 2008 May 16.","Tateno M","Neuroradiology","2008","2008/05/17","","","10.1007/s00234-008-0401-y"
"18430980","Neuropsychological rehabilitation in mild and moderate Alzheimer's disease patients","Avila R, Carvalho IA, Bottino CM, Miotto EC.","Behav Neurol. 2007;18(4):225-33. doi: 10.1155/2007/915816.","Avila R","Behav Neurol","2007","2008/04/24","PMC5469953","","10.1155/2007/915816"
"19573486","Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study","Hampel H, Ewers M, Bürger K, Annas P, Mörtberg A, Bogstedt A, Frölich L, Schröder J, Schönknecht P, Riepe MW, Kraft I, Gasser T, Leyhe T, Möller HJ, Kurz A, Basun H.","J Clin Psychiatry. 2009 Jun;70(6):922-31.","Hampel H","J Clin Psychiatry","2009","2009/07/04","","",""
"10362441","The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group","Raskind MA, Cyrus PA, Ruzicka BB, Gulanski BI.","J Clin Psychiatry. 1999 May;60(5):318-25. doi: 10.4088/jcp.v60n0510.","Raskind MA","J Clin Psychiatry","1999","1999/06/11","","","10.4088/jcp.v60n0510"
"14706467","Quantitative EEG and perfusional single photon emission computed tomography correlation during long-term donepezil therapy in Alzheimer's disease","Rodriguez G, Vitali P, Canfora M, Calvini P, Girtler N, De Leo C, Piccardo A, Nobili F.","Clin Neurophysiol. 2004 Jan;115(1):39-49. doi: 10.1016/s1388-2457(03)00321-3.","Rodriguez G","Clin Neurophysiol","2004","2004/01/07","","","10.1016/s1388-2457(03)00321-3"
"19328435","Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results","ADAPT Research Group; Meinert CL, McCaffrey LD, Breitner JC.","Alzheimers Dement. 2009 Mar;5(2):93-104. doi: 10.1016/j.jalz.2008.09.004.","ADAPT Research Group","Alzheimers Dement","2009","2009/03/31","PMC2866447","NIHMS185404","10.1016/j.jalz.2008.09.004"
"27094158","Poor self-rated health did not increase risk of permanent nursing placement or mortality in people with mild Alzheimer's disease","Nielsen AB, Siersma V, Waldemar G, Waldorff FB.","BMC Geriatr. 2016 Apr 19;16:87. doi: 10.1186/s12877-016-0262-x.","Nielsen AB","BMC Geriatr","2016","2016/04/21","PMC4837635","","10.1186/s12877-016-0262-x"
"11475012","Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype","Sjögren M, Hesse C, Basun H, Köl G, Thostrup H, Kilander L, Marcusson J, Edman A, Wallin A, Karlsson I, Troell M, Wachtmaister G, Ekdahl A, Olofsson H, Sandström A, Andreasen N, Minthon L, Blennow K.","J Neural Transm (Vienna). 2001;108(4):451-8. doi: 10.1007/s007020170066.","Sjögren M","J Neural Transm (Vienna)","2001","2001/07/28","","","10.1007/s007020170066"
"15156547","Memantine enhances autonomy in moderate to severe Alzheimer's disease","Rive B, Vercelletto M, Damier FD, Cochran J, François C.","Int J Geriatr Psychiatry. 2004 May;19(5):458-64. doi: 10.1002/gps.1112.","Rive B","Int J Geriatr Psychiatry","2004","2004/05/25","","","10.1002/gps.1112"
"14732621","Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials","Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR Jr, Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck CH, Mintzer J, Zamrini EY, Cahn-Weiner D, Thal LJ; Alzheimer's Disease Cooperative Study.","Arch Neurol. 2004 Jan;61(1):59-66. doi: 10.1001/archneur.61.1.59.","Grundman M","Arch Neurol","2004","2004/01/21","","","10.1001/archneur.61.1.59"
"34762980","Transcranial magnetic stimulation for sleep disorders in Alzheimer's disease: A double-blind, randomized, and sham-controlled pilot study","Zhou X, Wang Y, Lv S, Li Y, Jia S, Niu X, Peng D.","Neurosci Lett. 2022 Jan 1;766:136337. doi: 10.1016/j.neulet.2021.136337. Epub 2021 Nov 8.","Zhou X","Neurosci Lett","2022","2021/11/11","","","10.1016/j.neulet.2021.136337"
"30320574","Effects of Meditation and Music-Listening on Blood Biomarkers of Cellular Aging and Alzheimer's Disease in Adults with Subjective Cognitive Decline: An Exploratory Randomized Clinical Trial","Innes KE, Selfe TK, Brundage K, Montgomery C, Wen S, Kandati S, Bowles H, Khalsa DS, Huysmans Z.","J Alzheimers Dis. 2018;66(3):947-970. doi: 10.3233/JAD-180164.","Innes KE","J Alzheimers Dis","2018","2018/10/16","PMC6388631","NIHMS1012165","10.3233/JAD-180164"
"28655135","Home-Based Exercise Program Improves Balance and Fear of Falling in Community-Dwelling Older Adults with Mild Alzheimer's Disease: A Pilot Study","Padala KP, Padala PR, Lensing SY, Dennis RA, Bopp MM, Roberson PK, Sullivan DH.","J Alzheimers Dis. 2017;59(2):565-574. doi: 10.3233/JAD-170120.","Padala KP","J Alzheimers Dis","2017","2017/06/29","","","10.3233/JAD-170120"
"15990425","Functional disabilities profile of chinese elderly people with Alzheimer's disease - a validation study on the chinese version of the disability assessment for dementia","Mok CC, Siu AM, Chan WC, Yeung KM, Pan PC, Li SW.","Dement Geriatr Cogn Disord. 2005;20(2-3):112-9. doi: 10.1159/000086612. Epub 2005 Jun 30.","Mok CC","Dement Geriatr Cogn Disord","2005","2005/07/02","","","10.1159/000086612"
"25824567","Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study","Sabri O, Sabbagh MN, Seibyl J, Barthel H, Akatsu H, Ouchi Y, Senda K, Murayama S, Ishii K, Takao M, Beach TG, Rowe CC, Leverenz JB, Ghetti B, Ironside JW, Catafau AM, Stephens AW, Mueller A, Koglin N, Hoffmann A, Roth K, Reininger C, Schulz-Schaeffer WJ; Florbetaben Phase 3 Study Group.","Alzheimers Dement. 2015 Aug;11(8):964-74. doi: 10.1016/j.jalz.2015.02.004. Epub 2015 Mar 28.","Sabri O","Alzheimers Dement","2015","2015/04/01","","","10.1016/j.jalz.2015.02.004"
"8477148","Multicentre study of l-alpha-glyceryl-phosphorylcholine vs ST200 among patients with probable senile dementia of Alzheimer's type","Parnetti L, Abate G, Bartorelli L, Cucinotta D, Cuzzupoli M, Maggioni M, Villardita C, Senin U.","Drugs Aging. 1993 Mar-Apr;3(2):159-64. doi: 10.2165/00002512-199303020-00006.","Parnetti L","Drugs Aging","1993","1993/03/01","","","10.2165/00002512-199303020-00006"
"20098234","Low-dose divalproex in agitated patients with Alzheimer's disease","Dolder C, McKinsey J.","J Psychiatr Pract. 2010 Jan;16(1):63-7. doi: 10.1097/01.pra.0000367781.26507.86.","Dolder C","J Psychiatr Pract","2010","2010/01/26","","","10.1097/01.pra.0000367781.26507.86"
"16042028","Referential communication in Alzheimer's type dementia","Carlomagno S, Santoro A, Menditti A, Pandolfi M, Marini A.","Cortex. 2005 Aug;41(4):520-34. doi: 10.1016/s0010-9452(08)70192-8.","Carlomagno S","Cortex","2005","2005/07/27","","","10.1016/s0010-9452(08)70192-8"
"8464548","The effectiveness of amiridin in senile dementia of the Alzheimer's type","Bukatina EE, Grigor'eva IV, Sokol'chik EI.","Neurosci Behav Physiol. 1993 Jan-Feb;23(1):83-9. doi: 10.1007/BF01182643.","Bukatina EE","Neurosci Behav Physiol","1993","1993/01/01","","","10.1007/BF01182643"
"9883463","Spoken word recognition in individuals with dementia of the Alzheimer's type: changes in talker normalization and lexical discrimination","Sommers MS.","Psychol Aging. 1998 Dec;13(4):631-46. doi: 10.1037//0882-7974.13.4.631.","Sommers MS","Psychol Aging","1998","1999/01/12","","","10.1037//0882-7974.13.4.631"
"2690093","Double-blind study with phosphatidylserine (PS) in parkinsonian patients with senile dementia of Alzheimer's type (SDAT)","Fünfgeld EW, Baggen M, Nedwidek P, Richstein B, Mistlberger G.","Prog Clin Biol Res. 1989;317:1235-46.","Fünfgeld EW","Prog Clin Biol Res","1989","1989/01/01","","",""
"10556869","A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study","Dubois B, McKeith I, Orgogozo JM, Collins O, Meulien D.","Int J Geriatr Psychiatry. 1999 Nov;14(11):973-82.","Dubois B","Int J Geriatr Psychiatry","1999","1999/11/11","","",""
"9298628","Alzheimer's Disease Assessment Scale: the validation of the scale in Greece in elderly demented patients and normal subjects","Tsolaki M, Fountoulakis K, Nakopoulou E, Kazis A, Mohs RC.","Dement Geriatr Cogn Disord. 1997 Sep-Oct;8(5):273-80. doi: 10.1159/000106644.","Tsolaki M","Dement Geriatr Cogn Disord","1997","1997/09/23","","","10.1159/000106644"
"12397471","Brain SPET abnormalities in Alzheimer's disease before and after atrophy correction","Matsuda H, Kanetaka H, Ohnishi T, Asada T, Imabayashi E, Nakano S, Katoh A, Tanaka F.","Eur J Nucl Med Mol Imaging. 2002 Nov;29(11):1502-5. doi: 10.1007/s00259-002-0930-2. Epub 2002 Aug 24.","Matsuda H","Eur J Nucl Med Mol Imaging","2002","2002/10/25","","","10.1007/s00259-002-0930-2"
"10559562","No association between apolipoprotein A-IV codon 360 mutation and late-onset Alzheimer's disease in the Japanese population","Ji Y, Urakami K, Adachi Y, Nakashima K.","Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):473-5. doi: 10.1159/000017192.","Ji Y","Dement Geriatr Cogn Disord","1999","1999/11/24","","","10.1159/000017192"
"2036533","Cerebral pharmacodynamics of physostigmine in Alzheimer's disease investigated using single-photon computerised tomography","Hunter R, Wyper DJ, Patterson J, Hansen MT, Goodwin GM.","Br J Psychiatry. 1991 Mar;158:351-7. doi: 10.1192/bjp.158.3.351.","Hunter R","Br J Psychiatry","1991","1991/03/01","","","10.1192/bjp.158.3.351"
"19293567","Agreement in cognitive and clinical assessments in Alzheimer's disease","Tractenberg RE, Aisen PS.","Dement Geriatr Cogn Disord. 2009;27(4):344-52. doi: 10.1159/000209212. Epub 2009 Mar 17.","Tractenberg RE","Dement Geriatr Cogn Disord","2009","2009/03/19","PMC2820316","","10.1159/000209212"
"10648297","A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease","Magai C, Kennedy G, Cohen CI, Gomberg D.","Am J Geriatr Psychiatry. 2000 Winter;8(1):66-74. doi: 10.1097/00019442-200002000-00009.","Magai C","Am J Geriatr Psychiatry","2000","2000/01/29","","","10.1097/00019442-200002000-00009"
"9134457","Identification of body parts in Alzheimer's disease: evidence for a body schema hypothesis","Mozaz MJ, Morris RG.","Int J Neurosci. 1997 Feb;89(3-4):207-16. doi: 10.3109/00207459708988475.","Mozaz MJ","Int J Neurosci","1997","1997/02/01","","","10.3109/00207459708988475"
"15174457","Retrieval of episodic and semantic autobiographical memories in early Alzheimer's disease and semantic dementia","Ivanoiu A, Cooper JM, Shanks MF, Venneri A.","Cortex. 2004 Feb;40(1):173-5. doi: 10.1016/s0010-9452(08)70939-0.","Ivanoiu A","Cortex","2004","2004/06/04","","","10.1016/s0010-9452(08)70939-0"
"15590465","Three-word recall in normal aging","Chandler MJ, Lacritz LH, Cicerello AR, Chapman SB, Honig LS, Weiner MF, Cullum CM.","J Clin Exp Neuropsychol. 2004 Nov;26(8):1128-33. doi: 10.1080/13803390490515540.","Chandler MJ","J Clin Exp Neuropsychol","2004","2004/12/14","","","10.1080/13803390490515540"
"9547467","Differential neuropsychiatric symptom responses to tacrine in Alzheimer's disease: relationship to dementia severity","Kaufer D, Cummings JL, Christine D.","J Neuropsychiatry Clin Neurosci. 1998 Winter;10(1):55-63. doi: 10.1176/jnp.10.1.55.","Kaufer D","J Neuropsychiatry Clin Neurosci","1998","1998/04/21","","","10.1176/jnp.10.1.55"
"9386855","Cortisol secretion and Alzheimer's disease progression","Weiner MF, Vobach S, Olsson K, Svetlik D, Risser RC.","Biol Psychiatry. 1997 Dec 1;42(11):1030-8. doi: 10.1016/s0006-3223(97)00165-0.","Weiner MF","Biol Psychiatry","1997","1997/12/05","","","10.1016/s0006-3223(97)00165-0"
"2422004","Does an ACTH derivative (Org 2766) prevent deterioration of EEG in Alzheimer's disease?","Partanen JV, Soininen H, Riekkinen PJ.","Electroencephalogr Clin Neurophysiol. 1986 Jun;63(6):547-51. doi: 10.1016/0013-4694(86)90142-2.","Partanen JV","Electroencephalogr Clin Neurophysiol","1986","1986/06/01","","","10.1016/0013-4694(86)90142-2"
"34059401","Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical Trial","Devanand DP, Crocco E, Forester BP, Husain MM, Lee S, Vahia IV, Andrews H, Simon-Pearson L, Imran N, Luca L, Huey ED, Deliyannides DA, Pelton GH.","Am J Geriatr Psychiatry. 2022 Jan;30(1):32-42. doi: 10.1016/j.jagp.2021.04.014. Epub 2021 May 12.","Devanand DP","Am J Geriatr Psychiatry","2022","2021/06/01","PMC8586042","NIHMS1703560","10.1016/j.jagp.2021.04.014"
"33667281","Amyloid burden quantification depends on PET and MR image processing methodology","Kolinger GD, Vállez García D, Willemsen ATM, Reesink FE, de Jong BM, Dierckx RAJO, De Deyn PP, Boellaard R.","PLoS One. 2021 Mar 5;16(3):e0248122. doi: 10.1371/journal.pone.0248122. eCollection 2021.","Kolinger GD","PLoS One","2021","2021/03/05","PMC7935288","","10.1371/journal.pone.0248122"
"11954670","AD-venture program: therapeutic biking for the treatment of depression in long-term care residents with dementia","Buettner LL, Fitzsimmons S.","Am J Alzheimers Dis Other Demen. 2002 Mar-Apr;17(2):121-7. doi: 10.1177/153331750201700205.","Buettner LL","Am J Alzheimers Dis Other Demen","2002","2002/04/17","","","10.1177/153331750201700205"
"25216556","Non-invasive brain stimulation of the right inferior frontal gyrus may improve attention in early Alzheimer's disease: a pilot study","Eliasova I, Anderkova L, Marecek R, Rektorova I.","J Neurol Sci. 2014 Nov 15;346(1-2):318-22. doi: 10.1016/j.jns.2014.08.036. Epub 2014 Aug 29.","Eliasova I","J Neurol Sci","2014","2014/09/14","","","10.1016/j.jns.2014.08.036"
"19571727","A brief instrument to assess treatment response in the patient with advanced Alzheimer disease","Schmitt FA, Saxton JA, Xu Y, McRae T, Sun Y, Richardson S, Li H.","Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):377-83. doi: 10.1097/WAD.0b013e3181ac9cc1.","Schmitt FA","Alzheimer Dis Assoc Disord","2009","2009/07/03","","","10.1097/WAD.0b013e3181ac9cc1"
"15842075","Music enhances category fluency in healthy older adults and Alzheimer's disease patients","Thompson RG, Moulin CJ, Hayre S, Jones RW.","Exp Aging Res. 2005 Jan-Mar;31(1):91-9. doi: 10.1080/03610730590882819.","Thompson RG","Exp Aging Res","2005","2005/04/22","","","10.1080/03610730590882819"
"31781880","Salvage of the retinal ganglion cells in transition phase in Alzheimer's disease with topical coenzyme Q10: is it possible?","Karakahya RH, Özcan TŞ.","Graefes Arch Clin Exp Ophthalmol. 2020 Feb;258(2):411-418. doi: 10.1007/s00417-019-04544-3. Epub 2019 Nov 28.","Karakahya RH","Graefes Arch Clin Exp Ophthalmol","2020","2019/11/30","","","10.1007/s00417-019-04544-3"
"33798485","An Efficacy Trial of Long-Term Care Residents With Alzheimer's Disease Using Videos to Communicate Care Preferences","Towsley GL, Wong B, Baier RR, Neller S.","J Am Med Dir Assoc. 2021 Jul;22(7):1559-1560. doi: 10.1016/j.jamda.2021.02.032. Epub 2021 Mar 30.","Towsley GL","J Am Med Dir Assoc","2021","2021/04/02","PMC8297558","NIHMS1724594","10.1016/j.jamda.2021.02.032"
"11007727","Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study","Lyketsos CG, Sheppard JM, Steele CD, Kopunek S, Steinberg M, Baker AS, Brandt J, Rabins PV.","Am J Psychiatry. 2000 Oct;157(10):1686-9. doi: 10.1176/appi.ajp.157.10.1686.","Lyketsos CG","Am J Psychiatry","2000","2000/09/29","","","10.1176/appi.ajp.157.10.1686"
"23969994","Efficacy of musical interventions in dementia: evidence from a randomized controlled trial","Narme P, Clément S, Ehrlé N, Schiaratura L, Vachez S, Courtaigne B, Munsch F, Samson S.","J Alzheimers Dis. 2014;38(2):359-69. doi: 10.3233/JAD-130893.","Narme P","J Alzheimers Dis","2014","2013/08/24","","","10.3233/JAD-130893"
"14690867","Outcomes for patients with dementia from the Cleveland Alzheimer's Managed Care Demonstration","Clark PA, Bass DM, Looman WJ, McCarthy CA, Eckert S.","Aging Ment Health. 2004 Jan;8(1):40-51. doi: 10.1080/13607860310001613329.","Clark PA","Aging Ment Health","2004","2003/12/24","","","10.1080/13607860310001613329"
"8018843","Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease","Perry EK, Haroutunian V, Davis KL, Levy R, Lantos P, Eagger S, Honavar M, Dean A, Griffiths M, McKeith IG, et al.","Neuroreport. 1994 Mar 21;5(7):747-9. doi: 10.1097/00001756-199403000-00002.","Perry EK","Neuroreport","1994","1994/03/21","","","10.1097/00001756-199403000-00002"
"14690802","Results of a randomized placebo-controlled study of memory training for mildly impaired Alzheimer's disease patients","Cahn-Weiner DA, Malloy PF, Rebok GW, Ott BR.","Appl Neuropsychol. 2003;10(4):215-23. doi: 10.1207/s15324826an1004_3.","Cahn-Weiner DA","Appl Neuropsychol","2003","2003/12/24","","","10.1207/s15324826an1004_3"
"12673604","The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure","Mintzer JE, Kershaw P.","Int J Geriatr Psychiatry. 2003 Apr;18(4):292-7. doi: 10.1002/gps.826.","Mintzer JE","Int J Geriatr Psychiatry","2003","2003/04/04","","","10.1002/gps.826"
"19293172","Misplacing objects in mild to moderate Alzheimer's disease: a descriptive analysis from the VISTA clinical trial","Hamilton L, Fay S, Rockwood K.","J Neurol Neurosurg Psychiatry. 2009 Sep;80(9):960-5. doi: 10.1136/jnnp.2008.166801. Epub 2009 Mar 16.","Hamilton L","J Neurol Neurosurg Psychiatry","2009","2009/03/19","","","10.1136/jnnp.2008.166801"
"17135809","ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials","Galasko D, Bennett DA, Sano M, Marson D, Kaye J, Edland SD; Alzheimer's Disease Cooperative Study.","Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4 Suppl 3):S152-69. doi: 10.1097/01.wad.0000213873.25053.2b.","Galasko D","Alzheimer Dis Assoc Disord","2006","2006/12/01","","","10.1097/01.wad.0000213873.25053.2b"
"21671144","Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer's dementia","Ahmed MA, Darwish ES, Khedr EM, El Serogy YM, Ali AM.","J Neurol. 2012 Jan;259(1):83-92. doi: 10.1007/s00415-011-6128-4. Epub 2011 Jun 14.","Ahmed MA","J Neurol","2012","2011/06/15","","","10.1007/s00415-011-6128-4"
"10794844","Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease","Convit A, de Asis J, de Leon MJ, Tarshish CY, De Santi S, Rusinek H.","Neurobiol Aging. 2000 Jan-Feb;21(1):19-26. doi: 10.1016/s0197-4580(99)00107-4.","Convit A","Neurobiol Aging","2000","2000/05/05","","","10.1016/s0197-4580(99)00107-4"
"1516904","A single-case-study method for treating resistiveness in patients with Alzheimer's disease","Herz LR, Volicer L, Ross V, Rheaume Y.","Hosp Community Psychiatry. 1992 Jul;43(7):720-4. doi: 10.1176/ps.43.7.720.","Herz LR","Hosp Community Psychiatry","1992","1992/07/01","","","10.1176/ps.43.7.720"
"25379423","Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness","Lebedev AV, Westman E, Van Westen GJ, Kramberger MG, Lundervold A, Aarsland D, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Simmons A; Alzheimer's Disease Neuroimaging Initiative and the AddNeuroMed consortium.","Neuroimage Clin. 2014 Aug 28;6:115-25. doi: 10.1016/j.nicl.2014.08.023. eCollection 2014.","Lebedev AV","Neuroimage Clin","2014","2014/11/08","PMC4215532","","10.1016/j.nicl.2014.08.023"
"24121969","Animal spotting in Alzheimer's disease: an eye tracking study of object categorization","Boucart M, Bubbico G, Szaffarczyk S, Pasquier F.","J Alzheimers Dis. 2014;39(1):181-9. doi: 10.3233/JAD-131331.","Boucart M","J Alzheimers Dis","2014","2013/10/15","","","10.3233/JAD-131331"
"28956123","The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer's patients: An interobserver study","Martens RM, Bechten A, Ingala S, van Schijndel RA, Machado VB, de Jong MC, Sanchez E, Purcell D, Arrighi MH, Brashear RH, Wattjes MP, Barkhof F.","Eur Radiol. 2018 Mar;28(3):1215-1226. doi: 10.1007/s00330-017-5022-6. Epub 2017 Sep 27.","Martens RM","Eur Radiol","2018","2017/09/29","PMC5811582","","10.1007/s00330-017-5022-6"
"9484404","Long-term tacrine treatment effects","Knopman D, Schneider L, Davis K, Gracon S, Smith F.","Neurology. 1998 Feb;50(2):567-8. doi: 10.1212/wnl.50.2.567.","Knopman D","Neurology","1998","1998/03/04","","","10.1212/wnl.50.2.567"
"29550981","Combining drug and music therapy in patients with moderate Alzheimer's disease: a randomized study","Giovagnoli AR, Manfredi V, Schifano L, Paterlini C, Parente A, Tagliavini F.","Neurol Sci. 2018 Jun;39(6):1021-1028. doi: 10.1007/s10072-018-3316-3. Epub 2018 Mar 17.","Giovagnoli AR","Neurol Sci","2018","2018/03/19","","","10.1007/s10072-018-3316-3"
"28007635","PHARMAID study protocol: Randomized controlled trial to assess the impact of integrated pharmaceutical care at a psychosocial intervention on caregiver's burden in Alzheimer's disease or related diseases","Novais T, Moutet C, Delphin-Combe F, Dauphinot V, Colin C, Krolak-Salmon P, Mouchoux C; PHARMAID study group.","Contemp Clin Trials. 2017 Feb;53:137-142. doi: 10.1016/j.cct.2016.12.020. Epub 2016 Dec 19.","Novais T","Contemp Clin Trials","2017","2016/12/24","","","10.1016/j.cct.2016.12.020"
"23562431","Results of a follow-up study to the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT)","Alzheimer's Disease Anti-inflammatory Prevention Trial Research Group.","Alzheimers Dement. 2013 Nov;9(6):714-23. doi: 10.1016/j.jalz.2012.11.012. Epub 2013 Apr 3.","Alzheimer's Disease Anti-inflammatory Prevention Trial Research Group","Alzheimers Dement","2013","2013/04/09","PMC3823756","NIHMS465776","10.1016/j.jalz.2012.11.012"
"25310993","A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeks","Bowen RL, Perry G, Xiong C, Smith MA, Atwood CS.","J Alzheimers Dis. 2015;44(2):549-60. doi: 10.3233/JAD-141626.","Bowen RL","J Alzheimers Dis","2015","2014/10/15","","","10.3233/JAD-141626"
"34145880","Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease","Matthews DC, Mao X, Dowd K, Tsakanikas D, Jiang CS, Meuser C, Andrews RD, Lukic AS, Lee J, Hampilos N, Shafiian N, Sano M, David Mozley P, Fillit H, McEwen BS, Shungu DC, Pereira AC.","Brain. 2021 Dec 31;144(12):3742-3755. doi: 10.1093/brain/awab222.","Matthews DC","Brain","2021","2021/06/19","PMC8719848","","10.1093/brain/awab222"
"21143943","The fitness for the Ageing Brain Study II (FABS II): protocol for a randomized controlled clinical trial evaluating the effect of physical activity on cognitive function in patients with Alzheimer's disease","Cyarto EV, Cox KL, Almeida OP, Flicker L, Ames D, Byrne G, Hill KD, Beer CD, LoGiudice D, Appadurai K, Irish M, Renehan E, Lautenschlager NT.","Trials. 2010 Dec 10;11:120. doi: 10.1186/1745-6215-11-120.","Cyarto EV","Trials","2010","2010/12/15","PMC3016362","","10.1186/1745-6215-11-120"
"9745240","The rate of progression of Alzheimer's disease in the later stages: evidence from the Severe Impairment Battery","Wild KV, Kaye JA.","J Int Neuropsychol Soc. 1998 Sep;4(5):512-6. doi: 10.1017/s1355617798005104.","Wild KV","J Int Neuropsychol Soc","1998","1998/09/24","","","10.1017/s1355617798005104"
"3548443","Failure of nalmefene and estrogen to improve memory in Alzheimer's disease","Weiss BL.","Am J Psychiatry. 1987 Mar;144(3):386-7. doi: 10.1176/ajp.144.3.aj1443386.","Weiss BL","Am J Psychiatry","1987","1987/03/01","","","10.1176/ajp.144.3.aj1443386"
"25688081","Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β","Cohen ML, Kim C, Haldiman T, ElHag M, Mehndiratta P, Pichet T, Lissemore F, Shea M, Cohen Y, Chen W, Blevins J, Appleby BS, Surewicz K, Surewicz WK, Sajatovic M, Tatsuoka C, Zhang S, Mayo P, Butkiewicz M, Haines JL, Lerner AJ, Safar JG.","Brain. 2015 Apr;138(Pt 4):1009-22. doi: 10.1093/brain/awv006. Epub 2015 Feb 15.","Cohen ML","Brain","2015","2015/02/18","PMC5014074","","10.1093/brain/awv006"
"36199177","The effects of fenugreek seed extract supplementation in patients with Alzheimer's disease: A randomized, double-blind, placebo-controlled trial","Foroumandi E, Javan R, Moayed L, Fahimi H, Kheirabadi F, Neamatshahi M, Shogofteh F, Zarghi A.","Phytother Res. 2023 Jan;37(1):285-294. doi: 10.1002/ptr.7612. Epub 2022 Oct 5.","Foroumandi E","Phytother Res","2023","2022/10/06","","","10.1002/ptr.7612"
"15862926","Lactate infusion fails to improve semantic categorization in Alzheimer's disease","Kálmán J, Palotás A, Bódi N, Kincses TZ, Benedek G, Janka Z, Antal A.","Brain Res Bull. 2005 May 30;65(6):533-9. doi: 10.1016/j.brainresbull.2005.03.009. Epub 2005 Apr 7.","Kálmán J","Brain Res Bull","2005","2005/05/03","","","10.1016/j.brainresbull.2005.03.009"
"19548273","The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease","Rockwood K, Fay S, Gorman M.","Int J Geriatr Psychiatry. 2010 Feb;25(2):191-201. doi: 10.1002/gps.2319.","Rockwood K","Int J Geriatr Psychiatry","2010","2009/06/24","","","10.1002/gps.2319"
"15942243","Matrix metalloproteinase-9, its tissue inhibitor(TIMP)-1 and CRP in Alzheimer's disease","Inspector M, Aharon-Perez J, Glass-Marmor L, Miller A.","Eur Neurol. 2005;53(3):155-7. doi: 10.1159/000086124. Epub 2004 May 28.","Inspector M","Eur Neurol","2005","2005/06/09","","","10.1159/000086124"
"1681391","Reduced adrenal gland acetylcholinesterase activity in Alzheimer's disease","Appleyard ME, McDonald B.","Lancet. 1991 Oct 26;338(8774):1085-6. doi: 10.1016/0140-6736(91)91947-s.","Appleyard ME","Lancet","1991","1991/10/26","","","10.1016/0140-6736(91)91947-s"
"2411246","Evaluation of zimeldine in Alzheimer's disease. Cognitive and biochemical measures","Cutler NR, Haxby J, Kay AD, Narang PK, Lesko LJ, Costa JL, Ninos M, Linnoila M, Potter WZ, Renfrew JW, et al.","Arch Neurol. 1985 Aug;42(8):744-8. doi: 10.1001/archneur.1985.04210090008003.","Cutler NR","Arch Neurol","1985","1985/08/01","","","10.1001/archneur.1985.04210090008003"
"21476613","Changes in nursing burden following memantine for agitation and aggression in long-term care residents with moderate to severe Alzheimer's disease: an open-label pilot study","Herrmann N, Cappell J, Eryavec GM, Lanctôt KL.","CNS Drugs. 2011 May;25(5):425-33. doi: 10.2165/11588160-000000000-00000.","Herrmann N","CNS Drugs","2011","2011/04/12","","","10.2165/11588160-000000000-00000"
"23212456","Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder","Jakobsson J, Zetterberg H, Blennow K, Johan Ekman C, Johansson AG, Landén M.","Neuropsychopharmacology. 2013 Mar;38(4):664-72. doi: 10.1038/npp.2012.231. Epub 2012 Nov 6.","Jakobsson J","Neuropsychopharmacology","2013","2012/12/06","PMC3572463","","10.1038/npp.2012.231"
"22406101","Preventing cognitive decline in older African Americans with mild cognitive impairment: design and methods of a randomized clinical trial","Rovner BW, Casten RJ, Hegel MT, Leiby BE.","Contemp Clin Trials. 2012 Jul;33(4):712-20. doi: 10.1016/j.cct.2012.02.016. Epub 2012 Mar 2.","Rovner BW","Contemp Clin Trials","2012","2012/03/13","PMC3361551","NIHMS361165","10.1016/j.cct.2012.02.016"
"9462474","The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease","Tapiola T, Overmyer M, Lehtovirta M, Helisalmi S, Ramberg J, Alafuzoff I, Riekkinen P Sr, Soininen H.","Neuroreport. 1997 Dec 22;8(18):3961-3. doi: 10.1097/00001756-199712220-00022.","Tapiola T","Neuroreport","1997","1998/02/14","","","10.1097/00001756-199712220-00022"
"31112788","Cholinergic and serotonergic modulation of resting state functional brain connectivity in Alzheimer's disease","Klaassens BL, van Gerven JMA, Klaassen ES, van der Grond J, Rombouts SARB.","Neuroimage. 2019 Oct 1;199:143-152. doi: 10.1016/j.neuroimage.2019.05.044. Epub 2019 May 18.","Klaassens BL","Neuroimage","2019","2019/05/22","","","10.1016/j.neuroimage.2019.05.044"
"9240483","Monitoring frequency of occurrence without awareness: evidence from patients with Alzheimer's disease","Wiggs CL, Martin A, Sunderland T.","J Clin Exp Neuropsychol. 1997 Apr;19(2):235-44. doi: 10.1080/01688639708403854.","Wiggs CL","J Clin Exp Neuropsychol","1997","1997/04/01","","","10.1080/01688639708403854"
"26200930","Physical Activity and Amyloid-β Brain Levels in Elderly Adults with Intact Cognition and Mild Cognitive Impairment","de Souto Barreto P, Andrieu S, Payoux P, Demougeot L, Rolland Y, Vellas B; Multidomain Alzheimer Preventive Trial/Data Sharing Alzheimer Study Group.","J Am Geriatr Soc. 2015 Aug;63(8):1634-9. doi: 10.1111/jgs.13530. Epub 2015 Jul 22.","de Souto Barreto P","J Am Geriatr Soc","2015","2015/07/23","","","10.1111/jgs.13530"
"1482095","Action of acetyl-L-carnitine in neurodegeneration and Alzheimer's disease","Calvani M, Carta A, Caruso G, Benedetti N, Iannuccelli M.","Ann N Y Acad Sci. 1992 Nov 21;663:483-6. doi: 10.1111/j.1749-6632.1992.tb38710.x.","Calvani M","Ann N Y Acad Sci","1992","1992/11/21","","","10.1111/j.1749-6632.1992.tb38710.x"
"16945213","Change in circulating C-reactive protein is not associated with atorvastatin treatment in Alzheimer's disease","Stankovic G, Sparks DL.","Neurol Res. 2006 Sep;28(6):621-4. doi: 10.1179/016164106X130452.","Stankovic G","Neurol Res","2006","2006/09/02","","","10.1179/016164106X130452"
"23714287","The UP-TECH project, an intervention to support caregivers of Alzheimer's disease patients in Italy: study protocol for a randomized controlled trial","Chiatti C, Masera F, Rimland JM, Cherubini A, Scarpino O, Spazzafumo L, Lattanzio F; UP-TECH research group.","Trials. 2013 May 28;14:155. doi: 10.1186/1745-6215-14-155.","Chiatti C","Trials","2013","2013/05/30","PMC3748825","","10.1186/1745-6215-14-155"
"18587525","Intake of copper has no effect on cognition in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial","Kessler H, Bayer TA, Bach D, Schneider-Axmann T, Supprian T, Herrmann W, Haber M, Multhaup G, Falkai P, Pajonk FG.","J Neural Transm (Vienna). 2008 Aug;115(8):1181-7. doi: 10.1007/s00702-008-0080-1. Epub 2008 Jun 28.","Kessler H","J Neural Transm (Vienna)","2008","2008/07/01","PMC2516533","","10.1007/s00702-008-0080-1"
"8422739","A predictor for side effects in patients with Alzheimer's disease treated with deferoxamine mesylate","Kruck TP, Fisher EA, McLachlan DR.","Clin Pharmacol Ther. 1993 Jan;53(1):30-7. doi: 10.1038/clpt.1993.6.","Kruck TP","Clin Pharmacol Ther","1993","1993/01/01","","","10.1038/clpt.1993.6"
"10576491","Impaired preconscious auditory processing and cognitive functions in Alzheimer's disease","Pekkonen E, Jääskeläinen IP, Hietanen M, Huotilainen M, Näätänen R, Ilmoniemi RJ, Erkinjuntti T.","Clin Neurophysiol. 1999 Nov;110(11):1942-7. doi: 10.1016/s1388-2457(99)00153-4.","Pekkonen E","Clin Neurophysiol","1999","1999/11/27","","","10.1016/s1388-2457(99)00153-4"
"22269160","Memantine and brain atrophy in Alzheimer's disease: a 1-year randomized controlled trial","Wilkinson D, Fox NC, Barkhof F, Phul R, Lemming O, Scheltens P.","J Alzheimers Dis. 2012;29(2):459-69. doi: 10.3233/JAD-2011-111616.","Wilkinson D","J Alzheimers Dis","2012","2012/01/25","","","10.3233/JAD-2011-111616"
"18573585","The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study","Chiu CC, Su KP, Cheng TC, Liu HC, Chang CJ, Dewey ME, Stewart R, Huang SY.","Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1538-44. doi: 10.1016/j.pnpbp.2008.05.015. Epub 2008 May 25.","Chiu CC","Prog Neuropsychopharmacol Biol Psychiatry","2008","2008/06/25","","","10.1016/j.pnpbp.2008.05.015"
"32301028","Effects of short- and long-term neurostimulation (tDCS) on Alzheimer's disease patients: two randomized studies","Gangemi A, Colombo B, Fabio RA.","Aging Clin Exp Res. 2021 Feb;33(2):383-390. doi: 10.1007/s40520-020-01546-8. Epub 2020 Apr 16.","Gangemi A","Aging Clin Exp Res","2021","2020/04/18","","","10.1007/s40520-020-01546-8"
"31387606","Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's disease","Egan MF, Mukai Y, Voss T, Kost J, Stone J, Furtek C, Mahoney E, Cummings JL, Tariot PN, Aisen PS, Vellas B, Lines C, Michelson D.","Alzheimers Res Ther. 2019 Aug 7;11(1):68. doi: 10.1186/s13195-019-0520-1.","Egan MF","Alzheimers Res Ther","2019","2019/08/08","PMC6685277","","10.1186/s13195-019-0520-1"
"16866904","Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial","Sparks DL, Connor DJ, Sabbagh MN, Petersen RB, Lopez J, Browne P.","Acta Neurol Scand Suppl. 2006;185:3-7. doi: 10.1111/j.1600-0404.2006.00690.x.","Sparks DL","Acta Neurol Scand Suppl","2006","2006/07/27","","","10.1111/j.1600-0404.2006.00690.x"
"20005225","An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels","Petzold A, Chapman MD, Schraen S, Verwey NA, Pasquier F, Bombois S, Brettschneider J, Fox NC, von Arnim CA, Teunissen C, Pijnenburg Y, Riepe MW, Otto M, Tumani H, Scheltens P, Buee L, Rossor MN.","Exp Neurol. 2010 Jun;223(2):432-8. doi: 10.1016/j.expneurol.2009.11.010. Epub 2009 Dec 11.","Petzold A","Exp Neurol","2010","2009/12/17","","","10.1016/j.expneurol.2009.11.010"
"24855313","The Effectiveness of a Culturally Sensitive Cognitive Behavioral Group Intervention for Latino Alzheimer's Caregivers","Gonyea JG, López LM, Velásquez EH.","Gerontologist. 2016 Apr;56(2):292-302. doi: 10.1093/geront/gnu045. Epub 2014 May 22.","Gonyea JG","Gerontologist","2016","2014/05/24","PMC4906638","","10.1093/geront/gnu045"
"26191966","Correlation Between Caregiver Reports of Physical Function and Performance-based Measures in a Cohort of Older Adults With Alzheimer Disease","Bernard BL, Bracey LE, Lane KA, Ferguson DY, LaMantia MA, Gao S, Miller DK, Callahan CM.","Alzheimer Dis Assoc Disord. 2016 Apr-Jun;30(2):169-74. doi: 10.1097/WAD.0000000000000101.","Bernard BL","Alzheimer Dis Assoc Disord","2016","2015/07/21","PMC4715794","NIHMS700544","10.1097/WAD.0000000000000101"
"24498184","Differences in prefrontal, limbic, and white matter lesion volumes according to cognitive status in elderly patients with first-onset subsyndromal depression","Lee JY, Park S, Mackin S, Ewers M, Chui H, Jagust W, Insel PS, Weiner MW.","PLoS One. 2014 Jan 31;9(1):e87747. doi: 10.1371/journal.pone.0087747. eCollection 2014.","Lee JY","PLoS One","2014","2014/02/06","PMC3909227","","10.1371/journal.pone.0087747"
"10447151","Burden of Alzheimer's disease: helping the patient and caregiver","Donaldson C, Burns A.","J Geriatr Psychiatry Neurol. 1999 Spring;12(1):21-8. doi: 10.1177/089198879901200106.","Donaldson C","J Geriatr Psychiatry Neurol","1999","1999/08/14","","","10.1177/089198879901200106"
"23314060","Plasma proteomics for the identification of Alzheimer disease","Guo LH, Alexopoulos P, Wagenpfeil S, Kurz A, Perneczky R; Alzheimer’s Disease Neuroimaging Initiative.","Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):337-42. doi: 10.1097/WAD.0b013e31827b60d2.","Guo LH","Alzheimer Dis Assoc Disord","2013","2013/01/15","PMC3626738","NIHMS424683","10.1097/WAD.0b013e31827b60d2"
"7760585","Brain mapping activity and mental performance after chronic treatment with CDP-choline in Alzheimer's disease","Franco-Maside A, Caamaño J, Gómez MJ, Cacabelos R.","Methods Find Exp Clin Pharmacol. 1994 Oct;16(8):597-607.","Franco-Maside A","Methods Find Exp Clin Pharmacol","1994","1994/10/01","","",""
"2403997","Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer's type: a double-blind placebo-controlled trial","Jenike MA, Albert MS, Heller H, Gunther J, Goff D.","J Clin Psychiatry. 1990 Jan;51(1):3-7.","Jenike MA","J Clin Psychiatry","1990","1990/01/01","","",""
"33467972","Multicenter randomized controlled trial of the effects of individual reminiscence therapy on cognition, depression and quality of life: Analysis of a sample of older adults with Alzheimer's disease and vascular dementia","Pérez-Sáez E, Justo-Henriques SI, Alves Apóstolo JL.","Clin Neuropsychol. 2022 Oct;36(7):1975-1996. doi: 10.1080/13854046.2021.1871962. Epub 2021 Jan 19.","Pérez-Sáez E","Clin Neuropsychol","2022","2021/01/20","","","10.1080/13854046.2021.1871962"
"9458995","Management of problematic behavioral symptoms associated with dementia: a cognitive developmental approach","Matteson MA, Linton AD, Cleary BL, Barnes SJ, Lichtenstein MJ.","Aging (Milano). 1997 Oct;9(5):342-55. doi: 10.1007/BF03339613.","Matteson MA","Aging (Milano)","1997","1998/02/12","","","10.1007/BF03339613"
"8684234","Long-term tacrine treatment in patients with Alzheimer's disease","Solomon PR, Knapp MJ, Gracon SI, Groccia M, Pendlebury WW.","Lancet. 1996 Jul 27;348(9022):275-6. doi: 10.1016/s0140-6736(05)65594-8.","Solomon PR","Lancet","1996","1996/07/27","","","10.1016/s0140-6736(05)65594-8"
"31122994","Effects of brain training on brain blood flow (The Cognition and Flow Study-CogFlowS): protocol for a feasibility randomised controlled trial of cognitive training in dementia","Beishon L, Evley R, Panerai RB, Subramaniam H, Mukaetova-Ladinska E, Robinson T, Haunton V.","BMJ Open. 2019 May 22;9(5):e027817. doi: 10.1136/bmjopen-2018-027817.","Beishon L","BMJ Open","2019","2019/05/25","PMC6538045","","10.1136/bmjopen-2018-027817"
"12165396","Red blood cell copper, zinc superoxide dismutase activity is higher in Alzheimer's disease and is decreased by D-penicillamine","Rossi L, Squitti R, Pasqualetti P, Marchese E, Cassetta E, Forastiere E, Rotilio G, Rossini PM, Finazzi-Agró A.","Neurosci Lett. 2002 Aug 30;329(2):137-40. doi: 10.1016/s0304-3940(02)00599-2.","Rossi L","Neurosci Lett","2002","2002/08/08","","","10.1016/s0304-3940(02)00599-2"
"17052048","Safety and efficacy of donepezil in African Americans with mild-to-moderate Alzheimer's disease","Griffith P, Lichtenberg P, Goldman R, Payne-Parrish J.","J Natl Med Assoc. 2006 Oct;98(10):1590-7.","Griffith P","J Natl Med Assoc","2006","2006/10/21","PMC2569765","",""
"1944900","Long-term acetyl-L-carnitine treatment in Alzheimer's disease","Spagnoli A, Lucca U, Menasce G, Bandera L, Cizza G, Forloni G, Tettamanti M, Frattura L, Tiraboschi P, Comelli M, et al.","Neurology. 1991 Nov;41(11):1726-32. doi: 10.1212/wnl.41.11.1726.","Spagnoli A","Neurology","1991","1991/11/01","","","10.1212/wnl.41.11.1726"
"11193166","Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's disease","Hock C, Maddalena A, Heuser I, Naber D, Oertel W, von der Kammer H, Wienrich M, Raschig A, Deng M, Growdon JH, Nitsch RM.","Ann N Y Acad Sci. 2000;920:285-91. doi: 10.1111/j.1749-6632.2000.tb06937.x.","Hock C","Ann N Y Acad Sci","2000","2001/02/24","","","10.1111/j.1749-6632.2000.tb06937.x"
"9065319","Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment","Nordberg A, Lundqvist H, Hartvig P, Andersson J, Johansson M, Hellstrŏm-Lindahi E, Långström B.","Dement Geriatr Cogn Disord. 1997 Mar-Apr;8(2):78-84. doi: 10.1159/000106611.","Nordberg A","Dement Geriatr Cogn Disord","1997","1997/03/01","","","10.1159/000106611"
"11583476","Pharmacokinetic-pharmacodynamic modeling of rivastigmine, a cholinesterase inhibitor, in patients with Alzheimer's disease","Gobburu JV, Tammara V, Lesko L, Jhee SS, Sramek JJ, Cutler NR, Yuan R.","J Clin Pharmacol. 2001 Oct;41(10):1082-90. doi: 10.1177/00912700122012689.","Gobburu JV","J Clin Pharmacol","2001","2001/10/05","","","10.1177/00912700122012689"
"23943781","Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunization","Zotova E, Bharambe V, Cheaveau M, Morgan W, Holmes C, Harris S, Neal JW, Love S, Nicoll JA, Boche D.","Brain. 2013 Sep;136(Pt 9):2677-96. doi: 10.1093/brain/awt210. Epub 2013 Aug 13.","Zotova E","Brain","2013","2013/08/15","","","10.1093/brain/awt210"
"29235507","Blood-Brain Glucose Transfer in Alzheimer's disease: Effect of GLP-1 Analog Treatment","Gejl M, Brock B, Egefjord L, Vang K, Rungby J, Gjedde A.","Sci Rep. 2017 Dec 13;7(1):17490. doi: 10.1038/s41598-017-17718-y.","Gejl M","Sci Rep","2017","2017/12/14","PMC5727512","","10.1038/s41598-017-17718-y"
"35357079","Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease","Brody M, Agronin M, Herskowitz BJ, Bookheimer SY, Small GW, Hitchinson B, Ramdas K, Wishard T, McInerney KF, Vellas B, Sierra F, Jiang Z, Mcclain-Moss L, Perez C, Fuquay A, Rodriguez S, Hare JM, Oliva AA Jr, Baumel B.","Alzheimers Dement. 2023 Jan;19(1):261-273. doi: 10.1002/alz.12651. Epub 2022 Mar 31.","Brody M","Alzheimers Dement","2023","2022/03/31","PMC10084163","","10.1002/alz.12651"
"9039618","Regional cerebral blood volume measured by dynamic susceptibility contrast MR imaging in Alzheimer's disease: a principal components analysis","Maas LC, Harris GJ, Satlin A, English CD, Lewis RF, Renshaw PF.","J Magn Reson Imaging. 1997 Jan-Feb;7(1):215-9. doi: 10.1002/jmri.1880070133.","Maas LC","J Magn Reson Imaging","1997","1997/01/01","","","10.1002/jmri.1880070133"
"7659198","EEG delta, positron emission tomography, and memory deficit in Alzheimer's disease","Valladares-Neto DC, Buchsbaum MS, Evans WJ, Nguyen D, Nguyen P, Siegel BV, Stanley J, Starr A, Guich S, Rice D.","Neuropsychobiology. 1995;31(4):173-81. doi: 10.1159/000119189.","Valladares-Neto DC","Neuropsychobiology","1995","1995/01/01","","","10.1159/000119189"
"30271133","Patient characteristics associated with screening positive for Alzheimer's disease and related dementia","Fowler NR, Perkins AJ, Gao S, Sachs GA, Uebelhor AK, Boustani MA.","Clin Interv Aging. 2018 Sep 17;13:1779-1785. doi: 10.2147/CIA.S164957. eCollection 2018.","Fowler NR","Clin Interv Aging","2018","2018/10/02","PMC6152607","","10.2147/CIA.S164957"
"12849769","Intentional and automatic measures of specific-category effect in the semantic impairment of patients with Alzheimer's disease","Perri R, Carlesimo GA, Zannino GD, Mauri M, Muolo B, Pettenati C, Caltagirone C.","Neuropsychologia. 2003;41(11):1509-22. doi: 10.1016/s0028-3932(03)00075-7.","Perri R","Neuropsychologia","2003","2003/07/10","","","10.1016/s0028-3932(03)00075-7"
"17135807","ADCS Prevention Instrument Project: development of a brief verbal memory test for primary prevention clinical trials","Salmon DP, Cummings JL, Jin S, Sano M, Sperling RA, Zamrini E, Petersen RC, Edland SD, Thal LJ, Ferris SH; Alzheimer's Disease Cooperative Study.","Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4 Suppl 3):S139-46. doi: 10.1097/01.wad.0000213871.40300.68.","Salmon DP","Alzheimer Dis Assoc Disord","2006","2006/12/01","","","10.1097/01.wad.0000213871.40300.68"
"7824142","An aspect of sentence processing in Alzheimer's disease: quantifier-noun agreement","Grossman M, Mickanin J, Onishi K, Hughes E.","Neurology. 1995 Jan;45(1):85-91. doi: 10.1212/wnl.45.1.85.","Grossman M","Neurology","1995","1995/01/01","","","10.1212/wnl.45.1.85"
"18274807","Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression","Ridha BH, Anderson VM, Barnes J, Boyes RG, Price SL, Rossor MN, Whitwell JL, Jenkins L, Black RS, Grundman M, Fox NC.","J Neurol. 2008 Apr;255(4):567-74. doi: 10.1007/s00415-008-0750-9. Epub 2008 Feb 18.","Ridha BH","J Neurol","2008","2008/02/16","","","10.1007/s00415-008-0750-9"
"7814348","Behavioral effects of trazodone in Alzheimer's disease","Lebert F, Pasquier F, Petit H.","J Clin Psychiatry. 1994 Dec;55(12):536-8.","Lebert F","J Clin Psychiatry","1994","1994/12/01","","",""
"15118358","Quetiapine treatment for behavioral and psychological symptoms in patients with senile dementia of Alzheimer type","Fujikawa T, Takahashi T, Kinoshita A, Kajiyama H, Kurata A, Yamashita H, Yamawaki S.","Neuropsychobiology. 2004;49(4):201-4. doi: 10.1159/000077367.","Fujikawa T","Neuropsychobiology","2004","2004/05/01","","","10.1159/000077367"
"15129697","Heterogeneity of cerebral blood flow in frontotemporal lobar degeneration and Alzheimer's disease","Nagao M, Sugawara Y, Ikeda M, Fukuhara R, Hokoishi K, Murase K, Mochizuki T, Miki H, Kikuchi T.","Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):162-8. doi: 10.1007/s00259-003-1343-6.","Nagao M","Eur J Nucl Med Mol Imaging","2004","2004/05/08","","","10.1007/s00259-003-1343-6"
"16449754","Beneficial effect of cholinesterase inhibitor medications on recognition memory performance in mild to moderate Alzheimer's disease: preliminary findings","Crowell TA, Paramadevan J, Abdullah L, Mullan M.","J Geriatr Psychiatry Neurol. 2006 Mar;19(1):13-5. doi: 10.1177/0891988705284711.","Crowell TA","J Geriatr Psychiatry Neurol","2006","2006/02/02","","","10.1177/0891988705284711"
"22903151","A community-based approach to trials of aerobic exercise in aging and Alzheimer's disease","Vidoni ED, Van Sciver A, Johnson DK, He J, Honea R, Haines B, Goodwin J, Laubinger MP, Anderson HS, Kluding PM, Donnelly JE, Billinger SA, Burns JM.","Contemp Clin Trials. 2012 Nov;33(6):1105-16. doi: 10.1016/j.cct.2012.08.002. Epub 2012 Aug 7.","Vidoni ED","Contemp Clin Trials","2012","2012/08/21","PMC3468654","NIHMS403995","10.1016/j.cct.2012.08.002"
"30636738","Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease","Frölich L, Atri A, Ballard C, Tariot PN, Molinuevo JL, Boneva N, Geist MA, Raket LL, Cummings JL.","J Alzheimers Dis. 2019;67(1):303-313. doi: 10.3233/JAD-180595.","Frölich L","J Alzheimers Dis","2019","2019/01/15","","","10.3233/JAD-180595"
"35922871","Inflammatory plasma biomarkers in subjects with preclinical Alzheimer's disease","Prins S, de Kam ML, Teunissen CE, Groeneveld GJ.","Alzheimers Res Ther. 2022 Aug 3;14(1):106. doi: 10.1186/s13195-022-01051-2.","Prins S","Alzheimers Res Ther","2022","2022/08/03","PMC9347121","","10.1186/s13195-022-01051-2"
"10793322","Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study","Rogers SL, Doody RS, Pratt RD, Ieni JR.","Eur Neuropsychopharmacol. 2000 May;10(3):195-203. doi: 10.1016/s0924-977x(00)00067-5.","Rogers SL","Eur Neuropsychopharmacol","2000","2000/05/04","","","10.1016/s0924-977x(00)00067-5"
"26420886","IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia","Kile S, Au W, Parise C, Rose K, Donnel T, Hankins A, Chan M, Ghassemi A.","J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):106-112. doi: 10.1136/jnnp-2015-311486. Epub 2015 Sep 29.","Kile S","J Neurol Neurosurg Psychiatry","2017","2015/10/01","","","10.1136/jnnp-2015-311486"
"1288668","A strategy of ""combination chemotherapy"" in Alzheimer's disease: rationale and preliminary results with physostigmine plus deprenyl","Sunderland T, Molchan S, Lawlor B, Martinez R, Mellow A, Martinson H, Putnam K, Lalonde F.","Int Psychogeriatr. 1992;4 Suppl 2:291-309.","Sunderland T","Int Psychogeriatr","1992","1992/01/01","","",""
"26515660","Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses","Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Jones R, Jones R, McKeith I, Macharouthu A, O'Brien J, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown RG, Banerjee S, Adams J, Johnson T, Bentham P, Phillips PP.","Lancet Neurol. 2015 Dec;14(12):1171-81. doi: 10.1016/S1474-4422(15)00258-6. Epub 2015 Oct 27.","Howard R","Lancet Neurol","2015","2015/10/31","","","10.1016/S1474-4422(15)00258-6"
"26213579","Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease","Rijpma A, Meulenbroek O, van Hees AM, Sijben JW, Vellas B, Shah RC, Bennett DA, Scheltens P, Olde Rikkert MG.","Alzheimers Res Ther. 2015 Jul 24;7(1):51. doi: 10.1186/s13195-015-0134-1. eCollection 2015.","Rijpma A","Alzheimers Res Ther","2015","2015/07/28","PMC4513634","","10.1186/s13195-015-0134-1"
"21471647","Sustained effects of once-daily memantine treatment on cognition and functional communication skills in patients with moderate to severe Alzheimer's disease: results of a 16-week open-label trial","Schulz JB, Rainer M, Klünemann HH, Kurz A, Wolf S, Sternberg K, Tennigkeit F.","J Alzheimers Dis. 2011;25(3):463-75. doi: 10.3233/JAD-2011-101929.","Schulz JB","J Alzheimers Dis","2011","2011/04/08","","","10.3233/JAD-2011-101929"
"15209643","Galantamine maintains ability to perform activities of daily living in patients with Alzheimer's disease","Galasko D, Kershaw PR, Schneider L, Zhu Y, Tariot PN.","J Am Geriatr Soc. 2004 Jul;52(7):1070-6. doi: 10.1111/j.1532-5415.2004.52303.x.","Galasko D","J Am Geriatr Soc","2004","2004/06/24","","","10.1111/j.1532-5415.2004.52303.x"
"14579086","Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease","Encinas M, De Juan R, Marcos A, Gil P, Barabash A, Fernández C, De Ugarte C, Cabranes JA.","Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1473-80. doi: 10.1007/s00259-003-1277-z. Epub 2003 Aug 15.","Encinas M","Eur J Nucl Med Mol Imaging","2003","2003/10/28","","","10.1007/s00259-003-1277-z"
"26402011","Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer's Disease: A Randomized Phase 2 Study","Gauthier S, Rountree S, Finn B, LaPlante B, Weber E, Oltersdorf T.","J Alzheimers Dis. 2015;48(2):473-81. doi: 10.3233/JAD-150414.","Gauthier S","J Alzheimers Dis","2015","2015/09/25","","","10.3233/JAD-150414"
"23422370","Donepezil treatment stabilizes functional connectivity during resting state and brain activity during memory encoding in Alzheimer's disease","Solé-Padullés C, Bartrés-Faz D, Lladó A, Bosch B, Peña-Gómez C, Castellví M, Rami L, Bargalló N, Sánchez-Valle R, Molinuevo JL.","J Clin Psychopharmacol. 2013 Apr;33(2):199-205. doi: 10.1097/JCP.0b013e3182825bfd.","Solé-Padullés C","J Clin Psychopharmacol","2013","2013/02/21","","","10.1097/JCP.0b013e3182825bfd"
"16519265","Executive function asymmetry in older adults genetically at-risk for Alzheimer's disease: verbal versus design fluency","Houston WS, Delis DC, Lansing A, Jacobson MW, Cobell KR, Salmon DP, Bondi MW.","J Int Neuropsychol Soc. 2005 Nov;11(7):863-70. doi: 10.1017/s1355617705051015.","Houston WS","J Int Neuropsychol Soc","2005","2006/03/08","","","10.1017/s1355617705051015"
"10559568","Behavioral and psychological symptoms in Alzheimer's disease. Relation between apathy and regional cerebral perfusion","Benoit M, Dygai I, Migneco O, Robert PH, Bertogliati C, Darcourt J, Benoliel J, Aubin-Brunet V, Pringuey D.","Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):511-7. doi: 10.1159/000017198.","Benoit M","Dement Geriatr Cogn Disord","1999","1999/11/24","","","10.1159/000017198"
"33581283","Cortical plasticity is correlated with cognitive improvement in Alzheimer's disease patients after rTMS treatment","Li X, Qi G, Yu C, Lian G, Zheng H, Wu S, Yuan TF, Zhou D.","Brain Stimul. 2021 May-Jun;14(3):503-510. doi: 10.1016/j.brs.2021.01.012. Epub 2021 Feb 11.","Li X","Brain Stimul","2021","2021/02/13","","","10.1016/j.brs.2021.01.012"
"15273830","Effects of galantamine on attention and memory in Alzheimer's disease measured by computerized neuropsychological tests: results of the Brazilian Multi-Center Galantamine Study (GAL-BRA-01)","Caramelli P, Chaves ML, Engelhardt E, Machado JC, Schultz RR, Vale FA, Charchat-Fichman H; Brazilian Multi-Center Galantamine Study (GAL-BRA-01).","Arq Neuropsiquiatr. 2004 Jun;62(2B):379-84. doi: 10.1590/s0004-282x2004000300001. Epub 2004 Jul 20.","Caramelli P","Arq Neuropsiquiatr","2004","2004/07/27","","","10.1590/s0004-282x2004000300001"
"7654110","Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group","Antuono PG.","Arch Intern Med. 1995 Sep 11;155(16):1766-72.","Antuono PG","Arch Intern Med","1995","1995/09/11","","",""
"19149844","Emotional therapy for patients with dementia","Hirazakura A, Hatakeyama R, Fukuoka Y, Satoh A, Kobayashi K, Fujii M, Sasaki H.","Geriatr Gerontol Int. 2008 Dec;8(4):303-6. doi: 10.1111/j.1447-0594.2008.00486.x.","Hirazakura A","Geriatr Gerontol Int","2008","2009/01/20","","","10.1111/j.1447-0594.2008.00486.x"
"15883258","Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study","Mega MS, Dinov ID, Porter V, Chow G, Reback E, Davoodi P, O'Connor SM, Carter MF, Amezcua H, Cummings JL.","Arch Neurol. 2005 May;62(5):721-8. doi: 10.1001/archneur.62.5.721.","Mega MS","Arch Neurol","2005","2005/05/11","","","10.1001/archneur.62.5.721"
"17287448","Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment","Fleisher AS, Sowell BB, Taylor C, Gamst AC, Petersen RC, Thal LJ; Alzheimer's Disease Cooperative Study.","Neurology. 2007 May 8;68(19):1588-95. doi: 10.1212/01.wnl.0000258542.58725.4c. Epub 2007 Feb 7.","Fleisher AS","Neurology","2007","2007/02/09","","","10.1212/01.wnl.0000258542.58725.4c"
"15505371","Apolipoprotein E genotyping: accurate, simple, high throughput method using ABI Prism SNaPshot Multiplex System","Ben-Avi L, Durst R, Shpitzen S, Leitersdorf E, Meiner V.","J Alzheimers Dis. 2004 Oct;6(5):497-501. doi: 10.3233/jad-2004-6506.","Ben-Avi L","J Alzheimers Dis","2004","2004/10/27","","","10.3233/jad-2004-6506"
"21845596","A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease","Devanand DP, Pelton GH, Cunqueiro K, Sackeim HA, Marder K.","Int J Geriatr Psychiatry. 2011 Sep;26(9):937-43. doi: 10.1002/gps.2630. Epub 2010 Dec 28.","Devanand DP","Int J Geriatr Psychiatry","2011","2011/08/17","PMC3685500","NIHMS475451","10.1002/gps.2630"
"12391340","Assessment of low-flow CSF drainage as a treatment for AD: results of a randomized pilot study","Silverberg GD, Levinthal E, Sullivan EV, Bloch DA, Chang SD, Leverenz J, Flitman S, Winn R, Marciano F, Saul T, Huhn S, Mayo M, McGuire D.","Neurology. 2002 Oct 22;59(8):1139-45. doi: 10.1212/01.wnl.0000031794.42077.a1.","Silverberg GD","Neurology","2002","2002/10/23","","","10.1212/01.wnl.0000031794.42077.a1"
"1776751","Effect of citalopram, a selective 5-HT reuptake blocker, in emotionally disturbed patients with dementia","Gottfries CG, Nyth AL.","Ann N Y Acad Sci. 1991;640:276-9. doi: 10.1111/j.1749-6632.1991.tb00233.x.","Gottfries CG","Ann N Y Acad Sci","1991","1991/01/01","","","10.1111/j.1749-6632.1991.tb00233.x"
"16323385","Cognitive rehabilitation combined with drug treatment in Alzheimer's disease patients: a pilot study","Bottino CM, Carvalho IA, Alvarez AM, Avila R, Zukauskas PR, Bustamante SE, Andrade FC, Hototian SR, Saffi F, Câmargo CH.","Clin Rehabil. 2005 Dec;19(8):861-9. doi: 10.1191/0269215505cr911oa.","Bottino CM","Clin Rehabil","2005","2005/12/06","","","10.1191/0269215505cr911oa"
"24805971","Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials?","Cary MS, Rubright JD, Grill JD, Karlawish J.","Alzheimer Dis Assoc Disord. 2015 Jan-Mar;29(1):70-4. doi: 10.1097/WAD.0000000000000047.","Cary MS","Alzheimer Dis Assoc Disord","2015","2014/05/09","PMC4223007","NIHMS581578","10.1097/WAD.0000000000000047"
"9110909","A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study","Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ.","N Engl J Med. 1997 Apr 24;336(17):1216-22. doi: 10.1056/NEJM199704243361704.","Sano M","N Engl J Med","1997","1997/04/24","","","10.1056/NEJM199704243361704"
"28533045","[Evaluation of the animal-assisted therapy in Alzheimer's disease]","Quibel C, Bonin M, Bonnet M, Gaimard M, Mourey F, Moesch I, Ancet P.","Soins Gerontol. 2017 May-Jun;22(125):35-38. doi: 10.1016/j.sger.2017.03.008.","Quibel C","Soins Gerontol","2017","2017/05/24","","","10.1016/j.sger.2017.03.008"
"27080585","Methylation analysis of DNA repair genes in Alzheimer's disease","Coppedè F, Tannorella P, Stoccoro A, Chico L, Siciliano G, Bonuccelli U, Migliore L.","Mech Ageing Dev. 2017 Jan;161(Pt A):105-111. doi: 10.1016/j.mad.2016.04.003. Epub 2016 Apr 11.","Coppedè F","Mech Ageing Dev","2017","2016/04/16","","","10.1016/j.mad.2016.04.003"
"9339268","The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease","Bodick NC, Offen WW, Shannon HE, Satterwhite J, Lucas R, van Lier R, Paul SM.","Alzheimer Dis Assoc Disord. 1997;11 Suppl 4:S16-22.","Bodick NC","Alzheimer Dis Assoc Disord","1997","1997/01/01","","",""
"12480080","Cholinesterase inhibitor rivastigmine enhance the mitochondrial electron transport chain in lymphocytes of patients with Alzheimer's disease","Casademont J, Miró O, Rodriguez-Santiago B, Viedma P, Blesa R, Cardellach F.","J Neurol Sci. 2003 Jan 15;206(1):23-6. doi: 10.1016/s0022-510x(02)00319-2.","Casademont J","J Neurol Sci","2003","2002/12/14","","","10.1016/s0022-510x(02)00319-2"
"23076723","Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: a randomized, double-blind study","Rabey JM, Dobronevsky E, Aichenbaum S, Gonen O, Marton RG, Khaigrekht M.","J Neural Transm (Vienna). 2013 May;120(5):813-9. doi: 10.1007/s00702-012-0902-z. Epub 2012 Oct 18.","Rabey JM","J Neural Transm (Vienna)","2013","2012/10/19","","","10.1007/s00702-012-0902-z"
"17118098","Peripheral electrical nerve stimulation and rest-activity rhythm in Alzheimer's disease","Van Dijk KR, Luijpen MW, Van Someren EJ, Sergeant JA, Scheltens P, Scherder EJ.","J Sleep Res. 2006 Dec;15(4):415-23. doi: 10.1111/j.1365-2869.2006.00548.x.","Van Dijk KR","J Sleep Res","2006","2006/11/23","","","10.1111/j.1365-2869.2006.00548.x"
"15249277","Cognitive rehabilitation of mildly impaired Alzheimer disease patients on cholinesterase inhibitors","Loewenstein DA, Acevedo A, Czaja SJ, Duara R.","Am J Geriatr Psychiatry. 2004 Jul-Aug;12(4):395-402. doi: 10.1176/appi.ajgp.12.4.395.","Loewenstein DA","Am J Geriatr Psychiatry","2004","2004/07/14","","","10.1176/appi.ajgp.12.4.395"
"9236953","The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study","Schmitt FA, Ashford W, Ernesto C, Saxton J, Schneider LS, Clark CM, Ferris SH, Mackell JA, Schafer K, Thal LJ.","Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S51-6.","Schmitt FA","Alzheimer Dis Assoc Disord","1997","1997/01/01","","",""
"15259396","Encoding and retrieval in aging and memory loss, a fMRI study","Mandzia J, Black S, Grady C, McAndrews MP, Graham S.","Brain Cogn. 2002 Jul;49(2):225-8.","Mandzia J","Brain Cogn","2002","2004/07/21","","",""
"7890817","Effectiveness of self-generated cues in early Alzheimer's disease","Lipinska B, Bäckman L, Mäntylä T, Viitanen M.","J Clin Exp Neuropsychol. 1994 Dec;16(6):809-19. doi: 10.1080/01688639408402695.","Lipinska B","J Clin Exp Neuropsychol","1994","1994/12/01","","","10.1080/01688639408402695"
"36530084","Rationale and Design of the PARTNER Trial: Partnered Rhythmic Rehabilitation for Enhanced Motor-Cognition in Prodromal Alzheimer's Disease","Cao K, Bay AA, Hajjar I, Wharton W, Goldstein F, Qiu D, Prusin T, McKay JL, Perkins MM, Hackney ME.","J Alzheimers Dis. 2023;91(3):1019-1033. doi: 10.3233/JAD-220783.","Cao K","J Alzheimers Dis","2023","2022/12/19","PMC10105523","NIHMS1890166","10.3233/JAD-220783"
"9017531","Correlations between SPECT regional cerebral blood flow and psychometric testing in patients with Alzheimer's disease","Sabbagh MN, Lynn P, Jhingran S, Massman P, Villanueva-Meyer J, Olup J, Doody RS.","J Neuropsychiatry Clin Neurosci. 1997 Winter;9(1):68-74. doi: 10.1176/jnp.9.1.68.","Sabbagh MN","J Neuropsychiatry Clin Neurosci","1997","1997/01/01","","","10.1176/jnp.9.1.68"
"8872417","An enriched-population, double-blind, placebo-controlled, crossover study of tacrine and lecithin in Alzheimer's disease. The Tacrine 970-6 Study Group","Foster NL, Petersen RC, Gracon SI, Lewis K.","Dementia. 1996 Sep-Oct;7(5):260-6. doi: 10.1159/000106890.","Foster NL","Dementia","1996","1996/09/01","","","10.1159/000106890"
"36600109","Characterization of exposure-Clinical Dementia Rating-Sum of Boxes relationship in subjects with early Alzheimer's disease from the aducanumab Phase 3 trials","Muralidharan KK, Kowalski KG, Tong X, Haeberlein SB, Rajagovindan R, Nestorov I.","J Pharmacokinet Pharmacodyn. 2023 Feb;50(1):45-62. doi: 10.1007/s10928-022-09839-3. Epub 2023 Jan 4.","Muralidharan KK","J Pharmacokinet Pharmacodyn","2023","2023/01/04","","","10.1007/s10928-022-09839-3"
"7629473","Alzheimer's disease and the relationship between silicon and aluminium in water supplies in northern England","Taylor GA, Newens AJ, Edwardson JA, Kay DW, Forster DP.","J Epidemiol Community Health. 1995 Jun;49(3):323-4. doi: 10.1136/jech.49.3.323.","Taylor GA","J Epidemiol Community Health","1995","1995/06/01","PMC1060807","","10.1136/jech.49.3.323"
"1630720","Acetyl-carnitine and Alzheimer's disease","Bowman BA.","Nutr Rev. 1992 May;50(5):142-4. doi: 10.1111/j.1753-4887.1992.tb01306.x.","Bowman BA","Nutr Rev","1992","1992/05/01","","","10.1111/j.1753-4887.1992.tb01306.x"
"9460090","A new MRI ratio method for in-vivo estimation of signal hypointensity in aging and Alzheimer's disease","Parsey RV, Krishnan KR.","Prog Neuropsychopharmacol Biol Psychiatry. 1997 Nov;21(8):1257-67. doi: 10.1016/s0278-5846(97)00162-0.","Parsey RV","Prog Neuropsychopharmacol Biol Psychiatry","1997","1998/02/14","","","10.1016/s0278-5846(97)00162-0"
"7923916","Decreased sensitivity to dexamethasone in lymphocytes from patients with Alzheimer's disease","Nijhuis E, Hinloopen B, van Duijn C, Hofman A, Rozing J, Nagelkerken L.","Clin Immunol Immunopathol. 1994 Oct;73(1):45-52. doi: 10.1006/clin.1994.1168.","Nijhuis E","Clin Immunol Immunopathol","1994","1994/10/01","","","10.1006/clin.1994.1168"
"27911295","Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial","Boada M, Anaya F, Ortiz P, Olazarán J, Shua-Haim JR, Obisesan TO, Hernández I, Muñoz J, Buendia M, Alegret M, Lafuente A, Tárraga L, Núñez L, Torres M, Grifols JR, Ferrer I, Lopez OL, Páez A.","J Alzheimers Dis. 2017;56(1):129-143. doi: 10.3233/JAD-160565.","Boada M","J Alzheimers Dis","2017","2016/12/03","PMC5240541","","10.3233/JAD-160565"
"9119421","Histopathological & immunohistochemical evaluation of ageing changes in normal human brain","Yasha TC, Shankar L, Santosh V, Das S, Shankar SK.","Indian J Med Res. 1997 Mar;105:141-50.","Yasha TC","Indian J Med Res","1997","1997/03/01","","",""
"11884657","Impaired recognition of facial expressions of emotion in Alzheimer's disease","Hargrave R, Maddock RJ, Stone V.","J Neuropsychiatry Clin Neurosci. 2002 Winter;14(1):64-71. doi: 10.1176/jnp.14.1.64.","Hargrave R","J Neuropsychiatry Clin Neurosci","2002","2002/03/09","","","10.1176/jnp.14.1.64"
"30944040","Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)","Femminella GD, Frangou E, Love SB, Busza G, Holmes C, Ritchie C, Lawrence R, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood BR, Prasanna A, Koranteng P, Karim S, Junaid K, McGuinness B, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Harrison J, Hölscher C, Brooks DJ, Passmore AP, Ballard C, Edison P.","Trials. 2019 Apr 3;20(1):191. doi: 10.1186/s13063-019-3259-x.","Femminella GD","Trials","2019","2019/04/05","PMC6448216","","10.1186/s13063-019-3259-x"
"11495397","A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer's disease","Petracca GM, Chemerinski E, Starkstein SE.","Int Psychogeriatr. 2001 Jun;13(2):233-40. doi: 10.1017/s104161020100761x.","Petracca GM","Int Psychogeriatr","2001","2001/08/10","","","10.1017/s104161020100761x"
"25284993","Feasibility and efficacy of cognitive telerehabilitation in early Alzheimer's disease: a pilot study","Jelcic N, Agostini M, Meneghello F, Bussè C, Parise S, Galano A, Tonin P, Dam M, Cagnin A.","Clin Interv Aging. 2014 Sep 24;9:1605-11. doi: 10.2147/CIA.S68145. eCollection 2014.","Jelcic N","Clin Interv Aging","2014","2014/10/07","PMC4181448","","10.2147/CIA.S68145"
"33049114","Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease","Wessels AM, Lines C, Stern RA, Kost J, Voss T, Mozley LH, Furtek C, Mukai Y, Aisen PS, Cummings JL, Tariot PN, Vellas B, Dupre N, Randolph C, Michelson D, Andersen SW, Shering C, Sims JR, Egan MF.","Alzheimers Dement. 2020 Nov;16(11):1483-1492. doi: 10.1002/alz.12164. Epub 2020 Oct 13.","Wessels AM","Alzheimers Dement","2020","2020/10/13","","","10.1002/alz.12164"
"19715552","Assessing the relationship between health utilities, quality of life, and health care costs in Alzheimer's disease: the CATIE-AD study","Miller EA, Rosenheck RA, Schneider LS.","Curr Alzheimer Res. 2010 Jun;7(4):348-57. doi: 10.2174/156720510791162386.","Miller EA","Curr Alzheimer Res","2010","2009/09/01","","","10.2174/156720510791162386"
"15937702","Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer's disease","Höglund K, Syversen S, Lewczuk P, Wallin A, Wiltfang J, Blennow K.","Exp Brain Res. 2005 Jul;164(2):205-14. doi: 10.1007/s00221-005-2243-8. Epub 2005 Jun 4.","Höglund K","Exp Brain Res","2005","2005/06/07","","","10.1007/s00221-005-2243-8"
"19450614","Visual processing in Alzheimer's disease: surface detail and colour fail to aid object identification","Adlington RL, Laws KR, Gale TM.","Neuropsychologia. 2009 Oct;47(12):2574-83. doi: 10.1016/j.neuropsychologia.2009.05.004. Epub 2009 May 18.","Adlington RL","Neuropsychologia","2009","2009/05/20","","","10.1016/j.neuropsychologia.2009.05.004"
"7991118","The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease","Knopman DS, Knapp MJ, Gracon SI, Davis CS.","Neurology. 1994 Dec;44(12):2315-21. doi: 10.1212/wnl.44.12.2315.","Knopman DS","Neurology","1994","1994/12/01","","","10.1212/wnl.44.12.2315"
"9236955","Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study","Mackell JA, Ferris SH, Mohs R, Schneider L, Galasko D, Whitehouse P, Schmitt F, Sano M, Thal LJ.","Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S65-9.","Mackell JA","Alzheimer Dis Assoc Disord","1997","1997/01/01","","",""
"15477567","Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression","Ohrui T, Tomita N, Sato-Nakagawa T, Matsui T, Maruyama M, Niwa K, Arai H, Sasaki H.","Neurology. 2004 Oct 12;63(7):1324-5. doi: 10.1212/01.wnl.0000140705.23869.e9.","Ohrui T","Neurology","2004","2004/10/13","","","10.1212/01.wnl.0000140705.23869.e9"
"29635383","Attention Measures of Accuracy, Variability, and Fatigue Detect Early Response to Donepezil in Alzheimer's Disease: A Randomized, Double-blind, Placebo-Controlled Pilot Trial","Vila-Castelar C, Ly JJ, Kaplan L, Van Dyk K, Berger JT, Macina LO, Stewart JL, Foldi NS.","Arch Clin Neuropsychol. 2019 May 1;34(3):277-289. doi: 10.1093/arclin/acy032.","Vila-Castelar C","Arch Clin Neuropsychol","2019","2018/04/11","PMC6487534","","10.1093/arclin/acy032"
"28419192","Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial","Xiao S, Wang T, Ma X, Qin Y, Li X, Zhao Z, Liu X, Wang X, Xie H, Jiang Q, Sun L, Luo B, Shang L, Chen W, Bai Y, Tang M, He M, Wu L, Ma Q, Hou D, He J.","Age Ageing. 2017 Sep 1;46(5):767-773. doi: 10.1093/ageing/afx045.","Xiao S","Age Ageing","2017","2017/04/19","","","10.1093/ageing/afx045"
"31587995","Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial","Ehrhardt S, Porsteinsson AP, Munro CA, Rosenberg PB, Pollock BG, Devanand DP, Mintzer J, Rajji TK, Ismail Z, Schneider LS, Baksh SN, Drye LT, Avramopoulos D, Shade DM, Lyketsos CG; S-CitAD Research Group.","Alzheimers Dement. 2019 Nov;15(11):1427-1436. doi: 10.1016/j.jalz.2019.06.4946. Epub 2019 Oct 3.","Ehrhardt S","Alzheimers Dement","2019","2019/10/08","PMC6889953","NIHMS1533876","10.1016/j.jalz.2019.06.4946"
"7870908","Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB","Sahakian BJ, Owen AM, Morant NJ, Eagger SA, Boddington S, Crayton L, Crockford HA, Crooks M, Hill K, Levy R.","Psychopharmacology (Berl). 1993;110(4):395-401. doi: 10.1007/BF02244644.","Sahakian BJ","Psychopharmacology (Berl)","1993","1993/01/01","","","10.1007/BF02244644"
"10389597","Neuropsychological assessment of older adults with Down's syndrome: an epidemiological study using the Cambridge Cognitive Examination (CAMCOG)","Hon J, Huppert FA, Holland AJ, Watson P.","Br J Clin Psychol. 1999 Jun;38(2):155-65. doi: 10.1348/014466599162719.","Hon J","Br J Clin Psychol","1999","1999/07/02","","","10.1348/014466599162719"
"32568367","Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial","Craft S, Raman R, Chow TW, Rafii MS, Sun CK, Rissman RA, Donohue MC, Brewer JB, Jenkins C, Harless K, Gessert D, Aisen PS.","JAMA Neurol. 2020 Sep 1;77(9):1099-1109. doi: 10.1001/jamaneurol.2020.1840.","Craft S","JAMA Neurol","2020","2020/06/23","PMC7309571","","10.1001/jamaneurol.2020.1840"
"24156269","The prediction of response to galantamine treatment in patients with mild to moderate Alzheimer's disease","Ohnishi T, Sakiyama Y, Okuri Y, Kimura Y, Sugiyama N, Saito T, Takahashi M, Kobayashi T.","Curr Alzheimer Res. 2014 Feb;11(2):110-8. doi: 10.2174/15672050113106660167.","Ohnishi T","Curr Alzheimer Res","2014","2013/10/26","PMC3979115","","10.2174/15672050113106660167"
"16273995","Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study","Koontz J, Baskys A.","Am J Alzheimers Dis Other Demen. 2005 Sep-Oct;20(5):295-302. doi: 10.1177/153331750502000502.","Koontz J","Am J Alzheimers Dis Other Demen","2005","2005/11/09","","","10.1177/153331750502000502"
"25414047","Positive effects of soy lecithin-derived phosphatidylserine plus phosphatidic acid on memory, cognition, daily functioning, and mood in elderly patients with Alzheimer's disease and dementia","Moré MI, Freitas U, Rutenberg D.","Adv Ther. 2014 Dec;31(12):1247-62. doi: 10.1007/s12325-014-0165-1. Epub 2014 Nov 21.","Moré MI","Adv Ther","2014","2014/11/22","PMC4271139","","10.1007/s12325-014-0165-1"
"19628939","Effect of music therapy on anxiety and depression in patients with Alzheimer's type dementia: randomised, controlled study","Guétin S, Portet F, Picot MC, Pommié C, Messaoudi M, Djabelkir L, Olsen AL, Cano MM, Lecourt E, Touchon J.","Dement Geriatr Cogn Disord. 2009;28(1):36-46. doi: 10.1159/000229024. Epub 2009 Jul 23.","Guétin S","Dement Geriatr Cogn Disord","2009","2009/07/25","","","10.1159/000229024"
"17135805","ADCS Prevention Instrument Project: overview and initial results","Ferris SH, Aisen PS, Cummings J, Galasko D, Salmon DP, Schneider L, Sano M, Whitehouse PJ, Edland S, Thal LJ; Alzheimer's Disease Cooperative Study Group.","Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4 Suppl 3):S109-23. doi: 10.1097/01.wad.0000213870.40300.21.","Ferris SH","Alzheimer Dis Assoc Disord","2006","2006/12/01","","","10.1097/01.wad.0000213870.40300.21"
"26811674","Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer's disease: a prospective, open-label pilot study","Ohnuma T, Toda A, Kimoto A, Takebayashi Y, Higashiyama R, Tagata Y, Ito M, Ota T, Shibata N, Arai H.","Clin Interv Aging. 2016 Jan 8;11:29-36. doi: 10.2147/CIA.S95362. eCollection 2016.","Ohnuma T","Clin Interv Aging","2016","2016/01/27","PMC4712972","","10.2147/CIA.S95362"
"35802628","Dementia risk and dynamic response to exercise: A non-randomized clinical trial","Vidoni ED, Morris JK, Palmer JA, Li Y, White D, Kueck PJ, John CS, Honea RA, Lepping RJ, Lee P, Mahnken JD, Martin LE, Billinger SA.","PLoS One. 2022 Jul 8;17(7):e0265860. doi: 10.1371/journal.pone.0265860. eCollection 2022.","Vidoni ED","PLoS One","2022","2022/07/08","PMC9269742","","10.1371/journal.pone.0265860"
"16505133","Risperidone in the treatment of psychosis of Alzheimer disease: results from a prospective clinical trial","Mintzer J, Greenspan A, Caers I, Van Hove I, Kushner S, Weiner M, Gharabawi G, Schneider LS.","Am J Geriatr Psychiatry. 2006 Mar;14(3):280-91. doi: 10.1097/01.JGP.0000194643.63245.8c.","Mintzer J","Am J Geriatr Psychiatry","2006","2006/03/01","","","10.1097/01.JGP.0000194643.63245.8c"
"1609045","Noradrenergic intervention in Alzheimer's disease","Crook T, Wilner E, Rothwell A, Winterling D, McEntee W.","Psychopharmacol Bull. 1992;28(1):67-70.","Crook T","Psychopharmacol Bull","1992","1992/01/01","","",""
"27756421","ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension","Gault LM, Lenz RA, Ritchie CW, Meier A, Othman AA, Tang Q, Berry S, Pritchett Y, Robieson WZ.","Alzheimers Res Ther. 2016 Oct 18;8(1):44. doi: 10.1186/s13195-016-0210-1.","Gault LM","Alzheimers Res Ther","2016","2016/10/21","PMC5067903","","10.1186/s13195-016-0210-1"
"22235132","Amyloid-β oligomers induce differential gene expression in adult human brain slices","Sebollela A, Freitas-Correa L, Oliveira FF, Paula-Lima AC, Saraiva LM, Martins SM, Mota LD, Torres C, Alves-Leon S, de Souza JM, Carraro DM, Brentani H, De Felice FG, Ferreira ST.","J Biol Chem. 2012 Mar 2;287(10):7436-45. doi: 10.1074/jbc.M111.298471. Epub 2012 Jan 10.","Sebollela A","J Biol Chem","2012","2012/01/12","PMC3293600","","10.1074/jbc.M111.298471"
"26553313","Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease","Choe YM, Kim KW, Jhoo JH, Ryu SH, Seo EH, Sohn BK, Byun MS, Bak JH, Lee JM, Yun HJ, Han MI, Woo JI, Lee DY.","Int J Geriatr Psychiatry. 2016 Jul;31(7):731-9. doi: 10.1002/gps.4384. Epub 2015 Nov 9.","Choe YM","Int J Geriatr Psychiatry","2016","2015/11/11","","","10.1002/gps.4384"
"15383747","A 12-month study of the efficacy of rivastigmine in patients with advanced moderate Alzheimer's disease","Karaman Y, Erdoğan F, Köseoğlu E, Turan T, Ersoy AO.","Dement Geriatr Cogn Disord. 2005;19(1):51-6. doi: 10.1159/000080972. Epub 2004 Sep 21.","Karaman Y","Dement Geriatr Cogn Disord","2005","2004/09/24","","","10.1159/000080972"
"26556080","The Effects of Aerobic Exercise on Cognitive Function of Alzheimer's Disease Patients","Yang SY, Shan CL, Qing H, Wang W, Zhu Y, Yin MM, Machado S, Yuan TF, Wu T.","CNS Neurol Disord Drug Targets. 2015;14(10):1292-7. doi: 10.2174/1871527315666151111123319.","Yang SY","CNS Neurol Disord Drug Targets","2015","2015/11/12","","","10.2174/1871527315666151111123319"
"16158009","Validating the DemTect with 18-fluoro-2-deoxy-glucose positron emission tomography as a sensitive neuropsychological screening test for early alzheimer disease in patients of a memory clinic","Scheurich A, Muller MJ, Siessmeier T, Bartenstein P, Schmidt LG, Fellgiebel A.","Dement Geriatr Cogn Disord. 2005;20(5):271-7. doi: 10.1159/000088248. Epub 2005 Sep 12.","Scheurich A","Dement Geriatr Cogn Disord","2005","2005/09/15","","","10.1159/000088248"
"31053120","Peripheral vascular responses to acetylcholine as a predictive tool for response to cholinesterase inhibitors in Alzheimer's disease","Connelly PJ, Adams F, Tayar ZI, Khan F.","BMC Neurol. 2019 May 3;19(1):88. doi: 10.1186/s12883-019-1316-4.","Connelly PJ","BMC Neurol","2019","2019/05/05","PMC6500049","","10.1186/s12883-019-1316-4"
"29969907","Sex Differences in the Neuropsychiatric Symptoms of Patients With Alzheimer's Disease","Tao Y, Peters ME, Drye LT, Devanand DP, Mintzer JE, Pollock BG, Porsteinsson AP, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Munro CA.","Am J Alzheimers Dis Other Demen. 2018 Nov;33(7):450-457. doi: 10.1177/1533317518783278. Epub 2018 Jul 3.","Tao Y","Am J Alzheimers Dis Other Demen","2018","2018/07/05","PMC6219457","NIHMS990645","10.1177/1533317518783278"
"16832659","PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease","Kadir A, Almkvist O, Wall A, Långström B, Nordberg A.","Psychopharmacology (Berl). 2006 Nov;188(4):509-20. doi: 10.1007/s00213-006-0447-7. Epub 2006 Jul 11.","Kadir A","Psychopharmacology (Berl)","2006","2006/07/13","","","10.1007/s00213-006-0447-7"
"12482085","Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET","Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frölich L, Schönknecht P, Ito K, Mielke R, Kalbe E, Zündorf G, Delbeuck X, Pelati O, Anchisi D, Fazio F, Kerrouche N, Desgranges B, Eustache F, Beuthien-Baumann B, Menzel C, Schröder J, Kato T, Arahata Y, Henze M, Heiss WD.","Neuroimage. 2002 Sep;17(1):302-16. doi: 10.1006/nimg.2002.1208.","Herholz K","Neuroimage","2002","2002/12/17","","","10.1006/nimg.2002.1208"
"16473462","Loss of expectation-related mechanisms in Alzheimer's disease makes analgesic therapies less effective","Benedetti F, Arduino C, Costa S, Vighetti S, Tarenzi L, Rainero I, Asteggiano G.","Pain. 2006 Mar;121(1-2):133-44. doi: 10.1016/j.pain.2005.12.016. Epub 2006 Feb 10.","Benedetti F","Pain","2006","2006/02/14","","","10.1016/j.pain.2005.12.016"
"27169802","Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease","Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, Owen C, Aldea P, Su Y, Hassenstab J, Cairns NJ, Holtzman DM, Fagan AM, Morris JC, Benzinger TL, Ances BM.","Sci Transl Med. 2016 May 11;8(338):338ra66. doi: 10.1126/scitranslmed.aaf2362.","Brier MR","Sci Transl Med","2016","2016/05/13","PMC5267531","NIHMS830812","10.1126/scitranslmed.aaf2362"
"9460733","Semantic memory in Alzheimer's disease: representativeness, ontologic category, and material","Grossman M, Robinson K, Biassou N, White-Devine T, D'Esposito M.","Neuropsychology. 1998 Jan;12(1):34-42. doi: 10.1037//0894-4105.12.1.34.","Grossman M","Neuropsychology","1998","1998/02/14","","","10.1037//0894-4105.12.1.34"
"1776743","Acetyl-L-carnitine: a drug able to slow the progress of Alzheimer's disease?","Carta A, Calvani M.","Ann N Y Acad Sci. 1991;640:228-32. doi: 10.1111/j.1749-6632.1991.tb00223.x.","Carta A","Ann N Y Acad Sci","1991","1991/01/01","","","10.1111/j.1749-6632.1991.tb00223.x"
"34362303","Five-year outcomes after IVIG for mild cognitive impairment due to alzheimer disease","Kile S, Au W, Parise C, Rose K, Donnel T, Hankins A, Au Y, Chan M, Ghassemi A.","BMC Neurosci. 2021 Aug 6;22(1):49. doi: 10.1186/s12868-021-00651-2.","Kile S","BMC Neurosci","2021","2021/08/07","PMC8349062","","10.1186/s12868-021-00651-2"
"27344641","Effect of aerobic exercise on physical performance in patients with Alzheimer's disease","Sobol NA, Hoffmann K, Frederiksen KS, Vogel A, Vestergaard K, Brændgaard H, Gottrup H, Lolk A, Wermuth L, Jakobsen S, Laugesen L, Gergelyffy R, Høgh P, Bjerregaard E, Siersma V, Andersen BB, Johannsen P, Waldemar G, Hasselbalch SG, Beyer N.","Alzheimers Dement. 2016 Dec;12(12):1207-1215. doi: 10.1016/j.jalz.2016.05.004. Epub 2016 Jun 23.","Sobol NA","Alzheimers Dement","2016","2016/06/27","","","10.1016/j.jalz.2016.05.004"
"34521461","Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase I clinical trial","Kim HJ, Cho KR, Jang H, Lee NK, Jung YH, Kim JP, Lee JI, Chang JW, Park S, Kim ST, Moon SW, Seo SW, Choi SJ, Na DL.","Alzheimers Res Ther. 2021 Sep 14;13(1):154. doi: 10.1186/s13195-021-00897-2.","Kim HJ","Alzheimers Res Ther","2021","2021/09/15","PMC8439008","","10.1186/s13195-021-00897-2"
"2690095","Early clinical trials in Alzheimer's disease: selection and evaluation of drug candidates","Reines SA.","Prog Clin Biol Res. 1989;317:1283-90.","Reines SA","Prog Clin Biol Res","1989","1989/01/01","","",""
"16086129","Temporal gradients for media-mediated memory: Italian norms","Bizzozero I, Capitani E, Saetti MC, Spinnler H, Lucchelli F.","Neurol Sci. 2005 Jul;26(3):161-7. doi: 10.1007/s10072-005-0454-1.","Bizzozero I","Neurol Sci","2005","2005/08/09","","","10.1007/s10072-005-0454-1"
"9892053","Comparison between a ""traditional"" memory test and a ""behavioral"" memory battery in Spanish patients","Pérez M, Godoy J.","J Clin Exp Neuropsychol. 1998 Aug;20(4):496-502. doi: 10.1076/jcen.20.4.496.1478.","Pérez M","J Clin Exp Neuropsychol","1998","1999/01/19","","","10.1076/jcen.20.4.496.1478"
"19262960","New insights into clinical trial for Colostrinin in Alzheimer's disease","Szaniszlo P, German P, Hajas G, Saenz DN, Kruzel M, Boldogh I.","J Nutr Health Aging. 2009 Mar;13(3):235-41. doi: 10.1007/s12603-009-0065-2.","Szaniszlo P","J Nutr Health Aging","2009","2009/03/06","","","10.1007/s12603-009-0065-2"
"12457078","An economic evaluation of donepezil in mild to moderate Alzheimer's disease: results of a 1-year, double-blind, randomized trial","Wimo A, Winblad B, Engedal K, Soininen H, Verhey F, Waldemar G, Wetterholm AL, Mastey V, Haglund A, Zhang R, Miceli R, Chin W, Subbiah P; Donepezil Nordic Study Group.","Dement Geriatr Cogn Disord. 2003;15(1):44-54. doi: 10.1159/000066669.","Wimo A","Dement Geriatr Cogn Disord","2003","2002/11/29","","","10.1159/000066669"
"15488407","Differentiating AD from aging using semiautomated measurement of hippocampal atrophy rates","Barnes J, Scahill RI, Boyes RG, Frost C, Lewis EB, Rossor CL, Rossor MN, Fox NC.","Neuroimage. 2004 Oct;23(2):574-81. doi: 10.1016/j.neuroimage.2004.06.028.","Barnes J","Neuroimage","2004","2004/10/19","","","10.1016/j.neuroimage.2004.06.028"
"28269769","Do Hearing Aids Influence Behavioral and Psychological Symptoms of Dementia and Quality of Life in Hearing Impaired Alzheimer's Disease Patients and Their Caregivers?","Adrait A, Perrot X, Nguyen MF, Gueugnon M, Petitot C, Collet L, Roux A, Bonnefoy M; ADPHA study group.","J Alzheimers Dis. 2017;58(1):109-121. doi: 10.3233/JAD-160792.","Adrait A","J Alzheimers Dis","2017","2017/03/09","","","10.3233/JAD-160792"
"18833116","[The treatment of Alzheimer's disease in patients with comorbid somatic pathology]","Selezneva ND, Gavrilova SI, Kalyn IaB, Kolykhalov IV, Fedorova IaB.","Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(7):35-42.","Selezneva ND","Zh Nevrol Psikhiatr Im S S Korsakova","2008","2008/10/04","","",""
"29859917","Lithium Treatment for Agitation in Alzheimer's disease (Lit-AD): Clinical rationale and study design","Devanand DP, Strickler JG, Huey ED, Crocco E, Forester BP, Husain MM, Vahia IV, Andrews H, Wall MM, Pelton GH.","Contemp Clin Trials. 2018 Aug;71:33-39. doi: 10.1016/j.cct.2018.05.019. Epub 2018 May 31.","Devanand DP","Contemp Clin Trials","2018","2018/06/04","PMC6082137","NIHMS975587","10.1016/j.cct.2018.05.019"
"12837144","Donepezil use for advanced Alzheimer's disease--a case study from a long-term care facility","Tariot PN, Jakimovich L.","J Am Med Dir Assoc. 2003 Jul-Aug;4(4):216-9. doi: 10.1097/01.JAM.0000075830.81747.72.","Tariot PN","J Am Med Dir Assoc","2003","2003/07/03","","","10.1097/01.JAM.0000075830.81747.72"
"22456451","Tracking cognitive change over 24 weeks with longitudinal functional magnetic resonance imaging in Alzheimer's disease","McLaren DG, Sreenivasan A, Diamond EL, Mitchell MB, Van Dijk KR, Deluca AN, O'Brien JL, Rentz DM, Sperling RA, Atri A.","Neurodegener Dis. 2012;9(4):176-86. doi: 10.1159/000335876. Epub 2012 Mar 27.","McLaren DG","Neurodegener Dis","2012","2012/03/30","PMC3369254","","10.1159/000335876"
"19786776","Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease","Wilkinson D, Schindler R, Schwam E, Waldemar G, Jones RW, Gauthier S, Lopez OL, Cummings J, Xu Y, Feldman HH.","Dement Geriatr Cogn Disord. 2009;28(3):244-51. doi: 10.1159/000241877. Epub 2009 Sep 25.","Wilkinson D","Dement Geriatr Cogn Disord","2009","2009/09/30","PMC3202931","","10.1159/000241877"
"19562980","Safety and tolerability of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients","Senanarong V, Poungvarin N, Phanthumchinda K, Thavichachart N, Chankrachang S, Praditsuwan R, Nidhinandana S.","J Med Assoc Thai. 2009 Mar;92 Suppl 2:S12-8.","Senanarong V","J Med Assoc Thai","2009","2009/07/01","","",""
"12578926","Impaired financial abilities in mild cognitive impairment: a direct assessment approach","Griffith HR, Belue K, Sicola A, Krzywanski S, Zamrini E, Harrell L, Marson DC.","Neurology. 2003 Feb 11;60(3):449-57. doi: 10.1212/wnl.60.3.449.","Griffith HR","Neurology","2003","2003/02/13","","","10.1212/wnl.60.3.449"
"11571763","Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease","Wilkinson D, Murray J.","Int J Geriatr Psychiatry. 2001 Sep;16(9):852-7. doi: 10.1002/gps.409.","Wilkinson D","Int J Geriatr Psychiatry","2001","2001/09/26","","","10.1002/gps.409"
"9236951","A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. The Alzheimer's Disease Cooperative Study","Patterson MB, Mack JL, Mackell JA, Thomas R, Tariot P, Weiner M, Whitehouse PJ.","Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S40-4.","Patterson MB","Alzheimer Dis Assoc Disord","1997","1997/01/01","","",""
"35621327","Cognitive Stimulation in Moderate Alzheimer's Disease","Gonzalez-Moreno J, Satorres E, Soria-Urios G, Meléndez JC.","J Appl Gerontol. 2022 Aug;41(8):1934-1941. doi: 10.1177/07334648221089283. Epub 2022 May 27.","Gonzalez-Moreno J","J Appl Gerontol","2022","2022/05/27","","","10.1177/07334648221089283"
"8561165","Predicting the onset of Alzheimer's disease using Bayes' theorem","Prince MJ.","Am J Epidemiol. 1996 Feb 1;143(3):301-8. doi: 10.1093/oxfordjournals.aje.a008742.","Prince MJ","Am J Epidemiol","1996","1996/02/01","","","10.1093/oxfordjournals.aje.a008742"
"10599773","Metrifonate treatment of AD: influence of APOE genotype","Farlow MR, Cyrus PA, Nadel A, Lahiri DK, Brashear A, Gulanski B.","Neurology. 1999 Dec 10;53(9):2010-6. doi: 10.1212/wnl.53.9.2010.","Farlow MR","Neurology","1999","1999/12/22","","","10.1212/wnl.53.9.2010"
"14624026","Antioxidants in Alzheimer's disease-vitamin C delivery to a demanding brain","Quinn J, Suh J, Moore MM, Kaye J, Frei B.","J Alzheimers Dis. 2003 Aug;5(4):309-13. doi: 10.3233/jad-2003-5406.","Quinn J","J Alzheimers Dis","2003","2003/11/19","","","10.3233/jad-2003-5406"
"33766132","Research diagnostic criteria for Alzheimer's disease: findings from the LipiDiDiet randomized controlled trial","Rosenberg A, Solomon A, Soininen H, Visser PJ, Blennow K, Hartmann T, Kivipelto M; LipiDiDiet clinical study group.","Alzheimers Res Ther. 2021 Mar 25;13(1):64. doi: 10.1186/s13195-021-00799-3.","Rosenberg A","Alzheimers Res Ther","2021","2021/03/26","PMC7995792","","10.1186/s13195-021-00799-3"
"7866680","The function of the hypothalamic-pituitary-adrenal axis in Alzheimer's disease. Response to insulin hypoglycaemia","O'Brien JT, Schweitzer I, Ames D, Mastwyk M, Colman P.","Br J Psychiatry. 1994 Nov;165(5):650-7. doi: 10.1192/bjp.165.5.650.","O'Brien JT","Br J Psychiatry","1994","1994/11/01","","","10.1192/bjp.165.5.650"
"9916400","[Stepwise analysis of cerebral blood flow SPECT imaging on standard brain atlas in patients with dementia of Alzheimer's type]","Kumakura Y, Momose T, Oku S, Ohtake T, Nishikawa J, Ohtomo K.","Kaku Igaku. 1998 Nov;35(9):843-8.","Kumakura Y","Kaku Igaku","1998","1999/01/23","","",""
"1775605","Effects of long-term continuous infusion of the muscarinic cholinergic agonist arecoline on verbal memory in dementia of the Alzheimer type","Raffaele KC, Berardi A, Asthana S, Morris P, Haxby JV, Soncrant TT.","Psychopharmacol Bull. 1991;27(3):315-9.","Raffaele KC","Psychopharmacol Bull","1991","1991/01/01","","",""
"9258905","Histamine H2 blocking drugs and the risk for Alzheimer's disease: the Rotterdam Study","Launer LJ, Jama JW, Ott A, Breteler MM, Hoes AW, Hofman A.","Neurobiol Aging. 1997 Mar-Apr;18(2):257-9. doi: 10.1016/s0197-4580(97)00010-9.","Launer LJ","Neurobiol Aging","1997","1997/03/01","","","10.1016/s0197-4580(97)00010-9"
"15629765","Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing","Gilman S, Koeppe RA, Little R, An H, Junck L, Giordani B, Persad C, Heumann M, Wernette K.","Exp Neurol. 2005 Feb;191 Suppl 1:S95-S103. doi: 10.1016/j.expneurol.2004.06.017.","Gilman S","Exp Neurol","2005","2005/01/05","","","10.1016/j.expneurol.2004.06.017"
"15084794","Effects of cholinergic drugs and cognitive training on dementia","Requena C, López Ibor MI, Maestú F, Campo P, López Ibor JJ, Ortiz T.","Dement Geriatr Cogn Disord. 2004;18(1):50-4. doi: 10.1159/000077735. Epub 2004 Apr 6.","Requena C","Dement Geriatr Cogn Disord","2004","2004/04/16","","","10.1159/000077735"
"11809161","Age transformation of combined hippocampus and amygdala volume improves diagnostic accuracy in Alzheimer's disease","Hampel H, Teipel SJ, Bayer W, Alexander GE, Schwarz R, Schapiro MB, Rapoport SI, Möller HJ.","J Neurol Sci. 2002 Feb 15;194(1):15-9. doi: 10.1016/s0022-510x(01)00669-4.","Hampel H","J Neurol Sci","2002","2002/01/26","","","10.1016/s0022-510x(01)00669-4"
"11044779","Impaired processing of famous faces in Alzheimer's disease is related to neurofibrillary tangle densities in the prefrontal and anterior cingulate cortex","Giannakopoulos P, Gold G, Duc M, Michel JP, Hof PR, Bouras C.","Dement Geriatr Cogn Disord. 2000 Nov-Dec;11(6):336-41. doi: 10.1159/000017263.","Giannakopoulos P","Dement Geriatr Cogn Disord","2000","2000/10/25","","","10.1159/000017263"
"8612192","Screening for mutations at codon 717 of the amyloid precursor protein gene in Alzheimer's disease","Dai XY, Hattori M, Hirasawa H, Isse K, Ueki A, Nanko S.","Psychiatry Clin Neurosci. 1995 Jun;49(3):175-8. doi: 10.1111/j.1440-1819.1995.tb02224.x.","Dai XY","Psychiatry Clin Neurosci","1995","1995/06/01","","","10.1111/j.1440-1819.1995.tb02224.x"
"16260821","Reality orientation therapy combined with cholinesterase inhibitors in Alzheimer's disease: randomised controlled trial","Onder G, Zanetti O, Giacobini E, Frisoni GB, Bartorelli L, Carbone G, Lambertucci P, Silveri MC, Bernabei R.","Br J Psychiatry. 2005 Nov;187:450-5. doi: 10.1192/bjp.187.5.450.","Onder G","Br J Psychiatry","2005","2005/11/02","","","10.1192/bjp.187.5.450"
"29045769","Placebo Effects in the Treatment of Noncognitive Symptoms of Alzheimer's Disease: Analysis of the CATIE-AD Data","Ozawa C, Roberts R, Yoshida K, Suzuki T, Lebowitz B, Reeves S, Howard R, Abe T, Mimura M, Uchida H.","J Clin Psychiatry. 2017 Nov/Dec;78(9):e1204-e1210. doi: 10.4088/JCP.17m11461.","Ozawa C","J Clin Psychiatry","2017","2017/10/19","","","10.4088/JCP.17m11461"
"17380489","A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule","Winblad B, Cummings J, Andreasen N, Grossberg G, Onofrj M, Sadowsky C, Zechner S, Nagel J, Lane R.","Int J Geriatr Psychiatry. 2007 May;22(5):456-67. doi: 10.1002/gps.1788.","Winblad B","Int J Geriatr Psychiatry","2007","2007/03/24","","","10.1002/gps.1788"
"16217697","[Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery]","Barth S, Schönknecht P, Pantel J, Schröder J.","Fortschr Neurol Psychiatr. 2005 Oct;73(10):568-76. doi: 10.1055/s-2004-830249.","Barth S","Fortschr Neurol Psychiatr","2005","2005/10/12","","","10.1055/s-2004-830249"
"7890820","Alzheimer patients show a sensitivity decrement over time on a tonic alertness task","Brazzelli M, Cocchini G, Della Sala S, Spinnler H.","J Clin Exp Neuropsychol. 1994 Dec;16(6):851-60. doi: 10.1080/01688639408402698.","Brazzelli M","J Clin Exp Neuropsychol","1994","1994/12/01","","","10.1080/01688639408402698"
"17302650","Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial","Rolland Y, Pillard F, Klapouszczak A, Reynish E, Thomas D, Andrieu S, Rivière D, Vellas B.","J Am Geriatr Soc. 2007 Feb;55(2):158-65. doi: 10.1111/j.1532-5415.2007.01035.x.","Rolland Y","J Am Geriatr Soc","2007","2007/02/17","","","10.1111/j.1532-5415.2007.01035.x"
"15353387","Cognitive response to pharmacological treatment for depression in Alzheimer disease: secondary outcomes from the depression in Alzheimer's disease study (DIADS)","Munro CA, Brandt J, Sheppard JM, Steele CD, Samus QM, Steinberg M, Rabins PV, Lyketsos CG.","Am J Geriatr Psychiatry. 2004 Sep-Oct;12(5):491-8. doi: 10.1176/appi.ajgp.12.5.491.","Munro CA","Am J Geriatr Psychiatry","2004","2004/09/09","","","10.1176/appi.ajgp.12.5.491"
"8227897","L-deprenyl in the treatment of mild dementia of the Alzheimer type: results of a 15-month trial","Burke WJ, Roccaforte WH, Wengel SP, Bayer BL, Ranno AE, Willcockson NK.","J Am Geriatr Soc. 1993 Nov;41(11):1219-25. doi: 10.1111/j.1532-5415.1993.tb07306.x.","Burke WJ","J Am Geriatr Soc","1993","1993/11/01","","","10.1111/j.1532-5415.1993.tb07306.x"
"12488788","Generalized synchronization of MEG recordings in Alzheimer's Disease: evidence for involvement of the gamma band","Stam CJ, van Cappellen van Walsum AM, Pijnenburg YA, Berendse HW, de Munck JC, Scheltens P, van Dijk BW.","J Clin Neurophysiol. 2002 Dec;19(6):562-74. doi: 10.1097/00004691-200212000-00010.","Stam CJ","J Clin Neurophysiol","2002","2002/12/19","","","10.1097/00004691-200212000-00010"
"11369675","Rating of different olfactory judgements in Alzheimer's disease","Royet JP, Croisile B, Williamson-Vasta R, Hibert O, Serclerat D, Guerin J.","Chem Senses. 2001 May;26(4):409-17. doi: 10.1093/chemse/26.4.409.","Royet JP","Chem Senses","2001","2001/05/23","","","10.1093/chemse/26.4.409"
"20597141","Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease","Waldemar G, Gauthier S, Jones R, Wilkinson D, Cummings J, Lopez O, Zhang R, Xu Y, Sun Y, Knox S, Richardson S, Mackell J.","Int J Geriatr Psychiatry. 2011 Feb;26(2):150-7. doi: 10.1002/gps.2507.","Waldemar G","Int J Geriatr Psychiatry","2011","2010/07/03","","","10.1002/gps.2507"
"21502597","A phase II trial of huperzine A in mild to moderate Alzheimer disease","Rafii MS, Walsh S, Little JT, Behan K, Reynolds B, Ward C, Jin S, Thomas R, Aisen PS; Alzheimer's Disease Cooperative Study.","Neurology. 2011 Apr 19;76(16):1389-94. doi: 10.1212/WNL.0b013e318216eb7b.","Rafii MS","Neurology","2011","2011/04/20","PMC3269774","","10.1212/WNL.0b013e318216eb7b"
"10867777","The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort","Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agostino RB.","Arch Neurol. 2000 Jun;57(6):808-13. doi: 10.1001/archneur.57.6.808.","Elias MF","Arch Neurol","2000","2000/06/27","","","10.1001/archneur.57.6.808"
"9562305","Discrimination of facial identity and of emotions in Alzheimer's disease","Roudier M, Marcie P, Grancher AS, Tzortzis C, Starkstein S, Boller F.","J Neurol Sci. 1998 Feb 5;154(2):151-8. doi: 10.1016/s0022-510x(97)00222-0.","Roudier M","J Neurol Sci","1998","1998/04/30","","","10.1016/s0022-510x(97)00222-0"
"15683978","[Planning and activities of daily living in Alzheimer's disease and frontotemporal dementia]","Piquard A, Derouesné C, Lacomblez L, Siéroff E.","Psychol Neuropsychiatr Vieil. 2004 Jun;2(2):147-56.","Piquard A","Psychol Neuropsychiatr Vieil","2004","2005/02/03","","",""
"10408559","A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease","Scharf S, Mander A, Ugoni A, Vajda F, Christophidis N.","Neurology. 1999 Jul 13;53(1):197-201. doi: 10.1212/wnl.53.1.197.","Scharf S","Neurology","1999","1999/07/17","","","10.1212/wnl.53.1.197"
"9444467","Repetition of single words and nonwords in Alzheimer's disease","Glosser G, Kohn SE, Friedman RB, Sands L, Grugan P.","Cortex. 1997 Dec;33(4):653-66. doi: 10.1016/s0010-9452(08)70723-8.","Glosser G","Cortex","1997","1998/01/28","","","10.1016/s0010-9452(08)70723-8"
"10559565","Evaluation of serum-lipid-related cardiovascular risk factors in Alzheimer's disease","Kálmán J, Kudchodkar BJ, Murray K, McConathy WJ, Juhász A, Janka Z, Lacko AG.","Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):488-93. doi: 10.1159/000017195.","Kálmán J","Dement Geriatr Cogn Disord","1999","1999/11/24","","","10.1159/000017195"
"10823365","Savings in the cost of caring for patients with Alzheimer's disease in Canada: an analysis of treatment with rivastigmine","Hauber AB, Gnanasakthy A, Mauskopf JA.","Clin Ther. 2000 Apr;22(4):439-51. doi: 10.1016/s0149-2918(00)89012-8.","Hauber AB","Clin Ther","2000","2000/05/24","","","10.1016/s0149-2918(00)89012-8"
"29365294","Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease","Honig LS, Vellas B, Woodward M, Boada M, Bullock R, Borrie M, Hager K, Andreasen N, Scarpini E, Liu-Seifert H, Case M, Dean RA, Hake A, Sundell K, Poole Hoffmann V, Carlson C, Khanna R, Mintun M, DeMattos R, Selzler KJ, Siemers E.","N Engl J Med. 2018 Jan 25;378(4):321-330. doi: 10.1056/NEJMoa1705971.","Honig LS","N Engl J Med","2018","2018/01/25","","","10.1056/NEJMoa1705971"
"15157345","Risperidone is effective for wandering and disturbed sleep/wake patterns in Alzheimer's disease","Meguro K, Meguro M, Tanaka Y, Akanuma K, Yamaguchi K, Itoh M.","J Geriatr Psychiatry Neurol. 2004 Jun;17(2):61-7. doi: 10.1177/0891988704264535.","Meguro K","J Geriatr Psychiatry Neurol","2004","2004/05/26","","","10.1177/0891988704264535"
"16433943","Everyday action in dementia: evidence for differential deficits in Alzheimer's disease versus subcortical vascular dementia","Giovannetti T, Schmidt KS, Gallo JL, Sestito N, Libon DJ.","J Int Neuropsychol Soc. 2006 Jan;12(1):45-53. doi: 10.1017/S1355617706060012.","Giovannetti T","J Int Neuropsychol Soc","2006","2006/01/26","","","10.1017/S1355617706060012"
"14620073","Why participate in an Alzheimer's disease clinical trial? Is it of benefit to carers and patients?","Mastwyk M, Macfarlane S, LoGiudice D, Sullivan KA.","Int Psychogeriatr. 2003 Jun;15(2):149-56. doi: 10.1017/s1041610203008834.","Mastwyk M","Int Psychogeriatr","2003","2003/11/19","","","10.1017/s1041610203008834"
"12901781","Cognitive asymmetries associated with apolipoprotein E genotype in patients with Alzheimer's disease","Finton MJ, Lucas JA, Rippeth JD, Bohac DL, Smith GE, Ivnik RJ, Petersen RC, Graff-Radford NR.","J Int Neuropsychol Soc. 2003 Jul;9(5):751-9. doi: 10.1017/S1355617703950089.","Finton MJ","J Int Neuropsychol Soc","2003","2003/08/07","","","10.1017/S1355617703950089"
"8513661","Serum concentrations of tacrine hydrochloride predict its adverse effects in Alzheimer's disease","Ford JM, Truman CA, Wilcock GK, Roberts CJ.","Clin Pharmacol Ther. 1993 Jun;53(6):691-5. doi: 10.1038/clpt.1993.91.","Ford JM","Clin Pharmacol Ther","1993","1993/06/01","","","10.1038/clpt.1993.91"
"2642499","Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease","Thal LJ, Masur DM, Blau AD, Fuld PA, Klauber MR.","J Am Geriatr Soc. 1989 Jan;37(1):42-8. doi: 10.1111/j.1532-5415.1989.tb01567.x.","Thal LJ","J Am Geriatr Soc","1989","1989/01/01","","","10.1111/j.1532-5415.1989.tb01567.x"
"12040309","Cognitive and behavioral effects of quetiapine in Alzheimer disease patients","Scharre DW, Chang SI.","Alzheimer Dis Assoc Disord. 2002 Apr-Jun;16(2):128-30. doi: 10.1097/00002093-200204000-00011.","Scharre DW","Alzheimer Dis Assoc Disord","2002","2002/06/01","","","10.1097/00002093-200204000-00011"
"23493722","Utility of the AD8 as a self-rating tool for cognitive impairment in an Asian population","Chin R, Ng A, Narasimhalu K, Kandiah N.","Am J Alzheimers Dis Other Demen. 2013 May;28(3):284-8. doi: 10.1177/1533317513481090. Epub 2013 Mar 14.","Chin R","Am J Alzheimers Dis Other Demen","2013","2013/03/16","","","10.1177/1533317513481090"
"15894410","Differences in regional brain atrophy in genetic forms of Alzheimer's disease","Gregory GC, Macdonald V, Schofield PR, Kril JJ, Halliday GM.","Neurobiol Aging. 2006 Mar;27(3):387-93. doi: 10.1016/j.neurobiolaging.2005.03.011.","Gregory GC","Neurobiol Aging","2006","2005/05/17","","","10.1016/j.neurobiolaging.2005.03.011"
"11590117","Visual mechanisms of spatial disorientation in Alzheimer's disease","O'Brien HL, Tetewsky SJ, Avery LM, Cushman LA, Makous W, Duffy CJ.","Cereb Cortex. 2001 Nov;11(11):1083-92. doi: 10.1093/cercor/11.11.1083.","O'Brien HL","Cereb Cortex","2001","2001/10/09","","","10.1093/cercor/11.11.1083"
"27884817","Promise of new Alzheimer's drug is dashed after lack of evidence","Hawkes N.","BMJ. 2016 Nov 24;355:i6362. doi: 10.1136/bmj.i6362.","Hawkes N","BMJ","2016","2016/11/26","","","10.1136/bmj.i6362"
"14739543","Semantic knowledge of famous people in mild cognitive impairment and progression to Alzheimer's disease","Estévez-González A, García-Sánchez C, Boltes A, Otermín P, Pascual-Sedano B, Gironell A, Kulisevsky J.","Dement Geriatr Cogn Disord. 2004;17(3):188-95. doi: 10.1159/000076355. Epub 2004 Jan 20.","Estévez-González A","Dement Geriatr Cogn Disord","2004","2004/01/24","","","10.1159/000076355"
"10208564","The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease","Laws SM, Taddei K, Martins G, Paton A, Fisher C, Clarnette R, Hallmayer J, Brooks WS, Gandy SE, Martins RN.","Neuroreport. 1999 Mar 17;10(4):879-82. doi: 10.1097/00001756-199903170-00038.","Laws SM","Neuroreport","1999","1999/04/20","","","10.1097/00001756-199903170-00038"
"18310554","The views of Alzheimer disease patients and their study partners on proxy consent for clinical trial enrollment","Karlawish J, Kim SY, Knopman D, van Dyck CH, James BD, Marson D.","Am J Geriatr Psychiatry. 2008 Mar;16(3):240-7. doi: 10.1097/JGP.0b013e318162992d.","Karlawish J","Am J Geriatr Psychiatry","2008","2008/03/04","","","10.1097/JGP.0b013e318162992d"
"18489496","Sociodemographic and clinical correlates of utility scores in Alzheimer's disease","Miller EA, Schneider LS, Zbrozek A, Rosenheck RA.","Value Health. 2008 Dec;11(7):1120-30. doi: 10.1111/j.1524-4733.2008.00351.x. Epub 2008 May 16.","Miller EA","Value Health","2008","2008/05/21","","","10.1111/j.1524-4733.2008.00351.x"
"35180125","Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial","Hua X, Church K, Walker W, L'Hostis P, Viardot G, Danjou P, Hendrix S, Moebius HJ.","J Alzheimers Dis. 2022;86(3):1399-1413. doi: 10.3233/JAD-215511.","Hua X","J Alzheimers Dis","2022","2022/02/18","PMC9108585","","10.3233/JAD-215511"
"19042161","Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial","Burns A, Bernabei R, Bullock R, Cruz Jentoft AJ, Frölich L, Hock C, Raivio M, Triau E, Vandewoude M, Wimo A, Came E, Van Baelen B, Hammond GL, van Oene JC, Schwalen S.","Lancet Neurol. 2009 Jan;8(1):39-47. doi: 10.1016/S1474-4422(08)70261-8. Epub 2008 Nov 29.","Burns A","Lancet Neurol","2009","2008/12/02","","","10.1016/S1474-4422(08)70261-8"
"15465627","Association analysis of genes involved in cholesterol metabolism located within the linkage region on chromosome 10 and Alzheimer's disease","Riemenschneider M, Mahmoodzadeh S, Eisele T, Klopp N, Schwarz S, Wagenpfeil S, Diehl J, Mueller U, Foerstl H, Illig T, Kurz A.","Neurobiol Aging. 2004 Nov-Dec;25(10):1305-8. doi: 10.1016/j.neurobiolaging.2004.01.001.","Riemenschneider M","Neurobiol Aging","2004","2004/10/07","","","10.1016/j.neurobiolaging.2004.01.001"
"7828613","Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease: effects of region of interest selection","Claus JJ, van Harskamp F, Breteler MM, Krenning EP, van der Cammen TJ, Hofman A, Hasan D.","Eur J Nucl Med. 1994 Oct;21(10):1044-51. doi: 10.1007/BF00181058.","Claus JJ","Eur J Nucl Med","1994","1994/10/01","","","10.1007/BF00181058"
"8128835","Tetrahydroaminoacridine (THA) in Alzheimer's disease: an assessment of attentional and mnemonic function using CANTAB","Sahakian BJ, Coull JT.","Acta Neurol Scand Suppl. 1993;149:29-35. doi: 10.1111/j.1600-0404.1993.tb04251.x.","Sahakian BJ","Acta Neurol Scand Suppl","1993","1993/01/01","","","10.1111/j.1600-0404.1993.tb04251.x"
"11971084","Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease","Scarmeas N, Brandt J, Albert M, Devanand DP, Marder K, Bell K, Ciappa A, Tycko B, Stern Y.","Neurology. 2002 Apr 23;58(8):1182-8. doi: 10.1212/wnl.58.8.1182.","Scarmeas N","Neurology","2002","2002/04/24","PMC3029097","NIHMS262617","10.1212/wnl.58.8.1182"
"25186799","Safety and tolerability of immune globulin intravenous (human), 10% solution in Japanese subjects with mild to moderate Alzheimer's disease","Arai H, Ichimiya Y, Shibata N, Nakajima T, Sudoh S, Tokuda T, Sujaku T, Yokokawa S, Hoshii N, Noguchi H, Bille A.","Psychogeriatrics. 2014 Sep;14(3):165-74. doi: 10.1111/psyg.12055. Epub 2014 Sep 3.","Arai H","Psychogeriatrics","2014","2014/09/05","","","10.1111/psyg.12055"
"3903533","Multiple, single-dose naltrexone administrations fail to effect overall cognitive functioning and plasma cortisol in individuals with probable Alzheimer's disease","Pomara N, Roberts R, Rhiew HB, Stanley M, Gershon S.","Neurobiol Aging. 1985 Fall;6(3):233-6. doi: 10.1016/0197-4580(85)90055-7.","Pomara N","Neurobiol Aging","1985","1985/01/01","","","10.1016/0197-4580(85)90055-7"
"25304446","Personality, Alzheimer's disease and behavioural and cognitive symptoms of dementia: the PACO prospective cohort study protocol","Rouch I, Dorey JM, Boublay N, Henaff MA, Dibie-Racoupeau F, Makaroff Z, Harston S, Benoit M, Barrellon MO, Fédérico D, Laurent B, Padovan C, Krolak-Salmon P; PACO group.","BMC Geriatr. 2014 Oct 10;14:110. doi: 10.1186/1471-2318-14-110.","Rouch I","BMC Geriatr","2014","2014/10/12","PMC4200223","","10.1186/1471-2318-14-110"
"9438267","Greater metabolic rate decreases in hippocampal formation and proisocortex than in neocortex in Alzheimer's disease","Stein DJ, Buchsbaum MS, Hof PR, Siegel BV Jr, Shihabuddin L.","Neuropsychobiology. 1998;37(1):10-9. doi: 10.1159/000026471.","Stein DJ","Neuropsychobiology","1998","1998/01/23","","","10.1159/000026471"
"18525029","Continuous CSF drainage in AD: results of a double-blind, randomized, placebo-controlled study","Silverberg GD, Mayo M, Saul T, Fellmann J, Carvalho J, McGuire D.","Neurology. 2008 Jul 15;71(3):202-9. doi: 10.1212/01.wnl.0000316197.04157.6f. Epub 2008 Jun 4.","Silverberg GD","Neurology","2008","2008/06/06","","","10.1212/01.wnl.0000316197.04157.6f"
"29164798","Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer's disease","Tardif CL, Devenyi GA, Amaral RSC, Pelleieux S, Poirier J, Rosa-Neto P, Breitner J, Chakravarty MM; PREVENT-AD Research Group.","Hum Brain Mapp. 2018 Feb;39(2):971-984. doi: 10.1002/hbm.23897. Epub 2017 Nov 21.","Tardif CL","Hum Brain Mapp","2018","2017/11/23","PMC6866392","","10.1002/hbm.23897"
"21986341","CORDIAL: cognitive rehabilitation and cognitive-behavioral treatment for early dementia in Alzheimer disease: a multicenter, randomized, controlled trial","Kurz A, Thöne-Otto A, Cramer B, Egert S, Frölich L, Gertz HJ, Kehl V, Wagenpfeil S, Werheid K.","Alzheimer Dis Assoc Disord. 2012 Jul-Sep;26(3):246-53. doi: 10.1097/WAD.0b013e318231e46e.","Kurz A","Alzheimer Dis Assoc Disord","2012","2011/10/12","","","10.1097/WAD.0b013e318231e46e"
"24673497","Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan","Nakamura Y, Kitamura S, Homma A, Shiosakai K, Matsui D.","Expert Opin Pharmacother. 2014 May;15(7):913-25. doi: 10.1517/14656566.2014.902446. Epub 2014 Mar 27.","Nakamura Y","Expert Opin Pharmacother","2014","2014/03/29","PMC4025599","","10.1517/14656566.2014.902446"
"21543959","Modeling trajectories and transitions: results from the New York University caregiver intervention","Gaugler JE, Roth DL, Haley WE, Mittelman MS.","Nurs Res. 2011 May-Jun;60(3 Suppl):S28-37. doi: 10.1097/NNR.0b013e318216007d.","Gaugler JE","Nurs Res","2011","2011/05/06","PMC3131213","NIHMS300952","10.1097/NNR.0b013e318216007d"
"12928055","Apolipoprotein E epsilon 4 affects new learning in cognitively normal individuals at risk for Alzheimer's disease","Baxter LC, Caselli RJ, Johnson SC, Reiman E, Osborne D.","Neurobiol Aging. 2003 Nov;24(7):947-52. doi: 10.1016/s0197-4580(03)00006-x.","Baxter LC","Neurobiol Aging","2003","2003/08/21","","","10.1016/s0197-4580(03)00006-x"
"18300284","Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease","Kadir A, Andreasen N, Almkvist O, Wall A, Forsberg A, Engler H, Hagman G, Lärksäter M, Winblad B, Zetterberg H, Blennow K, Långström B, Nordberg A.","Ann Neurol. 2008 May;63(5):621-31. doi: 10.1002/ana.21345.","Kadir A","Ann Neurol","2008","2008/02/27","","","10.1002/ana.21345"
"22068922","Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy","Farlow MR, Grossberg GT, Meng X, Olin J, Somogyi M.","Int J Geriatr Psychiatry. 2011 Dec;26(12):1236-43. doi: 10.1002/gps.2669. Epub 2010 Dec 23.","Farlow MR","Int J Geriatr Psychiatry","2011","2011/11/10","","","10.1002/gps.2669"
"15525294","Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial","Pirttilä T, Wilcock G, Truyen L, Damaraju CV.","Eur J Neurol. 2004 Nov;11(11):734-41. doi: 10.1111/j.1468-1331.2004.00885.x.","Pirttilä T","Eur J Neurol","2004","2004/11/05","","","10.1111/j.1468-1331.2004.00885.x"
"15967527","Brain oscillatory responses to an auditory-verbal working memory task in mild cognitive impairment and Alzheimer's disease","Karrasch M, Laine M, Rinne JO, Rapinoja P, Sinervä E, Krause CM.","Int J Psychophysiol. 2006 Feb;59(2):168-78. doi: 10.1016/j.ijpsycho.2005.04.006. Epub 2005 Jun 20.","Karrasch M","Int J Psychophysiol","2006","2005/06/22","","","10.1016/j.ijpsycho.2005.04.006"
"19672237","[Galantamine (reminyl) in the treatment of severe Alzheimer's disease]","Gavrilova SI, Kolykhanov IV, Kalyn IaB, Selezneva ND.","Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(7):57-61.","Gavrilova SI","Zh Nevrol Psikhiatr Im S S Korsakova","2009","2009/08/13","","",""
"10559561","Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population","Schwab SG, Bagli M, Papassotiropoulos A, Jessen F, Maier W, Rao ML, Heun R.","Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):469-72. doi: 10.1159/000017191.","Schwab SG","Dement Geriatr Cogn Disord","1999","1999/11/24","","","10.1159/000017191"
"15237252","Longitudinal cerebral perfusion decrease in mild alzheimer's disease revealed by SPECT with statistical parametric mapping method","Lee YC, Liu RS, Liao YC, Wang PN, Lin KN, Liu HC.","Eur Neurol. 2004;52(1):42-9. doi: 10.1159/000079417. Epub 2004 Jun 29.","Lee YC","Eur Neurol","2004","2004/07/09","","","10.1159/000079417"
"3057398","Long-term administration of oral physostigmine in Alzheimer's disease","Stern Y, Sano M, Mayeux R.","Neurology. 1988 Dec;38(12):1837-41. doi: 10.1212/wnl.38.12.1837.","Stern Y","Neurology","1988","1988/12/01","","","10.1212/wnl.38.12.1837"
"15494622","Diagnostic utility of neuropsychological performance and quantitative MRI-based measurement in Alzheimer disease","Wang H, Shu L, Xie J, Zhang H, Zhang D.","Alzheimer Dis Assoc Disord. 2004 Jul-Sep;18(3):163-70. doi: 10.1097/01.wad.0000137521.61487.68.","Wang H","Alzheimer Dis Assoc Disord","2004","2004/10/21","","","10.1097/01.wad.0000137521.61487.68"
"16182410","Apolipoprotein E epsilon4 is associated with atrophy of the amygdala in Alzheimer's disease","Basso M, Gelernter J, Yang J, MacAvoy MG, Varma P, Bronen RA, van Dyck CH.","Neurobiol Aging. 2006 Oct;27(10):1416-24. doi: 10.1016/j.neurobiolaging.2005.08.002. Epub 2005 Sep 22.","Basso M","Neurobiol Aging","2006","2005/09/27","","","10.1016/j.neurobiolaging.2005.08.002"
"10404988","Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease","Clark CM, Sheppard L, Fillenbaum GG, Galasko D, Morris JC, Koss E, Mohs R, Heyman A.","Arch Neurol. 1999 Jul;56(7):857-62. doi: 10.1001/archneur.56.7.857.","Clark CM","Arch Neurol","1999","1999/07/15","","","10.1001/archneur.56.7.857"
"3528891","Desamino-D-arginine-vasopressin (DDAVP) in Alzheimer's disease","Peabody CA, Davies H, Berger PA, Tinklenberg JR.","Neurobiol Aging. 1986 Jul-Aug;7(4):301-3. doi: 10.1016/0197-4580(86)90011-4.","Peabody CA","Neurobiol Aging","1986","1986/07/01","","","10.1016/0197-4580(86)90011-4"
"18192497","Depressive symptom trajectories and associated risks among bereaved Alzheimer disease caregivers","Zhang B, Mitchell SL, Bambauer KZ, Jones R, Prigerson HG.","Am J Geriatr Psychiatry. 2008 Feb;16(2):145-55. doi: 10.1097/JGP.0b013e318157caec. Epub 2008 Jan 11.","Zhang B","Am J Geriatr Psychiatry","2008","2008/01/15","","","10.1097/JGP.0b013e318157caec"
"9003975","Essential fatty acids preparation (SR-3) improves Alzheimer's patients quality of life","Yehuda S, Rabinovtz S, Carasso RL, Mostofsky DI.","Int J Neurosci. 1996 Nov;87(3-4):141-9. doi: 10.3109/00207459609070833.","Yehuda S","Int J Neurosci","1996","1996/11/01","","","10.3109/00207459609070833"
"22678673","[Efficacy, safety and tolerability of a single dose of akatinol memantine in comparison to two-doses in patients with moderately expressed and moderately severe dementia in Alzheimer's disease]","Kolykhalov IV, Gavrilova SI, Kalyn IaB, Selezneva ND, Fedorova IaB.","Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(1):35-9.","Kolykhalov IV","Zh Nevrol Psikhiatr Im S S Korsakova","2012","2012/06/09","","",""
"34570177","Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity: A Randomized Clinical Trial","Vossel K, Ranasinghe KG, Beagle AJ, La A, Ah Pook K, Castro M, Mizuiri D, Honma SM, Venkateswaran N, Koestler M, Zhang W, Mucke L, Howell MJ, Possin KL, Kramer JH, Boxer AL, Miller BL, Nagarajan SS, Kirsch HE.","JAMA Neurol. 2021 Nov 1;78(11):1345-1354. doi: 10.1001/jamaneurol.2021.3310.","Vossel K","JAMA Neurol","2021","2021/09/27","PMC8477304","","10.1001/jamaneurol.2021.3310"
"10080566","Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment","Tsai GE, Falk WE, Gunther J, Coyle JT.","Am J Psychiatry. 1999 Mar;156(3):467-9. doi: 10.1176/ajp.156.3.467.","Tsai GE","Am J Psychiatry","1999","1999/03/18","","","10.1176/ajp.156.3.467"
"9258889","Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease","Convit A, De Leon MJ, Tarshish C, De Santi S, Tsui W, Rusinek H, George A.","Neurobiol Aging. 1997 Mar-Apr;18(2):131-8. doi: 10.1016/s0197-4580(97)00001-8.","Convit A","Neurobiol Aging","1997","1997/03/01","","","10.1016/s0197-4580(97)00001-8"
"34511121","Impact of an educational programme on Alzheimer's disease patients' quality of life: results of the randomized controlled trial THERAD","Villars H, Cantet C, de Peretti E, Perrin A, Soto-Martin M, Gardette V.","Alzheimers Res Ther. 2021 Sep 12;13(1):152. doi: 10.1186/s13195-021-00896-3.","Villars H","Alzheimers Res Ther","2021","2021/09/13","PMC8436545","","10.1186/s13195-021-00896-3"
"11753499","A nutritional education program could prevent weight loss and slow cognitive decline in Alzheimer's disease","Rivière S, Gillette-Guyonnet S, Voisin T, Reynish E, Andrieu S, Lauque S, Salva A, Frisoni G, Nourhashemi F, Micas M, Vellas B.","J Nutr Health Aging. 2001;5(4):295-9.","Rivière S","J Nutr Health Aging","2001","2001/12/26","","",""
"36946443","Investigating Partially Discordant Results in Phase 3 Studies of Aducanumab","Mallinckrodt C, Tian Y, Aisen PS, Barkhof F, Cohen S, Dent G, Hansson O, Harrison K, Iwatsubo T, Mummery CJ, Muralidharan KK, Nestorov I, Nisenbaum L, Rajagovindan R, von Hehn C, van Dyck CH, Vellas B, Wu S, Zhu Y, Sandrock A, Chen T, Budd Haeberlein S.","J Prev Alzheimers Dis. 2023;10(2):171-177. doi: 10.14283/jpad.2023.6.","Mallinckrodt C","J Prev Alzheimers Dis","2023","2023/03/22","","","10.14283/jpad.2023.6"
"17135811","ADCS Prevention Instrument Project: quality of life assessment (QOL)","Patterson MB, Whitehouse PJ, Edland SD, Sami SA, Sano M, Smyth K, Weiner MF; Alzheimer's Disease Cooperative Study Group.","Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4 Suppl 3):S179-90. doi: 10.1097/01.wad.0000213874.25053.e5.","Patterson MB","Alzheimer Dis Assoc Disord","2006","2006/12/01","","","10.1097/01.wad.0000213874.25053.e5"
"9236950","An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study","Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grundman M, Ferris S.","Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S33-9.","Galasko D","Alzheimer Dis Assoc Disord","1997","1997/01/01","","",""
"8239308","The use of the Computerized Neuropsychological Test Battery (CNTB) in an efficacy and safety trial of BMY 21,502 in Alzheimer's disease","Cutler NR, Shrotriya RC, Sramek JJ, Veroff AE, Seifert RD, Reich LA, Hironaka DY.","Ann N Y Acad Sci. 1993 Sep 24;695:332-6. doi: 10.1111/j.1749-6632.1993.tb23079.x.","Cutler NR","Ann N Y Acad Sci","1993","1993/09/24","","","10.1111/j.1749-6632.1993.tb23079.x"
"22101754","3D texture analysis on MRI images of Alzheimer's disease","Zhang J, Yu C, Jiang G, Liu W, Tong L.","Brain Imaging Behav. 2012 Mar;6(1):61-9. doi: 10.1007/s11682-011-9142-3.","Zhang J","Brain Imaging Behav","2012","2011/11/22","","","10.1007/s11682-011-9142-3"
"15718044","Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease","Kawamoto EM, Munhoz CD, Glezer I, Bahia VS, Caramelli P, Nitrini R, Gorjão R, Curi R, Scavone C, Marcourakis T.","Neurobiol Aging. 2005 Jun;26(6):857-64. doi: 10.1016/j.neurobiolaging.2004.08.011.","Kawamoto EM","Neurobiol Aging","2005","2005/02/19","","","10.1016/j.neurobiolaging.2004.08.011"
"9779926","Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease","Jelic V, Dierks T, Amberla K, Almkvist O, Winblad B, Nordberg A.","Neurosci Lett. 1998 Sep 25;254(2):85-8. doi: 10.1016/s0304-3940(98)00669-7.","Jelic V","Neurosci Lett","1998","1998/10/21","","","10.1016/s0304-3940(98)00669-7"
"16298237","Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD","Borroni B, Anchisi D, Paghera B, Vicini B, Kerrouche N, Garibotto V, Terzi A, Vignolo LA, Di Luca M, Giubbini R, Padovani A, Perani D.","Neurobiol Aging. 2006 Jan;27(1):24-31. doi: 10.1016/j.neurobiolaging.2004.12.010. Epub 2005 Mar 24.","Borroni B","Neurobiol Aging","2006","2005/11/22","","","10.1016/j.neurobiolaging.2004.12.010"
"16676290","Verbal repetition in patients with Alzheimer's disease who receive donepezil","Asp E, Cloutier F, Fay S, Cook C, Robertson ML, Fisk J, Dei DW, Rockwood K.","Int J Geriatr Psychiatry. 2006 May;21(5):426-31. doi: 10.1002/gps.1486.","Asp E","Int J Geriatr Psychiatry","2006","2006/05/06","","","10.1002/gps.1486"
"27160164","Effects of Exercise on Functional Performance and Fall Rate in Subjects with Mild or Advanced Alzheimer's Disease: Secondary Analyses of a Randomized Controlled Study","Öhman H, Savikko N, Strandberg T, Kautiainen H, Raivio M, Laakkonen ML, Tilvis R, Pitkälä KH.","Dement Geriatr Cogn Disord. 2016;41(3-4):233-41. doi: 10.1159/000445712. Epub 2016 May 10.","Öhman H","Dement Geriatr Cogn Disord","2016","2016/05/11","","","10.1159/000445712"
"9671174","A sandwich enzyme immunoassay for measuring AD7C-NTP as an Alzheimer's disease marker: AD7C test","Ghanbari K, Ghanbari HA.","J Clin Lab Anal. 1998;12(4):223-6. doi: 10.1002/(sici)1098-2825(1998)12:4<223::aid-jcla6>3.0.co;2-8.","Ghanbari K","J Clin Lab Anal","1998","1998/07/22","PMC6807901","","10.1002/(sici)1098-2825(1998)12:4<223::aid-jcla6>3.0.co;2-8"
"9326834","Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist","Satlin A, Bodick N, Offen WW, Renshaw PF.","Am J Psychiatry. 1997 Oct;154(10):1459-61. doi: 10.1176/ajp.154.10.1459.","Satlin A","Am J Psychiatry","1997","1997/10/27","","","10.1176/ajp.154.10.1459"
"14631268","[Oestro-progestagen treatment combined with rivastigmine in menopausal women suffering from Alzheimer's disease. The results of a 28-weeks controlled study]","Rigaud AS, André G, Vellas B, Touchon J, Pere JJ, Loria-Kanza Y.","Presse Med. 2003 Oct 25;32(35):1649-54.","Rigaud AS","Presse Med","2003","2003/11/25","","",""
"11748775","A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients","Chan WC, Lam LC, Choy CN, Leung VP, Li SW, Chiu HF.","Int J Geriatr Psychiatry. 2001 Dec;16(12):1156-62. doi: 10.1002/gps.504.","Chan WC","Int J Geriatr Psychiatry","2001","2001/12/19","","","10.1002/gps.504"
"10733052","The impact of metrifonate therapy on caregivers of patients with Alzheimer's disease: results from the MALT clinical trial. Metrifonate in Alzheimer's Disease Trial","Shikiar R, Shakespeare A, Sagnier PP, Wilkinson D, McKeith I, Dartigues JF, Dubois B.","J Am Geriatr Soc. 2000 Mar;48(3):268-74. doi: 10.1111/j.1532-5415.2000.tb02645.x.","Shikiar R","J Am Geriatr Soc","2000","2000/03/25","","","10.1111/j.1532-5415.2000.tb02645.x"
"17100508","Prospective memory and apolipoprotein E in healthy aging and early stage Alzheimer's disease","Duchek JM, Balota DA, Cortese M.","Neuropsychology. 2006 Nov;20(6):633-44. doi: 10.1037/0894-4105.20.6.633.","Duchek JM","Neuropsychology","2006","2006/11/15","","","10.1037/0894-4105.20.6.633"
"16670247","A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil","van Dyck CH, Schmitt FA, Olin JT; Memantine MEM-MD-02 Study Group.","Am J Geriatr Psychiatry. 2006 May;14(5):428-37. doi: 10.1097/01.JGP.0000203151.17311.38.","van Dyck CH","Am J Geriatr Psychiatry","2006","2006/05/04","","","10.1097/01.JGP.0000203151.17311.38"
"10997480","Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease","Greene RA.","Int J Fertil Womens Med. 2000 Jul-Aug;45(4):253-7.","Greene RA","Int J Fertil Womens Med","2000","2000/09/21","","",""
"17068392","Long-term efficacy and safety of celecoxib in Alzheimer's disease","Soininen H, West C, Robbins J, Niculescu L.","Dement Geriatr Cogn Disord. 2007;23(1):8-21. doi: 10.1159/000096588. Epub 2006 Oct 26.","Soininen H","Dement Geriatr Cogn Disord","2007","2006/10/28","","","10.1159/000096588"
"31766231","Elevated Plasma microRNA-206 Levels Predict Cognitive Decline and Progression to Dementia from Mild Cognitive Impairment","Kenny A, McArdle H, Calero M, Rabano A, Madden SF, Adamson K, Forster R, Spain E, Prehn JHM, Henshall DC, Medina M, Jimenez-Mateos EM, Engel T.","Biomolecules. 2019 Nov 13;9(11):734. doi: 10.3390/biom9110734.","Kenny A","Biomolecules","2019","2019/11/27","PMC6920950","","10.3390/biom9110734"
"22191565","Gender-dependent levels of hyaluronic acid in cerebrospinal fluid of patients with neurodegenerative dementia","Nielsen HM, Palmqvist S, Minthon L, Londos E, Wennström M.","Curr Alzheimer Res. 2012 Mar;9(3):257-66. doi: 10.2174/156720512800107537.","Nielsen HM","Curr Alzheimer Res","2012","2011/12/24","","","10.2174/156720512800107537"
"25346994","Time of day and caffeine influence some neuropsychological tests in the elderly","Walters ER, Lesk VE.","Psychol Assess. 2015 Mar;27(1):161-8. doi: 10.1037/a0038213. Epub 2014 Oct 27.","Walters ER","Psychol Assess","2015","2014/10/28","","","10.1037/a0038213"
"9345696","Perseverative behavior in Alzheimer's disease and subcortical ischemic vascular dementia","Lamar M, Podell K, Carew TG, Cloud BS, Resh R, Kennedy C, Goldberg E, Kaplan E, Libon DJ.","Neuropsychology. 1997 Oct;11(4):523-34. doi: 10.1037//0894-4105.11.4.523.","Lamar M","Neuropsychology","1997","1997/11/05","","","10.1037//0894-4105.11.4.523"
"10371772","[Epidemiology of Alzheimer's disease: the Paquid experience]","Salamon R, Dartigues JF.","Bull Acad Natl Med. 1999;183(1):129-40; discussion 140-2.","Salamon R","Bull Acad Natl Med","1999","1999/06/18","","",""
"7970167","Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients","Shalit F, Sredni B, Stern L, Kott E, Huberman M.","Neurosci Lett. 1994 Jun 20;174(2):130-2. doi: 10.1016/0304-3940(94)90003-5.","Shalit F","Neurosci Lett","1994","1994/06/20","","","10.1016/0304-3940(94)90003-5"
"20029710","Disclosing the disclosure: factors associated with communicating the results of genetic susceptibility testing for Alzheimer's disease","Ashida S, Koehly LM, Roberts JS, Chen CA, Hiraki S, Green RC.","J Health Commun. 2009 Dec;14(8):768-84. doi: 10.1080/10810730903295518.","Ashida S","J Health Commun","2009","2009/12/24","PMC2801901","NIHMS111804","10.1080/10810730903295518"
"29763448","Modulation of functional activity and connectivity by acupuncture in patients with Alzheimer disease as measured by resting-state fMRI","Zheng W, Su Z, Liu X, Zhang H, Han Y, Song H, Lu J, Li K, Wang Z.","PLoS One. 2018 May 15;13(5):e0196933. doi: 10.1371/journal.pone.0196933. eCollection 2018.","Zheng W","PLoS One","2018","2018/05/16","PMC5953467","","10.1371/journal.pone.0196933"
"18401173","Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease","Choi SH, Kim SY, Na HR, Kim BK, Yang DW, Kwon JC, Park MY.","Dement Geriatr Cogn Disord. 2008;25(5):445-50. doi: 10.1159/000124752. Epub 2008 Apr 10.","Choi SH","Dement Geriatr Cogn Disord","2008","2008/04/11","","","10.1159/000124752"
"1986300","Tacrine as a treatment for Alzheimer's dementia: editor's note. An interim report from the FDA. A response from Summers et al","","N Engl J Med. 1991 Jan 31;324(5):349-52. doi: 10.1056/NEJM199101313240525.","","N Engl J Med","1991","1991/01/31","","","10.1056/NEJM199101313240525"
"8815393","Thiamine therapy in Alzheimer's disease","Mimori Y, Katsuoka H, Nakamura S.","Metab Brain Dis. 1996 Mar;11(1):89-94. doi: 10.1007/BF02080934.","Mimori Y","Metab Brain Dis","1996","1996/03/01","","","10.1007/BF02080934"
"7905118","Long-term use of tacrine","Wilcock GK, Scott M, Pearsall T.","Lancet. 1994 Jan 29;343(8892):294. doi: 10.1016/s0140-6736(94)91140-1.","Wilcock GK","Lancet","1994","1994/01/29","","","10.1016/s0140-6736(94)91140-1"
"31616139","The LipiDiDiet trial: what does it add to the current evidence for Fortasyn Connect in early Alzheimer's disease?","Rasmussen J.","Clin Interv Aging. 2019 Aug 15;14:1481-1492. doi: 10.2147/CIA.S211739. eCollection 2019.","Rasmussen J","Clin Interv Aging","2019","2019/10/17","PMC6699494","","10.2147/CIA.S211739"
"36894171","Efficacy and safety of a transdermal donepezil patch in patients with mild-to-moderate Alzheimer's disease: A 24-week, randomized, multicenter, double-blind, parallel group, non-inferiority study","Nakamura Y, Kim R, Nishiyama K, Kikuchi T, Ishikawa I, Aoki H.","Geriatr Gerontol Int. 2023 Apr;23(4):275-281. doi: 10.1111/ggi.14566. Epub 2023 Mar 9.","Nakamura Y","Geriatr Gerontol Int","2023","2023/03/09","","","10.1111/ggi.14566"
"30123243","Beneficial Effect of Multidomain Cognitive Training on the Neuropsychological Performance of Patients with Early-Stage Alzheimer's Disease","Nousia A, Siokas V, Aretouli E, Messinis L, Aloizou AM, Martzoukou M, Karala M, Koumpoulis C, Nasios G, Dardiotis E.","Neural Plast. 2018 Jul 11;2018:2845176. doi: 10.1155/2018/2845176. eCollection 2018.","Nousia A","Neural Plast","2018","2018/08/21","PMC6079404","","10.1155/2018/2845176"
"19138567","The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial","Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, Gill R, Juszczak E, Yu LM, Jacoby R; DART-AD investigators.","Lancet Neurol. 2009 Feb;8(2):151-7. doi: 10.1016/S1474-4422(08)70295-3. Epub 2009 Jan 8.","Ballard C","Lancet Neurol","2009","2009/01/14","","","10.1016/S1474-4422(08)70295-3"
"17334274","Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: secondary analyses from a placebo-controlled randomized trial","Pomara N, Ott BR, Peskind E, Resnick EM.","Alzheimer Dis Assoc Disord. 2007 Jan-Mar;21(1):60-4. doi: 10.1097/WAD.0b013e318032cf29.","Pomara N","Alzheimer Dis Assoc Disord","2007","2007/03/06","","","10.1097/WAD.0b013e318032cf29"
"27334799","Long-term safety and tolerability of bapineuzumab in patients with Alzheimer's disease in two phase 3 extension studies","Ivanoiu A, Pariente J, Booth K, Lobello K, Luscan G, Hua L, Lucas P, Styren S, Yang L, Li D, Black RS, Brashear HR, McRae T.","Alzheimers Res Ther. 2016 Jun 23;8(1):24. doi: 10.1186/s13195-016-0193-y.","Ivanoiu A","Alzheimers Res Ther","2016","2016/06/24","PMC4918115","","10.1186/s13195-016-0193-y"
"14742608","Prediction of treatment response to rivastigmine in Alzheimer's dementia","Adler G, Brassen S, Chwalek K, Dieter B, Teufel M.","J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):292-4.","Adler G","J Neurol Neurosurg Psychiatry","2004","2004/01/27","PMC1738912","",""
"22531418","Amyloid-β(1-15/16) as a marker for γ-secretase inhibition in Alzheimer's disease","Portelius E, Zetterberg H, Dean RA, Marcil A, Bourgeois P, Nutu M, Andreasson U, Siemers E, Mawuenyega KG, Sigurdson WC, May PC, Paul SM, Holtzman DM, Blennow K, Bateman RJ.","J Alzheimers Dis. 2012;31(2):335-41. doi: 10.3233/JAD-2012-120508.","Portelius E","J Alzheimers Dis","2012","2012/04/26","PMC3609706","NIHMS450894","10.3233/JAD-2012-120508"
"12626849","Regional cerebral blood flow patterns and response to donepezil treatment in patients with Alzheimer's disease","Hanyu H, Shimizu T, Tanaka Y, Takasaki M, Koizumi K, Abe K.","Dement Geriatr Cogn Disord. 2003;15(4):177-82. doi: 10.1159/000068785.","Hanyu H","Dement Geriatr Cogn Disord","2003","2003/03/11","","","10.1159/000068785"
"9048794","APOE genotyping and response to drug treatment in Alzheimer's disease","Richard F, Helbecque N, Neuman E, Guez D, Levy R, Amouyel P.","Lancet. 1997 Feb 22;349(9051):539. doi: 10.1016/S0140-6736(97)80089-X.","Richard F","Lancet","1997","1997/02/22","","","10.1016/S0140-6736(97)80089-X"
"1543795","Nutrition and SDAT","Abalan F, Manciet G, Dartigues JF, Décamps A, Zapata E, Saumtally B, Galley P.","Biol Psychiatry. 1992 Jan 1;31(1):103-5. doi: 10.1016/0006-3223(92)90013-p.","Abalan F","Biol Psychiatry","1992","1992/01/01","","","10.1016/0006-3223(92)90013-p"
"22687392","A randomized, double-blind, placebo-controlled trial of modafinil for the treatment of apathy in individuals with mild-to-moderate Alzheimer's disease","Frakey LL, Salloway S, Buelow M, Malloy P.","J Clin Psychiatry. 2012 Jun;73(6):796-801. doi: 10.4088/JCP.10m06708. Epub 2012 May 15.","Frakey LL","J Clin Psychiatry","2012","2012/06/13","","","10.4088/JCP.10m06708"
"14501025","A position paper: based on observational data indicating an increased rate of altered blood chemistry requiring withdrawal from the Alzheimer's Disease Cholesterol-Lowering Treatment Trial (ADCLT)","Sparks DL, Lopez J, Connor D, Sabbagh M, Seward J, Browne P; Alzheimer's Disease Cholesterol-Lowering Treatment Team.","J Mol Neurosci. 2003;20(3):407-10. doi: 10.1385/JMN:20:3:407.","Sparks DL","J Mol Neurosci","2003","2003/09/23","","","10.1385/JMN:20:3:407"
"15800139","Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial","Yaffe K, Krueger K, Cummings SR, Blackwell T, Henderson VW, Sarkar S, Ensrud K, Grady D.","Am J Psychiatry. 2005 Apr;162(4):683-90. doi: 10.1176/appi.ajp.162.4.683.","Yaffe K","Am J Psychiatry","2005","2005/04/01","","","10.1176/appi.ajp.162.4.683"
"15582745","Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging","Yasar S, Corrada M, Brookmeyer R, Kawas C.","Neurobiol Aging. 2005 Feb;26(2):157-63. doi: 10.1016/j.neurobiolaging.2004.03.009.","Yasar S","Neurobiol Aging","2005","2004/12/08","","","10.1016/j.neurobiolaging.2004.03.009"
"27032628","Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study","Leonpacher AK, Peters ME, Drye LT, Makino KM, Newell JA, Devanand DP, Frangakis C, Munro CA, Mintzer JE, Pollock BG, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Porsteinsson AP; CitAD Research Group.","Am J Psychiatry. 2016 May 1;173(5):473-80. doi: 10.1176/appi.ajp.2016.15020248. Epub 2016 Apr 1.","Leonpacher AK","Am J Psychiatry","2016","2016/04/02","","","10.1176/appi.ajp.2016.15020248"
"23429813","A reminiscence program intervention to improve the quality of life of long-term care residents with Alzheimer's disease: a randomized controlled trial","Serrani Azcurra DJ.","Braz J Psychiatry. 2012 Dec;34(4):422-33. doi: 10.1016/j.rbp.2012.05.008.","Serrani Azcurra DJ","Braz J Psychiatry","2012","2013/02/23","","","10.1016/j.rbp.2012.05.008"
"9693995","The value of REM sleep parameters in differentiating Alzheimer's disease from old-age depression and normal aging","Dykierek P, Stadtmüller G, Schramm P, Bahro M, van Calker D, Braus DF, Steigleider P, Löw H, Hohagen F, Gattaz WF, Berger M, Riemann D.","J Psychiatr Res. 1998 Jan-Feb;32(1):1-9. doi: 10.1016/s0022-3956(97)00049-6.","Dykierek P","J Psychiatr Res","1998","1998/08/07","","","10.1016/s0022-3956(97)00049-6"
"15266207","Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial","Roberts JS, Barber M, Brown TM, Cupples LA, Farrer LA, LaRusse SA, Post SG, Quaid KA, Ravdin LD, Relkin NR, Sadovnick AD, Whitehouse PJ, Woodard JL, Green RC.","Genet Med. 2004 Jul-Aug;6(4):197-203. doi: 10.1097/01.gim.0000132688.55591.77.","Roberts JS","Genet Med","2004","2004/07/22","","","10.1097/01.gim.0000132688.55591.77"
"20043816","Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457, in Alzheimer's disease","Maher-Edwards G, Zvartau-Hind M, Hunter AJ, Gold M, Hopton G, Jacobs G, Davy M, Williams P.","Curr Alzheimer Res. 2010 Aug;7(5):374-85. doi: 10.2174/156720510791383831.","Maher-Edwards G","Curr Alzheimer Res","2010","2010/01/02","","","10.2174/156720510791383831"
"34822784","From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease","Brown AJH, Bradley SJ, Marshall FH, Brown GA, Bennett KA, Brown J, Cansfield JE, Cross DM, de Graaf C, Hudson BD, Dwomoh L, Dias JM, Errey JC, Hurrell E, Liptrot J, Mattedi G, Molloy C, Nathan PJ, Okrasa K, Osborne G, Patel JC, Pickworth M, Robertson N, Shahabi S, Bundgaard C, Phillips K, Broad LM, Goonawardena AV, Morairty SR, Browning M, Perini F, Dawson GR, Deakin JFW, Smith RT, Sexton PM, Warneck J, Vinson M, Tasker T, Tehan BG, Teobald B, Christopoulos A, Langmead CJ, Jazayeri A, Cooke RM, Rucktooa P, Congreve MS, Weir M, Tobin AB.","Cell. 2021 Nov 24;184(24):5886-5901.e22. doi: 10.1016/j.cell.2021.11.001.","Brown AJH","Cell","2021","2021/11/25","","","10.1016/j.cell.2021.11.001"
"26967206","Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease","Pasquier F, Sadowsky C, Holstein A, Leterme Gle P, Peng Y, Jackson N, Fox NC, Ketter N, Liu E, Ryan JM; ACC-001 (QS-21) Study Team.","J Alzheimers Dis. 2016;51(4):1131-43. doi: 10.3233/JAD-150376.","Pasquier F","J Alzheimers Dis","2016","2016/03/12","","","10.3233/JAD-150376"
"10325453","The effects of donepezil in Alzheimer's disease - results from a multinational trial","Burns A, Rossor M, Hecker J, Gauthier S, Petit H, Möller HJ, Rogers SL, Friedhoff LT.","Dement Geriatr Cogn Disord. 1999 May-Jun;10(3):237-44. doi: 10.1159/000017126.","Burns A","Dement Geriatr Cogn Disord","1999","1999/05/15","","","10.1159/000017126"
"18179495","Can counseling and support reduce burden and depressive symptoms in caregivers of people with Alzheimer's disease during the transition to institutionalization? Results from the New York University caregiver intervention study","Gaugler JE, Roth DL, Haley WE, Mittelman MS.","J Am Geriatr Soc. 2008 Mar;56(3):421-8. doi: 10.1111/j.1532-5415.2007.01593.x. Epub 2008 Jan 4.","Gaugler JE","J Am Geriatr Soc","2008","2008/01/09","PMC2700042","NIHMS113868","10.1111/j.1532-5415.2007.01593.x"
"8993489","Apolipoprotein E genotype and gender influence response to tacrine therapy","Farlow MR, Lahiri DK, Poirier J, Davignon J, Hui S.","Ann N Y Acad Sci. 1996 Dec 16;802:101-10. doi: 10.1111/j.1749-6632.1996.tb32603.x.","Farlow MR","Ann N Y Acad Sci","1996","1996/12/16","","","10.1111/j.1749-6632.1996.tb32603.x"
"9595966","Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group","Cummings JL, Cyrus PA, Bieber F, Mas J, Orazem J, Gulanski B.","Neurology. 1998 May;50(5):1214-21. doi: 10.1212/wnl.50.5.1214.","Cummings JL","Neurology","1998","1998/05/22","","","10.1212/wnl.50.5.1214"
"30309389","Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study","Scheltens P, Hallikainen M, Grimmer T, Duning T, Gouw AA, Teunissen CE, Wink AM, Maruff P, Harrison J, van Baal CM, Bruins S, Lues I, Prins ND.","Alzheimers Res Ther. 2018 Oct 12;10(1):107. doi: 10.1186/s13195-018-0431-6.","Scheltens P","Alzheimers Res Ther","2018","2018/10/13","PMC6182869","","10.1186/s13195-018-0431-6"
"16799903","[Observational study on safety, tolerability and effectiveness of galantamine in patients with mild to moderately severe Alzheimer's disease]","Blesa R, García Ribas G, Galdós L, Olascoaga J, Amer G, Marey López J, Barquero M, Marsall C, Ezpeleta D.","Neurologia. 2006 Jul-Aug;21(6):289-96.","Blesa R","Neurologia","2006","2006/06/27","","",""
"25187399","Confirmatory population pharmacokinetic analysis for bapineuzumab phase 3 studies in patients with mild to moderate Alzheimer's disease","Hu C, Adedokun O, Ito K, Raje S, Lu M.","J Clin Pharmacol. 2015 Feb;55(2):221-9. doi: 10.1002/jcph.393. Epub 2014 Sep 16.","Hu C","J Clin Pharmacol","2015","2014/09/05","","","10.1002/jcph.393"
"18373036","A randomized trial of the impact of a specific care plan in 1120 Alzheimer's patients (PLASA Study) over a two-year period: design and baseline data","Nourhashemi F, Gillette-Guyonnet S, Andrieu S, Rolland Y, Ousset PJ, Vellas B; PLASA group.","J Nutr Health Aging. 2008 Apr;12(4):263-71. doi: 10.1007/BF02982632.","Nourhashemi F","J Nutr Health Aging","2008","2008/04/01","","","10.1007/BF02982632"
"22930699","Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease","Salloway S, Mintzer J, Cummings JL, Geldmacher D, Sun Y, Yardley J, Mackell J.","Am J Alzheimers Dis Other Demen. 2012 Sep;27(6):421-32. doi: 10.1177/1533317512454708.","Salloway S","Am J Alzheimers Dis Other Demen","2012","2012/08/30","","","10.1177/1533317512454708"
"10326778","Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease","White HK, Levin ED.","Psychopharmacology (Berl). 1999 Apr;143(2):158-65. doi: 10.1007/s002130050931.","White HK","Psychopharmacology (Berl)","1999","1999/05/18","","","10.1007/s002130050931"
"10026381","White matter lesions in Alzheimer patients are influenced by apolipoprotein E genotype","Bronge L, Fernaeus SE, Blomberg M, Ingelson M, Lannfelt L, Isberg B, Wahlund LO.","Dement Geriatr Cogn Disord. 1999 Mar-Apr;10(2):89-96. doi: 10.1159/000017107.","Bronge L","Dement Geriatr Cogn Disord","1999","1999/02/23","","","10.1159/000017107"
"36460293","Efficacy and safety of simultaneous rTMS-tDCS over bilateral angular gyrus on neuropsychiatric symptoms in patients with moderate Alzheimer's disease: A prospective, randomized, sham-controlled pilot study","Hu Y, Jia Y, Sun Y, Ding Y, Huang Z, Liu C, Wang Y.","Brain Stimul. 2022 Nov-Dec;15(6):1530-1537. doi: 10.1016/j.brs.2022.11.009. Epub 2022 Nov 30.","Hu Y","Brain Stimul","2022","2022/12/02","","","10.1016/j.brs.2022.11.009"
"10505638","Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment","Andreasen N, Minthon L, Vanmechelen E, Vanderstichele H, Davidsson P, Winblad B, Blennow K.","Neurosci Lett. 1999 Sep 24;273(1):5-8. doi: 10.1016/s0304-3940(99)00617-5.","Andreasen N","Neurosci Lett","1999","1999/10/03","","","10.1016/s0304-3940(99)00617-5"
"23790699","[Practice example: neurodegenerative disorders: randomised controlled multicentre trial of home-based occupational therapy for patients with dementia]","Voigt-Radloff S, Hüll M.","Z Evid Fortbild Qual Gesundhwes. 2013;107(3):222-8. doi: 10.1016/j.zefq.2013.04.001. Epub 2013 May 14.","Voigt-Radloff S","Z Evid Fortbild Qual Gesundhwes","2013","2013/06/25","","","10.1016/j.zefq.2013.04.001"
"24880524","[Effects of a neuropsychology program based on mindfulness on Alzheimer's disease: randomized double-blind clinical study]","Quintana Hernández DJ, Miró Barrachina MT, Ibáñez Fernández I, del Pino AS, García Rodríguez Jr, Hernández JR.","Rev Esp Geriatr Gerontol. 2014 Jul-Aug;49(4):165-72. doi: 10.1016/j.regg.2014.03.002. Epub 2014 May 28.","Quintana Hernández DJ","Rev Esp Geriatr Gerontol","2014","2014/06/02","","","10.1016/j.regg.2014.03.002"
"2643155","Potential use of nerve growth factor to treat Alzheimer's disease","","Science. 1989 Jan 6;243(4887):11.","","Science","1989","1989/01/06","","",""
"6347143","Lecithin in the treatment of Alzheimer's disease","Weintraub S, Mesulam MM, Auty R, Baratz R, Cholakos BN, Kapust L, Ransil B, Tellers JG, Albert MS, LoCastro S, Moss M.","Arch Neurol. 1983 Aug;40(8):527-8. doi: 10.1001/archneur.1983.04210070067022.","Weintraub S","Arch Neurol","1983","1983/08/01","","","10.1001/archneur.1983.04210070067022"
"16326662","Training community consultants to help family members improve dementia care: a randomized controlled trial","Teri L, McCurry SM, Logsdon R, Gibbons LE.","Gerontologist. 2005 Dec;45(6):802-11. doi: 10.1093/geront/45.6.802.","Teri L","Gerontologist","2005","2005/12/06","","","10.1093/geront/45.6.802"
"18456094","Antipsychotics in individuals with intellectual disability","Gainotti S, Galeotti F, Izzicupo F, Petrini C, Raschetti R.","Lancet. 2008 May 3;371(9623):1501-2; author reply 1502. doi: 10.1016/S0140-6736(08)60648-0.","Gainotti S","Lancet","2008","2008/05/06","","","10.1016/S0140-6736(08)60648-0"
"31542965","Blood Pressure Variability and Progression of Clinical Alzheimer Disease","de Heus RAA, Olde Rikkert MGM, Tully PJ, Lawlor BA, Claassen JAHR; NILVAD Study Group.","Hypertension. 2019 Nov;74(5):1172-1180. doi: 10.1161/HYPERTENSIONAHA.119.13664. Epub 2019 Sep 23.","de Heus RAA","Hypertension","2019","2019/09/24","","","10.1161/HYPERTENSIONAHA.119.13664"
"32715623","A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study","Boada M, López OL, Olazarán J, Núñez L, Pfeffer M, Paricio M, Lorites J, Piñol-Ripoll G, Gámez JE, Anaya F, Kiprov D, Lima J, Grifols C, Torres M, Costa M, Bozzo J, Szczepiorkowski ZM, Hendrix S, Páez A.","Alzheimers Dement. 2020 Oct;16(10):1412-1425. doi: 10.1002/alz.12137. Epub 2020 Jul 27.","Boada M","Alzheimers Dement","2020","2020/07/28","PMC7984263","","10.1002/alz.12137"
"24012631","Epigenetic changes in the progression of Alzheimer's disease","Bradley-Whitman MA, Lovell MA.","Mech Ageing Dev. 2013 Oct;134(10):486-95. doi: 10.1016/j.mad.2013.08.005. Epub 2013 Sep 3.","Bradley-Whitman MA","Mech Ageing Dev","2013","2013/09/10","PMC3857018","NIHMS526737","10.1016/j.mad.2013.08.005"
"31377702","Tablet-based sensorimotor home-training system for amnestic mild cognitive impairments in the elderly: design of a randomised clinical trial","Bekrater-Bodmann R, Löffler A, Silvoni S, Frölich L, Hausner L, Desch S, Kleinböhl D, Flor H.","BMJ Open. 2019 Aug 2;9(8):e028632. doi: 10.1136/bmjopen-2018-028632.","Bekrater-Bodmann R","BMJ Open","2019","2019/08/05","PMC6687000","","10.1136/bmjopen-2018-028632"
"33032927","Preliminary Evidence That Cortical Amyloid Burden Predicts Poor Response to Antidepressant Medication Treatment in Cognitively Intact Individuals With Late-Life Depression","Taylor WD, Boyd BD, Elson D, Andrews P, Albert K, Vega J, Newhouse PA, Woodward ND, Kang H, Shokouhi S.","Am J Geriatr Psychiatry. 2021 May;29(5):448-457. doi: 10.1016/j.jagp.2020.09.019. Epub 2020 Sep 28.","Taylor WD","Am J Geriatr Psychiatry","2021","2020/10/09","PMC8004530","NIHMS1636695","10.1016/j.jagp.2020.09.019"
"10789876","Attenuation of brain high frequency electrocortical response after thiopental in early stages of Alzheimer's dementia","Holschneider DP, Leuchter AF.","Psychopharmacology (Berl). 2000 Mar;149(1):6-11. doi: 10.1007/s002139900330.","Holschneider DP","Psychopharmacology (Berl)","2000","2000/05/02","","","10.1007/s002139900330"
"16340722","A region-of-interest template for three-dimensional stereotactic surface projection images: initial application to the analysis of Alzheimer's disease and mild cognitive impairment","Kubota T, Ushijima Y, Okuyama C, Nishimura T.","Nucl Med Commun. 2006 Jan;27(1):37-44. doi: 10.1097/01.mnm.0000188220.99580.88.","Kubota T","Nucl Med Commun","2006","2005/12/13","","","10.1097/01.mnm.0000188220.99580.88"
"24676435","Treadmill training as an augmentation treatment for Alzheimer's disease: a pilot randomized controlled study","Arcoverde C, Deslandes A, Moraes H, Almeida C, Araujo NB, Vasques PE, Silveira H, Laks J.","Arq Neuropsiquiatr. 2014 Mar;72(3):190-6. doi: 10.1590/0004-282X20130231.","Arcoverde C","Arq Neuropsiquiatr","2014","2014/03/29","","","10.1590/0004-282X20130231"
"15800784","Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies","Ishii K, Sasaki H, Kono AK, Miyamoto N, Fukuda T, Mori E.","Eur J Nucl Med Mol Imaging. 2005 Aug;32(8):959-63. doi: 10.1007/s00259-004-1740-5. Epub 2005 Mar 31.","Ishii K","Eur J Nucl Med Mol Imaging","2005","2005/04/01","","","10.1007/s00259-004-1740-5"
"22763629","Head motion evaluation and correction for PET scans with 18F-FDG in the Japanese Alzheimer's disease neuroimaging initiative (J-ADNI) multi-center study","Ikari Y, Nishio T, Makishi Y, Miya Y, Ito K, Koeppe RA, Senda M.","Ann Nucl Med. 2012 Aug;26(7):535-44. doi: 10.1007/s12149-012-0605-4. Epub 2012 Jul 5.","Ikari Y","Ann Nucl Med","2012","2012/07/06","","","10.1007/s12149-012-0605-4"
"26177825","Early psychosocial intervention does not delay institutionalization in persons with mild Alzheimer disease and has impact on neither disease progression nor caregivers' well-being: ALSOVA 3-year follow-up","Koivisto AM, Hallikainen I, Välimäki T, Hongisto K, Hiltunen A, Karppi P, Sivenius J, Soininen H, Martikainen J.","Int J Geriatr Psychiatry. 2016 Mar;31(3):273-83. doi: 10.1002/gps.4321. Epub 2015 Jul 14.","Koivisto AM","Int J Geriatr Psychiatry","2016","2015/07/17","","","10.1002/gps.4321"
"17068314","Design of Depression in Alzheimer's Disease Study-2","Martin BK, Frangakis CE, Rosenberg PB, Mintzer JE, Katz IR, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Niederehe G, Lyketsos CG.","Am J Geriatr Psychiatry. 2006 Nov;14(11):920-30. doi: 10.1097/01.JGP.0000240977.71305.ee.","Martin BK","Am J Geriatr Psychiatry","2006","2006/10/28","","","10.1097/01.JGP.0000240977.71305.ee"
"30553760","Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data","Sörensen A, Blazhenets G, Rücker G, Schiller F, Meyer PT, Frings L; Alzheimer's Disease Neuroimaging Initiative.","Neuroimage Clin. 2019;21:101637. doi: 10.1016/j.nicl.2018.101637. Epub 2018 Dec 10.","Sörensen A","Neuroimage Clin","2019","2018/12/17","PMC6411907","","10.1016/j.nicl.2018.101637"
"9635475","Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down's syndrome","Sekijima Y, Ikeda S, Tokuda T, Satoh S, Hidaka H, Hidaka E, Ishikawa M, Yanagisawa N.","Eur Neurol. 1998;39(4):234-7. doi: 10.1159/000007940.","Sekijima Y","Eur Neurol","1998","1998/06/23","","","10.1159/000007940"
"29582053","Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial","Rafii MS, Tuszynski MH, Thomas RG, Barba D, Brewer JB, Rissman RA, Siffert J, Aisen PS; AAV2-NGF Study Team.","JAMA Neurol. 2018 Jul 1;75(7):834-841. doi: 10.1001/jamaneurol.2018.0233.","Rafii MS","JAMA Neurol","2018","2018/03/28","PMC5885277","","10.1001/jamaneurol.2018.0233"
"15877554","Nighttime insomnia treatment and education for Alzheimer's disease: a randomized, controlled trial","McCurry SM, Gibbons LE, Logsdon RG, Vitiello MV, Teri L.","J Am Geriatr Soc. 2005 May;53(5):793-802. doi: 10.1111/j.1532-5415.2005.53252.x.","McCurry SM","J Am Geriatr Soc","2005","2005/05/10","","","10.1111/j.1532-5415.2005.53252.x"
"2284328","Naftidrofuryl in the treatment of mild senile dementia. A double-blind study","Grossmann WM, Standl A, May U, van Laak HH, Hirche H.","Pharmacopsychiatry. 1990 Nov;23(6):265-73. doi: 10.1055/s-2007-1014517.","Grossmann WM","Pharmacopsychiatry","1990","1990/11/01","","","10.1055/s-2007-1014517"
"1531304","Plasma dehydroepiandrosterone sulfate in Alzheimer's disease","Schneider LS, Hinsey M, Lyness S.","Biol Psychiatry. 1992 Jan 15;31(2):205-8. doi: 10.1016/0006-3223(92)90206-f.","Schneider LS","Biol Psychiatry","1992","1992/01/15","","","10.1016/0006-3223(92)90206-f"
"27389402","Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device","Eyjolfsdottir H, Eriksdotter M, Linderoth B, Lind G, Juliusson B, Kusk P, Almkvist O, Andreasen N, Blennow K, Ferreira D, Westman E, Nennesmo I, Karami A, Darreh-Shori T, Kadir A, Nordberg A, Sundström E, Wahlund LO, Wall A, Wiberg M, Winblad B, Seiger Å, Wahlberg L, Almqvist P.","Alzheimers Res Ther. 2016 Jul 7;8(1):30. doi: 10.1186/s13195-016-0195-9.","Eyjolfsdottir H","Alzheimers Res Ther","2016","2016/07/09","PMC4936020","","10.1186/s13195-016-0195-9"
"11974514","[Effect of daily living-related cognitive training on attention and memory performance of persons with dementia]","Bernhardt T, Maurer K, Frölich L.","Z Gerontol Geriatr. 2002 Feb;35(1):32-8. doi: 10.1007/s003910200004.","Bernhardt T","Z Gerontol Geriatr","2002","2002/04/27","","","10.1007/s003910200004"
"23766638","Evaluation of a computer-assisted errorless learning-based memory training program for patients with early Alzheimer's disease in Hong Kong: a pilot study","Lee GY, Yip CC, Yu EC, Man DW.","Clin Interv Aging. 2013;8:623-33. doi: 10.2147/CIA.S45726. Epub 2013 Jun 7.","Lee GY","Clin Interv Aging","2013","2013/06/15","PMC3679968","","10.2147/CIA.S45726"
"8830309","Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians","Morris CM, Benjamin R, Leake A, McArthur FK, Candy JM, Ince PG, Torvik A, Bjertness E, Edwardson JA.","Neurosci Lett. 1995 Dec 1;201(1):45-7. doi: 10.1016/0304-3940(94)12126-b.","Morris CM","Neurosci Lett","1995","1995/12/01","","","10.1016/0304-3940(94)12126-b"
"10867783","Progression of parkinsonism and loss of cognitive function in Alzheimer disease","Wilson RS, Bennett DA, Gilley DW, Beckett LA, Schneider JA, Evans DA.","Arch Neurol. 2000 Jun;57(6):855-60. doi: 10.1001/archneur.57.6.855.","Wilson RS","Arch Neurol","2000","2000/06/27","","","10.1001/archneur.57.6.855"
"12770610","A multicenter, randomized, placebo controlled, multiple-dose, safety and pharmacokinetic study of AIT-082 (Neotrofin) in mild Alzheimer's disease patients","Grundman M, Capparelli E, Kim HT, Morris JC, Farlow M, Rubin EH, Heidebrink J, Hake A, Ho G, Schultz AN, Schafer K, Houston W, Thomas R, Thal LJ; Alzheimer's Disease Cooperative Study.","Life Sci. 2003 Jun 20;73(5):539-53. doi: 10.1016/s0024-3205(03)00320-5.","Grundman M","Life Sci","2003","2003/05/29","","","10.1016/s0024-3205(03)00320-5"
"11039460","Basal and activational 99Tcm-HMPAO brain SPECT in Alzheimer's disease","Sayit E, Yener G, Capa G, Ertay T, Keskin B, Fadiloglu S, Durak H.","Nucl Med Commun. 2000 Aug;21(8):763-8. doi: 10.1097/00006231-200008000-00010.","Sayit E","Nucl Med Commun","2000","2000/10/20","","","10.1097/00006231-200008000-00010"
"1418362","Alzheimer's patients should be included in phase I clinical trials to evaluate compounds for Alzheimer's disease","Cutler NR, Sramek JJ, Murphy MF, Nash RJ.","J Geriatr Psychiatry Neurol. 1992 Oct-Dec;5(4):192-4. doi: 10.1177/002383099200500402.","Cutler NR","J Geriatr Psychiatry Neurol","1992","1992/10/01","","","10.1177/002383099200500402"
"24314887","Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2","Flynn Longmire CV, Drye LT, Frangakis CE, Martin BK, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG; DIADS-2 Research Group.","Am J Geriatr Psychiatry. 2014 Jan;22(1):14-24. doi: 10.1016/j.jagp.2013.02.014.","Flynn Longmire CV","Am J Geriatr Psychiatry","2014","2013/12/10","PMC3910508","NIHMS540846","10.1016/j.jagp.2013.02.014"
"22684530","18F-labelled CCR1-receptor antagonist is not suitable for imaging of Alzheimer's disease","Beuthien-Baumann B, Holthoff VA, Mäding P, Bergmann R, Pawelke B, Holl G, von Kummer R, Kotzerke J, van den Hoff J.","Nuklearmedizin. 2012;51(6):239-43. doi: 10.3413/Nukmed-0457-12-01. Epub 2012 Jun 11.","Beuthien-Baumann B","Nuklearmedizin","2012","2012/06/12","","","10.3413/Nukmed-0457-12-01"
"7478254","Tetrahydroaminoacridine modulates technetium-99m labelled ethylene dicysteinate retention in Alzheimer's disease measured with single photon emission computed tomography imaging","Riekkinen P Jr, Kuikka J, Soininen H, Helkala EL, Hallikainen M, Riekkinen P.","Neurosci Lett. 1995 Jul 28;195(1):53-6. doi: 10.1016/0304-3940(95)11780-z.","Riekkinen P Jr","Neurosci Lett","1995","1995/07/28","","","10.1016/0304-3940(95)11780-z"
"16644278","Absent event-related potential (ERP) word repetition effects in mild Alzheimer's disease","Olichney JM, Iragui VJ, Salmon DP, Riggins BR, Morris SK, Kutas M.","Clin Neurophysiol. 2006 Jun;117(6):1319-30. doi: 10.1016/j.clinph.2006.02.022. Epub 2006 Apr 27.","Olichney JM","Clin Neurophysiol","2006","2006/04/29","PMC1544116","NIHMS11182","10.1016/j.clinph.2006.02.022"
"9521253","L-deprenyl in Alzheimer's disease: cognitive and behavioral effects","Freedman M, Rewilak D, Xerri T, Cohen S, Gordon AS, Shandling M, Logan AG.","Neurology. 1998 Mar;50(3):660-8. doi: 10.1212/wnl.50.3.660.","Freedman M","Neurology","1998","1998/04/01","","","10.1212/wnl.50.3.660"
"8512628","Evaluation of multiple doses of milacemide in the treatment of senile dementia of the Alzheimer's type","Cutler NR, Fakouhi TD, Smith WT, Hendrie HC, Matsuo F, Sramek JJ, Herting RL.","J Geriatr Psychiatry Neurol. 1993 Apr-Jun;6(2):115-9. doi: 10.1177/089198879300600210.","Cutler NR","J Geriatr Psychiatry Neurol","1993","1993/04/01","","","10.1177/089198879300600210"
"18179480","The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's disease","Nichols LO, Chang C, Lummus A, Burns R, Martindale-Adams J, Graney MJ, Coon DW, Czaja S; Resources for Enhancing Alzheimer's Caregivers Health II Investigators.","J Am Geriatr Soc. 2008 Mar;56(3):413-20. doi: 10.1111/j.1532-5415.2007.01569.x. Epub 2007 Dec 27.","Nichols LO","J Am Geriatr Soc","2008","2008/01/09","PMC2575686","NIHMS74342","10.1111/j.1532-5415.2007.01569.x"
"7970234","Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls","St Clair D, Norrman J, Perry R, Yates C, Wilcock G, Brookes A.","Neurosci Lett. 1994 Jul 18;176(1):45-6. doi: 10.1016/0304-3940(94)90867-2.","St Clair D","Neurosci Lett","1994","1994/07/18","","","10.1016/0304-3940(94)90867-2"
"9850940","Clinical experience with Donepezil (Aricept) in the UK","Wilkinson D.","J Neural Transm Suppl. 1998;54:311-5. doi: 10.1007/978-3-7091-7508-8_31.","Wilkinson D","J Neural Transm Suppl","1998","1998/12/16","","","10.1007/978-3-7091-7508-8_31"
"35098971","Multimodal Preventive Trial for Alzheimer's Disease: MIND-ADmini Pilot Trial Study Design and Progress","Sindi S, Thunborg C, Rosenberg A, Andersen P, Andrieu S, Broersen LM, Coley N, Couderc C, Duval CZ, Faxen-Irving G, Hagman G, Hallikainen M, Håkansson K, Lehtisalo J, Levak N, Mangialasche F, Pantel J, Kekkonen E, Rydström A, Stigsdotter-Neely A, Wimo A, Ngandu T, Soininen H, Hartmann T, Solomon A, Kivipelto M.","J Prev Alzheimers Dis. 2022;9(1):30-39. doi: 10.14283/jpad.2022.4.","Sindi S","J Prev Alzheimers Dis","2022","2022/01/31","PMC8783958","","10.14283/jpad.2022.4"
"10229057","Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease","Potter A, Corwin J, Lang J, Piasecki M, Lenox R, Newhouse PA.","Psychopharmacology (Berl). 1999 Mar;142(4):334-42. doi: 10.1007/s002130050897.","Potter A","Psychopharmacology (Berl)","1999","1999/05/06","","","10.1007/s002130050897"
"11116776","Impact of emotion on memory. Controlled study of the influence of emotionally charged material on declarative memory in Alzheimer's disease","Kazui H, Mori E, Hashimoto M, Hirono N, Imamura T, Tanimukai S, Hanihara T, Cahill L.","Br J Psychiatry. 2000 Oct;177:343-7. doi: 10.1192/bjp.177.4.343.","Kazui H","Br J Psychiatry","2000","2000/12/16","","","10.1192/bjp.177.4.343"
"36140138","The Feasibility of Early Alzheimer's Disease Diagnosis Using a Neural Network Hybrid Platform","Yu X, Srivastava S, Huang S, Hayden EY, Teplow DB, Xie YH.","Biosensors (Basel). 2022 Sep 13;12(9):753. doi: 10.3390/bios12090753.","Yu X","Biosensors (Basel)","2022","2022/09/23","PMC9496690","","10.3390/bios12090753"
"19208247","Changes in cognitive domains during three years in patients with Alzheimer's disease treated with donepezil","Persson CM, Wallin AK, Levander S, Minthon L.","BMC Neurol. 2009 Feb 10;9:7. doi: 10.1186/1471-2377-9-7.","Persson CM","BMC Neurol","2009","2009/02/12","PMC2666627","","10.1186/1471-2377-9-7"
"17509485","Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study","Feldman HH, Ferris S, Winblad B, Sfikas N, Mancione L, He Y, Tekin S, Burns A, Cummings J, del Ser T, Inzitari D, Orgogozo JM, Sauer H, Scheltens P, Scarpini E, Herrmann N, Farlow M, Potkin S, Charles HC, Fox NC, Lane R.","Lancet Neurol. 2007 Jun;6(6):501-12. doi: 10.1016/S1474-4422(07)70109-6.","Feldman HH","Lancet Neurol","2007","2007/05/19","","","10.1016/S1474-4422(07)70109-6"
"28528185","Simvastatin ameliorate memory deficits and inflammation in clinical and mouse model of Alzheimer's disease via modulating the expression of miR-106b","Huang W, Li Z, Zhao L, Zhao W.","Biomed Pharmacother. 2017 Aug;92:46-57. doi: 10.1016/j.biopha.2017.05.060. Epub 2017 May 18.","Huang W","Biomed Pharmacother","2017","2017/05/22","","","10.1016/j.biopha.2017.05.060"
"12025738","The effects of donepezil on quantitative EEG in patients with Alzheimer's disease","Reeves RR, Struve FA, Patrick G.","Clin Electroencephalogr. 2002 Apr;33(2):93-6. doi: 10.1177/155005940203300209.","Reeves RR","Clin Electroencephalogr","2002","2002/05/25","","","10.1177/155005940203300209"
"20201245","[Effect of memantine treatment on patients with moderate-to-severe Alzheimer's disease treated with donepezil]","Creţu O, Szalontay AS, Chiriţă R, Chiriţă V.","Rev Med Chir Soc Med Nat Iasi. 2008 Jul-Sep;112(3):641-5.","Creţu O","Rev Med Chir Soc Med Nat Iasi","2008","2010/03/06","","",""
"8750027","Cross-form priming in normal aging and in mild dementia of the Alzheimer type","Ergis AM, Van der Linden M, Deweer B.","Cortex. 1995 Dec;31(4):699-710. doi: 10.1016/s0010-9452(13)80021-4.","Ergis AM","Cortex","1995","1995/12/01","","","10.1016/s0010-9452(13)80021-4"
"11814647","Atrophy of the substantia innominata on magnetic resonance imaging and response to donepezil treatment in Alzheimer's disease","Hanyu H, Tanaka Y, Sakurai H, Takasaki M, Abe K.","Neurosci Lett. 2002 Feb 8;319(1):33-6. doi: 10.1016/s0304-3940(01)02507-1.","Hanyu H","Neurosci Lett","2002","2002/01/30","","","10.1016/s0304-3940(01)02507-1"
"12552349","Acetylcholine muscarinic receptors and response to anti-cholinesterase therapy in patients with Alzheimer's disease","Brown D, Chisholm JA, Owens J, Pimlott S, Patterson J, Wyper D.","Eur J Nucl Med Mol Imaging. 2003 Feb;30(2):296-300. doi: 10.1007/s00259-002-1028-6. Epub 2002 Nov 26.","Brown D","Eur J Nucl Med Mol Imaging","2003","2003/01/29","","","10.1007/s00259-002-1028-6"
"8852694","Stem-completion priming in Alzheimer's disease: the importance of target word articulation","Downes JJ, Davis EJ, De Mornay Davies P, Perfect TJ, Wilson K, Mayes AR, Sagar HJ.","Neuropsychologia. 1996 Jan;34(1):63-75. doi: 10.1016/0028-3932(95)00084-4.","Downes JJ","Neuropsychologia","1996","1996/01/01","","","10.1016/0028-3932(95)00084-4"
"22333201","[Effects of donepezil treatment on platelets α and β secretase activities in Alzheimer's disease patients]","Dong GS, Li X, Jiang QH, Yang HQ.","Zhonghua Yi Xue Za Zhi. 2011 Dec 20;91(47):3341-5.","Dong GS","Zhonghua Yi Xue Za Zhi","2011","2012/02/16","","",""
"36429962","Cost-Effectiveness of the Comprehensive Interdisciplinary Program-Care in Informal Caregivers of People with Alzheimer's Disease","Muñoz-Bermejo L, González-Becerra MJ, Barrios-Fernández S, Postigo-Mota S, Jerez-Barroso MDR, Martínez JAF, Suárez-Lantarón B, Marín DM, Martín-Bermúdez N, Ortés-Gómez R, Gómez-Ullate-García de León M, Martínez-Acevedo M, Rocha-Gómez L, Espejo-Antúnez S, Fraile-Bravo M, Galán MGS, Chato-Gonzalo I, Muñoz FJD, Hernández-Mocholí MÁ, Madruga-Vicente M, Prado-Solano A, Mendoza-Muñoz M, Carlos-Vivas J, Pérez-Gómez J, Pastor-Cisneros R, Fuentes-Flores P, Pereira-Payo D, De Los Ríos-Calonge J, Urbano-Mairena J, Guerra-Bustamante J, Adsuar JC.","Int J Environ Res Public Health. 2022 Nov 18;19(22):15243. doi: 10.3390/ijerph192215243.","Muñoz-Bermejo L","Int J Environ Res Public Health","2022","2022/11/26","PMC9691117","","10.3390/ijerph192215243"
"15636076","ApoE genotyping and response to galanthamine in Alzheimer's disease--a real life retrospective study","Babić T, Mahović Lakusić D, Sertić J, Petrovecki M, Stavljenić-Rukavina A.","Coll Antropol. 2004 Jun;28(1):199-204.","Babić T","Coll Antropol","2004","2005/01/08","","",""
"11488226","Diagnostic value of quantitative EEG in Alzheimer's disease","Bennys K, Rondouin G, Vergnes C, Touchon J.","Neurophysiol Clin. 2001 Jun;31(3):153-60. doi: 10.1016/s0987-7053(01)00254-4.","Bennys K","Neurophysiol Clin","2001","2001/08/08","","","10.1016/s0987-7053(01)00254-4"
"14763994","Serum testosterone levels in males with Alzheimer's disease","Pennanen C, Laakso MP, Kivipelto M, Ramberg J, Soininen H.","J Neuroendocrinol. 2004 Feb;16(2):95-8. doi: 10.1111/j.0953-8194.2004.01133.x.","Pennanen C","J Neuroendocrinol","2004","2004/02/07","","","10.1111/j.0953-8194.2004.01133.x"
"31296588","Effects of vitamin D supplementation on cognitive function and blood Aβ-related biomarkers in older adults with Alzheimer's disease: a randomised, double-blind, placebo-controlled trial","Jia J, Hu J, Huo X, Miao R, Zhang Y, Ma F.","J Neurol Neurosurg Psychiatry. 2019 Dec;90(12):1347-1352. doi: 10.1136/jnnp-2018-320199. Epub 2019 Jul 11.","Jia J","J Neurol Neurosurg Psychiatry","2019","2019/07/13","","","10.1136/jnnp-2018-320199"
"31084994","Sertraline and Mirtazapine Versus Placebo in Subgroups of Depression in Dementia: Findings From the HTA-SADD Randomized Controlled Trial","Zuidersma M, Chua KC, Hellier J, Voshaar RO, Banerjee S; HTA-SADD Investigator Group.","Am J Geriatr Psychiatry. 2019 Sep;27(9):920-931. doi: 10.1016/j.jagp.2019.03.021. Epub 2019 Apr 6.","Zuidersma M","Am J Geriatr Psychiatry","2019","2019/05/16","","","10.1016/j.jagp.2019.03.021"
"6366565","Effects of 4-aminopyridine in elderly patients with Alzheimer's disease","Wesseling H, Agoston S, Van Dam GB, Pasma J, DeWit DJ, Havinga H.","N Engl J Med. 1984 Apr 12;310(15):988-9. doi: 10.1056/NEJM198404123101514.","Wesseling H","N Engl J Med","1984","1984/04/12","","","10.1056/NEJM198404123101514"
"16223550","Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease","Ozturk A, DeKosky ST, Kamboh MI.","Neurobiol Aging. 2006 Oct;27(10):1440-4. doi: 10.1016/j.neurobiolaging.2005.08.024. Epub 2005 Oct 11.","Ozturk A","Neurobiol Aging","2006","2005/10/15","PMC1609962","NIHMS12159","10.1016/j.neurobiolaging.2005.08.024"
"24850540","Effects of functional tasks exercise on older adults with cognitive impairment at risk of Alzheimer's disease: a randomised controlled trial","Law LL, Barnett F, Yau MK, Gray MA.","Age Ageing. 2014 Nov;43(6):813-20. doi: 10.1093/ageing/afu055. Epub 2014 May 21.","Law LL","Age Ageing","2014","2014/05/23","","","10.1093/ageing/afu055"
"18246334","Diffusion abnormalities of the uncinate fasciculus in Alzheimer's disease: diffusion tensor tract-specific analysis using a new method to measure the core of the tract","Yasmin H, Nakata Y, Aoki S, Abe O, Sato N, Nemoto K, Arima K, Furuta N, Uno M, Hirai S, Masutani Y, Ohtomo K.","Neuroradiology. 2008 Apr;50(4):293-9. doi: 10.1007/s00234-007-0353-7. Epub 2008 Feb 2.","Yasmin H","Neuroradiology","2008","2008/02/05","","","10.1007/s00234-007-0353-7"
"16688496","Utility-based Quality of Life measures in Alzheimer's disease","Naglie G, Tomlinson G, Tansey C, Irvine J, Ritvo P, Black SE, Freedman M, Silberfeld M, Krahn M.","Qual Life Res. 2006 May;15(4):631-43. doi: 10.1007/s11136-005-4364-8.","Naglie G","Qual Life Res","2006","2006/05/12","","","10.1007/s11136-005-4364-8"
"1674295","Intramuscular desferrioxamine in patients with Alzheimer's disease","Crapper McLachlan DR, Dalton AJ, Kruck TP, Bell MY, Smith WL, Kalow W, Andrews DF.","Lancet. 1991 Jun 1;337(8753):1304-8. doi: 10.1016/0140-6736(91)92978-b.","Crapper McLachlan DR","Lancet","1991","1991/06/01","","","10.1016/0140-6736(91)92978-b"
"10521169","The effects of donepezil on the P300 auditory and visual cognitive evoked potentials of patients with Alzheimer's disease","Reeves RR, Struve FA, Patrick G, Booker JG, Nave DW.","Am J Geriatr Psychiatry. 1999 Fall;7(4):349-52.","Reeves RR","Am J Geriatr Psychiatry","1999","1999/10/16","","",""
"7667377","Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety","Wilson AL, Langley LK, Monley J, Bauer T, Rottunda S, McFalls E, Kovera C, McCarten JR.","Pharmacol Biochem Behav. 1995 Jun-Jul;51(2-3):509-14. doi: 10.1016/0091-3057(95)00043-v.","Wilson AL","Pharmacol Biochem Behav","1995","1995/06/01","","","10.1016/0091-3057(95)00043-v"
"12417372","Treatment with donepezil in Alzheimer patients with and without cerebrovascular disease","Frölich L, Klinger T, Berger FM.","J Neurol Sci. 2002 Nov 15;203-204:137-9. doi: 10.1016/s0022-510x(02)00275-7.","Frölich L","J Neurol Sci","2002","2002/11/06","","","10.1016/s0022-510x(02)00275-7"
"14559955","Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial","Teri L, Gibbons LE, McCurry SM, Logsdon RG, Buchner DM, Barlow WE, Kukull WA, LaCroix AZ, McCormick W, Larson EB.","JAMA. 2003 Oct 15;290(15):2015-22. doi: 10.1001/jama.290.15.2015.","Teri L","JAMA","2003","2003/10/16","","","10.1001/jama.290.15.2015"
"13130389","Response patterns of EGb 761 in Alzheimer's disease: influence of neuropsychological profiles","Le Bars PL.","Pharmacopsychiatry. 2003 Jun;36 Suppl 1:S50-5. doi: 10.1055/s-2003-40456.","Le Bars PL","Pharmacopsychiatry","2003","2003/09/18","","","10.1055/s-2003-40456"
"8876776","Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study","Sano M, Ernesto C, Klauber MR, Schafer K, Woodbury P, Thomas R, Grundman M, Growdon J, Thal LJ.","Alzheimer Dis Assoc Disord. 1996 Fall;10(3):132-40. doi: 10.1097/00002093-199601030-00004.","Sano M","Alzheimer Dis Assoc Disord","1996","1996/01/01","","","10.1097/00002093-199601030-00004"
"29376858","Exercise Training on Locomotion in Patients with Alzheimer's Disease: A Feasibility Study","Pedrinolla A, Venturelli M, Fonte C, Munari D, Benetti MV, Rudi D, Tamburin S, Muti E, Zanolla L, Smania N, Schena F.","J Alzheimers Dis. 2018;61(4):1599-1609. doi: 10.3233/JAD-170625.","Pedrinolla A","J Alzheimers Dis","2018","2018/01/30","","","10.3233/JAD-170625"
"34420949","Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study","Tofiq A, Zetterberg H, Blennow K, Basun H, Cederholm T, Eriksdotter M, Faxén-Irving G, Hjorth E, Jernerén F, Schultzberg M, Wahlund LO, Palmblad J, Freund-Levi Y.","J Alzheimers Dis. 2021;83(3):1291-1301. doi: 10.3233/JAD-210007.","Tofiq A","J Alzheimers Dis","2021","2021/08/23","","","10.3233/JAD-210007"
"12499050","A polymorphism in the complement component C1r is not associated with sporadic Alzheimer's disease","Rosenmann H, Meiner Z, Kahana E, Aladjem Z, Friedman G, Ben-Yehuda A, Grenader T, Wertman E, Abramsky O.","Neurosci Lett. 2003 Jan 16;336(2):101-4. doi: 10.1016/s0304-3940(02)01218-1.","Rosenmann H","Neurosci Lett","2003","2002/12/25","","","10.1016/s0304-3940(02)01218-1"
"24015315","Structural interactions within the default mode network identified by Bayesian network analysis in Alzheimer's disease","Wang Y, Chen K, Yao L, Jin Z, Guo X; Alzheimer's Disease Neuroimaging Initiative.","PLoS One. 2013 Aug 28;8(8):e74070. doi: 10.1371/journal.pone.0074070. eCollection 2013.","Wang Y","PLoS One","2013","2013/09/10","PMC3755999","","10.1371/journal.pone.0074070"
"29622037","A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer's disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil","Fullerton T, Binneman B, David W, Delnomdedieu M, Kupiec J, Lockwood P, Mancuso J, Miceli J, Bell J.","Alzheimers Res Ther. 2018 Apr 5;10(1):38. doi: 10.1186/s13195-018-0368-9.","Fullerton T","Alzheimers Res Ther","2018","2018/04/07","PMC5887246","","10.1186/s13195-018-0368-9"
"35791471","Efficacy and safety of sodium oligomannate in the treatment of Alzheimer's disease","Zhang LF, Zhang YP, Lin PX, Xue LH.","Pak J Pharm Sci. 2022 May;35(3):741-745.","Zhang LF","Pak J Pharm Sci","2022","2022/07/06","","",""
"8835883","A pilot study of prednisone in Alzheimer's disease","Aisen PS, Marin D, Altstiel L, Goodwin C, Baruch B, Jacobson R, Ryan T, Davis KL.","Dementia. 1996 Jul-Aug;7(4):201-6. doi: 10.1159/000106879.","Aisen PS","Dementia","1996","1996/07/01","","","10.1159/000106879"
"32920628","PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients","Wang HY, Pei Z, Lee KC, Lopez-Brignoni E, Nikolov B, Crowley CA, Marsman MR, Barbier R, Friedmann N, Burns LH.","J Prev Alzheimers Dis. 2020;7(4):256-264. doi: 10.14283/jpad.2020.6.","Wang HY","J Prev Alzheimers Dis","2020","2020/09/13","","","10.14283/jpad.2020.6"
"3107514","L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition","Tariot PN, Cohen RM, Sunderland T, Newhouse PA, Yount D, Mellow AM, Weingartner H, Mueller EA, Murphy DL.","Arch Gen Psychiatry. 1987 May;44(5):427-33. doi: 10.1001/archpsyc.1987.01800170041007.","Tariot PN","Arch Gen Psychiatry","1987","1987/05/01","","","10.1001/archpsyc.1987.01800170041007"
"17483854","Risk factors of distress in Alzheimer's patients","Zhou X, Xu J, Zhao Y.","Ann Acad Med Singap. 2007 Apr;36(4):253-8.","Zhou X","Ann Acad Med Singap","2007","2007/05/08","","",""
"29390538","The clinical efficacy of reminiscence therapy in patients with mild-to-moderate Alzheimer disease: Study protocol for a randomized parallel-design controlled trial","Li M, Lyu JH, Zhang Y, Gao ML, Li WJ, Ma X.","Medicine (Baltimore). 2017 Dec;96(51):e9381. doi: 10.1097/MD.0000000000009381.","Li M","Medicine (Baltimore)","2017","2018/02/03","PMC5758240","","10.1097/MD.0000000000009381"
"28615271","Cost-effectiveness of a randomised trial of physical activity in Alzheimer's disease: a secondary analysis exploring patient and proxy-reported health-related quality of life measures in Denmark","Sopina E, Sørensen J, Beyer N, Hasselbalch SG, Waldemar G.","BMJ Open. 2017 Jun 14;7(6):e015217. doi: 10.1136/bmjopen-2016-015217.","Sopina E","BMJ Open","2017","2017/06/16","PMC5734413","","10.1136/bmjopen-2016-015217"
"20164561","PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses","Faux NG, Ritchie CW, Gunn A, Rembach A, Tsatsanis A, Bedo J, Harrison J, Lannfelt L, Blennow K, Zetterberg H, Ingelsson M, Masters CL, Tanzi RE, Cummings JL, Herd CM, Bush AI.","J Alzheimers Dis. 2010;20(2):509-16. doi: 10.3233/JAD-2010-1390.","Faux NG","J Alzheimers Dis","2010","2010/02/19","","","10.3233/JAD-2010-1390"
"15219643","Growth hormone response to clonidine predicts aggression in Alzheimer's disease","Herrmann N, Lanctôt KL, Eryavec G, Van Reekum R, Khan LR.","Psychoneuroendocrinology. 2004 Oct;29(9):1192-7. doi: 10.1016/j.psyneuen.2004.02.001.","Herrmann N","Psychoneuroendocrinology","2004","2004/06/29","","","10.1016/j.psyneuen.2004.02.001"
"12670060","Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease","Gauthier S, Feldman H, Hecker J, Vellas B, Ames D, Subbiah P, Whalen E, Emir B; Donepezil MSAD Study Investigators Group.","Int Psychogeriatr. 2002 Dec;14(4):389-404. doi: 10.1017/s104161020200858x.","Gauthier S","Int Psychogeriatr","2002","2003/04/03","","","10.1017/s104161020200858x"
"26044070","Safety and pharmacokinetics of bapineuzumab in a single ascending-dose study in Japanese patients with mild to moderate Alzheimer's disease","Arai H, Umemura K, Ichimiya Y, Iseki E, Eto K, Miyakawa K, Kirino E, Shibata N, Baba H, Tsuchiwata S.","Geriatr Gerontol Int. 2016 May;16(5):644-50. doi: 10.1111/ggi.12516. Epub 2015 Jun 4.","Arai H","Geriatr Gerontol Int","2016","2015/06/06","","","10.1111/ggi.12516"
"9777427","Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease","MacGowan SH, Wilcock GK, Scott M.","Int J Geriatr Psychiatry. 1998 Sep;13(9):625-30. doi: 10.1002/(sici)1099-1166(199809)13:9<625::aid-gps835>3.0.co;2-2.","MacGowan SH","Int J Geriatr Psychiatry","1998","1998/10/20","","","10.1002/(sici)1099-1166(199809)13:9<625::aid-gps835>3.0.co;2-2"
"16202482","ApoE gene and familial risk of Alzheimer's disease as predictors of odour identification in older adults","Handley OJ, Morrison CM, Miles C, Bayer AJ.","Neurobiol Aging. 2006 Oct;27(10):1425-30. doi: 10.1016/j.neurobiolaging.2005.08.001. Epub 2005 Oct 3.","Handley OJ","Neurobiol Aging","2006","2005/10/06","","","10.1016/j.neurobiolaging.2005.08.001"
"12764551","Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study","Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A.","Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13. doi: 10.1007/s00259-003-1194-1. Epub 2003 May 23.","Drzezga A","Eur J Nucl Med Mol Imaging","2003","2003/05/24","","","10.1007/s00259-003-1194-1"
"26362286","A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease","Turner RS, Thomas RG, Craft S, van Dyck CH, Mintzer J, Reynolds BA, Brewer JB, Rissman RA, Raman R, Aisen PS; Alzheimer's Disease Cooperative Study.","Neurology. 2015 Oct 20;85(16):1383-91. doi: 10.1212/WNL.0000000000002035. Epub 2015 Sep 11.","Turner RS","Neurology","2015","2015/09/13","PMC4626244","","10.1212/WNL.0000000000002035"
"16513037","Quetiapine and rivastigmine for agitation in Alzheimer's disease","Ownby RL.","Curr Psychiatry Rep. 2006 Feb;8(1):10. doi: 10.1007/s11920-006-0075-2.","Ownby RL","Curr Psychiatry Rep","2006","2006/03/04","","","10.1007/s11920-006-0075-2"
"20129316","Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial","Scheltens P, Kamphuis PJ, Verhey FR, Olde Rikkert MG, Wurtman RJ, Wilkinson D, Twisk JW, Kurz A.","Alzheimers Dement. 2010 Jan;6(1):1-10.e1. doi: 10.1016/j.jalz.2009.10.003.","Scheltens P","Alzheimers Dement","2010","2010/02/05","","","10.1016/j.jalz.2009.10.003"
"26876309","Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease","Teipel SJ, Cavedo E, Grothe MJ, Lista S, Galluzzi S, Colliot O, Chupin M, Bakardjian H, Dormont D, Dubois B, Hampel H; Hippocampus Study Group.","Neuropharmacology. 2016 Sep;108:128-35. doi: 10.1016/j.neuropharm.2016.02.005. Epub 2016 Feb 10.","Teipel SJ","Neuropharmacology","2016","2016/02/16","","","10.1016/j.neuropharm.2016.02.005"
"10621949","Eye-head coordination abnormalities and regional cerebral blood flow in Alzheimer's disease","Nakano N, Hatakeyama Y, Fukatsu R, Hayashi S, Fujii M, Fujimori K, Takahata N.","Prog Neuropsychopharmacol Biol Psychiatry. 1999 Aug;23(6):1053-62. doi: 10.1016/s0278-5846(99)00054-8.","Nakano N","Prog Neuropsychopharmacol Biol Psychiatry","1999","2000/01/06","","","10.1016/s0278-5846(99)00054-8"
"17345042","Open label, multicenter, 28-week extension study of the safety and tolerability of memantine in patients with mild to moderate Alzheimer's disease","Ott BR, Blake LM, Kagan E, Resnick M; Memantine MEM-MD-11AB Study Group.","J Neurol. 2007 Mar;254(3):351-8. doi: 10.1007/s00415-006-0374-x. Epub 2007 Mar 7.","Ott BR","J Neurol","2007","2007/03/09","","","10.1007/s00415-006-0374-x"
"15785036","Cholinesterase inhibitor affects the amyloid precursor protein isoforms in patients with Alzheimer's disease","Liu HC, Chi CW, Ko SY, Wang HC, Hong CJ, Lin KN, Wang PN, Liu TY.","Dement Geriatr Cogn Disord. 2005;19(5-6):345-8. doi: 10.1159/000084561. Epub 2005 Mar 22.","Liu HC","Dement Geriatr Cogn Disord","2005","2005/03/24","","","10.1159/000084561"
"32160843","Nanoparticlized System: Promising Approach for the Management of Alzheimer's Disease through Intranasal Delivery","Bahadur S, Sachan N, Harwansh RK, Deshmukh R.","Curr Pharm Des. 2020;26(12):1331-1344. doi: 10.2174/1381612826666200311131658.","Bahadur S","Curr Pharm Des","2020","2020/03/13","","","10.2174/1381612826666200311131658"
"21525519","Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial","Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF.","Br J Psychiatry. 2011 May;198(5):351-6. doi: 10.1192/bjp.bp.110.080044.","Forlenza OV","Br J Psychiatry","2011","2011/04/29","","","10.1192/bjp.bp.110.080044"
"1609044","Effects of phosphatidylserine in Alzheimer's disease","Crook T, Petrie W, Wells C, Massari DC.","Psychopharmacol Bull. 1992;28(1):61-6.","Crook T","Psychopharmacol Bull","1992","1992/01/01","","",""
"23030807","Self-regulated music stimulation for persons with Alzheimer's disease: impact assessment and social validation","Lancioni GE, Singh NN, O'Reilly MF, Green VA, Ferlisi G, Ferrarese G, Zullo V, Perilli V, Cassano G, Cordiano N, Pinto K, Zonno N.","Dev Neurorehabil. 2013;16(1):17-26. doi: 10.3109/17518423.2012.707693. Epub 2012 Oct 3.","Lancioni GE","Dev Neurorehabil","2013","2012/10/04","","","10.3109/17518423.2012.707693"
"17582225","Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms","Freund-Levi Y, Basun H, Cederholm T, Faxén-Irving G, Garlind A, Grut M, Vedin I, Palmblad J, Wahlund LO, Eriksdotter-Jönhagen M.","Int J Geriatr Psychiatry. 2008 Feb;23(2):161-9. doi: 10.1002/gps.1857.","Freund-Levi Y","Int J Geriatr Psychiatry","2008","2007/06/22","","","10.1002/gps.1857"
"11425935","Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study","Polvikoski T, Sulkava R, Myllykangas L, Notkola IL, Niinistö L, Verkkoniemi A, Kainulainen K, Kontula K, Pérez-Tur J, Hardy J, Haltia M.","Neurology. 2001 Jun 26;56(12):1690-6. doi: 10.1212/wnl.56.12.1690.","Polvikoski T","Neurology","2001","2001/06/27","","","10.1212/wnl.56.12.1690"
"21666432","Greater responsiveness to donepezil in Alzheimer patients with higher levels of acetylcholinesterase based on attention task scores and a donepezil PET study","Kasuya M, Meguro K, Okamura N, Funaki Y, Ishikawa H, Tanaka N, Iwata R, Yanai K.","Alzheimer Dis Assoc Disord. 2012 Apr-Jun;26(2):113-8. doi: 10.1097/WAD.0b013e3182222bc0.","Kasuya M","Alzheimer Dis Assoc Disord","2012","2011/06/14","","","10.1097/WAD.0b013e3182222bc0"
"21592058","Effect of cholinergic stimulation in early Alzheimer's disease - functional imaging during a recognition memory task","Miettinen PS, Pihlajamäki M, Jauhiainen AM, Tarkka IM, Gröhn H, Niskanen E, Hänninen T, Vanninen R, Soininen H.","Curr Alzheimer Res. 2011 Nov;8(7):753-64. doi: 10.2174/156720511797633241.","Miettinen PS","Curr Alzheimer Res","2011","2011/05/20","","","10.2174/156720511797633241"
"7887197","Neurotransplantation--a new method of treatment in psychiatry?","Stárková L, Mrna B, Bartosová S.","Acta Univ Palacki Olomuc Fac Med. 1993;136:33-5.","Stárková L","Acta Univ Palacki Olomuc Fac Med","1993","1993/01/01","","",""
"12169216","Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial","Marder K.","Curr Neurol Neurosci Rep. 2002 Sep;2(5):389-90. doi: 10.1007/s11910-002-0062-x.","Marder K","Curr Neurol Neurosci Rep","2002","2002/08/10","","","10.1007/s11910-002-0062-x"
"32918484","Plasma isoprostanoids assessment as Alzheimer's disease progression biomarkers","Peña-Bautista C, Álvarez L, Baquero M, Ferrer I, García L, Hervás-Marín D, Cháfer-Pericás C.","J Neurochem. 2021 Jun;157(6):2187-2194. doi: 10.1111/jnc.15183. Epub 2020 Sep 30.","Peña-Bautista C","J Neurochem","2021","2020/09/12","","","10.1111/jnc.15183"
"14641507","Long-term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular disease","Kurz AF, Erkinjuntti T, Small GW, Lilienfeld S, Damaraju CR.","Eur J Neurol. 2003 Nov;10(6):633-40. doi: 10.1046/j.1468-1331.2003.00677.x.","Kurz AF","Eur J Neurol","2003","2003/12/03","","","10.1046/j.1468-1331.2003.00677.x"
"20687206","A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease","Laxton AW, Tang-Wai DF, McAndrews MP, Zumsteg D, Wennberg R, Keren R, Wherrett J, Naglie G, Hamani C, Smith GS, Lozano AM.","Ann Neurol. 2010 Oct;68(4):521-34. doi: 10.1002/ana.22089.","Laxton AW","Ann Neurol","2010","2010/08/06","","","10.1002/ana.22089"
"24619276","Comparing cerebral perfusion in Alzheimer's disease and Parkinson's disease dementia: an ASL-MRI study","Le Heron CJ, Wright SL, Melzer TR, Myall DJ, MacAskill MR, Livingston L, Keenan RJ, Watts R, Dalrymple-Alford JC, Anderson TJ.","J Cereb Blood Flow Metab. 2014 Jun;34(6):964-70. doi: 10.1038/jcbfm.2014.40. Epub 2014 Mar 12.","Le Heron CJ","J Cereb Blood Flow Metab","2014","2014/03/13","PMC4050238","","10.1038/jcbfm.2014.40"
"11493164","The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease","Mungas D, Reed BR, Ellis WG, Jagust WJ.","Arch Neurol. 2001 Aug;58(8):1243-7. doi: 10.1001/archneur.58.8.1243.","Mungas D","Arch Neurol","2001","2001/08/31","","","10.1001/archneur.58.8.1243"
"28124589","Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease","Hull M, Sadowsky C, Arai H, Le Prince Leterme G, Holstein A, Booth K, Peng Y, Yoshiyama T, Suzuki H, Ketter N, Liu E, Ryan JM.","Curr Alzheimer Res. 2017;14(7):696-708. doi: 10.2174/1567205014666170117101537.","Hull M","Curr Alzheimer Res","2017","2017/01/27","PMC5543567","","10.2174/1567205014666170117101537"
"10867780","Effect of anti-inflammatory medications on neuropathological findings in Alzheimer disease","Halliday GM, Shepherd CE, McCann H, Reid WG, Grayson DA, Broe GA, Kril JJ.","Arch Neurol. 2000 Jun;57(6):831-6. doi: 10.1001/archneur.57.6.831.","Halliday GM","Arch Neurol","2000","2000/06/27","","","10.1001/archneur.57.6.831"
"23472619","A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease","Herrmann N, Gauthier S, Boneva N, Lemming OM; 10158 Investigators.","Int Psychogeriatr. 2013 Jun;25(6):919-27. doi: 10.1017/S1041610213000239. Epub 2013 Mar 8.","Herrmann N","Int Psychogeriatr","2013","2013/03/12","","","10.1017/S1041610213000239"
"10851363","Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study","Wang PN, Liao SQ, Liu RS, Liu CY, Chao HT, Lu SR, Yu HY, Wang SJ, Liu HC.","Neurology. 2000 Jun 13;54(11):2061-6. doi: 10.1212/wnl.54.11.2061.","Wang PN","Neurology","2000","2000/06/14","","","10.1212/wnl.54.11.2061"
"9845158","The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity","Randolph C, Tierney MC, Mohr E, Chase TN.","J Clin Exp Neuropsychol. 1998 Jun;20(3):310-9. doi: 10.1076/jcen.20.3.310.823.","Randolph C","J Clin Exp Neuropsychol","1998","1998/12/09","","","10.1076/jcen.20.3.310.823"
"2690096","Design issues in clinical trials","Overall JE.","Prog Clin Biol Res. 1989;317:1291-9.","Overall JE","Prog Clin Biol Res","1989","1989/01/01","","",""
"10559564","Posterior cortical atrophy variants of Alzheimer's disease","Aharon-Peretz J, Israel O, Goldsher D, Peretz A.","Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):483-7. doi: 10.1159/000017194.","Aharon-Peretz J","Dement Geriatr Cogn Disord","1999","1999/11/24","","","10.1159/000017194"
"9258893","Olfactory identification in elderly schizophrenia and Alzheimer's disease","Moberg PJ, Doty RL, Mahr RN, Mesholam RI, Arnold SE, Turetsky BI, Gur RE.","Neurobiol Aging. 1997 Mar-Apr;18(2):163-7. doi: 10.1016/s0197-4580(97)00015-8.","Moberg PJ","Neurobiol Aging","1997","1997/03/01","","","10.1016/s0197-4580(97)00015-8"
"24292102","Changes of several brain receptor complexes in the cerebral cortex of patients with Alzheimer disease: probable new potential pharmaceutical targets","Falsafi SK, Roßner S, Ghafari M, Groessl M, Morawski M, Gerner C, Lubec G.","Amino Acids. 2014 Jan;46(1):223-33. doi: 10.1007/s00726-013-1623-9. Epub 2013 Nov 29.","Falsafi SK","Amino Acids","2014","2013/12/03","","","10.1007/s00726-013-1623-9"
"12083347","Influence of aromatherapy on medication administration to residential-care residents with dementia and behavioral challenges","Gray SG, Clair AA.","Am J Alzheimers Dis Other Demen. 2002 May-Jun;17(3):169-74. doi: 10.1177/153331750201700305.","Gray SG","Am J Alzheimers Dis Other Demen","2002","2002/06/27","","","10.1177/153331750201700305"
"30914707","Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease","Jasiecki J, Limon-Sztencel A, Żuk M, Chmara M, Cysewski D, Limon J, Wasąg B.","Sci Rep. 2019 Mar 26;9(1):5223. doi: 10.1038/s41598-019-41578-3.","Jasiecki J","Sci Rep","2019","2019/03/28","PMC6435664","","10.1038/s41598-019-41578-3"
"15220031","Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial","Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E, Edwards S, Hardyman W, Raftery J, Crome P, Lendon C, Shaw H, Bentham P; AD2000 Collaborative Group.","Lancet. 2004 Jun 26;363(9427):2105-15. doi: 10.1016/S0140-6736(04)16499-4.","Courtney C","Lancet","2004","2004/06/29","","","10.1016/S0140-6736(04)16499-4"
"26238225","Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease","Weintraub D, Drye LT, Porsteinsson AP, Rosenberg PB, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Schneider LS, Shade DM, Yesavage J, Lyketsos CG; CitAD Research Group.","Am J Geriatr Psychiatry. 2015 Nov;23(11):1127-33. doi: 10.1016/j.jagp.2015.05.006. Epub 2015 May 19.","Weintraub D","Am J Geriatr Psychiatry","2015","2015/08/05","PMC4653092","NIHMS692724","10.1016/j.jagp.2015.05.006"
"26967219","Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study","Remington R, Bechtel C, Larsen D, Samar A, Page R, Morrell C, Shea TB.","J Alzheimers Dis. 2016;51(4):991-5. doi: 10.3233/JAD-151098.","Remington R","J Alzheimers Dis","2016","2016/03/12","","","10.3233/JAD-151098"
"19968005","Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer's disease and obstructive sleep apnea: a preliminary study","Cooke JR, Ayalon L, Palmer BW, Loredo JS, Corey-Bloom J, Natarajan L, Liu L, Ancoli-Israel S.","J Clin Sleep Med. 2009 Aug 15;5(4):305-9.","Cooke JR","J Clin Sleep Med","2009","2009/12/09","PMC2725246","",""
"12714797","Lack of influence of the apolipoprotein E genotype on the outcome of selegiline treatment in Alzheimer's disease","Kálmán J, Juhász A, Rimanóczy A, Palotás A, Palotás M, Szabó Z, Boda K, Márki-Zay J, Janka Z.","Dement Geriatr Cogn Disord. 2003;16(1):31-4. doi: 10.1159/000069990.","Kálmán J","Dement Geriatr Cogn Disord","2003","2003/04/26","","","10.1159/000069990"
"15584791","Positive aspects of caregiving and adaptation to bereavement","Boerner K, Schulz R, Horowitz A.","Psychol Aging. 2004 Dec;19(4):668-75. doi: 10.1037/0882-7974.19.4.668.","Boerner K","Psychol Aging","2004","2004/12/09","","","10.1037/0882-7974.19.4.668"
"16136843","A randomized, controlled study of an Alzheimer's caregiver skills training program","Martin-Cook K, Davis BA, Hynan LS, Weiner MF.","Am J Alzheimers Dis Other Demen. 2005 Jul-Aug;20(4):204-10. doi: 10.1177/153331750502000411.","Martin-Cook K","Am J Alzheimers Dis Other Demen","2005","2005/09/03","","","10.1177/153331750502000411"
"11921156","A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease--pilot study","Prasher VP, Huxley A, Haque MS; Down syndrome Ageing Study Group.","Int J Geriatr Psychiatry. 2002 Mar;17(3):270-8. doi: 10.1002/gps.587.","Prasher VP","Int J Geriatr Psychiatry","2002","2002/03/29","","","10.1002/gps.587"
"16581404","Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study","Winblad B, Kilander L, Eriksson S, Minthon L, Båtsman S, Wetterholm AL, Jansson-Blixt C, Haglund A; Severe Alzheimer's Disease Study Group.","Lancet. 2006 Apr 1;367(9516):1057-1065. doi: 10.1016/S0140-6736(06)68350-5.","Winblad B","Lancet","2006","2006/04/04","","","10.1016/S0140-6736(06)68350-5"
"15716519","Predicting the outcome of cholinesterase inhibitor treatment in Alzheimer's disease","Connelly PJ, Prentice NP, Fowler KG.","J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):320-4. doi: 10.1136/jnnp.2004.043539.","Connelly PJ","J Neurol Neurosurg Psychiatry","2005","2005/02/18","PMC1739548","","10.1136/jnnp.2004.043539"
"20502014","Effects of rivastigmine transdermal patch and capsule on aspects of clinical global impression of change in Alzheimer's disease: a retrospective analysis","Cummings JL, Ferris SH, Farlow MR, Olin JT, Meng X.","Dement Geriatr Cogn Disord. 2010;29(5):406-12. doi: 10.1159/000296073. Epub 2010 May 21.","Cummings JL","Dement Geriatr Cogn Disord","2010","2010/05/27","","","10.1159/000296073"
"8139084","Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease","Watkins PB, Zimmerman HJ, Knapp MJ, Gracon SI, Lewis KW.","JAMA. 1994 Apr 6;271(13):992-8.","Watkins PB","JAMA","1994","1994/04/06","","",""
"16639610","Partial volume effect correction in SPECT for striatal uptake measurements in patients with neurodegenerative diseases: impact upon patient classification","Soret M, Koulibaly PM, Darcourt J, Buvat I.","Eur J Nucl Med Mol Imaging. 2006 Sep;33(9):1062-72. doi: 10.1007/s00259-005-0003-4. Epub 2006 Apr 26.","Soret M","Eur J Nucl Med Mol Imaging","2006","2006/04/28","","","10.1007/s00259-005-0003-4"
"11186596","Effect of a combined walking and conversation intervention on functional mobility of nursing home residents with Alzheimer disease","Tappen RM, Roach KE, Applegate EB, Stowell P.","Alzheimer Dis Assoc Disord. 2000 Oct-Dec;14(4):196-201. doi: 10.1097/00002093-200010000-00002.","Tappen RM","Alzheimer Dis Assoc Disord","2000","2001/02/24","PMC1950269","NIHMS25140","10.1097/00002093-200010000-00002"
"35041261","Effects of eszopiclone on sleep quality and cognitive function in elderly patients with Alzheimer's disease and sleep disorder: A randomized controlled trial","Huo S, Cheng L, Li S, Xu F.","Brain Behav. 2022 Feb;12(2):e2488. doi: 10.1002/brb3.2488. Epub 2022 Jan 18.","Huo S","Brain Behav","2022","2022/01/18","PMC8865158","","10.1002/brb3.2488"
"16286546","Neuroanatomical predictors of response to donepezil therapy in patients with dementia","Csernansky JG, Wang L, Miller JP, Galvin JE, Morris JC.","Arch Neurol. 2005 Nov;62(11):1718-22. doi: 10.1001/archneur.62.11.1718.","Csernansky JG","Arch Neurol","2005","2005/11/16","","","10.1001/archneur.62.11.1718"
"33829706","[A Preliminary Study of Applying Geometric Deep Learning in Brain Morphometry for Diagnosis of Alzheimer's Disease]","Xie W, Sun HQ, Chen JW, Zeng Y, Xu X, Li ZL, Xia CC.","Sichuan Da Xue Xue Bao Yi Xue Ban. 2021 Mar;52(2):300-305. doi: 10.12182/20210360103.","Xie W","Sichuan Da Xue Xue Bao Yi Xue Ban","2021","2021/04/08","","","10.12182/20210360103"
"15818530","[Cost-effectiveness of galantamine in a german context]","Happich M, Schweikert B, Mühlbacher A.","Psychiatr Prax. 2005 Apr;32(3):142-50. doi: 10.1055/s-2004-834709.","Happich M","Psychiatr Prax","2005","2005/04/09","","","10.1055/s-2004-834709"
"2160850","Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefit","Byrne EJ, Arie T.","BMJ. 1990 Apr 28;300(6732):1132-3; discussion 1131. doi: 10.1136/bmj.300.6732.1132.","Byrne EJ","BMJ","1990","1990/04/28","PMC1662815","","10.1136/bmj.300.6732.1132"
"17404193","Effect of galantamine on verbal repetition in AD: a secondary analysis of the VISTA trial","Rockwood K, Fay S, Jarrett P, Asp E.","Neurology. 2007 Apr 3;68(14):1116-21. doi: 10.1212/01.wnl.0000258661.61577.b7.","Rockwood K","Neurology","2007","2007/04/04","","","10.1212/01.wnl.0000258661.61577.b7"
"25324467","Reversal of cognitive decline: a novel therapeutic program","Bredesen DE.","Aging (Albany NY). 2014 Sep;6(9):707-17. doi: 10.18632/aging.100690.","Bredesen DE","Aging (Albany NY)","2014","2014/10/18","PMC4221920","","10.18632/aging.100690"
"7647944","Knowledge and experience with Alzheimer's disease. Relationship to resuscitation preference","Griffith CH 3rd, Wilson JF, Emmett KR, Ramsbottom-Lucier M, Rich EC.","Arch Fam Med. 1995 Sep;4(9):780-4. doi: 10.1001/archfami.4.9.780.","Griffith CH 3rd","Arch Fam Med","1995","1995/09/01","","","10.1001/archfami.4.9.780"
"12009501","Neutrophils CD11b and fibroblasts PGE(2) are elevated in Alzheimer's disease","Scali C, Prosperi C, Bracco L, Piccini C, Baronti R, Ginestroni A, Sorbi S, Pepeu G, Casamenti F.","Neurobiol Aging. 2002 Jul-Aug;23(4):523-30. doi: 10.1016/s0197-4580(01)00346-3.","Scali C","Neurobiol Aging","2002","2002/05/16","","","10.1016/s0197-4580(01)00346-3"
"23924050","A 24-week, randomized, controlled trial of rivastigmine patch 13.3 mg/24 h versus 4.6 mg/24 h in severe Alzheimer's dementia","Farlow MR, Grossberg GT, Sadowsky CH, Meng X, Somogyi M.","CNS Neurosci Ther. 2013 Oct;19(10):745-52. doi: 10.1111/cns.12158. Epub 2013 Aug 7.","Farlow MR","CNS Neurosci Ther","2013","2013/08/09","PMC4233957","","10.1111/cns.12158"
"33691142","Music Compared with Auditory Books: A Randomized Controlled Study Among Long-Term Care Residents with Alzheimer's Disease or Related Dementia","Harrison TC, Blozis SA, Schmidt B, Johnson A, Moreno R, Mead S, Gayle M.","J Am Med Dir Assoc. 2021 Jul;22(7):1415-1420. doi: 10.1016/j.jamda.2021.01.086. Epub 2021 Mar 7.","Harrison TC","J Am Med Dir Assoc","2021","2021/03/10","","","10.1016/j.jamda.2021.01.086"
"17388716","Antiaggressive effect of cyproterone versus haloperidol in Alzheimer's disease: a randomized double-blind pilot study","Huertas D, López-Ibor Aliño JJ, Molina JD, Chamorro L, Balanza J, Jiménez MP, Hornillos M.","J Clin Psychiatry. 2007 Mar;68(3):439-44. doi: 10.4088/jcp.v68n0314.","Huertas D","J Clin Psychiatry","2007","2007/03/29","","","10.4088/jcp.v68n0314"
"377082","Choline in Alzheimer's disease","Renvoize EB, Jerram T.","N Engl J Med. 1979 Aug 9;301(6):330. doi: 10.1056/NEJM197908093010614.","Renvoize EB","N Engl J Med","1979","1979/08/09","","","10.1056/NEJM197908093010614"
"35667959","Resources for Enhancing Alzheimer's Caregiver Health in Vietnam (REACH VN): Exploratory Analyses of Outcomes of a Cluster Randomized Controlled Trial to Test the Feasibility and Preliminary Efficacy of a Family Dementia Caregiver Intervention in Vietnam","Tran D, Nguyen H, Pham T, Nguyen AT, Nguyen HT, Nguyen NB, Harvey D, Hinton L.","Am J Geriatr Psychiatry. 2022 Aug;30(8):878-882. doi: 10.1016/j.jagp.2022.04.011. Epub 2022 May 6.","Tran D","Am J Geriatr Psychiatry","2022","2022/06/06","","","10.1016/j.jagp.2022.04.011"
"17521776","Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodium","Mhyre TR, Loy R, Tariot PN, Profenno LA, Maguire-Zeiss KA, Zhang D, Coleman PD, Federoff HJ.","Neurobiol Aging. 2008 Nov;29(11):1631-43. doi: 10.1016/j.neurobiolaging.2007.04.004. Epub 2007 May 22.","Mhyre TR","Neurobiol Aging","2008","2007/05/25","PMC2621111","NIHMS71532","10.1016/j.neurobiolaging.2007.04.004"
"3290936","Phosphatidylserine in the treatment of Alzheimer's disease: results of a multicenter study","Amaducci L.","Psychopharmacol Bull. 1988;24(1):130-4.","Amaducci L","Psychopharmacol Bull","1988","1988/01/01","","",""
"30129411","Long-Term Safety and Efficacy of Bapineuzumab in Patients with Mild-to-Moderate Alzheimer's Disease: A Phase 2, Open-Label Extension Study","Salloway S, Marshall GA, Lu M, Brashear HR.","Curr Alzheimer Res. 2018;15(13):1231-1243. doi: 10.2174/1567205015666180821114813.","Salloway S","Curr Alzheimer Res","2018","2018/08/22","","","10.2174/1567205015666180821114813"
"31196835","Effects of 6-month at-home transcranial direct current stimulation on cognition and cerebral glucose metabolism in Alzheimer's disease","Im JJ, Jeong H, Bikson M, Woods AJ, Unal G, Oh JK, Na S, Park JS, Knotkova H, Song IU, Chung YA.","Brain Stimul. 2019 Sep-Oct;12(5):1222-1228. doi: 10.1016/j.brs.2019.06.003. Epub 2019 Jun 4.","Im JJ","Brain Stimul","2019","2019/06/15","PMC6703942","NIHMS1530979","10.1016/j.brs.2019.06.003"
"27578455","Comprehensive effects of galantamine and cilostazol combination therapy on patients with Alzheimer's disease with asymptomatic lacunar infarction","Hishikawa N, Fukui Y, Sato K, Ohta Y, Yamashita T, Abe K.","Geriatr Gerontol Int. 2017 Oct;17(10):1384-1391. doi: 10.1111/ggi.12870. Epub 2016 Aug 31.","Hishikawa N","Geriatr Gerontol Int","2017","2016/09/01","","","10.1111/ggi.12870"
"24970906","Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study","Ong KT, Villemagne VL, Bahar-Fuchs A, Lamb F, Langdon N, Catafau AM, Stephens AW, Seibyl J, Dinkelborg LM, Reininger CB, Putz B, Rohde B, Masters CL, Rowe CC.","J Neurol Neurosurg Psychiatry. 2015 Apr;86(4):431-6. doi: 10.1136/jnnp-2014-308094. Epub 2014 Jun 26.","Ong KT","J Neurol Neurosurg Psychiatry","2015","2014/06/28","","","10.1136/jnnp-2014-308094"
"9276079","Mismatch negativity during attend and ignore conditions in Alzheimer's disease","Kazmerski VA, Friedman D, Ritter W.","Biol Psychiatry. 1997 Sep 1;42(5):382-402. doi: 10.1016/S0006-3223(96)00344-7.","Kazmerski VA","Biol Psychiatry","1997","1997/09/01","","","10.1016/S0006-3223(96)00344-7"
"16485863","The traveling salesman problem as a new screening test in early Alzheimer's disease: an exploratory study. Visual problem-solving in AD","De Vreese LP, Pradelli S, Massini G, Buscema M, Savarè R, Grossi E.","Aging Clin Exp Res. 2005 Dec;17(6):458-64. doi: 10.1007/BF03327412.","De Vreese LP","Aging Clin Exp Res","2005","2006/02/21","","","10.1007/BF03327412"
"11236819","Cognitive intervention in Alzheimer disease: a randomized placebo-controlled study","Davis RN, Massman PJ, Doody RS.","Alzheimer Dis Assoc Disord. 2001 Jan-Mar;15(1):1-9. doi: 10.1097/00002093-200101000-00001.","Davis RN","Alzheimer Dis Assoc Disord","2001","2001/03/10","","","10.1097/00002093-200101000-00001"
"12671528","Donepezil as add-on treatment of psychotic symptoms in patients with dementia of the Alzheimer's type","Bergman J, Brettholz I, Shneidman M, Lerner V.","Clin Neuropharmacol. 2003 Mar-Apr;26(2):88-92. doi: 10.1097/00002826-200303000-00008.","Bergman J","Clin Neuropharmacol","2003","2003/04/03","","","10.1097/00002826-200303000-00008"
"36281665","Amyloid-Related Imaging Abnormalities and Other MRI Findings in a Cognitively Unimpaired Population With and Without Cerebral Amyloid","Yaari R, Holdridge KC, Choi J, Donohue MC, Kantarci K, Jack CR Jr, Zuk SM, Sims JR, Johnson KA, Aisen PS, Sperling RA.","J Prev Alzheimers Dis. 2022;9(4):617-624. doi: 10.14283/jpad.2022.56.","Yaari R","J Prev Alzheimers Dis","2022","2022/10/25","","","10.14283/jpad.2022.56"
"34360360","Comparative Efficacy of Active Group Music Intervention versus Group Music Listening in Alzheimer's Disease","Gómez-Gallego M, Gómez-Gallego JC, Gallego-Mellado M, García-García J.","Int J Environ Res Public Health. 2021 Jul 30;18(15):8067. doi: 10.3390/ijerph18158067.","Gómez-Gallego M","Int J Environ Res Public Health","2021","2021/08/07","PMC8345612","","10.3390/ijerph18158067"
"11295884","Positron emission tomographic measurement of brain acetylcholinesterase activity using N-[(11)C]methylpiperidin-4-yl acetate without arterial blood sampling: methodology of shape analysis and its diagnostic power for Alzheimer's disease","Tanaka N, Fukushi K, Shinotoh H, Nagatsuka S, Namba H, Iyo M, Aotsuka A, Ota T, Tanada S, Irie T.","J Cereb Blood Flow Metab. 2001 Mar;21(3):295-306. doi: 10.1097/00004647-200103000-00013.","Tanaka N","J Cereb Blood Flow Metab","2001","2001/04/11","","","10.1097/00004647-200103000-00013"
"15353385","Long-term outcomes of galantamine treatment in patients with Alzheimer disease","Lyketsos CG, Reichman WE, Kershaw P, Zhu Y.","Am J Geriatr Psychiatry. 2004 Sep-Oct;12(5):473-82. doi: 10.1176/appi.ajgp.12.5.473.","Lyketsos CG","Am J Geriatr Psychiatry","2004","2004/09/09","","","10.1176/appi.ajgp.12.5.473"
"27436668","European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow","Meulenbroek O, O'Dwyer S, de Jong D, van Spijker G, Kennelly S, Cregg F, Olde Rikkert M, Abdullah L, Wallin A, Walsh C, Coen R, Kenny RA, Daly L, Segurado R, Borjesson-Hanson A, Crawford F, Mullan M, Lucca U, Banzi R, Pasquier F, Breuilh L, Riepe M, Kalman J, Molloy W, Tsolaki M, Howard R, Adams J, Gaynor S, Lawlor B.","BMJ Open. 2016 Jul 19;6(7):e011584. doi: 10.1136/bmjopen-2016-011584.","Meulenbroek O","BMJ Open","2016","2016/07/21","PMC4964180","","10.1136/bmjopen-2016-011584"
"10389359","Memory versus intelligence in dementia screening--MMSE","Zlotogorski Z, Lurie L, Oppenheim G.","Isr J Psychiatry Relat Sci. 1999;36(1):18-22.","Zlotogorski Z","Isr J Psychiatry Relat Sci","1999","1999/07/02","","",""
"29704641","Chronically raised C-reactive protein is inversely associated with cortical β-amyloid in older adults with subjective memory complaints","Hooper C, De Souto Barreto P, Cantet C, Cesari M, Payoux P, Salabert AS, Vellas B; MAPT/DSA study group.","Exp Gerontol. 2018 Jul 15;108:226-230. doi: 10.1016/j.exger.2018.04.014. Epub 2018 Apr 25.","Hooper C","Exp Gerontol","2018","2018/04/29","","","10.1016/j.exger.2018.04.014"
"10818550","Preliminary results from an MRI/CT-based database for vascular dementia and Alzheimer's disease","Scheltens P, Kittner B.","Ann N Y Acad Sci. 2000 Apr;903:542-6. doi: 10.1111/j.1749-6632.2000.tb06411.x.","Scheltens P","Ann N Y Acad Sci","2000","2000/05/20","","","10.1111/j.1749-6632.2000.tb06411.x"
"17132973","Efficacy of recreational and occupational activities associated to psychologic support in mild to moderate Alzheimer disease: a multicenter controlled study","Farina E, Mantovani F, Fioravanti R, Rotella G, Villanelli F, Imbornone E, Olivotto F, Tincani M, Alberoni M, Petrone E, Nemni R, Postiglione A.","Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):275-82. doi: 10.1097/01.wad.0000213846.66742.90.","Farina E","Alzheimer Dis Assoc Disord","2006","2006/11/30","","","10.1097/01.wad.0000213846.66742.90"
"9148201","Perceptual priming in Alzheimer's and Parkinson's diseases","Koivisto M, Portin R, Rinne JO.","Neuropsychologia. 1996 May;34(5):449-57. doi: 10.1016/0028-3932(95)00124-7.","Koivisto M","Neuropsychologia","1996","1996/05/01","","","10.1016/0028-3932(95)00124-7"
"32503473","The effect of physical activity on cognition relative to APOE genotype (PAAD-2): study protocol for a phase II randomized control trial","Park KS, Ganesh AB, Berry NT, Mobley YP, Karper WB, Labban JD, Wahlheim CN, Williams TM, Wideman L, Etnier JL.","BMC Neurol. 2020 Jun 6;20(1):231. doi: 10.1186/s12883-020-01732-1.","Park KS","BMC Neurol","2020","2020/06/07","PMC7274941","","10.1186/s12883-020-01732-1"
"22572767","Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer's disease: a subgroup analysis in patients already taking or not taking concomitant memantine","Doody RS, Geldmacher DS, Farlow MR, Sun Y, Moline M, Mackell J.","Dement Geriatr Cogn Disord. 2012;33(2-3):164-73. doi: 10.1159/000338236. Epub 2012 May 10.","Doody RS","Dement Geriatr Cogn Disord","2012","2012/05/11","","","10.1159/000338236"
"21912072","Effect of vitamin E administration on the elevated oxygen stress and the telomeric and subtelomeric status in Alzheimer's disease","Guan JZ, Guan WP, Maeda T, Makino N.","Gerontology. 2012;58(1):62-9. doi: 10.1159/000327821. Epub 2011 Sep 7.","Guan JZ","Gerontology","2012","2011/09/14","","","10.1159/000327821"
"6360031","Lack of clinical efficacy of chronic oral physostigmine in Alzheimer's disease","Jotkowitz S.","Ann Neurol. 1983 Dec;14(6):690-1. doi: 10.1002/ana.410140616.","Jotkowitz S","Ann Neurol","1983","1983/12/01","","","10.1002/ana.410140616"
"35932158","Effects of an essential amino acid mixture on behavioral and psychological symptoms of dementia and executive function in patients with Alzheimer's disease: A double-blind, randomized, placebo-controlled exploratory clinical trial","Takada M, Tanaka S, Tanaka K, Tsukie T, Tsukamoto-Yasui M, Suzuki K, Noguchi Y, Imaizumi A, Ishii M, Ikeuchi T.","Int J Geriatr Psychiatry. 2022 Sep;37(9):10.1002/gps.5782. doi: 10.1002/gps.5782.","Takada M","Int J Geriatr Psychiatry","2022","2022/08/06","PMC9544995","","10.1002/gps.5782"
"23869899","Caregiver outcomes of partners in dementia care: effect of a care coordination program for veterans with dementia and their family members and friends","Bass DM, Judge KS, Snow AL, Wilson NL, Morgan R, Looman WJ, McCarthy CA, Maslow K, Moye JA, Randazzo R, Garcia-Maldonado M, Elbein R, Odenheimer G, Kunik ME.","J Am Geriatr Soc. 2013 Aug;61(8):1377-86. doi: 10.1111/jgs.12362. Epub 2013 Jul 19.","Bass DM","J Am Geriatr Soc","2013","2013/07/23","","","10.1111/jgs.12362"
"9812111","A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease","Devanand DP, Marder K, Michaels KS, Sackeim HA, Bell K, Sullivan MA, Cooper TB, Pelton GH, Mayeux R.","Am J Psychiatry. 1998 Nov;155(11):1512-20. doi: 10.1176/ajp.155.11.1512.","Devanand DP","Am J Psychiatry","1998","1998/11/13","","","10.1176/ajp.155.11.1512"
"1664616","[Effectiveness of amiridin in senile dementia of the Alzheimer type]","Bukatina EE, Grigor'eva IV, Sokol'nik EI.","Zh Nevropatol Psikhiatr Im S S Korsakova. 1991;91(9):53-8.","Bukatina EE","Zh Nevropatol Psikhiatr Im S S Korsakova","1991","1991/01/01","","",""
"15718037","Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain","Blomqvist ME, Chalmers K, Andreasen N, Bogdanovic N, Wilcock GK, Cairns NJ, Feuk L, Brookes AJ, Love S, Blennow K, Kehoe PG, Prince JA.","Neurobiol Aging. 2005 Jun;26(6):795-802. doi: 10.1016/j.neurobiolaging.2004.07.011.","Blomqvist ME","Neurobiol Aging","2005","2005/02/19","","","10.1016/j.neurobiolaging.2004.07.011"
"36849969","Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial","Dubois B, López-Arrieta J, Lipschitz S, Doskas T, Spiru L, Moroz S, Venger O, Vermersch P, Moussy A, Mansfield CD, Hermine O, Tsolaki M; AB09004 Study Group Investigators.","Alzheimers Res Ther. 2023 Feb 28;15(1):39. doi: 10.1186/s13195-023-01169-x.","Dubois B","Alzheimers Res Ther","2023","2023/02/28","PMC9972756","","10.1186/s13195-023-01169-x"
"35867135","Neuroimaging analyses from a randomized, controlled study to evaluate plasma exchange with albumin replacement in mild-to-moderate Alzheimer's disease: additional results from the AMBAR study","Cuberas-Borrós G, Roca I, Castell-Conesa J, Núñez L, Boada M, López OL, Grifols C, Barceló M, Pareto D, Páez A.","Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4589-4600. doi: 10.1007/s00259-022-05915-5. Epub 2022 Jul 22.","Cuberas-Borrós G","Eur J Nucl Med Mol Imaging","2022","2022/07/22","PMC9606044","","10.1007/s00259-022-05915-5"
"2569126","Tacrine in Alzheimer's disease","Levy R.","Lancet. 1989 Aug 5;2(8658):329. doi: 10.1016/s0140-6736(89)90510-2.","Levy R","Lancet","1989","1989/08/05","","","10.1016/s0140-6736(89)90510-2"
"16250069","Olanzapine does not enhance cognition in non-agitated and non-psychotic patients with mild to moderate Alzheimer's dementia","Kennedy J, Deberdt W, Siegal A, Micca J, Degenhardt E, Ahl J, Meyers A, Kaiser C, Baker RW.","Int J Geriatr Psychiatry. 2005 Nov;20(11):1020-7. doi: 10.1002/gps.1397.","Kennedy J","Int J Geriatr Psychiatry","2005","2005/10/27","","","10.1002/gps.1397"
"27012596","Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24-week, Randomized, Double-Blind Parallel-Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily)","Zhang ZX, Hong Z, Wang YP, He L, Wang N, Zhao ZX, Zhao G, Shang L, Weisskopf M, Callegari F, Strohmaier C.","CNS Neurosci Ther. 2016 Jun;22(6):488-96. doi: 10.1111/cns.12521. Epub 2016 Mar 25.","Zhang ZX","CNS Neurosci Ther","2016","2016/03/26","PMC6492844","","10.1111/cns.12521"
"9099411","A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease","Steffens DC, Plassman BL, Helms MJ, Welsh-Bohmer KA, Saunders AM, Breitner JC.","Biol Psychiatry. 1997 Apr 15;41(8):851-6. doi: 10.1016/S0006-3223(96)00247-8.","Steffens DC","Biol Psychiatry","1997","1997/04/15","","","10.1016/S0006-3223(96)00247-8"
"9298629","Effect of normal aging and of Alzheimer's disease on, episodic memory","Le Moal S, Reymann JM, Thomas V, Cattenoz C, Lieury A, Allain H.","Dement Geriatr Cogn Disord. 1997 Sep-Oct;8(5):281-7. doi: 10.1159/000106645.","Le Moal S","Dement Geriatr Cogn Disord","1997","1997/09/23","","","10.1159/000106645"
"20200346","Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe","Feldman HH, Doody RS, Kivipelto M, Sparks DL, Waters DD, Jones RW, Schwam E, Schindler R, Hey-Hadavi J, DeMicco DA, Breazna A; LEADe Investigators.","Neurology. 2010 Mar 23;74(12):956-64. doi: 10.1212/WNL.0b013e3181d6476a. Epub 2010 Mar 3.","Feldman HH","Neurology","2010","2010/03/05","","","10.1212/WNL.0b013e3181d6476a"
"12789681","Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study","Prasher VP, Adams C, Holder R; Down Syndrome Research Group.","Int J Geriatr Psychiatry. 2003 Jun;18(6):549-51. doi: 10.1002/gps.859.","Prasher VP","Int J Geriatr Psychiatry","2003","2003/06/06","","","10.1002/gps.859"
"9678318","Cognitive profiles of autopsy-confirmed Lewy body variant vs pure Alzheimer disease","Connor DJ, Salmon DP, Sandy TJ, Galasko D, Hansen LA, Thal LJ.","Arch Neurol. 1998 Jul;55(7):994-1000. doi: 10.1001/archneur.55.7.994.","Connor DJ","Arch Neurol","1998","1998/07/25","","","10.1001/archneur.55.7.994"
"31879235","Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease","Sabbagh M, Sadowsky C, Tousi B, Agronin ME, Alva G, Armon C, Bernick C, Keegan AP, Karantzoulis S, Baror E, Ploznik M, Pascual-Leone A.","Alzheimers Dement. 2020 Apr;16(4):641-650. doi: 10.1016/j.jalz.2019.08.197. Epub 2020 Jan 16.","Sabbagh M","Alzheimers Dement","2020","2019/12/28","","","10.1016/j.jalz.2019.08.197"
"11311030","Priming performance in Alzheimer's disease: the role of task sensitivity","Norton LE, Ostergaard AL.","J Int Neuropsychol Soc. 2001 Mar;7(3):294-301. doi: 10.1017/s1355617701733036.","Norton LE","J Int Neuropsychol Soc","2001","2001/04/20","","","10.1017/s1355617701733036"
"30980923","Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma","Jensen CS, Bahl JM, Østergaard LB, Høgh P, Wermuth L, Heslegrave A, Zetterberg H, Heegaard NHH, Hasselbalch SG, Simonsen AH.","Exp Gerontol. 2019 Jul 1;121:91-98. doi: 10.1016/j.exger.2019.04.003. Epub 2019 Apr 11.","Jensen CS","Exp Gerontol","2019","2019/04/14","","","10.1016/j.exger.2019.04.003"
"16298235","Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease","Buerger K, Otto M, Teipel SJ, Zinkowski R, Blennow K, DeBernardis J, Kerkman D, Schröder J, Schönknecht P, Cepek L, McCulloch C, Möller HJ, Wiltfang J, Kretzschmar H, Hampel H.","Neurobiol Aging. 2006 Jan;27(1):10-5. doi: 10.1016/j.neurobiolaging.2004.12.003.","Buerger K","Neurobiol Aging","2006","2005/11/22","","","10.1016/j.neurobiolaging.2004.12.003"
"14764189","Behavioral and endocrinological evaluation of music therapy for elderly patients with dementia","Suzuki M, Kanamori M, Watanabe M, Nagasawa S, Kojima E, Ooshiro H, Nakahara D.","Nurs Health Sci. 2004 Mar;6(1):11-8. doi: 10.1111/j.1442-2018.2003.00168.x.","Suzuki M","Nurs Health Sci","2004","2004/02/07","","","10.1111/j.1442-2018.2003.00168.x"
"11802224","Challenging behaviours in nursing home residents with dementia: a randomized controlled trial of multidisciplinary interventions","Opie J, Doyle C, O'Connor DW.","Int J Geriatr Psychiatry. 2002 Jan;17(1):6-13. doi: 10.1002/gps.493.","Opie J","Int J Geriatr Psychiatry","2002","2002/01/22","","","10.1002/gps.493"
"20672243","Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?","Drye LT, Martin BK, Frangakis CE, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG; DIADS-2 Research Group.","Int J Geriatr Psychiatry. 2011 Jun;26(6):573-83. doi: 10.1002/gps.2565.","Drye LT","Int J Geriatr Psychiatry","2011","2010/07/31","PMC3414254","NIHMS380309","10.1002/gps.2565"
"16137793","Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease","Kamboh MI, Minster RL, Kenney M, Ozturk A, Desai PP, Kammerer CM, DeKosky ST.","Neurobiol Aging. 2006 Oct;27(10):1435-9. doi: 10.1016/j.neurobiolaging.2005.07.015. Epub 2005 Aug 30.","Kamboh MI","Neurobiol Aging","2006","2005/09/03","PMC1609963","NIHMS12158","10.1016/j.neurobiolaging.2005.07.015"
"18288936","Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial","Porsteinsson AP, Grossberg GT, Mintzer J, Olin JT; Memantine MEM-MD-12 Study Group.","Curr Alzheimer Res. 2008 Feb;5(1):83-9. doi: 10.2174/156720508783884576.","Porsteinsson AP","Curr Alzheimer Res","2008","2008/02/22","","","10.2174/156720508783884576"
"12566596","Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months","Blesa R, Davidson M, Kurz A, Reichman W, van Baelen B, Schwalen S.","Dement Geriatr Cogn Disord. 2003;15(2):79-87. doi: 10.1159/000067974.","Blesa R","Dement Geriatr Cogn Disord","2003","2003/02/05","","","10.1159/000067974"
"28269767","Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid","Bloniecki V, Aarsland D, Blennow K, Cummings J, Falahati F, Winblad B, Freund-Levi Y.","J Alzheimers Dis. 2017;57(2):387-393. doi: 10.3233/JAD-160758.","Bloniecki V","J Alzheimers Dis","2017","2017/03/09","PMC6203339","NIHMS935258","10.3233/JAD-160758"
"11234910","Cognitive and metabolic responses to metrifonate therapy in Alzheimer disease","Mega MS, Cummings JL, O'Connor SM, Dinov ID, Reback E, Felix J, Masterman DL, Phelps ME, Small GW, Toga AW.","Neuropsychiatry Neuropsychol Behav Neurol. 2001 Jan;14(1):63-8.","Mega MS","Neuropsychiatry Neuropsychol Behav Neurol","2001","2001/03/10","","",""
"17873681","Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial","Mowla A, Mosavinasab M, Haghshenas H, Borhani Haghighi A.","J Clin Psychopharmacol. 2007 Oct;27(5):484-7. doi: 10.1097/jcp.0b013e31814b98c1.","Mowla A","J Clin Psychopharmacol","2007","2007/09/18","","","10.1097/jcp.0b013e31814b98c1"
"32286939","Tau Protein Aggregation in Alzheimer's Disease: Recent Advances in the Development of Novel Therapeutic Agents","Monteiro KLC, Alcântara MGDS, de Aquino TM, da Silva-Júnior EF.","Curr Pharm Des. 2020;26(15):1682-1692. doi: 10.2174/1381612826666200414164038.","Monteiro KLC","Curr Pharm Des","2020","2020/04/15","","","10.2174/1381612826666200414164038"
"24169147","Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial","Lanctôt KL, Chau SA, Herrmann N, Drye LT, Rosenberg PB, Scherer RW, Black SE, Vaidya V, Bachman DL, Mintzer JE.","Int Psychogeriatr. 2014 Feb;26(2):239-46. doi: 10.1017/S1041610213001762. Epub 2013 Oct 29.","Lanctôt KL","Int Psychogeriatr","2014","2013/10/31","PMC3927455","NIHMS548138","10.1017/S1041610213001762"
"31888732","INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer's Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol","Moga DC, Beech BF, Abner EL, Schmitt FA, El Khouli RH, Martinez AI, Eckmann L, Huffmyer M, George R, Jicha GA.","Trials. 2019 Dec 30;20(1):806. doi: 10.1186/s13063-019-3993-0.","Moga DC","Trials","2019","2020/01/01","PMC6937673","","10.1186/s13063-019-3993-0"
"8314099","An intervention that delays institutionalization of Alzheimer's disease patients: treatment of spouse-caregivers","Mittelman MS, Ferris SH, Steinberg G, Shulman E, Mackell JA, Ambinder A, Cohen J.","Gerontologist. 1993 Dec;33(6):730-40. doi: 10.1093/geront/33.6.730.","Mittelman MS","Gerontologist","1993","1993/12/01","","","10.1093/geront/33.6.730"
"15942862","[Awareness of memory deficits in patients with probable Alzheimer's disease]","Retz-Junginger P, Supprian T, Retz W, Rösler M, Traue HC.","Fortschr Neurol Psychiatr. 2005 Jun;73(6):327-32. doi: 10.1055/s-2004-830245.","Retz-Junginger P","Fortschr Neurol Psychiatr","2005","2005/06/09","","","10.1055/s-2004-830245"
"9549662","Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's disease","Pettigrew LC, Bieber F, Lettieri J, Wermeling DP, Schmitt FA, Tikhtman AJ, Ashford JW, Smith CD, Wekstein DR, Markesbery WR, Orazem J, Ruzicka BB, Mas J, Gulanski B.","J Clin Pharmacol. 1998 Mar;38(3):236-45. doi: 10.1002/j.1552-4604.1998.tb04421.x.","Pettigrew LC","J Clin Pharmacol","1998","1998/04/29","","","10.1002/j.1552-4604.1998.tb04421.x"
"32116250","Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial","Tomaszewski N, He X, Solomon V, Lee M, Mack WJ, Quinn JF, Braskie MN, Yassine HN.","J Alzheimers Dis. 2020;74(3):975-990. doi: 10.3233/JAD-191017.","Tomaszewski N","J Alzheimers Dis","2020","2020/03/03","PMC7156328","NIHMS1572433","10.3233/JAD-191017"
"13679718","[The profile of memory disturbance in early Lewy body dementia differs from that in Alzheimer's disease]","Mormont E, Laurier-Grymonprez L, Baisset-Mouly C, Pasquier F.","Rev Neurol (Paris). 2003 Sep;159(8-9):762-6.","Mormont E","Rev Neurol (Paris)","2003","2003/09/19","","",""
"32716358","Baseline Prevalence of Polypharmacy in Older Hypertensive Study Subjects with Elevated Dementia Risk: Findings from the Risk Reduction for Alzheimer's Disease Study (rrAD)","Vidoni ED, Kamat A, Gahan WP, Ourso V, Woodard K, Kerwin DR, Binder EF, Burns JM, Cullum M, Hynan LS, Vongpatanasin W, Zhu DC, Zhang R, Keller JN.","J Alzheimers Dis. 2020;77(1):175-182. doi: 10.3233/JAD-200122.","Vidoni ED","J Alzheimers Dis","2020","2020/07/28","PMC8108402","NIHMS1693556","10.3233/JAD-200122"
"15990426","Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease","Brodaty H, Corey-Bloom J, Potocnik FC, Truyen L, Gold M, Damaraju CR.","Dement Geriatr Cogn Disord. 2005;20(2-3):120-32. doi: 10.1159/000086613. Epub 2005 Jun 30.","Brodaty H","Dement Geriatr Cogn Disord","2005","2005/07/02","","","10.1159/000086613"
"18953056","Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain","Boche D, Zotova E, Weller RO, Love S, Neal JW, Pickering RM, Wilkinson D, Holmes C, Nicoll JA.","Brain. 2008 Dec;131(Pt 12):3299-310. doi: 10.1093/brain/awn261. Epub 2008 Oct 25.","Boche D","Brain","2008","2008/10/28","","","10.1093/brain/awn261"
"10079048","Impaired acquisition and rapid forgetting of patterned visual stimuli in Alzheimer's disease","Reed BR, Paller KA, Mungas D.","J Clin Exp Neuropsychol. 1998 Oct;20(5):738-49. doi: 10.1076/jcen.20.5.738.1123.","Reed BR","J Clin Exp Neuropsychol","1998","1999/03/17","","","10.1076/jcen.20.5.738.1123"
"9084068","The ability of THA treatment to increase cortical alpha waves is related to apolipoprotein E genotype of Alzheimer disease patients","Riekkinen P Jr, Soininen H, Partanen J, Pääkkönen A, Helisalmi S, Riekkinen P Sr.","Psychopharmacology (Berl). 1997 Feb;129(3):285-8. doi: 10.1007/s002130050192.","Riekkinen P Jr","Psychopharmacology (Berl)","1997","1997/02/01","","","10.1007/s002130050192"
"8889914","Cognitive effects of flumazenil in patients with Alzheimer's disease","Ott BR, Thompson JA, Whelihan WM.","J Clin Psychopharmacol. 1996 Oct;16(5):400-2. doi: 10.1097/00004714-199610000-00010.","Ott BR","J Clin Psychopharmacol","1996","1996/10/01","","","10.1097/00004714-199610000-00010"
"21690032","[Semantic memory training in Alzheimer's disease]","Goudour A, Samson S, Bakchine S, Ehrlé N.","Geriatr Psychol Neuropsychiatr Vieil. 2011 Jun;9(2):237-47. doi: 10.1684/pnv.2011.0272.","Goudour A","Geriatr Psychol Neuropsychiatr Vieil","2011","2011/06/22","","","10.1684/pnv.2011.0272"
"12083600","No long-term effect of behavioral treatment on psychotropic drug use for agitation in Alzheimer's disease patients","Weiner MF, Tractenberg RE, Sano M, Logsdon R, Teri L, Galasko D, Gamst A, Thomas R, Thal LJ.","J Geriatr Psychiatry Neurol. 2002 Summer;15(2):95-8. doi: 10.1177/089198870201500208.","Weiner MF","J Geriatr Psychiatry Neurol","2002","2002/06/27","","","10.1177/089198870201500208"
"8394847","Behavioral effects of a synthetic corticotropin 4-9 analog in patients with depression and patients with Alzheimer's disease","Heuser I, Heuser-Link M, Gotthardt U, Grasser A, Holsboer F.","J Clin Psychopharmacol. 1993 Jun;13(3):171-4.","Heuser I","J Clin Psychopharmacol","1993","1993/06/01","","",""
"26587902","Lowered Levels of Carbonyl Proteins after Vitamin B Supplementation in Patients with Mild Cognitive Impairment and Alzheimer's Disease","Rommer PS, Fuchs D, Leblhuber F, Schroth R, Greilberger M, Tafeit E, Greilberger J.","Neurodegener Dis. 2016;16(3-4):284-9. doi: 10.1159/000441565. Epub 2015 Nov 21.","Rommer PS","Neurodegener Dis","2016","2015/11/21","","","10.1159/000441565"
"3512944","Physostigmine effects in Alzheimer's disease: relationship to dementia severity","Schwartz AS, Kohlstaedt EV.","Life Sci. 1986 Mar 17;38(11):1021-8. doi: 10.1016/0024-3205(86)90236-5.","Schwartz AS","Life Sci","1986","1986/03/17","","","10.1016/0024-3205(86)90236-5"
"29716655","A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study","Ridha BH, Crutch S, Cutler D, Frost C, Knight W, Barker S, Epie N, Warrington EK, Kukkastenvehmas R, Douglas J, Rossor MN.","Alzheimers Res Ther. 2018 May 1;10(1):44. doi: 10.1186/s13195-018-0363-1.","Ridha BH","Alzheimers Res Ther","2018","2018/05/03","PMC5930935","","10.1186/s13195-018-0363-1"
"8909368","Efficacy and tolerability of tacrine in nursing home residents with Alzheimer's dementia","Woo JK, Lantz MS, Marchello V, Libow LS.","J Am Geriatr Soc. 1996 Nov;44(11):1411-2. doi: 10.1111/j.1532-5415.1996.tb01426.x.","Woo JK","J Am Geriatr Soc","1996","1996/11/01","","","10.1111/j.1532-5415.1996.tb01426.x"
"17381186","Naturalistic treatment of Alzheimer's disease with galantamine: 12-month follow-up from the NATURE study","Brodaty H, Woodward M, Boundy K, Barnes N.","CNS Drugs. 2007;21(4):335-6. doi: 10.2165/00023210-200721040-00006.","Brodaty H","CNS Drugs","2007","2007/03/27","","","10.2165/00023210-200721040-00006"
"9813790","Relationship of cognitive and functional impairment to depressive features in Alzheimer's disease and other dementias","Payne JL, Lyketsos CG, Steele C, Baker L, Galik E, Kopunek S, Steinberg M, Warren A.","J Neuropsychiatry Clin Neurosci. 1998 Fall;10(4):440-7. doi: 10.1176/jnp.10.4.440.","Payne JL","J Neuropsychiatry Clin Neurosci","1998","1998/11/14","","","10.1176/jnp.10.4.440"
"7890824","Exploring visuospatial short-term memory defect in Alzheimer's disease","Trojano L, Chiacchio L, De Luca G, Grossi D.","J Clin Exp Neuropsychol. 1994 Dec;16(6):911-5. doi: 10.1080/01688639408402702.","Trojano L","J Clin Exp Neuropsychol","1994","1994/12/01","","","10.1080/01688639408402702"
"33999936","MADRID+90 study on factors associated with longevity: Study design and preliminary data","Fernández-Blázquez MA, Del Ser T, Frades-Payo B, Ávila-Villanueva M, Valentí-Soler M, Benítez-Robredo MT, Bermejo-Aguña A, Pedrero-Pérez EJ, Quilis-Sancho J, Pastor AB, Fernández-Garrido C, Morales-Alonso S, Diaz-Olalla JM, Santos NC, Maestú F, Gómez-Ramírez J.","PLoS One. 2021 May 17;16(5):e0251796. doi: 10.1371/journal.pone.0251796. eCollection 2021.","Fernández-Blázquez MA","PLoS One","2021","2021/05/17","PMC8128242","","10.1371/journal.pone.0251796"
"16955427","Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS","Mayer LS, Bay RC, Politis A, Steinberg M, Steele C, Baker AS, Rabins PV, Lyketsos CG.","Int J Geriatr Psychiatry. 2006 Oct;21(10):930-6. doi: 10.1002/gps.1583.","Mayer LS","Int J Geriatr Psychiatry","2006","2006/09/07","","","10.1002/gps.1583"
"29400666","Deep Brain Stimulation of Frontal Lobe Networks to Treat Alzheimer's Disease","Scharre DW, Weichart E, Nielson D, Zhang J, Agrawal P, Sederberg PB, Knopp MV, Rezai AR; Alzheimer’s Disease Neuroimaging Initiative.","J Alzheimers Dis. 2018;62(2):621-633. doi: 10.3233/JAD-170082.","Scharre DW","J Alzheimers Dis","2018","2018/02/06","","","10.3233/JAD-170082"
"21839143","Computer aided diagnosis system for Alzheimer disease using brain diffusion tensor imaging features selected by Pearson's correlation","Graña M, Termenon M, Savio A, Gonzalez-Pinto A, Echeveste J, Pérez JM, Besga A.","Neurosci Lett. 2011 Sep 20;502(3):225-9. doi: 10.1016/j.neulet.2011.07.049. Epub 2011 Aug 4.","Graña M","Neurosci Lett","2011","2011/08/16","","","10.1016/j.neulet.2011.07.049"
"3711028","Haloperidol versus thioridazine in the treatment of behavioral symptoms in senile dementia of the Alzheimer's type: preliminary findings","Steele C, Lucas MJ, Tune L.","J Clin Psychiatry. 1986 Jun;47(6):310-2.","Steele C","J Clin Psychiatry","1986","1986/06/01","","",""
"9213068","Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia","Minthon L, Edvinsson L, Gustafson L.","Dement Geriatr Cogn Disord. 1997 Jul-Aug;8(4):232-9. doi: 10.1159/000106636.","Minthon L","Dement Geriatr Cogn Disord","1997","1997/07/01","","","10.1159/000106636"
"19246907","Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan","Homma A, Imai Y, Tago H, Asada T, Shigeta M, Iwamoto T, Takita M, Arimoto I, Koma H, Takase T, Ohbayashi T.","Dement Geriatr Cogn Disord. 2009;27(3):232-9. doi: 10.1159/000203887. Epub 2009 Feb 25.","Homma A","Dement Geriatr Cogn Disord","2009","2009/02/28","","","10.1159/000203887"
"24502142","[Antioxidants in erythrocytes in aging and dementia]","","Biomed Khim. 2013 Jul-Aug;59(4):443-51.","","Biomed Khim","2013","2014/02/08","","",""
"15515440","Facilitating resident information seeking regarding meals in a special care unit: an environmental design intervention","Nolan BA, Mathews RM.","J Gerontol Nurs. 2004 Oct;30(10):12-6; quiz 55-6. doi: 10.3928/0098-9134-20041001-07.","Nolan BA","J Gerontol Nurs","2004","2004/11/02","","","10.3928/0098-9134-20041001-07"
"33004235","One call makes a difference: An evaluation of the Alzheimer's Association National Helpline on dementia caregiver outcomes","Hodgson NA, Petrovsky DV, Finegan K, Kallmyer BA, Pike J, Fazio S.","Patient Educ Couns. 2021 Apr;104(4):896-902. doi: 10.1016/j.pec.2020.09.026. Epub 2020 Sep 23.","Hodgson NA","Patient Educ Couns","2021","2020/10/02","PMC10001241","NIHMS1866619","10.1016/j.pec.2020.09.026"
"36776073","Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study","Agger MP, Danielsen ER, Carstensen MS, Nguyen NM, Horning M, Henney MA, Jensen CBR, Baandrup AO, Kjær TW, Madsen KH, Miskowiak K, Petersen PM, Høgh P.","J Alzheimers Dis. 2023;92(2):653-665. doi: 10.3233/JAD-221238.","Agger MP","J Alzheimers Dis","2023","2023/02/13","","","10.3233/JAD-221238"
"9467724","Risk factors, causality, and policy initiatives: the case of aluminum and mental impairment","Forbes WF, Gentleman JF.","Exp Gerontol. 1998 Jan-Mar;33(1-2):141-54. doi: 10.1016/s0531-5565(97)00061-2.","Forbes WF","Exp Gerontol","1998","1998/02/19","","","10.1016/s0531-5565(97)00061-2"
"29632177","β-Amyloid accumulation in the human brain after one night of sleep deprivation","Shokri-Kojori E, Wang GJ, Wiers CE, Demiral SB, Guo M, Kim SW, Lindgren E, Ramirez V, Zehra A, Freeman C, Miller G, Manza P, Srivastava T, De Santi S, Tomasi D, Benveniste H, Volkow ND.","Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):4483-4488. doi: 10.1073/pnas.1721694115. Epub 2018 Apr 9.","Shokri-Kojori E","Proc Natl Acad Sci U S A","2018","2018/04/11","PMC5924922","","10.1073/pnas.1721694115"
"23733403","The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors","Grossberg GT, Manes F, Allegri RF, Gutiérrez-Robledo LM, Gloger S, Xie L, Jia XD, Pejović V, Miller ML, Perhach JL, Graham SM.","CNS Drugs. 2013 Jun;27(6):469-78. doi: 10.1007/s40263-013-0077-7.","Grossberg GT","CNS Drugs","2013","2013/06/05","PMC3680656","","10.1007/s40263-013-0077-7"
"7630497","Interdependance of the level of the steady potential of the brain and visual evoked potentials in human aging: the norm and Alzheimer's disease","Fokin VF, Ponomareva NV.","Neurosci Behav Physiol. 1995 Mar-Apr;25(2):136-41. doi: 10.1007/BF02358584.","Fokin VF","Neurosci Behav Physiol","1995","1995/03/01","","","10.1007/BF02358584"
"8854297","A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease","Petracca G, Tesón A, Chemerinski E, Leiguarda R, Starkstein SE.","J Neuropsychiatry Clin Neurosci. 1996 Summer;8(3):270-5. doi: 10.1176/jnp.8.3.270.","Petracca G","J Neuropsychiatry Clin Neurosci","1996","1996/01/01","","","10.1176/jnp.8.3.270"
"3893271","Clinical drug trials in Alzheimer's disease","Crook T.","Ann N Y Acad Sci. 1985;444:428-36. doi: 10.1111/j.1749-6632.1985.tb37605.x.","Crook T","Ann N Y Acad Sci","1985","1985/01/01","","","10.1111/j.1749-6632.1985.tb37605.x"
"12784892","Visuospatial deficits due to impaired visual attention: investigation of two cases of slowly progressive visuospatial impairment","Suzuki K, Otsuka Y, Endo K, Ejima A, Saito H, Fujii T, Yamadori A.","Cortex. 2003 Apr;39(2):327-41. doi: 10.1016/s0010-9452(08)70112-6.","Suzuki K","Cortex","2003","2003/06/06","","","10.1016/s0010-9452(08)70112-6"
"18441625","The effects of Snoezelen (multi-sensory behavior therapy) and psychiatric care on agitation, apathy, and activities of daily living in dementia patients on a short term geriatric psychiatric inpatient unit","Staal JA, Sacks A, Matheis R, Collier L, Calia T, Hanif H, Kofman ES.","Int J Psychiatry Med. 2007;37(4):357-70. doi: 10.2190/PM.37.4.a.","Staal JA","Int J Psychiatry Med","2007","2008/04/30","","","10.2190/PM.37.4.a"
"10461029","Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender","Craft S, Asthana S, Schellenberg G, Cherrier M, Baker LD, Newcomer J, Plymate S, Latendresse S, Petrova A, Raskind M, Peskind E, Lofgreen C, Grimwood K.","Neuroendocrinology. 1999 Aug;70(2):146-52. doi: 10.1159/000054469.","Craft S","Neuroendocrinology","1999","1999/08/26","","","10.1159/000054469"
"10081980","Genetic polymorphism in the persyn (gamma-synuclein) gene and the risk of Alzheimer's disease","Luedecking EK, Ganguli M, DeKosky ST, Kamboh MI.","Neurosci Lett. 1999 Feb 19;261(3):186-8. doi: 10.1016/s0304-3940(99)00025-7.","Luedecking EK","Neurosci Lett","1999","1999/03/19","","","10.1016/s0304-3940(99)00025-7"
"9309469","Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease","Volicer L, Stelly M, Morris J, McLaughlin J, Volicer BJ.","Int J Geriatr Psychiatry. 1997 Sep;12(9):913-9.","Volicer L","Int J Geriatr Psychiatry","1997","1997/10/06","","",""
"9043744","Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia","Kertesz A, Davidson W, Fox H.","Can J Neurol Sci. 1997 Feb;24(1):29-36. doi: 10.1017/s0317167100021053.","Kertesz A","Can J Neurol Sci","1997","1997/02/01","","","10.1017/s0317167100021053"
"1360474","Influence of transcutaneous electrical nerve stimulation on memory in patients with dementia of the Alzheimer type","Scherder EJ, Bouma A, Steen L.","J Clin Exp Neuropsychol. 1992 Nov;14(6):951-60. doi: 10.1080/01688639208402546.","Scherder EJ","J Clin Exp Neuropsychol","1992","1992/11/01","","","10.1080/01688639208402546"
"30947755","Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial","Forlenza OV, Radanovic M, Talib LL, Gattaz WF.","Br J Psychiatry. 2019 Nov;215(5):668-674. doi: 10.1192/bjp.2019.76.","Forlenza OV","Br J Psychiatry","2019","2019/04/06","","","10.1192/bjp.2019.76"
"25425736","Using the Alzheimer's Association web site to improve knowledge of Alzheimer's disease in health care providers","Hughes ML, Lowe DA, Shine HE, Carpenter BD, Balsis S.","Am J Alzheimers Dis Other Demen. 2015 Feb;30(1):98-100. doi: 10.1177/1533317514559827. Epub 2014 Nov 25.","Hughes ML","Am J Alzheimers Dis Other Demen","2015","2014/11/27","","","10.1177/1533317514559827"
"34964149","Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's disease","Baakman AC, Gavan C, van Doeselaar L, de Kam M, Broekhuizen K, Bajenaru O, Camps L, Swart EL, Kalisvaart K, Schoonenboom N, Lemstra E, Scheltens P, Cohen A, van Gerven J, Groeneveld GJ.","Br J Clin Pharmacol. 2022 Jun;88(6):2814-2829. doi: 10.1111/bcp.15206. Epub 2022 Jan 26.","Baakman AC","Br J Clin Pharmacol","2022","2021/12/29","PMC9306507","","10.1111/bcp.15206"
"18334913","Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease","Lane R, Feldman HH, Meyer J, He Y, Ferris SH, Nordberg A, Darreh-Shori T, Soininen H, Pirttilä T, Farlow MR, Sfikas N, Ballard C, Greig NH.","Pharmacogenet Genomics. 2008 Apr;18(4):289-98. doi: 10.1097/FPC.0b013e3282f63f29.","Lane R","Pharmacogenet Genomics","2008","2008/03/13","","","10.1097/FPC.0b013e3282f63f29"
"18480686","Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge","Herrmann N, Rothenburg LS, Black SE, Ryan M, Liu BA, Busto UE, Lanctôt KL.","J Clin Psychopharmacol. 2008 Jun;28(3):296-301. doi: 10.1097/JCP.0b013e318172b479.","Herrmann N","J Clin Psychopharmacol","2008","2008/05/16","","","10.1097/JCP.0b013e318172b479"
"27183464","Exploratory human PET study of the effectiveness of (11)C-ketoprofen methyl ester, a potential biomarker of neuroinflammatory processes in Alzheimer's disease","Ohnishi A, Senda M, Yamane T, Mikami T, Nishida H, Nishio T, Akamatsu G, Ikari Y, Kimoto S, Aita K, Sasaki M, Shinkawa H, Yamamoto Y, Shukuri M, Mawatari A, Doi H, Watanabe Y, Onoe H.","Nucl Med Biol. 2016 Jul;43(7):438-44. doi: 10.1016/j.nucmedbio.2016.04.005. Epub 2016 Apr 28.","Ohnishi A","Nucl Med Biol","2016","2016/05/17","","","10.1016/j.nucmedbio.2016.04.005"
"9844752","Randomized, dim light controlled, crossover test of morning bright light therapy for rest-activity rhythm disorders in patients with vascular dementia and dementia of Alzheimer's type","Mishima K, Hishikawa Y, Okawa M.","Chronobiol Int. 1998 Nov;15(6):647-54. doi: 10.3109/07420529808993200.","Mishima K","Chronobiol Int","1998","1998/12/09","","","10.3109/07420529808993200"
"31415677","Investigation of base excision repair gene variants in late-onset Alzheimer's disease","Ertuzun T, Semerci A, Cakir ME, Ekmekcioglu A, Gok MO, Soltys DT, de Souza-Pinto NC, Sezerman U, Muftuoglu M.","PLoS One. 2019 Aug 15;14(8):e0221362. doi: 10.1371/journal.pone.0221362. eCollection 2019.","Ertuzun T","PLoS One","2019","2019/08/16","PMC6695184","","10.1371/journal.pone.0221362"
"12231461","Brain metabolic effects of Neotrofin in patients with Alzheimer's disease","Potkin SG, Alva G, Keator D, Carreon D, Fleming K, Fallon JH.","Brain Res. 2002 Sep 27;951(1):87-95. doi: 10.1016/s0006-8993(02)03140-2.","Potkin SG","Brain Res","2002","2002/09/17","","","10.1016/s0006-8993(02)03140-2"
"12959805","Can we help persons with dementia find their way in a new environment?","McGilton KS, Rivera TM, Dawson P.","Aging Ment Health. 2003 Sep;7(5):363-71. doi: 10.1080/1360786031000150676.","McGilton KS","Aging Ment Health","2003","2003/09/10","","","10.1080/1360786031000150676"
"17169938","Project CARE: a randomized controlled trial of a behavioral intervention group for Alzheimer's disease caregivers","Gonyea JG, O'Connor MK, Boyle PA.","Gerontologist. 2006 Dec;46(6):827-32. doi: 10.1093/geront/46.6.827.","Gonyea JG","Gerontologist","2006","2006/12/16","","","10.1093/geront/46.6.827"
"25893795","A missense variant in CST3 exerts a recessive effect on susceptibility to age-related macular degeneration resembling its association with Alzheimer's disease","Butler JM, Sharif U, Ali M, McKibbin M, Thompson JP, Gale R, Yang YC, Inglehearn C, Paraoan L.","Hum Genet. 2015 Jul;134(7):705-15. doi: 10.1007/s00439-015-1552-7. Epub 2015 Apr 19.","Butler JM","Hum Genet","2015","2015/04/21","PMC4460273","","10.1007/s00439-015-1552-7"
"25408222","The impact of supplemental macular carotenoids in Alzheimer's disease: a randomized clinical trial","Nolan JM, Loskutova E, Howard A, Mulcahy R, Moran R, Stack J, Bolger M, Coen RF, Dennison J, Akuffo KO, Owens N, Power R, Thurnham D, Beatty S.","J Alzheimers Dis. 2015;44(4):1157-69. doi: 10.3233/JAD-142265.","Nolan JM","J Alzheimers Dis","2015","2014/11/20","","","10.3233/JAD-142265"
"16125823","Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment","de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Rusinek H, Li J, Tsui W, Saint Louis LA, Clark CM, Tarshish C, Li Y, Lair L, Javier E, Rich K, Lesbre P, Mosconi L, Reisberg B, Sadowski M, DeBernadis JF, Kerkman DJ, Hampel H, Wahlund LO, Davies P.","Neurobiol Aging. 2006 Mar;27(3):394-401. doi: 10.1016/j.neurobiolaging.2005.07.003. Epub 2005 Aug 26.","de Leon MJ","Neurobiol Aging","2006","2005/08/30","","","10.1016/j.neurobiolaging.2005.07.003"
"11287373","A double dissociation between accuracy and time of execution on attentional tasks in Alzheimer's disease and multi-infarct dementia","Gainotti G, Marra C, Villa G.","Brain. 2001 Apr;124(Pt 4):731-8. doi: 10.1093/brain/124.4.731.","Gainotti G","Brain","2001","2001/04/05","","","10.1093/brain/124.4.731"
"1940094","Imipramine in the treatment of depressed Alzheimer's patients: impact on cognition","Teri L, Reifler BV, Veith RC, Barnes R, White E, McLean P, Raskind M.","J Gerontol. 1991 Nov;46(6):P372-7. doi: 10.1093/geronj/46.6.p372.","Teri L","J Gerontol","1991","1991/11/01","","","10.1093/geronj/46.6.p372"
"8592643","Plasma neuropeptide Y is reduced in patients with Alzheimer's disease","Koide S, Onishi H, Hashimoto H, Kai T, Yamagami S.","Neurosci Lett. 1995 Sep 29;198(2):149-51. doi: 10.1016/0304-3940(95)11973-z.","Koide S","Neurosci Lett","1995","1995/09/29","","","10.1016/0304-3940(95)11973-z"
"11851727","d-penicillamine reduces serum oxidative stress in Alzheimer's disease patients","Squitti R, Rossini PM, Cassetta E, Moffa F, Pasqualetti P, Cortesi M, Colloca A, Rossi L, Finazzi-Agró A.","Eur J Clin Invest. 2002 Jan;32(1):51-9. doi: 10.1046/j.1365-2362.2002.00933.x.","Squitti R","Eur J Clin Invest","2002","2002/02/20","","","10.1046/j.1365-2362.2002.00933.x"
"12928714","Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia","Asayama K, Yamadera H, Ito T, Suzuki H, Kudo Y, Endo S.","J Nippon Med Sch. 2003 Aug;70(4):334-41. doi: 10.1272/jnms.70.334.","Asayama K","J Nippon Med Sch","2003","2003/08/21","","","10.1272/jnms.70.334"
"10940681","Behavioral differences between white matter lacunar dementia and Alzheimer's disease: a comparison on the neuropsychiatric inventory","Aharon-Peretz J, Kliot D, Tomer R.","Dement Geriatr Cogn Disord. 2000 Sep-Oct;11(5):294-8. doi: 10.1159/000017252.","Aharon-Peretz J","Dement Geriatr Cogn Disord","2000","2000/08/15","","","10.1159/000017252"
"8544907","VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease","Zhou JN, Hofman MA, Swaab DF.","Neurobiol Aging. 1995 Jul-Aug;16(4):571-6. doi: 10.1016/0197-4580(95)00043-e.","Zhou JN","Neurobiol Aging","1995","1995/07/01","","","10.1016/0197-4580(95)00043-e"
"25796322","[Mindfulness-based stimulation in advanced Alzheimer's disease: A comparative, non-inferiority, clinical pilot study]","Quintana Hernández DJ, Miró Barrachina MT, Ibáñez Fernández I, Santana del Pino A, Rojas Hernández J, Rodríguez García J, Quintana Montesdeoca Mdel P.","Rev Esp Geriatr Gerontol. 2015 Jul-Aug;50(4):168-73. doi: 10.1016/j.regg.2014.11.010. Epub 2015 Mar 18.","Quintana Hernández DJ","Rev Esp Geriatr Gerontol","2015","2015/03/23","","","10.1016/j.regg.2014.11.010"
"9236949","Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study","Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, Schmitt FA, Grundman M, Thomas RG, Ferris SH.","Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S22-32. doi: 10.1097/00002093-199700112-00004.","Schneider LS","Alzheimer Dis Assoc Disord","1997","1997/01/01","","","10.1097/00002093-199700112-00004"
"21841257","CSF tau, Aβ42, and MHPG differentiate dementia with Lewy bodies from Alzheimer's disease","Aerts MB, Esselink RA, Claassen JA, Abdo WF, Bloem BR, Verbeek MM.","J Alzheimers Dis. 2011;27(2):377-84. doi: 10.3233/JAD-2011-110482.","Aerts MB","J Alzheimers Dis","2011","2011/08/16","","","10.3233/JAD-2011-110482"
"1410164","Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease","Jones GM, Sahakian BJ, Levy R, Warburton DM, Gray JA.","Psychopharmacology (Berl). 1992;108(4):485-94. doi: 10.1007/BF02247426.","Jones GM","Psychopharmacology (Berl)","1992","1992/01/01","","","10.1007/BF02247426"
"23018627","Perfusion SPECT studies with mapping of Brodmann areas in differentiating Alzheimer's disease from frontotemporal degeneration syndromes","Valotassiou V, Papatriantafyllou J, Sifakis N, Tzavara C, Tsougos I, Kapsalaki E, Hadjigeorgiou G, Georgoulias P.","Nucl Med Commun. 2012 Dec;33(12):1267-76. doi: 10.1097/MNM.0b013e3283599983.","Valotassiou V","Nucl Med Commun","2012","2012/09/29","","","10.1097/MNM.0b013e3283599983"
"23159787","Effect of rhythmic auditory cueing on gait in people with Alzheimer disease","Wittwer JE, Webster KE, Hill K.","Arch Phys Med Rehabil. 2013 Apr;94(4):718-24. doi: 10.1016/j.apmr.2012.11.009. Epub 2012 Nov 13.","Wittwer JE","Arch Phys Med Rehabil","2013","2012/11/20","","","10.1016/j.apmr.2012.11.009"
"20733306","Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study","Gold M, Alderton C, Zvartau-Hind M, Egginton S, Saunders AM, Irizarry M, Craft S, Landreth G, Linnamägi U, Sawchak S.","Dement Geriatr Cogn Disord. 2010;30(2):131-46. doi: 10.1159/000318845. Epub 2010 Aug 21.","Gold M","Dement Geriatr Cogn Disord","2010","2010/08/25","PMC3214882","","10.1159/000318845"
"10090427","Efficacy and safety of a loading-dose regimen versus a no-loading-dose regimen of metrifonate in the symptomatic treatment of Alzheimer's disease: a randomized, double-masked, placebo-controlled trial. Metrifonate Study Group","Jann MW, Cyrus PA, Eisner LS, Margolin DI, Griffin T, Gulanski B.","Clin Ther. 1999 Jan;21(1):88-102. doi: 10.1016/s0149-2918(00)88270-3.","Jann MW","Clin Ther","1999","1999/03/25","","","10.1016/s0149-2918(00)88270-3"
"25884637","Effects of physical activity training in patients with Alzheimer's dementia: results of a pilot RCT study","Holthoff VA, Marschner K, Scharf M, Steding J, Meyer S, Koch R, Donix M.","PLoS One. 2015 Apr 17;10(4):e0121478. doi: 10.1371/journal.pone.0121478. eCollection 2015.","Holthoff VA","PLoS One","2015","2015/04/18","PMC4401690","","10.1371/journal.pone.0121478"
"12966820","[Features of frontotemporal dementia from the perspective of a special family support group]","Diehl J, Mayer T, Kurz A, Förstl H.","Nervenarzt. 2003 May;74(5):445-9. doi: 10.1007/s00115-002-1411-3.","Diehl J","Nervenarzt","2003","2003/09/12","","","10.1007/s00115-002-1411-3"
"16125145","Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimer's disease","Elgh E, Lindqvist Astot A, Fagerlund M, Eriksson S, Olsson T, Näsman B.","Biol Psychiatry. 2006 Jan 15;59(2):155-61. doi: 10.1016/j.biopsych.2005.06.017. Epub 2005 Aug 25.","Elgh E","Biol Psychiatry","2006","2005/08/30","","","10.1016/j.biopsych.2005.06.017"
"17011743","Using verbal fluency to detect very mild dementia of the Alzheimer type","Gomez RG, White DA.","Arch Clin Neuropsychol. 2006 Dec;21(8):771-5. doi: 10.1016/j.acn.2006.06.012. Epub 2006 Sep 29.","Gomez RG","Arch Clin Neuropsychol","2006","2006/10/03","","","10.1016/j.acn.2006.06.012"
"35678747","Dissemination of a successful dementia care program: Lessons to facilitate spread of innovations","Reuben DB, Evertson LC, Jackson-Stoeckle R, Epstein-Lubow G, Spragens LH, Haggerty KL, Serrano KS, Jennings LA.","J Am Geriatr Soc. 2022 Sep;70(9):2686-2694. doi: 10.1111/jgs.17900. Epub 2022 Jun 9.","Reuben DB","J Am Geriatr Soc","2022","2022/06/09","PMC9489616","NIHMS1808987","10.1111/jgs.17900"
"15920713","Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy","Rozzini L, Vicini Chilovi B, Bellelli G, Bertoletti E, Trabucchi M, Padovani A.","Int J Geriatr Psychiatry. 2005 Jun;20(6):547-51. doi: 10.1002/gps.1312.","Rozzini L","Int J Geriatr Psychiatry","2005","2005/05/28","","","10.1002/gps.1312"
"21694461","A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease","Stein MS, Scherer SC, Ladd KS, Harrison LC.","J Alzheimers Dis. 2011;26(3):477-84. doi: 10.3233/JAD-2011-110149.","Stein MS","J Alzheimers Dis","2011","2011/06/23","","","10.3233/JAD-2011-110149"
"22502825","Persons with Alzheimer's disease make phone calls independently using a computer-aided telephone system","Perilli V, Lancioni GE, Singh NN, O'Reilly MF, Sigafoos J, Cassano G, Cordiano N, Pinto K, Minervini MG, Oliva D.","Res Dev Disabil. 2012 Jul-Aug;33(4):1014-20. doi: 10.1016/j.ridd.2012.01.007. Epub 2012 Feb 21.","Perilli V","Res Dev Disabil","2012","2012/04/17","","","10.1016/j.ridd.2012.01.007"
"18769065","Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting","Wattmo C, Hansson O, Wallin AK, Londos E, Minthon L.","Dement Geriatr Cogn Disord. 2008;26(3):203-11. doi: 10.1159/000152911. Epub 2008 Sep 4.","Wattmo C","Dement Geriatr Cogn Disord","2008","2008/09/05","","","10.1159/000152911"
"25973909","Adaptive, dose-finding phase 2 trial evaluating the safety and efficacy of ABT-089 in mild to moderate Alzheimer disease","Lenz RA, Pritchett YL, Berry SM, Llano DA, Han S, Berry DA, Sadowsky CH, Abi-Saab WM, Saltarelli MD.","Alzheimer Dis Assoc Disord. 2015 Jul-Sep;29(3):192-9. doi: 10.1097/WAD.0000000000000093.","Lenz RA","Alzheimer Dis Assoc Disord","2015","2015/05/15","","","10.1097/WAD.0000000000000093"
"21878804","Three-week nutritional supplementation effect on long-term nutritional status of patients with mild Alzheimer disease","de Sousa OL, Amaral TF.","Alzheimer Dis Assoc Disord. 2012 Apr-Jun;26(2):119-23. doi: 10.1097/WAD.0b013e31822c5bb3.","de Sousa OL","Alzheimer Dis Assoc Disord","2012","2011/09/01","","","10.1097/WAD.0b013e31822c5bb3"
"7119136","A dose-ranging study of lecithin in the treatment of primary degenerative dementia (Alzheimer disease)","Brinkman SD, Pomara N, Goodnick PJ, Barnett N, Domino EF.","J Clin Psychopharmacol. 1982 Aug;2(4):281-5.","Brinkman SD","J Clin Psychopharmacol","1982","1982/08/01","","",""
"21159055","Five Alzheimer's disease cases with refractory behavioural psychological symptoms of dementia treated with blonanserin","Hamuro A, Saito S.","Psychogeriatrics. 2010 Dec;10(4):198-200. doi: 10.1111/j.1479-8301.2010.00338.x.","Hamuro A","Psychogeriatrics","2010","2010/12/17","","","10.1111/j.1479-8301.2010.00338.x"
"16005409","The use of the occupational disruptiveness scale of the neuropsychiatric inventory-nursing home version to measure the impact of rivastigmine on the disruptive behavior of nursing home residents with Alzheimer's disease","Hatoum HT, Lin SJ, Arcona S, Thomas SK, Koumaras B, Mirski D.","J Am Med Dir Assoc. 2005 Jul-Aug;6(4):238-45. doi: 10.1016/j.jamda.2005.04.003.","Hatoum HT","J Am Med Dir Assoc","2005","2005/07/12","","","10.1016/j.jamda.2005.04.003"
"15852461","Detecting effects of donepezil on visual selective attention using signal detection parameters in Alzheimer's disease","Foldi NS, White RE, Schaefer LA.","Int J Geriatr Psychiatry. 2005 May;20(5):485-8. doi: 10.1002/gps.1319.","Foldi NS","Int J Geriatr Psychiatry","2005","2005/04/27","","","10.1002/gps.1319"
"29945352","Nutritional Intervention to Prevent Alzheimer's Disease: Potential Benefits of Xanthophyll Carotenoids and Omega-3 Fatty Acids Combined","Nolan JM, Mulcahy R, Power R, Moran R, Howard AN.","J Alzheimers Dis. 2018;64(2):367-378. doi: 10.3233/JAD-180160.","Nolan JM","J Alzheimers Dis","2018","2018/06/28","","","10.3233/JAD-180160"
"9782379","Biomedical applications of maghemite ferrofluid","Halbreich A, Roger J, Pons JN, Geldwerth D, Da Silva MF, Roudier M, Bacri JC.","Biochimie. 1998 May-Jun;80(5-6):379-90. doi: 10.1016/s0300-9084(00)80006-1.","Halbreich A","Biochimie","1998","1998/10/23","","","10.1016/s0300-9084(00)80006-1"
"15166883","Posterior cingulate hypoperfusion in Alzheimer's disease, senile dementia of Alzheimer type, and other dementias evaluated by three-dimensional stereotactic surface projections using Tc-99m HMPAO SPECT","Kaneko K, Kuwabara Y, Sasaki M, Ogomori K, Ichimiya A, Koga H, Nakagawa M, Hayashi K, Honda H.","Clin Nucl Med. 2004 Jun;29(6):362-6. doi: 10.1097/01.rlu.0000127091.43180.92.","Kaneko K","Clin Nucl Med","2004","2004/05/29","","","10.1097/01.rlu.0000127091.43180.92"
"21917766","A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease","Salloway S, Sperling R, Keren R, Porsteinsson AP, van Dyck CH, Tariot PN, Gilman S, Arnold D, Abushakra S, Hernandez C, Crans G, Liang E, Quinn G, Bairu M, Pastrak A, Cedarbaum JM; ELND005-AD201 Investigators.","Neurology. 2011 Sep 27;77(13):1253-62. doi: 10.1212/WNL.0b013e3182309fa5. Epub 2011 Sep 14.","Salloway S","Neurology","2011","2011/09/16","PMC3179648","","10.1212/WNL.0b013e3182309fa5"
"12803425","Facilitating acquisition and transfer of a continuous motor task in healthy older adults and patients with Alzheimer's disease","Dick MB, Hsieh S, Bricker J, Dick-Muehlke C.","Neuropsychology. 2003 Apr;17(2):202-12. doi: 10.1037/0894-4105.17.2.202.","Dick MB","Neuropsychology","2003","2003/06/14","","","10.1037/0894-4105.17.2.202"
"21560159","Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial","Leoutsakos JM, Muthen BO, Breitner JC, Lyketsos CG; ADAPT Research Team.","Int J Geriatr Psychiatry. 2012 Apr;27(4):364-74. doi: 10.1002/gps.2723. Epub 2011 May 10.","Leoutsakos JM","Int J Geriatr Psychiatry","2012","2011/05/12","PMC3208130","NIHMS306612","10.1002/gps.2723"
"18640436","Dimebon in Alzheimer's disease: old drug for new indication","Burns A, Jacoby R.","Lancet. 2008 Jul 19;372(9634):179-80. doi: 10.1016/S0140-6736(08)61046-6.","Burns A","Lancet","2008","2008/07/22","","","10.1016/S0140-6736(08)61046-6"
"31759193","In pursuit of a sensitive EEG functional connectivity outcome measure for clinical trials in Alzheimer's disease","Briels CT, Stam CJ, Scheltens P, Bruins S, Lues I, Gouw AA.","Clin Neurophysiol. 2020 Jan;131(1):88-95. doi: 10.1016/j.clinph.2019.09.014. Epub 2019 Nov 4.","Briels CT","Clin Neurophysiol","2020","2019/11/24","","","10.1016/j.clinph.2019.09.014"
"17284557","Cognitive training gain as a predictor of mental status","Boron JB, Willis SL, Schaie KW.","J Gerontol B Psychol Sci Soc Sci. 2007 Jan;62(1):P45-52. doi: 10.1093/geronb/62.1.p45.","Boron JB","J Gerontol B Psychol Sci Soc Sci","2007","2007/02/08","","","10.1093/geronb/62.1.p45"
"3069749","Cortisol responses to cholinergic drugs in Alzheimer's disease","Kumar V, Smith RC, Sherman KA, Ashford W, Murphy J, Giacobini E, Colliver J.","Int J Clin Pharmacol Ther Toxicol. 1988 Oct;26(10):471-6.","Kumar V","Int J Clin Pharmacol Ther Toxicol","1988","1988/10/01","","",""
"8600428","Pupillary response to tropicamide in patients with Alzheimer disease","Loupe DN, Newman NJ, Green RC, Lynn MJ, WIlliams KK, Geis TC, Edelhauser HF.","Ophthalmology. 1996 Mar;103(3):495-503. doi: 10.1016/s0161-6420(96)30666-0.","Loupe DN","Ophthalmology","1996","1996/03/01","","","10.1016/s0161-6420(96)30666-0"
"23306147","Transdermal is better than oral: observational research of the satisfaction of caregivers of patients with Alzheimer's disease treated with rivastigmine","Boada M, Arranz FJ.","Dement Geriatr Cogn Disord. 2013;35(1-2):23-33. doi: 10.1159/000345989. Epub 2013 Jan 9.","Boada M","Dement Geriatr Cogn Disord","2013","2013/01/12","","","10.1159/000345989"
"21572163","Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD","Vigen CL, Mack WJ, Keefe RS, Sano M, Sultzer DL, Stroup TS, Dagerman KS, Hsiao JK, Lebowitz BD, Lyketsos CG, Tariot PN, Zheng L, Schneider LS.","Am J Psychiatry. 2011 Aug;168(8):831-9. doi: 10.1176/appi.ajp.2011.08121844. Epub 2011 May 15.","Vigen CL","Am J Psychiatry","2011","2011/05/17","PMC3310182","NIHMS348870","10.1176/appi.ajp.2011.08121844"
"24694731","The relevance of short-range fibers to cognitive efficiency and brain activation in aging and dementia","Gao J, Cheung RT, Chan YS, Chu LW, Mak HK, Lee TM.","PLoS One. 2014 Apr 2;9(4):e90307. doi: 10.1371/journal.pone.0090307. eCollection 2014.","Gao J","PLoS One","2014","2014/04/04","PMC3973665","","10.1371/journal.pone.0090307"
"16600641","Donepezil effects on sources of cortical rhythms in mild Alzheimer's disease: Responders vs. Non-Responders","Babiloni C, Cassetta E, Dal Forno G, Del Percio C, Ferreri F, Ferri R, Lanuzza B, Miniussi C, Moretti DV, Nobili F, Pascual-Marqui RD, Rodriguez G, Luca Romani G, Salinari S, Zanetti O, Rossini PM.","Neuroimage. 2006 Jul 15;31(4):1650-65. doi: 10.1016/j.neuroimage.2006.02.015. Epub 2006 Apr 5.","Babiloni C","Neuroimage","2006","2006/04/08","","","10.1016/j.neuroimage.2006.02.015"
"24652899","The Impact of the REACH II Intervention on Caregivers' Perceived Health","Basu R, Hochhalter AK, Stevens AB.","J Appl Gerontol. 2015 Aug;34(5):590-608. doi: 10.1177/0733464813499640. Epub 2013 Sep 9.","Basu R","J Appl Gerontol","2015","2014/03/22","","","10.1177/0733464813499640"
"15377700","Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease","Dodel RC, Du Y, Depboylu C, Hampel H, Frölich L, Haag A, Hemmeter U, Paulsen S, Teipel SJ, Brettschneider S, Spottke A, Nölker C, Möller HJ, Wei X, Farlow M, Sommer N, Oertel WH.","J Neurol Neurosurg Psychiatry. 2004 Oct;75(10):1472-4. doi: 10.1136/jnnp.2003.033399.","Dodel RC","J Neurol Neurosurg Psychiatry","2004","2004/09/21","PMC1738770","","10.1136/jnnp.2003.033399"
"7554703","Clinical pharmacokinetics of physostigmine in patients with Alzheimer's disease","Asthana S, Greig NH, Hegedus L, Holloway HH, Raffaele KC, Schapiro MB, Soncrant TT.","Clin Pharmacol Ther. 1995 Sep;58(3):299-309. doi: 10.1016/0009-9236(95)90246-5.","Asthana S","Clin Pharmacol Ther","1995","1995/09/01","","","10.1016/0009-9236(95)90246-5"
"6433396","Comparison of therapeutic response to long-term treatment with lecithin versus piracetam plus lecithin in patients with Alzheimer's disease","Smith RC, Vroulis G, Johnson R, Morgan R.","Psychopharmacol Bull. 1984 Summer;20(3):542-5.","Smith RC","Psychopharmacol Bull","1984","1984/01/01","","",""
"9529823","Clustering and switching on verbal fluency tests in Alzheimer's and Parkinson's disease","Troyer AK, Moscovitch M, Winocur G, Leach L, Freedman M.","J Int Neuropsychol Soc. 1998 Mar;4(2):137-43. doi: 10.1017/s1355617798001374.","Troyer AK","J Int Neuropsychol Soc","1998","1998/04/08","","","10.1017/s1355617798001374"
"8788082","The effects of nicotine in dermal plaster on cognitive functions in patients with Alzheimer's disease","Snaedal J, Johannesson T, Jonsson JE, Gylfadottir G.","Dementia. 1996 Jan-Feb;7(1):47-52. doi: 10.1159/000106852.","Snaedal J","Dementia","1996","1996/01/01","","","10.1159/000106852"
"25273216","Decreased coherence and functional connectivity of electroencephalograph in Alzheimer's disease","Wang R, Wang J, Yu H, Wei X, Yang C, Deng B.","Chaos. 2014 Sep;24(3):033136. doi: 10.1063/1.4896095.","Wang R","Chaos","2014","2014/10/03","","","10.1063/1.4896095"
"19605530","Modulation of fusiform cortex activity by cholinesterase inhibition predicts effects on subsequent memory","Bentley P, Driver J, Dolan RJ.","Brain. 2009 Sep;132(Pt 9):2356-71. doi: 10.1093/brain/awp176. Epub 2009 Jul 15.","Bentley P","Brain","2009","2009/07/17","","","10.1093/brain/awp176"
"21946012","Using mental imagery to improve memory in patients with Alzheimer disease: trouble generating or remembering the mind's eye?","Hussey EP, Smolinsky JG, Piryatinsky I, Budson AE, Ally BA.","Alzheimer Dis Assoc Disord. 2012 Apr-Jun;26(2):124-34. doi: 10.1097/WAD.0b013e31822e0f73.","Hussey EP","Alzheimer Dis Assoc Disord","2012","2011/09/28","PMC3249019","NIHMS318884","10.1097/WAD.0b013e31822e0f73"
"9751437","The influence of semantic and perceptual encoding on recognition memory in Alzheimer's disease","Goldblum MC, Gomez CM, Dalla Barba G, Boller F, Deweer B, Hahn V, Dubois B.","Neuropsychologia. 1998 Aug;36(8):717-29. doi: 10.1016/s0028-3932(98)00007-4.","Goldblum MC","Neuropsychologia","1998","1998/09/29","","","10.1016/s0028-3932(98)00007-4"
"15001677","Functional interactions of the entorhinal cortex: an 18F-FDG PET study on normal aging and Alzheimer's disease","Mosconi L, Pupi A, De Cristofaro MT, Fayyaz M, Sorbi S, Herholz K.","J Nucl Med. 2004 Mar;45(3):382-92.","Mosconi L","J Nucl Med","2004","2004/03/06","","",""
"28926415","Semantic Memory in the Clinical Progression of Alzheimer Disease","Tchakoute CT, Sainani KL, Henderson VW; Raloxifene in Alzheimer’s Disease Investigators.","Cogn Behav Neurol. 2017 Sep;30(3):81-89. doi: 10.1097/WNN.0000000000000131.","Tchakoute CT","Cogn Behav Neurol","2017","2017/09/20","PMC5617354","NIHMS896916","10.1097/WNN.0000000000000131"
"11137759","Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke","Hesse C, Rosengren L, Andreasen N, Davidsson P, Vanderstichele H, Vanmechelen E, Blennow K.","Neurosci Lett. 2001 Jan 19;297(3):187-90. doi: 10.1016/s0304-3940(00)01697-9.","Hesse C","Neurosci Lett","2001","2001/01/04","","","10.1016/s0304-3940(00)01697-9"
"25596420","Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease","Dubois B, Chupin M, Hampel H, Lista S, Cavedo E, Croisile B, Louis Tisserand G, Touchon J, Bonafe A, Ousset PJ, Ait Ameur A, Rouaud O, Ricolfi F, Vighetto A, Pasquier F, Delmaire C, Ceccaldi M, Girard N, Dufouil C, Lehericy S, Tonelli I, Duveau F, Colliot O, Garnero L, Sarazin M, Dormont D; “Hippocampus Study Group”; Hippocampus Study Group.","Alzheimers Dement. 2015 Sep;11(9):1041-9. doi: 10.1016/j.jalz.2014.10.003. Epub 2015 Jan 14.","Dubois B","Alzheimers Dement","2015","2015/01/18","","","10.1016/j.jalz.2014.10.003"
"1638171","CBF and cognitive evaluation of Alzheimer type patients before and after IMAO-B treatment: a pilot study","Agnoli A, Fabbrini G, Fioravanti M, Martucci N.","Eur Neuropsychopharmacol. 1992 Mar;2(1):31-5. doi: 10.1016/0924-977x(92)90033-5.","Agnoli A","Eur Neuropsychopharmacol","1992","1992/03/01","","","10.1016/0924-977x(92)90033-5"
"11554917","Gabapentin as a possible treatment of behavioral alterations in Alzheimer disease (AD) patients","Moretti R, Torre P, Antonello RM, Cazzato G.","Eur J Neurol. 2001 Sep;8(5):501-2. doi: 10.1046/j.1468-1331.2001.00225.x.","Moretti R","Eur J Neurol","2001","2001/09/14","","","10.1046/j.1468-1331.2001.00225.x"
"23507773","Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease","Claxton A, Baker LD, Wilkinson CW, Trittschuh EH, Chapman D, Watson GS, Cholerton B, Plymate SR, Arbuckle M, Craft S.","J Alzheimers Dis. 2013;35(4):789-97. doi: 10.3233/JAD-122308.","Claxton A","J Alzheimers Dis","2013","2013/03/20","PMC4144993","NIHMS616577","10.3233/JAD-122308"
"11997490","Action-based memory in Alzheimer's disease: a longitudinal look at tea making","Rusted J, Sheppard L.","Neurocase. 2002;8(1-2):111-26. doi: 10.1093/neucas/8.1.111.","Rusted J","Neurocase","2002","2002/05/09","","","10.1093/neucas/8.1.111"
"36093704","Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease","Nolan JM, Power R, Howard AN, Bergin P, Roche W, Prado-Cabrero A, Pope G, Cooke J, Power T, Mulcahy R.","J Alzheimers Dis. 2022;90(1):233-249. doi: 10.3233/JAD-220556.","Nolan JM","J Alzheimers Dis","2022","2022/09/12","","","10.3233/JAD-220556"
"22499405","A controlled clinical trial on the effects of exercise on neuropsychiatric disorders and instrumental activities in women with Alzheimer's disease","Nascimento CM, Teixeira CV, Gobbi LT, Gobbi S, Stella F.","Rev Bras Fisioter. 2012 Jun;16(3):197-204. doi: 10.1590/s1413-35552012005000017. Epub 2012 Apr 12.","Nascimento CM","Rev Bras Fisioter","2012","2012/04/14","","","10.1590/s1413-35552012005000017"
"9805319","Compensatory recruitment of neural resources during overt rehearsal of word lists in Alzheimer's disease","Woodard JL, Grafton ST, Votaw JR, Green RC, Dobraski ME, Hoffman JM.","Neuropsychology. 1998 Oct;12(4):491-504. doi: 10.1037//0894-4105.12.4.491.","Woodard JL","Neuropsychology","1998","1998/11/07","","","10.1037//0894-4105.12.4.491"
"34065698","Virtual Reality-Based Cognitive Stimulation on People with Mild to Moderate Dementia due to Alzheimer's Disease: A Pilot Randomized Controlled Trial","Oliveira J, Gamito P, Souto T, Conde R, Ferreira M, Corotnean T, Fernandes A, Silva H, Neto T.","Int J Environ Res Public Health. 2021 May 16;18(10):5290. doi: 10.3390/ijerph18105290.","Oliveira J","Int J Environ Res Public Health","2021","2021/06/02","PMC8156930","","10.3390/ijerph18105290"
"2004862","Treatment of Alzheimer's disease with cholinergic drugs","Kumar V, Calache M.","Int J Clin Pharmacol Ther Toxicol. 1991 Jan;29(1):23-37.","Kumar V","Int J Clin Pharmacol Ther Toxicol","1991","1991/01/01","","",""
"7824052","Decreased levels of C1q in cerebrospinal fluid of living Alzheimer patients correlate with disease state","Smyth MD, Cribbs DH, Tenner AJ, Shankle WR, Dick M, Kesslak JP, Cotman CW.","Neurobiol Aging. 1994 Sep-Oct;15(5):609-14. doi: 10.1016/0197-4580(94)00055-7.","Smyth MD","Neurobiol Aging","1994","1994/09/01","","","10.1016/0197-4580(94)00055-7"
"35366050","Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial","Fruijtier AD, van der Schaar J, van Maurik IS, Zwan MD, Scheltens P, Bouwman F, Pijnenburg YAL, van Berckel BNM, Ebenau J, van der Flier WM, Smets EMA, Visser LNC.","Alzheimers Dement. 2023 Jan;19(1):285-295. doi: 10.1002/alz.12630. Epub 2022 Apr 2.","Fruijtier AD","Alzheimers Dement","2023","2022/04/02","PMC10084251","","10.1002/alz.12630"
"16286437","Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial","Tariot PN, Raman R, Jakimovich L, Schneider L, Porsteinsson A, Thomas R, Mintzer J, Brenner R, Schafer K, Thal L; Alzheimer's Disease Cooperative Study; Valproate Nursing Home Study Group.","Am J Geriatr Psychiatry. 2005 Nov;13(11):942-9. doi: 10.1176/appi.ajgp.13.11.942.","Tariot PN","Am J Geriatr Psychiatry","2005","2005/11/16","","","10.1176/appi.ajgp.13.11.942"
"3479525","Failure of long term high-dose lecithin to retard progression of early-onset Alzheimer's disease","Heyman A, Schmechel D, Wilkinson W, Rogers H, Krishnan R, Holloway D, Schultz K, Gwyther L, Peoples R, Utley C, et al.","J Neural Transm Suppl. 1987;24:279-86.","Heyman A","J Neural Transm Suppl","1987","1987/01/01","","",""
"9213065","Procedural memory in patients with mild Alzheimer's disease","Hirono N, Mori E, Ikejiri Y, Imamura T, Shimomura T, Ikeda M, Yamashita H, Takatsuki Y, Tokimasa A, Yamadori A.","Dement Geriatr Cogn Disord. 1997 Jul-Aug;8(4):210-6. doi: 10.1159/000106633.","Hirono N","Dement Geriatr Cogn Disord","1997","1997/07/01","","","10.1159/000106633"
"35339351","Effects of multisite anodal transcranial direct current stimulation combined with cognitive stimulation in patients with Alzheimer's disease and its neurophysiological correlates: A double-blind randomized clinical trial","Andrade SM, Machado DGDS, Silva-Sauerc LD, Regis CT, Mendes CKTT, de Araújo JSS, de Araújo KDT, Costa LP, Queiroz MEBS, Leitão MM, Fernández-Calvo B.","Neurophysiol Clin. 2022 Apr;52(2):117-127. doi: 10.1016/j.neucli.2022.02.003. Epub 2022 Mar 24.","Andrade SM","Neurophysiol Clin","2022","2022/03/27","","","10.1016/j.neucli.2022.02.003"
"14676042","Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial","Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, Kiers L, Cherny R, Li QX, Tammer A, Carrington D, Mavros C, Volitakis I, Xilinas M, Ames D, Davis S, Beyreuther K, Tanzi RE, Masters CL.","Arch Neurol. 2003 Dec;60(12):1685-91. doi: 10.1001/archneur.60.12.1685.","Ritchie CW","Arch Neurol","2003","2003/12/17","","","10.1001/archneur.60.12.1685"
"18195264","Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment","Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC, Jack CR Jr, Aisen PS, Thal LJ.","Neurology. 2008 Jan 15;70(3):191-9. doi: 10.1212/01.wnl.0000287091.57376.65.","Fleisher AS","Neurology","2008","2008/01/16","","","10.1212/01.wnl.0000287091.57376.65"
"18795985","Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study","Ancoli-Israel S, Palmer BW, Cooke JR, Corey-Bloom J, Fiorentino L, Natarajan L, Liu L, Ayalon L, He F, Loredo JS.","J Am Geriatr Soc. 2008 Nov;56(11):2076-81. doi: 10.1111/j.1532-5415.2008.01934.x. Epub 2008 Sep 15.","Ancoli-Israel S","J Am Geriatr Soc","2008","2008/09/18","PMC2585146","NIHMS57311","10.1111/j.1532-5415.2008.01934.x"
"8840352","Differential response to the cholinergic agonist arecoline among different cognitive modalities in Alzheimer's disease","Raffaele KC, Asthana S, Berardi A, Haxby JV, Morris PP, Schapiro MB, Soncrant TT.","Neuropsychopharmacology. 1996 Aug;15(2):163-70. doi: 10.1016/0893-133X(95)00179-H.","Raffaele KC","Neuropsychopharmacology","1996","1996/08/01","","","10.1016/0893-133X(95)00179-H"
"11949708","False recognition of pictures versus words in Alzheimer's disease: the distinctiveness heuristic","Budson AE, Sitarski J, Daffner KR, Schacter DL.","Neuropsychology. 2002 Apr;16(2):163-73. doi: 10.1037//0894-4105.16.2.163.","Budson AE","Neuropsychology","2002","2002/04/13","","","10.1037//0894-4105.16.2.163"
"11843990","A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting","Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.","J Am Geriatr Soc. 2001 Dec;49(12):1590-9.","Tariot PN","J Am Geriatr Soc","2001","2002/02/15","","",""
"9560018","Cytoarchitectonic alterations in the supramarginal gyrus of late onset Alzheimer's disease","Grignon Y, Duyckaerts C, Bennecib M, Hauw JJ.","Acta Neuropathol. 1998 Apr;95(4):395-406. doi: 10.1007/s004010050816.","Grignon Y","Acta Neuropathol","1998","1998/04/29","","","10.1007/s004010050816"
"34366347","High-Definition Transcranial Direct Current Stimulation Improves Delayed Memory in Alzheimer's Disease Patients: A Pilot Study Using Computational Modeling to Optimize Electrode Position","Rasmussen ID, Boayue NM, Mittner M, Bystad M, Grønli OK, Vangberg TR, Csifcsák G, Aslaksen PM.","J Alzheimers Dis. 2021;83(2):753-769. doi: 10.3233/JAD-210378.","Rasmussen ID","J Alzheimers Dis","2021","2021/08/09","","","10.3233/JAD-210378"
"16599649","Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease","Johannsen P, Salmon E, Hampel H, Xu Y, Richardson S, Qvitzau S, Schindler R; AWARE Study Group.","CNS Drugs. 2006;20(4):311-25. doi: 10.2165/00023210-200620040-00005.","Johannsen P","CNS Drugs","2006","2006/04/08","","","10.2165/00023210-200620040-00005"
"15603468","Effects of cognitive-communication stimulation for Alzheimer's disease patients treated with donepezil","Chapman SB, Weiner MF, Rackley A, Hynan LS, Zientz J.","J Speech Lang Hear Res. 2004 Oct;47(5):1149-63. doi: 10.1044/1092-4388(2004/085).","Chapman SB","J Speech Lang Hear Res","2004","2004/12/18","","","10.1044/1092-4388(2004/085)"
"2405720","Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study","Fitten LJ, Perryman KM, Gross PL, Fine H, Cummins J, Marshall C.","Am J Psychiatry. 1990 Feb;147(2):239-42. doi: 10.1176/ajp.147.2.239.","Fitten LJ","Am J Psychiatry","1990","1990/02/01","","","10.1176/ajp.147.2.239"
"17044730","A naturalistic study of galantamine for Alzheimer's disease","Brodaty H, Woodward M, Boundy K, Barnes N, Allen G; NATURE Investigators.","CNS Drugs. 2006;20(11):935-43. doi: 10.2165/00023210-200620110-00006.","Brodaty H","CNS Drugs","2006","2006/10/19","","","10.2165/00023210-200620110-00006"
"22606044","Donepezil combined with natural hirudin improves the clinical symptoms of patients with mild-to-moderate Alzheimer's disease: a 20-week open-label pilot study","Li DQ, Zhou YP, Yang H.","Int J Med Sci. 2012;9(3):248-55. doi: 10.7150/ijms.4363. Epub 2012 May 7.","Li DQ","Int J Med Sci","2012","2012/05/19","PMC3354329","","10.7150/ijms.4363"
"30248105","Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial","Lawlor B, Segurado R, Kennelly S, Olde Rikkert MGM, Howard R, Pasquier F, Börjesson-Hanson A, Tsolaki M, Lucca U, Molloy DW, Coen R, Riepe MW, Kálmán J, Kenny RA, Cregg F, O'Dwyer S, Walsh C, Adams J, Banzi R, Breuilh L, Daly L, Hendrix S, Aisen P, Gaynor S, Sheikhi A, Taekema DG, Verhey FR, Nemni R, Nobili F, Franceschi M, Frisoni G, Zanetti O, Konsta A, Anastasios O, Nenopoulou S, Tsolaki-Tagaraki F, Pakaski M, Dereeper O, de la Sayette V, Sénéchal O, Lavenu I, Devendeville A, Calais G, Crawford F, Mullan M; NILVAD Study Group.","PLoS Med. 2018 Sep 24;15(9):e1002660. doi: 10.1371/journal.pmed.1002660. eCollection 2018 Sep.","Lawlor B","PLoS Med","2018","2018/09/25","PMC6152871","","10.1371/journal.pmed.1002660"
"19923550","A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease","Salloway S, Sperling R, Gilman S, Fox NC, Blennow K, Raskind M, Sabbagh M, Honig LS, Doody R, van Dyck CH, Mulnard R, Barakos J, Gregg KM, Liu E, Lieberburg I, Schenk D, Black R, Grundman M; Bapineuzumab 201 Clinical Trial Investigators.","Neurology. 2009 Dec 15;73(24):2061-70. doi: 10.1212/WNL.0b013e3181c67808. Epub 2009 Nov 18.","Salloway S","Neurology","2009","2009/11/20","PMC2790221","","10.1212/WNL.0b013e3181c67808"
"17135813","ADCS Prevention Instrument Project: pilot testing of a book club as a psychosocial intervention and recruitment and retention strategy","Whitehouse PJ, Rajcan JL, Sami SA, Patterson MB, Smyth KA, Edland SD, George DR.","Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4 Suppl 3):S203-8. doi: 10.1097/01.wad.0000213876.70794.c6.","Whitehouse PJ","Alzheimer Dis Assoc Disord","2006","2006/12/01","","","10.1097/01.wad.0000213876.70794.c6"
"16777648","Evaluating two group programmes of cognitive training in mild-to-moderate AD: is there any difference between a 'global' stimulation and a 'cognitive-specific' one?","Farina E, Mantovani F, Fioravanti R, Pignatti R, Chiavari L, Imbornone E, Olivotto F, Alberoni M, Mariani C, Nemni R.","Aging Ment Health. 2006 May;10(3):211-8. doi: 10.1080/13607860500409492.","Farina E","Aging Ment Health","2006","2006/06/17","","","10.1080/13607860500409492"
"12364686","Utility and limits of the mini mental state examination in evaluating consent capacity in Alzheimer's disease","Kim SY, Caine ED.","Psychiatr Serv. 2002 Oct;53(10):1322-4. doi: 10.1176/appi.ps.53.10.1322.","Kim SY","Psychiatr Serv","2002","2002/10/05","","","10.1176/appi.ps.53.10.1322"
"26279176","Low-Dose Atypical Antipsychotic Risperidone Improves the 5-Year Outcome in Alzheimer's Disease Patients with Sleep Disturbances","Yin Y, Liu Y, Zhuang J, Pan X, Li P, Yang Y, Li YP, Zhao ZQ, Huang LQ, Zhao ZX.","Pharmacology. 2015;96(3-4):155-62. doi: 10.1159/000435889. Epub 2015 Aug 8.","Yin Y","Pharmacology","2015","2015/08/18","","","10.1159/000435889"
"28513303","Effects of Functional-Task Training on Older Adults With Alzheimer's Disease","Pedroso RV, Ayán C, Fraga FJ, da Silva TMV, Cancela JM, Santos-Galduròz RF.","J Aging Phys Act. 2018 Jan 1;26(1):97-105. doi: 10.1123/japa.2016-0147. Epub 2017 Dec 19.","Pedroso RV","J Aging Phys Act","2018","2017/05/18","","","10.1123/japa.2016-0147"
"19016254","Assessing the relationship between health utilities, quality of life, and health services use in Alzheimer's disease","Miller EA, Schneider LS, Rosenheck RA.","Int J Geriatr Psychiatry. 2009 Jan;24(1):96-105. doi: 10.1002/gps.2160.","Miller EA","Int J Geriatr Psychiatry","2009","2008/11/19","","","10.1002/gps.2160"
"15883262","Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results","Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Browne P, Wasser D, Johnson-Traver S, Lochhead J, Ziolwolski C.","Arch Neurol. 2005 May;62(5):753-7. doi: 10.1001/archneur.62.5.753.","Sparks DL","Arch Neurol","2005","2005/05/11","","","10.1001/archneur.62.5.753"
"12183214","Salivary cortisol day profiles in elderly with mild cognitive impairment","Wolf OT, Convit A, Thorn E, de Leon MJ.","Psychoneuroendocrinology. 2002 Oct;27(7):777-89. doi: 10.1016/s0306-4530(01)00079-8.","Wolf OT","Psychoneuroendocrinology","2002","2002/08/17","","","10.1016/s0306-4530(01)00079-8"
"12603251","Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment","Andreasen N, Vanmechelen E, Vanderstichele H, Davidsson P, Blennow K.","Acta Neurol Scand Suppl. 2003;179:47-51. doi: 10.1034/j.1600-0404.107.s179.9.x.","Andreasen N","Acta Neurol Scand Suppl","2003","2003/02/27","","","10.1034/j.1600-0404.107.s179.9.x"
"27863809","Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial","Gauthier S, Feldman HH, Schneider LS, Wilcock GK, Frisoni GB, Hardlund JH, Moebius HJ, Bentham P, Kook KA, Wischik DJ, Schelter BO, Davis CS, Staff RT, Bracoud L, Shamsi K, Storey JM, Harrington CR, Wischik CM.","Lancet. 2016 Dec 10;388(10062):2873-2884. doi: 10.1016/S0140-6736(16)31275-2. Epub 2016 Nov 16.","Gauthier S","Lancet","2016","2016/11/20","PMC5164296","NIHMS833643","10.1016/S0140-6736(16)31275-2"
"1418367","The SKT neuropsychological test battery","Overall JE, Schaltenbrand R.","J Geriatr Psychiatry Neurol. 1992 Oct-Dec;5(4):220-7. doi: 10.1177/002383099200500407.","Overall JE","J Geriatr Psychiatry Neurol","1992","1992/10/01","","","10.1177/002383099200500407"
"16307702","Effects of switching from an AChE inhibitor to a dual AChE-BuChE inhibitor in patients with Alzheimer's disease","Bartorelli L, Giraldi C, Saccardo M, Cammarata S, Bottini G, Fasanaro AM, Trequattrini A; Upgrade Study Group.","Curr Med Res Opin. 2005 Nov;21(11):1809-18. doi: 10.1185/030079905X65655.","Bartorelli L","Curr Med Res Opin","2005","2005/11/26","","","10.1185/030079905X65655"
"34807243","Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease","Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, Suhy J, Forrestal F, Tian Y, Umans K, Wang G, Singhal P, Budd Haeberlein S, Smirnakis K.","JAMA Neurol. 2022 Jan 1;79(1):13-21. doi: 10.1001/jamaneurol.2021.4161.","Salloway S","JAMA Neurol","2022","2021/11/22","PMC8609465","","10.1001/jamaneurol.2021.4161"
"29286983","Aerobic Exercise Sustains Performance of Instrumental Activities of Daily Living in Early-Stage Alzheimer Disease","Vidoni ED, Perales J, Alshehri M, Giles AM, Siengsukon CF, Burns JM.","J Geriatr Phys Ther. 2019 Jul/Sep;42(3):E129-E134. doi: 10.1519/JPT.0000000000000172.","Vidoni ED","J Geriatr Phys Ther","2019","2017/12/30","PMC6023779","NIHMS918527","10.1519/JPT.0000000000000172"
"12901784","Neuropsychological deficits associated with Alzheimer's disease in the very-old: discrepancies in raw vs. standardized scores","Bondi MW, Houston WS, Salmon DP, Corey-Bloom J, Katzman R, Thal LJ, Delis DC.","J Int Neuropsychol Soc. 2003 Jul;9(5):783-95. doi: 10.1017/S1355617703950119.","Bondi MW","J Int Neuropsychol Soc","2003","2003/08/07","PMC1621043","NIHMS12571","10.1017/S1355617703950119"
"11322014","[Ursodeoxycholic acid and prevention of tacrine-induced hepatotoxicity: a pilot study]","Salmon L, Montet JC, Oddoze C, Montet AM, Portugal H, Michel BF.","Therapie. 2001 Jan-Feb;56(1):29-34.","Salmon L","Therapie","2001","2001/04/27","","",""
"19150968","Development and evaluation of a computerized test battery for Alzheimer's disease screening in community-based settings","Inoue M, Jinbo D, Nakamura Y, Taniguchi M, Urakami K.","Am J Alzheimers Dis Other Demen. 2009 Apr-May;24(2):129-35. doi: 10.1177/1533317508330222. Epub 2009 Jan 15.","Inoue M","Am J Alzheimers Dis Other Demen","2009","2009/01/20","","","10.1177/1533317508330222"
"11255445","Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression","Farlow MR, Hake A, Messina J, Hartman R, Veach J, Anand R.","Arch Neurol. 2001 Mar;58(3):417-22. doi: 10.1001/archneur.58.3.417.","Farlow MR","Arch Neurol","2001","2001/03/20","","","10.1001/archneur.58.3.417"
"10345408","Caregiver supports: outcomes from the Medicare Alzheimer's disease demonstration","Yordi C, DuNah R, Bostrom A, Fox P, Wilkinson A, Newcomer R.","Health Care Financ Rev. 1997 Winter;19(2):97-117.","Yordi C","Health Care Financ Rev","1997","1997/01/01","PMC4194475","",""
"2570380","Induction of parkinsonism by intraventricular bethanechol in a patient with Alzheimer's disease","Fox JH, Bennett DA, Goetz CG, Penn RD, Savoy S, Clasen R, Wilson RS.","Neurology. 1989 Sep;39(9):1265. doi: 10.1212/wnl.39.9.1265.","Fox JH","Neurology","1989","1989/09/01","","","10.1212/wnl.39.9.1265"
"10364644","Validity of different linguistic versions of the Alzheimer's Disease Assessment Scale in an international multicentre Alzheimer's disease trial","Inzitari D, Rossi R, Lamassa M, Mugnai S, Carlucci G, Bianchi C, Amaducci L.","Dement Geriatr Cogn Disord. 1999 Jul-Aug;10(4):269-77. doi: 10.1159/000017131.","Inzitari D","Dement Geriatr Cogn Disord","1999","1999/06/12","","","10.1159/000017131"
"2572987","The necessity of human trials of putative therapies for Alzheimer's disease","Knopman D.","Neurobiol Aging. 1989 Sep-Oct;10(5):633-4; discussion 648-50. doi: 10.1016/0197-4580(89)90158-9.","Knopman D","Neurobiol Aging","1989","1989/09/01","","","10.1016/0197-4580(89)90158-9"
"26543236","Risk prediction for sporadic Alzheimer's disease using genetic risk score in the Han Chinese population","Xiao Q, Liu ZJ, Tao S, Sun YM, Jiang D, Li HL, Chen H, Liu X, Lapin B, Wang CH, Zheng SL, Xu J, Wu ZY.","Oncotarget. 2015 Nov 10;6(35):36955-64. doi: 10.18632/oncotarget.6271.","Xiao Q","Oncotarget","2015","2015/11/07","PMC4741908","","10.18632/oncotarget.6271"
"21992747","Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, double-blind, placebo-controlled study","Henderson ST, Poirier J.","BMC Med Genet. 2011 Oct 12;12:137. doi: 10.1186/1471-2350-12-137.","Henderson ST","BMC Med Genet","2011","2011/10/14","PMC3213220","","10.1186/1471-2350-12-137"
"20880294","Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease","Parnetti L, Chiasserini D, Andreasson U, Ohlson M, Hüls C, Zetterberg H, Minthon L, Wallin AK, Andreasen N, Talesa VN, Blennow K.","Acta Neurol Scand. 2011 Aug;124(2):122-9. doi: 10.1111/j.1600-0404.2010.01435.x. Epub 2010 Sep 29.","Parnetti L","Acta Neurol Scand","2011","2010/10/01","","","10.1111/j.1600-0404.2010.01435.x"
"9363797","Binding of platelet-activating factor to platelets of Alzheimer's disease and multiinfarct dementia patients","Hershkowitz M, Adunsky A.","Neurobiol Aging. 1996 Nov-Dec;17(6):865-8. doi: 10.1016/s0197-4580(96)00073-5.","Hershkowitz M","Neurobiol Aging","1996","1996/11/01","","","10.1016/s0197-4580(96)00073-5"
"7560704","Clinical trials in cognitively impaired older adults: home versus clinic assessments","Bédard M, Molloy DW, Standish T, Guyatt GH, D'Souza J, Mondadori C, Darzins PJ.","J Am Geriatr Soc. 1995 Oct;43(10):1127-30. doi: 10.1111/j.1532-5415.1995.tb07013.x.","Bédard M","J Am Geriatr Soc","1995","1995/10/01","","","10.1111/j.1532-5415.1995.tb07013.x"
"508162","Effect of physostigmine on constructional and memory tasks in Alzheimer's disease","Muramoto O, Sugishita M, Sugita H, Toyokura Y.","Arch Neurol. 1979 Aug;36(8):501-3. doi: 10.1001/archneur.1979.00500440071014.","Muramoto O","Arch Neurol","1979","1979/08/01","","","10.1001/archneur.1979.00500440071014"
"16767418","Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a double-blind cross-over trial","Teipel SJ, Drzezga A, Bartenstein P, Möller HJ, Schwaiger M, Hampel H.","Psychopharmacology (Berl). 2006 Jul;187(1):86-94. doi: 10.1007/s00213-006-0408-1. Epub 2006 Jun 1.","Teipel SJ","Psychopharmacology (Berl)","2006","2006/06/13","","","10.1007/s00213-006-0408-1"
"23375965","Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial","Dodel R, Rominger A, Bartenstein P, Barkhof F, Blennow K, Förster S, Winter Y, Bach JP, Popp J, Alferink J, Wiltfang J, Buerger K, Otto M, Antuono P, Jacoby M, Richter R, Stevens J, Melamed I, Goldstein J, Haag S, Wietek S, Farlow M, Jessen F.","Lancet Neurol. 2013 Mar;12(3):233-43. doi: 10.1016/S1474-4422(13)70014-0. Epub 2013 Jan 31.","Dodel R","Lancet Neurol","2013","2013/02/05","PMC4986921","NIHMS771305","10.1016/S1474-4422(13)70014-0"
"21598207","[Efficacy of an occupational group therapy in degenerative dementias: a controlled study in the nursing home setting]","Pickel S, Grässel E, Luttenberger K.","Psychiatr Prax. 2011 Nov;38(8):389-96. doi: 10.1055/s-0030-1266137. Epub 2011 May 19.","Pickel S","Psychiatr Prax","2011","2011/05/21","","","10.1055/s-0030-1266137"
"11467911","Auditory sensory memory and the cholinergic system: implications for Alzheimer's disease","Pekkonen E, Hirvonen J, Jääskeläinen IP, Kaakkola S, Huttunen J.","Neuroimage. 2001 Aug;14(2):376-82. doi: 10.1006/nimg.2001.0805.","Pekkonen E","Neuroimage","2001","2001/07/27","","","10.1006/nimg.2001.0805"
"16088143","Implicit and explicit memory for spatial information in Alzheimer's disease","Kessels RP, Feijen J, Postma A.","Dement Geriatr Cogn Disord. 2005;20(2-3):184-91. doi: 10.1159/000087233. Epub 2005 Jul 26.","Kessels RP","Dement Geriatr Cogn Disord","2005","2005/08/10","","","10.1159/000087233"
"11598313","Treatment of Alzheimer's disease with clioquinol","Regland B, Lehmann W, Abedini I, Blennow K, Jonsson M, Karlsson I, Sjögren M, Wallin A, Xilinas M, Gottfries CG.","Dement Geriatr Cogn Disord. 2001 Nov-Dec;12(6):408-14. doi: 10.1159/000051288.","Regland B","Dement Geriatr Cogn Disord","2001","2001/10/13","","","10.1159/000051288"
"9651008","Expression of differential immune factors in temporal cortex and cerebellum: the role of alpha-1-antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease","Styren SD, Kamboh MI, DeKosky ST.","J Comp Neurol. 1998 Jul 13;396(4):511-20.","Styren SD","J Comp Neurol","1998","1998/07/03","","",""
"12765607","Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease","Hock C, Konietzko U, Streffer JR, Tracy J, Signorell A, Müller-Tillmanns B, Lemke U, Henke K, Moritz E, Garcia E, Wollmer MA, Umbricht D, de Quervain DJ, Hofmann M, Maddalena A, Papassotiropoulos A, Nitsch RM.","Neuron. 2003 May 22;38(4):547-54. doi: 10.1016/s0896-6273(03)00294-0.","Hock C","Neuron","2003","2003/05/27","","","10.1016/s0896-6273(03)00294-0"
"36094645","Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial","Shcherbinin S, Evans CD, Lu M, Andersen SW, Pontecorvo MJ, Willis BA, Gueorguieva I, Hauck PM, Brooks DA, Mintun MA, Sims JR.","JAMA Neurol. 2022 Oct 1;79(10):1015-1024. doi: 10.1001/jamaneurol.2022.2793.","Shcherbinin S","JAMA Neurol","2022","2022/09/12","PMC9468959","","10.1001/jamaneurol.2022.2793"
"28231822","Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study","Tai SY, Chen CH, Chien CY, Yang YH.","BMC Neurol. 2017 Feb 23;17(1):40. doi: 10.1186/s12883-017-0800-y.","Tai SY","BMC Neurol","2017","2017/02/25","PMC5324327","","10.1186/s12883-017-0800-y"
"16316485","Treatment of behavioural, cognitive and circadian rest-activity cycle disturbances in Alzheimer's disease: haloperidol vs. quetiapine","Savaskan E, Schnitzler C, Schröder C, Cajochen C, Müller-Spahn F, Wirz-Justice A.","Int J Neuropsychopharmacol. 2006 Oct;9(5):507-16. doi: 10.1017/S1461145705006036. Epub 2005 Sep 5.","Savaskan E","Int J Neuropsychopharmacol","2006","2005/12/01","","","10.1017/S1461145705006036"
"30224383","The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease","Neumann U, Ufer M, Jacobson LH, Rouzade-Dominguez ML, Huledal G, Kolly C, Lüönd RM, Machauer R, Veenstra SJ, Hurth K, Rueeger H, Tintelnot-Blomley M, Staufenbiel M, Shimshek DR, Perrot L, Frieauff W, Dubost V, Schiller H, Vogg B, Beltz K, Avrameas A, Kretz S, Pezous N, Rondeau JM, Beckmann N, Hartmann A, Vormfelde S, David OJ, Galli B, Ramos R, Graf A, Lopez Lopez C.","EMBO Mol Med. 2018 Nov;10(11):e9316. doi: 10.15252/emmm.201809316.","Neumann U","EMBO Mol Med","2018","2018/09/19","PMC6220303","","10.15252/emmm.201809316"
"11949775","Effects of rapid tryptophan depletion on salivary and plasma cortisol in Alzheimer's disease and the healthy elderly","Porter RJ, Marshall EF, O'Brien JT.","J Psychopharmacol. 2002 Mar;16(1):73-8. doi: 10.1177/026988110201600105.","Porter RJ","J Psychopharmacol","2002","2002/04/13","","","10.1177/026988110201600105"
"26251112","The Effect of Reminiscence Therapy on Cognition, Depression, and Activities of Daily Living for Patients With Alzheimer Disease","Duru Aşiret G, Kapucu S.","J Geriatr Psychiatry Neurol. 2016 Jan;29(1):31-7. doi: 10.1177/0891988715598233. Epub 2015 Aug 6.","Duru Aşiret G","J Geriatr Psychiatry Neurol","2016","2015/08/08","","","10.1177/0891988715598233"
"14716700","A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease","Jones RW, Soininen H, Hager K, Aarsland D, Passmore P, Murthy A, Zhang R, Bahra R.","Int J Geriatr Psychiatry. 2004 Jan;19(1):58-67. doi: 10.1002/gps.1038.","Jones RW","Int J Geriatr Psychiatry","2004","2004/01/13","","","10.1002/gps.1038"
"10608295","Colostrinin: a proline-rich polypeptide (PRP) complex isolated from ovine colostrum for treatment of Alzheimer's disease. A double-blind, placebo-controlled study","Leszek J, Inglot AD, Janusz M, Lisowski J, Krukowska K, Georgiades JA.","Arch Immunol Ther Exp (Warsz). 1999;47(6):377-85.","Leszek J","Arch Immunol Ther Exp (Warsz)","1999","1999/12/23","","",""
"23936376","Using manifold learning for atlas selection in multi-atlas segmentation","Hoang Duc AK, Modat M, Leung KK, Cardoso MJ, Barnes J, Kadir T, Ourselin S; Alzheimer’s Disease Neuroimaging Initiative.","PLoS One. 2013 Aug 2;8(8):e70059. doi: 10.1371/journal.pone.0070059. Print 2013.","Hoang Duc AK","PLoS One","2013","2013/08/13","PMC3732273","","10.1371/journal.pone.0070059"
"10364647","A double-blind, placebo-controlled study of tacrine in Chinese patients with Alzheimer's disease","Wong WJ, Liu HC, Fuh JL, Wang SJ, Hsu LC, Wang PN, Sheng WY.","Dement Geriatr Cogn Disord. 1999 Jul-Aug;10(4):289-94. doi: 10.1159/000017134.","Wong WJ","Dement Geriatr Cogn Disord","1999","1999/06/12","","","10.1159/000017134"
"23948729","Effect of the timing of acetylcholinesterase inhibitor ingestion on sleep","Song HR, Woo YS, Wang HR, Jun TY, Bahk WM.","Int Clin Psychopharmacol. 2013 Nov;28(6):346-8. doi: 10.1097/YIC.0b013e328364f58d.","Song HR","Int Clin Psychopharmacol","2013","2013/08/17","","","10.1097/YIC.0b013e328364f58d"
"19672235","[Results of the open multicenter prospective study of safety and tolerability of rivastigmine (exelon) in different titration regimes in mild and moderate Alzheimer's disease]","Litvinenko IV, Sakharovskaia AA.","Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(7):29-35.","Litvinenko IV","Zh Nevrol Psikhiatr Im S S Korsakova","2009","2009/08/13","","",""
"28394917","Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease","Kasai T, Kondo M, Ishii R, Tanaka A, Ataka S, Shimada H, Tomiyama T, Mori H, Taylor M, Allsop D, Nakagawa M, Mizuno T, Tokuda T.","PLoS One. 2017 Apr 10;12(4):e0174630. doi: 10.1371/journal.pone.0174630. eCollection 2017.","Kasai T","PLoS One","2017","2017/04/11","PMC5386327","","10.1371/journal.pone.0174630"
"14722336","Effects of a caregiver intervention on negative caregiver appraisals of behavior problems in patients with Alzheimer's disease: results of a randomized trial","Mittelman MS, Roth DL, Haley WE, Zarit SH.","J Gerontol B Psychol Sci Soc Sci. 2004 Jan;59(1):P27-34. doi: 10.1093/geronb/59.1.p27.","Mittelman MS","J Gerontol B Psychol Sci Soc Sci","2004","2004/01/15","","","10.1093/geronb/59.1.p27"
"12207997","Spatial shifts in visual attention in normal ageing and dementia of the Alzheimer type","Tales A, Muir JL, Bayer A, Snowden RJ.","Neuropsychologia. 2002;40(12):2000-12. doi: 10.1016/s0028-3932(02)00057-x.","Tales A","Neuropsychologia","2002","2002/09/05","","","10.1016/s0028-3932(02)00057-x"
"16930364","Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study","Mazza M, Capuano A, Bria P, Mazza S.","Eur J Neurol. 2006 Sep;13(9):981-5. doi: 10.1111/j.1468-1331.2006.01409.x.","Mazza M","Eur J Neurol","2006","2006/08/26","","","10.1111/j.1468-1331.2006.01409.x"
"2567933","Tacrine in Alzheimer's disease","Davies B, Andrewes D, Stargatt R, Ames D, Tuckwell V, Davis S.","Lancet. 1989 Jul 15;2(8655):163-4. doi: 10.1016/s0140-6736(89)90225-0.","Davies B","Lancet","1989","1989/07/15","","","10.1016/s0140-6736(89)90225-0"
"34292973","Regional brain volumes relate to Alzheimer's disease cerebrospinal fluid biomarkers and neuropsychometry: A cross-sectional, observational study","Libowitz MR, Wei K, Tran T, Chu K, Moncrieffe K, Harrington MG, King K.","PLoS One. 2021 Jul 22;16(7):e0254332. doi: 10.1371/journal.pone.0254332. eCollection 2021.","Libowitz MR","PLoS One","2021","2021/07/22","PMC8297871","","10.1371/journal.pone.0254332"
"27383395","Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease","Collij LE, Heeman F, Kuijer JP, Ossenkoppele R, Benedictus MR, Möller C, Verfaillie SC, Sanz-Arigita EJ, van Berckel BN, van der Flier WM, Scheltens P, Barkhof F, Wink AM.","Radiology. 2016 Dec;281(3):865-875. doi: 10.1148/radiol.2016152703. Epub 2016 Jul 6.","Collij LE","Radiology","2016","2016/07/08","","","10.1148/radiol.2016152703"
"31944580","Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial","Herring WJ, Ceesay P, Snyder E, Bliwise D, Budd K, Hutzelmann J, Stevens J, Lines C, Michelson D.","Alzheimers Dement. 2020 Mar;16(3):541-551. doi: 10.1002/alz.12035. Epub 2020 Jan 15.","Herring WJ","Alzheimers Dement","2020","2020/01/17","PMC7984350","","10.1002/alz.12035"
"28372325","Cognitive Rehabilitation in Alzheimer's Disease: A Controlled Intervention Trial","Brueggen K, Kasper E, Ochmann S, Pfaff H, Webel S, Schneider W, Teipel S.","J Alzheimers Dis. 2017;57(4):1315-1324. doi: 10.3233/JAD-160771.","Brueggen K","J Alzheimers Dis","2017","2017/04/05","","","10.3233/JAD-160771"
"25301682","Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials","Donohue MC, Moghadam SH, Roe AD, Sun CK, Edland SD, Thomas RG, Petersen RC, Sano M, Galasko D, Aisen PS, Rissman RA.","Alzheimers Dement. 2015 Sep;11(9):1069-79. doi: 10.1016/j.jalz.2014.07.156. Epub 2014 Oct 7.","Donohue MC","Alzheimers Dement","2015","2014/10/11","PMC4387108","NIHMS623124","10.1016/j.jalz.2014.07.156"
"9292621","The acetylcholine releaser linopirdine increases parietal regional cerebral blood flow in Alzheimer's disease","van Dyck CH, Lin CH, Robinson R, Cellar J, Smith EO, Nelson JC, Arnsten AF, Hoffer PB.","Psychopharmacology (Berl). 1997 Aug;132(3):217-26. doi: 10.1007/s002130050339.","van Dyck CH","Psychopharmacology (Berl)","1997","1997/08/01","","","10.1007/s002130050339"
"15134388","Treatment of Alzheimer's disease with stabilized oral nicotinamide adenine dinucleotide: a randomized, double-blind study","Demarin V, Podobnik SS, Storga-Tomic D, Kay G.","Drugs Exp Clin Res. 2004;30(1):27-33.","Demarin V","Drugs Exp Clin Res","2004","2004/05/12","","",""
"12962529","Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease","Small G, Erkinjuntti T, Kurz A, Lilienfeld S.","CNS Drugs. 2003;17(12):905-14. doi: 10.2165/00023210-200317120-00004.","Small G","CNS Drugs","2003","2003/09/10","","","10.2165/00023210-200317120-00004"
"1986730","A trial of thiamine in Alzheimer's disease","Nolan KA, Black RS, Sheu KF, Langberg J, Blass JP.","Arch Neurol. 1991 Jan;48(1):81-3. doi: 10.1001/archneur.1991.00530130093025.","Nolan KA","Arch Neurol","1991","1991/01/01","","","10.1001/archneur.1991.00530130093025"
"16922471","Regional cerebral blood flow in Alzheimer's disease: comparison between short and long-term donepezil therapy","Ushuijima Y, Okuyama C, Mori S, Kubota T, Nakai T, Nishimura T.","Ann Nucl Med. 2006 Jul;20(6):425-9. doi: 10.1007/BF03027378.","Ushuijima Y","Ann Nucl Med","2006","2006/08/23","","","10.1007/BF03027378"
"22886018","Validation of a multiplex assay for simultaneous quantification of amyloid-β peptide species in human plasma with utility for measurements in studies of Alzheimer's disease therapeutics","Lachno DR, Emerson JK, Vanderstichele H, Gonzales C, Martényi F, Konrad RJ, Talbot JA, Lowe SL, Oefinger PE, Dean RA.","J Alzheimers Dis. 2012;32(4):905-18. doi: 10.3233/JAD-2012-121075.","Lachno DR","J Alzheimers Dis","2012","2012/08/14","","","10.3233/JAD-2012-121075"
"1592575","Alzheimer-type dementia and verbal memory performances: influence of selegiline therapy","Finali G, Piccirilli M, Oliani C, Piccinin GL.","Ital J Neurol Sci. 1992 Mar;13(2):141-8. doi: 10.1007/BF02226963.","Finali G","Ital J Neurol Sci","1992","1992/03/01","","","10.1007/BF02226963"
"22523108","Alzheimer's disease: is pacemaker implantation safe?","Osmonov D, Ozcan KS, Altay S, Erdinler I, Yildirim E, Türkkan C, Canga Y, Alper AT, Cakmak N, Gürkan K.","Am J Alzheimers Dis Other Demen. 2012 May;27(3):202-5. doi: 10.1177/1533317512444457. Epub 2012 Apr 20.","Osmonov D","Am J Alzheimers Dis Other Demen","2012","2012/04/24","","","10.1177/1533317512444457"
"27992572","Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer's Disease and Amnestic Mild Cognitive Impairment","Kobayashi N, Shinagawa S, Nagata T, Shimada K, Shibata N, Ohnuma T, Kasanuki K, Arai H, Yamada H, Nakayama K, Kondo K.","PLoS One. 2016 Dec 19;11(12):e0168816. doi: 10.1371/journal.pone.0168816. eCollection 2016.","Kobayashi N","PLoS One","2016","2016/12/20","PMC5167410","","10.1371/journal.pone.0168816"
"9460732","Visual and spatial perception in the early phase of Alzheimer's disease","Binetti G, Cappa SF, Magni E, Padovani A, Bianchetti A, Trabucchi M.","Neuropsychology. 1998 Jan;12(1):29-33. doi: 10.1037//0894-4105.12.1.29.","Binetti G","Neuropsychology","1998","1998/02/14","","","10.1037//0894-4105.12.1.29"
"25376930","Effect of rivastigmine or memantine add-on therapy is affected by butyrylcholinesterase genotype in patients with probable Alzheimer's disease","Han HJ, Kwon JC, Kim JE, Kim SG, Park JM, Park KW, Park KC, Park KH, Moon SY, Seo SW, Choi SH, Cho SJ.","Eur Neurol. 2015;73(1-2):23-8. doi: 10.1159/000366198. Epub 2014 Nov 1.","Han HJ","Eur Neurol","2015","2014/11/08","","","10.1159/000366198"
"9595967","Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease","Morris JC, Cyrus PA, Orazem J, Mas J, Bieber F, Ruzicka BB, Gulanski B.","Neurology. 1998 May;50(5):1222-30. doi: 10.1212/wnl.50.5.1222.","Morris JC","Neurology","1998","1998/05/22","","","10.1212/wnl.50.5.1222"
"22175654","Effects of atorvastatin on cerebral blood flow in middle-aged adults at risk for Alzheimer's disease: a pilot study","Carlsson CM, Xu G, Wen Z, Barnet JH, Blazel HM, Chappell RJ, Stein JH, Asthana S, Sager MA, Alsop DC, Rowley HA, Fain SB, Johnson SC.","Curr Alzheimer Res. 2012 Oct;9(8):990-7. doi: 10.2174/156720512803251075.","Carlsson CM","Curr Alzheimer Res","2012","2011/12/20","PMC3576818","NIHMS440773","10.2174/156720512803251075"
"18405055","Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia","Boban M, Grbić K, Mladinov M, Hof PR, Süssmair C, Ackl N, Stanić G, Bader B, Danek A, Simić G.","Coll Antropol. 2008 Jan;32 Suppl 1:31-6.","Boban M","Coll Antropol","2008","2008/04/15","","",""
"9566811","Physostigmine results in an increased decrement in brain glucose consumption in Alzheimer's disease","Blin J, Ivanoiu A, De Volder A, Michel C, Bol A, Verellen C, Seron X, Duprez T, Laterre EC.","Psychopharmacology (Berl). 1998 Apr;136(3):256-63. doi: 10.1007/s002130050564.","Blin J","Psychopharmacology (Berl)","1998","1998/05/05","","","10.1007/s002130050564"
"9143434","The presence of leuko-araiosis in patients with Alzheimer's disease predicts poor tolerance to tacrine, but does not discriminate responders from non-responders","Amar K, Wilcock GK, Scot M, Lewis T.","Age Ageing. 1997 Jan;26(1):25-9. doi: 10.1093/ageing/26.1.25.","Amar K","Age Ageing","1997","1997/01/01","","","10.1093/ageing/26.1.25"
"18068522","Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial","AD2000 Collaborative Group; Bentham P, Gray R, Sellwood E, Hills R, Crome P, Raftery J.","Lancet Neurol. 2008 Jan;7(1):41-9. doi: 10.1016/S1474-4422(07)70293-4.","AD2000 Collaborative Group","Lancet Neurol","2008","2007/12/11","","","10.1016/S1474-4422(07)70293-4"
"28334978","Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease","Reeves S, McLachlan E, Bertrand J, D'Antonio F, Brownings S, Nair A, Greaves S, Smith A, Taylor D, Dunn J, Marsden P, Kessler R, Howard R.","Brain. 2017 Apr 1;140(4):1117-1127. doi: 10.1093/brain/aww359.","Reeves S","Brain","2017","2017/03/24","","","10.1093/brain/aww359"
"12461765","Skill learning in patients with moderate Alzheimer's disease: a prospective pilot-study of waltz-lessons","Rösler A, Seifritz E, Kräuchi K, Spoerl D, Brokuslaus I, Proserpi SM, Gendre A, Savaskan E, Hofmann M.","Int J Geriatr Psychiatry. 2002 Dec;17(12):1155-6. doi: 10.1002/gps.705.","Rösler A","Int J Geriatr Psychiatry","2002","2002/12/04","","","10.1002/gps.705"
"79110","Choline therapy in Alzheimer's disease","Smith CM, Swash M, Exton-Smith AN, Phillips MJ, Overstall PW, Piper ME, Bailey MR.","Lancet. 1978 Aug 5;2(8084):318. doi: 10.1016/s0140-6736(78)91721-x.","Smith CM","Lancet","1978","1978/08/05","","","10.1016/s0140-6736(78)91721-x"
"2107926","Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine","Chatellier G, Lacomblez L.","BMJ. 1990 Feb 24;300(6723):495-9. doi: 10.1136/bmj.300.6723.495.","Chatellier G","BMJ","1990","1990/02/24","PMC1662308","","10.1136/bmj.300.6723.495"
"8805118","Alteration of acylphosphatase levels in familial Alzheimer's disease fibroblasts with presenilin gene mutations","Liguri G, Cecchi C, Latorraca S, Pieri A, Sorbi S, Degl'Innocenti D, Ramponi G.","Neurosci Lett. 1996 Jun 7;210(3):153-6. doi: 10.1016/0304-3940(96)12696-3.","Liguri G","Neurosci Lett","1996","1996/06/07","","","10.1016/0304-3940(96)12696-3"
"31659172","A quick test of cognitive speed can predict development of dementia in Parkinson's disease","Jalakas M, Palmqvist S, Hall S, Svärd D, Lindberg O, Pereira JB, van Westen D, Hansson O.","Sci Rep. 2019 Oct 28;9(1):15417. doi: 10.1038/s41598-019-51505-1.","Jalakas M","Sci Rep","2019","2019/10/30","PMC6817840","","10.1038/s41598-019-51505-1"
"24436135","The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area","Araki T, Wake R, Miyaoka T, Kawakami K, Nagahama M, Furuya M, Limoa E, Liaury K, Hashioka S, Murotani K, Horiguchi J.","Int J Geriatr Psychiatry. 2014 Sep;29(9):881-9. doi: 10.1002/gps.4074. Epub 2014 Jan 17.","Araki T","Int J Geriatr Psychiatry","2014","2014/01/18","","","10.1002/gps.4074"
"16416397","Short-term treatment with rivastigmine and plasma levels of Abeta peptides in Alzheimer's disease","Sobow T, Kloszewska I.","Folia Neuropathol. 2005;43(4):340-4.","Sobow T","Folia Neuropathol","2005","2006/01/18","","",""
"15821961","Diagnosis of Alzheimer's disease using brain perfusion SPECT and MR imaging: which modality achieves better diagnostic accuracy?","Kubota T, Ushijima Y, Yamada K, Okuyama C, Kizu O, Nishimura T.","Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):414-21. doi: 10.1007/s00259-004-1704-9. Epub 2004 Nov 20.","Kubota T","Eur J Nucl Med Mol Imaging","2005","2005/04/12","","","10.1007/s00259-004-1704-9"
"15718036","Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients","Guidi I, Galimberti D, Venturelli E, Lovati C, Del Bo R, Fenoglio C, Gatti A, Dominici R, Galbiati S, Virgilio R, Pomati S, Comi GP, Mariani C, Forloni G, Bresolin N, Scarpini E.","Neurobiol Aging. 2005 Jun;26(6):789-94. doi: 10.1016/j.neurobiolaging.2004.07.003.","Guidi I","Neurobiol Aging","2005","2005/02/19","","","10.1016/j.neurobiolaging.2004.07.003"
"15788278","Mechanism of the closing-in phenomenon in a figure copying task in Alzheimer's disease patients","Lee BH, Chin J, Kang SJ, Kim EJ, Park KC, Na DL.","Neurocase. 2004 Oct;10(5):393-7. doi: 10.1080/13554790490892194.","Lee BH","Neurocase","2004","2005/03/25","","","10.1080/13554790490892194"
"10665618","Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group","van Dyck CH, Newhouse P, Falk WE, Mattes JA.","Arch Gen Psychiatry. 2000 Feb;57(2):157-64. doi: 10.1001/archpsyc.57.2.157.","van Dyck CH","Arch Gen Psychiatry","2000","2000/02/09","","","10.1001/archpsyc.57.2.157"
"9309491","Assessment of motor and process skills as a measure of IADL functioning in pharmacologic studies of people with Alzheimer's disease: a pilot study","Oakley F, Sunderland T.","Int Psychogeriatr. 1997 Jun;9(2):197-206. doi: 10.1017/s1041610297004341.","Oakley F","Int Psychogeriatr","1997","1997/06/01","","","10.1017/s1041610297004341"
"24859851","Dopaminergic modulation of cortical plasticity in Alzheimer's disease patients","Koch G, Di Lorenzo F, Bonnì S, Giacobbe V, Bozzali M, Caltagirone C, Martorana A.","Neuropsychopharmacology. 2014 Oct;39(11):2654-61. doi: 10.1038/npp.2014.119. Epub 2014 May 26.","Koch G","Neuropsychopharmacology","2014","2014/05/27","PMC4207345","","10.1038/npp.2014.119"
"24492450","Parallel improvement of cognitive functions and P300 latency following donepezil treatment in patients with Alzheimer's disease: a case-control study","Chang YS, Chen HL, Hsu CY, Tang SH, Liu CK.","J Clin Neurophysiol. 2014 Feb;31(1):81-5. doi: 10.1097/01.wnp.0000436899.48243.5e.","Chang YS","J Clin Neurophysiol","2014","2014/02/05","","","10.1097/01.wnp.0000436899.48243.5e"
"18827045","A multi-center, randomized, double blind placebo-controlled trial of estrogens to prevent Alzheimer's disease and loss of memory in women: design and baseline characteristics","Sano M, Jacobs D, Andrews H, Bell K, Graff-Radford N, Lucas J, Rabins P, Bolla K, Tsai WY, Cross P, Andrews K, Costa R, Xiaodong Luo.","Clin Trials. 2008;5(5):523-33. doi: 10.1177/1740774508096313.","Sano M","Clin Trials","2008","2008/10/02","PMC3884686","NIHMS266773","10.1177/1740774508096313"
"21911655","Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B.","Arch Neurol. 2012 Jan;69(1):29-38. doi: 10.1001/archneurol.2011.233. Epub 2011 Sep 12.","Craft S","Arch Neurol","2012","2011/09/14","PMC3260944","NIHMS334923","10.1001/archneurol.2011.233"
"23687177","An open-label, nonplacebo-controlled study on Cistanche tubulosa glycoside capsules (Memoregain(®)) for treating moderate Alzheimer's Disease","Guo Q, Zhou Y, Wang CJ, Huang YM, Lee YT, Su MH, Lu J.","Am J Alzheimers Dis Other Demen. 2013 Jun;28(4):363-70. doi: 10.1177/1533317513488907. Epub 2013 May 17.","Guo Q","Am J Alzheimers Dis Other Demen","2013","2013/05/21","","","10.1177/1533317513488907"
"15832031","Do vascular lesions and related risk factors influence responsiveness to donepezil chloride in patients with Alzheimer's disease?","Fukui T, Taguchi S.","Dement Geriatr Cogn Disord. 2005;20(1):15-24. doi: 10.1159/000085069. Epub 2005 Apr 12.","Fukui T","Dement Geriatr Cogn Disord","2005","2005/04/16","","","10.1159/000085069"
"25121567","Effect of unawareness on rehabilitation outcome in a randomised controlled trial of multicomponent intervention for patients with mild Alzheimer's disease","Fernández-Calvo B, Contador I, Ramos F, Olazarán J, Mograbi DC, Morris RG.","Neuropsychol Rehabil. 2015;25(3):448-77. doi: 10.1080/09602011.2014.948461. Epub 2014 Aug 14.","Fernández-Calvo B","Neuropsychol Rehabil","2015","2014/08/15","","","10.1080/09602011.2014.948461"
"15259390","""Clockness"" in the detection of dementia: a semantic-conceptual effect","Saling MM, Maccuspie-Moore CM, Anderson VA, Chiu E.","Brain Cogn. 2002 Jul;49(2):205-7.","Saling MM","Brain Cogn","2002","2004/07/21","","",""
"9310089","A multinomial modeling analysis of memory deficits in Alzheimer's disease and vascular dementia","Batchelder WH, Chosak-Reiter J, Shankle WR, Dick MB.","J Gerontol B Psychol Sci Soc Sci. 1997 Sep;52(5):P206-15. doi: 10.1093/geronb/52b.5.p206.","Batchelder WH","J Gerontol B Psychol Sci Soc Sci","1997","1997/10/06","","","10.1093/geronb/52b.5.p206"
"10213976","[Longitudinal evaluation of early dementia of Alzheimer type using brain perfusion SPECT]","Kogure D, Matsuda H, Ohnishi T, Kunihiro T, Uno M, Asada T, Takasaki M.","Kaku Igaku. 1999 Feb;36(2):91-101.","Kogure D","Kaku Igaku","1999","1999/04/24","","",""
"10398355","Ten-point clock test sensitivity for Alzheimer's disease in patients with MMSE scores greater than 23","Manos PJ.","Int J Geriatr Psychiatry. 1999 Jun;14(6):454-8.","Manos PJ","Int J Geriatr Psychiatry","1999","1999/07/09","","",""
"16204712","Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET","Drzezga A, Grimmer T, Riemenschneider M, Lautenschlager N, Siebner H, Alexopoulus P, Minoshima S, Schwaiger M, Kurz A.","J Nucl Med. 2005 Oct;46(10):1625-32.","Drzezga A","J Nucl Med","2005","2005/10/06","","",""
"9381027","[Advantages in long-term treatment with Cognex in Alzheimer disease]","Gracon S, Smith F, Shokry A.","Praxis (Bern 1994). 1997 Aug 27;86(35):1350-4.","Gracon S","Praxis (Bern 1994)","1997","1997/08/27","","",""
"9162204","Semantic memory is impaired in schizophrenia","McKay AP, McKenna PJ, Bentham P, Mortimer AM, Holbery A, Hodges JR.","Biol Psychiatry. 1996 Jun 1;39(11):929-37. doi: 10.1016/0006-3223(95)00250-2.","McKay AP","Biol Psychiatry","1996","1996/06/01","","","10.1016/0006-3223(95)00250-2"
"11829205","Dynamic regulation of EEG power and coherence is lost early and globally in probable DAT","Stevens A, Kircher T, Nickola M, Bartels M, Rosellen N, Wormstall H.","Eur Arch Psychiatry Clin Neurosci. 2001 Oct;251(5):199-204. doi: 10.1007/s004060170027.","Stevens A","Eur Arch Psychiatry Clin Neurosci","2001","2002/02/07","","","10.1007/s004060170027"
"19512976","Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild Alzheimer disease: a functional magnetic resonance imaging study","Bokde AL, Karmann M, Teipel SJ, Born C, Lieb M, Reiser MF, Möller HJ, Hampel H.","J Clin Psychopharmacol. 2009 Apr;29(2):147-56. doi: 10.1097/JCP.0b013e31819a8f2e.","Bokde AL","J Clin Psychopharmacol","2009","2009/06/11","","","10.1097/JCP.0b013e31819a8f2e"
"24549933","Efficacy of higher-dose 13.3 mg/24 h (15 cm2) rivastigmine patch on the Alzheimer's Disease Assessment Scale-cognitive subscale: domain and individual item analysis","Alva G, Isaacson R, Sadowsky C, Grossberg G, Meng X, Somogyi M.","Int J Geriatr Psychiatry. 2014 Sep;29(9):920-7. doi: 10.1002/gps.4080. Epub 2014 Feb 18.","Alva G","Int J Geriatr Psychiatry","2014","2014/02/20","","","10.1002/gps.4080"
"35275529","A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients with Mild to Moderate Alzheimer's Disease Treated with Donepezil: DHP1401 Randomized Trial in Mild to Moderate Alzheimer's Disease (DRAMA)","Shim Y, Han HJ, Park KW, Kim BC, Park KH, Park MY, Kim HJ, Moon SY, Choi SH, Park KW, Yang DW, Yoon SJ, Kim SY, Youn YC, Choi H, Yoon KE, Cho HJ, Han SH.","J Alzheimers Dis. 2022;87(1):391-403. doi: 10.3233/JAD-215277.","Shim Y","J Alzheimers Dis","2022","2022/03/11","","","10.3233/JAD-215277"
"16227448","Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E","Fillenbaum GG, Kuchibhatla MN, Hanlon JT, Artz MB, Pieper CF, Schmader KE, Dysken MW, Gray SL.","Ann Pharmacother. 2005 Dec;39(12):2009-14. doi: 10.1345/aph.1G280. Epub 2005 Oct 14.","Fillenbaum GG","Ann Pharmacother","2005","2005/10/18","","","10.1345/aph.1G280"
"18288935","Rofecoxib in patients with mild cognitive impairment: further analyses of data from a randomized, double-blind, trial","Aisen PS, Thal LJ, Ferris SH, Assaid C, Nessly ML, Giuliani MJ, Lines CR, Norman BA, Potter WZ.","Curr Alzheimer Res. 2008 Feb;5(1):73-82. doi: 10.2174/156720508783884602.","Aisen PS","Curr Alzheimer Res","2008","2008/02/22","","","10.2174/156720508783884602"
"29870867","SPIRIT advance care planning intervention in early stage dementias: An NIH stage I behavioral intervention development trial","Song MK, Ward SE, Hepburn K, Paul S, Shah RC, Morhardt DJ.","Contemp Clin Trials. 2018 Aug;71:55-62. doi: 10.1016/j.cct.2018.06.005. Epub 2018 Jun 2.","Song MK","Contemp Clin Trials","2018","2018/06/06","PMC6067971","NIHMS973893","10.1016/j.cct.2018.06.005"
"9753176","Synaptic loss reflected by secretoneurin-like immunoreactivity in the human hippocampus in Alzheimer's disease","Kaufmann WA, Barnas U, Humpel C, Nowakowski K, DeCol C, Gurka P, Ransmayr G, Hinterhuber H, Winkler H, Marksteiner J.","Eur J Neurosci. 1998 Mar;10(3):1084-94. doi: 10.1046/j.1460-9568.1998.00121.x.","Kaufmann WA","Eur J Neurosci","1998","1998/09/30","","","10.1046/j.1460-9568.1998.00121.x"
"9850939","Sustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multicentre study","Gutzmann H, Hadler D.","J Neural Transm Suppl. 1998;54:301-10. doi: 10.1007/978-3-7091-7508-8_30.","Gutzmann H","J Neural Transm Suppl","1998","1998/12/16","","","10.1007/978-3-7091-7508-8_30"
"17351317","Utility of the Bender Gestalt Test for differentiation of dementia with Lewy bodies from Alzheimer's disease in patients showing mild to moderate dementia","Murayama N, Iseki E, Yamamoto R, Kimura M, Eto K, Arai H.","Dement Geriatr Cogn Disord. 2007;23(4):258-63. doi: 10.1159/000100772. Epub 2007 Mar 12.","Murayama N","Dement Geriatr Cogn Disord","2007","2007/03/14","","","10.1159/000100772"
"3893272","Clinical evaluation of compounds for the treatment of memory dysfunction","Growdon JH, Corkin S, Huff FJ.","Ann N Y Acad Sci. 1985;444:437-49. doi: 10.1111/j.1749-6632.1985.tb37606.x.","Growdon JH","Ann N Y Acad Sci","1985","1985/01/01","","","10.1111/j.1749-6632.1985.tb37606.x"
"23290159","[Effects of telmisartan on the level of Aβ1-42, interleukin-1β, tumor necrosis factor α and cognition in hypertensive patients with Alzheimer's disease]","Li W, Zhang JW, Lu F, Ma MM, Wang JQ, Suo AQ, Bai YY, Liu HQ.","Zhonghua Yi Xue Za Zhi. 2012 Oct 23;92(39):2743-6.","Li W","Zhonghua Yi Xue Za Zhi","2012","2013/01/08","","",""
"11186163","Visual exploration of facial emotion by healthy older adults and patients with Alzheimer disease","Ogrocki PK, Hills AC, Strauss ME.","Neuropsychiatry Neuropsychol Behav Neurol. 2000 Oct;13(4):271-8.","Ogrocki PK","Neuropsychiatry Neuropsychol Behav Neurol","2000","2001/02/24","","",""
"34970718","Neuronavigated Magnetic Stimulation combined with cognitive training for Alzheimer's patients: an EEG graph study","Vecchio F, Quaranta D, Miraglia F, Pappalettera C, Di Iorio R, L'Abbate F, Cotelli M, Marra C, Rossini PM.","Geroscience. 2022 Feb;44(1):159-172. doi: 10.1007/s11357-021-00508-w. Epub 2021 Dec 31.","Vecchio F","Geroscience","2022","2021/12/31","PMC8811083","","10.1007/s11357-021-00508-w"
"16770076","Memory for choices in Alzheimer's disease","Budson AE, Mather M, Chong H.","Dement Geriatr Cogn Disord. 2006;22(2):150-8. doi: 10.1159/000093839. Epub 2006 Jun 12.","Budson AE","Dement Geriatr Cogn Disord","2006","2006/06/14","","","10.1159/000093839"
"19617863","Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment","Ferris S, Nordberg A, Soininen H, Darreh-Shori T, Lane R.","Pharmacogenet Genomics. 2009 Aug;19(8):635-46. doi: 10.1097/FPC.0b013e32832f8c17.","Ferris S","Pharmacogenet Genomics","2009","2009/07/21","PMC4114757","NIHMS594357","10.1097/FPC.0b013e32832f8c17"
"10768622","Visuoperceptual impairment in dementia with Lewy bodies","Mori E, Shimomura T, Fujimori M, Hirono N, Imamura T, Hashimoto M, Tanimukai S, Kazui H, Hanihara T.","Arch Neurol. 2000 Apr;57(4):489-93. doi: 10.1001/archneur.57.4.489.","Mori E","Arch Neurol","2000","2000/04/18","","","10.1001/archneur.57.4.489"
"11925283","Ondansetron in the treatment of cognitive decline in Alzheimer dementia","Dysken M, Kuskowski M, Love S; Ondansetron Study Group.","Am J Geriatr Psychiatry. 2002 Mar-Apr;10(2):212-5.","Dysken M","Am J Geriatr Psychiatry","2002","2002/04/02","","",""
"2947105","[Methodology for a controlled trial in Alzheimer's disease]","Dehen H, Dordain G, Allard M.","Presse Med. 1986 Sep 25;15(31):1577-82.","Dehen H","Presse Med","1986","1986/09/25","","",""
"8841150","Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease","Asthana S, Greig NH, Holloway HW, Raffaele KC, Berardi A, Schapiro MB, Rapoport SI, Soncrant TT.","Clin Pharmacol Ther. 1996 Sep;60(3):276-82. doi: 10.1016/S0009-9236(96)90054-5.","Asthana S","Clin Pharmacol Ther","1996","1996/09/01","","","10.1016/S0009-9236(96)90054-5"
"9236572","Pupil dilation to tropicamide is not specific for Alzheimer disease","Growdon JH, Graefe K, Tennis M, Hayden D, Schoenfeld D, Wray SH.","Arch Neurol. 1997 Jul;54(7):841-4. doi: 10.1001/archneur.1997.00550190031011.","Growdon JH","Arch Neurol","1997","1997/07/01","","","10.1001/archneur.1997.00550190031011"
"22959283","The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results","Amenta F, Carotenuto A, Fasanaro AM, Rea R, Traini E.","J Neurol Sci. 2012 Nov 15;322(1-2):96-101. doi: 10.1016/j.jns.2012.07.003. Epub 2012 Sep 7.","Amenta F","J Neurol Sci","2012","2012/09/11","","","10.1016/j.jns.2012.07.003"
"19874395","Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy","Modrego PJ, Fayed N, Errea JM, Rios C, Pina MA, Sarasa M.","Eur J Neurol. 2010 Mar;17(3):405-12. doi: 10.1111/j.1468-1331.2009.02816.x. Epub 2009 Oct 28.","Modrego PJ","Eur J Neurol","2010","2009/10/31","","","10.1111/j.1468-1331.2009.02816.x"
"30569813","Parametric methods for [(18)F]flortaucipir PET","Golla SS, Wolters EE, Timmers T, Ossenkoppele R, van der Weijden CW, Scheltens P, Schwarte L, Mintun MA, Devous MD Sr, Schuit RC, Windhorst AD, Lammertsma AA, Yaqub M, van Berckel BN, Boellaard R.","J Cereb Blood Flow Metab. 2020 Feb;40(2):365-373. doi: 10.1177/0271678X18820765. Epub 2018 Dec 20.","Golla SS","J Cereb Blood Flow Metab","2020","2018/12/21","PMC7044757","","10.1177/0271678X18820765"
"31156170","Associated Factors of Total Costs of Alzheimer's Disease: A Cluster-Randomized Observational Study in China","Yan X, Li F, Chen S, Jia J.","J Alzheimers Dis. 2019;69(3):795-806. doi: 10.3233/JAD-190166.","Yan X","J Alzheimers Dis","2019","2019/06/04","","","10.3233/JAD-190166"
"8579807","Correlation between cognitive brain function and electrical brain activity in dementia of Alzheimer type","Dierks T, Frölich L, Ihl R, Maurer K.","J Neural Transm Gen Sect. 1995;99(1-3):55-62. doi: 10.1007/BF01271469.","Dierks T","J Neural Transm Gen Sect","1995","1995/01/01","","","10.1007/BF01271469"
"22959822","Walking stabilizes cognitive functioning in Alzheimer's disease (AD) across one year","Winchester J, Dick MB, Gillen D, Reed B, Miller B, Tinklenberg J, Mungas D, Chui H, Galasko D, Hewett L, Cotman CW.","Arch Gerontol Geriatr. 2013 Jan-Feb;56(1):96-103. doi: 10.1016/j.archger.2012.06.016. Epub 2012 Sep 5.","Winchester J","Arch Gerontol Geriatr","2013","2012/09/11","PMC3766353","NIHMS512918","10.1016/j.archger.2012.06.016"
"28295141","Adherence and Tolerability of Alzheimer's Disease Medications: A Pragmatic Randomized Trial","Campbell NL, Perkins AJ, Gao S, Skaar TC, Li L, Hendrie HC, Fowler N, Callahan CM, Boustani MA.","J Am Geriatr Soc. 2017 Jul;65(7):1497-1504. doi: 10.1111/jgs.14827. Epub 2017 Mar 14.","Campbell NL","J Am Geriatr Soc","2017","2017/03/16","PMC6604617","NIHMS890271","10.1111/jgs.14827"
"22642200","[Effectiveness of a case management program for the elderly in early stage dementia and their caregivers]","Tannen A.","Pflege Z. 2012 May;65(5):286.","Tannen A","Pflege Z","2012","2012/05/31","","",""
"21186596","[Study of chitosan-phospholipid complex on treatment to brain function of AD-patient]","Zhao GY, Li XY, Lu GH.","Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2006 Feb;22(1):112-3.","Zhao GY","Zhongguo Ying Yong Sheng Li Xue Za Zhi","2006","2010/12/29","","",""
"27111084","Effects on agitation with rivastigmine patch monotherapy and combination therapy with memantine in mild to moderate Alzheimer's disease: a multicenter 24-week prospective randomized open-label study (the Korean EXelon Patch and combination with mEmantine Comparative Trial study)","Yoon SJ, Choi SH, Na HR, Park KW, Kim EJ, Han HJ, Lee JH, Shim YS, Na DL.","Geriatr Gerontol Int. 2017 Mar;17(3):494-499. doi: 10.1111/ggi.12754. Epub 2016 Apr 25.","Yoon SJ","Geriatr Gerontol Int","2017","2016/04/26","","","10.1111/ggi.12754"
"12895452","Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease","Mancuso M, Filosto M, Bosetti F, Ceravolo R, Rocchi A, Tognoni G, Manca ML, Solaini G, Siciliano G, Murri L.","Exp Neurol. 2003 Aug;182(2):421-6. doi: 10.1016/s0014-4886(03)00092-x.","Mancuso M","Exp Neurol","2003","2003/08/05","","","10.1016/s0014-4886(03)00092-x"
"21801750","Detecting cognitive impairment by eye movement analysis using automatic classification algorithms","Lagun D, Manzanares C, Zola SM, Buffalo EA, Agichtein E.","J Neurosci Methods. 2011 Sep 30;201(1):196-203. doi: 10.1016/j.jneumeth.2011.06.027. Epub 2011 Jul 27.","Lagun D","J Neurosci Methods","2011","2011/08/02","PMC3403832","NIHMS341823","10.1016/j.jneumeth.2011.06.027"
"25809810","Tailored nutritional guidance for home-dwelling AD families: the Feasibility of and Elements Promoting Positive Changes in Diet (NuAD-Trial)","Puranen TM, Pitkala KH, Suominen MH.","J Nutr Health Aging. 2015 Apr;19(4):454-9. doi: 10.1007/s12603-014-0567-4.","Puranen TM","J Nutr Health Aging","2015","2015/03/27","","","10.1007/s12603-014-0567-4"
"16801647","Neuropathology of older persons without cognitive impairment from two community-based studies","Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, Wilson RS.","Neurology. 2006 Jun 27;66(12):1837-44. doi: 10.1212/01.wnl.0000219668.47116.e6.","Bennett DA","Neurology","2006","2006/06/28","","","10.1212/01.wnl.0000219668.47116.e6"
"7790287","Changes in visual fixation and saccadic eye movements in Alzheimer's disease","Bylsma FW, Rasmusson DX, Rebok GW, Keyl PM, Tune L, Brandt J.","Int J Psychophysiol. 1995 Feb;19(1):33-40. doi: 10.1016/0167-8760(94)00060-r.","Bylsma FW","Int J Psychophysiol","1995","1995/02/01","","","10.1016/0167-8760(94)00060-r"
"9576639","Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's disease","Cutler NR, Polinsky RJ, Sramek JJ, Enz A, Jhee SS, Mancione L, Hourani J, Zolnouni P.","Acta Neurol Scand. 1998 Apr;97(4):244-50. doi: 10.1111/j.1600-0404.1998.tb00645.x.","Cutler NR","Acta Neurol Scand","1998","1998/05/12","","","10.1111/j.1600-0404.1998.tb00645.x"
"8463521","L-deprenyl in the treatment of mild dementia of the Alzheimer type: preliminary results","Burke WJ, Ranno AE, Roccaforte WH, Wengel SP, Bayer BL, Willcockson NK.","J Am Geriatr Soc. 1993 Apr;41(4):367-70. doi: 10.1111/j.1532-5415.1993.tb06942.x.","Burke WJ","J Am Geriatr Soc","1993","1993/04/01","","","10.1111/j.1532-5415.1993.tb06942.x"
"12794389","Combination therapy of donepezil and vitamin E in Alzheimer disease","Klatte ET, Scharre DW, Nagaraja HN, Davis RA, Beversdorf DQ.","Alzheimer Dis Assoc Disord. 2003 Apr-Jun;17(2):113-6. doi: 10.1097/00002093-200304000-00010.","Klatte ET","Alzheimer Dis Assoc Disord","2003","2003/06/10","","","10.1097/00002093-200304000-00010"
"10559556","Apolipoprotein E epsilon4 is associated with neuronal loss in the substantia nigra in Alzheimer's disease","Camicioli R, Kaye J, Payami H, Ball MJ, Murdoch G.","Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):437-41. doi: 10.1159/000017186.","Camicioli R","Dement Geriatr Cogn Disord","1999","1999/11/24","","","10.1159/000017186"
"24349461","Influence of APOE genotype on whole-brain functional networks in cognitively normal elderly","Seo EH, Lee DY, Lee JM, Park JS, Sohn BK, Choe YM, Byun MS, Choi HJ, Woo JI.","PLoS One. 2013 Dec 11;8(12):e83205. doi: 10.1371/journal.pone.0083205. eCollection 2013.","Seo EH","PLoS One","2013","2013/12/19","PMC3859658","","10.1371/journal.pone.0083205"
"8868277","Examination of the working memory components in normal aging and in dementia of the Alzheimer type","Belleville S, Peretz I, Malenfant D.","Neuropsychologia. 1996 Mar;34(3):195-207. doi: 10.1016/0028-3932(95)00097-6.","Belleville S","Neuropsychologia","1996","1996/03/01","","","10.1016/0028-3932(95)00097-6"
"10078504","The temporal relationship between depressive symptoms and dementia: a community-based prospective study","Chen P, Ganguli M, Mulsant BH, DeKosky ST.","Arch Gen Psychiatry. 1999 Mar;56(3):261-6. doi: 10.1001/archpsyc.56.3.261.","Chen P","Arch Gen Psychiatry","1999","1999/03/17","","","10.1001/archpsyc.56.3.261"
"6345054","[The use of 1-acetylcarnitine in (presenile and senile) Alzheimer's disease. Preliminary results]","Acierno G.","Clin Ter. 1983 Apr 30;105(2):135-45.","Acierno G","Clin Ter","1983","1983/04/30","","",""
"29228201","Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia","Lowe VJ, Wiste HJ, Senjem ML, Weigand SD, Therneau TM, Boeve BF, Josephs KA, Fang P, Pandey MK, Murray ME, Kantarci K, Jones DT, Vemuri P, Graff-Radford J, Schwarz CG, Machulda MM, Mielke MM, Roberts RO, Knopman DS, Petersen RC, Jack CR Jr.","Brain. 2018 Jan 1;141(1):271-287. doi: 10.1093/brain/awx320.","Lowe VJ","Brain","2018","2017/12/12","PMC5837250","","10.1093/brain/awx320"
"81385","Influence of choline on amnesia in early Alzheimer's disease","Signoret JL, Whiteley A, Lhermitte F.","Lancet. 1978 Oct 14;2(8094):837. doi: 10.1016/s0140-6736(78)92612-0.","Signoret JL","Lancet","1978","1978/10/14","","","10.1016/s0140-6736(78)92612-0"
"11261800","A pharmacogenomic approach to Alzheimer's disease","Cacabelos R, Alvarez A, Fenández-Novoa L, Lombardi VR.","Acta Neurol Scand Suppl. 2000;176:12-9. doi: 10.1034/j.1600-0404.2000.00302.x.","Cacabelos R","Acta Neurol Scand Suppl","2000","2001/03/23","","","10.1034/j.1600-0404.2000.00302.x"
"16754694","Diffusion indices on magnetic resonance imaging and neuropsychological performance in amnestic mild cognitive impairment","Rose SE, McMahon KL, Janke AL, O'Dowd B, de Zubicaray G, Strudwick MW, Chalk JB.","J Neurol Neurosurg Psychiatry. 2006 Oct;77(10):1122-8. doi: 10.1136/jnnp.2005.074336. Epub 2006 Jun 5.","Rose SE","J Neurol Neurosurg Psychiatry","2006","2006/06/07","PMC2077533","","10.1136/jnnp.2005.074336"
"17646620","Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease","Blesa R, Ballard C, Orgogozo JM, Lane R, Thomas SK.","Neurology. 2007 Jul 24;69(4 Suppl 1):S23-8. doi: 10.1212/01.wnl.0000281848.25142.11.","Blesa R","Neurology","2007","2007/07/31","","","10.1212/01.wnl.0000281848.25142.11"
"15259394","Verbal learning and visuomotor attention in Alzheimer's disease and geriatric depression","Strang JM, Donnelly KZ, Grohman K, Kleiner J.","Brain Cogn. 2002 Jul;49(2):216-20.","Strang JM","Brain Cogn","2002","2004/07/21","","",""
"16210230","Metamemory accuracy in Alzheimer's disease and frontotemporal lobe dementia","Souchay C, Isingrini M, Pillon B, Gil R.","Neurocase. 2003 Dec;9(6):482-92. doi: 10.1076/neur.9.6.482.29376.","Souchay C","Neurocase","2003","2005/10/08","","","10.1076/neur.9.6.482.29376"
"15079026","Behavioral symptoms in mild cognitive impairment","Feldman H, Scheltens P, Scarpini E, Hermann N, Mesenbrink P, Mancione L, Tekin S, Lane R, Ferris S.","Neurology. 2004 Apr 13;62(7):1199-201. doi: 10.1212/01.wnl.0000118301.92105.ee.","Feldman H","Neurology","2004","2004/04/14","","","10.1212/01.wnl.0000118301.92105.ee"
"32410694","Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer's disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study","Novak G, Streffer JR, Timmers M, Henley D, Brashear HR, Bogert J, Russu A, Janssens L, Tesseur I, Tritsmans L, Van Nueten L, Engelborghs S.","Alzheimers Res Ther. 2020 May 14;12(1):58. doi: 10.1186/s13195-020-00614-5.","Novak G","Alzheimers Res Ther","2020","2020/05/16","PMC7227237","","10.1186/s13195-020-00614-5"
"14731059","Zotepine for behavioural and psychological symptoms in dementia: an open-label study","Rainer MK, Mucke HA, Krüger-Rainer C, Haushofer M, Kasper S.","CNS Drugs. 2004;18(1):49-55. doi: 10.2165/00023210-200418010-00005.","Rainer MK","CNS Drugs","2004","2004/01/21","","","10.2165/00023210-200418010-00005"
"9678319","Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease","McNamara MJ, Gomez-Isla T, Hyman BT.","Arch Neurol. 1998 Jul;55(7):1001-4. doi: 10.1001/archneur.55.7.1001.","McNamara MJ","Arch Neurol","1998","1998/07/25","","","10.1001/archneur.55.7.1001"
"18441524","Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study","Azevedo D, Tatsch M, Hototian SR, Bazzarella MC, Castro CC, Bottino CM.","Dement Geriatr Cogn Disord. 2008;25(6):491-500. doi: 10.1159/000128275. Epub 2008 Apr 28.","Azevedo D","Dement Geriatr Cogn Disord","2008","2008/04/29","","","10.1159/000128275"
"27466251","Negative Aging Stereotypes Impair Performance on Brief Cognitive Tests Used to Screen for Predementia","Mazerolle M, Régner I, Barber SJ, Paccalin M, Miazola AC, Huguet P, Rigalleau F.","J Gerontol B Psychol Sci Soc Sci. 2017 Oct 1;72(6):932-936. doi: 10.1093/geronb/gbw083.","Mazerolle M","J Gerontol B Psychol Sci Soc Sci","2017","2016/07/29","PMC5926988","","10.1093/geronb/gbw083"
"34570180","Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial","Mintzer J, Lanctôt KL, Scherer RW, Rosenberg PB, Herrmann N, van Dyck CH, Padala PR, Brawman-Mintzer O, Porsteinsson AP, Lerner AJ, Craft S, Levey AI, Burke W, Perin J, Shade D; ADMET 2 Research Group.","JAMA Neurol. 2021 Nov 1;78(11):1324-1332. doi: 10.1001/jamaneurol.2021.3356.","Mintzer J","JAMA Neurol","2021","2021/09/27","PMC8477302","","10.1001/jamaneurol.2021.3356"
"10088136","THA improves word priming and clonidine enhances fluency and working memory in Alzheimer's disease","Riekkinen P Jr, Riekkinen M.","Neuropsychopharmacology. 1999 Apr;20(4):357-64. doi: 10.1016/S0893-133X(98)00093-1.","Riekkinen P Jr","Neuropsychopharmacology","1999","1999/03/24","","","10.1016/S0893-133X(98)00093-1"
"36630846","The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease","Valis M, Dlabkova A, Hort J, Angelucci F, Pejchal J, Kuca K, Pavelek Z, Karasova JZ, Novotny M.","Biomed Pharmacother. 2023 Mar;159:114223. doi: 10.1016/j.biopha.2023.114223. Epub 2023 Jan 9.","Valis M","Biomed Pharmacother","2023","2023/01/11","","","10.1016/j.biopha.2023.114223"
"3278380","FDA queries Alzheimer's trial results","Marx JL.","Science. 1988 Feb 26;239(4843):969. doi: 10.1126/science.3278380.","Marx JL","Science","1988","1988/02/26","","","10.1126/science.3278380"
"26027814","Social Markers of Mild Cognitive Impairment: Proportion of Word Counts in Free Conversational Speech","Dodge HH, Mattek N, Gregor M, Bowman M, Seelye A, Ybarra O, Asgari M, Kaye JA.","Curr Alzheimer Res. 2015;12(6):513-9. doi: 10.2174/1567205012666150530201917.","Dodge HH","Curr Alzheimer Res","2015","2015/06/02","PMC4526336","NIHMS688752","10.2174/1567205012666150530201917"
"8966268","[Clinical and instrumental diagnosis of Alzheimer's and multi-infarct dementia]","Fornarelli D, Ascoli G, Rossi R, Manca A, Lanza R, Moretti V, Scarpino O, Guidi M.","Radiol Med. 1996 Jul-Aug;92(1-2):22-7.","Fornarelli D","Radiol Med","1996","1996/07/01","","",""
"30006299","Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study","Torosyan N, Sethanandha C, Grill JD, Dilley ML, Lee J, Cummings JL, Ossinalde C, Silverman DH.","Exp Gerontol. 2018 Oct 1;111:118-121. doi: 10.1016/j.exger.2018.07.009. Epub 2018 Jul 10.","Torosyan N","Exp Gerontol","2018","2018/07/15","","","10.1016/j.exger.2018.07.009"
"24200934","Ingestion of Chlorella reduced the oxidation of erythrocyte membrane lipids in senior Japanese subjects","Miyazawa T, Nakagawa K, Takekoshi H, Higuchi O, Kato S, Kondo M, Kimura F, Miyazawa T.","J Oleo Sci. 2013;62(11):873-81. doi: 10.5650/jos.62.873.","Miyazawa T","J Oleo Sci","2013","2013/11/09","","","10.5650/jos.62.873"
"26645514","Herbal medicine Davaie Loban in mild to moderate Alzheimer's disease: A 12-week randomized double-blind placebo-controlled clinical trial","Tajadini H, Saifadini R, Choopani R, Mehrabani M, Kamalinejad M, Haghdoost AA.","Complement Ther Med. 2015 Dec;23(6):767-72. doi: 10.1016/j.ctim.2015.06.009. Epub 2015 Aug 29.","Tajadini H","Complement Ther Med","2015","2015/12/10","","","10.1016/j.ctim.2015.06.009"
"18401810","Exercise training is beneficial for Alzheimer's patients","Santana-Sosa E, Barriopedro MI, López-Mojares LM, Pérez M, Lucia A.","Int J Sports Med. 2008 Oct;29(10):845-50. doi: 10.1055/s-2008-1038432. Epub 2008 Apr 9.","Santana-Sosa E","Int J Sports Med","2008","2008/04/11","","","10.1055/s-2008-1038432"
"3541052","Naltrexone and Alzheimer's disease","Serby M, Resnick R, Jordan B, Adler J, Corwin J, Rotrosen JP.","Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):587-90. doi: 10.1016/0278-5846(86)90028-x.","Serby M","Prog Neuropsychopharmacol Biol Psychiatry","1986","1986/01/01","","","10.1016/0278-5846(86)90028-x"
"22780999","Heat-processed ginseng enhances the cognitive function in patients with moderately severe Alzheimer's disease","Heo JH, Lee ST, Chu K, Oh MJ, Park HJ, Shim JY, Kim M.","Nutr Neurosci. 2012 Nov;15(6):278-82. doi: 10.1179/1476830512Y.0000000027.","Heo JH","Nutr Neurosci","2012","2012/07/12","","","10.1179/1476830512Y.0000000027"
"29182706","Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential","Abushakra S, Porsteinsson A, Scheltens P, Sadowsky C, Vellas B, Cummings J, Gauthier S, Hey JA, Power A, Wang P, Shen L, Tolar M.","J Prev Alzheimers Dis. 2017;4(3):149-156. doi: 10.14283/jpad.2017.26.","Abushakra S","J Prev Alzheimers Dis","2017","2017/11/29","","","10.14283/jpad.2017.26"
"35184428","(18)F-THK5351 PET Positivity and Longitudinal Changes in Cognitive Function in β-Amyloid-Negative Amnestic Mild Cognitive Impairment","Chun MY, Lee J, Jeong JH, Roh JH, Oh SJ, Oh M, Oh JS, Kim JS, Moon SH, Woo SY, Kim YJ, Choe YS, Kim HJ, Na DL, Jang H, Seo SW.","Yonsei Med J. 2022 Mar;63(3):259-264. doi: 10.3349/ymj.2022.63.3.259.","Chun MY","Yonsei Med J","2022","2022/02/20","PMC8860937","","10.3349/ymj.2022.63.3.259"
"17600848","A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease","Connelly PJ, Prentice NP, Cousland G, Bonham J.","Int J Geriatr Psychiatry. 2008 Feb;23(2):155-60. doi: 10.1002/gps.1856.","Connelly PJ","Int J Geriatr Psychiatry","2008","2007/06/30","","","10.1002/gps.1856"
"11852171","Double placebo design in a prevention trial for Alzheimer's disease","Martin BK, Meinert CL, Breitner JC; ADAPT Research Group.","Control Clin Trials. 2002 Feb;23(1):93-9. doi: 10.1016/s0197-2456(01)00189-1.","Martin BK","Control Clin Trials","2002","2002/02/20","","","10.1016/s0197-2456(01)00189-1"
"31099300","Definition and quantification of six immune- and neuroregulatory serum proteins in healthy and demented elderly","Schipke CG, Günter O, Weinert C, Scotton P, Sigle JP, Kallarackal J, Kabelitz D, Finzen A, Feuerhelm-Heidl A.","Neurodegener Dis Manag. 2019 Aug;9(4):193-203. doi: 10.2217/nmt-2019-0003. Epub 2019 May 17.","Schipke CG","Neurodegener Dis Manag","2019","2019/05/18","","","10.2217/nmt-2019-0003"
"18391486","Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial","Homma A, Imai Y, Tago H, Asada T, Shigeta M, Iwamoto T, Takita M, Arimoto I, Koma H, Ohbayashi T.","Dement Geriatr Cogn Disord. 2008;25(5):399-407. doi: 10.1159/000122961. Epub 2008 Apr 3.","Homma A","Dement Geriatr Cogn Disord","2008","2008/04/09","","","10.1159/000122961"
"9660105","Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease","Jiménez-Jiménez FJ, Molina JA, Gómez P, Vargas C, de Bustos F, Benito-León J, Tallón-Barranco A, Ortí-Pareja M, Gasalla T, Arenas J.","J Neural Transm (Vienna). 1998;105(2-3):269-77. doi: 10.1007/s007020050056.","Jiménez-Jiménez FJ","J Neural Transm (Vienna)","1998","1998/07/11","","","10.1007/s007020050056"
"9524880","Deterioration of generic knowledge in patients with Alzheimer's disease: evidence from the Number Information Test","Norton LE, Bondi MW, Salmon DP, Goodglass H.","J Clin Exp Neuropsychol. 1997 Dec;19(6):857-66. doi: 10.1080/01688639708403766.","Norton LE","J Clin Exp Neuropsychol","1997","1998/04/03","","","10.1080/01688639708403766"
"28086917","Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease","Moussa C, Hebron M, Huang X, Ahn J, Rissman RA, Aisen PS, Turner RS.","J Neuroinflammation. 2017 Jan 3;14(1):1. doi: 10.1186/s12974-016-0779-0.","Moussa C","J Neuroinflammation","2017","2017/01/15","PMC5234138","","10.1186/s12974-016-0779-0"
"10607978","Drug treatment of Alzheimer's disease and responders to rivastigmine beyond 12 weeks","McMillan H.","Int J Geriatr Psychiatry. 1999 Dec;14(12):1078-9. doi: 10.1002/(sici)1099-1166(199912)14:12<1078::aid-gps73>3.0.co;2-s.","McMillan H","Int J Geriatr Psychiatry","1999","1999/12/23","","","10.1002/(sici)1099-1166(199912)14:12<1078::aid-gps73>3.0.co;2-s"
"2991689","The effect of ACTH4-9 analog (Org2766) on some cerebrospinal fluid parameters in patients with Alzheimer's disease","Jolkkonen JT, Soininen HS, Riekkinen PJ.","Life Sci. 1985 Aug 19;37(7):585-90. doi: 10.1016/0024-3205(85)90424-2.","Jolkkonen JT","Life Sci","1985","1985/08/19","","","10.1016/0024-3205(85)90424-2"
"2061529","The effect of planned walking on communication in Alzheimer's disease","Friedman R, Tappen RM.","J Am Geriatr Soc. 1991 Jul;39(7):650-4. doi: 10.1111/j.1532-5415.1991.tb03617.x.","Friedman R","J Am Geriatr Soc","1991","1991/07/01","","","10.1111/j.1532-5415.1991.tb03617.x"
"16096820","Acetylcholine esterase inhibitor donepezil improves dynamic cerebrovascular regulation in Alzheimer patients","Rosengarten B, Paulsen S, Molnar S, Kaschel R, Gallhofer B, Kaps M.","J Neurol. 2006 Jan;253(1):58-64. doi: 10.1007/s00415-005-0926-5. Epub 2005 Aug 17.","Rosengarten B","J Neurol","2006","2005/08/13","","","10.1007/s00415-005-0926-5"
"24566512","Cognitive subdomain responses to galantamine in Alzheimer's disease","Song J, Ahn IS, Kang HS, Myung W, Lee Y, Woo SY, Ku HM, Hwang TY, Carroll BJ, Kim DK.","J Nerv Ment Dis. 2014 Mar;202(3):253-9. doi: 10.1097/NMD.0000000000000107.","Song J","J Nerv Ment Dis","2014","2014/02/26","","","10.1097/NMD.0000000000000107"
"18458605","Prediction of response to donepezil in Alzheimer's disease: combined MRI analysis of the substantia innominata and SPECT measurement of cerebral perfusion","Kanetaka H, Hanyu H, Hirao K, Shimizu S, Sato T, Akai T, Iwamoto T, Koizumi K.","Nucl Med Commun. 2008 Jun;29(6):568-73. doi: 10.1097/MNM.0b013e3282f5e5f4.","Kanetaka H","Nucl Med Commun","2008","2008/05/07","","","10.1097/MNM.0b013e3282f5e5f4"
"17148938","A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease","Herrmann N, Lanctôt KL, Rothenburg LS, Eryavec G.","Dement Geriatr Cogn Disord. 2007;23(2):116-9. doi: 10.1159/000097757. Epub 2006 Dec 4.","Herrmann N","Dement Geriatr Cogn Disord","2007","2006/12/07","","","10.1159/000097757"
"12927761","Re-evaluation of tropicamide in the pupillary response test for Alzheimer's disease","Iijima A, Haida M, Ishikawa N, Ueno A, Minamitani H, Shinohara Y.","Neurobiol Aging. 2003 Oct;24(6):789-96. doi: 10.1016/s0197-4580(02)00235-x.","Iijima A","Neurobiol Aging","2003","2003/08/21","","","10.1016/s0197-4580(02)00235-x"
"25499536","A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease","Green RC, Christensen KD, Cupples LA, Relkin NR, Whitehouse PJ, Royal CD, Obisesan TO, Cook-Deegan R, Linnenbringer E, Butson MB, Fasaye GA, Levinson E, Roberts JS; REVEAL Study Group.","Alzheimers Dement. 2015 Oct;11(10):1222-30. doi: 10.1016/j.jalz.2014.10.014. Epub 2014 Dec 9.","Green RC","Alzheimers Dement","2015","2014/12/16","PMC4461546","NIHMS642414","10.1016/j.jalz.2014.10.014"
"10364646","Magnetic resonance imaging-based hippocampal volumetry in patients with dementia of the Alzheimer type","Golebiowski M, Barcikowska M, Pfeffer A.","Dement Geriatr Cogn Disord. 1999 Jul-Aug;10(4):284-8. doi: 10.1159/000017133.","Golebiowski M","Dement Geriatr Cogn Disord","1999","1999/06/12","","","10.1159/000017133"
"10203120","Evaluation of Simulated Presence: a personalized approach to enhance well-being in persons with Alzheimer's disease","Camberg L, Woods P, Ooi WL, Hurley A, Volicer L, Ashley J, Odenheimer G, McIntyre K.","J Am Geriatr Soc. 1999 Apr;47(4):446-52. doi: 10.1111/j.1532-5415.1999.tb07237.x.","Camberg L","J Am Geriatr Soc","1999","1999/04/15","","","10.1111/j.1532-5415.1999.tb07237.x"
"9773102","[Balance sheet of tolerance-efficacy on the use of tacrine in 100 cases of Alzheimer's disease]","Estadieu MC, Machou C, Berthezène P, Pastor MJ, Angelini B, Bohor M, Bongrand MC, Timon-David P, Gastaut JL, Allain H, Michel BF.","Therapie. 1998 Jan-Feb;53(1):67-76.","Estadieu MC","Therapie","1998","1998/10/17","","",""
"16239176","Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease","Rovio S, Kåreholt I, Helkala EL, Viitanen M, Winblad B, Tuomilehto J, Soininen H, Nissinen A, Kivipelto M.","Lancet Neurol. 2005 Nov;4(11):705-11. doi: 10.1016/S1474-4422(05)70198-8.","Rovio S","Lancet Neurol","2005","2005/10/22","","","10.1016/S1474-4422(05)70198-8"
"18229874","Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease","Waldemar G, Hyvärinen M, Josiassen MK, Kørner A, Lehto H, Wetterberg P.","Int J Geriatr Psychiatry. 2008 Sep;23(9):979-81. doi: 10.1002/gps.1979.","Waldemar G","Int J Geriatr Psychiatry","2008","2008/01/31","","","10.1002/gps.1979"
"14967774","The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial","Raskind MA, Peskind ER, Truyen L, Kershaw P, Damaraju CV.","Arch Neurol. 2004 Feb;61(2):252-6. doi: 10.1001/archneur.61.2.252.","Raskind MA","Arch Neurol","2004","2004/02/18","","","10.1001/archneur.61.2.252"
"8983027","Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease","De Leon MJ, George AE, Golomb J, Tarshish C, Convit A, Kluger A, De Santi S, McRae T, Ferris SH, Reisberg B, Ince C, Rusinek H, Bobinski M, Quinn B, Miller DC, Wisniewski HM.","Neurobiol Aging. 1997 Jan-Feb;18(1):1-11. doi: 10.1016/s0197-4580(96)00213-8.","De Leon MJ","Neurobiol Aging","1997","1997/01/01","","","10.1016/s0197-4580(96)00213-8"
"28124585","Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's Disease: Results from a Double-Blind, Placebo-Controlled Trial","Decourt B, Drumm-Gurnee D, Wilson J, Jacobson S, Belden C, Sirrel S, Ahmadi M, Shill H, Powell J, Walker A, Gonzales A, Macias M, Sabbagh MN.","Curr Alzheimer Res. 2017;14(4):403-411. doi: 10.2174/1567205014666170117141330.","Decourt B","Curr Alzheimer Res","2017","2017/01/27","PMC5706445","NIHMS920707","10.2174/1567205014666170117141330"
"20184936","Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice","Hayashi Y, Ishida Y, Inoue T, Udagawa M, Takeuchi K, Yoshimuta H, Kiue K, Ninomiya Y, Kawano J, Sameshima T, Kawahara T, Goto I, Shudo K, Kurayama S, Nakamura J, Okahara K, Mitsuyama Y.","Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 16;34(3):541-5. doi: 10.1016/j.pnpbp.2010.02.016. Epub 2010 Feb 23.","Hayashi Y","Prog Neuropsychopharmacol Biol Psychiatry","2010","2010/02/27","","","10.1016/j.pnpbp.2010.02.016"
"23051684","Response to rivastigmine transdermal patch or memantine plus rivastigmine patch is affected by apolipoprotein E genotype in Alzheimer patients","Han HJ, Kim BC, Lee JY, Ryu SH, Na HR, Yoon SJ, Park HY, Shin JH, Cho SJ, Yi HA, Choi MS, Heo JH, Park KW, Kim KK, Choi SH.","Dement Geriatr Cogn Disord. 2012;34(3-4):167-73. doi: 10.1159/000342927. Epub 2012 Oct 5.","Han HJ","Dement Geriatr Cogn Disord","2012","2012/10/12","","","10.1159/000342927"
"17006874","Specific symptomatic changes following donepezil treatment of Alzheimer's disease: a multi-centre, primary care, open-label study","Rockwood K, Black S, Bedard MA, Tran T, Lussier I; TOPS Study Investigators.","Int J Geriatr Psychiatry. 2007 Apr;22(4):312-9. doi: 10.1002/gps.1675.","Rockwood K","Int J Geriatr Psychiatry","2007","2006/09/29","","","10.1002/gps.1675"
"21970467","Co-morbidity and drug treatment in Alzheimer's disease. A cross sectional study of participants in the dementia study in northern Norway","Andersen F, Viitanen M, Halvorsen DS, Straume B, Engstad TA.","BMC Geriatr. 2011 Oct 4;11:58. doi: 10.1186/1471-2318-11-58.","Andersen F","BMC Geriatr","2011","2011/10/06","PMC3204237","","10.1186/1471-2318-11-58"
"21849735","A pilot usability study of MINWii, a music therapy game for demented patients","Boulay M, Benveniste S, Boespflug S, Jouvelot P, Rigaud AS.","Technol Health Care. 2011;19(4):233-46. doi: 10.3233/THC-2011-0628.","Boulay M","Technol Health Care","2011","2011/08/19","","","10.3233/THC-2011-0628"
"16380679","Plasma beta carotene in Alzheimer's disease. Association with cerebrospinal fluid beta-amyloid 1-40, (Abeta40), beta-amyloid 1-42 (Abeta42) and total Tau","Stuerenburg HJ, Ganzer S, Müller-Thomsen T.","Neuro Endocrinol Lett. 2005 Dec;26(6):696-8.","Stuerenburg HJ","Neuro Endocrinol Lett","2005","2005/12/29","","",""
"16446752","Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease","Risner ME, Saunders AM, Altman JF, Ormandy GC, Craft S, Foley IM, Zvartau-Hind ME, Hosford DA, Roses AD; Rosiglitazone in Alzheimer's Disease Study Group.","Pharmacogenomics J. 2006 Jul-Aug;6(4):246-54. doi: 10.1038/sj.tpj.6500369. Epub 2006 Jan 31.","Risner ME","Pharmacogenomics J","2006","2006/02/01","","","10.1038/sj.tpj.6500369"
"9136253","A double-blind, randomized, fixed-dose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer's disease","Taragano FE, Lyketsos CG, Mangone CA, Allegri RF, Comesaña-Diaz E.","Psychosomatics. 1997 May-Jun;38(3):246-52. doi: 10.1016/S0033-3182(97)71461-0.","Taragano FE","Psychosomatics","1997","1997/05/01","","","10.1016/S0033-3182(97)71461-0"
"8561836","Evaluation of cycloserine in the treatment of Alzheimer's disease","Fakouhi TD, Jhee SS, Sramek JJ, Benes C, Schwartz P, Hantsburger G, Herting R, Swabb EA, Cutler NR.","J Geriatr Psychiatry Neurol. 1995 Oct;8(4):226-30. doi: 10.1177/089198879500800405.","Fakouhi TD","J Geriatr Psychiatry Neurol","1995","1995/10/01","","","10.1177/089198879500800405"
"20360050","Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology","Serrano-Pozo A, William CM, Ferrer I, Uro-Coste E, Delisle MB, Maurage CA, Hock C, Nitsch RM, Masliah E, Growdon JH, Frosch MP, Hyman BT.","Brain. 2010 May;133(Pt 5):1312-27. doi: 10.1093/brain/awq056. Epub 2010 Mar 31.","Serrano-Pozo A","Brain","2010","2010/04/03","PMC2859150","","10.1093/brain/awq056"
"17545737","The sex specificity of navigational strategies in Alzheimer disease","Cushman LA, Duffy CJ.","Alzheimer Dis Assoc Disord. 2007 Apr-Jun;21(2):122-9. doi: 10.1097/WAD.0b013e318047df2f.","Cushman LA","Alzheimer Dis Assoc Disord","2007","2007/06/05","","","10.1097/WAD.0b013e318047df2f"
"15955540","Corpus callosum size correlates with asymmetric performance on a dichotic listening task in healthy aging but not in Alzheimer's disease","Gootjes L, Bouma A, Van Strien JW, Van Schijndel R, Barkhof F, Scheltens P.","Neuropsychologia. 2006;44(2):208-17. doi: 10.1016/j.neuropsychologia.2005.05.002. Epub 2005 Jun 13.","Gootjes L","Neuropsychologia","2006","2005/06/16","","","10.1016/j.neuropsychologia.2005.05.002"
"29027727","Downregulated apoptosis and autophagy after anti-Aβ immunotherapy in Alzheimer's disease","Paquet C, Nicoll JA, Love S, Mouton-Liger F, Holmes C, Hugon J, Boche D.","Brain Pathol. 2018 Sep;28(5):603-610. doi: 10.1111/bpa.12567. Epub 2018 Feb 6.","Paquet C","Brain Pathol","2018","2017/10/14","PMC8028546","","10.1111/bpa.12567"
"27893087","Targeting Functional Decline in Alzheimer Disease: A Randomized Trial","Callahan CM, Boustani MA, Schmid AA, LaMantia MA, Austrom MG, Miller DK, Gao S, Ferguson DY, Lane KA, Hendrie HC.","Ann Intern Med. 2017 Feb 7;166(3):164-171. doi: 10.7326/M16-0830. Epub 2016 Nov 22.","Callahan CM","Ann Intern Med","2017","2016/11/29","PMC5554402","NIHMS889112","10.7326/M16-0830"
"3893273","Piracetam plus lecithin trials in senile dementia of the Alzheimer type","Samorajski T, Vroulis GA, Smith RC.","Ann N Y Acad Sci. 1985;444:478-81. doi: 10.1111/j.1749-6632.1985.tb37616.x.","Samorajski T","Ann N Y Acad Sci","1985","1985/01/01","","","10.1111/j.1749-6632.1985.tb37616.x"
"23126532","Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort","Wattmo C, Wallin AK, Minthon L.","BMC Neurol. 2012 Nov 5;12:134. doi: 10.1186/1471-2377-12-134.","Wattmo C","BMC Neurol","2012","2012/11/07","PMC3534216","","10.1186/1471-2377-12-134"
"22398958","Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease","Villemagne VL, Mulligan RS, Pejoska S, Ong K, Jones G, O'Keefe G, Chan JG, Young K, Tochon-Danguy H, Masters CL, Rowe CC.","Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):983-9. doi: 10.1007/s00259-012-2088-x. Epub 2012 Mar 8.","Villemagne VL","Eur J Nucl Med Mol Imaging","2012","2012/03/09","","","10.1007/s00259-012-2088-x"
"19705519","The effects of counseling spouse caregivers of people with Alzheimer disease taking donepezil and of country of residence on rates of admission to nursing homes and mortality","Brodaty H, Mittelman M, Gibson L, Seeher K, Burns A.","Am J Geriatr Psychiatry. 2009 Sep;17(9):734-43. doi: 10.1097/jgp.0b013e3181a65187.","Brodaty H","Am J Geriatr Psychiatry","2009","2009/08/26","PMC2738999","NIHMS114905","10.1097/jgp.0b013e3181a65187"
"17627490","National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness- Alzheimer's Disease (CATIE-AD): baseline characteristics","Ismail MS, Dagerman K, Tariot PN, Abbott S, Kavanagh S, Schneider LS.","Curr Alzheimer Res. 2007 Jul;4(3):325-35. doi: 10.2174/156720507781077214.","Ismail MS","Curr Alzheimer Res","2007","2007/07/14","","","10.2174/156720507781077214"
"21875410","Influence of lithium treatment on GDNF serum and CSF concentrations in patients with early Alzheimer's disease","Straten G, Saur R, Laske C, Gasser T, Annas P, Basun H, Leyhe T.","Curr Alzheimer Res. 2011 Dec;8(8):853-9. doi: 10.2174/156720511798192754.","Straten G","Curr Alzheimer Res","2011","2011/08/31","","","10.2174/156720511798192754"
"25297016","Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial","Wilkinson D, Windfeld K, Colding-Jørgensen E.","Lancet Neurol. 2014 Nov;13(11):1092-1099. doi: 10.1016/S1474-4422(14)70198-X. Epub 2014 Oct 5.","Wilkinson D","Lancet Neurol","2014","2014/10/10","","","10.1016/S1474-4422(14)70198-X"
"23670818","Prolonged running, not fluoxetine treatment, increases neurogenesis, but does not alter neuropathology, in the 3xTg mouse model of Alzheimer's disease","Marlatt MW, Potter MC, Bayer TA, van Praag H, Lucassen PJ.","Curr Top Behav Neurosci. 2013;15:313-40. doi: 10.1007/7854_2012_237.","Marlatt MW","Curr Top Behav Neurosci","2013","2013/05/15","PMC4554490","NIHMS718815","10.1007/7854_2012_237"
"9764962","Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's disease","Fontana RJ, deVries TM, Woolf TF, Knapp MJ, Brown AS, Kaminsky LS, Tang BK, Foster NL, Brown RR, Watkins PB.","Br J Clin Pharmacol. 1998 Sep;46(3):221-8. doi: 10.1046/j.1365-2125.1998.00776.x.","Fontana RJ","Br J Clin Pharmacol","1998","1998/10/09","PMC1873677","","10.1046/j.1365-2125.1998.00776.x"
"24135720","Preserving cognition, quality of life, physical health and functional ability in Alzheimer's disease: the effect of physical exercise (ADEX trial): rationale and design","Hoffmann K, Frederiksen KS, Sobol NA, Beyer N, Vogel A, Simonsen AH, Johannsen P, Lolk A, Terkelsen O, Cotman CW, Hasselbalch SG, Waldemar G.","Neuroepidemiology. 2013;41(3-4):198-207. doi: 10.1159/000354632. Epub 2013 Oct 15.","Hoffmann K","Neuroepidemiology","2013","2013/10/19","","","10.1159/000354632"
"10559558","Decreased plasma insulin-like growth factor-I level in familial Alzheimer's disease patients carrying the Swedish APP 670/671 mutation","Mustafa A, Lannfelt L, Lilius L, Islam A, Winblad B, Adem A.","Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):446-51. doi: 10.1159/000017188.","Mustafa A","Dement Geriatr Cogn Disord","1999","1999/11/24","","","10.1159/000017188"
"15207420","Physical activity and behavior in the elderly: a pilot study","Landi F, Russo A, Bernabei R.","Arch Gerontol Geriatr Suppl. 2004;(9):235-41. doi: 10.1016/j.archger.2004.04.033.","Landi F","Arch Gerontol Geriatr Suppl","2004","2004/06/23","","","10.1016/j.archger.2004.04.033"
"16965193","Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year","Merrill CA, Jonsson MA, Minthon L, Ejnell H, C-son Silander H, Blennow K, Karlsson M, Nordlund A, Rolstad S, Warkentin S, Ben-Menachem E, Sjögren MJ.","J Clin Psychiatry. 2006 Aug;67(8):1171-8. doi: 10.4088/jcp.v67n0801.","Merrill CA","J Clin Psychiatry","2006","2006/09/13","","","10.4088/jcp.v67n0801"
"36281667","Safety, Tolerability and Pharmacokinetics of Icapamespib, a Selective Epichaperome Inhibitor, in Healthy Adults","Silverman MH, Duggan S, Bardelli G, Sadler B, Key C, Medlock M, Reynolds L, Wallner B.","J Prev Alzheimers Dis. 2022;9(4):635-645. doi: 10.14283/jpad.2022.71.","Silverman MH","J Prev Alzheimers Dis","2022","2022/10/25","PMC9419134","","10.14283/jpad.2022.71"
"15491235","Behavioral and psychological symptoms in patients with dementia as a target for pharmacotherapy with risperidone","Rabinowitz J, Katz IR, De Deyn PP, Brodaty H, Greenspan A, Davidson M.","J Clin Psychiatry. 2004 Oct;65(10):1329-34. doi: 10.4088/jcp.v65n1006.","Rabinowitz J","J Clin Psychiatry","2004","2004/10/20","","","10.4088/jcp.v65n1006"
"11466161","Treatment with controlled-release lovastatin decreases serum concentrations of human beta-amyloid (A beta) peptide","Friedhoff LT, Cullen EI, Geoghagen NS, Buxbaum JD.","Int J Neuropsychopharmacol. 2001 Jun;4(2):127-30. doi: 10.1017/S1461145701002310.","Friedhoff LT","Int J Neuropsychopharmacol","2001","2001/07/24","","","10.1017/S1461145701002310"
"19700947","Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression","Wang LY, Shofer JB, Rohde K, Hart KL, Hoff DJ, McFall YH, Raskind MA, Peskind ER.","Am J Geriatr Psychiatry. 2009 Sep;17(9):744-51. doi: 10.1097/JGP.0b013e3181ab8c61.","Wang LY","Am J Geriatr Psychiatry","2009","2009/08/25","PMC2842091","NIHMS181108","10.1097/JGP.0b013e3181ab8c61"
"10171932","Networks for home care support: the ComputerLink project","Brennan PF, Moore SM.","Caring. 1994 Aug;13(8):64-6, 68-70.","Brennan PF","Caring","1994","1994/07/07","","",""
"26161932","Associations between physical function, dual-task performance and cognition in patients with mild Alzheimer's disease","Sobol NA, Hoffmann K, Vogel A, Lolk A, Gottrup H, Høgh P, Hasselbalch SG, Beyer N.","Aging Ment Health. 2016 Nov;20(11):1139-1146. doi: 10.1080/13607863.2015.1063108. Epub 2015 Jul 10.","Sobol NA","Aging Ment Health","2016","2015/07/11","","","10.1080/13607863.2015.1063108"
"20189881","11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study","Rinne JO, Brooks DJ, Rossor MN, Fox NC, Bullock R, Klunk WE, Mathis CA, Blennow K, Barakos J, Okello AA, Rodriguez Martinez de Liano S, Liu E, Koller M, Gregg KM, Schenk D, Black R, Grundman M.","Lancet Neurol. 2010 Apr;9(4):363-72. doi: 10.1016/S1474-4422(10)70043-0. Epub 2010 Feb 26.","Rinne JO","Lancet Neurol","2010","2010/03/02","","","10.1016/S1474-4422(10)70043-0"
"8522637","The safety and tolerance of xanomeline tartrate in patients with Alzheimer's disease","Sramek JJ, Hurley DJ, Wardle TS, Satterwhite JH, Hourani J, Dies F, Cutler NR.","J Clin Pharmacol. 1995 Aug;35(8):800-6. doi: 10.1002/j.1552-4604.1995.tb04123.x.","Sramek JJ","J Clin Pharmacol","1995","1995/08/01","","","10.1002/j.1552-4604.1995.tb04123.x"
"26501506","Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results","Gooblar J, Roe CM, Selsor NJ, Gabel MJ, Morris JC.","JAMA Neurol. 2015 Dec;72(12):1484-90. doi: 10.1001/jamaneurol.2015.2875.","Gooblar J","JAMA Neurol","2015","2015/10/27","PMC4694568","NIHMS742428","10.1001/jamaneurol.2015.2875"
"32496814","Assessing an evidence-based intervention for spouse caregivers of persons with Alzheimer's disease: results of a community implementation of the NYUCI in Israel","Werner P, Clay OJ, Goldstein D, Kermel-Schifmann I, Herz MK, Epstein C, Mittelman MS.","Aging Ment Health. 2021 Sep;25(9):1676-1683. doi: 10.1080/13607863.2020.1774740. Epub 2020 Jun 4.","Werner P","Aging Ment Health","2021","2020/06/05","","","10.1080/13607863.2020.1774740"
"11965273","Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial","Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV.","Lancet. 2002 Apr 13;359(9314):1283-90. doi: 10.1016/S0140-6736(02)08267-3.","Erkinjuntti T","Lancet","2002","2002/04/20","","","10.1016/S0140-6736(02)08267-3"
"3536774","Reactions to music, touch and object presentation in the final stage of dementia. An exploratory study","Norberg A, Melin E, Asplund K.","Int J Nurs Stud. 1986;23(4):315-23. doi: 10.1016/0020-7489(86)90054-4.","Norberg A","Int J Nurs Stud","1986","1986/01/01","","","10.1016/0020-7489(86)90054-4"
"10026392","Diffusion-weighted magnetic resonance imaging in Alzheimer's disease","Sandson TA, Felician O, Edelman RR, Warach S.","Dement Geriatr Cogn Disord. 1999 Mar-Apr;10(2):166-71. doi: 10.1159/000017099.","Sandson TA","Dement Geriatr Cogn Disord","1999","1999/02/23","","","10.1159/000017099"
"15298644","Improvement in behavioral symptoms and advance of activity acrophase after short-term bright light treatment in severe dementia","Skjerve A, Holsten F, Aarsland D, Bjorvatn B, Nygaard HA, Johansen IM.","Psychiatry Clin Neurosci. 2004 Aug;58(4):343-7. doi: 10.1111/j.1440-1819.2004.01265.x.","Skjerve A","Psychiatry Clin Neurosci","2004","2004/08/10","","","10.1111/j.1440-1819.2004.01265.x"
"7837931","A multiple-dose safety trial of eptastigmine in Alzheimer's disease, with pharmacodynamic observations of red blood cell cholinesterase","Sramek JJ, Block GA, Reines SA, Sawin SF, Barchowsky A, Cutler NR.","Life Sci. 1995;56(5):319-26. doi: 10.1016/0024-3205(94)00954-6.","Sramek JJ","Life Sci","1995","1995/01/01","","","10.1016/0024-3205(94)00954-6"
"8347333","A pilot study of oral physostigmine plus yohimbine in patients with Alzheimer disease","Bierer LM, Aisen PS, Davidson M, Ryan TM, Stern RG, Schmeidler J, Davis KL.","Alzheimer Dis Assoc Disord. 1993 Summer;7(2):98-104. doi: 10.1097/00002093-199307020-00005.","Bierer LM","Alzheimer Dis Assoc Disord","1993","1993/01/01","","","10.1097/00002093-199307020-00005"
"11044775","Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group","Homma A, Takeda M, Imai Y, Udaka F, Hasegawa K, Kameyama M, Nishimura T.","Dement Geriatr Cogn Disord. 2000 Nov-Dec;11(6):299-313. doi: 10.1159/000017259.","Homma A","Dement Geriatr Cogn Disord","2000","2000/10/25","","","10.1159/000017259"
"29326021","Similar clinical improvement and maintenance after rTMS at 5 Hz using a simple vs. complex protocol in Alzheimer's disease","Alcalá-Lozano R, Morelos-Santana E, Cortés-Sotres JF, Garza-Villarreal EA, Sosa-Ortiz AL, González-Olvera JJ.","Brain Stimul. 2018 May-Jun;11(3):625-627. doi: 10.1016/j.brs.2017.12.011. Epub 2017 Dec 29.","Alcalá-Lozano R","Brain Stimul","2018","2018/01/13","","","10.1016/j.brs.2017.12.011"
"9923589","Acetylcholinesterase assay may predict cognitive response of Alzheimer patients to eptastigmine treatment","Imbimbo BP, Nicoli M, Martini C, Tomelleri GP, Martelli P, Ferrari GP, Gambina G.","Eur J Clin Pharmacol. 1998 Nov-Dec;54(9-10):809-10. doi: 10.1007/s002280050556.","Imbimbo BP","Eur J Clin Pharmacol","1998","1999/01/29","","","10.1007/s002280050556"
"19931870","The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease: a longitudinal SPECT study","Hanyu H, Sato T, Hirao K, Kanetaka H, Iwamoto T, Koizumi K.","J Neurol Sci. 2010 Mar 15;290(1-2):96-101. doi: 10.1016/j.jns.2009.10.022. Epub 2009 Nov 20.","Hanyu H","J Neurol Sci","2010","2009/11/26","","","10.1016/j.jns.2009.10.022"
"2566381","Guanfacine treatment of Alzheimer's disease","Schlegel J, Mohr E, Williams J, Mann U, Gearing M, Chase TN.","Clin Neuropharmacol. 1989 Apr;12(2):124-8. doi: 10.1097/00002826-198904000-00007.","Schlegel J","Clin Neuropharmacol","1989","1989/04/01","","","10.1097/00002826-198904000-00007"
"3285899","Loss of the cortisol response to naltrexone in Alzheimer's disease","Pomara N, Stanley M, Rhiew HB, Bagne CA, Deptula D, Galloway MP, Tanimoto K, Verebey K, Tamminga CA.","Biol Psychiatry. 1988 Apr 1;23(7):726-33. doi: 10.1016/0006-3223(88)90057-1.","Pomara N","Biol Psychiatry","1988","1988/04/01","","","10.1016/0006-3223(88)90057-1"
"8586980","IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease","Huberman M, Sredni B, Stern L, Kott E, Shalit F.","J Neurol Sci. 1995 Jun;130(2):161-4. doi: 10.1016/0022-510x(95)00016-u.","Huberman M","J Neurol Sci","1995","1995/06/01","","","10.1016/0022-510x(95)00016-u"
"31159816","An augmented reality approach for ADL support in Alzheimer's disease: a crossover trial","Rohrbach N, Gulde P, Armstrong AR, Hartig L, Abdelrazeq A, Schröder S, Neuse J, Grimmer T, Diehl-Schmid J, Hermsdörfer J.","J Neuroeng Rehabil. 2019 Jun 3;16(1):66. doi: 10.1186/s12984-019-0530-z.","Rohrbach N","J Neuroeng Rehabil","2019","2019/06/05","PMC6547460","","10.1186/s12984-019-0530-z"
"36449413","Lecanemab in Early Alzheimer's Disease","van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T.","N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.","van Dyck CH","N Engl J Med","2023","2022/11/30","","","10.1056/NEJMoa2212948"
"20810219","Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD","Silverman DH, Geist CL, Kenna HA, Williams K, Wroolie T, Powers B, Brooks J, Rasgon NL.","Psychoneuroendocrinology. 2011 May;36(4):502-13. doi: 10.1016/j.psyneuen.2010.08.002. Epub 2010 Sep 1.","Silverman DH","Psychoneuroendocrinology","2011","2010/09/03","PMC3021636","NIHMS229073","10.1016/j.psyneuen.2010.08.002"
"17356273","Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine","Riepe MW, Adler G, Ibach B, Weinkauf B, Tracik F, Gunay I.","Dement Geriatr Cogn Disord. 2007;23(5):301-6. doi: 10.1159/000100875. Epub 2007 Mar 13.","Riepe MW","Dement Geriatr Cogn Disord","2007","2007/03/16","","","10.1159/000100875"
"15974900","Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD","Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Petanceska S, Browne P, Wassar D, Johnson-Traver S, Lochhead J, Ziolkowski C.","Curr Alzheimer Res. 2005 Jul;2(3):343-53. doi: 10.2174/1567205054367900.","Sparks DL","Curr Alzheimer Res","2005","2005/06/25","","","10.2174/1567205054367900"
"12803435","On the use of scaling and clustering in the study of semantic deficits","Storms G, Dirikx T, Saerens J, Verstraeten S, De Deyn PP.","Neuropsychology. 2003 Apr;17(2):289-301. doi: 10.1037/0894-4105.17.2.289.","Storms G","Neuropsychology","2003","2003/06/14","","","10.1037/0894-4105.17.2.289"
"34764150","Effects of 40 Hz transcranial alternating current stimulation (tACS) on cognitive functions of patients with Alzheimer's disease: a randomised, double-blind, sham-controlled clinical trial","Zhou D, Li A, Li X, Zhuang W, Liang Y, Zheng CY, Zheng H, Yuan TF.","J Neurol Neurosurg Psychiatry. 2022 May;93(5):568-570. doi: 10.1136/jnnp-2021-326885. Epub 2021 Nov 11.","Zhou D","J Neurol Neurosurg Psychiatry","2022","2021/11/12","","","10.1136/jnnp-2021-326885"
"36282451","Relieving care burden and promoting health-related quality of life for family caregivers of elderly people with Alzheimer's disease via an empowerment program","Yazdanmanesh M, Esmaeili R, Nasiri M, Vasli P.","Aging Clin Exp Res. 2023 Jan;35(1):73-83. doi: 10.1007/s40520-022-02277-8. Epub 2022 Oct 25.","Yazdanmanesh M","Aging Clin Exp Res","2023","2022/10/25","PMC9593982","","10.1007/s40520-022-02277-8"
"20805524","Change in risk of Alzheimer disease over time","Hebert LE, Bienias JL, Aggarwal NT, Wilson RS, Bennett DA, Shah RC, Evans DA.","Neurology. 2010 Aug 31;75(9):786-91. doi: 10.1212/WNL.0b013e3181f0754f.","Hebert LE","Neurology","2010","2010/09/01","PMC2938969","","10.1212/WNL.0b013e3181f0754f"
"12870820","An investigation of semantic errors in unimpaired and Alzheimer's speakers of Italian","Paganelli F, Vigliocco G, Vinson D, Siri S, Cappa S.","Cortex. 2003 Jun;39(3):419-39. doi: 10.1016/s0010-9452(08)70257-0.","Paganelli F","Cortex","2003","2003/07/23","","","10.1016/s0010-9452(08)70257-0"
"27310616","Case Finding of Mild Cognitive Impairment and Dementia and Subsequent Care; Results of a Cluster RCT in Primary Care","van den Dungen P, Moll van Charante EP, van de Ven PM, van Marwijk HW, van der Horst HE, van Hout HP.","PLoS One. 2016 Jun 16;11(6):e0156958. doi: 10.1371/journal.pone.0156958. eCollection 2016.","van den Dungen P","PLoS One","2016","2016/06/17","PMC4910994","","10.1371/journal.pone.0156958"
"12212666","Value of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer's Disease","Frodl T, Hampel H, Juckel G, Bürger K, Padberg F, Engel RR, Möller HJ, Hegerl U.","Psychophysiology. 2002 Mar;39(2):175-81. doi: 10.1017/S0048577202010260.","Frodl T","Psychophysiology","2002","2002/09/06","","","10.1017/S0048577202010260"
"30856112","Preliminary Report on the Feasibility and Efficacy of the Modified Atkins Diet for Treatment of Mild Cognitive Impairment and Early Alzheimer's Disease","Brandt J, Buchholz A, Henry-Barron B, Vizthum D, Avramopoulos D, Cervenka MC.","J Alzheimers Dis. 2019;68(3):969-981. doi: 10.3233/JAD-180995.","Brandt J","J Alzheimers Dis","2019","2019/03/12","","","10.3233/JAD-180995"
"35491787","Brain Photobiomodulation Improves Sleep Quality in Subjective Cognitive Decline: A Randomized, Sham-Controlled Study","Zhao X, Du W, Jiang J, Han Y.","J Alzheimers Dis. 2022;87(4):1581-1589. doi: 10.3233/JAD-215715.","Zhao X","J Alzheimers Dis","2022","2022/05/02","","","10.3233/JAD-215715"
"34563429","Are Care-Recipient Outcomes Attributable to Improved Caregiver Well-Being? A Cluster-Randomized Controlled Trial of Benefit-Finding Intervention","Cheng ST, Chan WC, Lam LCW.","Am J Geriatr Psychiatry. 2022 Aug;30(8):903-913. doi: 10.1016/j.jagp.2021.08.009. Epub 2021 Aug 28.","Cheng ST","Am J Geriatr Psychiatry","2022","2021/09/26","","","10.1016/j.jagp.2021.08.009"
"9539412","Effects of metrifonate on cognitive decline in Alzheimer disease: a double-blind, placebo-controlled, 6-month study","Becker RE, Colliver JA, Markwell SJ, Moriearty PL, Unni LK, Vicari S.","Alzheimer Dis Assoc Disord. 1998 Mar;12(1):54-7. doi: 10.1097/00002093-199803000-00009.","Becker RE","Alzheimer Dis Assoc Disord","1998","1998/04/16","","","10.1097/00002093-199803000-00009"
"17573074","Conceptual fluency at test shifts recognition response bias in Alzheimer's disease: implications for increased false recognition","Gold CA, Marchant NL, Koutstaal W, Schacter DL, Budson AE.","Neuropsychologia. 2007 Sep 20;45(12):2791-801. doi: 10.1016/j.neuropsychologia.2007.04.021. Epub 2007 May 10.","Gold CA","Neuropsychologia","2007","2007/06/19","PMC5941941","NIHMS28795","10.1016/j.neuropsychologia.2007.04.021"
"2526970","[Infantile psychosis, pseudo-Alzheimer syndrome, and trisomy 21. A trial of treatment with folinic acid: preliminary report]","Lejeune J, Rethoré MO, de Blois MC, Peeters M.","Therapie. 1989 Mar-Apr;44(2):115-21.","Lejeune J","Therapie","1989","1989/03/01","","",""
"18198262","Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study","Moraes W, Poyares D, Sukys-Claudino L, Guilleminault C, Tufik S.","Chest. 2008 Mar;133(3):677-83. doi: 10.1378/chest.07-1446. Epub 2008 Jan 15.","Moraes W","Chest","2008","2008/01/17","","","10.1378/chest.07-1446"
"19347685","Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial","Yancheva S, Ihl R, Nikolova G, Panayotov P, Schlaefke S, Hoerr R; GINDON Study Group.","Aging Ment Health. 2009 Mar;13(2):183-90. doi: 10.1080/13607860902749057.","Yancheva S","Aging Ment Health","2009","2009/04/07","","","10.1080/13607860902749057"
"19049544","Transcranial magnetic stimulation improves naming in Alzheimer disease patients at different stages of cognitive decline","Cotelli M, Manenti R, Cappa SF, Zanetti O, Miniussi C.","Eur J Neurol. 2008 Dec;15(12):1286-92. doi: 10.1111/j.1468-1331.2008.02202.x.","Cotelli M","Eur J Neurol","2008","2008/12/04","","","10.1111/j.1468-1331.2008.02202.x"
"17704975","Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial","Scripnikov A, Khomenko A, Napryeyenko O; GINDEM-NP Study Group.","Wien Med Wochenschr. 2007;157(13-14):295-300. doi: 10.1007/s10354-007-0427-5.","Scripnikov A","Wien Med Wochenschr","2007","2007/08/21","","","10.1007/s10354-007-0427-5"
"20532897","Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease","Boche D, Donald J, Love S, Harris S, Neal JW, Holmes C, Nicoll JA.","Acta Neuropathol. 2010 Jul;120(1):13-20. doi: 10.1007/s00401-010-0705-y. Epub 2010 Jun 9.","Boche D","Acta Neuropathol","2010","2010/06/10","","","10.1007/s00401-010-0705-y"
"23032478","Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease","Munro CA, Longmire CF, Drye LT, Martin BK, Frangakis CE, Meinert CL, Mintzer JE, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG; Depression in Alzheimer’s Disease Study–2 Research Group.","Am J Geriatr Psychiatry. 2012 Dec;20(12):1036-44. doi: 10.1097/JGP.0b013e31826ce4c5.","Munro CA","Am J Geriatr Psychiatry","2012","2012/10/04","PMC3508666","NIHMS421954","10.1097/JGP.0b013e31826ce4c5"
"11949706","Object recognition and object orientation in Alzheimer's disease","Caterini F, Della Sala S, Spinnler H, Stangalino C, Tumbull OH.","Neuropsychology. 2002 Apr;16(2):146-55.","Caterini F","Neuropsychology","2002","2002/04/13","","",""
"18690838","GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. i. rationale, design and baseline data","Andrieu S, Ousset PJ, Coley N, Ouzid M, Mathiex-Fortunet H, Vellas B; GuidAge study GROUP.","Curr Alzheimer Res. 2008 Aug;5(4):406-15. doi: 10.2174/156720508785132271.","Andrieu S","Curr Alzheimer Res","2008","2008/08/12","","","10.2174/156720508785132271"
"27739182","Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)","Knapp M, King D, Romeo R, Adams J, Baldwin A, Ballard C, Banerjee S, Barber R, Bentham P, Brown RG, Burns A, Dening T, Findlay D, Holmes C, Johnson T, Jones R, Katona C, Lindesay J, Macharouthu A, McKeith I, McShane R, O'Brien JT, Phillips PPJ, Sheehan B, Howard R.","Int J Geriatr Psychiatry. 2017 Dec;32(12):1205-1216. doi: 10.1002/gps.4583. Epub 2016 Oct 13.","Knapp M","Int J Geriatr Psychiatry","2017","2016/10/15","PMC5724694","","10.1002/gps.4583"
"12548360","Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors","Parnetti L, Amici S, Lanari A, Romani C, Antognelli C, Andreasen N, Minthon L, Davidsson P, Pottel H, Blennow K, Gallai V.","Neurol Sci. 2002 Sep;23 Suppl 2:S95-6. doi: 10.1007/s100720200086.","Parnetti L","Neurol Sci","2002","2003/01/28","","","10.1007/s100720200086"
"6132292","Early results from double-blind, placebo controlled trial of high dose phosphatidylcholine in Alzheimer's disease","Levy R, Little A, Chuaqui P, Reith M.","Lancet. 1983 Apr 30;1(8331):987-8. doi: 10.1016/s0140-6736(83)92108-6.","Levy R","Lancet","1983","1983/04/30","","","10.1016/s0140-6736(83)92108-6"
"9179132","Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease","Graff-Radford NR, Lin SC, Brazis PW, Bolling JP, Liesegang TJ, Lucas JA, Uitti RJ, O'Brien PC.","Mayo Clin Proc. 1997 Jun;72(6):495-504. doi: 10.4065/72.6.495.","Graff-Radford NR","Mayo Clin Proc","1997","1997/06/01","","","10.4065/72.6.495"
"12770699","Serum cholesterol levels modulate long-term efficacy of cholinesterase inhibitors in Alzheimer disease","Borroni B, Pettenati C, Bordonali T, Akkawi N, Di Luca M, Padovani A.","Neurosci Lett. 2003 Jun 12;343(3):213-5. doi: 10.1016/s0304-3940(03)00336-7.","Borroni B","Neurosci Lett","2003","2003/05/29","","","10.1016/s0304-3940(03)00336-7"
"11226635","Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease","Davidsson P, Blennow K, Andreasen N, Eriksson B, Minthon L, Hesse C.","Neurosci Lett. 2001 Mar 16;300(3):157-60. doi: 10.1016/s0304-3940(01)01586-5.","Davidsson P","Neurosci Lett","2001","2001/02/28","","","10.1016/s0304-3940(01)01586-5"
"12359103","Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial","Kertesz A.","Curr Neurol Neurosci Rep. 2002 Nov;2(6):503-4. doi: 10.1007/s11910-002-0036-z.","Kertesz A","Curr Neurol Neurosci Rep","2002","2002/10/03","","","10.1007/s11910-002-0036-z"
"19565731","[Clinical observation on acupuncture combined with Yizhi Jiannao granules for treatment of Alzheimer's disease]","Peng XW, Dong KL.","Zhongguo Zhen Jiu. 2009 Apr;29(4):269-71.","Peng XW","Zhongguo Zhen Jiu","2009","2009/07/02","","",""
"24296542","Prospective flutemetamol positron emission tomography and histopathology in normal pressure hydrocephalus","Rinne JO, Frantzen J, Leinonen V, Lonnrot K, Laakso A, Virtanen KA, Solin O, Kotkansalo A, Koivisto A, Sajanti J, Karppinen A, Lehto H, Rummukainen J, Buckley C, Smith A, Jones PA, Sherwin P, Farrar G, McLain R, Kailajarvi M, Grachev ID.","Neurodegener Dis. 2014;13(4):237-45. doi: 10.1159/000355256. Epub 2013 Nov 27.","Rinne JO","Neurodegener Dis","2014","2013/12/04","","","10.1159/000355256"
"12757558","Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden","Feldman H, Gauthier S, Hecker J, Vellas B, Emir B, Mastey V, Subbiah P; Donepezil MSAD Study Investigators Group.","J Am Geriatr Soc. 2003 Jun;51(6):737-44. doi: 10.1046/j.1365-2389.2003.51260.x.","Feldman H","J Am Geriatr Soc","2003","2003/05/22","","","10.1046/j.1365-2389.2003.51260.x"
"12207983","Visual search in Alzheimer's disease: a deficiency in processing conjunctions of features","Tales A, Butler SR, Fossey J, Gilchrist ID, Jones RW, Troscianko T.","Neuropsychologia. 2002;40(12):1849-57. doi: 10.1016/s0028-3932(02)00073-8.","Tales A","Neuropsychologia","2002","2002/09/05","","","10.1016/s0028-3932(02)00073-8"
"16191242","Memantine in vascular dementia","Möbius HJ, Stöffler A.","Int Psychogeriatr. 2003;15 Suppl 1:207-13. doi: 10.1017/S1041610203009219.","Möbius HJ","Int Psychogeriatr","2003","2005/09/30","","","10.1017/S1041610203009219"
"36281668","Intervention for Cognitive Reserve Enhancement in Delaying the Onset of Alzheimer's Symptomatic Expression (INCREASE) Study: Results from a Randomized Controlled Study of Medication Therapy Management Targeting a Delay in Prodromal Dementia Symptom Progression","Moga DC, Abner EL, Schmitt FA, Eckmann L, Huffmyer M, Martinez AI, Beech BF, George R, El Khouli RH, Ali D, Jicha GA.","J Prev Alzheimers Dis. 2022;9(4):646-654. doi: 10.14283/jpad.2022.55.","Moga DC","J Prev Alzheimers Dis","2022","2022/10/25","PMC9145115","","10.14283/jpad.2022.55"
"21199235","Galantamine (Reminyl) once daily outcome and satisfaction survey (RODOS) in mild to moderate Alzheimer's disease: a study in a real life population","Van Puyvelde K, Mets T; RODOS Study Group.","Geriatr Gerontol Int. 2011 Jul;11(3):256-61. doi: 10.1111/j.1447-0594.2010.00674.x. Epub 2011 Jan 4.","Van Puyvelde K","Geriatr Gerontol Int","2011","2011/01/05","","","10.1111/j.1447-0594.2010.00674.x"
"9461054","Apoptosis-related protein expression in the hippocampus in Alzheimer's disease","Nagy ZS, Esiri MM.","Neurobiol Aging. 1997 Nov-Dec;18(6):565-71. doi: 10.1016/s0197-4580(97)00157-7.","Nagy ZS","Neurobiol Aging","1997","1998/02/14","","","10.1016/s0197-4580(97)00157-7"
"15084792","Donepezil for Alzheimer's disease in clinical practice--The DONALD Study. A multicenter 24-week clinical trial in Germany","Froelich L, Gertz HJ, Heun R, Heuser I, Jendroska K, Kornhuber J, Kurz A, Mueller-Thomsen T, Ries F, Waechtler C, Metz M, Goebel C.","Dement Geriatr Cogn Disord. 2004;18(1):37-43. doi: 10.1159/000077733. Epub 2004 Apr 6.","Froelich L","Dement Geriatr Cogn Disord","2004","2004/04/16","","","10.1159/000077733"
"9063908","Neurochemical parameters in senile dementia of the Alzheimer type. A longitudinal study in four cases","Strittmatter M, Hamann G, Cramer H, Reuner C, Kuntzmann F, Strubel D.","Eur Arch Psychiatry Clin Neurosci. 1996;246(2):110-11. doi: 10.1007/BF02274903.","Strittmatter M","Eur Arch Psychiatry Clin Neurosci","1996","1996/01/01","","","10.1007/BF02274903"
"19700946","Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial)","Ballard C, Brown R, Fossey J, Douglas S, Bradley P, Hancock J, James IA, Juszczak E, Bentham P, Burns A, Lindesay J, Jacoby R, O'Brien J, Bullock R, Johnson T, Holmes C, Howard R.","Am J Geriatr Psychiatry. 2009 Sep;17(9):726-33. doi: 10.1097/JGP.0b013e3181b0f8c0.","Ballard C","Am J Geriatr Psychiatry","2009","2009/08/25","","","10.1097/JGP.0b013e3181b0f8c0"
"19700948","Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study","Mohs RC, Shiovitz TM, Tariot PN, Porsteinsson AP, Baker KD, Feldman PD.","Am J Geriatr Psychiatry. 2009 Sep;17(9):752-9. doi: 10.1097/JGP.0b013e3181aad585.","Mohs RC","Am J Geriatr Psychiatry","2009","2009/08/25","","","10.1097/JGP.0b013e3181aad585"
"25523430","Evaluating high-dose rivastigmine patch in severe Alzheimer's disease: analyses with concomitant memantine usage as a factor","Grossberg GT, Farlow MR, Meng X, Velting DM.","Curr Alzheimer Res. 2015;12(1):53-60. doi: 10.2174/1567205011666141218122835.","Grossberg GT","Curr Alzheimer Res","2015","2014/12/20","","","10.2174/1567205011666141218122835"
"11695500","Memory and metamemory performance in Alzheimer's disease and healthy elderly: the Contextual Memory Test (CMT)","Gil N, Josman N.","Aging (Milano). 2001 Aug;13(4):309-15. doi: 10.1007/BF03353427.","Gil N","Aging (Milano)","2001","2001/11/07","","","10.1007/BF03353427"
"15061827","Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients","Almkvist O, Darreh-Shori T, Stefanova E, Spiegel R, Nordberg A.","Eur J Neurol. 2004 Apr;11(4):253-61. doi: 10.1046/j.1468-1331.2003.00757.x.","Almkvist O","Eur J Neurol","2004","2004/04/06","","","10.1046/j.1468-1331.2003.00757.x"
"16508298","3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy","Winblad B, Wimo A, Engedal K, Soininen H, Verhey F, Waldemar G, Wetterholm AL, Haglund A, Zhang R, Schindler R.","Dement Geriatr Cogn Disord. 2006;21(5-6):353-63. doi: 10.1159/000091790. Epub 2006 Feb 27.","Winblad B","Dement Geriatr Cogn Disord","2006","2006/03/02","","","10.1159/000091790"
"14682086","Caregiver attribution and resentment in dementia care","Martin-Cook K, Remakel-Davis B, Svetlik D, Hynan LS, Weiner MF.","Am J Alzheimers Dis Other Demen. 2003 Nov-Dec;18(6):366-74. doi: 10.1177/153331750301800606.","Martin-Cook K","Am J Alzheimers Dis Other Demen","2003","2003/12/20","","","10.1177/153331750301800606"
"23273601","Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease","Berchtold NC, Coleman PD, Cribbs DH, Rogers J, Gillen DL, Cotman CW.","Neurobiol Aging. 2013 Jun;34(6):1653-61. doi: 10.1016/j.neurobiolaging.2012.11.024. Epub 2012 Dec 27.","Berchtold NC","Neurobiol Aging","2013","2013/01/01","PMC4022280","NIHMS498183","10.1016/j.neurobiolaging.2012.11.024"
"12762134","Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with Alzheimer's disease","Hock C, Maddalena A, Raschig A, Müller-Spahn F, Eschweiler G, Hager K, Heuser I, Hampel H, Müller-Thomsen T, Oertel W, Wienrich M, Signorell A, Gonzalez-Agosti C, Nitsch RM.","Amyloid. 2003 Mar;10(1):1-6. doi: 10.3109/13506120308995249.","Hock C","Amyloid","2003","2003/05/24","","","10.3109/13506120308995249"
"9802497","Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine","Harris GJ, Lewis RF, Satlin A, English CD, Scott TM, Yurgelun-Todd DA, Renshaw PF.","AJNR Am J Neuroradiol. 1998 Oct;19(9):1727-32.","Harris GJ","AJNR Am J Neuroradiol","1998","1998/11/05","PMC8337487","",""
"24450890","Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease","Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, Raman R, Sun X, Aisen PS, Siemers E, Liu-Seifert H, Mohs R; Alzheimer's Disease Cooperative Study Steering Committee; Solanezumab Study Group.","N Engl J Med. 2014 Jan 23;370(4):311-21. doi: 10.1056/NEJMoa1312889.","Doody RS","N Engl J Med","2014","2014/01/24","","","10.1056/NEJMoa1312889"
"26728933","Relearning of Activities of Daily Living: A Comparison of the Effectiveness of Three Learning Methods in Patients with Dementia of the Alzheimer Type","Bourgeois J, Laye M, Lemaire J, Leone E, Deudon A, Darmon N, Giaume C, Lafont V, Brinck-Jensen S, Dechamps A, König A, Robert P.","J Nutr Health Aging. 2016 Jan;20(1):48-55. doi: 10.1007/s12603-016-0675-4.","Bourgeois J","J Nutr Health Aging","2016","2016/01/06","","","10.1007/s12603-016-0675-4"
"22133165","Non-pharmacological, multicomponent group therapy in patients with degenerative dementia: a 12-month randomizied, controlled trial","Graessel E, Stemmer R, Eichenseer B, Pickel S, Donath C, Kornhuber J, Luttenberger K.","BMC Med. 2011 Dec 1;9:129. doi: 10.1186/1741-7015-9-129.","Graessel E","BMC Med","2011","2011/12/03","PMC3254071","","10.1186/1741-7015-9-129"
"3025926","Drug therapy of Alzheimer's disease: realistic or not?","Hollister LE.","Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):439-46. doi: 10.1016/0278-5846(86)90017-5.","Hollister LE","Prog Neuropsychopharmacol Biol Psychiatry","1986","1986/01/01","","","10.1016/0278-5846(86)90017-5"
"19448381","A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease","Pasqualetti P, Bonomini C, Dal Forno G, Paulon L, Sinforiani E, Marra C, Zanetti O, Rossini PM.","Aging Clin Exp Res. 2009 Apr;21(2):102-10. doi: 10.1007/BF03325217.","Pasqualetti P","Aging Clin Exp Res","2009","2009/05/19","","","10.1007/BF03325217"
"11058789","Polymorphisms in the alpha-2 macroglobulin gene in psychogeriatric patients","Zill P, Bürger K, Behrens S, Hampel H, Padberg F, Boetsch T, Möller HJ, Ackenheil M, Bondy B.","Neurosci Lett. 2000 Nov 17;294(2):69-72. doi: 10.1016/s0304-3940(00)01518-4.","Zill P","Neurosci Lett","2000","2000/11/04","","","10.1016/s0304-3940(00)01518-4"
"28538088","Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study","Koenig AM, Mechanic-Hamilton D, Xie SX, Combs MF, Cappola AR, Xie L, Detre JA, Wolk DA, Arnold SE.","Alzheimer Dis Assoc Disord. 2017 Apr-Jun;31(2):107-113. doi: 10.1097/WAD.0000000000000202.","Koenig AM","Alzheimer Dis Assoc Disord","2017","2017/05/25","PMC5476214","NIHMS866519","10.1097/WAD.0000000000000202"
"29236621","Helping Hispanic Dementia Caregivers Cope with Stress Using Technology-based Resources","Kajiyama B, Fernandez G, Carter EA, Humber MB, Thompson LW.","Clin Gerontol. 2018 May-Jun;41(3):209-216. doi: 10.1080/07317115.2017.1377797. Epub 2017 Dec 13.","Kajiyama B","Clin Gerontol","2018","2017/12/14","","","10.1080/07317115.2017.1377797"
"18334761","Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study","Bakchine S, Loft H.","J Alzheimers Dis. 2008 Feb;13(1):97-107. doi: 10.3233/jad-2008-13110.","Bakchine S","J Alzheimers Dis","2008","2008/03/13","","","10.3233/jad-2008-13110"
"11985183","Genetic screening for Alzheimer's disease: what factors predict intentions to take a test?","Frost S, Myers LB, Newman SP.","Behav Med. 2001 Fall;27(3):101-9. doi: 10.1080/08964280109595776.","Frost S","Behav Med","2001","2002/05/03","","","10.1080/08964280109595776"
"2284602","Evaluation of a model self-help telephone program: impact on natural networks","Goodman C.","Soc Work. 1990 Nov;35(6):556-62. doi: 10.1093/sw/35.6.556.","Goodman C","Soc Work","1990","1990/11/01","","","10.1093/sw/35.6.556"
"12537035","Effects of acute tryptophan depletion on cognitive function in Alzheimer's disease and in the healthy elderly","Porter RJ, Lunn BS, O'Brien JT.","Psychol Med. 2003 Jan;33(1):41-9. doi: 10.1017/s0033291702006906.","Porter RJ","Psychol Med","2003","2003/01/23","","","10.1017/s0033291702006906"
"17047484","Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease","Blesa R, Bullock R, He Y, Bergman H, Gambina G, Meyer J, Rapatz G, Nagel J, Lane R.","Pharmacogenet Genomics. 2006 Nov;16(11):771-4. doi: 10.1097/01.fpc.0000220573.05714.ac.","Blesa R","Pharmacogenet Genomics","2006","2006/10/19","","","10.1097/01.fpc.0000220573.05714.ac"
"19838862","A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease","Akhondzadeh S, Shafiee Sabet M, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi SS, Yousefi MH, Alimardani R, Jamshidi A, Rezazadeh SA, Yousefi A, Zare F, Moradi A, Vossoughi A.","Psychopharmacology (Berl). 2010 Jan;207(4):637-43. doi: 10.1007/s00213-009-1706-1. Epub 2009 Oct 20.","Akhondzadeh S","Psychopharmacology (Berl)","2010","2009/10/20","","","10.1007/s00213-009-1706-1"
"29975287","Apolipoprotein E4 genotype in combination with poor metabolic profile is associated with reduced cognitive performance in healthy postmenopausal women: implications for late onset Alzheimer's disease","Karim R, Koc M, Rettberg JR, Hodis HN, Henderson VW, St John JA, Allayee H, Brinton RD, Mack WJ.","Menopause. 2019 Jan;26(1):7-15. doi: 10.1097/GME.0000000000001160.","Karim R","Menopause","2019","2018/07/06","PMC7508039","NIHMS970159","10.1097/GME.0000000000001160"
"33253354","BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain","Sur C, Kost J, Scott D, Adamczuk K, Fox NC, Cummings JL, Tariot PN, Aisen PS, Vellas B, Voss T, Mahoney E, Mukai Y, Kennedy ME, Lines C, Michelson D, Egan MF.","Brain. 2020 Dec 1;143(12):3816-3826. doi: 10.1093/brain/awaa332.","Sur C","Brain","2020","2020/11/30","PMC8453290","","10.1093/brain/awaa332"
"28155182","Italians do it worse. Montreal Cognitive Assessment (MoCA) optimal cut-off scores for people with probable Alzheimer's disease and with probable cognitive impairment","Bosco A, Spano G, Caffò AO, Lopez A, Grattagliano I, Saracino G, Pinto K, Hoogeveen F, Lancioni GE.","Aging Clin Exp Res. 2017 Dec;29(6):1113-1120. doi: 10.1007/s40520-017-0727-6. Epub 2017 Feb 2.","Bosco A","Aging Clin Exp Res","2017","2017/02/04","","","10.1007/s40520-017-0727-6"
"30629123","Association Between Brain β-Amyloid and Frailty in Older Adults","Maltais M, De Souto Barreto P, Hooper C, Payoux P, Rolland Y, Vellas B; MAPT/DSA Study Group.","J Gerontol A Biol Sci Med Sci. 2019 Oct 4;74(11):1747-1752. doi: 10.1093/gerona/glz009.","Maltais M","J Gerontol A Biol Sci Med Sci","2019","2019/01/11","","","10.1093/gerona/glz009"
"15654671","[The effect of rivastigmine on cognitive functions and regional cerebral blood flow in Alzheimer's disease and vascular dementia: follow-up for 2 years]","Lipczyńska-Łojkowska W, Ryglewicz D, Jedrzejczak T, Jakubowska T, Kotapka-Minc S, Sienkiewicz-Jarosz H, Bochyńska A.","Neurol Neurochir Pol. 2004 Nov-Dec;38(6):471-81.","Lipczyńska-Łojkowska W","Neurol Neurochir Pol","2004","2005/01/18","","",""
"18077465","Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health","Bentley P, Driver J, Dolan RJ.","Brain. 2008 Feb;131(Pt 2):409-24. doi: 10.1093/brain/awm299. Epub 2007 Dec 12.","Bentley P","Brain","2008","2007/12/14","PMC2605268","UKMS3286","10.1093/brain/awm299"
"15716518","Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease","Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti BJ, Koeppe RA, Meltzer CC, Constantine G, Davis JG, Mathis CA, Dekosky ST, Moore RY.","J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):315-9. doi: 10.1136/jnnp.2004.038729.","Bohnen NI","J Neurol Neurosurg Psychiatry","2005","2005/02/18","PMC1739536","","10.1136/jnnp.2004.038729"
"25821958","Impact of cerebrospinal fluid shunting for idiopathic normal pressure hydrocephalus on the amyloid cascade","Moriya M, Miyajima M, Nakajima M, Ogino I, Arai H.","PLoS One. 2015 Mar 30;10(3):e0119973. doi: 10.1371/journal.pone.0119973. eCollection 2015.","Moriya M","PLoS One","2015","2015/03/31","PMC4379026","","10.1371/journal.pone.0119973"
"30611996","A pilot study on the effect of lactoferrin on Alzheimer's disease pathological sequelae: Impact of the p-Akt/PTEN pathway","Mohamed WA, Salama RM, Schaalan MF.","Biomed Pharmacother. 2019 Mar;111:714-723. doi: 10.1016/j.biopha.2018.12.118. Epub 2019 Jan 3.","Mohamed WA","Biomed Pharmacother","2019","2019/01/07","","","10.1016/j.biopha.2018.12.118"
"10559557","Tau immunoreactivity detected in human plasma, but no obvious increase in dementia","Ingelson M, Blomberg M, Benedikz E, Wahlund LO, Karlsson E, Vanmechelen E, Lannfelt L.","Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):442-5. doi: 10.1159/000017187.","Ingelson M","Dement Geriatr Cogn Disord","1999","1999/11/24","","","10.1159/000017187"
"25316430","Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product","Sadhu A, Upadhyay P, Agrawal A, Ilango K, Karmakar D, Singh GP, Dubey GP.","Clin Drug Investig. 2014 Dec;34(12):857-69. doi: 10.1007/s40261-014-0235-9.","Sadhu A","Clin Drug Investig","2014","2014/10/16","","","10.1007/s40261-014-0235-9"
"10739631","Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies","Higuchi M, Tashiro M, Arai H, Okamura N, Hara S, Higuchi S, Itoh M, Shin RW, Trojanowski JQ, Sasaki H.","Exp Neurol. 2000 Apr;162(2):247-56. doi: 10.1006/exnr.2000.7342.","Higuchi M","Exp Neurol","2000","2000/03/31","","","10.1006/exnr.2000.7342"
"26685923","Yoga and compassion meditation program improve quality of life and self-compassion in family caregivers of Alzheimer's disease patients: A randomized controlled trial","Danucalov MA, Kozasa EH, Afonso RF, Galduroz JC, Leite JR.","Geriatr Gerontol Int. 2017 Jan;17(1):85-91. doi: 10.1111/ggi.12675. Epub 2015 Dec 21.","Danucalov MA","Geriatr Gerontol Int","2017","2015/12/22","","","10.1111/ggi.12675"
"8973053","Bioavailability and pharmacokinetic disposition of tacrine in elderly patients with Alzheimer's disease","Lou G, Montgomery PR, Sitar DS.","J Psychiatry Neurosci. 1996 Nov;21(5):334-9.","Lou G","J Psychiatry Neurosci","1996","1996/11/01","PMC1188798","",""
"15775716","Cerebral blood flow in Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease according to three-dimensional stereotactic surface projection imaging","Kasama S, Tachibana H, Kawabata K, Yoshikawa H.","Dement Geriatr Cogn Disord. 2005;19(5-6):266-75. doi: 10.1159/000084551. Epub 2005 Mar 18.","Kasama S","Dement Geriatr Cogn Disord","2005","2005/03/19","","","10.1159/000084551"
"14670572","The effects of saliency and task difficulty on visual search performance in ageing and Alzheimer's disease","Tales A, Muir J, Jones R, Bayer A, Snowden RJ.","Neuropsychologia. 2004;42(3):335-45. doi: 10.1016/j.neuropsychologia.2003.08.002.","Tales A","Neuropsychologia","2004","2003/12/13","","","10.1016/j.neuropsychologia.2003.08.002"
"30940012","Therapeutic Role of Transcranial Direct Current Stimulation in Alzheimer Disease Patients: Double-Blind, Placebo-Controlled Clinical Trial","Khedr EM, Salama RH, Abdel Hameed M, Abo Elfetoh N, Seif P.","Neurorehabil Neural Repair. 2019 May;33(5):384-394. doi: 10.1177/1545968319840285. Epub 2019 Apr 3.","Khedr EM","Neurorehabil Neural Repair","2019","2019/04/04","","","10.1177/1545968319840285"
"7904698","Alzheimer's disease and caregiver time","Moore MJ, Clipp EC.","Lancet. 1994 Jan 22;343(8891):239-40. doi: 10.1016/s0140-6736(94)91027-8.","Moore MJ","Lancet","1994","1994/01/22","","","10.1016/s0140-6736(94)91027-8"
"18632806","Voxel-based analysis of 11C-PIB scans for diagnosing Alzheimer's disease","Mikhno A, Devanand D, Pelton G, Cuasay K, Gunn R, Upton N, Lai RY, Libri V, Mann JJ, Parsey RV.","J Nucl Med. 2008 Aug;49(8):1262-9. doi: 10.2967/jnumed.107.049932. Epub 2008 Jul 16.","Mikhno A","J Nucl Med","2008","2008/07/18","PMC3103049","NIHMS294178","10.2967/jnumed.107.049932"
"18580589","Panax ginseng enhances cognitive performance in Alzheimer disease","Lee ST, Chu K, Sim JY, Heo JH, Kim M.","Alzheimer Dis Assoc Disord. 2008 Jul-Sep;22(3):222-6. doi: 10.1097/WAD.0b013e31816c92e6.","Lee ST","Alzheimer Dis Assoc Disord","2008","2008/06/27","","","10.1097/WAD.0b013e31816c92e6"
"10568079","Educating nursing assistants to communicate more effectively with nursing home residents with dementia","McCallion P, Toseland RW, Lacey D, Banks S.","Gerontologist. 1999 Oct;39(5):546-58. doi: 10.1093/geront/39.5.546.","McCallion P","Gerontologist","1999","1999/11/24","","","10.1093/geront/39.5.546"
"17637213","Domperidone is effective in the prevention of rivastigmine-related gastrointestinal disturbances","Scarzella L, Costanza A, Vastola K.","Funct Neurol. 2007 Apr-Jun;22(2):101-4.","Scarzella L","Funct Neurol","2007","2007/07/20","","",""
"33762220","Exposure to gamma tACS in Alzheimer's disease: A randomized, double-blind, sham-controlled, crossover, pilot study","Benussi A, Cantoni V, Cotelli MS, Cotelli M, Brattini C, Datta A, Thomas C, Santarnecchi E, Pascual-Leone A, Borroni B.","Brain Stimul. 2021 May-Jun;14(3):531-540. doi: 10.1016/j.brs.2021.03.007. Epub 2021 Mar 21.","Benussi A","Brain Stimul","2021","2021/03/25","","","10.1016/j.brs.2021.03.007"
"10026377","Differential diagnosis of aging, dementia of the Alzheimer type and depression with EEG-segmentation","Ihl R, Brinkmeyer J.","Dement Geriatr Cogn Disord. 1999 Mar-Apr;10(2):64-9. doi: 10.1159/000017103.","Ihl R","Dement Geriatr Cogn Disord","1999","1999/02/23","","","10.1159/000017103"
"22427467","[Achetylcholinesterase (AChE) inhibition and serum lipokines in Alzheimer's disease: friend or foe?]","Kovacs J, Pakaski M, Juhasz A, Feher A, Drotos G, Fazekas CO, Horvath TL, Janka Z, Kalman J.","Neuropsychopharmacol Hung. 2012 Mar;14(1):19-27.","Kovacs J","Neuropsychopharmacol Hung","2012","2012/03/20","","",""
"10193912","Accelerated risk of hypertensive blood pressure recordings among Alzheimer caregivers","Shaw WS, Patterson TL, Ziegler MG, Dimsdale JE, Semple SJ, Grant I.","J Psychosom Res. 1999 Mar;46(3):215-27. doi: 10.1016/s0022-3999(98)00084-1.","Shaw WS","J Psychosom Res","1999","1999/04/08","","","10.1016/s0022-3999(98)00084-1"
"26736036","Sedation mediates part of Citalopram's effect on agitation in Alzheimer's disease","Newell J, Yesavage JA, Taylor JL, Kraemer HC, Munro CA, Friedman L, Rosenberg PB, Madore M, Chao SZ, Devanand DP, Drye LT, Mintzer JE, Pollock BG, Porsteinsson AP, Schneider LS, Shade DM, Weintraub D, Lyketsos CG, Noda A; CitAD Research Group.","J Psychiatr Res. 2016 Mar;74:17-21. doi: 10.1016/j.jpsychires.2015.12.005. Epub 2015 Dec 12.","Newell J","J Psychiatr Res","2016","2016/01/07","PMC4744510","NIHMS747915","10.1016/j.jpsychires.2015.12.005"
"11340368","Short-term rivastigmine treatment reduces EEG slow-wave power in Alzheimer patients","Adler G, Brassen S.","Neuropsychobiology. 2001;43(4):273-6. doi: 10.1159/000054902.","Adler G","Neuropsychobiology","2001","2001/05/08","","","10.1159/000054902"
"30041656","Shanghai cognitive intervention of mild cognitive impairment for delaying progress with longitudinal evaluation-a prospective, randomized controlled study (SIMPLE): rationale, design, and methodology","Lin Y, Li B, Tang H, Xu Q, Wu Y, Cheng Q, Li C, Xiao S, Shen L, Tang W, Yu H, He N, Lin H, Yan F, Cao W, Yang S, Liu Y, Zhao W, Lu D, Jiao B, Xiao X, Zhou L, Chen S.","BMC Neurol. 2018 Jul 24;18(1):103. doi: 10.1186/s12883-018-1100-x.","Lin Y","BMC Neurol","2018","2018/07/26","PMC6057042","","10.1186/s12883-018-1100-x"
"32979515","A dyadic approach for a remote physical activity intervention in adults with Alzheimer's disease and their caregivers: Rationale and design for an 18-month randomized trial","Ptomey LT, Szabo-Reed AN, Vidoni ED, Washburn RA, Gorczyca AM, Little TD, Lee J, Helsel BC, Williams KN, Donnelly JE.","Contemp Clin Trials. 2020 Nov;98:106158. doi: 10.1016/j.cct.2020.106158. Epub 2020 Sep 23.","Ptomey LT","Contemp Clin Trials","2020","2020/09/26","PMC7686020","NIHMS1633400","10.1016/j.cct.2020.106158"
"21196773","The Danish Alzheimer intervention study: rationale, study design and baseline characteristics of the cohort","Waldemar G, Waldorff FB, Buss DV, Eckermann A, Keiding N, Rishøj S, Siersma V, Sørensen J, Sørensen LV, Vogel A.","Neuroepidemiology. 2011;36(1):52-61. doi: 10.1159/000322942. Epub 2010 Dec 22.","Waldemar G","Neuroepidemiology","2011","2011/01/04","","","10.1159/000322942"
"12003253","Effects of transdermal nicotine on learning, memory, verbal fluency, concentration, and general health in a healthy sample at risk for dementia","Howe MN, Price IR.","Int Psychogeriatr. 2001 Dec;13(4):465-75. doi: 10.1017/s1041610201007888.","Howe MN","Int Psychogeriatr","2001","2002/05/11","","","10.1017/s1041610201007888"
"24166191","Language-enriched exercise plus socialization for older adults with dementia: translation to rural communities","La Rue A, Felten K, Duschene K, MacFarlane D, Price S, Zimmerman S, Hafez S.","Semin Speech Lang. 2013 Aug;34(3):170-84. doi: 10.1055/s-0033-1358370. Epub 2013 Oct 28.","La Rue A","Semin Speech Lang","2013","2013/10/30","","","10.1055/s-0033-1358370"
"2858052","Evaluation of an analogue of somatostatin (L363,586) in Alzheimer's disease","Cutler NR, Haxby JV, Narang PK, May C, Burg C, Reines SA.","N Engl J Med. 1985 Mar 14;312(11):725. doi: 10.1056/NEJM198503143121115.","Cutler NR","N Engl J Med","1985","1985/03/14","","","10.1056/NEJM198503143121115"
"29551889","Combined application of tenuigenin and β-asarone improved the efficacy of memantine in treating moderate-to-severe Alzheimer's disease","Chang W, Teng J.","Drug Des Devel Ther. 2018 Mar 5;12:455-462. doi: 10.2147/DDDT.S155567. eCollection 2018.","Chang W","Drug Des Devel Ther","2018","2018/03/20","PMC5842771","","10.2147/DDDT.S155567"
"10216789","Is donepezil effective for treating Alzheimer's disease?","Steele LS, Glazier RH.","Can Fam Physician. 1999 Apr;45:917-9.","Steele LS","Can Fam Physician","1999","1999/04/27","PMC2328349","",""
"34259071","Evaluation of [(18)F]-JNJ-64326067-AAA tau PET tracer in humans","Baker SL, Provost K, Thomas W, Whitman AJ, Janabi M, Schmidt ME, Timmers M, Kolb HC, Rabinovici GD, Jagust WJ.","J Cereb Blood Flow Metab. 2021 Dec;41(12):3302-3313. doi: 10.1177/0271678X211031035. Epub 2021 Jul 14.","Baker SL","J Cereb Blood Flow Metab","2021","2021/07/14","PMC8669274","","10.1177/0271678X211031035"
"16340391","An investigation of moral judgement in frontotemporal dementia","Mendez MF, Anderson E, Shapira JS.","Cogn Behav Neurol. 2005 Dec;18(4):193-7. doi: 10.1097/01.wnn.0000191292.17964.bb.","Mendez MF","Cogn Behav Neurol","2005","2005/12/13","","","10.1097/01.wnn.0000191292.17964.bb"
"28787712","Effectiveness of Florbetapir PET Imaging in Changing Patient Management","Pontecorvo MJ, Siderowf A, Dubois B, Doraiswamy PM, Frisoni GB, Grundman M, Nobili F, Sadowsky CH, Salloway S, Arora AK, Chevrette A, Deberdt W, Dell'Agnello G, Flitter M, Galante N, Lowrey MJ, Lu M, McGeehan A, Devous MD Sr, Mintun MA.","Dement Geriatr Cogn Disord. 2017;44(3-4):129-143. doi: 10.1159/000478007. Epub 2017 Aug 5.","Pontecorvo MJ","Dement Geriatr Cogn Disord","2017","2017/08/09","PMC5806476","","10.1159/000478007"
"9507951","Transferrin C2, metal binding and Alzheimer's disease","Van Landeghem GF, Sikström C, Beckman LE, Adolfsson R, Beckman L.","Neuroreport. 1998 Jan 26;9(2):177-9. doi: 10.1097/00001756-199801260-00001.","Van Landeghem GF","Neuroreport","1998","1998/03/21","","","10.1097/00001756-199801260-00001"
"22715491","Wavelet coherence model for diagnosis of Alzheimer disease","Sankari Z, Adeli H, Adeli A.","Clin EEG Neurosci. 2012 Oct;43(4):268-78. doi: 10.1177/1550059412444970. Epub 2012 May 10.","Sankari Z","Clin EEG Neurosci","2012","2012/06/21","","","10.1177/1550059412444970"
"2403716","Therapeutic trials using tacrine and other cholinesterase inhibitors","Gamzu ER, Thal LJ, Davis KL.","Adv Neurol. 1990;51:241-5.","Gamzu ER","Adv Neurol","1990","1990/01/01","","",""
"36641607","Buntanetap, a Novel Translational Inhibitor of Multiple Neurotoxic Proteins, Proves to Be Safe and Promising in Both Alzheimer's and Parkinson's Patients","Fang C, Hernandez P, Liow K, Damiano E, Zetterberg H, Blennow K, Feng D, Chen M, Maccecchini M.","J Prev Alzheimers Dis. 2023;10(1):25-33. doi: 10.14283/jpad.2022.84.","Fang C","J Prev Alzheimers Dis","2023","2023/01/15","","","10.14283/jpad.2022.84"
"24801218","A multicenter, double-blind, placebo-controlled trial of the PDE9A inhibitor, PF-04447943, in Alzheimer's disease","Schwam EM, Nicholas T, Chew R, Billing CB, Davidson W, Ambrose D, Altstiel LD.","Curr Alzheimer Res. 2014;11(5):413-21. doi: 10.2174/1567205011666140505100858.","Schwam EM","Curr Alzheimer Res","2014","2014/05/08","","","10.2174/1567205011666140505100858"
"19605829","Disclosure of APOE genotype for risk of Alzheimer's disease","Green RC, Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Brown T, Eckert SL, Butson M, Sadovnick AD, Quaid KA, Chen C, Cook-Deegan R, Farrer LA; REVEAL Study Group.","N Engl J Med. 2009 Jul 16;361(3):245-54. doi: 10.1056/NEJMoa0809578.","Green RC","N Engl J Med","2009","2009/07/17","PMC2778270","NIHMS133885","10.1056/NEJMoa0809578"
"15920715","Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial","Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni JR, Schwam EM; Donepezil MSAD Study Investigators Group.","Int J Geriatr Psychiatry. 2005 Jun;20(6):559-69. doi: 10.1002/gps.1325.","Feldman H","Int J Geriatr Psychiatry","2005","2005/05/28","","","10.1002/gps.1325"
"15802911","Peripheral electrical stimulation in Alzheimer's disease","van Dijk KR, Scheltens P, Luijpen MW, Sergeant JA, Scherder EJ.","Dement Geriatr Cogn Disord. 2005;19(5-6):361-8. doi: 10.1159/000084706. Epub 2005 Mar 30.","van Dijk KR","Dement Geriatr Cogn Disord","2005","2005/04/02","","","10.1159/000084706"
"8981374","Word-stem completion priming for perceptually and conceptually encoded words in patients with Alzheimer's disease","Fleischman DA, Gabrieli JD, Rinaldi JA, Reminger SL, Grinnell ER, Lange KL, Shapiro R.","Neuropsychologia. 1997 Jan;35(1):25-35. doi: 10.1016/s0028-3932(96)00057-7.","Fleischman DA","Neuropsychologia","1997","1997/01/01","","","10.1016/s0028-3932(96)00057-7"
"21723205","Magnetic resonance imaging-measured atrophy and its relationship to cognitive functioning in vascular dementia and Alzheimer's disease patients","Logue MW, Posner H, Green RC, Moline M, Cupples LA, Lunetta KL, Zou H, Hurt SW, Farrer LA, Decarli C; MIRAGE Study Group.","Alzheimers Dement. 2011 Sep;7(5):493-500. doi: 10.1016/j.jalz.2011.01.004. Epub 2011 Jul 1.","Logue MW","Alzheimers Dement","2011","2011/07/05","PMC3166967","NIHMS284269","10.1016/j.jalz.2011.01.004"
"9452942","Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study","Rogers SL, Friedhoff LT.","Eur Neuropsychopharmacol. 1998 Feb;8(1):67-75. doi: 10.1016/s0924-977x(97)00079-5.","Rogers SL","Eur Neuropsychopharmacol","1998","1998/02/07","","","10.1016/s0924-977x(97)00079-5"
"36341846","The Preventing Alzheimer's with Cognitive Training (PACT) randomized clinical trial","Nicholson JS, Hudak EM, Phillips CB, Chanti-Ketterl M, O'Brien JL, Ross LA, Lister JJ, Burke JR, Potter G, Plassman BL, Woods AJ, Krischer J, Edwards JD.","Contemp Clin Trials. 2022 Dec;123:106978. doi: 10.1016/j.cct.2022.106978. Epub 2022 Oct 28.","Nicholson JS","Contemp Clin Trials","2022","2022/11/07","","","10.1016/j.cct.2022.106978"
"14561444","Lexical processing in Spanish patients with probable Alzheimer's disease","Cuetos F, Martinez T, Martinez C, Izura C, Ellis AW.","Brain Res Cogn Brain Res. 2003 Oct;17(3):549-61. doi: 10.1016/s0926-6410(03)00169-1.","Cuetos F","Brain Res Cogn Brain Res","2003","2003/10/17","","","10.1016/s0926-6410(03)00169-1"
"17984395","Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in Alzheimer disease","Rosenheck RA, Leslie DL, Sindelar JL, Miller EA, Tariot PN, Dagerman KS, Davis SM, Lebowitz BD, Rabins P, Hsiao JK, Lieberman JA, Schneider LS; Clinical Antipsychotic Trial of Intervention Effectiveness-Alzheimer's Disease (CATIE-AD) investigators.","Arch Gen Psychiatry. 2007 Nov;64(11):1259-68. doi: 10.1001/archpsyc.64.11.1259.","Rosenheck RA","Arch Gen Psychiatry","2007","2007/11/07","","","10.1001/archpsyc.64.11.1259"
"2081897","Preliminary communication. A double-blind placebo-controlled trial of L-tryptophan to assess the degree of cognitive and behavioural improvement in patients with Alzheimer-type dementia and to compare differential response in clinical sub-groups","Bentham PW.","Int Clin Psychopharmacol. 1990 Oct;5(4):261-72. doi: 10.1097/00004850-199010000-00003.","Bentham PW","Int Clin Psychopharmacol","1990","1990/10/01","","","10.1097/00004850-199010000-00003"
"9813785","Lewy body disease: can we diagnose it?","Papka M, Rubio A, Schiffer RB, Cox C.","J Neuropsychiatry Clin Neurosci. 1998 Fall;10(4):405-12. doi: 10.1176/jnp.10.4.405.","Papka M","J Neuropsychiatry Clin Neurosci","1998","1998/11/14","","","10.1176/jnp.10.4.405"
"2506598","Low-dose oral lorazepam administration in Alzheimer subjects and age-matched controls","Sunderland T, Weingartner H, Cohen RM, Tariot PN, Newhouse PA, Thompson KE, Lawlor BA, Mueller EA.","Psychopharmacology (Berl). 1989;99(1):129-33. doi: 10.1007/BF00634466.","Sunderland T","Psychopharmacology (Berl)","1989","1989/01/01","","","10.1007/BF00634466"
"17296844","Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients","Behl P, Bocti C, Swartz RH, Gao F, Sahlas DJ, Lanctot KL, Streiner DL, Black SE.","Arch Neurol. 2007 Feb;64(2):266-72. doi: 10.1001/archneur.64.2.266.","Behl P","Arch Neurol","2007","2007/02/14","","","10.1001/archneur.64.2.266"
"22566505","Increased cerebral metabolism after 1 year of deep brain stimulation in Alzheimer disease","Smith GS, Laxton AW, Tang-Wai DF, McAndrews MP, Diaconescu AO, Workman CI, Lozano AM.","Arch Neurol. 2012 Sep;69(9):1141-8. doi: 10.1001/archneurol.2012.590.","Smith GS","Arch Neurol","2012","2012/05/09","","","10.1001/archneurol.2012.590"
"27955679","Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection","Ikonomovic MD, Buckley CJ, Heurling K, Sherwin P, Jones PA, Zanette M, Mathis CA, Klunk WE, Chakrabarty A, Ironside J, Ismail A, Smith C, Thal DR, Beach TG, Farrar G, Smith AP.","Acta Neuropathol Commun. 2016 Dec 12;4(1):130. doi: 10.1186/s40478-016-0399-z.","Ikonomovic MD","Acta Neuropathol Commun","2016","2016/12/14","PMC5154022","","10.1186/s40478-016-0399-z"
"7615916","Interventions for decreasing agitation behaviors in persons with dementia","Snyder M, Egan EC, Burns KR.","J Gerontol Nurs. 1995 Jul;21(7):34-40. doi: 10.3928/0098-9134-19950701-11.","Snyder M","J Gerontol Nurs","1995","1995/07/01","","","10.3928/0098-9134-19950701-11"
"15087581","Recognition of facial expressions of emotion by patients with dementia of the Alzheimer type","Burnham H, Hogervorst E.","Dement Geriatr Cogn Disord. 2004;18(1):75-9. doi: 10.1159/000077813. Epub 2004 Apr 14.","Burnham H","Dement Geriatr Cogn Disord","2004","2004/04/17","","","10.1159/000077813"
"7761293","The effects of a special computer network on caregivers of persons with Alzheimer's disease","Brennan PF, Moore SM, Smyth KA.","Nurs Res. 1995 May-Jun;44(3):166-72.","Brennan PF","Nurs Res","1995","1995/05/01","","",""
"10809936","An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors","Kumar V, Anand R, Messina J, Hartman R, Veach J.","Eur J Neurol. 2000 Mar;7(2):159-69. doi: 10.1046/j.1468-1331.2000.00046.x.","Kumar V","Eur J Neurol","2000","2000/05/16","","","10.1046/j.1468-1331.2000.00046.x"
"15259404","Noncognitive symptoms in Alzheimer disease and caregivers distress in Chile","Rohde G, Quiroga P, Fasce M, Fasce F.","Brain Cogn. 2002 Jul;49(2):253-5.","Rohde G","Brain Cogn","2002","2004/07/21","","",""
"15222827","Temporal patterns of negative and positive behavior among nursing home residents with Alzheimer's disease","McCann JJ, Gilley DW, Bienias JL, Beckett LA, Evans DA.","Psychol Aging. 2004 Jun;19(2):336-45. doi: 10.1037/0882-7974.19.2.336.","McCann JJ","Psychol Aging","2004","2004/06/30","","","10.1037/0882-7974.19.2.336"
"25374101","Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia","Claxton A, Baker LD, Hanson A, Trittschuh EH, Cholerton B, Morgan A, Callaghan M, Arbuckle M, Behl C, Craft S.","J Alzheimers Dis. 2015;44(3):897-906. doi: 10.3233/JAD-141791.","Claxton A","J Alzheimers Dis","2015","2014/11/07","","","10.3233/JAD-141791"
"28265571","Validation of the Italian Version of the Caregiver Abuse Screen among Family Caregivers of Older People with Alzheimer's Disease","Melchiorre MG, Di Rosa M, Barbabella F, Barbini N, Lattanzio F, Chiatti C.","Biomed Res Int. 2017;2017:3458372. doi: 10.1155/2017/3458372. Epub 2017 Feb 7.","Melchiorre MG","Biomed Res Int","2017","2017/03/08","PMC5318638","","10.1155/2017/3458372"
"2572988","Methodological considerations in cognitive disorders or: ""the baby needs enough bath water""","Read S.","Neurobiol Aging. 1989 Sep-Oct;10(5):634-5; discussion 648-50. doi: 10.1016/0197-4580(89)90159-0.","Read S","Neurobiol Aging","1989","1989/09/01","","","10.1016/0197-4580(89)90159-0"
"9106281","Dysgraphia in mild dementia of Alzheimer's type","Hughes JC, Graham N, Patterson K, Hodges JR.","Neuropsychologia. 1997 Apr;35(4):533-45. doi: 10.1016/s0028-3932(96)00102-9.","Hughes JC","Neuropsychologia","1997","1997/04/01","","","10.1016/s0028-3932(96)00102-9"
"16682794","Heterogeneity in executive impairment in patients with very mild Alzheimer's disease","Stokholm J, Vogel A, Gade A, Waldemar G.","Dement Geriatr Cogn Disord. 2006;22(1):54-9. doi: 10.1159/000093262. Epub 2006 May 8.","Stokholm J","Dement Geriatr Cogn Disord","2006","2006/05/10","","","10.1159/000093262"
"9855368","No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia","Arai H, Satoh-Nakagawa T, Higuchi M, Morikawa Y, Miura M, Kawakami H, Seki H, Takase S, Sasaki H.","Neurosci Lett. 1998 Nov 13;256(3):174-6. doi: 10.1016/s0304-3940(98)00781-2.","Arai H","Neurosci Lett","1998","1998/12/17","","","10.1016/s0304-3940(98)00781-2"
"7999348","Behavioral treatment of depression in patients with dementia","Teri L.","Alzheimer Dis Assoc Disord. 1994;8 Suppl 3:66-74.","Teri L","Alzheimer Dis Assoc Disord","1994","1994/01/01","","",""
"32275365","[Effect of electroacupuncture at governor vessel on learning-memory ability and serum level of APP, Aβ(1-42) in patients with Alzheimer's disease]","Xia KP, Pang J, Li SL, Zhang M, Li HL, Wang YJ.","Zhongguo Zhen Jiu. 2020 Apr 12;40(4):375-8. doi: 10.13703/j.0255-2930.20190728-0003.","Xia KP","Zhongguo Zhen Jiu","2020","2020/04/11","","","10.13703/j.0255-2930.20190728-0003"
"11287374","Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease","Grady CL, Furey ML, Pietrini P, Horwitz B, Rapoport SI.","Brain. 2001 Apr;124(Pt 4):739-56. doi: 10.1093/brain/124.4.739.","Grady CL","Brain","2001","2001/04/05","","","10.1093/brain/124.4.739"
"17272737","Comparison of two enhanced consent procedures for patients with mild Alzheimer disease or mild cognitive impairment","Mittal D, Palmer BW, Dunn LB, Landes R, Ghormley C, Beck C, Golshan S, Blevins D, Jeste DV.","Am J Geriatr Psychiatry. 2007 Feb;15(2):163-7. doi: 10.1097/JGP.0b013e31802dd379.","Mittal D","Am J Geriatr Psychiatry","2007","2007/02/03","","","10.1097/JGP.0b013e31802dd379"
"36251300","Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial","Pontecorvo MJ, Lu M, Burnham SC, Schade AE, Dage JL, Shcherbinin S, Collins EC, Sims JR, Mintun MA.","JAMA Neurol. 2022 Dec 1;79(12):1250-1259. doi: 10.1001/jamaneurol.2022.3392.","Pontecorvo MJ","JAMA Neurol","2022","2022/10/17","PMC9577883","","10.1001/jamaneurol.2022.3392"
"19699148","Continuous positive airway pressure deepens sleep in patients with Alzheimer's disease and obstructive sleep apnea","Cooke JR, Ancoli-Israel S, Liu L, Loredo JS, Natarajan L, Palmer BS, He F, Corey-Bloom J.","Sleep Med. 2009 Dec;10(10):1101-6. doi: 10.1016/j.sleep.2008.12.016. Epub 2009 Aug 20.","Cooke JR","Sleep Med","2009","2009/08/25","PMC2783482","NIHMS140024","10.1016/j.sleep.2008.12.016"
"19946869","Evaluation of a brief educational program for dementia carers: the AENEAS study","Kurz A, Wagenpfeil S, Hallauer J, Schneider-Schelte H, Jansen S; AENEAS Study.","Int J Geriatr Psychiatry. 2010 Aug;25(8):861-9. doi: 10.1002/gps.2428.","Kurz A","Int J Geriatr Psychiatry","2010","2009/12/01","","","10.1002/gps.2428"
"26639952","Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial","Quintana-Hernández DJ, Miró-Barrachina MT, Ibáñez-Fernández IJ, Pino AS, Quintana-Montesdeoca MP, Rodríguez-de Vera B, Morales-Casanova D, Pérez-Vieitez Mdel C, Rodríguez-García J, Bravo-Caraduje N.","J Alzheimers Dis. 2016;50(1):217-32. doi: 10.3233/JAD-143009.","Quintana-Hernández DJ","J Alzheimers Dis","2016","2015/12/08","","","10.3233/JAD-143009"
"16252573","Efficacy of rivastigmine on activities of daily living in Sri Lankan patients with Alzheimer disease and on improving caregiver burden: a prospective study","de Silva HA, Pathmeswaran A, Gunatilake SB.","Ceylon Med J. 2005 Sep;50(3):106-9. doi: 10.4038/cmj.v50i3.1426.","de Silva HA","Ceylon Med J","2005","2005/10/29","","","10.4038/cmj.v50i3.1426"
"33771205","Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial","Koh SH, Kwon HS, Choi SH, Jeong JH, Na HR, Lee CN, Yang Y, Lee AY, Lee JH, Park KW, Han HJ, Kim BC, Park JS, Lee JY, Kim S, Lee KY.","Alzheimers Res Ther. 2021 Mar 26;13(1):66. doi: 10.1186/s13195-021-00803-w.","Koh SH","Alzheimers Res Ther","2021","2021/03/27","PMC7995588","","10.1186/s13195-021-00803-w"
"14696022","Risperidone use in Korean patients with Alzheimer's disease: optimal dosage and effect on behavioural and psychological symptoms, cognitive function and activities of daily living","Yoon JS, Kim JM, Lee H, Shin IS, Choi SK.","Hum Psychopharmacol. 2003 Dec;18(8):627-33. doi: 10.1002/hup.543.","Yoon JS","Hum Psychopharmacol","2003","2003/12/30","","","10.1002/hup.543"
"19859884","[Orally disintegrating donepezil: are the main caregivers of patients with Alzheimer's disease more satisfied with this formulation of donepezil than with the traditional one?]","Sevilla C, Jiménez-Caballero PE, Alfonso V.","Rev Neurol. 2009 Nov 1-15;49(9):451-7.","Sevilla C","Rev Neurol","2009","2009/10/28","","",""
"17990049","Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease","Leyhe T, Stransky E, Eschweiler GW, Buchkremer G, Laske C.","Eur Arch Psychiatry Clin Neurosci. 2008 Mar;258(2):124-8. doi: 10.1007/s00406-007-0764-9. Epub 2007 Nov 7.","Leyhe T","Eur Arch Psychiatry Clin Neurosci","2008","2007/11/09","","","10.1007/s00406-007-0764-9"
"33988909","Effects of comprehensive intervention on life quality among the elderly with Alzheimer Disease and their caregivers based on mixed models","Yang L, Xuan C, Yu C, Jin X, Zheng P, Yan J.","Nurs Open. 2022 Mar;9(2):1412-1422. doi: 10.1002/nop2.917. Epub 2021 May 14.","Yang L","Nurs Open","2022","2021/05/14","PMC8859043","","10.1002/nop2.917"
"25466702","Biperiden selectively induces memory impairment in healthy volunteers: no interaction with citalopram","Sambeth A, Riedel WJ, Klinkenberg I, Kähkönen S, Blokland A.","Psychopharmacology (Berl). 2015 Jun;232(11):1887-97. doi: 10.1007/s00213-014-3822-9. Epub 2014 Dec 4.","Sambeth A","Psychopharmacology (Berl)","2015","2014/12/04","","","10.1007/s00213-014-3822-9"
"15961323","Altered generation of spontaneous oscillations in Alzheimer's disease","Osipova D, Ahveninen J, Jensen O, Ylikoski A, Pekkonen E.","Neuroimage. 2005 Oct 1;27(4):835-41. doi: 10.1016/j.neuroimage.2005.05.011.","Osipova D","Neuroimage","2005","2005/06/18","","","10.1016/j.neuroimage.2005.05.011"
"16453249","Transdermal rivastigmine treatment does not worsen impaired performance of complex motions in patients with Alzheimer's disease","Muhlack S, Przuntek H, Müller T.","Pharmacopsychiatry. 2006 Jan;39(1):16-9. doi: 10.1055/s-2006-931473.","Muhlack S","Pharmacopsychiatry","2006","2006/02/03","","","10.1055/s-2006-931473"
"24898643","The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer's Disease) Trial: interim results after two years of treatment","Amenta F, Carotenuto A, Fasanaro AM, Rea R, Traini E.","J Alzheimers Dis. 2014;42 Suppl 3:S281-8. doi: 10.3233/JAD-140150.","Amenta F","J Alzheimers Dis","2014","2014/06/06","","","10.3233/JAD-140150"
"12859348","Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease","Kemppainen N, Laine M, Laakso MP, Kaasinen V, Någren K, Vahlberg T, Kurki T, Rinne JO.","Eur J Neurosci. 2003 Jul;18(1):149-54. doi: 10.1046/j.1460-9568.2003.02716.x.","Kemppainen N","Eur J Neurosci","2003","2003/07/16","","","10.1046/j.1460-9568.2003.02716.x"
"34612190","Properties of the Cognitive Function Battery for the MIND Diet Intervention to Prevent Alzheimer's Disease","Krueger KR, Dhana K, Aggarwal NT, Arfanakis K, Carey VJ, Sacks FM, Barnes LL.","J Int Neuropsychol Soc. 2022 Sep;28(8):790-797. doi: 10.1017/S1355617721001089. Epub 2021 Oct 6.","Krueger KR","J Int Neuropsychol Soc","2022","2021/10/06","PMC8983783","NIHMS1729384","10.1017/S1355617721001089"
"10565707","Olanzapine in whole, not half, tablets for psychosis from Alzheimer's dementia","Wolfgang SA.","Am J Health Syst Pharm. 1999 Nov 1;56(21):2245-6. doi: 10.1093/ajhp/56.21.2245.","Wolfgang SA","Am J Health Syst Pharm","1999","1999/11/24","","","10.1093/ajhp/56.21.2245"
"23871120","A randomized cross-over controlled study on cognitive rehabilitation of instrumental activities of daily living in Alzheimer disease","Thivierge S, Jean L, Simard M.","Am J Geriatr Psychiatry. 2014 Nov;22(11):1188-99. doi: 10.1016/j.jagp.2013.03.008. Epub 2013 Jul 17.","Thivierge S","Am J Geriatr Psychiatry","2014","2013/07/23","","","10.1016/j.jagp.2013.03.008"
"19259965","Free radical damage to cerebral cortex in Alzheimer's disease, microvascular brain injury, and smoking","Sonnen JA, Larson EB, Gray SL, Wilson A, Kohama SG, Crane PK, Breitner JC, Montine TJ.","Ann Neurol. 2009 Feb;65(2):226-9. doi: 10.1002/ana.21508.","Sonnen JA","Ann Neurol","2009","2009/03/05","PMC2729331","NIHMS131811","10.1002/ana.21508"
"15254794","Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: evidence from a dopamine transporter imaging study","Ceravolo R, Volterrani D, Gambaccini G, Bernardini S, Rossi C, Logi C, Tognoni G, Manca G, Mariani G, Bonuccelli U, Murri L.","J Neural Transm (Vienna). 2004 Aug;111(8):1065-73. doi: 10.1007/s00702-004-0140-0. Epub 2004 Jun 18.","Ceravolo R","J Neural Transm (Vienna)","2004","2004/07/16","","","10.1007/s00702-004-0140-0"
"30712752","Mindfulness mechanisms and psychological effects for aMCI patients: A comparison with psychoeducation","Larouche E, Hudon C, Goulet S.","Complement Ther Clin Pract. 2019 Feb;34:93-104. doi: 10.1016/j.ctcp.2018.11.008. Epub 2018 Nov 12.","Larouche E","Complement Ther Clin Pract","2019","2019/02/05","","","10.1016/j.ctcp.2018.11.008"
"22986607","Effect of CYP2D6*10 and APOE polymorphisms on the efficacy of donepezil in patients with Alzheimer's disease","Zhong Y, Zheng X, Miao Y, Wan L, Yan H, Wang B.","Am J Med Sci. 2013 Mar;345(3):222-6. doi: 10.1097/MAJ.0b013e318255a8f9.","Zhong Y","Am J Med Sci","2013","2012/09/19","","","10.1097/MAJ.0b013e318255a8f9"
"35815777","The design and conduct of a pragmatic cluster randomized trial of an advance care planning program for nursing home residents with dementia","Hickman SE, Mitchell SL, Hanson LC, Tu W, Stump TE, Unroe KT.","Clin Trials. 2022 Dec;19(6):623-635. doi: 10.1177/17407745221108992. Epub 2022 Jul 10.","Hickman SE","Clin Trials","2022","2022/07/11","PMC9691516","NIHMS1815034","10.1177/17407745221108992"
"3042841","High-dose naloxone in older normal subjects: implications for Alzheimer's disease","Tariot PN, Gross M, Sunderland T, Cohen MR, Weingartner H, Murphy DL, Cohen RM.","J Am Geriatr Soc. 1988 Aug;36(8):681-6. doi: 10.1111/j.1532-5415.1988.tb07168.x.","Tariot PN","J Am Geriatr Soc","1988","1988/08/01","","","10.1111/j.1532-5415.1988.tb07168.x"
"18566544","Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey","García Santos JM, Gavrila D, Antúnez C, Tormo MJ, Salmerón D, Carles R, Jiménez Veiga J, Parrilla G, Torres del Río S, Fortuna L, Navarro C.","Dement Geriatr Cogn Disord. 2008;26(1):15-25. doi: 10.1159/000140624. Epub 2008 Jun 20.","García Santos JM","Dement Geriatr Cogn Disord","2008","2008/06/21","","","10.1159/000140624"
"29710726","Effectiveness of Anti-Dementia Drugs in Extremely Severe Alzheimer's Disease: A 12-Week, Multicenter, Randomized, Single-Blind Study","Hong YJ, Choi SH, Jeong JH, Park KW, Na HR.","J Alzheimers Dis. 2018;63(3):1035-1044. doi: 10.3233/JAD-180159.","Hong YJ","J Alzheimers Dis","2018","2018/05/02","","","10.3233/JAD-180159"
"23551405","Rivastigmine patch for treatment of Alzheimer's disease in clinical practice in Thailand","Kulkantrakorn K, Tanyakitpisal P, Towanabut S, Dejthevaporn C, Rangseekajee P, Pongpakdee S, Laptikultham S, Rodprasert K, Setthawatcharawanich S, Thinkhamrop B.","Psychogeriatrics. 2013 Mar;13(1):1-8. doi: 10.1111/j.1479-8301.2012.00403.x. Epub 2012 Feb 17.","Kulkantrakorn K","Psychogeriatrics","2013","2013/04/05","","","10.1111/j.1479-8301.2012.00403.x"
"1633433","Double-blind cross-over study of phosphatidylserine vs. placebo in patients with early dementia of the Alzheimer type","Engel RR, Satzger W, Günther W, Kathmann N, Bove D, Gerke S, Münch U, Hippius H.","Eur Neuropsychopharmacol. 1992 Jun;2(2):149-55. doi: 10.1016/0924-977x(92)90025-4.","Engel RR","Eur Neuropsychopharmacol","1992","1992/06/01","","","10.1016/0924-977x(92)90025-4"
"26414022","Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial","Coric V, Salloway S, van Dyck CH, Dubois B, Andreasen N, Brody M, Curtis C, Soininen H, Thein S, Shiovitz T, Pilcher G, Ferris S, Colby S, Kerselaers W, Dockens R, Soares H, Kaplita S, Luo F, Pachai C, Bracoud L, Mintun M, Grill JD, Marek K, Seibyl J, Cedarbaum JM, Albright C, Feldman HH, Berman RM.","JAMA Neurol. 2015 Nov;72(11):1324-33. doi: 10.1001/jamaneurol.2015.0607.","Coric V","JAMA Neurol","2015","2015/09/29","","","10.1001/jamaneurol.2015.0607"
"14617718","A randomised placebo controlled study to assess the effects of cholinergic treatment on muscarinic receptors in Alzheimer's disease","Kemp PM, Holmes C, Hoffmann S, Wilkinson S, Zivanovic M, Thom J, Bolt L, Fleming J, Wilkinson DG.","J Neurol Neurosurg Psychiatry. 2003 Nov;74(11):1567-70. doi: 10.1136/jnnp.74.11.1567.","Kemp PM","J Neurol Neurosurg Psychiatry","2003","2003/11/18","PMC1738233","","10.1136/jnnp.74.11.1567"
"3001233","Effect of naltrexone on senile dementia of the Alzheimer type","Hyman BT, Eslinger PJ, Damasio AR.","J Neurol Neurosurg Psychiatry. 1985 Nov;48(11):1169-71. doi: 10.1136/jnnp.48.11.1169.","Hyman BT","J Neurol Neurosurg Psychiatry","1985","1985/11/01","PMC1028579","","10.1136/jnnp.48.11.1169"
"9417975","Cholinergic neurotransmission has different effects on cerebral glucose consumption and blood flow in young normals, aged normals, and Alzheimer's disease patients","Blin J, Ivanoiu A, Coppens A, De Volder A, Labar D, Michel C, Laterre EC.","Neuroimage. 1997 Nov;6(4):335-43. doi: 10.1006/nimg.1997.0296.","Blin J","Neuroimage","1997","1998/02/07","","","10.1006/nimg.1997.0296"
"10867786","Assessing financial capacity in patients with Alzheimer disease: A conceptual model and prototype instrument","Marson DC, Sawrie SM, Snyder S, McInturff B, Stalvey T, Boothe A, Aldridge T, Chatterjee A, Harrell LE.","Arch Neurol. 2000 Jun;57(6):877-84. doi: 10.1001/archneur.57.6.877.","Marson DC","Arch Neurol","2000","2000/06/27","","","10.1001/archneur.57.6.877"
"18474729","Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib","ADAPT Research Group; Martin BK, Szekely C, Brandt J, Piantadosi S, Breitner JC, Craft S, Evans D, Green R, Mullan M.","Arch Neurol. 2008 Jul;65(7):896-905. doi: 10.1001/archneur.2008.65.7.nct70006. Epub 2008 May 12.","ADAPT Research Group","Arch Neurol","2008","2008/05/14","PMC2925195","NIHMS226281","10.1001/archneur.2008.65.7.nct70006"
"11790638","Brain proton magnetic resonance spectroscopy in Alzheimer disease: changes after treatment with xanomeline","Frederick Bd, Satlin A, Wald LL, Hennen J, Bodick N, Renshaw PF.","Am J Geriatr Psychiatry. 2002 Jan-Feb;10(1):81-8.","Frederick Bd","Am J Geriatr Psychiatry","2002","2002/01/16","","",""
"23412645","Mental exercises for cognitive function: clinical evidence","Kawashima R.","J Prev Med Public Health. 2013 Jan;46 Suppl 1(Suppl 1):S22-7. doi: 10.3961/jpmph.2013.46.S.S22. Epub 2013 Jan 30.","Kawashima R","J Prev Med Public Health","2013","2013/02/16","PMC3567314","","10.3961/jpmph.2013.46.S.S22"
"32667654","Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial","Koch G, Motta C, Bonnì S, Pellicciari MC, Picazio S, Casula EP, Maiella M, Di Lorenzo F, Ponzo V, Ferrari C, Scaricamazza E, Caltagirone C, Martorana A.","JAMA Netw Open. 2020 Jul 1;3(7):e2010372. doi: 10.1001/jamanetworkopen.2020.10372.","Koch G","JAMA Netw Open","2020","2020/07/16","PMC7364345","","10.1001/jamanetworkopen.2020.10372"
"9342643","Individual differences in auditory middle latency responses in elderly adults and patients with Alzheimer's disease","Phillips NA, Connolly JF, Mate-Kole CC, Gray J.","Int J Psychophysiol. 1997 Sep;27(2):125-36. doi: 10.1016/s0167-8760(97)00051-2.","Phillips NA","Int J Psychophysiol","1997","1997/10/29","","","10.1016/s0167-8760(97)00051-2"
"22631442","Practical lessons from amyloid immunotherapy trials in Alzheimer disease","Solomon A, Akenine U, Andreasen N, Mangialasche F, Wimo A, Jelic V, Kivipelto M, Winblad B.","Curr Alzheimer Res. 2012 Dec;9(10):1126-34. doi: 10.2174/156720512804142958.","Solomon A","Curr Alzheimer Res","2012","2012/05/29","","","10.2174/156720512804142958"
"34101779","Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer's Disease","Kellar D, Lockhart SN, Aisen P, Raman R, Rissman RA, Brewer J, Craft S.","J Prev Alzheimers Dis. 2021;8(3):240-248. doi: 10.14283/jpad.2021.14.","Kellar D","J Prev Alzheimers Dis","2021","2021/06/08","","","10.14283/jpad.2021.14"
"16945217","Transcranial and extracranial ultrasound assessment of cerebral hemodynamics in vascular and Alzheimer's dementia","Doepp F, Valdueza JM, Schreiber SJ.","Neurol Res. 2006 Sep;28(6):645-9. doi: 10.1179/016164106X130380.","Doepp F","Neurol Res","2006","2006/09/02","","","10.1179/016164106X130380"
"22023759","The role of reelin gene polymorphisms in the pathogenesis of Alzheimer's disease in a Greek population","Antoniades D, Katopodi T, Pappa S, Lampropoulos A, Konsta V, Frydas E, Mpalogiannis S, Hatzistilianou M.","J Biol Regul Homeost Agents. 2011 Jul-Sep;25(3):351-8.","Antoniades D","J Biol Regul Homeost Agents","2011","2011/10/26","","",""
"25379952","Trazodone and cognitive performance in Alzheimer disease","Camargos EF, Quintas JL, Louzada LL, Naves JO, Furioso AC, Nóbrega OT.","J Clin Psychopharmacol. 2015 Feb;35(1):88-9. doi: 10.1097/JCP.0000000000000237.","Camargos EF","J Clin Psychopharmacol","2015","2014/11/08","","","10.1097/JCP.0000000000000237"
"20930279","Phenserine efficacy in Alzheimer's disease","Winblad B, Giacobini E, Frölich L, Friedhoff LT, Bruinsma G, Becker RE, Greig NH.","J Alzheimers Dis. 2010;22(4):1201-8. doi: 10.3233/JAD-2010-101311.","Winblad B","J Alzheimers Dis","2010","2010/10/09","PMC5161452","NIHMS836235","10.3233/JAD-2010-101311"
"17998454","Statins differentially affect amyloid precursor protein metabolism in presymptomatic PS1 and non-PS1 subjects","Hinerfeld DA, Moonis M, Swearer JM, Baker SP, Caselli RJ, Rogaeva E, St George-Hyslop P, Pollen DA.","Arch Neurol. 2007 Nov;64(11):1672-3. doi: 10.1001/archneur.64.11.1672.","Hinerfeld DA","Arch Neurol","2007","2007/11/14","","","10.1001/archneur.64.11.1672"
"36581878","CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer's disease","Lerner AJ, Arnold SE, Maxfield E, Koenig A, Toth ME, Fortin B, Mast N, Trombetta BA, Denker J, Pieper AA, Tatsuoka C, Raghupathy S, Pikuleva IA.","Alzheimers Res Ther. 2022 Dec 29;14(1):198. doi: 10.1186/s13195-022-01151-z.","Lerner AJ","Alzheimers Res Ther","2022","2022/12/29","PMC9797897","","10.1186/s13195-022-01151-z"
"15259398","Nicotine and sensory memory in Alzheimer's disease: an event-related potential study","Engeland C, Mahoney C, Mohr E, Ilivitsky V, Knott V.","Brain Cogn. 2002 Jul;49(2):232-4.","Engeland C","Brain Cogn","2002","2004/07/21","","",""
"19358086","[Effects of a training of power and balance on the use of mechanical restraint among in-patients with dementia]","Steinert T, Bohnet U, Flammer E, Lüchtenberg D, Eisele F.","Psychiatr Prax. 2009 Sep;36(6):273-8. doi: 10.1055/s-0028-1090216. Epub 2009 Apr 8.","Steinert T","Psychiatr Prax","2009","2009/04/10","","","10.1055/s-0028-1090216"
"21929736","Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer's disease","Kume K, Hanyu H, Sakurai H, Takada Y, Onuma T, Iwamoto T.","Geriatr Gerontol Int. 2012 Apr;12(2):207-14. doi: 10.1111/j.1447-0594.2011.00746.x. Epub 2011 Sep 19.","Kume K","Geriatr Gerontol Int","2012","2011/09/21","","","10.1111/j.1447-0594.2011.00746.x"
"8940864","[Tau protein in cerebrospinal fluid--a potential marker of Alzheimer's disease]","Arai H, Satoh K, Terajima M, Nakagawa T, Higuchi M, Kosaka Y, Zhu C, Sasaki H.","Nihon Ronen Igakkai Zasshi. 1996 Sep;33(9):669-75. doi: 10.3143/geriatrics.33.669.","Arai H","Nihon Ronen Igakkai Zasshi","1996","1996/09/01","","","10.3143/geriatrics.33.669"
"10192639","Assessing individual patients for cognitive benefits from acetylcholinesterase inhibitors","Sands LP, Katz I, Schneider L.","Alzheimer Dis Assoc Disord. 1999 Jan;13(1):26-33. doi: 10.1097/00002093-199903000-00004.","Sands LP","Alzheimer Dis Assoc Disord","1999","1999/04/07","","","10.1097/00002093-199903000-00004"
"34044875","A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's disease","Prins ND, Harrison JE, Chu HM, Blackburn K, Alam JJ, Scheltens P; REVERSE-SD Study Investigators.","Alzheimers Res Ther. 2021 May 27;13(1):106. doi: 10.1186/s13195-021-00843-2.","Prins ND","Alzheimers Res Ther","2021","2021/05/28","PMC8157623","","10.1186/s13195-021-00843-2"
"16138529","Care intervention for older adults with Alzheimer's disease and related dementias: effect of family involvement on cognitive and functional outcomes in nursing homes","Jablonski RA, Reed D, Maas ML.","J Gerontol Nurs. 2005 Jun;31(6):38-48. doi: 10.3928/0098-9134-20050601-10.","Jablonski RA","J Gerontol Nurs","2005","2005/09/06","","","10.3928/0098-9134-20050601-10"
"2688700","Combined administration of physostigmine and clonidine to patients with dementia of the Alzheimer type: a pilot safety study","Davidson M, Bierer LM, Kaminsky R, Ryan TM, Davis KL.","Alzheimer Dis Assoc Disord. 1989 Winter;3(4):224-7.","Davidson M","Alzheimer Dis Assoc Disord","1989","1989/01/01","","",""
"17101889","Improving caregiver well-being delays nursing home placement of patients with Alzheimer disease","Mittelman MS, Haley WE, Clay OJ, Roth DL.","Neurology. 2006 Nov 14;67(9):1592-9. doi: 10.1212/01.wnl.0000242727.81172.91.","Mittelman MS","Neurology","2006","2006/11/15","","","10.1212/01.wnl.0000242727.81172.91"
"9236571","Effect of tacrine on language, praxis, and noncognitive behavioral problems in Alzheimer disease","Raskind MA, Sadowsky CH, Sigmund WR, Beitler PJ, Auster SB.","Arch Neurol. 1997 Jul;54(7):836-40. doi: 10.1001/archneur.1997.00550190026010.","Raskind MA","Arch Neurol","1997","1997/07/01","","","10.1001/archneur.1997.00550190026010"
"7582042","Therapeutic trials in Alzheimer's disease","Whitehouse PJ, Voci J.","Curr Opin Neurol. 1995 Aug;8(4):275-8. doi: 10.1097/00019052-199508000-00005.","Whitehouse PJ","Curr Opin Neurol","1995","1995/08/01","","","10.1097/00019052-199508000-00005"
"23164552","Impact of molecular imaging on the diagnostic process in a memory clinic","Ossenkoppele R, Prins ND, Pijnenburg YA, Lemstra AW, van der Flier WM, Adriaanse SF, Windhorst AD, Handels RL, Wolfs CA, Aalten P, Verhey FR, Verbeek MM, van Buchem MA, Hoekstra OS, Lammertsma AA, Scheltens P, van Berckel BN.","Alzheimers Dement. 2013 Jul;9(4):414-21. doi: 10.1016/j.jalz.2012.07.003. Epub 2012 Nov 16.","Ossenkoppele R","Alzheimers Dement","2013","2012/11/21","","","10.1016/j.jalz.2012.07.003"
"14764998","False recognition in Alzheimer disease: evidence from categorized pictures","Budson AE, Michalska KJ, Sullivan AL, Rentz DM, Daffner KR, Schacter DL.","Cogn Behav Neurol. 2003 Mar;16(1):16-27. doi: 10.1097/00146965-200303000-00003.","Budson AE","Cogn Behav Neurol","2003","2004/02/07","","","10.1097/00146965-200303000-00003"
"35183180","Costs associated with treatment of insomnia in Alzheimer's disease caregivers: a comparison of mindfulness meditation and cognitive behavioral therapy for insomnia","Bentley TGK, Castillo D, Sadeghi N, Piber D, Carroll J, Olmstead R, Irwin MR.","BMC Health Serv Res. 2022 Feb 19;22(1):231. doi: 10.1186/s12913-022-07619-w.","Bentley TGK","BMC Health Serv Res","2022","2022/02/20","PMC8858547","","10.1186/s12913-022-07619-w"
"18093312","The development of a theory-based intervention to promote appropriate disclosure of a diagnosis of dementia","Foy R, Francis JJ, Johnston M, Eccles M, Lecouturier J, Bamford C, Grimshaw J.","BMC Health Serv Res. 2007 Dec 19;7:207. doi: 10.1186/1472-6963-7-207.","Foy R","BMC Health Serv Res","2007","2007/12/21","PMC2211296","","10.1186/1472-6963-7-207"
"1822317","Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study","Senin U, Abate G, Fieschi C, Gori G, Guala A, Marini G, Villardita C, Parnetti L.","Eur Neuropsychopharmacol. 1991 Dec;1(4):511-7. doi: 10.1016/0924-977x(91)90004-e.","Senin U","Eur Neuropsychopharmacol","1991","1991/12/01","","","10.1016/0924-977x(91)90004-e"
"25344383","Increased CSF APPs-α levels in patients with Alzheimer disease treated with acitretin","Endres K, Fahrenholz F, Lotz J, Hiemke C, Teipel S, Lieb K, Tüscher O, Fellgiebel A.","Neurology. 2014 Nov 18;83(21):1930-5. doi: 10.1212/WNL.0000000000001017. Epub 2014 Oct 24.","Endres K","Neurology","2014","2014/10/26","","","10.1212/WNL.0000000000001017"
"12928050","Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease","Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P.","Neurobiol Aging. 2003 Nov;24(7):915-9. doi: 10.1016/s0197-4580(03)00031-9.","Rinaldi P","Neurobiol Aging","2003","2003/08/21","","","10.1016/s0197-4580(03)00031-9"
"1490430","Aluminium and the pathogenesis of Alzheimer's disease: a summary of evidence","McLachlan DR, Fraser PE, Dalton AJ.","Ciba Found Symp. 1992;169:87-98; discussion 99-108. doi: 10.1002/9780470514306.ch6.","McLachlan DR","Ciba Found Symp","1992","1992/01/01","","","10.1002/9780470514306.ch6"
"9578672","[Usefulness of SPECT in the study of Alzheimer's disease]","Blanco A, Alberca R, Marqués, López Domínguez JM, Gil Néciga E, Carrizosa E.","Neurologia. 1998 Feb;13(2):63-8.","Blanco A","Neurologia","1998","1998/05/14","","",""
"20164553","Radiofrequency fields, transthyretin, and Alzheimer's disease","Söderqvist F, Hardell L, Carlberg M, Mild KH.","J Alzheimers Dis. 2010;20(2):599-606. doi: 10.3233/JAD-2010-1395.","Söderqvist F","J Alzheimers Dis","2010","2010/02/19","","","10.3233/JAD-2010-1395"
"7023592","Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia","Christie JE, Shering A, Ferguson J, Glen AI.","Br J Psychiatry. 1981 Jan;138:46-50. doi: 10.1192/bjp.138.1.46.","Christie JE","Br J Psychiatry","1981","1981/01/01","","","10.1192/bjp.138.1.46"
"18949763","Effectiveness of a psychoeducational intervention program in the reduction of caregiver burden in Alzheimer's disease patients' caregivers","Martín-Carrasco M, Martín MF, Valero CP, Millán PR, García CI, Montalbán SR, Vázquez AL, Piris SP, Vilanova MB.","Int J Geriatr Psychiatry. 2009 May;24(5):489-99. doi: 10.1002/gps.2142.","Martín-Carrasco M","Int J Geriatr Psychiatry","2009","2008/10/25","","","10.1002/gps.2142"
"22330824","Effect of six months of treatment with V0191 in patients with suspected prodromal Alzheimer's disease","Dubois B, Zaim M, Touchon J, Vellas B, Robert P, Murphy MF, Pujadas-Navinés F, Rainer M, Soininen H, Riordan HJ, Kanony-Truc C.","J Alzheimers Dis. 2012;29(3):527-35. doi: 10.3233/JAD-2012-111370.","Dubois B","J Alzheimers Dis","2012","2012/02/15","","","10.3233/JAD-2012-111370"
"28381506","A phase 3 trial of IV immunoglobulin for Alzheimer disease","Relkin NR, Thomas RG, Rissman RA, Brewer JB, Rafii MS, van Dyck CH, Jack CR, Sano M, Knopman DS, Raman R, Szabo P, Gelmont DM, Fritsch S, Aisen PS; Alzheimer's Disease Cooperative Study.","Neurology. 2017 May 2;88(18):1768-1775. doi: 10.1212/WNL.0000000000003904. Epub 2017 Apr 5.","Relkin NR","Neurology","2017","2017/04/07","PMC5409846","","10.1212/WNL.0000000000003904"
"11044777","Intrathecal release of nitric oxide in Alzheimer's disease and vascular dementia","Tarkowski E, Ringqvist A, Blennow K, Wallin A, Wennmalm A.","Dement Geriatr Cogn Disord. 2000 Nov-Dec;11(6):322-6. doi: 10.1159/000017261.","Tarkowski E","Dement Geriatr Cogn Disord","2000","2000/10/25","","","10.1159/000017261"
"9532344","Adrenal responsivity in normal aging and mild to moderate Alzheimer's disease","Rasmuson S, Näsman B, Eriksson S, Carlström K, Olsson T.","Biol Psychiatry. 1998 Mar 15;43(6):401-7. doi: 10.1016/s0006-3223(97)00283-7.","Rasmuson S","Biol Psychiatry","1998","1998/04/09","","","10.1016/s0006-3223(97)00283-7"
"29570705","Random support vector machine cluster analysis of resting-state fMRI in Alzheimer's disease","Bi XA, Shu Q, Sun Q, Xu Q.","PLoS One. 2018 Mar 23;13(3):e0194479. doi: 10.1371/journal.pone.0194479. eCollection 2018.","Bi XA","PLoS One","2018","2018/03/24","PMC5865739","","10.1371/journal.pone.0194479"
"1673209","Tacrine in Alzheimer's disease","Eagger SA, Levy R, Sahakian BJ.","Lancet. 1991 Apr 27;337(8748):989-92. doi: 10.1016/0140-6736(91)92656-m.","Eagger SA","Lancet","1991","1991/04/27","","","10.1016/0140-6736(91)92656-m"
"15800138","Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?","Hashimoto M, Kazui H, Matsumoto K, Nakano Y, Yasuda M, Mori E.","Am J Psychiatry. 2005 Apr;162(4):676-82. doi: 10.1176/appi.ajp.162.4.676.","Hashimoto M","Am J Psychiatry","2005","2005/04/01","","","10.1176/appi.ajp.162.4.676"
"10363287","[A proposal for application and scoring of the Clock Drawing Test in Alzheimer's disease]","Cacho J, García-García R, Arcaya J, Vicente JL, Lantada N.","Rev Neurol. 1999 Apr 1-15;28(7):648-55.","Cacho J","Rev Neurol","1999","1999/06/11","","",""
"28671332","Association between malnutrition and hyperhomocysteine in Alzheimer's disease patients and diet intervention of betaine","Sun J, Wen S, Zhou J, Ding S.","J Clin Lab Anal. 2017 Sep;31(5):e22090. doi: 10.1002/jcla.22090. Epub 2016 Nov 7.","Sun J","J Clin Lab Anal","2017","2017/07/04","PMC6817125","","10.1002/jcla.22090"
"10198825","NGF content in the cerebral cortex of non-demented patients with amyloid-plaques and in symptomatic Alzheimer's disease","Hellweg R, Gericke CA, Jendroska K, Hartung HD, Cervós-Navarro J.","Int J Dev Neurosci. 1998 Nov-Dec;16(7-8):787-94. doi: 10.1016/s0736-5748(98)00088-4.","Hellweg R","Int J Dev Neurosci","1998","1999/04/13","","","10.1016/s0736-5748(98)00088-4"
"8666469","The effects of a life review program on disorientation, social interaction and self-esteem of nursing home residents","Tabourne CE.","Int J Aging Hum Dev. 1995;41(3):251-66. doi: 10.2190/EG53-878E-MGRK-BCPP.","Tabourne CE","Int J Aging Hum Dev","1995","1995/01/01","","","10.2190/EG53-878E-MGRK-BCPP"
"10421878","Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease","Gilmor ML, Erickson JD, Varoqui H, Hersh LB, Bennett DA, Cochran EJ, Mufson EJ, Levey AI.","J Comp Neurol. 1999 Sep 6;411(4):693-704.","Gilmor ML","J Comp Neurol","1999","1999/07/28","","",""
"32449919","Orthostatic Blood Pressure Recovery Is Associated With the Rate of Cognitive Decline and Mortality in Clinical Alzheimer's Disease","de Heus RAA, de Jong DLK, Rijpma A, Lawlor BA, Olde Rikkert MGM, Claassen JAHR.","J Gerontol A Biol Sci Med Sci. 2020 Oct 15;75(11):2169-2176. doi: 10.1093/gerona/glaa129.","de Heus RAA","J Gerontol A Biol Sci Med Sci","2020","2020/05/26","PMC7566323","","10.1093/gerona/glaa129"
"11204323","[Apolipoprotein E(ApoE)and tau protein in Alzheimer type dementia]","Paradowski B, Szczepaniak M, Dobosz T, Sasiadek M.","Pol Merkur Lekarski. 2000 Nov;9(53):758-9.","Paradowski B","Pol Merkur Lekarski","2000","2001/02/24","","",""
"32411323","Oxidative Stress and Dementia in Alzheimer's Patients: Effects of Synbiotic Supplementation","Ton AMM, Campagnaro BP, Alves GA, Aires R, Côco LZ, Arpini CM, Guerra E Oliveira T, Campos-Toimil M, Meyrelles SS, Pereira TMC, Vasquez EC.","Oxid Med Cell Longev. 2020 Jan 13;2020:2638703. doi: 10.1155/2020/2638703. eCollection 2020.","Ton AMM","Oxid Med Cell Longev","2020","2020/05/16","PMC7201593","","10.1155/2020/2638703"
"11445252","Hippocampal formation glucose metabolism and volume losses in MCI and AD","De Santi S, de Leon MJ, Rusinek H, Convit A, Tarshish CY, Roche A, Tsui WH, Kandil E, Boppana M, Daisley K, Wang GJ, Schlyer D, Fowler J.","Neurobiol Aging. 2001 Jul-Aug;22(4):529-39. doi: 10.1016/s0197-4580(01)00230-5.","De Santi S","Neurobiol Aging","2001","2001/07/11","","","10.1016/s0197-4580(01)00230-5"
"10759111","Effect of oral administration of L-arginine on senile dementia","Ohtsuka Y, Nakaya J.","Am J Med. 2000 Apr 1;108(5):439. doi: 10.1016/s0002-9343(99)00396-4.","Ohtsuka Y","Am J Med","2000","2000/04/12","","","10.1016/s0002-9343(99)00396-4"
"2082953","Lack of efficacy of hydergine in patients with Alzheimer's disease","Thompson TL 2nd, Filley CM, Mitchell WD, Culig KM, LoVerde M, Byyny RL.","N Engl J Med. 1990 Aug 16;323(7):445-8. doi: 10.1056/NEJM199008163230704.","Thompson TL 2nd","N Engl J Med","1990","1990/08/16","","","10.1056/NEJM199008163230704"
"17944896","The effect of ambient bright light therapy on depressive symptoms in persons with dementia","Hickman SE, Barrick AL, Williams CS, Zimmerman S, Connell BR, Preisser JS, Mitchell CM, Sloane PD.","J Am Geriatr Soc. 2007 Nov;55(11):1817-24. doi: 10.1111/j.1532-5415.2007.01428.x. Epub 2007 Oct 16.","Hickman SE","J Am Geriatr Soc","2007","2007/10/20","","","10.1111/j.1532-5415.2007.01428.x"
"15852017","A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease","Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, Bakay R, Patel P, Blesch A, Vahlsing HL, Ho G, Tong G, Potkin SG, Fallon J, Hansen L, Mufson EJ, Kordower JH, Gall C, Conner J.","Nat Med. 2005 May;11(5):551-5. doi: 10.1038/nm1239. Epub 2005 Apr 24.","Tuszynski MH","Nat Med","2005","2005/04/27","","","10.1038/nm1239"
"10223255","Relationship between denial of memory deficit and dementia severity in Alzheimer disease","Sevush S.","Neuropsychiatry Neuropsychol Behav Neurol. 1999 Apr;12(2):88-94.","Sevush S","Neuropsychiatry Neuropsychol Behav Neurol","1999","1999/05/01","","",""
"27231129","Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer Disease","Dumanski JP, Lambert JC, Rasi C, Giedraitis V, Davies H, Grenier-Boley B, Lindgren CM, Campion D, Dufouil C; European Alzheimer’s Disease Initiative Investigators; Pasquier F, Amouyel P, Lannfelt L, Ingelsson M, Kilander L, Lind L, Forsberg LA.","Am J Hum Genet. 2016 Jun 2;98(6):1208-1219. doi: 10.1016/j.ajhg.2016.05.014. Epub 2016 May 23.","Dumanski JP","Am J Hum Genet","2016","2016/05/28","PMC4908225","","10.1016/j.ajhg.2016.05.014"
"10855461","A prospective PMS study to validate the sensitivity for change of the D-scale in advanced stages of dementia using the NMDA-antagonist memantine","Rüther E, Glaser A, Bleich S, Degner D, Wiltfang J.","Pharmacopsychiatry. 2000 May;33(3):103-8. doi: 10.1055/s-2000-341.","Rüther E","Pharmacopsychiatry","2000","2000/06/16","","","10.1055/s-2000-341"
"11391090","The disability assessment for dementia scale: a 12-month study of functional ability in mild to moderate severity Alzheimer disease","Feldman H, Sauter A, Donald A, Gélinas I, Gauthier S, Torfs K, Parys W, Mehnert A.","Alzheimer Dis Assoc Disord. 2001 Apr-Jun;15(2):89-95. doi: 10.1097/00002093-200104000-00008.","Feldman H","Alzheimer Dis Assoc Disord","2001","2001/06/08","","","10.1097/00002093-200104000-00008"
"12803428","Working memory in mild Alzheimer's disease and early Parkinson's disease","Kensinger EA, Shearer DK, Locascio JJ, Growdon JH, Corkin S.","Neuropsychology. 2003 Apr;17(2):230-9. doi: 10.1037/0894-4105.17.2.230.","Kensinger EA","Neuropsychology","2003","2003/06/14","","","10.1037/0894-4105.17.2.230"
"11044776","Acetylcholinesterase inhibition in dementia with Lewy bodies: results of a prospective pilot trial","Querfurth HW, Allam GJ, Geffroy MA, Schiff HB, Kaplan RF.","Dement Geriatr Cogn Disord. 2000 Nov-Dec;11(6):314-21. doi: 10.1159/000017260.","Querfurth HW","Dement Geriatr Cogn Disord","2000","2000/10/25","","","10.1159/000017260"
"20878665","The effects on cognitive functions of a movement-based intervention in patients with Alzheimer's type dementia: a pilot study","Yágüez L, Shaw KN, Morris R, Matthews D.","Int J Geriatr Psychiatry. 2011 Feb;26(2):173-81. doi: 10.1002/gps.2510. Epub 2010 Sep 27.","Yágüez L","Int J Geriatr Psychiatry","2011","2010/09/30","","","10.1002/gps.2510"
"10550905","Music therapy increases serum melatonin levels in patients with Alzheimer's disease","Kumar AM, Tims F, Cruess DG, Mintzer MJ, Ironson G, Loewenstein D, Cattan R, Fernandez JB, Eisdorfer C, Kumar M.","Altern Ther Health Med. 1999 Nov;5(6):49-57.","Kumar AM","Altern Ther Health Med","1999","1999/11/07","","",""
"16315159","Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial","Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, Lee E, Greenspan A.","Int J Geriatr Psychiatry. 2005 Dec;20(12):1153-7. doi: 10.1002/gps.1409.","Brodaty H","Int J Geriatr Psychiatry","2005","2005/11/30","","","10.1002/gps.1409"
"15605367","Preliminary communication: urodynamic assessment of donepezil hydrochloride in patients with Alzheimer's disease","Sakakibara R, Uchiyama T, Yoshiyama M, Yamanishi T, Hattori T.","Neurourol Urodyn. 2005;24(3):273-5. doi: 10.1002/nau.20102.","Sakakibara R","Neurourol Urodyn","2005","2004/12/18","","","10.1002/nau.20102"
"36155516","Modulation of Amyloid-β and Tau in Alzheimer's Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin® and Donepezil","Alvarez XA, Winston CN, Barlow JW, Sarsoza FM, Alvarez I, Aleixandre M, Linares C, García-Fantini M, Kastberger B, Winter S, Rissman RA.","J Alzheimers Dis. 2022;90(2):705-717. doi: 10.3233/JAD-220575.","Alvarez XA","J Alzheimers Dis","2022","2022/09/26","PMC9697063","","10.3233/JAD-220575"
"25616438","Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study","Wang X, Hjorth E, Vedin I, Eriksdotter M, Freund-Levi Y, Wahlund LO, Cederholm T, Palmblad J, Schultzberg M.","J Lipid Res. 2015 Mar;56(3):674-681. doi: 10.1194/jlr.P055418. Epub 2015 Jan 23.","Wang X","J Lipid Res","2015","2015/01/25","PMC4340314","","10.1194/jlr.P055418"
"8386005","An ACTH 4-9 analog (Org 2766) and cognitive performance: high-dose efficacy and safety in dementia of the Alzheimer's type","Miller TP, Fong K, Tinklenberg JR.","Biol Psychiatry. 1993 Feb 15;33(4):307-9. doi: 10.1016/0006-3223(93)90303-u.","Miller TP","Biol Psychiatry","1993","1993/02/15","","","10.1016/0006-3223(93)90303-u"
"22314267","The profile of hippocampal metabolites differs between Alzheimer's disease and subcortical ischemic vascular dementia, as measured by proton magnetic resonance spectroscopy","Shiino A, Watanabe T, Shirakashi Y, Kotani E, Yoshimura M, Morikawa S, Inubushi T, Akiguchi I.","J Cereb Blood Flow Metab. 2012 May;32(5):805-15. doi: 10.1038/jcbfm.2012.9. Epub 2012 Feb 8.","Shiino A","J Cereb Blood Flow Metab","2012","2012/02/09","PMC3345919","","10.1038/jcbfm.2012.9"
"12417380","Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease","Traykov L, Rigaud AS, Baudic S, Smagghe A, Boller F, Forette F.","J Neurol Sci. 2002 Nov 15;203-204:177-81. doi: 10.1016/s0022-510x(02)00287-3.","Traykov L","J Neurol Sci","2002","2002/11/06","","","10.1016/s0022-510x(02)00287-3"
"15718040","Fibroblast glutamate transport in aging and in AD: correlations with disease severity","Zoia CP, Tagliabue E, Isella V, Begni B, Fumagalli L, Brighina L, Appollonio I, Racchi M, Ferrarese C.","Neurobiol Aging. 2005 Jun;26(6):825-32. doi: 10.1016/j.neurobiolaging.2004.07.007.","Zoia CP","Neurobiol Aging","2005","2005/02/19","","","10.1016/j.neurobiolaging.2004.07.007"
"27598794","The impact of educational experiences on nursing students' knowledge and attitudes toward people with Alzheimer's disease: A mixed method study","Kimzey M, Mastel-Smith B, Alfred D.","Nurse Educ Today. 2016 Nov;46:57-63. doi: 10.1016/j.nedt.2016.08.031. Epub 2016 Aug 30.","Kimzey M","Nurse Educ Today","2016","2016/09/07","","","10.1016/j.nedt.2016.08.031"
"17364906","Estimating the effects of right median nerve stimulation on memory in Alzheimer's disease: a randomized controlled pilot study","Scherder EJ, Vuijk PJ, Swaab DF, van Someren EJ.","Exp Aging Res. 2007 Apr-Jun;33(2):177-86. doi: 10.1080/03610730701238915.","Scherder EJ","Exp Aging Res","2007","2007/03/17","","","10.1080/03610730701238915"
"12803424","Electrophysiological analysis of context effects in Alzheimer's disease","Schwartz TJ, Federmeier KD, Van Petten C, Salmon DP, Kutas M.","Neuropsychology. 2003 Apr;17(2):187-201. doi: 10.1037/0894-4105.17.2.187.","Schwartz TJ","Neuropsychology","2003","2003/06/14","","","10.1037/0894-4105.17.2.187"
"19355844","Responders to ChEI treatment of Alzheimer's disease show restitution of normal regional cortical activation","Venneri A, McGeown WJ, Shanks MF.","Curr Alzheimer Res. 2009 Apr;6(2):97-111. doi: 10.2174/156720509787602933.","Venneri A","Curr Alzheimer Res","2009","2009/04/10","","","10.2174/156720509787602933"
"15788274","Visual facial grasp","Riestra AR, Heilman KM.","Neurocase. 2004 Oct;10(5):363-5. doi: 10.1080/13554790490892211.","Riestra AR","Neurocase","2004","2005/03/25","","","10.1080/13554790490892211"
"22498844","Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease","Roberts JS, Chen CA, Uhlmann WR, Green RC.","Genet Med. 2012 Aug;14(8):742-8. doi: 10.1038/gim.2012.37. Epub 2012 Apr 12.","Roberts JS","Genet Med","2012","2012/04/14","PMC3718049","NIHMS461341","10.1038/gim.2012.37"
"8955958","Enhancement of immunoreactivity for NF-kappa B in human cerebral infarctions","Terai K, Matsuo A, McGeer EG, McGeer PL.","Brain Res. 1996 Nov 11;739(1-2):343-9. doi: 10.1016/s0006-8993(96)01073-6.","Terai K","Brain Res","1996","1996/11/11","","","10.1016/s0006-8993(96)01073-6"
"22782510","Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging","Whitwell JL, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Roberts RO, Boeve BF, Petersen RC, Jack CR Jr; Alzheimer Disease Neuroimaging Initiative.","Arch Neurol. 2012 May;69(5):614-22. doi: 10.1001/archneurol.2011.3029.","Whitwell JL","Arch Neurol","2012","2012/07/12","PMC3569033","NIHMS434028","10.1001/archneurol.2011.3029"
"16594879","A randomised controlled trial testing the impact of exercise on cognitive symptoms and disability of residents with dementia","Stevens J, Killeen M.","Contemp Nurse. 2006 Feb-Mar;21(1):32-40. doi: 10.5172/conu.2006.21.1.32.","Stevens J","Contemp Nurse","2006","2006/04/06","","","10.5172/conu.2006.21.1.32"
"30740833","Efficacy of animal-assisted therapy adapted to reality orientation therapy: measurement of salivary cortisol","Menna LF, Santaniello A, Gerardi F, Sansone M, Di Maggio A, Di Palma A, Perruolo G, D'Esposito V, Formisano P.","Psychogeriatrics. 2019 Sep;19(5):510-512. doi: 10.1111/psyg.12418. Epub 2019 Feb 10.","Menna LF","Psychogeriatrics","2019","2019/02/12","","","10.1111/psyg.12418"
"17100507","Overdependence on degraded gist memory in Alzheimer's disease","Gallo DA, Shahid KR, Olson MA, Solomon TM, Schacter DL, Budson AE.","Neuropsychology. 2006 Nov;20(6):625-32. doi: 10.1037/0894-4105.20.6.625.","Gallo DA","Neuropsychology","2006","2006/11/15","","","10.1037/0894-4105.20.6.625"
"23596063","Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden","Qiu C, von Strauss E, Bäckman L, Winblad B, Fratiglioni L.","Neurology. 2013 May 14;80(20):1888-94. doi: 10.1212/WNL.0b013e318292a2f9. Epub 2013 Apr 17.","Qiu C","Neurology","2013","2013/04/19","","","10.1212/WNL.0b013e318292a2f9"
"22801819","The essential dialogue: a Norwegian study of art communication in mental health care","Ingeberg MH, Wikstrøm BM, Berg A.","J Psychosoc Nurs Ment Health Serv. 2012 Aug;50(8):22-30. doi: 10.3928/02793695-20120703-01. Epub 2012 Jul 15.","Ingeberg MH","J Psychosoc Nurs Ment Health Serv","2012","2012/07/18","","","10.3928/02793695-20120703-01"
"2248080","Potential of moclobemide to improve cerebral insufficiency identified using a scopolamine model of aging and dementia","Wesnes K, Anand R, Lorscheid T.","Acta Psychiatr Scand Suppl. 1990;360:71-2. doi: 10.1111/j.1600-0447.1990.tb05338.x.","Wesnes K","Acta Psychiatr Scand Suppl","1990","1990/01/01","","","10.1111/j.1600-0447.1990.tb05338.x"
"15964100","Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype","Reger MA, Watson GS, Frey WH 2nd, Baker LD, Cholerton B, Keeling ML, Belongia DA, Fishel MA, Plymate SR, Schellenberg GD, Cherrier MM, Craft S.","Neurobiol Aging. 2006 Mar;27(3):451-8. doi: 10.1016/j.neurobiolaging.2005.03.016. Epub 2005 Jun 16.","Reger MA","Neurobiol Aging","2006","2005/06/21","","","10.1016/j.neurobiolaging.2005.03.016"
"8736567","Analysis of the episodic memory deficit in early Alzheimer's disease: evidence from the doors and people test","Greene JD, Baddeley AD, Hodges JR.","Neuropsychologia. 1996 Jun;34(6):537-51. doi: 10.1016/0028-3932(95)00151-4.","Greene JD","Neuropsychologia","1996","1996/06/01","","","10.1016/0028-3932(95)00151-4"
"1712206","Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl","Martignoni E, Bono G, Blandini F, Sinforiani E, Merlo P, Nappi G.","J Neural Transm Park Dis Dement Sect. 1991;3(1):15-25. doi: 10.1007/BF02251133.","Martignoni E","J Neural Transm Park Dis Dement Sect","1991","1991/01/01","","","10.1007/BF02251133"
"25220149","3.0 T MRI arterial spin labeling and magnetic resonance spectroscopy technology in the application of Alzheimer's disease","Zou JX, Wang MJ, Lei XJ, Chen XG.","Exp Gerontol. 2014 Dec;60:31-6. doi: 10.1016/j.exger.2014.09.009. Epub 2014 Sep 16.","Zou JX","Exp Gerontol","2014","2014/09/16","","","10.1016/j.exger.2014.09.009"
"35239819","Medication reconciliation role and value in Alzheimer's disease treatment","Shen X, Zhang Q, Shao W, Shi J, Liu B.","Arq Neuropsiquiatr. 2022 Mar;80(3):233-239. doi: 10.1590/0004-282X-ANP-2021-0147.","Shen X","Arq Neuropsiquiatr","2022","2022/03/03","PMC9648934","","10.1590/0004-282X-ANP-2021-0147"
"18999343","Semantic error patterns on the Boston Naming Test in normal aging, amnestic mild cognitive impairment, and mild Alzheimer's disease: is there semantic disruption?","Balthazar ML, Cendes F, Damasceno BP.","Neuropsychology. 2008 Nov;22(6):703-9. doi: 10.1037/a0012919.","Balthazar ML","Neuropsychology","2008","2008/11/13","","","10.1037/a0012919"
"2292704","Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine","Bottiglieri T, Godfrey P, Flynn T, Carney MW, Toone BK, Reynolds EH.","J Neurol Neurosurg Psychiatry. 1990 Dec;53(12):1096-8. doi: 10.1136/jnnp.53.12.1096.","Bottiglieri T","J Neurol Neurosurg Psychiatry","1990","1990/12/01","PMC488323","","10.1136/jnnp.53.12.1096"
"20622335","[Effect of compound Polygonum multiflorum extract on Alzheimer's disease]","Chen L, Huang J, Xue L.","Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Jun;35(6):612-5. doi: 10.3969/j.issn.1672-7347.2010.06.012.","Chen L","Zhong Nan Da Xue Xue Bao Yi Xue Ban","2010","2010/07/13","","","10.3969/j.issn.1672-7347.2010.06.012"
"23583234","Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data","Dysken MW, Guarino PD, Vertrees JE, Asthana S, Sano M, Llorente M, Pallaki M, Love S, Schellenberg GD, McCarten JR, Malphurs J, Prieto S, Chen P, Loreck DJ, Carney S, Trapp G, Bakshi RS, Mintzer JE, Heidebrink JL, Vidal-Cardona A, Arroyo LM, Cruz AR, Kowall NW, Chopra MP, Craft S, Thielke S, Turvey CL, Woodman C, Monnell KA, Gordon K, Tomaska J, Vatassery G.","Alzheimers Dement. 2014 Jan;10(1):36-44. doi: 10.1016/j.jalz.2013.01.014. Epub 2013 Apr 11.","Dysken MW","Alzheimers Dement","2014","2013/04/16","PMC4128187","NIHMS487996","10.1016/j.jalz.2013.01.014"
"33399511","Blood-Brain Barrier Opening with MRI-guided Focused Ultrasound Elicits Meningeal Venous Permeability in Humans with Early Alzheimer Disease","Mehta RI, Carpenter JS, Mehta RI, Haut MW, Ranjan M, Najib U, Lockman P, Wang P, D'haese PF, Rezai AR.","Radiology. 2021 Mar;298(3):654-662. doi: 10.1148/radiol.2021200643. Epub 2021 Jan 5.","Mehta RI","Radiology","2021","2021/01/05","PMC7924515","","10.1148/radiol.2021200643"
"32098256","CLIC1 Protein Accumulates in Circulating Monocyte Membrane during Neurodegeneration","Carlini V, Verduci I, Cianci F, Cannavale G, Fenoglio C, Galimberti D, Mazzanti M.","Int J Mol Sci. 2020 Feb 21;21(4):1484. doi: 10.3390/ijms21041484.","Carlini V","Int J Mol Sci","2020","2020/02/27","PMC7073046","","10.3390/ijms21041484"
"22207418","Auditory delta event-related oscillatory responses are decreased in Alzheimer's disease","Yener GG, Güntekin B, Örken DN, Tülay E, Forta H, Başar E.","Behav Neurol. 2012;25(1):3-11. doi: 10.3233/BEN-2012-0344.","Yener GG","Behav Neurol","2012","2011/12/31","PMC5294260","","10.3233/BEN-2012-0344"
"2753374","A controlled study of respite service for caregivers of Alzheimer's patients","Lawton MP, Brody EM, Saperstein AR.","Gerontologist. 1989 Feb;29(1):8-16. doi: 10.1093/geront/29.1.8.","Lawton MP","Gerontologist","1989","1989/02/01","","","10.1093/geront/29.1.8"
"15709131","Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images","Ishii K, Kawachi T, Sasaki H, Kono AK, Fukuda T, Kojima Y, Mori E.","AJNR Am J Neuroradiol. 2005 Feb;26(2):333-40.","Ishii K","AJNR Am J Neuroradiol","2005","2005/02/15","PMC7974092","",""
"8422658","Safety and efficacy of oral physostigmine in the treatment of Alzheimer disease","Sano M, Bell K, Marder K, Stricks L, Stern Y, Mayeux R.","Clin Neuropharmacol. 1993 Feb;16(1):61-9. doi: 10.1097/00002826-199302000-00007.","Sano M","Clin Neuropharmacol","1993","1993/02/01","","","10.1097/00002826-199302000-00007"
"9539236","Word reading in Alzheimer's disease: cross-sectional and longitudinal analyses of response time and accuracy data","Strain E, Patterson K, Graham N, Hodges JR.","Neuropsychologia. 1998 Feb;36(2):155-71. doi: 10.1016/s0028-3932(97)00092-4.","Strain E","Neuropsychologia","1998","1998/04/16","","","10.1016/s0028-3932(97)00092-4"
"12928049","Peripheral cytokine release in Alzheimer patients: correlation with disease severity","Sala G, Galimberti G, Canevari C, Raggi ME, Isella V, Facheris M, Appollonio I, Ferrarese C.","Neurobiol Aging. 2003 Nov;24(7):909-14. doi: 10.1016/s0197-4580(03)00010-1.","Sala G","Neurobiol Aging","2003","2003/08/21","","","10.1016/s0197-4580(03)00010-1"
"31326523","MIND food and speed of processing training in older adults with low education, the MINDSpeed Alzheimer's disease prevention pilot trial","Clark DO, Xu H, Moser L, Adeoye P, Lin AW, Tangney CC, Risacher SL, Saykin AJ, Considine RV, Unverzagt FW.","Contemp Clin Trials. 2019 Sep;84:105814. doi: 10.1016/j.cct.2019.105814. Epub 2019 Jul 18.","Clark DO","Contemp Clin Trials","2019","2019/07/22","PMC6721976","NIHMS1535843","10.1016/j.cct.2019.105814"
"16252379","A randomized trial of early psychiatric intervention in residential care: impact on health outcomes","Kotynia-English R, McGowan H, Almeida OP.","Int Psychogeriatr. 2005 Sep;17(3):475-85. doi: 10.1017/s1041610205001572.","Kotynia-English R","Int Psychogeriatr","2005","2005/10/28","","","10.1017/s1041610205001572"
"14579087","A new approach for improving diagnostic accuracy in Alzheimer's disease and frontal lobe dementia utilising the intrinsic properties of the SPET dataset","Pagani M, Kovalev VA, Lundqvist R, Jacobsson H, Larsson SA, Thurfjell L.","Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1481-8. doi: 10.1007/s00259-003-1196-z. Epub 2003 May 29.","Pagani M","Eur J Nucl Med Mol Imaging","2003","2003/10/28","","","10.1007/s00259-003-1196-z"
"10681082","Differences between Pick disease and Alzheimer disease in clinical appearance and rate of cognitive decline","Binetti G, Locascio JJ, Corkin S, Vonsattel JP, Growdon JH.","Arch Neurol. 2000 Feb;57(2):225-32. doi: 10.1001/archneur.57.2.225.","Binetti G","Arch Neurol","2000","2000/02/19","","","10.1001/archneur.57.2.225"
"11462798","Antihistamine agent Dimebon as a novel neuroprotector and a cognition enhancer","Bachurin S, Bukatina E, Lermontova N, Tkachenko S, Afanasiev A, Grigoriev V, Grigorieva I, Ivanov Y, Sablin S, Zefirov N.","Ann N Y Acad Sci. 2001 Jun;939:425-35. doi: 10.1111/j.1749-6632.2001.tb03654.x.","Bachurin S","Ann N Y Acad Sci","2001","2001/07/21","","","10.1111/j.1749-6632.2001.tb03654.x"
"22441582","Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET","Ossenkoppele R, Tolboom N, Foster-Dingley JC, Adriaanse SF, Boellaard R, Yaqub M, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN.","Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):990-1000. doi: 10.1007/s00259-012-2102-3. Epub 2012 Mar 23.","Ossenkoppele R","Eur J Nucl Med Mol Imaging","2012","2012/03/24","","","10.1007/s00259-012-2102-3"
"30145595","Effects of Physical Activity in Nursing Home Residents with Dementia: A Randomized Controlled Trial","Henskens M, Nauta IM, van Eekeren MCA, Scherder EJA.","Dement Geriatr Cogn Disord. 2018;46(1-2):60-80. doi: 10.1159/000491818. Epub 2018 Aug 24.","Henskens M","Dement Geriatr Cogn Disord","2018","2018/08/27","PMC6187838","","10.1159/000491818"
"15378678","Evidence for synergistic modulation of early information processing by nicotinic and muscarinic receptors in humans","Erskine FF, Ellis JR, Ellis KA, Stuber E, Hogan K, Miller V, Moore E, Bartholomeusz C, Harrison BJ, Lee B, Phan KL, Liley D, Nathan PJ.","Hum Psychopharmacol. 2004 Oct;19(7):503-9. doi: 10.1002/hup.613.","Erskine FF","Hum Psychopharmacol","2004","2004/09/21","","","10.1002/hup.613"
"8976498","Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: a pilot double blind transdermal nicotine positron emission tomography study","Parks RW, Becker RE, Rippey RF, Gilbert DG, Matthews JR, Kabatay E, Young CS, Vohs C, Danz V, Keim P, Collins GT, Zigler SS, Urycki PG.","Neuropsychol Rev. 1996 Jun;6(2):61-79. doi: 10.1007/BF01875368.","Parks RW","Neuropsychol Rev","1996","1996/06/01","","","10.1007/BF01875368"
"16274386","Mortality risk and prospective medicare expenditures for persons with dementia","Newcomer RJ, Clay TH, Yaffe K, Covinsky KE.","J Am Geriatr Soc. 2005 Nov;53(11):2001-6. doi: 10.1111/j.1532-5415.2005.00472.x.","Newcomer RJ","J Am Geriatr Soc","2005","2005/11/09","","","10.1111/j.1532-5415.2005.00472.x"
"9469265","Alanyl-aminopeptidase activity decrease in cerebrospinal fluid of Alzheimer patients","Iribar MC, Montes J, Gonzalez Maldonado R, Peinado JM.","Dement Geriatr Cogn Disord. 1998 Jan-Feb;9(1):44-9. doi: 10.1159/000017021.","Iribar MC","Dement Geriatr Cogn Disord","1998","1998/02/20","","","10.1159/000017021"
"34635802","The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer's disease: a randomized, triple-blind, placebo-controlled trial","Louzada LL, Machado FV, Quintas JL, Ribeiro GA, Silva MV, Mendonça-Silva DL, Gonçalves BSB, Nóbrega OT, Camargos EF.","Neuropsychopharmacology. 2022 Jan;47(2):570-579. doi: 10.1038/s41386-021-01191-3. Epub 2021 Oct 11.","Louzada LL","Neuropsychopharmacology","2022","2021/10/12","PMC8674235","","10.1038/s41386-021-01191-3"
"15123336","Effects of beta-hydroxybutyrate on cognition in memory-impaired adults","Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, Hyde K, Chapman D, Craft S.","Neurobiol Aging. 2004 Mar;25(3):311-4. doi: 10.1016/S0197-4580(03)00087-3.","Reger MA","Neurobiol Aging","2004","2004/05/05","","","10.1016/S0197-4580(03)00087-3"
"17914039","Donepezil for the treatment of agitation in Alzheimer's disease","Howard RJ, Juszczak E, Ballard CG, Bentham P, Brown RG, Bullock R, Burns AS, Holmes C, Jacoby R, Johnson T, Knapp M, Lindesay J, O'Brien JT, Wilcock G, Katona C, Jones RW, DeCesare J, Rodger M; CALM-AD Trial Group.","N Engl J Med. 2007 Oct 4;357(14):1382-92. doi: 10.1056/NEJMoa066583.","Howard RJ","N Engl J Med","2007","2007/10/05","","","10.1056/NEJMoa066583"
"8528370","Long-term effects of tacrine on regional cerebral blood flow changes in Alzheimer's disease","Minthon L, Nilsson K, Edvinsson L, Wendt PE, Gustafson L.","Dementia. 1995 Sep-Oct;6(5):245-51. doi: 10.1159/000106954.","Minthon L","Dementia","1995","1995/09/01","","","10.1159/000106954"
"7491368","Reduced beta-amyloid response in lymphocytes of patients with Alzheimer's disease","Bondy B, Hofmann M, Müller-Spahn F, Witzko M, Hock C.","Pharmacopsychiatry. 1995 Jul;28(4):143-6. doi: 10.1055/s-2007-979606.","Bondy B","Pharmacopsychiatry","1995","1995/07/01","","","10.1055/s-2007-979606"
"9133763","Memory, language, and praxis in Alzheimer's disease: norms for outpatient clinical trial populations","Doraiswamy PM, Bieber F, Kaiser L, Connors K, Krishnan KR, Reuning-Scherer J, Gulanski B.","Psychopharmacol Bull. 1997;33(1):123-8.","Doraiswamy PM","Psychopharmacol Bull","1997","1997/01/01","","",""
"9282480","Analysis of pattern reversal visual evoked potentials (PRVEP's) by spline wavelets","Ademoglu A, Micheli-Tzanakou E, Istefanopulos Y.","IEEE Trans Biomed Eng. 1997 Sep;44(9):881-90. doi: 10.1109/10.623057.","Ademoglu A","IEEE Trans Biomed Eng","1997","1997/09/01","","","10.1109/10.623057"
"9547469","Determinants of spontaneous extrapyramidal symptoms in elderly psychiatric inpatients diagnosed with Alzheimer's disease, major depressive disorder, or psychotic disorders","Sweet RA, Akil M, Mulsant BH, Ulrich R, Pasternak RE, Zubenko GS.","J Neuropsychiatry Clin Neurosci. 1998 Winter;10(1):68-77. doi: 10.1176/jnp.10.1.68.","Sweet RA","J Neuropsychiatry Clin Neurosci","1998","1998/04/21","","","10.1176/jnp.10.1.68"
"9240480","Performance of elderly White and African American community residents on the abbreviated CERAD Boston Naming Test","Fillenbaum GG, Huber M, Taussig IM.","J Clin Exp Neuropsychol. 1997 Apr;19(2):204-10. doi: 10.1080/01688639708403851.","Fillenbaum GG","J Clin Exp Neuropsychol","1997","1997/04/01","","","10.1080/01688639708403851"
"31613323","Is Ongoing Anticholinergic Burden Associated With Greater Cognitive Decline and Dementia Severity in Mild to Moderate Alzheimer's Disease?","Dyer AH, Murphy C, Segurado R, Lawlor B, Kennelly SP; NILVAD Study Group.","J Gerontol A Biol Sci Med Sci. 2020 Apr 17;75(5):987-994. doi: 10.1093/gerona/glz244.","Dyer AH","J Gerontol A Biol Sci Med Sci","2020","2019/10/16","","","10.1093/gerona/glz244"
"21593010","The impact of TCARE® on service recommendation, use, and caregiver well-being","Kwak J, Montgomery RJ, Kosloski K, Lang J.","Gerontologist. 2011 Oct;51(5):704-13. doi: 10.1093/geront/gnr047. Epub 2011 May 17.","Kwak J","Gerontologist","2011","2011/05/20","PMC3218637","","10.1093/geront/gnr047"
"30340468","Item distribution, internal consistency, and structural validity of the German version of the DEMQOL and DEMQOL-proxy","Schwab CGG, Dichter MN, Berwig M.","BMC Geriatr. 2018 Oct 19;18(1):247. doi: 10.1186/s12877-018-0930-0.","Schwab CGG","BMC Geriatr","2018","2018/10/21","PMC6194625","","10.1186/s12877-018-0930-0"
"29432613","Circulating Dkk1 and TRAIL Are Associated With Cognitive Decline in Community-Dwelling, Older Adults With Cognitive Concerns","Ross RD, Shah RC, Leurgans S, Bottiglieri T, Wilson RS, Sumner DR.","J Gerontol A Biol Sci Med Sci. 2018 Nov 10;73(12):1688-1694. doi: 10.1093/gerona/glx252.","Ross RD","J Gerontol A Biol Sci Med Sci","2018","2018/02/13","PMC6230213","","10.1093/gerona/glx252"
"18972062","Effect of copper intake on CSF parameters in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial","Kessler H, Pajonk FG, Bach D, Schneider-Axmann T, Falkai P, Herrmann W, Multhaup G, Wiltfang J, Schäfer S, Wirths O, Bayer TA.","J Neural Transm (Vienna). 2008 Dec;115(12):1651-9. doi: 10.1007/s00702-008-0136-2. Epub 2008 Oct 30.","Kessler H","J Neural Transm (Vienna)","2008","2008/10/31","","","10.1007/s00702-008-0136-2"
"17196712","Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine","Darreh-Shori T, Kadir A, Almkvist O, Grut M, Wall A, Blomquist G, Eriksson B, Långström B, Nordberg A.","Neurobiol Aging. 2008 Feb;29(2):168-84. doi: 10.1016/j.neurobiolaging.2006.09.020. Epub 2006 Dec 29.","Darreh-Shori T","Neurobiol Aging","2008","2007/01/02","","","10.1016/j.neurobiolaging.2006.09.020"
"27294873","Racial and Ethnic Differences in the Delivery of the Resources for Enhancing Alzheimer's Caregiver Health II Intervention","Graham-Phillips A, Roth DL, Huang J, Dilworth-Anderson P, Gitlin LN.","J Am Geriatr Soc. 2016 Aug;64(8):1662-7. doi: 10.1111/jgs.14204. Epub 2016 Jun 13.","Graham-Phillips A","J Am Geriatr Soc","2016","2016/06/14","PMC4988871","NIHMS770713","10.1111/jgs.14204"
"26058692","Reduced uptake of 18F-FDG and 15O-H2O in Alzheimer's disease-related regions after glucose loading","Ishibashi K, Kawasaki K, Ishiwata K, Ishii K.","J Cereb Blood Flow Metab. 2015 Aug;35(8):1380-5. doi: 10.1038/jcbfm.2015.127. Epub 2015 Jun 10.","Ishibashi K","J Cereb Blood Flow Metab","2015","2015/06/11","PMC4527997","","10.1038/jcbfm.2015.127"
"2355106","Clinical safety, tolerance, and plasma levels of the oral anticholinesterase 1,2,3,4-tetrahydro-9-aminoacridin-1-oL-maleate (HP 029) in Alzheimer's disease: preliminary findings","Cutler NR, Murphy MF, Nash RJ, Prior PL, De Luna DM.","J Clin Pharmacol. 1990 Jun;30(6):556-61. doi: 10.1002/j.1552-4604.1990.tb03620.x.","Cutler NR","J Clin Pharmacol","1990","1990/06/01","","","10.1002/j.1552-4604.1990.tb03620.x"
"10599054","Effects of time and cholinesterase inhibitor treatment on multiple cerebrospinal fluid parameters in Alzheimer's disease","Moriearty PL, Seubert P, Galasko D, Markwell S, Unni L, Vicari S, Becker RE.","Methods Find Exp Clin Pharmacol. 1999 Oct;21(8):549-54. doi: 10.1358/mf.1999.21.8.794837.","Moriearty PL","Methods Find Exp Clin Pharmacol","1999","1999/12/22","","","10.1358/mf.1999.21.8.794837"
"21917762","Chronic divalproex sodium use and brain atrophy in Alzheimer disease","Fleisher AS, Truran D, Mai JT, Langbaum JB, Aisen PS, Cummings JL, Jack CR Jr, Weiner MW, Thomas RG, Schneider LS, Tariot PN; Alzheimer's Disease Cooperative Study.","Neurology. 2011 Sep 27;77(13):1263-71. doi: 10.1212/WNL.0b013e318230a16c. Epub 2011 Sep 14.","Fleisher AS","Neurology","2011","2011/09/16","PMC3179645","","10.1212/WNL.0b013e318230a16c"
"23982674","Efficacy of higher dose 13.3 mg/24 h rivastigmine patch on instrumental activities of daily living in patients with mild-to-moderate Alzheimer's disease","Grossberg G, Cummings J, Frölich L, Bellelli G, Molinuevo JL, Krahnke T, Strohmaier C.","Am J Alzheimers Dis Other Demen. 2013 Sep;28(6):583-91. doi: 10.1177/1533317513495104.","Grossberg G","Am J Alzheimers Dis Other Demen","2013","2013/08/29","","","10.1177/1533317513495104"
"8637408","Double-blind placebo-controlled study of velnacrine in Alzheimer's disease","Zemlan FP, Keys M, Richter RW, Strub RL.","Life Sci. 1996;58(21):1823-32. doi: 10.1016/0024-3205(96)00166-x.","Zemlan FP","Life Sci","1996","1996/01/01","","","10.1016/0024-3205(96)00166-x"
"34193504","Repurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer's disease with presenilin 1 (PSEN1) mutations","Kondo T, Banno H, Okunomiya T, Amino Y, Endo K, Nakakura A, Uozumi R, Kinoshita A, Tada H, Morita S, Ishikawa H, Shindo A, Yasuda K, Taruno Y, Maki T, Suehiro T, Mori K, Ikeda M, Fujita K, Izumi Y, Kanemaru K, Ishii K, Shigenobu K, Kutoku Y, Sunada Y, Kawakatsu S, Shiota S, Watanabe T, Uchikawa O, Takahashi R, Tomimoto H, Inoue H.","BMJ Open. 2021 Jun 30;11(6):e051343. doi: 10.1136/bmjopen-2021-051343.","Kondo T","BMJ Open","2021","2021/07/01","PMC8246358","","10.1136/bmjopen-2021-051343"
"2236581","Nimodipine in the treatment of old age dementias","Ban TA, Morey L, Aguglia E, Azzarelli O, Balsano F, Marigliano V, Caglieris N, Sterlicchio M, Capurso A, Tomasi NA, et al.","Prog Neuropsychopharmacol Biol Psychiatry. 1990;14(4):525-51. doi: 10.1016/0278-5846(90)90005-2.","Ban TA","Prog Neuropsychopharmacol Biol Psychiatry","1990","1990/01/01","","","10.1016/0278-5846(90)90005-2"
"18835425","No change in total length of white matter fibers in Alzheimer's disease","Jørgensen AM, Marner L, Pakkenberg B.","Neuroscience. 2008 Dec 10;157(4):878-83. doi: 10.1016/j.neuroscience.2008.06.075. Epub 2008 Sep 10.","Jørgensen AM","Neuroscience","2008","2008/10/07","","","10.1016/j.neuroscience.2008.06.075"
"9442345","Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls)","Krasuski JS, Alexander GE, Horwitz B, Daly EM, Murphy DG, Rapoport SI, Schapiro MB.","Biol Psychiatry. 1998 Jan 1;43(1):60-8. doi: 10.1016/s0006-3223(97)00013-9.","Krasuski JS","Biol Psychiatry","1998","1998/01/27","","","10.1016/s0006-3223(97)00013-9"
"34251287","NM101 Phase III study of NE3107 in Alzheimer's disease: rationale, design and therapeutic modulation of neuroinflammation and insulin resistance","Reading CL, Ahlem CN, Murphy MF.","Neurodegener Dis Manag. 2021 Aug;11(4):289-298. doi: 10.2217/nmt-2021-0022. Epub 2021 Jul 12.","Reading CL","Neurodegener Dis Manag","2021","2021/07/12","","","10.2217/nmt-2021-0022"
"16401736","A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease","Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ.","Arch Neurol. 2006 Jan;63(1):49-54. doi: 10.1001/archneur.63.1.49.","Reisberg B","Arch Neurol","2006","2006/01/13","","","10.1001/archneur.63.1.49"
"20122038","Enhancing caregiver health: findings from the resources for enhancing Alzheimer's caregiver health II intervention","Elliott AF, Burgio LD, Decoster J.","J Am Geriatr Soc. 2010 Jan;58(1):30-7. doi: 10.1111/j.1532-5415.2009.02631.x.","Elliott AF","J Am Geriatr Soc","2010","2010/02/04","PMC2819276","NIHMS172521","10.1111/j.1532-5415.2009.02631.x"
"11419566","Efficacy of metrifonate in improving the psychiatric and behavioral disturbances of patients with Alzheimer's disease","Cummings JL, Nadel A, Masterman D, Cyrus PA.","J Geriatr Psychiatry Neurol. 2001 Summer;14(2):101-8. doi: 10.1177/089198870101400211.","Cummings JL","J Geriatr Psychiatry Neurol","2001","2001/06/23","","","10.1177/089198870101400211"
"22813231","The effect of stimulation therapy and donepezil on cognitive function in Alzheimer's disease. A community based RCT with a two-by-two factorial design","Andersen F, Viitanen M, Halvorsen DS, Straume B, Wilsgaard T, Engstad TA.","BMC Neurol. 2012 Jul 19;12:59. doi: 10.1186/1471-2377-12-59.","Andersen F","BMC Neurol","2012","2012/07/21","PMC3481364","","10.1186/1471-2377-12-59"
"22237255","Memantine in everyday clinical practice: a comparison of studies in Germany and Greece","Förstl H, Stamouli SS, Janetzky W, Galanopoulos A, Karageorgiou C, Tzanakaki M.","Dement Geriatr Cogn Disord. 2011;32(4):267-72. doi: 10.1159/000334991. Epub 2012 Jan 9.","Förstl H","Dement Geriatr Cogn Disord","2011","2012/01/13","","","10.1159/000334991"
"15494617","Disease stage in Alzheimer disease and treatment effects of rivastigmine","Kurz A, Farlow M, Quarg P, Spiegel R.","Alzheimer Dis Assoc Disord. 2004 Jul-Sep;18(3):123-8. doi: 10.1097/01.wad.0000127445.00442.a1.","Kurz A","Alzheimer Dis Assoc Disord","2004","2004/10/21","","","10.1097/01.wad.0000127445.00442.a1"
"23390181","Alzheimer disease in the United States (2010-2050) estimated using the 2010 census","Hebert LE, Weuve J, Scherr PA, Evans DA.","Neurology. 2013 May 7;80(19):1778-83. doi: 10.1212/WNL.0b013e31828726f5. Epub 2013 Feb 6.","Hebert LE","Neurology","2013","2013/02/08","PMC3719424","","10.1212/WNL.0b013e31828726f5"
"3114812","Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG","Gustafson L, Edvinsson L, Dahlgren N, Hagberg B, Risberg J, Rosén I, Fernö H.","Psychopharmacology (Berl). 1987;93(1):31-5. doi: 10.1007/BF02439583.","Gustafson L","Psychopharmacology (Berl)","1987","1987/01/01","","","10.1007/BF02439583"
"27079717","The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial","Berger M, Nadler JW, Friedman A, McDonagh DL, Bennett ER, Cooter M, Qi W, Laskowitz DT, Ponnusamy V, Newman MF, Shaw LM, Warner DS, Mathew JP, James ML; MAD-PIA trial team.","J Alzheimers Dis. 2016 Apr 15;52(4):1299-310. doi: 10.3233/JAD-151190.","Berger M","J Alzheimers Dis","2016","2016/04/16","PMC5938737","NIHMS962987","10.3233/JAD-151190"
"12901777","Primary progressive aphasia: diagnosis, varieties, evolution","Kertesz A, Davidson W, McCabe P, Takagi K, Munoz D.","J Int Neuropsychol Soc. 2003 Jul;9(5):710-9. doi: 10.1017/S1355617703950041.","Kertesz A","J Int Neuropsychol Soc","2003","2003/08/07","","","10.1017/S1355617703950041"
"9803423","Loss of dopamine D2 receptors in Alzheimer's disease with parkinsonism but not Parkinson's or Alzheimer's disease","Joyce JN, Murray AM, Hurtig HI, Gottlieb GL, Trojanowski JQ.","Neuropsychopharmacology. 1998 Dec;19(6):472-80. doi: 10.1016/S0893-133X(98)00044-X.","Joyce JN","Neuropsychopharmacology","1998","1998/11/06","","","10.1016/S0893-133X(98)00044-X"
"12611749","Effect of light on agitation in institutionalized patients with severe Alzheimer disease","Ancoli-Israel S, Martin JL, Gehrman P, Shochat T, Corey-Bloom J, Marler M, Nolan S, Levi L.","Am J Geriatr Psychiatry. 2003 Mar-Apr;11(2):194-203.","Ancoli-Israel S","Am J Geriatr Psychiatry","2003","2003/03/04","","",""
"26537053","Raloxifene for women with Alzheimer disease: A randomized controlled pilot trial","Henderson VW, Ala T, Sainani KL, Bernstein AL, Stephenson BS, Rosen AC, Farlow MR.","Neurology. 2015 Dec 1;85(22):1937-44. doi: 10.1212/WNL.0000000000002171. Epub 2015 Nov 4.","Henderson VW","Neurology","2015","2015/11/06","PMC4664126","","10.1212/WNL.0000000000002171"
"15115951","The clinical efficacy and safety of galantamine in the treatment of Alzheimer's disease","Dengiz AN, Kershaw P.","CNS Spectr. 2004 May;9(5):377-92. doi: 10.1017/s1092852900009378.","Dengiz AN","CNS Spectr","2004","2004/04/30","","","10.1017/s1092852900009378"
"29237271","Suvorexant for the treatment of insomnia in patients with Alzheimer's disease","Hamuro A, Honda M, Wakaura Y.","Aust N Z J Psychiatry. 2018 Feb;52(2):207-208. doi: 10.1177/0004867417747402. Epub 2017 Dec 14.","Hamuro A","Aust N Z J Psychiatry","2018","2017/12/15","","","10.1177/0004867417747402"
"7854546","What can preservation of autobiographic memory after muscarinic blockade tell us about the scopolamine model of dementia?","Litvan I, Sirigu A, Toothman J, Grafman J.","Neurology. 1995 Feb;45(2):387-9. doi: 10.1212/wnl.45.2.387.","Litvan I","Neurology","1995","1995/02/01","","","10.1212/wnl.45.2.387"
"36806506","Factors Associated with Participation in a Multidomain Web-Based Dementia Prevention Trial: Evidence from Maintain Your Brain (MYB)","Welberry HJ, Chau T, Heffernan M, San Jose JC, Jorm LR, Singh MF, Sachdev PS, Anstey KJ, Lautenschlager NT, Valenzuela M, McNeil JJ, Brodaty H.","J Alzheimers Dis. 2023;92(3):959-974. doi: 10.3233/JAD-220990.","Welberry HJ","J Alzheimers Dis","2023","2023/02/22","","","10.3233/JAD-220990"
"1776747","Evaluation of HP 029 (velnacrine maleate) in Alzheimer's disease","Murphy MF, Hardiman ST, Nash RJ, Huff FJ, Demkovich JJ, Dobson C, Knappe UE.","Ann N Y Acad Sci. 1991;640:253-62. doi: 10.1111/j.1749-6632.1991.tb00229.x.","Murphy MF","Ann N Y Acad Sci","1991","1991/01/01","","","10.1111/j.1749-6632.1991.tb00229.x"
"15537673","Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy","Lerch JP, Pruessner JC, Zijdenbos A, Hampel H, Teipel SJ, Evans AC.","Cereb Cortex. 2005 Jul;15(7):995-1001. doi: 10.1093/cercor/bhh200. Epub 2004 Nov 10.","Lerch JP","Cereb Cortex","2005","2004/11/13","","","10.1093/cercor/bhh200"
"12212781","Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone","Belanoff JK, Jurik J, Schatzberg LD, DeBattista C, Schatzberg AF.","J Mol Neurosci. 2002 Aug-Oct;19(1-2):201-6. doi: 10.1007/s12031-002-0033-3.","Belanoff JK","J Mol Neurosci","2002","2002/09/06","","","10.1007/s12031-002-0033-3"
"33903610","Classification of patients with Alzheimer's disease using the arterial pulse spectrum and a multilayer-perceptron analysis","Lin SK, Hsiu H, Chen HS, Yang CJ.","Sci Rep. 2021 Apr 26;11(1):8882. doi: 10.1038/s41598-021-87903-7.","Lin SK","Sci Rep","2021","2021/04/27","PMC8076260","","10.1038/s41598-021-87903-7"
"32007991","Why Not a Global Postural Reeducation as an Alternative Therapy Applied to Alzheimer's Patients in Nursing Homes? A Pioneer Randomized Controlled Trial","Todri J, Todri A, Lena O.","Dement Geriatr Cogn Disord. 2019;48(3-4):172-179. doi: 10.1159/000505397. Epub 2020 Jan 31.","Todri J","Dement Geriatr Cogn Disord","2019","2020/02/03","","","10.1159/000505397"
"22672107","Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: a pilot study","Sakurai H, Hanyu H, Sato T, Kume K, Hirao K, Kanetaka H, Iwamoto T.","Geriatr Gerontol Int. 2013 Jan;13(1):90-7. doi: 10.1111/j.1447-0594.2012.00866.x. Epub 2012 Jun 4.","Sakurai H","Geriatr Gerontol Int","2013","2012/06/08","","","10.1111/j.1447-0594.2012.00866.x"
"9213073","Senile dementia and apolipoprotein E4","McConathy W, Lacko A, Kalman J.","Dement Geriatr Cogn Disord. 1997 Jul-Aug;8(4):258. doi: 10.1159/000106641.","McConathy W","Dement Geriatr Cogn Disord","1997","1997/07/01","","","10.1159/000106641"
"18830857","The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone","Akuffo EL, Davis JB, Fox SM, Gloger IS, Hosford D, Kinsey EE, Jones NA, Nock CM, Roses AD, Saunders AM, Skehel JM, Smith MA, Cutler P.","Biomarkers. 2008 Sep;13(6):618-36. doi: 10.1080/13547500802445199.","Akuffo EL","Biomarkers","2008","2008/10/03","","","10.1080/13547500802445199"
"15933281","Pilot study of behavioral treatment in dementia care units","Lichtenberg PA, Kemp-Havican J, Macneill SE, Schafer Johnson A.","Gerontologist. 2005 Jun;45(3):406-10. doi: 10.1093/geront/45.3.406.","Lichtenberg PA","Gerontologist","2005","2005/06/04","","","10.1093/geront/45.3.406"
"11403336","Pilot tolerability studies of hydroxychloroquine and colchicine in Alzheimer disease","Aisen PS, Marin DB, Brickman AM, Santoro J, Fusco M.","Alzheimer Dis Assoc Disord. 2001 Apr-Jun;15(2):96-101. doi: 10.1097/00002093-200104000-00009.","Aisen PS","Alzheimer Dis Assoc Disord","2001","2001/06/14","","","10.1097/00002093-200104000-00009"
"20808145","Goal-oriented cognitive rehabilitation for people with early-stage Alzheimer disease: a single-blind randomized controlled trial of clinical efficacy","Clare L, Linden DE, Woods RT, Whitaker R, Evans SJ, Parkinson CH, van Paasschen J, Nelis SM, Hoare Z, Yuen KS, Rugg MD.","Am J Geriatr Psychiatry. 2010 Oct;18(10):928-39. doi: 10.1097/JGP.0b013e3181d5792a.","Clare L","Am J Geriatr Psychiatry","2010","2010/09/03","","","10.1097/JGP.0b013e3181d5792a"
"21694454","Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial","Wharton W, Baker LD, Gleason CE, Dowling M, Barnet JH, Johnson S, Carlsson C, Craft S, Asthana S.","J Alzheimers Dis. 2011;26(3):495-505. doi: 10.3233/JAD-2011-110341.","Wharton W","J Alzheimers Dis","2011","2011/06/23","PMC3302351","NIHMS358446","10.3233/JAD-2011-110341"
"22086220","Neuropsychiatric profiles in dementia","Johnson DK, Watts AS, Chapin BA, Anderson R, Burns JM.","Alzheimer Dis Assoc Disord. 2011 Oct-Dec;25(4):326-32. doi: 10.1097/WAD.0b013e31820d89b6.","Johnson DK","Alzheimer Dis Assoc Disord","2011","2011/11/17","PMC3218373","NIHMS268835","10.1097/WAD.0b013e31820d89b6"
"9876955","First International Pharmacoeconomic Conference on Alzheimer's Disease: report and summary","Whitehouse PJ, Winblad B, Shostak D, Bhattacharjya A, Brod M, Brodaty H, Dor A, Feldman H, Forette F, Gauthier S, Hay J, Henke C, Hill S, Mastey V, Neumann P, O'Brien B, Pugner K, Sano M, Sawada T, Stone R, Wimo A.","Alzheimer Dis Assoc Disord. 1998 Dec;12(4):266-80. doi: 10.1097/00002093-199812000-00006.","Whitehouse PJ","Alzheimer Dis Assoc Disord","1998","1999/01/07","","","10.1097/00002093-199812000-00006"
"20979032","[Memantine in the pharmacologic treatment of moderately severe to severe Alzheimer's disease in Spain (MEMORY study)]","Agüera-Ortiz LF; Grupo de Investigadores del Estudio MEMORY.","Rev Neurol. 2010 Nov 1;51(9):525-34.","Agüera-Ortiz LF","Rev Neurol","2010","2010/10/28","","",""
"19054188","Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease study","Irving GF, Freund-Levi Y, Eriksdotter-Jönhagen M, Basun H, Brismar K, Hjorth E, Palmblad J, Vessby B, Vedin I, Wahlund LO, Cederholm T.","J Am Geriatr Soc. 2009 Jan;57(1):11-7. doi: 10.1111/j.1532-5415.2008.02055.x. Epub 2008 Nov 20.","Irving GF","J Am Geriatr Soc","2009","2008/12/05","","","10.1111/j.1532-5415.2008.02055.x"
"16179669","The use of olanzapine in the treatment of negative symptoms in Alzheimer's disease","Rankin ED, Layne RD.","J Neuropsychiatry Clin Neurosci. 2005 Summer;17(3):423-4. doi: 10.1176/jnp.17.3.423.","Rankin ED","J Neuropsychiatry Clin Neurosci","2005","2005/09/24","","","10.1176/jnp.17.3.423"
"17310387","Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET","Kadir A, Darreh-Shori T, Almkvist O, Wall A, Långström B, Nordberg A.","Psychopharmacology (Berl). 2007 May;191(4):1005-14. doi: 10.1007/s00213-007-0725-z. Epub 2007 Feb 20.","Kadir A","Psychopharmacology (Berl)","2007","2007/02/21","","","10.1007/s00213-007-0725-z"
"11843991","Caregivers' utilization of health services: results from the Medicare Alzheimer's Disease Demonstration, Illinois site","Shelton P, Schraeder C, Dworak D, Fraser C, Sager MA.","J Am Geriatr Soc. 2001 Dec;49(12):1600-5.","Shelton P","J Am Geriatr Soc","2001","2002/02/15","","",""
"12397880","Informant-rated cognitive symptoms in normal aging, mild cognitive impairment, and dementia. Initial development of an informant-rated screen (Brief Cognitive Scale) for mild cognitive impairment and dementia","Krishnan KR, Levy RM, Wagner HR, Chen G, Gersing K, Doraiswamy PM.","Psychopharmacol Bull. 2001 Summer;35(3):79-88.","Krishnan KR","Psychopharmacol Bull","2001","2002/10/26","","",""
"11216885","Olfactory-evoked regional cerebral blood flow in Alzheimer's disease","Kareken DA, Doty RL, Moberg PJ, Mosnik D, Chen SH, Farlow MR, Hutchins GD.","Neuropsychology. 2001 Jan;15(1):18-29. doi: 10.1037//0894-4105.15.1.18.","Kareken DA","Neuropsychology","2001","2001/02/24","","","10.1037//0894-4105.15.1.18"
"15860476","Maintenance of effects of the home environmental skill-building program for family caregivers and individuals with Alzheimer's disease and related disorders","Gitlin LN, Hauck WW, Dennis MP, Winter L.","J Gerontol A Biol Sci Med Sci. 2005 Mar;60(3):368-74. doi: 10.1093/gerona/60.3.368.","Gitlin LN","J Gerontol A Biol Sci Med Sci","2005","2005/04/30","","","10.1093/gerona/60.3.368"
"10362895","Positive association between an estrogen receptor gene polymorphism and Parkinson's disease with dementia","Isoe-Wada K, Maeda M, Yong J, Adachi Y, Harada H, Urakami K, Nakashima K.","Eur J Neurol. 1999 Jul;6(4):431-5. doi: 10.1046/j.1468-1331.1999.640431.x.","Isoe-Wada K","Eur J Neurol","1999","1999/06/11","","","10.1046/j.1468-1331.1999.640431.x"
"8797468","A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease","Thal LJ, Carta A, Clarke WR, Ferris SH, Friedland RP, Petersen RC, Pettegrew JW, Pfeiffer E, Raskind MA, Sano M, Tuszynski MH, Woolson RF.","Neurology. 1996 Sep;47(3):705-11. doi: 10.1212/wnl.47.3.705.","Thal LJ","Neurology","1996","1996/09/01","","","10.1212/wnl.47.3.705"
"8656584","[Cerebral hemodynamics in patients with dementia]","Abe S, Hanyu H, Arai H, Iwamoto T, Takasaki M.","Nihon Ronen Igakkai Zasshi. 1996 Feb;33(2):95-104. doi: 10.3143/geriatrics.33.95.","Abe S","Nihon Ronen Igakkai Zasshi","1996","1996/02/01","","","10.3143/geriatrics.33.95"
"19528519","Donepezil delays progression to AD in MCI subjects with depressive symptoms","Lu PH, Edland SD, Teng E, Tingus K, Petersen RC, Cummings JL; Alzheimer's Disease Cooperative Study Group.","Neurology. 2009 Jun 16;72(24):2115-21. doi: 10.1212/WNL.0b013e3181aa52d3.","Lu PH","Neurology","2009","2009/06/17","PMC2697965","","10.1212/WNL.0b013e3181aa52d3"
"33351971","First-in-man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M(1) -receptor partial agonist for the treatment of dementias","Bakker C, Tasker T, Liptrot J, Hart EP, Klaassen ES, Prins S, van der Doef TF, Brown GA, Brown A, Congreve M, Weir M, Marshall FH, Cross DM, Groeneveld GJ, Nathan PJ.","Br J Clin Pharmacol. 2021 Jul;87(7):2945-2955. doi: 10.1111/bcp.14710. Epub 2021 Feb 5.","Bakker C","Br J Clin Pharmacol","2021","2020/12/22","PMC8359307","","10.1111/bcp.14710"
"28122529","Monetary costs of Alzheimer's disease in China: protocol for a cluster-randomised observational study","Li F, Chen S, Wei C, Jia J.","BMC Neurol. 2017 Jan 25;17(1):15. doi: 10.1186/s12883-017-0802-9.","Li F","BMC Neurol","2017","2017/01/27","PMC5264294","","10.1186/s12883-017-0802-9"
"20550745","Peaceful Mind: an open trial of cognitive-behavioral therapy for anxiety in persons with dementia","Paukert AL, Calleo J, Kraus-Schuman C, Snow L, Wilson N, Petersen NJ, Kunik ME, Stanley MA.","Int Psychogeriatr. 2010 Sep;22(6):1012-21. doi: 10.1017/S1041610210000694. Epub 2010 Jun 16.","Paukert AL","Int Psychogeriatr","2010","2010/06/17","PMC3071800","NIHMS284013","10.1017/S1041610210000694"
"2991817","Treatment of Alzheimer's disease with a synthetic ACTH 4-9 analog","Soininen H, Koskinen T, Helkala EL, Pigache R, Riekkinen PJ.","Neurology. 1985 Sep;35(9):1348-51. doi: 10.1212/wnl.35.9.1348.","Soininen H","Neurology","1985","1985/09/01","","","10.1212/wnl.35.9.1348"
"16378661","The LDLR locus in Alzheimer's disease: a family-based study and meta-analysis of case-control data","Bertram L, Hsiao M, McQueen MB, Parkinson M, Mullin K, Blacker D, Tanzi RE.","Neurobiol Aging. 2007 Jan;28(1):18.e1-4. doi: 10.1016/j.neurobiolaging.2005.11.005. Epub 2005 Dec 27.","Bertram L","Neurobiol Aging","2007","2005/12/28","","","10.1016/j.neurobiolaging.2005.11.005"
"22459694","Do nurse-led skill training interventions affect informal caregivers' out-of-pocket expenditures?","Van Houtven CH, Thorpe JM, Chestnutt D, Molloy M, Boling JC, Davis LL.","Gerontologist. 2013 Feb;53(1):60-70. doi: 10.1093/geront/gns045. Epub 2012 Mar 28.","Van Houtven CH","Gerontologist","2013","2012/03/31","PMC3551205","","10.1093/geront/gns045"
"34155411","A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease","Salloway S, Farlow M, McDade E, Clifford DB, Wang G, Llibre-Guerra JJ, Hitchcock JM, Mills SL, Santacruz AM, Aschenbrenner AJ, Hassenstab J, Benzinger TLS, Gordon BA, Fagan AM, Coalier KA, Cruchaga C, Goate AA, Perrin RJ, Xiong C, Li Y, Morris JC, Snider BJ, Mummery C, Surti GM, Hannequin D, Wallon D, Berman SB, Lah JJ, Jimenez-Velazquez IZ, Roberson ED, van Dyck CH, Honig LS, Sánchez-Valle R, Brooks WS, Gauthier S, Galasko DR, Masters CL, Brosch JR, Hsiung GR, Jayadev S, Formaglio M, Masellis M, Clarnette R, Pariente J, Dubois B, Pasquier F, Jack CR Jr, Koeppe R, Snyder PJ, Aisen PS, Thomas RG, Berry SM, Wendelberger BA, Andersen SW, Holdridge KC, Mintun MA, Yaari R, Sims JR, Baudler M, Delmar P, Doody RS, Fontoura P, Giacobino C, Kerchner GA, Bateman RJ; Dominantly Inherited Alzheimer Network–Trials Unit.","Nat Med. 2021 Jul;27(7):1187-1196. doi: 10.1038/s41591-021-01369-8. Epub 2021 Jun 21.","Salloway S","Nat Med","2021","2021/06/22","PMC8988051","NIHMS1790300","10.1038/s41591-021-01369-8"
"11989722","Speed and capacity of language processing test: normative data from an older American community-dwelling sample","Saxton JA, Ratcliff G, Dodge H, Pandav R, Baddeley A, Ganguli M.","Appl Neuropsychol. 2001;8(4):193-203. doi: 10.1207/S15324826AN0804_1.","Saxton JA","Appl Neuropsychol","2001","2002/05/07","","","10.1207/S15324826AN0804_1"
"10960883","Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic","Matthews HP, Korbey J, Wilkinson DG, Rowden J.","Int J Geriatr Psychiatry. 2000 Aug;15(8):713-20. doi: 10.1002/1099-1166(200008)15:8<713::aid-gps187>3.0.co;2-i.","Matthews HP","Int J Geriatr Psychiatry","2000","2000/08/29","","","10.1002/1099-1166(200008)15:8<713::aid-gps187>3.0.co;2-i"
"12714796","Treatment with simvastatin in patients with Alzheimer's disease lowers both alpha- and beta-cleaved amyloid precursor protein","Sjögren M, Gustafsson K, Syversen S, Olsson A, Edman A, Davidsson P, Wallin A, Blennow K.","Dement Geriatr Cogn Disord. 2003;16(1):25-30. doi: 10.1159/000069989.","Sjögren M","Dement Geriatr Cogn Disord","2003","2003/04/26","","","10.1159/000069989"
"33970752","EEG coherence and power spectra during REM sleep related to melatonin intake in mild-to-moderate Alzheimer's disease: a pilot study","Cruz-Aguilar MA, Ramírez-Salado I, Hernández-González M, Guevara MA, Rivera-García AP.","Int J Neurosci. 2023 Apr;133(4):441-449. doi: 10.1080/00207454.2021.1928115. Epub 2021 Jun 1.","Cruz-Aguilar MA","Int J Neurosci","2023","2021/05/10","","","10.1080/00207454.2021.1928115"
"26952713","The Effects of Cognitive Training for Elderly: Results from My Mind Project","Giuli C, Papa R, Lattanzio F, Postacchini D.","Rejuvenation Res. 2016 Dec;19(6):485-494. doi: 10.1089/rej.2015.1791. Epub 2016 Apr 8.","Giuli C","Rejuvenation Res","2016","2016/03/09","PMC5178004","","10.1089/rej.2015.1791"
"17069875","Analysis of premature centromere division (PCD) of the chromosome 18 in peripheral blood lymphocytes in Alzheimer disease patients","Zivković L, Spremo-Potparević B, Djelić N, Bajić V.","Mech Ageing Dev. 2006 Dec;127(12):892-6. doi: 10.1016/j.mad.2006.09.004. Epub 2006 Oct 27.","Zivković L","Mech Ageing Dev","2006","2006/10/31","","","10.1016/j.mad.2006.09.004"
"18580597","Long-term course and effectiveness of combination therapy in Alzheimer disease","Atri A, Shaughnessy LW, Locascio JJ, Growdon JH.","Alzheimer Dis Assoc Disord. 2008 Jul-Sep;22(3):209-21. doi: 10.1097/WAD.0b013e31816653bc.","Atri A","Alzheimer Dis Assoc Disord","2008","2008/06/27","PMC2718545","NIHMS124780","10.1097/WAD.0b013e31816653bc"
"20875945","A validity study of the Working Group's Autobiographical Memory Test for individuals with moderate to severe intellectual disability","Pyo G, Ala T, Kyrouac GA, Verhulst SJ.","Res Dev Disabil. 2011 Jan-Feb;32(1):70-4. doi: 10.1016/j.ridd.2010.08.011. Epub 2010 Sep 28.","Pyo G","Res Dev Disabil","2011","2010/09/30","","","10.1016/j.ridd.2010.08.011"
"7968373","Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease","Chandrasekaran K, Giordano T, Brady DR, Stoll J, Martin LJ, Rapoport SI.","Brain Res Mol Brain Res. 1994 Jul;24(1-4):336-40. doi: 10.1016/0169-328x(94)90147-3.","Chandrasekaran K","Brain Res Mol Brain Res","1994","1994/07/01","","","10.1016/0169-328x(94)90147-3"
"20825496","Donepezil treatment in Alzheimer's disease patients with and without cerebrovascular lesions: a preliminary report","Na HR, Kim S, Choi SH, Yang DW, Bae HJ, Kim JE, Park MY, Shim YS, Kim BK, Kwon JC, Yoo BG, Kim BC, Lee JS.","Geriatr Gerontol Int. 2011 Jan;11(1):90-7. doi: 10.1111/j.1447-0594.2010.00649.x. Epub 2010 Sep 3.","Na HR","Geriatr Gerontol Int","2011","2010/09/10","","","10.1111/j.1447-0594.2010.00649.x"
"19593181","Smell identification test as a treatment response marker in patients with Alzheimer disease receiving donepezil","Velayudhan L, Lovestone S.","J Clin Psychopharmacol. 2009 Aug;29(4):387-90. doi: 10.1097/JCP.0b013e3181aba5a5.","Velayudhan L","J Clin Psychopharmacol","2009","2009/07/14","","","10.1097/JCP.0b013e3181aba5a5"
"31203725","Effects of Nilvadipine on Cerebral Blood Flow in Patients With Alzheimer Disease","de Jong DLK, de Heus RAA, Rijpma A, Donders R, Olde Rikkert MGM, Günther M, Lawlor BA, van Osch MJP, Claassen JAHR.","Hypertension. 2019 Aug;74(2):413-420. doi: 10.1161/HYPERTENSIONAHA.119.12892. Epub 2019 Jun 17.","de Jong DLK","Hypertension","2019","2019/06/18","","","10.1161/HYPERTENSIONAHA.119.12892"
"17313606","A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong","Chu LW, Yik PY, Mok W, Chung CP.","Int J Clin Pract. 2007 Mar;61(3):403-10. doi: 10.1111/j.1742-1241.2007.01284.x.","Chu LW","Int J Clin Pract","2007","2007/02/23","","","10.1111/j.1742-1241.2007.01284.x"
"3931154","Scopolamine challenges in Alzheimer's disease","Sunderland T, Tariot P, Murphy DL, Weingartner H, Mueller EA, Cohen RM.","Psychopharmacology (Berl). 1985;87(2):247-9. doi: 10.1007/BF00431817.","Sunderland T","Psychopharmacology (Berl)","1985","1985/01/01","","","10.1007/BF00431817"
"33122694","Safety and efficacy of Melissa officinalis extract containing rosmarinic acid in the prevention of Alzheimer's disease progression","Noguchi-Shinohara M, Ono K, Hamaguchi T, Nagai T, Kobayashi S, Komatsu J, Samuraki-Yokohama M, Iwasa K, Yokoyama K, Nakamura H, Yamada M.","Sci Rep. 2020 Oct 29;10(1):18627. doi: 10.1038/s41598-020-73729-2.","Noguchi-Shinohara M","Sci Rep","2020","2020/10/30","PMC7596544","","10.1038/s41598-020-73729-2"
"17389305","AMPA potentiator treatment of cognitive deficits in Alzheimer disease","Chappell AS, Gonzales C, Williams J, Witte MM, Mohs RC, Sperling R.","Neurology. 2007 Mar 27;68(13):1008-12. doi: 10.1212/01.wnl.0000260240.46070.7c.","Chappell AS","Neurology","2007","2007/03/29","","","10.1212/01.wnl.0000260240.46070.7c"
"34618817","Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease","Bartl M, Dakna M, Galasko D, Hutten SJ, Foroud T, Quan M, Marek K, Siderowf A, Franz J, Trenkwalder C, Mollenhauer B; Parkinson’s Progression Markers Initiative.","PLoS One. 2021 Oct 7;16(10):e0257372. doi: 10.1371/journal.pone.0257372. eCollection 2021.","Bartl M","PLoS One","2021","2021/10/07","PMC8496858","","10.1371/journal.pone.0257372"
"10188004","Effects of transcutaneous electrical nerve stimulation on memory and behavior in Alzheimer's disease may be stage-dependent","Scherder EJ, Bouma A.","Biol Psychiatry. 1999 Mar 15;45(6):743-9. doi: 10.1016/s0006-3223(98)00072-9.","Scherder EJ","Biol Psychiatry","1999","1999/04/03","","","10.1016/s0006-3223(98)00072-9"
"25454987","Short and long telomeres increase risk of amnestic mild cognitive impairment","Roberts RO, Boardman LA, Cha RH, Pankratz VS, Johnson RA, Druliner BR, Christianson TJ, Roberts LR, Petersen RC.","Mech Ageing Dev. 2014 Nov-Dec;141-142:64-9. doi: 10.1016/j.mad.2014.10.002. Epub 2014 Oct 22.","Roberts RO","Mech Ageing Dev","2014","2014/12/03","PMC4310802","NIHMS638571","10.1016/j.mad.2014.10.002"
"10426143","No effect of anti-leprosy drugs in the prevention of Alzheimer's disease and beta-amyloid neurotoxicity","Endoh M, Kunishita T, Tabira T.","J Neurol Sci. 1999 May 1;165(1):28-30. doi: 10.1016/s0022-510x(99)00057-x.","Endoh M","J Neurol Sci","1999","1999/07/30","","","10.1016/s0022-510x(99)00057-x"
"22776970","The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial","Wharton W, Stein JH, Korcarz C, Sachs J, Olson SR, Zetterberg H, Dowling M, Ye S, Gleason CE, Underbakke G, Jacobson LE, Johnson SC, Sager MA, Asthana S, Carlsson CM.","J Alzheimers Dis. 2012;32(1):147-56. doi: 10.3233/JAD-2012-120763.","Wharton W","J Alzheimers Dis","2012","2012/07/11","PMC3593582","NIHMS440777","10.3233/JAD-2012-120763"
"34851866","Impact of Donepezil and Memantine on Behavioral and Psychological Symptoms of Alzheimer Disease: Six-month Open-label Study","Bago Rožanković P, Rožanković M, Badžak J, Stojić M, Šušak Sporiš I.","Cogn Behav Neurol. 2021 Dec 2;34(4):288-294. doi: 10.1097/WNN.0000000000000285.","Bago Rožanković P","Cogn Behav Neurol","2021","2021/12/01","","","10.1097/WNN.0000000000000285"
"17035647","Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease","Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, Lebowitz BD, Lyketsos CG, Ryan JM, Stroup TS, Sultzer DL, Weintraub D, Lieberman JA; CATIE-AD Study Group.","N Engl J Med. 2006 Oct 12;355(15):1525-38. doi: 10.1056/NEJMoa061240.","Schneider LS","N Engl J Med","2006","2006/10/13","","","10.1056/NEJMoa061240"
"33464300","Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial","Sperling R, Henley D, Aisen PS, Raman R, Donohue MC, Ernstrom K, Rafii MS, Streffer J, Shi Y, Karcher K, Raghavan N, Tymofyeyev Y, Bogert J, Brashear HR, Novak G, Thipphawong J, Saad ZS, Kolb H, Rofael H, Sanga P, Romano G.","JAMA Neurol. 2021 Mar 1;78(3):293-301. doi: 10.1001/jamaneurol.2020.4857.","Sperling R","JAMA Neurol","2021","2021/01/19","PMC7816119","","10.1001/jamaneurol.2020.4857"
"36120781","Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil","Tariot PN, Braeckman R, Oh C.","J Alzheimers Dis. 2022;90(1):161-172. doi: 10.3233/JAD-220530.","Tariot PN","J Alzheimers Dis","2022","2022/09/19","PMC9661317","","10.3233/JAD-220530"
"2893314","Intraventricular bethanechol infusion for Alzheimer's disease: results of double-blind and escalating-dose trials","Penn RD, Martin EM, Wilson RS, Fox JH, Savoy SM.","Neurology. 1988 Feb;38(2):219-22. doi: 10.1212/wnl.38.2.219.","Penn RD","Neurology","1988","1988/02/01","","","10.1212/wnl.38.2.219"
"9065539","Respiratory chain enzyme activities in isolated mitochondria of lymphocytes from patients with Alzheimer's disease","Molina JA, de Bustos F, Jiménez-Jiménez FJ, Benito-León J, Gasalla T, Ortí-Pareja M, Vela L, Bermejo F, Martín MA, Campos Y, Arenas J.","Neurology. 1997 Mar;48(3):636-8. doi: 10.1212/wnl.48.3.636.","Molina JA","Neurology","1997","1997/03/01","","","10.1212/wnl.48.3.636"
"9810483","Abnormal functional connectivity in Alzheimer's disease: intrahemispheric EEG coherence during rest and photic stimulation","Wada Y, Nanbu Y, Kikuchi M, Koshino Y, Hashimoto T, Yamaguchi N.","Eur Arch Psychiatry Clin Neurosci. 1998;248(4):203-8. doi: 10.1007/s004060050038.","Wada Y","Eur Arch Psychiatry Clin Neurosci","1998","1998/11/12","","","10.1007/s004060050038"
"25766898","Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein","Lyoo CH, Ikawa M, Liow JS, Zoghbi SS, Morse CL, Pike VW, Fujita M, Innis RB, Kreisl WC.","J Nucl Med. 2015 May;56(5):701-6. doi: 10.2967/jnumed.114.146027. Epub 2015 Mar 12.","Lyoo CH","J Nucl Med","2015","2015/03/14","PMC4839390","NIHMS777239","10.2967/jnumed.114.146027"
"20054753","Predictors of long-term treatment effect of rivastigmine in Alzheimer's disease: a role for beta-amyloid plasma levels?","Sobów T, Kłoszewska I, Flirski M, Liberski P.","Neurol Neurochir Pol. 2009 Nov-Dec;43(6):507-16.","Sobów T","Neurol Neurochir Pol","2009","2010/01/08","","",""
"21510896","Study of Mental Activity and Regular Training (SMART) in at risk individuals: a randomised double blind, sham controlled, longitudinal trial","Gates NJ, Valenzuela M, Sachdev PS, Singh NA, Baune BT, Brodaty H, Suo C, Jain N, Wilson GC, Wang Y, Baker MK, Williamson D, Foroughi N, Fiatarone Singh MA.","BMC Geriatr. 2011 Apr 21;11:19. doi: 10.1186/1471-2318-11-19.","Gates NJ","BMC Geriatr","2011","2011/04/23","PMC3110111","","10.1186/1471-2318-11-19"
"21818628","Longitudinal changes of fractional anisotropy in Alzheimer's disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study","Likitjaroen Y, Meindl T, Friese U, Wagner M, Buerger K, Hampel H, Teipel SJ.","Eur Arch Psychiatry Clin Neurosci. 2012 Jun;262(4):341-50. doi: 10.1007/s00406-011-0234-2. Epub 2011 Aug 5.","Likitjaroen Y","Eur Arch Psychiatry Clin Neurosci","2012","2011/08/06","","","10.1007/s00406-011-0234-2"
"8665532","Cognitive and quantified electroencephalographic correlates of cycloserine treatment in Alzheimer's disease","Mohr E, Knott V, Sampson M, Wesnes K, Herting R, Mendis T.","Clin Neuropharmacol. 1995 Feb;18(1):28-38. doi: 10.1097/00002826-199502000-00004.","Mohr E","Clin Neuropharmacol","1995","1995/02/01","","","10.1097/00002826-199502000-00004"
"10687744","Apolipoprotein E phenotypes in healthy normal controls and demented subjects with Alzheimer's disease and vascular dementia in Mie Prefecture of Japan","Nakayama S, Kuzuhara S.","Psychiatry Clin Neurosci. 1999 Dec;53(6):643-8. doi: 10.1046/j.1440-1819.1999.00619.x.","Nakayama S","Psychiatry Clin Neurosci","1999","2000/02/25","","","10.1046/j.1440-1819.1999.00619.x"
"14694028","Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia","Haier RJ, Alkire MT, White NS, Uncapher MR, Head E, Lott IT, Cotman CW.","Neurology. 2003 Dec 23;61(12):1673-9. doi: 10.1212/01.wnl.0000098935.36984.25.","Haier RJ","Neurology","2003","2003/12/25","","","10.1212/01.wnl.0000098935.36984.25"
"9608414","A preliminary study of D-cycloserine treatment in Alzheimer's disease","Tsai GE, Falk WE, Gunther J.","J Neuropsychiatry Clin Neurosci. 1998 Spring;10(2):224-6. doi: 10.1176/jnp.10.2.224.","Tsai GE","J Neuropsychiatry Clin Neurosci","1998","1998/06/03","","","10.1176/jnp.10.2.224"
"33990649","Combination of automated brain volumetry on MRI and quantitative tau deposition on THK-5351 PET to support diagnosis of Alzheimer's disease","Kim M, Kim SJ, Park JE, Yun J, Shim WH, Oh JS, Oh M, Roh JH, Seo SW, Oh SJ, Kim JS.","Sci Rep. 2021 May 14;11(1):10343. doi: 10.1038/s41598-021-89797-x.","Kim M","Sci Rep","2021","2021/05/15","PMC8121780","","10.1038/s41598-021-89797-x"
"21463871","Increased plasma levels of lipocalin 2 in mild cognitive impairment","Choi J, Lee HW, Suk K.","J Neurol Sci. 2011 Jun 15;305(1-2):28-33. doi: 10.1016/j.jns.2011.03.023. Epub 2011 Apr 3.","Choi J","J Neurol Sci","2011","2011/04/06","","","10.1016/j.jns.2011.03.023"
"23079898","Personality factors moderate the associations between apolipoprotein genotype and cognitive function as well as late onset Alzheimer disease","Dar-Nimrod I, Chapman BP, Franks P, Robbins J, Porsteinsson A, Mapstone M, Duberstein PR.","Am J Geriatr Psychiatry. 2012 Dec;20(12):1026-35. doi: 10.1097/JGP.0b013e318267016b.","Dar-Nimrod I","Am J Geriatr Psychiatry","2012","2012/10/20","PMC4184145","NIHMS397186","10.1097/JGP.0b013e318267016b"
"36551289","Development of a Gastrointestinal-Myoelectrical-Activity-Based Nomogram Model for Predicting the Risk of Mild Cognitive Impairment","Li B, Ji S, Peng A, Yang N, Zhao X, Feng P, Zhang Y, Chen L.","Biomolecules. 2022 Dec 12;12(12):1861. doi: 10.3390/biom12121861.","Li B","Biomolecules","2022","2022/12/23","PMC9775682","","10.3390/biom12121861"
"21227548","Evaluation of the convenience of changing the rivastigmine administration route in patients with Alzheimer disease","Blesa González R, Boada Rovira M, Martínez Parra C, Gil-Saladié D, Almagro CA, Gobartt Vázquez AL; en representación del grupo de investigadores del estudio kAPA.","Neurologia. 2011 Jun;26(5):262-71. doi: 10.1016/j.nrl.2010.10.007. Epub 2011 Jan 11.","Blesa González R","Neurologia","2011","2011/01/14","","","10.1016/j.nrl.2010.10.007"
"23034259","Association analysis of dopaminergic gene variants (Comt, Drd4 And Dat1) with Alzheimer s disease","Lin WY, Wu BT, Lee CC, Sheu JJ, Liu SH, Wang WF, Tsai CH, Liu HP, Tsai FJ.","J Biol Regul Homeost Agents. 2012 Jul-Sep;26(3):401-10.","Lin WY","J Biol Regul Homeost Agents","2012","2012/10/05","","",""
"8369100","Effects of monoamine oxidase inhibition by selegiline on concentrations of noradrenaline and monoamine metabolites in CSF of patients with Alzheimer's disease","Heinonen EH, Savijärvi M, Kotila M, Hajba A, Scheinin M.","J Neural Transm Park Dis Dement Sect. 1993;5(3):193-202. doi: 10.1007/BF02257674.","Heinonen EH","J Neural Transm Park Dis Dement Sect","1993","1993/01/01","","","10.1007/BF02257674"
"19194878","Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden","Kellner A, Matschke J, Bernreuther C, Moch H, Ferrer I, Glatzel M.","Ann Neurol. 2009 Jan;65(1):24-31. doi: 10.1002/ana.21475.","Kellner A","Ann Neurol","2009","2009/02/06","","","10.1002/ana.21475"
"18644112","Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease","Tobinick EL, Gross H.","BMC Neurol. 2008 Jul 21;8:27. doi: 10.1186/1471-2377-8-27.","Tobinick EL","BMC Neurol","2008","2008/07/23","PMC2500042","","10.1186/1471-2377-8-27"
"26501267","No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer's Disease: A Randomised Controlled Trial","Phillips MA, Childs CE, Calder PC, Rogers PJ.","Int J Mol Sci. 2015 Oct 16;16(10):24600-13. doi: 10.3390/ijms161024600.","Phillips MA","Int J Mol Sci","2015","2015/10/27","PMC4632767","","10.3390/ijms161024600"
"12860778","Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS","Lyketsos CG, DelCampo L, Steinberg M, Miles Q, Steele CD, Munro C, Baker AS, Sheppard JM, Frangakis C, Brandt J, Rabins PV.","Arch Gen Psychiatry. 2003 Jul;60(7):737-46. doi: 10.1001/archpsyc.60.7.737.","Lyketsos CG","Arch Gen Psychiatry","2003","2003/07/16","","","10.1001/archpsyc.60.7.737"
"9745232","Cognitive and motor slowing in Alzheimer's disease and geriatric depression","Nebes RD, Halligan EM, Rosen J, Reynolds CF 3rd.","J Int Neuropsychol Soc. 1998 Sep;4(5):426-34. doi: 10.1017/s1355617798455024.","Nebes RD","J Int Neuropsychol Soc","1998","1998/09/24","","","10.1017/s1355617798455024"
"15488423","Contrasting metabolic impairment in frontotemporal degeneration and early onset Alzheimer's disease","Ibach B, Poljansky S, Marienhagen J, Sommer M, Männer P, Hajak G.","Neuroimage. 2004 Oct;23(2):739-43. doi: 10.1016/j.neuroimage.2004.06.041.","Ibach B","Neuroimage","2004","2004/10/19","","","10.1016/j.neuroimage.2004.06.041"
"12218255","Alzheimer disease - effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme","Svennerholm L, Bråne G, Karlsson I, Lekman A, Ramström I, Wikkelsö C.","Dement Geriatr Cogn Disord. 2002;14(3):128-36. doi: 10.1159/000063604.","Svennerholm L","Dement Geriatr Cogn Disord","2002","2002/09/10","","","10.1159/000063604"
"31194916","Spaced Retrieval Using Static and Dynamic Images to Improve Face-Name Recognition: Alzheimer's Dementia and Vascular Dementia","Viccaro E, Sands E, Springer C.","Am J Speech Lang Pathol. 2019 Aug 9;28(3):1184-1197. doi: 10.1044/2019_AJSLP-18-0131. Epub 2019 Jun 13.","Viccaro E","Am J Speech Lang Pathol","2019","2019/06/14","","","10.1044/2019_AJSLP-18-0131"
"31604674","Cognitive Outcomes of Long-term Benzodiazepine and Related Drug (BDZR) Use in People Living With Mild to Moderate Alzheimer's Disease: Results From NILVAD","Dyer AH, Murphy C, Lawlor B, Kennelly SP; NILVAD Study Group.","J Am Med Dir Assoc. 2020 Feb;21(2):194-200. doi: 10.1016/j.jamda.2019.08.006. Epub 2019 Oct 8.","Dyer AH","J Am Med Dir Assoc","2020","2019/10/13","","","10.1016/j.jamda.2019.08.006"
"33568083","Rivastigmine improves dual-task gait velocity in patients with Alzheimer's disease","Shimura H, Saiko A, Hayashi A, Hattori N, Urabe T.","BMC Neurol. 2021 Feb 10;21(1):61. doi: 10.1186/s12883-021-02098-8.","Shimura H","BMC Neurol","2021","2021/02/11","PMC7874473","","10.1186/s12883-021-02098-8"
"7899539","A subtle disturbance in the feedback regulation of the hypothalamic-pituitary-adrenal axis in the early phase of Alzheimer's disease","Näsman B, Olsson T, Viitanen M, Carlström K.","Psychoneuroendocrinology. 1995;20(2):211-20. doi: 10.1016/0306-4530(94)00054-e.","Näsman B","Psychoneuroendocrinology","1995","1995/01/01","","","10.1016/0306-4530(94)00054-e"
"22449664","Cardiac safety of donepezil in elderly patients with Alzheimer disease","Isik AT, Yildiz GB, Bozoglu E, Yay A, Aydemir E.","Intern Med. 2012;51(6):575-8. doi: 10.2169/internalmedicine.51.6671. Epub 2012 Mar 15.","Isik AT","Intern Med","2012","2012/03/28","","","10.2169/internalmedicine.51.6671"
"16805928","Keep music live: music and the alleviation of apathy in dementia subjects","Holmes C, Knights A, Dean C, Hodkinson S, Hopkins V.","Int Psychogeriatr. 2006 Dec;18(4):623-30. doi: 10.1017/S1041610206003887.","Holmes C","Int Psychogeriatr","2006","2006/06/30","","","10.1017/S1041610206003887"
"15722369","Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial","Ballard C, Margallo-Lana M, Juszczak E, Douglas S, Swann A, Thomas A, O'Brien J, Everratt A, Sadler S, Maddison C, Lee L, Bannister C, Elvish R, Jacoby R.","BMJ. 2005 Apr 16;330(7496):874. doi: 10.1136/bmj.38369.459988.8F. Epub 2005 Feb 18.","Ballard C","BMJ","2005","2005/02/22","PMC556156","","10.1136/bmj.38369.459988.8F"
"23275593","Effects of the apolipoprotein E ε4 allele on functional MRI during n-back working memory tasks in healthy middle-aged adults","Chen CJ, Chen CC, Wu D, Chi NF, Chen PC, Liao YP, Chiu HW, Hu CJ.","AJNR Am J Neuroradiol. 2013 Jun-Jul;34(6):1197-202. doi: 10.3174/ajnr.A3369. Epub 2012 Dec 28.","Chen CJ","AJNR Am J Neuroradiol","2013","2013/01/01","PMC7964576","","10.3174/ajnr.A3369"
"10931368","Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes","Chen CP, Eastwood SL, Hope T, McDonald B, Francis PT, Esiri MM.","Neuropathol Appl Neurobiol. 2000 Aug;26(4):347-55. doi: 10.1046/j.1365-2990.2000.00254.x.","Chen CP","Neuropathol Appl Neurobiol","2000","2000/08/10","","","10.1046/j.1365-2990.2000.00254.x"
"16287775","The relation between p70S6k expression in lymphocytes and the decline of cognitive test scores in patients with Alzheimer disease","Paccalin M, Pain-Barc S, Pluchon C, Paul C, Bazin H, Gil R, Hugon J.","Arch Intern Med. 2005 Nov 14;165(20):2428-9. doi: 10.1001/archinte.165.20.2428.","Paccalin M","Arch Intern Med","2005","2005/11/17","","","10.1001/archinte.165.20.2428"
"21564154","A community-based exercise programme to improve functional ability in people with Alzheimer's disease: a randomized controlled trial","Vreugdenhil A, Cannell J, Davies A, Razay G.","Scand J Caring Sci. 2012 Mar;26(1):12-9. doi: 10.1111/j.1471-6712.2011.00895.x. Epub 2011 May 12.","Vreugdenhil A","Scand J Caring Sci","2012","2011/05/14","","","10.1111/j.1471-6712.2011.00895.x"
"23075176","Relapse risk after discontinuation of risperidone in Alzheimer's disease","Devanand DP, Mintzer J, Schultz SK, Andrews HF, Sultzer DL, de la Pena D, Gupta S, Colon S, Schimming C, Pelton GH, Levin B.","N Engl J Med. 2012 Oct 18;367(16):1497-507. doi: 10.1056/NEJMoa1114058.","Devanand DP","N Engl J Med","2012","2012/10/19","PMC3490406","NIHMS415940","10.1056/NEJMoa1114058"
"11595093","Longitudinal profiles of semantic impairment for living and nonliving concepts in dementia of Alzheimer's type","Garrard P, Lambon Ralph MA, Watson PC, Powis J, Patterson K, Hodges JR.","J Cogn Neurosci. 2001 Oct 1;13(7):892-909. doi: 10.1162/089892901753165818.","Garrard P","J Cogn Neurosci","2001","2001/10/12","","","10.1162/089892901753165818"
"18631948","One-week dose titration of extended release galantamine in patients with Alzheimer's disease","Scharre DW, Shiovitz T, Zhu Y, Amatniek J.","Alzheimers Dement. 2008 Jan;4(1):30-7. doi: 10.1016/j.jalz.2007.10.013. Epub 2007 Dec 21.","Scharre DW","Alzheimers Dement","2008","2008/07/18","","","10.1016/j.jalz.2007.10.013"
"19293130","Switching from donepezil tablets to rivastigmine transdermal patch in Alzheimer's disease","Sadowsky CH, Dengiz A, Olin JT, Koumaras B, Meng X, Brannan S; US38 study group.","Am J Alzheimers Dis Other Demen. 2009 Jun-Jul;24(3):267-75. doi: 10.1177/1533317509333037. Epub 2009 Mar 16.","Sadowsky CH","Am J Alzheimers Dis Other Demen","2009","2009/03/19","","","10.1177/1533317509333037"
"8548515","Observed affect in nursing home residents with Alzheimer's disease","Lawton MP, Van Haitsma K, Klapper J.","J Gerontol B Psychol Sci Soc Sci. 1996 Jan;51(1):P3-14. doi: 10.1093/geronb/51b.1.p3.","Lawton MP","J Gerontol B Psychol Sci Soc Sci","1996","1996/01/01","","","10.1093/geronb/51b.1.p3"
"8563789","Evidence of blood-cerebrospinal fluid-barrier impairment in a subgroup of patients with dementia of the Alzheimer type and major depression: a possible indicator for immunoactivation","Hampel H, Müller-Spahn F, Berger C, Haberl A, Ackenheil M, Hock C.","Dementia. 1995 Nov-Dec;6(6):348-54. doi: 10.1159/000106969.","Hampel H","Dementia","1995","1995/11/01","","","10.1159/000106969"
"3232537","Procedures in evaluating dementia--a study of conjoint application of two rating scales (SCAG and BCRS) and psychometric tests","Lolk A, Nielsen H, Kragh-Sørensen P.","Acta Psychiatr Scand. 1988 Nov;78(5):592-8. doi: 10.1111/j.1600-0447.1988.tb06389.x.","Lolk A","Acta Psychiatr Scand","1988","1988/11/01","","","10.1111/j.1600-0447.1988.tb06389.x"
"27340344","Folic Acid Supplementation Mitigates Alzheimer's Disease by Reducing Inflammation: A Randomized Controlled Trial","Chen H, Liu S, Ji L, Wu T, Ji Y, Zhou Y, Zheng M, Zhang M, Xu W, Huang G.","Mediators Inflamm. 2016;2016:5912146. doi: 10.1155/2016/5912146. Epub 2016 Jun 2.","Chen H","Mediators Inflamm","2016","2016/06/25","PMC4909909","","10.1155/2016/5912146"
"3049561","Long-term outpatient treatment of senile dementia with oral physostigmine","Beller SA, Overall JE, Rhoades HM, Swann AC.","J Clin Psychiatry. 1988 Oct;49(10):400-4.","Beller SA","J Clin Psychiatry","1988","1988/10/01","","",""
"34856171","Alzheimer's Disease THErapy With NEuroaid (ATHENE): A Randomized Double-Blind Delayed-Start Trial","Chen CLH, Lu Q, Moorakonda RB, Kandiah N, Tan BY, Villaraza SG, Cano J, Venketasubramanian N.","J Am Med Dir Assoc. 2022 Mar;23(3):379-386.e3. doi: 10.1016/j.jamda.2021.10.018. Epub 2021 Nov 29.","Chen CLH","J Am Med Dir Assoc","2022","2021/12/02","","","10.1016/j.jamda.2021.10.018"
"19516251","Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients","Martorana A, Mori F, Esposito Z, Kusayanagi H, Monteleone F, Codecà C, Sancesario G, Bernardi G, Koch G.","Neuropsychopharmacology. 2009 Sep;34(10):2323-8. doi: 10.1038/npp.2009.60. Epub 2009 Jun 10.","Martorana A","Neuropsychopharmacology","2009","2009/06/12","","","10.1038/npp.2009.60"
"19146641","CSF biomarker profile and diagnostic value in vascular dementia","Paraskevas GP, Kapaki E, Papageorgiou SG, Kalfakis N, Andreadou E, Zalonis I, Vassilopoulos D.","Eur J Neurol. 2009 Feb;16(2):205-11. doi: 10.1111/j.1468-1331.2008.02387.x.","Paraskevas GP","Eur J Neurol","2009","2009/01/17","","","10.1111/j.1468-1331.2008.02387.x"
"10869578","Disturbances of spatial vision and object vision correlate differently with regional cerebral glucose metabolism in Alzheimer's disease","Fujimori M, Imamura T, Hirono N, Ishii K, Sasaki M, Mori E.","Neuropsychologia. 2000;38(10):1356-61. doi: 10.1016/s0028-3932(00)00060-9.","Fujimori M","Neuropsychologia","2000","2000/06/28","","","10.1016/s0028-3932(00)00060-9"
"16384626","PIN1 promoter polymorphisms are associated with Alzheimer's disease","Segat L, Pontillo A, Annoni G, Trabattoni D, Vergani C, Clerici M, Arosio B, Crovella S.","Neurobiol Aging. 2007 Jan;28(1):69-74. doi: 10.1016/j.neurobiolaging.2005.11.009. Epub 2005 Dec 27.","Segat L","Neurobiol Aging","2007","2005/12/31","","","10.1016/j.neurobiolaging.2005.11.009"
"12140003","Effects of long-term Donepezil therapy on rCBF of Alzheimer's patients","Nobili F, Vitali P, Canfora M, Girtler N, De Leo C, Mariani G, Pupi A, Rodriguez G.","Clin Neurophysiol. 2002 Aug;113(8):1241-8. doi: 10.1016/s1388-2457(02)00110-4.","Nobili F","Clin Neurophysiol","2002","2002/07/26","","","10.1016/s1388-2457(02)00110-4"
"15829527","Vitamin E and donepezil for the treatment of mild cognitive impairment","Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ; Alzheimer's Disease Cooperative Study Group.","N Engl J Med. 2005 Jun 9;352(23):2379-88. doi: 10.1056/NEJMoa050151. Epub 2005 Apr 13.","Petersen RC","N Engl J Med","2005","2005/04/15","","","10.1056/NEJMoa050151"
"34492709","Exercise Dose and Aerobic Fitness Response in Alzheimer's Dementia: Findings from the FIT-AD Trial","Salisbury D, Mathiason MA, Yu F.","Int J Sports Med. 2022 Sep;43(10):850-858. doi: 10.1055/a-1639-2307. Epub 2021 Sep 7.","Salisbury D","Int J Sports Med","2022","2021/09/07","","","10.1055/a-1639-2307"
"9046703","Modifying repetitive verbalizations of community-dwelling patients with AD","Bourgeois MS, Burgio LD, Schulz R, Beach S, Palmer B.","Gerontologist. 1997 Feb;37(1):30-9. doi: 10.1093/geront/37.1.30.","Bourgeois MS","Gerontologist","1997","1997/02/01","","","10.1093/geront/37.1.30"
"7674813","A ""bridging"" (safety/tolerance) study of besipirdine hydrochloride in patients with Alzheimer's disease","Sramek JJ, Viereck C, Huff FJ, Wardle T, Hourani J, Stewart JA, Cutler NR.","Life Sci. 1995;57(12):1241-8. doi: 10.1016/0024-3205(95)02068-t.","Sramek JJ","Life Sci","1995","1995/01/01","","","10.1016/0024-3205(95)02068-t"
"2890709","Intracerebroventricular cholinergic drug administration in Alzheimer's disease: preliminary results of a double-blind study","Harbaugh RE.","J Neural Transm Suppl. 1987;24:271-7.","Harbaugh RE","J Neural Transm Suppl","1987","1987/01/01","","",""
"27681702","Effects of Renal Impairment on Steady-State Plasma Concentrations of Rivastigmine: A Population Pharmacokinetic Analysis of Capsule and Patch Formulations in Patients with Alzheimer's Disease","Lefèvre G, Callegari F, Gsteiger S, Xiong Y.","Drugs Aging. 2016 Oct;33(10):725-736. doi: 10.1007/s40266-016-0405-y.","Lefèvre G","Drugs Aging","2016","2016/09/30","PMC5075013","","10.1007/s40266-016-0405-y"
"9809777","Cost effectiveness of non pharmacological interventions in Alzheimer's disease","Zanetti O, Bianchetti A, Trabucchi M.","J Am Geriatr Soc. 1998 Nov;46(11):1481. doi: 10.1111/j.1532-5415.1998.tb06024.x.","Zanetti O","J Am Geriatr Soc","1998","1998/11/11","","","10.1111/j.1532-5415.1998.tb06024.x"
"16734932","Observations from a 14-week open-label trial with memantine suggest variable response on behavioral symptoms and cognition, depending on former treatment of AD","Dautzenberg PL, Wouters CJ, Bootsma JE.","Int Psychogeriatr. 2006 Mar;18(1):179-81. doi: 10.1017/S104161020625347X.","Dautzenberg PL","Int Psychogeriatr","2006","2006/06/01","","","10.1017/S104161020625347X"
"27633250","Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer's disease and elderly controls after oral administration of sembragiline","Sturm S, Forsberg A, Nave S, Stenkrona P, Seneca N, Varrone A, Comley RA, Fazio P, Jamois C, Nakao R, Ejduk Z, Al-Tawil N, Akenine U, Halldin C, Andreasen N, Ricci B.","Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):382-391. doi: 10.1007/s00259-016-3510-6. Epub 2016 Sep 16.","Sturm S","Eur J Nucl Med Mol Imaging","2017","2016/09/17","PMC5281649","","10.1007/s00259-016-3510-6"
"15462693","Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study","Aupperle PM, Koumaras B, Chen M, Rabinowicz A, Mirski D.","Curr Med Res Opin. 2004 Oct;20(10):1605-12. doi: 10.1185/030079904125004204.","Aupperle PM","Curr Med Res Opin","2004","2004/10/07","","","10.1185/030079904125004204"
"14503055","[Clinical study on treatment of Alzheimer's disease from the viewpoint of Xin and Shen]","Lin SM, Wang J, Zhou RQ.","Zhongguo Zhong Xi Yi Jie He Za Zhi. 2003 Aug;23(8):583-6.","Lin SM","Zhongguo Zhong Xi Yi Jie He Za Zhi","2003","2003/09/25","","",""
"11001602","Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory","Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, Lopez OL, DeKosky ST.","J Neuropsychiatry Clin Neurosci. 2000 Spring;12(2):233-9. doi: 10.1176/jnp.12.2.233.","Kaufer DI","J Neuropsychiatry Clin Neurosci","2000","2000/09/23","","","10.1176/jnp.12.2.233"
"27977231","African American Dementia Caregiver Problem Inventory: Descriptive analysis and initial psychometric evaluation","Wells BA, Glueckauf RL, Bernabe D, Kazmer MM, Schettini G, Springer J, Sharma D, Meng H, Willis FB, Graff-Radford N.","Rehabil Psychol. 2017 Feb;62(1):25-35. doi: 10.1037/rep0000110. Epub 2016 Dec 15.","Wells BA","Rehabil Psychol","2017","2016/12/16","","","10.1037/rep0000110"
"16513035","Rofecoxib in mild cognitive impairment","Ownby RL.","Curr Psychiatry Rep. 2006 Feb;8(1):9-10.","Ownby RL","Curr Psychiatry Rep","2006","2006/03/04","","",""
"35607946","Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease","Benussi A, Cantoni V, Grassi M, Brechet L, Michel CM, Datta A, Thomas C, Gazzina S, Cotelli MS, Bianchi M, Premi E, Gadola Y, Cotelli M, Pengo M, Perrone F, Scolaro M, Archetti S, Solje E, Padovani A, Pascual-Leone A, Borroni B.","Ann Neurol. 2022 Aug;92(2):322-334. doi: 10.1002/ana.26411. Epub 2022 Jun 6.","Benussi A","Ann Neurol","2022","2022/05/24","PMC9546168","","10.1002/ana.26411"
"15797175","Automated neuropsychological assessment metrics (ANAM) measures of cognitive effects of Alzheimer's disease","Levinson D, Reeves D, Watson J, Harrison M.","Arch Clin Neuropsychol. 2005 May;20(3):403-8. doi: 10.1016/j.acn.2004.09.001.","Levinson D","Arch Clin Neuropsychol","2005","2005/03/31","","","10.1016/j.acn.2004.09.001"
"36502333","Effects of Melissa officinalis Extract Containing Rosmarinic Acid on Cognition in Older Adults Without Dementia: A Randomized Controlled Trial","Noguchi-Shinohara M, Hamaguchi T, Sakai K, Komatsu J, Iwasa K, Horimoto M, Nakamura H, Yamada M, Ono K.","J Alzheimers Dis. 2023;91(2):805-814. doi: 10.3233/JAD-220953.","Noguchi-Shinohara M","J Alzheimers Dis","2023","2022/12/11","","","10.3233/JAD-220953"
"9838127","Fibroblast growth factor (FGF)-9 immunoreactivity in senile plaques","Nakamura S, Arima K, Haga S, Aizawa T, Motoi Y, Otsuka M, Ueki A, Ikeda K.","Brain Res. 1998 Dec 14;814(1-2):222-5. doi: 10.1016/s0006-8993(98)01042-7.","Nakamura S","Brain Res","1998","1998/12/05","","","10.1016/s0006-8993(98)01042-7"
"12218259","Plasma levels of Abeta42 and Abeta40 in Alzheimer patients during treatment with the acetylcholinesterase inhibitor tacrine","Basun H, Nilsberth C, Eckman C, Lannfelt L, Younkin S.","Dement Geriatr Cogn Disord. 2002;14(3):156-60. doi: 10.1159/000063605.","Basun H","Dement Geriatr Cogn Disord","2002","2002/09/10","","","10.1159/000063605"
"26412285","Changes in Nutritional Status after Deep Brain Stimulation of the Nucleus Basalis of Meynert in Alzheimer's Disease--Results of a Phase I Study","Noreik M, Kuhn J, Hardenacke K, Lenartz D, Bauer A, Bührle CP, Häussermann P, Hellmich M, Klosterkötter J, Wiltfang J, Maarouf M, Freund HJ, Visser-Vandewalle V, Sturm V, Schulz RJ.","J Nutr Health Aging. 2015 Oct;19(8):812-8. doi: 10.1007/s12603-015-0595-8.","Noreik M","J Nutr Health Aging","2015","2015/09/29","","","10.1007/s12603-015-0595-8"
"17342790","Efficacy of aromatherapy (Lavandula angustifolia) as an intervention for agitated behaviours in Chinese older persons with dementia: a cross-over randomized trial","Lin PW, Chan WC, Ng BF, Lam LC.","Int J Geriatr Psychiatry. 2007 May;22(5):405-10. doi: 10.1002/gps.1688.","Lin PW","Int J Geriatr Psychiatry","2007","2007/03/08","","","10.1002/gps.1688"
"15849163","Reappraising contemporary theories of subcortical participation in language: proposing an interhemispheric regulatory function for the subthalamic nucleus (STN) in the mediation of high-level linguistic processes","Whelan BM, Murdoch BE, Theodoros DG, Silburn P, Hall B.","Neurocase. 2004 Feb;10(1):70-7. doi: 10.1080/13554790490960521.","Whelan BM","Neurocase","2004","2005/04/26","","","10.1080/13554790490960521"
"16157451","Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease","Minoretti P, Gazzaruso C, Vito CD, Emanuele E, Bianchi M, Coen E, Reino M, Geroldi D.","Neurosci Lett. 2006 Jan 2;391(3):147-9. doi: 10.1016/j.neulet.2005.08.047. Epub 2005 Sep 12.","Minoretti P","Neurosci Lett","2006","2005/09/15","","","10.1016/j.neulet.2005.08.047"
"8570774","L-deprenyl and physostigmine for the treatment of Alzheimer's disease","Marin DB, Bierer LM, Lawlor BA, Ryan TM, Jacobson R, Schmeidler J, Mohs RC, Davis KL.","Psychiatry Res. 1995 Oct 16;58(3):181-9. doi: 10.1016/0165-1781(95)02714-8.","Marin DB","Psychiatry Res","1995","1995/10/16","","","10.1016/0165-1781(95)02714-8"
"17545739","A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease","van Dyck CH, Tariot PN, Meyers B, Malca Resnick E; Memantine MEM-MD-01 Study Group.","Alzheimer Dis Assoc Disord. 2007 Apr-Jun;21(2):136-43. doi: 10.1097/WAD.0b013e318065c495.","van Dyck CH","Alzheimer Dis Assoc Disord","2007","2007/06/05","","","10.1097/WAD.0b013e318065c495"
"7580172","Cerebral magnetic resonance imaging compared in Alzheimer's and multi-infarct dementia","Reed KM, Rogers RL, Meyer JS.","J Neuropsychiatry Clin Neurosci. 1991 Winter;3(1):51-7. doi: 10.1176/jnp.3.1.51.","Reed KM","J Neuropsychiatry Clin Neurosci","1991","1991/01/01","","","10.1176/jnp.3.1.51"
"15177793","Pantomime and imitation of limb gestures in relation to the severity of Alzheimer's disease","Parakh R, Roy E, Koo E, Black S.","Brain Cogn. 2004 Jul;55(2):272-4. doi: 10.1016/j.bandc.2004.02.049.","Parakh R","Brain Cogn","2004","2004/06/05","","","10.1016/j.bandc.2004.02.049"
"11225688","Fluvoxamine for psychosis in Alzheimer's disease","Levkovitz Y, Bloch Y, Kaplan D, Diskin A, Abramovitchi I.","J Nerv Ment Dis. 2001 Feb;189(2):126-9. doi: 10.1097/00005053-200102000-00011.","Levkovitz Y","J Nerv Ment Dis","2001","2001/02/28","","","10.1097/00005053-200102000-00011"
"34762376","[Abdominal acupoint thread embedding therapy based on ""brain-intestinal connection"" for mild-to-moderate Alzheimer's disease and its effects on serum levels of APP and Aβ(1-42)]","Yang SQ, Fan DH, Yuan ZX, Su MY, Zhang ZN, Lin Y, Lin HG.","Zhongguo Zhen Jiu. 2021 Nov 12;41(11):1231-5. doi: 10.13703/j.0255-2930.20201106-k0002.","Yang SQ","Zhongguo Zhen Jiu","2021","2021/11/11","","","10.13703/j.0255-2930.20201106-k0002"
"12080579","[Effects of autogenic training in elderly patients]","Kircher T, Teutsch E, Wormstall H, Buchkremer G, Thimm E.","Z Gerontol Geriatr. 2002 Apr;35(2):157-65. doi: 10.1007/s003910200020.","Kircher T","Z Gerontol Geriatr","2002","2002/06/26","","","10.1007/s003910200020"
"11317951","A randomized controlled trial of the effects of multi-sensory stimulation (MSS) for people with dementia","Baker R, Bell S, Baker E, Gibson S, Holloway J, Pearce R, Dowling Z, Thomas P, Assey J, Wareing LA.","Br J Clin Psychol. 2001 Mar;40(1):81-96. doi: 10.1348/014466501163508.","Baker R","Br J Clin Psychol","2001","2001/04/25","","","10.1348/014466501163508"
"18482301","Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use","Holmes HM, Sachs GA, Shega JW, Hougham GW, Cox Hayley D, Dale W.","J Am Geriatr Soc. 2008 Jul;56(7):1306-11. doi: 10.1111/j.1532-5415.2008.01741.x. Epub 2008 May 12.","Holmes HM","J Am Geriatr Soc","2008","2008/05/17","","","10.1111/j.1532-5415.2008.01741.x"
"21453045","Capacity of the Catalan and Spanish versions of the Bilingual Aphasia Test to distinguish between healthy aging, mild cognitive impairment and Alzheimer's disease","Gómez-Ruiz I, Aguilar-Alonso A.","Clin Linguist Phon. 2011 Jun;25(6-7):444-63. doi: 10.3109/02699206.2011.560989. Epub 2011 Mar 31.","Gómez-Ruiz I","Clin Linguist Phon","2011","2011/04/02","","","10.3109/02699206.2011.560989"
"28122366","Comprehensive, Individualized, Person-Centered Management of Community-Residing Persons with Moderate-to-Severe Alzheimer Disease: A Randomized Controlled Trial","Reisberg B, Shao Y, Golomb J, Monteiro I, Torossian C, Boksay I, Shulman M, Heller S, Zhu Z, Atif A, Sidhu J, Vedvyas A, Kenowsky S.","Dement Geriatr Cogn Disord. 2017;43(1-2):100-117. doi: 10.1159/000455397. Epub 2017 Jan 26.","Reisberg B","Dement Geriatr Cogn Disord","2017","2017/01/26","PMC5562438","NIHMS845534","10.1159/000455397"
"12629237","A visuospatial variant of mild cognitive impairment: getting lost between aging and AD","Mapstone M, Steffenella TM, Duffy CJ.","Neurology. 2003 Mar 11;60(5):802-8. doi: 10.1212/01.wnl.0000049471.76799.de.","Mapstone M","Neurology","2003","2003/03/12","","","10.1212/01.wnl.0000049471.76799.de"
"16254428","Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease","Suh GH, Jung HY, Lee CU, Oh BH, Lee SK, Lee N, Kim J, Kee BS, Ko D, Kim YH, Ju YS, Hong I, Choi S; Korean Galantamine Study Group.","Dement Geriatr Cogn Disord. 2006;21(1):33-9. doi: 10.1159/000089217. Epub 2005 Oct 25.","Suh GH","Dement Geriatr Cogn Disord","2006","2005/10/29","","","10.1159/000089217"
"11235926","The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease","Clark WS, Street JS, Feldman PD, Breier A.","J Clin Psychiatry. 2001 Jan;62(1):34-40. doi: 10.4088/jcp.v62n0108.","Clark WS","J Clin Psychiatry","2001","2001/03/10","","","10.4088/jcp.v62n0108"
"9701676","Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease","Eriksdotter Jönhagen M, Nordberg A, Amberla K, Bäckman L, Ebendal T, Meyerson B, Olson L, Seiger, Shigeta M, Theodorsson E, Viitanen M, Winblad B, Wahlund LO.","Dement Geriatr Cogn Disord. 1998 Sep-Oct;9(5):246-57. doi: 10.1159/000017069.","Eriksdotter Jönhagen M","Dement Geriatr Cogn Disord","1998","1998/08/14","","","10.1159/000017069"
"15465622","Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome","Cataldo AM, Petanceska S, Terio NB, Peterhoff CM, Durham R, Mercken M, Mehta PD, Buxbaum J, Haroutunian V, Nixon RA.","Neurobiol Aging. 2004 Nov-Dec;25(10):1263-72. doi: 10.1016/j.neurobiolaging.2004.02.027.","Cataldo AM","Neurobiol Aging","2004","2004/10/07","","","10.1016/j.neurobiolaging.2004.02.027"
"18631958","The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics","Jones RW, Kivipelto M, Feldman H, Sparks L, Doody R, Waters DD, Hey-Hadavi J, Breazna A, Schindler RJ, Ramos H; LEADe investigators.","Alzheimers Dement. 2008 Mar;4(2):145-53. doi: 10.1016/j.jalz.2008.02.001.","Jones RW","Alzheimers Dement","2008","2008/07/18","","","10.1016/j.jalz.2008.02.001"
"27572272","RHAPSODY - Internet-based support for caregivers of people with young onset dementia: program design and methods of a pilot study","Kurz A, Bakker C, Böhm M, Diehl-Schmid J, Dubois B, Ferreira C, Gage H, Graff C, Hergueta T, Jansen S, Jones B, Komar A, de Mendonça A, Metcalfe A, Milecka K, Millenaar J, Orrung Wallin A, Oyebode J, Schneider-Schelte H, Saxl S, de Vugt M.","Int Psychogeriatr. 2016 Dec;28(12):2091-2099. doi: 10.1017/S1041610216001186. Epub 2016 Aug 30.","Kurz A","Int Psychogeriatr","2016","2016/08/31","","","10.1017/S1041610216001186"
"17599421","The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods","Williamson JD, Miller ME, Bryan RN, Lazar RM, Coker LH, Johnson J, Cukierman T, Horowitz KR, Murray A, Launer LJ; ACCORD Study Group.","Am J Cardiol. 2007 Jun 18;99(12A):112i-122i. doi: 10.1016/j.amjcard.2007.03.029. Epub 2007 Apr 12.","Williamson JD","Am J Cardiol","2007","2007/07/31","","","10.1016/j.amjcard.2007.03.029"
"17284556","Resilience and transitions from dementia caregiving","Gaugler JE, Kane RL, Newcomer R.","J Gerontol B Psychol Sci Soc Sci. 2007 Jan;62(1):P38-44. doi: 10.1093/geronb/62.1.p38.","Gaugler JE","J Gerontol B Psychol Sci Soc Sci","2007","2007/02/08","","","10.1093/geronb/62.1.p38"
"11976799","A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping","Colloby SJ, Fenwick JD, Williams ED, Paling SM, Lobotesis K, Ballard C, McKeith I, O'Brien JT.","Eur J Nucl Med Mol Imaging. 2002 May;29(5):615-22. doi: 10.1007/s00259-002-0778-5. Epub 2002 Mar 5.","Colloby SJ","Eur J Nucl Med Mol Imaging","2002","2002/04/27","","","10.1007/s00259-002-0778-5"
"10984725","Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study","Samuel W, Caligiuri M, Galasko D, Lacro J, Marini M, McClure FS, Warren K, Jeste DV.","Int J Geriatr Psychiatry. 2000 Sep;15(9):794-802. doi: 10.1002/1099-1166(200009)15:9<794::aid-gps178>3.0.co;2-1.","Samuel W","Int J Geriatr Psychiatry","2000","2000/09/14","","","10.1002/1099-1166(200009)15:9<794::aid-gps178>3.0.co;2-1"
"24780290","Cardiopulmonary exercise testing is well tolerated in people with Alzheimer-related cognitive impairment","Billinger SA, Vidoni ED, Greer CS, Graves RS, Mattlage AE, Burns JM.","Arch Phys Med Rehabil. 2014 Sep;95(9):1714-8. doi: 10.1016/j.apmr.2014.04.007. Epub 2014 Apr 26.","Billinger SA","Arch Phys Med Rehabil","2014","2014/05/01","PMC4149924","NIHMS590244","10.1016/j.apmr.2014.04.007"
"2206016","Statistical analysis of the clinical trial of a therapy for Alzheimer's disease. Univariate tests and logistic regression","Comelli M, Lucca U, Spagnoli A.","Acta Neurol (Napoli). 1990 Jun;12(3):222-30.","Comelli M","Acta Neurol (Napoli)","1990","1990/06/01","","",""
"34797294","Acupuncture for amnestic mild cognitive impairment: A pilot multicenter, randomized, parallel controlled trial","Zhang J, Kuang X, Tang C, Xu N, Xiao S, Xiao L, Wang S, Dong Y, Lu L, Zhang L.","Medicine (Baltimore). 2021 Nov 19;100(46):e27686. doi: 10.1097/MD.0000000000027686.","Zhang J","Medicine (Baltimore)","2021","2021/11/19","PMC8601273","","10.1097/MD.0000000000027686"
"12095908","Alzheimer disease, serotonin systems, and tryptophan depletion","Newhouse P, Tatro A, Naylor M, Quealey K, Delgado P.","Am J Geriatr Psychiatry. 2002 Jul-Aug;10(4):483-4.","Newhouse P","Am J Geriatr Psychiatry","2002","2002/07/04","","",""
"10340193","The impact of behavioral impairment of functional ability in Alzheimer's disease","Green CR, Marin DB, Mohs RC, Schmeidler J, Aryan M, Fine E, Davis KL.","Int J Geriatr Psychiatry. 1999 Apr;14(4):307-16. doi: 10.1002/(sici)1099-1166(199904)14:4<307::aid-gps908>3.0.co;2-e.","Green CR","Int J Geriatr Psychiatry","1999","1999/05/26","","","10.1002/(sici)1099-1166(199904)14:4<307::aid-gps908>3.0.co;2-e"
"10170803","The Medicare Alzheimer's Project in Portland, Oregon","Warren PA, Dunn L, Jackson-Clark A.","Pride Inst J Long Term Home Health Care. 1991 Spring;10(2):20-7.","Warren PA","Pride Inst J Long Term Home Health Care","1991","1992/01/04","","",""
"10669911","Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion","Alvarez XA, Mouzo R, Pichel V, Pérez P, Laredo M, Fernández-Novoa L, Corzo L, Zas R, Alcaraz M, Secades JJ, Lozano R, Cacabelos R.","Methods Find Exp Clin Pharmacol. 1999 Nov;21(9):633-44.","Alvarez XA","Methods Find Exp Clin Pharmacol","1999","2000/02/12","","",""
"10867211","Hemorheological changes and overproduction of cytokines from immune cells in mild to moderate dementia of the Alzheimer's type: adverse effects on cerebromicrovascular system","Solerte SB, Ceresini G, Ferrari E, Fioravanti M.","Neurobiol Aging. 2000 Mar-Apr;21(2):271-81. doi: 10.1016/s0197-4580(00)00105-6.","Solerte SB","Neurobiol Aging","2000","2000/06/27","","","10.1016/s0197-4580(00)00105-6"
"7993133","Effects of two caregiver-training programs on burden and attitude toward help","Robinson K, Yates K.","Arch Psychiatr Nurs. 1994 Oct;8(5):312-9. doi: 10.1016/0883-9417(94)90029-9.","Robinson K","Arch Psychiatr Nurs","1994","1994/10/01","","","10.1016/0883-9417(94)90029-9"
"36120775","Effects of Simvastatin on Plasma Amyloid-β Transport in Patients with Hyperlipidemia: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial","Wei S, Dang L, Gao F, Wang J, Wang J, Qu Q.","J Alzheimers Dis. 2022;90(1):349-362. doi: 10.3233/JAD-220240.","Wei S","J Alzheimers Dis","2022","2022/09/19","","","10.3233/JAD-220240"
"12240739","Olfactory event-related potentials in Alzheimer's disease","Morgan CD, Murphy C.","J Int Neuropsychol Soc. 2002 Sep;8(6):753-63. doi: 10.1017/s1355617702860039.","Morgan CD","J Int Neuropsychol Soc","2002","2002/09/21","","","10.1017/s1355617702860039"
"28786990","Alzheimer's disease pathology and shunt surgery outcome in normal pressure hydrocephalus","Yasar S, Jusue-Torres I, Lu J, Robison J, Patel MA, Crain B, Carson KA, Hoffberger J, Batra S, Sankey E, Moghekar A, Rigamonti D.","PLoS One. 2017 Aug 7;12(8):e0182288. doi: 10.1371/journal.pone.0182288. eCollection 2017.","Yasar S","PLoS One","2017","2017/08/09","PMC5546572","","10.1371/journal.pone.0182288"
"21406956","Cognitive intervention response is related to habitual physical activity in older adults","Thiel C, Vogt L, Tesky VA, Meroth L, Jakob M, Sahlender S, Pantel J, Banzer W.","Aging Clin Exp Res. 2012 Feb;24(1):47-55. doi: 10.3275/7569. Epub 2011 Mar 14.","Thiel C","Aging Clin Exp Res","2012","2011/03/17","","","10.3275/7569"
"10928743","Alterations of visual search strategy in Alzheimer's disease and aging","Rösler A, Mapstone ME, Hays AK, Mesulam MM, Rademaker A, Gitelman DR, Weintraub S.","Neuropsychology. 2000 Jul;14(3):398-408. doi: 10.1037//0894-4105.14.3.398.","Rösler A","Neuropsychology","2000","2000/08/06","","","10.1037//0894-4105.14.3.398"
"27145364","R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation","Ho T, Pollock BG, Mulsant BH, Schantz O, Devanand DP, Mintzer JE, Porsteinsson AP, Schneider LS, Weintraub D, Yesavage J, Drye LT, Munro CA, Shade DM, Lyketsos C, Bies R.","Br J Clin Pharmacol. 2016 Sep;82(3):784-92. doi: 10.1111/bcp.12997. Epub 2016 Jun 20.","Ho T","Br J Clin Pharmacol","2016","2016/05/05","PMC6445501","","10.1111/bcp.12997"
"34287475","Dengzhan shengmai capsule combined with donepezil hydrochloride in the treatment of Alzheimer's disease: preliminary findings, randomized and controlled clinical trial","Huang P, He XY, Xu M.","Rev Assoc Med Bras (1992). 2021 Feb;67(2):190-194. doi: 10.1590/1806-9282.67.02.20200378.","Huang P","Rev Assoc Med Bras (1992)","2021","2021/07/21","","","10.1590/1806-9282.67.02.20200378"
"17804953","Validity of the clinical dementia rating scale for the detection and staging of dementia in Brazilian patients","Chaves ML, Camozzato AL, Godinho C, Kochhann R, Schuh A, de Almeida VL, Kaye J.","Alzheimer Dis Assoc Disord. 2007 Jul-Sep;21(3):210-7. doi: 10.1097/WAD.0b013e31811ff2b4.","Chaves ML","Alzheimer Dis Assoc Disord","2007","2007/09/07","","","10.1097/WAD.0b013e31811ff2b4"
"24974383","Pyramidal neurons of the prefrontal cortex in post-stroke, vascular and other ageing-related dementias","Foster V, Oakley AE, Slade JY, Hall R, Polvikoski TM, Burke M, Thomas AJ, Khundakar A, Allan LM, Kalaria RN.","Brain. 2014 Sep;137(Pt 9):2509-21. doi: 10.1093/brain/awu172. Epub 2014 Jun 28.","Foster V","Brain","2014","2014/06/30","","","10.1093/brain/awu172"
"18533272","Navigated TMS combined with EEG in mild cognitive impairment and Alzheimer's disease: a pilot study","Julkunen P, Jauhiainen AM, Westerén-Punnonen S, Pirinen E, Soininen H, Könönen M, Pääkkönen A, Määttä S, Karhu J.","J Neurosci Methods. 2008 Jul 30;172(2):270-6. doi: 10.1016/j.jneumeth.2008.04.021. Epub 2008 Apr 29.","Julkunen P","J Neurosci Methods","2008","2008/06/06","","","10.1016/j.jneumeth.2008.04.021"
"12388930","Colostrinin proline-rich polypeptide complex from ovine colostrum--a long-term study of its efficacy in Alzheimer's disease","Leszek J, Inglot AD, Janusz M, Byczkiewicz F, Kiejna A, Georgiades J, Lisowski J.","Med Sci Monit. 2002 Oct;8(10):PI93-6.","Leszek J","Med Sci Monit","2002","2002/10/22","","",""
"11346473","Factors affecting the use of a telephone-based intervention for caregivers of people with Alzheimer's disease","Mahoney DM, Tarlow B, Jones RN, Tennstedt S, Kasten L.","J Telemed Telecare. 2001;7(3):139-48. doi: 10.1258/1357633011936291.","Mahoney DM","J Telemed Telecare","2001","2001/05/11","","","10.1258/1357633011936291"
"12482066","Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias","Good CD, Scahill RI, Fox NC, Ashburner J, Friston KJ, Chan D, Crum WR, Rossor MN, Frackowiak RS.","Neuroimage. 2002 Sep;17(1):29-46. doi: 10.1006/nimg.2002.1202.","Good CD","Neuroimage","2002","2002/12/17","","","10.1006/nimg.2002.1202"
"6752738","A signal detectability analysis of the effect of physostigmine on memory in patients with Alzheimer's disease","Mohs RC, Davis KL.","Neurobiol Aging. 1982 Summer;3(2):105-10. doi: 10.1016/0197-4580(82)90004-5.","Mohs RC","Neurobiol Aging","1982","1982/01/01","","","10.1016/0197-4580(82)90004-5"
"15488906","Loss of high-level perceptual knowledge of object structure in DAT","Done DJ, Hajilou BB.","Neuropsychologia. 2005;43(1):60-8. doi: 10.1016/j.neuropsychologia.2004.06.004.","Done DJ","Neuropsychologia","2005","2004/10/19","","","10.1016/j.neuropsychologia.2004.06.004"
"20837824","A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease","Geldmacher DS, Fritsch T, McClendon MJ, Landreth G.","Arch Neurol. 2011 Jan;68(1):45-50. doi: 10.1001/archneurol.2010.229. Epub 2010 Sep 13.","Geldmacher DS","Arch Neurol","2011","2010/09/15","","","10.1001/archneurol.2010.229"
"2918192","Impact of mild to moderate hearing loss on mental status testing. Comparability of standard and written Mini-Mental State Examinations","Uhlmann RF, Teri L, Rees TS, Mozlowski KJ, Larson EB.","J Am Geriatr Soc. 1989 Mar;37(3):223-8. doi: 10.1111/j.1532-5415.1989.tb06811.x.","Uhlmann RF","J Am Geriatr Soc","1989","1989/03/01","","","10.1111/j.1532-5415.1989.tb06811.x"
"7741012","Possible role of ammonia in the brain in dementia of Alzheimer type","Hoyer S.","Adv Exp Med Biol. 1994;368:197-205. doi: 10.1007/978-1-4615-1989-8_21.","Hoyer S","Adv Exp Med Biol","1994","1994/01/01","","","10.1007/978-1-4615-1989-8_21"
"1581445","The effect of long-term high dose lecithin on erythrocyte choline transport in Alzheimer patients","Uney JB, Jones GM, Rebeiro A, Levy R.","Biol Psychiatry. 1992 Mar 15;31(6):630-3. doi: 10.1016/0006-3223(92)90252-u.","Uney JB","Biol Psychiatry","1992","1992/03/15","","","10.1016/0006-3223(92)90252-u"
"31907330","[Current Clinical Trials in the Treatment of Alzheimer's Disease]","Tamaoka A.","Brain Nerve. 2020 Jan;72(1):23-34. doi: 10.11477/mf.1416201475.","Tamaoka A","Brain Nerve","2020","2020/01/08","","","10.11477/mf.1416201475"
"21555634","Test-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials","Atri A, O'Brien JL, Sreenivasan A, Rastegar S, Salisbury S, DeLuca AN, O'Keefe KM, LaViolette PS, Rentz DM, Locascio JJ, Sperling RA.","Arch Neurol. 2011 May;68(5):599-606. doi: 10.1001/archneurol.2011.94.","Atri A","Arch Neurol","2011","2011/05/11","PMC3291175","NIHMS358173","10.1001/archneurol.2011.94"
"9154590","Nursing home research from industry's perspective","Brecher M.","Int Psychogeriatr. 1996;8 Suppl 3:367-70. doi: 10.1017/s1041610297003645.","Brecher M","Int Psychogeriatr","1996","1996/01/01","","","10.1017/s1041610297003645"
"34146512","Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial","Burns DK, Alexander RC, Welsh-Bohmer KA, Culp M, Chiang C, O'Neil J, Evans RM, Harrigan P, Plassman BL, Burke JR, Wu J, Lutz MW, Haneline S, Schwarz AJ, Schneider LS, Yaffe K, Saunders AM, Ratti E; TOMMORROW study investigators.","Lancet Neurol. 2021 Jul;20(7):537-547. doi: 10.1016/S1474-4422(21)00043-0.","Burns DK","Lancet Neurol","2021","2021/06/19","","","10.1016/S1474-4422(21)00043-0"
"16122963","Analysis of EEG background activity in Alzheimer's disease patients with Lempel-Ziv complexity and central tendency measure","Abásolo D, Hornero R, Gómez C, García M, López M.","Med Eng Phys. 2006 May;28(4):315-22. doi: 10.1016/j.medengphy.2005.07.004. Epub 2005 Aug 24.","Abásolo D","Med Eng Phys","2006","2005/08/27","","","10.1016/j.medengphy.2005.07.004"
"22746245","Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease","Nunes MA, Viel TA, Buck HS.","Curr Alzheimer Res. 2013 Jan;10(1):104-7. doi: 10.2174/1567205011310010014.","Nunes MA","Curr Alzheimer Res","2013","2012/07/04","","","10.2174/1567205011310010014"
"23116458","A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease","Moss DE, Fariello RG, Sahlmann J, Sumaya I, Pericle F, Braglia E.","Br J Clin Pharmacol. 2013 May;75(5):1231-9. doi: 10.1111/bcp.12018.","Moss DE","Br J Clin Pharmacol","2013","2012/11/03","PMC3635594","","10.1111/bcp.12018"
"16970646","Energy-containing nutritional supplements can affect usual energy intake postsupplementation in institutionalized seniors with probable Alzheimer's disease","Parrott MD, Young KW, Greenwood CE.","J Am Geriatr Soc. 2006 Sep;54(9):1382-7. doi: 10.1111/j.1532-5415.2006.00844.x.","Parrott MD","J Am Geriatr Soc","2006","2006/09/15","","","10.1111/j.1532-5415.2006.00844.x"
"12860500","Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States","Migliaccio-Walle K, Getsios D, Caro JJ, Ishak KJ, O'Brien JA, Papadopoulos G; AHEAD Study Group.","Clin Ther. 2003 Jun;25(6):1806-25. doi: 10.1016/s0149-2918(03)80171-6.","Migliaccio-Walle K","Clin Ther","2003","2003/07/16","","","10.1016/s0149-2918(03)80171-6"
"30347431","Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK-8931) in Healthy Japanese Adults: A Randomized, Placebo-Controlled Study","Chris Min K, Dockendorf MF, Palcza J, Tseng J, Ma L, Stone JA, Kleijn HJ, Hodsman P, Masuo K, Tanen M, Troyer MD, van Vugt M, Forman MS.","Clin Pharmacol Ther. 2019 May;105(5):1234-1243. doi: 10.1002/cpt.1258. Epub 2019 Jan 18.","Chris Min K","Clin Pharmacol Ther","2019","2018/10/23","","","10.1002/cpt.1258"
"23866514","Efficacy of rivastigmine in comparison to ginkgo for treating Alzheimer's dementia","Nasab NM, Bahrammi MA, Nikpour MR, Rahim F, Naghibis SN.","J Pak Med Assoc. 2012 Jul;62(7):677-80.","Nasab NM","J Pak Med Assoc","2012","2013/07/23","","",""
"16801648","Voxel-based detection of white matter abnormalities in mild Alzheimer disease","Xie S, Xiao JX, Gong GL, Zang YF, Wang YH, Wu HK, Jiang XX.","Neurology. 2006 Jun 27;66(12):1845-9. doi: 10.1212/01.wnl.0000219625.77625.aa.","Xie S","Neurology","2006","2006/06/28","","","10.1212/01.wnl.0000219625.77625.aa"
"27356191","Theory of Mind (ToM) and language: stimulating metalinguistic skills in people with dementia","Rosell-Clari V, González BV.","Codas. 2016 Jun 23;0:0. doi: 10.1590/2317-1782/20162015295.","Rosell-Clari V","Codas","2016","2016/06/30","","","10.1590/2317-1782/20162015295"
"27321610","Improving Prospective Memory in Healthy Older Adults and Individuals with Very Mild Alzheimer's Disease","Shelton JT, Lee JH, Scullin MK, Rose NS, Rendell PG, McDaniel MA.","J Am Geriatr Soc. 2016 Jun;64(6):1307-12. doi: 10.1111/jgs.14134.","Shelton JT","J Am Geriatr Soc","2016","2016/06/21","PMC4976780","NIHMS764776","10.1111/jgs.14134"
"31026331","Effects of an Interdisciplinary Care Team on the Management of Alzheimer's Disease in China","Chen C, Huang Y, Liu C, Xu Y, Zheng L, Li J.","J Gerontol Nurs. 2019 May 1;45(5):39-45. doi: 10.3928/00989134-20190318-01.","Chen C","J Gerontol Nurs","2019","2019/04/27","","","10.3928/00989134-20190318-01"
"9109979","Brain SPECT in dementia. A clinical-scintigraphic correlation","Buchpiguel CA, Mathias SC, Itaya LY, Barros NG, Portela LA, Freitas JM, Caramelli P, Carrilho PE, Bacheschi LA, Hironaka FH, Nitrini R.","Arq Neuropsiquiatr. 1996 Sep;54(3):375-83. doi: 10.1590/s0004-282x1996000300003.","Buchpiguel CA","Arq Neuropsiquiatr","1996","1996/09/01","","","10.1590/s0004-282x1996000300003"
"11459000","No evidence for cognitive improvement from oral nicotinamide adenine dinucleotide (NADH) in dementia","Rainer M, Kraxberger E, Haushofer M, Mucke HA, Jellinger KA.","J Neural Transm (Vienna). 2000;107(12):1475-81. doi: 10.1007/s007020070011.","Rainer M","J Neural Transm (Vienna)","2000","2001/07/19","","","10.1007/s007020070011"
"2687355","Pyritinol treatment of SDAT patients: evaluation by psychiatric and neurological examination, psychometric testing and rCBF measurements","Knezevic S, Mubrin Z, Risberg J, Vucinic G, Spilich G, Gubarev N, Wannenmacher W.","Int Clin Psychopharmacol. 1989 Jan;4(1):25-38.","Knezevic S","Int Clin Psychopharmacol","1989","1989/01/01","","",""
"10681079","Association between angiotensin-converting enzyme and Alzheimer disease","Farrer LA, Sherbatich T, Keryanov SA, Korovaitseva GI, Rogaeva EA, Petruk S, Premkumar S, Moliaka Y, Song YQ, Pei Y, Sato C, Selezneva ND, Voskresenskaya S, Golimbet V, Sorbi S, Duara R, Gavrilova S, St George-Hyslop PH, Rogaev EI.","Arch Neurol. 2000 Feb;57(2):210-4. doi: 10.1001/archneur.57.2.210.","Farrer LA","Arch Neurol","2000","2000/02/19","","","10.1001/archneur.57.2.210"
"36703196","Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial","Yulug B, Altay O, Li X, Hanoglu L, Cankaya S, Lam S, Velioglu HA, Yang H, Coskun E, Idil E, Nogaylar R, Ozsimsek A, Bayram C, Bolat I, Oner S, Tozlu OO, Arslan ME, Hacimuftuoglu A, Yildirim S, Arif M, Shoaie S, Zhang C, Nielsen J, Turkez H, Borén J, Uhlén M, Mardinoglu A.","Transl Neurodegener. 2023 Jan 26;12(1):4. doi: 10.1186/s40035-023-00336-2.","Yulug B","Transl Neurodegener","2023","2023/01/26","PMC9879258","","10.1186/s40035-023-00336-2"
"20094015","Effects of hormone therapy on depressive symptoms and cognitive functions in women with Alzheimer disease: a 12 month randomized, double-blind, placebo-controlled study of low-dose estradiol and norethisterone","Valen-Sendstad A, Engedal K, Stray-Pedersen B; ADACT Study Group; Strobel C, Barnett L, Meyer N, Nurminemi M.","Am J Geriatr Psychiatry. 2010 Jan;18(1):11-20. doi: 10.1097/JGP.0b013e3181beaaf4.","Valen-Sendstad A","Am J Geriatr Psychiatry","2010","2010/01/23","","","10.1097/JGP.0b013e3181beaaf4"
"17030655","Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial","Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J.","Arch Neurol. 2006 Oct;63(10):1402-8. doi: 10.1001/archneur.63.10.1402.","Freund-Levi Y","Arch Neurol","2006","2006/10/13","","","10.1001/archneur.63.10.1402"
"10364643","Inheritance of the ApoE epsilon4 allele increases the rate of brain atrophy in dementia patients","Wahlund LO, Julin P, Lannfelt L, Lindqvist J, Svensson L.","Dement Geriatr Cogn Disord. 1999 Jul-Aug;10(4):262-8. doi: 10.1159/000017130.","Wahlund LO","Dement Geriatr Cogn Disord","1999","1999/06/12","","","10.1159/000017130"
"36583148","A Feasibility Study of Individuals Living at Home with Alzheimer's Disease and Related Dementias: Utilization of Visual Mapping Assistive Technology to Enhance Quality of Life and Reduce Caregiver Burden","Han SS, White K, Cisek E.","Clin Interv Aging. 2022 Dec 23;17:1885-1892. doi: 10.2147/CIA.S387255. eCollection 2022.","Han SS","Clin Interv Aging","2022","2022/12/30","PMC9793743","","10.2147/CIA.S387255"
"27716660","The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer's Disease Subjects","An H, Choi B, Park KW, Kim DH, Yang DW, Hong CH, Kim SY, Han SH.","J Alzheimers Dis. 2017;55(2):727-735. doi: 10.3233/JAD-160225.","An H","J Alzheimers Dis","2017","2016/10/08","","","10.3233/JAD-160225"
"20522656","Effectiveness of a specific care plan in patients with Alzheimer's disease: cluster randomised trial (PLASA study)","Nourhashemi F, Andrieu S, Gillette-Guyonnet S, Giraudeau B, Cantet C, Coley N, Vellas B; PLASA Group.","BMJ. 2010 Jun 3;340:c2466. doi: 10.1136/bmj.c2466.","Nourhashemi F","BMJ","2010","2010/06/05","PMC2881198","","10.1136/bmj.c2466"
"11890487","Does behavioral improvement with haloperidol or trazodone treatment depend on psychosis or mood symptoms in patients with dementia?","Sultzer DL, Gray KF, Gunay I, Wheatley MV, Mahler ME.","J Am Geriatr Soc. 2001 Oct;49(10):1294-300. doi: 10.1046/j.1532-5415.2001.49256.x.","Sultzer DL","J Am Geriatr Soc","2001","2002/03/14","","","10.1046/j.1532-5415.2001.49256.x"
"25343269","Teleneuropsychology: evidence for video teleconference-based neuropsychological assessment","Munro Cullum C, Hynan LS, Grosch M, Parikh M, Weiner MF.","J Int Neuropsychol Soc. 2014 Nov;20(10):1028-33. doi: 10.1017/S1355617714000873. Epub 2014 Oct 24.","Munro Cullum C","J Int Neuropsychol Soc","2014","2014/10/25","PMC4410096","NIHMS680925","10.1017/S1355617714000873"
"9298634","A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group","Marcusson J, Rother M, Kittner B, Rössner M, Smith RJ, Babic T, Folnegovic-Smalc V, Möller HJ, Labs KH.","Dement Geriatr Cogn Disord. 1997 Sep-Oct;8(5):320-8. doi: 10.1159/000106650.","Marcusson J","Dement Geriatr Cogn Disord","1997","1997/09/23","","","10.1159/000106650"
"33987915","Individualized Prediction of Early Alzheimer's Disease Based on Magnetic Resonance Imaging Radiomics, Clinical, and Laboratory Examinations: A 60-Month Follow-Up Study","Tang L, Wu X, Liu H, Wu F, Song R, Zhang W, Guo D, Feng J, Li C.","J Magn Reson Imaging. 2021 Nov;54(5):1647-1657. doi: 10.1002/jmri.27689. Epub 2021 May 13.","Tang L","J Magn Reson Imaging","2021","2021/05/14","","","10.1002/jmri.27689"
"16533956","Antihypertensive medication use and incident Alzheimer disease: the Cache County Study","Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, Tschanz JT, Mayer LS, Welsh-Bohmer KA, Breitner JC.","Arch Neurol. 2006 May;63(5):686-92. doi: 10.1001/archneur.63.5.noc60013. Epub 2006 Mar 13.","Khachaturian AS","Arch Neurol","2006","2006/03/15","","","10.1001/archneur.63.5.noc60013"
"15596605","Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial","Seltzer B, Zolnouni P, Nunez M, Goldman R, Kumar D, Ieni J, Richardson S; Donepezil ""402"" Study Group.","Arch Neurol. 2004 Dec;61(12):1852-6. doi: 10.1001/archneur.61.12.1852.","Seltzer B","Arch Neurol","2004","2004/12/15","","","10.1001/archneur.61.12.1852"
"25084489","Patients' diagnosis decisions in Alzheimer's disease: the influence of family factors","Rapp T.","Soc Sci Med. 2014 Oct;118:9-16. doi: 10.1016/j.socscimed.2014.07.052. Epub 2014 Jul 24.","Rapp T","Soc Sci Med","2014","2014/08/02","","","10.1016/j.socscimed.2014.07.052"
"8483655","Effects of music on Alzheimer patients","Lord TR, Garner JE.","Percept Mot Skills. 1993 Apr;76(2):451-5. doi: 10.2466/pms.1993.76.2.451.","Lord TR","Percept Mot Skills","1993","1993/04/01","","","10.2466/pms.1993.76.2.451"
"11801437","Auditory event-related potentials during target detection are abnormal in mild cognitive impairment","Golob EJ, Johnson JK, Starr A.","Clin Neurophysiol. 2002 Jan;113(1):151-61. doi: 10.1016/s1388-2457(01)00713-1.","Golob EJ","Clin Neurophysiol","2002","2002/01/22","","","10.1016/s1388-2457(01)00713-1"
"10940680","First symptoms--frontotemporal dementia versus Alzheimer's disease","Lindau M, Almkvist O, Kushi J, Boone K, Johansson SE, Wahlund LO, Cummings JL, Miller BL.","Dement Geriatr Cogn Disord. 2000 Sep-Oct;11(5):286-93. doi: 10.1159/000017251.","Lindau M","Dement Geriatr Cogn Disord","2000","2000/08/15","","","10.1159/000017251"
"15193361","Is pigment epithelium-derived factor level in cerebrospinal fluid a promising biomarker for early diagnosis of Alzheimer's disease?","Yamagishi S, Inagaki Y, Takeuchi M, Sasaki N.","Med Hypotheses. 2004;63(1):115-7. doi: 10.1016/j.mehy.2004.02.022.","Yamagishi S","Med Hypotheses","2004","2004/06/15","","","10.1016/j.mehy.2004.02.022"
"7529680","Effects of a single intravenous dose of scopolamine on the quantitative EEG in Alzheimer's disease patients and age-matched controls","Neufeld MY, Rabey MJ, Parmet Y, Sifris P, Treves TA, Korczyn AD.","Electroencephalogr Clin Neurophysiol. 1994 Dec;91(6):407-12. doi: 10.1016/0013-4694(94)90162-7.","Neufeld MY","Electroencephalogr Clin Neurophysiol","1994","1994/12/01","","","10.1016/0013-4694(94)90162-7"
"36849448","Updated Percentiles for the University of Pennsylvania Smell Identification Test in Adults 50 Years of Age and Older","Brumm MC, Pierz KA, Lafontant DE, Caspell-Garcia C, Coffey CS, Siderowf A, Marek K.","Neurology. 2023 Apr 18;100(16):e1691-e1701. doi: 10.1212/WNL.0000000000207077. Epub 2023 Feb 27.","Brumm MC","Neurology","2023","2023/02/27","PMC10115503","","10.1212/WNL.0000000000207077"
"22094481","Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease","Chen Y, Wolk DA, Reddin JS, Korczykowski M, Martinez PM, Musiek ES, Newberg AB, Julin P, Arnold SE, Greenberg JH, Detre JA.","Neurology. 2011 Nov 29;77(22):1977-85. doi: 10.1212/WNL.0b013e31823a0ef7. Epub 2011 Nov 16.","Chen Y","Neurology","2011","2011/11/19","PMC3235355","","10.1212/WNL.0b013e31823a0ef7"
"18376061","Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease","Carlsson CM, Gleason CE, Hess TM, Moreland KA, Blazel HM, Koscik RL, Schreiber NT, Johnson SC, Atwood CS, Puglielli L, Hermann BP, McBride PE, Stein JH, Sager MA, Asthana S.","J Alzheimers Dis. 2008 Mar;13(2):187-97. doi: 10.3233/jad-2008-13209.","Carlsson CM","J Alzheimers Dis","2008","2008/04/01","","","10.3233/jad-2008-13209"
"1444880","Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease","Sano M, Bell K, Cote L, Dooneief G, Lawton A, Legler L, Marder K, Naini A, Stern Y, Mayeux R.","Arch Neurol. 1992 Nov;49(11):1137-41. doi: 10.1001/archneur.1992.00530350051019.","Sano M","Arch Neurol","1992","1992/11/01","","","10.1001/archneur.1992.00530350051019"
"17458361","[IDA project--concept and implementation of a cluster-randomized trial on dementia management in a general practice setting]","Lauterberg J, Grossfeld-Schmitz M, Ruckdäschel S, Neubauer S, Mehlig H, Gaudig M, Hruschka D, Vollmar HC, Holle R, Grässel E.","Z Arztl Fortbild Qualitatssich. 2007;101(1):21-6. doi: 10.1016/j.zgesun.2006.12.004.","Lauterberg J","Z Arztl Fortbild Qualitatssich","2007","2007/04/27","","","10.1016/j.zgesun.2006.12.004"
"16700849","Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimen","Thavichachart N, Phanthumchinda K, Chankrachang S, Praditsuwan R, Nidhinandana S, Senanarong V, Poungvarin N.","Int J Clin Pract. 2006 May;60(5):533-40. doi: 10.1111/j.1368-5031.2006.00892.x.","Thavichachart N","Int J Clin Pract","2006","2006/05/17","PMC1473179","","10.1111/j.1368-5031.2006.00892.x"
"29615123","Representativeness of European clinical trial populations in mild Alzheimer's disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational study","Reed C, Belger M, Dell'Agnello G, Kahle-Wrobleski K, Sethuraman G, Hake A, Raskin J, Henley D.","Alzheimers Res Ther. 2018 Apr 3;10(1):36. doi: 10.1186/s13195-018-0360-4.","Reed C","Alzheimers Res Ther","2018","2018/04/05","PMC5883304","","10.1186/s13195-018-0360-4"
"33686089","Disrupted metabolic connectivity in dopaminergic and cholinergic networks at different stages of dementia from (18)F-FDG PET brain persistent homology network","Hsu TW, Fuh JL, Wang DW, Chen LF, Chang CJ, Huang WS, Wu HM, Guo WY.","Sci Rep. 2021 Mar 8;11(1):5396. doi: 10.1038/s41598-021-84722-8.","Hsu TW","Sci Rep","2021","2021/03/09","PMC7940645","","10.1038/s41598-021-84722-8"
"32579671","Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer's disease model","Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H, Ward M, Siddiqui O, Paul R, Gilfillan S, Ibrahim A, Rhinn H, Tassi I, Rosenthal A, Schwabe T, Colonna M.","J Exp Med. 2020 Sep 7;217(9):e20200785. doi: 10.1084/jem.20200785.","Wang S","J Exp Med","2020","2020/06/25","PMC7478730","","10.1084/jem.20200785"
"10940678","Comprehension of emotions: comparison between Alzheimer type and vascular type dementias","Shimokawa A, Yatomi N, Anamizu S, Ashikari I, Kohno M, Maki Y, Torii S, Isono H, Sugai Y, Koyama N, Matsuno Y.","Dement Geriatr Cogn Disord. 2000 Sep-Oct;11(5):268-74. doi: 10.1159/000017249.","Shimokawa A","Dement Geriatr Cogn Disord","2000","2000/08/15","","","10.1159/000017249"
"25649991","Quantification of [18F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients","Golla SS, Boellaard R, Oikonen V, Hoffmann A, van Berckel BN, Windhorst AD, Virta J, Haaparanta-Solin M, Luoto P, Savisto N, Solin O, Valencia R, Thiele A, Eriksson J, Schuit RC, Lammertsma AA, Rinne JO.","J Cereb Blood Flow Metab. 2015 May;35(5):766-72. doi: 10.1038/jcbfm.2014.261. Epub 2015 Feb 4.","Golla SS","J Cereb Blood Flow Metab","2015","2015/02/05","PMC4420859","","10.1038/jcbfm.2014.261"
"29070566","A high-glycemic diet is associated with cerebral amyloid burden in cognitively normal older adults","Taylor MK, Sullivan DK, Swerdlow RH, Vidoni ED, Morris JK, Mahnken JD, Burns JM.","Am J Clin Nutr. 2017 Dec;106(6):1463-1470. doi: 10.3945/ajcn.117.162263. Epub 2017 Oct 25.","Taylor MK","Am J Clin Nutr","2017","2017/10/27","PMC5698843","","10.3945/ajcn.117.162263"
"30546063","Apolipoprotein E genotypes among diverse middle-aged and older Latinos: Study of Latinos-Investigation of Neurocognitive Aging results (HCHS/SOL)","González HM, Tarraf W, Jian X, Vásquez PM, Kaplan R, Thyagarajan B, Daviglus M, Lamar M, Gallo LC, Zeng D, Fornage M.","Sci Rep. 2018 Dec 13;8(1):17578. doi: 10.1038/s41598-018-35573-3.","González HM","Sci Rep","2018","2018/12/15","PMC6292877","","10.1038/s41598-018-35573-3"
"22892585","Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease","Coric V, van Dyck CH, Salloway S, Andreasen N, Brody M, Richter RW, Soininen H, Thein S, Shiovitz T, Pilcher G, Colby S, Rollin L, Dockens R, Pachai C, Portelius E, Andreasson U, Blennow K, Soares H, Albright C, Feldman HH, Berman RM.","Arch Neurol. 2012 Nov;69(11):1430-40. doi: 10.1001/archneurol.2012.2194.","Coric V","Arch Neurol","2012","2012/08/16","","","10.1001/archneurol.2012.2194"
"18294023","Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies","Wilcock GK, Ballard CG, Cooper JA, Loft H.","J Clin Psychiatry. 2008 Mar;69(3):341-8. doi: 10.4088/jcp.v69n0302.","Wilcock GK","J Clin Psychiatry","2008","2008/02/26","","","10.4088/jcp.v69n0302"
"8274593","Fluvoxamine treatment of dementia: tryptophan levels","Jørgenson S, Bille A, Andersen J, Jensen HV, Olafsson K, Arup P, Møller SE.","Biol Psychiatry. 1993 Oct 15;34(8):587-8. doi: 10.1016/0006-3223(93)90209-v.","Jørgenson S","Biol Psychiatry","1993","1993/10/15","","","10.1016/0006-3223(93)90209-v"
"14607313","The effect of cholinesterase inhibitors on the regional blood flow in patients with Alzheimer's disease and vascular dementia","Lojkowska W, Ryglewicz D, Jedrzejczak T, Minc S, Jakubowska T, Jarosz H, Bochynska A.","J Neurol Sci. 2003 Dec 15;216(1):119-26. doi: 10.1016/s0022-510x(03)00229-6.","Lojkowska W","J Neurol Sci","2003","2003/11/11","","","10.1016/s0022-510x(03)00229-6"
"24748780","Public-private partnerships improve health outcomes in individuals with early stage Alzheimer's disease","Galvin JE, Tolea MI, George N, Wingbermuehle C.","Clin Interv Aging. 2014 Apr 10;9:621-30. doi: 10.2147/CIA.S60838. eCollection 2014.","Galvin JE","Clin Interv Aging","2014","2014/04/22","PMC3986334","","10.2147/CIA.S60838"
"10026378","Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation","Yilmazer-Hanke DM, Hanke J.","Dement Geriatr Cogn Disord. 1999 Mar-Apr;10(2):70-6. doi: 10.1159/000017104.","Yilmazer-Hanke DM","Dement Geriatr Cogn Disord","1999","1999/02/23","","","10.1159/000017104"
"33190659","Effects of repetitive paired associative stimulation on brain plasticity and working memory in Alzheimer's disease: a pilot randomized double-blind-controlled trial","Kumar S, Zomorrodi R, Ghazala Z, Goodman MS, Blumberger DM, Daskalakis ZJ, Fischer CE, Mulsant BH, Pollock BG, Rajji TK.","Int Psychogeriatr. 2023 Mar;35(3):143-155. doi: 10.1017/S1041610220003518. Epub 2020 Nov 16.","Kumar S","Int Psychogeriatr","2023","2020/11/16","","","10.1017/S1041610220003518"
"10896687","Cerebral correlates of psychotic symptoms in Alzheimer's disease","Mega MS, Lee L, Dinov ID, Mishkin F, Toga AW, Cummings JL.","J Neurol Neurosurg Psychiatry. 2000 Aug;69(2):167-71. doi: 10.1136/jnnp.69.2.167.","Mega MS","J Neurol Neurosurg Psychiatry","2000","2000/07/15","PMC1737034","","10.1136/jnnp.69.2.167"
"32578152","Brain (18)F-FDG PET analysis via interval-valued reconstruction: proof of concept for Alzheimer's disease diagnosis","Kucharczak F, Suau M, Strauss O, Ben Bouallègue F, Mariano-Goulart D.","Ann Nucl Med. 2020 Aug;34(8):565-574. doi: 10.1007/s12149-020-01490-7. Epub 2020 Jun 23.","Kucharczak F","Ann Nucl Med","2020","2020/06/25","","","10.1007/s12149-020-01490-7"
"30978462","Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker","Peña-Bautista C, Roca M, Hervás D, Cuevas A, López-Cuevas R, Vento M, Baquero M, García-Blanco A, Cháfer-Pericás C.","J Proteomics. 2019 May 30;200:144-152. doi: 10.1016/j.jprot.2019.04.008. Epub 2019 Apr 9.","Peña-Bautista C","J Proteomics","2019","2019/04/13","","","10.1016/j.jprot.2019.04.008"
"20850133","Effect of an antioxidant drink on homocysteine levels in Alzheimer's patients","Morillas-Ruiz JM, Rubio-Perez JM, Albaladejo MD, Zafrilla P, Parra S, Vidal-Guevara ML.","J Neurol Sci. 2010 Dec 15;299(1-2):175-8. doi: 10.1016/j.jns.2010.08.050. Epub 2010 Sep 20.","Morillas-Ruiz JM","J Neurol Sci","2010","2010/09/21","","","10.1016/j.jns.2010.08.050"
"15212837","Soluble Abeta homeostasis in AD and DS: impairment of anti-amyloidogenic protection by lipoproteins","Matsubara E, Sekijima Y, Tokuda T, Urakami K, Amari M, Shizuka-Ikeda M, Tomidokoro Y, Ikeda M, Kawarabayashi T, Harigaya Y, Ikeda S, Murakami T, Abe K, Otomo E, Hirai S, Frangione B, Ghiso J, Shoji M.","Neurobiol Aging. 2004 Aug;25(7):833-41. doi: 10.1016/j.neurobiolaging.2003.10.004.","Matsubara E","Neurobiol Aging","2004","2004/06/24","","","10.1016/j.neurobiolaging.2003.10.004"
"21192237","PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease","Sabbagh MN, Agro A, Bell J, Aisen PS, Schweizer E, Galasko D.","Alzheimer Dis Assoc Disord. 2011 Jul-Sep;25(3):206-12. doi: 10.1097/WAD.0b013e318204b550.","Sabbagh MN","Alzheimer Dis Assoc Disord","2011","2010/12/31","PMC3346183","NIHMS369015","10.1097/WAD.0b013e318204b550"
"15340356","Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease","Funalot B, Ouimet T, Claperon A, Fallet C, Delacourte A, Epelbaum J, Subkowski T, Léonard N, Codron V, David JP, Amouyel P, Schwartz JC, Helbecque N.","Mol Psychiatry. 2004 Dec;9(12):1122-8, 1059. doi: 10.1038/sj.mp.4001584.","Funalot B","Mol Psychiatry","2004","2004/09/02","","","10.1038/sj.mp.4001584"
"29857884","Shiatsu as an adjuvant therapy for depression in patients with Alzheimer's disease: A pilot study","Lanza G, Centonze SS, Destro G, Vella V, Bellomo M, Pennisi M, Bella R, Ciavardelli D.","Complement Ther Med. 2018 Jun;38:74-78. doi: 10.1016/j.ctim.2018.04.013. Epub 2018 May 5.","Lanza G","Complement Ther Med","2018","2018/06/03","","","10.1016/j.ctim.2018.04.013"
"8739399","Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia","Bancher C, Jellinger K, Lassmann H, Fischer P, Leblhuber F.","Eur Arch Psychiatry Clin Neurosci. 1996;246(3):137-46. doi: 10.1007/BF02189115.","Bancher C","Eur Arch Psychiatry Clin Neurosci","1996","1996/01/01","","","10.1007/BF02189115"
"28777749","Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial","Sindi S, Ngandu T, Hovatta I, Kåreholt I, Antikainen R, Hänninen T, Levälahti E, Laatikainen T, Lindström J, Paajanen T, Peltonen M, Khalsa DS, Wolozin B, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M, Solomon A; FINGER study group.","J Alzheimers Dis. 2017;59(4):1459-1470. doi: 10.3233/JAD-170123.","Sindi S","J Alzheimers Dis","2017","2017/08/05","PMC5611796","","10.3233/JAD-170123"
"15260910","Noradrenergic activity is associated with response to pindolol in aggressive Alzheimer's disease patients","Herrmann N, Lanctôt KL, Eryavec G, Khan LR.","J Psychopharmacol. 2004 Jun;18(2):215-20. doi: 10.1177/0269881104042625.","Herrmann N","J Psychopharmacol","2004","2004/07/21","","","10.1177/0269881104042625"
"24381967","Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial","Dysken MW, Sano M, Asthana S, Vertrees JE, Pallaki M, Llorente M, Love S, Schellenberg GD, McCarten JR, Malphurs J, Prieto S, Chen P, Loreck DJ, Trapp G, Bakshi RS, Mintzer JE, Heidebrink JL, Vidal-Cardona A, Arroyo LM, Cruz AR, Zachariah S, Kowall NW, Chopra MP, Craft S, Thielke S, Turvey CL, Woodman C, Monnell KA, Gordon K, Tomaska J, Segal Y, Peduzzi PN, Guarino PD.","JAMA. 2014 Jan 1;311(1):33-44. doi: 10.1001/jama.2013.282834.","Dysken MW","JAMA","2014","2014/01/02","PMC4109898","NIHMS557752","10.1001/jama.2013.282834"
"10896689","Hallucinations, delusions, and cognitive decline in Alzheimer's disease","Wilson RS, Gilley DW, Bennett DA, Beckett LA, Evans DA.","J Neurol Neurosurg Psychiatry. 2000 Aug;69(2):172-7. doi: 10.1136/jnnp.69.2.172.","Wilson RS","J Neurol Neurosurg Psychiatry","2000","2000/07/15","PMC1737043","","10.1136/jnnp.69.2.172"
"16042027","The ""zoom lens"" of focal attention in visual search: changes in aging and Alzheimer's disease","Rösler A, Mapstone M, Hays-Wicklund A, Gitelman DR, Weintraub S.","Cortex. 2005 Aug;41(4):512-9. doi: 10.1016/s0010-9452(08)70191-6.","Rösler A","Cortex","2005","2005/07/27","","","10.1016/s0010-9452(08)70191-6"
"16684985","Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial","Callahan CM, Boustani MA, Unverzagt FW, Austrom MG, Damush TM, Perkins AJ, Fultz BA, Hui SL, Counsell SR, Hendrie HC.","JAMA. 2006 May 10;295(18):2148-57. doi: 10.1001/jama.295.18.2148.","Callahan CM","JAMA","2006","2006/05/11","","","10.1001/jama.295.18.2148"
"20574108","Improved language performance in Alzheimer disease following brain stimulation","Cotelli M, Calabria M, Manenti R, Rosini S, Zanetti O, Cappa SF, Miniussi C.","J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):794-7. doi: 10.1136/jnnp.2009.197848. Epub 2010 Jun 23.","Cotelli M","J Neurol Neurosurg Psychiatry","2011","2010/06/25","","","10.1136/jnnp.2009.197848"
"31708380","Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials","Grossberg GT, Kohegyi E, Mergel V, Josiassen MK, Meulien D, Hobart M, Slomkowski M, Baker RA, McQuade RD, Cummings JL.","Am J Geriatr Psychiatry. 2020 Apr;28(4):383-400. doi: 10.1016/j.jagp.2019.09.009. Epub 2019 Oct 1.","Grossberg GT","Am J Geriatr Psychiatry","2020","2019/11/12","","","10.1016/j.jagp.2019.09.009"
"19129751","Assessment of MAO-B occupancy in the brain with PET and [11C]-L-deprenyl-D2: a dose-finding study with a novel MAO-B inhibitor, EVT 301","Hirvonen J, Kailajärvi M, Haltia T, Koskimies S, Någren K, Virsu P, Oikonen V, Sipilä H, Ruokoniemi P, Virtanen K, Scheinin M, Rinne JO.","Clin Pharmacol Ther. 2009 May;85(5):506-12. doi: 10.1038/clpt.2008.241. Epub 2009 Jan 7.","Hirvonen J","Clin Pharmacol Ther","2009","2009/01/09","","","10.1038/clpt.2008.241"
"26952092","Donepezil plasma concentrations, CYP2D6 and CYP3A4 phenotypes, and cognitive outcome in Alzheimer's disease","Coin A, Pamio MV, Alexopoulos C, Granziera S, Groppa F, de Rosa G, Girardi A, Sergi G, Manzato E, Padrini R.","Eur J Clin Pharmacol. 2016 Jun;72(6):711-7. doi: 10.1007/s00228-016-2033-1. Epub 2016 Mar 8.","Coin A","Eur J Clin Pharmacol","2016","2016/03/09","","","10.1007/s00228-016-2033-1"
"18568983","Visual recognition memory in Alzheimer's disease: repetition-lag effects","Viggiano MP, Galli G, Righi S, Brancati C, Gori G, Cincotta M.","Exp Aging Res. 2008 Jul-Sep;34(3):267-81. doi: 10.1080/03610730802070241.","Viggiano MP","Exp Aging Res","2008","2008/06/24","","","10.1080/03610730802070241"
"15042637","Alzheimer's disease caregiving information and skills, part III: group process issues and concerns","Perraud S, Farran CJ, Loukissa D, Paun O.","Res Nurs Health. 2004 Apr;27(2):110-20. doi: 10.1002/nur.20013.","Perraud S","Res Nurs Health","2004","2004/03/26","","","10.1002/nur.20013"
"12566177","Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid1-42 (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients","Stefanova E, Blennow K, Almkvist O, Hellström-Lindahl E, Nordberg A.","Neurosci Lett. 2003 Feb 27;338(2):159-63. doi: 10.1016/s0304-3940(02)01384-8.","Stefanova E","Neurosci Lett","2003","2003/02/05","","","10.1016/s0304-3940(02)01384-8"
"21784351","Extended results of the Alzheimer's disease anti-inflammatory prevention trial","Breitner JC, Baker LD, Montine TJ, Meinert CL, Lyketsos CG, Ashe KH, Brandt J, Craft S, Evans DE, Green RC, Ismail MS, Martin BK, Mullan MJ, Sabbagh M, Tariot PN; ADAPT Research Group.","Alzheimers Dement. 2011 Jul;7(4):402-11. doi: 10.1016/j.jalz.2010.12.014.","Breitner JC","Alzheimers Dement","2011","2011/07/26","PMC3149804","NIHMS304530","10.1016/j.jalz.2010.12.014"
"9588436","Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group","Rogers SL, Doody RS, Mohs RC, Friedhoff LT.","Arch Intern Med. 1998 May 11;158(9):1021-31. doi: 10.1001/archinte.158.9.1021.","Rogers SL","Arch Intern Med","1998","1998/05/20","","","10.1001/archinte.158.9.1021"
"19176895","Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial","Doody RS, Ferris SH, Salloway S, Sun Y, Goldman R, Watkins WE, Xu Y, Murthy AK.","Neurology. 2009 May 5;72(18):1555-61. doi: 10.1212/01.wnl.0000344650.95823.03. Epub 2009 Jan 28.","Doody RS","Neurology","2009","2009/01/30","","","10.1212/01.wnl.0000344650.95823.03"
"20143386","3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI","Apostolova LG, Thompson PM, Green AE, Hwang KS, Zoumalan C, Jack CR Jr, Harvey DJ, Petersen RC, Thal LJ, Aisen PS, Toga AW, Cummings JL, Decarli CS.","Hum Brain Mapp. 2010 May;31(5):786-97. doi: 10.1002/hbm.20905.","Apostolova LG","Hum Brain Mapp","2010","2010/02/10","PMC2938765","NIHMS225551","10.1002/hbm.20905"
"32228330","Melatonin effects on EEG activity during non-rapid eye movement sleep in mild-to-moderate Alzheimer´s disease: a pilot study","Cruz-Aguilar MA, Ramírez-Salado I, Hernández-González M, Guevara MA, Del Río JM.","Int J Neurosci. 2021 Jun;131(6):580-590. doi: 10.1080/00207454.2020.1750392. Epub 2020 Apr 13.","Cruz-Aguilar MA","Int J Neurosci","2021","2020/04/02","","","10.1080/00207454.2020.1750392"
"7828614","HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern","Mielke R, Pietrzyk U, Jacobs A, Fink GR, Ichimiya A, Kessler J, Herholz K, Heiss WD.","Eur J Nucl Med. 1994 Oct;21(10):1052-60. doi: 10.1007/BF00181059.","Mielke R","Eur J Nucl Med","1994","1994/10/01","","","10.1007/BF00181059"
"12442882","Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease","Gauthier S, Feldman H, Hecker J, Vellas B, Emir B, Subbiah P; Donepezil MSAD Study Investigators' Group.","Curr Med Res Opin. 2002;18(6):347-54. doi: 10.1185/030079902125001029.","Gauthier S","Curr Med Res Opin","2002","2002/11/22","","","10.1185/030079902125001029"
"17379359","PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD","Kadir A, Darreh-Shori T, Almkvist O, Wall A, Grut M, Strandberg B, Ringheim A, B Eriksson, Blomquist G, Långström B, Nordberg A.","Neurobiol Aging. 2008 Aug;29(8):1204-17. doi: 10.1016/j.neurobiolaging.2007.02.020. Epub 2007 Mar 26.","Kadir A","Neurobiol Aging","2008","2007/03/24","","","10.1016/j.neurobiolaging.2007.02.020"
"32767414","Effect of Feru-guard 100M on amyloid-beta deposition in individuals with mild cognitive impairment","Matsuyama K, Yamamoto Y, Sora I.","Psychogeriatrics. 2020 Sep;20(5):726-736. doi: 10.1111/psyg.12581. Epub 2020 Aug 6.","Matsuyama K","Psychogeriatrics","2020","2020/08/09","","","10.1111/psyg.12581"
"23948786","Effects of memantine on clinical ratings, fluorodeoxyglucose positron emission tomography measurements, and cerebrospinal fluid assays in patients with moderate to severe Alzheimer dementia: a 24-week, randomized, clinical trial","Wang T, Huang Q, Reiman EM, Chen K, Li X, Li G, Lin Z, Li C, Xiao S.","J Clin Psychopharmacol. 2013 Oct;33(5):636-42. doi: 10.1097/JCP.0b013e31829a876a.","Wang T","J Clin Psychopharmacol","2013","2013/08/17","","","10.1097/JCP.0b013e31829a876a"
"8023065","[Screening for mutations of the precursor of beta-amyloid protein in early forms of Alzheimer disease. French Study Group of Alzheimer Disease]","","Rev Neurol (Paris). 1993;149(10):528-31.","","Rev Neurol (Paris)","1993","1993/01/01","","",""
"18978250","A three-country randomized controlled trial of a psychosocial intervention for caregivers combined with pharmacological treatment for patients with Alzheimer disease: effects on caregiver depression","Mittelman MS, Brodaty H, Wallen AS, Burns A.","Am J Geriatr Psychiatry. 2008 Nov;16(11):893-904. doi: 10.1097/JGP.0b013e3181898095.","Mittelman MS","Am J Geriatr Psychiatry","2008","2008/11/04","PMC2753499","NIHMS126870","10.1097/JGP.0b013e3181898095"
"10855459","Cyclandelate in the treatment of patients with mild to moderate primary degenerative dementia of the Alzheimer type or vascular dementia: experience from a placebo controlled multi-center study","Weyer G, Eul A, Milde K, Wierich W, Herrmann WM.","Pharmacopsychiatry. 2000 May;33(3):89-97. doi: 10.1055/s-2000-7978.","Weyer G","Pharmacopsychiatry","2000","2000/06/16","","","10.1055/s-2000-7978"
"10751266","Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF","Kahle PJ, Jakowec M, Teipel SJ, Hampel H, Petzinger GM, Di Monte DA, Silverberg GD, Möller HJ, Yesavage JA, Tinklenberg JR, Shooter EM, Murphy GM Jr.","Neurology. 2000 Apr 11;54(7):1498-504. doi: 10.1212/wnl.54.7.1498.","Kahle PJ","Neurology","2000","2000/04/06","","","10.1212/wnl.54.7.1498"
"9329348","Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease","de Leon MJ, McRae T, Rusinek H, Convit A, De Santi S, Tarshish C, Golomb J, Volkow N, Daisley K, Orentreich N, McEwen B.","J Clin Endocrinol Metab. 1997 Oct;82(10):3251-9. doi: 10.1210/jcem.82.10.4305.","de Leon MJ","J Clin Endocrinol Metab","1997","1997/11/05","","","10.1210/jcem.82.10.4305"
"17037952","Value of musical instruments used by the therapist to elicit responses from individuals in various stages of Alzheimer's disease","Cevasco AM, Grant RE.","J Music Ther. 2006 Fall;43(3):226-46. doi: 10.1093/jmt/43.3.226.","Cevasco AM","J Music Ther","2006","2006/10/14","","","10.1093/jmt/43.3.226"
"15896220","Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients","Shimabukuro J, Awata S, Matsuoka H.","Psychiatry Clin Neurosci. 2005 Jun;59(3):274-9. doi: 10.1111/j.1440-1819.2005.01371.x.","Shimabukuro J","Psychiatry Clin Neurosci","2005","2005/05/18","","","10.1111/j.1440-1819.2005.01371.x"
"28577267","Cognitive training in Alzheimer's disease: a controlled randomized study","Giovagnoli AR, Manfredi V, Parente A, Schifano L, Oliveri S, Avanzini G.","Neurol Sci. 2017 Aug;38(8):1485-1493. doi: 10.1007/s10072-017-3003-9. Epub 2017 Jun 2.","Giovagnoli AR","Neurol Sci","2017","2017/06/04","","","10.1007/s10072-017-3003-9"
"14609811","A pilot open-label trial of citalopram for restless activity and aberrant motor behaviors in Alzheimer disease","Scharre DW, Davis RA, Warner JL, Chang SI, Beversdorf DQ.","Am J Geriatr Psychiatry. 2003 Nov-Dec;11(6):687-91. doi: 10.1176/appi.ajgp.11.6.687.","Scharre DW","Am J Geriatr Psychiatry","2003","2003/11/12","","","10.1176/appi.ajgp.11.6.687"
"9862643","Curly fiber and tangle-like inclusions in the ependyma and choroid plexus--a pathogenetic relationship with the cortical Alzheimer-type changes?","Miklossy J, Kraftsik R, Pillevuit O, Lepori D, Genton C, Bosman FT.","J Neuropathol Exp Neurol. 1998 Dec;57(12):1202-12. doi: 10.1097/00005072-199812000-00012.","Miklossy J","J Neuropathol Exp Neurol","1998","1998/12/23","","","10.1097/00005072-199812000-00012"
"19240960","Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease","Kountouras J, Boziki M, Gavalas E, Zavos C, Grigoriadis N, Deretzi G, Tzilves D, Katsinelos P, Tsolaki M, Chatzopoulos D, Venizelos I.","J Neurol. 2009 May;256(5):758-67. doi: 10.1007/s00415-009-5011-z. Epub 2009 Feb 25.","Kountouras J","J Neurol","2009","2009/02/26","","","10.1007/s00415-009-5011-z"
"21707533","Effects of galantamine in Alzheimer's disease: double-blind withdrawal studies evaluating sustained versus interrupted treatment","Gaudig M, Richarz U, Han J, Van Baelen B, Schäuble B.","Curr Alzheimer Res. 2011 Nov;8(7):771-80. doi: 10.2174/156720511797633205.","Gaudig M","Curr Alzheimer Res","2011","2011/06/29","","","10.2174/156720511797633205"
"11398762","[Clinical study of patients with Alzheimer's disease under treatment with tacrine]","García-López MT, Guardado-Santervás P.","Rev Neurol. 2001 Feb 16-28;32(4):394-7.","García-López MT","Rev Neurol","2001","2001/06/12","","",""
"11524468","A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease","Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E; Donepezil MSAD Study Investigators Group.","Neurology. 2001 Aug 28;57(4):613-20. doi: 10.1212/wnl.57.4.613.","Feldman H","Neurology","2001","2001/08/29","","","10.1212/wnl.57.4.613"
"16549261","Summary measures were a useful alternative for analyzing therapeutic clinical trial data","Carusone SC, Goldsmith CH, Smieja M, Loeb M.","J Clin Epidemiol. 2006 Apr;59(4):387-92. doi: 10.1016/j.jclinepi.2005.05.009.","Carusone SC","J Clin Epidemiol","2006","2006/03/22","","","10.1016/j.jclinepi.2005.05.009"
"32729631","Evaluation of the efficacy of pimavanserin in the treatment of agitation and aggression in patients with Alzheimer's disease psychosis: A post hoc analysis","Ballard CG, Coate B, Abler V, Stankovic S, Foff E.","Int J Geriatr Psychiatry. 2020 Nov;35(11):1402-1408. doi: 10.1002/gps.5381. Epub 2020 Aug 25.","Ballard CG","Int J Geriatr Psychiatry","2020","2020/07/31","","","10.1002/gps.5381"
"28215900","Lack of Early Improvement with Antipsychotics is a Marker for Subsequent Nonresponse in Behavioral and Psychological Symptoms of Dementia: Analysis of CATIE-AD Data","Yoshida K, Roberts R, Suzuki T, Lebowitz B, Reeves S, Howard R, Abe T, Mimura M, Uchida H.","Am J Geriatr Psychiatry. 2017 Jul;25(7):708-716. doi: 10.1016/j.jagp.2017.01.016. Epub 2017 Jan 30.","Yoshida K","Am J Geriatr Psychiatry","2017","2017/02/21","PMC5474154","NIHMS848165","10.1016/j.jagp.2017.01.016"
"8994509","Bridging study of S12024 in 53 in-patients with Alzheimer's disease","Allain H, Neuman E, Malbezin M, Salzman V, Guez D, Wesnes K, Gandon JM.","J Am Geriatr Soc. 1997 Jan;45(1):125-6. doi: 10.1111/j.1532-5415.1997.tb01002.x.","Allain H","J Am Geriatr Soc","1997","1997/01/01","","","10.1111/j.1532-5415.1997.tb01002.x"
"12028823","Clinical study of a urinary competitve ELISA for neural thread protein in Alzheimer disease","Munzar M, Levy S, Rush R, Averback P.","Neurol Clin Neurophysiol. 2002;2002(1):2-8. doi: 10.1162/15268740252769709.","Munzar M","Neurol Clin Neurophysiol","2002","2002/05/25","","","10.1162/15268740252769709"
"23022042","Amyloid-β oligomer detection by ELISA in cerebrospinal fluid and brain tissue","Bruggink KA, Jongbloed W, Biemans EA, Veerhuis R, Claassen JA, Kuiperij HB, Verbeek MM.","Anal Biochem. 2013 Feb 15;433(2):112-20. doi: 10.1016/j.ab.2012.09.014. Epub 2012 Sep 26.","Bruggink KA","Anal Biochem","2013","2012/10/02","","","10.1016/j.ab.2012.09.014"
"29809030","Are visual cues helpful for virtual spatial navigation and spatial memory in patients with mild cognitive impairment or Alzheimer's disease?","Cogné M, Auriacombe S, Vasa L, Tison F, Klinger E, Sauzéon H, Joseph PA, N Kaoua B.","Neuropsychology. 2018 May;32(4):385-400. doi: 10.1037/neu0000435.","Cogné M","Neuropsychology","2018","2018/05/30","","","10.1037/neu0000435"
"27037872","Effects of Exercise on Cognition: The Finnish Alzheimer Disease Exercise Trial: A Randomized, Controlled Trial","Öhman H, Savikko N, Strandberg TE, Kautiainen H, Raivio MM, Laakkonen ML, Tilvis R, Pitkälä KH.","J Am Geriatr Soc. 2016 Apr;64(4):731-8. doi: 10.1111/jgs.14059. Epub 2016 Apr 1.","Öhman H","J Am Geriatr Soc","2016","2016/04/03","","","10.1111/jgs.14059"
"21463914","Public financial support receipt and non-medical resource utilization in Alzheimer's disease results from the PLASA study","Rapp T, Grand A, Cantet C, Andrieu S, Coley N, Portet F, Vellas B.","Soc Sci Med. 2011 Apr;72(8):1310-6. doi: 10.1016/j.socscimed.2011.02.039. Epub 2011 Mar 21.","Rapp T","Soc Sci Med","2011","2011/04/06","","","10.1016/j.socscimed.2011.02.039"
"10210264","NXX-066 in patients with Alzheimer's disease: a bridging study","Sramek JJ, Hourani J, Jhee SS, Cutler NR.","Life Sci. 1999;64(14):1215-21. doi: 10.1016/s0024-3205(99)00053-3.","Sramek JJ","Life Sci","1999","1999/04/21","","","10.1016/s0024-3205(99)00053-3"
"28726810","A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone","Christensen KD, Uhlmann WR, Roberts JS, Linnenbringer E, Whitehouse PJ, Royal CDM, Obisesan TO, Cupples LA, Butson MB, Fasaye GA, Hiraki S, Chen CA, Siebert U, Cook-Deegan R, Green RC.","Genet Med. 2018 Jan;20(1):132-141. doi: 10.1038/gim.2017.103. Epub 2017 Jul 20.","Christensen KD","Genet Med","2018","2017/07/21","PMC5897910","NIHMS885102","10.1038/gim.2017.103"
"10881260","Facial frequency manipulation normalizes face discrimination in AD","Cronin-Golomb A, Cronin-Golomb M, Dunne TE, Brown AC, Jain K, Cipolloni PB, Auerbach SH.","Neurology. 2000 Jun 27;54(12):2316-8. doi: 10.1212/wnl.54.12.2316.","Cronin-Golomb A","Neurology","2000","2000/07/06","","","10.1212/wnl.54.12.2316"
"17076986","A large, naturalistic, community-based study of rivastigmine in mild-to-moderate AD: the EXTEND Study","Gauthier S, Juby A, Morelli L, Rehel B, Schecter R; EXTEND Investigators.","Curr Med Res Opin. 2006 Nov;22(11):2251-65. doi: 10.1185/030079906X132749.","Gauthier S","Curr Med Res Opin","2006","2006/11/02","","","10.1185/030079906X132749"
"16402259","FMRI of working memory in patients with mild cognitive impairment and probable Alzheimer's disease","Yetkin FZ, Rosenberg RN, Weiner MF, Purdy PD, Cullum CM.","Eur Radiol. 2006 Jan;16(1):193-206. doi: 10.1007/s00330-005-2794-x. Epub 2005 Jun 14.","Yetkin FZ","Eur Radiol","2006","2006/01/13","","","10.1007/s00330-005-2794-x"
"9224439","Behavioral treatment of depression in dementia patients: a controlled clinical trial","Teri L, Logsdon RG, Uomoto J, McCurry SM.","J Gerontol B Psychol Sci Soc Sci. 1997 Jul;52(4):P159-66. doi: 10.1093/geronb/52b.4.p159.","Teri L","J Gerontol B Psychol Sci Soc Sci","1997","1997/07/01","","","10.1093/geronb/52b.4.p159"
"16191241","Rivastigmine in vascular dementia","Vincent S, Lane R.","Int Psychogeriatr. 2003;15 Suppl 1:201-5. doi: 10.1017/S1041610203009207.","Vincent S","Int Psychogeriatr","2003","2005/09/30","","","10.1017/S1041610203009207"
"18199892","Sex, race, and smoking impact olanzapine exposure","Bigos KL, Pollock BG, Coley KC, Miller DD, Marder SR, Aravagiri M, Kirshner MA, Schneider LS, Bies RR.","J Clin Pharmacol. 2008 Feb;48(2):157-65. doi: 10.1177/0091270007310385.","Bigos KL","J Clin Pharmacol","2008","2008/01/18","","","10.1177/0091270007310385"
"21222604","EHT0202 in Alzheimer's disease: a 3-month, randomized, placebo-controlled, double-blind study","Vellas B, Sol O, Snyder PJ, Ousset PJ, Haddad R, Maurin M, Lemarié JC, Désiré L, Pando MP; EHT0202/002 study group.","Curr Alzheimer Res. 2011 Mar;8(2):203-12. doi: 10.2174/156720511795256053.","Vellas B","Curr Alzheimer Res","2011","2011/01/13","","","10.2174/156720511795256053"
"8649552","Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease","Schneider LS, Farlow MR, Henderson VW, Pogoda JM.","Neurology. 1996 Jun;46(6):1580-4. doi: 10.1212/wnl.46.6.1580.","Schneider LS","Neurology","1996","1996/06/01","","","10.1212/wnl.46.6.1580"
"8847542","Low intensity areas observed on T2-weighted magnetic resonance imaging of the cerebral cortex in various neurological diseases","Imon Y, Yamaguchi S, Yamamura Y, Tsuji S, Kajima T, Ito K, Nakamura S.","J Neurol Sci. 1995 Dec;134 Suppl:27-32. doi: 10.1016/0022-510x(95)00205-g.","Imon Y","J Neurol Sci","1995","1995/12/01","","","10.1016/0022-510x(95)00205-g"
"19836029","Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2","Plastino M, Fava A, Pirritano D, Cotronei P, Sacco N, Sperlì T, Spanò A, Gallo D, Mungari P, Consoli D, Bosco D.","J Neurol Sci. 2010 Jan 15;288(1-2):112-6. doi: 10.1016/j.jns.2009.09.022.","Plastino M","J Neurol Sci","2010","2009/10/20","","","10.1016/j.jns.2009.09.022"
"23334070","Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study","Landen JW, Zhao Q, Cohen S, Borrie M, Woodward M, Billing CB Jr, Bales K, Alvey C, McCush F, Yang J, Kupiec JW, Bednar MM.","Clin Neuropharmacol. 2013 Jan-Feb;36(1):14-23. doi: 10.1097/WNF.0b013e31827db49b.","Landen JW","Clin Neuropharmacol","2013","2013/01/22","","","10.1097/WNF.0b013e31827db49b"
"11125238","Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients","Almkvist O, Jelic V, Amberla K, Hellström-Lindahl E, Meurling L, Nordberg A.","Dement Geriatr Cogn Disord. 2001 Jan-Feb;12(1):22-32. doi: 10.1159/000051232.","Almkvist O","Dement Geriatr Cogn Disord","2001","2000/12/23","","","10.1159/000051232"
"7510447","Clinical experiences and biochemical findings with tacrine (THA)","Nybäck H, Hassan M, Junthé T, Ahlin A.","Acta Neurol Scand Suppl. 1993;149:36-8. doi: 10.1111/j.1600-0404.1993.tb04252.x.","Nybäck H","Acta Neurol Scand Suppl","1993","1993/01/01","","","10.1111/j.1600-0404.1993.tb04252.x"
"8736566","Asymmetrical memory decline in normal aging and dementia","Janowsky JS, Carper RA, Kaye JA.","Neuropsychologia. 1996 Jun;34(6):527-35. doi: 10.1016/0028-3932(95)00138-7.","Janowsky JS","Neuropsychologia","1996","1996/06/01","","","10.1016/0028-3932(95)00138-7"
"1446027","[Cytoplasmic casein kinase 2 and its substrate proteins in the brain in Alzheimer's disease]","Aksenova MV, Karaseva MV, Burbaeva GSh.","Biull Eksp Biol Med. 1992 Jun;113(6):602-3.","Aksenova MV","Biull Eksp Biol Med","1992","1992/06/01","","",""
"12901776","Relationship between positive and negative symptoms and neuropsychological scores in frontotemporal dementia and Alzheimer's disease","Boone KB, Miller BL, Swartz R, Lu P, Lee A.","J Int Neuropsychol Soc. 2003 Jul;9(5):698-709. doi: 10.1017/S135561770395003X.","Boone KB","J Int Neuropsychol Soc","2003","2003/08/07","","","10.1017/S135561770395003X"
"32505710","Inter-individual differences in the responses to aerobic exercise in Alzheimer's disease: Findings from the FIT-AD trial","Yu F, Salisbury D, Mathiason MA.","J Sport Health Sci. 2021 Jan;10(1):65-72. doi: 10.1016/j.jshs.2020.05.007. Epub 2020 Jun 4.","Yu F","J Sport Health Sci","2021","2020/06/08","PMC7858037","","10.1016/j.jshs.2020.05.007"
"26967222","Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial","Homma A, Atarashi H, Kubota N, Nakai K, Takase T.","J Alzheimers Dis. 2016 Mar 11;52(1):345-57. doi: 10.3233/JAD-151149.","Homma A","J Alzheimers Dis","2016","2016/03/12","","","10.3233/JAD-151149"
"29025866","Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease","Goetzl EJ, Abner EL, Jicha GA, Kapogiannis D, Schwartz JB.","FASEB J. 2018 Feb;32(2):888-893. doi: 10.1096/fj.201700731R. Epub 2018 Jan 4.","Goetzl EJ","FASEB J","2018","2017/10/14","PMC5888398","","10.1096/fj.201700731R"
"16257816","Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: a 26-week, multicenter, open-label study","Cummings JL, Koumaras B, Chen M, Mirski D; Rivastigmine Nursing Home Study Team.","Am J Geriatr Pharmacother. 2005 Sep;3(3):137-48. doi: 10.1016/s1543-5946(05)80020-0.","Cummings JL","Am J Geriatr Pharmacother","2005","2005/11/01","","","10.1016/s1543-5946(05)80020-0"
"10803476","Dexamethasone effects on cortisol secretion in Alzheimer's disease: some clinical and hormonal features in suppressor and nonsuppressor patients","Murialdo G, Barreca A, Nobili F, Rollero A, Timossi G, Gianelli MV, Copello F, Rodriguez G, Polleri A.","J Endocrinol Invest. 2000 Mar;23(3):178-86. doi: 10.1007/BF03343703.","Murialdo G","J Endocrinol Invest","2000","2000/05/10","","","10.1007/BF03343703"
"32741240","A social dancing pilot intervention for older adults at high risk for Alzheimer's disease and related dementias","Blumen HM, Ayers E, Wang C, Ambrose AF, Verghese J.","Neurodegener Dis Manag. 2020 Aug;10(4):183-194. doi: 10.2217/nmt-2020-0002. Epub 2020 Aug 3.","Blumen HM","Neurodegener Dis Manag","2020","2020/08/04","PMC7426754","","10.2217/nmt-2020-0002"
"26738355","Neurodegeneration in ocular and central nervous systems: optical coherence tomography study in normal-tension glaucoma and Alzheimer disease","Eraslan M, Çerman E, Çekiç O, Balci S, Dericioğlu V, Sahin Ö, Süer D, Chabou B, Tuncer Elmaci EN.","Turk J Med Sci. 2015;45(5):1106-14. doi: 10.3906/sag-1406-145.","Eraslan M","Turk J Med Sci","2015","2016/01/08","","","10.3906/sag-1406-145"
"23203162","Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline","Grundman M, Pontecorvo MJ, Salloway SP, Doraiswamy PM, Fleisher AS, Sadowsky CH, Nair AK, Siderowf A, Lu M, Arora AK, Agbulos A, Flitter ML, Krautkramer MJ, Sarsour K, Skovronsky DM, Mintun MA; 45-A17 Study Group.","Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):4-15. doi: 10.1097/WAD.0b013e318279d02a.","Grundman M","Alzheimer Dis Assoc Disord","2013","2012/12/04","","","10.1097/WAD.0b013e318279d02a"
"12860497","An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia","Erkinjuntti T, Kurz A, Small GW, Bullock R, Lilienfeld S, Damaraju CV; GAL-INT-6 Study Group.","Clin Ther. 2003 Jun;25(6):1765-82. doi: 10.1016/s0149-2918(03)80168-6.","Erkinjuntti T","Clin Ther","2003","2003/07/16","","","10.1016/s0149-2918(03)80168-6"
"8563783","Chromogranin A in cerebrospinal fluid: a biochemical marker for synaptic degeneration in Alzheimer's disease?","Blennow K, Davidsson P, Wallin A, Ekman R.","Dementia. 1995 Nov-Dec;6(6):306-11. doi: 10.1159/000106963.","Blennow K","Dementia","1995","1995/11/01","","","10.1159/000106963"
"25518957","Why do patients with neurodegenerative frontal syndrome fail to answer: 'In what way are an orange and a banana alike?'","Lagarde J, Valabrègue R, Corvol JC, Garcin B, Volle E, Le Ber I, Vidailhet M, Dubois B, Levy R.","Brain. 2015 Feb;138(Pt 2):456-71. doi: 10.1093/brain/awu359. Epub 2014 Dec 16.","Lagarde J","Brain","2015","2014/12/19","","","10.1093/brain/awu359"
"22681723","Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer's disease","Tariot P, Salloway S, Yardley J, Mackell J, Moline M.","BMC Res Notes. 2012 Jun 8;5:283. doi: 10.1186/1756-0500-5-283.","Tariot P","BMC Res Notes","2012","2012/06/12","PMC3493328","","10.1186/1756-0500-5-283"
"6338388","Memory enhancement with oral physostigmine in Alzheimer's disease","","N Engl J Med. 1983 Mar 24;308(12):720-1. doi: 10.1056/NEJM198303243081212.","","N Engl J Med","1983","1983/03/24","","","10.1056/NEJM198303243081212"
"12895683","Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial","Perry NS, Bollen C, Perry EK, Ballard C.","Pharmacol Biochem Behav. 2003 Jun;75(3):651-9. doi: 10.1016/s0091-3057(03)00108-4.","Perry NS","Pharmacol Biochem Behav","2003","2003/08/05","","","10.1016/s0091-3057(03)00108-4"
"26885819","Amyloid PET Screening for Enrichment of Early-Stage Alzheimer Disease Clinical Trials: Experience in a Phase 1b Clinical Trial","Sevigny J, Suhy J, Chiao P, Chen T, Klein G, Purcell D, Oh J, Verma A, Sampat M, Barakos J.","Alzheimer Dis Assoc Disord. 2016 Jan-Mar;30(1):1-7. doi: 10.1097/WAD.0000000000000144.","Sevigny J","Alzheimer Dis Assoc Disord","2016","2016/02/18","","","10.1097/WAD.0000000000000144"
"24828897","Treatment of sleep apnoea syndrome decreases cognitive decline in patients with Alzheimer's disease","Troussière AC, Charley CM, Salleron J, Richard F, Delbeuck X, Derambure P, Pasquier F, Bombois S.","J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1405-8. doi: 10.1136/jnnp-2013-307544. Epub 2014 May 14.","Troussière AC","J Neurol Neurosurg Psychiatry","2014","2014/05/16","","","10.1136/jnnp-2013-307544"
"33009542","The Gray Matters App Targeting Health Behaviors Associated with Alzheimer's Risk: Improvements in Intrinsic Motivation and Impact on Diet Quality and Physical Activity","Schiwal AT, Fauth EB, Wengreen H, Norton M.","J Nutr Health Aging. 2020;24(8):893-899. doi: 10.1007/s12603-020-1421-5.","Schiwal AT","J Nutr Health Aging","2020","2020/10/03","","","10.1007/s12603-020-1421-5"
"1773423","L-deprenyl therapy improves verbal memory in amnesic Alzheimer patients","Finali G, Piccirilli M, Oliani C, Piccinin GL.","Clin Neuropharmacol. 1991 Dec;14(6):523-36. doi: 10.1097/00002826-199112000-00005.","Finali G","Clin Neuropharmacol","1991","1991/12/01","","","10.1097/00002826-199112000-00005"
"9576638","Kanji-predominant alexia in advanced Alzheimer's disease","Nakamura K, Meguro K, Yamazaki H, Ishizaki J, Saito H, Saito N, Shimada M, Yamaguchi S, Shimada Y, Yamadori A.","Acta Neurol Scand. 1998 Apr;97(4):237-43. doi: 10.1111/j.1600-0404.1998.tb00644.x.","Nakamura K","Acta Neurol Scand","1998","1998/05/12","","","10.1111/j.1600-0404.1998.tb00644.x"
"21236699","Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study","Bettermann K, Arnold AM, Williamson J, Rapp S, Sink K, Toole JF, Carlson MC, Yasar S, Dekosky S, Burke GL.","J Stroke Cerebrovasc Dis. 2012 Aug;21(6):436-44. doi: 10.1016/j.jstrokecerebrovasdis.2010.11.002. Epub 2011 Jan 14.","Bettermann K","J Stroke Cerebrovasc Dis","2012","2011/01/18","PMC3140577","NIHMS254242","10.1016/j.jstrokecerebrovasdis.2010.11.002"
"33731209","A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia","Xiao S, Chan P, Wang T, Hong Z, Wang S, Kuang W, He J, Pan X, Zhou Y, Ji Y, Wang L, Cheng Y, Peng Y, Ye Q, Wang X, Wu Y, Qu Q, Chen S, Li S, Chen W, Xu J, Peng D, Zhao Z, Li Y, Zhang J, Du Y, Chen W, Fan D, Yan Y, Liu X, Zhang W, Luo B, Wu W, Shen L, Liu C, Mao P, Wang Q, Zhao Q, Guo Q, Zhou Y, Li Y, Jiang L, Ren W, Ouyang Y, Wang Y, Liu S, Jia J, Zhang N, Liu Z, He R, Feng T, Lu W, Tang H, Gao P, Zhang Y, Chen L, Wang L, Yin Y, Xu Q, Xiao J, Cong L, Cheng X, Zhang H, Gao D, Xia M, Lian T, Peng G, Zhang X, Jiao B, Hu H, Chen X, Guan Y, Cui R, Huang Q, Xin X, Chen H, Ding Y, Zhang J, Feng T, Cantillon M, Chen K, Cummings JL, Ding J, Geng M, Zhang Z.","Alzheimers Res Ther. 2021 Mar 17;13(1):62. doi: 10.1186/s13195-021-00795-7.","Xiao S","Alzheimers Res Ther","2021","2021/03/18","PMC7967962","","10.1186/s13195-021-00795-7"
"21571500","Persons with mild or moderate Alzheimer's disease learn to use urine alarms and prompts to avoid large urinary accidents","Lancioni GE, Singh NN, O'Reilly MF, Sigafoos J, Bosco A, Zonno N, Badagliacca F.","Res Dev Disabil. 2011 Sep-Oct;32(5):1998-2004. doi: 10.1016/j.ridd.2011.04.011. Epub 2011 May 14.","Lancioni GE","Res Dev Disabil","2011","2011/05/17","","","10.1016/j.ridd.2011.04.011"
"15172104","Prolongation of T(2) relaxation times of hippocampus and amygdala in Alzheimer's disease","Wang H, Yuan H, Shu L, Xie J, Zhang D.","Neurosci Lett. 2004 Jun 10;363(2):150-3. doi: 10.1016/j.neulet.2004.03.061.","Wang H","Neurosci Lett","2004","2004/06/03","","","10.1016/j.neulet.2004.03.061"
"33962026","Feasibility of reducing frailty components in older adults with Alzheimer's dementia: a randomized controlled home-based exercise trial (AD-HOMEX)","Cezar NOC, Aprahamian I, Ansai JH, de Oliveira MPB, da Silva DCP, Gomes WL, Barreiros BA, Langelli TCO, de Andrade LP.","Exp Gerontol. 2021 Jul 15;150:111390. doi: 10.1016/j.exger.2021.111390. Epub 2021 May 5.","Cezar NOC","Exp Gerontol","2021","2021/05/07","","","10.1016/j.exger.2021.111390"
"2469952","Ateroid in the treatment of dementia: results of a clinical trial","Conti L, Placidi GF, Cassano GB.","Mod Probl Pharmacopsychiatry. 1989;23:76-84. doi: 10.1159/000416681.","Conti L","Mod Probl Pharmacopsychiatry","1989","1989/01/01","","","10.1159/000416681"
"2738277","Education to assist spouses in coping with Alzheimer's disease. A controlled trial","Chiverton P, Caine ED.","J Am Geriatr Soc. 1989 Jul;37(7):593-8. doi: 10.1111/j.1532-5415.1989.tb01248.x.","Chiverton P","J Am Geriatr Soc","1989","1989/07/01","","","10.1111/j.1532-5415.1989.tb01248.x"
"10791835","Hemispheric differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer's disease","de Toledo-Morrell L, Dickerson B, Sullivan MP, Spanovic C, Wilson R, Bennett DA.","Hippocampus. 2000;10(2):136-42. doi: 10.1002/(SICI)1098-1063(2000)10:2<136::AID-HIPO2>3.0.CO;2-J.","de Toledo-Morrell L","Hippocampus","2000","2000/05/03","","","10.1002/(SICI)1098-1063(2000)10:2<136::AID-HIPO2>3.0.CO;2-J"
"23764722","Novel white matter tract integrity metrics sensitive to Alzheimer disease progression","Fieremans E, Benitez A, Jensen JH, Falangola MF, Tabesh A, Deardorff RL, Spampinato MV, Babb JS, Novikov DS, Ferris SH, Helpern JA.","AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2105-12. doi: 10.3174/ajnr.A3553. Epub 2013 Jun 13.","Fieremans E","AJNR Am J Neuroradiol","2013","2013/06/15","PMC3962262","NIHMS562351","10.3174/ajnr.A3553"
"7484061","Posatirelin for the treatment of late-onset Alzheimer's disease: a double-blind multicentre study vs citicoline and ascorbic acid","Parnetti L, Ambrosoli L, Abate G, Azzini C, Balestreri R, Bartorelli L, Bordin A, Crepaldi G, Cristianini G, Cucinotta D, et al.","Acta Neurol Scand. 1995 Aug;92(2):135-40. doi: 10.1111/j.1600-0404.1995.tb01027.x.","Parnetti L","Acta Neurol Scand","1995","1995/08/01","","","10.1111/j.1600-0404.1995.tb01027.x"
"34752934","Accelerated intermittent theta-burst stimulation broadly ameliorates symptoms and cognition in Alzheimer's disease: A randomized controlled trial","Wu X, Ji GJ, Geng Z, Wang L, Yan Y, Wu Y, Xiao G, Gao L, Wei Q, Zhou S, Wei L, Tian Y, Wang K.","Brain Stimul. 2022 Jan-Feb;15(1):35-45. doi: 10.1016/j.brs.2021.11.007. Epub 2021 Nov 6.","Wu X","Brain Stimul","2022","2021/11/09","","","10.1016/j.brs.2021.11.007"
"9401795","Variabilities in the distribution of neurofibrillary tangles in the anterior parahippocampal gyrus at initial stages of Alzheimer's disease","Hanke J, Yilmazer-Hanke DM.","Clin Neuropathol. 1997 Nov-Dec;16(6):299-302.","Hanke J","Clin Neuropathol","1997","1997/12/24","","",""
"1950924","The interuncal distance: a new MR measurement for the hippocampal atrophy of Alzheimer disease","Dahlbeck JW, McCluney KW, Yeakley JW, Fenstermacher MJ, Bonmati C, Van Horn G 3rd, Aldag J.","AJNR Am J Neuroradiol. 1991 Sep-Oct;12(5):931-2.","Dahlbeck JW","AJNR Am J Neuroradiol","1991","1991/09/01","PMC8333519","",""
"30930904","CSF Cytokines in Aging, Multiple Sclerosis, and Dementia","Hu WT, Howell JC, Ozturk T, Gangishetti U, Kollhoff AL, Hatcher-Martin JM, Anderson AM, Tyor WR.","Front Immunol. 2019 Mar 15;10:480. doi: 10.3389/fimmu.2019.00480. eCollection 2019.","Hu WT","Front Immunol","2019","2019/04/02","PMC6428695","","10.3389/fimmu.2019.00480"
"10678697","Insights from semantic dementia on the relationship between episodic and semantic memory","Graham KS, Simons JS, Pratt KH, Patterson K, Hodges JR.","Neuropsychologia. 2000;38(3):313-24. doi: 10.1016/s0028-3932(99)00073-1.","Graham KS","Neuropsychologia","2000","2000/03/11","","","10.1016/s0028-3932(99)00073-1"
"26086535","Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US","Saint-Laurent Thibault C, Özer Stillman I, Chen S, Getsios D, Proskorovsky I, Hernandez L, Dixit S.","J Med Econ. 2015;18(11):930-43. doi: 10.3111/13696998.2015.1063501. Epub 2015 Aug 26.","Saint-Laurent Thibault C","J Med Econ","2015","2015/06/19","","","10.3111/13696998.2015.1063501"
"29558759","Vitamin B12 in Association with Antipsychotic Drugs Can Modulate the Expression of Pro-/Anti-Inflammatory Cytokines in Alzheimer Disease Patients","Vakilian A, Razavi-Nasab SM, Ravari A, Mirzaei T, Moghadam-Ahmadi A, Jalali N, Bahramabadi R, Rezayati M, Yazdanpanah-Ravari A, Bahmaniar F, Bagheri MR, Sheikh Fathollahi M, Asadikaram G, Kazemi Arababadi M.","Neuroimmunomodulation. 2017;24(6):310-319. doi: 10.1159/000486597. Epub 2018 Mar 20.","Vakilian A","Neuroimmunomodulation","2017","2018/03/21","","","10.1159/000486597"
"15638069","[Delay in progression of dependency and need of care of dementia patients treated with Ginkgo special extract EGb 761]","Haan J, Hörr R.","Wien Med Wochenschr. 2004 Nov;154(21-22):511-4. doi: 10.1007/s10354-004-0116-6.","Haan J","Wien Med Wochenschr","2004","2005/01/11","","","10.1007/s10354-004-0116-6"
"14599005","What can modern statistics offer imaging neuroscience?","Lange N.","Stat Methods Med Res. 2003 Oct;12(5):447-69. doi: 10.1191/0962280203sm342ra.","Lange N","Stat Methods Med Res","2003","2003/11/06","","","10.1191/0962280203sm342ra"
"29440563","In vivo (18)F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms","Jones DT, Knopman DS, Graff-Radford J, Syrjanen JA, Senjem ML, Schwarz CG, Dheel C, Wszolek Z, Rademakers R, Kantarci K, Petersen RC, Jack CR Jr, Lowe VJ, Boeve BF.","Neurology. 2018 Mar 13;90(11):e947-e954. doi: 10.1212/WNL.0000000000005117. Epub 2018 Feb 9.","Jones DT","Neurology","2018","2018/02/15","PMC5858948","","10.1212/WNL.0000000000005117"
"17030755","Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI","Du AT, Jahng GH, Hayasaka S, Kramer JH, Rosen HJ, Gorno-Tempini ML, Rankin KP, Miller BL, Weiner MW, Schuff N.","Neurology. 2006 Oct 10;67(7):1215-20. doi: 10.1212/01.wnl.0000238163.71349.78.","Du AT","Neurology","2006","2006/10/13","PMC1779761","NIHMS15718","10.1212/01.wnl.0000238163.71349.78"
"15259393","Changes to the object recognition system in patients with dementia of the Alzheimer's type","Purdy KS, McMullen PA, Freedman M.","Brain Cogn. 2002 Jul;49(2):213-6.","Purdy KS","Brain Cogn","2002","2004/07/21","","",""
"35079029","Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer's disease: a randomized trial","Kellar D, Register T, Lockhart SN, Aisen P, Raman R, Rissman RA, Brewer J, Craft S.","Sci Rep. 2022 Jan 25;12(1):1346. doi: 10.1038/s41598-022-05165-3.","Kellar D","Sci Rep","2022","2022/01/26","PMC8789895","","10.1038/s41598-022-05165-3"
"24524367","A pilot study on the use of interferon beta-1a in early Alzheimer's disease subjects","Grimaldi LM, Zappalà G, Iemolo F, Castellano AE, Ruggieri S, Bruno G, Paolillo A.","J Neuroinflammation. 2014 Feb 13;11:30. doi: 10.1186/1742-2094-11-30.","Grimaldi LM","J Neuroinflammation","2014","2014/02/15","PMC3931325","","10.1186/1742-2094-11-30"
"2264980","Oral physostigmine as treatment for dementia of the Alzheimer type: a long-term outpatient trial","Jenike MA, Albert MS, Baer L.","Alzheimer Dis Assoc Disord. 1990 Winter;4(4):226-31. doi: 10.1097/00002093-199040400-00004.","Jenike MA","Alzheimer Dis Assoc Disord","1990","1990/01/01","","","10.1097/00002093-199040400-00004"
"27666598","Calcium-Channel Blockers and Dementia Risk in Older Adults　- National Health Insurance Service - Senior Cohort (2002-2013)","Hwang D, Kim S, Choi H, Oh IH, Kim BS, Choi HR, Kim SY, Won CW.","Circ J. 2016 Oct 25;80(11):2336-2342. doi: 10.1253/circj.CJ-16-0692. Epub 2016 Sep 21.","Hwang D","Circ J","2016","2016/09/27","","","10.1253/circj.CJ-16-0692"
"7868848","Tacrine in Alzheimer's disease: pharmacokinetic and clinical comparison of oral and rectal administration","Ahlin A, Hassan M, Junthé T, Nybäck H.","Int Clin Psychopharmacol. 1994 Winter;9(4):263-70.","Ahlin A","Int Clin Psychopharmacol","1994","1994/01/01","","",""
"26346648","Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer","Bailly M, Destrieux C, Hommet C, Mondon K, Cottier JP, Beaufils E, Vierron E, Vercouillie J, Ibazizene M, Voisin T, Payoux P, Barré L, Camus V, Guilloteau D, Ribeiro MJ.","Biomed Res Int. 2015;2015:583931. doi: 10.1155/2015/583931. Epub 2015 Jun 17.","Bailly M","Biomed Res Int","2015","2015/09/09","PMC4539420","","10.1155/2015/583931"
"16160622","Aripiprazole for the treatment of psychosis in patients with Alzheimer's disease: a randomized, placebo-controlled study","De Deyn P, Jeste DV, Swanink R, Kostic D, Breder C, Carson WH, Iwamoto T.","J Clin Psychopharmacol. 2005 Oct;25(5):463-7. doi: 10.1097/01.jcp.0000178415.22309.8f.","De Deyn P","J Clin Psychopharmacol","2005","2005/09/15","","","10.1097/01.jcp.0000178415.22309.8f"
"19623601","The long-term efficacy and tolerability of donepezil in patients with vascular dementia","Wilkinson D, Róman G, Salloway S, Hecker J, Boundy K, Kumar D, Posner H, Schindler R.","Int J Geriatr Psychiatry. 2010 Mar;25(3):305-13. doi: 10.1002/gps.2340.","Wilkinson D","Int J Geriatr Psychiatry","2010","2009/07/23","","","10.1002/gps.2340"
"12454562","Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease","Kaasinen V, Någren K, Järvenpää T, Roivainen A, Yu M, Oikonen V, Kurki T, Rinne JO.","J Clin Psychopharmacol. 2002 Dec;22(6):615-20. doi: 10.1097/00004714-200212000-00012.","Kaasinen V","J Clin Psychopharmacol","2002","2002/11/28","","","10.1097/00004714-200212000-00012"
"14568499","Regional cerebral blood flow in Parkinson's disease with and without dementia","Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O'Brien JT.","Neuroimage. 2003 Oct;20(2):1309-19. doi: 10.1016/S1053-8119(03)00364-1.","Firbank MJ","Neuroimage","2003","2003/10/22","","","10.1016/S1053-8119(03)00364-1"
"15207427","Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a ""real world"" study","Mossello E, Tonon E, Caleri V, Tilli S, Cantini C, Cavallini MC, Bencini F, Mecacci R, Marini M, Bardelli F, Sarcone E, Razzi E, Biagini CA, Masotti G.","Arch Gerontol Geriatr Suppl. 2004;(9):297-307. doi: 10.1016/j.archger.2004.04.040.","Mossello E","Arch Gerontol Geriatr Suppl","2004","2004/06/23","","","10.1016/j.archger.2004.04.040"
"11110737","Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group","Wilcock GK, Lilienfeld S, Gaens E.","BMJ. 2000 Dec 9;321(7274):1445-9. doi: 10.1136/bmj.321.7274.1445.","Wilcock GK","BMJ","2000","2000/12/09","PMC27547","","10.1136/bmj.321.7274.1445"
"24617278","A trial of dementia caregiver telephone support","Martindale-Adams J, Nichols LO, Burns R, Graney MJ, Zuber J.","Can J Nurs Res. 2013 Dec;45(4):30-48. doi: 10.1177/084456211304500404.","Martindale-Adams J","Can J Nurs Res","2013","2014/03/13","","","10.1177/084456211304500404"
"9562498","Volumes of the entorhinal and perirhinal cortices in Alzheimer's disease","Juottonen K, Laakso MP, Insausti R, Lehtovirta M, Pitkänen A, Partanen K, Soininen H.","Neurobiol Aging. 1998 Jan-Feb;19(1):15-22. doi: 10.1016/s0197-4580(98)00007-4.","Juottonen K","Neurobiol Aging","1998","1998/04/30","","","10.1016/s0197-4580(98)00007-4"
"9710002","Cognitive decline is faster in Lewy body variant than in Alzheimer's disease","Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, Thal LJ.","Neurology. 1998 Aug;51(2):351-7. doi: 10.1212/wnl.51.2.351.","Olichney JM","Neurology","1998","1998/08/26","","","10.1212/wnl.51.2.351"
"16616406","Predictors of improvement in social support: Five-year effects of a structured intervention for caregivers of spouses with Alzheimer's disease","Drentea P, Clay OJ, Roth DL, Mittelman MS.","Soc Sci Med. 2006 Aug;63(4):957-67. doi: 10.1016/j.socscimed.2006.02.020. Epub 2006 Apr 17.","Drentea P","Soc Sci Med","2006","2006/04/18","","","10.1016/j.socscimed.2006.02.020"
"83485","Physostigmine in Alzheimer's disease","Smith CM, Swash M.","Lancet. 1979 Jan 6;1(8106):42. doi: 10.1016/s0140-6736(79)90479-3.","Smith CM","Lancet","1979","1979/01/06","","","10.1016/s0140-6736(79)90479-3"
"25675992","Evaluating Response to High-Dose 13.3 mg/24 h Rivastigmine Patch in Patients with Severe Alzheimer's Disease","Farlow MR, Sadowsky CH, Velting DM, Meng X, Islam MZ.","CNS Neurosci Ther. 2015 Jun;21(6):513-9. doi: 10.1111/cns.12385. Epub 2015 Feb 10.","Farlow MR","CNS Neurosci Ther","2015","2015/02/14","PMC6495641","","10.1111/cns.12385"
"33639543","Heart-focused breathing and perceptions of burden in Alzheimer's caregivers: An online randomized controlled pilot study","James TA, James D, Larkey LK.","Geriatr Nurs. 2021 Mar-Apr;42(2):397-404. doi: 10.1016/j.gerinurse.2021.02.006. Epub 2021 Feb 24.","James TA","Geriatr Nurs","2021","2021/02/27","","","10.1016/j.gerinurse.2021.02.006"
"10860300","Apolipoprotein E, methylenetetrahydrofolate reductase (MTHFR) mutation and the risk of senile dementia--an epidemiological study using the polymerase chain reaction (PCR) method","Nishiyama M, Kato Y, Hashimoto M, Yukawa S, Omori K.","J Epidemiol. 2000 May;10(3):163-72. doi: 10.2188/jea.10.163.","Nishiyama M","J Epidemiol","2000","2000/06/22","","","10.2188/jea.10.163"
"12917125","Heterogeneity of cerebral blood flow in Alzheimer disease and vascular dementia","Yoshikawa T, Murase K, Oku N, Imaizumi M, Takasawa M, Rishu P, Kimura Y, Ikejiri Y, Kitagawa K, Hori M, Hatazawa J.","AJNR Am J Neuroradiol. 2003 Aug;24(7):1341-7.","Yoshikawa T","AJNR Am J Neuroradiol","2003","2003/08/15","PMC7973674","",""
"9307253","Apolipoprotein E genotypes in a neuropathological series from the Consortium to Establish a Registry for Alzheimer's Disease","Welsh-Bohmer KA, Gearing M, Saunders AM, Roses AD, Mirra S.","Ann Neurol. 1997 Sep;42(3):319-25. doi: 10.1002/ana.410420308.","Welsh-Bohmer KA","Ann Neurol","1997","1997/10/23","","","10.1002/ana.410420308"
"16442186","Determinants of platelet activation in Alzheimer's disease","Ciabattoni G, Porreca E, Di Febbo C, Di Iorio A, Paganelli R, Bucciarelli T, Pescara L, Del Re L, Giusti C, Falco A, Sau A, Patrono C, Davì G.","Neurobiol Aging. 2007 Mar;28(3):336-42. doi: 10.1016/j.neurobiolaging.2005.12.011. Epub 2006 Jan 24.","Ciabattoni G","Neurobiol Aging","2007","2006/01/31","","","10.1016/j.neurobiolaging.2005.12.011"
"10362893","Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease","Traykov L, Rigaud AS, Caputo L, Couderc R, Coste J, Michot JL, de Rotrou J, Amouyel P, Forette F, Boller F.","Eur J Neurol. 1999 Jul;6(4):415-21. doi: 10.1046/j.1468-1331.1999.640415.x.","Traykov L","Eur J Neurol","1999","1999/06/11","","","10.1046/j.1468-1331.1999.640415.x"
"16289476","Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment","Scheff SW, Price DA, Schmitt FA, Mufson EJ.","Neurobiol Aging. 2006 Oct;27(10):1372-84. doi: 10.1016/j.neurobiolaging.2005.09.012. Epub 2005 Nov 9.","Scheff SW","Neurobiol Aging","2006","2005/11/18","","","10.1016/j.neurobiolaging.2005.09.012"
"9876958","Efficacy of xanomeline in Alzheimer disease: cognitive improvement measured using the Computerized Neuropsychological Test Battery (CNTB)","Veroff AE, Bodick NC, Offen WW, Sramek JJ, Cutler NR.","Alzheimer Dis Assoc Disord. 1998 Dec;12(4):304-12. doi: 10.1097/00002093-199812000-00010.","Veroff AE","Alzheimer Dis Assoc Disord","1998","1999/01/07","","","10.1097/00002093-199812000-00010"
"25874654","The economic impact of moderate stage Alzheimer's disease in Italy: evidence from the UP-TECH randomized trial","Chiatti C, Furneri G, Rimland JM, Demma F, Bonfranceschi F, Cassetta L, Masera F, Cherubini A, Corsonello A, Lattanzio F; UP-TECH research group.","Int Psychogeriatr. 2015 Sep;27(9):1563-72. doi: 10.1017/S104161021500040X. Epub 2015 Apr 15.","Chiatti C","Int Psychogeriatr","2015","2015/04/16","","","10.1017/S104161021500040X"
"16603301","Efficacy of milnacipran on the depressive state in patients with Alzheimer's disease","Mizukami K, Tanaka Y, Asada T.","Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1342-6. doi: 10.1016/j.pnpbp.2006.03.004. Epub 2006 Apr 17.","Mizukami K","Prog Neuropsychopharmacol Biol Psychiatry","2006","2006/04/11","","","10.1016/j.pnpbp.2006.03.004"
"14615074","The contribution of autobiographical significance to semantic memory: evidence from Alzheimer's disease, semantic dementia, and amnesia","Westmacott R, Black SE, Freedman M, Moscovitch M.","Neuropsychologia. 2004;42(1):25-48. doi: 10.1016/s0028-3932(03)00147-7.","Westmacott R","Neuropsychologia","2004","2003/11/15","","","10.1016/s0028-3932(03)00147-7"
"12386525","[Rivastigmine in current clinical practice in patients with mild to moderate Alzheimer's disease]","Dartigues JF, Goulley F, Bourdeix I, Péré JJ, Barberger-Gateau P.","Rev Neurol (Paris). 2002 Sep;158(8-9):807-12.","Dartigues JF","Rev Neurol (Paris)","2002","2002/10/19","","",""
"24979265","Evaluation of selective positron emission tomography template method for spatial normalization of amyloid imaging with 11C-Pittsburgh Compound B","Chae SY, Kim HO, Oh M, Lee DY, Jin S, Oh SJ, Lee JH, Na DL, Seo SW, Lee CS, Kim JS.","J Comput Assist Tomogr. 2014 Nov-Dec;38(6):924-9. doi: 10.1097/RCT.0000000000000123.","Chae SY","J Comput Assist Tomogr","2014","2014/07/01","","","10.1097/RCT.0000000000000123"
"29719179","Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease","Egan MF, Kost J, Tariot PN, Aisen PS, Cummings JL, Vellas B, Sur C, Mukai Y, Voss T, Furtek C, Mahoney E, Harper Mozley L, Vandenberghe R, Mo Y, Michelson D.","N Engl J Med. 2018 May 3;378(18):1691-1703. doi: 10.1056/NEJMoa1706441.","Egan MF","N Engl J Med","2018","2018/05/03","PMC6776074","NIHMS1046479","10.1056/NEJMoa1706441"
"15510240","Memantine hydrochloride: pharmacological and clinical profile","Möbius HJ, Stöffler A, Graham SM.","Drugs Today (Barc). 2004 Aug;40(8):685-95.","Möbius HJ","Drugs Today (Barc)","2004","2004/10/29","","",""
"12841930","Effects of acetyl-L-carnitine in Alzheimer's disease patients unresponsive to acetylcholinesterase inhibitors","Bianchetti A, Rozzini R, Trabucchi M.","Curr Med Res Opin. 2003;19(4):350-3. doi: 10.1185/030079903125001776.","Bianchetti A","Curr Med Res Opin","2003","2003/07/05","","","10.1185/030079903125001776"
"7654129","Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine","Peskind ER, Wingerson D, Murray S, Pascualy M, Dobie DJ, Le Corre P, Le Verge R, Veith RC, Raskind MA.","Arch Gen Psychiatry. 1995 Sep;52(9):774-82. doi: 10.1001/archpsyc.1995.03950210068012.","Peskind ER","Arch Gen Psychiatry","1995","1995/09/01","","","10.1001/archpsyc.1995.03950210068012"
"7049290","Fluctuations of free choline levels in plasma of Alzheimer patients receiving lecithin: preliminary observations","Chuaqui P, Levy R.","Br J Psychiatry. 1982 May;140:464-9. doi: 10.1192/bjp.140.5.464.","Chuaqui P","Br J Psychiatry","1982","1982/05/01","","","10.1192/bjp.140.5.464"
"12637119","Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial","De Jesus Moreno Moreno M.","Clin Ther. 2003 Jan;25(1):178-93. doi: 10.1016/s0149-2918(03)90023-3.","De Jesus Moreno Moreno M","Clin Ther","2003","2003/03/15","","","10.1016/s0149-2918(03)90023-3"
"9678311","High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype","Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles L, Boss MA, Seubert P.","Arch Neurol. 1998 Jul;55(7):937-45. doi: 10.1001/archneur.55.7.937.","Galasko D","Arch Neurol","1998","1998/07/25","","","10.1001/archneur.55.7.937"
"16042022","When is category specific in Alzheimer's disease?","Laws KR, Gale TM, Leeson VC, Crawford JR.","Cortex. 2005 Aug;41(4):452-63. doi: 10.1016/s0010-9452(08)70186-2.","Laws KR","Cortex","2005","2005/07/27","","","10.1016/s0010-9452(08)70186-2"
"32909259","Lifestyle Risk Factors and Cognitive Outcomes from the Multidomain Dementia Risk Reduction Randomized Controlled Trial, Body Brain Life for Cognitive Decline (BBL-CD)","McMaster M, Kim S, Clare L, Torres SJ, Cherbuin N, DʼEste C, Anstey KJ.","J Am Geriatr Soc. 2020 Nov;68(11):2629-2637. doi: 10.1111/jgs.16762. Epub 2020 Sep 9.","McMaster M","J Am Geriatr Soc","2020","2020/09/10","","","10.1111/jgs.16762"
"16794882","[Persons with dementia in individual everyday situations. First results of an intervention study]","Bär M, Böggemann M, Kaspar R, Re S, Berendonk C, Seidl U, Kruse A, Schröder J.","Z Gerontol Geriatr. 2006 Jun;39(3):173-82. doi: 10.1007/s00391-006-0384-4.","Bär M","Z Gerontol Geriatr","2006","2006/06/24","","","10.1007/s00391-006-0384-4"
"9099419","Increased mydriatic response to tropicamide is a sign of cholinergic hypersensitivity but not specific to late-onset sporadic type of Alzheimer's dementia","Kálmán J, Kanka A, Maglóczky E, Szóke A, Járdánházy T, Janka Z.","Biol Psychiatry. 1997 Apr 15;41(8):909-11. doi: 10.1016/S0006-3223(97)00021-8.","Kálmán J","Biol Psychiatry","1997","1997/04/15","","","10.1016/S0006-3223(97)00021-8"
"19604325","Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan","Nozawa M, Ichimiya Y, Nozawa E, Utumi Y, Sugiyama H, Murayama N, Iseki E, Arai H.","Psychogeriatrics. 2009 Jun;9(2):50-5. doi: 10.1111/j.1479-8301.2009.00291.x.","Nozawa M","Psychogeriatrics","2009","2009/07/17","","","10.1111/j.1479-8301.2009.00291.x"
"20808143","(99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease","Devanand DP, Van Heertum RL, Kegeles LS, Liu X, Jin ZH, Pradhaban G, Rusinek H, Pratap M, Pelton GH, Prohovnik I, Stern Y, Mann JJ, Parsey R.","Am J Geriatr Psychiatry. 2010 Nov;18(11):959-72. doi: 10.1097/JGP.0b013e3181ec8696.","Devanand DP","Am J Geriatr Psychiatry","2010","2010/09/03","PMC3103107","NIHMS294186","10.1097/JGP.0b013e3181ec8696"
"19923038","Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease","Sato T, Hanyu H, Hirao K, Kanetaka H, Sakurai H, Iwamoto T.","Neurobiol Aging. 2011 Sep;32(9):1626-33. doi: 10.1016/j.neurobiolaging.2009.10.009. Epub 2009 Nov 17.","Sato T","Neurobiol Aging","2011","2009/11/20","","","10.1016/j.neurobiolaging.2009.10.009"
"30215171","Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer's Disease","Cardoso BR, Roberts BR, Malpas CB, Vivash L, Genc S, Saling MM, Desmond P, Steward C, Hicks RJ, Callahan J, Brodtmann A, Collins S, Macfarlane S, Corcoran NM, Hovens CM, Velakoulis D, O'Brien TJ, Hare DJ, Bush AI.","Neurotherapeutics. 2019 Jan;16(1):192-202. doi: 10.1007/s13311-018-0662-z.","Cardoso BR","Neurotherapeutics","2019","2018/09/15","PMC6361071","","10.1007/s13311-018-0662-z"
"22114806","The effects of researcher-composed music at mealtime on agitation in nursing home residents with dementia","Ho SY, Lai HL, Jeng SY, Tang CW, Sung HC, Chen PW.","Arch Psychiatr Nurs. 2011 Dec;25(6):e49-55. doi: 10.1016/j.apnu.2011.08.006.","Ho SY","Arch Psychiatr Nurs","2011","2011/11/26","","","10.1016/j.apnu.2011.08.006"
"26336931","Selective Ability of Some CANTAB Battery Test Measures to Detect Cognitive Response to a Single Dose of Donepezil in Alzheimer Disease","Kuzmickienė J, Kaubrys G.","Med Sci Monit. 2015 Aug 31;21:2572-82. doi: 10.12659/MSM.895381.","Kuzmickienė J","Med Sci Monit","2015","2015/09/05","PMC4562612","","10.12659/MSM.895381"
"26515786","Cholinergic circuitry functioning in patients with vascular cognitive impairment--no dementia","Bella R, Cantone M, Lanza G, Ferri R, Vinciguerra L, Puglisi V, Pennisi M, Ricceri R, Di Lazzaro V, Pennisi G.","Brain Stimul. 2016 Mar-Apr;9(2):225-33. doi: 10.1016/j.brs.2015.09.013. Epub 2015 Oct 9.","Bella R","Brain Stimul","2016","2015/10/31","","","10.1016/j.brs.2015.09.013"
"2059002","ComputerLink: electronic support for the home caregiver","Brennan PF, Moore SM, Smyth KA.","ANS Adv Nurs Sci. 1991 Jun;13(4):14-27. doi: 10.1097/00012272-199106000-00004.","Brennan PF","ANS Adv Nurs Sci","1991","1991/06/01","","","10.1097/00012272-199106000-00004"
"25101659","Induction of salivary nerve growth factor by Yogic breathing: a randomized controlled trial","Balasubramanian S, Mintzer JE, Wahlquist AE.","Int Psychogeriatr. 2015 Jan;27(1):168-70. doi: 10.1017/S1041610214001616. Epub 2014 Aug 7.","Balasubramanian S","Int Psychogeriatr","2015","2014/08/08","PMC4501575","NIHMS702673","10.1017/S1041610214001616"
"34225517","The effects of a multi-disciplinary team on sleep quality assessment in mild-to-moderate Alzheimer's disease patients with sleep disorders","Chen Z, Wang L, Chen K, Mi Q, Zu X, Xu Q, Na W, He W, Li X, Xu C, Wang F, Shen C, Shao L, Tang C, Shen X.","Scott Med J. 2021 Aug;66(3):134-141. doi: 10.1177/00369330211027450. Epub 2021 Jul 5.","Chen Z","Scott Med J","2021","2021/07/06","","","10.1177/00369330211027450"
"11103680","[Cerebrospinal fluid protein tau levels in the differential diagnosis of Alzheimer's disease]","Schonknecht P, Pantel J, Werle E, Hartmann T, Essig M, Baudendistel K, Beyreuther K, Schroder J.","Fortschr Neurol Psychiatr. 2000 Oct;68(10):439-46. doi: 10.1055/s-2000-7732.","Schonknecht P","Fortschr Neurol Psychiatr","2000","2000/12/05","","","10.1055/s-2000-7732"
"26856756","Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET","van Westen D, Lindqvist D, Blennow K, Minthon L, Nägga K, Stomrud E, Zetterberg H, Hansson O.","Sci Rep. 2016 Feb 9;6:20709. doi: 10.1038/srep20709.","van Westen D","Sci Rep","2016","2016/02/10","PMC4746584","","10.1038/srep20709"
"19554672","Variability in depressive symptoms predicts cognitive decline in age-related macular degeneration","Rovner BW, Casten RJ, Leiby BE.","Am J Geriatr Psychiatry. 2009 Jul;17(7):574-81. doi: 10.1097/jgp.0b013e31819a7f46.","Rovner BW","Am J Geriatr Psychiatry","2009","2009/06/26","PMC2704479","NIHMS118004","10.1097/jgp.0b013e31819a7f46"
"9447569","Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type","Maurer K, Ihl R, Dierks T, Frölich L.","J Psychiatr Res. 1997 Nov-Dec;31(6):645-55. doi: 10.1016/s0022-3956(97)00022-8.","Maurer K","J Psychiatr Res","1997","1998/02/03","","","10.1016/s0022-3956(97)00022-8"
"8868964","[Melatonin. Hormone or wonder drug?]","Stoll S, Müller WE.","Med Monatsschr Pharm. 1996 Mar;19(3):69-75.","Stoll S","Med Monatsschr Pharm","1996","1996/03/01","","",""
"11673605","Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease","Adair JC, Knoefel JE, Morgan N.","Neurology. 2001 Oct 23;57(8):1515-7. doi: 10.1212/wnl.57.8.1515.","Adair JC","Neurology","2001","2001/10/24","","","10.1212/wnl.57.8.1515"
"7854529","Gender differences in language of AD patients: a longitudinal study","Ripich DN, Petrill SA, Whitehouse PJ, Ziol EW.","Neurology. 1995 Feb;45(2):299-302. doi: 10.1212/wnl.45.2.299.","Ripich DN","Neurology","1995","1995/02/01","","","10.1212/wnl.45.2.299"
"15465628","Increased galanin receptor occupancy in Alzheimer's disease","McMillan PJ, Peskind E, Raskind MA, Leverenz JB.","Neurobiol Aging. 2004 Nov-Dec;25(10):1309-14. doi: 10.1016/j.neurobiolaging.2004.01.004.","McMillan PJ","Neurobiol Aging","2004","2004/10/07","","","10.1016/j.neurobiolaging.2004.01.004"
"3453431","Contingent negative variation and reaction time in patients with presenile idiopathic cognitive decline and presenile Alzheimer-type dementia. Preliminary report on long-term nicergoline treatment","Zappoli R, Arnetoli G, Paganini M, Versari A, Battaglia A, Grignani A, Sacchetti G.","Neuropsychobiology. 1987;18(3):149-54. doi: 10.1159/000118409.","Zappoli R","Neuropsychobiology","1987","1987/01/01","","","10.1159/000118409"
"8753675","Changes in local cerebral blood flow by neuroactivation and vasoactivation in patients with impaired cognitive function","Knapp WH, Dannenberg C, Marschall B, Zedlick D, Löschmann K, Bettin S, Barthel H, Seese A.","Eur J Nucl Med. 1996 Aug;23(8):878-88. doi: 10.1007/BF01084360.","Knapp WH","Eur J Nucl Med","1996","1996/08/01","","","10.1007/BF01084360"
"29136094","Effects of multidomain lifestyle intervention, omega-3 supplementation or their combination on physical activity levels in older adults: secondary analysis of the Multidomain Alzheimer Preventive Trial (MAPT) randomised controlled trial","Barreto PS, Rolland Y, Cesari M, Dupuy C, Andrieu S, Vellas B; MAPT study group.","Age Ageing. 2018 Mar 1;47(2):281-288. doi: 10.1093/ageing/afx164.","Barreto PS","Age Ageing","2018","2017/11/15","","","10.1093/ageing/afx164"
"19262966","Methodological improvements in quantifying cognitive change in clinical trials: an example with single-dose administration of donepezil","Pietrzak RH, Maruff P, Snyder PJ.","J Nutr Health Aging. 2009 Mar;13(3):268-73. doi: 10.1007/s12603-009-0071-4.","Pietrzak RH","J Nutr Health Aging","2009","2009/03/06","","","10.1007/s12603-009-0071-4"
"20722838","The role of tumor necrosis factor-alpha in cognitive improvement after peroxisome proliferator-activator receptor gamma agonist pioglitazone treatment in Alzheimer's disease","Hanyu H, Sato T, Sakurai H, Iwamoto T.","J Am Geriatr Soc. 2010 May;58(5):1000-1. doi: 10.1111/j.1532-5415.2010.02841.x.","Hanyu H","J Am Geriatr Soc","2010","2010/08/21","","","10.1111/j.1532-5415.2010.02841.x"
"1776750","Pharmacologic and clinicopharmacologic properties of SDZ ENA 713, a centrally selective acetylcholinesterase inhibitor","Enz A, Boddeke H, Gray J, Spiegel R.","Ann N Y Acad Sci. 1991;640:272-5. doi: 10.1111/j.1749-6632.1991.tb00232.x.","Enz A","Ann N Y Acad Sci","1991","1991/01/01","","","10.1111/j.1749-6632.1991.tb00232.x"
"12810768","Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial","Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M.","J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):863-6. doi: 10.1136/jnnp.74.7.863.","Akhondzadeh S","J Neurol Neurosurg Psychiatry","2003","2003/06/18","PMC1738567","","10.1136/jnnp.74.7.863"
"18586865","Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine","Schmidt R, Ropele S, Pendl B, Ofner P, Enzinger C, Schmidt H, Berghold A, Windisch M, Kolassa H, Fazekas F.","J Neurol Neurosurg Psychiatry. 2008 Dec;79(12):1312-7. doi: 10.1136/jnnp.2007.141648. Epub 2008 Jun 27.","Schmidt R","J Neurol Neurosurg Psychiatry","2008","2008/07/01","PMC2582338","","10.1136/jnnp.2007.141648"
"32283762","Dietary Supplementation with Curcumin Reduce Circulating Levels of Glycogen Synthase Kinase-3β and Islet Amyloid Polypeptide in Adults with High Risk of Type 2 Diabetes and Alzheimer's Disease","Thota RN, Rosato JI, Dias CB, Burrows TL, Martins RN, Garg ML.","Nutrients. 2020 Apr 9;12(4):1032. doi: 10.3390/nu12041032.","Thota RN","Nutrients","2020","2020/04/15","PMC7230780","","10.3390/nu12041032"
"12742626","Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease","Lai MK, Tsang SW, Francis PT, Esiri MM, Keene J, Hope T, Chen CP.","Brain Res. 2003 Jun 6;974(1-2):82-7. doi: 10.1016/s0006-8993(03)02554-x.","Lai MK","Brain Res","2003","2003/05/14","","","10.1016/s0006-8993(03)02554-x"
"20188634","Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease","Cumbo E, Ligori LD.","Epilepsy Behav. 2010 Apr;17(4):461-6. doi: 10.1016/j.yebeh.2010.01.015. Epub 2010 Feb 25.","Cumbo E","Epilepsy Behav","2010","2010/03/02","","","10.1016/j.yebeh.2010.01.015"
"16175023","Predictive model for assessing cognitive impairment by quantitative electroencephalography","Onishi J, Suzuki Y, Yoshiko K, Hibino S, Iguchi A.","Cogn Behav Neurol. 2005 Sep;18(3):179-84. doi: 10.1097/01.wnn.0000178227.54315.38.","Onishi J","Cogn Behav Neurol","2005","2005/09/22","","","10.1097/01.wnn.0000178227.54315.38"
"9386853","Association of plasma homovanillic acid with behavioral symptoms in patients diagnosed with dementia: a preliminary report","Sweet RA, Pollock BG, Mulsant BH, Rosen J, Lo KH, Yao JK, Henteleff RA, Mazumdar S.","Biol Psychiatry. 1997 Dec 1;42(11):1016-23. doi: 10.1016/s0006-3223(97)00146-7.","Sweet RA","Biol Psychiatry","1997","1997/12/05","","","10.1016/s0006-3223(97)00146-7"
"9167869","Single case evaluation of the effects of aromatherapy and massage on disturbed behaviour in severe dementia","Brooker DJ, Snape M, Johnson E, Ward D, Payne M.","Br J Clin Psychol. 1997 May;36(2):287-96. doi: 10.1111/j.2044-8260.1997.tb01415.x.","Brooker DJ","Br J Clin Psychol","1997","1997/05/01","","","10.1111/j.2044-8260.1997.tb01415.x"
"28157100","Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial","Jia J, Wei C, Jia L, Tang Y, Liang J, Zhou A, Li F, Shi L, Doody RS.","J Alzheimers Dis. 2017;56(4):1495-1504. doi: 10.3233/JAD-161117.","Jia J","J Alzheimers Dis","2017","2017/02/04","","","10.3233/JAD-161117"
"24333824","[Contribution of relaxation to a psychoeducational intervention program for family carers of persons with Alzheimer's disease]","Pitteri F, Soulas T, Essertaise AL, Roux J.","Geriatr Psychol Neuropsychiatr Vieil. 2013 Dec;11(4):443-51. doi: 10.1684/pnv.2013.0426.","Pitteri F","Geriatr Psychol Neuropsychiatr Vieil","2013","2013/12/17","","","10.1684/pnv.2013.0426"
"12397463","Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks","Varrone A, Pappatà S, Caracò C, Soricelli A, Milan G, Quarantelli M, Alfano B, Postiglione A, Salvatore M.","Eur J Nucl Med Mol Imaging. 2002 Nov;29(11):1447-54. doi: 10.1007/s00259-002-0883-5. Epub 2002 Aug 28.","Varrone A","Eur J Nucl Med Mol Imaging","2002","2002/10/25","","","10.1007/s00259-002-0883-5"
"1587974","The Clock Test: a sensitive measure to differentiate normal elderly from those with Alzheimer disease","Tuokko H, Hadjistavropoulos T, Miller JA, Beattie BL.","J Am Geriatr Soc. 1992 Jun;40(6):579-84. doi: 10.1111/j.1532-5415.1992.tb02106.x.","Tuokko H","J Am Geriatr Soc","1992","1992/06/01","","","10.1111/j.1532-5415.1992.tb02106.x"
"24518149","Automated algorithm to measure changes in medial temporal lobe volume in Alzheimer disease","Kazemifar S, Drozd JJ, Rajakumar N, Borrie MJ, Bartha R; Alzheimer's Disease Neuroimaging Initiative.","J Neurosci Methods. 2014 Apr 30;227:35-46. doi: 10.1016/j.jneumeth.2014.01.033. Epub 2014 Feb 8.","Kazemifar S","J Neurosci Methods","2014","2014/02/13","","","10.1016/j.jneumeth.2014.01.033"
"36777777","Testing the knowledge of Alzheimer's disease via an intervention study among community health service center staff in Jiaxing, China","Ma W, Zhu L, Tang J, Diao W, Qian L, Feng X, Zhang X.","Front Public Health. 2023 Jan 27;10:969653. doi: 10.3389/fpubh.2022.969653. eCollection 2022.","Ma W","Front Public Health","2023","2023/02/13","PMC9911520","","10.3389/fpubh.2022.969653"
"29771687","Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer's Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholinesterase Inhibitors","Grossberg GT, Alva G, Hendrix S, Ellison N, Kane MC, Edwards J.","Alzheimer Dis Assoc Disord. 2018 Jul-Sep;32(3):173-178. doi: 10.1097/WAD.0000000000000261.","Grossberg GT","Alzheimer Dis Assoc Disord","2018","2018/05/18","PMC6110375","","10.1097/WAD.0000000000000261"
"27599818","Incontinence in nursing home residents with dementia : Influence of an educational program and nursing case conferences","Kohler M, Schwarz J, Burgstaller M, Saxer S.","Z Gerontol Geriatr. 2018 Jan;51(1):48-53. doi: 10.1007/s00391-016-1120-3. Epub 2016 Sep 6.","Kohler M","Z Gerontol Geriatr","2018","2016/09/08","","","10.1007/s00391-016-1120-3"
"25589719","A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease","Remington R, Bechtel C, Larsen D, Samar A, Doshanjh L, Fishman P, Luo Y, Smyers K, Page R, Morrell C, Shea TB.","J Alzheimers Dis. 2015;45(2):395-405. doi: 10.3233/JAD-142499.","Remington R","J Alzheimers Dis","2015","2015/01/16","","","10.3233/JAD-142499"
"15249280","Rivastigmine in Alzheimer disease: efficacy over two years","Grossberg G, Irwin P, Satlin A, Mesenbrink P, Spiegel R.","Am J Geriatr Psychiatry. 2004 Jul-Aug;12(4):420-31. doi: 10.1176/appi.ajgp.12.4.420.","Grossberg G","Am J Geriatr Psychiatry","2004","2004/07/14","","","10.1176/appi.ajgp.12.4.420"
"8263078","99mTc-bicisate (neurolite) SPECT brain imaging and cognitive impairment in dementia of the Alzheimer type: a blinded read of image sets from a multicenter SPECT trial","Waldemar G, Walovitch RC, Andersen AR, Hasselbalch SG, Bigelow R, Joseph JL, Paulson OB, Lassen NA.","J Cereb Blood Flow Metab. 1994 Jan;14 Suppl 1:S99-105.","Waldemar G","J Cereb Blood Flow Metab","1994","1994/01/01","","",""
"20558849","Efficacy and safety of donepezil in patients with Alzheimer's disease in assisted living facilities","Rosenblatt A, Gao J, Mackell J, Richardson S.","Am J Alzheimers Dis Other Demen. 2010 Sep;25(6):483-9. doi: 10.1177/1533317510372923. Epub 2010 Jun 17.","Rosenblatt A","Am J Alzheimers Dis Other Demen","2010","2010/06/19","","","10.1177/1533317510372923"
"16905684","Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial","Tariot PN, Schneider L, Katz IR, Mintzer JE, Street J, Copenhaver M, Williams-Hughes C.","Am J Geriatr Psychiatry. 2006 Sep;14(9):767-76. doi: 10.1097/01.JGP.0000196628.12010.35. Epub 2006 Aug 11.","Tariot PN","Am J Geriatr Psychiatry","2006","2006/08/15","","","10.1097/01.JGP.0000196628.12010.35"
"2201714","Relation of cognitive status and abnormal behaviors in Alzheimer's disease","Cooper JK, Mungas D, Weiler PG.","J Am Geriatr Soc. 1990 Aug;38(8):867-70. doi: 10.1111/j.1532-5415.1990.tb05701.x.","Cooper JK","J Am Geriatr Soc","1990","1990/08/01","","","10.1111/j.1532-5415.1990.tb05701.x"
"11044778","Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease","Walker MP, Ayre GA, Perry EK, Wesnes K, McKeith IG, Tovee M, Edwardson JA, Ballard CG.","Dement Geriatr Cogn Disord. 2000 Nov-Dec;11(6):327-35. doi: 10.1159/000017262.","Walker MP","Dement Geriatr Cogn Disord","2000","2000/10/25","","","10.1159/000017262"
"9862635","Extracellular neurofibrillary tangles are immunopositive for the 40 carboxy-terminal sequence of beta-amyloid protein","Schwab C, Akiyama H, McGeer EG, McGeer PL.","J Neuropathol Exp Neurol. 1998 Dec;57(12):1131-7. doi: 10.1097/00005072-199812000-00004.","Schwab C","J Neuropathol Exp Neurol","1998","1998/12/23","","","10.1097/00005072-199812000-00004"
"35098970","Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD): A Pilot Clinical Trial","Gonzales MM, Garbarino VR, Marques Zilli E, Petersen RC, Kirkland JL, Tchkonia T, Musi N, Seshadri S, Craft S, Orr ME.","J Prev Alzheimers Dis. 2022;9(1):22-29. doi: 10.14283/jpad.2021.62.","Gonzales MM","J Prev Alzheimers Dis","2022","2022/01/31","PMC8612719","","10.14283/jpad.2021.62"
"10896690","Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease?","Bozeat S, Gregory CA, Ralph MA, Hodges JR.","J Neurol Neurosurg Psychiatry. 2000 Aug;69(2):178-86. doi: 10.1136/jnnp.69.2.178.","Bozeat S","J Neurol Neurosurg Psychiatry","2000","2000/07/15","PMC1737062","","10.1136/jnnp.69.2.178"
"10095316","[Cholinesterase inhibitor and ginkgo extracts in therapy of dementia. A comparison of effectiveness based on controlled studies]","Wettstein A.","Fortschr Med. 1999 Feb 20;117(5):48-9.","Wettstein A","Fortschr Med","1999","1999/03/30","","",""
"12580705","Estrogen levels do not correlate with improvement in cognition","Thal LJ, Thomas RG, Mulnard R, Sano M, Grundman M, Schneider L.","Arch Neurol. 2003 Feb;60(2):209-12. doi: 10.1001/archneur.60.2.209.","Thal LJ","Arch Neurol","2003","2003/02/13","","","10.1001/archneur.60.2.209"
"11949711","Memory encoding and retrieval in frontotemporal dementia and Alzheimer's disease","Glosser G, Gallo JL, Clark CM, Grossman M.","Neuropsychology. 2002 Apr;16(2):190-6.","Glosser G","Neuropsychology","2002","2002/04/13","","",""
"28916821","Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease","Cavedo E, Grothe MJ, Colliot O, Lista S, Chupin M, Dormont D, Houot M, Lehéricy S, Teipel S, Dubois B, Hampel H; Hippocampus Study Group.","Sci Rep. 2017 Sep 15;7(1):11706. doi: 10.1038/s41598-017-09780-3.","Cavedo E","Sci Rep","2017","2017/09/17","PMC5601919","","10.1038/s41598-017-09780-3"
"25634646","Factors affecting recall of different types of personal genetic information about Alzheimer's disease risk: the REVEAL study","Besser AG, Sanderson SC, Roberts JS, Chen CA, Christensen KD, Lautenbach DM, Cupples LA, Green RC.","Public Health Genomics. 2015;18(2):78-86. doi: 10.1159/000368888. Epub 2015 Jan 24.","Besser AG","Public Health Genomics","2015","2015/01/31","PMC4470386","NIHMS645971","10.1159/000368888"
"17101822","Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study","Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PW, Wolf PA.","Arch Neurol. 2006 Nov;63(11):1545-50. doi: 10.1001/archneur.63.11.1545.","Schaefer EJ","Arch Neurol","2006","2006/11/15","","","10.1001/archneur.63.11.1545"
"34166841","Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's","Butler T, Goldberg JD, Galvin JE, Maloney T, Ravdin L, Glodzik L, de Leon MJ, Hochman T, Bowen RL, Atwood CS.","Contemp Clin Trials. 2021 Aug;107:106488. doi: 10.1016/j.cct.2021.106488. Epub 2021 Jun 22.","Butler T","Contemp Clin Trials","2021","2021/06/24","PMC8550816","NIHMS1721038","10.1016/j.cct.2021.106488"
"11151682","A diagnostic method for suspected Alzheimer's disease using H(2)15O positron emission tomography perfusion Z score","Ishii K, Sasaki M, Matsui M, Sakamoto S, Yamaji S, Hayashi N, Mori T, Kitagaki H, Hirono N, Mori E.","Neuroradiology. 2000 Nov;42(11):787-94. doi: 10.1007/s002340000404.","Ishii K","Neuroradiology","2000","2001/01/11","","","10.1007/s002340000404"
"16085339","Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sample","Ibach B, Binder H, Dragon M, Poljansky S, Haen E, Schmitz E, Koch H, Putzhammer A, Kluenemann H, Wieland W, Hajak G.","Neurobiol Aging. 2006 Sep;27(9):1202-11. doi: 10.1016/j.neurobiolaging.2005.06.005. Epub 2005 Aug 8.","Ibach B","Neurobiol Aging","2006","2005/08/09","","","10.1016/j.neurobiolaging.2005.06.005"
"26237827","Alzheimer's disease treated with combined therapy based on nourishing marrow and reinforcing Qi","Chen S, Yao X, Liang Y, Mei W, Liu X, Zhang C.","J Tradit Chin Med. 2015 Jun;35(3):255-9. doi: 10.1016/s0254-6272(15)30094-7.","Chen S","J Tradit Chin Med","2015","2015/08/05","","","10.1016/s0254-6272(15)30094-7"
"19241637","Errorless practice as a possible adjuvant to donepezil in Alzheimer's disease","Rothi LJ, Fuller R, Leon SA, Kendall D, Moore A, Wu SS, Crosson B, Heilman KM, Nadeau SE.","J Int Neuropsychol Soc. 2009 Mar;15(2):311-22. doi: 10.1017/s1355617709090201.","Rothi LJ","J Int Neuropsychol Soc","2009","2009/02/27","PMC3010871","NIHMS246199","10.1017/s1355617709090201"
"17297213","The effects of a comprehensive rehabilitation program of Alzheimer's Disease in a hospital setting","Raggi A, Iannaccone S, Marcone A, Ginex V, Ortelli P, Nonis A, Giusti MC, Cappa SF.","Behav Neurol. 2007;18(1):1-6. doi: 10.1155/2007/782959.","Raggi A","Behav Neurol","2007","2007/02/14","PMC5469961","","10.1155/2007/782959"
"10362894","A phase II study in patients with Alzheimer's disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (Exelon)","Forette F, Anand R, Gharabawi G.","Eur J Neurol. 1999 Jul;6(4):423-9. doi: 10.1046/j.1468-1331.1999.640423.x.","Forette F","Eur J Neurol","1999","1999/06/11","","","10.1046/j.1468-1331.1999.640423.x"
"9547164","Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients","März P, Heese K, Hock C, Golombowski S, Müller-Spahn F, Rose-John S, Otten U.","Neurosci Lett. 1997 Dec 12;239(1):29-32. doi: 10.1016/s0304-3940(97)00886-0.","März P","Neurosci Lett","1997","1998/04/18","","","10.1016/s0304-3940(97)00886-0"
"18317253","Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study","Chao S, Roberts JS, Marteau TM, Silliman R, Cupples LA, Green RC.","Alzheimer Dis Assoc Disord. 2008 Jan-Mar;22(1):94-7. doi: 10.1097/WAD.0b013e31815a9dcc.","Chao S","Alzheimer Dis Assoc Disord","2008","2008/03/05","PMC2483341","NIHMS57712","10.1097/WAD.0b013e31815a9dcc"
"35701227","Combined physical exercise-working memory training on slowing down cognitive decline in elders with mild clinical Alzheimer disease: a randomised controlled study (abridged secondary publication)","Lam LCW, Chan WC, Kwok TCY, Lee JSW, Yu BML, Lee S, Lee ATC, Ma SL, Cheng ST.","Hong Kong Med J. 2022 Jun;28 Suppl 3(3):28-30.","Lam LCW","Hong Kong Med J","2022","2022/06/14","","",""
"22893943","[Psychosocial care assistants caring for residents with dementia according to section 87b SGB XI. Emotional and cognitive effects]","Rexhausen EM.","Pflege Z. 2012 Jul;65(7):418-22.","Rexhausen EM","Pflege Z","2012","2012/08/17","","",""
"10520942","Progression of clinical deterioration and pathological changes in patients with Alzheimer disease evaluated at biopsy and autopsy","Di Patre PL, Read SL, Cummings JL, Tomiyasu U, Vartavarian LM, Secor DL, Vinters HV.","Arch Neurol. 1999 Oct;56(10):1254-61. doi: 10.1001/archneur.56.10.1254.","Di Patre PL","Arch Neurol","1999","1999/10/16","","","10.1001/archneur.56.10.1254"
"34883313","The relative contributions of biomarkers, disease modifying treatment, and dementia severity to Alzheimer's stigma: A vignette-based experiment","Stites SD, Gill J, Largent EA, Harkins K, Sankar P, Krieger A, Karlawish J.","Soc Sci Med. 2022 Jan;292:114620. doi: 10.1016/j.socscimed.2021.114620. Epub 2021 Dec 1.","Stites SD","Soc Sci Med","2022","2021/12/09","PMC8748419","NIHMS1762559","10.1016/j.socscimed.2021.114620"
"23620414","Time until incident dementia among Medicare beneficiaries using centrally acting or non-centrally acting ACE inhibitors","Hebert PL, McBean AM, O'Connor H, Frank B, Good C, Maciejewski ML.","Pharmacoepidemiol Drug Saf. 2013 Jun;22(6):641-8. doi: 10.1002/pds.3449.","Hebert PL","Pharmacoepidemiol Drug Saf","2013","2013/04/27","","","10.1002/pds.3449"
"7988944","Idebenone, a new drug in the treatment of cognitive impairment in patients with dementia of the Alzheimer type","Bergamasco B, Scarzella L, La Commare P.","Funct Neurol. 1994 May-Jun;9(3):161-8.","Bergamasco B","Funct Neurol","1994","1994/05/01","","",""
"18695053","Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease","Fleisher AS, Raman R, Siemers ER, Becerra L, Clark CM, Dean RA, Farlow MR, Galvin JE, Peskind ER, Quinn JF, Sherzai A, Sowell BB, Aisen PS, Thal LJ.","Arch Neurol. 2008 Aug;65(8):1031-8. doi: 10.1001/archneur.65.8.1031.","Fleisher AS","Arch Neurol","2008","2008/08/13","PMC2682361","NIHMS106908","10.1001/archneur.65.8.1031"
"33814437","β-Lactolin Enhances Neural Activity, Indicated by Event-Related P300 Amplitude, in Healthy Adults: A Randomized Controlled Trial","Kanatome A, Ano Y, Shinagawa K, Ide Y, Shibata M, Umeda S.","J Alzheimers Dis. 2021;81(2):787-796. doi: 10.3233/JAD-201413.","Kanatome A","J Alzheimers Dis","2021","2021/04/05","PMC8203246","","10.3233/JAD-201413"
"20634594","Effect of donepezil on cognition in severe Alzheimer's disease: a pooled data analysis","Cummings J, Jones R, Wilkinson D, Lopez O, Gauthier S, Waldemar G, Zhang R, Xu Y, Sun Y, Richardson S, Mackell J.","J Alzheimers Dis. 2010;21(3):843-51. doi: 10.3233/JAD-2010-100078.","Cummings J","J Alzheimers Dis","2010","2010/07/17","","","10.3233/JAD-2010-100078"
"22473769","Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease","Blennow K, Zetterberg H, Rinne JO, Salloway S, Wei J, Black R, Grundman M, Liu E; AAB-001 201/202 Investigators.","Arch Neurol. 2012 Aug;69(8):1002-10. doi: 10.1001/archneurol.2012.90.","Blennow K","Arch Neurol","2012","2012/04/05","","","10.1001/archneurol.2012.90"
"2430180","Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type","Summers WK, Majovski LV, Marsh GM, Tachiki K, Kling A.","N Engl J Med. 1986 Nov 13;315(20):1241-5. doi: 10.1056/NEJM198611133152001.","Summers WK","N Engl J Med","1986","1986/11/13","","","10.1056/NEJM198611133152001"
"19657203","The effect of therapeutic touch on behavioral symptoms and cortisol in persons with dementia","Woods DL, Beck C, Sinha K.","Forsch Komplementmed. 2009 Jun;16(3):181-9. doi: 10.1159/000220479. Epub 2009 Jun 5.","Woods DL","Forsch Komplementmed","2009","2009/08/07","","","10.1159/000220479"
"2692057","Brain electrical activity mapping in different stages of SDAT","Fuenfgeld EW.","Psychiatry Res. 1989 Sep;29(3):411-2. doi: 10.1016/0165-1781(89)90105-4.","Fuenfgeld EW","Psychiatry Res","1989","1989/09/01","","","10.1016/0165-1781(89)90105-4"
"8747858","Apolipoprotein E genotype in Spanish patients of Alzheimer's or Parkinson's disease","Ibarreta D, Gómez-Isla T, Portera-Sánchez A, Parrilla R, Ayuso MS.","J Neurol Sci. 1995 Dec;134(1-2):146-9. doi: 10.1016/0022-510x(95)00238-3.","Ibarreta D","J Neurol Sci","1995","1995/12/01","","","10.1016/0022-510x(95)00238-3"
"16601628","Challenges to intervention implementation: lessons learned in the Bathing Persons with Alzheimer's Disease at Home study","Mahoney EK, Trudeau SA, Penyack SE, MacLeod CE.","Nurs Res. 2006 Mar-Apr;55(2 Suppl):S10-6. doi: 10.1097/00006199-200603001-00003.","Mahoney EK","Nurs Res","2006","2006/04/08","","","10.1097/00006199-200603001-00003"
"33583479","Quantifying the heterogeneity of cognitive functioning in Alzheimer's disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil","Levine SZ, Goldberg Y, Yoshida K, Samara M, Cipriani A, Iwatsubo T, Leucht S, Furawaka TA.","Eur Psychiatry. 2021 Feb 15;64(1):e16. doi: 10.1192/j.eurpsy.2021.8.","Levine SZ","Eur Psychiatry","2021","2021/02/15","PMC8057455","","10.1192/j.eurpsy.2021.8"
"31211178","No apparent effect of naproxen on CSF markers of innate immune activation","Meyer PF, Labonté A, Rosa-Neto P, Poirier J, Breitner JCS; PREVENT‐AD Research Group.","Ann Clin Transl Neurol. 2019 Jun 6;6(6):1127-1133. doi: 10.1002/acn3.788. eCollection 2019 Jun.","Meyer PF","Ann Clin Transl Neurol","2019","2019/06/19","PMC6562029","","10.1002/acn3.788"
"9682830","The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations","Crawford F, Fallin D, Suo Z, Abdullah L, Gold M, Gauntlett A, Duara R, Mullan M.","Neurosci Lett. 1998 Jun 19;249(2-3):115-8. doi: 10.1016/s0304-3940(98)00423-6.","Crawford F","Neurosci Lett","1998","1998/07/31","","","10.1016/s0304-3940(98)00423-6"
"19682661","Effects of gender on response to treatment with rivastigmine in mild cognitive impairment: A post hoc statistical modeling approach","Ferris S, Lane R, Sfikas N, Winblad B, Farlow M, Feldman HH.","Gend Med. 2009 Jul;6(2):345-55. doi: 10.1016/j.genm.2009.06.004.","Ferris S","Gend Med","2009","2009/08/18","","","10.1016/j.genm.2009.06.004"
"26302439","Nerve Growth Factor Gene Therapy: Activation of Neuronal Responses in Alzheimer Disease","Tuszynski MH, Yang JH, Barba D, U HS, Bakay RA, Pay MM, Masliah E, Conner JM, Kobalka P, Roy S, Nagahara AH.","JAMA Neurol. 2015 Oct;72(10):1139-47. doi: 10.1001/jamaneurol.2015.1807.","Tuszynski MH","JAMA Neurol","2015","2015/08/25","PMC4944824","NIHMS796718","10.1001/jamaneurol.2015.1807"
"16478570","Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study","Mazeh D, Zemishlani H, Barak Y, Mirecki I, Paleacu D.","Int Psychogeriatr. 2006 Sep;18(3):429-36. doi: 10.1017/S1041610205003017. Epub 2006 Feb 15.","Mazeh D","Int Psychogeriatr","2006","2006/02/16","","","10.1017/S1041610205003017"
"12631527","Multiple patterns of writing disorders in dementia of the Alzheimer type and their evolution","Luzzatti C, Laiacona M, Agazzi D.","Neuropsychologia. 2003;41(7):759-72. doi: 10.1016/s0028-3932(02)00328-7.","Luzzatti C","Neuropsychologia","2003","2003/03/13","","","10.1016/s0028-3932(02)00328-7"
"7675161","An attentional grasp reflex in patients with Alzheimer's disease","Maruff P, Currie J.","Neuropsychologia. 1995 Jun;33(6):689-701. doi: 10.1016/0028-3932(95)00016-v.","Maruff P","Neuropsychologia","1995","1995/06/01","","","10.1016/0028-3932(95)00016-v"
"34260986","Feasibility of improving strength and functioning and decreasing the risk of falls in older adults with Alzheimer's dementia: a randomized controlled home-based exercise trial","Cezar NOC, Ansai JH, Oliveira MPB, da Silva DCP, Gomes WL, Barreiros BA, Langelli TCO, de Andrade LP.","Arch Gerontol Geriatr. 2021 Sep-Oct;96:104476. doi: 10.1016/j.archger.2021.104476. Epub 2021 Jul 4.","Cezar NOC","Arch Gerontol Geriatr","2021","2021/07/14","","","10.1016/j.archger.2021.104476"
"32320844","Protocol for an embedded pragmatic clinical trial to test the effectiveness of Aliviado Dementia Care in improving quality of life for persons living with dementia and their informal caregivers","Bristol AA, Convery KA, Sotelo V, Schneider CE, Lin SY, Fletcher J, Rupper R, Galvin JE, Brody AA.","Contemp Clin Trials. 2020 Jun;93:106005. doi: 10.1016/j.cct.2020.106005. Epub 2020 Apr 19.","Bristol AA","Contemp Clin Trials","2020","2020/04/23","PMC7269690","NIHMS1589265","10.1016/j.cct.2020.106005"
"22768288","Sexual dimorphism in healthy aging and mild cognitive impairment: a DTI study","O'Dwyer L, Lamberton F, Bokde AL, Ewers M, Faluyi YO, Tanner C, Mazoyer B, O'Neill D, Bartley M, Collins R, Coughlan T, Prvulovic D, Hampel H.","PLoS One. 2012;7(7):e37021. doi: 10.1371/journal.pone.0037021. Epub 2012 Jul 2.","O'Dwyer L","PLoS One","2012","2012/07/07","PMC3388101","","10.1371/journal.pone.0037021"
"11971086","Women at risk for AD show increased parietal activation during a fluency task","Smith CD, Andersen AH, Kryscio RJ, Schmitt FA, Kindy MS, Blonder LX, Avison MJ.","Neurology. 2002 Apr 23;58(8):1197-202. doi: 10.1212/wnl.58.8.1197.","Smith CD","Neurology","2002","2002/04/24","","","10.1212/wnl.58.8.1197"
"10678692","The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: relationship to episodic and semantic memory impairment","Perry RJ, Watson P, Hodges JR.","Neuropsychologia. 2000;38(3):252-71. doi: 10.1016/s0028-3932(99)00079-2.","Perry RJ","Neuropsychologia","2000","2000/03/11","","","10.1016/s0028-3932(99)00079-2"
"12928051","Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain","Licastro F, Grimaldi LM, Bonafè M, Martina C, Olivieri F, Cavallone L, Giovanietti S, Masliah E, Franceschi C.","Neurobiol Aging. 2003 Nov;24(7):921-6. doi: 10.1016/s0197-4580(03)00013-7.","Licastro F","Neurobiol Aging","2003","2003/08/21","","","10.1016/s0197-4580(03)00013-7"
"9651141","Transcutaneous electrical nerve stimulation (TENS) improves circadian rhythm disturbances in Alzheimer disease","Van Someren EJ, Scherder EJ, Swaab DF.","Alzheimer Dis Assoc Disord. 1998 Jun;12(2):114-8. doi: 10.1097/00002093-199806000-00010.","Van Someren EJ","Alzheimer Dis Assoc Disord","1998","1998/07/03","","","10.1097/00002093-199806000-00010"
"33311571","Cellular correlates of cortical thinning throughout the lifespan","Vidal-Pineiro D, Parker N, Shin J, French L, Grydeland H, Jackowski AP, Mowinckel AM, Patel Y, Pausova Z, Salum G, Sørensen Ø, Walhovd KB, Paus T, Fjell AM; Alzheimer’s Disease Neuroimaging Initiative and the Australian Imaging Biomarkers and Lifestyle flagship study of ageing.","Sci Rep. 2020 Dec 11;10(1):21803. doi: 10.1038/s41598-020-78471-3.","Vidal-Pineiro D","Sci Rep","2020","2020/12/14","PMC7732849","","10.1038/s41598-020-78471-3"
"21547601","Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls","Barthel H, Luthardt J, Becker G, Patt M, Hammerstein E, Hartwig K, Eggers B, Sattler B, Schildan A, Hesse S, Meyer PM, Wolf H, Zimmermann T, Reischl J, Rohde B, Gertz HJ, Reininger C, Sabri O.","Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1702-14. doi: 10.1007/s00259-011-1821-1. Epub 2011 May 6.","Barthel H","Eur J Nucl Med Mol Imaging","2011","2011/05/07","","","10.1007/s00259-011-1821-1"
"24983746","Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings","Henley DB, Sundell KL, Sethuraman G, Dowsett SA, May PC.","Curr Med Res Opin. 2014 Oct;30(10):2021-32. doi: 10.1185/03007995.2014.939167. Epub 2014 Jul 14.","Henley DB","Curr Med Res Opin","2014","2014/07/02","","","10.1185/03007995.2014.939167"
"3281057","No response to high-dose muscarinic agonist therapy in Alzheimer's disease","Mouradian MM, Mohr E, Williams JA, Chase TN.","Neurology. 1988 Apr;38(4):606-8. doi: 10.1212/wnl.38.4.606.","Mouradian MM","Neurology","1988","1988/04/01","","","10.1212/wnl.38.4.606"
"1698217","Rating of the lesions in senile dementia of the Alzheimer type: concordance between laboratories. A European multicenter study under the auspices of EURAGE","Duyckaerts C, Delaère P, Hauw JJ, Abbamondi-Pinto AL, Sorbi S, Allen I, Brion JP, Flament-Durand J, Duchen L, Kauss J, et al.","J Neurol Sci. 1990 Jul;97(2-3):295-323. doi: 10.1016/0022-510x(90)90226-d.","Duyckaerts C","J Neurol Sci","1990","1990/07/01","","","10.1016/0022-510x(90)90226-d"
"24261605","Anti-dementia drugs and changes in gait: a pre-post quasi-experimental pilot study","Beauchet O, Launay CP, Allali G, Watfa G, Gallouj K, Herrmann FR, Annweiler C.","BMC Neurol. 2013 Nov 21;13:184. doi: 10.1186/1471-2377-13-184.","Beauchet O","BMC Neurol","2013","2013/11/23","PMC3898226","","10.1186/1471-2377-13-184"
"18252268","High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease","Bartha R, Smith M, Rupsingh R, Rylett J, Wells JL, Borrie MJ.","Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):786-93. doi: 10.1016/j.pnpbp.2007.12.011. Epub 2007 Dec 23.","Bartha R","Prog Neuropsychopharmacol Biol Psychiatry","2008","2008/02/07","","","10.1016/j.pnpbp.2007.12.011"
"22718435","A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer's disease: the DARAD trial","Molloy DW, Standish TI, Zhou Q, Guyatt G; DARAD Study Group.","Int J Geriatr Psychiatry. 2013 May;28(5):463-70. doi: 10.1002/gps.3846. Epub 2012 Jun 21.","Molloy DW","Int J Geriatr Psychiatry","2013","2012/06/22","","","10.1002/gps.3846"
"19786778","Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI)","Haense C, Herholz K, Jagust WJ, Heiss WD.","Dement Geriatr Cogn Disord. 2009;28(3):259-66. doi: 10.1159/000241879. Epub 2009 Sep 25.","Haense C","Dement Geriatr Cogn Disord","2009","2009/09/30","PMC7077083","","10.1159/000241879"
"8624122","Preliminary evaluation of besipirdine for the treatment of Alzheimer's disease. Besipirdine Study Group","Huff FJ.","Ann N Y Acad Sci. 1996 Jan 17;777:410-4. doi: 10.1111/j.1749-6632.1996.tb34454.x.","Huff FJ","Ann N Y Acad Sci","1996","1996/01/17","","","10.1111/j.1749-6632.1996.tb34454.x"
"10705162","Absorption of aluminium-26 in Alzheimer's disease, measured using accelerator mass spectrometry","Moore PB, Day JP, Taylor GA, Ferrier IN, Fifield LK, Edwardson JA.","Dement Geriatr Cogn Disord. 2000 Mar-Apr;11(2):66-9. doi: 10.1159/000017216.","Moore PB","Dement Geriatr Cogn Disord","2000","2000/03/08","","","10.1159/000017216"
"27463280","Antihypertensiva-Stopp ohne Effekt auf die kognitive Funktion alter Menschen","Zechmann S.","Praxis (Bern 1994). 2016 Jul;105(15):917-8. doi: 10.1024/1661-8157/a002417.","Zechmann S","Praxis (Bern 1994)","2016","2016/07/28","","","10.1024/1661-8157/a002417"
"16867031","Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimer's disease","Mauri M, Mancioli A, Rebecchi V, Corbetta S, Colombo C, Bono G.","Acta Neurol Scand. 2006 Aug;114(2):97-101. doi: 10.1111/j.1600-0404.2006.00660.x.","Mauri M","Acta Neurol Scand","2006","2006/07/27","","","10.1111/j.1600-0404.2006.00660.x"
"36121669","Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials","Ostrowitzki S, Bittner T, Sink KM, Mackey H, Rabe C, Honig LS, Cassetta E, Woodward M, Boada M, van Dyck CH, Grimmer T, Selkoe DJ, Schneider A, Blondeau K, Hu N, Quartino A, Clayton D, Dolton M, Dang Y, Ostaszewski B, Sanabria-Bohórquez SM, Rabbia M, Toth B, Eichenlaub U, Smith J, Honigberg LA, Doody RS.","JAMA Neurol. 2022 Nov 1;79(11):1113-1121. doi: 10.1001/jamaneurol.2022.2909.","Ostrowitzki S","JAMA Neurol","2022","2022/09/19","PMC9486635","","10.1001/jamaneurol.2022.2909"
"22286593","Prognostic factors for a favourable long-term outcome from an integrative psychotherapeutic nursing home programme","Bakker TJ, Duivenvoorden HJ, van der Lee J, Olde Rikkert MG, Beekman AT, Ribbe MW.","Dement Geriatr Cogn Disord. 2011;32(5):318-31. doi: 10.1159/000334969. Epub 2012 Jan 25.","Bakker TJ","Dement Geriatr Cogn Disord","2011","2012/01/31","","","10.1159/000334969"
"29188863","Cross-Sectional Associations of Total Plasma Homocysteine with Cortical β-Amyloid Independently and as a Function of Omega 3 Polyunsaturated Fatty Acid Status in Older Adults at Risk of Dementia","Hooper C, De Souto Barreto P, Coley N, Caussé E, Payoux P, Salabert AS, Cesari M, Andrieu S, Bowman GL, Weiner M, Vellas B.","J Nutr Health Aging. 2017;21(10):1075-1080. doi: 10.1007/s12603-017-0989-x.","Hooper C","J Nutr Health Aging","2017","2017/12/01","","","10.1007/s12603-017-0989-x"
"16650578","Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease","Depboylu C, Lohmüller F, Du Y, Riemenschneider M, Kurz A, Gasser T, Müller U, Dodel RC.","Neurosci Lett. 2006 Jun 12;400(3):187-90. doi: 10.1016/j.neulet.2006.01.040. Epub 2006 May 2.","Depboylu C","Neurosci Lett","2006","2006/05/03","","","10.1016/j.neulet.2006.01.040"
"24156907","Reducing post-lumbar puncture headaches with small bore atraumatic needles","Vidoni ED, Morris JK, Raider K, Burns JM; Alzheimer’s Disease Neuroimaging Initiative.","J Clin Neurosci. 2014 Mar;21(3):536-7. doi: 10.1016/j.jocn.2013.07.001. Epub 2013 Oct 22.","Vidoni ED","J Clin Neurosci","2014","2013/10/26","PMC3946374","NIHMS505805","10.1016/j.jocn.2013.07.001"
"1656348","Evaluation of a multicentre study with Iomazenil--a benzodiazepine receptor ligand","Schubiger PA, Hasler PH, Beer-Wohlfahrt H, Bekier A, Oettli R, Cordes M, Ferstl F, Deisenhammer E, De Roo M, Moser E, et al.","Nucl Med Commun. 1991 Jul;12(7):569-82. doi: 10.1097/00006231-199107000-00002.","Schubiger PA","Nucl Med Commun","1991","1991/07/01","","","10.1097/00006231-199107000-00002"
"16364684","Altered response to rTMS in patients with Alzheimer's disease","Inghilleri M, Conte A, Frasca V, Scaldaferri N, Gilio F, Santini M, Fabbrini G, Prencipe M, Berardelli A.","Clin Neurophysiol. 2006 Jan;117(1):103-9. doi: 10.1016/j.clinph.2005.09.016. Epub 2005 Dec 20.","Inghilleri M","Clin Neurophysiol","2006","2005/12/21","","","10.1016/j.clinph.2005.09.016"
"15259402","Differential memory impairment in dementia with Lewy bodies and Alzheimer's disease","Simard M, van Reekum R, Myran D, Panisset M, Cohen T, Freedman M, Black S, Suvajac B.","Brain Cogn. 2002 Jul;49(2):244-9.","Simard M","Brain Cogn","2002","2004/07/21","","",""
"10066203","Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial","Rösler M, Anand R, Cicin-Sain A, Gauthier S, Agid Y, Dal-Bianco P, Stähelin HB, Hartman R, Gharabawi M.","BMJ. 1999 Mar 6;318(7184):633-8. doi: 10.1136/bmj.318.7184.633.","Rösler M","BMJ","1999","1999/03/05","PMC27767","","10.1136/bmj.318.7184.633"
"18519523","Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial","Sultzer DL, Davis SM, Tariot PN, Dagerman KS, Lebowitz BD, Lyketsos CG, Rosenheck RA, Hsiao JK, Lieberman JA, Schneider LS; CATIE-AD Study Group.","Am J Psychiatry. 2008 Jul;165(7):844-54. doi: 10.1176/appi.ajp.2008.07111779. Epub 2008 Jun 2.","Sultzer DL","Am J Psychiatry","2008","2008/06/04","PMC2714365","NIHMS102344","10.1176/appi.ajp.2008.07111779"
"16817981","A preliminary open-label study of 5-HT1A partial agonist tandospirone for behavioural and psychological symptoms associated with dementia","Sato S, Mizukami K, Asada T.","Int J Neuropsychopharmacol. 2007 Apr;10(2):281-3. doi: 10.1017/S1461145706007000. Epub 2006 Jul 3.","Sato S","Int J Neuropsychopharmacol","2007","2006/07/05","","","10.1017/S1461145706007000"
"30861027","Circulating mitochondrial DNA: New indices of type 2 diabetes-related cognitive impairment in Mexican Americans","Silzer T, Barber R, Sun J, Pathak G, Johnson L, O'Bryant S, Phillips N.","PLoS One. 2019 Mar 12;14(3):e0213527. doi: 10.1371/journal.pone.0213527. eCollection 2019.","Silzer T","PLoS One","2019","2019/03/13","PMC6414026","","10.1371/journal.pone.0213527"
"10940758","Hippocampal perfusion and pituitary-adrenal axis in Alzheimer's disease","Murialdo G, Nobili F, Rollero A, Gianelli MV, Copello F, Rodriguez G, Polleri A.","Neuropsychobiology. 2000;42(2):51-7. doi: 10.1159/000026672.","Murialdo G","Neuropsychobiology","2000","2000/08/15","","","10.1159/000026672"
"36319674","Morphometric imaging biomarker identifies Alzheimer's disease even among mixed dementia patients","Chirila FV, Xu G, Fontaine D, Kern G, Khan TK, Brandt J, Konishi Y, Nebe-von-Caron G, White CL 3rd, Alkon DL.","Sci Rep. 2022 Nov 1;12(1):17675. doi: 10.1038/s41598-022-21796-y.","Chirila FV","Sci Rep","2022","2022/11/02","PMC9626495","","10.1038/s41598-022-21796-y"
"12975222","Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis","Lanctôt KL, Herrmann N, Yau KK, Khan LR, Liu BA, LouLou MM, Einarson TR.","CMAJ. 2003 Sep 16;169(6):557-64.","Lanctôt KL","CMAJ","2003","2003/09/17","PMC191283","",""
"16375657","A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type","Schneider LS, DeKosky ST, Farlow MR, Tariot PN, Hoerr R, Kieser M.","Curr Alzheimer Res. 2005 Dec;2(5):541-51. doi: 10.2174/156720505774932287.","Schneider LS","Curr Alzheimer Res","2005","2005/12/27","","","10.2174/156720505774932287"
"15817181","Allothetic orientation and sequential ordering of places is impaired in early stages of Alzheimer's disease: corresponding results in real space tests and computer tests","Kalová E, Vlcek K, Jarolímová E, Bures J.","Behav Brain Res. 2005 Apr 30;159(2):175-86. doi: 10.1016/j.bbr.2004.10.016. Epub 2004 Dec 7.","Kalová E","Behav Brain Res","2005","2005/04/09","","","10.1016/j.bbr.2004.10.016"
"2883175","Dementia and antipsychotic drugs","Raskind MA, Risse SC, Lampe TH.","J Clin Psychiatry. 1987 May;48 Suppl:16-8.","Raskind MA","J Clin Psychiatry","1987","1987/05/01","","",""
"9138754","[Neuronal apoptosis in the course of human immunodeficiency virus infection]","Gray F, Adle-Biassette H, Levy Y, Wingertsmann L, Hery C, Tardieu M.","Bull Acad Natl Med. 1996 Nov;180(8):1855-67; discussion 1867-8.","Gray F","Bull Acad Natl Med","1996","1996/11/01","","",""
"15084793","Does the pattern of atrophy of the Corpus callosum differ between patients with frontotemporal dementia and patients with Alzheimer's disease?","Hensel A, Ibach B, Muller U, Kruggel F, Kiefer M, Gertz HJ.","Dement Geriatr Cogn Disord. 2004;18(1):44-9. doi: 10.1159/000077734. Epub 2004 Apr 6.","Hensel A","Dement Geriatr Cogn Disord","2004","2004/04/16","","","10.1159/000077734"
"33434704","Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) study: Rationale, design and baseline characteristics of a randomized control trial of the MIND diet on cognitive decline","Liu X, Morris MC, Dhana K, Ventrelle J, Johnson K, Bishop L, Hollings CS, Boulin A, Laranjo N, Stubbs BJ, Reilly X, Carey VJ, Wang Y, Furtado JD, Marcovina SM, Tangney C, Aggarwal NT, Arfanakis K, Sacks FM, Barnes LL.","Contemp Clin Trials. 2021 Mar;102:106270. doi: 10.1016/j.cct.2021.106270. Epub 2021 Jan 9.","Liu X","Contemp Clin Trials","2021","2021/01/12","PMC8042655","NIHMS1679066","10.1016/j.cct.2021.106270"
"36368169","Effectiveness of motor-cognitive dual-task exercise via telerehabilitation in Alzheimer's disease: An online pilot randomized controlled study","Menengi Ç KN, Yeldan İ, Çınar N, Şahiner T.","Clin Neurol Neurosurg. 2022 Dec;223:107501. doi: 10.1016/j.clineuro.2022.107501. Epub 2022 Oct 31.","Menengi Ç KN","Clin Neurol Neurosurg","2022","2022/11/11","","","10.1016/j.clineuro.2022.107501"
"34310044","Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid-life: A randomized trial","Hoscheidt S, Sanderlin AH, Baker LD, Jung Y, Lockhart S, Kellar D, Whitlow CT, Hanson AJ, Friedman S, Register T, Leverenz JB, Craft S.","Alzheimers Dement. 2022 Mar;18(3):457-468. doi: 10.1002/alz.12421. Epub 2021 Jul 26.","Hoscheidt S","Alzheimers Dement","2022","2021/07/26","PMC9207984","NIHMS1716856","10.1002/alz.12421"
"17132970","Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis","Schmitt FA, van Dyck CH, Wichems CH, Olin JT; Memantine MEM-MD-02 Study Group.","Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):255-62. doi: 10.1097/01.wad.0000213860.35355.d4.","Schmitt FA","Alzheimer Dis Assoc Disord","2006","2006/11/30","","","10.1097/01.wad.0000213860.35355.d4"
"16513036","Donepezil and vitamin E for mild cognitive impairment","Ownby RL.","Curr Psychiatry Rep. 2006 Feb;8(1):9.","Ownby RL","Curr Psychiatry Rep","2006","2006/03/04","","",""
"34585215","Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging","Lowe SL, Duggan Evans C, Shcherbinin S, Cheng YJ, Willis BA, Gueorguieva I, Lo AC, Fleisher AS, Dage JL, Ardayfio P, Aguiar G, Ishibai M, Takaichi G, Chua L, Mullins G, Sims JR.","J Prev Alzheimers Dis. 2021;8(4):414-424. doi: 10.14283/jpad.2021.56.","Lowe SL","J Prev Alzheimers Dis","2021","2021/09/29","","","10.14283/jpad.2021.56"
"18344711","Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience","Christensen KD, Roberts JS, Royal CD, Fasaye GA, Obisesan T, Cupples LA, Whitehouse PJ, Butson MB, Linnenbringer E, Relkin NR, Farrer L, Cook-Deegan R, Green RC.","Genet Med. 2008 Mar;10(3):207-14. doi: 10.1097/GIM.0b013e318164e4cf.","Christensen KD","Genet Med","2008","2008/03/18","PMC2483343","NIHMS57716","10.1097/GIM.0b013e318164e4cf"
"31039806","Safety and tolerability of donepezil 23 mg with or without intermediate dose titration in patients with Alzheimer's disease taking donepezil 10 mg: a multicenter, randomized, open-label, parallel-design, three-arm, prospective trial","Hong YJ, Han HJ, Youn YC, Park KW, Yang DW, Kim S, Kim HJ, Kim JE, Lee JH; ODESA study (Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23 mg).","Alzheimers Res Ther. 2019 May 1;11(1):37. doi: 10.1186/s13195-019-0492-1.","Hong YJ","Alzheimers Res Ther","2019","2019/05/02","PMC6492390","","10.1186/s13195-019-0492-1"
"26711658","Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease","Furukawa K, Tomita N, Uematsu D, Okahara K, Shimada H, Ikeda M, Matsui T, Kozaki K, Fujii M, Ogawa T, Umegaki H, Urakami K, Nomura H, Kobayashi N, Nakanishi A, Washimi Y, Yonezawa H, Takahashi S, Kubota M, Wakutani Y, Ito D, Sasaki T, Matsubara E, Une K, Ishiki A, Yahagi Y, Shoji M, Sato H, Terayama Y, Kuzuya M, Araki N, Kodama M, Yamaguchi T, Arai H.","Geriatr Gerontol Int. 2017 Feb;17(2):211-218. doi: 10.1111/ggi.12696. Epub 2015 Dec 29.","Furukawa K","Geriatr Gerontol Int","2017","2015/12/30","","","10.1111/ggi.12696"
"8994482","HM-PAO (CERETEC) SPECT brain scanning in the diagnosis of Alzheimer's disease","Bergman H, Chertkow H, Wolfson C, Stern J, Rush C, Whitehead V, Dixon R.","J Am Geriatr Soc. 1997 Jan;45(1):15-20. doi: 10.1111/j.1532-5415.1997.tb00972.x.","Bergman H","J Am Geriatr Soc","1997","1997/01/01","","","10.1111/j.1532-5415.1997.tb00972.x"
"30134967","Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study","Timmers M, Streffer JR, Russu A, Tominaga Y, Shimizu H, Shiraishi A, Tatikola K, Smekens P, Börjesson-Hanson A, Andreasen N, Matias-Guiu J, Baquero M, Boada M, Tesseur I, Tritsmans L, Van Nueten L, Engelborghs S.","Alzheimers Res Ther. 2018 Aug 23;10(1):85. doi: 10.1186/s13195-018-0415-6.","Timmers M","Alzheimers Res Ther","2018","2018/08/24","PMC6106931","","10.1186/s13195-018-0415-6"
"6441959","Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT)","Wettstein A, Spiegel R.","Psychopharmacology (Berl). 1984;84(4):572-3. doi: 10.1007/BF00431470.","Wettstein A","Psychopharmacology (Berl)","1984","1984/01/01","","","10.1007/BF00431470"
"10364642","Early-onset and late-onset depression are independent of the genetic polymorphism of apolipoprotein E","Papassotiropoulos A, Bagli M, Jessen F, Rao ML, Schwab SG, Heun R.","Dement Geriatr Cogn Disord. 1999 Jul-Aug;10(4):258-61. doi: 10.1159/000017129.","Papassotiropoulos A","Dement Geriatr Cogn Disord","1999","1999/06/12","","","10.1159/000017129"
"15572876","Responsiveness of the quality of life in late-stage dementia scale to psychotropic drug treatment in late-stage dementia","Martin-Cook K, Hynan LS, Rice-Koch K, Svetlik DA, Weiner MF.","Dement Geriatr Cogn Disord. 2005;19(2-3):82-5. doi: 10.1159/000082353. Epub 2004 Nov 29.","Martin-Cook K","Dement Geriatr Cogn Disord","2005","2004/12/02","","","10.1159/000082353"
"16982570","Validation study of the three-objects-three-places test: a screening test for Alzheimer's disease","Prestia A, Rossi R, Geroldi C, Galluzzi S, Ettori M, Alaimo G, Frisoni GB.","Exp Aging Res. 2006 Oct-Dec;32(4):395-410. doi: 10.1080/03610730600875767.","Prestia A","Exp Aging Res","2006","2006/09/20","","","10.1080/03610730600875767"
"10953178","Rates of hippocampal atrophy correlate with change in clinical status in aging and AD","Jack CR Jr, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Tangalos EG, Kokmen E.","Neurology. 2000 Aug 22;55(4):484-89. doi: 10.1212/wnl.55.4.484.","Jack CR Jr","Neurology","2000","2000/08/23","PMC2724764","NIHMS135343","10.1212/wnl.55.4.484"
"15178171","The impact of lexical-semantic impairment and of executive dysfunction on the word reading performance of patients with probable Alzheimer dementia","Colombo L, Fonti C, Cappa S.","Neuropsychologia. 2004;42(9):1192-202. doi: 10.1016/j.neuropsychologia.2004.02.004.","Colombo L","Neuropsychologia","2004","2004/06/05","","","10.1016/j.neuropsychologia.2004.02.004"
"17697100","A population-based study of cholinesterase inhibitor use for dementia","Herrmann N, Gill SS, Bell CM, Anderson GM, Bronskill SE, Shulman KI, Fischer HD, Sykora K, Shi HS, Rochon PA.","J Am Geriatr Soc. 2007 Oct;55(10):1517-23. doi: 10.1111/j.1532-5415.2007.01377.x. Epub 2007 Aug 14.","Herrmann N","J Am Geriatr Soc","2007","2007/08/19","","","10.1111/j.1532-5415.2007.01377.x"
"17132971","Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment","Feldman HH, Schmitt FA, Olin JT; Memantine MEM-MD-02 Study Group.","Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):263-8. doi: 10.1097/01.wad.0000213859.35355.59.","Feldman HH","Alzheimer Dis Assoc Disord","2006","2006/11/30","","","10.1097/01.wad.0000213859.35355.59"
"15659242","Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years","Farlow MR, Lilly ML; ENA713 B352 Study Group.","BMC Geriatr. 2005 Jan 19;5:3. doi: 10.1186/1471-2318-5-3.","Farlow MR","BMC Geriatr","2005","2005/01/22","PMC548267","","10.1186/1471-2318-5-3"
"34996522","Plasma MCP-1 and changes on cognitive function in community-dwelling older adults","Sanchez-Sanchez JL, Giudici KV, Guyonnet S, Delrieu J, Li Y, Bateman RJ, Parini A, Vellas B, de Souto Barreto P; MAPT/DSA Group.","Alzheimers Res Ther. 2022 Jan 7;14(1):5. doi: 10.1186/s13195-021-00940-2.","Sanchez-Sanchez JL","Alzheimers Res Ther","2022","2022/01/08","PMC8742409","","10.1186/s13195-021-00940-2"
"36281767","Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial","Koch G, Casula EP, Bonnì S, Borghi I, Assogna M, Minei M, Pellicciari MC, Motta C, D'Acunto A, Porrazzini F, Maiella M, Ferrari C, Caltagirone C, Santarnecchi E, Bozzali M, Martorana A.","Brain. 2022 Nov 21;145(11):3776-3786. doi: 10.1093/brain/awac285.","Koch G","Brain","2022","2022/10/25","PMC9679166","","10.1093/brain/awac285"
"35489133","Blood pressure, antihypertensive drugs, and incident frailty: The Multidomain Alzheimer Preventive Trial (MAPT)","Rouch L, Rolland Y, Hanon O, Vidal JS, Cestac P, Sallerin B, Andrieu S, Vellas B, Barreto PS; MAPT/DSA Group.","Maturitas. 2022 Aug;162:8-14. doi: 10.1016/j.maturitas.2022.03.001. Epub 2022 Mar 15.","Rouch L","Maturitas","2022","2022/04/30","","","10.1016/j.maturitas.2022.03.001"
"23563245","Effects on transthyretin in plasma and cerebrospinal fluid by DHA-rich n - 3 fatty acid supplementation in patients with Alzheimer's disease: the OmegAD study","Faxén-Irving G, Freund-Levi Y, Eriksdotter-Jönhagen M, Basun H, Hjorth E, Palmblad J, Vedin I, Cederholm T, Wahlund LO.","J Alzheimers Dis. 2013;36(1):1-6. doi: 10.3233/JAD-121828.","Faxén-Irving G","J Alzheimers Dis","2013","2013/04/09","","","10.3233/JAD-121828"
"25306292","Role of the extended MAPT haplotype in the worsening of psychotic symptoms and treatment response in Alzheimer disease","Creese B, Corbett A, Jones E, Fox C, Ballard C.","J Am Med Dir Assoc. 2014 Dec;15(12):934-7. doi: 10.1016/j.jamda.2014.08.011. Epub 2014 Oct 11.","Creese B","J Am Med Dir Assoc","2014","2014/10/13","","","10.1016/j.jamda.2014.08.011"
"21987394","Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab","Ostrowitzki S, Deptula D, Thurfjell L, Barkhof F, Bohrmann B, Brooks DJ, Klunk WE, Ashford E, Yoo K, Xu ZX, Loetscher H, Santarelli L.","Arch Neurol. 2012 Feb;69(2):198-207. doi: 10.1001/archneurol.2011.1538. Epub 2011 Oct 10.","Ostrowitzki S","Arch Neurol","2012","2011/10/12","","","10.1001/archneurol.2011.1538"
"11502918","A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD","Winblad B, Engedal K, Soininen H, Verhey F, Waldemar G, Wimo A, Wetterholm AL, Zhang R, Haglund A, Subbiah P; Donepezil Nordic Study Group.","Neurology. 2001 Aug 14;57(3):489-95. doi: 10.1212/wnl.57.3.489.","Winblad B","Neurology","2001","2001/08/15","","","10.1212/wnl.57.3.489"
"10928745","Visuoconstructional problems in dementia: contribution of executive systems functions","Freeman RQ, Giovannetti T, Lamar M, Cloud BS, Stern RA, Kaplan E, Libon DJ.","Neuropsychology. 2000 Jul;14(3):415-26. doi: 10.1037//0894-4105.14.3.415.","Freeman RQ","Neuropsychology","2000","2000/08/06","","","10.1037//0894-4105.14.3.415"
"8915035","The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group","Rogers SL, Friedhoff LT.","Dementia. 1996 Nov-Dec;7(6):293-303. doi: 10.1159/000106895.","Rogers SL","Dementia","1996","1996/11/01","","","10.1159/000106895"
"18591575","Apathy associated with Alzheimer disease: use of dextroamphetamine challenge","Lanctôt KL, Herrmann N, Black SE, Ryan M, Rothenburg LS, Liu BA, Busto UE.","Am J Geriatr Psychiatry. 2008 Jul;16(7):551-7. doi: 10.1097/JGP.0b013e318170a6d1.","Lanctôt KL","Am J Geriatr Psychiatry","2008","2008/07/02","","","10.1097/JGP.0b013e318170a6d1"
"18672400","Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial","Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, Harrison J, Masters CL, Targum S, Bush AI, Murdoch R, Wilson J, Ritchie CW; PBT2-201-EURO study group.","Lancet Neurol. 2008 Sep;7(9):779-86. doi: 10.1016/S1474-4422(08)70167-4. Epub 2008 Jul 30.","Lannfelt L","Lancet Neurol","2008","2008/08/02","","","10.1016/S1474-4422(08)70167-4"
"2478368","Clinical and biochemical responses to therapy in Alzheimer's disease and multi-infarct dementia","Corona GL, Cucchi ML, Frattini P, Santagostino G, Schinelli S, Romani A, Pola A, Zerbi F, Savoldi F.","Eur Arch Psychiatry Neurol Sci. 1989;239(2):79-86. doi: 10.1007/BF01759579.","Corona GL","Eur Arch Psychiatry Neurol Sci","1989","1989/01/01","","","10.1007/BF01759579"
"21977857","Clinical research on comprehensive treatment of senile vascular dementia","Chen LP, Wang FW, Zuo F, Jia JJ, Jiao WG.","J Tradit Chin Med. 2011 Sep;31(3):178-81. doi: 10.1016/s0254-6272(11)60036-8.","Chen LP","J Tradit Chin Med","2011","2011/10/08","","","10.1016/s0254-6272(11)60036-8"
"2690117","Serum concentration of alpha 1-antichymotrypsin is elevated in patients with senile dementia of the Alzheimer type","Matsubara E, Amari M, Shoji M, Harigaya Y, Yamaguchi H, Okamoto K, Hirai S.","Prog Clin Biol Res. 1989;317:707-14.","Matsubara E","Prog Clin Biol Res","1989","1989/01/01","","",""
"22473855","Efficacy of an adjunctive computer-based cognitive training program in amnestic mild cognitive impairment and Alzheimer's disease: a single-blind, randomized clinical trial","Gaitán A, Garolera M, Cerulla N, Chico G, Rodriguez-Querol M, Canela-Soler J.","Int J Geriatr Psychiatry. 2013 Jan;28(1):91-9. doi: 10.1002/gps.3794. Epub 2012 Apr 3.","Gaitán A","Int J Geriatr Psychiatry","2013","2012/04/05","","","10.1002/gps.3794"
"12087119","Effects of a multimedia project on users' knowledge about normal forgetting and serious memory loss","Mahoney DF, Tarlow BJ, Jones RN, Sandaire J.","J Am Med Inform Assoc. 2002 Jul-Aug;9(4):383-94. doi: 10.1197/jamia.m1021.","Mahoney DF","J Am Med Inform Assoc","2002","2002/06/28","PMC346625","","10.1197/jamia.m1021"
"7847686","The calcium rationale in aging and Alzheimer's disease. Evidence from an animal model of normal aging","Disterhoft JF, Moyer JR Jr, Thompson LT.","Ann N Y Acad Sci. 1994 Dec 15;747:382-406. doi: 10.1111/j.1749-6632.1994.tb44424.x.","Disterhoft JF","Ann N Y Acad Sci","1994","1994/12/15","","","10.1111/j.1749-6632.1994.tb44424.x"
"17312368","Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting","Wallin AK, Andreasen N, Eriksson S, Båtsman S, Nasman B, Ekdahl A, Kilander L, Grut M, Rydén M, Wallin A, Jonsson M, Olofsson H, Londos E, Wattmo C, Eriksdotter Jonhagen M, Minthon L; Swedish Alzheimer Treatment Study Group.","Dement Geriatr Cogn Disord. 2007;23(3):150-60. doi: 10.1159/000098052. Epub 2006 Dec 18.","Wallin AK","Dement Geriatr Cogn Disord","2007","2007/02/22","","","10.1159/000098052"
"2858705","Minaprine for senile dementia","Passeri M, Cucinotta D, de Mello M, Storchi G, Roncucci R, Bizière K.","Lancet. 1985 Apr 6;1(8432):824. doi: 10.1016/s0140-6736(85)91488-6.","Passeri M","Lancet","1985","1985/04/06","","","10.1016/s0140-6736(85)91488-6"
"8139083","A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group","Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI.","JAMA. 1994 Apr 6;271(13):985-91.","Knapp MJ","JAMA","1994","1994/04/06","","",""
"16409439","Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment","Dantoine T, Auriacombe S, Sarazin M, Becker H, Pere JJ, Bourdeix I.","Int J Clin Pract. 2006 Jan;60(1):110-8. doi: 10.1111/j.1368-5031.2005.00769.x.","Dantoine T","Int J Clin Pract","2006","2006/01/18","","","10.1111/j.1368-5031.2005.00769.x"
"12166542","A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's disease","Wilkinson DG, Passmore AP, Bullock R, Hopker SW, Smith R, Potocnik FC, Maud CM, Engelbrecht I, Hock C, Ieni JR, Bahra RS.","Int J Clin Pract. 2002 Jul-Aug;56(6):441-6.","Wilkinson DG","Int J Clin Pract","2002","2002/08/09","","",""
"18768414","Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial","Lautenschlager NT, Cox KL, Flicker L, Foster JK, van Bockxmeer FM, Xiao J, Greenop KR, Almeida OP.","JAMA. 2008 Sep 3;300(9):1027-37. doi: 10.1001/jama.300.9.1027.","Lautenschlager NT","JAMA","2008","2008/09/05","","","10.1001/jama.300.9.1027"
"2071560","Improved verbal learning after outpatient oral physostigmine therapy in patients with dementia of the Alzheimer type","Sevush S, Guterman A, Villalon AV.","J Clin Psychiatry. 1991 Jul;52(7):300-3.","Sevush S","J Clin Psychiatry","1991","1991/07/01","","",""
"3579494","Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study","Sunderland T, Tariot PN, Cohen RM, Weingartner H, Mueller EA 3rd, Murphy DL.","Arch Gen Psychiatry. 1987 May;44(5):418-26. doi: 10.1001/archpsyc.1987.01800170032006.","Sunderland T","Arch Gen Psychiatry","1987","1987/05/01","","","10.1001/archpsyc.1987.01800170032006"
"8356361","Dementia day care and its effects on symptoms and institutionalization--a controlled Swedish study","Wimo A, Mattsson B, Adolfsson R, Eriksson T, Nelvig A.","Scand J Prim Health Care. 1993 Jun;11(2):117-23. doi: 10.3109/02813439308994913.","Wimo A","Scand J Prim Health Care","1993","1993/06/01","","","10.3109/02813439308994913"
"35504802","Diagnostic performance of brief cognitive tests in cognitive impairment screening","Carnero-Pardo C, Rego-García I, Mené Llorente M, Alonso Ródenas M, Vílchez Carrillo R.","Neurologia (Engl Ed). 2022 Jul-Aug;37(6):441-449. doi: 10.1016/j.nrleng.2019.05.011. Epub 2022 Apr 30.","Carnero-Pardo C","Neurologia (Engl Ed)","2022","2022/05/03","","","10.1016/j.nrleng.2019.05.011"
"20220589","Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes","Weintraub D, Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG; DIADS-2 Research Group.","Am J Geriatr Psychiatry. 2010 Apr;18(4):332-40. doi: 10.1097/JGP.0b013e3181cc0333.","Weintraub D","Am J Geriatr Psychiatry","2010","2010/03/12","PMC2849739","NIHMS181111","10.1097/JGP.0b013e3181cc0333"
"35696185","Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial","Teng E, Manser PT, Pickthorn K, Brunstein F, Blendstrup M, Sanabria Bohorquez S, Wildsmith KR, Toth B, Dolton M, Ramakrishnan V, Bobbala A, Sikkes SAM, Ward M, Fuji RN, Kerchner GA; Tauriel Investigators.","JAMA Neurol. 2022 Aug 1;79(8):758-767. doi: 10.1001/jamaneurol.2022.1375.","Teng E","JAMA Neurol","2022","2022/06/13","PMC9194753","","10.1001/jamaneurol.2022.1375"
"11968135","Senile plaques do not induce susceptibility effects in T2*-weighted MR microscopic images","Dhenain M, Privat N, Duyckaerts C, Jacobs RE.","NMR Biomed. 2002 May;15(3):197-203. doi: 10.1002/nbm.760.","Dhenain M","NMR Biomed","2002","2002/04/23","","","10.1002/nbm.760"
"7675160","Cognitive modelling of face processing: evidence from Alzheimer patients","Della Sala S, Muggia S, Spinnler H, Zuffi M.","Neuropsychologia. 1995 Jun;33(6):675-87. doi: 10.1016/0028-3932(95)00009-r.","Della Sala S","Neuropsychologia","1995","1995/06/01","","","10.1016/0028-3932(95)00009-r"
"33514817","A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer's disease","El-Sappagh S, Alonso JM, Islam SMR, Sultan AM, Kwak KS.","Sci Rep. 2021 Jan 29;11(1):2660. doi: 10.1038/s41598-021-82098-3.","El-Sappagh S","Sci Rep","2021","2021/01/30","PMC7846613","","10.1038/s41598-021-82098-3"
"28806917","Study protocol: pragmatic randomized control trial of an internet-based intervention (My tools 4 care) for family carers","Duggleby W, Ploeg J, McAiney C, Fisher K, Swindle J, Chambers T, Ghosh S, Peacock S, Markle-Reid M, Triscott J, Williams A, Forbes D, Pollard L.","BMC Geriatr. 2017 Aug 14;17(1):181. doi: 10.1186/s12877-017-0581-6.","Duggleby W","BMC Geriatr","2017","2017/08/16","PMC5557259","","10.1186/s12877-017-0581-6"
"26985502","[Multidimensional prevention of dementia diseases]","Diener HC.","MMW Fortschr Med. 2015 Oct 22;157(18):39. doi: 10.1007/s15006-015-3658-1.","Diener HC","MMW Fortschr Med","2015","2016/03/18","","","10.1007/s15006-015-3658-1"
"21810649","Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease","Tariot PN, Schneider LS, Cummings J, Thomas RG, Raman R, Jakimovich LJ, Loy R, Bartocci B, Fleisher A, Ismail MS, Porsteinsson A, Weiner M, Jack CR Jr, Thal L, Aisen PS; Alzheimer's Disease Cooperative Study Group.","Arch Gen Psychiatry. 2011 Aug;68(8):853-61. doi: 10.1001/archgenpsychiatry.2011.72.","Tariot PN","Arch Gen Psychiatry","2011","2011/08/04","PMC7003728","NIHMS1002590","10.1001/archgenpsychiatry.2011.72"
"9476719","Hippocampus and parahippocampal gyrus linear measurements based on magnetic resonance in Alzheimer's disease","Pucci E, Belardinelli N, Regnicolo L, Nolfe G, Signorino M, Salvolini U, Angeleri F.","Eur Neurol. 1998;39(1):16-25. doi: 10.1159/000007893.","Pucci E","Eur Neurol","1998","1998/02/26","","","10.1159/000007893"
"36049127","Revisiting global cognitive and functional state 13 years after a clinical trial of lithium for mild cognitive impairment","Damiano RF, Loureiro JC, Pais MV, Pereira RF, Corradi MM, Di Santi T, Bezerra GAM, Radanovic M, Talib LL, Forlenza OV.","Braz J Psychiatry. 2023 Mar 11;45(1):46-49. doi: 10.47626/1516-4446-2022-2767.","Damiano RF","Braz J Psychiatry","2023","2022/09/01","PMC9976922","","10.47626/1516-4446-2022-2767"
"12243209","Correlates of dropout, efficacy, and adverse events in treatment with acetylcholinesterase inhibitors in Korean patients with Alzheimer's disease","Kim JM, Shin IS, Yoon JS.","Int Psychogeriatr. 2002 Jun;14(2):187-95. doi: 10.1017/s1041610202008384.","Kim JM","Int Psychogeriatr","2002","2002/09/24","","","10.1017/s1041610202008384"
"14527601","High b value diffusion-weighted imaging is more sensitive to white matter degeneration in Alzheimer's disease","Yoshiura T, Mihara F, Tanaka A, Ogomori K, Ohyagi Y, Taniwaki T, Yamada T, Yamasaki T, Ichimiya A, Kinukawa N, Kuwabara Y, Honda H.","Neuroimage. 2003 Sep;20(1):413-9. doi: 10.1016/s1053-8119(03)00342-2.","Yoshiura T","Neuroimage","2003","2003/10/07","","","10.1016/s1053-8119(03)00342-2"
"11790229","Research evaluation and prospective diagnosis of dementia with Lewy bodies","Lopez OL, Becker JT, Kaufer DI, Hamilton RL, Sweet RA, Klunk W, DeKosky ST.","Arch Neurol. 2002 Jan;59(1):43-6. doi: 10.1001/archneur.59.1.43.","Lopez OL","Arch Neurol","2002","2002/01/16","","","10.1001/archneur.59.1.43"
"20837822","Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes","Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S.","Arch Neurol. 2011 Jan;68(1):51-7. doi: 10.1001/archneurol.2010.225. Epub 2010 Sep 13.","Baker LD","Arch Neurol","2011","2010/09/15","PMC3023149","NIHMS257053","10.1001/archneurol.2010.225"
"12812866","Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype","Craft S, Asthana S, Cook DG, Baker LD, Cherrier M, Purganan K, Wait C, Petrova A, Latendresse S, Watson GS, Newcomer JW, Schellenberg GD, Krohn AJ.","Psychoneuroendocrinology. 2003 Aug;28(6):809-22. doi: 10.1016/s0306-4530(02)00087-2.","Craft S","Psychoneuroendocrinology","2003","2003/06/19","","","10.1016/s0306-4530(02)00087-2"
"12411833","Measurement of cerebral perfusion volume and 99mTc-HMPAO uptake using SPECT in controls and patients with Alzheimer's disease","Fleming JS, Kemp PM, Bolt L, Goatman KA.","Nucl Med Commun. 2002 Nov;23(11):1057-64. doi: 10.1097/00006231-200211000-00004.","Fleming JS","Nucl Med Commun","2002","2002/11/02","","","10.1097/00006231-200211000-00004"
"8347328","A pilot clinical trial of the angiotensin-converting enzyme inhibitor ceranapril in Alzheimer disease","Sudilovsky A, Cutler NR, Sramek JJ, Wardle T, Veroff AE, Mickelson W, Markowitz J, Repetti S.","Alzheimer Dis Assoc Disord. 1993 Summer;7(2):105-11. doi: 10.1097/00002093-199307020-00006.","Sudilovsky A","Alzheimer Dis Assoc Disord","1993","1993/01/01","","","10.1097/00002093-199307020-00006"
"10881252","Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer's disease","Perry RJ, Hodges JR.","Neurology. 2000 Jun 27;54(12):2277-84. doi: 10.1212/wnl.54.12.2277.","Perry RJ","Neurology","2000","2000/07/06","","","10.1212/wnl.54.12.2277"
"22525705","Positive effects of computer-based cognitive training in adults with mild cognitive impairment","Herrera C, Chambon C, Michel BF, Paban V, Alescio-Lautier B.","Neuropsychologia. 2012 Jul;50(8):1871-81. doi: 10.1016/j.neuropsychologia.2012.04.012. Epub 2012 Apr 21.","Herrera C","Neuropsychologia","2012","2012/04/25","","","10.1016/j.neuropsychologia.2012.04.012"
"16770728","The effect of mifepristone (RU 486) on plasma cortisol in Alzheimer's disease","Pomara N, Hernando RT, de la Pena CB, Sidtis JJ, Cooper TB, Ferris S.","Neurochem Res. 2006 May;31(5):585-8. doi: 10.1007/s11064-006-9055-5. Epub 2006 May 23.","Pomara N","Neurochem Res","2006","2006/06/14","","","10.1007/s11064-006-9055-5"
"10353373","Visual attention deficits in Alzheimer's disease: simple versus conjoined feature search","Foster JK, Behrmann M, Stuss DT.","Neuropsychology. 1999 Apr;13(2):223-45. doi: 10.1037//0894-4105.13.2.223.","Foster JK","Neuropsychology","1999","1999/06/03","","","10.1037//0894-4105.13.2.223"
"27955995","Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial","Novak P, Schmidt R, Kontsekova E, Zilka N, Kovacech B, Skrabana R, Vince-Kazmerova Z, Katina S, Fialova L, Prcina M, Parrak V, Dal-Bianco P, Brunner M, Staffen W, Rainer M, Ondrus M, Ropele S, Smisek M, Sivak R, Winblad B, Novak M.","Lancet Neurol. 2017 Feb;16(2):123-134. doi: 10.1016/S1474-4422(16)30331-3. Epub 2016 Dec 10.","Novak P","Lancet Neurol","2017","2016/12/14","","","10.1016/S1474-4422(16)30331-3"
"27887597","Technology-enhanced multi-domain at home continuum of care program with respect to usual care for people with cognitive impairment: the Ability-TelerehABILITation study protocol for a randomized controlled trial","Realdon O, Rossetto F, Nalin M, Baroni I, Cabinio M, Fioravanti R, Saibene FL, Alberoni M, Mantovani F, Romano M, Nemni R, Baglio F.","BMC Psychiatry. 2016 Nov 25;16(1):425. doi: 10.1186/s12888-016-1132-y.","Realdon O","BMC Psychiatry","2016","2016/11/27","PMC5123349","","10.1186/s12888-016-1132-y"
"7986489","D-cycloserine treatment of Alzheimer disease","Randolph C, Roberts JW, Tierney MC, Bravi D, Mouradian MM, Chase TN.","Alzheimer Dis Assoc Disord. 1994 Fall;8(3):198-205. doi: 10.1097/00002093-199408030-00006.","Randolph C","Alzheimer Dis Assoc Disord","1994","1994/01/01","","","10.1097/00002093-199408030-00006"
"17656827","Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study","Bakchine S, Loft H.","J Alzheimers Dis. 2007 Jul;11(4):471-9. doi: 10.3233/jad-2007-11409.","Bakchine S","J Alzheimers Dis","2007","2007/07/28","","","10.3233/jad-2007-11409"
"20630702","A pilot study of a test for visual recognition memory in adults with moderate to severe intellectual disability","Pyo G, Ala T, Kyrouac GA, Verhulst SJ.","Res Dev Disabil. 2010 Nov-Dec;31(6):1475-80. doi: 10.1016/j.ridd.2010.06.010. Epub 2010 Jul 13.","Pyo G","Res Dev Disabil","2010","2010/07/16","","","10.1016/j.ridd.2010.06.010"
"35694924","Training with Odors Impacts Hippocampal Thickness in Patients with Mild Cognitive Impairment","Haehner A, Chen B, Espin M, Haussmann R, Matthes C, Desser D, Loessner L, Brandt MD, Donix M, Hummel T.","J Alzheimers Dis. 2022;88(2):743-755. doi: 10.3233/JAD-220248.","Haehner A","J Alzheimers Dis","2022","2022/06/13","","","10.3233/JAD-220248"
"11882746","H2 histamine receptor blockade in the treatment of Alzheimer disease: a randomized, double-blind, placebo-controlled trial of nizatidine","Carlson MC, Tschanz JT, Norton MC, Welsh-Bohmer K, Martin BK, Breitner JC.","Alzheimer Dis Assoc Disord. 2002 Jan-Mar;16(1):24-30. doi: 10.1097/00002093-200201000-00004.","Carlson MC","Alzheimer Dis Assoc Disord","2002","2002/03/08","","","10.1097/00002093-200201000-00004"
"9094144","Loss of high-frequency brain electrical response to thiopental administration in Alzheimer's-type dementia","Holschneider DP, Leuchter AF, Uijtdehaage SH, Abrams M, Rosenberg-Thompson S.","Neuropsychopharmacology. 1997 Apr;16(4):269-75. doi: 10.1016/S0893-133X(96)00220-5.","Holschneider DP","Neuropsychopharmacology","1997","1997/04/01","","","10.1016/S0893-133X(96)00220-5"
"29920980","Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Bapineuzumab: A Single-Ascending-Dose Study in Patients With Mild to Moderate Alzheimer Disease","Lu M, Brashear HR.","Clin Pharmacol Drug Dev. 2019 Apr;8(3):326-335. doi: 10.1002/cpdd.584. Epub 2018 Jun 19.","Lu M","Clin Pharmacol Drug Dev","2019","2018/06/20","","","10.1002/cpdd.584"
"27535304","Revising the Resistiveness to Care Scale","Jablonski-Jaudon RA, Winstead V, Jones-Townsend C, Azuero A, Mahoney E, Kolanowski AM.","J Nurs Meas. 2016;24(2):72-82. doi: 10.1891/1061-3749.24.2.E72.","Jablonski-Jaudon RA","J Nurs Meas","2016","2016/08/19","PMC5897769","NIHMS956360","10.1891/1061-3749.24.2.E72"
"18617735","Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease","Watanabe T, Shiino A, Akiguchi I.","Dement Geriatr Cogn Disord. 2008;26(1):89-100. doi: 10.1159/000144044. Epub 2008 Jul 11.","Watanabe T","Dement Geriatr Cogn Disord","2008","2008/07/12","","","10.1159/000144044"
"22796905","Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm²) in Alzheimer's disease","Cummings J, Froelich L, Black SE, Bakchine S, Bellelli G, Molinuevo JL, Kressig RW, Downs P, Caputo A, Strohmaier C.","Dement Geriatr Cogn Disord. 2012;33(5):341-53. doi: 10.1159/000340056. Epub 2012 Jul 11.","Cummings J","Dement Geriatr Cogn Disord","2012","2012/07/17","","","10.1159/000340056"
"15324524","Impact of donepezil treatment for Alzheimer's disease on caregiver time","Wimo A, Winblad B, Shah SN, Chin W, Zhang R, McRae T.","Curr Med Res Opin. 2004 Aug;20(8):1221-5. doi: 10.1185/030079902125004349.","Wimo A","Curr Med Res Opin","2004","2004/08/25","","","10.1185/030079902125004349"
"9154591","Nursing home research from investigators' perspective","Finkel SI, Lyons J.","Int Psychogeriatr. 1996;8 Suppl 3:371-3; discussion 381-2. doi: 10.1017/s1041610297003657.","Finkel SI","Int Psychogeriatr","1996","1996/01/01","","","10.1017/s1041610297003657"
"10913320","Movement-related electroencephalographic reactivity in Alzheimer disease","Babiloni C, Babiloni F, Carducci F, Cincotti F, Del Percio C, De Pino G, Maestrini S, Priori A, Tisei P, Zanetti O, Rossini PM.","Neuroimage. 2000 Aug;12(2):139-46. doi: 10.1006/nimg.2000.0602.","Babiloni C","Neuroimage","2000","2000/07/29","","","10.1006/nimg.2000.0602"
"20065132","Effects of aerobic exercise on mild cognitive impairment: a controlled trial","Baker LD, Frank LL, Foster-Schubert K, Green PS, Wilkinson CW, McTiernan A, Plymate SR, Fishel MA, Watson GS, Cholerton BA, Duncan GE, Mehta PD, Craft S.","Arch Neurol. 2010 Jan;67(1):71-9. doi: 10.1001/archneurol.2009.307.","Baker LD","Arch Neurol","2010","2010/01/13","PMC3056436","NIHMS267645","10.1001/archneurol.2009.307"
"12967058","Folic acid supplementation in dementia: a preliminary report","Sommer BR, Hoff AL, Costa M.","J Geriatr Psychiatry Neurol. 2003 Sep;16(3):156-9. doi: 10.1177/0891988703256052.","Sommer BR","J Geriatr Psychiatry Neurol","2003","2003/09/12","","","10.1177/0891988703256052"
"12640228","Kinematic analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer dementia","Hegerl U, Mergl R, Henkel V, Gallinat J, Kotter G, Müller-Siecheneder F, Pogarell O, Juckel G, Schröter A, Bahra R, Emir B, Laux G, Möller HJ.","J Clin Psychopharmacol. 2003 Apr;23(2):214-6. doi: 10.1097/00004714-200304000-00020.","Hegerl U","J Clin Psychopharmacol","2003","2003/03/18","","","10.1097/00004714-200304000-00020"
"10680787","A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study","Aisen PS, Davis KL, Berg JD, Schafer K, Campbell K, Thomas RG, Weiner MF, Farlow MR, Sano M, Grundman M, Thal LJ.","Neurology. 2000 Feb 8;54(3):588-93. doi: 10.1212/wnl.54.3.588.","Aisen PS","Neurology","2000","2000/02/19","","","10.1212/wnl.54.3.588"
"23250109","In vivo detection of cerebral cortical microinfarcts with high-resolution 7T MRI","van Veluw SJ, Zwanenburg JJ, Engelen-Lee J, Spliet WG, Hendrikse J, Luijten PR, Biessels GJ.","J Cereb Blood Flow Metab. 2013 Mar;33(3):322-9. doi: 10.1038/jcbfm.2012.196. Epub 2012 Dec 19.","van Veluw SJ","J Cereb Blood Flow Metab","2013","2012/12/20","PMC3587820","","10.1038/jcbfm.2012.196"
"17495473","Cognitive predictors of donepezil therapy response in Alzheimer disease","Saumier D, Murtha S, Bergman H, Phillips N, Whitehead V, Chertkow H.","Dement Geriatr Cogn Disord. 2007;24(1):28-35. doi: 10.1159/000102569. Epub 2007 May 10.","Saumier D","Dement Geriatr Cogn Disord","2007","2007/05/15","","","10.1159/000102569"
"24175580","Mean platelet volume and platelet distribution width in vascular dementia and Alzheimer's disease","Liang QC, Jin D, Li Y, Wang RT.","Platelets. 2014;25(6):433-8. doi: 10.3109/09537104.2013.831064. Epub 2013 Oct 8.","Liang QC","Platelets","2014","2013/11/02","","","10.3109/09537104.2013.831064"
"22805083","[Chinese herbal medicine for patients with mild to moderate Alzheimer disease based on syndrome differentiation: a randomized controlled trial]","Yu L, Lin SM, Zhou RQ, Tang WJ, Huang PX, Dong Y, Wang J, Yu ZH, Chen JL, Wei L, Xing SL, Cao HJ, Zhao HB.","Zhong Xi Yi Jie He Xue Bao. 2012 Jul;10(7):766-76. doi: 10.3736/jcim20120707.","Yu L","Zhong Xi Yi Jie He Xue Bao","2012","2012/07/19","","","10.3736/jcim20120707"
"19935404","Estimation of plasma IC50 of donepezil for cerebral acetylcholinesterase inhibition in patients with Alzheimer disease using positron emission tomography","Ota T, Shinotoh H, Fukushi K, Kikuchi T, Sato K, Tanaka N, Shimada H, Hirano S, Miyoshi M, Arai H, Suhara T, Irie T.","Clin Neuropharmacol. 2010 Mar-Apr;33(2):74-8. doi: 10.1097/WNF.0b013e3181c71be9.","Ota T","Clin Neuropharmacol","2010","2009/11/26","","","10.1097/WNF.0b013e3181c71be9"
"10762503","Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia","Walker MP, Ayre GA, Cummings JL, Wesnes K, McKeith IG, O'Brien JT, Ballard CG.","Neurology. 2000 Apr 25;54(8):1616-25. doi: 10.1212/wnl.54.8.1616.","Walker MP","Neurology","2000","2000/04/13","","","10.1212/wnl.54.8.1616"
"10705167","Differential mechanisms of impairment of remote memory in Alzheimer's and frontotemporal dementia","Thomas-Antérion C, Jacquin K, Laurent B.","Dement Geriatr Cogn Disord. 2000 Mar-Apr;11(2):100-6. doi: 10.1159/000017221.","Thomas-Antérion C","Dement Geriatr Cogn Disord","2000","2000/03/08","","","10.1159/000017221"
"22105407","Driving simulator performance in patients with possible and probable Alzheimer's disease","Stein AC, Dubinsky RM.","Ann Adv Automot Med. 2011;55:325-34.","Stein AC","Ann Adv Automot Med","2011","2011/11/23","PMC3256816","",""
"7835898","Marked changes in mitochondrial DNA deletion levels in Alzheimer brains","Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, McKee AC, Beal MF, Graham BH, Wallace DC.","Genomics. 1994 Sep 15;23(2):471-6. doi: 10.1006/geno.1994.1525.","Corral-Debrinski M","Genomics","1994","1994/09/15","","","10.1006/geno.1994.1525"
"16868793","Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment","Darreh-Shori T, Meurling L, Pettersson T, Hugosson K, Hellström-Lindahl E, Andreasen N, Minthon L, Nordberg A.","J Neural Transm (Vienna). 2006 Nov;113(11):1791-801. doi: 10.1007/s00702-006-0526-2. Epub 2006 Aug 1.","Darreh-Shori T","J Neural Transm (Vienna)","2006","2006/07/27","","","10.1007/s00702-006-0526-2"
"8983038","Different manifestations of circadian rhythms in senile dementia of Alzheimer's type and multi-infarct dementia","Mishima K, Okawa M, Satoh K, Shimizu T, Hozumi S, Hishikawa Y.","Neurobiol Aging. 1997 Jan-Feb;18(1):105-9. doi: 10.1016/s0197-4580(96)00167-4.","Mishima K","Neurobiol Aging","1997","1997/01/01","","","10.1016/s0197-4580(96)00167-4"
"33720637","Donanemab in Early Alzheimer's Disease","Mintun MA, Lo AC, Duggan Evans C, Wessels AM, Ardayfio PA, Andersen SW, Shcherbinin S, Sparks J, Sims JR, Brys M, Apostolova LG, Salloway SP, Skovronsky DM.","N Engl J Med. 2021 May 6;384(18):1691-1704. doi: 10.1056/NEJMoa2100708. Epub 2021 Mar 13.","Mintun MA","N Engl J Med","2021","2021/03/15","","","10.1056/NEJMoa2100708"
"25735442","Using ApoE Genotyping to Promote Healthy Lifestyles in Finland - Psychological Impacts: Randomized Controlled Trial","Hietaranta-Luoma HL, Luomala HT, Puolijoki H, Hopia A.","J Genet Couns. 2015 Dec;24(6):908-21. doi: 10.1007/s10897-015-9826-8. Epub 2015 Mar 5.","Hietaranta-Luoma HL","J Genet Couns","2015","2015/03/05","","","10.1007/s10897-015-9826-8"
"19307864","A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: pilot follow-up study","Arai H, Takahashi T.","Am J Geriatr Psychiatry. 2009 Apr;17(4):353-4. doi: 10.1097/JGP.0b013e31819431ea.","Arai H","Am J Geriatr Psychiatry","2009","2009/03/25","","","10.1097/JGP.0b013e31819431ea"
"24549548","Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial","Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG; CitAD Research Group.","JAMA. 2014 Feb 19;311(7):682-91. doi: 10.1001/jama.2014.93.","Porsteinsson AP","JAMA","2014","2014/02/20","PMC4086818","NIHMS582015","10.1001/jama.2014.93"
"21905098","Demonstration of safety in Alzheimer's patients for intervention with an anti-hypertensive drug Nilvadipine: results from a 6-week open label study","Kennelly SP, Abdullah L, Paris D, Parish J, Mathura V, Mullan M, Crawford F, Lawlor BA, Kenny RA.","Int J Geriatr Psychiatry. 2011 Oct;26(10):1038-45. doi: 10.1002/gps.2638. Epub 2010 Oct 29.","Kennelly SP","Int J Geriatr Psychiatry","2011","2011/09/10","","","10.1002/gps.2638"
"20375655","Safety and changes in plasma and cerebrospinal fluid amyloid beta after a single administration of an amyloid beta monoclonal antibody in subjects with Alzheimer disease","Siemers ER, Friedrich S, Dean RA, Gonzales CR, Farlow MR, Paul SM, Demattos RB.","Clin Neuropharmacol. 2010 Mar-Apr;33(2):67-73. doi: 10.1097/WNF.0b013e3181cb577a.","Siemers ER","Clin Neuropharmacol","2010","2010/04/09","","","10.1097/WNF.0b013e3181cb577a"
"22134132","Comparison of pharmacokinetics, pharmacodynamics, safety, and tolerability of the amyloid β monoclonal antibody solanezumab in Japanese and white patients with mild to moderate alzheimer disease","Uenaka K, Nakano M, Willis BA, Friedrich S, Ferguson-Sells L, Dean RA, Ieiri I, Siemers ER.","Clin Neuropharmacol. 2012 Jan-Feb;35(1):25-9. doi: 10.1097/WNF.0b013e31823a13d3.","Uenaka K","Clin Neuropharmacol","2012","2011/12/03","","","10.1097/WNF.0b013e31823a13d3"
"17876402","Lexical semantic memory in amnestic mild cognitive impairment and mild Alzheimer's disease","Balthazar ML, Martinelli JE, Cendes F, Damasceno BP.","Arq Neuropsiquiatr. 2007 Sep;65(3A):619-22. doi: 10.1590/s0004-282x2007000400014.","Balthazar ML","Arq Neuropsiquiatr","2007","2007/09/19","","","10.1590/s0004-282x2007000400014"
"12901778","The neuropsychological profiles of mild Alzheimer's disease and questionable dementia as compared to age-related cognitive decline","Vliet EC, Manly J, Tang MX, Marder K, Bell K, Stern Y.","J Int Neuropsychol Soc. 2003 Jul;9(5):720-32. doi: 10.1017/S1355617703950053.","Vliet EC","J Int Neuropsychol Soc","2003","2003/08/07","","","10.1017/S1355617703950053"
"27314365","Association between Cognitive Status and Physical Activity: Study Profile on Baseline Survey of the My Mind Project","Gagliardi C, Papa R, Postacchini D, Giuli C.","Int J Environ Res Public Health. 2016 Jun 14;13(6):585. doi: 10.3390/ijerph13060585.","Gagliardi C","Int J Environ Res Public Health","2016","2016/06/18","PMC4924042","","10.3390/ijerph13060585"
"21159050","Short-term effect of combined drug therapy and cognitive stimulation therapy on the cognitive function of Alzheimer's disease","Matsuda O, Shido E, Hashikai A, Shibuya H, Kouno M, Hara C, Saito M.","Psychogeriatrics. 2010 Dec;10(4):167-72. doi: 10.1111/j.1479-8301.2010.00335.x.","Matsuda O","Psychogeriatrics","2010","2010/12/17","","","10.1111/j.1479-8301.2010.00335.x"
"26684775","Bilateral deep brain stimulation of the fornix for Alzheimer's disease: surgical safety in the ADvance trial","Ponce FA, Asaad WF, Foote KD, Anderson WS, Rees Cosgrove G, Baltuch GH, Beasley K, Reymers DE, Oh ES, Targum SD, Smith GS, Lyketsos CG, Lozano AM; ADvance Research Group.","J Neurosurg. 2016 Jul;125(1):75-84. doi: 10.3171/2015.6.JNS15716. Epub 2015 Dec 18.","Ponce FA","J Neurosurg","2016","2015/12/20","PMC4912949","NIHMS771557","10.3171/2015.6.JNS15716"
"17016152","Sensory gating deficit assessed by P50/Pb middle latency event related potential in Alzheimer's disease","Cancelli I, Cadore IP, Merlino G, Valentinis L, Moratti U, Bergonzi P, Gigli GL, Valente M.","J Clin Neurophysiol. 2006 Oct;23(5):421-5. doi: 10.1097/01.wnp.0000218991.99714.ee.","Cancelli I","J Clin Neurophysiol","2006","2006/10/04","","","10.1097/01.wnp.0000218991.99714.ee"
"28763881","[Efficacy and tolerance of Memantine monotherapy and combination therapy with Reinhartdt And Sea Cucumber Capsule on agitation in moderate to severe Alzheimer disease]","Yu EY, Liao ZL, Tan YF, Qiu YJ, Zhu JP, Chen Y, Lin SS, Wu MH.","Zhonghua Yi Xue Za Zhi. 2017 Jul 18;97(27):2091-2094. doi: 10.3760/cma.j.issn.0376-2491.2017.27.003.","Yu EY","Zhonghua Yi Xue Za Zhi","2017","2017/08/02","","","10.3760/cma.j.issn.0376-2491.2017.27.003"
"8563782","Heat shock protein 70 mRNA levels in mononuclear blood cells from patients with dementia of the Alzheimer type","Wakutani Y, Urakami K, Shimomura T, Takahashi K.","Dementia. 1995 Nov-Dec;6(6):301-5. doi: 10.1159/000106962.","Wakutani Y","Dementia","1995","1995/11/01","","","10.1159/000106962"
"26399707","LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention","Dias HK, Brown CL, Polidori MC, Lip GY, Griffiths HR.","Clin Sci (Lond). 2015 Dec;129(12):1195-206. doi: 10.1042/CS20150351. Epub 2015 Sep 23.","Dias HK","Clin Sci (Lond)","2015","2015/09/25","PMC5055810","EMS70154","10.1042/CS20150351"
"11015815","Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group","Street JS, Clark WS, Gannon KS, Cummings JL, Bymaster FP, Tamura RN, Mitan SJ, Kadam DL, Sanger TM, Feldman PD, Tollefson GD, Breier A.","Arch Gen Psychiatry. 2000 Oct;57(10):968-76. doi: 10.1001/archpsyc.57.10.968.","Street JS","Arch Gen Psychiatry","2000","2000/10/04","","","10.1001/archpsyc.57.10.968"
"25866191","Identification of amyloid beta mid-domain fragments in human cerebrospinal fluid","Rogeberg M, Wettergreen M, Nilsson LN, Fladby T.","Biochimie. 2015 Jun;113:86-92. doi: 10.1016/j.biochi.2015.03.022. Epub 2015 Apr 10.","Rogeberg M","Biochimie","2015","2015/04/14","","","10.1016/j.biochi.2015.03.022"
"17522596","Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients","Lefèvre G, Sedek G, Jhee SS, Leibowitz MT, Huang HL, Enz A, Maton S, Ereshefsky L, Pommier F, Schmidli H, Appel-Dingemanse S.","Clin Pharmacol Ther. 2008 Jan;83(1):106-14. doi: 10.1038/sj.clpt.6100242. Epub 2007 May 23.","Lefèvre G","Clin Pharmacol Ther","2008","2007/05/25","","","10.1038/sj.clpt.6100242"
"21399485","Safety and effectiveness of donepezil on behavioral symptoms in patients with Alzheimer disease","Carrasco MM, Agüera L, Gil P, Moríñigo A, Leon T.","Alzheimer Dis Assoc Disord. 2011 Oct-Dec;25(4):333-40. doi: 10.1097/WAD.0b013e318212ab7a.","Carrasco MM","Alzheimer Dis Assoc Disord","2011","2011/03/15","","","10.1097/WAD.0b013e318212ab7a"
"16050432","Effect of morning bright light treatment for rest-activity disruption in institutionalized patients with severe Alzheimer's disease","Dowling GA, Hubbard EM, Mastick J, Luxenberg JS, Burr RL, Van Someren EJ.","Int Psychogeriatr. 2005 Jun;17(2):221-36. doi: 10.1017/s1041610205001584.","Dowling GA","Int Psychogeriatr","2005","2005/07/30","PMC2387132","NIHMS46907","10.1017/s1041610205001584"
"24971004","Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial","Wade AG, Farmer M, Harari G, Fund N, Laudon M, Nir T, Frydman-Marom A, Zisapel N.","Clin Interv Aging. 2014 Jun 18;9:947-61. doi: 10.2147/CIA.S65625. eCollection 2014.","Wade AG","Clin Interv Aging","2014","2014/06/28","PMC4069047","","10.2147/CIA.S65625"
"26643548","Relationship of regional brain β-amyloid to gait speed","Del Campo N, Payoux P, Djilali A, Delrieu J, Hoogendijk EO, Rolland Y, Cesari M, Weiner MW, Andrieu S, Vellas B; MAPT/DSA Study Group.","Neurology. 2016 Jan 5;86(1):36-43. doi: 10.1212/WNL.0000000000002235. Epub 2015 Dec 7.","Del Campo N","Neurology","2016","2015/12/09","PMC4731288","","10.1212/WNL.0000000000002235"
"9213069","Apolipoprotein-E genotyping in Alzheimer's disease and frontotemporal dementia","Gustafson L, Abrahamson M, Grubb A, Nilsson K, Fex G.","Dement Geriatr Cogn Disord. 1997 Jul-Aug;8(4):240-3. doi: 10.1159/000106637.","Gustafson L","Dement Geriatr Cogn Disord","1997","1997/07/01","","","10.1159/000106637"
"8705294","Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin","Jefferies WA, Food MR, Gabathuler R, Rothenberger S, Yamada T, Yasuhara O, McGeer PL.","Brain Res. 1996 Mar 11;712(1):122-6. doi: 10.1016/0006-8993(95)01407-1.","Jefferies WA","Brain Res","1996","1996/03/11","","","10.1016/0006-8993(95)01407-1"
"32568196","Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer's Disease Treated with Escalating Doses for up to 133 Weeks","Guthrie H, Honig LS, Lin H, Sink KM, Blondeau K, Quartino A, Dolton M, Carrasco-Triguero M, Lian Q, Bittner T, Clayton D, Smith J, Ostrowitzki S.","J Alzheimers Dis. 2020;76(3):967-979. doi: 10.3233/JAD-200134.","Guthrie H","J Alzheimers Dis","2020","2020/06/23","PMC7505005","","10.3233/JAD-200134"
"15623698","Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease","Olazarán J, Muñiz R, Reisberg B, Peña-Casanova J, del Ser T, Cruz-Jentoft AJ, Serrano P, Navarro E, García de la Rocha ML, Frank A, Galiano M, Fernández-Bullido Y, Serra JA, González-Salvador MT, Sevilla C.","Neurology. 2004 Dec 28;63(12):2348-53. doi: 10.1212/01.wnl.0000147478.03911.28.","Olazarán J","Neurology","2004","2004/12/30","","","10.1212/01.wnl.0000147478.03911.28"
"31220560","Long-term efficacy of Chinese medicine Bushen Capsule on cognition and brain activity in patients with amnestic mild cognitive impairment","Zhang J, Yang C, Wei D, Li H, Leung EL, Deng Q, Liu Z, Fan XX, Zhang Z.","Pharmacol Res. 2019 Aug;146:104319. doi: 10.1016/j.phrs.2019.104319. Epub 2019 Jun 17.","Zhang J","Pharmacol Res","2019","2019/06/21","","","10.1016/j.phrs.2019.104319"
"35797268","The effect of framing on attitudes towards Alzheimer's disease. A comparative study between younger and older adults","Cuadrado F, Antolí A, Fernández-Calvo B.","PLoS One. 2022 Jul 7;17(7):e0270959. doi: 10.1371/journal.pone.0270959. eCollection 2022.","Cuadrado F","PLoS One","2022","2022/07/07","PMC9262181","","10.1371/journal.pone.0270959"
"21739598","Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation","Lott IT, Doran E, Nguyen VQ, Tournay A, Head E, Gillen DL.","Am J Med Genet A. 2011 Aug;155A(8):1939-48. doi: 10.1002/ajmg.a.34114. Epub 2011 Jul 7.","Lott IT","Am J Med Genet A","2011","2011/07/09","PMC3410645","NIHMS392921","10.1002/ajmg.a.34114"
"18450517","Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial","Wilcock GK, Black SE, Hendrix SB, Zavitz KH, Swabb EA, Laughlin MA; Tarenflurbil Phase II Study investigators.","Lancet Neurol. 2008 Jun;7(6):483-93. doi: 10.1016/S1474-4422(08)70090-5. Epub 2008 Apr 29.","Wilcock GK","Lancet Neurol","2008","2008/05/03","","","10.1016/S1474-4422(08)70090-5"
"11403184","57Co SPECT, 99mTc-ECD SPECT, MRI and neuropsychological testing in senile dementia of the Alzheimer type","Versijpt J, Decoo D, Van Laere KJ, Achten E, Audenaert K, D'Asseler Y, Slegers G, Dierckx RA, Korf J.","Nucl Med Commun. 2001 Jun;22(6):713-9. doi: 10.1097/00006231-200106000-00016.","Versijpt J","Nucl Med Commun","2001","2001/06/14","","","10.1097/00006231-200106000-00016"
"22929437","Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia","Gejl M, Egefjord L, Lerche S, Vang K, Bibby BM, Holst JJ, Mengel A, Møller N, Rungby J, Brock B, Gjedde A.","J Cereb Blood Flow Metab. 2012 Dec;32(12):2146-52. doi: 10.1038/jcbfm.2012.118. Epub 2012 Aug 29.","Gejl M","J Cereb Blood Flow Metab","2012","2012/08/30","PMC3519409","","10.1038/jcbfm.2012.118"
"14716694","A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil","Finkel SI, Mintzer JE, Dysken M, Krishnan KR, Burt T, McRae T.","Int J Geriatr Psychiatry. 2004 Jan;19(1):9-18. doi: 10.1002/gps.998.","Finkel SI","Int J Geriatr Psychiatry","2004","2004/01/13","","","10.1002/gps.998"
"24423155","Effect of TTP488 in patients with mild to moderate Alzheimer's disease","Burstein AH, Grimes I, Galasko DR, Aisen PS, Sabbagh M, Mjalli AM.","BMC Neurol. 2014 Jan 15;14:12. doi: 10.1186/1471-2377-14-12.","Burstein AH","BMC Neurol","2014","2014/01/16","PMC4021072","","10.1186/1471-2377-14-12"
"33622392","Randomized crossover trial of a modified ketogenic diet in Alzheimer's disease","Phillips MCL, Deprez LM, Mortimer GMN, Murtagh DKJ, McCoy S, Mylchreest R, Gilbertson LJ, Clark KM, Simpson PV, McManus EJ, Oh JE, Yadavaraj S, King VM, Pillai A, Romero-Ferrando B, Brinkhuis M, Copeland BM, Samad S, Liao S, Schepel JAC.","Alzheimers Res Ther. 2021 Feb 23;13(1):51. doi: 10.1186/s13195-021-00783-x.","Phillips MCL","Alzheimers Res Ther","2021","2021/02/24","PMC7901512","","10.1186/s13195-021-00783-x"
"6347034","Oral physostigmine and lecithin improve memory in Alzheimer disease","Thal LJ, Fuld PA, Masur DM, Sharpless NS.","Ann Neurol. 1983 May;13(5):491-6. doi: 10.1002/ana.410130504.","Thal LJ","Ann Neurol","1983","1983/05/01","","","10.1002/ana.410130504"
"15917103","Color-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment","Fellgiebel A, Müller MJ, Wille P, Dellani PR, Scheurich A, Schmidt LG, Stoeter P.","Neurobiol Aging. 2005 Aug-Sep;26(8):1193-8. doi: 10.1016/j.neurobiolaging.2004.11.006. Epub 2005 Jan 12.","Fellgiebel A","Neurobiol Aging","2005","2005/05/27","","","10.1016/j.neurobiolaging.2004.11.006"
"3290312","Depot neuroleptics in the treatment of behavioral disorders in patients with Alzheimer's disease","Gottlieb GL, McAllister TW, Gur RC.","J Am Geriatr Soc. 1988 Jul;36(7):619-21. doi: 10.1111/j.1532-5415.1988.tb06157.x.","Gottlieb GL","J Am Geriatr Soc","1988","1988/07/01","","","10.1111/j.1532-5415.1988.tb06157.x"
"25300460","NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease","Lawlor B, Kennelly S, O'Dwyer S, Cregg F, Walsh C, Coen R, Kenny RA, Howard R, Murphy C, Adams J, Daly L, Segurado R, Gaynor S, Crawford F, Mullan M, Lucca U, Banzi R, Pasquier F, Breuilh L, Riepe M, Kalman J, Wallin A, Borjesson A, Molloy W, Tsolaki M, Olde Rikkert M.","BMJ Open. 2014 Oct 9;4(10):e006364. doi: 10.1136/bmjopen-2014-006364.","Lawlor B","BMJ Open","2014","2014/10/11","PMC4194801","","10.1136/bmjopen-2014-006364"
"29515131","Machine Learning-based Individual Assessment of Cortical Atrophy Pattern in Alzheimer's Disease Spectrum: Development of the Classifier and Longitudinal Evaluation","Lee JS, Kim C, Shin JH, Cho H, Shin DS, Kim N, Kim HJ, Kim Y, Lockhart SN, Na DL, Seo SW, Seong JK.","Sci Rep. 2018 Mar 7;8(1):4161. doi: 10.1038/s41598-018-22277-x.","Lee JS","Sci Rep","2018","2018/03/09","PMC5841386","","10.1038/s41598-018-22277-x"
"11843691","Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain","Locatelli S, Lütjohann D, Schmidt HH, Otto C, Beisiegel U, von Bergmann K.","Arch Neurol. 2002 Feb;59(2):213-6. doi: 10.1001/archneur.59.2.213.","Locatelli S","Arch Neurol","2002","2002/02/15","","","10.1001/archneur.59.2.213"
"15109997","Mapping distributed sources of cortical rhythms in mild Alzheimer's disease. A multicentric EEG study","Babiloni C, Binetti G, Cassetta E, Cerboneschi D, Dal Forno G, Del Percio C, Ferreri F, Ferri R, Lanuzza B, Miniussi C, Moretti DV, Nobili F, Pascual-Marqui RD, Rodriguez G, Romani GL, Salinari S, Tecchio F, Vitali P, Zanetti O, Zappasodi F, Rossini PM.","Neuroimage. 2004 May;22(1):57-67. doi: 10.1016/j.neuroimage.2003.09.028.","Babiloni C","Neuroimage","2004","2004/04/28","","","10.1016/j.neuroimage.2003.09.028"
"15535887","Psychometric performance of an assessment scale for strain in nursing care: the M-NCAS","Kleinman L, Frank L, Ciesla G, Rupnow M, Brodaty H.","Health Qual Life Outcomes. 2004 Nov 9;2:62. doi: 10.1186/1477-7525-2-62.","Kleinman L","Health Qual Life Outcomes","2004","2004/11/13","PMC535543","","10.1186/1477-7525-2-62"
"36327127","Dietary fish oil increases catalase activity in patients with probable Alzheimer's disease","Torres-Mendoza BMG, Ortiz GG, Sánchez-Romero L, Delgado-Lara DLC, García Martínez MT, Mireles-Ramírez MA, Cruz Serrano JA, Pacheco Moisés FP.","Nutr Hosp. 2022 Dec 20;39(6):1364-1368. doi: 10.20960/nh.04153.","Torres-Mendoza BMG","Nutr Hosp","2022","2022/11/03","","","10.20960/nh.04153"
"17011650","Increased frontal phase-locking of event-related theta oscillations in Alzheimer patients treated with cholinesterase inhibitors","Yener GG, Güntekin B, Oniz A, Başar E.","Int J Psychophysiol. 2007 Apr;64(1):46-52. doi: 10.1016/j.ijpsycho.2006.07.006. Epub 2006 Oct 2.","Yener GG","Int J Psychophysiol","2007","2006/10/03","","","10.1016/j.ijpsycho.2006.07.006"
"11490043","Come talk with me: improving communication between nursing assistants and nursing home residents during care routines","Burgio LD, Allen-Burge R, Roth DL, Bourgeois MS, Dijkstra K, Gerstle J, Jackson E, Bankester L.","Gerontologist. 2001 Aug;41(4):449-60. doi: 10.1093/geront/41.4.449.","Burgio LD","Gerontologist","2001","2001/08/08","","","10.1093/geront/41.4.449"
"22787053","An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of Aβ","Adolfsson O, Pihlgren M, Toni N, Varisco Y, Buccarello AL, Antoniello K, Lohmann S, Piorkowska K, Gafner V, Atwal JK, Maloney J, Chen M, Gogineni A, Weimer RM, Mortensen DL, Friesenhahn M, Ho C, Paul R, Pfeifer A, Muhs A, Watts RJ.","J Neurosci. 2012 Jul 11;32(28):9677-89. doi: 10.1523/JNEUROSCI.4742-11.2012.","Adolfsson O","J Neurosci","2012","2012/07/13","PMC6622286","","10.1523/JNEUROSCI.4742-11.2012"
"17664405","Donepezil preserves cognition and global function in patients with severe Alzheimer disease","Black SE, Doody R, Li H, McRae T, Jambor KM, Xu Y, Sun Y, Perdomo CA, Richardson S.","Neurology. 2007 Jul 31;69(5):459-69. doi: 10.1212/01.wnl.0000266627.96040.5a.","Black SE","Neurology","2007","2007/08/01","","","10.1212/01.wnl.0000266627.96040.5a"
"10629357","A 6-month, double-blind, placebo-controlled trial of eptastigmine in Alzheimer's disease","Imbimbo BP, Troetel WM, Martelli P, Lucchelli F.","Dement Geriatr Cogn Disord. 2000 Jan-Feb;11(1):17-24. doi: 10.1159/000017208.","Imbimbo BP","Dement Geriatr Cogn Disord","2000","2000/01/12","","","10.1159/000017208"
"11388367","Memory impairment in Parkinson's disease","Zakharov VV, Akhutina TV, Yakhno NN.","Neurosci Behav Physiol. 2001 Mar-Apr;31(2):157-63. doi: 10.1023/a:1005256122649.","Zakharov VV","Neurosci Behav Physiol","2001","2001/06/05","","","10.1023/a:1005256122649"
"15985573","Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment","Cherrier MM, Matsumoto AM, Amory JK, Asthana S, Bremner W, Peskind ER, Raskind MA, Craft S.","Neurology. 2005 Jun 28;64(12):2063-8. doi: 10.1212/01.WNL.0000165995.98986.F1.","Cherrier MM","Neurology","2005","2005/06/30","","","10.1212/01.WNL.0000165995.98986.F1"
"10668706","Lu 25-109, a muscarinic agonist, fails to improve cognition in Alzheimer's disease. Lu25-109 Study Group","Thal LJ, Forrest M, Loft H, Mengel H.","Neurology. 2000 Jan 25;54(2):421-6. doi: 10.1212/wnl.54.2.421.","Thal LJ","Neurology","2000","2000/02/11","","","10.1212/wnl.54.2.421"
"9562466","Complete genomic screen in late-onset familial Alzheimer's disease","Pericak-Vance MA, Bass ML, Yamaoka LH, Gaskell PC, Scott WK, Terwedow HA, Menold MM, Conneally PM, Small GW, Saunders AM, Roses AD, Haines JL.","Neurobiol Aging. 1998 Jan-Feb;19(1 Suppl):S39-42. doi: 10.1016/s0197-4580(98)00037-2.","Pericak-Vance MA","Neurobiol Aging","1998","1998/04/30","","","10.1016/s0197-4580(98)00037-2"
"30952794","INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease","Meyer PF, Tremblay-Mercier J, Leoutsakos J, Madjar C, Lafaille-Maignan MÉ, Savard M, Rosa-Neto P, Poirier J, Etienne P, Breitner J; PREVENT-AD Research Group.","Neurology. 2019 Apr 30;92(18):e2070-e2080. doi: 10.1212/WNL.0000000000007232. Epub 2019 Apr 5.","Meyer PF","Neurology","2019","2019/04/07","PMC6512884","","10.1212/WNL.0000000000007232"
"9240488","Examining the diagnostic utility of the Fuld cholinergic deficit profile on the Japanese WAIS-R","Yamashita H, Hirono N, Ikeda M, Ikejiri Y, Imamura T, Shimomura T, Mori E.","J Clin Exp Neuropsychol. 1997 Apr;19(2):300-4. doi: 10.1080/01688639708403859.","Yamashita H","J Clin Exp Neuropsychol","1997","1997/04/01","","","10.1080/01688639708403859"
"1414239","Oxiracetam in dementia: a double-blind, placebo-controlled study","Bottini G, Vallar G, Cappa S, Monza GC, Scarpini E, Baron P, Cheldi A, Scarlato G.","Acta Neurol Scand. 1992 Sep;86(3):237-41. doi: 10.1111/j.1600-0404.1992.tb05077.x.","Bottini G","Acta Neurol Scand","1992","1992/09/01","","","10.1111/j.1600-0404.1992.tb05077.x"
"28012682","Disclosing genetic risk of Alzheimer's disease to cognitively impaired patients and visit companions: Findings from the REVEAL Study","Guan Y, Roter DL, Erby LH, Wolff JL, Gitlin LN, Roberts JS, Green RC, Christensen KD.","Patient Educ Couns. 2017 May;100(5):927-935. doi: 10.1016/j.pec.2016.12.005. Epub 2016 Dec 14.","Guan Y","Patient Educ Couns","2017","2016/12/26","PMC5400683","NIHMS838562","10.1016/j.pec.2016.12.005"
"3835091","[Preliminary results of a long-term double-blind study of naftidrofuryl and a placebo in patients with moderate Alzheimer-type senile dementia]","Cucinotta D, Dall'Asta D, Benaglia F, Barbagallo M, Butturini L, Pioli G, Salomone M.","G Clin Med. 1985 Nov-Dec;66(11-12):467-76.","Cucinotta D","G Clin Med","1985","1985/11/01","","",""
"12821730","Insulin increases CSF Abeta42 levels in normal older adults","Watson GS, Peskind ER, Asthana S, Purganan K, Wait C, Chapman D, Schwartz MW, Plymate S, Craft S.","Neurology. 2003 Jun 24;60(12):1899-903. doi: 10.1212/01.wnl.0000065916.25128.25.","Watson GS","Neurology","2003","2003/06/25","","","10.1212/01.wnl.0000065916.25128.25"
"24970674","Diagnostic accuracy of the Phototest for cognitive impairment and dementia in Argentina","Russo MJ, Iturry M, Sraka MA, Bartoloni L, Carnero Pardo C, Allegri RF.","Clin Neuropsychol. 2014;28(5):826-40. doi: 10.1080/13854046.2014.928748. Epub 2014 Jun 27.","Russo MJ","Clin Neuropsychol","2014","2014/06/28","","","10.1080/13854046.2014.928748"
"9844950","A comparison of the Cohen-Mansfield agitation inventory with the CERAD behavioral rating scale for dementia in community-dwelling persons with Alzheimer's disease","Weiner MF, Koss E, Patterson M, Jin S, Teri L, Thomas R, Thal LJ, Whitehouse P.","J Psychiatr Res. 1998 Nov-Dec;32(6):347-51. doi: 10.1016/s0022-3956(98)00027-2.","Weiner MF","J Psychiatr Res","1998","1998/12/09","","","10.1016/s0022-3956(98)00027-2"
"23281111","Auditory cortical function during verbal episodic memory encoding in Alzheimer's disease","Dhanjal NS, Warren JE, Patel MC, Wise RJ.","Ann Neurol. 2013 Feb;73(2):294-302. doi: 10.1002/ana.23789. Epub 2012 Dec 31.","Dhanjal NS","Ann Neurol","2013","2013/01/03","","","10.1002/ana.23789"
"19439966","Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study","Freund-Levi Y, Hjorth E, Lindberg C, Cederholm T, Faxen-Irving G, Vedin I, Palmblad J, Wahlund LO, Schultzberg M, Basun H, Eriksdotter Jönhagen M.","Dement Geriatr Cogn Disord. 2009;27(5):481-90. doi: 10.1159/000218081. Epub 2009 May 12.","Freund-Levi Y","Dement Geriatr Cogn Disord","2009","2009/05/15","","","10.1159/000218081"
"30315403","Effect of Exercise on Drug-Related Falls Among Persons with Alzheimer's Disease: A Secondary Analysis of the FINALEX Study","Perttila NM, Öhman H, Strandberg TE, Kautiainen H, Raivio M, Laakkonen ML, Savikko N, Tilvis RS, Pitkälä KH.","Drugs Aging. 2018 Nov;35(11):1017-1023. doi: 10.1007/s40266-018-0594-7.","Perttila NM","Drugs Aging","2018","2018/10/14","","","10.1007/s40266-018-0594-7"
"15263903","Variations in estrogen receptor alpha gene and risk of dementia, and brain volumes on MRI","den Heijer T, Schuit SC, Pols HA, van Meurs JB, Hofman A, Koudstaal PJ, van Duijn CM, Uitterlinden AG, Breteler MM.","Mol Psychiatry. 2004 Dec;9(12):1129-35. doi: 10.1038/sj.mp.4001553.","den Heijer T","Mol Psychiatry","2004","2004/07/21","","","10.1038/sj.mp.4001553"
"11520478","Clinical management of agitation in the elderly with tiapride","Robert PH, Allain H.","Eur Psychiatry. 2001 Jan;16 Suppl 1:42s-47s. doi: 10.1016/s0924-9338(00)00527-7.","Robert PH","Eur Psychiatry","2001","2001/08/25","","","10.1016/s0924-9338(00)00527-7"
"16298234","Elevated levels of neural recognition molecule L1 in the cerebrospinal fluid of patients with Alzheimer disease and other dementia syndromes","Strekalova H, Buhmann C, Kleene R, Eggers C, Saffell J, Hemperly J, Weiller C, Müller-Thomsen T, Schachner M.","Neurobiol Aging. 2006 Jan;27(1):1-9. doi: 10.1016/j.neurobiolaging.2004.11.013.","Strekalova H","Neurobiol Aging","2006","2005/11/22","","","10.1016/j.neurobiolaging.2004.11.013"
"24410954","Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study","Freund Levi Y, Vedin I, Cederholm T, Basun H, Faxén Irving G, Eriksdotter M, Hjorth E, Schultzberg M, Vessby B, Wahlund LO, Salem N Jr, Palmblad J.","J Intern Med. 2014 Apr;275(4):428-36. doi: 10.1111/joim.12166. Epub 2014 Jan 11.","Freund Levi Y","J Intern Med","2014","2014/01/14","","","10.1111/joim.12166"
"15233279","A simple method for the detection of abnormal brain regions in Alzheimer's disease patients using [11C]MP4A: comparison with [123I]IMP SPECT","Ota T, Shinotoh H, Fukushi K, Nagatsuka S, Namba H, Iyo M, Aotsuka A, Tanaka N, Sato K, Shiraishi T, Tanada S, Arai H, Irie T.","Ann Nucl Med. 2004 May;18(3):187-93. doi: 10.1007/BF02984999.","Ota T","Ann Nucl Med","2004","2004/07/06","","","10.1007/BF02984999"
"10399774","Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study","Asthana S, Craft S, Baker LD, Raskind MA, Birnbaum RS, Lofgreen CP, Veith RC, Plymate SR.","Psychoneuroendocrinology. 1999 Aug;24(6):657-77. doi: 10.1016/s0306-4530(99)00020-7.","Asthana S","Psychoneuroendocrinology","1999","1999/07/10","","","10.1016/s0306-4530(99)00020-7"
"15764868","Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: a placebo-controlled study","Peskind ER, Tsuang DW, Bonner LT, Pascualy M, Riekse RG, Snowden MB, Thomas R, Raskind MA.","Alzheimer Dis Assoc Disord. 2005 Jan-Mar;19(1):23-8. doi: 10.1097/01.wad.0000155067.16313.5e.","Peskind ER","Alzheimer Dis Assoc Disord","2005","2005/03/15","","","10.1097/01.wad.0000155067.16313.5e"
"30191060","Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer's disease progression","Begcevic I, Tsolaki M, Brinc D, Brown M, Martinez-Morillo E, Lazarou I, Kozori M, Tagaraki F, Nenopoulou S, Gkioka M, Lazarou E, Lim B, Batruch I, Diamandis EP.","F1000Res. 2018 Jul 5;7:1012. doi: 10.12688/f1000research.15095.1. eCollection 2018.","Begcevic I","F1000Res","2018","2018/09/08","PMC6081984","","10.12688/f1000research.15095.1"
"18297478","Managing behavioural symptoms of dementia: effectiveness of staff education and peer support","Visser SM, McCabe MP, Hudgson C, Buchanan G, Davison TE, George K.","Aging Ment Health. 2008 Jan;12(1):47-55. doi: 10.1080/13607860701366012.","Visser SM","Aging Ment Health","2008","2008/02/26","","","10.1080/13607860701366012"
"11522934","An open-label, 24-week pilot study of the methyl donor betaine in Alzheimer disease patients","Knopman D, Patterson M.","Alzheimer Dis Assoc Disord. 2001 Jul-Sep;15(3):162-5. doi: 10.1097/00002093-200107000-00008.","Knopman D","Alzheimer Dis Assoc Disord","2001","2001/08/28","","","10.1097/00002093-200107000-00008"
"8622366","Ethics committees. Wandsworth District Research Ethics Committee","Sonneborn K, Collier J.","Lancet. 1996 Mar 23;347(9004):833-4. doi: 10.1016/s0140-6736(96)90912-5.","Sonneborn K","Lancet","1996","1996/03/23","","","10.1016/s0140-6736(96)90912-5"
"11461772","Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease","Kontush A, Mann U, Arlt S, Ujeyl A, Lührs C, Müller-Thomsen T, Beisiegel U.","Free Radic Biol Med. 2001 Aug 1;31(3):345-54. doi: 10.1016/s0891-5849(01)00595-0.","Kontush A","Free Radic Biol Med","2001","2001/07/20","","","10.1016/s0891-5849(01)00595-0"
"29914389","Item distribution and inter-rater reliability of the German version of the quality of life in Alzheimer's disease scale (QoL-AD) proxy for people with dementia living in nursing homes","Dichter MN, Wolschon EM, Schwab CGG, Meyer G, Köpke S.","BMC Geriatr. 2018 Jun 19;18(1):145. doi: 10.1186/s12877-018-0834-z.","Dichter MN","BMC Geriatr","2018","2018/06/20","PMC6006695","","10.1186/s12877-018-0834-z"
"18303192","Economic and clinical benefits of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population: a 52-week prospective study","Suh GH, Jung HY, Lee CU, Choi S; Korean Galantamine Study Group.","J Korean Med Sci. 2008 Feb;23(1):10-7. doi: 10.3346/jkms.2008.23.1.10.","Suh GH","J Korean Med Sci","2008","2008/02/28","PMC2526501","","10.3346/jkms.2008.23.1.10"
"11702050","Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling","Nagatsuka Si S, Fukushi K, Shinotoh H, Namba H, Iyo M, Tanaka N, Aotsuka A, Ota T, Tanada S, Irie T.","J Cereb Blood Flow Metab. 2001 Nov;21(11):1354-66. doi: 10.1097/00004647-200111000-00011.","Nagatsuka Si S","J Cereb Blood Flow Metab","2001","2001/11/10","","","10.1097/00004647-200111000-00011"
"34919634","A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment","Levey AI, Qiu D, Zhao L, Hu WT, Duong DM, Higginbotham L, Dammer EB, Seyfried NT, Wingo TS, Hales CM, Gámez Tansey M, Goldstein DS, Abrol A, Calhoun VD, Goldstein FC, Hajjar I, Fagan AM, Galasko D, Edland SD, Hanfelt J, Lah JJ, Weinshenker D.","Brain. 2022 Jun 30;145(6):1924-1938. doi: 10.1093/brain/awab452.","Levey AI","Brain","2022","2021/12/17","PMC9630662","","10.1093/brain/awab452"
"19433889","1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients","Masoumi A, Goldenson B, Ghirmai S, Avagyan H, Zaghi J, Abel K, Zheng X, Espinosa-Jeffrey A, Mahanian M, Liu PT, Hewison M, Mizwickie M, Cashman J, Fiala M.","J Alzheimers Dis. 2009;17(3):703-17. doi: 10.3233/JAD-2009-1080.","Masoumi A","J Alzheimers Dis","2009","2009/05/13","","","10.3233/JAD-2009-1080"
"31578055","Evaluation of the effect of aroma oil as a bath salt on cognitive function","Kouzuki M, Kitao S, Kaju T, Urakami K.","Psychogeriatrics. 2020 Mar;20(2):163-171. doi: 10.1111/psyg.12481. Epub 2019 Oct 2.","Kouzuki M","Psychogeriatrics","2020","2019/10/03","PMC7079117","","10.1111/psyg.12481"
"9718228","The clinical trial protocol of the Metrifonate in Alzheimer's Trial (MALT)","McKeith IG.","Dement Geriatr Cogn Disord. 1998;9 Suppl 2:2-7. doi: 10.1159/000051192.","McKeith IG","Dement Geriatr Cogn Disord","1998","1998/08/26","","","10.1159/000051192"
"23016924","Safety, tolerability and pharmacokinetics of the histamine H3 receptor antagonist, ABT-288, in healthy young adults and elderly volunteers","Othman AA, Haig G, Florian H, Locke C, Zhang J, Dutta S.","Br J Clin Pharmacol. 2013 May;75(5):1299-311. doi: 10.1111/j.1365-2125.2012.04472.x.","Othman AA","Br J Clin Pharmacol","2013","2012/09/29","PMC3635600","","10.1111/j.1365-2125.2012.04472.x"
"25259643","Compassion fatigue in adult daughter caregivers of a parent with dementia","Day JR, Anderson RA, Davis LL.","Issues Ment Health Nurs. 2014 Oct;35(10):796-804. doi: 10.3109/01612840.2014.917133.","Day JR","Issues Ment Health Nurs","2014","2014/09/27","PMC4683933","NIHMS743759","10.3109/01612840.2014.917133"
"36335573","Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease","Lane HY, Wang SH, Lin CH.","Psychiatry Clin Neurosci. 2023 Feb;77(2):102-109. doi: 10.1111/pcn.13504. Epub 2022 Nov 24.","Lane HY","Psychiatry Clin Neurosci","2023","2022/11/06","PMC10099492","","10.1111/pcn.13504"
"15537482","Effects of galantamine in patients with mild Alzheimer's disease","Orgogozo JM, Small GW, Hammond G, Van Baelen B, Schwalen S.","Curr Med Res Opin. 2004 Nov;20(11):1815-20. doi: 10.1185/030079904X12555.","Orgogozo JM","Curr Med Res Opin","2004","2004/11/13","","","10.1185/030079904X12555"
"30087557","Effects of creative expression therapy for older adults with mild cognitive impairment at risk of Alzheimer's disease: a randomized controlled clinical trial","Zhao J, Li H, Lin R, Wei Y, Yang A.","Clin Interv Aging. 2018 Jul 24;13:1313-1320. doi: 10.2147/CIA.S161861. eCollection 2018.","Zhao J","Clin Interv Aging","2018","2018/08/09","PMC6063252","","10.2147/CIA.S161861"
"16924032","CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias","Holsinger RM, Lee JS, Boyd A, Masters CL, Collins SJ.","Neurology. 2006 Aug 22;67(4):710-2. doi: 10.1212/01.wnl.0000229925.52203.4c.","Holsinger RM","Neurology","2006","2006/08/23","","","10.1212/01.wnl.0000229925.52203.4c"
"20554627","Replication of CLU, CR1, and PICALM associations with alzheimer disease","Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, Crook JE, Pankratz VS, Dickson DW, Graff-Radford NR, Petersen RC, Morgan K, Younkin SG.","Arch Neurol. 2010 Aug;67(8):961-4. doi: 10.1001/archneurol.2010.147. Epub 2010 Jun 14.","Carrasquillo MM","Arch Neurol","2010","2010/06/18","PMC2919638","NIHMS181833","10.1001/archneurol.2010.147"
"27568453","Anti-Dementia Drugs, Gait Performance and Mental Imagery of Gait: A Non-Randomized Open-Label Trial","Beauchet O, Barden J, Liu-Ambrose T, Chester VL, Annweiler C, Szturm T, Grenier S, Léonard G, Bherer L, Allali G; Canadian Gait Consortium.","Drugs Aging. 2016 Sep;33(9):665-73. doi: 10.1007/s40266-016-0391-0.","Beauchet O","Drugs Aging","2016","2016/08/29","","","10.1007/s40266-016-0391-0"
"19290751","Outcomes from the Resources for Enhancing Alzheimer's Caregiver Health (REACH) program for bereaved caregivers","Holland JM, Currier JM, Gallagher-Thompson D.","Psychol Aging. 2009 Mar;24(1):190-202. doi: 10.1037/a0014303.","Holland JM","Psychol Aging","2009","2009/03/18","","","10.1037/a0014303"
"10798453","Effects of individualized versus classical ""relaxation"" music on the frequency of agitation in elderly persons with Alzheimer's disease and related disorders","Gerdner LA.","Int Psychogeriatr. 2000 Mar;12(1):49-65. doi: 10.1017/s1041610200006190.","Gerdner LA","Int Psychogeriatr","2000","2000/05/08","","","10.1017/s1041610200006190"
"25024314","A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer's dementia","Haig GM, Pritchett Y, Meier A, Othman AA, Hall C, Gault LM, Lenz RA.","J Alzheimers Dis. 2014;42(3):959-71. doi: 10.3233/JAD-140291.","Haig GM","J Alzheimers Dis","2014","2014/07/16","","","10.3233/JAD-140291"
"19657549","Trospium and cognition in patients with late onset Alzheimer disease","Isik AT, Celik T, Bozoglu E, Doruk H.","J Nutr Health Aging. 2009 Oct;13(8):672-6. doi: 10.1007/s12603-009-0196-5.","Isik AT","J Nutr Health Aging","2009","2009/08/07","","","10.1007/s12603-009-0196-5"
"17132969","Relationship between the efficacy of rivastigmine and apolipoprotein E (epsilon4) in patients with mild to moderately severe Alzheimer disease","Blesa R, Aguilar M, Casanova JP, Boada M, Martínez S, Alom J, de la Hoz CH, Sancho J, Fernández O, Gil-Neciga E, Massó JF.","Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):248-54. doi: 10.1097/01.wad.0000213880.93665.c7.","Blesa R","Alzheimer Dis Assoc Disord","2006","2006/11/30","","","10.1097/01.wad.0000213880.93665.c7"
"1676507","Neuroleptic drugs in the management of behavioral symptoms of Alzheimer's disease","Tune LE, Steele C, Cooper T.","Psychiatr Clin North Am. 1991 Jun;14(2):353-73.","Tune LE","Psychiatr Clin North Am","1991","1991/06/01","","",""
"36189594","Time of Day Effects on Inhibitory Functioning: Cognitive and Neural Evidence of Sundowning in Amnestic Mild Cognitive Impairment","Rabi R, Chow R, Paracha S, Hasher L, Gardner S, Anderson ND, Alain C.","J Alzheimers Dis. 2022;90(2):869-890. doi: 10.3233/JAD-220580.","Rabi R","J Alzheimers Dis","2022","2022/10/03","","","10.3233/JAD-220580"
"9390771","Alzheimer's disease: in vivo detection of differential vulnerability of brain regions","Detoledo-Morrell L, Sullivan MP, Morrell F, Wilson RS, Bennett DA, Spencer S.","Neurobiol Aging. 1997 Sep-Oct;18(5):463-8. doi: 10.1016/s0197-4580(97)00114-0.","Detoledo-Morrell L","Neurobiol Aging","1997","1997/12/09","","","10.1016/s0197-4580(97)00114-0"
"21792587","A modified method of 3D-SSP analysis for amyloid PET imaging using [¹¹C]BF-227","Kaneta T, Okamura N, Minoshima S, Furukawa K, Tashiro M, Furumoto S, Iwata R, Fukuda H, Takahashi S, Yanai K, Kudo Y, Arai H.","Ann Nucl Med. 2011 Dec;25(10):732-9. doi: 10.1007/s12149-011-0518-7. Epub 2011 Jul 27.","Kaneta T","Ann Nucl Med","2011","2011/07/28","","","10.1007/s12149-011-0518-7"
"15110003","An automated algorithm for the computation of brain volume change from sequential MRIs using an iterative principal component analysis and its evaluation for the assessment of whole-brain atrophy rates in patients with probable Alzheimer's disease","Chen K, Reiman EM, Alexander GE, Bandy D, Renaut R, Crum WR, Fox NC, Rossor MN.","Neuroimage. 2004 May;22(1):134-43. doi: 10.1016/j.neuroimage.2004.01.002.","Chen K","Neuroimage","2004","2004/04/28","","","10.1016/j.neuroimage.2004.01.002"
"34922475","Remote activity monitoring for family caregivers of persons living with dementia: a mixed methods, randomized controlled evaluation","Gaugler JE, Zmora R, Mitchell LL, Finlay J, Rosebush CE, Nkimbeng M, Baker ZG, Albers EA, Peterson CM.","BMC Geriatr. 2021 Dec 18;21(1):715. doi: 10.1186/s12877-021-02634-8.","Gaugler JE","BMC Geriatr","2021","2021/12/19","PMC8684277","","10.1186/s12877-021-02634-8"
"11524467","High-dose estradiol improves cognition for women with AD: results of a randomized study","Asthana S, Baker LD, Craft S, Stanczyk FZ, Veith RC, Raskind MA, Plymate SR.","Neurology. 2001 Aug 28;57(4):605-12. doi: 10.1212/wnl.57.4.605.","Asthana S","Neurology","2001","2001/08/29","","","10.1212/wnl.57.4.605"
"16906456","Application of clinical trial simulation to compare proof-of-concept study designs for drugs with a slow onset of effect; an example in Alzheimer's disease","Lockwood P, Ewy W, Hermann D, Holford N.","Pharm Res. 2006 Sep;23(9):2050-9. doi: 10.1007/s11095-006-9048-8. Epub 2006 Aug 12.","Lockwood P","Pharm Res","2006","2006/08/15","","","10.1007/s11095-006-9048-8"
"17117395","A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI)","Ferris S, Schneider L, Farmer M, Kay G, Crook T.","Int J Geriatr Psychiatry. 2007 May;22(5):448-55. doi: 10.1002/gps.1711.","Ferris S","Int J Geriatr Psychiatry","2007","2006/11/23","","","10.1002/gps.1711"
"10573447","Assessment of agitation in Alzheimer's disease: the agitated behavior in dementia scale. Alzheimer's Disease Cooperative Study","Logsdon RG, Teri L, Weiner MF, Gibbons LE, Raskind M, Peskind E, Grundman M, Koss E, Thomas RG, Thal LJ.","J Am Geriatr Soc. 1999 Nov;47(11):1354-8. doi: 10.1111/j.1532-5415.1999.tb07439.x.","Logsdon RG","J Am Geriatr Soc","1999","1999/11/26","","","10.1111/j.1532-5415.1999.tb07439.x"
"28678332","Effect of different blood glucose intervention plans on elderly people with type 2 diabetes mellitus combined with dementia","Chen Y, Wang J, Wang LJ, Lin H, Huang PJ.","Eur Rev Med Pharmacol Sci. 2017 Jun;21(11):2702-2707.","Chen Y","Eur Rev Med Pharmacol Sci","2017","2017/07/06","","",""
"17334275","Category fluency as a screening test for Alzheimer disease in illiterate and literate patients","Caramelli P, Carthery-Goulart MT, Porto CS, Charchat-Fichman H, Nitrini R.","Alzheimer Dis Assoc Disord. 2007 Jan-Mar;21(1):65-7. doi: 10.1097/WAD.0b013e31802f244f.","Caramelli P","Alzheimer Dis Assoc Disord","2007","2007/03/06","","","10.1097/WAD.0b013e31802f244f"
"23902701","Risk of incident stroke in patients with Alzheimer disease or vascular dementia","Imfeld P, Bodmer M, Schuerch M, Jick SS, Meier CR.","Neurology. 2013 Sep 3;81(10):910-9. doi: 10.1212/WNL.0b013e3182a35151. Epub 2013 Jul 31.","Imfeld P","Neurology","2013","2013/08/02","","","10.1212/WNL.0b013e3182a35151"
"15277611","The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease","Holmes C, Wilkinson D, Dean C, Vethanayagam S, Olivieri S, Langley A, Pandita-Gunawardena ND, Hogg F, Clare C, Damms J.","Neurology. 2004 Jul 27;63(2):214-9. doi: 10.1212/01.wnl.0000129990.32253.7b.","Holmes C","Neurology","2004","2004/07/28","","","10.1212/01.wnl.0000129990.32253.7b"
"9678314","Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study","Slooter AJ, Cruts M, Kalmijn S, Hofman A, Breteler MM, Van Broeckhoven C, van Duijn CM.","Arch Neurol. 1998 Jul;55(7):964-8. doi: 10.1001/archneur.55.7.964.","Slooter AJ","Arch Neurol","1998","1998/07/25","","","10.1001/archneur.55.7.964"
"35049127","Is more always better? Dose effect in a multidomain intervention in older adults at risk of dementia","Belleville S, Cloutier S, Mellah S, Willis S, Vellas B, Andrieu S, Coley N, Ngandu T; MAPT/DSA group.","Alzheimers Dement. 2022 Nov;18(11):2140-2150. doi: 10.1002/alz.12544. Epub 2022 Jan 20.","Belleville S","Alzheimers Dement","2022","2022/01/20","PMC9786573","","10.1002/alz.12544"
"34687634","Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial","Kehoe PG, Turner N, Howden B, Jarutyte L, Clegg SL, Malone IB, Barnes J, Nielsen C, Sudre CH, Wilson A, Thai NJ, Blair PS, Coulthard E, Lane JA, Passmore P, Taylor J, Mutsaerts HJ, Thomas DL, Fox NC, Wilkinson I, Ben-Shlomo Y; RADAR investigators.","Lancet Neurol. 2021 Nov;20(11):895-906. doi: 10.1016/S1474-4422(21)00263-5.","Kehoe PG","Lancet Neurol","2021","2021/10/23","PMC8528717","","10.1016/S1474-4422(21)00263-5"
"8968446","Efficacy and safety of BMY 21,502 in Alzheimer disease","Shrotriya RC, Cutler NR, Sramek JJ, Veroff AE, Hironaka DY.","Ann Pharmacother. 1996 Dec;30(12):1376-80. doi: 10.1177/106002809603001202.","Shrotriya RC","Ann Pharmacother","1996","1996/12/01","","","10.1177/106002809603001202"
"8727171","A treatment and withdrawal trial of besipirdine in Alzheimer disease","Huff FJ, Antuono PG, Delagandara JE, McDonald MA, Cutler NR, Cohen SR, Green RC, Zemlan FP, Crismon ML, Alter M, Shipley JE, Reichman WE.","Alzheimer Dis Assoc Disord. 1996 Summer;10(2):93-102. doi: 10.1097/00002093-199601020-00007.","Huff FJ","Alzheimer Dis Assoc Disord","1996","1996/01/01","","","10.1097/00002093-199601020-00007"
"15908748","Association between cognitive impairment and gait disturbance in patients with idiopathic normal pressure hydrocephalus","Miyoshi N, Kazui H, Ogino A, Ishikawa M, Miyake H, Tokunaga H, Ikejiri Y, Takeda M.","Dement Geriatr Cogn Disord. 2005;20(2-3):71-6. doi: 10.1159/000085858. Epub 2005 May 20.","Miyoshi N","Dement Geriatr Cogn Disord","2005","2005/05/24","","","10.1159/000085858"
"15297089","Visual contrast enhances food and liquid intake in advanced Alzheimer's disease","Dunne TE, Neargarder SA, Cipolloni PB, Cronin-Golomb A.","Clin Nutr. 2004 Aug;23(4):533-8. doi: 10.1016/j.clnu.2003.09.015.","Dunne TE","Clin Nutr","2004","2004/08/07","","","10.1016/j.clnu.2003.09.015"
"19300399","Combination of voxel based morphometry and diffusion tensor imaging in patients with Alzheimer's disease","Ibrahim I, Horacek J, Bartos A, Hajek M, Ripova D, Brunovsky M, Tintera J.","Neuro Endocrinol Lett. 2009 Mar;30(1):39-45.","Ibrahim I","Neuro Endocrinol Lett","2009","2009/03/21","","",""
"12164722","Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231","Buerger K, Zinkowski R, Teipel SJ, Tapiola T, Arai H, Blennow K, Andreasen N, Hofmann-Kiefer K, DeBernardis J, Kerkman D, McCulloch C, Kohnken R, Padberg F, Pirttilä T, Schapiro MB, Rapoport SI, Möller HJ, Davies P, Hampel H.","Arch Neurol. 2002 Aug;59(8):1267-72. doi: 10.1001/archneur.59.8.1267.","Buerger K","Arch Neurol","2002","2002/08/08","","","10.1001/archneur.59.8.1267"
"9154589","Behavioral symptoms in dementia: community-based research","Auer SR, Monteiro IM, Reisberg B.","Int Psychogeriatr. 1996;8 Suppl 3:363-6; discussion 381-2. doi: 10.1017/s1041610297003633.","Auer SR","Int Psychogeriatr","1996","1996/01/01","","","10.1017/s1041610297003633"
"2189430","Hydergine treatment and psychophysiological measures in primary degenerative dementia","Kuskowski MA, Morley G, Malone SM, Dysken MW, Okaya A.","J Geriatr Psychiatry Neurol. 1990 Jan-Mar;3(1):41-7. doi: 10.1177/089198879000300109.","Kuskowski MA","J Geriatr Psychiatry Neurol","1990","1990/01/01","","","10.1177/089198879000300109"
"23911756","Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study","Yasar S, Xia J, Yao W, Furberg CD, Xue QL, Mercado CI, Fitzpatrick AL, Fried LP, Kawas CH, Sink KM, Williamson JD, DeKosky ST, Carlson MC; Ginkgo Evaluation of Memory (GEM) Study Investigators.","Neurology. 2013 Sep 3;81(10):896-903. doi: 10.1212/WNL.0b013e3182a35228. Epub 2013 Aug 2.","Yasar S","Neurology","2013","2013/08/06","PMC3885216","","10.1212/WNL.0b013e3182a35228"
"17082468","A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease","Aisen PS, Saumier D, Briand R, Laurin J, Gervais F, Tremblay P, Garceau D.","Neurology. 2006 Nov 28;67(10):1757-63. doi: 10.1212/01.wnl.0000244346.08950.64. Epub 2006 Nov 2.","Aisen PS","Neurology","2006","2006/11/04","","","10.1212/01.wnl.0000244346.08950.64"
"20872778","SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study","Maher-Edwards G, Dixon R, Hunter J, Gold M, Hopton G, Jacobs G, Hunter J, Williams P.","Int J Geriatr Psychiatry. 2011 May;26(5):536-44. doi: 10.1002/gps.2562. Epub 2010 Sep 24.","Maher-Edwards G","Int J Geriatr Psychiatry","2011","2010/09/28","","","10.1002/gps.2562"
"15118486","Alzheimer patients treated with an AchE inhibitor show higher IL-4 and lower IL-1 beta levels and expression in peripheral blood mononuclear cells","Gambi F, Reale M, Iarlori C, Salone A, Toma L, Paladini C, De Luca G, Feliciani C, Salvatore M, Salerno RM, Theoharides TC, Conti P, Exton M, Gambi D.","J Clin Psychopharmacol. 2004 Jun;24(3):314-21. doi: 10.1097/01.jcp.0000125683.74595.2f.","Gambi F","J Clin Psychopharmacol","2004","2004/05/01","","","10.1097/01.jcp.0000125683.74595.2f"
"20452365","Music as a memory enhancer in patients with Alzheimer's disease","Simmons-Stern NR, Budson AE, Ally BA.","Neuropsychologia. 2010 Aug;48(10):3164-7. doi: 10.1016/j.neuropsychologia.2010.04.033. Epub 2010 May 7.","Simmons-Stern NR","Neuropsychologia","2010","2010/05/11","PMC2914108","NIHMS204792","10.1016/j.neuropsychologia.2010.04.033"
"15768051","ACAT1 is not associated with Alzheimer's disease in two independent family-based samples","Bertram L, Hsiao M, Mullin K, Parkinson M, Menon R, Moscarillo TJ, Blacker D, Tanzi RE.","Mol Psychiatry. 2005 Jun;10(6):522-4. doi: 10.1038/sj.mp.4001646.","Bertram L","Mol Psychiatry","2005","2005/03/16","","","10.1038/sj.mp.4001646"
"16166413","Caregiver assessment of patients' depression in Alzheimer disease: longitudinal analysis in a drug treatment study","Rosenberg PB, Mielke MM, Lyketsos CG.","Am J Geriatr Psychiatry. 2005 Sep;13(9):822-6. doi: 10.1176/appi.ajgp.13.9.822.","Rosenberg PB","Am J Geriatr Psychiatry","2005","2005/09/17","","","10.1176/appi.ajgp.13.9.822"
"16477587","An open-label study of escitalopram (Lexapro) for the treatment of 'Depression of Alzheimer's disease' (dAD)","Rao V, Spiro JR, Rosenberg PB, Lee HB, Rosenblatt A, Lyketsos CG.","Int J Geriatr Psychiatry. 2006 Mar;21(3):273-4. doi: 10.1002/gps.1459.","Rao V","Int J Geriatr Psychiatry","2006","2006/02/16","","","10.1002/gps.1459"
"21350422","[Neuromidin in mixed vascular and Alzheimer's dementia]","Damulin IV, Stepkina DA, Lokshina AB.","Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(2):40-3.","Damulin IV","Zh Nevrol Psikhiatr Im S S Korsakova","2011","2011/02/26","","",""
"8614273","Safety/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's disease","Sramek JJ, Anand R, Wardle TS, Irwin P, Hartman RD, Cutler NR.","Life Sci. 1996;58(15):1201-7. doi: 10.1016/0024-3205(96)00081-1.","Sramek JJ","Life Sci","1996","1996/01/01","","","10.1016/0024-3205(96)00081-1"
"16952488","A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease","Bauer M, Langer O, Dal-Bianco P, Karch R, Brunner M, Abrahim A, Lanzenberger R, Hofmann A, Joukhadar C, Carminati P, Ghirardi O, Piovesan P, Forloni G, Corrado ME, Lods N, Dudczak R, Auff E, Kletter K, Müller M.","Clin Pharmacol Ther. 2006 Sep;80(3):216-27. doi: 10.1016/j.clpt.2006.05.007.","Bauer M","Clin Pharmacol Ther","2006","2006/09/06","","","10.1016/j.clpt.2006.05.007"
"17942819","Intranasal insulin improves cognition and modulates beta-amyloid in early AD","Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B, Fishel MA, Plymate SR, Breitner JC, DeGroodt W, Mehta P, Craft S.","Neurology. 2008 Feb 5;70(6):440-8. doi: 10.1212/01.WNL.0000265401.62434.36. Epub 2007 Oct 17.","Reger MA","Neurology","2008","2007/10/19","","","10.1212/01.WNL.0000265401.62434.36"
"19929127","Integrative cognitive-behavioral and spiritual counseling for rural dementia caregivers with depression","Glueckauf RL, Davis WS, Allen K, Chipi P, Schettini G, Tegen L, Jian X, Gustafson DJ, Maze J, Mosser B, Prescott S, Robinson F, Short C, Tickel S, VanMatre J, DiGeronimo T, Ramirez C.","Rehabil Psychol. 2009 Nov;54(4):449-61. doi: 10.1037/a0017855.","Glueckauf RL","Rehabil Psychol","2009","2009/11/26","","","10.1037/a0017855"
"23656989","Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease","Serrano-Pozo A, Muzikansky A, Gómez-Isla T, Growdon JH, Betensky RA, Frosch MP, Hyman BT.","J Neuropathol Exp Neurol. 2013 Jun;72(6):462-71. doi: 10.1097/NEN.0b013e3182933788.","Serrano-Pozo A","J Neuropathol Exp Neurol","2013","2013/05/10","PMC3661683","NIHMS470960","10.1097/NEN.0b013e3182933788"
"35129210","Public opinion regarding U.S. Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative survey","DiStefano MJ, Alexander GC, Polsky D, Anderson GF.","J Am Geriatr Soc. 2022 Jun;70(6):1685-1694. doi: 10.1111/jgs.17692. Epub 2022 Feb 7.","DiStefano MJ","J Am Geriatr Soc","2022","2022/02/07","PMC9177789","NIHMS1800203","10.1111/jgs.17692"
"3729666","Naloxone and Alzheimer's disease. Cognitive and behavioral effects of a range of doses","Tariot PN, Sunderland T, Weingartner H, Murphy DL, Cohen MR, Cohen RM.","Arch Gen Psychiatry. 1986 Aug;43(8):727-32. doi: 10.1001/archpsyc.1986.01800080013002.","Tariot PN","Arch Gen Psychiatry","1986","1986/08/01","","","10.1001/archpsyc.1986.01800080013002"
"10921134","Treatment of 50 cases of senile dementia by acupuncture combined with inhalation of herbal drugs and oxygen","Geng J.","J Tradit Chin Med. 1999 Dec;19(4):287-9.","Geng J","J Tradit Chin Med","1999","2000/08/02","","",""
"24828079","An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice","Sheline YI, West T, Yarasheski K, Swarm R, Jasielec MS, Fisher JR, Ficker WD, Yan P, Xiong C, Frederiksen C, Grzelak MV, Chott R, Bateman RJ, Morris JC, Mintun MA, Lee JM, Cirrito JR.","Sci Transl Med. 2014 May 14;6(236):236re4. doi: 10.1126/scitranslmed.3008169.","Sheline YI","Sci Transl Med","2014","2014/05/16","PMC4269372","NIHMS648666","10.1126/scitranslmed.3008169"
"17992269","Molecule of the Month. Dimebolin hydrochloride","","Drug News Perspect. 2007 Sep;20(7):467.","","Drug News Perspect","2007","2007/11/10","","",""
"23369983","Cognitive rehabilitation changes memory-related brain activity in people with Alzheimer disease","van Paasschen J, Clare L, Yuen KS, Woods RT, Evans SJ, Parkinson CH, Rugg MD, Linden DE.","Neurorehabil Neural Repair. 2013 Jun;27(5):448-59. doi: 10.1177/1545968312471902. Epub 2013 Jan 31.","van Paasschen J","Neurorehabil Neural Repair","2013","2013/02/02","","","10.1177/1545968312471902"
"30046032","Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound","Lipsman N, Meng Y, Bethune AJ, Huang Y, Lam B, Masellis M, Herrmann N, Heyn C, Aubert I, Boutet A, Smith GS, Hynynen K, Black SE.","Nat Commun. 2018 Jul 25;9(1):2336. doi: 10.1038/s41467-018-04529-6.","Lipsman N","Nat Commun","2018","2018/07/27","PMC6060168","","10.1038/s41467-018-04529-6"
"21538537","Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group study","De Deyn PP, Eriksson H, Svensson H; Study 115 investigators.","Int J Geriatr Psychiatry. 2012 Mar;27(3):296-304. doi: 10.1002/gps.2720. Epub 2011 Apr 27.","De Deyn PP","Int J Geriatr Psychiatry","2012","2011/05/04","","","10.1002/gps.2720"
"9240484","Cognitive changes in very old persons with dementia: the influence of demographic, psychometric, and biological variables","Small BJ, Viitanen M, Winblad B, Bäckman L.","J Clin Exp Neuropsychol. 1997 Apr;19(2):245-60. doi: 10.1080/01688639708403855.","Small BJ","J Clin Exp Neuropsychol","1997","1997/04/01","","","10.1080/01688639708403855"
"22264496","Interview for Deterioration in Daily Living Activities in Dementia: construct and concurrent validity in patients with mild to moderate dementia","Voigt-Radloff S, Leonhart R, Schützwohl M, Jurjanz L, Reuster T, Gerner A, Marschner K, van Nes F, Graff M, Vernooij-Dassen M, Rikkert MO, Holthoff V, Hüll M.","Int Psychogeriatr. 2012 Mar;24(3):382-90. doi: 10.1017/S1041610211001785.","Voigt-Radloff S","Int Psychogeriatr","2012","2012/01/24","","","10.1017/S1041610211001785"
"7566524","Peripheral serotonin in Alzheimer's disease","Kumar AM, Sevush S, Kumar M, Ruiz J, Eisdorfer C.","Neuropsychobiology. 1995;32(1):9-12. doi: 10.1159/000119205.","Kumar AM","Neuropsychobiology","1995","1995/01/01","","","10.1159/000119205"
"23694947","Ventricular enlargement and its clinical correlates in the imaging cohort from the ADCS MCI donepezil/vitamin E study","Apostolova LG, Babakchanian S, Hwang KS, Green AE, Zlatev D, Chou YY, DeCarli C, Jack CR Jr, Petersen RC, Aisen PS, Cummings JL, Toga AW, Thompson PM.","Alzheimer Dis Assoc Disord. 2013 Apr-Jun;27(2):174-81. doi: 10.1097/WAD.0b013e3182677b3d.","Apostolova LG","Alzheimer Dis Assoc Disord","2013","2013/05/23","PMC3662002","NIHMS397817","10.1097/WAD.0b013e3182677b3d"
"8960716","A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group","Thal LJ, Schwartz G, Sano M, Weiner M, Knopman D, Harrell L, Bodenheimer S, Rossor M, Philpot M, Schor J, Goldberg A.","Neurology. 1996 Dec;47(6):1389-95. doi: 10.1212/wnl.47.6.1389.","Thal LJ","Neurology","1996","1996/12/01","","","10.1212/wnl.47.6.1389"
"15450048","Improvement of weight and fat-free mass with oral nutritional supplementation in patients with Alzheimer's disease at risk of malnutrition: a prospective randomized study","Lauque S, Arnaud-Battandier F, Gillette S, Plaze JM, Andrieu S, Cantet C, Vellas B.","J Am Geriatr Soc. 2004 Oct;52(10):1702-7. doi: 10.1111/j.1532-5415.2004.52464.x.","Lauque S","J Am Geriatr Soc","2004","2004/09/29","","","10.1111/j.1532-5415.2004.52464.x"
"36972279","Semantic-based memory-encoding strategy and cognitive stimulation in enhancing cognitive function and daily task performance for older adults with mild cognitive impairment: A pilot non-randomised cluster controlled trial","Mraz H, Tong CY, Liu KPY.","PLoS One. 2023 Mar 27;18(3):e0283449. doi: 10.1371/journal.pone.0283449. eCollection 2023.","Mraz H","PLoS One","2023","2023/03/27","PMC10042350","","10.1371/journal.pone.0283449"
"16327351","Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot study","Ancoli-Israel S, Amatniek J, Ascher S, Sadik K, Ramaswamy K.","Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):240-5. doi: 10.1097/01.wad.0000189052.48688.36.","Ancoli-Israel S","Alzheimer Dis Assoc Disord","2005","2005/12/06","","","10.1097/01.wad.0000189052.48688.36"
"12783912","Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial","Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thal LJ; Alzheimer's Disease Cooperative Study.","JAMA. 2003 Jun 4;289(21):2819-26. doi: 10.1001/jama.289.21.2819.","Aisen PS","JAMA","2003","2003/06/05","","","10.1001/jama.289.21.2819"
"31659197","Proteins and microRNAs are differentially expressed in tear fluid from patients with Alzheimer's disease","Kenny A, Jiménez-Mateos EM, Zea-Sevilla MA, Rábano A, Gili-Manzanaro P, Prehn JHM, Henshall DC, Ávila J, Engel T, Hernández F.","Sci Rep. 2019 Oct 28;9(1):15437. doi: 10.1038/s41598-019-51837-y.","Kenny A","Sci Rep","2019","2019/10/30","PMC6817868","","10.1038/s41598-019-51837-y"
"21335973","A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease","Burns A, Perry E, Holmes C, Francis P, Morris J, Howes MJ, Chazot P, Lees G, Ballard C.","Dement Geriatr Cogn Disord. 2011;31(2):158-64. doi: 10.1159/000324438. Epub 2011 Feb 19.","Burns A","Dement Geriatr Cogn Disord","2011","2011/02/22","","","10.1159/000324438"
"17969889","[Clinical study on effect of Shenyin Oral Liquid in treating mild cognitive impairment]","Zhou RQ, Lin SM, Yuan Q.","Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007 Sep;27(9):793-5.","Zhou RQ","Zhongguo Zhong Xi Yi Jie He Za Zhi","2007","2007/11/01","","",""
"23334069","Safety and pharmacology of ponezumab (PF-04360365) after a single 10-minute intravenous infusion in subjects with mild to moderate Alzheimer disease","Burstein AH, Zhao Q, Ross J, Styren S, Landen JW, Ma WW, McCush F, Alvey C, Kupiec JW, Bednar MM.","Clin Neuropharmacol. 2013 Jan-Feb;36(1):8-13. doi: 10.1097/WNF.0b013e318279bcfa.","Burstein AH","Clin Neuropharmacol","2013","2013/01/22","","","10.1097/WNF.0b013e318279bcfa"
"21795660","A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease","Sano M, Bell KL, Galasko D, Galvin JE, Thomas RG, van Dyck CH, Aisen PS.","Neurology. 2011 Aug 9;77(6):556-63. doi: 10.1212/WNL.0b013e318228bf11. Epub 2011 Jul 27.","Sano M","Neurology","2011","2011/07/29","PMC3149154","","10.1212/WNL.0b013e318228bf11"
"12707064","Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease","Vega GL, Weiner MF, Lipton AM, Von Bergmann K, Lutjohann D, Moore C, Svetlik D.","Arch Neurol. 2003 Apr;60(4):510-5. doi: 10.1001/archneur.60.4.510.","Vega GL","Arch Neurol","2003","2003/04/23","","","10.1001/archneur.60.4.510"
"18705678","Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study","Wroolie TE, Kenna HA, Williams KE, Powers BN, Holcomb M, Lazzeroni L, Rasgon NL.","Acta Neurol Scand. 2009 Mar;119(3):172-9. doi: 10.1111/j.1600-0404.2008.01084.x. Epub 2008 Aug 14.","Wroolie TE","Acta Neurol Scand","2009","2008/08/19","","","10.1111/j.1600-0404.2008.01084.x"
"9298632","Excitatory pattern of gamma-interferon on natural killer cell activity in senile dementia of the Alzheimer type","Solerte SB, Fioravanti M, Severgnini S, Pezza N, Locatelli M, Cerutti N, Terenzi F, Ferrari E.","Dement Geriatr Cogn Disord. 1997 Sep-Oct;8(5):308-13. doi: 10.1159/000106648.","Solerte SB","Dement Geriatr Cogn Disord","1997","1997/09/23","","","10.1159/000106648"
"16149765","[Preliminary assessment of ginkgo biloba (Ginkofar) in patients with dementia]","Bidzan L, Biliekiewicz A, Turczyński J.","Psychiatr Pol. 2005 May-Jun;39(3):559-66.","Bidzan L","Psychiatr Pol","2005","2005/09/10","","",""
"20447562","Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent--a pilot study","Lin KJ, Hsu WC, Hsiao IT, Wey SP, Jin LW, Skovronsky D, Wai YY, Chang HP, Lo CW, Yao CH, Yen TC, Kung MP.","Nucl Med Biol. 2010 May;37(4):497-508. doi: 10.1016/j.nucmedbio.2010.02.003. Epub 2010 Apr 7.","Lin KJ","Nucl Med Biol","2010","2010/05/08","","","10.1016/j.nucmedbio.2010.02.003"
"15959843","Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer's disease: comparison of a semiquantitative and a visual evaluation","Staffen W, Schönauer U, Zauner H, Spindler I, Mair A, Iglseder B, Bernroider G, Ladurner G.","J Neural Transm (Vienna). 2006 Feb;113(2):195-203. doi: 10.1007/s00702-005-0321-5. Epub 2005 Jun 15.","Staffen W","J Neural Transm (Vienna)","2006","2005/06/17","","","10.1007/s00702-005-0321-5"
"31492718","Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial","Schneider LS, Geffen Y, Rabinowitz J, Thomas RG, Schmidt R, Ropele S, Weinstock M; Ladostigil Study Group.","Neurology. 2019 Oct 8;93(15):e1474-e1484. doi: 10.1212/WNL.0000000000008239. Epub 2019 Sep 6.","Schneider LS","Neurology","2019","2019/09/08","PMC7010322","","10.1212/WNL.0000000000008239"
"12604748","The Cleveland Alzheimer's managed care demonstration: outcomes after 12 months of implementation","Bass DM, Clark PA, Looman WJ, McCarthy CA, Eckert S.","Gerontologist. 2003 Feb;43(1):73-85. doi: 10.1093/geront/43.1.73.","Bass DM","Gerontologist","2003","2003/02/27","","","10.1093/geront/43.1.73"
"25789616","First administration of the Fc-attenuated anti-β amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study","Andreasen N, Simeoni M, Ostlund H, Lisjo PI, Fladby T, Loercher AE, Byrne GJ, Murray F, Scott-Stevens PT, Wallin A, Zhang YY, Bronge LH, Zetterberg H, Nordberg AK, Yeo AJ, Khan SA, Hilpert J, Mistry PC.","PLoS One. 2015 Mar 19;10(3):e0098153. doi: 10.1371/journal.pone.0098153. eCollection 2015.","Andreasen N","PLoS One","2015","2015/03/20","PMC4366075","","10.1371/journal.pone.0098153"
"21266141","[Efficacy of cognitive training programs based on new software technologies in patients with Alzheimer-type dementia]","Fernández-Calvo B, Rodríguez-Pérez R, Contador I, Rubio-Santorum A, Ramos F.","Psicothema. 2011 Feb;23(1):44-50.","Fernández-Calvo B","Psicothema","2011","2011/01/27","","",""
"7020434","Double-blind trial of 2-dimethylaminoethanol in Alzheimer's disease","Fisman M, Mersky H, Helmes E.","Am J Psychiatry. 1981 Jul;138(7):970-2. doi: 10.1176/ajp.138.7.970.","Fisman M","Am J Psychiatry","1981","1981/07/01","","","10.1176/ajp.138.7.970"
"17974864","Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses","Mintzer JE, Tune LE, Breder CD, Swanink R, Marcus RN, McQuade RD, Forbes A.","Am J Geriatr Psychiatry. 2007 Nov;15(11):918-31. doi: 10.1097/JGP.0b013e3181557b47.","Mintzer JE","Am J Geriatr Psychiatry","2007","2007/11/03","","","10.1097/JGP.0b013e3181557b47"
"19735591","Antidepressant use in Alzheimer's disease patients: results of the REAL.FR cohort","Arbus C, Gardette V, Bui E, Cantet C, Andrieu S, Nourhashémi F, Schmitt L, Vellas B; REAL.FR Group.","Int Psychogeriatr. 2010 Feb;22(1):120-8. doi: 10.1017/S1041610209990780. Epub 2009 Sep 7.","Arbus C","Int Psychogeriatr","2010","2009/09/09","","","10.1017/S1041610209990780"
"8675160","The caffeine breath test does not identify patients susceptible to tacrine hepatotoxicity","Fontana RJ, Turgeon DK, Woolf TF, Knapp MJ, Foster NL, Watkins PB.","Hepatology. 1996 Jun;23(6):1429-35. doi: 10.1002/hep.510230619.","Fontana RJ","Hepatology","1996","1996/06/01","","","10.1002/hep.510230619"
"11893836","Characteristics of two telephone screens for cognitive impairment","Järvenpää T, Rinne JO, Räihä I, Koskenvuo M, Löppönen M, Hinkka S, Kaprio J.","Dement Geriatr Cogn Disord. 2002;13(3):149-55. doi: 10.1159/000048646.","Järvenpää T","Dement Geriatr Cogn Disord","2002","2002/03/15","","","10.1159/000048646"
"31088188","Blood Pressure Lowering With Nilvadipine in Patients With Mild-to-Moderate Alzheimer Disease Does Not Increase the Prevalence of Orthostatic Hypotension","de Heus RAA, Donders R, Santoso AMM, Olde Rikkert MGM, Lawlor BA, Claassen JAHR; Nilvad Study Group.","J Am Heart Assoc. 2019 May 21;8(10):e011938. doi: 10.1161/JAHA.119.011938.","de Heus RAA","J Am Heart Assoc","2019","2019/05/16","PMC6585342","","10.1161/JAHA.119.011938"
"9547167","Paired helical filament morphology varies with intracellular location in Alzheimer's disease brain","Kurt MA, Davies DC, Kidd M.","Neurosci Lett. 1997 Dec 12;239(1):41-4. doi: 10.1016/s0304-3940(97)00876-8.","Kurt MA","Neurosci Lett","1997","1998/04/18","","","10.1016/s0304-3940(97)00876-8"
"12938815","Sleep-related outcomes in persons with mild to moderate Alzheimer disease in a placebo-controlled trial of galantamine","Markowitz JS, Gutterman EM, Lilienfeld S, Papadopoulos G.","Sleep. 2003 Aug 1;26(5):602-6. doi: 10.1093/sleep/26.5.602.","Markowitz JS","Sleep","2003","2003/08/27","","","10.1093/sleep/26.5.602"
"25967983","A web-based psychoeducational program for informal caregivers of patients with Alzheimer's disease: a pilot randomized controlled trial","Cristancho-Lacroix V, Wrobel J, Cantegreil-Kallen I, Dub T, Rouquette A, Rigaud AS.","J Med Internet Res. 2015 May 12;17(5):e117. doi: 10.2196/jmir.3717.","Cristancho-Lacroix V","J Med Internet Res","2015","2015/05/14","PMC4468784","","10.2196/jmir.3717"
"23361395","Multivariate spatial covariance analysis of 99mTc-exametazime SPECT images in dementia with Lewy bodies and Alzheimer's disease: utility in differential diagnosis","Colloby SJ, Taylor JP, Davison CM, Lloyd JJ, Firbank MJ, McKeith IG, O'Brien JT.","J Cereb Blood Flow Metab. 2013 Apr;33(4):612-8. doi: 10.1038/jcbfm.2013.2. Epub 2013 Jan 30.","Colloby SJ","J Cereb Blood Flow Metab","2013","2013/01/31","PMC3618400","","10.1038/jcbfm.2013.2"
"15037057","Effects of Alzheimer disease on memory for verbal emotional information","Kensinger EA, Anderson A, Growdon JH, Corkin S.","Neuropsychologia. 2004;42(6):791-800. doi: 10.1016/j.neuropsychologia.2003.11.011.","Kensinger EA","Neuropsychologia","2004","2004/03/24","","","10.1016/j.neuropsychologia.2003.11.011"
"12633121","A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia","Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, Lee E, Lyons B, Grossman F.","J Clin Psychiatry. 2003 Feb;64(2):134-43. doi: 10.4088/jcp.v64n0205.","Brodaty H","J Clin Psychiatry","2003","2003/03/14","","","10.4088/jcp.v64n0205"
"14718699","Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study","Reines SA, Block GA, Morris JC, Liu G, Nessly ML, Lines CR, Norman BA, Baranak CC; Rofecoxib Protocol 091 Study Group.","Neurology. 2004 Jan 13;62(1):66-71. doi: 10.1212/wnl.62.1.66.","Reines SA","Neurology","2004","2004/01/14","","","10.1212/wnl.62.1.66"
"15677866","Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period","López-Pousa S, Turon-Estrada A, Garre-Olmo J, Pericot-Nierga I, Lozano-Gallego M, Vilalta-Franch M, Hernández-Ferràndiz M, Morante-Muñoz V, Isern-Vila A, Gelada-Batlle E, Majó-Llopart J.","Dement Geriatr Cogn Disord. 2005;19(4):189-95. doi: 10.1159/000083498. Epub 2005 Jan 25.","López-Pousa S","Dement Geriatr Cogn Disord","2005","2005/01/29","","","10.1159/000083498"
"20500802","Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin","Alvarez XA, Cacabelos R, Sampedro C, Aleixandre M, Linares C, Granizo E, Doppler E, Moessler H.","Eur J Neurol. 2011 Jan;18(1):59-68. doi: 10.1111/j.1468-1331.2010.03092.x.","Alvarez XA","Eur J Neurol","2011","2010/05/27","","","10.1111/j.1468-1331.2010.03092.x"
"7623616","Safety and tolerability of CI-979 in patients with Alzheimer's disease","Sramek JJ, Sedman AJ, Reece PA, Hourani J, Bockbrader H, Cutler NR.","Life Sci. 1995;57(5):503-10. doi: 10.1016/0024-3205(95)00283-c.","Sramek JJ","Life Sci","1995","1995/01/01","","","10.1016/0024-3205(95)00283-c"
"26066622","The Effect of Memantine on Cognitive Function and Behavioral and Psychological Symptoms in Mild-to-Moderate Alzheimer's Disease Patients","Zhang N, Wei C, Du H, Shi FD, Cheng Y.","Dement Geriatr Cogn Disord. 2015;40(1-2):85-93. doi: 10.1159/000430808. Epub 2015 Jun 5.","Zhang N","Dement Geriatr Cogn Disord","2015","2015/06/13","","","10.1159/000430808"
"11161627","Alpha 2-macroglobulin-mediated degradation of amyloid beta 1--42: a mechanism to enhance amyloid beta catabolism","Lauer D, Reichenbach A, Birkenmeier G.","Exp Neurol. 2001 Feb;167(2):385-92. doi: 10.1006/exnr.2000.7569.","Lauer D","Exp Neurol","2001","2001/02/13","","","10.1006/exnr.2000.7569"
"11482124","Effects of the Medicare Alzheimer's disease demonstration on Medicare expenditures","Newcomer R, Miller R, Clay T, Fox P.","Health Care Financ Rev. 1999 Summer;20(4):45-65.","Newcomer R","Health Care Financ Rev","1999","2001/08/03","PMC4194605","",""
"19210039","Cognitive decline from estimated premorbid status predicts neurodegeneration in Alzheimer's disease","Almkvist O, Tallberg IM.","Neuropsychology. 2009 Jan;23(1):117-24. doi: 10.1037/a0014074.","Almkvist O","Neuropsychology","2009","2009/02/13","","","10.1037/a0014074"
"12957490","Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients","Olsson A, Höglund K, Sjögren M, Andreasen N, Minthon L, Lannfelt L, Buerger K, Möller HJ, Hampel H, Davidsson P, Blennow K.","Exp Neurol. 2003 Sep;183(1):74-80. doi: 10.1016/s0014-4886(03)00027-x.","Olsson A","Exp Neurol","2003","2003/09/06","","","10.1016/s0014-4886(03)00027-x"
"6889709","Lecithin administration in Alzheimer dementia","Dysken MW, Fovall P, Harris CM, Davis JM, Noronha A.","Neurology. 1982 Oct;32(10):1203-4. doi: 10.1212/wnl.32.10.1203.","Dysken MW","Neurology","1982","1982/10/01","","","10.1212/wnl.32.10.1203"
"17923611","Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment","van de Pol LA, van der Flier WM, Korf ES, Fox NC, Barkhof F, Scheltens P.","Neurology. 2007 Oct 9;69(15):1491-7. doi: 10.1212/01.wnl.0000277458.26846.96.","van de Pol LA","Neurology","2007","2007/10/10","","","10.1212/01.wnl.0000277458.26846.96"
"31444046","Effect of Resistance Exercise on Depression in Mild Alzheimer Disease Patients With Sarcopenia","Chang MC, Lee AY, Kwak S, Kwak SG.","Am J Geriatr Psychiatry. 2020 May;28(5):587-589. doi: 10.1016/j.jagp.2019.07.013. Epub 2019 Jul 27.","Chang MC","Am J Geriatr Psychiatry","2020","2019/08/25","","","10.1016/j.jagp.2019.07.013"
"10939942","Alzheimer's congress. Drug shows promise for advanced disease","Marx J.","Science. 2000 Jul 21;289(5478):375-7. doi: 10.1126/science.289.5478.375b.","Marx J","Science","2000","2000/08/12","","","10.1126/science.289.5478.375b"
"16717466","Investigating the enhancing effect of music on autobiographical memory in mild Alzheimer's disease","Irish M, Cunningham CJ, Walsh JB, Coakley D, Lawlor BA, Robertson IH, Coen RF.","Dement Geriatr Cogn Disord. 2006;22(1):108-20. doi: 10.1159/000093487. Epub 2006 May 23.","Irish M","Dement Geriatr Cogn Disord","2006","2006/05/24","","","10.1159/000093487"
"10096415","Functional anatomy of verbal and visuospatial span tasks in Alzheimer's disease","Collette F, Salmon E, Van der Linden M, Degueldre C, Franck G.","Hum Brain Mapp. 1997;5(2):110-8. doi: 10.1002/(sici)1097-0193(1997)5:2<110::aid-hbm4>3.0.co;2-6.","Collette F","Hum Brain Mapp","1997","1997/01/01","","","10.1002/(sici)1097-0193(1997)5:2<110::aid-hbm4>3.0.co;2-6"
"14962152","A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer's disease","Loeb MB, Molloy DW, Smieja M, Standish T, Goldsmith CH, Mahony J, Smith S, Borrie M, Decoteau E, Davidson W, McDougall A, Gnarpe J, O'DONNell M, Chernesky M.","J Am Geriatr Soc. 2004 Mar;52(3):381-7. doi: 10.1111/j.1532-5415.2004.52109.x.","Loeb MB","J Am Geriatr Soc","2004","2004/02/14","","","10.1111/j.1532-5415.2004.52109.x"
"34697913","Population pharmacokinetics and standard uptake value ratio of aducanumab, an amyloid plaque-removing agent, in patients with Alzheimer's disease","Kandadi Muralidharan K, Tong X, Kowalski KG, Rajagovindan R, Lin L, Budd Haberlain S, Nestorov I.","CPT Pharmacometrics Syst Pharmacol. 2022 Jan;11(1):7-19. doi: 10.1002/psp4.12728. Epub 2021 Oct 26.","Kandadi Muralidharan K","CPT Pharmacometrics Syst Pharmacol","2022","2021/10/26","PMC8752104","","10.1002/psp4.12728"
"29742702","Spore powder of Ganoderma lucidum for the treatment of Alzheimer disease: A pilot study","Wang GH, Wang LH, Wang C, Qin LH.","Medicine (Baltimore). 2018 May;97(19):e0636. doi: 10.1097/MD.0000000000010636.","Wang GH","Medicine (Baltimore)","2018","2018/05/10","PMC5959386","","10.1097/MD.0000000000010636"
"17627484","Does the cholinesterase inhibitor, donepezil, benefit both declarative and non-declarative processes in mild to moderate Alzheimer's disease?","Winstein CJ, Bentzen KR, Boyd L, Schneider LS.","Curr Alzheimer Res. 2007 Jul;4(3):273-6. doi: 10.2174/156720507781077296.","Winstein CJ","Curr Alzheimer Res","2007","2007/07/14","","","10.2174/156720507781077296"
"20847636","Long-term outcome and prediction models of activities of daily living in Alzheimer disease with cholinesterase inhibitor treatment","Wattmo C, Wallin ÅK, Londos E, Minthon L.","Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):63-72. doi: 10.1097/WAD.0b013e3181f5dd97.","Wattmo C","Alzheimer Dis Assoc Disord","2011","2010/09/18","","","10.1097/WAD.0b013e3181f5dd97"
"2125242","Selegiline versus oxiracetam in patients with Alzheimer-type dementia","Falsaperla A, Monici Preti PA, Oliani C.","Clin Ther. 1990 Sep-Oct;12(5):376-84.","Falsaperla A","Clin Ther","1990","1990/09/01","","",""
"8915574","Trk receptor alterations in Alzheimer's disease","Connor B, Young D, Lawlor P, Gai W, Waldvogel H, Faull RL, Dragunow M.","Brain Res Mol Brain Res. 1996 Nov;42(1):1-17. doi: 10.1016/s0169-328x(96)00040-x.","Connor B","Brain Res Mol Brain Res","1996","1996/11/01","","","10.1016/s0169-328x(96)00040-x"
"32332458","An Alzheimer Disease Challenge Model: 24-Hour Sleep Deprivation in Healthy Volunteers, Impact on Working Memory, and Reversal Effect of Pharmacological Intervention: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study","Chan Kwong A, Cassé-Perrot C, Costes-Salon MC, Jouve E, Lanteaume L, Audebert C, Rouby F, Lefebvre MN, Ranjeva JP, Beck A, Deplanque D, Ponchel A, Vervueren C, Truillet R, Babilon C, Auffret A, Richardson JC, Payoux P, Bartrés-Faz D, Blin O, Bordet R, Micallef J; Pharmacog Consortium.","J Clin Psychopharmacol. 2020 May/Jun;40(3):222-230. doi: 10.1097/JCP.0000000000001199.","Chan Kwong A","J Clin Psychopharmacol","2020","2020/04/26","","","10.1097/JCP.0000000000001199"
"10188788","Preclinical and phase 1 clinical characterization of CI-979/RU35926, a novel muscarinic agonist for the treatment of Alzheimer's disease","Sedman AJ, Bockbrader H, Schwarz RD.","Life Sci. 1995;56(11-12):877-82. doi: 10.1016/0024-3205(95)00023-y.","Sedman AJ","Life Sci","1995","1995/01/01","","","10.1016/0024-3205(95)00023-y"
"32463470","Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial","Maier F, Spottke A, Bach JP, Bartels C, Buerger K, Dodel R, Fellgiebel A, Fliessbach K, Frölich L, Hausner L, Hellmich M, Klöppel S, Klostermann A, Kornhuber J, Laske C, Peters O, Priller J, Richter-Schmidinger T, Schneider A, Shah-Hosseini K, Teipel S, von Arnim CAF, Wiltfang J, Jessen F.","JAMA Netw Open. 2020 May 1;3(5):e206027. doi: 10.1001/jamanetworkopen.2020.6027.","Maier F","JAMA Netw Open","2020","2020/05/29","PMC7256670","","10.1001/jamanetworkopen.2020.6027"
"9191757","The Alzheimer's Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials","Doraiswamy PM, Bieber F, Kaiser L, Krishnan KR, Reuning-Scherer J, Gulanski B.","Neurology. 1997 Jun;48(6):1511-7. doi: 10.1212/wnl.48.6.1511.","Doraiswamy PM","Neurology","1997","1997/06/01","","","10.1212/wnl.48.6.1511"
"32284421","Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound","Rezai AR, Ranjan M, D'Haese PF, Haut MW, Carpenter J, Najib U, Mehta RI, Chazen JL, Zibly Z, Yates JR, Hodder SL, Kaplitt M.","Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9180-9182. doi: 10.1073/pnas.2002571117. Epub 2020 Apr 13.","Rezai AR","Proc Natl Acad Sci U S A","2020","2020/04/15","PMC7196825","","10.1073/pnas.2002571117"
"36454969","Gamma frequency sensory stimulation in mild probable Alzheimer's dementia patients: Results of feasibility and pilot studies","Chan D, Suk HJ, Jackson BL, Milman NP, Stark D, Klerman EB, Kitchener E, Fernandez Avalos VS, de Weck G, Banerjee A, Beach SD, Blanchard J, Stearns C, Boes AD, Uitermarkt B, Gander P, Howard M 3rd, Sternberg EJ, Nieto-Castanon A, Anteraper S, Whitfield-Gabrieli S, Brown EN, Boyden ES, Dickerson BC, Tsai LH.","PLoS One. 2022 Dec 1;17(12):e0278412. doi: 10.1371/journal.pone.0278412. eCollection 2022.","Chan D","PLoS One","2022","2022/12/01","PMC9714926","","10.1371/journal.pone.0278412"
"29429971","Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab","Liu E, Wang D, Sperling R, Salloway S, Fox NC, Blennow K, Scheltens P, Schmidt ME, Streffer J, Novak G, Einstein S, Booth K, Ketter N, Brashear HR; ELN115727-301/302 Investigator Group.","Neurology. 2018 Mar 6;90(10):e877-e886. doi: 10.1212/WNL.0000000000005060. Epub 2018 Feb 2.","Liu E","Neurology","2018","2018/02/13","","","10.1212/WNL.0000000000005060"
"24717382","High-dose cholinergic therapy with rivastigmine patch does not prolong QTc time in patients with Alzheimer's disease","Riepe MW.","J Clin Psychiatry. 2014 Mar;75(3):288. doi: 10.4088/JCP.13l08730.","Riepe MW","J Clin Psychiatry","2014","2014/04/11","","","10.4088/JCP.13l08730"
"18843429","Dysphagia in elderly nursing home residents with severe cognitive impairment can be attenuated by cervical spine mobilization","Bautmans I, Demarteau J, Cruts B, Lemper JC, Mets T.","J Rehabil Med. 2008 Oct;40(9):755-60. doi: 10.2340/16501977-0243.","Bautmans I","J Rehabil Med","2008","2008/10/10","","","10.2340/16501977-0243"
"14610119","Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer's disease: an MRI study","Cousins DA, Burton EJ, Burn D, Gholkar A, McKeith IG, O'Brien JT.","Neurology. 2003 Nov 11;61(9):1191-5. doi: 10.1212/01.wnl.0000091889.20347.30.","Cousins DA","Neurology","2003","2003/11/12","","","10.1212/01.wnl.0000091889.20347.30"
"34755655","Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial","Lin PY, Cheng C, Satyanarayanan SK, Chiu LT, Chien YC, Chuu CP, Lan TH, Su KP.","Brain Behav Immun. 2022 Jan;99:289-298. doi: 10.1016/j.bbi.2021.10.014. Epub 2021 Oct 29.","Lin PY","Brain Behav Immun","2022","2021/11/10","","","10.1016/j.bbi.2021.10.014"
"24888381","Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial","Cooper SA, Caslake M, Evans J, Hassiotis A, Jahoda A, McConnachie A, Morrison J, Ring H, Starr J, Stiles C, Sullivan F.","Trials. 2014 Jun 3;15:202. doi: 10.1186/1745-6215-15-202.","Cooper SA","Trials","2014","2014/06/04","PMC4061534","","10.1186/1745-6215-15-202"
"19153649","The assessment of beta amyloid, tau protein and cystatin C in the cerebrospinal fluid: laboratory markers of neurodegenerative diseases","Mares J, Kanovsky P, Herzig R, Stejskal D, Vavrouskova J, Hlustik P, Vranova H, Burval S, Zapletalova J, Pidrman V, Obereigneru R, Suchy A, Vesely J, Podivinsky J, Urbanek K.","Neurol Sci. 2009 Feb;30(1):1-7. doi: 10.1007/s10072-008-0005-7. Epub 2009 Jan 20.","Mares J","Neurol Sci","2009","2009/01/21","","","10.1007/s10072-008-0005-7"
"12794385","Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease","Roberts JS, LaRusse SA, Katzen H, Whitehouse PJ, Barber M, Post SG, Relkin N, Quaid K, Pietrzak RH, Cupples LA, Farrer LA, Brown T, Green RC.","Alzheimer Dis Assoc Disord. 2003 Apr-Jun;17(2):86-93. doi: 10.1097/00002093-200304000-00006.","Roberts JS","Alzheimer Dis Assoc Disord","2003","2003/06/10","","","10.1097/00002093-200304000-00006"
"33719017","A Phase II, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Therapeutic Efficacy of Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease","Rosenbloom M, Barclay TR, Kashyap B, Hage L, O'Keefe LR, Svitak A, Pyle M, Frey W, Hanson LR.","Drugs Aging. 2021 May;38(5):407-415. doi: 10.1007/s40266-021-00845-7. Epub 2021 Mar 15.","Rosenbloom M","Drugs Aging","2021","2021/03/15","","","10.1007/s40266-021-00845-7"
"28864409","Changes in brain amyloid-β accumulation after donepezil administration","Ishibashi K, Miura Y, Wagatsuma K, Ishiwata K, Ishii K.","J Clin Neurosci. 2017 Nov;45:328-329. doi: 10.1016/j.jocn.2017.08.025. Epub 2017 Aug 31.","Ishibashi K","J Clin Neurosci","2017","2017/09/03","","","10.1016/j.jocn.2017.08.025"
"22930137","[Feasibility of a telemedicine support system for diagnosing dementia in primary care]","Vilalta-Franch J, Garre-Olmo J, López-Pousa S, Llinàs-Reglà J, Calvó-Perxas L, Cubí-Montfort R; SISDDAP.","Rev Neurol. 2012 Sep 1;55(5):263-9.","Vilalta-Franch J","Rev Neurol","2012","2012/08/30","","",""
"12456069","Sustained improvement of cognition and global function in patients with moderately severe Alzheimer's disease: a double-blind, placebo-controlled study with the neurotrophic agent Cerebrolysin","Ruether E, Alvarez XA, Rainer M, Moessler H.","J Neural Transm Suppl. 2002;(62):265-75. doi: 10.1007/978-3-7091-6139-5_24.","Ruether E","J Neural Transm Suppl","2002","2002/11/29","","","10.1007/978-3-7091-6139-5_24"
"11890189","Rivastigmine in outpatient services: experience of 114 neurologists in Austria","Schmidt R, Lechner A, Petrovic K.","Int Clin Psychopharmacol. 2002 Mar;17(2):81-5. doi: 10.1097/00004850-200203000-00007.","Schmidt R","Int Clin Psychopharmacol","2002","2002/03/14","","","10.1097/00004850-200203000-00007"
"16861375","Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial","Peskind ER, Potkin SG, Pomara N, Ott BR, Graham SM, Olin JT, McDonald S.","Am J Geriatr Psychiatry. 2006 Aug;14(8):704-15. doi: 10.1097/01.JGP.0000224350.82719.83.","Peskind ER","Am J Geriatr Psychiatry","2006","2006/07/25","","","10.1097/01.JGP.0000224350.82719.83"
"10705169","Medial temporal lobe width on CT scanning in Alzheimer's disease: comparison with vascular dementia, depression and dementia with Lewy bodies","O'Brien JT, Metcalfe S, Swann A, Hobson J, Jobst K, Ballard C, McKeith I, Gholkar A.","Dement Geriatr Cogn Disord. 2000 Mar-Apr;11(2):114-8. doi: 10.1159/000017223.","O'Brien JT","Dement Geriatr Cogn Disord","2000","2000/03/08","","","10.1159/000017223"
"32990494","Transitioning to Long-Term Care: Family Caregiver Experiences of Dementia, Communities, and Counseling","Zmora R, Statz TL, Birkeland RW, McCarron HR, Finlay JM, Rosebush CE, Gaugler JE.","J Aging Health. 2021 Jan;33(1-2):133-146. doi: 10.1177/0898264320963588. Epub 2020 Sep 29.","Zmora R","J Aging Health","2021","2020/09/29","PMC7891851","NIHMS1664099","10.1177/0898264320963588"
"19182483","Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia","Sommer OH, Aga O, Cvancarova M, Olsen IC, Selbaek G, Engedal K.","Dement Geriatr Cogn Disord. 2009;27(2):155-63. doi: 10.1159/000199236. Epub 2009 Feb 2.","Sommer OH","Dement Geriatr Cogn Disord","2009","2009/02/03","","","10.1159/000199236"
"25163440","Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial","Farokhnia M, Shafiee Sabet M, Iranpour N, Gougol A, Yekehtaz H, Alimardani R, Farsad F, Kamalipour M, Akhondzadeh S.","Hum Psychopharmacol. 2014 Jul;29(4):351-9. doi: 10.1002/hup.2412.","Farokhnia M","Hum Psychopharmacol","2014","2014/08/29","","","10.1002/hup.2412"
"31529691","Randomized controlled trial of TDCS on cognition in 201 seniors with mild neurocognitive disorder","Lu H, Chan SSM, Chan WC, Lin C, Cheng CPW, Linda Chiu Wa L.","Ann Clin Transl Neurol. 2019 Oct;6(10):1938-1948. doi: 10.1002/acn3.50823. Epub 2019 Sep 17.","Lu H","Ann Clin Transl Neurol","2019","2019/09/19","PMC6801176","","10.1002/acn3.50823"
"2197635","Efficacy of xantinolnicotinate in patients with dementia","Kanowski S, Fischhof PK, Grobe-Einsler R, Wagner G, Litschauer G.","Pharmacopsychiatry. 1990 May;23(3):118-24. doi: 10.1055/s-2007-1014493.","Kanowski S","Pharmacopsychiatry","1990","1990/05/01","","","10.1055/s-2007-1014493"
"31817451","Oxidative Damage of DNA as Early Marker of Alzheimer's Disease","Peña-Bautista C, Tirle T, López-Nogueroles M, Vento M, Baquero M, Cháfer-Pericás C.","Int J Mol Sci. 2019 Dec 5;20(24):6136. doi: 10.3390/ijms20246136.","Peña-Bautista C","Int J Mol Sci","2019","2019/12/11","PMC6940966","","10.3390/ijms20246136"
"15015012","Weight loss, nutritional status and physical activity in patients with Alzheimer's disease. A controlled study","Wang PN, Yang CL, Lin KN, Chen WT, Chwang LC, Liu HC.","J Neurol. 2004 Mar;251(3):314-20. doi: 10.1007/s00415-004-0316-4.","Wang PN","J Neurol","2004","2004/03/12","","","10.1007/s00415-004-0316-4"
"23609381","Concentration of donepezil to the cognitive response in Alzheimer disease","Yang YH, Chen CH, Chou MC, Li CH, Liu CK, Chen SH.","J Clin Psychopharmacol. 2013 Jun;33(3):351-5. doi: 10.1097/JCP.0b013e31828b5087.","Yang YH","J Clin Psychopharmacol","2013","2013/04/24","","","10.1097/JCP.0b013e31828b5087"
"30724405","Individual goal-oriented cognitive rehabilitation to improve everyday functioning for people with early-stage dementia: A multicentre randomised controlled trial (the GREAT trial)","Clare L, Kudlicka A, Oyebode JR, Jones RW, Bayer A, Leroi I, Kopelman M, James IA, Culverwell A, Pool J, Brand A, Henderson C, Hoare Z, Knapp M, Woods B.","Int J Geriatr Psychiatry. 2019 May;34(5):709-721. doi: 10.1002/gps.5076. Epub 2019 Mar 1.","Clare L","Int J Geriatr Psychiatry","2019","2019/02/07","PMC6593854","","10.1002/gps.5076"
"15111668","Evaluation of visual recognition memory in MCI patients","Barbeau E, Didic M, Tramoni E, Felician O, Joubert S, Sontheimer A, Ceccaldi M, Poncet M.","Neurology. 2004 Apr 27;62(8):1317-22. doi: 10.1212/01.wnl.0000120548.24298.db.","Barbeau E","Neurology","2004","2004/04/28","","","10.1212/01.wnl.0000120548.24298.db"
"35368930","Effect of Resveratrol Combined with Donepezil Hydrochloride on Inflammatory Factor Level and Cognitive Function Level of Patients with Alzheimer's Disease","Fang X, Zhang J, Zhao J, Wang L.","J Healthc Eng. 2022 Mar 25;2022:9148650. doi: 10.1155/2022/9148650. eCollection 2022.","Fang X","J Healthc Eng","2022","2022/04/04","PMC8975642","","10.1155/2022/9148650"
"15488420","Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease","Karas GB, Scheltens P, Rombouts SA, Visser PJ, van Schijndel RA, Fox NC, Barkhof F.","Neuroimage. 2004 Oct;23(2):708-16. doi: 10.1016/j.neuroimage.2004.07.006.","Karas GB","Neuroimage","2004","2004/10/19","","","10.1016/j.neuroimage.2004.07.006"
"23748990","Caring for parents with neurodegenerative disease: a qualitative description","Habermann B, Hines D, Davis L.","Clin Nurse Spec. 2013 Jul-Aug;27(4):182-7. doi: 10.1097/NUR.0b013e318295576b.","Habermann B","Clin Nurse Spec","2013","2013/06/11","PMC3682660","NIHMS476121","10.1097/NUR.0b013e318295576b"
"6338389","Effects of naloxone in senile dementia: a double-blind trial","Reisberg B, Ferris SH, Anand R, Mir P, Geibel V, De Leon MJ, Roberts E.","N Engl J Med. 1983 Mar 24;308(12):721-2. doi: 10.1056/NEJM198303243081213.","Reisberg B","N Engl J Med","1983","1983/03/24","","","10.1056/NEJM198303243081213"
"23744697","Evaluation of Parkinson disease and Alzheimer disease with the use of neuromelanin MR imaging and (123)I-metaiodobenzylguanidine scintigraphy","Miyoshi F, Ogawa T, Kitao SI, Kitayama M, Shinohara Y, Takasugi M, Fujii S, Kaminou T.","AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2113-8. doi: 10.3174/ajnr.A3567. Epub 2013 Jun 6.","Miyoshi F","AJNR Am J Neuroradiol","2013","2013/06/08","PMC7964843","","10.3174/ajnr.A3567"
"7824139","Visual field loss in senile dementia of the Alzheimer's type","Trick GL, Trick LR, Morris P, Wolf M.","Neurology. 1995 Jan;45(1):68-74. doi: 10.1212/wnl.45.1.68.","Trick GL","Neurology","1995","1995/01/01","","","10.1212/wnl.45.1.68"
"1454836","Results and validation of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine","Holford NH, Peace KE.","Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11471-5. doi: 10.1073/pnas.89.23.11471.","Holford NH","Proc Natl Acad Sci U S A","1992","1992/12/01","PMC50573","","10.1073/pnas.89.23.11471"
"7535938","The utility of salivary amylase as an evaluation of M3 muscarinic agonist activity in Alzheimer's disease","Sramek JJ, Cutler NR, Hurley DJ, Seifert RD.","Prog Neuropsychopharmacol Biol Psychiatry. 1995 Jan;19(1):85-91. doi: 10.1016/0278-5846(94)00107-s.","Sramek JJ","Prog Neuropsychopharmacol Biol Psychiatry","1995","1995/01/01","","","10.1016/0278-5846(94)00107-s"
"10678137","Huperzine-A in capsules and tablets for treating patients with Alzheimer disease","Xu SS, Cai ZY, Qu ZW, Yang RM, Cai YL, Wang GQ, Su XQ, Zhong XS, Cheng RY, Xu WA, Li JX, Feng B.","Zhongguo Yao Li Xue Bao. 1999 Jun;20(6):486-90.","Xu SS","Zhongguo Yao Li Xue Bao","1999","2000/05/08","","",""
"18384230","A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial)","Ballard C, Lana MM, Theodoulou M, Douglas S, McShane R, Jacoby R, Kossakowski K, Yu LM, Juszczak E; Investigators DART AD.","PLoS Med. 2008 Apr 1;5(4):e76. doi: 10.1371/journal.pmed.0050076.","Ballard C","PLoS Med","2008","2008/04/04","PMC2276521","","10.1371/journal.pmed.0050076"
"29380267","Safety, Tolerability and Pharmacokinetics of the Serotonin 5-HT6 Receptor Antagonist, SUVN-502, in Healthy Young Adults and Elderly Subjects","Nirogi R, Mudigonda K, Bhyrapuneni G, Muddana NR, Goyal VK, Pandey SK, Palacharla RC.","Clin Drug Investig. 2018 May;38(5):401-415. doi: 10.1007/s40261-018-0618-4.","Nirogi R","Clin Drug Investig","2018","2018/01/31","","","10.1007/s40261-018-0618-4"
"21873835","Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens","Wroolie TE, Kenna HA, Williams KE, Powers BN, Holcomb M, Khaylis A, Rasgon NL.","Am J Geriatr Psychiatry. 2011 Sep;19(9):792-802. doi: 10.1097/JGP.0b013e3181ff678a.","Wroolie TE","Am J Geriatr Psychiatry","2011","2011/08/30","PMC3164805","NIHMS237545","10.1097/JGP.0b013e3181ff678a"
"9818309","A comparison of three measures of estimating premorbid intellectual level in dementia of the Alzheimer type","Law R, O'Carroll RE.","Int J Geriatr Psychiatry. 1998 Oct;13(10):727-30. doi: 10.1002/(sici)1099-1166(1998100)13:10<727::aid-gps851>3.0.co;2-2.","Law R","Int J Geriatr Psychiatry","1998","1998/11/18","","","10.1002/(sici)1099-1166(1998100)13:10<727::aid-gps851>3.0.co;2-2"
"8845698","Quantified electroencephalographic correlates of relative frontal or parietal hypoperfusion in dementia","Pozzi D, Vázquez S, Petracchi M, Dancygier G, García H, Starkstein S.","J Neuropsychiatry Clin Neurosci. 1996 Winter;8(1):26-32. doi: 10.1176/jnp.8.1.26.","Pozzi D","J Neuropsychiatry Clin Neurosci","1996","1996/01/01","","","10.1176/jnp.8.1.26"
"7808223","NGF mRNA is not decreased in frontal cortex from Alzheimer's disease patients","Jetté N, Cole MS, Fahnestock M.","Brain Res Mol Brain Res. 1994 Sep;25(3-4):242-50. doi: 10.1016/0169-328x(94)90159-7.","Jetté N","Brain Res Mol Brain Res","1994","1994/09/01","","","10.1016/0169-328x(94)90159-7"
"8159781","Efficacy of the peptidergic nootropic drug cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT)","Rüther E, Ritter R, Apecechea M, Freytag S, Windisch M.","Pharmacopsychiatry. 1994 Jan;27(1):32-40. doi: 10.1055/s-2007-1014271.","Rüther E","Pharmacopsychiatry","1994","1994/01/01","","","10.1055/s-2007-1014271"
"18541979","Effects of donepezil on verbal memory after semantic processing in healthy older adults","FitzGerald DB, Crucian GP, Mielke JB, Shenal BV, Burks D, Womack KB, Ghacibeh G, Drago V, Foster PS, Valenstein E, Heilman KM.","Cogn Behav Neurol. 2008 Jun;21(2):57-64. doi: 10.1097/WNN.0b013e3181799df1.","FitzGerald DB","Cogn Behav Neurol","2008","2008/06/11","","","10.1097/WNN.0b013e3181799df1"
"11182467","Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly","Wolf H, Grunwald M, Kruggel F, Riedel-Heller SG, Angerhöfer S, Hojjatoleslami A, Hensel A, Arendt T, Gertz H.","Neurobiol Aging. 2001 Mar-Apr;22(2):177-86. doi: 10.1016/s0197-4580(00)00238-4.","Wolf H","Neurobiol Aging","2001","2001/02/22","","","10.1016/s0197-4580(00)00238-4"
"8988795","Minimal effects of dextroamphetamine on scopolamine-induced cognitive impairments in humans","Martinez R, Molchan SE, Lawlor BA, Thompson K, Martinson H, Latham G, Weingartner H, Sunderland T.","Biol Psychiatry. 1997 Jan 1;41(1):50-7. doi: 10.1016/0006-3223(95)00674-5.","Martinez R","Biol Psychiatry","1997","1997/01/01","","","10.1016/0006-3223(95)00674-5"
"11981242","Centrally acting antiemetics mitigate nausea and vomiting in patients with Alzheimer's disease who receive rivastigmine","Jhee SS, Shiovitz T, Hartman RD, Messina J, Anand R, Sramek J, Cutler NR.","Clin Neuropharmacol. 2002 Mar-Apr;25(2):122-3. doi: 10.1097/00002826-200203000-00013.","Jhee SS","Clin Neuropharmacol","2002","2002/05/01","","","10.1097/00002826-200203000-00013"
"3524514","Muscarinic agonist therapy of Alzheimer's disease. A clinical trial of RS-86","Bruno G, Mohr E, Gillespie M, Fedio P, Chase TN.","Arch Neurol. 1986 Jul;43(7):659-61. doi: 10.1001/archneur.1986.00520070017009.","Bruno G","Arch Neurol","1986","1986/07/01","","","10.1001/archneur.1986.00520070017009"
"21797835","Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer's disease: results of a randomized, controlled trial","McCurry SM, Pike KC, Vitiello MV, Logsdon RG, Larson EB, Teri L.","J Am Geriatr Soc. 2011 Aug;59(8):1393-402. doi: 10.1111/j.1532-5415.2011.03519.x. Epub 2011 Jul 28.","McCurry SM","J Am Geriatr Soc","2011","2011/07/30","PMC3158242","NIHMS309039","10.1111/j.1532-5415.2011.03519.x"
"8961571","Computer networks: new tools for nursing practice","Brennan PF.","Appl Nurs Res. 1996 Nov;9(4):159-60. doi: 10.1016/s0897-1897(96)80001-2.","Brennan PF","Appl Nurs Res","1996","1996/11/01","","","10.1016/s0897-1897(96)80001-2"
"9205834","Relations between symptomatology and brain function in dementias: double-blind, placebo-controlled, clinical and EEG/ERP mapping studies with nicergoline","Saletu B, Anderer P, Semlitsch HV.","Dement Geriatr Cogn Disord. 1997;8 Suppl 1:12-21. doi: 10.1159/000106666.","Saletu B","Dement Geriatr Cogn Disord","1997","1997/01/01","","","10.1159/000106666"
"35700915","Effect of cerebellum stimulation on cognitive recovery in patients with Alzheimer disease: A randomized clinical trial","Yao Q, Tang F, Wang Y, Yan Y, Dong L, Wang T, Zhu D, Tian M, Lin X, Shi J.","Brain Stimul. 2022 Jul-Aug;15(4):910-920. doi: 10.1016/j.brs.2022.06.004. Epub 2022 Jun 11.","Yao Q","Brain Stimul","2022","2022/06/14","","","10.1016/j.brs.2022.06.004"
"32728820","Exercise training improves vascular function in patients with Alzheimer's disease","Pedrinolla A, Venturelli M, Fonte C, Tamburin S, Di Baldassarre A, Naro F, Varalta V, Giuriato G, Ghinassi B, Muti E, Smania N, Schena F.","Eur J Appl Physiol. 2020 Oct;120(10):2233-2245. doi: 10.1007/s00421-020-04447-w. Epub 2020 Jul 30.","Pedrinolla A","Eur J Appl Physiol","2020","2020/07/31","PMC7502067","","10.1007/s00421-020-04447-w"
"12040303","The effects of a walking/talking program on communication, ambulation, and functional status in residents with Alzheimer disease","Cott CA, Dawson P, Sidani S, Wells D.","Alzheimer Dis Assoc Disord. 2002 Apr-Jun;16(2):81-7. doi: 10.1097/00002093-200204000-00005.","Cott CA","Alzheimer Dis Assoc Disord","2002","2002/06/01","","","10.1097/00002093-200204000-00005"
"9043743","Regional HmPAO SPECT and CT measurements in the diagnosis of Alzheimer's disease","Mattman A, Feldman H, Forster B, Li D, Szasz I, Beattie BL, Schulzer M.","Can J Neurol Sci. 1997 Feb;24(1):22-8. doi: 10.1017/s0317167100021041.","Mattman A","Can J Neurol Sci","1997","1997/02/01","","","10.1017/s0317167100021041"
"22272611","Pilot randomized controlled study of a histamine receptor inverse agonist in the symptomatic treatment of AD","Egan M, Yaari R, Liu L, Ryan M, Peng Y, Lines C, Michelson D.","Curr Alzheimer Res. 2012 May;9(4):481-90. doi: 10.2174/156720512800492530.","Egan M","Curr Alzheimer Res","2012","2012/01/26","","","10.2174/156720512800492530"
"15760626","Optimized neuropsychological procedures at different stages of dementia diagnostics","Damian M, Kreis M, Krumm B, Hentschel F.","J Neurol Sci. 2005 Mar 15;229-230:95-101. doi: 10.1016/j.jns.2004.11.043. Epub 2004 Dec 29.","Damian M","J Neurol Sci","2005","2005/03/12","","","10.1016/j.jns.2004.11.043"
"30832581","Implementation and evaluation of a driving cessation intervention to improve community mobility and wellbeing outcomes for people living with dementia: study protocol of the 'CarFreeMe' for people with dementia program","Scott T, Liddle J, Mitchell G, Beattie E, Pachana N.","BMC Geriatr. 2019 Mar 4;19(1):66. doi: 10.1186/s12877-019-1074-6.","Scott T","BMC Geriatr","2019","2019/03/06","PMC6399961","","10.1186/s12877-019-1074-6"
"21606568","Cessation versus continuation of galantamine treatment after 12 months of therapy in patients with Alzheimer's disease: a randomized, double blind, placebo controlled withdrawal trial","Scarpini E, Bruno G, Zappalà G, Adami M, Richarz U, Gaudig M, Jacobs A, Schäuble B.","J Alzheimers Dis. 2011;26(2):211-20. doi: 10.3233/JAD-2011-110134.","Scarpini E","J Alzheimers Dis","2011","2011/05/25","","","10.3233/JAD-2011-110134"
"23064592","Classification of mild cognitive impairment and Alzheimer disease using model-based MR and magnetization transfer imaging","Wiest R, Burren Y, Hauf M, Schroth G, Pruessner J, Zbinden M, Cattapan-Ludewig K, Kiefer C.","AJNR Am J Neuroradiol. 2013 Apr;34(4):740-6. doi: 10.3174/ajnr.A3307. Epub 2012 Oct 11.","Wiest R","AJNR Am J Neuroradiol","2013","2012/10/16","PMC7964474","","10.3174/ajnr.A3307"
"16416345","Annual conversion to alzheimer disease among patients with memory complaints attending an outpatient memory clinic: the influence of amnestic mild cognitive impairment and the predictive value of neuropsychological testing","Lehrner J, Gufler R, Guttmann G, Maly J, Gleiss A, Auff E, Dal-Bianco P.","Wien Klin Wochenschr. 2005 Sep;117(18):629-35. doi: 10.1007/s00508-005-0428-6.","Lehrner J","Wien Klin Wochenschr","2005","2006/01/18","","","10.1007/s00508-005-0428-6"
"10867785","Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4","Olichney JM, Hansen LA, Hofstetter CR, Lee JH, Katzman R, Thal LJ.","Arch Neurol. 2000 Jun;57(6):869-74. doi: 10.1001/archneur.57.6.869.","Olichney JM","Arch Neurol","2000","2000/06/27","","","10.1001/archneur.57.6.869"
"3043998","Potential pharmacotherapy of Alzheimer disease. A comparison of various forms of physostigmine administration","Becker R, Giacobini E, Elble R, McIlhany M, Sherman K.","Acta Neurol Scand Suppl. 1988;116:19-32. doi: 10.1111/j.1600-0404.1988.tb07983.x.","Becker R","Acta Neurol Scand Suppl","1988","1988/01/01","","","10.1111/j.1600-0404.1988.tb07983.x"
"18213383","No effect of one-year treatment with indomethacin on Alzheimer's disease progression: a randomized controlled trial","de Jong D, Jansen R, Hoefnagels W, Jellesma-Eggenkamp M, Verbeek M, Borm G, Kremer B.","PLoS One. 2008 Jan 23;3(1):e1475. doi: 10.1371/journal.pone.0001475.","de Jong D","PLoS One","2008","2008/01/24","PMC2194921","","10.1371/journal.pone.0001475"
"16327349","Safety and acceptability of the research lumbar puncture","Peskind ER, Riekse R, Quinn JF, Kaye J, Clark CM, Farlow MR, Decarli C, Chabal C, Vavrek D, Raskind MA, Galasko D.","Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):220-5. doi: 10.1097/01.wad.0000194014.43575.fd.","Peskind ER","Alzheimer Dis Assoc Disord","2005","2005/12/06","","","10.1097/01.wad.0000194014.43575.fd"
"10867210","Hemodynamic changes during aging associated with cerebral blood flow and impaired cognitive function","Ajmani RS, Metter EJ, Jaykumar R, Ingram DK, Spangler EL, Abugo OO, Rifkind JM.","Neurobiol Aging. 2000 Mar-Apr;21(2):257-69. doi: 10.1016/s0197-4580(00)00118-4.","Ajmani RS","Neurobiol Aging","2000","2000/06/27","","","10.1016/s0197-4580(00)00118-4"
"23624756","Phase I study on the pharmacokinetics and tolerance of ZT-1, a prodrug of huperzine A, for the treatment of Alzheimer's disease","Jia JY, Zhao QH, Liu Y, Gui YZ, Liu GY, Zhu DY, Yu C, Hong Z.","Acta Pharmacol Sin. 2013 Jul;34(7):976-82. doi: 10.1038/aps.2013.7. Epub 2013 Apr 29.","Jia JY","Acta Pharmacol Sin","2013","2013/04/30","PMC4002618","","10.1038/aps.2013.7"
"18925978","Cognitive and psychiatric effects of vitamin B12 replacement in dementia with low serum B12 levels: a nursing home study","van Dyck CH, Lyness JM, Rohrbaugh RM, Siegal AP.","Int Psychogeriatr. 2009 Feb;21(1):138-47. doi: 10.1017/S1041610208007904. Epub 2008 Oct 17.","van Dyck CH","Int Psychogeriatr","2009","2008/10/18","PMC3523212","NIHMS343673","10.1017/S1041610208007904"
"30011310","Distinct expression of the neurotoxic microRNA family let-7 in the cerebrospinal fluid of patients with Alzheimer's disease","Derkow K, Rössling R, Schipke C, Krüger C, Bauer J, Fähling M, Stroux A, Schott E, Ruprecht K, Peters O, Lehnardt S.","PLoS One. 2018 Jul 16;13(7):e0200602. doi: 10.1371/journal.pone.0200602. eCollection 2018.","Derkow K","PLoS One","2018","2018/07/17","PMC6047809","","10.1371/journal.pone.0200602"
"30076539","Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain","Hey JA, Kocis P, Hort J, Abushakra S, Power A, Vyhnálek M, Yu JY, Tolar M.","CNS Drugs. 2018 Sep;32(9):849-861. doi: 10.1007/s40263-018-0554-0.","Hey JA","CNS Drugs","2018","2018/08/05","PMC6153967","","10.1007/s40263-018-0554-0"
"17494679","Magnetization transfer ratio in Alzheimer disease: comparison with volumetric measurements","Ridha BH, Symms MR, Tozer DJ, Stockton KC, Frost C, Siddique MM, Lewis EB, MacManus DG, Boulby PA, Barker GJ, Rossor MN, Fox NC, Tofts PS.","AJNR Am J Neuroradiol. 2007 May;28(5):965-70.","Ridha BH","AJNR Am J Neuroradiol","2007","2007/05/15","PMC8134339","",""
"28187125","Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial","Morris JK, Vidoni ED, Johnson DK, Van Sciver A, Mahnken JD, Honea RA, Wilkins HM, Brooks WM, Billinger SA, Swerdlow RH, Burns JM.","PLoS One. 2017 Feb 10;12(2):e0170547. doi: 10.1371/journal.pone.0170547. eCollection 2017.","Morris JK","PLoS One","2017","2017/02/11","PMC5302785","","10.1371/journal.pone.0170547"
"14997933","Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease","Ferrer I, Boada Rovira M, Sánchez Guerra ML, Rey MJ, Costa-Jussá F.","Brain Pathol. 2004 Jan;14(1):11-20. doi: 10.1111/j.1750-3639.2004.tb00493.x.","Ferrer I","Brain Pathol","2004","2004/03/05","PMC8095815","","10.1111/j.1750-3639.2004.tb00493.x"
"16872233","Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease","Cooke JR, Loredo JS, Liu L, Marler M, Corey-Bloom J, Fiorentino L, Harrison T, Ancoli-Israel S.","Drugs Aging. 2006;23(6):503-11. doi: 10.2165/00002512-200623060-00005.","Cooke JR","Drugs Aging","2006","2006/07/29","","","10.2165/00002512-200623060-00005"
"31601260","Dietary intakes and biomarker patterns of folate, vitamin B(6), and vitamin B(12) can be associated with cognitive impairment by hypermethylation of redox-related genes NUDT15 and TXNRD1","An Y, Feng L, Zhang X, Wang Y, Wang Y, Tao L, Qin Z, Xiao R.","Clin Epigenetics. 2019 Oct 11;11(1):139. doi: 10.1186/s13148-019-0741-y.","An Y","Clin Epigenetics","2019","2019/10/12","PMC6787977","","10.1186/s13148-019-0741-y"
"9013398","Velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled trial. The Mentane Study Group","Zemlan FP.","J Neural Transm (Vienna). 1996;103(8-9):1105-16. doi: 10.1007/BF01291795.","Zemlan FP","J Neural Transm (Vienna)","1996","1996/01/01","","","10.1007/BF01291795"
"25878180","The lower hippocampus global connectivity, the higher its local metabolism in Alzheimer disease","Tahmasian M, Pasquini L, Scherr M, Meng C, Förster S, Mulej Bratec S, Shi K, Yakushev I, Schwaiger M, Grimmer T, Diehl-Schmid J, Riedl V, Sorg C, Drzezga A.","Neurology. 2015 May 12;84(19):1956-63. doi: 10.1212/WNL.0000000000001575. Epub 2015 Apr 15.","Tahmasian M","Neurology","2015","2015/04/17","","","10.1212/WNL.0000000000001575"
"12084785","Evaluation of geriatric day care units: effects on patients and caregivers","Zank S, Schacke C.","J Gerontol B Psychol Sci Soc Sci. 2002 Jul;57(4):P348-57. doi: 10.1093/geronb/57.4.p348.","Zank S","J Gerontol B Psychol Sci Soc Sci","2002","2002/06/27","","","10.1093/geronb/57.4.p348"
"16801649","Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD","Yoshita M, Taki J, Yokoyama K, Noguchi-Shinohara M, Matsumoto Y, Nakajima K, Yamada M.","Neurology. 2006 Jun 27;66(12):1850-4. doi: 10.1212/01.wnl.0000219640.59984.a7.","Yoshita M","Neurology","2006","2006/06/28","","","10.1212/01.wnl.0000219640.59984.a7"
"15249851","The effect of a structured intervention on caregivers of patients with dementia and problem behaviors: a randomized controlled pilot study","Nobili A, Riva E, Tettamanti M, Lucca U, Liscio M, Petrucci B, Porro GS.","Alzheimer Dis Assoc Disord. 2004 Apr-Jun;18(2):75-82. doi: 10.1097/01.wad.0000126618.98867.fc.","Nobili A","Alzheimer Dis Assoc Disord","2004","2004/07/14","","","10.1097/01.wad.0000126618.98867.fc"
"32180150","Clinical Experience in Treatment of Alzheimer's Disease with Jiannao Yizhi Formula () and Routine Western Medicine","Wang HC, Liu NY, Zhang S, Yang Y, Wang ZY, Wei Y, Liu JG, Pei H, Li H.","Chin J Integr Med. 2020 Mar;26(3):212-218. doi: 10.1007/s11655-019-2718-2. Epub 2020 Mar 16.","Wang HC","Chin J Integr Med","2020","2020/03/18","","","10.1007/s11655-019-2718-2"
"22581594","Clinical application of the Polish adaptation of the Montreal Cognitive Assessment (MoCA) test in screening for cognitive impairment","Magierska J, Magierski R, Fendler W, Kłoszewska I, Sobów TM.","Neurol Neurochir Pol. 2012 Mar-Apr;46(2):130-9. doi: 10.5114/ninp.2012.28255.","Magierska J","Neurol Neurochir Pol","2012","2012/05/15","","","10.5114/ninp.2012.28255"
"12928047","Combination of serum markers related to several mechanisms in Alzheimer's disease","Teunissen CE, Lütjohann D, von Bergmann K, Verhey F, Vreeling F, Wauters A, Bosmans E, Bosma H, van Boxtel MP, Maes M, Delanghe J, Blom HJ, Verbeek MM, Rieckmann P, De Bruijn C, Steinbusch HW, de Vente J.","Neurobiol Aging. 2003 Nov;24(7):893-902. doi: 10.1016/s0197-4580(03)00005-8.","Teunissen CE","Neurobiol Aging","2003","2003/08/21","","","10.1016/s0197-4580(03)00005-8"
"1904354","Effects of a MAO-B inhibitor in the treatment of Alzheimer disease","Mangoni A, Grassi MP, Frattola L, Piolti R, Bassi S, Motta A, Marcone A, Smirne S.","Eur Neurol. 1991;31(2):100-7. doi: 10.1159/000116655.","Mangoni A","Eur Neurol","1991","1991/01/01","","","10.1159/000116655"
"25918972","Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation","Kudoh C, Arita R, Honda M, Kishi T, Komatsu Y, Asou H, Mimura M.","Psychogeriatrics. 2016 Mar;16(2):85-92. doi: 10.1111/psyg.12125. Epub 2015 Apr 27.","Kudoh C","Psychogeriatrics","2016","2015/04/29","","","10.1111/psyg.12125"
"34183688","Plasma neurofilament light chain is associated with cognitive decline in non-dementia older adults","He L, Morley JE, Aggarwal G, Nguyen AD, Vellas B, de Souto Barreto P; MAPT/DSA Group.","Sci Rep. 2021 Jun 28;11(1):13394. doi: 10.1038/s41598-021-91038-0.","He L","Sci Rep","2021","2021/06/29","PMC8238930","","10.1038/s41598-021-91038-0"
"17597552","Key lessons learned from short-term treatment trials of cholinesterase inhibitors for amnestic MCI","Salloway S, Correia S, Richardson S.","Int Psychogeriatr. 2008 Feb;20(1):40-6. doi: 10.1017/S1041610207005650. Epub 2007 Jun 28.","Salloway S","Int Psychogeriatr","2008","2007/06/29","","","10.1017/S1041610207005650"
"26572551","Group and individual cognitive therapies in Alzheimer's disease: the ETNA3 randomized trial","Amieva H, Robert PH, Grandoulier AS, Meillon C, De Rotrou J, Andrieu S, Berr C, Desgranges B, Dubois B, Girtanner C, Joël ME, Lavallart B, Nourhashemi F, Pasquier F, Rainfray M, Touchon J, Chêne G, Dartigues JF.","Int Psychogeriatr. 2016 May;28(5):707-17. doi: 10.1017/S1041610215001830. Epub 2015 Nov 17.","Amieva H","Int Psychogeriatr","2016","2015/11/18","","","10.1017/S1041610215001830"
"2694229","Can the pattern of neuropsychological improvement obtained with cholinergic drugs be used to infer a cholinergic mechanism in other nootropic drugs?","Gainotti G, Nocentini U, Sena E.","Prog Neuropsychopharmacol Biol Psychiatry. 1989;13 Suppl:S47-59. doi: 10.1016/0278-5846(89)90110-3.","Gainotti G","Prog Neuropsychopharmacol Biol Psychiatry","1989","1989/01/01","","","10.1016/0278-5846(89)90110-3"
"22301195","Citalopram for agitation in Alzheimer's disease: design and methods","Drye LT, Ismail Z, Porsteinsson AP, Rosenberg PB, Weintraub D, Marano C, Pelton G, Frangakis C, Rabins PV, Munro CA, Meinert CL, Devanand DP, Yesavage J, Mintzer JE, Schneider LS, Pollock BG, Lyketsos CG; CitAD Research Group.","Alzheimers Dement. 2012;8(2):121-30. doi: 10.1016/j.jalz.2011.01.007. Epub 2012 Feb 1.","Drye LT","Alzheimers Dement","2012","2012/02/04","PMC3333484","NIHMS354705","10.1016/j.jalz.2011.01.007"
"21679156","Combination treatment in Alzheimer's disease: results of a randomized, controlled trial with cerebrolysin and donepezil","Alvarez XA, Cacabelos R, Sampedro C, Couceiro V, Aleixandre M, Vargas M, Linares C, Granizo E, García-Fantini M, Baurecht W, Doppler E, Moessler H.","Curr Alzheimer Res. 2011 Aug;8(5):583-91. doi: 10.2174/156720511796391863.","Alvarez XA","Curr Alzheimer Res","2011","2011/06/18","","","10.2174/156720511796391863"
"25320813","Deep learning based imaging data completion for improved brain disease diagnosis","Li R, Zhang W, Suk HI, Wang L, Li J, Shen D, Ji S.","Med Image Comput Comput Assist Interv. 2014;17(Pt 3):305-12. doi: 10.1007/978-3-319-10443-0_39.","Li R","Med Image Comput Comput Assist Interv","2014","2014/10/17","PMC4464771","NIHMS697166","10.1007/978-3-319-10443-0_39"
"21968863","Effect of a medical food on body mass index and activities of daily living in patients with Alzheimer's disease: secondary analyses from a randomized, controlled trial","Kamphuis PJ, Verhey FR, Olde Rikkert MG, Twisk JW, Swinkels SH, Scheltens P.","J Nutr Health Aging. 2011 Aug;15(8):672-6. doi: 10.1007/s12603-011-0339-3.","Kamphuis PJ","J Nutr Health Aging","2011","2011/10/05","","","10.1007/s12603-011-0339-3"
"16521031","Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia","Walther S, Mahlberg R, Eichmann U, Kunz D.","Psychopharmacology (Berl). 2006 May;185(4):524-8. doi: 10.1007/s00213-006-0343-1. Epub 2006 Mar 7.","Walther S","Psychopharmacology (Berl)","2006","2006/03/08","","","10.1007/s00213-006-0343-1"
"19347683","Dementia care consultation for family caregivers: collaborative model linking an Alzheimer's association chapter with primary care physicians","Fortinsky RH, Kulldorff M, Kleppinger A, Kenyon-Pesce L.","Aging Ment Health. 2009 Mar;13(2):162-70. doi: 10.1080/13607860902746160.","Fortinsky RH","Aging Ment Health","2009","2009/04/07","","","10.1080/13607860902746160"
"10629930","[The influence of cerebrolysin on the efficiency of subsequent therapy with amiridine++ in Alzheimer's disease patients (neuropsychological investigation)]","Roshchina IF, Kolykhalov IV, Selezneva ND, Zharikov GA, Gerasimov NP, Gavrilova SI.","Zh Nevrol Psikhiatr Im S S Korsakova. 1999;99(12):43-6.","Roshchina IF","Zh Nevrol Psikhiatr Im S S Korsakova","1999","2000/01/12","","",""
"11290880","Donepezil, rivastigmine, and vitamin E in Alzheimer disease: a combined P300 event-related potentials/neuropsychologic evaluation over 6 months","Thomas A, Iacono D, Bonanni L, D'Andreamatteo G, Onofrj M.","Clin Neuropharmacol. 2001 Jan-Feb;24(1):31-42. doi: 10.1097/00002826-200101000-00007.","Thomas A","Clin Neuropharmacol","2001","2001/04/06","","","10.1097/00002826-200101000-00007"
"6753611","Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine","Davis KL, Mohs RC.","Am J Psychiatry. 1982 Nov;139(11):1421-4. doi: 10.1176/ajp.139.11.1421.","Davis KL","Am J Psychiatry","1982","1982/11/01","","","10.1176/ajp.139.11.1421"
"10354658","Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group","Filip V, Kolibás E.","J Psychiatry Neurosci. 1999 May;24(3):234-43.","Filip V","J Psychiatry Neurosci","1999","1999/06/04","PMC1189014","",""
"26076022","Cognitive Improvement during Treatment for Mild Alzheimer's Disease with a Chinese Herbal Formula: A Randomized Controlled Trial","Zhang Y, Lin C, Zhang L, Cui Y, Gu Y, Guo J, Wu D, Li Q, Song W.","PLoS One. 2015 Jun 15;10(6):e0130353. doi: 10.1371/journal.pone.0130353. eCollection 2015.","Zhang Y","PLoS One","2015","2015/06/16","PMC4468068","","10.1371/journal.pone.0130353"
"16261949","[The situation of patients with dementia may be rectified by Ginkgo biloba. Results of a health services research study concerning the ability of patients with dementia, quality of life of the nursing family members and total treatment costs]","Heinen-Kammerer T, Motzkat K, Daniel D, Gertz HJ, Koller M, Lorenz W, Pilartz H, Zimmer B, Habs M, von den Driesch V, Rychlik R.","MMW Fortschr Med. 2005 Oct 6;147 Suppl 3:127-33.","Heinen-Kammerer T","MMW Fortschr Med","2005","2005/11/03","","",""
"17356308","Amisulpride versus risperidone treatment for behavioral and psychological symptoms in patients with dementia of the Alzheimer type: a randomized, open, prospective study","Lim HK, Pae CU, Lee C, Lee CU.","Neuropsychobiology. 2006;54(4):247-51. doi: 10.1159/000100779. Epub 2007 Mar 15.","Lim HK","Neuropsychobiology","2006","2007/03/16","","","10.1159/000100779"
"27899350","Sixty seconds on . . . solanezumab","Hawkes N.","BMJ. 2016 Nov 29;355:i6389. doi: 10.1136/bmj.i6389.","Hawkes N","BMJ","2016","2016/12/01","","","10.1136/bmj.i6389"
"11755018","Elevated levels of oxidative DNA damage in lymphocytes from patients with Alzheimer's disease","Mórocz M, Kálmán J, Juhász A, Sinkó I, McGlynn AP, Downes CS, Janka Z, Raskó I.","Neurobiol Aging. 2002 Jan-Feb;23(1):47-53. doi: 10.1016/s0197-4580(01)00257-3.","Mórocz M","Neurobiol Aging","2002","2002/01/05","","","10.1016/s0197-4580(01)00257-3"
"16286438","Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study","Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, Fishel MA, Kulstad JJ, Green PS, Cook DG, Kahn SE, Keeling ML, Craft S.","Am J Geriatr Psychiatry. 2005 Nov;13(11):950-8. doi: 10.1176/appi.ajgp.13.11.950.","Watson GS","Am J Geriatr Psychiatry","2005","2005/11/16","","","10.1176/appi.ajgp.13.11.950"
"36549548","Cross-sectional and prospective associations between homocysteine and a frailty index: A post-hoc analysis of the multidomain Alzheimer's prevention trial (MAPT)","St-Martin P, Dionne IJ, Maltais M, Rolland Y; MAPT/DSA Study Group.","Exp Gerontol. 2023 Feb;172:112066. doi: 10.1016/j.exger.2022.112066. Epub 2022 Dec 20.","St-Martin P","Exp Gerontol","2023","2022/12/22","","","10.1016/j.exger.2022.112066"
"17342994","[Clinical study of Reinhartdt and sea cucumber capsule combined with donepezil in treating Alzheimer's disease]","Zhou ZL, Liang LZ, Yan YX.","Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007 Feb;27(2):110-3.","Zhou ZL","Zhongguo Zhong Xi Yi Jie He Za Zhi","2007","2007/03/09","","",""
"22567095","Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial","Fox C, Crugel M, Maidment I, Auestad BH, Coulton S, Treloar A, Ballard C, Boustani M, Katona C, Livingston G.","PLoS One. 2012;7(5):e35185. doi: 10.1371/journal.pone.0035185. Epub 2012 May 2.","Fox C","PLoS One","2012","2012/05/09","PMC3342281","","10.1371/journal.pone.0035185"
"19355849","Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders","Vellas B, Black R, Thal LJ, Fox NC, Daniels M, McLennan G, Tompkins C, Leibman C, Pomfret M, Grundman M; AN1792 (QS-21)-251 Study Team.","Curr Alzheimer Res. 2009 Apr;6(2):144-51. doi: 10.2174/156720509787602852.","Vellas B","Curr Alzheimer Res","2009","2009/04/10","PMC2825665","","10.2174/156720509787602852"
"27291982","Home-based caregiver training: Benefits differ by care receivers' dementia diagnosis","Kuo LM, Huang HL, Hsu WC, Wang YT, Shyu YL.","Geriatr Nurs. 2016 Sep-Oct;37(5):376-384. doi: 10.1016/j.gerinurse.2016.05.005. Epub 2016 Jun 10.","Kuo LM","Geriatr Nurs","2016","2016/06/14","","","10.1016/j.gerinurse.2016.05.005"
"20713437","Cognitive stimulation therapy in the treatment of neuropsychiatric symptoms in Alzheimer's disease: a randomized controlled trial","Niu YX, Tan JP, Guan JQ, Zhang ZQ, Wang LN.","Clin Rehabil. 2010 Dec;24(12):1102-11. doi: 10.1177/0269215510376004. Epub 2010 Aug 16.","Niu YX","Clin Rehabil","2010","2010/08/18","","","10.1177/0269215510376004"
"21749214","Willingness to pay for genetic testing for Alzheimer's disease: a measure of personal utility","Kopits IM, Chen C, Roberts JS, Uhlmann W, Green RC.","Genet Test Mol Biomarkers. 2011 Dec;15(12):871-5. doi: 10.1089/gtmb.2011.0028. Epub 2011 Jul 12.","Kopits IM","Genet Test Mol Biomarkers","2011","2011/07/14","PMC3241735","","10.1089/gtmb.2011.0028"
"21258153","Effects of AZD3480 on cognition in patients with mild-to-moderate Alzheimer's disease: a phase IIb dose-finding study","Frölich L, Ashwood T, Nilsson J, Eckerwall G; Sirocco Investigators.","J Alzheimers Dis. 2011;24(2):363-74. doi: 10.3233/JAD-2011-101554.","Frölich L","J Alzheimers Dis","2011","2011/01/25","","","10.3233/JAD-2011-101554"
"10923073","Abnormal erythrocyte anion exchange in Alzheimer disease","Greco FA, Satlin A, Solomon AK.","Arch Pathol Lab Med. 2000 Aug;124(8):1141-6. doi: 10.5858/2000-124-1141-AEAEIA.","Greco FA","Arch Pathol Lab Med","2000","2000/08/03","","","10.5858/2000-124-1141-AEAEIA"
"2354800","A model telephone information and support program for caregivers of Alzheimer's patients","Goodman CC, Pynoos J.","Gerontologist. 1990 Jun;30(3):399-404. doi: 10.1093/geront/30.3.399.","Goodman CC","Gerontologist","1990","1990/06/01","","","10.1093/geront/30.3.399"
"36455762","Optimizing quantification of MK6240 tau PET in unimpaired older adults","Harrison TM, Ward TJ, Murphy A, Baker SL, Dominguez PA, Koeppe R, Vemuri P, Lockhart SN, Jung Y, Harvey DJ, Lovato L, Toga AW, Masdeu J, Oh H, Gitelman DR, Aggarwal N, Snyder HM, Baker LD, DeCarli C, Jagust WJ, Landau SM; U.S. POINTER Study Group.","Neuroimage. 2023 Jan;265:119761. doi: 10.1016/j.neuroimage.2022.119761. Epub 2022 Nov 28.","Harrison TM","Neuroimage","2023","2022/12/01","PMC9957642","NIHMS1872566","10.1016/j.neuroimage.2022.119761"
"26818096","Mirtazapine does not improve sleep disorders in Alzheimer's disease: results from a double-blind, placebo-controlled pilot study","Scoralick FM, Louzada LL, Quintas JL, Naves JO, Camargos EF, Nóbrega OT.","Psychogeriatrics. 2017 Mar;17(2):89-96. doi: 10.1111/psyg.12191. Epub 2016 Jan 27.","Scoralick FM","Psychogeriatrics","2017","2016/01/29","","","10.1111/psyg.12191"
"16920998","Concordance of race or ethnicity of interventionists and caregivers of dementia patients: relationship to attrition and treatment outcomes in the REACH study","McGinnis KA, Schulz R, Stone RA, Klinger J, Mercurio R.","Gerontologist. 2006 Aug;46(4):449-55. doi: 10.1093/geront/46.4.449.","McGinnis KA","Gerontologist","2006","2006/08/22","","","10.1093/geront/46.4.449"
"21060014","Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative","Carmichael O, Schwarz C, Drucker D, Fletcher E, Harvey D, Beckett L, Jack CR Jr, Weiner M, DeCarli C; Alzheimer's Disease Neuroimaging Initiative.","Arch Neurol. 2010 Nov;67(11):1370-8. doi: 10.1001/archneurol.2010.284.","Carmichael O","Arch Neurol","2010","2010/11/10","PMC3082636","NIHMS285039","10.1001/archneurol.2010.284"
"29452684","Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study","Ballard C, Banister C, Khan Z, Cummings J, Demos G, Coate B, Youakim JM, Owen R, Stankovic S; ADP Investigators.","Lancet Neurol. 2018 Mar;17(3):213-222. doi: 10.1016/S1474-4422(18)30039-5.","Ballard C","Lancet Neurol","2018","2018/02/18","","","10.1016/S1474-4422(18)30039-5"
"8838779","Mixed-model analysis of incomplete longitudinal data from a high-dose trial of tacrine (Cognex) in Alzheimer's patients","Smith F.","J Biopharm Stat. 1996 Mar;6(1):59-67. doi: 10.1080/10543409608835122.","Smith F","J Biopharm Stat","1996","1996/03/01","","","10.1080/10543409608835122"
"16879763","Treating behavioral and psychological symptoms in patients with psychosis of Alzheimer's disease using risperidone","Rabinowitz J, Katz I, De Deyn PP, Greenspan A, Brodaty H.","Int Psychogeriatr. 2007 Apr;19(2):227-40. doi: 10.1017/S1041610206003942. Epub 2006 Jul 31.","Rabinowitz J","Int Psychogeriatr","2007","2006/08/02","","","10.1017/S1041610206003942"
"31168802","Target engagement in an alzheimer trial: Crenezumab lowers amyloid β oligomers in cerebrospinal fluid","Yang T, Dang Y, Ostaszewski B, Mengel D, Steffen V, Rabe C, Bittner T, Walsh DM, Selkoe DJ.","Ann Neurol. 2019 Aug;86(2):215-224. doi: 10.1002/ana.25513. Epub 2019 Jun 22.","Yang T","Ann Neurol","2019","2019/06/07","PMC6771589","","10.1002/ana.25513"
"26810768","Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial","Christensen KD, Roberts JS, Whitehouse PJ, Royal CD, Obisesan TO, Cupples LA, Vernarelli JA, Bhatt DL, Linnenbringer E, Butson MB, Fasaye GA, Uhlmann WR, Hiraki S, Wang N, Cook-Deegan R, Green RC; REVEAL Study Group*.","Ann Intern Med. 2016 Feb 2;164(3):155-63. doi: 10.7326/M15-0187. Epub 2016 Jan 26.","Christensen KD","Ann Intern Med","2016","2016/01/27","PMC4979546","NIHMS805683","10.7326/M15-0187"
"22086747","Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer's disease and vascular dementia: results from a randomised controlled trial","Ihl R, Tribanek M, Bachinskaya N; GOTADAY Study Group.","Pharmacopsychiatry. 2012 Mar;45(2):41-6. doi: 10.1055/s-0031-1291217. Epub 2011 Nov 15.","Ihl R","Pharmacopsychiatry","2012","2011/11/17","","","10.1055/s-0031-1291217"
"25826319","Anti-aβ oligomer IgG and surface sialic acid in intravenous immunoglobulin: measurement and correlation with clinical outcomes in Alzheimer's disease treatment","Kwon H, Crisostomo AC, Smalls HM, Finke JM.","PLoS One. 2015 Mar 31;10(3):e0120420. doi: 10.1371/journal.pone.0120420. eCollection 2015.","Kwon H","PLoS One","2015","2015/04/01","PMC4380445","","10.1371/journal.pone.0120420"
"9876959","A 25-week placebo-controlled study of eptastigmine in patients with Alzheimer disease","Imbimbo BP, Lucca U, Lucchelli F, Alberoni M, Thal LJ.","Alzheimer Dis Assoc Disord. 1998 Dec;12(4):313-22. doi: 10.1097/00002093-199812000-00011.","Imbimbo BP","Alzheimer Dis Assoc Disord","1998","1999/01/07","","","10.1097/00002093-199812000-00011"
"12117361","Down syndrome and Alzheimer disease: response to donepezil","Lott IT, Osann K, Doran E, Nelson L.","Arch Neurol. 2002 Jul;59(7):1133-6. doi: 10.1001/archneur.59.7.1133.","Lott IT","Arch Neurol","2002","2002/07/16","","","10.1001/archneur.59.7.1133"
"12011303","Mifepristone (RU 486) for Alzheimer's disease","Pomara N, Doraiswamy PM, Tun H, Ferris S.","Neurology. 2002 May 14;58(9):1436. doi: 10.1212/wnl.58.9.1436.","Pomara N","Neurology","2002","2002/05/16","","","10.1212/wnl.58.9.1436"
"27780331","Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease","Cavedo E, Dubois B, Colliot O, Lista S, Croisile B, Tisserand GL, Touchon J, Bonafe A, Ousset PJ, Rouaud O, Ricolfi F, Vighetto A, Pasquier F, Galluzzi S, Delmaire C, Ceccaldi M, Girard N, Lehericy S, Duveau F, Chupin M, Sarazin M, Dormont D, Hampel H; Hippocampus Study Group.","J Clin Psychiatry. 2016 Dec;77(12):e1631-e1638. doi: 10.4088/JCP.15m10413.","Cavedo E","J Clin Psychiatry","2016","2016/10/26","","","10.4088/JCP.15m10413"
"17507923","A positron emission tomography study to assess binding of lecozotan, a novel 5-hydroxytryptamine-1A silent antagonist, to brain 5-HT1A receptors in healthy young and elderly subjects, and in patients with Alzheimer's disease","Raje S, Patat AA, Parks V, Schechter L, Plotka A, Paul J, Langstrom B.","Clin Pharmacol Ther. 2008 Jan;83(1):86-96. doi: 10.1038/sj.clpt.6100232. Epub 2007 May 16.","Raje S","Clin Pharmacol Ther","2008","2007/05/18","","","10.1038/sj.clpt.6100232"
"1457622","EEG mapping and psychopharmacological studies with denbufylline in SDAT and MID","Saletu B, Anderer P, Fischhof PK, Lorenz H, Barousch R, Böhmer F.","Biol Psychiatry. 1992 Oct 15;32(8):668-81. doi: 10.1016/0006-3223(92)90296-c.","Saletu B","Biol Psychiatry","1992","1992/10/15","","","10.1016/0006-3223(92)90296-c"
"16710109","Regional cerebral blood flow in the assessment of major depression and Alzheimer's disease in the early elderly","Hanada K, Hosono M, Kudo T, Hitomi Y, Yagyu Y, Kirime E, Komeya Y, Tsujii N, Hitomi K, Nishimura Y.","Nucl Med Commun. 2006 Jun;27(6):535-41. doi: 10.1097/00006231-200606000-00010.","Hanada K","Nucl Med Commun","2006","2006/05/20","","","10.1097/00006231-200606000-00010"
"15380822","Ethyl-EPA in Alzheimer's disease--a pilot study","Boston PF, Bennett A, Horrobin DF, Bennett CN.","Prostaglandins Leukot Essent Fatty Acids. 2004 Nov;71(5):341-6. doi: 10.1016/j.plefa.2004.07.001.","Boston PF","Prostaglandins Leukot Essent Fatty Acids","2004","2004/09/24","","","10.1016/j.plefa.2004.07.001"
"16175018","Characteristics of visual target influence detection of change in naturalistic scenes in Alzheimer disease","Neargarder SA, Cronin-Golomb A.","Cogn Behav Neurol. 2005 Sep;18(3):151-8. doi: 10.1097/01.wnn.0000178229.39068.9b.","Neargarder SA","Cogn Behav Neurol","2005","2005/09/22","","","10.1097/01.wnn.0000178229.39068.9b"
"10634454","Donepezil therapy in clinical practice: a randomized crossover study","Greenberg SM, Tennis MK, Brown LB, Gomez-Isla T, Hayden DL, Schoenfeld DA, Walsh KL, Corwin C, Daffner KR, Friedman P, Meadows ME, Sperling RA, Growdon JH.","Arch Neurol. 2000 Jan;57(1):94-9. doi: 10.1001/archneur.57.1.94.","Greenberg SM","Arch Neurol","2000","2000/01/14","","","10.1001/archneur.57.1.94"
"10815703","Semantic priming in patients with Alzheimer and semantic dementia","Nakamura H, Nakanishi M, Hamanaka T, Nakaaki S, Yoshida S.","Cortex. 2000 Apr;36(2):151-62. doi: 10.1016/s0010-9452(08)70521-5.","Nakamura H","Cortex","2000","2000/05/18","","","10.1016/s0010-9452(08)70521-5"
"24418055","Efficacy and safety evaluation of HSD-1 inhibitor ABT-384 in Alzheimer's disease","Marek GJ, Katz DA, Meier A, Greco N 4th, Zhang W, Liu W, Lenz RA.","Alzheimers Dement. 2014 Oct;10(5 Suppl):S364-73. doi: 10.1016/j.jalz.2013.09.010. Epub 2014 Jan 10.","Marek GJ","Alzheimers Dement","2014","2014/01/15","","","10.1016/j.jalz.2013.09.010"
"19833161","Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease","Penner J, Rupsingh R, Smith M, Wells JL, Borrie MJ, Bartha R.","Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):104-10. doi: 10.1016/j.pnpbp.2009.10.007. Epub 2009 Oct 13.","Penner J","Prog Neuropsychopharmacol Biol Psychiatry","2010","2009/10/17","","","10.1016/j.pnpbp.2009.10.007"
"27521377","Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial","Charlesworth G, Burnell K, Crellin N, Hoare Z, Hoe J, Knapp M, Russell I, Wenborn J, Woods B, Orrell M.","J Neurol Neurosurg Psychiatry. 2016 Nov;87(11):1218-1228. doi: 10.1136/jnnp-2016-313736. Epub 2016 Aug 12.","Charlesworth G","J Neurol Neurosurg Psychiatry","2016","2016/08/14","PMC5099314","","10.1136/jnnp-2016-313736"
"10445898","Effects of the Medicare Alzheimer's Disease Demonstration on nursing home entry","Miller R, Newcomer R, Fox P.","Health Serv Res. 1999 Aug;34(3):691-714.","Miller R","Health Serv Res","1999","1999/08/13","PMC1089033","",""
"1454835","Methodologic aspects of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine","Holford NH, Peace KE.","Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11466-70. doi: 10.1073/pnas.89.23.11466.","Holford NH","Proc Natl Acad Sci U S A","1992","1992/12/01","PMC50572","","10.1073/pnas.89.23.11466"
"9065320","The use of SPECT in a multidisciplinary memory clinic","Pasquier F, Lavenu I, Lebert F, Jacob B, Steinling M, Petit H.","Dement Geriatr Cogn Disord. 1997 Mar-Apr;8(2):85-91. doi: 10.1159/000106669.","Pasquier F","Dement Geriatr Cogn Disord","1997","1997/03/01","","","10.1159/000106669"
"16445950","The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer's disease patients","Reale M, Iarlori C, Gambi F, Feliciani C, Isabella L, Gambi D.","Neuropharmacology. 2006 Apr;50(5):606-13. doi: 10.1016/j.neuropharm.2005.11.006. Epub 2006 Jan 30.","Reale M","Neuropharmacology","2006","2006/02/01","","","10.1016/j.neuropharm.2005.11.006"
"12605619","Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial","Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M.","J Clin Pharm Ther. 2003 Feb;28(1):53-9. doi: 10.1046/j.1365-2710.2003.00463.x.","Akhondzadeh S","J Clin Pharm Ther","2003","2003/02/28","","","10.1046/j.1365-2710.2003.00463.x"
"2193838","A review of long-term safety data with buflomedil","Bachand RT, Dubourg AY.","J Int Med Res. 1990 May-Jun;18(3):245-52. doi: 10.1177/030006059001800311.","Bachand RT","J Int Med Res","1990","1990/05/01","","","10.1177/030006059001800311"
"14719691","Accurate template-based correction of brain MRI intensity distortion with application to dementia and aging","Studholme C, Cardenas V, Song E, Ezekiel F, Maudsley A, Weiner M.","IEEE Trans Med Imaging. 2004 Jan;23(1):99-110. doi: 10.1109/TMI.2003.820029.","Studholme C","IEEE Trans Med Imaging","2004","2004/01/15","PMC2291516","NIHMS17120","10.1109/TMI.2003.820029"
"12913198","Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD","Schuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, Jagust WJ, Chui HC, Kramer JH, Reed BR, Miller BL, Yaffe K, Weiner MW.","Neurology. 2003 Aug 12;61(3):358-64. doi: 10.1212/01.wnl.0000078942.63360.22.","Schuff N","Neurology","2003","2003/08/13","PMC1820863","NIHMS17061","10.1212/01.wnl.0000078942.63360.22"
"11256873","Frail older women's participation in a trial of hormone replacement therapy: perceived benefits and concerns","Jeffe DB, Binder EF, Williams DB, Kohrt WM.","Menopause. 2001 Summer;8(2):127-34. doi: 10.1097/00042192-200103000-00008.","Jeffe DB","Menopause","2001","2001/03/21","","","10.1097/00042192-200103000-00008"
"14991240","Effects of partial volume correction on discrimination between very early Alzheimer's dementia and controls using brain perfusion SPECT","Kanetaka H, Matsuda H, Asada T, Ohnishi T, Yamashita F, Imabayashi E, Tanaka F, Nakano S, Takasaki M.","Eur J Nucl Med Mol Imaging. 2004 Jul;31(7):975-80. doi: 10.1007/s00259-004-1491-3. Epub 2004 Feb 28.","Kanetaka H","Eur J Nucl Med Mol Imaging","2004","2004/03/03","","","10.1007/s00259-004-1491-3"
"3006861","Cholinergic approaches to the treatment of Alzheimer's disease","Hollander E, Mohs RC, Davis KL.","Br Med Bull. 1986 Jan;42(1):97-100. doi: 10.1093/oxfordjournals.bmb.a072106.","Hollander E","Br Med Bull","1986","1986/01/01","","","10.1093/oxfordjournals.bmb.a072106"
"31692559","Utilization, effect, and benefit of the individualized Meeting Centers Support Program for people with dementia and caregivers","Dröes RM, van Rijn A, Rus E, Dacier S, Meiland F.","Clin Interv Aging. 2019 Aug 26;14:1527-1553. doi: 10.2147/CIA.S212852. eCollection 2019.","Dröes RM","Clin Interv Aging","2019","2019/11/07","PMC6717152","","10.2147/CIA.S212852"
"23589097","Effects of the Finnish Alzheimer disease exercise trial (FINALEX): a randomized controlled trial","Pitkälä KH, Pöysti MM, Laakkonen ML, Tilvis RS, Savikko N, Kautiainen H, Strandberg TE.","JAMA Intern Med. 2013 May 27;173(10):894-901. doi: 10.1001/jamainternmed.2013.359.","Pitkälä KH","JAMA Intern Med","2013","2013/04/17","","","10.1001/jamainternmed.2013.359"
"6149490","Preliminary report: intracranial cholinergic drug infusion in patients with Alzheimer's disease","Harbaugh RE, Roberts DW, Coombs DW, Saunders RL, Reeder TM.","Neurosurgery. 1984 Oct;15(4):514-8. doi: 10.1227/00006123-198410000-00007.","Harbaugh RE","Neurosurgery","1984","1984/10/01","","","10.1227/00006123-198410000-00007"
"11255448","Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment","Borroni B, Colciaghi F, Pastorino L, Pettenati C, Cottini E, Rozzini L, Monastero R, Lenzi GL, Cattabeni F, Di Luca M, Padovani A.","Arch Neurol. 2001 Mar;58(3):442-6. doi: 10.1001/archneur.58.3.442.","Borroni B","Arch Neurol","2001","2001/03/20","","","10.1001/archneur.58.3.442"
"11351141","Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease","Doody RS, Dunn JK, Clark CM, Farlow M, Foster NL, Liao T, Gonzales N, Lai E, Massman P.","Dement Geriatr Cogn Disord. 2001 Jul-Aug;12(4):295-300. doi: 10.1159/000051272.","Doody RS","Dement Geriatr Cogn Disord","2001","2001/05/15","","","10.1159/000051272"
"12456070","Improved global function and activities of daily living in patients with AD: a placebo-controlled clinical study with the neurotrophic agent Cerebrolysin","Muresanu DF, Rainer M, Moessler H.","J Neural Transm Suppl. 2002;(62):277-85. doi: 10.1007/978-3-7091-6139-5_25.","Muresanu DF","J Neural Transm Suppl","2002","2002/11/29","","","10.1007/978-3-7091-6139-5_25"
"11502917","A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients","Mohs RC, Doody RS, Morris JC, Ieni JR, Rogers SL, Perdomo CA, Pratt RD; ""312"" Study Group.","Neurology. 2001 Aug 14;57(3):481-8. doi: 10.1212/wnl.57.3.481.","Mohs RC","Neurology","2001","2001/08/15","","","10.1212/wnl.57.3.481"
"17274394","[Tanakan (EGb 761) in the therapy of mild cognitive impairment]","Iakhno NN, Zakharov VV, Lokshina AB, Gavrilova SI, Fedorova IaB, Gustov AV, Korshunova IuA, Dziak LA, Miziakina EV, Odinak MM, Emelin AIu, PilipenkoP I, Vostrikova EV.","Zh Nevrol Psikhiatr Im S S Korsakova. 2006;106(12):41-6.","Iakhno NN","Zh Nevrol Psikhiatr Im S S Korsakova","2006","2007/02/06","","",""
"14511168","Training caregivers to change the sleep hygiene practices of patients with dementia: the NITE-AD project","McCurry SM, Gibbons LE, Logsdon RG, Vitiello M, Teri L.","J Am Geriatr Soc. 2003 Oct;51(10):1455-60. doi: 10.1046/j.1532-5415.2003.51466.x.","McCurry SM","J Am Geriatr Soc","2003","2003/09/27","","","10.1046/j.1532-5415.2003.51466.x"
"26482056","A Randomized Placebo-Controlled Discontinuation Study of Cholinesterase Inhibitors in Institutionalized Patients With Moderate to Severe Alzheimer Disease","Herrmann N, O'Regan J, Ruthirakuhan M, Kiss A, Eryavec G, Williams E, Lanctôt KL.","J Am Med Dir Assoc. 2016 Feb;17(2):142-7. doi: 10.1016/j.jamda.2015.08.019. Epub 2015 Oct 9.","Herrmann N","J Am Med Dir Assoc","2016","2015/10/21","","","10.1016/j.jamda.2015.08.019"
"31595772","Is Benzodiazepine Use Associated With the Risk of Dementia and Cognitive Impairment-Not Dementia in Older Persons? The Canadian Study of Health and Aging","Nafti M, Sirois C, Kröger E, Carmichael PH, Laurin D.","Ann Pharmacother. 2020 Mar;54(3):219-225. doi: 10.1177/1060028019882037. Epub 2019 Oct 9.","Nafti M","Ann Pharmacother","2020","2019/10/10","","","10.1177/1060028019882037"
"19199870","Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients","Nordberg A, Darreh-Shori T, Peskind E, Soininen H, Mousavi M, Eagle G, Lane R.","Curr Alzheimer Res. 2009 Feb;6(1):4-14. doi: 10.2174/156720509787313961.","Nordberg A","Curr Alzheimer Res","2009","2009/02/10","PMC4046577","NIHMS101565","10.2174/156720509787313961"
"10214735","A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer's disease","Thal LJ, Ferguson JM, Mintzer J, Raskin A, Targum SD.","Neurology. 1999 Apr 12;52(6):1146-52. doi: 10.1212/wnl.52.6.1146.","Thal LJ","Neurology","1999","1999/04/24","","","10.1212/wnl.52.6.1146"
"30272094","Effect of Multidomain Intervention, Omega-3 Polyunsaturated Fatty Acids Supplementation or their Combinaison on Cognitive Function in Non-Demented Older Adults According to Frail Status: Results from the MAPT Study","Tabue-Teguo M, Barreto de Souza P, Cantet C, Andrieu S, Simo N, Fougère B, Dartigues JF, Vellas B.","J Nutr Health Aging. 2018;22(8):923-927. doi: 10.1007/s12603-018-1024-6.","Tabue-Teguo M","J Nutr Health Aging","2018","2018/10/02","","","10.1007/s12603-018-1024-6"
"11803237","Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease","Le Bars PL, Velasco FM, Ferguson JM, Dessain EC, Kieser M, Hoerr R.","Neuropsychobiology. 2002;45(1):19-26. doi: 10.1159/000048668.","Le Bars PL","Neuropsychobiology","2002","2002/01/23","","","10.1159/000048668"
"12837675","Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease","Lu CJ, Tune LE.","Am J Geriatr Psychiatry. 2003 Jul-Aug;11(4):458-61.","Lu CJ","Am J Geriatr Psychiatry","2003","2003/07/03","","",""
"18322263","Safety and efficacy of galantamine in subjects with mild cognitive impairment","Winblad B, Gauthier S, Scinto L, Feldman H, Wilcock GK, Truyen L, Mayorga AJ, Wang D, Brashear HR, Nye JS; GAL-INT-11/18 Study Group.","Neurology. 2008 May 27;70(22):2024-35. doi: 10.1212/01.wnl.0000303815.69777.26. Epub 2008 Mar 5.","Winblad B","Neurology","2008","2008/03/07","","","10.1212/01.wnl.0000303815.69777.26"
"17646619","IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease","Winblad B, Grossberg G, Frölich L, Farlow M, Zechner S, Nagel J, Lane R.","Neurology. 2007 Jul 24;69(4 Suppl 1):S14-22. doi: 10.1212/01.wnl.0000281847.17519.e0.","Winblad B","Neurology","2007","2007/07/31","","","10.1212/01.wnl.0000281847.17519.e0"
"22987781","Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease","Wu G, Sankaranarayanan S, Wong J, Tugusheva K, Michener MS, Shi X, Cook JJ, Simon AJ, Savage MJ.","J Neurosci Res. 2012 Dec;90(12):2247-58. doi: 10.1002/jnr.23122. Epub 2012 Sep 18.","Wu G","J Neurosci Res","2012","2012/09/19","","","10.1002/jnr.23122"
"19179833","Serum albumin level interferes with the effect of donepezil in Alzheimer's disease","Rozzini L, Chilovi BV, Bertoletti E, Ghianda D, Conti M, Trabucchi M, Padovani A.","Aging Clin Exp Res. 2008 Dec;20(6):509-12. doi: 10.1007/BF03324877.","Rozzini L","Aging Clin Exp Res","2008","2009/01/31","","","10.1007/BF03324877"
"18319598","Voxel-based analysis of gray matter and CSF space in idiopathic normal pressure hydrocephalus","Ishii K, Kawaguchi T, Shimada K, Ohkawa S, Miyamoto N, Kanda T, Uemura T, Yoshikawa T, Mori E.","Dement Geriatr Cogn Disord. 2008;25(4):329-35. doi: 10.1159/000119521. Epub 2008 Mar 5.","Ishii K","Dement Geriatr Cogn Disord","2008","2008/03/06","","","10.1159/000119521"
"16554498","Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial","Rockwood K, Fay S, Song X, MacKnight C, Gorman M; Video-Imaging Synthesis of Treating Alzheimer's Disease (VISTA) Investigators.","CMAJ. 2006 Apr 11;174(8):1099-105. doi: 10.1503/cmaj.051432. Epub 2006 Mar 22.","Rockwood K","CMAJ","2006","2006/03/24","PMC1421447","","10.1503/cmaj.051432"
"30099030","Neural correlates of liraglutide effects in persons at risk for Alzheimer's disease","Watson KT, Wroolie TE, Tong G, Foland-Ross LC, Frangou S, Singh M, McIntyre RS, Roat-Shumway S, Myoraku A, Reiss AL, Rasgon NL.","Behav Brain Res. 2019 Jan 1;356:271-278. doi: 10.1016/j.bbr.2018.08.006. Epub 2018 Aug 9.","Watson KT","Behav Brain Res","2019","2018/08/13","","","10.1016/j.bbr.2018.08.006"
"20505438","A single ascending dose study of bapineuzumab in patients with Alzheimer disease","Black RS, Sperling RA, Safirstein B, Motter RN, Pallay A, Nichols A, Grundman M.","Alzheimer Dis Assoc Disord. 2010 Apr-Jun;24(2):198-203. doi: 10.1097/WAD.0b013e3181c53b00.","Black RS","Alzheimer Dis Assoc Disord","2010","2010/05/28","PMC3715117","NIHMS487723","10.1097/WAD.0b013e3181c53b00"
"23887837","Cerebral atherosclerosis is associated with cystic infarcts and microinfarcts but not Alzheimer pathologic changes","Zheng L, Vinters HV, Mack WJ, Zarow C, Ellis WG, Chui HC.","Stroke. 2013 Oct;44(10):2835-41. doi: 10.1161/STROKEAHA.113.001945. Epub 2013 Jul 25.","Zheng L","Stroke","2013","2013/07/27","PMC4049465","NIHMS581803","10.1161/STROKEAHA.113.001945"
"25528280","SAIDO learning as a cognitive intervention for dementia care: a preliminary study","Kawashima R, Hiller DL, Sereda SL, Antonczak M, Serger K, Gannon D, Ito S, Otake H, Yunomae D, Kobayashi A, Muller C, Murata H, FallCreek S.","J Am Med Dir Assoc. 2015 Jan;16(1):56-62. doi: 10.1016/j.jamda.2014.10.021.","Kawashima R","J Am Med Dir Assoc","2015","2014/12/22","","","10.1016/j.jamda.2014.10.021"
"12937336","Change in indices of distress among Latino and Anglo female caregivers of elderly relatives with dementia: site-specific results from the REACH national collaborative study","Gallagher-Thompson D, Coon DW, Solano N, Ambler C, Rabinowitz Y, Thompson LW.","Gerontologist. 2003 Aug;43(4):580-91. doi: 10.1093/geront/43.4.580.","Gallagher-Thompson D","Gerontologist","2003","2003/08/26","","","10.1093/geront/43.4.580"
"8591497","ComputerLink: the impact of a computer network on Alzheimer's caregivers' decision-making confidence and skill","Casper GR, Calvitti A, Brennan PF, Overholt JL.","Medinfo. 1995;8 Pt 2:1546.","Casper GR","Medinfo","1995","1995/01/01","","",""
"12578931","Atrophy rates of entorhinal cortex in AD and normal aging","Du AT, Schuff N, Zhu XP, Jagust WJ, Miller BL, Reed BR, Kramer JH, Mungas D, Yaffe K, Chui HC, Weiner MW.","Neurology. 2003 Feb 11;60(3):481-6. doi: 10.1212/01.wnl.0000044400.11317.ec.","Du AT","Neurology","2003","2003/02/13","PMC1851672","NIHMS17045","10.1212/01.wnl.0000044400.11317.ec"
"7045914","Clinical trials of neuropeptides in psychiatric disorders","","Psychopharmacol Bull. 1982 Jan;18(1):44-9.","","Psychopharmacol Bull","1982","1982/01/01","","",""
"20501908","In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)","Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, Dannals RF, Nandi A, Brasić JR, Ye W, Hilton J, Lyketsos C, Kung HF, Joshi AD, Skovronsky DM, Pontecorvo MJ.","J Nucl Med. 2010 Jun;51(6):913-20. doi: 10.2967/jnumed.109.069088.","Wong DF","J Nucl Med","2010","2010/05/27","PMC3101877","NIHMS260423","10.2967/jnumed.109.069088"
"19017911","Ginkgo biloba for prevention of dementia: a randomized controlled trial","DeKosky ST, Williamson JD, Fitzpatrick AL, Kronmal RA, Ives DG, Saxton JA, Lopez OL, Burke G, Carlson MC, Fried LP, Kuller LH, Robbins JA, Tracy RP, Woolard NF, Dunn L, Snitz BE, Nahin RL, Furberg CD; Ginkgo Evaluation of Memory (GEM) Study Investigators.","JAMA. 2008 Nov 19;300(19):2253-62. doi: 10.1001/jama.2008.683.","DeKosky ST","JAMA","2008","2008/11/20","PMC2823569","NIHMS103555","10.1001/jama.2008.683"
"24461047","Galantamine treatment in outpatients with mild Alzheimer's disease","Richarz U, Gaudig M, Rettig K, Schauble B.","Acta Neurol Scand. 2014 Jun;129(6):382-92. doi: 10.1111/ane.12195. Epub 2014 Jan 25.","Richarz U","Acta Neurol Scand","2014","2014/01/28","","","10.1111/ane.12195"
"12077953","Religious beliefs and practices in acute mental health patients","Hilton C, Ghaznavi F, Zuberi T.","Nurs Stand. 2002 Jun 5-11;16(38):33-6. doi: 10.7748/ns2002.06.16.38.33.c3204.","Hilton C","Nurs Stand","2002","2002/06/25","","","10.7748/ns2002.06.16.38.33.c3204"
"17982894","Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis","Hager K, Kenklies M, McAfoose J, Engel J, Münch G.","J Neural Transm Suppl. 2007;(72):189-93. doi: 10.1007/978-3-211-73574-9_24.","Hager K","J Neural Transm Suppl","2007","2007/11/07","","","10.1007/978-3-211-73574-9_24"
"31182351","Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease","Herrmann N, Ruthirakuhan M, Gallagher D, Verhoeff NPLG, Kiss A, Black SE, Lanctôt KL.","Am J Geriatr Psychiatry. 2019 Nov;27(11):1161-1173. doi: 10.1016/j.jagp.2019.05.002. Epub 2019 May 8.","Herrmann N","Am J Geriatr Psychiatry","2019","2019/06/12","","","10.1016/j.jagp.2019.05.002"
"18854539","High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial","Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, Thal LJ; Alzheimer Disease Cooperative Study.","JAMA. 2008 Oct 15;300(15):1774-83. doi: 10.1001/jama.300.15.1774.","Aisen PS","JAMA","2008","2008/10/16","PMC2684821","NIHMS80270","10.1001/jama.300.15.1774"
"19995097","Rivastigmine transdermal patch skin tolerability: results of a 1-year clinical trial in patients with mild-to-moderate Alzheimer's disease","Cummings JL, Farlow MR, Meng X, Tekin S, Olin JT.","Clin Drug Investig. 2010;30(1):41-9. doi: 10.2165/11531270-000000000-00000.","Cummings JL","Clin Drug Investig","2010","2009/12/10","","","10.2165/11531270-000000000-00000"
"9050958","Medial temporal lobe atrophy in memory disorders","Pasquier F, Hamon M, Lebert F, Jacob B, Pruvo JP, Petit H.","J Neurol. 1997 Mar;244(3):175-81. doi: 10.1007/s004150050069.","Pasquier F","J Neurol","1997","1997/03/01","","","10.1007/s004150050069"
"10227625","Neuropsychological correlates of apathy and depression in patients with dementia","Kuzis G, Sabe L, Tiberti C, Dorrego F, Starkstein SE.","Neurology. 1999 Apr 22;52(7):1403-7. doi: 10.1212/wnl.52.7.1403.","Kuzis G","Neurology","1999","1999/05/05","","","10.1212/wnl.52.7.1403"
"18825439","Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia","van Straaten EC, Harvey D, Scheltens P, Barkhof F, Petersen RC, Thal LJ, Jack CR Jr, DeCarli C; Alzheimer's Disease Cooperative Study Group.","J Neurol. 2008 Sep;255(9):1302-8. doi: 10.1007/s00415-008-0874-y. Epub 2008 Sep 25.","van Straaten EC","J Neurol","2008","2008/10/01","PMC2879405","NIHMS204576","10.1007/s00415-008-0874-y"
"35976758","The influence of Alzheimer's disease stigma on pain assessment in older persons","Vitou V, Gély-Nargeot MC, Jeandel C, Bayard S.","Dementia (London). 2022 Nov;21(8):2418-2441. doi: 10.1177/14713012221117907. Epub 2022 Aug 17.","Vitou V","Dementia (London)","2022","2022/08/17","","","10.1177/14713012221117907"
"22193353","Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease","Freitas S, Simões MR, Alves L, Santana I.","Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):37-43. doi: 10.1097/WAD.0b013e3182420bfe.","Freitas S","Alzheimer Dis Assoc Disord","2013","2011/12/24","","","10.1097/WAD.0b013e3182420bfe"
"33336219","Safety and Efficacy of Lemborexant in Patients With Irregular Sleep-Wake Rhythm Disorder and Alzheimer's Disease Dementia: Results From a Phase 2 Randomized Clinical Trial","Moline M, Thein S, Bsharat M, Rabbee N, Kemethofer-Waliczky M, Filippov G, Kubota N, Dhadda S.","J Prev Alzheimers Dis. 2021;8(1):7-18. doi: 10.14283/jpad.2020.69.","Moline M","J Prev Alzheimers Dis","2021","2020/12/18","","","10.14283/jpad.2020.69"
"19630974","DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT","Jones R, Sheehan B, Phillips P, Juszczak E, Adams J, Baldwin A, Ballard C, Banerjee S, Barber B, Bentham P, Brown R, Burns A, Dening T, Findlay D, Gray R, Griffin M, Holmes C, Hughes A, Jacoby R, Johnson T, Jones R, Knapp M, Lindesay J, McKeith I, McShane R, Macharouthu A, O'Brien J, Onions C, Passmore P, Raftery J, Ritchie C, Howard R; DOMINO-AD team.","Trials. 2009 Jul 24;10:57. doi: 10.1186/1745-6215-10-57.","Jones R","Trials","2009","2009/07/28","PMC2723100","","10.1186/1745-6215-10-57"
"15563479","Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology","Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B, Rosengren L, Vanmechelen E, Blennow K.","Clin Chem. 2005 Feb;51(2):336-45. doi: 10.1373/clinchem.2004.039347. Epub 2004 Nov 24.","Olsson A","Clin Chem","2005","2004/11/26","","","10.1373/clinchem.2004.039347"
"12611755","A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease","Aisen PS, Egelko S, Andrews H, Diaz-Arrastia R, Weiner M, DeCarli C, Jagust W, Miller JW, Green R, Bell K, Sano M.","Am J Geriatr Psychiatry. 2003 Mar-Apr;11(2):246-9.","Aisen PS","Am J Geriatr Psychiatry","2003","2003/03/04","","",""
"20962290","Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease","Tokuda T, Qureshi MM, Ardah MT, Varghese S, Shehab SA, Kasai T, Ishigami N, Tamaoka A, Nakagawa M, El-Agnaf OM.","Neurology. 2010 Nov 16;75(20):1766-72. doi: 10.1212/WNL.0b013e3181fd613b. Epub 2010 Oct 20.","Tokuda T","Neurology","2010","2010/10/22","","","10.1212/WNL.0b013e3181fd613b"
"8730823","Polymorphism in AACT gene may lower age of onset of Alzheimer's disease","Talbot C, Houlden H, Craddock N, Crook R, Hutton M, Lendon C, Prihar G, Morris JC, Hardy J, Goate A.","Neuroreport. 1996 Jan 31;7(2):534-6. doi: 10.1097/00001756-199601310-00038.","Talbot C","Neuroreport","1996","1996/01/31","","","10.1097/00001756-199601310-00038"
"18178372","Trail Making Test errors in normal aging, mild cognitive impairment, and dementia","Ashendorf L, Jefferson AL, O'Connor MK, Chaisson C, Green RC, Stern RA.","Arch Clin Neuropsychol. 2008 Mar;23(2):129-37. doi: 10.1016/j.acn.2007.11.005. Epub 2008 Feb 21.","Ashendorf L","Arch Clin Neuropsychol","2008","2008/01/08","PMC2693196","NIHMS45912","10.1016/j.acn.2007.11.005"
"20473136","Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers","Serrano-Pozo A, Vega GL, Lütjohann D, Locascio JJ, Tennis MK, Deng A, Atri A, Hyman BT, Irizarry MC, Growdon JH.","Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):220-6. doi: 10.1097/WAD.0b013e3181d61fea.","Serrano-Pozo A","Alzheimer Dis Assoc Disord","2010","2010/05/18","PMC3694274","NIHMS486252","10.1097/WAD.0b013e3181d61fea"
"23583001","Effects of SolCos model-based individual reminiscence on older adults with mild to moderate dementia due to Alzheimer disease: a pilot study","Van Bogaert P, Van Grinsven R, Tolson D, Wouters K, Engelborghs S, Van der Mussele S.","J Am Med Dir Assoc. 2013 Jul;14(7):528.e9-13. doi: 10.1016/j.jamda.2013.01.020. Epub 2013 Apr 9.","Van Bogaert P","J Am Med Dir Assoc","2013","2013/04/16","","","10.1016/j.jamda.2013.01.020"
"15259397","Cognitive impairment in dementia: correlations with atrophy and cerebrovascular disease quantified by magnetic resonance imaging","Swartz RH, Black SE, Sela G, Bronskill MJ.","Brain Cogn. 2002 Jul;49(2):228-32.","Swartz RH","Brain Cogn","2002","2004/07/21","","",""
"7777138","Hypothalamic-pituitary-adrenal system function in patients with Alzheimer's disease","Hatzinger M, Z'Brun A, Hemmeter U, Seifritz E, Baumann F, Holsboer-Trachsler E, Heuser IJ.","Neurobiol Aging. 1995 Mar-Apr;16(2):205-9. doi: 10.1016/0197-4580(94)00159-6.","Hatzinger M","Neurobiol Aging","1995","1995/03/01","","","10.1016/0197-4580(94)00159-6"
"11959402","Taste, smell and neuropsychological performance of individuals at familial risk for Alzheimer's disease","Schiffman SS, Graham BG, Sattely-Miller EA, Zervakis J, Welsh-Bohmer K.","Neurobiol Aging. 2002 May-Jun;23(3):397-404. doi: 10.1016/s0197-4580(01)00337-2.","Schiffman SS","Neurobiol Aging","2002","2002/04/18","","","10.1016/s0197-4580(01)00337-2"
"7198209","Alzheimer disease: lack of effect of lecithin treatment for 3 months","Etienne P, Dastoor D, Gauthier S, Ludwick R, Collier B.","Neurology. 1981 Dec;31(12):1552-4. doi: 10.1212/wnl.31.12.1552.","Etienne P","Neurology","1981","1981/12/01","","","10.1212/wnl.31.12.1552"
"1776744","Efficacy of CDP-choline in the treatment of senile alterations in memory","de la Morena E.","Ann N Y Acad Sci. 1991;640:233-6. doi: 10.1111/j.1749-6632.1991.tb00224.x.","de la Morena E","Ann N Y Acad Sci","1991","1991/01/01","","","10.1111/j.1749-6632.1991.tb00224.x"
"33683313","Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial","Nasrallah IM, Gaussoin SA, Pomponio R, Dolui S, Erus G, Wright CB, Launer LJ, Detre JA, Wolk DA, Davatzikos C, Williamson JD, Pajewski NM, Bryan RN; SPRINT Research Group.","JAMA Neurol. 2021 May 1;78(5):568-577. doi: 10.1001/jamaneurol.2021.0178.","Nasrallah IM","JAMA Neurol","2021","2021/03/08","PMC7941253","NIHMS1681875","10.1001/jamaneurol.2021.0178"
"11255440","Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice","Andreasen N, Minthon L, Davidsson P, Vanmechelen E, Vanderstichele H, Winblad B, Blennow K.","Arch Neurol. 2001 Mar;58(3):373-9. doi: 10.1001/archneur.58.3.373.","Andreasen N","Arch Neurol","2001","2001/03/20","","","10.1001/archneur.58.3.373"
"10867779","Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study","Ganguli M, Chandra V, Kamboh MI, Johnston JM, Dodge HH, Thelma BK, Juyal RC, Pandav R, Belle SH, DeKosky ST.","Arch Neurol. 2000 Jun;57(6):824-30. doi: 10.1001/archneur.57.6.824.","Ganguli M","Arch Neurol","2000","2000/06/27","","","10.1001/archneur.57.6.824"
"17324246","Population pharmacokinetic modelling of NS2330 (tesofensine) and its major metabolite in patients with Alzheimer's disease","Lehr T, Staab A, Tillmann C, Trommeshauser D, Raschig A, Schaefer HG, Kloft C.","Br J Clin Pharmacol. 2007 Jul;64(1):36-48. doi: 10.1111/j.1365-2125.2007.02855.x. Epub 2007 Feb 23.","Lehr T","Br J Clin Pharmacol","2007","2007/02/28","PMC2000606","","10.1111/j.1365-2125.2007.02855.x"
"11748787","The central cholinergic system profile of olanzapine compared with placebo in Alzheimer's disease","Kennedy JS, Zagar A, Bymaster F, Nomikos G, Trzepacz PT, Gilmore JA, Rotelli MD, Breier A, Tollefson G.","Int J Geriatr Psychiatry. 2001 Dec;16 Suppl 1:S24-32. doi: 10.1002/1099-1166(200112)16:1+<::aid-gps570>3.0.co;2-8.","Kennedy JS","Int J Geriatr Psychiatry","2001","2001/12/19","","","10.1002/1099-1166(200112)16:1+<::aid-gps570>3.0.co;2-8"
"32966585","Nighttime Agitation and Restless Legs Syndrome in Persons With Alzheimer's Disease: Study Protocol for a Double-Blind, Placebo-Controlled, Randomized Trial (NightRest)","Richards K, Morrison J, Wang YY, Rangel A, Loera A, Hanlon A, Lozano A, Kovach C, Gooneratne N, Fry L, Allen R.","Res Gerontol Nurs. 2020 Nov 1;13(6):280-288. doi: 10.3928/19404921-20200918-01. Epub 2020 Sep 24.","Richards K","Res Gerontol Nurs","2020","2020/09/23","PMC9112187","NIHMS1787367","10.3928/19404921-20200918-01"
"7871964","[Citalopram in treatment of behavioral disorders in demented patients]","Leblhuber F.","Acta Med Austriaca. 1994;21(4):104-6.","Leblhuber F","Acta Med Austriaca","1994","1994/01/01","","",""
"28821686","Effect of simvastatin on CSF Alzheimer disease biomarkers in cognitively normal adults","Li G, Mayer CL, Morelli D, Millard SP, Raskind WH, Petrie EC, Cherrier M, Fagan AM, Raskind MA, Peskind ER.","Neurology. 2017 Sep 19;89(12):1251-1255. doi: 10.1212/WNL.0000000000004392. Epub 2017 Aug 18.","Li G","Neurology","2017","2017/08/20","PMC5606918","","10.1212/WNL.0000000000004392"
"12714795","A large, community-based, open-label trial of donepezil in the treatment of Alzheimer's disease","Relkin NR, Reichman WE, Orazem J, McRae T.","Dement Geriatr Cogn Disord. 2003;16(1):15-24. doi: 10.1159/000069988.","Relkin NR","Dement Geriatr Cogn Disord","2003","2003/04/26","","","10.1159/000069988"
"27908967","Kinetic Modeling of the Tau PET Tracer (18)F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects","Barret O, Alagille D, Sanabria S, Comley RA, Weimer RM, Borroni E, Mintun M, Seneca N, Papin C, Morley T, Marek K, Seibyl JP, Tamagnan GD, Jennings D.","J Nucl Med. 2017 Jul;58(7):1124-1131. doi: 10.2967/jnumed.116.182881. Epub 2016 Dec 1.","Barret O","J Nucl Med","2017","2016/12/03","","","10.2967/jnumed.116.182881"
"7201100","Lysine vasopressin in Alzheimer disease","Durso R, Fedio P, Brouwers P, Cox C, Martin AJ, Ruggieri SA, Tamminga CA, Chase TN.","Neurology. 1982 Jun;32(6):674-7. doi: 10.1212/wnl.32.6.674.","Durso R","Neurology","1982","1982/06/01","","","10.1212/wnl.32.6.674"
"22686551","Telephone-based, cognitive-behavioral therapy for African American dementia caregivers with depression: initial findings","Glueckauf RL, Davis WS, Willis F, Sharma D, Gustafson DJ, Hayes J, Stutzman M, Proctor J, Kazmer MM, Murray L, Shipman J, McIntyre V, Wesley L, Schettini G, Xu J, Parfitt F, Graff-Radford N, Baxter C, Burnett K, Noël LT, Haire K, Springer J.","Rehabil Psychol. 2012 May;57(2):124-39. doi: 10.1037/a0028688.","Glueckauf RL","Rehabil Psychol","2012","2012/06/13","","","10.1037/a0028688"
"30383097","Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study: A Randomized Clinical Trial","Sha SJ, Deutsch GK, Tian L, Richardson K, Coburn M, Gaudioso JL, Marcal T, Solomon E, Boumis A, Bet A, Mennes M, van Oort E, Beckmann CF, Braithwaite SP, Jackson S, Nikolich K, Stephens D, Kerchner GA, Wyss-Coray T.","JAMA Neurol. 2019 Jan 1;76(1):35-40. doi: 10.1001/jamaneurol.2018.3288.","Sha SJ","JAMA Neurol","2019","2018/11/02","PMC6439869","","10.1001/jamaneurol.2018.3288"
"21707862","Pet therapy in elderly patients with mental illness","Moretti F, De Ronchi D, Bernabei V, Marchetti L, Ferrari B, Forlani C, Negretti F, Sacchetti C, Atti AR.","Psychogeriatrics. 2011 Jun;11(2):125-9. doi: 10.1111/j.1479-8301.2010.00329.x. Epub 2010 Sep 14.","Moretti F","Psychogeriatrics","2011","2011/06/29","","","10.1111/j.1479-8301.2010.00329.x"
"9469260","Epidermal growth factor receptor expression in skin does not predict dementia in the elderly","Styren SD, Styren GC, DeKosky ST.","Dement Geriatr Cogn Disord. 1998 Jan-Feb;9(1):20-3. doi: 10.1159/000017016.","Styren SD","Dement Geriatr Cogn Disord","1998","1998/02/20","","","10.1159/000017016"
"36501136","Extra-Virgin Olive Oil Enhances the Blood-Brain Barrier Function in Mild Cognitive Impairment: A Randomized Controlled Trial","Kaddoumi A, Denney TS Jr, Deshpande G, Robinson JL, Beyers RJ, Redden DT, Praticò D, Kyriakides TC, Lu B, Kirby AN, Beck DT, Merner ND.","Nutrients. 2022 Dec 1;14(23):5102. doi: 10.3390/nu14235102.","Kaddoumi A","Nutrients","2022","2022/12/11","PMC9736478","","10.3390/nu14235102"
"20930165","Aspirin in Alzheimer's disease: increased risk of intracerebral hemorrhage: cause for concern?","Thoonsen H, Richard E, Bentham P, Gray R, van Geloven N, De Haan RJ, Van Gool WA, Nederkoorn PJ.","Stroke. 2010 Nov;41(11):2690-2. doi: 10.1161/STROKEAHA.109.576975. Epub 2010 Oct 7.","Thoonsen H","Stroke","2010","2010/10/09","","","10.1161/STROKEAHA.109.576975"
"20077983","Therapeutic conversation to improve mood in nursing home residents with Alzheimer's disease","Tappen RM, Williams CL.","Res Gerontol Nurs. 2009 Oct;2(4):267-75. doi: 10.3928/19404921-20090428-02. Epub 2009 Oct 27.","Tappen RM","Res Gerontol Nurs","2009","2010/01/19","","","10.3928/19404921-20090428-02"
"8747138","Network analysis of PET-mapped visual pathways in Alzheimer type dementia","Horwitz B, McIntosh AR, Haxby JV, Furey M, Salerno JA, Schapiro MB, Rapoport SI, Grady CL.","Neuroreport. 1995 Nov 27;6(17):2287-92. doi: 10.1097/00001756-199511270-00005.","Horwitz B","Neuroreport","1995","1995/11/27","","","10.1097/00001756-199511270-00005"
"12928052","Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease","Sciacca FL, Ferri C, Licastro F, Veglia F, Biunno I, Gavazzi A, Calabrese E, Martinelli Boneschi F, Sorbi S, Mariani C, Franceschi M, Grimaldi LM.","Neurobiol Aging. 2003 Nov;24(7):927-31. doi: 10.1016/s0197-4580(03)00011-3.","Sciacca FL","Neurobiol Aging","2003","2003/08/21","","","10.1016/s0197-4580(03)00011-3"
"11044781","People with dementia use schemata to support episodic memory","Rusted J, Gaskell M, Watts S, Sheppard L.","Dement Geriatr Cogn Disord. 2000 Nov-Dec;11(6):350-6. doi: 10.1159/000017265.","Rusted J","Dement Geriatr Cogn Disord","2000","2000/10/25","","","10.1159/000017265"
"21840840","Effects of the TCARE® intervention on caregiver burden and depressive symptoms: preliminary findings from a randomized controlled study","Montgomery RJ, Kwak J, Kosloski K, O'Connell Valuch K.","J Gerontol B Psychol Sci Soc Sci. 2011 Sep;66(5):640-7. doi: 10.1093/geronb/gbr088.","Montgomery RJ","J Gerontol B Psychol Sci Soc Sci","2011","2011/08/16","PMC3202705","","10.1093/geronb/gbr088"
"9605727","Wide range of disease onset in a family with Alzheimer disease and a His163Tyr mutation in the presenilin-1 gene","Axelman K, Basun H, Lannfelt L.","Arch Neurol. 1998 May;55(5):698-702. doi: 10.1001/archneur.55.5.698.","Axelman K","Arch Neurol","1998","1998/05/30","","","10.1001/archneur.55.5.698"
"35135524","The effects of involvement in training and volunteering with families of people with dementia on the knowledge and attitudes of volunteers towards dementia","Cheung DSK, Ho LYW, Kwok RKH, Lai DLL, Lai CKY.","BMC Public Health. 2022 Feb 8;22(1):258. doi: 10.1186/s12889-022-12687-y.","Cheung DSK","BMC Public Health","2022","2022/02/09","PMC8822773","","10.1186/s12889-022-12687-y"
"31084336","Chronic Cortical Cerebral Microinfarcts Slow Down Cognitive Recovery After Acute Ischemic Stroke","Sagnier S, Okubo G, Catheline G, Munsch F, Bigourdan A, Debruxelles S, Poli M, Olindo S, Renou P, Rouanet F, Dousset V, Tourdias T, Sibon I.","Stroke. 2019 Jun;50(6):1430-1436. doi: 10.1161/STROKEAHA.118.024672. Epub 2019 May 14.","Sagnier S","Stroke","2019","2019/05/16","","","10.1161/STROKEAHA.118.024672"
"31628215","Predictive Value of (18)F-Florbetapir and (18)F-FDG PET for Conversion from Mild Cognitive Impairment to Alzheimer Dementia","Blazhenets G, Ma Y, Sörensen A, Schiller F, Rücker G, Eidelberg D, Frings L, Meyer PT; Alzheimer Disease Neuroimaging Initiative.","J Nucl Med. 2020 Apr;61(4):597-603. doi: 10.2967/jnumed.119.230797. Epub 2019 Oct 18.","Blazhenets G","J Nucl Med","2020","2019/10/20","PMC7198373","","10.2967/jnumed.119.230797"
"9363292","An open trial of valproate for agitation in geriatric neuropsychiatric disorders","Porsteinsson AP, Tariot PN, Erb R, Gaile S.","Am J Geriatr Psychiatry. 1997 Fall;5(4):344-51. doi: 10.1097/00019442-199700540-00010.","Porsteinsson AP","Am J Geriatr Psychiatry","1997","1997/11/18","","","10.1097/00019442-199700540-00010"
"16420138","Changes in social support as mediators of the impact of a psychosocial intervention for spouse caregivers of persons with Alzheimer's disease","Roth DL, Mittelman MS, Clay OJ, Madan A, Haley WE.","Psychol Aging. 2005 Dec;20(4):634-44. doi: 10.1037/0882-7974.20.4.634.","Roth DL","Psychol Aging","2005","2006/01/20","","","10.1037/0882-7974.20.4.634"
"22309001","Are clinical diagnoses of Alzheimer's disease and other dementias affected by education and self-reported race?","Teresi JA, Grober E, Eimicke JP, Ehrlich AR.","Psychol Assess. 2012 Sep;24(3):531-44. doi: 10.1037/a0027008. Epub 2012 Feb 6.","Teresi JA","Psychol Assess","2012","2012/02/08","PMC3518032","NIHMS415904","10.1037/a0027008"
"12611754","17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary study","Baker LD, Sambamurti K, Craft S, Cherrier M, Raskind MA, Stanczyk FZ, Plymate SR, Asthana S.","Am J Geriatr Psychiatry. 2003 Mar-Apr;11(2):239-44.","Baker LD","Am J Geriatr Psychiatry","2003","2003/03/04","","",""
"14971605","Three-dimensional stereotactic surface projection of brain perfusion SPECT improves diagnosis of Alzheimer's disease","Honda N, Machida K, Matsumoto T, Matsuda H, Imabayashi E, Hashimoto J, Hosono M, Inoue Y, Koizum K, Kosuda S, Momose T, Mori Y, Oshima M.","Ann Nucl Med. 2003 Dec;17(8):641-8. doi: 10.1007/BF02984969.","Honda N","Ann Nucl Med","2003","2004/02/20","","","10.1007/BF02984969"
"2290848","Clinical testing of compounds modifying acute and chronic neurodegeneration in the CNS","Etienne P, Hakim A.","Prog Clin Biol Res. 1990;361:387-407.","Etienne P","Prog Clin Biol Res","1990","1990/01/01","","",""
"24192578","Effect of donepezil in Alzheimer disease can be measured by a computerized human analog of the Morris water maze","Hort J, Andel R, Mokrisova I, Gazova I, Amlerova J, Valis M, Coulson EJ, Harrison J, Windisch M, Laczó J.","Neurodegener Dis. 2014;13(2-3):192-6. doi: 10.1159/000355517. Epub 2013 Oct 30.","Hort J","Neurodegener Dis","2014","2013/11/07","","","10.1159/000355517"
"21937893","A randomized controlled trial of an activity specific exercise program for individuals with Alzheimer disease in long-term care settings","Roach KE, Tappen RM, Kirk-Sanchez N, Williams CL, Loewenstein D.","J Geriatr Phys Ther. 2011 Apr-Jun;34(2):50-6. doi: 10.1519/JPT.0b013e31820aab9c.","Roach KE","J Geriatr Phys Ther","2011","2011/09/23","PMC3179603","NIHMS272203","10.1519/JPT.0b013e31820aab9c"
"21407047","The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design","Devanand DP, Mintzer J, Schultz S, Sultzer D, de la Pena D, Gupta S, Colon S, Schimming C, Pelton GH, Andrews H, Levin B.","Am J Geriatr Psychiatry. 2012 Apr;20(4):362-73. doi: 10.1097/JGP.0b013e3182110563.","Devanand DP","Am J Geriatr Psychiatry","2012","2011/03/17","PMC3146556","NIHMS274784","10.1097/JGP.0b013e3182110563"
"22040605","Does theatre improve the quality of life of people with dementia?","van Dijk AM, van Weert JC, Dröes RM.","Int Psychogeriatr. 2012 Mar;24(3):367-81. doi: 10.1017/S1041610211001992. Epub 2011 Nov 1.","van Dijk AM","Int Psychogeriatr","2012","2011/11/02","","","10.1017/S1041610211001992"
"19453305","Development of the risk appraisal measure: a brief screen to identify risk areas and guide interventions for dementia caregivers","Czaja SJ, Gitlin LN, Schulz R, Zhang S, Burgio LD, Stevens AB, Nichols LO, Gallagher-Thompson D.","J Am Geriatr Soc. 2009 Jun;57(6):1064-72. doi: 10.1111/j.1532-5415.2009.02260.x. Epub 2009 Apr 21.","Czaja SJ","J Am Geriatr Soc","2009","2009/05/21","PMC2722069","NIHMS102383","10.1111/j.1532-5415.2009.02260.x"
"15945577","[ReduFix--a study of reducing physical restraint: preventing risk of injury]","Branitzki S, Koczy P.","Pflege Z. 2005 May;58(5):310-3.","Branitzki S","Pflege Z","2005","2005/06/11","","",""
"8974721","[Effectiveness of brief infusions with Ginkgo biloba Special Extract EGb 761 in dementia of the vascular and Alzheimer type]","Haase J, Halama P, Hörr R.","Z Gerontol Geriatr. 1996 Jul-Aug;29(4):302-9.","Haase J","Z Gerontol Geriatr","1996","1996/07/01","","",""
"33864068","Associations Between Physical Activity, Blood-Based Biomarkers of Neurodegeneration, and Cognition in Healthy Older Adults: The MAPT Study","Raffin J, Rolland Y, Aggarwal G, Nguyen AD, Morley JE, Li Y, Bateman RJ, Vellas B, Barreto PS; MAPT/DSA Group.","J Gerontol A Biol Sci Med Sci. 2021 Jul 13;76(8):1382-1390. doi: 10.1093/gerona/glab094.","Raffin J","J Gerontol A Biol Sci Med Sci","2021","2021/04/17","","","10.1093/gerona/glab094"
"20544413","EDUCA study: Psychometric properties of the Spanish version of the Zarit Caregiver Burden Scale","Martin-Carrasco M, Otermin P, Pérez-Camo V, Pujol J, Agüera L, Martín MJ, Gobartt AL, Pons S, Balañá M.","Aging Ment Health. 2010 Aug;14(6):705-11. doi: 10.1080/13607860903586094.","Martin-Carrasco M","Aging Ment Health","2010","2010/06/15","","","10.1080/13607860903586094"
"22747914","A benefit-finding intervention for family caregivers of persons with Alzheimer disease: study protocol of a randomized controlled trial","Cheng ST, Lau RW, Mak EP, Ng NS, Lam LC, Fung HH, Lai JC, Kwok T, Lee DT.","Trials. 2012 Jul 2;13:98. doi: 10.1186/1745-6215-13-98.","Cheng ST","Trials","2012","2012/07/04","PMC3413525","","10.1186/1745-6215-13-98"
"16955450","Early diagnosis of dementia in primary care: a representative eight-year follow-up study in Lower Saxony, Germany","Maeck L, Haak S, Knoblauch A, Stoppe G.","Int J Geriatr Psychiatry. 2007 Jan;22(1):23-31. doi: 10.1002/gps.1646.","Maeck L","Int J Geriatr Psychiatry","2007","2006/09/07","","","10.1002/gps.1646"
"22236802","Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial","Hanney M, Prasher V, Williams N, Jones EL, Aarsland D, Corbett A, Lawrence D, Yu LM, Tyrer S, Francis PT, Johnson T, Bullock R, Ballard C; MEADOWS trial researchers.","Lancet. 2012 Feb 11;379(9815):528-36. doi: 10.1016/S0140-6736(11)61676-0. Epub 2012 Jan 10.","Hanney M","Lancet","2012","2012/01/13","","","10.1016/S0140-6736(11)61676-0"
"12928048","Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease","Selley ML.","Neurobiol Aging. 2003 Nov;24(7):903-7. doi: 10.1016/s0197-4580(03)00007-1.","Selley ML","Neurobiol Aging","2003","2003/08/21","","","10.1016/s0197-4580(03)00007-1"
"34843329","Self-efficacy in controlling upsetting thoughts, but not positive gains, mediates the effects of benefit-finding group intervention for Alzheimer family caregivers","Cheng ST, Chan WC, Fung HH, Lam LCW.","Psychol Aging. 2022 Sep;37(6):766-775. doi: 10.1037/pag0000654. Epub 2021 Nov 29.","Cheng ST","Psychol Aging","2022","2021/11/29","","","10.1037/pag0000654"
"8872871","Cognitive effects of scopolamine in dementia","Rabey JM, Neufeld MY, Treves TA, Sifris P, Korczyn AD.","J Neural Transm (Vienna). 1996;103(7):873-81. doi: 10.1007/BF01273365.","Rabey JM","J Neural Transm (Vienna)","1996","1996/01/01","","","10.1007/BF01273365"
"17353259","Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer's disease","Feldman HH, Lane R; Study 304 Group.","J Neurol Neurosurg Psychiatry. 2007 Oct;78(10):1056-63. doi: 10.1136/jnnp.2006.099424. Epub 2007 Mar 12.","Feldman HH","J Neurol Neurosurg Psychiatry","2007","2007/03/14","PMC2117538","","10.1136/jnnp.2006.099424"
"22492589","Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study","Holthoff V, Ferris S, Gauthier S, Ihl R, Robert P, Winblad B, Sternberg K, Tennigkeit F; ROSA Study Group.","Int J Geriatr Psychiatry. 2013 Feb;28(2):164-72. doi: 10.1002/gps.3805. Epub 2012 Apr 11.","Holthoff V","Int J Geriatr Psychiatry","2013","2012/04/12","","","10.1002/gps.3805"
"22897903","Study protocol: EXERcise and cognition in sedentary adults with early-ONset dementia (EXERCISE-ON)","Hooghiemstra AM, Eggermont LH, Scheltens P, van der Flier WM, Bakker J, de Greef MH, Koppe PA, Scherder EJ.","BMC Neurol. 2012 Aug 16;12:75. doi: 10.1186/1471-2377-12-75.","Hooghiemstra AM","BMC Neurol","2012","2012/08/18","PMC3488467","","10.1186/1471-2377-12-75"
"28034509","MAXCOG-Maximizing Cognition: A Randomized Controlled Trial of the Efficacy of Goal-Oriented Cognitive Rehabilitation for People with Mild Cognitive Impairment and Early Alzheimer Disease","Regan B, Wells Y, Farrow M, O'Halloran P, Workman B.","Am J Geriatr Psychiatry. 2017 Mar;25(3):258-269. doi: 10.1016/j.jagp.2016.11.008. Epub 2016 Nov 16.","Regan B","Am J Geriatr Psychiatry","2017","2016/12/31","","","10.1016/j.jagp.2016.11.008"
"9686277","Progression of Alzheimer histopathological changes","Duyckaerts C, Colle MA, Dessi F, Piette F, Hauw JJ.","Acta Neurol Belg. 1998 Jun;98(2):180-5.","Duyckaerts C","Acta Neurol Belg","1998","1998/08/01","","",""
"21457292","Correlates of care relationship mutuality among carers of people with Alzheimer's and Parkinson's disease","Shim B, Landerman LR, Davis LL.","J Adv Nurs. 2011 Aug;67(8):1729-38. doi: 10.1111/j.1365-2648.2011.05618.x. Epub 2011 Apr 4.","Shim B","J Adv Nurs","2011","2011/04/05","PMC3839350","NIHMS525838","10.1111/j.1365-2648.2011.05618.x"
"10862805","Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's disease: a morphometric MRI study","Laakso MP, Frisoni GB, Könönen M, Mikkonen M, Beltramello A, Geroldi C, Bianchetti A, Trabucchi M, Soininen H, Aronen HJ.","Biol Psychiatry. 2000 Jun 15;47(12):1056-63. doi: 10.1016/s0006-3223(99)00306-6.","Laakso MP","Biol Psychiatry","2000","2000/06/23","","","10.1016/s0006-3223(99)00306-6"
"10192638","Methanesulfonyl fluoride (MSF): a double-blind, placebo-controlled study of safety and efficacy in the treatment of senile dementia of the Alzheimer type","Moss DE, Berlanga P, Hagan MM, Sandoval H, Ishida C.","Alzheimer Dis Assoc Disord. 1999 Jan;13(1):20-5. doi: 10.1097/00002093-199903000-00003.","Moss DE","Alzheimer Dis Assoc Disord","1999","1999/04/07","","","10.1097/00002093-199903000-00003"
"2592587","The effect of food on the bioavailability of velnacrine (HP 029) in healthy elderly men: a potential Alzheimer agent","Puri SK, Hsu RS, Ho I, Lassman HB.","J Clin Pharmacol. 1989 Oct;29(10):956-60. doi: 10.1002/j.1552-4604.1989.tb03261.x.","Puri SK","J Clin Pharmacol","1989","1989/10/01","","","10.1002/j.1552-4604.1989.tb03261.x"
"12937333","Primary care interventions for dementia caregivers: 2-year outcomes from the REACH study","Burns R, Nichols LO, Martindale-Adams J, Graney MJ, Lummus A.","Gerontologist. 2003 Aug;43(4):547-55. doi: 10.1093/geront/43.4.547.","Burns R","Gerontologist","2003","2003/08/26","","","10.1093/geront/43.4.547"
"33638661","Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison","Altomare D, Caprioglio C, Assal F, Allali G, Mendes A, Ribaldi F, Ceyzeriat K, Martins M, Tomczyk S, Stampacchia S, Dodich A, Boccardi M, Chicherio C, Frisoni GB, Garibotto V.","Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2200-2211. doi: 10.1007/s00259-021-05246-x. Epub 2021 Feb 27.","Altomare D","Eur J Nucl Med Mol Imaging","2021","2021/02/27","PMC8175315","","10.1007/s00259-021-05246-x"
"9390784","Cerebrospinal fluid C3a increases with age, but does not increase further in Alzheimer's disease","Loeffler DA, Brickman CM, Juneau PL, Perry MF, Pomara N, Lewitt PA.","Neurobiol Aging. 1997 Sep-Oct;18(5):555-7. doi: 10.1016/s0197-4580(97)00110-3.","Loeffler DA","Neurobiol Aging","1997","1997/12/09","","","10.1016/s0197-4580(97)00110-3"
"12937332","Effects of the home environmental skill-building program on the caregiver-care recipient dyad: 6-month outcomes from the Philadelphia REACH Initiative","Gitlin LN, Winter L, Corcoran M, Dennis MP, Schinfeld S, Hauck WW.","Gerontologist. 2003 Aug;43(4):532-46. doi: 10.1093/geront/43.4.532.","Gitlin LN","Gerontologist","2003","2003/08/26","","","10.1093/geront/43.4.532"
"12468901","Therapeutic psychosocial intervention for elderly subjects with very mild Alzheimer disease in a community: the tajiri project","Ishizaki J, Meguro K, Ohe K, Kimura E, Tsuchiya E, Ishii H, Sekita Y, Yamadori A.","Alzheimer Dis Assoc Disord. 2002 Oct-Dec;16(4):261-9. doi: 10.1097/00002093-200210000-00008.","Ishizaki J","Alzheimer Dis Assoc Disord","2002","2002/12/07","","","10.1097/00002093-200210000-00008"
"16373183","Effects of a comprehensive educational program on quality of life and emotional issues of dementia patient caregivers","Kuzu N, Beşer N, Zencir M, Sahiner T, Nesrin E, Ahmet E, Binali C, Cagdaş E.","Geriatr Nurs. 2005 Nov-Dec;26(6):378-86. doi: 10.1016/j.gerinurse.2005.09.015.","Kuzu N","Geriatr Nurs","2005","2005/12/24","","","10.1016/j.gerinurse.2005.09.015"
"7702702","Free D-amino acids in human cerebrospinal fluid of Alzheimer disease, multiple sclerosis, and healthy control subjects","Fisher GH, Petrucelli L, Gardner C, Emory C, Frey WH 2nd, Amaducci L, Sorbi S, Sorrentino G, Borghi M, D'Aniello A.","Mol Chem Neuropathol. 1994 Oct-Dec;23(2-3):115-24. doi: 10.1007/BF02815405.","Fisher GH","Mol Chem Neuropathol","1994","1994/10/01","","","10.1007/BF02815405"
"24217282","Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors","Darreh-Shori T, Hosseini SM, Nordberg A.","J Alzheimers Dis. 2014;39(2):423-40. doi: 10.3233/JAD-130845.","Darreh-Shori T","J Alzheimers Dis","2014","2013/11/13","","","10.3233/JAD-130845"
"31764959","Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials","Wessels AM, Tariot PN, Zimmer JA, Selzler KJ, Bragg SM, Andersen SW, Landry J, Krull JH, Downing AM, Willis BA, Shcherbinin S, Mullen J, Barker P, Schumi J, Shering C, Matthews BR, Stern RA, Vellas B, Cohen S, MacSweeney E, Boada M, Sims JR.","JAMA Neurol. 2020 Feb 1;77(2):199-209. doi: 10.1001/jamaneurol.2019.3988.","Wessels AM","JAMA Neurol","2020","2019/11/26","PMC6902191","","10.1001/jamaneurol.2019.3988"
"19533583","[Workplace health promotion through human resources development part I: development and evaluation of qualification programme for prevention of psychic stresses]","Zimber A, Gregersen S, Kuhnert S, Nienhaus A.","Gesundheitswesen. 2010 Apr;72(4):209-15. doi: 10.1055/s-0029-1214403. Epub 2009 Jun 16.","Zimber A","Gesundheitswesen","2010","2009/06/18","","","10.1055/s-0029-1214403"
"10435208","Physiologic and neuroendocrine responses to intravenous naloxone in subjects with Alzheimer's disease and age-matched controls","Tariot PN, Upadhyaya A, Sunderland T, Cox C, Cohen RM, Murphy DL, Loy R.","Biol Psychiatry. 1999 Aug 1;46(3):412-9. doi: 10.1016/s0006-3223(98)00329-1.","Tariot PN","Biol Psychiatry","1999","1999/08/06","","","10.1016/s0006-3223(98)00329-1"
"31239114","Three months of multimodal training contributes to mobility and executive function in elderly individuals with mild cognitive impairment, but not in those with Alzheimer's disease: A randomized controlled trial","de Oliveira Silva F, Ferreira JV, Plácido J, Sant'Anna P, Araújo J, Marinho V, Laks J, Camaz Deslandes A.","Maturitas. 2019 Aug;126:28-33. doi: 10.1016/j.maturitas.2019.04.217. Epub 2019 Apr 27.","de Oliveira Silva F","Maturitas","2019","2019/06/27","","","10.1016/j.maturitas.2019.04.217"
"24495406","Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study","Camargos EF, Louzada LL, Quintas JL, Naves JO, Louzada FM, Nóbrega OT.","Am J Geriatr Psychiatry. 2014 Dec;22(12):1565-74. doi: 10.1016/j.jagp.2013.12.174. Epub 2014 Jan 4.","Camargos EF","Am J Geriatr Psychiatry","2014","2014/02/06","","","10.1016/j.jagp.2013.12.174"
"8345158","Aggression in the demented patient: a double-blind study of loxapine versus haloperidol","Carlyle W, Ancill RJ, Sheldon L.","Int Clin Psychopharmacol. 1993 Summer;8(2):103-8. doi: 10.1097/00004850-199300820-00004.","Carlyle W","Int Clin Psychopharmacol","1993","1993/01/01","","","10.1097/00004850-199300820-00004"
"17951067","Curcumin effects on blood lipid profile in a 6-month human study","Baum L, Cheung SK, Mok VC, Lam LC, Leung VP, Hui E, Ng CC, Chow M, Ho PC, Lam S, Woo J, Chiu HF, Goggins W, Zee B, Wong A, Mok H, Cheng WK, Fong C, Lee JS, Chan MH, Szeto SS, Lui VW, Tsoh J, Kwok TC, Chan IH, Lam CW.","Pharmacol Res. 2007 Dec;56(6):509-14. doi: 10.1016/j.phrs.2007.09.013. Epub 2007 Sep 18.","Baum L","Pharmacol Res","2007","2007/10/24","","","10.1016/j.phrs.2007.09.013"
"16151770","Memory-provoked rCBF-SPECT as a diagnostic tool in Alzheimer's disease?","Sundström T, Elgh E, Larsson A, Näsman B, Nyberg L, Riklund KA.","Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):73-80. doi: 10.1007/s00259-005-1874-0. Epub 2005 Sep 9.","Sundström T","Eur J Nucl Med Mol Imaging","2006","2005/09/10","","","10.1007/s00259-005-1874-0"
"26138948","Facilitating text reading in posterior cortical atrophy","Yong KX, Rajdev K, Shakespeare TJ, Leff AP, Crutch SJ.","Neurology. 2015 Jul 28;85(4):339-48. doi: 10.1212/WNL.0000000000001782. Epub 2015 Jul 2.","Yong KX","Neurology","2015","2015/07/04","PMC4520813","","10.1212/WNL.0000000000001782"
"1716558","Effects of scopolamine on visual evoked potentials in aging and dementia","Ray PG, Meador KJ, Loring DW, Murro AM, Buccafusco JJ, Yang XH, Zamrini EY, Thompson WO, Thompson EE.","Electroencephalogr Clin Neurophysiol. 1991 Sep-Oct;80(5):347-51. doi: 10.1016/0168-5597(91)90081-8.","Ray PG","Electroencephalogr Clin Neurophysiol","1991","1991/09/01","","","10.1016/0168-5597(91)90081-8"
"8823240","Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer's disease. Eptastigmine Study Group","Canal N, Imbimbo BP.","Clin Pharmacol Ther. 1996 Aug;60(2):218-28. doi: 10.1016/S0009-9236(96)90138-1.","Canal N","Clin Pharmacol Ther","1996","1996/08/01","","","10.1016/S0009-9236(96)90138-1"
"26303700","Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences","Peters ME, Vaidya V, Drye LT, Devanand DP, Mintzer JE, Pollock BG, Porsteinsson AP, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Avramopoulos D; CitAD Research Group.","J Geriatr Psychiatry Neurol. 2016 Mar;29(2):59-64. doi: 10.1177/0891988715601735. Epub 2015 Aug 23.","Peters ME","J Geriatr Psychiatry Neurol","2016","2015/08/26","PMC5166612","NIHMS834443","10.1177/0891988715601735"
"10317839","Informed consent to participation in medical research employing elderly human subjects","Schwartz RL.","J Contemp Health Law Policy. 1985 Spring;1(1):115-31.","Schwartz RL","J Contemp Health Law Policy","1985","1986/01/05","","",""
"8741021","Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia","Kanowski S, Herrmann WM, Stephan K, Wierich W, Hörr R.","Pharmacopsychiatry. 1996 Mar;29(2):47-56. doi: 10.1055/s-2007-979544.","Kanowski S","Pharmacopsychiatry","1996","1996/03/01","","","10.1055/s-2007-979544"
"9460734","Repetition priming with nonverbal stimuli in patients with dementia of the Alzheimer type","Heindel WC, Salmon DP, Fennema-Notestine C, Chan AS.","Neuropsychology. 1998 Jan;12(1):43-51. doi: 10.1037//0894-4105.12.1.43.","Heindel WC","Neuropsychology","1998","1998/02/14","","","10.1037//0894-4105.12.1.43"
"29318278","Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials","Atri A, Frölich L, Ballard C, Tariot PN, Molinuevo JL, Boneva N, Windfeld K, Raket LL, Cummings JL.","JAMA. 2018 Jan 9;319(2):130-142. doi: 10.1001/jama.2017.20373.","Atri A","JAMA","2018","2018/01/11","PMC5833662","","10.1001/jama.2017.20373"
"29504488","""It's Like a Cyber-Security Blanket"": The Utility of Remote Activity Monitoring in Family Dementia Care","Mitchell LL, Peterson CM, Rud SR, Jutkowitz E, Sarkinen A, Trost S, Porta CM, Finlay JM, Gaugler JE.","J Appl Gerontol. 2020 Jan;39(1):86-98. doi: 10.1177/0733464818760238. Epub 2018 Mar 4.","Mitchell LL","J Appl Gerontol","2020","2018/03/06","PMC6353693","NIHMS938846","10.1177/0733464818760238"
"10505966","MRI-SPECT fusion for the synthesis of high resolution 3D functional brain images: a preliminary study","Colin A, Boire JY.","Comput Methods Programs Biomed. 1999 Sep;60(2):107-16. doi: 10.1016/s0169-2607(99)00006-1.","Colin A","Comput Methods Programs Biomed","1999","1999/10/03","","","10.1016/s0169-2607(99)00006-1"
"20429946","Recruitment methods in Alzheimer's disease research: general practice versus population based screening by mail","Andersen F, Engstad TA, Straume B, Viitanen M, Halvorsen DS, Hykkerud S, Sjøbrend K.","BMC Med Res Methodol. 2010 Apr 29;10:35. doi: 10.1186/1471-2288-10-35.","Andersen F","BMC Med Res Methodol","2010","2010/05/01","PMC2880123","","10.1186/1471-2288-10-35"
"23076666","[Effectivity of early psychosocial counselling for family caregivers in general practioner based dementia care]","Geschke K, Scheurich A, Schermuly I, Laux N, Böttcher A, Fellgiebel A.","Dtsch Med Wochenschr. 2012 Oct;137(43):2201-6. doi: 10.1055/s-0032-1305320. Epub 2012 Oct 17.","Geschke K","Dtsch Med Wochenschr","2012","2012/10/19","","","10.1055/s-0032-1305320"
"26359573","Improved Diagnostic Accuracy of SPECT Through Statistical Analysis and the Detection of Hot Spots at the Primary Sensorimotor Area for the Diagnosis of Alzheimer Disease in a Community-Based Study: ""The Osaki-Tajiri Project""","Kaneta T, Nakatsuka M, Nakamura K, Seki T, Yamaguchi S, Tsuboi M, Meguro K.","Clin Nucl Med. 2016 Jan;41(1):e1-6. doi: 10.1097/RLU.0000000000000976.","Kaneta T","Clin Nucl Med","2016","2015/09/12","","","10.1097/RLU.0000000000000976"
"21992111","Two galantamine titration regimens in patients switched from donepezil","Engedal K, Davis B, Richarz U, Han J, Schäuble B, Andreasen N.","Acta Neurol Scand. 2012 Jul;126(1):37-44. doi: 10.1111/j.1600-0404.2011.01594.x. Epub 2011 Oct 13.","Engedal K","Acta Neurol Scand","2012","2011/10/14","","","10.1111/j.1600-0404.2011.01594.x"
"9608577","Combined nicotinic and muscarinic blockade in elderly normal volunteers: cognitive, behavioral, and physiologic responses","Little JT, Johnson DN, Minichiello M, Weingartner H, Sunderland T.","Neuropsychopharmacology. 1998 Jul;19(1):60-9. doi: 10.1016/S0893-133X(98)00002-5.","Little JT","Neuropsychopharmacology","1998","1998/06/03","","","10.1016/S0893-133X(98)00002-5"
"34315519","Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker profile","Milà-Alomà M, Shekari M, Salvadó G, Gispert JD, Arenaza-Urquijo EM, Operto G, Falcon C, Vilor-Tejedor N, Grau-Rivera O, Sala-Vila A, Sánchez-Benavides G, González-de-Echávarri JM, Minguillon C, Fauria K, Niñerola-Baizán A, Perissinotti A, Simon M, Kollmorgen G, Zetterberg H, Blennow K, Suárez-Calvet M, Molinuevo JL; ALFA study.","Alzheimers Res Ther. 2021 Jul 27;13(1):134. doi: 10.1186/s13195-021-00863-y.","Milà-Alomà M","Alzheimers Res Ther","2021","2021/07/28","PMC8314554","","10.1186/s13195-021-00863-y"
"10431061","[Risperidone in the treatment of psychotic, affective and behavioral symptoms associated to Alzheimer's disease]","Barcia D, Giles E, Herraiz M, Moríñigo A, Roca M, Rodríguez A.","Actas Esp Psiquiatr. 1999 May-Jun;27(3):185-90.","Barcia D","Actas Esp Psiquiatr","1999","1999/08/04","","",""
"25523285","A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD)","Ballard C, Thomas A, Gerry S, Yu LM, Aarsland D, Merritt C, Corbett A, Davison C, Sharma N, Khan Z, Creese B, Loughlin P, Bannister C, Burns A, Win SN, Walker Z; MAIN-AD investigators.","J Am Med Dir Assoc. 2015 Apr;16(4):316-22. doi: 10.1016/j.jamda.2014.11.002. Epub 2014 Dec 15.","Ballard C","J Am Med Dir Assoc","2015","2014/12/20","","","10.1016/j.jamda.2014.11.002"
"1475039","Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID)","Fischhof PK, Saletu B, Rüther E, Litschauer G, Möslinger-Gehmayr R, Herrmann WM.","Neuropsychobiology. 1992;26(1-2):65-70. doi: 10.1159/000118898.","Fischhof PK","Neuropsychobiology","1992","1992/01/01","","","10.1159/000118898"
"28786987","Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer's dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial","Park KW, Kim EJ, Han HJ, Shim YS, Kwon JC, Ku BD, Park KH, Yi HA, Kim KK, Yang DW, Lee HW, Kang H, Kwon OD, Kim S, Lee JH, Chung EJ, Park SW, Park MY, Yoon B, Kim BC, Seo SW, Choi SH.","PLoS One. 2017 Aug 7;12(8):e0182123. doi: 10.1371/journal.pone.0182123. eCollection 2017.","Park KW","PLoS One","2017","2017/08/09","PMC5546604","","10.1371/journal.pone.0182123"
"31916847","Effect of Self-Efficacy on Quality of Life in People With Mild Cognitive Impairment and Mild Dementia: The Mediating Roles of Depression and Anxiety","Tonga JB, Eilertsen DE, Solem IKL, Arnevik EA, Korsnes MS, Ulstein ID.","Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317519885264. doi: 10.1177/1533317519885264.","Tonga JB","Am J Alzheimers Dis Other Demen","2020","2020/01/10","","","10.1177/1533317519885264"
"24554232","Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial","Hatta K, Kishi Y, Wada K, Takeuchi T, Odawara T, Usui C, Nakamura H; DELIRIA-J Group.","JAMA Psychiatry. 2014 Apr;71(4):397-403. doi: 10.1001/jamapsychiatry.2013.3320.","Hatta K","JAMA Psychiatry","2014","2014/02/21","","","10.1001/jamapsychiatry.2013.3320"
"31985467","Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer's Disease","Jia J, Wei C, Chen W, Jia L, Zhou A, Wang F, Tang Y, Xu L.","J Alzheimers Dis. 2020;74(1):199-211. doi: 10.3233/JAD-190940.","Jia J","J Alzheimers Dis","2020","2020/01/28","","","10.3233/JAD-190940"
"29188876","Association of Cortical β-Amyloid with Erythrocyte Membrane Monounsaturated and Saturated Fatty Acids in Older Adults at Risk of Dementia","Hooper C, De Souto Barreto P, Payoux P, Salabert AS, Guyonnet S, Andrieu S, Sourdet S, Delrieu J, Vellas B.","J Nutr Health Aging. 2017;21(10):1170-1175. doi: 10.1007/s12603-017-0975-3.","Hooper C","J Nutr Health Aging","2017","2017/12/01","","","10.1007/s12603-017-0975-3"
"12552040","MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD","Jack CR Jr, Slomkowski M, Gracon S, Hoover TM, Felmlee JP, Stewart K, Xu Y, Shiung M, O'Brien PC, Cha R, Knopman D, Petersen RC.","Neurology. 2003 Jan 28;60(2):253-60. doi: 10.1212/01.wnl.0000042480.86872.03.","Jack CR Jr","Neurology","2003","2003/01/29","PMC2745302","NIHMS136225","10.1212/01.wnl.0000042480.86872.03"
"16288313","Genome scan on Swedish Alzheimer's disease families","Sillén A, Forsell C, Lilius L, Axelman K, Björk BF, Onkamo P, Kere J, Winblad B, Graff C.","Mol Psychiatry. 2006 Feb;11(2):182-6. doi: 10.1038/sj.mp.4001772.","Sillén A","Mol Psychiatry","2006","2005/11/17","","","10.1038/sj.mp.4001772"
"9342788","THA disrupts mismatch negativity in Alzheimer disease","Riekkinen P Jr, Pääkkönen A, Karhu J, Partanen J, Soininen H, Laakso M, Riekkine P Sr.","Psychopharmacology (Berl). 1997 Sep;133(2):203-6. doi: 10.1007/s002130050392.","Riekkinen P Jr","Psychopharmacology (Berl)","1997","1997/10/29","","","10.1007/s002130050392"
"22014101","Alzheimer's disease--input of vitamin D with mEmantine assay (AD-IDEA trial): study protocol for a randomized controlled trial","Annweiler C, Fantino B, Parot-Schinkel E, Thiery S, Gautier J, Beauchet O.","Trials. 2011 Oct 20;12:230. doi: 10.1186/1745-6215-12-230.","Annweiler C","Trials","2011","2011/10/22","PMC3212921","","10.1186/1745-6215-12-230"
"15197297","Resident-Assisted Montessori Programming (RAMP): training persons with dementia to serve as group activity leaders","Camp CJ, Skrajner MJ.","Gerontologist. 2004 Jun;44(3):426-31. doi: 10.1093/geront/44.3.426.","Camp CJ","Gerontologist","2004","2004/06/16","","","10.1093/geront/44.3.426"
"15852437","Switching from donepezil to galantamine: a double-blind study of two wash-out periods","Wilkinson DG, Howe I.","Int J Geriatr Psychiatry. 2005 May;20(5):489-91. doi: 10.1002/gps.1301.","Wilkinson DG","Int J Geriatr Psychiatry","2005","2005/04/27","","","10.1002/gps.1301"
"31710340","Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial","Tsai RM, Miller Z, Koestler M, Rojas JC, Ljubenkov PA, Rosen HJ, Rabinovici GD, Fagan AM, Cobigo Y, Brown JA, Jung JI, Hare E, Geldmacher DS, Natelson-Love M, McKinley EC, Luong PN, Chuu EL, Powers R, Mumford P, Wolf A, Wang P, Shamloo M, Miller BL, Roberson ED, Boxer AL.","JAMA Neurol. 2020 Feb 1;77(2):215-224. doi: 10.1001/jamaneurol.2019.3812.","Tsai RM","JAMA Neurol","2020","2019/11/12","PMC6865783","","10.1001/jamaneurol.2019.3812"
"23117349","Feasibility, safety and preliminary evidence of the effectiveness of a home-based exercise programme for older people with Alzheimer's disease: a pilot randomized controlled trial","Suttanon P, Hill KD, Said CM, Williams SB, Byrne KN, LoGiudice D, Lautenschlager NT, Dodd KJ.","Clin Rehabil. 2013 May;27(5):427-38. doi: 10.1177/0269215512460877. Epub 2012 Nov 1.","Suttanon P","Clin Rehabil","2013","2012/11/03","","","10.1177/0269215512460877"
"3651528","RS 86 in the treatment of Alzheimer's disease: cognitive and biological effects","Hollander E, Davidson M, Mohs RC, Horvath TB, Davis BM, Zemishlany Z, Davis KL.","Biol Psychiatry. 1987 Sep;22(9):1067-78. doi: 10.1016/0006-3223(87)90049-7.","Hollander E","Biol Psychiatry","1987","1987/09/01","","","10.1016/0006-3223(87)90049-7"
"9343463","A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group","Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF.","JAMA. 1997 Oct 22-29;278(16):1327-32. doi: 10.1001/jama.278.16.1327.","Le Bars PL","JAMA","1997","1997/10/29","","","10.1001/jama.278.16.1327"
"8876775","Double-blind, placebo-controlled study of metrifonate, an acetylcholinesterase inhibitor, for Alzheimer disease","Becker RE, Colliver JA, Markwell SJ, Moriearty PL, Unni LK, Vicari S.","Alzheimer Dis Assoc Disord. 1996 Fall;10(3):124-31. doi: 10.1097/00002093-199601030-00003.","Becker RE","Alzheimer Dis Assoc Disord","1996","1996/01/01","","","10.1097/00002093-199601030-00003"
"7799246","Cholinergic neurotransmission, REM sleep and depression","Riemann D, Hohagen F, Bahro M, Lis S, Stadmüller G, Gann H, Berger M.","J Psychosom Res. 1994;38 Suppl 1:15-25. doi: 10.1016/0022-3999(94)90132-5.","Riemann D","J Psychosom Res","1994","1994/01/01","","","10.1016/0022-3999(94)90132-5"
"21312297","Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analyses","Alva G, Grossberg GT, Schmitt FA, Meng X, Olin JT.","Int J Geriatr Psychiatry. 2011 Apr;26(4):356-63. doi: 10.1002/gps.2534.","Alva G","Int J Geriatr Psychiatry","2011","2011/02/12","","","10.1002/gps.2534"
"10850728","Nerve growth factor treatment in dementia","Jönhagen ME.","Alzheimer Dis Assoc Disord. 2000;14 Suppl 1:S31-8. doi: 10.1097/00002093-200000001-00006.","Jönhagen ME","Alzheimer Dis Assoc Disord","2000","2000/06/13","","","10.1097/00002093-200000001-00006"
"16832078","Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment","Cummings JL, Schneider E, Tariot PN, Graham SM; Memantine MEM-MD-02 Study Group.","Neurology. 2006 Jul 11;67(1):57-63. doi: 10.1212/01.wnl.0000223333.42368.f1.","Cummings JL","Neurology","2006","2006/07/13","","","10.1212/01.wnl.0000223333.42368.f1"
"17183151","Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid","Riekse RG, Li G, Petrie EC, Leverenz JB, Vavrek D, Vuletic S, Albers JJ, Montine TJ, Lee VM, Lee M, Seubert P, Galasko D, Schellenberg GD, Hazzard WR, Peskind ER.","J Alzheimers Dis. 2006 Dec;10(4):399-406. doi: 10.3233/jad-2006-10408.","Riekse RG","J Alzheimers Dis","2006","2006/12/22","","","10.3233/jad-2006-10408"
"11347790","Dementia family caregiver training: affecting beliefs about caregiving and caregiver outcomes","Hepburn KW, Tornatore J, Center B, Ostwald SW.","J Am Geriatr Soc. 2001 Apr;49(4):450-7. doi: 10.1046/j.1532-5415.2001.49090.x.","Hepburn KW","J Am Geriatr Soc","2001","2001/05/12","","","10.1046/j.1532-5415.2001.49090.x"
"10867781","The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample","Small BJ, Fratiglioni L, Viitanen M, Winblad B, Bäckman L.","Arch Neurol. 2000 Jun;57(6):839-44. doi: 10.1001/archneur.57.6.839.","Small BJ","Arch Neurol","2000","2000/06/27","","","10.1001/archneur.57.6.839"
"21195775","Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND","Vemuri P, Simon G, Kantarci K, Whitwell JL, Senjem ML, Przybelski SA, Gunter JL, Josephs KA, Knopman DS, Boeve BF, Ferman TJ, Dickson DW, Parisi JE, Petersen RC, Jack CR Jr.","Neuroimage. 2011 Mar 15;55(2):522-31. doi: 10.1016/j.neuroimage.2010.12.073. Epub 2010 Dec 31.","Vemuri P","Neuroimage","2011","2011/01/04","PMC3039279","NIHMS267091","10.1016/j.neuroimage.2010.12.073"
"18575355","Computer-based cognitive intervention for dementia: preliminary results of a randomized clinical trial","Galante E, Venturini G, Fiaccadori C.","G Ital Med Lav Ergon. 2007 Jul-Sep;29(3 Suppl B):B26-32.","Galante E","G Ital Med Lav Ergon","2007","2008/06/26","","",""
"7716695","Effects of medication on parotid salivary flow rates in an individual with dementia of the Alzheimer type","Fedele DJ, Jones JA, Volicer L, Herz LR, Oppenheim FG.","Spec Care Dentist. 1993 Sep-Oct;13(5):215-8. doi: 10.1111/j.1754-4505.1993.tb01499.x.","Fedele DJ","Spec Care Dentist","1993","1993/09/01","","","10.1111/j.1754-4505.1993.tb01499.x"
"21131671","Development and validation of the Memory Orientation Screening Test (MOST™): A better screening test for dementia","Clionsky MI, Clionsky E.","Am J Alzheimers Dis Other Demen. 2010 Dec;25(8):650-6. doi: 10.1177/1533317510386216.","Clionsky MI","Am J Alzheimers Dis Other Demen","2010","2010/12/07","","","10.1177/1533317510386216"
"9605726","Pathologic correlates of apraxia in Alzheimer disease","Giannakopoulos P, Duc M, Gold G, Hof PR, Michel JP, Bouras C.","Arch Neurol. 1998 May;55(5):689-95. doi: 10.1001/archneur.55.5.689.","Giannakopoulos P","Arch Neurol","1998","1998/05/30","","","10.1001/archneur.55.5.689"
"3898182","Cognitive and behavioral sensitivity to scopolamine in Alzheimer patients and controls","Sunderland T, Tariot PN, Mueller EA, Murphy DL, Weingartner H, Cohen RM.","Psychopharmacol Bull. 1985;21(3):676-9.","Sunderland T","Psychopharmacol Bull","1985","1985/01/01","","",""
"15362759","Perioperative music therapy with a key-lighting keyboard system in elderly patients undergoing digestive tract surgery","Chikamori F, Kuniyoshi N, Shibuya S, Takase Y.","Hepatogastroenterology. 2004 Sep-Oct;51(59):1384-6.","Chikamori F","Hepatogastroenterology","2004","2004/09/15","","",""
"31113277","Sodium benzoate for the treatment of behavioral and psychological symptoms of dementia (BPSD): A randomized, double-blind, placebo-controlled, 6-week trial","Lin CH, Chen PK, Wang SH, Lane HY.","J Psychopharmacol. 2019 Aug;33(8):1030-1033. doi: 10.1177/0269881119849815. Epub 2019 May 22.","Lin CH","J Psychopharmacol","2019","2019/05/23","","","10.1177/0269881119849815"
"12196650","Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months","Darreh-Shori T, Almkvist O, Guan ZZ, Garlind A, Strandberg B, Svensson AL, Soreq H, Hellström-Lindahl E, Nordberg A.","Neurology. 2002 Aug 27;59(4):563-72. doi: 10.1212/wnl.59.4.563.","Darreh-Shori T","Neurology","2002","2002/08/28","","","10.1212/wnl.59.4.563"
"24074637","Benzoate, a D-amino acid oxidase inhibitor, for the treatment of early-phase Alzheimer disease: a randomized, double-blind, placebo-controlled trial","Lin CH, Chen PK, Chang YC, Chuo LJ, Chen YS, Tsai GE, Lane HY.","Biol Psychiatry. 2014 May 1;75(9):678-85. doi: 10.1016/j.biopsych.2013.08.010. Epub 2013 Sep 25.","Lin CH","Biol Psychiatry","2014","2013/10/01","","","10.1016/j.biopsych.2013.08.010"
"20077053","Quantitative pharmacology approach in Alzheimer's disease: efficacy modeling of early clinical data to predict clinical outcome of tesofensine","Lehr T, Staab A, Trommeshauser D, Schaefer HG, Kloft C.","AAPS J. 2010 Jun;12(2):117-29. doi: 10.1208/s12248-009-9164-6. Epub 2010 Jan 15.","Lehr T","AAPS J","2010","2010/01/16","PMC2844519","","10.1208/s12248-009-9164-6"
"35253623","Aerobic Training and Circulating Neurotrophins in Alzheimer's Disease Patients: A Controlled Trial","Stein AM, Coelho FGM, Vital-Silva TM, Rueda AV, Pereira JR, Deslandes AC, Camarini R, Santos Galduróz RF.","Exp Aging Res. 2023 Jan-Feb;49(1):1-17. doi: 10.1080/0361073X.2022.2048586. Epub 2022 Mar 6.","Stein AM","Exp Aging Res","2023","2022/03/07","","","10.1080/0361073X.2022.2048586"
"19272293","[Transdermal rivastigmine patch in outpatient services in Austria: a naturalistic study in 103 patients with Alzheimer dementia]","Schmidt R, Alf C, Bancher C, Benke T, Berek K, Dal-Bianco P, Führwürth G, Imarhiagbe D, Jagsch C, Lechner A, Rainer M, Reisecker F, Rotaru J, Uranüs M, Walter A, Winkler A, Wuschitz A.","Neuropsychiatr. 2009;23(1):58-63.","Schmidt R","Neuropsychiatr","2009","2009/03/11","","",""
"9065323","Functional imaging of the frontal lobes in organic dementia. Regional cerebral blood flow findings in normals, in patients with frontotemporal dementia and in patients with Alzheimer's disease, performing a word fluency test","Warkentin S, Passant U.","Dement Geriatr Cogn Disord. 1997 Mar-Apr;8(2):105-9. doi: 10.1159/000106614.","Warkentin S","Dement Geriatr Cogn Disord","1997","1997/03/01","","","10.1159/000106614"
"10681081","Intracranial volume and Alzheimer disease: evidence against the cerebral reserve hypothesis","Jenkins R, Fox NC, Rossor AM, Harvey RJ, Rossor MN.","Arch Neurol. 2000 Feb;57(2):220-4. doi: 10.1001/archneur.57.2.220.","Jenkins R","Arch Neurol","2000","2000/02/19","","","10.1001/archneur.57.2.220"
"10196463","Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type","Yamamoto-Sasaki M, Ozawa H, Saito T, Rösler M, Riederer P.","Brain Res. 1999 Apr 10;824(2):300-3. doi: 10.1016/s0006-8993(99)01220-2.","Yamamoto-Sasaki M","Brain Res","1999","1999/04/10","","","10.1016/s0006-8993(99)01220-2"
"8749612","Treatment of Alzheimer disease by continuous intravenous infusion of physostigmine","Asthana S, Raffaele KC, Berardi A, Greig NH, Haxby JV, Schapiro MB, Soncrant TT.","Alzheimer Dis Assoc Disord. 1995 Winter;9(4):223-32.","Asthana S","Alzheimer Dis Assoc Disord","1995","1995/01/01","","",""
"9646152","Scopolamine-induced cognitive impairment as a predictor of cognitive decline in healthy elderly volunteers: a 6-year follow-up","Barker A, Jones R, Prior J, Wesnes K.","Int J Geriatr Psychiatry. 1998 Apr;13(4):244-7. doi: 10.1002/(sici)1099-1166(199804)13:4<244::aid-gps764>3.0.co;2-1.","Barker A","Int J Geriatr Psychiatry","1998","1998/07/01","","","10.1002/(sici)1099-1166(199804)13:4<244::aid-gps764>3.0.co;2-1"
"25943346","Imaging characteristics and safety of florbetapir (¹⁸F) in Japanese healthy volunteers, patients with mild cognitive impairment and patients with Alzheimer's disease","Namiki C, Takita Y, Iwata A, Momose T, Senda M, Okubo Y, Joshi AD, Lu M, Agbulos A, Breault C, Pontecorvo MJ.","Ann Nucl Med. 2015 Aug;29(7):570-81. doi: 10.1007/s12149-015-0978-2. Epub 2015 May 6.","Namiki C","Ann Nucl Med","2015","2015/05/07","","","10.1007/s12149-015-0978-2"
"3898183","Low- and high-dose naloxone in dementia of the Alzheimer type","Tariot PN, Sunderland T, Weingartner H, Murphy DL, Cohen MR, Cohen RM.","Psychopharmacol Bull. 1985;21(3):680-2.","Tariot PN","Psychopharmacol Bull","1985","1985/01/01","","",""
"12847155","Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization","Orgogozo JM, Gilman S, Dartigues JF, Laurent B, Puel M, Kirby LC, Jouanny P, Dubois B, Eisner L, Flitman S, Michel BF, Boada M, Frank A, Hock C.","Neurology. 2003 Jul 8;61(1):46-54. doi: 10.1212/01.wnl.0000073623.84147.a8.","Orgogozo JM","Neurology","2003","2003/07/09","","","10.1212/01.wnl.0000073623.84147.a8"
"19250707","Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment","Habert MO, Horn JF, Sarazin M, Lotterie JA, Puel M, Onen F, Zanca M, Portet F, Touchon J, Verny M, Mahieux F, Giron A, Fertil B, Dubois B.","Neurobiol Aging. 2011 Jan;32(1):15-23. doi: 10.1016/j.neurobiolaging.2009.01.013. Epub 2009 Feb 27.","Habert MO","Neurobiol Aging","2011","2009/03/03","","","10.1016/j.neurobiolaging.2009.01.013"
"16083542","Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period","Bullock R, Touchon J, Bergman H, Gambina G, He Y, Rapatz G, Nagel J, Lane R.","Curr Med Res Opin. 2005 Aug;21(8):1317-27. doi: 10.1185/030079905X56565.","Bullock R","Curr Med Res Opin","2005","2005/08/09","","","10.1185/030079905X56565"
"10705166","Association between changes in adrenal secretion and cerebral morphometric correlates in normal aging and senile dementia","Magri F, Terenzi F, Ricciardi T, Fioravanti M, Solerte SB, Stabile M, Balza G, Gandini C, Villa M, Ferrari E.","Dement Geriatr Cogn Disord. 2000 Mar-Apr;11(2):90-9. doi: 10.1159/000017220.","Magri F","Dement Geriatr Cogn Disord","2000","2000/03/08","","","10.1159/000017220"
"10559567","Denbufylline in dementia: a double-blind controlled study","Treves TA, Korczyn AD.","Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):505-10. doi: 10.1159/000017197.","Treves TA","Dement Geriatr Cogn Disord","1999","1999/11/24","","","10.1159/000017197"
"12611746","Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebo-controlled study","Tune L, Tiseo PJ, Ieni J, Perdomo C, Pratt RD, Votaw JR, Jewart RD, Hoffman JM.","Am J Geriatr Psychiatry. 2003 Mar-Apr;11(2):169-77.","Tune L","Am J Geriatr Psychiatry","2003","2003/03/04","","",""
"10840147","Effects of transcutaneous electrical nerve stimulation (TENS) on cognition and behaviour in aging","Scherder EJ, Van Someren EJ, Bouma A, v d Berg M.","Behav Brain Res. 2000 Jun 15;111(1-2):223-5. doi: 10.1016/s0166-4328(00)00170-4.","Scherder EJ","Behav Brain Res","2000","2000/06/07","","","10.1016/s0166-4328(00)00170-4"
"19427574","Effects of cranial electrical stimulation on sleep disturbances, depressive symptoms, and caregiving appraisal in spousal caregivers of persons with Alzheimer's disease","Rose KM, Taylor AG, Bourguignon C.","Appl Nurs Res. 2009 May;22(2):119-25. doi: 10.1016/j.apnr.2007.06.001.","Rose KM","Appl Nurs Res","2009","2009/05/12","PMC2713101","NIHMS119710","10.1016/j.apnr.2007.06.001"
"16344336","Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men","Lu PH, Masterman DA, Mulnard R, Cotman C, Miller B, Yaffe K, Reback E, Porter V, Swerdloff R, Cummings JL.","Arch Neurol. 2006 Feb;63(2):177-85. doi: 10.1001/archneur.63.2.nct50002. Epub 2005 Dec 12.","Lu PH","Arch Neurol","2006","2005/12/14","","","10.1001/archneur.63.2.nct50002"
"3103163","Senile dementia of the Alzheimer type treated with aniracetam: a new nootropic agent","Sourander LB, Portin R, Mölsä P, Lahdes A, Rinne UK.","Psychopharmacology (Berl). 1987;91(1):90-5. doi: 10.1007/BF00690933.","Sourander LB","Psychopharmacology (Berl)","1987","1987/01/01","","","10.1007/BF00690933"
"22270014","Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients","Zellner M, Baureder M, Rappold E, Bugert P, Kotzailias N, Babeluk R, Baumgartner R, Attems J, Gerner C, Jellinger K, Roth E, Oehler R, Umlauf E.","J Proteomics. 2012 Apr 3;75(7):2080-92. doi: 10.1016/j.jprot.2012.01.014. Epub 2012 Jan 17.","Zellner M","J Proteomics","2012","2012/01/25","","","10.1016/j.jprot.2012.01.014"
"10026388","Two-year treatment of Alzheimer's disease with eptastigmine. The Eptastigmine Study Group","Imbimbo BP, Verdelli G, Martelli P, Marchesini D.","Dement Geriatr Cogn Disord. 1999 Mar-Apr;10(2):139-47. doi: 10.1159/000017114.","Imbimbo BP","Dement Geriatr Cogn Disord","1999","1999/02/23","","","10.1159/000017114"
"35897078","Evaluation of tau deposition using (18)F-PI-2620 PET in MCI and early AD subjects-a MissionAD tau sub-study","Bullich S, Mueller A, De Santi S, Koglin N, Krause S, Kaplow J, Kanekiyo M, Roé-Vellvé N, Perrotin A, Jovalekic A, Scott D, Gee M, Stephens A, Irizarry M.","Alzheimers Res Ther. 2022 Jul 27;14(1):105. doi: 10.1186/s13195-022-01048-x.","Bullich S","Alzheimers Res Ther","2022","2022/07/27","PMC9327167","","10.1186/s13195-022-01048-x"
"11704081","The effects of light therapy on mini-mental state examination scores in demented patients","Graf A, Wallner C, Schubert V, Willeit M, Wlk W, Fischer P, Kasper S, Neumeister A.","Biol Psychiatry. 2001 Nov 1;50(9):725-7. doi: 10.1016/s0006-3223(01)01178-7.","Graf A","Biol Psychiatry","2001","2001/11/13","","","10.1016/s0006-3223(01)01178-7"
"24359500","A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's disease","Grove RA, Harrington CM, Mahler A, Beresford I, Maruff P, Lowy MT, Nicholls AP, Boardley RL, Berges AC, Nathan PJ, Horrigan JP.","Curr Alzheimer Res. 2014 Jan;11(1):47-58. doi: 10.2174/1567205010666131212110148.","Grove RA","Curr Alzheimer Res","2014","2013/12/24","","","10.2174/1567205010666131212110148"
"19929593","A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: a post hoc analysis","Farlow MR, Alva G, Meng X, Olin JT.","Curr Med Res Opin. 2010 Feb;26(2):263-9. doi: 10.1185/03007990903434914.","Farlow MR","Curr Med Res Opin","2010","2009/11/26","","","10.1185/03007990903434914"
"12568941","Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer's and Parkinson's disease","Granholm E, Morris S, Galasko D, Shults C, Rogers E, Vukov B.","Int J Psychophysiol. 2003 Feb;47(2):95-115. doi: 10.1016/s0167-8760(02)00122-8.","Granholm E","Int J Psychophysiol","2003","2003/02/06","","","10.1016/s0167-8760(02)00122-8"
"28259590","Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial","Fujino T, Yamada T, Asada T, Tsuboi Y, Wakana C, Mawatari S, Kono S.","EBioMedicine. 2017 Mar;17:199-205. doi: 10.1016/j.ebiom.2017.02.012. Epub 2017 Feb 24.","Fujino T","EBioMedicine","2017","2017/03/06","PMC5360580","","10.1016/j.ebiom.2017.02.012"
"23141384","Intersite variability of CSF Alzheimer's disease biomarkers in clinical setting","Dumurgier J, Vercruysse O, Paquet C, Bombois S, Chaulet C, Laplanche JL, Peoc'h K, Schraen S, Pasquier F, Touchon J, Hugon J, Lehmann S, Gabelle A.","Alzheimers Dement. 2013 Jul;9(4):406-13. doi: 10.1016/j.jalz.2012.06.006. Epub 2012 Nov 8.","Dumurgier J","Alzheimers Dement","2013","2012/11/13","","","10.1016/j.jalz.2012.06.006"
"16108961","Treatment persistency with rivastigmine and donepezil in a large state medicaid program","Singh G, Thomas SK, Arcona S, Lingala V, Mithal A.","J Am Geriatr Soc. 2005 Jul;53(7):1269-70. doi: 10.1111/j.1532-5415.2005.53384_9.x.","Singh G","J Am Geriatr Soc","2005","2005/08/20","","","10.1111/j.1532-5415.2005.53384_9.x"
"12875613","A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease","Wilcock G, Howe I, Coles H, Lilienfeld S, Truyen L, Zhu Y, Bullock R, Kershaw P; GAL-GBR-2 Study Group.","Drugs Aging. 2003;20(10):777-89. doi: 10.2165/00002512-200320100-00006.","Wilcock G","Drugs Aging","2003","2003/07/24","","","10.2165/00002512-200320100-00006"
"28590369","Adverse Events With Sustained-Release Donepezil in Alzheimer Disease: Relation to Body Mass Index","Lee C, Lee K, Yu H, Ryu SH, Moon SW, Han C, Lee JY, Lee YM, Kim SG, Kim KW, Lee DW, Kim SY, Lee SY, Bae JN, Jung YE, Kim JL, Kim BS, Shin IS, Kim YH, Kim BJ, Kang HS, Myung W, Carroll BJ, Kim DK.","J Clin Psychopharmacol. 2017 Aug;37(4):401-404. doi: 10.1097/JCP.0000000000000726.","Lee C","J Clin Psychopharmacol","2017","2017/06/08","","","10.1097/JCP.0000000000000726"
"18181229","A feasibility and tolerability study of lithium in Alzheimer's disease","Macdonald A, Briggs K, Poppe M, Higgins A, Velayudhan L, Lovestone S.","Int J Geriatr Psychiatry. 2008 Jul;23(7):704-11. doi: 10.1002/gps.1964.","Macdonald A","Int J Geriatr Psychiatry","2008","2008/01/09","","","10.1002/gps.1964"
"12469005","Donepezil for the treatment of behavioral symptoms in patients with Alzheimer's disease","Paleacu D, Mazeh D, Mirecki I, Even M, Barak Y.","Clin Neuropharmacol. 2002 Nov-Dec;25(6):313-7. doi: 10.1097/00002826-200211000-00007.","Paleacu D","Clin Neuropharmacol","2002","2002/12/07","","","10.1097/00002826-200211000-00007"
"33587110","Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease: Results From 2 Phase III Clinical Trials","Lu M, Pontecorvo MJ, Devous MD Sr, Arora AK, Galante N, McGeehan A, Devadanam C, Salloway SP, Doraiswamy PM, Curtis C, Truocchio SP, Flitter M, Locascio T, Devine M, Zimmer JA, Fleisher AS, Mintun MA; AVID Collaborators.","JAMA Neurol. 2021 Apr 1;78(4):445-453. doi: 10.1001/jamaneurol.2020.5505.","Lu M","JAMA Neurol","2021","2021/02/15","PMC7885097","","10.1001/jamaneurol.2020.5505"
"17368974","WHI risks: any relevance to menopause management?","Burger HG.","Maturitas. 2007 May 20;57(1):6-10. doi: 10.1016/j.maturitas.2007.02.002. Epub 2007 Mar 21.","Burger HG","Maturitas","2007","2007/03/21","","","10.1016/j.maturitas.2007.02.002"
"35550158","Association between lower body temperature and increased tau pathology in cognitively normal older adults","Blessing EM, Parekh A, Betensky RA, Babb J, Saba N, Debure L, Varga AW, Ayappa I, Rapoport DM, Butler TA, de Leon MJ, Wisniewski T, Lopresti BJ, Osorio RS.","Neurobiol Dis. 2022 Sep;171:105748. doi: 10.1016/j.nbd.2022.105748. Epub 2022 May 10.","Blessing EM","Neurobiol Dis","2022","2022/05/13","PMC9751849","NIHMS1856912","10.1016/j.nbd.2022.105748"
"9520072","Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity","Hock C, Golombowski S, Müller-Spahn F, Naser W, Beyreuther K, Mönning U, Schenk D, Vigo-Pelfrey C, Bush AM, Moir R, Tanzi RE, Growdon JH, Nitsch RM.","Eur Neurol. 1998;39(2):111-8. doi: 10.1159/000007917.","Hock C","Eur Neurol","1998","1998/03/31","","","10.1159/000007917"
"24914549","Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trial","Drye LT, Spragg D, Devanand DP, Frangakis C, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Pollock BG, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG; CitAD Research Group.","PLoS One. 2014 Jun 10;9(6):e98426. doi: 10.1371/journal.pone.0098426. eCollection 2014.","Drye LT","PLoS One","2014","2014/06/11","PMC4051660","","10.1371/journal.pone.0098426"
"9803422","Cerebrospinal fluid epinephrine in Alzheimer's disease and normal aging","Peskind ER, Elrod R, Dobie DJ, Pascualy M, Petrie E, Jensen C, Brodkin K, Murray S, Veith RC, Raskind MA.","Neuropsychopharmacology. 1998 Dec;19(6):465-71. doi: 10.1016/S0893-133X(98)00054-2.","Peskind ER","Neuropsychopharmacology","1998","1998/11/06","","","10.1016/S0893-133X(98)00054-2"
"33881530","Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial","Lin CH, Chen PK, Wang SH, Lane HY.","JAMA Netw Open. 2021 Apr 1;4(4):e216156. doi: 10.1001/jamanetworkopen.2021.6156.","Lin CH","JAMA Netw Open","2021","2021/04/21","PMC8060832","","10.1001/jamanetworkopen.2021.6156"
"9719348","Evaluating driving performance of outpatients with Alzheimer disease","Cox DJ, Quillian WC, Thorndike FP, Kovatchev BP, Hanna G.","J Am Board Fam Pract. 1998 Jul-Aug;11(4):264-71. doi: 10.3122/jabfm.11.4.264.","Cox DJ","J Am Board Fam Pract","1998","1998/08/27","","","10.3122/jabfm.11.4.264"
"9065537","Risk of Alzheimer's disease and duration of NSAID use","Stewart WF, Kawas C, Corrada M, Metter EJ.","Neurology. 1997 Mar;48(3):626-32. doi: 10.1212/wnl.48.3.626.","Stewart WF","Neurology","1997","1997/03/01","","","10.1212/wnl.48.3.626"
"9169302","Controlled trials of inositol in psychiatry","Levine J.","Eur Neuropsychopharmacol. 1997 May;7(2):147-55. doi: 10.1016/s0924-977x(97)00409-4.","Levine J","Eur Neuropsychopharmacol","1997","1997/05/01","","","10.1016/s0924-977x(97)00409-4"
"8140901","Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia","Mishima K, Okawa M, Hishikawa Y, Hozumi S, Hori H, Takahashi K.","Acta Psychiatr Scand. 1994 Jan;89(1):1-7. doi: 10.1111/j.1600-0447.1994.tb01477.x.","Mishima K","Acta Psychiatr Scand","1994","1994/01/01","","","10.1111/j.1600-0447.1994.tb01477.x"
"14758580","Patient predictors of response to treatment of depression in Alzheimer's disease: the DIADS study","Steinberg M, Munro CA, Samus Q, V Rabins P, Brandt J, Lyketsos CG.","Int J Geriatr Psychiatry. 2004 Feb;19(2):144-50. doi: 10.1002/gps.1048.","Steinberg M","Int J Geriatr Psychiatry","2004","2004/02/06","","","10.1002/gps.1048"
"34518459","Effects of Body Weight on the Safety of High-Dose Donepezil in Alzheimer's Disease: Post hoc Analysis of a Multicenter, Randomized, Open-Label, Parallel Design, Three-Arm Clinical Trial","Hong YJ, Han HJ, Youn YC, Park KW, Yang DW, Kim S, Kim HJ, Kim HJ, Lee Y, Kwon M, Lee JH; ODESA study (Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23 mg).","Dement Geriatr Cogn Disord. 2021;50(3):289-295. doi: 10.1159/000518470. Epub 2021 Sep 10.","Hong YJ","Dement Geriatr Cogn Disord","2021","2021/09/14","","","10.1159/000518470"
"2657467","Acute effects of oral pyridostigmine on memory and cognitive function in SDAT","Molloy DW, Cape RD.","Neurobiol Aging. 1989 Mar-Apr;10(2):199-204. doi: 10.1016/0197-4580(89)90031-6.","Molloy DW","Neurobiol Aging","1989","1989/03/01","","","10.1016/0197-4580(89)90031-6"
"9488097","A bridging study of LU 25-109 in patients with probable Alzheimer's disease","Sramek JJ, Forrest M, Mengel H, Jhee SS, Hourani J, Cutler NR.","Life Sci. 1998;62(3):195-202. doi: 10.1016/s0024-3205(97)01087-4.","Sramek JJ","Life Sci","1998","1998/03/06","","","10.1016/s0024-3205(97)01087-4"
"10940674","Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementia","Rodriguez Martin T, Calella AM, Silva S, Munna E, Modena P, Chiesa R, Terrevazzi S, Ruggieri RM, Palermo R, Piccoli F, Confalonieri R, Tiraboschi P, Fragiacomo C, Quadri P, Lucca U, Forloni G.","Dement Geriatr Cogn Disord. 2000 Sep-Oct;11(5):239-44. doi: 10.1159/000017245.","Rodriguez Martin T","Dement Geriatr Cogn Disord","2000","2000/08/15","","","10.1159/000017245"
"10817585","Alpha2-macroglobulin gene polymorphisms show racial diversity and are not associated with Alzheimer's disease","Higuchi S, Matsushita S, Nakane J, Arai H, Matsui T, Urakami K, Yuzuriha T, Takeda A.","Neuroreport. 2000 Apr 27;11(6):1167-71. doi: 10.1097/00001756-200004270-00005.","Higuchi S","Neuroreport","2000","2000/05/19","","","10.1097/00001756-200004270-00005"
"24969380","Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study","Freund-Levi Y, Bloniecki V, Auestad B, Tysen Bäckström AC, Lärksäter M, Aarsland D.","Dement Geriatr Cogn Disord. 2014;38(3-4):234-44. doi: 10.1159/000362204. Epub 2014 Jun 25.","Freund-Levi Y","Dement Geriatr Cogn Disord","2014","2014/06/28","","","10.1159/000362204"
"10525981","Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals","Helisalmi S, Hiltunen M, Valonen P, Mannermaa A, Koivisto AM, Lehtovirta M, Ryynänen M, Soininen H.","J Neurol. 1999 Sep;246(9):821-4. doi: 10.1007/s004150050461.","Helisalmi S","J Neurol","1999","1999/10/20","","","10.1007/s004150050461"
"18317244","Effects of galantamine on measures of attention: results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezil","Galvin JE, Cornblatt B, Newhouse P, Ancoli-Israel S, Wesnes K, Williamson D, Zhu Y, Sorra K, Amatniek J.","Alzheimer Dis Assoc Disord. 2008 Jan-Mar;22(1):30-8. doi: 10.1097/WAD.0b013e3181630b81.","Galvin JE","Alzheimer Dis Assoc Disord","2008","2008/03/05","","","10.1097/WAD.0b013e3181630b81"
"18759798","Long-term rivastigmine treatment in a routine clinical setting","Minthon L, Wallin AK, Eriksson S, Wattmo C, Andreasen N.","Acta Neurol Scand. 2009 Mar;119(3):180-5. doi: 10.1111/j.1600-0404.2008.01086.x. Epub 2008 Aug 26.","Minthon L","Acta Neurol Scand","2009","2008/09/02","","","10.1111/j.1600-0404.2008.01086.x"
"35220356","Simulated Electroconvulsive Therapy: A Novel Approach to a Control Group in Clinical Trials","McManus KR, Lapid MI, Forester BP, Mueller M, Hermida AP, Nykamp L, Harper DG, Seiner SJ, Sanghani S, Patrick R, Gentry MT, Kung S, Leal JC, Johnson EK, Petrides G.","J ECT. 2022 Sep 1;38(3):165-170. doi: 10.1097/YCT.0000000000000832. Epub 2022 Mar 1.","McManus KR","J ECT","2022","2022/02/27","PMC9420159","NIHMS1767680","10.1097/YCT.0000000000000832"
"2244643","Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients","Coccaro EF, Kramer E, Zemishlany Z, Thorne A, Rice CM 3rd, Giordani B, Duvvi K, Patel BM, Torres J, Nora R, et al.","Am J Psychiatry. 1990 Dec;147(12):1640-5. doi: 10.1176/ajp.147.12.1640.","Coccaro EF","Am J Psychiatry","1990","1990/12/01","","","10.1176/ajp.147.12.1640"
"32421163","The Effects of Aerobic Exercise on Psychological Functioning in Family Caregivers: Secondary Analyses of a Randomized Controlled Trial","Hives BA, Buckler EJ, Weiss J, Schilf S, Johansen KL, Epel ES, Puterman E.","Ann Behav Med. 2021 Feb 12;55(1):65-76. doi: 10.1093/abm/kaaa031.","Hives BA","Ann Behav Med","2021","2020/05/19","PMC7880222","","10.1093/abm/kaaa031"
"18323507","Misclassified tissue volumes in Alzheimer disease patients with white matter hyperintensities: importance of lesion segmentation procedures for volumetric analysis","Levy-Cooperman N, Ramirez J, Lobaugh NJ, Black SE.","Stroke. 2008 Apr;39(4):1134-41. doi: 10.1161/STROKEAHA.107.498196. Epub 2008 Mar 6.","Levy-Cooperman N","Stroke","2008","2008/03/08","","","10.1161/STROKEAHA.107.498196"
"30304477","Translating an Evidence-based Multicomponent Intervention for Older Adults With Dementia and Caregivers","Teri L, Logsdon RG, McCurry SM, Pike KC, McGough EL.","Gerontologist. 2020 Apr 2;60(3):548-557. doi: 10.1093/geront/gny122.","Teri L","Gerontologist","2020","2018/10/11","PMC7117621","","10.1093/geront/gny122"
"34672635","The incremental validity of primacy as a predictor of everyday functioning","Weitzner DS, Divers R, Calamia M.","Neuropsychology. 2022 Jan;36(1):23-34. doi: 10.1037/neu0000778. Epub 2021 Oct 21.","Weitzner DS","Neuropsychology","2022","2021/10/21","","","10.1037/neu0000778"
"12937331","The effect of a family therapy and technology-based intervention on caregiver depression","Eisdorfer C, Czaja SJ, Loewenstein DA, Rubert MP, Argüelles S, Mitrani VB, Szapocznik J.","Gerontologist. 2003 Aug;43(4):521-31. doi: 10.1093/geront/43.4.521.","Eisdorfer C","Gerontologist","2003","2003/08/26","PMC2413057","NIHMS52129","10.1093/geront/43.4.521"
"26208959","Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials","Liu E, Schmidt ME, Margolin R, Sperling R, Koeppe R, Mason NS, Klunk WE, Mathis CA, Salloway S, Fox NC, Hill DL, Les AS, Collins P, Gregg KM, Di J, Lu Y, Tudor IC, Wyman BT, Booth K, Broome S, Yuen E, Grundman M, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.","Neurology. 2015 Aug 25;85(8):692-700. doi: 10.1212/WNL.0000000000001877. Epub 2015 Jul 24.","Liu E","Neurology","2015","2015/07/26","PMC4553028","","10.1212/WNL.0000000000001877"
"21216507","A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people","Kwok T, Lee J, Law CB, Pan PC, Yung CY, Choi KC, Lam LC.","Clin Nutr. 2011 Jun;30(3):297-302. doi: 10.1016/j.clnu.2010.12.004. Epub 2011 Jan 8.","Kwok T","Clin Nutr","2011","2011/01/11","","","10.1016/j.clnu.2010.12.004"
"534419","Effects of physostigmine and lecithin on memory in Alzheimer disease","Peters BH, Levin HS.","Ann Neurol. 1979 Sep;6(3):219-21. doi: 10.1002/ana.410060307.","Peters BH","Ann Neurol","1979","1979/09/01","","","10.1002/ana.410060307"
"15217778","Does a nurse-led mental health liaison service for older people reduce psychiatric morbidity in acute general medical wards? A randomised controlled trial","Baldwin R, Pratt H, Goring H, Marriott A, Roberts C.","Age Ageing. 2004 Sep;33(5):472-8. doi: 10.1093/ageing/afh154. Epub 2004 Jun 24.","Baldwin R","Age Ageing","2004","2004/06/26","","","10.1093/ageing/afh154"
"20224282","Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohort","Sparks DL, Kryscio RJ, Connor DJ, Sabbagh MN, Sparks LM, Lin Y, Liebsack C.","Neurodegener Dis. 2010;7(1-3):183-6. doi: 10.1159/000295660. Epub 2010 Mar 12.","Sparks DL","Neurodegener Dis","2010","2010/03/13","PMC2859238","","10.1159/000295660"
"17366346","Brain activation in elderly people with and without dementia: Influences of gender and medication","Richter MM, Herrmann MJ, Ehlis AC, Plichta MM, Fallgatter AJ.","World J Biol Psychiatry. 2007;8(1):23-9. doi: 10.1080/15622970600960132.","Richter MM","World J Biol Psychiatry","2007","2007/03/17","","","10.1080/15622970600960132"
"8526997","Indoleamine concentrations in cerebrospinal fluid from patients with Alzheimer type and Binswanger type dementias before and after administration of citalopram, a synthetic serotonin uptake inhibitor","Tohgi H, Abe T, Takahashi S, Saheki M, Kimura M.","J Neural Transm Park Dis Dement Sect. 1995;9(2-3):121-31. doi: 10.1007/BF02259654.","Tohgi H","J Neural Transm Park Dis Dement Sect","1995","1995/01/01","","","10.1007/BF02259654"
"15876213","Predictive genetic testing for Alzheimer's disease: impact upon risk perception","Marteau TM, Roberts S, LaRusse S, Green RC.","Risk Anal. 2005 Apr;25(2):397-404. doi: 10.1111/j.1539-6924.2005.00598.x.","Marteau TM","Risk Anal","2005","2005/05/07","","","10.1111/j.1539-6924.2005.00598.x"
"11255446","Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease","Doody RS, Geldmacher DS, Gordon B, Perdomo CA, Pratt RD; Donepezil Study Group.","Arch Neurol. 2001 Mar;58(3):427-33. doi: 10.1001/archneur.58.3.427.","Doody RS","Arch Neurol","2001","2001/03/20","","","10.1001/archneur.58.3.427"
"15326236","Economic evaluation of donepezil in moderate to severe Alzheimer disease","Feldman H, Gauthier S, Hecker J, Vellas B, Hux M, Xu Y, Schwam EM, Shah S, Mastey V; Donepezil MSAD Study Investigators Group.","Neurology. 2004 Aug 24;63(4):644-50. doi: 10.1212/01.wnl.0000134663.79663.6e.","Feldman H","Neurology","2004","2004/08/25","","","10.1212/01.wnl.0000134663.79663.6e"
"24131736","Safety and pharmacokinetics of PF-04360365 following a single-dose intravenous infusion in Japanese subjects with mild-to-moderate Alzheimer's disease: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation study","Miyoshi I, Fujimoto Y, Yamada M, Abe S, Zhao Q, Cronenberger C, Togo K, Ishibashi T, Bednar MM, Kupiec JW, Binneman B.","Int J Clin Pharmacol Ther. 2013 Dec;51(12):911-23. doi: 10.5414/CP201816.","Miyoshi I","Int J Clin Pharmacol Ther","2013","2013/10/18","","","10.5414/CP201816"
"11037003","The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial","van Dongen MC, van Rossum E, Kessels AG, Sielhorst HJ, Knipschild PG.","J Am Geriatr Soc. 2000 Oct;48(10):1183-94. doi: 10.1111/j.1532-5415.2000.tb02589.x.","van Dongen MC","J Am Geriatr Soc","2000","2000/10/19","","","10.1111/j.1532-5415.2000.tb02589.x"
"15664003","RETRACTED: Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease","Sato Y, Kanoko T, Satoh K, Iwamoto J.","Bone. 2005 Jan;36(1):61-8. doi: 10.1016/j.bone.2004.09.018. Epub 2004 Nov 24.","Sato Y","Bone","2005","2005/01/25","","","10.1016/j.bone.2004.09.018"
"18384590","Determining care management activities associated with mastery and relationship strain for dementia caregivers","Connor KI, McNeese-Smith DK, Vickrey BG, van Servellen GM, Chang BL, Lee ML, Vassar SD, Chodosh J.","J Am Geriatr Soc. 2008 May;56(5):891-7. doi: 10.1111/j.1532-5415.2008.01643.x. Epub 2008 Apr 1.","Connor KI","J Am Geriatr Soc","2008","2008/04/04","","","10.1111/j.1532-5415.2008.01643.x"
"15686606","Differential effects of Alzheimer's disease and Huntington's disease on the performance of mental rotation","Lineweaver TT, Salmon DP, Bondi MW, Corey-Bloom J.","J Int Neuropsychol Soc. 2005 Jan;11(1):30-9. doi: 10.1017/S1355617705050034.","Lineweaver TT","J Int Neuropsychol Soc","2005","2005/02/03","","","10.1017/S1355617705050034"
"26912445","Visualization and Quantification of 3-Dimensional Stereotactic Surface Projections for 18F-Flutemetamol PET Using Variable Depth","Lilja J, Thurfjell L, Sörensen J.","J Nucl Med. 2016 Jul;57(7):1078-83. doi: 10.2967/jnumed.115.169169. Epub 2016 Feb 16.","Lilja J","J Nucl Med","2016","2016/02/26","","","10.2967/jnumed.115.169169"
"21309961","Dose effects associated with rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer's disease","Grossberg GT, Olin JT, Somogyi M, Meng X.","Int J Clin Pract. 2011 Apr;65(4):465-71. doi: 10.1111/j.1742-1241.2011.02641.x. Epub 2011 Feb 11.","Grossberg GT","Int J Clin Pract","2011","2011/02/12","","","10.1111/j.1742-1241.2011.02641.x"
"1346198","Amyloid beta-protein deposition in skin of patients with dementia","Soininen H, Syrjänen S, Heinonen O, Neittaanmäki H, Miettinen R, Paljärvi L, Syrjänen K, Beyreuther K, Riekkinen P.","Lancet. 1992 Jan 25;339(8787):245. doi: 10.1016/0140-6736(92)90046-6.","Soininen H","Lancet","1992","1992/01/25","","","10.1016/0140-6736(92)90046-6"
"10445897","Effects of the Medicare Alzheimer's Disease Demonstration on caregiver burden and depression","Newcomer R, Yordi C, DuNah R, Fox P, Wilkinson A.","Health Serv Res. 1999 Aug;34(3):669-89.","Newcomer R","Health Serv Res","1999","1999/08/13","PMC1089032","",""
"34645914","Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression","Siafarikas N, Kirsebom BE, Srivastava DP, Eriksson CM, Auning E, Hessen E, Selbaek G, Blennow K, Aarsland D, Fladby T.","Sci Rep. 2021 Oct 13;11(1):20375. doi: 10.1038/s41598-021-99794-9.","Siafarikas N","Sci Rep","2021","2021/10/14","PMC8514484","","10.1038/s41598-021-99794-9"
"23521503","The safety, tolerability, pharmacokinetics and cognitive effects of GSK239512, a selective histamine H₃ receptor antagonist in patients with mild to moderate Alzheimer's disease: a preliminary investigation","Nathan PJ, Boardley R, Scott N, Berges A, Maruff P, Sivananthan T, Upton N, Lowy MT, Nestor PJ, Lai R.","Curr Alzheimer Res. 2013 Mar;10(3):240-51. doi: 10.2174/1567205011310030003.","Nathan PJ","Curr Alzheimer Res","2013","2013/03/26","","","10.2174/1567205011310030003"
"20845395","Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models","Nagy B, Brennan A, Brandtmüller A, Thomas SK, Sullivan SD, Akehurst R.","Int J Geriatr Psychiatry. 2011 May;26(5):483-94. doi: 10.1002/gps.2551. Epub 2010 Sep 15.","Nagy B","Int J Geriatr Psychiatry","2011","2010/09/17","","","10.1002/gps.2551"
"22785496","Visual assessment versus quantitative three-dimensional stereotactic surface projection fluorodeoxyglucose positron emission tomography for detection of mild cognitive impairment and Alzheimer disease","Lehman VT, Carter RE, Claassen DO, Murphy RC, Lowe V, Petersen RC, Peller PJ.","Clin Nucl Med. 2012 Aug;37(8):721-6. doi: 10.1097/RLU.0b013e3182478d89.","Lehman VT","Clin Nucl Med","2012","2012/07/13","","","10.1097/RLU.0b013e3182478d89"
"20220603","The accuracy of short clinical rating scales in neuropathologically diagnosed dementia","Gustafson L, Englund E, Brunnström H, Brun A, Erikson C, Warkentin S, Passant U.","Am J Geriatr Psychiatry. 2010 Sep;18(9):810-20. doi: 10.1097/JGP.0b013e3181cdef7a.","Gustafson L","Am J Geriatr Psychiatry","2010","2010/03/12","","","10.1097/JGP.0b013e3181cdef7a"
"16375656","Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT)","Sparks DL, Petanceska S, Sabbagh M, Connor D, Soares H, Adler C, Lopez J, Ziolkowski C, Lochhead J, Browne P.","Curr Alzheimer Res. 2005 Dec;2(5):527-39. doi: 10.2174/156720505774932296.","Sparks DL","Curr Alzheimer Res","2005","2005/12/27","","","10.2174/156720505774932296"
"29331848","Repetitive transcranial magnetic stimulation for apathy in mild cognitive impairment: A double-blind, randomized, sham-controlled, cross-over pilot study","Padala PR, Padala KP, Lensing SY, Jackson AN, Hunter CR, Parkes CM, Dennis RA, Bopp MM, Caceda R, Mennemeier MS, Roberson PK, Sullivan DH.","Psychiatry Res. 2018 Mar;261:312-318. doi: 10.1016/j.psychres.2017.12.063. Epub 2018 Jan 5.","Padala PR","Psychiatry Res","2018","2018/01/15","PMC7334038","NIHMS934743","10.1016/j.psychres.2017.12.063"
"11979067","Effects of acute nicotine administration on cognitive event-related potentials in tacrine-treated and non-treated patients with Alzheimer's disease","Knott V, Mohr E, Mahoney C, Engeland C, Ilivitsky V.","Neuropsychobiology. 2002;45(3):156-60. doi: 10.1159/000054957.","Knott V","Neuropsychobiology","2002","2002/04/30","","","10.1159/000054957"
"12932111","Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation","Mizumura S, Kumita S, Cho K, Ishihara M, Nakajo H, Toba M, Kumazaki T.","Ann Nucl Med. 2003 Jun;17(4):289-95. doi: 10.1007/BF02988523.","Mizumura S","Ann Nucl Med","2003","2003/08/23","","","10.1007/BF02988523"
"3048225","The effects of acute scopolamine in geriatric depression","Newhouse PA, Sunderland T, Tariot PN, Weingartner H, Thompson K, Mellow AM, Cohen RM, Murphy DL.","Arch Gen Psychiatry. 1988 Oct;45(10):906-12. doi: 10.1001/archpsyc.1988.01800340028004.","Newhouse PA","Arch Gen Psychiatry","1988","1988/10/01","","","10.1001/archpsyc.1988.01800340028004"
"14745855","Alzheimer's disease caregiving information and skills. Part II: family caregiver issues and concerns","Farran CJ, Loukissa D, Perraud S, Paun O.","Res Nurs Health. 2004 Feb;27(1):40-51. doi: 10.1002/nur.20006.","Farran CJ","Res Nurs Health","2004","2004/01/28","","","10.1002/nur.20006"
"12730320","Predicting 12-month mortality for persons with dementia","Newcomer R, Covinsky KE, Clay T, Yaffe K.","J Gerontol B Psychol Sci Soc Sci. 2003 May;58(3):S187-98. doi: 10.1093/geronb/58.3.s187.","Newcomer R","J Gerontol B Psychol Sci Soc Sci","2003","2003/05/06","","","10.1093/geronb/58.3.s187"
"2121360","Selegiline in the treatment of mild to moderate Alzheimer-type dementia","Monteverde A, Gnemmi P, Rossi F, Monteverde A, Finali GC.","Clin Ther. 1990 Jul-Aug;12(4):315-22.","Monteverde A","Clin Ther","1990","1990/07/01","","",""
"19617318","Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease","Nelissen N, Van Laere K, Thurfjell L, Owenius R, Vandenbulcke M, Koole M, Bormans G, Brooks DJ, Vandenberghe R.","J Nucl Med. 2009 Aug;50(8):1251-9. doi: 10.2967/jnumed.109.063305. Epub 2009 Jul 17.","Nelissen N","J Nucl Med","2009","2009/07/21","","","10.2967/jnumed.109.063305"
"10881250","Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group","Raskind MA, Peskind ER, Wessel T, Yuan W.","Neurology. 2000 Jun 27;54(12):2261-8. doi: 10.1212/wnl.54.12.2261.","Raskind MA","Neurology","2000","2000/07/06","","","10.1212/wnl.54.12.2261"
"26305876","Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial","Rosenberg PB, Drye LT, Porsteinsson AP, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Schneider LS, Shade DM, Weintraub D, Newell J, Yesavage J, Lyketsos CG; CitAD Research Group.","Int Psychogeriatr. 2015 Dec;27(12):2059-67. doi: 10.1017/S1041610215001106. Epub 2015 Aug 25.","Rosenberg PB","Int Psychogeriatr","2015","2015/08/26","PMC4669064","NIHMS729151","10.1017/S1041610215001106"
"9803773","The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine","Itil TM, Eralp E, Ahmed I, Kunitz A, Itil KZ.","Psychopharmacol Bull. 1998;34(3):391-7.","Itil TM","Psychopharmacol Bull","1998","1998/11/06","","",""
"20828359","The ACTION study: methodology of a trial to evaluate safety and efficacy of a higher dose rivastigmine transdermal patch in severe Alzheimer's disease","Farlow MR, Grossberg G, Gauthier S, Meng X, Olin JT.","Curr Med Res Opin. 2010 Oct;26(10):2441-7. doi: 10.1185/03007995.2010.513849.","Farlow MR","Curr Med Res Opin","2010","2010/09/11","","","10.1185/03007995.2010.513849"
"12536285","General Knowledge of the World: a standardised assessment","Mariani C, Sacco L, Spinnler H, Venneri A.","Neurol Sci. 2002 Oct;23(4):161-75. doi: 10.1007/s100720200057.","Mariani C","Neurol Sci","2002","2003/01/22","","","10.1007/s100720200057"
"12397141","Goal setting and attainment in Alzheimer's disease patients treated with donepezil","Rockwood K, Graham JE, Fay S; ACADIE Investigators.","J Neurol Neurosurg Psychiatry. 2002 Nov;73(5):500-7. doi: 10.1136/jnnp.73.5.500.","Rockwood K","J Neurol Neurosurg Psychiatry","2002","2002/10/25","PMC1738123","","10.1136/jnnp.73.5.500"
"11993532","Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjects","Visser PJ, Verhey FR, Scheltens P, Cruts M, Ponds RW, Van Broeckhoven CL, Jolles J.","J Neurol. 2002 Mar;249(3):312-9. doi: 10.1007/s004150200011.","Visser PJ","J Neurol","2002","2002/05/08","","","10.1007/s004150200011"
"14560062","Management of patients with Alzheimer's disease plus cerebrovascular disease: 12-month treatment with galantamine","Bullock R, Erkinjuntti T, Lilienfeld S; GAL-INT-6 Study Group.","Dement Geriatr Cogn Disord. 2004;17(1-2):29-34. doi: 10.1159/000074140. Epub 2003 Oct 13.","Bullock R","Dement Geriatr Cogn Disord","2004","2003/10/16","","","10.1159/000074140"
"24386372","Investigating the association of ApoE genotypes with blood-brain barrier dysfunction measured by cerebrospinal fluid-serum albumin ratio in a cohort of patients with different types of dementia","Karch A, Manthey H, Ponto C, Hermann P, Heinemann U, Schmidt C, Zerr I.","PLoS One. 2013 Dec 27;8(12):e84405. doi: 10.1371/journal.pone.0084405. eCollection 2013.","Karch A","PLoS One","2013","2014/01/04","PMC3874026","","10.1371/journal.pone.0084405"
"11733828","Efficacy and safety of risperidone oral solution in agitation associated with dementia in the elderly","Laks J, Engelhardt E, Marinho V, Rozenthal M, Souza FC, Bacaltchuk J, Stoppe A Jr, Ferreira RC, Bottino C, Scalco M.","Arq Neuropsiquiatr. 2001 Dec;59(4):859-64. doi: 10.1590/s0004-282x2001000600005.","Laks J","Arq Neuropsiquiatr","2001","2001/12/06","","","10.1590/s0004-282x2001000600005"
"35465913","Preliminary analysis of a shortened picture version of the Free and Cued Selective Reminding Test","Rodrigo-Herrero S, Mendez-Barrio C, Bernal Sánchez-Arjona M, de Miguel-Tristancho M, Graciani-Cantisán E, Carnero-Pardo C, Franco-Macías E.","Neurologia (Engl Ed). 2022 Apr;37(3):192-198. doi: 10.1016/j.nrleng.2018.12.019. Epub 2021 Feb 26.","Rodrigo-Herrero S","Neurologia (Engl Ed)","2022","2022/04/25","","","10.1016/j.nrleng.2018.12.019"
"11940691","Randomized pilot study of nimesulide treatment in Alzheimer's disease","Aisen PS, Schmeidler J, Pasinetti GM.","Neurology. 2002 Apr 9;58(7):1050-4. doi: 10.1212/wnl.58.7.1050.","Aisen PS","Neurology","2002","2002/04/10","","","10.1212/wnl.58.7.1050"
"29097166","24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial","Soininen H, Solomon A, Visser PJ, Hendrix SB, Blennow K, Kivipelto M, Hartmann T; LipiDiDiet clinical study group.","Lancet Neurol. 2017 Dec;16(12):965-975. doi: 10.1016/S1474-4422(17)30332-0. Epub 2017 Oct 30.","Soininen H","Lancet Neurol","2017","2017/11/04","PMC5697936","","10.1016/S1474-4422(17)30332-0"
"15899095","Pharmacokinetic simulation for switching from galantamine immediate-release to extended-release formulation","Hing JP, Piotrovsky V, Kimko H, Brashear HR, Zhao Q.","Curr Med Res Opin. 2005 Apr;21(4):483-8. doi: 10.1185/030079905X38213.","Hing JP","Curr Med Res Opin","2005","2005/05/19","","","10.1185/030079905X38213"
"20362677","Determining the optimal level of smoothing in cortical thickness analysis: a hierarchical approach based on sequential statistical thresholding","Bernal-Rusiel JL, Atienza M, Cantero JL.","Neuroimage. 2010 Aug 1;52(1):158-71. doi: 10.1016/j.neuroimage.2010.03.074. Epub 2010 Apr 1.","Bernal-Rusiel JL","Neuroimage","2010","2010/04/06","","","10.1016/j.neuroimage.2010.03.074"
"31855161","Effects of a Tailored Lighting Intervention on Sleep Quality, Rest-Activity, Mood, and Behavior in Older Adults With Alzheimer Disease and Related Dementias: A Randomized Clinical Trial","Figueiro MG, Plitnick B, Roohan C, Sahin L, Kalsher M, Rea MS.","J Clin Sleep Med. 2019 Dec 15;15(12):1757-1767. doi: 10.5664/jcsm.8078. Epub 2019 Nov 8.","Figueiro MG","J Clin Sleep Med","2019","2019/12/20","PMC7099185","","10.5664/jcsm.8078"
"10509375","Candidate neuroanatomic substrates of psychosis in old-aged depression","Kim DK, Kim BL, Sohn SE, Lim SW, Na DG, Paik CH, Krishnan KR, Carroll BJ.","Prog Neuropsychopharmacol Biol Psychiatry. 1999 Jul;23(5):793-807. doi: 10.1016/s0278-5846(99)00041-x.","Kim DK","Prog Neuropsychopharmacol Biol Psychiatry","1999","1999/10/06","","","10.1016/s0278-5846(99)00041-x"
"9258891","Activated Alzheimer disease platelets retain more beta amyloid precursor protein","Davies TA, Long HJ, Sgro K, Rathbun WH, McMenamin ME, Seetoo K, Tibbles H, Billingslea AM, Fine RE, Fishman JB, Levesque CA, Smith SJ, Wells JM, Simons ER.","Neurobiol Aging. 1997 Mar-Apr;18(2):147-53. doi: 10.1016/s0197-4580(97)00013-4.","Davies TA","Neurobiol Aging","1997","1997/03/01","","","10.1016/s0197-4580(97)00013-4"
"25083601","Coping strategies as mediators of the effect of the START (strategies for RelaTives) intervention on psychological morbidity for family carers of people with dementia in a randomised controlled trial","Li R, Cooper C, Barber J, Rapaport P, Griffin M, Livingston G.","J Affect Disord. 2014 Oct;168:298-305. doi: 10.1016/j.jad.2014.07.008. Epub 2014 Jul 17.","Li R","J Affect Disord","2014","2014/08/02","","","10.1016/j.jad.2014.07.008"
"9329702","Combined tacrine and estrogen replacement therapy in patients with Alzheimer's disease","Schneider LS, Farlow M.","Ann N Y Acad Sci. 1997 Sep 26;826:317-22. doi: 10.1111/j.1749-6632.1997.tb48482.x.","Schneider LS","Ann N Y Acad Sci","1997","1997/11/05","","","10.1111/j.1749-6632.1997.tb48482.x"
"20220576","Methylphenidate for apathy and functional status in dementia of the Alzheimer type","Padala PR, Burke WJ, Shostrom VK, Bhatia SC, Wengel SP, Potter JF, Petty F.","Am J Geriatr Psychiatry. 2010 Apr;18(4):371-4. doi: 10.1097/JGP.0b013e3181cabcf6.","Padala PR","Am J Geriatr Psychiatry","2010","2010/03/12","","","10.1097/JGP.0b013e3181cabcf6"
"33980574","Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's disease","Ayalon G, Lee SH, Adolfsson O, Foo-Atkins C, Atwal JK, Blendstrup M, Booler H, Bravo J, Brendza R, Brunstein F, Chan R, Chandra P, Couch JA, Datwani A, Demeule B, DiCara D, Erickson R, Ernst JA, Foreman O, He D, Hötzel I, Keeley M, Kwok MCM, Lafrance-Vanasse J, Lin H, Lu Y, Luk W, Manser P, Muhs A, Ngu H, Pfeifer A, Pihlgren M, Rao GK, Scearce-Levie K, Schauer SP, Smith WB, Solanoy H, Teng E, Wildsmith KR, Bumbaca Yadav D, Ying Y, Fuji RN, Kerchner GA.","Sci Transl Med. 2021 May 12;13(593):eabb2639. doi: 10.1126/scitranslmed.abb2639.","Ayalon G","Sci Transl Med","2021","2021/05/13","","","10.1126/scitranslmed.abb2639"
"19323872","Bright light therapy for agitation in dementia: a randomized controlled trial","Burns A, Allen H, Tomenson B, Duignan D, Byrne J.","Int Psychogeriatr. 2009 Aug;21(4):711-21. doi: 10.1017/S1041610209008886. Epub 2009 Mar 27.","Burns A","Int Psychogeriatr","2009","2009/03/28","","","10.1017/S1041610209008886"
"22431837","Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures","Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P; Alzheimer’s Disease Cooperative Study.","Arch Neurol. 2012 Jul;69(7):836-41. doi: 10.1001/archneurol.2012.85.","Galasko DR","Arch Neurol","2012","2012/03/21","PMC3661272","NIHMS446574","10.1001/archneurol.2012.85"
"15212838","Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical ""disconnection"" in aging and Alzheimer's disease","Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings JL.","Neurobiol Aging. 2004 Aug;25(7):843-51. doi: 10.1016/j.neurobiolaging.2003.09.005.","Bartzokis G","Neurobiol Aging","2004","2004/06/24","","","10.1016/j.neurobiolaging.2003.09.005"
"18517044","Factors associated with concordance and variability of sleep quality in persons with Alzheimer's disease and their caregivers","McCurry SM, Pike KC, Vitiello MV, Logsdon RG, Teri L.","Sleep. 2008 May;31(5):741-8. doi: 10.1093/sleep/31.5.741.","McCurry SM","Sleep","2008","2008/06/04","PMC2398744","","10.1093/sleep/31.5.741"
"10364640","The role of the polymorphic genes apolipoprotein E and methylene- tetrahydrofolate reductase in the development of dementia of the Alzheimer type","Regland B, Blennow K, Germgård T, Koch-Schmidt AC, Gottfries CG.","Dement Geriatr Cogn Disord. 1999 Jul-Aug;10(4):245-51. doi: 10.1159/000017127.","Regland B","Dement Geriatr Cogn Disord","1999","1999/06/12","","","10.1159/000017127"
"16170074","Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?","Visser PJ, Scheltens P, Verhey FR.","J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1348-54. doi: 10.1136/jnnp.2004.047720.","Visser PJ","J Neurol Neurosurg Psychiatry","2005","2005/09/20","PMC1739362","","10.1136/jnnp.2004.047720"
"14655926","A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease","Singer C, Tractenberg RE, Kaye J, Schafer K, Gamst A, Grundman M, Thomas R, Thal LJ; Alzheimer's Disease Cooperative Study.","Sleep. 2003 Nov 1;26(7):893-901. doi: 10.1093/sleep/26.7.893.","Singer C","Sleep","2003","2003/12/06","PMC4418658","NIHMS683803","10.1093/sleep/26.7.893"
"19286192","Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial","Napryeyenko O, Sonnik G, Tartakovsky I.","J Neurol Sci. 2009 Aug 15;283(1-2):224-9. doi: 10.1016/j.jns.2009.02.353. Epub 2009 Mar 14.","Napryeyenko O","J Neurol Sci","2009","2009/03/17","","","10.1016/j.jns.2009.02.353"
"21574893","Reliability of peak treadmill exercise tests in mild Alzheimer disease","Anderson HS, Kluding PM, Gajewski BJ, Donnelly JE, Burns JM.","Int J Neurosci. 2011 Aug;121(8):450-6. doi: 10.3109/00207454.2011.574762. Epub 2011 May 17.","Anderson HS","Int J Neurosci","2011","2011/05/18","PMC3143203","NIHMS292140","10.3109/00207454.2011.574762"
"1705151","The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study","Nyth AL, Gottfries CG.","Br J Psychiatry. 1990 Dec;157:894-901. doi: 10.1192/bjp.157.6.894.","Nyth AL","Br J Psychiatry","1990","1990/12/01","","","10.1192/bjp.157.6.894"
"16494088","The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: a double-blind placebo-controlled study","Moraes Wdos S, Poyares DR, Guilleminault C, Ramos LR, Bertolucci PH, Tufik S.","Sleep. 2006 Feb;29(2):199-205. doi: 10.1093/sleep/29.2.199.","Moraes Wdos S","Sleep","2006","2006/02/24","","","10.1093/sleep/29.2.199"
"2560521","In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type)","Honjo H, Ogino Y, Naitoh K, Urabe M, Kitawaki J, Yasuda J, Yamamoto T, Ishihara S, Okada H, Yonezawa T, et al.","J Steroid Biochem. 1989;34(1-6):521-5. doi: 10.1016/0022-4731(89)90137-4.","Honjo H","J Steroid Biochem","1989","1989/01/01","","","10.1016/0022-4731(89)90137-4"
"18446692","[A comparative study of the effectiveness and tolerability of a procedure involving slow dose-escalation of rivastigmine in patients with mild or moderate Alzheimer-type dementia: the SCALEX study]","Agüera-Ortiz LF, Ramos-García M, Gobartt AL; en Representación del Grupo de Investigadores del Estudio SCALEX.","Rev Neurol. 2008 May 1-15;46(9):517-24.","Agüera-Ortiz LF","Rev Neurol","2008","2008/05/01","","",""
"8130476","Differential use of computer network services","Brennan PF.","Proc Annu Symp Comput Appl Med Care. 1993:27-31.","Brennan PF","Proc Annu Symp Comput Appl Med Care","1993","1993/01/01","PMC2248470","",""
"34151595","Preliminary Validation of the Triana Test: A New Story Recall Test Based on Emotional Material","Luque-Tirado A, Rodrigo-Herrero S, Sánchez-Arjona MB, Franco-Macías E.","Am J Alzheimers Dis Other Demen. 2021 Jan-Dec;36:15333175211025911. doi: 10.1177/15333175211025911.","Luque-Tirado A","Am J Alzheimers Dis Other Demen","2021","2021/06/21","","","10.1177/15333175211025911"
"23317986","Exacerbation of psoriatic skin lesions in a patient with Alzheimer disease receiving gamma-secretase inhibitor","Hsu CK, Hsu CC, Lee JY, Kuo YM, Pai MC.","J Am Acad Dermatol. 2013 Feb;68(2):e46-8. doi: 10.1016/j.jaad.2012.07.012.","Hsu CK","J Am Acad Dermatol","2013","2013/01/16","","","10.1016/j.jaad.2012.07.012"
"24614271","Cognitive behavioral group intervention for Alzheimer caregivers","Passoni S, Moroni L, Toraldo A, Mazzà MT, Bertolotti G, Vanacore N, Bottini G.","Alzheimer Dis Assoc Disord. 2014 Jul-Sep;28(3):275-82. doi: 10.1097/WAD.0000000000000033.","Passoni S","Alzheimer Dis Assoc Disord","2014","2014/03/12","","","10.1097/WAD.0000000000000033"
"36877496","Alzheimer Disease Blood Biomarkers in Patients With Out-of-Hospital Cardiac Arrest","Ashton NJ, Moseby-Knappe M, Benedet AL, Grötschel L, Lantero-Rodriguez J, Karikari TK, Hassager C, Wise MP, Stammet P, Kjaergaard J, Friberg H, Nielsen N, Cronberg T, Zetterberg H, Blennow K.","JAMA Neurol. 2023 Apr 1;80(4):388-396. doi: 10.1001/jamaneurol.2023.0050.","Ashton NJ","JAMA Neurol","2023","2023/03/06","PMC9989959","","10.1001/jamaneurol.2023.0050"
"3517967","Memantine in the treatment of senile dementia of the Alzheimer type","Fleischhacker WW, Buchgeher A, Schubert H.","Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(1):87-93. doi: 10.1016/0278-5846(86)90047-3.","Fleischhacker WW","Prog Neuropsychopharmacol Biol Psychiatry","1986","1986/01/01","","","10.1016/0278-5846(86)90047-3"
"26624212","Analysing Time to Event Data in Dementia Prevention Trials: The Example of the GuidAge Study of EGb761","Scherrer B, Andrieu S, Ousset PJ, Berrut G, Dartigues JF, Dubois B, Pasquier F, Piette F, Robert P, Touchon J, Garnier P, Mathiex-Fortunet H, Vellas B.","J Nutr Health Aging. 2015 Dec;19(10):1009-11. doi: 10.1007/s12603-015-0661-2.","Scherrer B","J Nutr Health Aging","2015","2015/12/02","","","10.1007/s12603-015-0661-2"
"29851748","The Applicability of a High-Intensity Functional Exercise Program Among Older People With Dementia Living in Nursing Homes","Sondell A, Rosendahl E, Gustafson Y, Lindelöf N, Littbrand H.","J Geriatr Phys Ther. 2019 Oct/Dec;42(4):E16-E24. doi: 10.1519/JPT.0000000000000199.","Sondell A","J Geriatr Phys Ther","2019","2018/06/01","PMC6791515","","10.1519/JPT.0000000000000199"
"15174474","Dual-task interference of encoding and retrieval processes in healthy and impaired working memory","MacPherson SE, Della Sala S, Logie RH.","Cortex. 2004 Feb;40(1):183-4. doi: 10.1016/s0010-9452(08)70943-2.","MacPherson SE","Cortex","2004","2004/06/04","","","10.1016/s0010-9452(08)70943-2"
"17407176","Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease","Winblad B, Kawata AK, Beusterien KM, Thomas SK, Wimo A, Lane R, Fillit H, Blesa R.","Int J Geriatr Psychiatry. 2007 May;22(5):485-91. doi: 10.1002/gps.1806.","Winblad B","Int J Geriatr Psychiatry","2007","2007/04/05","","","10.1002/gps.1806"
"28157093","BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants","Timmers M, Barão S, Van Broeck B, Tesseur I, Slemmon J, De Waepenaert K, Bogert J, Shaw LM, Engelborghs S, Moechars D, Mercken M, Van Nueten L, Tritsmans L, de Strooper B, Streffer JR.","J Alzheimers Dis. 2017;56(4):1437-1449. doi: 10.3233/JAD-160829.","Timmers M","J Alzheimers Dis","2017","2017/02/04","PMC5325057","","10.3233/JAD-160829"
"25731629","Vanutide cridificar and the QS-21 adjuvant in Japanese subjects with mild to moderate Alzheimer's disease: results from two phase 2 studies","Arai H, Suzuki H, Yoshiyama T.","Curr Alzheimer Res. 2015;12(3):242-54. doi: 10.2174/1567205012666150302154121.","Arai H","Curr Alzheimer Res","2015","2015/03/04","","","10.2174/1567205012666150302154121"
"16406154","Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLD","Barnes J, Godbolt AK, Frost C, Boyes RG, Jones BF, Scahill RI, Rossor MN, Fox NC.","Neurobiol Aging. 2007 Jan;28(1):20-8. doi: 10.1016/j.neurobiolaging.2005.11.012. Epub 2006 Jan 6.","Barnes J","Neurobiol Aging","2007","2006/01/13","","","10.1016/j.neurobiolaging.2005.11.012"
"12181083","[Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial]","Zhang Z, Wang X, Chen Q, Shu L, Wang J, Shan G.","Zhonghua Yi Xue Za Zhi. 2002 Jul 25;82(14):941-4.","Zhang Z","Zhonghua Yi Xue Za Zhi","2002","2002/08/16","","",""
"34425883","Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD-VIVIAD","Vijverberg EGB, Axelsen TM, Bihlet AR, Henriksen K, Weber F, Fuchs K, Harrison JE, Kühn-Wache K, Alexandersen P, Prins ND, Scheltens P.","Alzheimers Res Ther. 2021 Aug 23;13(1):142. doi: 10.1186/s13195-021-00882-9.","Vijverberg EGB","Alzheimers Res Ther","2021","2021/08/24","PMC8381483","","10.1186/s13195-021-00882-9"
"22545106","Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study","Vedin I, Cederholm T, Freund-Levi Y, Basun H, Garlind A, Irving GF, Eriksdotter-Jönhagen M, Wahlund LO, Dahlman I, Palmblad J.","PLoS One. 2012;7(4):e35425. doi: 10.1371/journal.pone.0035425. Epub 2012 Apr 24.","Vedin I","PLoS One","2012","2012/05/01","PMC3335851","","10.1371/journal.pone.0035425"
"16696580","Cardiovascular effects and risk of syncope related to donepezil in patients with Alzheimer's disease","Bordier P, Garrigue S, Lanusse S, Margaine J, Robert F, Gencel L, Lafitte A.","CNS Drugs. 2006;20(5):411-7. doi: 10.2165/00023210-200620050-00005.","Bordier P","CNS Drugs","2006","2006/05/16","","","10.2165/00023210-200620050-00005"
"25131945","Detection of disease-associated α-synuclein in the cerebrospinal fluid: a feasibility study","Unterberger U, Lachmann I, Voigtländer T, Pirker W, Berghoff AS, Flach K, Wagner U, Geneste A, Perret-Liaudet A, Kovacs GG.","Clin Neuropathol. 2014 Sep-Oct;33(5):329-34. doi: 10.5414/np300796.","Unterberger U","Clin Neuropathol","2014","2014/08/19","PMC4151342","","10.5414/np300796"
"30826452","Rationale and methods for a multicenter clinical trial assessing exercise and intensive vascular risk reduction in preventing dementia (rrAD Study)","Szabo-Reed AN, Vidoni E, Binder EF, Burns J, Cullum CM, Gahan WP, Gupta A, Hynan LS, Kerwin DR, Rossetti H, Stowe AM, Vongpatanasin W, Zhu DC, Zhang R, Keller JN.","Contemp Clin Trials. 2019 Apr;79:44-54. doi: 10.1016/j.cct.2019.02.007. Epub 2019 Mar 1.","Szabo-Reed AN","Contemp Clin Trials","2019","2019/03/04","PMC6436980","NIHMS1018230","10.1016/j.cct.2019.02.007"
"26270474","High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal Fluid","Hendrickson RC, Lee AY, Song Q, Liaw A, Wiener M, Paweletz CP, Seeburger JL, Li J, Meng F, Deyanova EG, Mazur MT, Settlage RE, Zhao X, Southwick K, Du Y, Holder D, Sachs JR, Laterza OF, Dallob A, Chappell DL, Snyder K, Modur V, King E, Joachim C, Bondarenko AY, Shearman M, Soper KA, Smith AD, Potter WZ, Koblan KS, Sachs AB, Yates NA.","PLoS One. 2015 Aug 13;10(8):e0135365. doi: 10.1371/journal.pone.0135365. eCollection 2015.","Hendrickson RC","PLoS One","2015","2015/08/14","PMC4535975","","10.1371/journal.pone.0135365"
"21645184","A 24-week, multicentre, open evaluation of the clinical effectiveness of the rivastigmine patch in patients with probable Alzheimer's disease","Articus K, Baier M, Tracik F, Kühn F, Preuss UW, Kurz A.","Int J Clin Pract. 2011 Jul;65(7):790-6. doi: 10.1111/j.1742-1241.2011.02713.x. Epub 2011 Jun 6.","Articus K","Int J Clin Pract","2011","2011/06/08","","","10.1111/j.1742-1241.2011.02713.x"
"18070004","Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease","Dowling GA, Burr RL, Van Someren EJ, Hubbard EM, Luxenberg JS, Mastick J, Cooper BA.","J Am Geriatr Soc. 2008 Feb;56(2):239-46. doi: 10.1111/j.1532-5415.2007.01543.x. Epub 2007 Dec 7.","Dowling GA","J Am Geriatr Soc","2008","2007/12/12","PMC2642966","NIHMS46909","10.1111/j.1532-5415.2007.01543.x"
"29182458","Multimedia Aided Consent for Alzheimer's Disease Research","Palmer BW, Harmell AL, Dunn LB, Kim SY, Pinto LL, Golshan S, Jeste DV.","Clin Gerontol. 2018 Jan-Feb;41(1):20-32. doi: 10.1080/07317115.2017.1373177. Epub 2017 Nov 28.","Palmer BW","Clin Gerontol","2018","2017/11/29","PMC6085078","NIHMS1501175","10.1080/07317115.2017.1373177"
"33260532","Hearing Loss in Alzheimer's Disease Is Associated with Altered Serum Lipidomic Biomarker Profiles","Llano DA, Issa LK, Devanarayan P, Devanarayan V, Alzheimer's Disease Neuroimaging Initiative Adni.","Cells. 2020 Nov 28;9(12):2556. doi: 10.3390/cells9122556.","Llano DA","Cells","2020","2020/12/02","PMC7760745","","10.3390/cells9122556"
"24073978","Evaluation of an 8-item Severe Impairment Battery (SIB-8) vs. the full SIB in moderate to severe Alzheimer's disease patients participating in a donepezil study","Schmitt FA, Saxton J, Ferris SH, Mackell J, Sun Y.","Int J Clin Pract. 2013 Oct;67(10):1050-6. doi: 10.1111/ijcp.12188.","Schmitt FA","Int J Clin Pract","2013","2013/10/01","PMC3930878","NIHMS472469","10.1111/ijcp.12188"
"30325721","Communication Predictors of Patient and Companion Satisfaction with Alzheimer's Genetic Risk Disclosure","Guan Y, Roter DL, Erby LH, Wolff JL, Gitlin LN, Roberts JS, Green RC, Christensen KD.","J Health Commun. 2018;23(8):807-814. doi: 10.1080/10810730.2018.1528319.","Guan Y","J Health Commun","2018","2018/10/17","PMC6452435","NIHMS1016090","10.1080/10810730.2018.1528319"
"17675917","[Effects of the association of sulbutiamine with an acetylcholinesterase inhibitor in early stage and moderate Alzheimer disease]","Ollat H, Laurent B, Bakchine S, Michel BF, Touchon J, Dubois B.","Encephale. 2007 Mar-Apr;33(2):211-5. doi: 10.1016/s0013-7006(07)91552-3.","Ollat H","Encephale","2007","2007/08/07","","","10.1016/s0013-7006(07)91552-3"
"34329196","Chocolate consumption and all-cause and cause-specific mortality in a US population: a post hoc analysis of the PLCO cancer screening trial","Zhong GC, Hu TY, Yang PF, Peng Y, Wu JJ, Sun WP, Cheng L, Wang CR.","Aging (Albany NY). 2021 Jul 29;13(14):18564-18585. doi: 10.18632/aging.203302. Epub 2021 Jul 29.","Zhong GC","Aging (Albany NY)","2021","2021/07/30","PMC8351724","","10.18632/aging.203302"
"10705163","Apolipoprotein E genotype and lipid and lipoprotein levels in dementia","Wehr H, Parnowski T, Puzyński S, Bednarska-Makaruk M, Bisko M, Kotapka-Minc S, Rodo M, Wołkowska M.","Dement Geriatr Cogn Disord. 2000 Mar-Apr;11(2):70-3. doi: 10.1159/000017217.","Wehr H","Dement Geriatr Cogn Disord","2000","2000/03/08","","","10.1159/000017217"
"33199752","Effect of desalted Salicornia europaea L. ethanol extract (PM-EE) on the subjects complaining memory dysfunction without dementia: a 12 week, randomized, double-blind, placebo-controlled clinical trial","Lee WJ, Shin YW, Kim DE, Kweon MH, Kim M.","Sci Rep. 2020 Nov 16;10(1):19914. doi: 10.1038/s41598-020-76938-x.","Lee WJ","Sci Rep","2020","2020/11/17","PMC7670404","","10.1038/s41598-020-76938-x"
"30207586","Relationship Between Brain Amyloid Deposition and Instrumental Activities of Daily Living in Older Adults: A Longitudinal Study from the Multidomain Alzheimer Prevention Trial","Lilamand M, Cesari M, Cantet C, Payoux P, Andrieu S, Vellas B; the MAPT/DSA study group.","J Am Geriatr Soc. 2018 Oct;66(10):1940-1947. doi: 10.1111/jgs.15497. Epub 2018 Sep 12.","Lilamand M","J Am Geriatr Soc","2018","2018/09/13","","","10.1111/jgs.15497"
"31969201","[(18)F]FDDNP PET binding predicts change in executive function in a pilot clinical trial of geriatric depression","Krause-Sorio B, Siddarth P, Laird KT, Ercoli L, Narr K, Barrio JR, Small G, Lavretsky H.","Int Psychogeriatr. 2021 Feb;33(2):149-156. doi: 10.1017/S1041610219002047. Epub 2020 Jan 23.","Krause-Sorio B","Int Psychogeriatr","2021","2020/01/24","PMC7375908","NIHMS1545934","10.1017/S1041610219002047"
"26541776","Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans","Rullmann M, Dukart J, Hoffmann KT, Luthardt J, Tiepolt S, Patt M, Gertz HJ, Schroeter ML, Seibyl J, Schulz-Schaeffer WJ, Sabri O, Barthel H.","J Nucl Med. 2016 Feb;57(2):198-203. doi: 10.2967/jnumed.115.161893. Epub 2015 Nov 5.","Rullmann M","J Nucl Med","2016","2015/11/07","","","10.2967/jnumed.115.161893"
"20808101","A memory and organizational aid improves Alzheimer disease research consent capacity: results of a randomized, controlled trial","Rubright J, Sankar P, Casarett DJ, Gur R, Xie SX, Karlawish J.","Am J Geriatr Psychiatry. 2010 Dec;18(12):1124-32. doi: 10.1097/JGP.0b013e3181dd1c3b.","Rubright J","Am J Geriatr Psychiatry","2010","2010/09/03","PMC2992096","NIHMS198722","10.1097/JGP.0b013e3181dd1c3b"
"16470370","Fully automatic diagnostic system for early- and late-onset mild Alzheimer's disease using FDG PET and 3D-SSP","Ishii K, Kono AK, Sasaki H, Miyamoto N, Fukuda T, Sakamoto S, Mori E.","Eur J Nucl Med Mol Imaging. 2006 May;33(5):575-83. doi: 10.1007/s00259-005-0015-0. Epub 2006 Feb 10.","Ishii K","Eur J Nucl Med Mol Imaging","2006","2006/02/14","","","10.1007/s00259-005-0015-0"
"17596638","Light treatment for neuropsychiatric behaviors in Alzheimer's disease","Dowling GA, Graf CL, Hubbard EM, Luxenberg JS.","West J Nurs Res. 2007 Dec;29(8):961-75. doi: 10.1177/0193945907303083. Epub 2007 Jun 27.","Dowling GA","West J Nurs Res","2007","2007/06/29","PMC2387134","NIHMS46910","10.1177/0193945907303083"
"15537474","An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting","Aguglia E, Onor ML, Saina M, Maso E.","Curr Med Res Opin. 2004 Nov;20(11):1747-52. doi: 10.1185/030079904X6273.","Aguglia E","Curr Med Res Opin","2004","2004/11/13","","","10.1185/030079904X6273"
"16905216","Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction","Kotani S, Sakaguchi E, Warashina S, Matsukawa N, Ishikura Y, Kiso Y, Sakakibara M, Yoshimoto T, Guo J, Yamashima T.","Neurosci Res. 2006 Oct;56(2):159-64. doi: 10.1016/j.neures.2006.06.010. Epub 2006 Aug 14.","Kotani S","Neurosci Res","2006","2006/08/15","","","10.1016/j.neures.2006.06.010"
"12937334","Effects of an automated telephone support system on caregiver burden and anxiety: findings from the REACH for TLC intervention study","Mahoney DF, Tarlow BJ, Jones RN.","Gerontologist. 2003 Aug;43(4):556-67. doi: 10.1093/geront/43.4.556.","Mahoney DF","Gerontologist","2003","2003/08/26","","","10.1093/geront/43.4.556"
"12496309","Efficacy of a psychoeducative group program for caregivers of demented persons living at home: a randomized controlled trial","Hébert R, Lévesque L, Vézina J, Lavoie JP, Ducharme F, Gendron C, Préville M, Voyer L, Dubois MF.","J Gerontol B Psychol Sci Soc Sci. 2003 Jan;58(1):S58-67. doi: 10.1093/geronb/58.1.s58.","Hébert R","J Gerontol B Psychol Sci Soc Sci","2003","2002/12/24","","","10.1093/geronb/58.1.s58"
"18294736","18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease","Relkin NR, Szabo P, Adamiak B, Burgut T, Monthe C, Lent RW, Younkin S, Younkin L, Schiff R, Weksler ME.","Neurobiol Aging. 2009 Nov;30(11):1728-36. doi: 10.1016/j.neurobiolaging.2007.12.021. Epub 2008 Feb 21.","Relkin NR","Neurobiol Aging","2009","2008/02/26","","","10.1016/j.neurobiolaging.2007.12.021"
"21670398","Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment","Bayer-Carter JL, Green PS, Montine TJ, VanFossen B, Baker LD, Watson GS, Bonner LM, Callaghan M, Leverenz JB, Walter BK, Tsai E, Plymate SR, Postupna N, Wilkinson CW, Zhang J, Lampe J, Kahn SE, Craft S.","Arch Neurol. 2011 Jun;68(6):743-52. doi: 10.1001/archneurol.2011.125.","Bayer-Carter JL","Arch Neurol","2011","2011/06/15","PMC3175115","NIHMS266838","10.1001/archneurol.2011.125"
"10445896","Effects of the Medicare Alzheimer's Disease Demonstration on the use of community-based services","Newcomer R, Spitalny M, Fox P, Yordi C.","Health Serv Res. 1999 Aug;34(3):645-67.","Newcomer R","Health Serv Res","1999","1999/08/13","PMC1089031","",""
"24495273","Taste-masked and affordable donepezil hydrochloride orally disintegrating tablet as promising solution for non-compliance in Alzheimer's disease patients","Liew KB, Tan YT, Peh KK.","Drug Dev Ind Pharm. 2015 Apr;41(4):583-93. doi: 10.3109/03639045.2014.884130. Epub 2014 Feb 5.","Liew KB","Drug Dev Ind Pharm","2015","2014/02/06","","","10.3109/03639045.2014.884130"
"2410219","A longitudinal EEG study of mild senile dementia of Alzheimer type: changes at 1 year and at 2.5 years","Coben LA, Danziger W, Storandt M.","Electroencephalogr Clin Neurophysiol. 1985 Aug;61(2):101-12. doi: 10.1016/0013-4694(85)91048-x.","Coben LA","Electroencephalogr Clin Neurophysiol","1985","1985/08/01","","","10.1016/0013-4694(85)91048-x"
"3895014","Desglycinamide-9-arginine-8-vasopressin (DGAVP, Organon 5667) in patients with dementia","Peabody CA, Thiemann S, Pigache R, Miller TP, Berger PA, Yesavage J, Tinklenberg JR.","Neurobiol Aging. 1985 Summer;6(2):95-100. doi: 10.1016/0197-4580(85)90024-7.","Peabody CA","Neurobiol Aging","1985","1985/01/01","","","10.1016/0197-4580(85)90024-7"
"9919321","Racial differences in neuropsychiatric symptoms among dementia outpatients","Cohen CI, Magai C.","Am J Geriatr Psychiatry. 1999 Winter;7(1):57-63.","Cohen CI","Am J Geriatr Psychiatry","1999","1999/01/27","","",""
"23779114","Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial","Hanson AJ, Bayer-Carter JL, Green PS, Montine TJ, Wilkinson CW, Baker LD, Watson GS, Bonner LM, Callaghan M, Leverenz JB, Tsai E, Postupna N, Zhang J, Lampe J, Craft S.","JAMA Neurol. 2013 Aug;70(8):972-80. doi: 10.1001/jamaneurol.2013.396.","Hanson AJ","JAMA Neurol","2013","2013/06/20","PMC3859238","NIHMS535141","10.1001/jamaneurol.2013.396"
"17243195","Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease","Jones RW, Bayer A, Inglis F, Barker A, Phul R.","Int J Geriatr Psychiatry. 2007 Mar;22(3):258-62. doi: 10.1002/gps.1752.","Jones RW","Int J Geriatr Psychiatry","2007","2007/01/24","","","10.1002/gps.1752"
"9585171","Safety and tolerability of metrifonate in patients with Alzheimer's disease: results of a maximum tolerated dose study","Cutler NR, Jhee SS, Cyrus P, Bieber F, TanPiengco P, Sramek JJ, Gulanski B.","Life Sci. 1998;62(16):1433-41. doi: 10.1016/s0024-3205(98)00082-4.","Cutler NR","Life Sci","1998","1998/05/19","","","10.1016/s0024-3205(98)00082-4"
"16696743","Continuous positive airway pressure reduces subjective daytime sleepiness in patients with mild to moderate Alzheimer's disease with sleep disordered breathing","Chong MS, Ayalon L, Marler M, Loredo JS, Corey-Bloom J, Palmer BW, Liu L, Ancoli-Israel S.","J Am Geriatr Soc. 2006 May;54(5):777-81. doi: 10.1111/j.1532-5415.2006.00694.x.","Chong MS","J Am Geriatr Soc","2006","2006/05/16","","","10.1111/j.1532-5415.2006.00694.x"
"16375658","A randomized, double-blind, placebo-controlled pilot trial of safety and tolerability of two doses of divalproex sodium in outpatients with probable Alzheimer's disease","Profenno LA, Jakimovich L, Holt CJ, Porsteinsson A, Tariot PN.","Curr Alzheimer Res. 2005 Dec;2(5):553-8. doi: 10.2174/156720505774932205.","Profenno LA","Curr Alzheimer Res","2005","2005/12/27","","","10.2174/156720505774932205"
"15756485","[Effectiveness of a multifactorial intervention to reduce physical restraints in nursing home residents with dementia]","Koczy P, Klie T, Kron M, Bredthauer D, Rissmann U, Branitzki S, Guerra V, Klein A, Pfundstein T, Nikolaus T, Sander S, Becker C.","Z Gerontol Geriatr. 2005 Feb;38(1):33-9. doi: 10.1007/s00391-005-0289-7.","Koczy P","Z Gerontol Geriatr","2005","2005/03/10","","","10.1007/s00391-005-0289-7"
"28855224","DHA-rich n-3 fatty acid supplementation decreases DNA methylation in blood leukocytes: the OmegAD study","Karimi M, Vedin I, Freund Levi Y, Basun H, Faxén Irving G, Eriksdotter M, Wahlund LO, Schultzberg M, Hjorth E, Cederholm T, Palmblad J.","Am J Clin Nutr. 2017 Oct;106(4):1157-1165. doi: 10.3945/ajcn.117.155648. Epub 2017 Aug 30.","Karimi M","Am J Clin Nutr","2017","2017/09/01","","","10.3945/ajcn.117.155648"
"9345695","Fluency and memory differences between ischemic vascular dementia and Alzheimer's disease","Lafosse JM, Reed BR, Mungas D, Sterling SB, Wahbeh H, Jagust WJ.","Neuropsychology. 1997 Oct;11(4):514-22. doi: 10.1037//0894-4105.11.4.514.","Lafosse JM","Neuropsychology","1997","1997/11/05","","","10.1037//0894-4105.11.4.514"
"19012865","Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease","Cassidy MR, Roberts JS, Bird TD, Steinbart EJ, Cupples LA, Chen CA, Linnenbringer E, Green RC.","Alzheimers Dement. 2008 Nov;4(6):406-13. doi: 10.1016/j.jalz.2008.04.007.","Cassidy MR","Alzheimers Dement","2008","2008/11/18","PMC2610442","NIHMS79419","10.1016/j.jalz.2008.04.007"
"9052903","Effects of central muscarinic-1 receptor stimulation on blood pressure regulation","Medina A, Bodick N, Goldberger AL, Mac Mahon M, Lipsitz LA.","Hypertension. 1997 Mar;29(3):828-34. doi: 10.1161/01.hyp.29.3.828.","Medina A","Hypertension","1997","1997/03/01","","","10.1161/01.hyp.29.3.828"
"16150197","Clinical observation and mechanism study on treatment of senile dementia with Naohuandan","Meng RS, Li QM, Wei CX, Chen B, Liao HY, Zhou YT.","Chin J Integr Med. 2005 Jun;11(2):111-6. doi: 10.1007/BF02836466.","Meng RS","Chin J Integr Med","2005","2005/09/10","","","10.1007/BF02836466"
"29604402","Effects of aquatic and land-based exercises on amyloid beta, heat shock protein 27, and pulse wave velocity in elderly women","Kim JH, Jung YS, Kim JW, Ha MS, Ha SM, Kim DY.","Exp Gerontol. 2018 Jul 15;108:62-68. doi: 10.1016/j.exger.2018.03.024. Epub 2018 Mar 28.","Kim JH","Exp Gerontol","2018","2018/04/01","","","10.1016/j.exger.2018.03.024"
"35193041","Screening for deficits on intrinsic capacity domains and associated healthcare costs","Pagès A, Costa N, González-Bautista E, Mounié M, Juillard-Condat B, Molinier L, Cestac P, Rolland Y, Vellas B, De Souto Barreto P; MAPT/DSA Group.","Arch Gerontol Geriatr. 2022 May-Jun;100:104654. doi: 10.1016/j.archger.2022.104654. Epub 2022 Feb 7.","Pagès A","Arch Gerontol Geriatr","2022","2022/02/22","","","10.1016/j.archger.2022.104654"
"32777010","Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment","Grill JD, Raman R, Ernstrom K, Sultzer DL, Burns JM, Donohue MC, Johnson KA, Aisen PS, Sperling RA, Karlawish J; A4 Study Team.","JAMA Neurol. 2020 Dec 1;77(12):1504-1513. doi: 10.1001/jamaneurol.2020.2734.","Grill JD","JAMA Neurol","2020","2020/08/11","PMC7418046","","10.1001/jamaneurol.2020.2734"
"7581918","High-performance liquid chromatographic assay for xanomeline, a specific M-1 agonist, and its metabolite in human plasma","Kasper SC, Bonate PL, DeLong AF.","J Chromatogr B Biomed Appl. 1995 Jul 21;669(2):397-403. doi: 10.1016/0378-4347(95)00124-2.","Kasper SC","J Chromatogr B Biomed Appl","1995","1995/07/21","","","10.1016/0378-4347(95)00124-2"
"10367991","Dissociation between I2-imidazoline receptors and MAO-B activity in platelets of patients with Alzheimer's type dementia","Soto J, Ulibarri I, Jauregui JV, Ballesteros J, Meana JJ.","J Psychiatr Res. 1999 May-Jun;33(3):251-7. doi: 10.1016/s0022-3956(98)00065-x.","Soto J","J Psychiatr Res","1999","1999/06/15","","","10.1016/s0022-3956(98)00065-x"
"16842692","[Outcome and cognitive changes of mild cognitive impairment in the elderly: a follow-up study of 47 cases]","Xiao SF, Xue HB, Li GJ, Li CB, Wu WY, Zhang MY.","Zhonghua Yi Xue Za Zhi. 2006 Jun 6;86(21):1441-6.","Xiao SF","Zhonghua Yi Xue Za Zhi","2006","2006/07/18","","",""
"21592048","Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies","Harrington C, Sawchak S, Chiang C, Davies J, Donovan C, Saunders AM, Irizarry M, Jeter B, Zvartau-Hind M, van Dyck CH, Gold M.","Curr Alzheimer Res. 2011 Aug;8(5):592-606. doi: 10.2174/156720511796391935.","Harrington C","Curr Alzheimer Res","2011","2011/05/20","","","10.2174/156720511796391935"
"20605008","[Memantine for treatment of behavioural disturbances and psychotic symptoms in moderate to moderately severe Alzheimer dementia: a naturalistic study in outpatient services in Austria]","Schmidt R, Baumhackl U, Berek K, Brücke T, Kapeller P, Lechner A, Rainer M, Stögerer EM.","Neuropsychiatr. 2010;24(2):125-31.","Schmidt R","Neuropsychiatr","2010","2010/07/08","","",""
"10536456","[Bladder dysfunction in dementia patients showing urinary incontinence: evaluation with cystometry and treatment with propiverine hydrochloride]","Mori S, Kojima M, Sakai Y, Nakajima K.","Nihon Ronen Igakkai Zasshi. 1999 Jul;36(7):489-94. doi: 10.3143/geriatrics.36.489.","Mori S","Nihon Ronen Igakkai Zasshi","1999","1999/10/28","","","10.3143/geriatrics.36.489"
"31111516","Online information and support for carers of people with young-onset dementia: A multi-site randomised controlled pilot study","Metcalfe A, Jones B, Mayer J, Gage H, Oyebode J, Boucault S, Aloui S, Schwertel U, Böhm M, Tezenas du Montcel S, Lebbah S, De Mendonça A, De Vugt M, Graff C, Jansen S, Hergueta T, Dubois B, Kurz A.","Int J Geriatr Psychiatry. 2019 Oct;34(10):1455-1464. doi: 10.1002/gps.5154. Epub 2019 Jul 26.","Metcalfe A","Int J Geriatr Psychiatry","2019","2019/05/22","","","10.1002/gps.5154"
"27767991","AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease","Cebers G, Alexander RC, Haeberlein SB, Han D, Goldwater R, Ereshefsky L, Olsson T, Ye N, Rosen L, Russell M, Maltby J, Eketjäll S, Kugler AR.","J Alzheimers Dis. 2017;55(3):1039-1053. doi: 10.3233/JAD-160701.","Cebers G","J Alzheimers Dis","2017","2016/10/22","","","10.3233/JAD-160701"
"33844014","Visit-to-Visit Blood Pressure Variability and Incident Frailty in Older Adults","Rouch L, De Souto Barreto P, Hanon O, Vidal JS, Amar J, Andrieu S, Cestac P, Rolland Y, Vellas B; MAPT/DSA Group.","J Gerontol A Biol Sci Med Sci. 2021 Jul 13;76(8):1369-1375. doi: 10.1093/gerona/glab112.","Rouch L","J Gerontol A Biol Sci Med Sci","2021","2021/04/12","","","10.1093/gerona/glab112"
"20139767","""I know what you told me, but this is what I think:"" perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate","Linnenbringer E, Roberts JS, Hiraki S, Cupples LA, Green RC.","Genet Med. 2010 Apr;12(4):219-27. doi: 10.1097/GIM.0b013e3181cef9e1.","Linnenbringer E","Genet Med","2010","2010/02/09","PMC2921681","NIHMS224582","10.1097/GIM.0b013e3181cef9e1"
"31324405","Effect of a 24-month physical activity program on brain changes in older adults at risk of Alzheimer's disease: the AIBL active trial","Venkatraman VK, Sanderson A, Cox KL, Ellis KA, Steward C, Phal PM, Gorelik A, Sharman MJ, Villemagne VL, Lai M, Cyarto EV, Merkel B, Ames D, Szoeke C, Rowe CC, Masters CL, Lautenschlager NT, Desmond PM.","Neurobiol Aging. 2020 May;89:132-141. doi: 10.1016/j.neurobiolaging.2019.02.030. Epub 2019 May 27.","Venkatraman VK","Neurobiol Aging","2020","2019/07/21","","","10.1016/j.neurobiolaging.2019.02.030"
"12325052","Effects of emotion-oriented care on elderly people with cognitive impairment and behavioral problems","Schrijnemaekers V, van Rossum E, Candel M, Frederiks C, Derix M, Sielhorst H, van den Brandt P.","Int J Geriatr Psychiatry. 2002 Oct;17(10):926-37. doi: 10.1002/gps.681.","Schrijnemaekers V","Int J Geriatr Psychiatry","2002","2002/09/27","","","10.1002/gps.681"
"33763470","ABCA1-Labeled Exosomes in Serum Contain Higher MicroRNA-193b Levels in Alzheimer's Disease","Liu CG, Zhao Y, Lu Y, Wang PC.","Biomed Res Int. 2021 Mar 8;2021:5450397. doi: 10.1155/2021/5450397. eCollection 2021.","Liu CG","Biomed Res Int","2021","2021/03/25","PMC7963893","","10.1155/2021/5450397"
"18959553","Australian consumer responses to DTCA and other pharmaceutical company sponsored advertisements","Hall DV, Jones SC.","Aust N Z J Public Health. 2008 Oct;32(5):471-8. doi: 10.1111/j.1753-6405.2008.00282.x.","Hall DV","Aust N Z J Public Health","2008","2008/10/31","","","10.1111/j.1753-6405.2008.00282.x"
"22159768","Health and nutrition promotion program for patients with dementia (NutriAlz): cluster randomized trial","Salvà A, Andrieu S, Fernandez E, Schiffrin EJ, Moulin J, Decarli B, Rojano-i-Luque X, Guigoz Y, Vellas B; NutriAlz group.","J Nutr Health Aging. 2011 Dec;15(10):822-30. doi: 10.1007/s12603-011-0363-3.","Salvà A","J Nutr Health Aging","2011","2011/12/14","","","10.1007/s12603-011-0363-3"
"9433339","Efficacy and tolerability of carbamazepine for agitation and aggression in dementia","Tariot PN, Erb R, Podgorski CA, Cox C, Patel S, Jakimovich L, Irvine C.","Am J Psychiatry. 1998 Jan;155(1):54-61. doi: 10.1176/ajp.155.1.54.","Tariot PN","Am J Psychiatry","1998","1998/01/20","","","10.1176/ajp.155.1.54"
"19139247","Long-term effects of bereavement and caregiver intervention on dementia caregiver depressive symptoms","Haley WE, Bergman EJ, Roth DL, McVie T, Gaugler JE, Mittelman MS.","Gerontologist. 2008 Dec;48(6):732-40. doi: 10.1093/geront/48.6.732.","Haley WE","Gerontologist","2008","2009/01/14","PMC2846300","NIHMS114864","10.1093/geront/48.6.732"
"6355883","Measurement of cholinergic drug effects on memory in Alzheimer's disease","Brinkman SD, Gershon S.","Neurobiol Aging. 1983 Summer;4(2):139-45. doi: 10.1016/0197-4580(83)90038-6.","Brinkman SD","Neurobiol Aging","1983","1983/01/01","","","10.1016/0197-4580(83)90038-6"
"17530572","CYP2D6 gene polymorphism as a probable risk factor for Alzheimer's disease and Parkinson's disease with dementia","Gołab-Janowska M, Honczarenko K, Gawrońska-Szklarz B, Potemkowski A.","Neurol Neurochir Pol. 2007 Mar-Apr;41(2):113-21.","Gołab-Janowska M","Neurol Neurochir Pol","2007","2007/05/29","","",""
"12695884","Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study","Lin AP, Shic F, Enriquez C, Ross BD.","MAGMA. 2003 Feb;16(1):29-42. doi: 10.1007/s10334-003-0004-x.","Lin AP","MAGMA","2003","2003/04/16","","","10.1007/s10334-003-0004-x"
"28582280","Lorazepam Challenge for Individuals at Varying Genetic Risk for Alzheimer Disease","Stonnington CM, Harel B, Locke DEC, Hentz JG, Zhang N, Maruff P, Caselli RJ.","Alzheimer Dis Assoc Disord. 2017 Oct-Dec;31(4):271-277. doi: 10.1097/WAD.0000000000000200.","Stonnington CM","Alzheimer Dis Assoc Disord","2017","2017/06/06","PMC5699956","NIHMS866206","10.1097/WAD.0000000000000200"
"16007329","Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in hospitalized, elderly women with Alzheimer's disease: a randomized controlled trial","Sato Y, Iwamoto J, Kanoko T, Satoh K.","J Bone Miner Res. 2005 Aug;20(8):1327-33. doi: 10.1359/JBMR.050402. Epub 2005 Apr 4.","Sato Y","J Bone Miner Res","2005","2005/07/12","","","10.1359/JBMR.050402"
"33883008","Safety, pharmacokinetics and exploratory pro-cognitive effects of HTL0018318, a selective M(1) receptor agonist, in healthy younger adult and elderly subjects: a multiple ascending dose study","Bakker C, Tasker T, Liptrot J, Hart EP, Klaassen ES, Doll RJ, Brown GA, Brown A, Congreve M, Weir M, Marshall FH, Cross DM, Groeneveld GJ, Nathan PJ.","Alzheimers Res Ther. 2021 Apr 21;13(1):87. doi: 10.1186/s13195-021-00816-5.","Bakker C","Alzheimers Res Ther","2021","2021/04/22","PMC8061066","","10.1186/s13195-021-00816-5"
"12782920","First clinical evaluation of ganstigmine in patients with probable Alzheimer's disease","Jhee SS, Fabbri L, Piccinno A, Monici P, Moran S, Zarotsky V, Tan EY, Frackiewicz EJ, Shiovitz T.","Clin Neuropharmacol. 2003 May-Jun;26(3):164-9. doi: 10.1097/00002826-200305000-00011.","Jhee SS","Clin Neuropharmacol","2003","2003/06/05","","","10.1097/00002826-200305000-00011"
"20375503","Spine Surgery under general anesthesia may not increase the risk of Alzheimer's disease","Zuo C, Zuo Z.","Dement Geriatr Cogn Disord. 2010;29(3):233-9. doi: 10.1159/000295114. Epub 2010 Apr 6.","Zuo C","Dement Geriatr Cogn Disord","2010","2010/04/09","PMC2865396","","10.1159/000295114"
"23920020","Brain imaging and cognitive predictors of stroke and Alzheimer disease in the Framingham Heart Study","Weinstein G, Beiser AS, Decarli C, Au R, Wolf PA, Seshadri S.","Stroke. 2013 Oct;44(10):2787-94. doi: 10.1161/STROKEAHA.113.000947. Epub 2013 Aug 6.","Weinstein G","Stroke","2013","2013/08/08","PMC3974341","NIHMS514643","10.1161/STROKEAHA.113.000947"
"18198454","[Family caregiver burden caused by behavioral and psychological symptoms of dementia: measurement with a new original scale]","Sugiura K, Ito M, Mikami H.","Nihon Ronen Igakkai Zasshi. 2007 Nov;44(6):717-25. doi: 10.3143/geriatrics.44.717.","Sugiura K","Nihon Ronen Igakkai Zasshi","2007","2008/01/17","","","10.3143/geriatrics.44.717"
"9447502","Pilot study of haloperidol, fluoxetine, and placebo for agitation in Alzheimer's disease","Auchus AP, Bissey-Black C.","J Neuropsychiatry Clin Neurosci. 1997 Fall;9(4):591-3. doi: 10.1176/jnp.9.4.591.","Auchus AP","J Neuropsychiatry Clin Neurosci","1997","1998/02/03","","","10.1176/jnp.9.4.591"
"23299383","A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE Trial","Kryscio RJ, Abner EL, Schmitt FA, Goodman PJ, Mendiondo M, Caban-Holt A, Dennis BC, Mathews M, Klein EA, Crowley JJ; SELECT Investigators.","J Nutr Health Aging. 2013 Jan;17(1):72-5. doi: 10.1007/s12603-012-0083-3.","Kryscio RJ","J Nutr Health Aging","2013","2013/01/10","PMC3636980","NIHMS456736","10.1007/s12603-012-0083-3"
"9351648","An CSF anamalous molecular form of acetylcholinesterase in demented and non-demented subjects","Shen ZX.","Neuroreport. 1997 Oct 20;8(15):3229-32. doi: 10.1097/00001756-199710200-00009.","Shen ZX","Neuroreport","1997","1997/11/14","","","10.1097/00001756-199710200-00009"
"8884757","Therapeutic efficacy of vincamine in dementia","Fischhof PK, Möslinger-Gehmayr R, Herrmann WM, Friedmann A, Russmann DL.","Neuropsychobiology. 1996;34(1):29-35. doi: 10.1159/000119288.","Fischhof PK","Neuropsychobiology","1996","1996/01/01","","","10.1159/000119288"
"17879256","Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study","Paleacu D, Barak Y, Mirecky I, Mazeh D.","Int J Geriatr Psychiatry. 2008 Apr;23(4):393-400. doi: 10.1002/gps.1892.","Paleacu D","Int J Geriatr Psychiatry","2008","2007/09/20","","","10.1002/gps.1892"
"26393847","Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial","Cummings JL, Lyketsos CG, Peskind ER, Porsteinsson AP, Mintzer JE, Scharre DW, De La Gandara JE, Agronin M, Davis CS, Nguyen U, Shin P, Tariot PN, Siffert J.","JAMA. 2015 Sep 22-29;314(12):1242-54. doi: 10.1001/jama.2015.10214.","Cummings JL","JAMA","2015","2015/09/23","","","10.1001/jama.2015.10214"
"18272750","Therapeutic touch and agitation in individuals with Alzheimer's disease","Hawranik P, Johnston P, Deatrich J.","West J Nurs Res. 2008 Jun;30(4):417-34. doi: 10.1177/0193945907305126. Epub 2008 Feb 13.","Hawranik P","West J Nurs Res","2008","2008/02/15","","","10.1177/0193945907305126"
"4076305","Memory performance in individuals with primary degenerative dementia: its similarity to diazepam-induced impairments","Block RI, DeVoe M, Stanley B, Stanley M, Pomara N.","Exp Aging Res. 1985 Autumn-Winter;11(3-4):151-5. doi: 10.1080/03610738508259179.","Block RI","Exp Aging Res","1985","1985/01/01","","","10.1080/03610738508259179"
"2121359","Selegiline versus L-acetylcarnitine in the treatment of Alzheimer-type dementia","Campi N, Todeschini GP, Scarzella L.","Clin Ther. 1990 Jul-Aug;12(4):306-14.","Campi N","Clin Ther","1990","1990/07/01","","",""
"22110158","A novel technology to screen for cognitive impairment in the elderly","Wright DW, Nevárez H, Kilgo P, LaPlaca M, Robinson A, Fowler S, Brumfield J, Goldstein FC.","Am J Alzheimers Dis Other Demen. 2011 Sep;26(6):484-91. doi: 10.1177/1533317511426133. Epub 2011 Nov 22.","Wright DW","Am J Alzheimers Dis Other Demen","2011","2011/11/24","","","10.1177/1533317511426133"
"9733162","Cerebrospinal fluid production is normal in Down syndrome","Atack JR, Rapoport SI, Schapiro MB.","Neurobiol Aging. 1998 Jul-Aug;19(4):307-9. doi: 10.1016/s0197-4580(98)00069-4.","Atack JR","Neurobiol Aging","1998","1998/09/11","","","10.1016/s0197-4580(98)00069-4"
"20687209","18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial","Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E, Hasselbalch S, Law I, Andersen A, Korner A, Minthon L, Garraux G, Nelissen N, Bormans G, Buckley C, Owenius R, Thurfjell L, Farrar G, Brooks DJ.","Ann Neurol. 2010 Sep;68(3):319-29. doi: 10.1002/ana.22068.","Vandenberghe R","Ann Neurol","2010","2010/08/06","","","10.1002/ana.22068"
"34082625","Neuroimaging correlates of persistent fatigue in older adults: A secondary analysis from the Multidomain Alzheimer Preventive Trial (MAPT) trial","Angioni D, Cesari M, Raffin J, Virecoulon Giudici K, Mangin JF, Bouyahia A, Chupin M, Fischer C, Gourieux E, Rolland Y, De Breucker S, Vellas B, de Souto Barreto P; MAPT/DSA group.","Aging Ment Health. 2022 Aug;26(8):1654-1660. doi: 10.1080/13607863.2021.1932737. Epub 2021 Jun 4.","Angioni D","Aging Ment Health","2022","2021/06/04","","","10.1080/13607863.2021.1932737"
"15883316","Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial","Gilman S, Koller M, Black RS, Jenkins L, Griffith SG, Fox NC, Eisner L, Kirby L, Rovira MB, Forette F, Orgogozo JM; AN1792(QS-21)-201 Study Team.","Neurology. 2005 May 10;64(9):1553-62. doi: 10.1212/01.WNL.0000159740.16984.3C.","Gilman S","Neurology","2005","2005/05/11","","","10.1212/01.WNL.0000159740.16984.3C"
"16671160","[Misdemeanor in frontotemporal dementia]","Diehl J, Ernst J, Krapp S, Förstl H, Nedopil N, Kurz A.","Fortschr Neurol Psychiatr. 2006 Apr;74(4):203-10. doi: 10.1055/s-2005-870962.","Diehl J","Fortschr Neurol Psychiatr","2006","2006/05/04","","","10.1055/s-2005-870962"
"15528096","The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease","Colloby SJ, O'Brien JT, Fenwick JD, Firbank MJ, Burn DJ, McKeith IG, Williams ED.","Neuroimage. 2004 Nov;23(3):956-66. doi: 10.1016/j.neuroimage.2004.06.045.","Colloby SJ","Neuroimage","2004","2004/11/06","","","10.1016/j.neuroimage.2004.06.045"
"19759102","The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies","Lim SM, Katsifis A, Villemagne VL, Best R, Jones G, Saling M, Bradshaw J, Merory J, Woodward M, Hopwood M, Rowe CC.","J Nucl Med. 2009 Oct;50(10):1638-45. doi: 10.2967/jnumed.109.065870. Epub 2009 Sep 16.","Lim SM","J Nucl Med","2009","2009/09/18","","","10.2967/jnumed.109.065870"
"20975519","Effects of body weight on tolerability of rivastigmine transdermal patch: a post-hoc analysis of a double-blind trial in patients with Alzheimer disease","Lee JH, Sevigny J.","Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):58-62. doi: 10.1097/WAD.0b013e3181f32829.","Lee JH","Alzheimer Dis Assoc Disord","2011","2010/10/27","","","10.1097/WAD.0b013e3181f32829"
"32101630","Effects of a lifestyle development program designed to reduce the risk factors for cognitive decline on the mental health of elderly individuals","Takeda S, Fukushima H, Okamoto C, Kitawaki Y, Nakayama S.","Psychogeriatrics. 2020 Jul;20(4):480-486. doi: 10.1111/psyg.12538. Epub 2020 Feb 26.","Takeda S","Psychogeriatrics","2020","2020/02/27","","","10.1111/psyg.12538"
"11606667","Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial","Rockwood K, Mintzer J, Truyen L, Wessel T, Wilkinson D.","J Neurol Neurosurg Psychiatry. 2001 Nov;71(5):589-95. doi: 10.1136/jnnp.71.5.589.","Rockwood K","J Neurol Neurosurg Psychiatry","2001","2001/10/19","PMC1737604","","10.1136/jnnp.71.5.589"
"12611757","A structured, open trial of risperidone therapy for delusions of theft in Alzheimer disease","Shigenobu K, Ikeda M, Fukuhara R, Komori K, Tanabe H.","Am J Geriatr Psychiatry. 2003 Mar-Apr;11(2):256-7.","Shigenobu K","Am J Geriatr Psychiatry","2003","2003/03/04","","",""
"20678673","Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study","Farlow MR, Salloway S, Tariot PN, Yardley J, Moline ML, Wang Q, Brand-Schieber E, Zou H, Hsu T, Satlin A.","Clin Ther. 2010 Jul;32(7):1234-51. doi: 10.1016/j.clinthera.2010.06.019.","Farlow MR","Clin Ther","2010","2010/08/04","PMC3068609","NIHMS238683","10.1016/j.clinthera.2010.06.019"
"15465626","Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients","Walter A, Korth U, Hilgert M, Hartmann J, Weichel O, Hilgert M, Fassbender K, Schmitt A, Klein J.","Neurobiol Aging. 2004 Nov-Dec;25(10):1299-303. doi: 10.1016/j.neurobiolaging.2004.02.016.","Walter A","Neurobiol Aging","2004","2004/10/07","","","10.1016/j.neurobiolaging.2004.02.016"
"28287803","Benefit-finding and effect on caregiver depression: A double-blind randomized controlled trial","Cheng ST, Mak EPM, Fung HH, Kwok T, Lee DTF, Lam LCW.","J Consult Clin Psychol. 2017 May;85(5):521-529. doi: 10.1037/ccp0000176. Epub 2017 Mar 13.","Cheng ST","J Consult Clin Psychol","2017","2017/03/14","","","10.1037/ccp0000176"
"15912389","A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer's disease","Raschetti R, Maggini M, Sorrentino GC, Martini N, Caffari B, Vanacore N.","Eur J Clin Pharmacol. 2005 Jul;61(5-6):361-8. doi: 10.1007/s00228-005-0946-1. Epub 2005 May 24.","Raschetti R","Eur J Clin Pharmacol","2005","2005/05/25","","","10.1007/s00228-005-0946-1"
"12464756","Impact of a psychoeducational intervention on caregiver response to behavioral problems","Gerdner LA, Buckwalter KC, Reed D.","Nurs Res. 2002 Nov-Dec;51(6):363-74. doi: 10.1097/00006199-200211000-00004.","Gerdner LA","Nurs Res","2002","2002/12/05","","","10.1097/00006199-200211000-00004"
"22460609","Effects of lexical-semantic treatment on memory in early Alzheimer disease: an observer-blinded randomized controlled trial","Jelcic N, Cagnin A, Meneghello F, Turolla A, Ermani M, Dam M.","Neurorehabil Neural Repair. 2012 Oct;26(8):949-56. doi: 10.1177/1545968312440146. Epub 2012 Mar 28.","Jelcic N","Neurorehabil Neural Repair","2012","2012/03/31","","","10.1177/1545968312440146"
"28739492","Efficacy and Safety of Citalopram Compared to Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia","Viscogliosi G, Chiriac IM, Ettorre E.","J Am Med Dir Assoc. 2017 Sep 1;18(9):799-802. doi: 10.1016/j.jamda.2017.06.010. Epub 2017 Jul 21.","Viscogliosi G","J Am Med Dir Assoc","2017","2017/07/26","","","10.1016/j.jamda.2017.06.010"
"7838445","A new method for the relative quantification of rCBF examined by 99Tcm-HMPAO SPECT","Arlig A, Larsson A, Bergh AC, Jacobsson L, Wikkelsö C.","Nucl Med Commun. 1994 Oct;15(10):814-23. doi: 10.1097/00006231-199410000-00007.","Arlig A","Nucl Med Commun","1994","1994/10/01","","","10.1097/00006231-199410000-00007"
"27252090","Comparison of a single-channel EEG sleep study to polysomnography","Lucey BP, Mcleland JS, Toedebusch CD, Boyd J, Morris JC, Landsness EC, Yamada K, Holtzman DM.","J Sleep Res. 2016 Dec;25(6):625-635. doi: 10.1111/jsr.12417. Epub 2016 Jun 2.","Lucey BP","J Sleep Res","2016","2016/06/03","PMC5135638","NIHMS775200","10.1111/jsr.12417"
"10867450","A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia","Le Bars PL, Kieser M, Itil KZ.","Dement Geriatr Cogn Disord. 2000 Jul-Aug;11(4):230-7. doi: 10.1159/000017242.","Le Bars PL","Dement Geriatr Cogn Disord","2000","2000/06/27","","","10.1159/000017242"
"20399477","[The five-word test in three age-groups of mild Alzheimer's disease (60, 70 and 80 year-old patients): Utility of the Total Score, Total Weighted Score, Learning Score and Memory Score]","Croisile B, Astier JL, Beaumont C, Mollion H.","Rev Neurol (Paris). 2010 Aug-Sep;166(8-9):711-20. doi: 10.1016/j.neurol.2010.03.008.","Croisile B","Rev Neurol (Paris)","2010","2010/04/20","","","10.1016/j.neurol.2010.03.008"
"31556447","Benefit-Finding Intervention Delivered Individually to Alzheimer Family Caregivers: Longer-Term Outcomes of a Randomized Double-Blind Controlled Trial","Cheng ST, Mak EPM, Kwok T, Fung H, Lam LCW.","J Gerontol B Psychol Sci Soc Sci. 2020 Oct 16;75(9):1884-1893. doi: 10.1093/geronb/gbz118.","Cheng ST","J Gerontol B Psychol Sci Soc Sci","2020","2019/09/27","","","10.1093/geronb/gbz118"
"16891386","Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment","Geroldi C, Rossi R, Calvagna C, Testa C, Bresciani L, Binetti G, Zanetti O, Frisoni GB.","J Neurol Neurosurg Psychiatry. 2006 Nov;77(11):1219-22. doi: 10.1136/jnnp.2005.082651. Epub 2006 Aug 4.","Geroldi C","J Neurol Neurosurg Psychiatry","2006","2006/08/08","PMC2077364","","10.1136/jnnp.2005.082651"
"18698140","Different atrophic patterns in early- and late-onset Alzheimer's disease and evaluation of clinical utility of a method of regional z-score analysis using voxel-based morphometry","Shiino A, Watanabe T, Kitagawa T, Kotani E, Takahashi J, Morikawa S, Akiguchi I.","Dement Geriatr Cogn Disord. 2008;26(2):175-86. doi: 10.1159/000151241. Epub 2008 Aug 12.","Shiino A","Dement Geriatr Cogn Disord","2008","2008/08/14","","","10.1159/000151241"
"35404972","No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab","Korthauer LE, Giugliano RP, Guo J, Sabatine MS, Sever P, Keech A, Atar D, Kurtz C, Ruff CT, Mach F, Ott BR.","PLoS One. 2022 Apr 11;17(4):e0266615. doi: 10.1371/journal.pone.0266615. eCollection 2022.","Korthauer LE","PLoS One","2022","2022/04/11","PMC9000128","","10.1371/journal.pone.0266615"
"12834513","Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease","Geldmacher DS, Provenzano G, McRae T, Mastey V, Ieni JR.","J Am Geriatr Soc. 2003 Jul;51(7):937-44. doi: 10.1046/j.1365-2389.2003.51306.x.","Geldmacher DS","J Am Geriatr Soc","2003","2003/07/02","","","10.1046/j.1365-2389.2003.51306.x"
"12377138","Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry","Burton EJ, Karas G, Paling SM, Barber R, Williams ED, Ballard CG, McKeith IG, Scheltens P, Barkhof F, O'Brien JT.","Neuroimage. 2002 Oct;17(2):618-30.","Burton EJ","Neuroimage","2002","2002/10/16","","",""
"10025425","Neurofibrillary pathology in Alzheimer disease with Lewy bodies: two subgroups","Gearing M, Lynn M, Mirra SS.","Arch Neurol. 1999 Feb;56(2):203-8. doi: 10.1001/archneur.56.2.203.","Gearing M","Arch Neurol","1999","1999/02/20","","","10.1001/archneur.56.2.203"
"16505324","Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease","Siemers ER, Quinn JF, Kaye J, Farlow MR, Porsteinsson A, Tariot P, Zoulnouni P, Galvin JE, Holtzman DM, Knopman DS, Satterwhite J, Gonzales C, Dean RA, May PC.","Neurology. 2006 Feb 28;66(4):602-4. doi: 10.1212/01.WNL.0000198762.41312.E1.","Siemers ER","Neurology","2006","2006/03/01","","","10.1212/01.WNL.0000198762.41312.E1"
"23883379","A phase 3 trial of semagacestat for treatment of Alzheimer's disease","Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, He F, Sun X, Thomas RG, Aisen PS; Alzheimer's Disease Cooperative Study Steering Committee; Siemers E, Sethuraman G, Mohs R; Semagacestat Study Group.","N Engl J Med. 2013 Jul 25;369(4):341-50. doi: 10.1056/NEJMoa1210951.","Doody RS","N Engl J Med","2013","2013/07/26","","","10.1056/NEJMoa1210951"
"23989256","Comparison of non-vertebral fracture between minodronate and risedronate therapy in elderly female patients with Alzheimer disease","Sato Y, Honda Y, Iwamoto J, Amano N.","J Musculoskelet Neuronal Interact. 2013 Sep;13(3):346-52.","Sato Y","J Musculoskelet Neuronal Interact","2013","2013/08/31","","",""
"15956273","Galantamine treatment of problematic behavior in Alzheimer disease: post-hoc analysis of pooled data from three large trials","Herrmann N, Rabheru K, Wang J, Binder C.","Am J Geriatr Psychiatry. 2005 Jun;13(6):527-34. doi: 10.1176/appi.ajgp.13.6.527.","Herrmann N","Am J Geriatr Psychiatry","2005","2005/06/16","","","10.1176/appi.ajgp.13.6.527"
"28775055","In Vivo Imaging of Venous Side Cerebral Small-Vessel Disease in Older Adults: An MRI Method at 7T","Shaaban CE, Aizenstein HJ, Jorgensen DR, MacCloud RL, Meckes NA, Erickson KI, Glynn NW, Mettenburg J, Guralnik J, Newman AB, Ibrahim TS, Laurienti PJ, Vallejo AN, Rosano C; LIFE Study Group.","AJNR Am J Neuroradiol. 2017 Oct;38(10):1923-1928. doi: 10.3174/ajnr.A5327. Epub 2017 Aug 3.","Shaaban CE","AJNR Am J Neuroradiol","2017","2017/08/05","PMC5632121","NIHMS885148","10.3174/ajnr.A5327"
"22433803","[Ceraxon (citicoline) in the treatment of the mild cognitive impairment syndrome]","Gavrilova SI, Fedorova IaB, Gantman, Kalyn IaB, Kolykhalov IV.","Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(12):16-20.","Gavrilova SI","Zh Nevrol Psikhiatr Im S S Korsakova","2011","2012/03/22","","",""
"10533840","Automatic attentional shifts induced by a noradrenergic drug in Alzheimer's disease: evidence from evoked potentials","Missonnier P, Ragot R, Derouesné C, Guez D, Renault B.","Int J Psychophysiol. 1999 Sep;33(3):243-51. doi: 10.1016/s0167-8760(99)00059-8.","Missonnier P","Int J Psychophysiol","1999","1999/10/26","","","10.1016/s0167-8760(99)00059-8"
"16204713","Rapid scanning protocol for brain (18)F-FDG PET: a validation study","Chen WP, Matsunari I, Noda A, Yanase D, Yajima K, Takeda N, Yamada M, Minoshima S, Nishimura S.","J Nucl Med. 2005 Oct;46(10):1633-41.","Chen WP","J Nucl Med","2005","2005/10/06","","",""
"31969177","Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer's disease","Yoshida K, Moein A, Bittner T, Ostrowitzki S, Lin H, Honigberg L, Jin JY, Quartino A.","Alzheimers Res Ther. 2020 Jan 22;12(1):16. doi: 10.1186/s13195-020-0580-2.","Yoshida K","Alzheimers Res Ther","2020","2020/01/24","PMC6977279","","10.1186/s13195-020-0580-2"
"17988434","Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy","Sakka P, Tsolaki M, Hort J, Hager K, Soininen H, López Pousa S, Li C, Schwam E.","Curr Med Res Opin. 2007 Dec;23(12):3153-65. doi: 10.1185/030079907X242773.","Sakka P","Curr Med Res Opin","2007","2007/11/09","","","10.1185/030079907X242773"
"7892497","Probable Alzheimer disease: diagnosis with proton MR spectroscopy","Shonk TK, Moats RA, Gifford P, Michaelis T, Mandigo JC, Izumi J, Ross BD.","Radiology. 1995 Apr;195(1):65-72. doi: 10.1148/radiology.195.1.7892497.","Shonk TK","Radiology","1995","1995/04/01","","","10.1148/radiology.195.1.7892497"
"2723116","Single dose safety, tolerance, and pharmacokinetics of HP 029 in healthy young men: a potential Alzheimer agent","Puri SK, Hsu RS, Ho I, Lassman HB.","J Clin Pharmacol. 1989 Mar;29(3):278-84. doi: 10.1002/j.1552-4604.1989.tb03328.x.","Puri SK","J Clin Pharmacol","1989","1989/03/01","","","10.1002/j.1552-4604.1989.tb03328.x"
"351807","Physostigmine: improvement of long-term memory processes in normal humans","Davis KL, Mohs RC, Tinklenberg JR, Pfefferbaum A, Hollister LE, Kopell BS.","Science. 1978 Jul 21;201(4352):272-4. doi: 10.1126/science.351807.","Davis KL","Science","1978","1978/07/21","","","10.1126/science.351807"
"31076215","Long-Term Outcomes of the Benefit-Finding Group Intervention for Alzheimer Family Caregivers: A Cluster-Randomized Double-Blind Controlled Trial","Cheng ST, Chan WC, Lam LCW.","Am J Geriatr Psychiatry. 2019 Sep;27(9):984-994. doi: 10.1016/j.jagp.2019.03.013. Epub 2019 Mar 26.","Cheng ST","Am J Geriatr Psychiatry","2019","2019/05/12","","","10.1016/j.jagp.2019.03.013"
"16621446","The effect of acetyl-L-carnitine administration on persons with Down syndrome","Pueschel SM.","Res Dev Disabil. 2006 Nov-Dec;27(6):599-604. doi: 10.1016/j.ridd.2004.07.009. Epub 2006 Apr 18.","Pueschel SM","Res Dev Disabil","2006","2006/04/20","","","10.1016/j.ridd.2004.07.009"
"8534412","The target population in phase I clinical trials of cholinergic compounds in Alzheimer disease: the role of the ""bridging study""","Cutler NR, Sramek JJ.","Alzheimer Dis Assoc Disord. 1995 Fall;9(3):139-45.","Cutler NR","Alzheimer Dis Assoc Disord","1995","1995/01/01","","",""
"36894900","Acceptability of patient-centered, multi-disciplinary medication therapy management recommendations: results from the INCREASE randomized study","Smith NI, Martinez AI, Huffmyer M, Eckmann L, George R, Abner EL, Jicha GA, Moga DC.","BMC Geriatr. 2023 Mar 10;23(1):137. doi: 10.1186/s12877-023-03876-4.","Smith NI","BMC Geriatr","2023","2023/03/09","PMC9999619","","10.1186/s12877-023-03876-4"
"16163677","A hybrid qualitative method for pretesting questionnaires: the example of a questionnaire to caregivers of Alzheimer disease patients","Oremus M, Cosby JL, Wolfson C.","Res Nurs Health. 2005 Oct;28(5):419-30. doi: 10.1002/nur.20095.","Oremus M","Res Nurs Health","2005","2005/09/16","","","10.1002/nur.20095"
"25320049","Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer's disease","Baddeley TC, McCaffrey J, Storey JM, Cheung JK, Melis V, Horsley D, Harrington CR, Wischik CM.","J Pharmacol Exp Ther. 2015 Jan;352(1):110-8. doi: 10.1124/jpet.114.219352. Epub 2014 Oct 15.","Baddeley TC","J Pharmacol Exp Ther","2015","2014/10/17","","","10.1124/jpet.114.219352"
"9677501","Crystallized and fluid intelligence in elderly patients with mild dementia of the Alzheimer type","Matsuda O, Saito M.","Int Psychogeriatr. 1998 Jun;10(2):147-54. doi: 10.1017/s1041610298005250.","Matsuda O","Int Psychogeriatr","1998","1998/07/25","","","10.1017/s1041610298005250"
"24475144","The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: a randomised controlled study","de Waal H, Stam CJ, Lansbergen MM, Wieggers RL, Kamphuis PJ, Scheltens P, Maestú F, van Straaten EC.","PLoS One. 2014 Jan 27;9(1):e86558. doi: 10.1371/journal.pone.0086558. eCollection 2014.","de Waal H","PLoS One","2014","2014/01/30","PMC3903587","","10.1371/journal.pone.0086558"
"33559354","Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification","Izzo NJ, Yuede CM, LaBarbera KM, Limegrover CS, Rehak C, Yurko R, Waybright L, Look G, Rishton G, Safferstein H, Hamby ME, Williams C, Sadlek K, Edwards HM, Davis CS, Grundman M, Schneider LS, DeKosky ST, Chelsky D, Pike I, Henstridge C, Blennow K, Zetterberg H, LeVine H 3rd, Spires-Jones TL, Cirrito JR, Catalano SM.","Alzheimers Dement. 2021 Aug;17(8):1365-1382. doi: 10.1002/alz.12302. Epub 2021 Feb 8.","Izzo NJ","Alzheimers Dement","2021","2021/02/09","PMC8349378","NIHMS1699785","10.1002/alz.12302"
"10362906","Serum levels of beta-carotene, alpha-carotene and vitamin A in patients with Alzheimer's disease","Jiménez-Jiménez FJ, Molina JA, de Bustos F, Ortí-Pareja M, Benito-León J, Tallón-Barranco A, Gasalla T, Porta J, Arenas J.","Eur J Neurol. 1999 Jul;6(4):495-7. doi: 10.1046/j.1468-1331.1999.640495.x.","Jiménez-Jiménez FJ","Eur J Neurol","1999","1999/06/11","","","10.1046/j.1468-1331.1999.640495.x"
"18042476","Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients","Sun Y, Lu CJ, Chien KL, Chen ST, Chen RC.","Clin Ther. 2007 Oct;29(10):2204-14. doi: 10.1016/j.clinthera.2007.10.012.","Sun Y","Clin Ther","2007","2007/11/29","","","10.1016/j.clinthera.2007.10.012"
"28473597","Diagnostic Performance of the Visual Reading of (123)I-Ioflupane SPECT Images With or Without Quantification in Patients With Movement Disorders or Dementia","Booij J, Dubroff J, Pryma D, Yu J, Agarwal R, Lakhani P, Kuo PH.","J Nucl Med. 2017 Nov;58(11):1821-1826. doi: 10.2967/jnumed.116.189266. Epub 2017 May 4.","Booij J","J Nucl Med","2017","2017/05/06","","","10.2967/jnumed.116.189266"
"35649245","Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I/Ib studies in healthy subjects and patients","Vissers MFJM, Heuberger JAAC, Groeneveld GJ, Oude Nijhuis J, De Deyn PP, Hadi S, Harris J, Tsai RM, Cruz-Herranz A, Huang F, Tong V, Erickson R, Zhu Y, Scearce-Levie K, Hsiao-Nakamoto J, Tang X, Chang M, Fox BM, Estrada AA, Pomponio RJ, Alonso-Alonso M, Zilberstein M, Atassi N, Troyer MD, Ho C.","Clin Transl Sci. 2022 Aug;15(8):2010-2023. doi: 10.1111/cts.13317. Epub 2022 Jun 1.","Vissers MFJM","Clin Transl Sci","2022","2022/06/01","PMC9372423","","10.1111/cts.13317"
"8834355","Coenzyme nicotinamide adenine dinucleotide: new therapeutic approach for improving dementia of the Alzheimer type","Birkmayer JG.","Ann Clin Lab Sci. 1996 Jan-Feb;26(1):1-9.","Birkmayer JG","Ann Clin Lab Sci","1996","1996/01/01","","",""
"8788081","Senile dementia of Alzheimer type and multi-infarct dementia investigated by transcranial Doppler sonography","Sattel H, Förstl H, Biedert S.","Dementia. 1996 Jan-Feb;7(1):41-6. doi: 10.1159/000106851.","Sattel H","Dementia","1996","1996/01/01","","","10.1159/000106851"
"9106282","Remote memory in Parkinson's disease and senile dementia","Leplow B, Dierks C, Herrmann P, Pieper N, Annecke R, Ulm G.","Neuropsychologia. 1997 Apr;35(4):547-57. doi: 10.1016/s0028-3932(96)00116-9.","Leplow B","Neuropsychologia","1997","1997/04/01","","","10.1016/s0028-3932(96)00116-9"
"28856569","Pharmacokinetics of Cromolyn and Ibuprofen in Healthy Elderly Volunteers","Brazier D, Perry R, Keane J, Barrett K, Elmaleh DR.","Clin Drug Investig. 2017 Nov;37(11):1025-1034. doi: 10.1007/s40261-017-0549-5.","Brazier D","Clin Drug Investig","2017","2017/09/01","PMC5643367","","10.1007/s40261-017-0549-5"
"17804831","Preserving health of Alzheimer caregivers: impact of a spouse caregiver intervention","Mittelman MS, Roth DL, Clay OJ, Haley WE.","Am J Geriatr Psychiatry. 2007 Sep;15(9):780-9. doi: 10.1097/JGP.0b013e31805d858a.","Mittelman MS","Am J Geriatr Psychiatry","2007","2007/09/07","","","10.1097/JGP.0b013e31805d858a"
"19369318","Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study","Zheng L, Mack WJ, Dagerman KS, Hsiao JK, Lebowitz BD, Lyketsos CG, Stroup TS, Sultzer DL, Tariot PN, Vigen C, Schneider LS.","Am J Psychiatry. 2009 May;166(5):583-90. doi: 10.1176/appi.ajp.2008.08081218. Epub 2009 Apr 15.","Zheng L","Am J Psychiatry","2009","2009/04/17","PMC2891018","NIHMS202203","10.1176/appi.ajp.2008.08081218"
"18855165","Voxel-based correlation between coregistered single-photon emission computed tomography and dynamic susceptibility contrast magnetic resonance imaging in subjects with suspected Alzheimer disease","Cavallin L, Axelsson R, Wahlund LO, Oksengard AR, Svensson L, Juhlin P, Wiberg MK, Frank A.","Acta Radiol. 2008 Dec;49(10):1154-61. doi: 10.1080/02841850802438512.","Cavallin L","Acta Radiol","2008","2008/10/16","","","10.1080/02841850802438512"
"11739062","National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology","Schneider LS, Tariot PN, Lyketsos CG, Dagerman KS, Davis KL, Davis S, Hsiao JK, Jeste DV, Katz IR, Olin JT, Pollock BG, Rabins PV, Rosenheck RA, Small GW, Lebowitz B, Lieberman JA.","Am J Geriatr Psychiatry. 2001 Fall;9(4):346-60.","Schneider LS","Am J Geriatr Psychiatry","2001","2001/12/12","","",""
"33536430","Blood-brain barrier opening with focused ultrasound in Parkinson's disease dementia","Gasca-Salas C, Fernández-Rodríguez B, Pineda-Pardo JA, Rodríguez-Rojas R, Obeso I, Hernández-Fernández F, Del Álamo M, Mata D, Guida P, Ordás-Bandera C, Montero-Roblas JI, Martínez-Fernández R, Foffani G, Rachmilevitch I, Obeso JA.","Nat Commun. 2021 Feb 3;12(1):779. doi: 10.1038/s41467-021-21022-9.","Gasca-Salas C","Nat Commun","2021","2021/02/04","PMC7859400","","10.1038/s41467-021-21022-9"
"23690582","Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment","Douaud G, Refsum H, de Jager CA, Jacoby R, Nichols TE, Smith SM, Smith AD.","Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9523-8. doi: 10.1073/pnas.1301816110. Epub 2013 May 20.","Douaud G","Proc Natl Acad Sci U S A","2013","2013/05/22","PMC3677457","","10.1073/pnas.1301816110"
"9455982","Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia","Ihara Y, Hayabara T, Sasaki K, Fujisawa Y, Kawada R, Yamamoto T, Nakashima Y, Yoshimune S, Kawai M, Kibata M, Kuroda S.","J Neurol Sci. 1997 Dec 9;153(1):76-81. doi: 10.1016/s0022-510x(97)00172-x.","Ihara Y","J Neurol Sci","1997","1998/02/10","","","10.1016/s0022-510x(97)00172-x"
"16977645","Differential attrition in a caregiver skill training trial","Davis LL, Weaver M, Habermann B.","Res Nurs Health. 2006 Oct;29(5):498-506. doi: 10.1002/nur.20138.","Davis LL","Res Nurs Health","2006","2006/09/16","","","10.1002/nur.20138"
"31738372","Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial","Howard R, Zubko O, Bradley R, Harper E, Pank L, O'Brien J, Fox C, Tabet N, Livingston G, Bentham P, McShane R, Burns A, Ritchie C, Reeves S, Lovestone S, Ballard C, Noble W, Nilforooshan R, Wilcock G, Gray R; Minocycline in Alzheimer Disease Efficacy (MADE) Trialist Group.","JAMA Neurol. 2020 Feb 1;77(2):164-174. doi: 10.1001/jamaneurol.2019.3762.","Howard R","JAMA Neurol","2020","2019/11/19","PMC6865324","","10.1001/jamaneurol.2019.3762"
"27189973","The γ-Secretase Modulator, BMS-932481, Modulates Aβ Peptides in the Plasma and Cerebrospinal Fluid of Healthy Volunteers","Soares HD, Gasior M, Toyn JH, Wang JS, Hong Q, Berisha F, Furlong MT, Raybon J, Lentz KA, Sweeney F, Zheng N, Akinsanya B, Berman RM, Thompson LA, Olson RE, Morrison J, Drexler DM, Macor JE, Albright CF, Ahlijanian MK, AbuTarif M.","J Pharmacol Exp Ther. 2016 Jul;358(1):138-50. doi: 10.1124/jpet.116.232256. Epub 2016 Apr 20.","Soares HD","J Pharmacol Exp Ther","2016","2016/05/19","PMC4931877","","10.1124/jpet.116.232256"
"16686011","An inverse problem approach to the estimation of volume change","Schweiger M, Camara-Rey O, Crum WR, Lewis E, Schnabel J, Arridge SR, Hill DL, Fox N.","Med Image Comput Comput Assist Interv. 2005;8(Pt 2):616-23. doi: 10.1007/11566489_76.","Schweiger M","Med Image Comput Comput Assist Interv","2005","2006/05/12","","","10.1007/11566489_76"
"1978479","Antipsychotics in the elderly","Rosen J, Bohon S, Gershon S.","Acta Psychiatr Scand Suppl. 1990;358:170-5. doi: 10.1111/j.1600-0447.1990.tb05312.x.","Rosen J","Acta Psychiatr Scand Suppl","1990","1990/01/01","","","10.1111/j.1600-0447.1990.tb05312.x"
"8710072","Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group","Knopman D, Schneider L, Davis K, Talwalker S, Smith F, Hoover T, Gracon S.","Neurology. 1996 Jul;47(1):166-77. doi: 10.1212/wnl.47.1.166.","Knopman D","Neurology","1996","1996/07/01","","","10.1212/wnl.47.1.166"
"19111849","A randomized, double-blind, placebo-controlled tolerability study of intramuscular aripiprazole in acutely agitated patients with Alzheimer's, vascular, or mixed dementia","Rappaport SA, Marcus RN, Manos G, McQuade RD, Oren DA.","J Am Med Dir Assoc. 2009 Jan;10(1):21-7. doi: 10.1016/j.jamda.2008.06.006. Epub 2008 Sep 27.","Rappaport SA","J Am Med Dir Assoc","2009","2008/12/30","","","10.1016/j.jamda.2008.06.006"
"32665410","Education Research: Online Alzheimer education for high school and college students: A randomized controlled trial","Saif N, Niotis K, Dominguez M, Hodes JF, Woodbury M, Amini Y, Sadek G, Scheyer O, Caesar E, Hristov H, Knowlton N, Lee P, McInnis M, Isaacson RS.","Neurology. 2020 Oct 20;95(16):e2305-e2313. doi: 10.1212/WNL.0000000000009859. Epub 2020 Jul 14.","Saif N","Neurology","2020","2020/07/16","PMC7713789","","10.1212/WNL.0000000000009859"
"10853348","[Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia]","Tariska P, Paksy A.","Orv Hetil. 2000 May 28;141(22):1189-93.","Tariska P","Orv Hetil","2000","2000/06/15","","",""
"23436269","Population pharmacokinetic modeling of sertraline treatment in patients with Alzheimer disease: the DIADS-2 study","Li CH, Pollock BG, Lyketsos CG, Vaidya V, Drye LT, Kirshner M, Sorisio D, Bies RR; DIADS-2 Research Group.","J Clin Pharmacol. 2013 Feb;53(2):234-9. doi: 10.1177/0091270012445793. Epub 2013 Jan 24.","Li CH","J Clin Pharmacol","2013","2013/02/26","PMC3604147","NIHMS426162","10.1177/0091270012445793"
"11819153","Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease: results of a randomized, double-blind, parallel-group multicenter study","Gutzmann H, Kühl KP, Hadler D, Rapp MA.","Pharmacopsychiatry. 2002 Jan;35(1):12-8. doi: 10.1055/s-2002-19833.","Gutzmann H","Pharmacopsychiatry","2002","2002/01/31","","","10.1055/s-2002-19833"
"22921881","The effect of HMG-CoA reductase inhibitors on cognition in patients with Alzheimer's dementia: a prospective withdrawal and rechallenge pilot study","Padala KP, Padala PR, McNeilly DP, Geske JA, Sullivan DH, Potter JF.","Am J Geriatr Pharmacother. 2012 Oct;10(5):296-302. doi: 10.1016/j.amjopharm.2012.08.002. Epub 2012 Aug 22.","Padala KP","Am J Geriatr Pharmacother","2012","2012/08/28","","","10.1016/j.amjopharm.2012.08.002"
"2865282","Clinical studies of the cholinergic deficit in Alzheimer's disease. II. Psychopharmacologic studies","Mohs RC, Davis BM, Greenwald BS, Mathé AA, Johns CA, Horvath TB, Davis KL.","J Am Geriatr Soc. 1985 Nov;33(11):749-57. doi: 10.1111/j.1532-5415.1985.tb04185.x.","Mohs RC","J Am Geriatr Soc","1985","1985/11/01","","","10.1111/j.1532-5415.1985.tb04185.x"
"10325444","Aminotransferase levels and silymarin in de novo tacrine-treated patients with Alzheimer's disease","Allain H, Schück S, Lebreton S, Strenge-Hesse A, Braun W, Gandon JM, Brissot P.","Dement Geriatr Cogn Disord. 1999 May-Jun;10(3):181-5. doi: 10.1159/000017117.","Allain H","Dement Geriatr Cogn Disord","1999","1999/05/15","","","10.1159/000017117"
"28177691","Caffeine intake increases plasma ketones: an acute metabolic study in humans","Vandenberghe C, St-Pierre V, Courchesne-Loyer A, Hennebelle M, Castellano CA, Cunnane SC.","Can J Physiol Pharmacol. 2017 Apr;95(4):455-458. doi: 10.1139/cjpp-2016-0338. Epub 2016 Nov 25.","Vandenberghe C","Can J Physiol Pharmacol","2017","2017/02/09","","","10.1139/cjpp-2016-0338"
"15883317","Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease","Fox NC, Black RS, Gilman S, Rossor MN, Griffith SG, Jenkins L, Koller M; AN1792(QS-21)-201 Study.","Neurology. 2005 May 10;64(9):1563-72. doi: 10.1212/01.WNL.0000159743.08996.99.","Fox NC","Neurology","2005","2005/05/11","","","10.1212/01.WNL.0000159743.08996.99"
"16216935","Risk factors associated with beta-amyloid(1-42) immunotherapy in preimmunization gene expression patterns of blood cells","O'Toole M, Janszen DB, Slonim DK, Reddy PS, Ellis DK, Legault HM, Hill AA, Whitley MZ, Mounts WM, Zuberek K, Immermann FW, Black RS, Dorner AJ.","Arch Neurol. 2005 Oct;62(10):1531-6. doi: 10.1001/archneur.62.10.1531.","O'Toole M","Arch Neurol","2005","2005/10/12","","","10.1001/archneur.62.10.1531"
"33211152","The positive effect of spermidine in older adults suffering from dementia : First results of a 3-month trial","Pekar T, Bruckner K, Pauschenwein-Frantsich S, Gschaider A, Oppliger M, Willesberger J, Ungersbäck P, Wendzel A, Kremer A, Flak W, Wantke F, Jarisch R.","Wien Klin Wochenschr. 2021 May;133(9-10):484-491. doi: 10.1007/s00508-020-01758-y. Epub 2020 Nov 19.","Pekar T","Wien Klin Wochenschr","2021","2020/11/19","PMC8116233","","10.1007/s00508-020-01758-y"
"15598477","A prospective, double-blind, community-controlled comparison of three doses of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population","Suh GH, Yeon Jung H, Uk Lee C, Hoon Oh B, Nam Bae J, Jung HY, Ju YS, Kil Yeon B, Park J, Hong I, Choi S, Ho Lee J; Korean Galantamine Study Group.","Clin Ther. 2004 Oct;26(10):1608-18. doi: 10.1016/j.clinthera.2004.10.006.","Suh GH","Clin Ther","2004","2004/12/16","","","10.1016/j.clinthera.2004.10.006"
"34859493","Safety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo-Controlled Trial","Biglan K, Munsie L, Svensson KA, Ardayfio P, Pugh M, Sims J, Brys M.","Mov Disord. 2022 Mar;37(3):513-524. doi: 10.1002/mds.28879. Epub 2021 Dec 2.","Biglan K","Mov Disord","2022","2021/12/03","PMC9300146","","10.1002/mds.28879"
"20603300","A randomized controlled trial exploring the effect of music on quality of life and depression in older people with dementia","Cooke M, Moyle W, Shum D, Harrison S, Murfield J.","J Health Psychol. 2010 Jul;15(5):765-76. doi: 10.1177/1359105310368188.","Cooke M","J Health Psychol","2010","2010/07/07","","","10.1177/1359105310368188"
"11809164","A new rapid landmark-based regional MRI segmentation method of the brain","Bokde AL, Teipel SJ, Zebuhr Y, Leinsinger G, Gootjes L, Schwarz R, Buerger K, Scheltens P, Moeller HJ, Hampel H.","J Neurol Sci. 2002 Feb 15;194(1):35-40. doi: 10.1016/s0022-510x(01)00667-0.","Bokde AL","J Neurol Sci","2002","2002/01/26","","","10.1016/s0022-510x(01)00667-0"
"34001020","Learning to play golf for elderly people with subjective memory complaints: feasibility of a single-blinded randomized pilot trial","Stroehlein JK, Vieluf S, Zimmer P, Schenk A, Oberste M, Goelz C, van den Bongard F, Reinsberger C.","BMC Neurol. 2021 May 17;21(1):200. doi: 10.1186/s12883-021-02186-9.","Stroehlein JK","BMC Neurol","2021","2021/05/18","PMC8127313","","10.1186/s12883-021-02186-9"
"11775050","Effect of risperidone on behavioral and psychological symptoms and cognitive function in dementia","Rainer MK, Masching AJ, Ertl MG, Kraxberger E, Haushofer M.","J Clin Psychiatry. 2001 Nov;62(11):894-900. doi: 10.4088/jcp.v62n1110.","Rainer MK","J Clin Psychiatry","2001","2002/01/05","","","10.4088/jcp.v62n1110"
"31385203","Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline","Cintoli S, Radicchi C, Noale M, Maggi S, Meucci G, Tognoni G, Bonuccelli U, Sale A, Berardi N, Maffei L; Train the Brain Consortium.","Aging Clin Exp Res. 2021 May;33(5):1249-1257. doi: 10.1007/s40520-019-01280-w. Epub 2019 Aug 5.","Cintoli S","Aging Clin Exp Res","2021","2019/08/07","","","10.1007/s40520-019-01280-w"
"15586629","Evaluation of the use of a standard input function for compartment analysis of [123I]iomazenil data: factors influencing the quantitative results","Seike Y, Hashikawa K, Oku N, Moriwaki H, Yamamoto H, Fukuchi K, Watanabe Y, Matsumoto M, Hori M, Nishimura T.","Ann Nucl Med. 2004 Oct;18(7):563-72. doi: 10.1007/BF02984577.","Seike Y","Ann Nucl Med","2004","2004/12/14","","","10.1007/BF02984577"
"12029208","Brain SPECT: a controlled, blinded assessment of intra-reader and inter-reader agreement","Stockbridge HL, Lewis D, Eisenberg B, Lee M, Schacher S, van Belle G, Keifer M, Brodkin CA, Buchwald D.","Nucl Med Commun. 2002 Jun;23(6):537-44. doi: 10.1097/00006231-200206000-00005.","Stockbridge HL","Nucl Med Commun","2002","2002/05/25","","","10.1097/00006231-200206000-00005"
"12240749","The National Adult Reading Test as a measure of premorbid intelligence: a comparison with estimates derived from demographic variables","Bright P, Jaldow E, Kopelman MD.","J Int Neuropsychol Soc. 2002 Sep;8(6):847-54. doi: 10.1017/s1355617702860131.","Bright P","J Int Neuropsychol Soc","2002","2002/09/21","","","10.1017/s1355617702860131"
"20087081","Sertraline for the treatment of depression in Alzheimer disease","Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Weintraub D, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG; DIADS-2 Research Group.","Am J Geriatr Psychiatry. 2010 Feb;18(2):136-45. doi: 10.1097/JGP.0b013e3181c796eb.","Rosenberg PB","Am J Geriatr Psychiatry","2010","2010/01/21","PMC2842121","NIHMS166961","10.1097/JGP.0b013e3181c796eb"
"3090600","Scopolamine and the control of attention in humans","Dunne MP, Hartley LR.","Psychopharmacology (Berl). 1986;89(1):94-7. doi: 10.1007/BF00175197.","Dunne MP","Psychopharmacology (Berl)","1986","1986/01/01","","","10.1007/BF00175197"
"36933568","Acupressure Improves Cognition and Quality of Life Among Older Adults with Cognitive Disorders in Long-Term Care Settings: A Clustered Randomized Controlled Trial","Lin YK, Liao HY, Watson K, Yeh TP, Chen IH.","J Am Med Dir Assoc. 2023 Apr;24(4):548-554. doi: 10.1016/j.jamda.2023.02.011. Epub 2023 Mar 15.","Lin YK","J Am Med Dir Assoc","2023","2023/03/18","","","10.1016/j.jamda.2023.02.011"
"22975501","A single-center, randomized, open-label, dose-escalation study to evaluate the pharmacokinetics of tacrine analogue octahydrogenacridine succinate tablets in healthy Chinese subjects","Zhao X, Liang Y, Xu J, Zhang D, Wang D, Gu J, Cui Y.","Biol Pharm Bull. 2012;35(9):1502-8. doi: 10.1248/bpb.b1200242.","Zhao X","Biol Pharm Bull","2012","2012/09/15","","","10.1248/bpb.b1200242"
"12543279","Dawn-dusk simulation light therapy of disturbed circadian rest-activity cycles in demented elderly","Fontana Gasio P, Kräuchi K, Cajochen C, Someren Ev, Amrhein I, Pache M, Savaskan E, Wirz-Justice A.","Exp Gerontol. 2003 Jan-Feb;38(1-2):207-16. doi: 10.1016/s0531-5565(02)00164-x.","Fontana Gasio P","Exp Gerontol","2003","2003/01/25","","","10.1016/s0531-5565(02)00164-x"
"19536424","Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase study","Gauthier S, Aisen PS, Ferris SH, Saumier D, Duong A, Haine D, Garceau D, Suhy J, Oh J, Lau W, Sampalis J.","J Nutr Health Aging. 2009 Jun;13(6):550-7. doi: 10.1007/s12603-009-0106-x.","Gauthier S","J Nutr Health Aging","2009","2009/06/19","","","10.1007/s12603-009-0106-x"
"12017350","Electrocardiographic effects of rivastigmine","Morganroth J, Graham S, Hartman R, Anand R.","J Clin Pharmacol. 2002 May;42(5):558-68. doi: 10.1177/00912700222011490.","Morganroth J","J Clin Pharmacol","2002","2002/05/23","","","10.1177/00912700222011490"
"29982413","Six-Month Effectiveness of Remote Activity Monitoring for Persons Living With Dementia and Their Family Caregivers: An Experimental Mixed Methods Study","Gaugler JE, Zmora R, Mitchell LL, Finlay JM, Peterson CM, McCarron H, Jutkowitz E.","Gerontologist. 2019 Jan 9;59(1):78-89. doi: 10.1093/geront/gny078.","Gaugler JE","Gerontologist","2019","2018/07/09","PMC6326253","","10.1093/geront/gny078"
"33818221","Effect of horticultural therapy on apathy in nursing home residents with dementia: a pilot randomized controlled trial","Yang Y, Kwan RYC, Zhai HM, Xiong Y, Zhao T, Fang KL, Zhang HQ.","Aging Ment Health. 2022 Apr;26(4):745-753. doi: 10.1080/13607863.2021.1907304. Epub 2021 Apr 5.","Yang Y","Aging Ment Health","2022","2021/04/05","","","10.1080/13607863.2021.1907304"
"19583056","A stress-busting program for family caregivers","Lewis SL, Miner-Williams D, Novian A, Escamilla MI, Blackwell PH, Kretzschmar JH, Arévalo-Flechas LC, Bonner PN.","Rehabil Nurs. 2009 Jul-Aug;34(4):151-9. doi: 10.1002/j.2048-7940.2009.tb00271.x.","Lewis SL","Rehabil Nurs","2009","2009/07/09","","","10.1002/j.2048-7940.2009.tb00271.x"
"15729955","Effect of non-steroidal anti-inflammatory drugs on natural killer cell activity in patients with dementia","Aizen E, Kagan G, Assy B, Iobel R, Bershadsky Y, Gilhar A.","Isr Med Assoc J. 2005 Feb;7(2):78-81.","Aizen E","Isr Med Assoc J","2005","2005/02/26","","",""
"11974515","[Effects of social support on well-being of demented nursing home residents. The Käferberg Visitation Study]","Oppikofer S, Albrecht K, Schelling HR, Wettstein A.","Z Gerontol Geriatr. 2002 Feb;35(1):39-48. doi: 10.1007/s003910200005.","Oppikofer S","Z Gerontol Geriatr","2002","2002/04/27","","","10.1007/s003910200005"
"18001519","Rivastigmine exposure provided by a transdermal patch versus capsules","Mercier F, Lefèvre G, Huang HL, Schmidli H, Amzal B, Appel-Dingemanse S.","Curr Med Res Opin. 2007 Dec;23(12):3199-204. doi: 10.1185/030079908X253438.","Mercier F","Curr Med Res Opin","2007","2007/11/16","","","10.1185/030079908X253438"
"1421679","Implications of the study population in the early evaluation of anticholinesterase inhibitors for Alzheimer's disease","Cutler NR, Sramek JJ, Murphy MF, Nash RJ.","Ann Pharmacother. 1992 Sep;26(9):1118-22. doi: 10.1177/106002809202600914.","Cutler NR","Ann Pharmacother","1992","1992/09/01","","","10.1177/106002809202600914"
"9258892","Moderate and advanced Alzheimer's patients exhibit platelet activation differences","Davies TA, Long HJ, Tibbles HE, Sgro KR, Wells JM, Rathbun WH, Seetoo KF, McMenamin ME, Smith SJ, Feldman RG, Levesque CA, Fine RE, Simons ER.","Neurobiol Aging. 1997 Mar-Apr;18(2):155-62. doi: 10.1016/s0197-4580(97)00016-x.","Davies TA","Neurobiol Aging","1997","1997/03/01","","","10.1016/s0197-4580(97)00016-x"
"10801254","Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity","Simon T, Becquemont L, Mary-Krause M, de Waziers I, Beaune P, Funck-Brentano C, Jaillon P.","Clin Pharmacol Ther. 2000 Apr;67(4):432-7. doi: 10.1067/mcp.2000.104944.","Simon T","Clin Pharmacol Ther","2000","2000/05/09","","","10.1067/mcp.2000.104944"
"3518329","Double-blind randomized controlled study of phosphatidylserine in senile demented patients","Delwaide PJ, Gyselynck-Mambourg AM, Hurlet A, Ylieff M.","Acta Neurol Scand. 1986 Feb;73(2):136-40. doi: 10.1111/j.1600-0404.1986.tb03254.x.","Delwaide PJ","Acta Neurol Scand","1986","1986/02/01","","","10.1111/j.1600-0404.1986.tb03254.x"
"12094822","Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil","Auriacombe S, Pere JJ, Loria-Kanza Y, Vellas B.","Curr Med Res Opin. 2002;18(3):129-38. doi: 10.1185/030079902125000471.","Auriacombe S","Curr Med Res Opin","2002","2002/07/04","","","10.1185/030079902125000471"
"8624083","M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update","Fisher A, Heldman E, Gurwitz D, Haring R, Karton Y, Meshulam H, Pittel Z, Marciano D, Brandeis R, Sadot E, Barg Y, Pinkas-Kramarski R, Vogel Z, Ginzburg I, Treves TA, Verchovsky R, Klimowsky S, Korczyn AD.","Ann N Y Acad Sci. 1996 Jan 17;777:189-96. doi: 10.1111/j.1749-6632.1996.tb34418.x.","Fisher A","Ann N Y Acad Sci","1996","1996/01/17","","","10.1111/j.1749-6632.1996.tb34418.x"
"26656642","Cognitive Results of CANTAB Tests and Their Change Due to the First Dose of Donepezil May Predict Treatment Efficacy in Alzheimer Disease","Kuzmickienė J, Kaubrys G.","Med Sci Monit. 2015 Dec 14;21:3887-99. doi: 10.12659/msm.896327.","Kuzmickienė J","Med Sci Monit","2015","2015/12/15","PMC4684140","","10.12659/msm.896327"
"20009055","Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial","Green RC, Schneider LS, Amato DA, Beelen AP, Wilcock G, Swabb EA, Zavitz KH; Tarenflurbil Phase 3 Study Group.","JAMA. 2009 Dec 16;302(23):2557-64. doi: 10.1001/jama.2009.1866.","Green RC","JAMA","2009","2009/12/17","PMC2902875","NIHMS205268","10.1001/jama.2009.1866"
"36097005","Association between urate-lowering therapies and cognitive decline in community-dwelling older adults","Molet-Benhamou L, Giudici KV, de Souto Barreto P, Cantet C, Rolland Y; MAPT/DSA group.","Sci Rep. 2022 Sep 12;12(1):15299. doi: 10.1038/s41598-022-17808-6.","Molet-Benhamou L","Sci Rep","2022","2022/09/12","PMC9467991","","10.1038/s41598-022-17808-6"
"8983037","Lymphocyte content of amyloid precursor protein is increased in Down's syndrome and aging","Pallister C, Jung SS, Shaw I, Nalbantoglu J, Gauthier S, Cashman NR.","Neurobiol Aging. 1997 Jan-Feb;18(1):97-103. doi: 10.1016/s0197-4580(96)00207-2.","Pallister C","Neurobiol Aging","1997","1997/01/01","","","10.1016/s0197-4580(96)00207-2"
"12480773","Cholesterol and cognition: rationale for the AD cholesterol-lowering treatment trial and sex-related Differences in beta-amyloid accumulation in the brains of spontaneously hypercholesterolemic Watanabe rabbits","Sparks DL, Martins R, Martin T.","Ann N Y Acad Sci. 2002 Nov;977:356-66. doi: 10.1111/j.1749-6632.2002.tb04838.x.","Sparks DL","Ann N Y Acad Sci","2002","2002/12/14","","","10.1111/j.1749-6632.2002.tb04838.x"
"10850749","Propentofylline treatment for Alzheimer disease and vascular dementia: an economic evaluation based on functional abilities","Bachynsky J, McCracken P, Lier D, Alloul K, Jacobs P.","Alzheimer Dis Assoc Disord. 2000 Apr-Jun;14(2):102-11. doi: 10.1097/00002093-200004000-00008.","Bachynsky J","Alzheimer Dis Assoc Disord","2000","2000/06/13","","","10.1097/00002093-200004000-00008"
"12810489","Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial","Farlow M, Potkin S, Koumaras B, Veach J, Mirski D.","Arch Neurol. 2003 Jun;60(6):843-8. doi: 10.1001/archneur.60.6.843.","Farlow M","Arch Neurol","2003","2003/06/18","","","10.1001/archneur.60.6.843"
"7777201","Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia","Yamada K, Kono K, Umegaki H, Yamada K, Iguchi A, Fukatsu T, Nakashima N, Nishiwaki H, Shimada Y, Sugita Y, et al.","Neurosci Lett. 1995 Feb 17;186(2-3):219-21. doi: 10.1016/0304-3940(95)11318-q.","Yamada K","Neurosci Lett","1995","1995/02/17","","","10.1016/0304-3940(95)11318-q"
"11929322","Estimation of the absolute bioavailability of rivastigmine in patients with mild to moderate dementia of the Alzheimer's type","Hossain M, Jhee SS, Shiovitz T, McDonald C, Sedek G, Pommier F, Cutler NR.","Clin Pharmacokinet. 2002;41(3):225-34. doi: 10.2165/00003088-200241030-00006.","Hossain M","Clin Pharmacokinet","2002","2002/04/04","","","10.2165/00003088-200241030-00006"
"18050054","Effect of regular exercise on senile dementia patients","Kwak YS, Um SY, Son TG, Kim DJ.","Int J Sports Med. 2008 Jun;29(6):471-4. doi: 10.1055/s-2007-964853. Epub 2007 Nov 30.","Kwak YS","Int J Sports Med","2008","2007/12/01","","","10.1055/s-2007-964853"
"22468985","Effects of multimodal nondrug therapy on dementia symptoms and need for care in nursing home residents with degenerative dementia: a randomized-controlled study with 6-month follow-up","Luttenberger K, Donath C, Uter W, Graessel E.","J Am Geriatr Soc. 2012 May;60(5):830-40. doi: 10.1111/j.1532-5415.2012.03938.x. Epub 2012 Apr 3.","Luttenberger K","J Am Geriatr Soc","2012","2012/04/04","","","10.1111/j.1532-5415.2012.03938.x"
"24964105","Effects of galantamine and galantamine combined with nimodipine on cognitive speed and quality of life in mixed dementia: a 24-week, randomized, placebo-controlled exploratory trial (the REMIX study)","Caramelli P, Laks J, Palmini AL, Nitrini R, Chaves ML, Forlenza OV, Vale Fde A, Barbosa MT, Bottino CM, Machado JC, Charchat-Fichman H, Lawson FL.","Arq Neuropsiquiatr. 2014 Jun;72(6):411-7. doi: 10.1590/0004-282x20140055.","Caramelli P","Arq Neuropsiquiatr","2014","2014/06/26","","","10.1590/0004-282x20140055"
"17452579","Quetiapine for agitation or psychosis in patients with dementia and parkinsonism","Kurlan R, Cummings J, Raman R, Thal L; Alzheimer's Disease Cooperative Study Group.","Neurology. 2007 Apr 24;68(17):1356-63. doi: 10.1212/01.wnl.0000260060.60870.89.","Kurlan R","Neurology","2007","2007/04/25","","","10.1212/01.wnl.0000260060.60870.89"
"25412766","Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects","Varrone A, Oikonen V, Forsberg A, Joutsa J, Takano A, Solin O, Haaparanta-Solin M, Nag S, Nakao R, Al-Tawil N, Wells LA, Rabiner EA, Valencia R, Schultze-Mosgau M, Thiele A, Vollmer S, Dyrks T, Lehmann L, Heinrich T, Hoffmann A, Nordberg A, Halldin C, Rinne JO.","Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):438-46. doi: 10.1007/s00259-014-2955-8. Epub 2014 Nov 21.","Varrone A","Eur J Nucl Med Mol Imaging","2015","2014/11/22","","","10.1007/s00259-014-2955-8"
"16269641","Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia","van Oijen M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM.","Stroke. 2005 Dec;36(12):2637-41. doi: 10.1161/01.STR.0000189721.31432.26. Epub 2005 Nov 3.","van Oijen M","Stroke","2005","2005/11/05","","","10.1161/01.STR.0000189721.31432.26"
"6372566","Ergoloid mesylates for senile dementias: unanswered questions","Hollister LE, Yesavage J.","Ann Intern Med. 1984 Jun;100(6):894-8. doi: 10.7326/0003-4819-100-6-894.","Hollister LE","Ann Intern Med","1984","1984/06/01","","","10.7326/0003-4819-100-6-894"
"28857263","Psychosocial behaviour management programme for home-dwelling people with dementia: A cluster-randomized controlled trial","Nakanishi M, Endo K, Hirooka K, Granvik E, Minthon L, Nägga K, Nishida A.","Int J Geriatr Psychiatry. 2018 Mar;33(3):495-503. doi: 10.1002/gps.4784. Epub 2017 Aug 31.","Nakanishi M","Int J Geriatr Psychiatry","2018","2017/09/01","","","10.1002/gps.4784"
"12164673","Awareness of naturalistic action errors in dementia","Giovannetti T, Libon DJ, Hart T.","J Int Neuropsychol Soc. 2002 Jul;8(5):633-44. doi: 10.1017/s135561770280131x.","Giovannetti T","J Int Neuropsychol Soc","2002","2002/08/08","","","10.1017/s135561770280131x"
"30730347","Primary Endpoints in Current Phase II/III Trials for Alzheimer Disease: A Systematic Survey of Trials Registered at ClinicalTrials.gov","Takeshima N, Ishiwata K, Sozu T, Furukawa TA.","Alzheimer Dis Assoc Disord. 2020 Jan-Mar;34(1):97-100. doi: 10.1097/WAD.0000000000000297.","Takeshima N","Alzheimer Dis Assoc Disord","2020","2019/02/08","","","10.1097/WAD.0000000000000297"
"20671063","Differences in microstructural alterations of the hippocampus in Alzheimer disease and idiopathic normal pressure hydrocephalus: a diffusion tensor imaging study","Hong YJ, Yoon B, Shim YS, Cho AH, Lim SC, Ahn KJ, Yang DW.","AJNR Am J Neuroradiol. 2010 Nov;31(10):1867-72. doi: 10.3174/ajnr.A2207. Epub 2010 Jul 29.","Hong YJ","AJNR Am J Neuroradiol","2010","2010/07/31","PMC7964035","","10.3174/ajnr.A2207"
"33377138","Findings of Sequential Pilot Trials of Aliviado Dementia Care to Inform an Embedded Pragmatic Clinical Trial","Lin SY, Schneider CE, Bristol AA, Clancy M, Sprague SA, Aldridge M, Cortes T, Goldfeld KS, Kutner JS, Mitchell SL, Shega JW, Wu B, Zhu CW, Brody AA.","Gerontologist. 2022 Feb 9;62(2):304-314. doi: 10.1093/geront/gnaa220.","Lin SY","Gerontologist","2022","2020/12/30","PMC8827334","","10.1093/geront/gnaa220"
"7924632","Chrono-neuroendocrinological aspects of physiological aging and senile dementia","Dori D, Casale G, Solerte SB, Fioravanti M, Migliorati G, Cuzzoni G, Ferrari E.","Chronobiologia. 1994 Jan-Jun;21(1-2):121-6.","Dori D","Chronobiologia","1994","1994/01/01","","",""
"16087821","The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial","Sato Y, Kanoko T, Satoh K, Iwamoto J.","Arch Intern Med. 2005 Aug 8-22;165(15):1737-42. doi: 10.1001/archinte.165.15.1737.","Sato Y","Arch Intern Med","2005","2005/08/10","","","10.1001/archinte.165.15.1737"
"3299440","Cholinergic effects on constructional abilities and on mnemonic processes: a case report","Sahakian B, Joyce E, Lishman WA.","Psychol Med. 1987 May;17(2):329-33. doi: 10.1017/s0033291700024867.","Sahakian B","Psychol Med","1987","1987/05/01","","","10.1017/s0033291700024867"
"22090477","Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor","May PC, Dean RA, Lowe SL, Martenyi F, Sheehan SM, Boggs LN, Monk SA, Mathes BM, Mergott DJ, Watson BM, Stout SL, Timm DE, Smith Labell E, Gonzales CR, Nakano M, Jhee SS, Yen M, Ereshefsky L, Lindstrom TD, Calligaro DO, Cocke PJ, Greg Hall D, Friedrich S, Citron M, Audia JE.","J Neurosci. 2011 Nov 16;31(46):16507-16. doi: 10.1523/JNEUROSCI.3647-11.2011.","May PC","J Neurosci","2011","2011/11/18","PMC6633289","","10.1523/JNEUROSCI.3647-11.2011"
"35853750","Association of Self-reflection With Cognition and Brain Health in Cognitively Unimpaired Older Adults","Demnitz-King H, Gonneaud J, Klimecki OM, Chocat A, Collette F, Dautricourt S, Jessen F, Krolak-Salmon P, Lutz A, Morse RM, Molinuevo JL, Poisnel G, Touron E, Wirth M, Walker Z, Chételat G, Marchant NL; Medit-Ageing Research Group.","Neurology. 2022 Sep 27;99(13):e1422-e1431. doi: 10.1212/WNL.0000000000200951. Epub 2022 Jul 19.","Demnitz-King H","Neurology","2022","2022/07/19","","","10.1212/WNL.0000000000200951"
"10188789","Phase I clinical trials with WAL 2014, a new muscarinic agonist for the treatment of Alzheimer's disease","Adamus WS, Leonard JP, Tröger W.","Life Sci. 1995;56(11-12):883-90. doi: 10.1016/0024-3205(95)00024-z.","Adamus WS","Life Sci","1995","1995/01/01","","","10.1016/0024-3205(95)00024-z"
"14663654","Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial","Kanowski S, Hoerr R.","Pharmacopsychiatry. 2003 Nov;36(6):297-303. doi: 10.1055/s-2003-45117.","Kanowski S","Pharmacopsychiatry","2003","2003/12/10","","","10.1055/s-2003-45117"
"12821755","Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients","Baskin F, Rosenberg RN, Fang X, Hynan LS, Moore CB, Weiner M, Vega GL.","Neurology. 2003 Jun 24;60(12):2006-7. doi: 10.1212/01.wnl.0000068029.56740.96.","Baskin F","Neurology","2003","2003/06/25","","","10.1212/01.wnl.0000068029.56740.96"
"27718143","Concentration of Donepezil in the Cerebrospinal Fluid of AD Patients: Evaluation of Dosage Sufficiency in Standard Treatment Strategy","Valis M, Masopust J, Vysata O, Hort J, Dolezal R, Tomek J, Misik J, Kuca K, Karasova JZ.","Neurotox Res. 2017 Jan;31(1):162-168. doi: 10.1007/s12640-016-9672-y. Epub 2016 Oct 7.","Valis M","Neurotox Res","2017","2016/10/09","PMC5209410","","10.1007/s12640-016-9672-y"
"16166775","The neuropsychological profile of alcohol-related dementia suggests cortical and subcortical pathology","Schmidt KS, Gallo JL, Ferri C, Giovannetti T, Sestito N, Libon DJ, Schmidt PS.","Dement Geriatr Cogn Disord. 2005;20(5):286-91. doi: 10.1159/000088306. Epub 2005 Sep 13.","Schmidt KS","Dement Geriatr Cogn Disord","2005","2005/09/17","","","10.1159/000088306"
"29425372","Sleep deprivation and cerebrospinal fluid biomarkers for Alzheimer's disease","Olsson M, Ärlig J, Hedner J, Blennow K, Zetterberg H.","Sleep. 2018 May 1;41(5). doi: 10.1093/sleep/zsy025.","Olsson M","Sleep","2018","2018/02/10","","","10.1093/sleep/zsy025"
"26016820","A novel once-daily fixed-dose combination of memantine extended release and donepezil for the treatment of moderate to severe Alzheimer's disease: two phase I studies in healthy volunteers","Boinpally R, Chen L, Zukin SR, McClure N, Hofbauer RK, Periclou A.","Clin Drug Investig. 2015 Jul;35(7):427-35. doi: 10.1007/s40261-015-0296-4.","Boinpally R","Clin Drug Investig","2015","2015/05/29","PMC4488451","","10.1007/s40261-015-0296-4"
"8800620","Generation effect in short-term verbal and visuospatial memory: comparisons between dementia of Alzheimer type and dementia of frontal lobe type","Souliez L, Pasquier F, Lebert F, Leconte P, Petit H.","Cortex. 1996 Jun;32(2):347-56. doi: 10.1016/s0010-9452(96)80056-6.","Souliez L","Cortex","1996","1996/06/01","","","10.1016/s0010-9452(96)80056-6"
"9443470","A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group","Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT.","Neurology. 1998 Jan;50(1):136-45. doi: 10.1212/wnl.50.1.136.","Rogers SL","Neurology","1998","1998/01/27","","","10.1212/wnl.50.1.136"
"19436724","Incidence and prediction of falls in dementia: a prospective study in older people","Allan LM, Ballard CG, Rowan EN, Kenny RA.","PLoS One. 2009;4(5):e5521. doi: 10.1371/journal.pone.0005521. Epub 2009 May 13.","Allan LM","PLoS One","2009","2009/05/14","PMC2677107","","10.1371/journal.pone.0005521"
"20593742","[Oral galantamine versus rivastigmine transdermal patch: a descriptive study at a memory clinic in The Netherlands]","Wouters CJ, Dautzenberg L, Thissen A, Dautzenberg PL.","Tijdschr Gerontol Geriatr. 2010 Jun;41(3):146-50. doi: 10.1007/BF03096196.","Wouters CJ","Tijdschr Gerontol Geriatr","2010","2010/07/03","","","10.1007/BF03096196"
"24315979","Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): clinical rationale and design","Pelton GH, Andrews H, Roose SP, Marcus SM, D'Antonio K, Husn H, Petrella JR, Zannas AS, Doraiswamy PM, Devanand DP.","Contemp Clin Trials. 2014 Mar;37(2):200-8. doi: 10.1016/j.cct.2013.11.015. Epub 2013 Dec 5.","Pelton GH","Contemp Clin Trials","2014","2013/12/10","PMC3981878","NIHMS546528","10.1016/j.cct.2013.11.015"
"6364210","Vasopressin-like peptides and the treatment of memory disorders in man","Jolles J.","Prog Brain Res. 1983;60:169-82.","Jolles J","Prog Brain Res","1983","1983/01/01","","",""
"27332627","Transdermal Rivastigmine Delivery for Alzheimer Disease: Amenability of Exposure Predictions of Rivastigmine and Metabolite, NAP226-90, by Linear Regression Model Using Limited Samples","Srinivas NR.","Clin Neuropharmacol. 2016 Jul-Aug;39(4):169-77. doi: 10.1097/WNF.0000000000000154.","Srinivas NR","Clin Neuropharmacol","2016","2016/06/23","","","10.1097/WNF.0000000000000154"
"12021419","An exercise program for women who are caring for relatives with dementia","Castro CM, Wilcox S, O'Sullivan P, Baumann K, King AC.","Psychosom Med. 2002 May-Jun;64(3):458-68. doi: 10.1097/00006842-200205000-00010.","Castro CM","Psychosom Med","2002","2002/05/22","","","10.1097/00006842-200205000-00010"
"30409550","BrainWorks: A Comparative Effectiveness Trial to Examine Alzheimer's Disease Education for Community-Dwelling African Americans","Lincoln KD, Chow TW, Gaines BF.","Am J Geriatr Psychiatry. 2019 Jan;27(1):53-61. doi: 10.1016/j.jagp.2018.09.010. Epub 2018 Sep 21.","Lincoln KD","Am J Geriatr Psychiatry","2019","2018/11/10","","","10.1016/j.jagp.2018.09.010"
"2333483","The effect of prompting and reinforcement of activity in elderly demented inpatients","Götestam KG, Melin L.","Scand J Psychol. 1990;31(1):2-8. doi: 10.1111/j.1467-9450.1990.tb00796.x.","Götestam KG","Scand J Psychol","1990","1990/01/01","","","10.1111/j.1467-9450.1990.tb00796.x"
"18498913","Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry","Liu MY, Meng SN, Wu HZ, Wang S, Wei MJ.","Clin Ther. 2008 Apr;30(4):641-53. doi: 10.1016/j.clinthera.2008.04.005.","Liu MY","Clin Ther","2008","2008/05/24","","","10.1016/j.clinthera.2008.04.005"
"14734594","Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial","Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I; Memantine Study Group.","JAMA. 2004 Jan 21;291(3):317-24. doi: 10.1001/jama.291.3.317.","Tariot PN","JAMA","2004","2004/01/22","","","10.1001/jama.291.3.317"
"16274373","Effect of acetaminophen on behavior, well-being, and psychotropic medication use in nursing home residents with moderate-to-severe dementia","Chibnall JT, Tait RC, Harman B, Luebbert RA.","J Am Geriatr Soc. 2005 Nov;53(11):1921-9. doi: 10.1111/j.1532-5415.2005.53572.x.","Chibnall JT","J Am Geriatr Soc","2005","2005/11/09","","","10.1111/j.1532-5415.2005.53572.x"
"10463377","Double-blind, randomized, placebo-controlled clinical trial on the efficacy and tolerability of a physostigmine patch in patients with senile dementia of the Alzheimer type","Möller H-J, Hampel H, Hegerl U, Schmitt W, Walter K.","Pharmacopsychiatry. 1999 May;32(3):99-106. doi: 10.1055/s-2007-979202.","Möller H-J","Pharmacopsychiatry","1999","1999/08/27","","","10.1055/s-2007-979202"
"10718203","Randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and tolerability of metrifonate in patients with probable Alzheimer disease. The Metrifonate Study Group","Blass JP, Cyrus PA, Bieber F, Gulanski B.","Alzheimer Dis Assoc Disord. 2000 Jan-Mar;14(1):39-45. doi: 10.1097/00002093-200001000-00005.","Blass JP","Alzheimer Dis Assoc Disord","2000","2000/03/16","","","10.1097/00002093-200001000-00005"
"33036701","Effect of long-term omega-3 supplementation and a lifestyle multidomain intervention on intrinsic capacity among community-dwelling older adults: Secondary analysis of a randomized, placebo-controlled trial (MAPT study)","Giudici KV, de Souto Barreto P, Beard J, Cantet C, Araujo de Carvalho I, Rolland Y, Vellas B; MAPT DSA group.","Maturitas. 2020 Nov;141:39-45. doi: 10.1016/j.maturitas.2020.06.012. Epub 2020 Jun 26.","Giudici KV","Maturitas","2020","2020/10/10","","","10.1016/j.maturitas.2020.06.012"
"36137949","Repetitive Transcranial Magnetic Stimulation Decreases Serum Amyloid-β and Increases Ectodomain of p75 Neurotrophin Receptor in Patients with Alzheimer's Disease","Tao Y, Lei B, Zhu Y, Fang X, Liao L, Chen D, Gao C.","J Integr Neurosci. 2022 Jul 29;21(5):140. doi: 10.31083/j.jin2105140.","Tao Y","J Integr Neurosci","2022","2022/09/22","","","10.31083/j.jin2105140"
"32636325","Diagnostic and prognostic value of EEG in prodromal dementia with Lewy bodies","van der Zande JJ, Gouw AA, van Steenoven I, van de Beek M, Scheltens P, Stam CJ, Lemstra AW.","Neurology. 2020 Aug 11;95(6):e662-e670. doi: 10.1212/WNL.0000000000009977. Epub 2020 Jul 7.","van der Zande JJ","Neurology","2020","2020/07/09","","","10.1212/WNL.0000000000009977"
"17620494","Magnetic resonance imaging predictors of cognition in mild cognitive impairment","van de Pol LA, Korf ES, van der Flier WM, Brashear HR, Fox NC, Barkhof F, Scheltens P.","Arch Neurol. 2007 Jul;64(7):1023-8. doi: 10.1001/archneur.64.7.1023.","van de Pol LA","Arch Neurol","2007","2007/07/11","","","10.1001/archneur.64.7.1023"
"28138837","Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease","Chase TN, Farlow MR, Clarence-Smith K.","Neurotherapeutics. 2017 Apr;14(2):405-416. doi: 10.1007/s13311-016-0511-x.","Chase TN","Neurotherapeutics","2017","2017/02/01","PMC5398986","","10.1007/s13311-016-0511-x"
"22252372","Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment","Camus V, Payoux P, Barré L, Desgranges B, Voisin T, Tauber C, La Joie R, Tafani M, Hommet C, Chételat G, Mondon K, de La Sayette V, Cottier JP, Beaufils E, Ribeiro MJ, Gissot V, Vierron E, Vercouillie J, Vellas B, Eustache F, Guilloteau D.","Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):621-31. doi: 10.1007/s00259-011-2021-8. Epub 2012 Jan 18.","Camus V","Eur J Nucl Med Mol Imaging","2012","2012/01/19","PMC3315642","","10.1007/s00259-011-2021-8"
"28319243","Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE)","Kryscio RJ, Abner EL, Caban-Holt A, Lovell M, Goodman P, Darke AK, Yee M, Crowley J, Schmitt FA.","JAMA Neurol. 2017 May 1;74(5):567-573. doi: 10.1001/jamaneurol.2016.5778.","Kryscio RJ","JAMA Neurol","2017","2017/03/21","PMC5506489","NIHMS870934","10.1001/jamaneurol.2016.5778"
"20299441","Effects of age on the glucose metabolic changes in mild cognitive impairment","Kantarci K, Senjem ML, Lowe VJ, Wiste HJ, Weigand SD, Kemp BJ, Frank AR, Shiung MM, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr.","AJNR Am J Neuroradiol. 2010 Aug;31(7):1247-53. doi: 10.3174/ajnr.A2070. Epub 2010 Mar 18.","Kantarci K","AJNR Am J Neuroradiol","2010","2010/03/20","PMC2890033","NIHMS176101","10.3174/ajnr.A2070"
"34786815","Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT)","Pajewski NM, Elahi FM, Tamura MK, Hinman JD, Nasrallah IM, Ix JH, Miller LM, Launer LJ, Wright CB, Supiano MA, Lerner AJ, Sudduth TL, Killeen AA, Cheung AK, Reboussin DM, Wilcock DM, Williamson JD.","Alzheimers Dement. 2022 Aug;18(8):1472-1483. doi: 10.1002/alz.12496. Epub 2021 Nov 17.","Pajewski NM","Alzheimers Dement","2022","2021/11/17","PMC9110563","NIHMS1743025","10.1002/alz.12496"
"21105282","Association of 9-hydroxy risperidone concentrations with risk of switching or discontinuation in the clinical antipsychotic trial of intervention effectiveness-Alzheimer's disease trial","Wessels AM, Pollock BG, Anyama NG, Schneider LS, Lieberman JA, Marder SR, Bies RR.","J Clin Psychopharmacol. 2010 Dec;30(6):683-7. doi: 10.1097/jcp.0b013e3181fa05bb.","Wessels AM","J Clin Psychopharmacol","2010","2010/11/25","","","10.1097/jcp.0b013e3181fa05bb"
"24247022","Phase II crossover trial of varenicline in mild-to-moderate Alzheimer's disease","Kim SY, Choi SH, Rollema H, Schwam EM, McRae T, Dubrava S, Jacobsen J.","Dement Geriatr Cogn Disord. 2014;37(3-4):232-45. doi: 10.1159/000355373. Epub 2013 Nov 14.","Kim SY","Dement Geriatr Cogn Disord","2014","2013/11/20","","","10.1159/000355373"
"21816921","Altered microstructure in corticospinal tract in idiopathic normal pressure hydrocephalus: comparison with Alzheimer disease and Parkinson disease with dementia","Hattori T, Yuasa T, Aoki S, Sato R, Sawaura H, Mori T, Mizusawa H.","AJNR Am J Neuroradiol. 2011 Oct;32(9):1681-7. doi: 10.3174/ajnr.A2570. Epub 2011 Aug 4.","Hattori T","AJNR Am J Neuroradiol","2011","2011/08/06","PMC7965405","","10.3174/ajnr.A2570"
"28618005","BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid Aβ Peptides","Sakamoto K, Matsuki S, Matsuguma K, Yoshihara T, Uchida N, Azuma F, Russell M, Hughes G, Haeberlein SB, Alexander RC, Eketjäll S, Kugler AR.","J Clin Pharmacol. 2017 Nov;57(11):1460-1471. doi: 10.1002/jcph.950. Epub 2017 Jun 15.","Sakamoto K","J Clin Pharmacol","2017","2017/06/16","","","10.1002/jcph.950"
"12837670","Psychosis of Alzheimer disease: validity of the construct and response to risperidone","Schneider LS, Katz IR, Park S, Napolitano J, Martinez RA, Azen SP.","Am J Geriatr Psychiatry. 2003 Jul-Aug;11(4):414-25.","Schneider LS","Am J Geriatr Psychiatry","2003","2003/07/03","","",""
"30817982","Lifestyle multidomain intervention, omega-3 supplementation, or both for reducing the risk of developing clinically relevant depressive symptoms in older adults with memory complaints? Secondary analysis from the MAPT trial","Maltais M, de Souto Barreto P, Pothier K, Cantet C, Andrieu S, Rolland Y, Vellas B; MAPT/DSA Study Group.","Exp Gerontol. 2019 Jun;120:28-34. doi: 10.1016/j.exger.2019.02.010. Epub 2019 Feb 26.","Maltais M","Exp Gerontol","2019","2019/03/01","","","10.1016/j.exger.2019.02.010"
"23013352","Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people","DiSilvestro RA, Joseph E, Zhao S, Bomser J.","Nutr J. 2012 Sep 26;11:79. doi: 10.1186/1475-2891-11-79.","DiSilvestro RA","Nutr J","2012","2012/09/28","PMC3518252","","10.1186/1475-2891-11-79"
"23418430","Accelerated cell aging in female APOE-ε4 carriers: implications for hormone therapy use","Jacobs EG, Kroenke C, Lin J, Epel ES, Kenna HA, Blackburn EH, Rasgon NL.","PLoS One. 2013;8(2):e54713. doi: 10.1371/journal.pone.0054713. Epub 2013 Feb 13.","Jacobs EG","PLoS One","2013","2013/02/19","PMC3572118","","10.1371/journal.pone.0054713"
"3025928","Design and interpretation of opiate antagonist trials in dementia","Tariot PN, Sunderland T, Murphy DL, Cohen MR, Welkowitz JA, Weingartner H, Newhouse PA, Cohen RM.","Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):611-26. doi: 10.1016/0278-5846(86)90031-x.","Tariot PN","Prog Neuropsychopharmacol Biol Psychiatry","1986","1986/01/01","","","10.1016/0278-5846(86)90031-x"
"7983290","The neglected half of Alzheimer disease: cognitive and functional concomitants of severe dementia","Auer SR, Sclan SG, Yaffee RA, Reisberg B.","J Am Geriatr Soc. 1994 Dec;42(12):1266-72. doi: 10.1111/j.1532-5415.1994.tb06509.x.","Auer SR","J Am Geriatr Soc","1994","1994/12/01","","","10.1111/j.1532-5415.1994.tb06509.x"
"27163830","Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition","Kantarci K, Lowe VJ, Lesnick TG, Tosakulwong N, Bailey KR, Fields JA, Shuster LT, Zuk SM, Senjem ML, Mielke MM, Gleason C, Jack CR, Rocca WA, Miller VM.","J Alzheimers Dis. 2016 May 7;53(2):547-56. doi: 10.3233/JAD-160258.","Kantarci K","J Alzheimers Dis","2016","2016/05/11","PMC4955514","NIHMS793796","10.3233/JAD-160258"
"22397651","Donepezil and memantine for moderate-to-severe Alzheimer's disease","Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Hughes A, Jacoby R, Jones R, Jones R, McKeith I, Macharouthu A, O'Brien J, Passmore P, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown R, Banerjee S, Onions C, Griffin M, Adams J, Gray R, Johnson T, Bentham P, Phillips P.","N Engl J Med. 2012 Mar 8;366(10):893-903. doi: 10.1056/NEJMoa1106668.","Howard R","N Engl J Med","2012","2012/03/09","","","10.1056/NEJMoa1106668"
"31252161","Effects of a dawn-dusk simulation on circadian rest-activity cycles, sleep, mood and well-being in dementia patients","Bromundt V, Wirz-Justice A, Boutellier M, Winter S, Haberstroh M, Terman M, Münch M.","Exp Gerontol. 2019 Sep;124:110641. doi: 10.1016/j.exger.2019.110641. Epub 2019 Jun 25.","Bromundt V","Exp Gerontol","2019","2019/06/29","","","10.1016/j.exger.2019.110641"
"19155748","Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease","Gehrman PR, Connor DJ, Martin JL, Shochat T, Corey-Bloom J, Ancoli-Israel S.","Am J Geriatr Psychiatry. 2009 Feb;17(2):166-9. doi: 10.1097/JGP.0b013e318187de18.","Gehrman PR","Am J Geriatr Psychiatry","2009","2009/01/22","PMC2630117","NIHMS82649","10.1097/JGP.0b013e318187de18"
"17460158","Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial","ADAPT Research Group; Lyketsos CG, Breitner JC, Green RC, Martin BK, Meinert C, Piantadosi S, Sabbagh M.","Neurology. 2007 May 22;68(21):1800-8. doi: 10.1212/01.wnl.0000260269.93245.d2. Epub 2007 Apr 25.","ADAPT Research Group","Neurology","2007","2007/04/27","","","10.1212/01.wnl.0000260269.93245.d2"
"30970186","Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease","Egan MF, Kost J, Voss T, Mukai Y, Aisen PS, Cummings JL, Tariot PN, Vellas B, van Dyck CH, Boada M, Zhang Y, Li W, Furtek C, Mahoney E, Harper Mozley L, Mo Y, Sur C, Michelson D.","N Engl J Med. 2019 Apr 11;380(15):1408-1420. doi: 10.1056/NEJMoa1812840.","Egan MF","N Engl J Med","2019","2019/04/11","PMC6776078","NIHMS1046474","10.1056/NEJMoa1812840"
"8563786","Number of platelet dense granules varies with age, schizophrenia and dementia","Kessler A, Shinitzky M, Kessler B.","Dementia. 1995 Nov-Dec;6(6):330-3. doi: 10.1159/000106966.","Kessler A","Dementia","1995","1995/11/01","","","10.1159/000106966"
"14758577","Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease","De Deyn PP, Carrasco MM, Deberdt W, Jeandel C, Hay DP, Feldman PD, Young CA, Lehman DL, Breier A.","Int J Geriatr Psychiatry. 2004 Feb;19(2):115-26. doi: 10.1002/gps.1032.","De Deyn PP","Int J Geriatr Psychiatry","2004","2004/02/06","","","10.1002/gps.1032"
"31426362","Effect of Long-Term Omega 3 Polyunsaturated Fatty Acid Supplementation with or without Multidomain Lifestyle Intervention on Muscle Strength in Older Adults: Secondary Analysis of the Multidomain Alzheimer Preventive Trial (MAPT)","Rolland Y, Barreto PS, Maltais M, Guyonnet S, Cantet C, Andrieu S, Vellas B.","Nutrients. 2019 Aug 16;11(8):1931. doi: 10.3390/nu11081931.","Rolland Y","Nutrients","2019","2019/08/21","PMC6723398","","10.3390/nu11081931"
"22500712","Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial","Miao YC, Tian JZ, Shi J, Mao M.","Zhong Xi Yi Jie He Xue Bao. 2012 Apr;10(4):390-7. doi: 10.3736/jcim20120407.","Miao YC","Zhong Xi Yi Jie He Xue Bao","2012","2012/04/17","","","10.3736/jcim20120407"
"27801937","Self-Reported Sleep Apnea and Dementia Risk: Findings from the Prevention of Alzheimer's Disease with Vitamin E and Selenium Trial","Ding X, Kryscio RJ, Turner J, Jicha GA, Cooper G, Caban-Holt A, Schmitt FA, Abner EL.","J Am Geriatr Soc. 2016 Dec;64(12):2472-2478. doi: 10.1111/jgs.14393. Epub 2016 Nov 1.","Ding X","J Am Geriatr Soc","2016","2016/11/02","PMC5173398","NIHMS787716","10.1111/jgs.14393"
"20847403","Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease","Baker LD, Frank LL, Foster-Schubert K, Green PS, Wilkinson CW, McTiernan A, Cholerton BA, Plymate SR, Fishel MA, Watson GS, Duncan GE, Mehta PD, Craft S.","J Alzheimers Dis. 2010;22(2):569-79. doi: 10.3233/JAD-2010-100768.","Baker LD","J Alzheimers Dis","2010","2010/09/18","PMC3049111","NIHMS267530","10.3233/JAD-2010-100768"
"36543253","Effects of caregiver counselling on medication persistence and adherence in patients with dementia at a pharmacist-managed clinic: A pilot study","Huang CY, Hu CJ, Huang LK, Chang EH.","J Clin Pharm Ther. 2022 Dec;47(12):2074-2082. doi: 10.1111/jcpt.13752. Epub 2022 Aug 10.","Huang CY","J Clin Pharm Ther","2022","2022/12/21","","","10.1111/jcpt.13752"
"1467811","Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model","Molchan SE, Martinez RA, Hill JL, Weingartner HJ, Thompson K, Vitiello B, Sunderland T.","Brain Res Brain Res Rev. 1992 Sep-Dec;17(3):215-26. doi: 10.1016/0165-0173(92)90017-g.","Molchan SE","Brain Res Brain Res Rev","1992","1992/09/01","","","10.1016/0165-0173(92)90017-g"
"3898413","Effect of buflomedil on behaviour, memory, and intellectual capacity in patients with dementia. A placebo-controlled study","Levinson B, Wright P, Barklem S.","S Afr Med J. 1985 Aug 31;68(5):302-7.","Levinson B","S Afr Med J","1985","1985/08/31","","",""
"12408216","The effect of therapeutic touch on agitated behavior and cortisol in persons with Alzheimer's disease","Woods DL, Dimond M.","Biol Res Nurs. 2002 Oct;4(2):104-14. doi: 10.1177/1099800402238331.","Woods DL","Biol Res Nurs","2002","2002/11/01","","","10.1177/1099800402238331"
"24450891","Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.","N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.","Salloway S","N Engl J Med","2014","2014/01/24","PMC4159618","NIHMS593138","10.1056/NEJMoa1304839"
"8314652","Pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy male volunteers","Mihara M, Ohnishi A, Tomono Y, Hasegawa J, Shimamura Y, Yamazaki K, Morishita N.","Int J Clin Pharmacol Ther Toxicol. 1993 May;31(5):223-9.","Mihara M","Int J Clin Pharmacol Ther Toxicol","1993","1993/05/01","","",""
"16085789","Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia","Deberdt WG, Dysken MW, Rappaport SA, Feldman PD, Young CA, Hay DP, Lehman DL, Dossenbach M, Degenhardt EK, Breier A.","Am J Geriatr Psychiatry. 2005 Aug;13(8):722-30. doi: 10.1176/appi.ajgp.13.8.722.","Deberdt WG","Am J Geriatr Psychiatry","2005","2005/08/09","","","10.1176/appi.ajgp.13.8.722"
"21335298","Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer's disease","Isik AT, Bozoglu E, Naharci MI, Kilic S.","Am J Geriatr Pharmacother. 2010 Oct;8(5):454-9. doi: 10.1016/j.amjopharm.2010.09.001.","Isik AT","Am J Geriatr Pharmacother","2010","2011/02/22","","","10.1016/j.amjopharm.2010.09.001"
"7924055","[Cerebral blood flow patterns in patients with leukoaraiosis and lacunar infarction]","Ohsawa N, Takahashi S, Yonezawa H.","Rinsho Shinkeigaku. 1994 May;34(5):443-8.","Ohsawa N","Rinsho Shinkeigaku","1994","1994/05/01","","",""
"24886353","A complex multimodal activity intervention to reduce the risk of dementia in mild cognitive impairment--ThinkingFit: pilot and feasibility study for a randomized controlled trial","Dannhauser TM, Cleverley M, Whitfield TJ, Fletcher BC, Stevens T, Walker Z.","BMC Psychiatry. 2014 May 5;14:129. doi: 10.1186/1471-244X-14-129.","Dannhauser TM","BMC Psychiatry","2014","2014/06/03","PMC4037760","","10.1186/1471-244X-14-129"
"19965584","Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD study","Vedin I, Cederholm T, Freund-Levi Y, Basun H, Hjorth E, Irving GF, Eriksdotter-Jönhagen M, Schultzberg M, Wahlund LO, Palmblad J.","J Lipid Res. 2010 May;51(5):1179-85. doi: 10.1194/jlr.M002667. Epub 2009 Nov 24.","Vedin I","J Lipid Res","2010","2009/12/08","PMC2853444","","10.1194/jlr.M002667"
"10885864","Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine)","Winblad B, Poritis N.","Int J Geriatr Psychiatry. 1999 Feb;14(2):135-46. doi: 10.1002/(sici)1099-1166(199902)14:2<135::aid-gps906>3.0.co;2-0.","Winblad B","Int J Geriatr Psychiatry","1999","2000/07/08","","","10.1002/(sici)1099-1166(199902)14:2<135::aid-gps906>3.0.co;2-0"
"20075646","Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial","Mowla A, Pani A.","J Clin Psychopharmacol. 2010 Feb;30(1):40-3. doi: 10.1097/JCP.0b013e3181ca0c59.","Mowla A","J Clin Psychopharmacol","2010","2010/01/16","","","10.1097/JCP.0b013e3181ca0c59"
"12611748","Usefulness of plasma haloperidol levels for monitoring clinical efficacy and side effects in Alzheimer patients with psychosis and behavioral dyscontrol","Pelton GH, Devanand DP, Bell K, Marder K, Marston K, Liu X, Cooper TB.","Am J Geriatr Psychiatry. 2003 Mar-Apr;11(2):186-93.","Pelton GH","Am J Geriatr Psychiatry","2003","2003/03/04","","",""
"15642910","Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD","Bayer AJ, Bullock R, Jones RW, Wilkinson D, Paterson KR, Jenkins L, Millais SB, Donoghue S.","Neurology. 2005 Jan 11;64(1):94-101. doi: 10.1212/01.WNL.0000148604.77591.67.","Bayer AJ","Neurology","2005","2005/01/12","","","10.1212/01.WNL.0000148604.77591.67"
"24955552","Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients","Mokhber N, Abdollahian E, Soltanifar A, Samadi R, Saghebi A, Haghighi MB, Azarpazhooh A.","Pharmacopsychiatry. 2014 Jul;47(4-5):131-40. doi: 10.1055/s-0034-1377041. Epub 2014 Jun 23.","Mokhber N","Pharmacopsychiatry","2014","2014/06/24","","","10.1055/s-0034-1377041"
"10085474","Effect of melatonin in selected populations of sleep-disturbed patients","Brusco LI, Fainstein I, Márquez M, Cardinali DP.","Biol Signals Recept. 1999 Jan-Apr;8(1-2):126-31. doi: 10.1159/000014580.","Brusco LI","Biol Signals Recept","1999","1999/03/23","","","10.1159/000014580"
"19064472","At the crossroads: development and evaluation of a dementia caregiver group intervention to assist in driving cessation","Stern RA, D'Ambrosio LA, Mohyde M, Carruth A, Tracton-Bishop B, Hunter JC, Daneshvar DH, Coughlin JF.","Gerontol Geriatr Educ. 2008;29(4):363-82. doi: 10.1080/02701960802497936.","Stern RA","Gerontol Geriatr Educ","2008","2008/12/10","PMC2679525","NIHMS97392","10.1080/02701960802497936"
"10705939","SPECT in Alzheimer's disease: features associated with bilateral parietotemporal hypoperfusion","Nitrini R, Buchpiguel CA, Caramelli P, Bahia VS, Mathias SC, Nascimento CM, Degenszajn J, Caixeta L.","Acta Neurol Scand. 2000 Mar;101(3):172-6. doi: 10.1034/j.1600-0404.2000.101003172.x.","Nitrini R","Acta Neurol Scand","2000","2000/03/08","","","10.1034/j.1600-0404.2000.101003172.x"
"16574032","Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease","Bullock R, Bergman H, Touchon J, Gambina G, He Y, Nagel J, Lane R.","Curr Med Res Opin. 2006 Mar;22(3):483-94. doi: 10.1185/030079906X89685.","Bullock R","Curr Med Res Opin","2006","2006/04/01","","","10.1185/030079906X89685"
"15589109","Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study","Goekoop R, Rombouts SA, Jonker C, Hibbel A, Knol DL, Truyen L, Barkhof F, Scheltens P.","Neuroimage. 2004 Dec;23(4):1450-9. doi: 10.1016/j.neuroimage.2004.08.006.","Goekoop R","Neuroimage","2004","2004/12/14","","","10.1016/j.neuroimage.2004.08.006"
"21764118","Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial","Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Knapp M, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A.","Lancet. 2011 Jul 30;378(9789):403-11. doi: 10.1016/S0140-6736(11)60830-1. Epub 2011 Jul 19.","Banerjee S","Lancet","2011","2011/07/19","","","10.1016/S0140-6736(11)60830-1"
"24154647","The influence of nutritional supplement drinks on providing adequate calorie and protein intake in older adults with dementia","Allen V, Methven L, Gosney M.","J Nutr Health Aging. 2013 Sep;17(9):752-5. doi: 10.1007/s12603-013-0364-5.","Allen V","J Nutr Health Aging","2013","2013/10/25","","","10.1007/s12603-013-0364-5"
"18184948","Different responses to rivastigmine in subcortical vascular dementia and multi-infarct dementia","Moretti R, Torre P, Antonello RM, Cazzato G, Pizzolato G.","Am J Alzheimers Dis Other Demen. 2008 Apr-May;23(2):167-76. doi: 10.1177/1533317507312558. Epub 2008 Jan 9.","Moretti R","Am J Alzheimers Dis Other Demen","2008","2008/01/11","","","10.1177/1533317507312558"
"14663655","Short-term effects of acetylcholinesterase inhibitor treatment on EEG and memory performance in Alzheimer patients: an open, controlled trial","Brassen S, Adler G.","Pharmacopsychiatry. 2003 Nov;36(6):304-8. doi: 10.1055/s-2003-45118.","Brassen S","Pharmacopsychiatry","2003","2003/12/10","","","10.1055/s-2003-45118"
"2183056","Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study","Gauthier S, Bouchard R, Lamontagne A, Bailey P, Bergman H, Ratner J, Tesfaye Y, Saint-Martin M, Bacher Y, Carrier L, et al.","N Engl J Med. 1990 May 3;322(18):1272-6. doi: 10.1056/NEJM199005033221804.","Gauthier S","N Engl J Med","1990","1990/05/03","","","10.1056/NEJM199005033221804"
"34444766","Efficacy and Safety of Sesame Oil Cake Extract on Memory Function Improvement: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Pilot Study","Jung SJ, Jung ES, Ha KC, Baek HI, Park YK, Han SK, Chae SW, Lee SO, Chung YC.","Nutrients. 2021 Jul 28;13(8):2606. doi: 10.3390/nu13082606.","Jung SJ","Nutrients","2021","2021/08/27","PMC8399671","","10.3390/nu13082606"
"20505433","NIA-funded Alzheimer centers are more efficient than commercial clinical recruitment sites for conducting secondary prevention trials of dementia","Edland SD, Emond JA, Aisen PS, Petersen RC.","Alzheimer Dis Assoc Disord. 2010 Apr-Jun;24(2):159-64. doi: 10.1097/WAD.0b013e3181c9983f.","Edland SD","Alzheimer Dis Assoc Disord","2010","2010/05/28","PMC2922976","NIHMS167201","10.1097/WAD.0b013e3181c9983f"
"10828731","Acute nicotine administration in Alzheimer's disease: an exploratory EEG study","Knott V, Engeland C, Mohr E, Mahoney C, Ilivitsky V.","Neuropsychobiology. 2000;41(4):210-20. doi: 10.1159/000026662.","Knott V","Neuropsychobiology","2000","2000/06/01","","","10.1159/000026662"
"34251396","The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial","Mitchell SL, D'Agata EMC, Hanson LC, Loizeau AJ, Habtemariam DA, Tsai T, Anderson RA, Shaffer ML.","JAMA Intern Med. 2021 Sep 1;181(9):1174-1182. doi: 10.1001/jamainternmed.2021.3098.","Mitchell SL","JAMA Intern Med","2021","2021/07/12","PMC8276127","","10.1001/jamainternmed.2021.3098"
"34354136","Lower regional gray matter volume in the absence of higher cortical amyloid burden in late-life depression","Takamiya A, Vande Casteele T, Koole M, De Winter FL, Bouckaert F, Van den Stock J, Sunaert S, Dupont P, Vandenberghe R, Van Laere K, Vandenbulcke M, Emsell L.","Sci Rep. 2021 Aug 5;11(1):15981. doi: 10.1038/s41598-021-95206-0.","Takamiya A","Sci Rep","2021","2021/08/06","PMC8342521","","10.1038/s41598-021-95206-0"
"10372954","Neuroendocrine responses to intravenous infusion of physostigmine in patients with Alzheimer disease","Asthana S, Raffaele KC, Greig NH, Schapiro MB, Blackman MR, Soncrant TT.","Alzheimer Dis Assoc Disord. 1999 Apr-Jun;13(2):102-8. doi: 10.1097/00002093-199904000-00008.","Asthana S","Alzheimer Dis Assoc Disord","1999","1999/06/18","","","10.1097/00002093-199904000-00008"
"7604138","Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study","Saletu B, Paulus E, Linzmayer L, Anderer P, Semlitsch HV, Grünberger J, Wicke L, Neuhold A, Podreka I.","Psychopharmacology (Berl). 1995 Feb;117(4):385-95. doi: 10.1007/BF02246209.","Saletu B","Psychopharmacology (Berl)","1995","1995/02/01","","","10.1007/BF02246209"
"16244481","Olanzapine versus haloperidol in the treatment of agitation in elderly patients with dementia: results of a randomized controlled double-blind trial","Verhey FR, Verkaaik M, Lousberg R; Olanzapine-Haloperidol in Dementia Study group.","Dement Geriatr Cogn Disord. 2006;21(1):1-8. doi: 10.1159/000089136. Epub 2005 Oct 21.","Verhey FR","Dement Geriatr Cogn Disord","2006","2005/10/26","","","10.1159/000089136"
"22178419","Impairment of the ABCA1 and SR-BI-mediated cholesterol efflux pathways and HDL anti-inflammatory activity in Alzheimer's disease","Khalil A, Berrougui H, Pawelec G, Fulop T.","Mech Ageing Dev. 2012 Jan;133(1):20-9. doi: 10.1016/j.mad.2011.11.008. Epub 2011 Dec 9.","Khalil A","Mech Ageing Dev","2012","2011/12/20","","","10.1016/j.mad.2011.11.008"
"23631810","Disturbance in uniformly 13C-labelled DHA metabolism in elderly human subjects carrying the apoE ε4 allele","Chouinard-Watkins R, Rioux-Perreault C, Fortier M, Tremblay-Mercier J, Zhang Y, Lawrence P, Vohl MC, Perron P, Lorrain D, Brenna JT, Cunnane SC, Plourde M.","Br J Nutr. 2013 Nov;110(10):1751-9. doi: 10.1017/S0007114513001268. Epub 2013 Apr 30.","Chouinard-Watkins R","Br J Nutr","2013","2013/05/02","","","10.1017/S0007114513001268"
"17414243","The influence of galantamine on reaction time, attention processes, and performance variability in elderly Alzheimer patients","Gorus E, Lambert M, De Raedt R, Mets T.","J Clin Psychopharmacol. 2007 Apr;27(2):182-7. doi: 10.1097/JCP.0b013e318032eadb.","Gorus E","J Clin Psychopharmacol","2007","2007/04/07","","","10.1097/JCP.0b013e318032eadb"
"18838662","Subjective cognitive failures and hippocampal volume in elderly with white matter lesions","van Norden AG, Fick WF, de Laat KF, van Uden IW, van Oudheusden LJ, Tendolkar I, Zwiers MP, de Leeuw FE.","Neurology. 2008 Oct 7;71(15):1152-9. doi: 10.1212/01.wnl.0000327564.44819.49.","van Norden AG","Neurology","2008","2008/10/08","","","10.1212/01.wnl.0000327564.44819.49"
"17966072","Effects of acute exposure to aluminum on cognition in humans","Molloy DW, Standish TI, Nieboer E, Turnbull JD, Smith SD, Dubois S.","J Toxicol Environ Health A. 2007 Dec;70(23):2011-9. doi: 10.1080/15287390701551142.","Molloy DW","J Toxicol Environ Health A","2007","2007/10/30","","","10.1080/15287390701551142"
"24499394","Cognitive-behavioural group therapy improves a psychophysiological marker of stress in caregivers of patients with Alzheimer's disease","Aboulafia-Brakha T, Suchecki D, Gouveia-Paulino F, Nitrini R, Ptak R.","Aging Ment Health. 2014;18(6):801-8. doi: 10.1080/13607863.2014.880406. Epub 2014 Feb 5.","Aboulafia-Brakha T","Aging Ment Health","2014","2014/02/07","","","10.1080/13607863.2014.880406"
"8739821","Variability in the plasma protein binding of velnacrine (1-hydroxy tacrine hydrochloride). A potential agent for Alzheimer's disease","Wood DM, Ford JM, Roberts CJ.","Eur J Clin Pharmacol. 1996;50(1-2):115-9. doi: 10.1007/s002280050078.","Wood DM","Eur J Clin Pharmacol","1996","1996/01/01","","","10.1007/s002280050078"
"20634303","Measurement of gray and white matter atrophy in dementia with Lewy bodies using diffeomorphic anatomic registration through exponentiated lie algebra: A comparison with conventional voxel-based morphometry","Takahashi R, Ishii K, Miyamoto N, Yoshikawa T, Shimada K, Ohkawa S, Kakigi T, Yokoyama K.","AJNR Am J Neuroradiol. 2010 Nov;31(10):1873-8. doi: 10.3174/ajnr.A2200. Epub 2010 Jul 15.","Takahashi R","AJNR Am J Neuroradiol","2010","2010/07/17","PMC7964010","","10.3174/ajnr.A2200"
"12525745","No additional benefit of HRT on response to rivastigmine in menopausal women with AD","Rigaud AS, André G, Vellas B, Touchon J, Pere JJ; French Study Group.","Neurology. 2003 Jan 14;60(1):148-9. doi: 10.1212/wnl.60.1.148-a.","Rigaud AS","Neurology","2003","2003/01/15","","","10.1212/wnl.60.1.148-a"
"16330295","Investigation of the pharmacokinetic and pharmacodynamic interactions between memantine and glyburide/metformin in healthy young subjects: a single-center, multiple-dose, open-label study","Rao N, Chou T, Ventura D, Abramowitz W.","Clin Ther. 2005 Oct;27(10):1596-606. doi: 10.1016/j.clinthera.2005.10.006.","Rao N","Clin Ther","2005","2005/12/07","","","10.1016/j.clinthera.2005.10.006"
"15763392","The age-related down-regulation of the growth hormone/insulin-like growth factor-1 axis in the elderly male is reversed considerably by donepezil, a drug for Alzheimer's disease","Obermayr RP, Mayerhofer L, Knechtelsdorfer M, Mersich N, Huber ER, Geyer G, Tragl KH.","Exp Gerontol. 2005 Mar;40(3):157-63. doi: 10.1016/j.exger.2004.11.001. Epub 2004 Dec 23.","Obermayr RP","Exp Gerontol","2005","2005/03/15","","","10.1016/j.exger.2004.11.001"
"11739066","A pilot randomized trial of carbamazepine for behavioral symptoms in treatment-resistant outpatients with Alzheimer disease","Olin JT, Fox LS, Pawluczyk S, Taggart NA, Schneider LS.","Am J Geriatr Psychiatry. 2001 Fall;9(4):400-5.","Olin JT","Am J Geriatr Psychiatry","2001","2001/12/12","","",""
"25751083","A Pilot Evaluation of Psychosocial Support for Family Caregivers of Relatives with Dementia in Long-Term Care: The Residential Care Transition Module","Gaugler JE, Reese M, Sauld J.","Res Gerontol Nurs. 2015 Jul-Aug;8(4):161-72. doi: 10.3928/19404921-20150304-01. Epub 2015 Mar 10.","Gaugler JE","Res Gerontol Nurs","2015","2015/03/10","PMC5997398","NIHMS972155","10.3928/19404921-20150304-01"
"25516316","Turmeric improves post-prandial working memory in pre-diabetes independent of insulin","Lee MS, Wahlqvist ML, Chou YC, Fang WH, Lee JT, Kuan JC, Liu HY, Lu TM, Xiu L, Hsu CC, Andrews ZB, Pan WH.","Asia Pac J Clin Nutr. 2014;23(4):581-91. doi: 10.6133/apjcn.2014.23.4.24.","Lee MS","Asia Pac J Clin Nutr","2014","2014/12/18","","","10.6133/apjcn.2014.23.4.24"
"7624918","A patient-side technique for real-time measurement of acetylcholinesterase activity during monitoring of eptastigmine treatment","Mosca A, Onelli E, Rosti E, Paleari R, Luzzana M, Imbimbo BP.","Ther Drug Monit. 1995 Jun;17(3):230-8. doi: 10.1097/00007691-199506000-00004.","Mosca A","Ther Drug Monit","1995","1995/06/01","","","10.1097/00007691-199506000-00004"
"11220813","A randomized, controlled trial of a home environmental intervention: effect on efficacy and upset in caregivers and on daily function of persons with dementia","Gitlin LN, Corcoran M, Winter L, Boyce A, Hauck WW.","Gerontologist. 2001 Feb;41(1):4-14. doi: 10.1093/geront/41.1.4.","Gitlin LN","Gerontologist","2001","2001/02/28","","","10.1093/geront/41.1.4"
"29358714","Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer's disease hallmarks","Reinhardt S, Stoye N, Luderer M, Kiefer F, Schmitt U, Lieb K, Endres K.","Sci Rep. 2018 Jan 22;8(1):1329. doi: 10.1038/s41598-018-19577-7.","Reinhardt S","Sci Rep","2018","2018/01/24","PMC5778060","","10.1038/s41598-018-19577-7"
"11900994","Pharmacological concentrations of the HMG-CoA reductase inhibitor lovastatin decrease the formation of the Alzheimer beta-amyloid peptide in vitro and in patients","Buxbaum JD, Cullen EI, Friedhoff LT.","Front Biosci. 2002 Apr 1;7:a50-9. doi: 10.2741/A739.","Buxbaum JD","Front Biosci","2002","2002/03/20","","","10.2741/A739"
"16569466","MR features of the substantia innominata and therapeutic implications in dementias","Hanyu H, Shimizu S, Tanaka Y, Hirao K, Iwamoto T, Abe K.","Neurobiol Aging. 2007 Apr;28(4):548-54. doi: 10.1016/j.neurobiolaging.2006.02.009. Epub 2006 Mar 29.","Hanyu H","Neurobiol Aging","2007","2006/03/30","","","10.1016/j.neurobiolaging.2006.02.009"
"10078713","Efficacy and safety of eptastigmine for the treatment of patients with Alzheimer's disease","Imbimbo BP, Martelli P, Troetel WM, Lucchelli F, Lucca U, Thal LJ.","Neurology. 1999 Mar 10;52(4):700-8. doi: 10.1212/wnl.52.4.700.","Imbimbo BP","Neurology","1999","1999/03/17","","","10.1212/wnl.52.4.700"
"36905719","Wrist-worn sensor-based measurements for drug effect detection with small samples in people with Lewy Body Dementia","Chen C, Kowahl NR, Rainaldi E, Burq M, Munsie LM, Battioui C, Wang J, Biglan K, Marks WJ Jr, Kapur R.","Parkinsonism Relat Disord. 2023 Apr;109:105355. doi: 10.1016/j.parkreldis.2023.105355. Epub 2023 Mar 4.","Chen C","Parkinsonism Relat Disord","2023","2023/03/11","","","10.1016/j.parkreldis.2023.105355"
"15207442","Cognitive impairment and infectious burden in the elderly","Strandberg TE, Pitkala KH, Linnavuori K, Tilvis RS.","Arch Gerontol Geriatr Suppl. 2004;(9):419-23. doi: 10.1016/j.archger.2004.04.053.","Strandberg TE","Arch Gerontol Geriatr Suppl","2004","2004/06/23","","","10.1016/j.archger.2004.04.053"
"21561398","Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study","Choi SH, Park KW, Na DL, Han HJ, Kim EJ, Shim YS, Lee JH; Expect Study Group.","Curr Med Res Opin. 2011 Jul;27(7):1375-83. doi: 10.1185/03007995.2011.582484. Epub 2011 May 12.","Choi SH","Curr Med Res Opin","2011","2011/05/13","","","10.1185/03007995.2011.582484"
"9581208","A structured trial of risperidone for the treatment of agitation in dementia","Lavretsky H, Sultzer D.","Am J Geriatr Psychiatry. 1998 Spring;6(2):127-35.","Lavretsky H","Am J Geriatr Psychiatry","1998","1998/05/15","","",""
"35532913","Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial","Rafii MS, Sol O, Mobley WC, Delpretti S, Skotko BG, Burke AD, Sabbagh MN, Yuan SH, Rissman RA, Pulsifer M, Evans C, Evans AC, Beth G, Fournier N, Gray JA, Dos Santos AM, Hliva V, Vukicevic M, Kosco-Vilbois M, Streffer J, Pfeifer A, Feldman HH.","JAMA Neurol. 2022 Jun 1;79(6):565-574. doi: 10.1001/jamaneurol.2022.0983.","Rafii MS","JAMA Neurol","2022","2022/05/09","PMC9086937","","10.1001/jamaneurol.2022.0983"
"23311593","Effect of polymer, plasticizer and filler on orally disintegrating film","Liew KB, Tan YT, Peh KK.","Drug Dev Ind Pharm. 2014 Jan;40(1):110-9. doi: 10.3109/03639045.2012.749889. Epub 2013 Jan 11.","Liew KB","Drug Dev Ind Pharm","2014","2013/01/15","","","10.3109/03639045.2012.749889"
"7970159","Concentrations of alpha-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia","Tohgi H, Abe T, Nakanishi M, Hamato F, Sasaki K, Takahashi S.","Neurosci Lett. 1994 Jun 6;174(1):73-6. doi: 10.1016/0304-3940(94)90122-8.","Tohgi H","Neurosci Lett","1994","1994/06/06","","","10.1016/0304-3940(94)90122-8"
"32376818","Dietary Melatonin Therapy Alleviates the Lamina Cribrosa Damages in Patients with Mild Cognitive Impairments: A Double-Blinded, Randomized Controlled Study","Xu L, Yu H, Sun H, Hu B, Geng Y.","Med Sci Monit. 2020 May 7;26:e923232. doi: 10.12659/MSM.923232.","Xu L","Med Sci Monit","2020","2020/05/08","PMC7233010","","10.12659/MSM.923232"
"25609939","Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy","Campbell NL, Skaar TC, Perkins AJ, Gao S, Li L, Khan BA, Boustani MA.","Clin Interv Aging. 2015 Jan 14;10:269-75. doi: 10.2147/CIA.S65980. eCollection 2015.","Campbell NL","Clin Interv Aging","2015","2015/01/23","PMC4298284","","10.2147/CIA.S65980"
"15886752","Serum estradiol, progesterone, testosterone, FSH and LH levels in postmenopausal women with Alzheimer's dementia","Tsolaki M, Grammaticos P, Karanasou C, Balaris V, Kapoukranidou D, Kalpidis I, Petsanis K, Dedousi E.","Hell J Nucl Med. 2005 Jan-Apr;8(1):39-42.","Tsolaki M","Hell J Nucl Med","2005","2005/05/12","","",""
"8940320","A family intervention to delay nursing home placement of patients with Alzheimer disease. A randomized controlled trial","Mittelman MS, Ferris SH, Shulman E, Steinberg G, Levin B.","JAMA. 1996 Dec 4;276(21):1725-31.","Mittelman MS","JAMA","1996","1996/12/04","","",""
"22655593","Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery","Wahlberg LU, Lind G, Almqvist PM, Kusk P, Tornøe J, Juliusson B, Söderman M, Selldén E, Seiger Å, Eriksdotter-Jönhagen M, Linderoth B.","J Neurosurg. 2012 Aug;117(2):340-7. doi: 10.3171/2012.2.JNS11714. Epub 2012 Jun 1.","Wahlberg LU","J Neurosurg","2012","2012/06/05","","","10.3171/2012.2.JNS11714"
"26482691","Nutritional Guidance Improves Nutrient Intake and Quality of Life, and May Prevent Falls in Aged Persons with Alzheimer Disease Living with a Spouse (NuAD Trial)","Suominen MH, Puranen TM, Jyväkorpi SK, Eloniemi-Sulkava U, Kautiainen H, Siljamäki-Ojansuu U, Pitkalä KH.","J Nutr Health Aging. 2015 Nov;19(9):901-7. doi: 10.1007/s12603-015-0558-0.","Suominen MH","J Nutr Health Aging","2015","2015/10/21","","","10.1007/s12603-015-0558-0"
"15780532","Effect of raloxifene and hormone therapy on serum markers of brain and whole-body cholesterol metabolism in postmenopausal women","Vogelvang TE, Mijatovic V, van der Mooren MJ, Pinsdorf U, von Bergmann K, Netelenbos JC, Lütjohann D.","Maturitas. 2005 Apr 11;50(4):312-20. doi: 10.1016/j.maturitas.2004.08.004.","Vogelvang TE","Maturitas","2005","2005/03/23","","","10.1016/j.maturitas.2004.08.004"
"12867353","Acute procoagulant stress response as a dynamic measure of allostatic load in Alzheimer caregivers","von Känel R, Dimsdale JE, Patterson TL, Grant I.","Ann Behav Med. 2003 Aug;26(1):42-8. doi: 10.1207/S15324796ABM2601_06.","von Känel R","Ann Behav Med","2003","2003/07/18","","","10.1207/S15324796ABM2601_06"
"3931138","Efficacy of oral physostigmine in primary degenerative dementia. A double-blind study of response to different dose level","Beller SA, Overall JE, Swann AC.","Psychopharmacology (Berl). 1985;87(2):147-51. doi: 10.1007/BF00431798.","Beller SA","Psychopharmacology (Berl)","1985","1985/01/01","","","10.1007/BF00431798"
"18838742","Persisting burden predicts depressive symptoms in dementia caregivers","Epstein-Lubow G, Davis JD, Miller IW, Tremont G.","J Geriatr Psychiatry Neurol. 2008 Sep;21(3):198-203. doi: 10.1177/0891988708320972.","Epstein-Lubow G","J Geriatr Psychiatry Neurol","2008","2008/10/08","","","10.1177/0891988708320972"
"33582979","What day is today? Cognitive capacity and the risk of incident dementia in the context of integrated care for older people (ICOPE Step 1)","González-Bautista E, de Souto Barreto P, Andrieu S, Rolland Y, Vellas B; MAPT/DSA group.","Aging Clin Exp Res. 2021 Nov;33(11):3135-3139. doi: 10.1007/s40520-021-01803-4. Epub 2021 Feb 13.","González-Bautista E","Aging Clin Exp Res","2021","2021/02/14","","","10.1007/s40520-021-01803-4"
"10681083","Lack of an association of estrogen receptor alpha gene polymorphisms and transcriptional activity with Alzheimer disease","Maruyama H, Toji H, Harrington CR, Sasaki K, Izumi Y, Ohnuma T, Arai H, Yasuda M, Tanaka C, Emson PC, Nakamura S, Kawakami H.","Arch Neurol. 2000 Feb;57(2):236-40. doi: 10.1001/archneur.57.2.236.","Maruyama H","Arch Neurol","2000","2000/02/19","","","10.1001/archneur.57.2.236"
"19484917","Safety and tolerability of the rivastigmine patch: results of a 28-week open-label extension","Grossberg G, Sadowsky C, Fröstl H, Frölich L, Nagel J, Tekin S, Zechner S, Ros J, Orgogozo JM.","Alzheimer Dis Assoc Disord. 2009 Apr-Jun;23(2):158-64. doi: 10.1097/wad.0b013e31818b1c2c.","Grossberg G","Alzheimer Dis Assoc Disord","2009","2009/06/03","","","10.1097/wad.0b013e31818b1c2c"
"9469218","Use of SSRIs in ""very old"" depressed nursing home residents","Trappler B, Cohen CI.","Am J Geriatr Psychiatry. 1998 Winter;6(1):83-9.","Trappler B","Am J Geriatr Psychiatry","1998","1998/02/20","","",""
"9522547","[Ginkgo biloba special extract EGb 761--an anti-dementia drug]","Hörr R, Kieser M.","Fortschr Med. 1998 Jan 30;116(3):39-40.","Hörr R","Fortschr Med","1998","1998/04/02","","",""
"30346431","[The addition of memantine to galantamine increases treatment efficacy in patients with moderate dementia with Lewy bodies]","Vasenina EE, Gankina OA, Levin OS.","Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(6. Vyp. 2):32-36. doi: 10.17116/jnevro201811806232.","Vasenina EE","Zh Nevrol Psikhiatr Im S S Korsakova","2018","2018/10/23","","","10.17116/jnevro201811806232"
"30098049","Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study","Andre L, Gallini A, Montastruc F, Coley N, Montastruc JL, Vellas B, Andrieu S, Gardette V; MAPT/DSA study group.","Br J Clin Pharmacol. 2019 Jan;85(1):71-99. doi: 10.1111/bcp.13734. Epub 2018 Oct 17.","Andre L","Br J Clin Pharmacol","2019","2018/08/12","PMC6303211","","10.1111/bcp.13734"
"19523013","Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects","Patat A, Parks V, Raje S, Plotka A, Chassard D, Le Coz F.","Br J Clin Pharmacol. 2009 Mar;67(3):299-308. doi: 10.1111/j.1365-2125.2008.03348.x.","Patat A","Br J Clin Pharmacol","2009","2009/06/16","PMC2675040","","10.1111/j.1365-2125.2008.03348.x"
"8257478","Oral 5'-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study","Passeri M, Cucinotta D, Abate G, Senin U, Ventura A, Stramba Badiale M, Diana R, La Greca P, Le Grazie C.","Aging (Milano). 1993 Feb;5(1):63-71. doi: 10.1007/BF03324128.","Passeri M","Aging (Milano)","1993","1993/02/01","","","10.1007/BF03324128"
"16191240","Patient populations in clinical studies of donepezil in vascular dementia","Pratt RD.","Int Psychogeriatr. 2003;15 Suppl 1:195-200. doi: 10.1017/S1041610203009190.","Pratt RD","Int Psychogeriatr","2003","2005/09/30","","","10.1017/S1041610203009190"
"20224285","Treatment of Alzheimer's disease with a cholinesterase inhibitor combined with antioxidants","Cornelli U.","Neurodegener Dis. 2010;7(1-3):193-202. doi: 10.1159/000295663. Epub 2010 Mar 12.","Cornelli U","Neurodegener Dis","2010","2010/03/13","","","10.1159/000295663"
"3529834","A comparison of chlormethiazole and thioridazine in agitated confusional states of the elderly","Ather SA, Shaw SH, Stoker MJ.","Acta Psychiatr Scand Suppl. 1986;329:81-91. doi: 10.1111/j.1600-0447.1986.tb10541.x.","Ather SA","Acta Psychiatr Scand Suppl","1986","1986/01/01","","","10.1111/j.1600-0447.1986.tb10541.x"
"17997623","The temporal limits of cognitive change from music therapy in elderly persons with dementia or dementia-like cognitive impairment: a randomized controlled trial","Bruer RA, Spitznagel E, Cloninger CR.","J Music Ther. 2007 Winter;44(4):308-28. doi: 10.1093/jmt/44.4.308.","Bruer RA","J Music Ther","2007","2007/11/14","","","10.1093/jmt/44.4.308"
"15344469","Permutation tests for classification: towards statistical significance in image-based studies","Golland P, Fischl B.","Inf Process Med Imaging. 2003 Jul;18:330-41. doi: 10.1007/978-3-540-45087-0_28.","Golland P","Inf Process Med Imaging","2003","2004/09/04","","","10.1007/978-3-540-45087-0_28"
"16780671","[Clinical efficacy and safety of akatinol memantine in treatment of mild to moderate Alzheimer disease: a donepezil-controlled, randomized trial]","Hu HT, Zhang ZX, Yao JL, Yu HZ, Wang YH, Tang HC, Ji CJ, Xu T.","Zhonghua Nei Ke Za Zhi. 2006 Apr;45(4):277-80.","Hu HT","Zhonghua Nei Ke Za Zhi","2006","2006/06/20","","",""
"18591574","A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease","Streim JE, Porsteinsson AP, Breder CD, Swanink R, Marcus R, McQuade R, Carson WH.","Am J Geriatr Psychiatry. 2008 Jul;16(7):537-50. doi: 10.1097/JGP.0b013e318165db77.","Streim JE","Am J Geriatr Psychiatry","2008","2008/07/02","","","10.1097/JGP.0b013e318165db77"
"9164689","""Familial Parkinson's disease""--a case-control study of families","Uitti RJ, Shinotoh H, Hayward M, Schulzer M, Mak E, Calne DB.","Can J Neurol Sci. 1997 May;24(2):127-32. doi: 10.1017/s0317167100021454.","Uitti RJ","Can J Neurol Sci","1997","1997/05/01","","","10.1017/s0317167100021454"
"18257603","Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease","Doody RS, Corey-Bloom J, Zhang R, Li H, Ieni J, Schindler R.","Drugs Aging. 2008;25(2):163-74. doi: 10.2165/00002512-200825020-00008.","Doody RS","Drugs Aging","2008","2008/02/09","","","10.2165/00002512-200825020-00008"
"15197285","Neuroticism and longitudinal change in caregiver depression: impact of a spouse-caregiver intervention program","Jang Y, Clay OJ, Roth DL, Haley WE, Mittelman MS.","Gerontologist. 2004 Jun;44(3):311-7. doi: 10.1093/geront/44.3.311.","Jang Y","Gerontologist","2004","2004/06/16","","","10.1093/geront/44.3.311"
"1603291","Clinical studies with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia of mild to moderate degree","Villardita C, Grioli S, Lomeo C, Cattaneo C, Parini J.","Neuropsychobiology. 1992;25(1):24-8. doi: 10.1159/000118805.","Villardita C","Neuropsychobiology","1992","1992/01/01","","","10.1159/000118805"
"25609634","The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans","May PC, Willis BA, Lowe SL, Dean RA, Monk SA, Cocke PJ, Audia JE, Boggs LN, Borders AR, Brier RA, Calligaro DO, Day TA, Ereshefsky L, Erickson JA, Gevorkyan H, Gonzales CR, James DE, Jhee SS, Komjathy SF, Li L, Lindstrom TD, Mathes BM, Martényi F, Sheehan SM, Stout SL, Timm DE, Vaught GM, Watson BM, Winneroski LL, Yang Z, Mergott DJ.","J Neurosci. 2015 Jan 21;35(3):1199-210. doi: 10.1523/JNEUROSCI.4129-14.2015.","May PC","J Neurosci","2015","2015/01/23","PMC6605527","","10.1523/JNEUROSCI.4129-14.2015"
"8300891","Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly subjects","Ohnishi A, Mihara M, Kamakura H, Tomono Y, Hasegawa J, Yamazaki K, Morishita N, Tanaka T.","J Clin Pharmacol. 1993 Nov;33(11):1086-91. doi: 10.1002/j.1552-4604.1993.tb01945.x.","Ohnishi A","J Clin Pharmacol","1993","1993/11/01","","","10.1002/j.1552-4604.1993.tb01945.x"
"7827311","Cortical CSF volume fluctuations by MRI in brain aging, dementia and hydrocephalus","Emerson JF, Chen PC, Shankle WR, Greensite FS, Foltz EL, Lott IT, Nalcioglu O.","Neuroreport. 1994 Sep 8;5(14):1699-704. doi: 10.1097/00001756-199409080-00003.","Emerson JF","Neuroreport","1994","1994/09/08","","","10.1097/00001756-199409080-00003"
"10639394","Mapping morphology of the corpus callosum in schizophrenia","Narr KL, Thompson PM, Sharma T, Moussai J, Cannestra AF, Toga AW.","Cereb Cortex. 2000 Jan;10(1):40-9. doi: 10.1093/cercor/10.1.40.","Narr KL","Cereb Cortex","2000","2000/01/20","","","10.1093/cercor/10.1.40"
"14644147","The application of serial MRI analysis techniques to the study of cerebral atrophy in late-onset dementia","Paling SM, Williams ED, Barber R, Burton EJ, Crum WR, Fox NC, O'Brien JT.","Med Image Anal. 2004 Mar;8(1):69-79. doi: 10.1016/j.media.2003.07.004.","Paling SM","Med Image Anal","2004","2003/12/04","","","10.1016/j.media.2003.07.004"
"10084637","Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group","Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M.","J Clin Psychiatry. 1999 Feb;60(2):107-15. doi: 10.4088/jcp.v60n0207.","Katz IR","J Clin Psychiatry","1999","1999/03/20","","","10.4088/jcp.v60n0207"
"19064469","Continued driving and time to transition to nondriver status through error-specific driving restrictions","Freund B, Petrakos D.","Gerontol Geriatr Educ. 2008;29(4):326-35. doi: 10.1080/02701960802497852.","Freund B","Gerontol Geriatr Educ","2008","2008/12/10","","","10.1080/02701960802497852"
"10914620","Patient knowledge about hormone replacement therapy: implications for treatment","Connelly MT, Rusinak D, Livingston W, Raeke L, Inui TS.","Menopause. 2000 Jul-Aug;7(4):266-72. doi: 10.1097/00042192-200007040-00009.","Connelly MT","Menopause","2000","2000/07/29","","","10.1097/00042192-200007040-00009"
"31169912","Association of 3-Year Multidomain Intervention and Omega-3 Supplementation with Frailty Incidence","Guerville F, de Souto Barreto P, Giudici KV, Rolland Y, Vellas B; MAPT/DSA Group.","J Am Geriatr Soc. 2019 Aug;67(8):1700-1706. doi: 10.1111/jgs.15994. Epub 2019 Jun 6.","Guerville F","J Am Geriatr Soc","2019","2019/06/07","","","10.1111/jgs.15994"
"24284060","Identification and validation of platelet low biological variation proteins, superior to GAPDH, actin and tubulin, as tools in clinical proteomics","Baumgartner R, Umlauf E, Veitinger M, Guterres S, Rappold E, Babeluk R, Mitulović G, Oehler R, Zellner M.","J Proteomics. 2013 Dec 6;94:540-51. doi: 10.1016/j.jprot.2013.10.015. Epub 2013 Oct 25.","Baumgartner R","J Proteomics","2013","2013/11/29","","","10.1016/j.jprot.2013.10.015"
"11527656","Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects","Chandra RK.","Nutrition. 2001 Sep;17(9):709-12. doi: 10.1016/s0899-9007(01)00610-4.","Chandra RK","Nutrition","2001","2001/08/31","","","10.1016/s0899-9007(01)00610-4"
"34908159","Associations of plasma neurofilament light chain and progranulin with frailty in older adults","Lu WH, Giudici KV, Guyonnet S, Aggarwal G, Nguyen AD, Morley JE, Vellas B, de Souto Barreto P; MAPT/DSA Group.","J Am Geriatr Soc. 2022 Apr;70(4):1236-1243. doi: 10.1111/jgs.17604. Epub 2021 Dec 15.","Lu WH","J Am Geriatr Soc","2022","2021/12/15","","","10.1111/jgs.17604"
"10705161","Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes","Ballard C, McKeith I, O'Brien J, Kalaria R, Jaros E, Ince P, Perry R.","Dement Geriatr Cogn Disord. 2000 Mar-Apr;11(2):59-65. doi: 10.1159/000017215.","Ballard C","Dement Geriatr Cogn Disord","2000","2000/03/08","","","10.1159/000017215"
"25934853","Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial","Butchart J, Brook L, Hopkins V, Teeling J, Püntener U, Culliford D, Sharples R, Sharif S, McFarlane B, Raybould R, Thomas R, Passmore P, Perry VH, Holmes C.","Neurology. 2015 May 26;84(21):2161-8. doi: 10.1212/WNL.0000000000001617. Epub 2015 May 1.","Butchart J","Neurology","2015","2015/05/03","PMC4451045","","10.1212/WNL.0000000000001617"
"11196347","Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics","Alvarez XA, Pichel V, Pérez P, Laredo M, Corzo D, Zas R, Fernández-Novoa L, Sempere JM, Díaz J, Cacabelos R.","Methods Find Exp Clin Pharmacol. 2000 Sep;22(7):585-94.","Alvarez XA","Methods Find Exp Clin Pharmacol","2000","2001/02/24","","",""
"35945508","Promoting independence in Lewy body dementia through exercise: the PRIDE study","Inskip MJ, Mavros Y, Sachdev PS, Hausdorff JM, Hillel I, Singh MAF.","BMC Geriatr. 2022 Aug 9;22(1):650. doi: 10.1186/s12877-022-03347-2.","Inskip MJ","BMC Geriatr","2022","2022/08/09","PMC9361699","","10.1186/s12877-022-03347-2"
"22863599","Dopamine D₂-agonist rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients","Martorana A, Di Lorenzo F, Esposito Z, Lo Giudice T, Bernardi G, Caltagirone C, Koch G.","Neuropharmacology. 2013 Jan;64:108-13. doi: 10.1016/j.neuropharm.2012.07.015. Epub 2012 Aug 1.","Martorana A","Neuropharmacology","2013","2012/08/07","","","10.1016/j.neuropharm.2012.07.015"
"16252374","The effects of the implementation of snoezelen on the quality of working life in psychogeriatric care","van Weert JC, van Dulmen AM, Spreeuwenberg PM, Bensing JM, Ribbe MW.","Int Psychogeriatr. 2005 Sep;17(3):407-27. doi: 10.1017/s1041610205002176.","van Weert JC","Int Psychogeriatr","2005","2005/10/28","","","10.1017/s1041610205002176"
"33588527","Discovery of Atabecestat (JNJ-54861911): A Thiazine-Based β-Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor Advanced to the Phase 2b/3 EARLY Clinical Trial","Koriyama Y, Hori A, Ito H, Yonezawa S, Baba Y, Tanimoto N, Ueno T, Yamamoto S, Yamamoto T, Asada N, Morimoto K, Einaru S, Sakai K, Kanazu T, Matsuda A, Yamaguchi Y, Oguma T, Timmers M, Tritsmans L, Kusakabe KI, Kato A, Sakaguchi G.","J Med Chem. 2021 Feb 25;64(4):1873-1888. doi: 10.1021/acs.jmedchem.0c01917. Epub 2021 Feb 15.","Koriyama Y","J Med Chem","2021","2021/02/16","","","10.1021/acs.jmedchem.0c01917"
"21612646","Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease","Farlow M, Veloso F, Moline M, Yardley J, Brand-Schieber E, Bibbiani F, Zou H, Hsu T, Satlin A.","BMC Neurol. 2011 May 25;11:57. doi: 10.1186/1471-2377-11-57.","Farlow M","BMC Neurol","2011","2011/05/27","PMC3126705","","10.1186/1471-2377-11-57"
"21778673","The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial","Sato Y, Honda Y, Umeno K, Hayashida N, Iwamoto J, Takeda T, Matsumoto H.","Kurume Med J. 2011;57(4):117-24. doi: 10.2739/kurumemedj.57.117.","Sato Y","Kurume Med J","2011","2011/07/23","","","10.2739/kurumemedj.57.117"
"29063518","Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer's Disease","Hey JA, Yu JY, Versavel M, Abushakra S, Kocis P, Power A, Kaplan PL, Amedio J, Tolar M.","Clin Pharmacokinet. 2018 Mar;57(3):315-333. doi: 10.1007/s40262-017-0608-3.","Hey JA","Clin Pharmacokinet","2018","2017/10/25","PMC5814546","","10.1007/s40262-017-0608-3"
"10559563","Plasma homocysteine is a sensitive marker for tissue deficiency of both cobalamines and folates in a psychogeriatric population","Nilsson K, Gustafson L, Hultberg B.","Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):476-82. doi: 10.1159/000017193.","Nilsson K","Dement Geriatr Cogn Disord","1999","1999/11/24","","","10.1159/000017193"
"30136756","Evaluation of Pharmacokinetics and Pharmacodynamics of BI 425809, a Novel GlyT1 Inhibitor: Translational Studies","Rosenbrock H, Desch M, Kleiner O, Dorner-Ciossek C, Schmid B, Keller S, Schlecker C, Moschetti V, Goetz S, Liesenfeld KH, Fillon G, Giovannini R, Ramael S, Wunderlich G, Wind S.","Clin Transl Sci. 2018 Nov;11(6):616-623. doi: 10.1111/cts.12578. Epub 2018 Aug 23.","Rosenbrock H","Clin Transl Sci","2018","2018/08/24","PMC6226115","","10.1111/cts.12578"
"18204357","Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease","Baum L, Lam CW, Cheung SK, Kwok T, Lui V, Tsoh J, Lam L, Leung V, Hui E, Ng C, Woo J, Chiu HF, Goggins WB, Zee BC, Cheng KF, Fong CY, Wong A, Mok H, Chow MS, Ho PC, Ip SP, Ho CS, Yu XW, Lai CY, Chan MH, Szeto S, Chan IH, Mok V.","J Clin Psychopharmacol. 2008 Feb;28(1):110-3. doi: 10.1097/jcp.0b013e318160862c.","Baum L","J Clin Psychopharmacol","2008","2008/01/22","","","10.1097/jcp.0b013e318160862c"
"19175441","A practice-based intervention to improve primary care for falls, urinary incontinence, and dementia","Wenger NS, Roth CP, Shekelle PG, Young RT, Solomon DH, Kamberg CJ, Chang JT, Louie R, Higashi T, MacLean CH, Adams J, Min LC, Ransohoff K, Hoffing M, Reuben DB.","J Am Geriatr Soc. 2009 Mar;57(3):547-55. doi: 10.1111/j.1532-5415.2008.02128.x. Epub 2009 Jan 16.","Wenger NS","J Am Geriatr Soc","2009","2009/01/30","","","10.1111/j.1532-5415.2008.02128.x"
"31961762","Elevated cerebrospinal fluid sodium in hypertensive human subjects with a family history of Alzheimer's disease","Souza LAC, Trebak F, Kumar V, Satou R, Kehoe PG, Yang W, Wharton W, Feng Earley Y.","Physiol Genomics. 2020 Mar 1;52(3):133-142. doi: 10.1152/physiolgenomics.00093.2019. Epub 2020 Jan 21.","Souza LAC","Physiol Genomics","2020","2020/01/22","PMC7099411","","10.1152/physiolgenomics.00093.2019"
"15207416","Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD)","Gareri P, Cotroneo A, Lacava R, Seminara G, Marigliano N, Loiacono A, De Sarro G.","Arch Gerontol Geriatr Suppl. 2004;(9):207-15. doi: 10.1016/j.archger.2004.04.029.","Gareri P","Arch Gerontol Geriatr Suppl","2004","2004/06/23","","","10.1016/j.archger.2004.04.029"
"21071943","Transcultural influences in dementia care: observations from a psychosocial intervention study","Burns A, Mittelman M, Cole C, Morris J, Winter J, Page S, Brodaty H.","Dement Geriatr Cogn Disord. 2010;30(5):417-23. doi: 10.1159/000314860. Epub 2010 Nov 12.","Burns A","Dement Geriatr Cogn Disord","2010","2010/11/13","","","10.1159/000314860"
"14527599","A voxel-based morphometric study of nondemented adults with Down Syndrome","White NS, Alkire MT, Haier RJ.","Neuroimage. 2003 Sep;20(1):393-403. doi: 10.1016/s1053-8119(03)00273-8.","White NS","Neuroimage","2003","2003/10/07","","","10.1016/s1053-8119(03)00273-8"
"10873925","Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone","Jeste DV, Okamoto A, Napolitano J, Kane JM, Martinez RA.","Am J Psychiatry. 2000 Jul;157(7):1150-5. doi: 10.1176/appi.ajp.157.7.1150.","Jeste DV","Am J Psychiatry","2000","2000/06/30","","","10.1176/appi.ajp.157.7.1150"
"32202593","Association of Sleep-Disordered Breathing With Alzheimer Disease Biomarkers in Community-Dwelling Older Adults: A Secondary Analysis of a Randomized Clinical Trial","André C, Rehel S, Kuhn E, Landeau B, Moulinet I, Touron E, Ourry V, Le Du G, Mézenge F, Tomadesso C, de Flores R, Bejanin A, Sherif S, Delcroix N, Manrique A, Abbas A, Marchant NL, Lutz A, Klimecki OM, Collette F, Arenaza-Urquijo EM, Poisnel G, Vivien D, Bertran F, de la Sayette V, Chételat G, Rauchs G; Medit-Ageing Research Group.","JAMA Neurol. 2020 Jun 1;77(6):716-724. doi: 10.1001/jamaneurol.2020.0311.","André C","JAMA Neurol","2020","2020/03/24","PMC7091393","","10.1001/jamaneurol.2020.0311"
"23471985","Genome-wide scan of healthy human connectome discovers SPON1 gene variant influencing dementia severity","Jahanshad N, Rajagopalan P, Hua X, Hibar DP, Nir TM, Toga AW, Jack CR Jr, Saykin AJ, Green RC, Weiner MW, Medland SE, Montgomery GW, Hansell NK, McMahon KL, de Zubicaray GI, Martin NG, Wright MJ, Thompson PM; Alzheimer’s Disease Neuroimaging Initiative.","Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4768-73. doi: 10.1073/pnas.1216206110. Epub 2013 Mar 5.","Jahanshad N","Proc Natl Acad Sci U S A","2013","2013/03/09","PMC3606977","","10.1073/pnas.1216206110"
"16866673","Pain in severe dementia: self-assessment or observational scales?","Pautex S, Michon A, Guedira M, Emond H, Le Lous P, Samaras D, Michel JP, Herrmann F, Giannakopoulos P, Gold G.","J Am Geriatr Soc. 2006 Jul;54(7):1040-5. doi: 10.1111/j.1532-5415.2006.00766.x.","Pautex S","J Am Geriatr Soc","2006","2006/07/27","","","10.1111/j.1532-5415.2006.00766.x"
"12837672","Valproate therapy for agitation in dementia: open-label extension of a double-blind trial","Porsteinsson AP, Tariot PN, Jakimovich LJ, Kowalski N, Holt C, Erb R, Cox C.","Am J Geriatr Psychiatry. 2003 Jul-Aug;11(4):434-40.","Porsteinsson AP","Am J Geriatr Psychiatry","2003","2003/07/03","","",""
"34164794","Safety and Pharmacokinetics of HTL0018318, a Novel M(1) Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects","Bakker C, van der Aart J, Labots G, Liptrot J, Cross DM, Klaassen ES, Dickinson S, Tasker T, Groeneveld GJ.","Drugs R D. 2021 Sep;21(3):295-304. doi: 10.1007/s40268-021-00352-5. Epub 2021 Jun 23.","Bakker C","Drugs R D","2021","2021/06/24","PMC8363684","","10.1007/s40268-021-00352-5"
"36130946","Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration","Jiang Y, Alam JJ, Gomperts SN, Maruff P, Lemstra AW, Germann UA, Stavrides PH, Darji S, Malampati S, Peddy J, Bleiwas C, Pawlik M, Pensalfini A, Yang DS, Subbanna S, Basavarajappa BS, Smiley JF, Gardner A, Blackburn K, Chu HM, Prins ND, Teunissen CE, Harrison JE, Scheltens P, Nixon RA.","Nat Commun. 2022 Sep 21;13(1):5308. doi: 10.1038/s41467-022-32944-3.","Jiang Y","Nat Commun","2022","2022/09/21","PMC9492778","","10.1038/s41467-022-32944-3"
"16750451","Post hoc comparison of daily rates of nausea and vomiting with once- and twice-daily galantamine from a double-blind, placebo-controlled, parallel-group, 6-month study","Dunbar F, Zhu Y, Brashear HR.","Clin Ther. 2006 Mar;28(3):365-72. doi: 10.1016/j.clinthera.2006.03.002.","Dunbar F","Clin Ther","2006","2006/06/06","","","10.1016/j.clinthera.2006.03.002"
"18316457","Participation in dementia research: rates and correlates of capacity to give informed consent","Warner J, McCarney R, Griffin M, Hill K, Fisher P.","J Med Ethics. 2008 Mar;34(3):167-70. doi: 10.1136/jme.2006.019786.","Warner J","J Med Ethics","2008","2008/03/05","","","10.1136/jme.2006.019786"
"32960456","Introduction of a Management Toolkit for Lewy Body Dementia: A Pilot Cluster-Randomized Trial","O'Brien JT, McKeith IG, Thomas AJ, Bamford C, Vale L, Hill S, Allan L, Finch T, McNally R, Hayes L, Surendranathan A, Kane JPM, Dunn S, Bentley A, Barker S, Mason J, Burn D, Taylor JP.","Mov Disord. 2021 Jan;36(1):143-151. doi: 10.1002/mds.28282. Epub 2020 Sep 22.","O'Brien JT","Mov Disord","2021","2020/09/22","","","10.1002/mds.28282"
"35606646","Healthcare Costs Associated with Potentially Inappropriate Medication Prescribing Detected by Computer Algorithm Among Older Patients","Pagès A, Costa N, Mounié M, Cestac P, De Souto Barreto P, Rolland Y, Vellas B, Molinier L, Juillard-Condat B; MAPT/DSA Group.","Drugs Aging. 2022 May;39(5):367-375. doi: 10.1007/s40266-022-00938-x. Epub 2022 May 24.","Pagès A","Drugs Aging","2022","2022/05/23","","","10.1007/s40266-022-00938-x"
"23461355","Exploring the effectiveness of an internet-based program for reducing caregiver distress using the iCare Stress Management e-Training Program","Kajiyama B, Thompson LW, Eto-Iwase T, Yamashita M, Di Mario J, Marian Tzuang Y, Gallagher-Thompson D.","Aging Ment Health. 2013;17(5):544-54. doi: 10.1080/13607863.2013.775641. Epub 2013 Mar 6.","Kajiyama B","Aging Ment Health","2013","2013/03/07","PMC3695021","NIHMS452701","10.1080/13607863.2013.775641"
"12682308","DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study","Wolkowitz OM, Kramer JH, Reus VI, Costa MM, Yaffe K, Walton P, Raskind M, Peskind E, Newhouse P, Sack D, De Souza E, Sadowsky C, Roberts E; DHEA-Alzheimer's Disease Collaborative Research.","Neurology. 2003 Apr 8;60(7):1071-6. doi: 10.1212/01.wnl.0000052994.54660.58.","Wolkowitz OM","Neurology","2003","2003/04/12","","","10.1212/01.wnl.0000052994.54660.58"
"26225140","An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter","Lucey BP, Gonzales C, Das U, Li J, Siemers ER, Slemmon JR, Bateman RJ, Huang Y, Fox GB, Claassen JA, Slats D, Verbeek MM, Tong G, Soares H, Savage MJ, Kennedy M, Forman M, Sjögren M, Margolin R, Chen X, Farlow MR, Dean RA, Waring JF.","Alzheimers Res Ther. 2015 Jul 29;7(1):53. doi: 10.1186/s13195-015-0136-z. eCollection 2015.","Lucey BP","Alzheimers Res Ther","2015","2015/07/31","PMC4518529","","10.1186/s13195-015-0136-z"
"36359767","Empagliflozin Induced Ketosis, Upregulated IGF-1/Insulin Receptors and the Canonical Insulin Signaling Pathway in Neurons, and Decreased the Excitatory Neurotransmitter Glutamate in the Brain of Non-Diabetics","Avgerinos KI, Mullins RJ, Vreones M, Mustapic M, Chen Q, Melvin D, Kapogiannis D, Egan JM.","Cells. 2022 Oct 25;11(21):3372. doi: 10.3390/cells11213372.","Avgerinos KI","Cells","2022","2022/11/11","PMC9657243","","10.3390/cells11213372"
"23164551","Prevalence of mild cognitive impairment subtypes in patients attending a memory outpatient clinic--comparison of two modes of mild cognitive impairment classification. Results of the Vienna Conversion to Dementia Study","Pusswald G, Moser D, Gleiss A, Janzek-Hawlat S, Auff E, Dal-Bianco P, Lehrner J.","Alzheimers Dement. 2013 Jul;9(4):366-76. doi: 10.1016/j.jalz.2011.12.009. Epub 2012 Nov 16.","Pusswald G","Alzheimers Dement","2013","2012/11/21","","","10.1016/j.jalz.2011.12.009"
"10881251","A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group","Tariot PN, Solomon PR, Morris JC, Kershaw P, Lilienfeld S, Ding C.","Neurology. 2000 Jun 27;54(12):2269-76. doi: 10.1212/wnl.54.12.2269.","Tariot PN","Neurology","2000","2000/07/06","","","10.1212/wnl.54.12.2269"
"24041307","Effect of the Tottori familial disease mutation (D7N) on the monomers and dimers of Aβ40 and Aβ42","Viet MH, Nguyen PH, Ngo ST, Li MS, Derreumaux P.","ACS Chem Neurosci. 2013 Nov 20;4(11):1446-57. doi: 10.1021/cn400110d. Epub 2013 Sep 16.","Viet MH","ACS Chem Neurosci","2013","2013/09/18","PMC3837376","","10.1021/cn400110d"
"20102786","The interactive effect of acute ovarian suppression and the cholinergic system on visuospatial working memory in young women","Craig MC, Brammer M, Maki PM, Fletcher PC, Daly EM, Rymer J, Giampietro V, Picchioni M, Stahl D, Murphy DG.","Psychoneuroendocrinology. 2010 Aug;35(7):987-1000. doi: 10.1016/j.psyneuen.2009.12.012. Epub 2010 Jan 25.","Craig MC","Psychoneuroendocrinology","2010","2010/01/28","","","10.1016/j.psyneuen.2009.12.012"
"10700598","Low plasma epinephrine in elderly female subjects of dementia of Alzheimer type","Umegaki H, Ikari H, Nakahata H, Yoshimura J, Endo H, Yamamoto T, Iguchi A.","Brain Res. 2000 Mar 6;858(1):67-70. doi: 10.1016/s0006-8993(99)02440-3.","Umegaki H","Brain Res","2000","2000/03/04","","","10.1016/s0006-8993(99)02440-3"
"11739067","A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients","Mulsant BH, Pollock BG, Nebes R, Miller MD, Sweet RA, Stack J, Houck PR, Bensasi S, Mazumdar S, Reynolds CF 3rd.","Am J Geriatr Psychiatry. 2001 Fall;9(4):406-14.","Mulsant BH","Am J Geriatr Psychiatry","2001","2001/12/12","","",""
"9844034","Dehydroepiandrosterone sulfate decreases the interleukin-2-mediated overactivity of the natural killer cell compartment in senile dementia of the Alzheimer type","Solerte SB, Fioravanti M, Schifino N, Cuzzoni G, Fontana I, Vignati G, Govoni S, Ferrari E.","Dement Geriatr Cogn Disord. 1999 Jan-Feb;10(1):21-7. doi: 10.1159/000017093.","Solerte SB","Dement Geriatr Cogn Disord","1999","1998/12/09","","","10.1159/000017093"
"16954689","Effects of cholinergic drugs and cognitive training on dementia: 2-year follow-up","Requena C, Maestú F, Campo P, Fernández A, Ortiz T.","Dement Geriatr Cogn Disord. 2006;22(4):339-45. doi: 10.1159/000095600. Epub 2006 Sep 4.","Requena C","Dement Geriatr Cogn Disord","2006","2006/09/07","","","10.1159/000095600"
"16861368","The moderating effect of self-efficacy on intervention response in women family caregivers of older adults with dementia","Rabinowitz YG, Mausbach BT, Coon DW, Depp C, Thompson LW, Gallagher-Thompson D.","Am J Geriatr Psychiatry. 2006 Aug;14(8):642-9. doi: 10.1097/01.JGP.0000192496.73673.e5.","Rabinowitz YG","Am J Geriatr Psychiatry","2006","2006/07/25","","","10.1097/01.JGP.0000192496.73673.e5"
"35006106","Brain FDG PET for Short- to Medium-Term Prediction of Further Cognitive Decline and Need for Assisted Living in Acutely Hospitalized Geriatric Patients With Newly Detected Clinically Uncertain Cognitive Impairment","Lange C, Mäurer A, Suppa P, Apostolova I, Steffen IG, Grothe MJ, Buchert R.","Clin Nucl Med. 2022 Feb 1;47(2):123-129. doi: 10.1097/RLU.0000000000003981.","Lange C","Clin Nucl Med","2022","2022/01/10","","","10.1097/RLU.0000000000003981"
"34093436","Effects of Aerobic Exercise Training on Systemic Biomarkers and Cognition in Late Middle-Aged Adults at Risk for Alzheimer's Disease","Gaitán JM, Moon HY, Stremlau M, Dubal DB, Cook DB, Okonkwo OC, van Praag H.","Front Endocrinol (Lausanne). 2021 May 20;12:660181. doi: 10.3389/fendo.2021.660181. eCollection 2021.","Gaitán JM","Front Endocrinol (Lausanne)","2021","2021/06/07","PMC8173166","","10.3389/fendo.2021.660181"
"20174466","Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT","Montine TJ, Sonnen JA, Milne G, Baker LD, Breitner JC.","PLoS One. 2010 Feb 19;5(2):e9340. doi: 10.1371/journal.pone.0009340.","Montine TJ","PLoS One","2010","2010/02/23","PMC2824826","","10.1371/journal.pone.0009340"
"25790673","[Nourishing Xin and Shen method improved mild cognitive impairment due to subcortical small vessel disease: a clinical study]","","Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015 Jan;35(1):41-5.","","Zhongguo Zhong Xi Yi Jie He Za Zhi","2015","2015/03/21","","",""
"32867552","Early-start vs delayed-start donepezil against cognitive decline in Parkinson disease: a randomized clinical trial","Sawada H, Oeda T, Kohsaka M, Tomita S, Umemura A, Park K, Yamamoto K, Kiyohara K.","Expert Opin Pharmacother. 2021 Feb;22(3):363-371. doi: 10.1080/14656566.2020.1814255. Epub 2020 Aug 31.","Sawada H","Expert Opin Pharmacother","2021","2020/09/02","","","10.1080/14656566.2020.1814255"
"29953782","Application of combined intraperitoneal and intravenous neoadjuvant chemotherapy in senile patients with advanced ovarian cancer and massive ascites","Liu EL, Mi RR, Wang DH, Wang LQ, Zhang YM, Chen WM.","Eur J Gynaecol Oncol. 2017;38(2):209-213.","Liu EL","Eur J Gynaecol Oncol","2017","2018/06/29","","",""
"18541548","Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study","Vedin I, Cederholm T, Freund Levi Y, Basun H, Garlind A, Faxén Irving G, Jönhagen ME, Vessby B, Wahlund LO, Palmblad J.","Am J Clin Nutr. 2008 Jun;87(6):1616-22. doi: 10.1093/ajcn/87.6.1616.","Vedin I","Am J Clin Nutr","2008","2008/06/11","","","10.1093/ajcn/87.6.1616"
"21220718","Effectiveness of a modified Continuum curriculum for medical students: a randomized trial","Isaacson RS, Safdieh JE, Ochner CN.","Neurology. 2011 Jan 11;76(2):125-30. doi: 10.1212/WNL.0b013e318205d4fa.","Isaacson RS","Neurology","2011","2011/01/12","PMC3271388","","10.1212/WNL.0b013e318205d4fa"
"24180295","Improving psychotropic drug prescription in nursing home patients with dementia: design of a cluster randomized controlled trial","Smeets CH, Smalbrugge M, Gerritsen DL, Nelissen-Vrancken MH, Wetzels RB, van der Spek K, Zuidema SU, Koopmans RT.","BMC Psychiatry. 2013 Nov 1;13:280. doi: 10.1186/1471-244X-13-280.","Smeets CH","BMC Psychiatry","2013","2013/11/05","PMC3840636","","10.1186/1471-244X-13-280"
"18637980","A prospective study of the effect of hypertension and baseline blood pressure on cognitive decline and dementia in postmenopausal women: the Women's Health Initiative Memory Study","Johnson KC, Margolis KL, Espeland MA, Colenda CC, Fillit H, Manson JE, Masaki KH, Mouton CP, Prineas R, Robinson JG, Wassertheil-Smoller S; Women's Health Initiative Memory Study and Women's Health Initiative Investigators.","J Am Geriatr Soc. 2008 Aug;56(8):1449-58. doi: 10.1111/j.1532-5415.2008.01806.x. Epub 2008 Jul 15.","Johnson KC","J Am Geriatr Soc","2008","2008/07/22","","","10.1111/j.1532-5415.2008.01806.x"
"22659994","A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI","Peters O, Lorenz D, Fesche A, Schmidtke K, Hüll M, Perneczky R, Rüther E, Möller HJ, Jessen F, Maier W, Kornhuber J, Jahn H, Luckhaus C, Gertz HJ, Schröder J, Pantel J, Teipel S, Wellek S, Frölich L, Heuser I.","J Nutr Health Aging. 2012;16(6):544-8. doi: 10.1007/s12603-012-0062-8.","Peters O","J Nutr Health Aging","2012","2012/06/05","","","10.1007/s12603-012-0062-8"
"32054507","Tianzhi granule improves cognition and BPSD of vascular dementia: a randomized controlled trial","Shi J, Wei M, Ni J, Sun F, Sun L, Wang J, Yu T, Wang K, Lv P, Wang Y, Zhang Y, Gao X, Gao X, Luo B, Mao S, Zhang B, Ren X, Yu F, Hu W, Yin P, Wu N, Liu X, Bi Q, Wang Y, Tian J; CHASE Study Group.","J Transl Med. 2020 Feb 13;18(1):76. doi: 10.1186/s12967-020-02232-z.","Shi J","J Transl Med","2020","2020/02/15","PMC7017567","","10.1186/s12967-020-02232-z"
"1350734","The development of polyanhydrides for drug delivery applications","Tamada J, Langer R.","J Biomater Sci Polym Ed. 1992;3(4):315-53. doi: 10.1163/156856292x00402.","Tamada J","J Biomater Sci Polym Ed","1992","1992/01/01","","","10.1163/156856292x00402"
"30872114","A randomized clinical trial to evaluate home-based assessment of people over 75 years old","Sano M, Zhu CW, Kaye J, Mundt JC, Hayes TL, Ferris S, Thomas RG, Sun CK, Jiang Y, Donohue MC, Schneider LS, Egelko S, Aisen PS, Feldman HH; Alzheimer Disease Cooperative Study Investigators.","Alzheimers Dement. 2019 May;15(5):615-624. doi: 10.1016/j.jalz.2019.01.007. Epub 2019 Mar 11.","Sano M","Alzheimers Dement","2019","2019/03/16","","","10.1016/j.jalz.2019.01.007"
"35765711","Striatal Blood-Brain Barrier Opening in Parkinson's Disease Dementia: A Pilot Exploratory Study","Pineda-Pardo JA, Gasca-Salas C, Fernández-Rodríguez B, Rodríguez-Rojas R, Del Álamo M, Obeso I, Hernández-Fernández F, Trompeta C, Martínez-Fernández R, Matarazzo M, Mata-Marín D, Guida P, Duque A, Albillo D, Plaza de Las Heras I, Montero JI, Foffani G, Toltsis G, Rachmilevitch I, Blesa J, Obeso JA.","Mov Disord. 2022 Oct;37(10):2057-2065. doi: 10.1002/mds.29134. Epub 2022 Jun 28.","Pineda-Pardo JA","Mov Disord","2022","2022/06/29","","","10.1002/mds.29134"
"26402075","A Nutritional Formulation for Cognitive Performance in Mild Cognitive Impairment: A Placebo-Controlled Trial with an Open-Label Extension","Remington R, Lortie JJ, Hoffmann H, Page R, Morrell C, Shea TB.","J Alzheimers Dis. 2015;48(3):591-5. doi: 10.3233/JAD-150057.","Remington R","J Alzheimers Dis","2015","2015/09/25","","","10.3233/JAD-150057"
"24821476","Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities","Tosto G, Zimmerman ME, Carmichael OT, Brickman AM; Alzheimer’s Disease Neuroimaging Initiative.","JAMA Neurol. 2014 Jul 1;71(7):872-7. doi: 10.1001/jamaneurol.2014.667.","Tosto G","JAMA Neurol","2014","2014/05/14","PMC4107926","NIHMS614460","10.1001/jamaneurol.2014.667"
"27060951","Mindfulness Training for Older Adults with Subjective Cognitive Decline: Results from a Pilot Randomized Controlled Trial","Smart CM, Segalowitz SJ, Mulligan BP, Koudys J, Gawryluk JR.","J Alzheimers Dis. 2016 Apr 5;52(2):757-74. doi: 10.3233/JAD-150992.","Smart CM","J Alzheimers Dis","2016","2016/04/11","","","10.3233/JAD-150992"
"34602470","Diet Effects on Cerebrospinal Fluid Amino Acids Levels in Adults with Normal Cognition and Mild Cognitive Impairment","Russin KJ, Nair KS, Montine TJ, Baker LD, Craft S.","J Alzheimers Dis. 2021;84(2):843-853. doi: 10.3233/JAD-210471.","Russin KJ","J Alzheimers Dis","2021","2021/10/04","PMC8673538","","10.3233/JAD-210471"
"22751086","Rivastigmine treatment for the prevention of electroconvulsive therapy-induced memory deficits in patients with schizophrenia","Stryjer R, Ophir D, Bar F, Spivak B, Weizman A, Strous RD.","Clin Neuropharmacol. 2012 Jul-Aug;35(4):161-4. doi: 10.1097/WNF.0b013e31825e7945.","Stryjer R","Clin Neuropharmacol","2012","2012/07/04","","","10.1097/WNF.0b013e31825e7945"
"30741684","Pharmacokinetics and Pharmacodynamics of LY2599666, a PEG-Linked Antigen Binding Fragment that Targets Soluble Monomer Amyloid-β","Li L, Zhen EY, Decker RL, Willis BA, Waters D, Liu P, Hake AM, Demattos RB, Ayan-Oshodi M.","J Alzheimers Dis. 2019;68(1):137-144. doi: 10.3233/JAD-180925.","Li L","J Alzheimers Dis","2019","2019/02/12","","","10.3233/JAD-180925"
"34366337","Pilot Evaluation of the Unsupervised, At-Home Cogstate Brief Battery in ADNI-2","Edgar CJ, Siemers E, Maruff P, Petersen RC, Aisen PS, Weiner MW, Albala B; Alzheimer’s Disease Neuroimaging Initiative.","J Alzheimers Dis. 2021;83(2):915-925. doi: 10.3233/JAD-210201.","Edgar CJ","J Alzheimers Dis","2021","2021/08/09","PMC8543269","","10.3233/JAD-210201"
"27031473","Vitamin D Supplementation Appears to Increase Plasma Aβ40 in Vitamin D Insufficient Older Adults: A Pilot Randomized Controlled Trial","Miller BJ, Whisner CM, Johnston CS.","J Alzheimers Dis. 2016 Mar 31;52(3):843-7. doi: 10.3233/JAD-150901.","Miller BJ","J Alzheimers Dis","2016","2016/04/01","","","10.3233/JAD-150901"
"29181488","Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other Tauopathies","West T, Hu Y, Verghese PB, Bateman RJ, Braunstein JB, Fogelman I, Budur K, Florian H, Mendonca N, Holtzman DM.","J Prev Alzheimers Dis. 2017;4(4):236-241. doi: 10.14283/jpad.2017.36.","West T","J Prev Alzheimers Dis","2017","2017/11/29","","","10.14283/jpad.2017.36"
"27911325","Autonomic Nervous System Dysfunctions as a Basis for a Predictive Model of Risk of Neurological Disorders in Subjects with Prior History of Traumatic Brain Injury: Implications in Alzheimer's Disease","Ho L, Legere M, Li T, Levine S, Hao K, Valcarcel B, Pasinetti GM.","J Alzheimers Dis. 2017;56(1):305-315. doi: 10.3233/JAD-160948.","Ho L","J Alzheimers Dis","2017","2016/12/03","PMC8162894","NIHMS1698545","10.3233/JAD-160948"
"26012577","Electroacupuncture for older adults with mild cognitive impairment: study protocol for a randomized controlled trial","Leung AW, Lam LC, Kwan AK, Tsang CL, Zhang HW, Guo YQ, Xu CS.","Trials. 2015 May 27;16:232. doi: 10.1186/s13063-015-0740-z.","Leung AW","Trials","2015","2015/05/28","PMC4451728","","10.1186/s13063-015-0740-z"
"32580164","REducing SEDENTary Behavior Among Mild to Moderate Cognitively Impaired Assisted Living Residents: A Pilot Randomized Controlled Trial (RESEDENT Study)","Dillon K, Prapavessis H.","J Aging Phys Act. 2021 Feb 1;29(1):27-35. doi: 10.1123/japa.2019-0440. Epub 2020 Jun 23.","Dillon K","J Aging Phys Act","2021","2020/06/25","","","10.1123/japa.2019-0440"
"15956166","Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment","Fleisher A, Grundman M, Jack CR Jr, Petersen RC, Taylor C, Kim HT, Schiller DH, Bagwell V, Sencakova D, Weiner MF, DeCarli C, DeKosky ST, van Dyck CH, Thal LJ; Alzheimer's Disease Cooperative Study.","Arch Neurol. 2005 Jun;62(6):953-7. doi: 10.1001/archneur.62.6.953.","Fleisher A","Arch Neurol","2005","2005/06/16","","","10.1001/archneur.62.6.953"
"32057125","Sleep Deprivation Affects Tau Phosphorylation in Human Cerebrospinal Fluid","Barthélemy NR, Liu H, Lu W, Kotzbauer PT, Bateman RJ, Lucey BP.","Ann Neurol. 2020 May;87(5):700-709. doi: 10.1002/ana.25702. Epub 2020 Feb 27.","Barthélemy NR","Ann Neurol","2020","2020/02/15","PMC7289061","NIHMS1566002","10.1002/ana.25702"
"18317243","A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI study","Gómez-Isla T, Blesa R, Boada M, Clarimón J, Del Ser T, Domenech G, Ferro JM, Gómez-Ansón B, Manubens JM, Martínez-Lage JM, Muñoz D, Peña-Casanova J, Torres F; TRIMCI Study Group.","Alzheimer Dis Assoc Disord. 2008 Jan-Mar;22(1):21-9. doi: 10.1097/WAD.0b013e3181611024.","Gómez-Isla T","Alzheimer Dis Assoc Disord","2008","2008/03/05","","","10.1097/WAD.0b013e3181611024"
"34864678","The Effect of Olfactory Training on Olfaction, Cognition, and Brain Function in Patients with Mild Cognitive Impairment","Chen B, Espin M, Haussmann R, Matthes C, Donix M, Hummel T, Haehner A.","J Alzheimers Dis. 2022;85(2):745-754. doi: 10.3233/JAD-215257.","Chen B","J Alzheimers Dis","2022","2021/12/05","","","10.3233/JAD-215257"
"33103819","A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT","Fortier M, Castellano CA, St-Pierre V, Myette-Côté É, Langlois F, Roy M, Morin MC, Bocti C, Fulop T, Godin JP, Delannoy C, Cuenoud B, Cunnane SC.","Alzheimers Dement. 2021 Mar;17(3):543-552. doi: 10.1002/alz.12206. Epub 2020 Oct 26.","Fortier M","Alzheimers Dement","2021","2020/10/26","PMC8048678","","10.1002/alz.12206"
"23864720","Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG PET","Shokouhi S, Claassen D, Kang H, Ding Z, Rogers B, Mishra A, Riddle WR; Alzheimer’s Disease Neuroimaging Initiative.","J Nucl Med. 2013 Sep;54(9):1564-9. doi: 10.2967/jnumed.112.116137. Epub 2013 Jul 17.","Shokouhi S","J Nucl Med","2013","2013/07/19","PMC4134885","NIHMS614134","10.2967/jnumed.112.116137"
"19700669","The northwestern anagram test: measuring sentence production in primary progressive aphasia","Weintraub S, Mesulam MM, Wieneke C, Rademaker A, Rogalski EJ, Thompson CK.","Am J Alzheimers Dis Other Demen. 2009 Oct-Nov;24(5):408-16. doi: 10.1177/1533317509343104. Epub 2009 Aug 21.","Weintraub S","Am J Alzheimers Dis Other Demen","2009","2009/08/25","PMC2836907","NIHMS128224","10.1177/1533317509343104"
"33843675","Effects of Morning Blue-Green 500 nm Light Therapy on Cognition and Biomarkers in Middle-Aged and Older Adults with Subjective Cognitive Decline and Mild Cognitive Impairment: Study Protocol for a Randomized Controlled Trial","Wang Z, Zhang Y, Dong L, Zheng Z, Zhong D, Long X, Cai Q, Jian W, Zhang S, Wu W, Yao D.","J Alzheimers Dis. 2021;83(4):1521-1536. doi: 10.3233/JAD-201560.","Wang Z","J Alzheimers Dis","2021","2021/04/12","","","10.3233/JAD-201560"
"35012439","Effectiveness of a year-long individual cognitive stimulation program in Portuguese older adults with cognitive impairment","Justo-Henriques SI, Pérez-Sáez E, Marques-Castro AE, Carvalho JO.","Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2023 May;30(3):321-335. doi: 10.1080/13825585.2021.2023458. Epub 2022 Jan 11.","Justo-Henriques SI","Neuropsychol Dev Cogn B Aging Neuropsychol Cogn","2023","2022/01/11","","","10.1080/13825585.2021.2023458"
"35404286","A Bayesian Reanalysis of the Phase III Aducanumab (ADU) Trial","Costa T, Cauda F.","J Alzheimers Dis. 2022;87(3):1009-1012. doi: 10.3233/JAD-220132.","Costa T","J Alzheimers Dis","2022","2022/04/11","","","10.3233/JAD-220132"
"34297895","Recruitment of a multi-site randomized controlled trial of aerobic exercise for older adults with amnestic mild cognitive impairment: The EXERT trial","Shadyab AH, LaCroix AZ, Feldman HH, van Dyck CH, Okonkwo OC, Tam SP, Fairchild JK, Welsh-Bohmer KA, Matthews G, Bennett D, Shadyab AA, Schafer KA, Morrison RH, Kipperman SA, Mason J, Tan D, Thomas RG, Cotman CW, Baker LD; ADCS EXERT Study Group.","Alzheimers Dement. 2021 Nov;17(11):1808-1817. doi: 10.1002/alz.12401. Epub 2021 Jul 23.","Shadyab AH","Alzheimers Dement","2021","2021/07/23","PMC9292825","","10.1002/alz.12401"
"16816014","Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders","Cummings JL, McRae T, Zhang R; Donepezil-Sertraline Study Group.","Am J Geriatr Psychiatry. 2006 Jul;14(7):605-12. doi: 10.1097/01.JGP.0000221293.91312.d3.","Cummings JL","Am J Geriatr Psychiatry","2006","2006/07/04","","","10.1097/01.JGP.0000221293.91312.d3"
"23332672","The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress","Kivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J, Antikainen R, Bäckman L, Hänninen T, Jula A, Laatikainen T, Lindström J, Mangialasche F, Nissinen A, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H.","Alzheimers Dement. 2013 Nov;9(6):657-65. doi: 10.1016/j.jalz.2012.09.012. Epub 2013 Jan 17.","Kivipelto M","Alzheimers Dement","2013","2013/01/22","","","10.1016/j.jalz.2012.09.012"
"17267378","Efficacy and tolerability of quetiapine in the treatment of behavioral and psychological symptoms of dementia","Onor ML, Saina M, Aguglia E.","Am J Alzheimers Dis Other Demen. 2006 Dec-2007 Jan;21(6):448-53. doi: 10.1177/1533317506294775.","Onor ML","Am J Alzheimers Dis Other Demen","2006","2007/02/03","","","10.1177/1533317506294775"
"28106552","Meditation and Music Improve Memory and Cognitive Function in Adults with Subjective Cognitive Decline: A Pilot Randomized Controlled Trial","Innes KE, Selfe TK, Khalsa DS, Kandati S.","J Alzheimers Dis. 2017;56(3):899-916. doi: 10.3233/JAD-160867.","Innes KE","J Alzheimers Dis","2017","2017/01/21","PMC7967907","NIHMS1678793","10.3233/JAD-160867"
"30149444","Psychological and Mnemonic Benefits of Nostalgia for People with Dementia","Ismail S, Christopher G, Dodd E, Wildschut T, Sedikides C, Ingram TA, Jones RW, Noonan KA, Tingley D, Cheston R.","J Alzheimers Dis. 2018;65(4):1327-1344. doi: 10.3233/JAD-180075.","Ismail S","J Alzheimers Dis","2018","2018/08/29","","","10.3233/JAD-180075"
"28106562","Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study","Peters KE, Davis WA, Taddei K, Martins RN, Masters CL, Davis TM, Bruce DG.","J Alzheimers Dis. 2017;56(3):1127-1133. doi: 10.3233/JAD-161050.","Peters KE","J Alzheimers Dis","2017","2017/01/21","","","10.3233/JAD-161050"
"26311735","Managing Loss and Change: Grief Interventions for Dementia Caregivers in a CBT-Based Trial","Meichsner F, Schinköthe D, Wilz G.","Am J Alzheimers Dis Other Demen. 2016 May;31(3):231-40. doi: 10.1177/1533317515602085. Epub 2015 Aug 26.","Meichsner F","Am J Alzheimers Dis Other Demen","2016","2015/08/28","","","10.1177/1533317515602085"
"33403822","Quantifying dementia prevention potential in the FINGER randomized controlled trial using the LIBRA prevention index","Deckers K, Köhler S, Ngandu T, Antikainen R, Laatikainen T, Soininen H, Strandberg T, Verhey F, Kivipelto M, Solomon A.","Alzheimers Dement. 2021 Jul;17(7):1205-1212. doi: 10.1002/alz.12281. Epub 2021 Jan 6.","Deckers K","Alzheimers Dement","2021","2021/01/06","PMC8359273","","10.1002/alz.12281"
"29399825","Testing Tele-Savvy: Protocol for a randomized controlled trial","Kovaleva MA, Bilsborough E, Griffiths PC, Nocera J, Higgins M, Epps F, Kilgore K, Lindauer A, Morhardt D, Shah RC, Hepburn K.","Res Nurs Health. 2018 Apr;41(2):107-120. doi: 10.1002/nur.21859. Epub 2018 Feb 5.","Kovaleva MA","Res Nurs Health","2018","2018/02/06","PMC5945279","NIHMS958318","10.1002/nur.21859"
"30569089","Bifidobacterium Breve A1 Supplementation Improved Cognitive Decline in Older Adults with Mild Cognitive Impairment: An Open-Label, Single-Arm Study","Kobayashi Y, Kinoshita T, Matsumoto A, Yoshino K, Saito I, Xiao JZ.","J Prev Alzheimers Dis. 2019;6(1):70-75. doi: 10.14283/jpad.2018.32.","Kobayashi Y","J Prev Alzheimers Dis","2019","2018/12/21","","","10.14283/jpad.2018.32"
"28984580","Memory Complaints and Cognitive Decline: Data from the GUIDAGE Study1","Dardenne S, Delrieu J, Sourdet S, Cantet C, Andrieu S, Mathiex-Fortunet H, Fougère B, Vellas B.","J Alzheimers Dis. 2017;60(4):1567-1578. doi: 10.3233/JAD-170229.","Dardenne S","J Alzheimers Dis","2017","2017/10/07","","","10.3233/JAD-170229"
"28222531","Physical Exercise with Music Maintains Activities of Daily Living in Patients with Dementia: Mihama-Kiho Project Part 21","Satoh M, Ogawa JI, Tokita T, Nakaguchi N, Nakao K, Kida H, Tomimoto H.","J Alzheimers Dis. 2017;57(1):85-96. doi: 10.3233/JAD-161217.","Satoh M","J Alzheimers Dis","2017","2017/02/23","","","10.3233/JAD-161217"
"17827418","Circulating interleukin-15 in dementia disorders","Rentzos M, Paraskevas GP, Kapaki E, Nikolaou C, Zoga M, Tsoutsou A, Rombos A, Vassilopoulos D.","J Neuropsychiatry Clin Neurosci. 2007 Summer;19(3):318-25. doi: 10.1176/jnp.2007.19.3.318.","Rentzos M","J Neuropsychiatry Clin Neurosci","2007","2007/09/11","","","10.1176/jnp.2007.19.3.318"
"33044178","A Randomized Clinical Trial of Greek High Phenolic Early Harvest Extra Virgin Olive Oil in Mild Cognitive Impairment: The MICOIL Pilot Study","Tsolaki M, Lazarou E, Kozori M, Petridou N, Tabakis I, Lazarou I, Karakota M, Saoulidis I, Melliou E, Magiatis P.","J Alzheimers Dis. 2020;78(2):801-817. doi: 10.3233/JAD-200405.","Tsolaki M","J Alzheimers Dis","2020","2020/10/12","","","10.3233/JAD-200405"
"32651327","Using a Timed Motor Task to Predict One-Year Functional Decline in Amnestic Mild Cognitive Impairment","Schaefer SY, Hooyman A, Duff K.","J Alzheimers Dis. 2020;77(1):53-58. doi: 10.3233/JAD-200518.","Schaefer SY","J Alzheimers Dis","2020","2020/07/12","PMC7484390","NIHMS1618467","10.3233/JAD-200518"
"12379846","Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease","Hock C, Konietzko U, Papassotiropoulos A, Wollmer A, Streffer J, von Rotz RC, Davey G, Moritz E, Nitsch RM.","Nat Med. 2002 Nov;8(11):1270-5. doi: 10.1038/nm783. Epub 2002 Oct 15.","Hock C","Nat Med","2002","2002/10/16","","","10.1038/nm783"
"14569646","Measuring and enhancing self-efficacy among professional caregivers of individuals with dementia","Mackenzie CS, Peragine G.","Am J Alzheimers Dis Other Demen. 2003 Sep-Oct;18(5):291-9. doi: 10.1177/153331750301800507.","Mackenzie CS","Am J Alzheimers Dis Other Demen","2003","2003/10/23","","","10.1177/153331750301800507"
"28093088","Diagnostic impact of [(18)F]flutemetamol PET in early-onset dementia","Zwan MD, Bouwman FH, Konijnenberg E, van der Flier WM, Lammertsma AA, Verhey FR, Aalten P, van Berckel BN, Scheltens P.","Alzheimers Res Ther. 2017 Jan 17;9(1):2. doi: 10.1186/s13195-016-0228-4.","Zwan MD","Alzheimers Res Ther","2017","2017/01/18","PMC5240413","","10.1186/s13195-016-0228-4"
"27079708","Effects of Meditation versus Music Listening on Perceived Stress, Mood, Sleep, and Quality of Life in Adults with Early Memory Loss: A Pilot Randomized Controlled Trial","Innes KE, Selfe TK, Khalsa DS, Kandati S.","J Alzheimers Dis. 2016 Apr 8;52(4):1277-98. doi: 10.3233/JAD-151106.","Innes KE","J Alzheimers Dis","2016","2016/04/16","PMC5649740","NIHMS907932","10.3233/JAD-151106"
"18581467","Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients","Barone P, Burn DJ, van Laar T, Hsu C, Poewe W, Lane RM.","Mov Disord. 2008 Aug 15;23(11):1532-40. doi: 10.1002/mds.21997.","Barone P","Mov Disord","2008","2008/06/27","","","10.1002/mds.21997"
"30741682","Cerebral Amyloid-β Deposition Is Associated with Impaired Gait Speed and Lower Extremity Function","Dao E, Hsiung GR, Sossi V, Tam R, Shahinfard E, Nicklin E, Al Keridy W, Liu-Ambrose T.","J Alzheimers Dis. 2019;71(s1):S41-S49. doi: 10.3233/JAD-180848.","Dao E","J Alzheimers Dis","2019","2019/02/12","","","10.3233/JAD-180848"
"33971764","Psychoeducational Program for the Family Member Caregivers of People with Dementia to Reduce Perceived Burden and Increase Patient's Quality of Life: A Randomized Controlled Trial","Tawfik NM, Sabry NA, Darwish H, Mowafy M, Soliman SSA.","J Prim Care Community Health. 2021 Jan-Dec;12:21501327211014088. doi: 10.1177/21501327211014088.","Tawfik NM","J Prim Care Community Health","2021","2021/05/11","PMC8120530","","10.1177/21501327211014088"
"8761863","Interpretation variability of 18FDG-positron emission tomography studies in dementia","Hoffman JM, Hanson MW, Welsh KA, Earl N, Paine S, Delong D, Coleman RE.","Invest Radiol. 1996 Jun;31(6):316-22. doi: 10.1097/00004424-199606000-00002.","Hoffman JM","Invest Radiol","1996","1996/06/01","","","10.1097/00004424-199606000-00002"
"28453471","A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia","Rafii MS, Skotko BG, McDonough ME, Pulsifer M, Evans C, Doran E, Muranevici G, Kesslak P, Abushakra S, Lott IT; ELND005-DS Study Group.","J Alzheimers Dis. 2017;58(2):401-411. doi: 10.3233/JAD-160965.","Rafii MS","J Alzheimers Dis","2017","2017/04/29","PMC5777855","NIHMS931990","10.3233/JAD-160965"
"36843256","A long-term study of NeuroAid (MLC601, MLC901) in Patients with Alzheimer's disease; An Extension 8-year Follow-up Study","Pakdaman H, Amini Harandi A, Gharagozli K, Siavoshi F, Shirzadeh Barough S, Sharifipour E, Esfandani A, Ilkhani S, Tabatabaei FS, Sobhanian SA.","Curr Aging Sci. 2023 Feb 24. doi: 10.2174/1874609816666230224111759. Online ahead of print.","Pakdaman H","Curr Aging Sci","2023","2023/02/27","","","10.2174/1874609816666230224111759"
"19085384","Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration","Landa G, Butovsky O, Shoshani J, Schwartz M, Pollack A.","Curr Eye Res. 2008 Nov;33(11):1011-3. doi: 10.1080/02713680802484637.","Landa G","Curr Eye Res","2008","2008/12/17","","","10.1080/02713680802484637"
"27104905","Feasibility of a Memory Clinic-Based Physical Activity Prescription Program","Vidoni ED, Watts AS, Burns JM, Greer CS, Graves RS, Van Sciver A, Black JR, Cooper SK, Nagely AC, Uphoff E, Volmer JM, Bieberle NA.","J Alzheimers Dis. 2016 Apr 21;53(1):161-70. doi: 10.3233/JAD-160158.","Vidoni ED","J Alzheimers Dis","2016","2016/04/23","PMC5839638","NIHMS946638","10.3233/JAD-160158"
"27206648","Impact of frequent cerebrospinal fluid sampling on Aβ levels: systematic approach to elucidate influencing factors","Van Broeck B, Timmers M, Ramael S, Bogert J, Shaw LM, Mercken M, Slemmon J, Van Nueten L, Engelborghs S, Streffer JR.","Alzheimers Res Ther. 2016 May 19;8(1):21. doi: 10.1186/s13195-016-0184-z.","Van Broeck B","Alzheimers Res Ther","2016","2016/05/22","PMC4875639","","10.1186/s13195-016-0184-z"
"31868666","Comparative Cognitive Effects of Choreographed Exercise and Multimodal Physical Therapy in Older Adults with Amnestic Mild Cognitive Impairment: Randomized Clinical Trial","Bisbe M, Fuente-Vidal A, López E, Moreno M, Naya M, de Benetti C, Milà R, Bruna O, Boada M, Alegret M.","J Alzheimers Dis. 2020;73(2):769-783. doi: 10.3233/JAD-190552.","Bisbe M","J Alzheimers Dis","2020","2019/12/24","PMC7029368","","10.3233/JAD-190552"
"29865075","Effects of a 3-Year Multi-Domain Intervention with or without Omega-3 Supplementation on Cognitive Functions in Older Subjects with Increased CAIDE Dementia Scores","Chhetri JK, de Souto Barreto P, Cantet C, Pothier K, Cesari M, Andrieu S, Coley N, Vellas B.","J Alzheimers Dis. 2018;64(1):71-78. doi: 10.3233/JAD-180209.","Chhetri JK","J Alzheimers Dis","2018","2018/06/06","","","10.3233/JAD-180209"
"31127782","A Multidomain Intervention for Modifying Lifestyle Habits Reduces the Dementia Risk in Community-Dwelling Older Adults: A Single-Blinded Randomized Controlled Pilot Study","Park JE, Jeon SY, Kim SA, Kim JH, Kim SH, Lee KW, Hwang YJ, Jung G, Suk HW, Park S, Lee DY.","J Alzheimers Dis. 2019;70(1):51-60. doi: 10.3233/JAD-190016.","Park JE","J Alzheimers Dis","2019","2019/05/26","","","10.3233/JAD-190016"
"1794296","The clinical effect of bifemelane hydrochloride on dementia in aged patients","Yamagami S, Mui K, Hirayama E, Furutsuka D, Soma T, Soejima S, Nishiwaki S, Kiriike N, Boku S.","Drugs Exp Clin Res. 1991;17(4):217-23.","Yamagami S","Drugs Exp Clin Res","1991","1991/01/01","","",""
"34459400","Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial","Cummings J, Schwartz GG, Nicholls SJ, Khan A, Halliday C, Toth PP, Sweeney M, Johansson JO, Wong NCW, Kulikowski E, Kalantar-Zadeh K, Lebioda K, Ginsberg HN, Winblad B, Zetterberg H, Ray KK.","J Alzheimers Dis. 2021;83(4):1703-1715. doi: 10.3233/JAD-210570.","Cummings J","J Alzheimers Dis","2021","2021/08/30","PMC8609701","","10.3233/JAD-210570"
"35142055","Occupational complexity and cognition in the FINGER multidomain intervention trial","Rydström A, Darin-Mattsson A, Kåreholt I, Ngandu T, Lehtisalo J, Solomon A, Antikainen R, Bäckman L, Hänninen T, Laatikainen T, Levälahti E, Lindström J, Paajanen T, Havulinna S, Peltonen M, Sindi S, Soininen H, Neely AS, Strandberg T, Tuomilehto J, Kivipelto M, Mangialasche F.","Alzheimers Dement. 2022 Dec;18(12):2438-2447. doi: 10.1002/alz.12561. Epub 2022 Feb 9.","Rydström A","Alzheimers Dement","2022","2022/02/10","","","10.1002/alz.12561"
"23567407","Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET)","Drye LT, Scherer RW, Lanctôt KL, Rosenberg PB, Herrmann N, Bachman D, Mintzer JE; ADMET Research Group.","Am J Geriatr Psychiatry. 2013 Jun;21(6):549-59. doi: 10.1016/j.jagp.2012.12.018. Epub 2013 Jan 18.","Drye LT","Am J Geriatr Psychiatry","2013","2013/04/10","PMC3402588","NIHMS357006","10.1016/j.jagp.2012.12.018"
"27716665","Effects of DHA Supplementation on Hippocampal Volume and Cognitive Function in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized, Double-Blind, Placebo-Controlled Trial","Zhang YP, Miao R, Li Q, Wu T, Ma F.","J Alzheimers Dis. 2017;55(2):497-507. doi: 10.3233/JAD-160439.","Zhang YP","J Alzheimers Dis","2017","2016/10/08","","","10.3233/JAD-160439"
"34250940","Qualitative Analysis of the Cognition and Flow (CoGFlowS) Study: An Individualized Approach to Cognitive Training for Dementia Is Needed","Beishon L, Haunton V, Subramaniam H, Mukaetova-Ladinska EB, Panerai RB, Robinson T, Evley R.","J Alzheimers Dis. 2021;83(1):209-225. doi: 10.3233/JAD-210428.","Beishon L","J Alzheimers Dis","2021","2021/07/12","","","10.3233/JAD-210428"
"34957728","Increasing the efficiency of randomized trial estimates via linear adjustment for a prognostic score","Schuler A, Walsh D, Hall D, Walsh J, Fisher C; Critical Path for Alzheimer’s Disease; Alzheimer’s Disease Neuroimaging Initiative; Alzheimer’s Disease Cooperative Study.","Int J Biostat. 2021 Dec 22;18(2):329-356. doi: 10.1515/ijb-2021-0072. eCollection 2022 Nov 1.","Schuler A","Int J Biostat","2021","2021/12/27","","","10.1515/ijb-2021-0072"
"34647482","Implications of the COVID-19 Pandemic on Adult Day Services and the Families They Serve","Parker LJ, Marx K, Gaugler JE, Gitlin LN.","Am J Alzheimers Dis Other Demen. 2021 Jan-Dec;36:15333175211050152. doi: 10.1177/15333175211050152.","Parker LJ","Am J Alzheimers Dis Other Demen","2021","2021/10/14","PMC8745481","NIHMS1761314","10.1177/15333175211050152"
"27662296","Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium","Idland AV, Wyller TB, Støen R, Eri LM, Frihagen F, Ræder J, Chaudhry FA, Hansson O, Zetterberg H, Blennow K, Bogdanovic N, Brækhus A, Watne LO.","J Alzheimers Dis. 2017;55(1):371-379. doi: 10.3233/JAD-160461.","Idland AV","J Alzheimers Dis","2017","2016/09/24","","","10.3233/JAD-160461"
"27272538","Cognitive stimulation therapy in the Italian context: its efficacy in cognitive and non-cognitive measures in older adults with dementia","Capotosto E, Belacchi C, Gardini S, Faggian S, Piras F, Mantoan V, Salvalaio E, Pradelli S, Borella E.","Int J Geriatr Psychiatry. 2017 Mar;32(3):331-340. doi: 10.1002/gps.4521. Epub 2016 Jun 7.","Capotosto E","Int J Geriatr Psychiatry","2017","2016/06/09","","","10.1002/gps.4521"
"33044487","Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment","Insel PS, Hansson O, Mattsson-Carlgren N.","JAMA Neurol. 2021 Feb 1;78(2):229-235. doi: 10.1001/jamaneurol.2020.3780.","Insel PS","JAMA Neurol","2021","2020/10/12","PMC7551211","","10.1001/jamaneurol.2020.3780"
"22651941","Predictors for cognitive decline in patients with confluent white matter hyperintensities","Mok V, Xiong Y, Wong KK, Wong A, Schmidt R, Chu WW, Hu X, Lung Leung EY, Chen S, Chen Y, Tang WK, Chen X, Ho CL, Wong KS, Wong ST.","Alzheimers Dement. 2012 Oct;8(5 Suppl):S96-S103. doi: 10.1016/j.jalz.2011.10.004. Epub 2012 May 30.","Mok V","Alzheimers Dement","2012","2012/06/02","","","10.1016/j.jalz.2011.10.004"
"29777003","Impact of Reference and Target Region Selection on Amyloid PET SUV Ratios in the Phase 1b PRIME Study of Aducanumab","Chiao P, Bedell BJ, Avants B, Zijdenbos AP, Grand'Maison M, O'Neill P, O'Gorman J, Chen T, Koeppe R.","J Nucl Med. 2019 Jan;60(1):100-106. doi: 10.2967/jnumed.118.209130. Epub 2018 May 18.","Chiao P","J Nucl Med","2019","2018/05/20","","","10.2967/jnumed.118.209130"
"24887018","Effect of 1 night of total sleep deprivation on cerebrospinal fluid β-amyloid 42 in healthy middle-aged men: a randomized clinical trial","Ooms S, Overeem S, Besse K, Rikkert MO, Verbeek M, Claassen JA.","JAMA Neurol. 2014 Aug;71(8):971-7. doi: 10.1001/jamaneurol.2014.1173.","Ooms S","JAMA Neurol","2014","2014/06/03","","","10.1001/jamaneurol.2014.1173"
"23742705","Early detection of memory impairment in people over 65 years old consulting at Health Examination Centers for the French health insurance: the EVATEM protocol","Vannier-Nitenberg C, Dauphinot V, Bongue B, Sass C, Rouch I, Beauchet O, Krolak-Salmon P, Fantino B.","BMC Geriatr. 2013 Jun 6;13:55. doi: 10.1186/1471-2318-13-55.","Vannier-Nitenberg C","BMC Geriatr","2013","2013/06/08","PMC3681660","","10.1186/1471-2318-13-55"
"32546992","Effect of the Casein-Derived Peptide Met-Lys-Pro on Cognitive Function in Community-Dwelling Adults Without Dementia: A Randomized, Double-Blind, Placebo-Controlled Trial","Yuda N, Tanaka M, Yamauchi K, Abe F, Kakiuchi I, Kiyosawa K, Miyasaka M, Sakane N, Nakamura M.","Clin Interv Aging. 2020 May 27;15:743-754. doi: 10.2147/CIA.S253116. eCollection 2020.","Yuda N","Clin Interv Aging","2020","2020/06/18","PMC7266326","","10.2147/CIA.S253116"
"27031469","Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology","Beach TG, Thal DR, Zanette M, Smith A, Buckley C.","J Alzheimers Dis. 2016 Mar 31;52(3):863-73. doi: 10.3233/JAD-150732.","Beach TG","J Alzheimers Dis","2016","2016/04/01","","","10.3233/JAD-150732"
"29405229","Effects of Omega-3 Fatty Acids on Resting Cerebral Perfusion in Patients with Mild Cognitive Impairment: A Randomized Controlled Trial","Schwarz C, Wirth M, Gerischer L, Grittner U, Witte AV, Köbe T, Flöel A.","J Prev Alzheimers Dis. 2018;5(1):26-30. doi: 10.14283/jpad.2017.23.","Schwarz C","J Prev Alzheimers Dis","2018","2018/02/07","","","10.14283/jpad.2017.23"
"32308012","Advance Care Planning for African American Caregivers of Relatives With Dementias: Cluster Randomized Controlled Trial","Bonner GJ, Freels S, Ferrans C, Steffen A, Suarez ML, Dancy BL, Watkins YJ, Collinge W, Hart AS, Aggarwal NT, Wilkie DJ.","Am J Hosp Palliat Care. 2021 Jun;38(6):547-556. doi: 10.1177/1049909120916127. Epub 2020 Apr 20.","Bonner GJ","Am J Hosp Palliat Care","2021","2020/04/21","PMC8443116","NIHMS1691554","10.1177/1049909120916127"
"34077494","Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects","Pereira JB, Janelidze S, Stomrud E, Palmqvist S, van Westen D, Dage JL, Mattsson-Carlgren N, Hansson O.","Brain. 2021 Oct 22;144(9):2826-2836. doi: 10.1093/brain/awab163.","Pereira JB","Brain","2021","2021/06/02","PMC8557344","","10.1093/brain/awab163"
"23575995","Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia","Rowe CC, Pejoska S, Mulligan RS, Jones G, Chan JG, Svensson S, Cselényi Z, Masters CL, Villemagne VL.","J Nucl Med. 2013 Jun;54(6):880-6. doi: 10.2967/jnumed.112.114785. Epub 2013 Apr 10.","Rowe CC","J Nucl Med","2013","2013/04/12","","","10.2967/jnumed.112.114785"
"29055814","Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: The FINGER trial","Rosenberg A, Ngandu T, Rusanen M, Antikainen R, Bäckman L, Havulinna S, Hänninen T, Laatikainen T, Lehtisalo J, Levälahti E, Lindström J, Paajanen T, Peltonen M, Soininen H, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Solomon A, Kivipelto M.","Alzheimers Dement. 2018 Mar;14(3):263-270. doi: 10.1016/j.jalz.2017.09.006. Epub 2017 Oct 19.","Rosenberg A","Alzheimers Dement","2018","2017/10/23","","","10.1016/j.jalz.2017.09.006"
"20500891","Dementia in residential care: education intervention trial (DIRECT); protocol for a randomised controlled trial","Beer CD, Horner B, Almeida OP, Scherer S, Lautenschlager NT, Bretland N, Flett P, Schaper F, Flicker L.","Trials. 2010 May 26;11:63. doi: 10.1186/1745-6215-11-63.","Beer CD","Trials","2010","2010/05/27","PMC2887857","","10.1186/1745-6215-11-63"
"25648589","Acceptability of a guided self-help Internet intervention for family caregivers: mastery over dementia","Pot AM, Blom MM, Willemse BM.","Int Psychogeriatr. 2015 Aug;27(8):1343-54. doi: 10.1017/S1041610215000034. Epub 2015 Feb 4.","Pot AM","Int Psychogeriatr","2015","2015/02/05","","","10.1017/S1041610215000034"
"27102361","Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults","Rainey-Smith SR, Brown BM, Sohrabi HR, Shah T, Goozee KG, Gupta VB, Martins RN.","Br J Nutr. 2016 Jun;115(12):2106-13. doi: 10.1017/S0007114516001203. Epub 2016 Apr 22.","Rainey-Smith SR","Br J Nutr","2016","2016/04/23","","","10.1017/S0007114516001203"
"31424395","Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PF-06751979, a Potent and Selective Oral BACE1 Inhibitor: Results from Phase I Studies in Healthy Adults and Healthy Older Subjects","Qiu R, Ahn JE, Alexander R, Brodney MA, He P, Leurent C, Mancuso J, Margolin RA, Tankisheva E, Chen D.","J Alzheimers Dis. 2019;71(2):581-595. doi: 10.3233/JAD-190228.","Qiu R","J Alzheimers Dis","2019","2019/08/20","PMC6839502","","10.3233/JAD-190228"
"15353389","A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances","Suh GH, Son HG, Ju YS, Jcho KH, Yeon BK, Shin YM, Kee BS, Choi SK.","Am J Geriatr Psychiatry. 2004 Sep-Oct;12(5):509-16. doi: 10.1176/appi.ajgp.12.5.509.","Suh GH","Am J Geriatr Psychiatry","2004","2004/09/09","","","10.1176/appi.ajgp.12.5.509"
"26519439","Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial","Liu G, Weinger JG, Lu ZL, Xue F, Sadeghpour S.","J Alzheimers Dis. 2016;49(4):971-90. doi: 10.3233/JAD-150538.","Liu G","J Alzheimers Dis","2016","2015/11/01","PMC4927823","","10.3233/JAD-150538"
"36447737","Translation of Collaborative Dementia Care Management into Different Healthcare Settings: Study Protocol for a Multicenter Implementation Trial (DCM:IMPact)","Platen M, Hoffmann W, Rädke A, Scharf A, Mohr W, Mühlichen F, Michalowsky B.","J Alzheimers Dis Rep. 2022 Oct 13;6(1):617-626. doi: 10.3233/ADR-220045. eCollection 2022.","Platen M","J Alzheimers Dis Rep","2022","2022/11/30","PMC9661350","","10.3233/ADR-220045"
"32588971","A randomized controlled trial of amyloid positron emission tomography results disclosure in mild cognitive impairment","Lingler JH, Sereika SM, Butters MA, Cohen AD, Klunk WE, Knox ML, McDade E, Nadkarni NK, Roberts JS, Tamres LK, Lopez OL.","Alzheimers Dement. 2020 Sep;16(9):1330-1337. doi: 10.1002/alz.12129. Epub 2020 Jun 26.","Lingler JH","Alzheimers Dement","2020","2020/06/27","PMC7541680","NIHMS1614254","10.1002/alz.12129"
"19949165","Safety and tolerability of donepezil in mild cognitive impairment: open-label extension study","Doody RS, Ferris S, Salloway S, Yijun Sun, Goldman R, Yikang Xu, Gao J, Murthy AK.","Am J Alzheimers Dis Other Demen. 2010 Mar;25(2):155-9. doi: 10.1177/1533317509352334. Epub 2009 Nov 30.","Doody RS","Am J Alzheimers Dis Other Demen","2010","2009/12/02","","","10.1177/1533317509352334"
"29538413","Functional autoantibodies in patients with different forms of dementia","Wallukat G, Prüss H, Müller J, Schimke I.","PLoS One. 2018 Mar 14;13(3):e0192778. doi: 10.1371/journal.pone.0192778. eCollection 2018.","Wallukat G","PLoS One","2018","2018/03/15","PMC5851545","","10.1371/journal.pone.0192778"
"26674122","Comparing three methods of computerised cognitive training for older adults with subclinical cognitive decline","Gooding AL, Choi J, Fiszdon JM, Wilkins K, Kirwin PD, van Dyck CH, Devanand D, Bell MD, Rivera Mindt M.","Neuropsychol Rehabil. 2016 Oct;26(5-6):810-21. doi: 10.1080/09602011.2015.1118389. Epub 2015 Dec 16.","Gooding AL","Neuropsychol Rehabil","2016","2015/12/18","","","10.1080/09602011.2015.1118389"
"25196239","A pilot randomised controlled trial to compare changes in quality of life for participants with early diagnosis dementia who attend a 'Living Well with Dementia' group compared to waiting-list control","Marshall A, Spreadbury J, Cheston R, Coleman P, Ballinger C, Mullee M, Pritchard J, Russell C, Bartlett E.","Aging Ment Health. 2015;19(6):526-35. doi: 10.1080/13607863.2014.954527. Epub 2014 Sep 8.","Marshall A","Aging Ment Health","2015","2014/09/09","","","10.1080/13607863.2014.954527"
"7798982","A neuropsychological instrument adding to the description of patients with suspected cortical dementia: the Milan overall dementia assessment","Brazzelli M, Capitani E, Della Sala S, Spinnler H, Zuffi M.","J Neurol Neurosurg Psychiatry. 1994 Dec;57(12):1510-7. doi: 10.1136/jnnp.57.12.1510.","Brazzelli M","J Neurol Neurosurg Psychiatry","1994","1994/12/01","PMC1073234","","10.1136/jnnp.57.12.1510"
"15374364","Idebenone in senile dementia of Alzheimer type: a multicentre study","Senin U, Parnetti L, Barbagallo-Sangiorgi G, Bartorelli L, Bocola V, Capurso A, Cuzzupoli M, Denaro M, Marigliano V, Tammaro AE, Fioravanti M.","Arch Gerontol Geriatr. 1992 Nov-Dec;15(3):249-60. doi: 10.1016/0167-4943(92)90060-h.","Senin U","Arch Gerontol Geriatr","1992","1992/11/01","","","10.1016/0167-4943(92)90060-h"
"1993008","The distribution of cerebral muscarinic acetylcholine receptors in vivo in patients with dementia. A controlled study with 123IQNB and single photon emission computed tomography","Weinberger DR, Gibson R, Coppola R, Jones DW, Molchan S, Sunderland T, Berman KF, Reba RC.","Arch Neurol. 1991 Feb;48(2):169-76. doi: 10.1001/archneur.1991.00530140061018.","Weinberger DR","Arch Neurol","1991","1991/02/01","","","10.1001/archneur.1991.00530140061018"
"32310162","Brain Perfusion Change in Patients with Mild Cognitive Impairment After 12 Months of Aerobic Exercise Training","Thomas BP, Tarumi T, Sheng M, Tseng B, Womack KB, Cullum CM, Rypma B, Zhang R, Lu H.","J Alzheimers Dis. 2020;75(2):617-631. doi: 10.3233/JAD-190977.","Thomas BP","J Alzheimers Dis","2020","2020/04/21","PMC8062932","NIHMS1690389","10.3233/JAD-190977"
"15374185","Dihydroergokryptine vs. placebo in dementia of Alzheimer type: interim results of a randomized multicenter study after a 1-year follow-up","Cucinotta D, De Leo D, Frattola L, Trabucchi M, Parnetti L.","Arch Gerontol Geriatr. 1996 Mar-Apr;22(2):169-80. doi: 10.1016/0167-4943(95)00691-5.","Cucinotta D","Arch Gerontol Geriatr","1996","1996/03/01","","","10.1016/0167-4943(95)00691-5"
"32925045","White Matter Changes on Diffusion Tensor Imaging in the FINGER Randomized Controlled Trial","Stephen R, Solomon A, Ngandu T, Levälahti E, Rinne JO, Kemppainen N, Parkkola R, Antikainen R, Strandberg T, Kivipelto M, Soininen H, Liu Y; FINGER study group.","J Alzheimers Dis. 2020;78(1):75-86. doi: 10.3233/JAD-200423.","Stephen R","J Alzheimers Dis","2020","2020/09/14","PMC7683078","","10.3233/JAD-200423"
"26580744","Effects of Repetitive Transcranial Magnetic Stimulation in the Rehabilitation of Communication and Deglutition Disorders: Systematic Review of Randomized Controlled Trials","Gadenz CD, Moreira Tde C, Capobianco DM, Cassol M.","Folia Phoniatr Logop. 2015;67(2):97-105. doi: 10.1159/000439128. Epub 2015 Nov 19.","Gadenz CD","Folia Phoniatr Logop","2015","2015/11/19","","","10.1159/000439128"
"32169093","Comparison of Instrumental Activities of Daily Living assessment by face-to-face or telephone interviews: a randomized, crossover study","Dauphinot V, Boublay N, Moutet C, Achi S, Bathsavanis A, Krolak-Salmon P.","Alzheimers Res Ther. 2020 Mar 13;12(1):24. doi: 10.1186/s13195-020-00590-w.","Dauphinot V","Alzheimers Res Ther","2020","2020/03/15","PMC7068883","","10.1186/s13195-020-00590-w"
"31409541","Cost-effectiveness of a collaborative dementia care management-Results of a cluster-randomized controlled trial","Michalowsky B, Xie F, Eichler T, Hertel J, Kaczynski A, Kilimann I, Teipel S, Wucherer D, Zwingmann I, Thyrian JR, Hoffmann W.","Alzheimers Dement. 2019 Oct;15(10):1296-1308. doi: 10.1016/j.jalz.2019.05.008. Epub 2019 Aug 10.","Michalowsky B","Alzheimers Dement","2019","2019/08/15","","","10.1016/j.jalz.2019.05.008"
"27164691","Vitamin E in aging persons with Down syndrome: A randomized, placebo-controlled clinical trial","Sano M, Aisen PS, Andrews HF, Tsai WY, Lai F, Dalton AJ; International Down Syndrome and Alzheimer's Disease Consortium.","Neurology. 2016 May 31;86(22):2071-6. doi: 10.1212/WNL.0000000000002714. Epub 2016 May 4.","Sano M","Neurology","2016","2016/05/11","PMC4891209","","10.1212/WNL.0000000000002714"
"31749018","Randomized controlled trial on the efficacy of a multilevel non-pharmacologic intervention in older adults with subjective memory decline: design and baseline findings of the E.Mu.N.I. study","Rolandi E, Dodich A, Galluzzi S, Ferrari C, Mandelli S, Ribaldi F, Munaretto G, Ambrosi C, Gasparotti R, Violi D, Canessa N, Iannaccone S, Marcone A, Falini A, Hampel H, Frisoni GB, Cerami C, Cavedo E.","Aging Clin Exp Res. 2020 May;32(5):817-826. doi: 10.1007/s40520-019-01403-3. Epub 2019 Nov 20.","Rolandi E","Aging Clin Exp Res","2020","2019/11/22","","","10.1007/s40520-019-01403-3"
"31171596","A Fully Automatic Technique for Precise Localization and Quantification of Amyloid-β PET Scans","Tahmi M, Bou-Zeid W, Razlighi QR.","J Nucl Med. 2019 Dec;60(12):1771-1779. doi: 10.2967/jnumed.119.228510. Epub 2019 Jun 6.","Tahmi M","J Nucl Med","2019","2019/06/08","PMC6894379","","10.2967/jnumed.119.228510"
"21575870","Language and behavior domains enhance the value of the clinical dementia rating scale","Knopman DS, Weintraub S, Pankratz VS.","Alzheimers Dement. 2011 May;7(3):293-9. doi: 10.1016/j.jalz.2010.12.006.","Knopman DS","Alzheimers Dement","2011","2011/05/18","PMC3096831","NIHMS260537","10.1016/j.jalz.2010.12.006"
"20434961","Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline","Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, Blackwell A, Salem N Jr, Stedman M; MIDAS Investigators.","Alzheimers Dement. 2010 Nov;6(6):456-64. doi: 10.1016/j.jalz.2010.01.013.","Yurko-Mauro K","Alzheimers Dement","2010","2010/05/04","","","10.1016/j.jalz.2010.01.013"
"15590953","Rivastigmine for dementia associated with Parkinson's disease","Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G, De Deyn PP, Durif F, Kulisevsky J, van Laar T, Lees A, Poewe W, Robillard A, Rosa MM, Wolters E, Quarg P, Tekin S, Lane R.","N Engl J Med. 2004 Dec 9;351(24):2509-18. doi: 10.1056/NEJMoa041470.","Emre M","N Engl J Med","2004","2004/12/14","","","10.1056/NEJMoa041470"
"27802233","Multimodal Cognitive Enhancement Therapy for Patients with Mild Cognitive Impairment and Mild Dementia: A Multi- Center, Randomized, Controlled, Double-Blind, Crossover Trial","Han JW, Lee H, Hong JW, Kim K, Kim T, Byun HJ, Ko JW, Youn JC, Ryu SH, Lee NJ, Pae CU, Kim KW.","J Alzheimers Dis. 2017;55(2):787-796. doi: 10.3233/JAD-160619.","Han JW","J Alzheimers Dis","2017","2016/11/02","","","10.3233/JAD-160619"
"34134758","Enriched gardens improve cognition and independence of nursing home residents with dementia: a pilot controlled trial","Bourdon E, Belmin J.","Alzheimers Res Ther. 2021 Jun 16;13(1):116. doi: 10.1186/s13195-021-00849-w.","Bourdon E","Alzheimers Res Ther","2021","2021/06/17","PMC8207740","","10.1186/s13195-021-00849-w"
"26682691","Effect of Anserine/Carnosine Supplementation on Verbal Episodic Memory in Elderly People","Hisatsune T, Kaneko J, Kurashige H, Cao Y, Satsu H, Totsuka M, Katakura Y, Imabayashi E, Matsuda H.","J Alzheimers Dis. 2016;50(1):149-59. doi: 10.3233/JAD-150767.","Hisatsune T","J Alzheimers Dis","2016","2015/12/20","PMC4927867","","10.3233/JAD-150767"
"21495523","Donepezil significantly improves abilities in daily lives of female Down syndrome patients with severe cognitive impairment: a 24-week randomized, double-blind, placebo-controlled trial","Kondoh T, Kanno A, Itoh H, Nakashima M, Honda R, Kojima M, Noguchi M, Nakane H, Nozaki H, Sasaki H, Nagai T, Kosaki R, Kakee N, Okuyama T, Fukuda M, Ikeda M, Shibata Y, Moriuchi H.","Int J Psychiatry Med. 2011;41(1):71-89. doi: 10.2190/PM.41.1.g.","Kondoh T","Int J Psychiatry Med","2011","2011/04/19","","","10.2190/PM.41.1.g"
"34776442","Partnering a Compensatory Application with Activity-Aware Prompting to Improve Use in Individuals with Amnestic Mild Cognitive Impairment: A Randomized Controlled Pilot Clinical Trial","Schmitter-Edgecombe M, Brown K, Luna C, Chilton R, Sumida CA, Holder L, Cook D.","J Alzheimers Dis. 2022;85(1):73-90. doi: 10.3233/JAD-215022.","Schmitter-Edgecombe M","J Alzheimers Dis","2022","2021/11/15","PMC9922794","NIHMS1868610","10.3233/JAD-215022"
"34459396","Prevalence of Low-Value Care and Its Associations with Patient-Centered Outcomes in Dementia","Platen M, Fleßa S, Rädke A, Wucherer D, Thyrian JR, Mohr W, Scharf A, Mühlichen F, Hoffmann W, Michalowsky B.","J Alzheimers Dis. 2021;83(4):1775-1787. doi: 10.3233/JAD-210439.","Platen M","J Alzheimers Dis","2021","2021/08/30","PMC8609693","","10.3233/JAD-210439"
"29480198","Impact of a Virtual Dementia Experience on Medical and Pharmacy Students' Knowledge and Attitudes Toward People with Dementia: A Controlled Study","Gilmartin-Thomas JF, McNeil J, Powell A, Malone DT, Wolfe R, Larson IC, O'Reilly CL, Kirkpatrick CM, Kipen E, Petrovich T, Bell JS.","J Alzheimers Dis. 2018;62(2):867-876. doi: 10.3233/JAD-170982.","Gilmartin-Thomas JF","J Alzheimers Dis","2018","2018/02/27","","","10.3233/JAD-170982"
"31281076","Resistance training enhances delayed memory in healthy middle-aged and older adults: A randomised controlled trial","Marston KJ, Peiffer JJ, Rainey-Smith SR, Gordon N, Teo SY, Laws SM, Sohrabi HR, Martins RN, Brown BM.","J Sci Med Sport. 2019 Nov;22(11):1226-1231. doi: 10.1016/j.jsams.2019.06.013. Epub 2019 Jun 27.","Marston KJ","J Sci Med Sport","2019","2019/07/09","","","10.1016/j.jsams.2019.06.013"
"28295134","Impact of the REACH II and REACH VA Dementia Caregiver Interventions on Healthcare Costs","Nichols LO, Martindale-Adams J, Zhu CW, Kaplan EK, Zuber JK, Waters TM.","J Am Geriatr Soc. 2017 May;65(5):931-936. doi: 10.1111/jgs.14716. Epub 2017 Mar 13.","Nichols LO","J Am Geriatr Soc","2017","2017/03/16","PMC5435565","NIHMS819145","10.1111/jgs.14716"
"33119435","The mnemic neglect effect and information about dementia: age differences in recall","Cheston R, Dodd E, Christopher G, Wildschut T, Sedikides C.","Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2022 Jan;29(1):1-13. doi: 10.1080/13825585.2020.1842850. Epub 2020 Oct 29.","Cheston R","Neuropsychol Dev Cogn B Aging Neuropsychol Cogn","2022","2020/10/29","","","10.1080/13825585.2020.1842850"
"30856111","Comorbidity in Dementia Diseases and Associated Health Care Resources Utilization and Cost","Kaczynski A, Michalowsky B, Eichler T, Thyrian JR, Wucherer D, Zwingmann I, Hoffmann W.","J Alzheimers Dis. 2019;68(2):635-646. doi: 10.3233/JAD-180896.","Kaczynski A","J Alzheimers Dis","2019","2019/03/12","","","10.3233/JAD-180896"
"15560694","Differentiation of dementia with Lewy bodies, Alzheimer's disease and vascular dementia by cardiac 131I-meta-iodobenzylguanidine (MIBG) uptake (preliminary report)","Jindahra P, Vejjajiva A, Witoonpanich R, Sirisriro R, Sritara C, Pulkes T.","J Med Assoc Thai. 2004 Oct;87(10):1176-81.","Jindahra P","J Med Assoc Thai","2004","2004/11/25","","",""
"2305013","Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed","Flicker C, Serby M, Ferris SH.","Psychopharmacology (Berl). 1990;100(2):243-50. doi: 10.1007/BF02244414.","Flicker C","Psychopharmacology (Berl)","1990","1990/01/01","","","10.1007/BF02244414"
"29107051","Added value of (18)F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study","Ceccaldi M, Jonveaux T, Verger A, Krolak-Salmon P, Houzard C, Godefroy O, Shields T, Perrotin A, Gismondi R, Bullich S, Jovalekic A, Raffa N, Pasquier F, Semah F, Dubois B, Habert MO, Wallon D, Chastan M, Payoux P; NEUUS in AD study group; Stephens A, Guedj E.","Alzheimers Dement. 2018 Mar;14(3):293-305. doi: 10.1016/j.jalz.2017.09.009. Epub 2017 Nov 4.","Ceccaldi M","Alzheimers Dement","2018","2017/11/07","","","10.1016/j.jalz.2017.09.009"
"36470522","Modeling digestion, absorption, and ketogenesis after administration of tricaprilin formulations to humans","Li Z, Ramirez G, Tang R, Paul CKX, Nair M, Henderson S, Morimoto B, Liu J, Kaasgaard T, Boyd BJ, Wacker MG.","Eur J Pharm Biopharm. 2023 Jan;182:41-52. doi: 10.1016/j.ejpb.2022.11.022. Epub 2022 Dec 5.","Li Z","Eur J Pharm Biopharm","2023","2022/12/05","","","10.1016/j.ejpb.2022.11.022"
"27261989","A randomized controlled trial of two simple mind-body programs, Kirtan Kriya meditation and music listening, for adults with subjective cognitive decline: Feasibility and acceptability","Innes KE, Selfe TK, Khalsa DS, Kandati S.","Complement Ther Med. 2016 Jun;26:98-107. doi: 10.1016/j.ctim.2016.03.002. Epub 2016 Mar 5.","Innes KE","Complement Ther Med","2016","2016/06/05","","","10.1016/j.ctim.2016.03.002"
"19001351","Levetiracetam: a practical option for seizure management in elderly patients with cognitive impairment","Lippa CF, Rosso A, Hepler M, Jenssen S, Pillai J, Irwin D.","Am J Alzheimers Dis Other Demen. 2010 Mar;25(2):149-54. doi: 10.1177/1533317508325095. Epub 2008 Nov 10.","Lippa CF","Am J Alzheimers Dis Other Demen","2010","2008/11/13","","","10.1177/1533317508325095"
"29614679","Effects of Composite Supplement Containing Astaxanthin and Sesamin on Cognitive Functions in People with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial","Ito N, Saito H, Seki S, Ueda F, Asada T.","J Alzheimers Dis. 2018;62(4):1767-1775. doi: 10.3233/JAD-170969.","Ito N","J Alzheimers Dis","2018","2018/04/05","PMC5900571","","10.3233/JAD-170969"
"24120430","Meditation's impact on default mode network and hippocampus in mild cognitive impairment: a pilot study","Wells RE, Yeh GY, Kerr CE, Wolkin J, Davis RB, Tan Y, Spaeth R, Wall RB, Walsh J, Kaptchuk TJ, Press D, Phillips RS, Kong J.","Neurosci Lett. 2013 Nov 27;556:15-9. doi: 10.1016/j.neulet.2013.10.001. Epub 2013 Oct 10.","Wells RE","Neurosci Lett","2013","2013/10/15","PMC4022038","NIHMS540394","10.1016/j.neulet.2013.10.001"
"28120486","A phase I, randomized, proof-of-clinical-mechanism study assessing the pharmacokinetics and pharmacodynamics of the oral PDE9A inhibitor BI 409306 in healthy male volunteers","Boland K, Moschetti V, Dansirikul C, Pichereau S, Gheyle L, Runge F, Zimdahl-Gelling H, Sand M.","Hum Psychopharmacol. 2017 Jan;32(1). doi: 10.1002/hup.2569.","Boland K","Hum Psychopharmacol","2017","2017/01/26","","","10.1002/hup.2569"
"26757190","Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment","Oulhaj A, Jernerén F, Refsum H, Smith AD, de Jager CA.","J Alzheimers Dis. 2016;50(2):547-57. doi: 10.3233/JAD-150777.","Oulhaj A","J Alzheimers Dis","2016","2016/01/13","PMC4927899","","10.3233/JAD-150777"
"33640979","Results of a Randomized Trial Testing the Efficacy of Tele-Savvy, an Online Synchronous/Asynchronous Psychoeducation Program for Family Caregivers of Persons Living with Dementia","Hepburn K, Nocera J, Higgins M, Epps F, Brewster GS, Lindauer A, Morhardt D, Shah R, Bonds K, Nash R, Griffiths PC.","Gerontologist. 2022 Apr 20;62(4):616-628. doi: 10.1093/geront/gnab029.","Hepburn K","Gerontologist","2022","2021/02/28","PMC7989248","","10.1093/geront/gnab029"
"28535785","Optimizing medication appropriateness in older adults: a randomized clinical interventional trial to decrease anticholinergic burden","Moga DC, Abner EL, Rigsby DN, Eckmann L, Huffmyer M, Murphy RR, Coy BB, Jicha GA.","Alzheimers Res Ther. 2017 May 23;9(1):36. doi: 10.1186/s13195-017-0263-9.","Moga DC","Alzheimers Res Ther","2017","2017/05/25","PMC5442667","","10.1186/s13195-017-0263-9"
"33676572","27-Hydroxycholesterol, cognition, and brain imaging markers in the FINGER randomized controlled trial","Sandebring-Matton A, Goikolea J, Björkhem I, Paternain L, Kemppainen N, Laatikainen T, Ngandu T, Rinne J, Soininen H, Cedazo-Minguez A, Solomon A, Kivipelto M.","Alzheimers Res Ther. 2021 Mar 6;13(1):56. doi: 10.1186/s13195-021-00790-y.","Sandebring-Matton A","Alzheimers Res Ther","2021","2021/03/07","PMC7937194","","10.1186/s13195-021-00790-y"
"26890736","Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial","Luchsinger JA, Perez T, Chang H, Mehta P, Steffener J, Pradabhan G, Ichise M, Manly J, Devanand DP, Bagiella E.","J Alzheimers Dis. 2016;51(2):501-14. doi: 10.3233/JAD-150493.","Luchsinger JA","J Alzheimers Dis","2016","2016/02/19","PMC5079271","NIHMS823392","10.3233/JAD-150493"
"11466162","Neuropsychological changes after 30-day Ginkgo biloba administration in healthy participants","Stough C, Clarke J, Lloyd J, Nathan PJ.","Int J Neuropsychopharmacol. 2001 Jun;4(2):131-4. doi: 10.1017/S1461145701002292.","Stough C","Int J Neuropsychopharmacol","2001","2001/07/24","","","10.1017/S1461145701002292"
"23112868","Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment","Wu L, Rowley J, Mohades S, Leuzy A, Dauar MT, Shin M, Fonov V, Jia J, Gauthier S, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative.","PLoS One. 2012;7(10):e47905. doi: 10.1371/journal.pone.0047905. Epub 2012 Oct 24.","Wu L","PLoS One","2012","2012/11/01","PMC3480449","","10.1371/journal.pone.0047905"
"32716355","Combining Visual Rating Scales for Medial Temporal Lobe Atrophy and Posterior Atrophy to Identify Amnestic Mild Cognitive Impairment from Cognitively Normal Older Adults: Evidence Based on Two Cohorts","Sheng C, Sun Y, Wang M, Wang X, Liu Y, Pang D, Liu J, Bi X, Du W, Zhao M, Li Y, Li X, Jiang J, Han Y.","J Alzheimers Dis. 2020;77(1):323-337. doi: 10.3233/JAD-200016.","Sheng C","J Alzheimers Dis","2020","2020/07/28","","","10.3233/JAD-200016"
"18674411","Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study","Ballard C, Sauter M, Scheltens P, He Y, Barkhof F, van Straaten EC, van der Flier WM, Hsu C, Wu S, Lane R.","Curr Med Res Opin. 2008 Sep;24(9):2561-74. doi: 10.1185/03007990802328142. Epub 2008 Jul 31.","Ballard C","Curr Med Res Opin","2008","2008/08/05","","","10.1185/03007990802328142"
"30611286","The quest for synergy between physical exercise and cognitive stimulation via exergaming in people with dementia: a randomized controlled trial","Karssemeijer EGA, Aaronson JA, Bossers WJR, Donders R, Olde Rikkert MGM, Kessels RPC.","Alzheimers Res Ther. 2019 Jan 5;11(1):3. doi: 10.1186/s13195-018-0454-z.","Karssemeijer EGA","Alzheimers Res Ther","2019","2019/01/07","PMC6320611","","10.1186/s13195-018-0454-z"
"24343761","Safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel γ-secretase modulator, E2212, in healthy human subjects","Yu Y, Logovinsky V, Schuck E, Kaplow J, Chang MK, Miyagawa T, Wong N, Ferry J.","J Clin Pharmacol. 2014 May;54(5):528-36. doi: 10.1002/jcph.249. Epub 2014 Jan 2.","Yu Y","J Clin Pharmacol","2014","2013/12/18","","","10.1002/jcph.249"
"25449530","Transcranial direct current stimulation in mild cognitive impairment: Behavioral effects and neural mechanisms","Meinzer M, Lindenberg R, Phan MT, Ulm L, Volk C, Flöel A.","Alzheimers Dement. 2015 Sep;11(9):1032-40. doi: 10.1016/j.jalz.2014.07.159. Epub 2014 Nov 20.","Meinzer M","Alzheimers Dement","2015","2014/12/03","","","10.1016/j.jalz.2014.07.159"
"29630549","Brazilian Green Propolis Prevents Cognitive Decline into Mild Cognitive Impairment in Elderly People Living at High Altitude","Zhu A, Wu Z, Zhong X, Ni J, Li Y, Meng J, Du C, Zhao X, Nakanishi H, Wu S.","J Alzheimers Dis. 2018;63(2):551-560. doi: 10.3233/JAD-170630.","Zhu A","J Alzheimers Dis","2018","2018/04/10","","","10.3233/JAD-170630"
"31319510","Effects of Anserine/Carnosine Supplementation on Mild Cognitive Impairment with APOE4","Masuoka N, Yoshimine C, Hori M, Tanaka M, Asada T, Abe K, Hisatsune T.","Nutrients. 2019 Jul 17;11(7):1626. doi: 10.3390/nu11071626.","Masuoka N","Nutrients","2019","2019/07/20","PMC6683059","","10.3390/nu11071626"
"15374309","Efficacy of a support group programme for care-givers of demented patients in the community: a randomized controlled trial","Hébert R, Leclerc G, Bravo G, Girouard D, Lefrançois R.","Arch Gerontol Geriatr. 1994 Jan-Feb;18(1):1-14. doi: 10.1016/0167-4943(94)90043-4.","Hébert R","Arch Gerontol Geriatr","1994","1994/01/01","","","10.1016/0167-4943(94)90043-4"
"26851974","Effects of rivastigmine on visual attention in subjects with amnestic mild cognitive impairment: A serial functional MRI activation pilot-study","Bokde AL, Cavedo E, Lopez-Bayo P, Lista S, Meindl T, Born C, Galluzzi S, Faltraco F, Dubois B, Teipel SJ, Reiser M, Möller HJ, Hampel H.","Psychiatry Res Neuroimaging. 2016 Mar 30;249:84-90. doi: 10.1016/j.pscychresns.2016.01.018. Epub 2016 Jan 18.","Bokde AL","Psychiatry Res Neuroimaging","2016","2016/02/08","","","10.1016/j.pscychresns.2016.01.018"
"27473843","Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): A pilot randomised controlled trial","Cooper SA, Ademola T, Caslake M, Douglas E, Evans J, Greenlaw N, Haig C, Hassiotis A, Jahoda A, McConnachie A, Morrison J, Ring H, Starr J, Stiles C, Sirisena C, Sullivan F.","Trials. 2016 Jul 29;17:370. doi: 10.1186/s13063-016-1370-9.","Cooper SA","Trials","2016","2016/07/31","PMC4966871","","10.1186/s13063-016-1370-9"
"31360988","Associations of dietary choline intake with risk of incident dementia and with cognitive performance: the Kuopio Ischaemic Heart Disease Risk Factor Study","Ylilauri MPT, Voutilainen S, Lönnroos E, Virtanen HEK, Tuomainen TP, Salonen JT, Virtanen JK.","Am J Clin Nutr. 2019 Dec 1;110(6):1416-1423. doi: 10.1093/ajcn/nqz148.","Ylilauri MPT","Am J Clin Nutr","2019","2019/07/31","","","10.1093/ajcn/nqz148"
"33336223","Prospective Associations between Plasma Amyloid-Beta 42/40 and Frailty in Community-Dwelling Older Adults","Lu WH, Giudici KV, Rolland Y, Guyonnet S, Li Y, Bateman RJ, de Souto Barreto P, Vellas B.","J Prev Alzheimers Dis. 2021;8(1):41-47. doi: 10.14283/jpad.2020.60.","Lu WH","J Prev Alzheimers Dis","2021","2020/12/18","PMC9982745","NIHMS1847595","10.14283/jpad.2020.60"
"27484173","The beneficial effects of cognitive training with simple calculation and reading aloud in an elderly postsurgical population: study protocol for a randomized controlled trial","Kulason K, Nouchi R, Hoshikawa Y, Noda M, Okada Y, Kawashima R.","Trials. 2016 Jul 22;17:334. doi: 10.1186/s13063-016-1476-0.","Kulason K","Trials","2016","2016/08/04","PMC4971755","","10.1186/s13063-016-1476-0"
"31842821","The effects of repetitive transcranial magnetic stimulation in older adults with mild cognitive impairment: a protocol for a randomized, controlled three-arm trial","Taylor JL, Hambro BC, Strossman ND, Bhatt P, Hernandez B, Ashford JW, Cheng JJ, Iv M, Adamson MM, Lazzeroni LC, McNerney MW.","BMC Neurol. 2019 Dec 16;19(1):326. doi: 10.1186/s12883-019-1552-7.","Taylor JL","BMC Neurol","2019","2019/12/18","PMC6912947","","10.1186/s12883-019-1552-7"
"8270928","Cholinergic treatment of an amnestic man with a basal forebrain lesion: theoretical implications","Chatterjee A, Morris MK, Bowers D, Williamson DJ, Doty L, Heilman KM.","J Neurol Neurosurg Psychiatry. 1993 Dec;56(12):1282-9. doi: 10.1136/jnnp.56.12.1282.","Chatterjee A","J Neurol Neurosurg Psychiatry","1993","1993/12/01","PMC1015375","","10.1136/jnnp.56.12.1282"
"34217888","An innovative protocol for the artificial speech-directed, contactless administration of laboratory-based comprehensive cognitive assessments: PAAD-2 trial management during the COVID-19 pandemic","Park KS, Etnier JL.","Contemp Clin Trials. 2021 Aug;107:106500. doi: 10.1016/j.cct.2021.106500. Epub 2021 Jul 2.","Park KS","Contemp Clin Trials","2021","2021/07/04","PMC8249106","","10.1016/j.cct.2021.106500"
"22796985","Nicotine increases brain functional network efficiency","Wylie KP, Rojas DC, Tanabe J, Martin LF, Tregellas JR.","Neuroimage. 2012 Oct 15;63(1):73-80. doi: 10.1016/j.neuroimage.2012.06.079. Epub 2012 Jul 14.","Wylie KP","Neuroimage","2012","2012/07/17","PMC3429645","NIHMS394388","10.1016/j.neuroimage.2012.06.079"
"15729085","Effects of N-PEP-12 on memory among older adults","Crook TH, Ferris SH, Alvarez XA, Laredo M, Moessler H.","Int Clin Psychopharmacol. 2005 Mar;20(2):97-100. doi: 10.1097/00004850-200503000-00006.","Crook TH","Int Clin Psychopharmacol","2005","2005/02/25","","","10.1097/00004850-200503000-00006"
"14651443","Gabapentin for the treatment of behavioural alterations in dementia: preliminary 15-month investigation","Moretti R, Torre P, Antonello RM, Cazzato G, Bava A.","Drugs Aging. 2003;20(14):1035-40. doi: 10.2165/00002512-200320140-00003.","Moretti R","Drugs Aging","2003","2003/12/04","","","10.2165/00002512-200320140-00003"
"33066895","Remote Ischemic Post-Conditioning may Improve Post-Stroke Cognitive Impairment: A Pilot Single Center Randomized Controlled Trial","Li YJ, Liang KK, Zhang L, Pan R, Hu YM, Zhao JH.","J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105217. doi: 10.1016/j.jstrokecerebrovasdis.2020.105217. Epub 2020 Aug 13.","Li YJ","J Stroke Cerebrovasc Dis","2020","2020/10/17","","","10.1016/j.jstrokecerebrovasdis.2020.105217"
"23599941","Late-life depression, mild cognitive impairment, and dementia","Richard E, Reitz C, Honig LH, Schupf N, Tang MX, Manly JJ, Mayeux R, Devanand D, Luchsinger JA.","JAMA Neurol. 2013 Mar 1;70(3):374-82. doi: 10.1001/jamaneurol.2013.603.","Richard E","JAMA Neurol","2013","2013/04/20","PMC3694613","NIHMS453062","10.1001/jamaneurol.2013.603"
"20838622","Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial","Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, Oulhaj A, Bradley KM, Jacoby R, Refsum H.","PLoS One. 2010 Sep 8;5(9):e12244. doi: 10.1371/journal.pone.0012244.","Smith AD","PLoS One","2010","2010/09/15","PMC2935890","","10.1371/journal.pone.0012244"
"28064170","Cardiorespiratory fitness and brain volumes in men and women in the FINGER study","Pentikäinen H, Ngandu T, Liu Y, Savonen K, Komulainen P, Hallikainen M, Kivipelto M, Rauramaa R, Soininen H.","Age Ageing. 2017 Mar 1;46(2):310-313. doi: 10.1093/ageing/afw191.","Pentikäinen H","Age Ageing","2017","2017/01/09","","","10.1093/ageing/afw191"
"30819077","Distinctive Effects of Aerobic and Resistance Exercise Modes on Neurocognitive and Biochemical Changes in Individuals with Mild Cognitive Impairment","Tsai CL, Pai MC, Ukropec J, Ukropcová B.","Curr Alzheimer Res. 2019;16(4):316-332. doi: 10.2174/1567205016666190228125429.","Tsai CL","Curr Alzheimer Res","2019","2019/03/02","","","10.2174/1567205016666190228125429"
"32213642","Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline","Ryan J, Storey E, Murray AM, Woods RL, Wolfe R, Reid CM, Nelson MR, Chong TTJ, Williamson JD, Ward SA, Lockery JE, Orchard SG, Trevaks R, Kirpach B, Newman AB, Ernst ME, McNeil JJ, Shah RC; ASPREE Investigator Group.","Neurology. 2020 Jul 21;95(3):e320-e331. doi: 10.1212/WNL.0000000000009277. Epub 2020 Mar 25.","Ryan J","Neurology","2020","2020/03/28","PMC7455352","","10.1212/WNL.0000000000009277"
"28542742","Exercise or Social Intervention for Nursing Home Residents with Dementia: A Pilot Randomized, Controlled Trial","de Souto Barreto P, Cesari M, Denormandie P, Armaingaud D, Vellas B, Rolland Y.","J Am Geriatr Soc. 2017 Sep;65(9):E123-E129. doi: 10.1111/jgs.14947. Epub 2017 May 19.","de Souto Barreto P","J Am Geriatr Soc","2017","2017/05/26","","","10.1111/jgs.14947"
"31127779","Repetitive Transcranial Magnetic Stimulation Induced Hypoconnectivity Within the Default Mode Network Yields Cognitive Improvements in Amnestic Mild Cognitive Impairment: A Randomized Controlled Study","Cui H, Ren R, Lin G, Zou Y, Jiang L, Wei Z, Li C, Wang G.","J Alzheimers Dis. 2019;69(4):1137-1151. doi: 10.3233/JAD-181296.","Cui H","J Alzheimers Dis","2019","2019/05/26","","","10.3233/JAD-181296"
"23950642","Effect of Memo®, a natural formula combination, on Mini-Mental State Examination scores in patients with mild cognitive impairment","Yakoot M, Salem A, Helmy S.","Clin Interv Aging. 2013;8:975-81. doi: 10.2147/CIA.S44777. Epub 2013 Jul 24.","Yakoot M","Clin Interv Aging","2013","2013/08/17","PMC3740822","","10.2147/CIA.S44777"
"31894029","Efficacy and safety of NAD+ ADP-ribosyltransferase 1 agonist versus Donepezil in elderly Chinese patients with Alzheimer disease: A novel target for effective therapy","Wang J, Yang S, Hu Z, Yang H, Wei D, Wang D, Guo F.","Pak J Pharm Sci. 2019 Sep;32(5(Special)):2427-2432.","Wang J","Pak J Pharm Sci","2019","2020/01/03","","",""
"21841261","Executive dysfunction in mild cognitive impairment is associated with changes in frontal and cingulate white matter tracts","Grambaite R, Selnes P, Reinvang I, Aarsland D, Hessen E, Gjerstad L, Fladby T.","J Alzheimers Dis. 2011;27(2):453-62. doi: 10.3233/JAD-2011-110290.","Grambaite R","J Alzheimers Dis","2011","2011/08/16","","","10.3233/JAD-2011-110290"
"15486516","Rivastigmine augmentation in the management of chronic schizophrenia with comorbid dementia: an open-label study investigating effects on cognition, behaviour and activities of daily living","Mendelsohn E, Rosenthal M, Bohiri Y, Werber E, Kotler M, Strous RD.","Int Clin Psychopharmacol. 2004 Nov;19(6):319-24. doi: 10.1097/00004850-200411000-00001.","Mendelsohn E","Int Clin Psychopharmacol","2004","2004/10/16","","","10.1097/00004850-200411000-00001"
"10681076","Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability","Chui HC, Mack W, Jackson JE, Mungas D, Reed BR, Tinklenberg J, Chang FL, Skinner K, Tasaki C, Jagust WJ.","Arch Neurol. 2000 Feb;57(2):191-6. doi: 10.1001/archneur.57.2.191.","Chui HC","Arch Neurol","2000","2000/02/19","","","10.1001/archneur.57.2.191"
"34420970","An Online, Person-Centered, Risk Factor Management Program to Prevent Cognitive Decline: Protocol for A Prospective Behavior-Modification Blinded Endpoint Randomized Controlled Trial","Lim YY, Ayton D, Perin S, Lavale A, Yassi N, Buckley R, Barton C, Bruns L, Morello R, Pirotta S, Rosenich E, Rajaratnam SMW, Sinnott R, Brodtmann A, Bush AI, Maruff P, Churilov L, Barker A, Pase MP; BetterBrains Research Group.","J Alzheimers Dis. 2021;83(4):1603-1622. doi: 10.3233/JAD-210589.","Lim YY","J Alzheimers Dis","2021","2021/08/23","","","10.3233/JAD-210589"
"24430001","The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition","Wharton W, Gleason CE, Dowling NM, Carlsson CM, Brinton EA, Santoro MN, Neal-Perry G, Taylor H, Naftolin F, Lobo RA, Merriam G, Manson JE, Cedars MI, Miller VM, Black DM, Budoff M, Hodis HN, Harman SM, Asthana S.","J Alzheimers Dis. 2014;40(2):331-41. doi: 10.3233/JAD-130245.","Wharton W","J Alzheimers Dis","2014","2014/01/17","PMC4367860","NIHMS666001","10.3233/JAD-130245"
"31853557","Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers","Family N, Maillet EL, Williams LTJ, Krediet E, Carhart-Harris RL, Williams TM, Nichols CD, Goble DJ, Raz S.","Psychopharmacology (Berl). 2020 Mar;237(3):841-853. doi: 10.1007/s00213-019-05417-7. Epub 2019 Dec 18.","Family N","Psychopharmacology (Berl)","2020","2019/12/20","PMC7036065","","10.1007/s00213-019-05417-7"
"29480182","Simultaneous Aerobic Exercise and Memory Training Program in Older Adults with Subjective Memory Impairments","McEwen SC, Siddarth P, Rahi B, Kim Y, Mui W, Wu P, Emerson ND, Lee J, Greenberg S, Shelton T, Kaiser S, Small GW, Merrill DA.","J Alzheimers Dis. 2018;62(2):795-806. doi: 10.3233/JAD-170846.","McEwen SC","J Alzheimers Dis","2018","2018/02/27","PMC5870016","","10.3233/JAD-170846"
"8736145","[Digital EEG with brain mapping in Alzheimer's dementia and Parkinson's disease. A prospective controlled study]","Sandmann MC, Piana ER, Sousa DS, De Bittencourt PR.","Arq Neuropsiquiatr. 1996 Mar;54(1):50-6. doi: 10.1590/s0004-282x1996000100009.","Sandmann MC","Arq Neuropsiquiatr","1996","1996/03/01","","","10.1590/s0004-282x1996000100009"
"30997917","The Association of ApoE ε4 Status with Lower Limb Function and Handgrip Strength in Older Adults","Maltais M, de Souto Barreto P, Rolland Y, Vellas B.","J Frailty Aging. 2019;8(2):62-66. doi: 10.14283/jfa.2019.7.","Maltais M","J Frailty Aging","2019","2019/04/19","","","10.14283/jfa.2019.7"
"23707331","The effect of Nigella sativa Linn. seed on memory, attention and cognition in healthy human volunteers","Bin Sayeed MS, Asaduzzaman M, Morshed H, Hossain MM, Kadir MF, Rahman MR.","J Ethnopharmacol. 2013 Jul 30;148(3):780-6. doi: 10.1016/j.jep.2013.05.004. Epub 2013 May 21.","Bin Sayeed MS","J Ethnopharmacol","2013","2013/05/28","","","10.1016/j.jep.2013.05.004"
"11903959","Copper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down's syndrome","Tórsdóttir G, Kristinsson J, Hreidarsson S, Snaedal J, Jóhannesson T.","Pharmacol Toxicol. 2001 Dec;89(6):320-5. doi: 10.1034/j.1600-0773.2001.d01-168.x.","Tórsdóttir G","Pharmacol Toxicol","2001","2002/03/21","","","10.1034/j.1600-0773.2001.d01-168.x"
"19349206","Hippocampal atrophy predicts conversion to dementia after STN-DBS in Parkinson's disease","Aybek S, Lazeyras F, Gronchi-Perrin A, Burkhard PR, Villemure JG, Vingerhoets FJ.","Parkinsonism Relat Disord. 2009 Aug;15(7):521-4. doi: 10.1016/j.parkreldis.2009.01.003. Epub 2009 Apr 5.","Aybek S","Parkinsonism Relat Disord","2009","2009/04/08","","","10.1016/j.parkreldis.2009.01.003"
"17452287","Effects of NMDA receptor antagonist memantine on mismatch negativity","Korostenskaja M, Nikulin VV, Kicić D, Nikulina AV, Kähkönen S.","Brain Res Bull. 2007 May 30;72(4-6):275-83. doi: 10.1016/j.brainresbull.2007.01.007. Epub 2007 Feb 2.","Korostenskaja M","Brain Res Bull","2007","2007/04/25","","","10.1016/j.brainresbull.2007.01.007"
"23298693","Comparing the effects of different individualized music interventions for elderly individuals with severe dementia","Sakamoto M, Ando H, Tsutou A.","Int Psychogeriatr. 2013 May;25(5):775-84. doi: 10.1017/S1041610212002256. Epub 2013 Jan 8.","Sakamoto M","Int Psychogeriatr","2013","2013/01/10","PMC3605862","","10.1017/S1041610212002256"
"21851594","Study protocol of the multi-site randomised controlled REDALI-DEM trial--the effects of structured relearning methods on daily living task performance of persons with dementia","Voigt-Radloff S, Leonhart R, Rikkert MO, Kessels R, Hüll M.","BMC Geriatr. 2011 Aug 18;11:44. doi: 10.1186/1471-2318-11-44.","Voigt-Radloff S","BMC Geriatr","2011","2011/08/20","PMC3166897","","10.1186/1471-2318-11-44"
"14501003","Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment","Grundman M, Jack CR Jr, Petersen RC, Kim HT, Taylor C, Datvian M, Weiner MF, DeCarli C, DeKosky ST, van Dyck C, Darvesh S, Yaffe K, Kaye J, Ferris SH, Thomas RG, Thal LJ; Alzheimer's Disease Cooperative Study.","J Mol Neurosci. 2003;20(3):241-8. doi: 10.1385/jmn:20:3:241.","Grundman M","J Mol Neurosci","2003","2003/09/23","","","10.1385/jmn:20:3:241"
"12948999","Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial","Spector A, Thorgrimsen L, Woods B, Royan L, Davies S, Butterworth M, Orrell M.","Br J Psychiatry. 2003 Sep;183:248-54. doi: 10.1192/bjp.183.3.248.","Spector A","Br J Psychiatry","2003","2003/09/02","","","10.1192/bjp.183.3.248"
"20423560","Improved cognitive-cerebral function in older adults with chromium supplementation","Krikorian R, Eliassen JC, Boespflug EL, Nash TA, Shidler MD.","Nutr Neurosci. 2010 Jun;13(3):116-22. doi: 10.1179/147683010X12611460764084.","Krikorian R","Nutr Neurosci","2010","2010/04/29","","","10.1179/147683010X12611460764084"
"34006157","Lessons from the COVID-19 pandemic for improving outpatient neuropalliative care: A qualitative study of patient and caregiver perspectives","Macchi ZA, Ayele R, Dini M, Lamira J, Katz M, Pantilat SZ, Jones J, Kluger BM.","Palliat Med. 2021 Jul;35(7):1258-1266. doi: 10.1177/02692163211017383. Epub 2021 May 18.","Macchi ZA","Palliat Med","2021","2021/05/19","PMC9447864","NIHMS1831334","10.1177/02692163211017383"
"23011220","Prediction of amyloid-β pathology in amnestic mild cognitive impairment with neuropsychological tests","Bahar-Fuchs A, Villemagne V, Ong K, Chetélat G, Lamb F, Reininger CB, Woodward M, Rowe CC.","J Alzheimers Dis. 2013;33(2):451-62. doi: 10.3233/JAD-2012-121315.","Bahar-Fuchs A","J Alzheimers Dis","2013","2012/09/27","","","10.3233/JAD-2012-121315"
"31373868","Can Persons with Dementia Meaningfully Participate in Advance Care Planning Discussions? A Mixed-Methods Study of SPIRIT","Song MK, Ward SE, Hepburn K, Paul S, Kim H, Shah RC, Morhardt DJ, Medders L, Lah JJ, Clevenger CC.","J Palliat Med. 2019 Nov;22(11):1410-1416. doi: 10.1089/jpm.2019.0088. Epub 2019 Aug 2.","Song MK","J Palliat Med","2019","2019/08/03","PMC6818478","","10.1089/jpm.2019.0088"
"27639640","Absolute bioavailability and safety of a novel rivastigmine nasal spray in healthy elderly individuals","Morgan TM, Soh B.","Br J Clin Pharmacol. 2017 Mar;83(3):510-516. doi: 10.1111/bcp.13133. Epub 2016 Oct 26.","Morgan TM","Br J Clin Pharmacol","2017","2016/09/19","PMC5306491","","10.1111/bcp.13133"
"31050950","Effects of Home Photobiomodulation Treatments on Cognitive and Behavioral Function, Cerebral Perfusion, and Resting-State Functional Connectivity in Patients with Dementia: A Pilot Trial","Chao LL.","Photobiomodul Photomed Laser Surg. 2019 Mar;37(3):133-141. doi: 10.1089/photob.2018.4555. Epub 2019 Feb 13.","Chao LL","Photobiomodul Photomed Laser Surg","2019","2019/05/04","","","10.1089/photob.2018.4555"
"33891333","Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M(1) -acetylcholine receptor agonist: A randomized cross-over trial","Bakker C, Prins S, Liptrot J, Hart EP, Klaassen ES, Brown GA, Brown A, Congreve M, Weir M, Marshall FH, Stevens J, Cross DM, Tasker T, Nathan PJ, Groeneveld GJ.","Br J Clin Pharmacol. 2021 Nov;87(11):4439-4449. doi: 10.1111/bcp.14872. Epub 2021 May 8.","Bakker C","Br J Clin Pharmacol","2021","2021/04/23","PMC8596821","","10.1111/bcp.14872"
"27033674","Rhythm experience and Africana culture trial (REACT!): A culturally salient intervention to promote neurocognitive health, mood, and well-being in older African Americans","Lukach AJ, Jedrziewski MK, Grove GA, Mechanic-Hamilton DJ, Williams SS, Wollam ME, Erickson KI.","Contemp Clin Trials. 2016 May;48:41-5. doi: 10.1016/j.cct.2016.03.010. Epub 2016 Mar 28.","Lukach AJ","Contemp Clin Trials","2016","2016/04/02","PMC5462111","NIHMS860926","10.1016/j.cct.2016.03.010"
"24534013","Peripheral inflammation acutely impairs human spatial memory via actions on medial temporal lobe glucose metabolism","Harrison NA, Doeller CF, Voon V, Burgess N, Critchley HD.","Biol Psychiatry. 2014 Oct 1;76(7):585-93. doi: 10.1016/j.biopsych.2014.01.005. Epub 2014 Jan 19.","Harrison NA","Biol Psychiatry","2014","2014/02/19","PMC4166523","","10.1016/j.biopsych.2014.01.005"
"2682330","Direct comparisons of CNS directed therapies are needed","Gash DM.","Neurobiol Aging. 1989 Sep-Oct;10(5):645-6; discussion 648-50. doi: 10.1016/0197-4580(89)90166-8.","Gash DM","Neurobiol Aging","1989","1989/09/01","","","10.1016/0197-4580(89)90166-8"
"12819409","A metabolic imaging severity rating scale for the assessment of cognitive impairment","Newberg A, Cotter A, Udeshi M, Alavi A, Clark C.","Clin Nucl Med. 2003 Jul;28(7):565-70. doi: 10.1097/00003072-200307000-00006.","Newberg A","Clin Nucl Med","2003","2003/06/24","","","10.1097/00003072-200307000-00006"
"33437991","Cognitive Stimulation Therapy for Older Adults With Mild-to-Moderate Dementia in Italy: Effects on Cognitive Functioning, and on Emotional and Neuropsychiatric Symptoms","Carbone E, Gardini S, Pastore M, Piras F, Vincenzi M, Borella E.","J Gerontol B Psychol Sci Soc Sci. 2021 Oct 30;76(9):1700-1710. doi: 10.1093/geronb/gbab007.","Carbone E","J Gerontol B Psychol Sci Soc Sci","2021","2021/01/13","","","10.1093/geronb/gbab007"
"10850744","Why we are not ready for a biopsychosocial approach to dementia research and intervention: commentary on ""Heterogeneity in dementia: challenges and opportunities""","Karlawish JH.","Alzheimer Dis Assoc Disord. 2000 Apr-Jun;14(2):64-7. doi: 10.1097/00002093-200004000-00003.","Karlawish JH","Alzheimer Dis Assoc Disord","2000","2000/06/13","","","10.1097/00002093-200004000-00003"
"10939786","Blood pressure reduction and risk of dementia in patients with stroke: rationale of the dementia assessment in PROGRESS (Perindopril Protection Against Recurrent Stroke Study). PROGRESS Management Committee","Tzourio C, Anderson C; PROGRESS Management Committee.","J Hypertens Suppl. 2000 May;18(1):S21-4.","Tzourio C","J Hypertens Suppl","2000","2000/08/12","","",""
"27760869","Aerobic exercise and vascular cognitive impairment: A randomized controlled trial","Liu-Ambrose T, Best JR, Davis JC, Eng JJ, Lee PE, Jacova C, Boyd LA, Brasher PM, Munkacsy M, Cheung W, Hsiung GR.","Neurology. 2016 Nov 15;87(20):2082-2090. doi: 10.1212/WNL.0000000000003332. Epub 2016 Oct 19.","Liu-Ambrose T","Neurology","2016","2016/10/21","PMC5109938","","10.1212/WNL.0000000000003332"
"12567159","Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementia","Stryjer R, Strous RD, Bar F, Werber E, Shaked G, Buhiri Y, Kotler M, Weizman A, Rabey JM.","Clin Neuropharmacol. 2003 Jan-Feb;26(1):12-7. doi: 10.1097/00002826-200301000-00004.","Stryjer R","Clin Neuropharmacol","2003","2003/02/05","","","10.1097/00002826-200301000-00004"
"12474023","HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier","Sparks DL, Connor DJ, Browne PJ, Lopez JE, Sabbagh MN.","J Nutr Health Aging. 2002;6(5):324-31.","Sparks DL","J Nutr Health Aging","2002","2002/12/11","","",""
"16769962","Tau protein hyperphosphorylation in sporadic ALS with cognitive impairment","Strong MJ, Yang W, Strong WL, Leystra-Lantz C, Jaffe H, Pant HC.","Neurology. 2006 Jun 13;66(11):1770-1. doi: 10.1212/01.wnl.0000218161.15834.db.","Strong MJ","Neurology","2006","2006/06/14","","","10.1212/01.wnl.0000218161.15834.db"
"16960863","Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease","Burn D, Emre M, McKeith I, De Deyn PP, Aarsland D, Hsu C, Lane R.","Mov Disord. 2006 Nov;21(11):1899-907. doi: 10.1002/mds.21077.","Burn D","Mov Disord","2006","2006/09/09","","","10.1002/mds.21077"
"32967146","Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model","Lin CH, Chiu SI, Chen TF, Jang JR, Chiu MJ.","Int J Mol Sci. 2020 Sep 21;21(18):6914. doi: 10.3390/ijms21186914.","Lin CH","Int J Mol Sci","2020","2020/09/24","PMC7555120","","10.3390/ijms21186914"
"12417387","SPECT as a diagnostic test in the investigation of dementia","Lojkowska W, Ryglewicz D, Jedrzejczak T, Sienkiewicz-Jarosz H, Minc S, Jakubowska T, Kozlowicz-Gudzinska I.","J Neurol Sci. 2002 Nov 15;203-204:215-9. doi: 10.1016/s0022-510x(02)00294-0.","Lojkowska W","J Neurol Sci","2002","2002/11/06","","","10.1016/s0022-510x(02)00294-0"
"36782122","Implementing a home-based personalised cognitive rehabilitation intervention for people with mild-to-moderate dementia: GREAT into Practice","Clare L, Kudlicka A, Collins R, Evans S, Pool J, Henderson C, Knapp M, Litherland R, Oyebode J, Woods R.","BMC Geriatr. 2023 Feb 13;23(1):93. doi: 10.1186/s12877-022-03705-0.","Clare L","BMC Geriatr","2023","2023/02/14","PMC9925212","","10.1186/s12877-022-03705-0"
"9469262","Alpha-1-antichymotrypsin is not associated with the increased frequency of apolipoprotein-E-epsilon-4 allele in elderly non-demented leprosy patients","Endoh M, Ueki A, Takahashi K, Yamanaka H, Izumi S, Tabira T.","Dement Geriatr Cogn Disord. 1998 Jan-Feb;9(1):26-8. doi: 10.1159/000017018.","Endoh M","Dement Geriatr Cogn Disord","1998","1998/02/20","","","10.1159/000017018"
"21140383","Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial","Ihl R, Bachinskaya N, Korczyn AD, Vakhapova V, Tribanek M, Hoerr R, Napryeyenko O; GOTADAY Study Group.","Int J Geriatr Psychiatry. 2011 Nov;26(11):1186-94. doi: 10.1002/gps.2662. Epub 2010 Dec 7.","Ihl R","Int J Geriatr Psychiatry","2011","2010/12/09","","","10.1002/gps.2662"
"36145090","The Effects of Spirulina maxima Extract on Memory Improvement in Those with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial","Choi WY, Lee WK, Kim TH, Ryu YK, Park A, Lee YJ, Heo SJ, Oh C, Chung YC, Kang DH.","Nutrients. 2022 Sep 9;14(18):3714. doi: 10.3390/nu14183714.","Choi WY","Nutrients","2022","2022/09/23","PMC9505028","","10.3390/nu14183714"
"29142143","DHA supplementation improves cognitive function via enhancing Aβ-mediated autophagy in Chinese elderly with mild cognitive impairment: a randomised placebo-controlled trial","Zhang YP, Lou Y, Hu J, Miao R, Ma F.","J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):382-388. doi: 10.1136/jnnp-2017-316176. Epub 2017 Nov 15.","Zhang YP","J Neurol Neurosurg Psychiatry","2018","2017/11/17","","","10.1136/jnnp-2017-316176"
"33185602","Dyadic Group Exercises for Persons with Memory Deficits and Care Partners: Mixed-Method Findings from the Paired Preventing Loss of Independence through Exercise (PLIÉ) Randomized Trial","Mehling WE, Scott TM, Duffy J, Whitmer RA, Chesney MA, Boscardin WJ, Barnes DE.","J Alzheimers Dis. 2020;78(4):1689-1706. doi: 10.3233/JAD-200713.","Mehling WE","J Alzheimers Dis","2020","2020/11/13","","","10.3233/JAD-200713"
"23732272","Cerebrospinal fluid aβ to tau ratio and postoperative cognitive change","Xie Z, McAuliffe S, Swain CA, Ward SA, Crosby CA, Zheng H, Sherman J, Dong Y, Zhang Y, Sunder N, Burke D, Washicosky KJ, Tanzi RE, Marcantonio ER.","Ann Surg. 2013 Aug;258(2):364-9. doi: 10.1097/SLA.0b013e318298b077.","Xie Z","Ann Surg","2013","2013/06/05","PMC3880113","NIHMS542125","10.1097/SLA.0b013e318298b077"
"31892526","High density lipoprotein and its apolipoprotein-defined subspecies and risk of dementia","Koch M, DeKosky ST, Goodman M, Sun J, Furtado JD, Fitzpatrick AL, Mackey RH, Cai T, Lopez OL, Kuller LH, Mukamal KJ, Jensen MK.","J Lipid Res. 2020 Mar;61(3):445-454. doi: 10.1194/jlr.P119000473. Epub 2019 Dec 31.","Koch M","J Lipid Res","2020","2020/01/02","PMC7053836","","10.1194/jlr.P119000473"
"31792940","Risks and Benefits of Screening for Dementia in Primary Care: The Indiana University Cognitive Health Outcomes Investigation of the Comparative Effectiveness of Dementia Screening (IU CHOICE)Trial","Fowler NR, Perkins AJ, Gao S, Sachs GA, Boustani MA.","J Am Geriatr Soc. 2020 Mar;68(3):535-543. doi: 10.1111/jgs.16247. Epub 2019 Dec 2.","Fowler NR","J Am Geriatr Soc","2020","2019/12/04","PMC7187902","NIHMS1066400","10.1111/jgs.16247"
"31408838","APOE gene-dependent BOLD responses to a breath-hold across the adult lifespan","Rasmussen PM, Aamand R, Weitzberg E, Christiansen M, Østergaard L, Lund TE.","Neuroimage Clin. 2019;24:101955. doi: 10.1016/j.nicl.2019.101955. Epub 2019 Jul 22.","Rasmussen PM","Neuroimage Clin","2019","2019/08/14","PMC6699560","","10.1016/j.nicl.2019.101955"
"25085109","Complementarity of visual and voxel-based FDG-PET analysis to detect MCI-like hypometabolic pattern in elderly patients with hypertension and isolated memory complaints","Van Der Gucht A, Verger A, Yagdigul Y, Poussier S, Joly L, Watfa G, Benetos A, Karcher G, Marie PY.","Acta Radiol. 2015 Aug;56(8):980-9. doi: 10.1177/0284185114542366. Epub 2014 Aug 1.","Van Der Gucht A","Acta Radiol","2015","2014/08/03","","","10.1177/0284185114542366"
"2775607","EEG brain mapping in evaluating the time-course of the central action of DUP 996--a new acetylcholine releasing drug","Saletu B, Darragh A, Salmon P, Coen R.","Br J Clin Pharmacol. 1989 Jul;28(1):1-16. doi: 10.1111/j.1365-2125.1989.tb03500.x.","Saletu B","Br J Clin Pharmacol","1989","1989/07/01","PMC1379965","","10.1111/j.1365-2125.1989.tb03500.x"
"17462050","Weight increase in patients with dementia, and alteration in meal routines and meal environment after integrity promoting care","Mamhidir AG, Karlsson I, Norberg A, Mona K.","J Clin Nurs. 2007 May;16(5):987-96. doi: 10.1111/j.1365-2702.2006.01780.x.","Mamhidir AG","J Clin Nurs","2007","2007/04/28","","","10.1111/j.1365-2702.2006.01780.x"
"7611936","[Neuropsychological tests of simple application for diagnosing dementia]","Nitrini R, Lefèvre BH, Mathias SC, Caramelli P, Carrilho PE, Sauaia N, Massad E, Takiguti C, Da Silva IO, Porto CS, et al.","Arq Neuropsiquiatr. 1994 Dec;52(4):457-65. doi: 10.1590/s0004-282x1994000400001.","Nitrini R","Arq Neuropsiquiatr","1994","1994/12/01","","","10.1590/s0004-282x1994000400001"
"34404290","Evaluating pimavanserin as a treatment for psychiatric disorders: A pharmacological property in search of an indication","Davis J, Zamora D, Horowitz M, Leucht S.","Expert Opin Pharmacother. 2021 Sep;22(13):1651-1660. doi: 10.1080/14656566.2021.1942455. Epub 2021 Aug 18.","Davis J","Expert Opin Pharmacother","2021","2021/08/18","","","10.1080/14656566.2021.1942455"
"22710913","Dietary antioxidants and dementia in a population-based case-control study among older people in South Germany","von Arnim CA, Herbolsheimer F, Nikolaus T, Peter R, Biesalski HK, Ludolph AC, Riepe M, Nagel G; ActiFE Ulm Study Group.","J Alzheimers Dis. 2012;31(4):717-24. doi: 10.3233/JAD-2012-120634.","von Arnim CA","J Alzheimers Dis","2012","2012/06/20","","","10.3233/JAD-2012-120634"
"34989288","Empowering patients with dementia to make legally effective decisions: a randomized controlled trial on enhancing capacity to consent to treatment","Poth A, Penger S, Knebel M, Müller T, Pantel J, Oswald F, Haberstroh J.","Aging Ment Health. 2023 Feb;27(2):292-300. doi: 10.1080/13607863.2021.2024797. Epub 2022 Jan 6.","Poth A","Aging Ment Health","2023","2022/01/06","","","10.1080/13607863.2021.2024797"
"31039826","Effects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline (SmartAge)-study protocol for a randomized controlled trial","Wirth M, Schwarz C, Benson G, Horn N, Buchert R, Lange C, Köbe T, Hetzer S, Maglione M, Michael E, Märschenz S, Mai K, Kopp U, Schmitz D, Grittner U, Sigrist SJ, Stekovic S, Madeo F, Flöel A.","Alzheimers Res Ther. 2019 May 1;11(1):36. doi: 10.1186/s13195-019-0484-1.","Wirth M","Alzheimers Res Ther","2019","2019/05/02","PMC6492385","","10.1186/s13195-019-0484-1"
"22038392","Quality of life of community-residing persons with dementia based on self-rated and caregiver-rated measures","Black BS, Johnston D, Morrison A, Rabins PV, Lyketsos CG, Samus QM.","Qual Life Res. 2012 Oct;21(8):1379-89. doi: 10.1007/s11136-011-0044-z. Epub 2011 Oct 26.","Black BS","Qual Life Res","2012","2011/11/01","PMC3296880","NIHMS340010","10.1007/s11136-011-0044-z"
"12771112","Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial","Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J; WHIMS Investigators.","JAMA. 2003 May 28;289(20):2651-62. doi: 10.1001/jama.289.20.2651.","Shumaker SA","JAMA","2003","2003/05/29","","","10.1001/jama.289.20.2651"
"9708136","Effective caregiving approaches for patients with Alzheimer's disease","Burgener SC, Bakas T, Murray C, Dunahee J, Tossey S.","Geriatr Nurs. 1998 May-Jun;19(3):121-6. doi: 10.1016/s0197-4572(98)90055-6.","Burgener SC","Geriatr Nurs","1998","1998/08/26","","","10.1016/s0197-4572(98)90055-6"
"17362834","Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study","McKeith I, O'Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, Padovani A, Giubbini R, Bonuccelli U, Volterrani D, Holmes C, Kemp P, Tabet N, Meyer I, Reininger C; DLB Study Group.","Lancet Neurol. 2007 Apr;6(4):305-13. doi: 10.1016/S1474-4422(07)70057-1.","McKeith I","Lancet Neurol","2007","2007/03/17","","","10.1016/S1474-4422(07)70057-1"
"22642712","Steps, stages, and structure: finding compensatory order in scientific theories","Rutjens BT, van Harreveld F, van der Pligt J, Kreemers LM, Noordewier MK.","J Exp Psychol Gen. 2013 May;142(2):313-8. doi: 10.1037/a0028716. Epub 2012 May 28.","Rutjens BT","J Exp Psychol Gen","2013","2012/05/31","","","10.1037/a0028716"
"34560903","Disparities in the participation and adherence of older adults in lifestyle-based multidomain dementia prevention and the motivational role of perceived disease risk and intervention benefits: an observational ancillary study to a randomised controlled trial","Coley N, Coniasse-Brioude D, Igier V, Fournier T, Poulain JP, Andrieu S; ACCEPT study group.","Alzheimers Res Ther. 2021 Sep 24;13(1):157. doi: 10.1186/s13195-021-00904-6.","Coley N","Alzheimers Res Ther","2021","2021/09/25","PMC8464095","","10.1186/s13195-021-00904-6"
"24042414","[Correlation between cognitive impairment and plasma levels of clusterin/ApoJ in Parkinson disease patients not affected by dementia]","Niccoli Asabella A, Ruggeri M, Rubini D, Polimeno L, Spinelli C, Polito M, Pennelli M, Altini C, De Caro MS, Defazio G, Rubini G.","Recenti Prog Med. 2013 Jul-Aug;104(7-8):393-7. doi: 10.1701/1315.14582.","Niccoli Asabella A","Recenti Prog Med","2013","2013/09/18","","","10.1701/1315.14582"
"7854539","Selective neuroanatomic abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry","Raz N, Torres IJ, Briggs SD, Spencer WD, Thornton AE, Loken WJ, Gunning FM, McQuain JD, Driesen NR, Acker JD.","Neurology. 1995 Feb;45(2):356-66. doi: 10.1212/wnl.45.2.356.","Raz N","Neurology","1995","1995/02/01","","","10.1212/wnl.45.2.356"
"9844033","Identification of cognitive impairment in the elderly: homocysteine is an early marker","Lehmann M, Gottfries CG, Regland B.","Dement Geriatr Cogn Disord. 1999 Jan-Feb;10(1):12-20. doi: 10.1159/000017092.","Lehmann M","Dement Geriatr Cogn Disord","1999","1998/12/09","","","10.1159/000017092"
"14591143","An experimental evaluation of the efficacy of suloctidil in the treatment of primary degenerative dementia","McCaffrey RJ, Sleckler RA, Gansler DA, Roman LO, Holub RF.","Arch Clin Neuropsychol. 1987;2(2):155-61.","McCaffrey RJ","Arch Clin Neuropsychol","1987","1987/01/01","","",""
"16864841","Identification of subgroups in amnestic mild cognitive impairment","Guedj E, Barbeau EJ, Didic M, Felician O, de Laforte C, Ceccaldi M, Mundler O, Poncet M.","Neurology. 2006 Jul 25;67(2):356-8. doi: 10.1212/01.wnl.0000225076.73312.d4.","Guedj E","Neurology","2006","2006/07/26","","","10.1212/01.wnl.0000225076.73312.d4"
"33472172","Anserine, HClO-scavenger, protected against cognitive decline in individuals with mild cognitive impairment","Masuoka N, Lei C, Li H, Inamura N, Shiotani S, Yanai N, Sato K, Sakurai K, Hisatsune T.","Aging (Albany NY). 2021 Jan 20;13(2):1729-1741. doi: 10.18632/aging.202535. Epub 2021 Jan 20.","Masuoka N","Aging (Albany NY)","2021","2021/01/20","PMC7880346","","10.18632/aging.202535"
"33271506","Few Structural Brain Changes Associated With Moderate-Intensity Interval Training and Low-Intensity Continuous Training in a Randomized Trial of Fitness and Older Adults","Martin-Willett R, Ellingson JE, Fries J, Helmuth T, Karoly H, Giordano G, Calhoun VD, Bryan AD.","J Aging Phys Act. 2021 Jun 1;29(3):505-515. doi: 10.1123/japa.2019-0352. Epub 2020 Dec 2.","Martin-Willett R","J Aging Phys Act","2021","2020/12/03","PMC9092807","NIHMS1790923","10.1123/japa.2019-0352"
"29871544","Findings From a Prospective Randomized Controlled Trial of an Individualized Music Listening Program for Persons With Dementia","Kwak J, Anderson K, O'Connell Valuch K.","J Appl Gerontol. 2020 Jun;39(6):567-575. doi: 10.1177/0733464818778991. Epub 2018 Jun 6.","Kwak J","J Appl Gerontol","2020","2018/06/07","","","10.1177/0733464818778991"
"27567842","Combination of Structural MRI and FDG-PET of the Brain Improves Diagnostic Accuracy in Newly Manifested Cognitive Impairment in Geriatric Inpatients","Ritter K, Lange C, Weygandt M, Mäurer A, Roberts A, Estrella M, Suppa P, Spies L, Prasad V, Steffen I, Apostolova I, Bittner D, Gövercin M, Brenner W, Mende C, Peters O, Seybold J, Fiebach JB, Steinhagen-Thiessen E, Hampel H, Haynes JD, Buchert R.","J Alzheimers Dis. 2016 Oct 18;54(4):1319-1331. doi: 10.3233/JAD-160380.","Ritter K","J Alzheimers Dis","2016","2016/08/29","","","10.3233/JAD-160380"
"28124590","A Multicentre Italian Validation Study in Aging Adults with Down Syndrome and Other Forms of Intellectual Disabilities: Dementia Screening Questionnaire for Individuals with Intellectual Disabilities","Gomiero T, Bertelli M, Deb S, Weger E, Marangoni A, De Bastiani E, Mantesso U, De Vreese LP.","Curr Alzheimer Res. 2017;14(7):709-721. doi: 10.2174/1567205014666170117094757.","Gomiero T","Curr Alzheimer Res","2017","2017/01/27","","","10.2174/1567205014666170117094757"
"21334099","Age and amyloid-related alterations in default network habituation to stimulus repetition","Vannini P, Hedden T, Becker JA, Sullivan C, Putcha D, Rentz D, Johnson KA, Sperling RA.","Neurobiol Aging. 2012 Jul;33(7):1237-52. doi: 10.1016/j.neurobiolaging.2011.01.003. Epub 2011 Feb 18.","Vannini P","Neurobiol Aging","2012","2011/02/22","PMC3111876","NIHMS276432","10.1016/j.neurobiolaging.2011.01.003"
"21383112","""Learning to become a family caregiver"" efficacy of an intervention program for caregivers following diagnosis of dementia in a relative","Ducharme FC, Lévesque LL, Lachance LM, Kergoat MJ, Legault AJ, Beaudet LM, Zarit SH.","Gerontologist. 2011 Aug;51(4):484-94. doi: 10.1093/geront/gnr014. Epub 2011 Mar 7.","Ducharme FC","Gerontologist","2011","2011/03/09","","","10.1093/geront/gnr014"
"9170118","Pathophysiology and psychopharmacology of dementia--a new study design. 2. Cyclandelate treatment--a placebo-controlled double-blind clinical trial","Schellenberg R, Todorova A, Wedekind W, Schober F, Dimpfel W.","Neuropsychobiology. 1997;35(3):132-42. doi: 10.1159/000119334.","Schellenberg R","Neuropsychobiology","1997","1997/01/01","","","10.1159/000119334"
"21072603","Cognitive function in elderly marathon runners: cross-sectional data from the marathon trial (APSOEM)","Winker R, Lukas I, Perkmann T, Haslacher H, Ponocny E, Lehrner J, Tscholakoff D, Dal-Bianco P.","Wien Klin Wochenschr. 2010 Dec;122(23-24):704-16. doi: 10.1007/s00508-010-1485-z. Epub 2010 Nov 15.","Winker R","Wien Klin Wochenschr","2010","2010/11/13","","","10.1007/s00508-010-1485-z"
"19001543","Effects of donepezil on cortical activation in mild cognitive impairment: a pilot double-blind placebo-controlled trial using functional MR imaging","Petrella JR, Prince SE, Krishnan S, Husn H, Kelley L, Doraiswamy PM.","AJNR Am J Neuroradiol. 2009 Feb;30(2):411-6. doi: 10.3174/ajnr.A1359. Epub 2008 Nov 11.","Petrella JR","AJNR Am J Neuroradiol","2009","2008/11/13","PMC7051379","","10.3174/ajnr.A1359"
"19699261","BT-11 is effective for enhancing cognitive functions in the elderly humans","Shin KY, Lee JY, Won BY, Jung HY, Chang KA, Koppula S, Suh YH.","Neurosci Lett. 2009 Nov 13;465(2):157-9. doi: 10.1016/j.neulet.2009.08.033. Epub 2009 Aug 20.","Shin KY","Neurosci Lett","2009","2009/08/25","","","10.1016/j.neulet.2009.08.033"
"9509747","Pupil noise is a discriminator between narcoleptics and controls","O'Neill WD, Oroujeh AM, Merritt SL.","IEEE Trans Biomed Eng. 1998 Mar;45(3):314-22. doi: 10.1109/10.661156.","O'Neill WD","IEEE Trans Biomed Eng","1998","1998/03/24","","","10.1109/10.661156"
"17257729","Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder","Iga J, Ueno S, Yamauchi K, Numata S, Tayoshi-Shibuya S, Kinouchi S, Nakataki M, Song H, Hokoishi K, Tanabe H, Sano A, Ohmori T.","Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13;31(3):658-63. doi: 10.1016/j.pnpbp.2006.12.011. Epub 2006 Dec 28.","Iga J","Prog Neuropsychopharmacol Biol Psychiatry","2007","2007/01/30","","","10.1016/j.pnpbp.2006.12.011"
"15023808","Plasma levels of beta-amyloid(1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins","Höglund K, Wiklund O, Vanderstichele H, Eikenberg O, Vanmechelen E, Blennow K.","Arch Neurol. 2004 Mar;61(3):333-7. doi: 10.1001/archneur.61.3.333.","Höglund K","Arch Neurol","2004","2004/03/17","","","10.1001/archneur.61.3.333"
"11052587","Effects of transdermal nicotine on cognitive performance in Down's syndrome","Seidl R, Tiefenthaler M, Hauser E, Lubec G.","Lancet. 2000 Oct 21;356(9239):1409-10. doi: 10.1016/S0140-6736(00)02848-8.","Seidl R","Lancet","2000","2000/10/29","","","10.1016/S0140-6736(00)02848-8"
"1573199","Testing for limits of cognitive reserve capacity: a promising strategy for early diagnosis of dementia?","Baltes MM, Kühl KP, Sowarka D.","J Gerontol. 1992 May;47(3):P165-7. doi: 10.1093/geronj/47.3.p165.","Baltes MM","J Gerontol","1992","1992/05/01","","","10.1093/geronj/47.3.p165"
"31327120","Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients","Duma C, Kopyov O, Kopyov A, Berman M, Lander E, Elam M, Arata M, Weiland D, Cannell R, Caraway C, Berman S, Scord K, Stemler L, Chung K, Khoudari S, McRory R, Duma C, Farmer S, Bravo A, Yassa C, Sanathara A, Singh E, Rapaport B.","Mol Biol Rep. 2019 Oct;46(5):5257-5272. doi: 10.1007/s11033-019-04983-5. Epub 2019 Jul 20.","Duma C","Mol Biol Rep","2019","2019/07/22","","","10.1007/s11033-019-04983-5"
"9443056","Visual association encoding activates the medial temporal lobe: a functional magnetic resonance imaging study","Rombouts SA, Machielsen WC, Witter MP, Barkhof F, Lindeboom J, Scheltens P.","Hippocampus. 1997;7(6):594-601. doi: 10.1002/(SICI)1098-1063(1997)7:6<594::AID-HIPO2>3.0.CO;2-F.","Rombouts SA","Hippocampus","1997","1997/01/01","","","10.1002/(SICI)1098-1063(1997)7:6<594::AID-HIPO2>3.0.CO;2-F"
"27106880","Racial Differences in Program Evaluation of a Lifestyle Physical Activity Randomized Controlled Trial","Cothran FA, Paun O, Farran CJ, Barnes LL.","West J Nurs Res. 2016 Oct;38(10):1264-81. doi: 10.1177/0193945916644686. Epub 2016 Apr 22.","Cothran FA","West J Nurs Res","2016","2016/04/24","PMC5033672","NIHMS790663","10.1177/0193945916644686"
"16801670","Family history of dementia is a risk factor for Lewy body disease","Woodruff BK, Graff-Radford NR, Ferman TJ, Dickson DW, DeLucia MW, Crook JE, Arvanitakis Z, Brassler S, Waters C, Barker W, Duara R.","Neurology. 2006 Jun 27;66(12):1949-50. doi: 10.1212/01.wnl.0000219812.20616.b3.","Woodruff BK","Neurology","2006","2006/06/28","","","10.1212/01.wnl.0000219812.20616.b3"
"31067489","Mnemonic strategy training increases neocortical activation in healthy older adults and patients with mild cognitive impairment","Hampstead BM, Stringer AY, Stilla RF, Sathian K.","Int J Psychophysiol. 2020 Aug;154:27-36. doi: 10.1016/j.ijpsycho.2019.04.011. Epub 2019 May 5.","Hampstead BM","Int J Psychophysiol","2020","2019/05/09","PMC7218756","NIHMS1529091","10.1016/j.ijpsycho.2019.04.011"
"31535922","The Effect of the ""Great Village"" on Psychological Outcomes, Burden, and Mastery in African American Caregivers of Persons Living With Dementia","Brewster GS, Epps F, Dye CE, Hepburn K, Higgins MK, Parker ML.","J Appl Gerontol. 2020 Oct;39(10):1059-1068. doi: 10.1177/0733464819874574. Epub 2019 Sep 19.","Brewster GS","J Appl Gerontol","2020","2019/09/20","PMC7080571","NIHMS1049089","10.1177/0733464819874574"
"29064406","Diosgenin-Rich Yam Extract Enhances Cognitive Function: A Placebo-Controlled, Randomized, Double-Blind, Crossover Study of Healthy Adults","Tohda C, Yang X, Matsui M, Inada Y, Kadomoto E, Nakada S, Watari H, Shibahara N.","Nutrients. 2017 Oct 24;9(10):1160. doi: 10.3390/nu9101160.","Tohda C","Nutrients","2017","2017/10/25","PMC5691776","","10.3390/nu9101160"
"34027851","Comparison of Neuropsychological Assessment by Videoconference and Face to Face","Gnassounou R, Defontaines B, Denolle S, Brun S, Germain R, Schwartz D, Schück S, Michon A, Belin C, Maillet D.","J Int Neuropsychol Soc. 2022 May;28(5):483-493. doi: 10.1017/S1355617721000679. Epub 2021 May 24.","Gnassounou R","J Int Neuropsychol Soc","2022","2021/05/24","","","10.1017/S1355617721000679"
"30203668","Cost impact of the transitional care model for hospitalized cognitively impaired older adults","Pauly MV, Hirschman KB, Hanlon AL, Huang L, Bowles KH, Bradway C, McCauley K, Naylor MD.","J Comp Eff Res. 2018 Sep;7(9):913-922. doi: 10.2217/cer-2018-0040. Epub 2018 Sep 11.","Pauly MV","J Comp Eff Res","2018","2018/09/12","PMC6219439","","10.2217/cer-2018-0040"
"19156121","[Efficacy of memantine in Parkinson's disease with dementia]","Levin OS, Batukaeva LA.","Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(12):16-23.","Levin OS","Zh Nevrol Psikhiatr Im S S Korsakova","2008","2009/01/22","","",""
"18805604","Cardiovascular risk and memory in non-demented elderly women","Wang S, Jacobs D, Andrews H, Tsai WY, Luo X, Bergmann C, Sano M.","Neurobiol Aging. 2010 Jul;31(7):1250-3. doi: 10.1016/j.neurobiolaging.2008.08.007. Epub 2008 Sep 21.","Wang S","Neurobiol Aging","2010","2008/09/23","PMC2900768","NIHMS210388","10.1016/j.neurobiolaging.2008.08.007"
"35147535","The Rationale and Design of Behavioral Interventions for Management of Agitation in Dementia in a Multi-Site Clinical Trial","Zarei S, Colman S, Rostas A, Burhan AM, Chu L, Davies SJ, Derkach P, Elmi S, Hussain M, Gerretsen P, Graff-Guerrero A, Ismail Z, Kim D, Krisman L, Moghabghab R, Mulsant BH, Nair V, Pollock BG, Rej S, Simmons J, Van Bussel L, Rajji TK, Kumar S; StaN Study Group.","J Alzheimers Dis. 2022;86(2):827-840. doi: 10.3233/JAD-215261.","Zarei S","J Alzheimers Dis","2022","2022/02/11","","","10.3233/JAD-215261"
"32252544","A feasibility randomised control trial of individual cognitive stimulation therapy for dementia: impact on cognition, quality of life and positive psychology","Gibbor L, Forde L, Yates L, Orfanos S, Komodromos C, Page H, Harvey K, Spector A.","Aging Ment Health. 2021 Jun;25(6):999-1007. doi: 10.1080/13607863.2020.1747048. Epub 2020 Apr 7.","Gibbor L","Aging Ment Health","2021","2020/04/08","","","10.1080/13607863.2020.1747048"
"22408266","Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial","Bergh S, Selbæk G, Engedal K.","BMJ. 2012 Mar 9;344:e1566. doi: 10.1136/bmj.e1566.","Bergh S","BMJ","2012","2012/03/13","","","10.1136/bmj.e1566"
"31476161","Clinical Benefits of Antioxidative Supplement Twendee X for Mild Cognitive Impairment: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Prospective Interventional Study","Tadokoro K, Morihara R, Ohta Y, Hishikawa N, Kawano S, Sasaki R, Matsumoto N, Nomura E, Nakano Y, Takahashi Y, Takemoto M, Yamashita T, Ueno S, Wakutani Y, Takao Y, Morimoto N, Kutoku Y, Sunada Y, Taomoto K, Manabe Y, Deguchi K, Higashi Y, Inufusa H, You F, Yoshikawa T, von Greiffenclau MM, Abe K.","J Alzheimers Dis. 2019;71(3):1063-1069. doi: 10.3233/JAD-190644.","Tadokoro K","J Alzheimers Dis","2019","2019/09/03","","","10.3233/JAD-190644"
"30219087","Patterns of cognitive function in middle-aged and elderly Chinese adults-findings from the EMCOA study","An Y, Feng L, Zhang X, Wang Y, Wang Y, Tao L, Lu Y, Qin Z, Xiao R.","Alzheimers Res Ther. 2018 Sep 15;10(1):93. doi: 10.1186/s13195-018-0421-8.","An Y","Alzheimers Res Ther","2018","2018/09/17","PMC6138914","","10.1186/s13195-018-0421-8"
"26519435","Clinical and Demographic Factors Associated with the Cognitive and Emotional Efficacy of Regular Musical Activities in Dementia","Särkämö T, Laitinen S, Numminen A, Kurki M, Johnson JK, Rantanen P.","J Alzheimers Dis. 2016;49(3):767-81. doi: 10.3233/JAD-150453.","Särkämö T","J Alzheimers Dis","2016","2015/11/01","","","10.3233/JAD-150453"
"22571978","Insulin and sex interactions in older adults with mild cognitive impairment","Cholerton B, Baker LD, Trittschuh EH, Crane PK, Larson EB, Arbuckle M, Saucedo HH, McCurry SM, Bowen JD, McCormick WC, Craft S.","J Alzheimers Dis. 2012;31(2):401-10. doi: 10.3233/JAD-2012-120202.","Cholerton B","J Alzheimers Dis","2012","2012/05/11","PMC3798013","NIHMS488739","10.3233/JAD-2012-120202"
"32417770","The MARBLE Study Protocol: Modulating ApoE Signaling to Reduce Brain Inflammation, DeLirium, and PostopErative Cognitive Dysfunction","VanDusen KW, Eleswarpu S, Moretti EW, Devinney MJ, Crabtree DM, Laskowitz DT, Woldorff MG, Roberts KC, Whittle J, Browndyke JN, Cooter M, Rockhold FW, Anakwenze O, Bolognesi MP, Easley ME, Ferrandino MN, Jiranek WA, Berger M; MARBLE Study Investigators.","J Alzheimers Dis. 2020;75(4):1319-1328. doi: 10.3233/JAD-191185.","VanDusen KW","J Alzheimers Dis","2020","2020/05/18","PMC7923142","NIHMS1672258","10.3233/JAD-191185"
"31683483","Effect of Chlorogenic Acids on Cognitive Function in Mild Cognitive Impairment: A Randomized Controlled Crossover Trial","Ochiai R, Saitou K, Suzukamo C, Osaki N, Asada T.","J Alzheimers Dis. 2019;72(4):1209-1216. doi: 10.3233/JAD-190757.","Ochiai R","J Alzheimers Dis","2019","2019/11/06","PMC6971825","","10.3233/JAD-190757"
"31215755","Safety, Tolerability, and Pharmacokinetics of the β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor Verubecestat (MK-8931) in Healthy Elderly Male and Female Subjects","Forman M, Palcza J, Tseng J, Stone JA, Walker B, Swearingen D, Troyer MD, Dockendorf MF.","Clin Transl Sci. 2019 Sep;12(5):545-555. doi: 10.1111/cts.12645. Epub 2019 Jun 19.","Forman M","Clin Transl Sci","2019","2019/06/20","PMC6742941","","10.1111/cts.12645"
"23831174","A videophone psychosocial intervention for dementia caregivers","Czaja SJ, Loewenstein D, Schulz R, Nair SN, Perdomo D.","Am J Geriatr Psychiatry. 2013 Nov;21(11):1071-81. doi: 10.1016/j.jagp.2013.02.019. Epub 2013 Jul 3.","Czaja SJ","Am J Geriatr Psychiatry","2013","2013/07/09","","","10.1016/j.jagp.2013.02.019"
"14744180","A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome","Ballard CG, Thomas A, Fossey J, Lee L, Jacoby R, Lana MM, Bannister C, McShane R, Swann A, Juszczak E, O'Brien JT.","J Clin Psychiatry. 2004 Jan;65(1):114-9. doi: 10.4088/jcp.v65n0120.","Ballard CG","J Clin Psychiatry","2004","2004/01/28","","","10.4088/jcp.v65n0120"
"23158942","Effects of Chinese medicine for promoting blood circulation and removing blood stasis in treating patients with mild to moderate vascular dementia: a randomized, double-blind and parallel-controlled trial","Wei MQ, Tian JZ, Shi J, Ma FY, Miao YC, Wang YY.","Zhong Xi Yi Jie He Xue Bao. 2012 Nov;10(11):1240-6. doi: 10.3736/jcim20121107.","Wei MQ","Zhong Xi Yi Jie He Xue Bao","2012","2012/11/20","","","10.3736/jcim20121107"
"12768361","The clinical use of P300 event related potentials for the evaluation of cholinesterase inhibitors treatment in demented patients","Werber EA, Gandelman-Marton R, Klein C, Rabey JM.","J Neural Transm (Vienna). 2003 Jun;110(6):659-69. doi: 10.1007/s00702-003-0817-9.","Werber EA","J Neural Transm (Vienna)","2003","2003/05/28","","","10.1007/s00702-003-0817-9"
"26221954","Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population","Gu Y, Razlighi QR, Zahodne LB, Janicki SC, Ichise M, Manly JJ, Devanand DP, Brickman AM, Schupf N, Mayeux R, Stern Y.","PLoS One. 2015 Jul 29;10(7):e0123743. doi: 10.1371/journal.pone.0123743. eCollection 2015.","Gu Y","PLoS One","2015","2015/07/30","PMC4519341","","10.1371/journal.pone.0123743"
"20170698","Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease","Okahara K, Ishida Y, Hayashi Y, Inoue T, Tsuruta K, Takeuchi K, Yoshimuta H, Kiue K, Ninomiya Y, Kawano J, Yoshida K, Noda S, Tomita S, Fujimoto M, Hosomi J, Mitsuyama Y.","Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 16;34(3):532-6. doi: 10.1016/j.pnpbp.2010.02.013. Epub 2010 Feb 17.","Okahara K","Prog Neuropsychopharmacol Biol Psychiatry","2010","2010/02/23","","","10.1016/j.pnpbp.2010.02.013"
"20395618","Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size","Román GC, Salloway S, Black SE, Royall DR, Decarli C, Weiner MW, Moline M, Kumar D, Schindler R, Posner H.","Stroke. 2010 Jun;41(6):1213-21. doi: 10.1161/STROKEAHA.109.570077. Epub 2010 Apr 15.","Román GC","Stroke","2010","2010/04/17","PMC2954887","NIHMS232062","10.1161/STROKEAHA.109.570077"
"29018129","Neuroimaging Correlates of Cerebral Microbleeds: The ARIC Study (Atherosclerosis Risk in Communities)","Graff-Radford J, Simino J, Kantarci K, Mosley TH Jr, Griswold ME, Windham BG, Sharrett AR, Albert MS, Gottesman RF, Jack CR Jr, Vemuri P, Knopman DS.","Stroke. 2017 Nov;48(11):2964-2972. doi: 10.1161/STROKEAHA.117.018336. Epub 2017 Oct 10.","Graff-Radford J","Stroke","2017","2017/10/12","PMC5685663","NIHMS907534","10.1161/STROKEAHA.117.018336"
"17545734","Symptoms of memory loss as predictors of cognitive impairment?: the use and reliability of memory ratings in a clinic population","Archer HA, McFarlane F, Frost C, Cutler D, Fox NC, Rossor MN.","Alzheimer Dis Assoc Disord. 2007 Apr-Jun;21(2):101-6. doi: 10.1097/WAD.0b013e318065bfc2.","Archer HA","Alzheimer Dis Assoc Disord","2007","2007/06/05","","","10.1097/WAD.0b013e318065bfc2"
"9524882","Variable memory profiles in Parkinson's disease","Filoteo JV, Rilling LM, Cole B, Williams BJ, Davis JD, Roberts JW.","J Clin Exp Neuropsychol. 1997 Dec;19(6):878-88. doi: 10.1080/01688639708403768.","Filoteo JV","J Clin Exp Neuropsychol","1997","1998/04/03","","","10.1080/01688639708403768"
"17173920","Estrogen therapy and brain muscarinic receptor density in healthy females: a SPET study","Norbury R, Travis MJ, Erlandsson K, Waddington W, Ell PJ, Murphy DG.","Horm Behav. 2007 Feb;51(2):249-57. doi: 10.1016/j.yhbeh.2006.10.007. Epub 2006 Dec 14.","Norbury R","Horm Behav","2007","2006/12/19","","","10.1016/j.yhbeh.2006.10.007"
"11163298","Post-dexamethasone cortisol level and memory performance in elderly depressed patients","Adler G, Jajcevic A.","Neurosci Lett. 2001 Feb 2;298(2):142-4. doi: 10.1016/s0304-3940(00)01754-7.","Adler G","Neurosci Lett","2001","2001/02/13","","","10.1016/s0304-3940(00)01754-7"
"33444615","Psychological Symptoms Among Surrogates of Critically Ill Patients During and Before the COVID-19 Pandemic","Greenberg JA, Basapur S, Quinn TV, Bulger JL, Glover CM, Shah RC.","Chest. 2021 Jun;159(6):2318-2320. doi: 10.1016/j.chest.2020.12.056. Epub 2021 Jan 12.","Greenberg JA","Chest","2021","2021/01/14","PMC7832129","","10.1016/j.chest.2020.12.056"
"30879470","Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT","Clare L, Kudlicka A, Oyebode JR, Jones RW, Bayer A, Leroi I, Kopelman M, James IA, Culverwell A, Pool J, Brand A, Henderson C, Hoare Z, Knapp M, Morgan-Trimmer S, Burns A, Corbett A, Whitaker R, Woods B.","Health Technol Assess. 2019 Mar;23(10):1-242. doi: 10.3310/hta23100.","Clare L","Health Technol Assess","2019","2019/03/19","PMC6441850","","10.3310/hta23100"
"32108738","One Year of Continuous Positive Airway Pressure Adherence Improves Cognition in Older Adults With Mild Apnea and Mild Cognitive Impairment","Wang Y, Cheng C, Moelter S, Fuentecilla JL, Kincheloe K, Lozano AJ, Carter P, Gooneratne N, Richards KC.","Nurs Res. 2020 Mar/Apr;69(2):157-164. doi: 10.1097/NNR.0000000000000420.","Wang Y","Nurs Res","2020","2020/02/29","PMC7212768","NIHMS1549587","10.1097/NNR.0000000000000420"
"24965720","Identifying at-risk dementia caregivers following institutionalization: the nursing home admission-burden and nursing home admission-depression prognostic tools","Gaugler JE, Mittelman MS, Hepburn K, Newcomer R.","J Appl Gerontol. 2014 Aug;33(5):624-46. doi: 10.1177/0733464812454008. Epub 2012 Aug 7.","Gaugler JE","J Appl Gerontol","2014","2014/06/27","PMC4076154","NIHMS401042","10.1177/0733464812454008"
"29485197","Testing the evidence integration triangle for implementation of interventions to manage behavioral and psychological symptoms associated with dementia: Protocol for a pragmatic trial","Resnick B, Kolanowski A, Van Haitsma K, Galik E, Boltz M, Ellis J, Behrens L, Flanagan NM, Eshraghi KJ, Zhu S.","Res Nurs Health. 2018 Jun;41(3):228-242. doi: 10.1002/nur.21866. Epub 2018 Feb 27.","Resnick B","Res Nurs Health","2018","2018/02/28","PMC6400658","NIHMS1013630","10.1002/nur.21866"
"32972311","Reflections on a personalized cognitive rehabilitation intervention: Experiences of people living with dementia and their carers participating in the GREAT trial","Warmoth K, Morgan-Trimmer S, Kudlicka A, Toms G, James IA, Woods B; GREAT trial team.","Neuropsychol Rehabil. 2022 Mar;32(2):268-286. doi: 10.1080/09602011.2020.1820876. Epub 2020 Sep 24.","Warmoth K","Neuropsychol Rehabil","2022","2020/09/25","","","10.1080/09602011.2020.1820876"
"28661262","Memantine improves semantic memory in patients with amnestic mild cognitive impairment: A single-photon emission computed tomography study","Ilhan Algin D, Dagli Atalay S, Ozkan S, Ozbabalik Adapinar D, Ak Sivrioz I.","J Int Med Res. 2017 Dec;45(6):2053-2064. doi: 10.1177/0300060517715166. Epub 2017 Jun 29.","Ilhan Algin D","J Int Med Res","2017","2017/06/30","PMC5805216","","10.1177/0300060517715166"
"25525349","Effectiveness of weekly cognitive stimulation therapy for people with dementia and the additional impact of enhancing cognitive stimulation therapy with a carer training program","Cove J, Jacobi N, Donovan H, Orrell M, Stott J, Spector A.","Clin Interv Aging. 2014 Dec 11;9:2143-50. doi: 10.2147/CIA.S66232. eCollection 2014.","Cove J","Clin Interv Aging","2014","2014/12/20","PMC4267515","","10.2147/CIA.S66232"
"23410232","AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans","Georgievska B, Sandin J, Doherty J, Mörtberg A, Neelissen J, Andersson A, Gruber S, Nilsson Y, Schött P, Arvidsson PI, Hellberg S, Osswald G, Berg S, Fälting J, Bhat RV.","J Neurochem. 2013 May;125(3):446-56. doi: 10.1111/jnc.12203. Epub 2013 Mar 11.","Georgievska B","J Neurochem","2013","2013/02/16","","","10.1111/jnc.12203"
"34528692","Communication Partner Engagement: A Relevant Factor for Functional Outcomes in Speech-Language Therapy for Aphasic Dementia","Rogalski E, Roberts A, Salley E, Saxon M, Fought A, Esparza M, Blaze E, Coventry C, Mesulam MM, Weintraub S, Mooney A, Khayum B, Rademaker A.","J Gerontol B Psychol Sci Soc Sci. 2022 Jun 1;77(6):1017-1025. doi: 10.1093/geronb/gbab165.","Rogalski E","J Gerontol B Psychol Sci Soc Sci","2022","2021/09/16","PMC9159055","","10.1093/geronb/gbab165"
"16242812","Gene expression correlates of neurofibrillary tangles in Alzheimer's disease","Dunckley T, Beach TG, Ramsey KE, Grover A, Mastroeni D, Walker DG, LaFleur BJ, Coon KD, Brown KM, Caselli R, Kukull W, Higdon R, McKeel D, Morris JC, Hulette C, Schmechel D, Reiman EM, Rogers J, Stephan DA.","Neurobiol Aging. 2006 Oct;27(10):1359-71. doi: 10.1016/j.neurobiolaging.2005.08.013. Epub 2005 Oct 19.","Dunckley T","Neurobiol Aging","2006","2005/10/26","PMC2259291","NIHMS40843","10.1016/j.neurobiolaging.2005.08.013"
"16192723","Donepezil in vascular dementia: combined analysis of two large-scale clinical trials","Román GC, Wilkinson DG, Doody RS, Black SE, Salloway SP, Schindler RJ.","Dement Geriatr Cogn Disord. 2005;20(6):338-44. doi: 10.1159/000088494. Epub 2005 Sep 23.","Román GC","Dement Geriatr Cogn Disord","2005","2005/09/30","","","10.1159/000088494"
"29876831","Six-month observational follow-up on activities of daily living in people with dementia living in nursing homes after a 6-month group based on either exercise or social activities","Maltais M, Rolland Y, Haÿ PE, Armaingaud D, Vellas B, de Souto Barreto P.","Aging Clin Exp Res. 2019 Mar;31(3):361-366. doi: 10.1007/s40520-018-0984-z. Epub 2018 Jun 7.","Maltais M","Aging Clin Exp Res","2019","2018/06/08","","","10.1007/s40520-018-0984-z"
"27266867","The efficacy and safety of Fufangdanshen tablets (Radix Salviae miltiorrhizae formula tablets) for mild to moderate vascular dementia: a study protocol for a randomized controlled trial","Tian J, Shi J, Wei M, Qin R, Ni J, Zhang X, Li T, Wang Y.","Trials. 2016 Jun 8;17(1):281. doi: 10.1186/s13063-016-1410-5.","Tian J","Trials","2016","2016/06/09","PMC4897894","","10.1186/s13063-016-1410-5"
"17664404","Galantamine treatment of vascular dementia: a randomized trial","Auchus AP, Brashear HR, Salloway S, Korczyn AD, De Deyn PP, Gassmann-Mayer C; GAL-INT-26 Study Group.","Neurology. 2007 Jul 31;69(5):448-58. doi: 10.1212/01.wnl.0000266625.31615.f6.","Auchus AP","Neurology","2007","2007/08/01","","","10.1212/01.wnl.0000266625.31615.f6"
"12059047","A phase I study of AIT-082 in healthy elderly volunteers","Grundman M, Farlow M, Peavy G, Kim HT, Capparelli E, Schultz AN, Salmon DP, Ferris SH, Mobs R, Thomas RG, Schafer K, Campbell K, Hake AM, Schoos B, Thal LJ; Alzheimer's Disease Cooperative Study.","J Mol Neurosci. 2002 Jun;18(3):283-93. doi: 10.1385/jmn:18:3:283.","Grundman M","J Mol Neurosci","2002","2002/06/13","","","10.1385/jmn:18:3:283"
"25666216","A break-even analysis for dementia care collaboration: Partners in Dementia Care","Morgan RO, Bass DM, Judge KS, Liu CF, Wilson N, Snow AL, Pirraglia P, Garcia-Maldonado M, Raia P, Fouladi NN, Kunik ME.","J Gen Intern Med. 2015 Jun;30(6):804-9. doi: 10.1007/s11606-015-3205-x. Epub 2015 Feb 10.","Morgan RO","J Gen Intern Med","2015","2015/02/11","PMC4441671","","10.1007/s11606-015-3205-x"
"10613616","Plasma tacrine concentrations are significantly increased by concomitant hormone replacement therapy","Laine K, Palovaara S, Tapanainen P, Manninen P.","Clin Pharmacol Ther. 1999 Dec;66(6):602-8. doi: 10.1053/cp.1999.v66.103404001.","Laine K","Clin Pharmacol Ther","1999","1999/12/29","","","10.1053/cp.1999.v66.103404001"
"36157386","The Effects of Standardised versus Individualised Aerobic Exercise Prescription on Fitness-Fatness Index in Sedentary Adults: A Randomised Controlled Trial","Kirton MJ, Burnley MT, Ramos JS, Weatherwax R, Dalleck LC.","J Sports Sci Med. 2022 Sep 1;21(3):347-355. doi: 10.52082/jssm.2022.347. eCollection 2022 Sep.","Kirton MJ","J Sports Sci Med","2022","2022/09/26","PMC9459763","","10.52082/jssm.2022.347"
"17116917","Enhancing the quality of life of dementia caregivers from different ethnic or racial groups: a randomized, controlled trial","Belle SH, Burgio L, Burns R, Coon D, Czaja SJ, Gallagher-Thompson D, Gitlin LN, Klinger J, Koepke KM, Lee CC, Martindale-Adams J, Nichols L, Schulz R, Stahl S, Stevens A, Winter L, Zhang S; Resources for Enhancing Alzheimer's Caregiver Health (REACH) II Investigators.","Ann Intern Med. 2006 Nov 21;145(10):727-38. doi: 10.7326/0003-4819-145-10-200611210-00005.","Belle SH","Ann Intern Med","2006","2006/11/23","PMC2585490","NIHMS72020","10.7326/0003-4819-145-10-200611210-00005"
"23438677","Effects of anesthetic isoflurane and desflurane on human cerebrospinal fluid Aβ and τ level","Zhang B, Tian M, Zheng H, Zhen Y, Yue Y, Li T, Li S, Marcantonio ER, Xie Z.","Anesthesiology. 2013 Jul;119(1):52-60. doi: 10.1097/ALN.0b013e31828ce55d.","Zhang B","Anesthesiology","2013","2013/02/27","PMC3938174","NIHMS554380","10.1097/ALN.0b013e31828ce55d"
"32072866","Effects of a Video-based Intervention on Caregiver Confidence for Managing Dementia Care Challenges: Findings from the FamTechCare Clinical Trial","Shaw CA, Williams KN, Perkhounkova Y, Hein M, Coleman CK.","Clin Gerontol. 2020 Oct-Dec;43(5):508-517. doi: 10.1080/07317115.2020.1729917. Epub 2020 Feb 19.","Shaw CA","Clin Gerontol","2020","2020/02/20","PMC7434650","NIHMS1563810","10.1080/07317115.2020.1729917"
"8557206","A comprehensive support program: effect on depression in spouse-caregivers of AD patients","Mittelman MS, Ferris SH, Shulman E, Steinberg G, Ambinder A, Mackell JA, Cohen J.","Gerontologist. 1995 Dec;35(6):792-802. doi: 10.1093/geront/35.6.792.","Mittelman MS","Gerontologist","1995","1995/12/01","","","10.1093/geront/35.6.792"
"10549687","Donepezil for psychotropic-induced memory loss","Jacobsen FM, Comas-Díaz L.","J Clin Psychiatry. 1999 Oct;60(10):698-704. doi: 10.4088/jcp.v60n1009.","Jacobsen FM","J Clin Psychiatry","1999","1999/11/05","","","10.4088/jcp.v60n1009"
"27810267","Walking Aids Moderate Exercise Effects on Gait Speed in People With Dementia: A Randomized Controlled Trial","Toots A, Littbrand H, Holmberg H, Nordström P, Lundin-Olsson L, Gustafson Y, Rosendahl E.","J Am Med Dir Assoc. 2017 Mar 1;18(3):227-233. doi: 10.1016/j.jamda.2016.09.003. Epub 2016 Oct 31.","Toots A","J Am Med Dir Assoc","2017","2016/11/05","","","10.1016/j.jamda.2016.09.003"
"16601937","P300 auditory event-related potentials and neuropsychological study during donepezil treatment in vascular dementia","Paci C, Gobbato R, Carboni T, Sanguigni S, Santone A, Curatola L.","Neurol Sci. 2006 Feb;26(6):435-7. doi: 10.1007/s10072-006-0528-8.","Paci C","Neurol Sci","2006","2006/04/08","","","10.1007/s10072-006-0528-8"
"9352289","Executive control and the comprehension of medical information by elderly retirees","Royall DR, Cordes J, Polk M.","Exp Aging Res. 1997 Oct-Dec;23(4):301-13. doi: 10.1080/03610739708254033.","Royall DR","Exp Aging Res","1997","1997/11/14","","","10.1080/03610739708254033"
"9148240","Amyloid beta protein and transthyretin, sequestrating protein colocalize in normal human kidney","Tsuzuki K, Fukatsu R, Hayashi Y, Yoshida T, Sasaki N, Takamaru Y, Yamaguchi H, Tateno M, Fujii N, Takahata N.","Neurosci Lett. 1997 Feb 7;222(3):163-6. doi: 10.1016/s0304-3940(97)13369-9.","Tsuzuki K","Neurosci Lett","1997","1997/02/07","","","10.1016/s0304-3940(97)13369-9"
"31547145","VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies","van Steenoven I, Noli B, Cocco C, Ferri GL, Oeckl P, Otto M, Koel-Simmelink MJA, Bridel C, van der Flier WM, Lemstra AW, Teunissen CE.","Int J Mol Sci. 2019 Sep 20;20(19):4674. doi: 10.3390/ijms20194674.","van Steenoven I","Int J Mol Sci","2019","2019/09/25","PMC6801397","","10.3390/ijms20194674"
"17210817","Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia","DeCarli C, Frisoni GB, Clark CM, Harvey D, Grundman M, Petersen RC, Thal LJ, Jin S, Jack CR Jr, Scheltens P; Alzheimer's Disease Cooperative Study Group.","Arch Neurol. 2007 Jan;64(1):108-15. doi: 10.1001/archneur.64.1.108.","DeCarli C","Arch Neurol","2007","2007/01/11","","","10.1001/archneur.64.1.108"
"9524883","Use of the odds ratio to translate neuropsychological test scores into real-world outcomes: from statistical significance to clinical significance","Bieliauskas LA, Fastenau PS, Lacy MA, Roper BL.","J Clin Exp Neuropsychol. 1997 Dec;19(6):889-96. doi: 10.1080/01688639708403769.","Bieliauskas LA","J Clin Exp Neuropsychol","1997","1998/04/03","","","10.1080/01688639708403769"
"9547928","Olfactory deficits in patients with schizophrenia and severe polydipsia","Kopala LC, Good KP, Koczapski AB, Honer WG.","Biol Psychiatry. 1998 Apr 1;43(7):497-502. doi: 10.1016/S0006-3223(97)00436-8.","Kopala LC","Biol Psychiatry","1998","1998/04/21","","","10.1016/S0006-3223(97)00436-8"
"35570493","Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial","Asaoka D, Xiao J, Takeda T, Yanagisawa N, Yamazaki T, Matsubara Y, Sugiyama H, Endo N, Higa M, Kasanuki K, Ichimiya Y, Koido S, Ohno K, Bernier F, Katsumata N, Nagahara A, Arai H, Ohkusa T, Sato N.","J Alzheimers Dis. 2022;88(1):75-95. doi: 10.3233/JAD-220148.","Asaoka D","J Alzheimers Dis","2022","2022/05/16","PMC9277669","","10.3233/JAD-220148"
"33720893","Neurocognitive Plasticity Is Associated with Cardiorespiratory Fitness Following Physical Exercise in Older Adults with Amnestic Mild Cognitive Impairment","Yogev-Seligmann G, Eisenstein T, Ash E, Giladi N, Sharon H, Nachman S, Bregman N, Kodesh E, Hendler T, Lerner Y.","J Alzheimers Dis. 2021;81(1):91-112. doi: 10.3233/JAD-201429.","Yogev-Seligmann G","J Alzheimers Dis","2021","2021/03/15","","","10.3233/JAD-201429"
"32333590","The Efficacy of COGnitive tRaining in patiEnts with Amnestic mild coGnitive impairmENT (COG-REAGENT): Protocol for a Multi-Center Randomized Controlled Trial","Xing Y, Zhu Z, Du Y, Zhang J, Qu Q, Sun L, Li Y, Guo Y, Peng G, Liu Y, Yu Y, Qiao Y, Xie B, Shi X, Lu J, Jia J, Tang Y.","J Alzheimers Dis. 2020;75(3):779-787. doi: 10.3233/JAD-191314.","Xing Y","J Alzheimers Dis","2020","2020/04/26","","","10.3233/JAD-191314"
"30372675","Growth Hormone-Releasing Hormone Modulation of Neuronal Exosome Biomarkers in Mild Cognitive Impairment","Winston CN, Goetzl EJ, Baker LD, Vitiello MV, Rissman RA.","J Alzheimers Dis. 2018;66(3):971-981. doi: 10.3233/JAD-180302.","Winston CN","J Alzheimers Dis","2018","2018/10/30","PMC6487872","NIHMS1019797","10.3233/JAD-180302"
"23506125","Exploring the effect of companion robots on emotional expression in older adults with dementia: a pilot randomized controlled trial","Moyle W, Cooke M, Beattie E, Jones C, Klein B, Cook G, Gray C.","J Gerontol Nurs. 2013 May;39(5):46-53. doi: 10.3928/00989134-20130313-03. Epub 2013 Mar 22.","Moyle W","J Gerontol Nurs","2013","2013/03/20","","","10.3928/00989134-20130313-03"
"26714488","Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software","Akter S, Hassan MR, Shahriar M, Akter N, Abbas MG, Bhuiyan MA.","Alzheimers Res Ther. 2015 Dec 27;7:79. doi: 10.1186/s13195-015-0164-8.","Akter S","Alzheimers Res Ther","2015","2015/12/31","PMC4696341","","10.1186/s13195-015-0164-8"
"24898640","Rates of formal diagnosis in people screened positive for dementia in primary care: results of the DelpHi-Trial","Eichler T, Thyrian JR, Hertel J, Köhler L, Wucherer D, Dreier A, Michalowsky B, Teipel S, Hoffmann W.","J Alzheimers Dis. 2014;42(2):451-8. doi: 10.3233/JAD-140354.","Eichler T","J Alzheimers Dis","2014","2014/06/06","","","10.3233/JAD-140354"
"36056417","Hypnosis for pain and anxiety management in cognitively impaired older adults undergoing scheduled lumbar punctures: a randomized controlled pilot study","Courtois-Amiot P, Cloppet-Fontaine A, Poissonnet A, Benit E, Dauzet M, Raynaud-Simon A, Paquet C, Lilamand M.","Alzheimers Res Ther. 2022 Sep 2;14(1):120. doi: 10.1186/s13195-022-01065-w.","Courtois-Amiot P","Alzheimers Res Ther","2022","2022/09/02","PMC9438329","","10.1186/s13195-022-01065-w"
"32280093","Impact of 3-Day Combined Anodal Transcranial Direct Current Stimulation-Visuospatial Training on Object-Location Memory in Healthy Older Adults and Patients with Mild Cognitive Impairment","de Sousa AVC, Grittner U, Rujescu D, Külzow N, Flöel A.","J Alzheimers Dis. 2020;75(1):223-244. doi: 10.3233/JAD-191234.","de Sousa AVC","J Alzheimers Dis","2020","2020/04/14","PMC7306891","","10.3233/JAD-191234"
"28851451","Structured physical exercise improves neuropsychiatric symptoms in acute dementia care: a hospital-based RCT","Fleiner T, Dauth H, Gersie M, Zijlstra W, Haussermann P.","Alzheimers Res Ther. 2017 Aug 29;9(1):68. doi: 10.1186/s13195-017-0289-z.","Fleiner T","Alzheimers Res Ther","2017","2017/08/31","PMC5576378","","10.1186/s13195-017-0289-z"
"16165272","Increased levels of CSF phosphorylated tau in apolipoprotein E epsilon4 carriers with mild cognitive impairment","Buerger K, Teipel SJ, Zinkowski R, Sunderland T, Andreasen N, Blennow K, Ewers M, DeBernardis J, Shen Y, Kerkman D, Du Y, Hampel H.","Neurosci Lett. 2005 Dec 31;391(1-2):48-50. doi: 10.1016/j.neulet.2005.08.030. Epub 2005 Sep 13.","Buerger K","Neurosci Lett","2005","2005/09/17","","","10.1016/j.neulet.2005.08.030"
"28800328","Effects of Exercise on Cognitive Function in Older People with Dementia: A Randomized Controlled Trial","Toots A, Littbrand H, Boström G, Hörnsten C, Holmberg H, Lundin-Olsson L, Lindelöf N, Nordström P, Gustafson Y, Rosendahl E.","J Alzheimers Dis. 2017;60(1):323-332. doi: 10.3233/JAD-170014.","Toots A","J Alzheimers Dis","2017","2017/08/12","PMC5611799","","10.3233/JAD-170014"
"9116213","Brain cognition and metabolism in Down syndrome adults in association with development of dementia","Dani A, Pietrini P, Furey ML, McIntosh AR, Grady CL, Horwitz B, Freo U, Alexander GE, Schapiro MB.","Neuroreport. 1996 Nov 25;7(18):2933-6. doi: 10.1097/00001756-199611250-00026.","Dani A","Neuroreport","1996","1996/11/25","","","10.1097/00001756-199611250-00026"
"33406269","Brain Activity of Benzoate, a D-Amino Acid Oxidase Inhibitor, in Patients With Mild Cognitive Impairment in a Randomized, Double-Blind, Placebo Controlled Clinical Trial","Lane HY, Tu CH, Lin WC, Lin CH.","Int J Neuropsychopharmacol. 2021 May 18;24(5):392-399. doi: 10.1093/ijnp/pyab001.","Lane HY","Int J Neuropsychopharmacol","2021","2021/01/06","PMC8130199","","10.1093/ijnp/pyab001"
"29769247","Dementia And Physical Activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: randomised controlled trial","Lamb SE, Sheehan B, Atherton N, Nichols V, Collins H, Mistry D, Dosanjh S, Slowther AM, Khan I, Petrou S, Lall R; DAPA Trial Investigators.","BMJ. 2018 May 16;361:k1675. doi: 10.1136/bmj.k1675.","Lamb SE","BMJ","2018","2018/05/18","PMC5953238","","10.1136/bmj.k1675"
"33905474","Mapping autonomic, mood and cognitive effects of hypothalamic region deep brain stimulation","Neudorfer C, Elias GJB, Jakobs M, Boutet A, Germann J, Narang K, Loh A, Paff M, Horn A, Kucharczyk W, Deeb W, Salvato B, Almeida L, Foote KD, Rosenberg PB, Tang-Wai DF, Anderson WS, Mari Z, Ponce FA, Wolk DA, Burke AD, Salloway S, Sabbagh MN, Chakravarty MM, Smith GS, Lyketsos CG, Okun MS, Lozano AM.","Brain. 2021 Oct 22;144(9):2837-2851. doi: 10.1093/brain/awab170.","Neudorfer C","Brain","2021","2021/04/27","PMC8557336","","10.1093/brain/awab170"
"28851447","Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort","Dufouil C, Dubois B, Vellas B, Pasquier F, Blanc F, Hugon J, Hanon O, Dartigues JF, Harston S, Gabelle A, Ceccaldi M, Beauchet O, Krolak-Salmon P, David R, Rouaud O, Godefroy O, Belin C, Rouch I, Auguste N, Wallon D, Benetos A, Pariente J, Paccalin M, Moreaud O, Hommet C, Sellal F, Boutoleau-Bretonniére C, Jalenques I, Gentric A, Vandel P, Azouani C, Fillon L, Fischer C, Savarieau H, Operto G, Bertin H, Chupin M, Bouteloup V, Habert MO, Mangin JF, Chêne G; MEMENTO cohort Study Group.","Alzheimers Res Ther. 2017 Aug 29;9(1):67. doi: 10.1186/s13195-017-0288-0.","Dufouil C","Alzheimers Res Ther","2017","2017/08/31","PMC5576287","","10.1186/s13195-017-0288-0"
"28388897","Does left ventricular hypertrophy affect cognition and brain structural integrity in type 2 diabetes? Study design and rationale of the Diabetes and Dementia (D2) study","Patel SK, Restrepo C, Werden E, Churilov L, Ekinci EI, Srivastava PM, Ramchand J, Wai B, Chambers B, O'Callaghan CJ, Darby D, Hachinski V, Cumming T, Donnan G, Burrell LM, Brodtmann A.","BMC Endocr Disord. 2017 Apr 7;17(1):24. doi: 10.1186/s12902-017-0173-7.","Patel SK","BMC Endocr Disord","2017","2017/04/09","PMC5384138","","10.1186/s12902-017-0173-7"
"27402093","Investigation of the Brain Biodistribution of the Lipoprotein-Associated Phospholipase A(2) (Lp-PLA(2)) Inhibitor [(18)F]GSK2647544 in Healthy Male Subjects","Huiban M, Coello C, Wu K, Xu Y, Lewis Y, Brown AP, Buraglio M, Guan C, Shabbir S, Fong R, Passchier J, Rabiner EA, Lockhart A.","Mol Imaging Biol. 2017 Feb;19(1):153-161. doi: 10.1007/s11307-016-0982-5.","Huiban M","Mol Imaging Biol","2017","2016/07/13","PMC5209404","","10.1007/s11307-016-0982-5"
"17375985","Tolerability, safety and pharmacokinetics of the FGLL peptide, a novel mimetic of neural cell adhesion molecule, following intranasal administration in healthy volunteers","Anand R, Seiberling M, Kamtchoua T, Pokorny R.","Clin Pharmacokinet. 2007;46(4):351-8. doi: 10.2165/00003088-200746040-00007.","Anand R","Clin Pharmacokinet","2007","2007/03/23","","","10.2165/00003088-200746040-00007"
"25805212","Transcutaneous vagus nerve stimulation boosts associative memory in older individuals","Jacobs HI, Riphagen JM, Razat CM, Wiese S, Sack AT.","Neurobiol Aging. 2015 May;36(5):1860-7. doi: 10.1016/j.neurobiolaging.2015.02.023. Epub 2015 Feb 28.","Jacobs HI","Neurobiol Aging","2015","2015/03/26","","","10.1016/j.neurobiolaging.2015.02.023"
"25628299","Effects of the Minnesota Adaptation of the NYU Caregiver Intervention on Primary Subjective Stress of Adult Child Caregivers of Persons With Dementia","Gaugler JE, Reese M, Mittelman MS.","Gerontologist. 2016 Jun;56(3):461-74. doi: 10.1093/geront/gnu125. Epub 2015 Jan 27.","Gaugler JE","Gerontologist","2016","2015/01/29","PMC4873767","","10.1093/geront/gnu125"
"34622228","Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetes","Overgaard RV, Hertz CL, Ingwersen SH, Navarria A, Drucker DJ.","Cell Rep Med. 2021 Sep 3;2(9):100387. doi: 10.1016/j.xcrm.2021.100387. eCollection 2021 Sep 21.","Overgaard RV","Cell Rep Med","2021","2021/10/08","PMC8484505","","10.1016/j.xcrm.2021.100387"
"23339050","Effects of the NYU caregiver intervention-adult child on residential care placement","Gaugler JE, Reese M, Mittelman MS.","Gerontologist. 2013 Dec;53(6):985-97. doi: 10.1093/geront/gns193. Epub 2013 Jan 20.","Gaugler JE","Gerontologist","2013","2013/01/23","PMC3826164","","10.1093/geront/gns193"
"32902313","Satisfaction, utilization, and feasibility of a telehealth intervention for in-home dementia care support: A mixed methods study","Williams KN, Shaw CA, Perkhounkova Y, Hein M, Coleman CK.","Dementia (London). 2021 Jul;20(5):1565-1585. doi: 10.1177/1471301220957905. Epub 2020 Sep 9.","Williams KN","Dementia (London)","2021","2020/09/09","PMC7940465","NIHMS1652249","10.1177/1471301220957905"
"15718045","Small hippocampal size in cognitively normal subjects with coronary artery disease","Koschack J, Irle E.","Neurobiol Aging. 2005 Jun;26(6):865-71. doi: 10.1016/j.neurobiolaging.2004.08.009.","Koschack J","Neurobiol Aging","2005","2005/02/19","","","10.1016/j.neurobiolaging.2004.08.009"
"30971215","Continuation versus discontinuation of treatment for severe dementia: randomized, pragmatic, open-label, clinical trial to evaluate the efficacy of continuing drug treatment in patients with severe dementia (STOP-DEM)","Soler A, Amer G, Leiva A, Ripoll J, Llorente MA, Leiva A, Taltavull JM, Molina R, Llobera J.","BMC Geriatr. 2019 Apr 11;19(1):101. doi: 10.1186/s12877-019-1122-2.","Soler A","BMC Geriatr","2019","2019/04/12","PMC6458648","","10.1186/s12877-019-1122-2"
"23916631","A randomized clinical trial of Behavioral Activation (BA) therapy for improving psychological and physical health in dementia caregivers: results of the Pleasant Events Program (PEP)","Moore RC, Chattillion EA, Ceglowski J, Ho J, von Känel R, Mills PJ, Ziegler MG, Patterson TL, Grant I, Mausbach BT.","Behav Res Ther. 2013 Oct;51(10):623-32. doi: 10.1016/j.brat.2013.07.005. Epub 2013 Jul 19.","Moore RC","Behav Res Ther","2013","2013/08/07","PMC3774137","NIHMS507754","10.1016/j.brat.2013.07.005"
"10229302","Type 2 diabetes mellitus, cognitive impairment and dementia","Stewart R, Liolitsa D.","Diabet Med. 1999 Feb;16(2):93-112. doi: 10.1046/j.1464-5491.1999.00027.x.","Stewart R","Diabet Med","1999","1999/05/06","","","10.1046/j.1464-5491.1999.00027.x"
"25391431","Effect of acupuncture treatment on vascular cognitive impairment without dementia: study protocol for a randomized controlled trial","Yang BF, Zeng XH, Liu Y, Fu QN, He T, Li F, Shi GX, Liu BZ, Sun SF, Wang J, Xiao L, Deng YM, Liu CZ.","Trials. 2014 Nov 13;15:442. doi: 10.1186/1745-6215-15-442.","Yang BF","Trials","2014","2014/11/14","PMC4242470","","10.1186/1745-6215-15-442"
"16687511","Differentiating the roles of the hippocampus and perirhinal cortex in processes beyond long-term declarative memory: a double dissociation in dementia","Lee AC, Buckley MJ, Gaffan D, Emery T, Hodges JR, Graham KS.","J Neurosci. 2006 May 10;26(19):5198-203. doi: 10.1523/JNEUROSCI.3157-05.2006.","Lee AC","J Neurosci","2006","2006/05/12","PMC6674247","","10.1523/JNEUROSCI.3157-05.2006"
"8526973","Nimodipine increases CSF somatostatin in affectively ill patients","Pazzaglia PJ, George MS, Post RM, Rubinow DR, Davis CL.","Neuropsychopharmacology. 1995 Aug;13(1):75-83. doi: 10.1016/0893-133X(95)00024-8.","Pazzaglia PJ","Neuropsychopharmacology","1995","1995/08/01","","","10.1016/0893-133X(95)00024-8"
"35698099","Communication Bridge™-2 (CB2): an NIH Stage 2 randomized control trial of a speech-language intervention for communication impairments in individuals with mild to moderate primary progressive aphasia","Roberts AC, Rademaker AW, Salley EA, Mooney A, Morhardt D, Fried-Oken M, Weintraub S, Mesulam M, Rogalski E.","Trials. 2022 Jun 13;23(1):487. doi: 10.1186/s13063-022-06162-7.","Roberts AC","Trials","2022","2022/06/13","PMC9190461","","10.1186/s13063-022-06162-7"
"11755021","Olfactory impairment increases as a function of age in persons with Down syndrome","Nijjar RK, Murphy C.","Neurobiol Aging. 2002 Jan-Feb;23(1):65-73. doi: 10.1016/s0197-4580(01)00263-9.","Nijjar RK","Neurobiol Aging","2002","2002/01/05","","","10.1016/s0197-4580(01)00263-9"
"16168525","Hippocampal atrophy in the healthy is initially linear and independent of age","Cohen RM, Szczepanik J, McManus M, Mirza N, Putnam K, Levy J, Sunderland T.","Neurobiol Aging. 2006 Oct;27(10):1385-94. doi: 10.1016/j.neurobiolaging.2005.07.018. Epub 2005 Sep 15.","Cohen RM","Neurobiol Aging","2006","2005/09/20","","","10.1016/j.neurobiolaging.2005.07.018"
"12626850","Cardiovascular effects of donepezil in patients with dementia","McLaren AT, Allen J, Murray A, Ballard CG, Kenny RA.","Dement Geriatr Cogn Disord. 2003;15(4):183-8. doi: 10.1159/000068781.","McLaren AT","Dement Geriatr Cogn Disord","2003","2003/03/11","","","10.1159/000068781"
"17192668","Cognitive enhancement in man with ispronicline, a nicotinic partial agonist","Dunbar GC, Kuchibhatla R.","J Mol Neurosci. 2006;30(1-2):169-72. doi: 10.1385/JMN:30:1:169.","Dunbar GC","J Mol Neurosci","2006","2006/12/29","","","10.1385/JMN:30:1:169"
"7986832","Determination of xanomeline in human plasma by ion-spray tandem mass spectrometry","Murphy AT, Bonate PL, Kasper SC, Gillespie TA, DeLong AF.","Biol Mass Spectrom. 1994 Oct;23(10):621-5. doi: 10.1002/bms.1200231004.","Murphy AT","Biol Mass Spectrom","1994","1994/10/01","","","10.1002/bms.1200231004"
"26086183","The effects of DL-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: A multicentre, randomized, double-blind, placebo-controlled trial","Jia J, Wei C, Liang J, Zhou A, Zuo X, Song H, Wu L, Chen X, Chen S, Zhang J, Wu J, Wang K, Chu L, Peng D, Lv P, Guo H, Niu X, Chen Y, Dong W, Han X, Fang B, Peng M, Li D, Jia Q, Huang L.","Alzheimers Dement. 2016 Feb;12(2):89-99. doi: 10.1016/j.jalz.2015.04.010. Epub 2015 Jun 15.","Jia J","Alzheimers Dement","2016","2015/06/19","","","10.1016/j.jalz.2015.04.010"
"29550783","Study protocol for Vitality: a proof-of-concept randomised controlled trial of exercise training or complex mental and social activities to promote cognition in adults with chronic stroke","Best JR, Eng JJ, Davis JC, Hsiung R, Hall PA, Middleton LE, Graf P, Goldsmith CH, Liu-Ambrose T.","BMJ Open. 2018 Mar 17;8(3):e021490. doi: 10.1136/bmjopen-2018-021490.","Best JR","BMJ Open","2018","2018/03/19","PMC5875626","","10.1136/bmjopen-2018-021490"
"30408230","Magnetic resonance T1w/T2w ratio: A parsimonious marker for Parkinson disease","Du G, Lewis MM, Sica C, Kong L, Huang X.","Ann Neurol. 2019 Jan;85(1):96-104. doi: 10.1002/ana.25376. Epub 2018 Dec 19.","Du G","Ann Neurol","2019","2018/11/09","PMC6342624","NIHMS998841","10.1002/ana.25376"
"23831177","Animal-assisted therapy and agitation and depression in nursing home residents with dementia: a matched case-control trial","Majić T, Gutzmann H, Heinz A, Lang UE, Rapp MA.","Am J Geriatr Psychiatry. 2013 Nov;21(11):1052-9. doi: 10.1016/j.jagp.2013.03.004. Epub 2013 Jul 3.","Majić T","Am J Geriatr Psychiatry","2013","2013/07/09","","","10.1016/j.jagp.2013.03.004"
"10822236","Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial","McKeith IG, Grace JB, Walker Z, Byrne EJ, Wilkinson D, Stevens T, Perry EK.","Int J Geriatr Psychiatry. 2000 May;15(5):387-92. doi: 10.1002/(sici)1099-1166(200005)15:5<387::aid-gps131>3.0.co;2-9.","McKeith IG","Int J Geriatr Psychiatry","2000","2000/05/24","","","10.1002/(sici)1099-1166(200005)15:5<387::aid-gps131>3.0.co;2-9"
"19360898","A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system","Bateman RJ, Siemers ER, Mawuenyega KG, Wen G, Browning KR, Sigurdson WC, Yarasheski KE, Friedrich SW, Demattos RB, May PC, Paul SM, Holtzman DM.","Ann Neurol. 2009 Jul;66(1):48-54. doi: 10.1002/ana.21623.","Bateman RJ","Ann Neurol","2009","2009/04/11","PMC2730994","NIHMS86184","10.1002/ana.21623"
"30185213","Clinical dementia severity associated with ventricular size is differentially moderated by cognitive reserve in men and women","Sapkota S, Ramirez J, Stuss DT, Masellis M, Black SE.","Alzheimers Res Ther. 2018 Sep 5;10(1):89. doi: 10.1186/s13195-018-0419-2.","Sapkota S","Alzheimers Res Ther","2018","2018/09/07","PMC6123907","","10.1186/s13195-018-0419-2"
"29550779","Protocol for a pragmatic randomised controlled trial of Body Brain Life-General Practice and a Lifestyle Modification Programme to decrease dementia risk exposure in a primary care setting","Kim S, McMaster M, Torres S, Cox KL, Lautenschlager N, Rebok GW, Pond D, D'Este C, McRae I, Cherbuin N, Anstey KJ.","BMJ Open. 2018 Mar 17;8(3):e019329. doi: 10.1136/bmjopen-2017-019329.","Kim S","BMJ Open","2018","2018/03/19","PMC5875671","","10.1136/bmjopen-2017-019329"
"26948580","A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans","Hölttä M, Dean RA, Siemers E, Mawuenyega KG, Sigurdson W, May PC, Holtzman DM, Portelius E, Zetterberg H, Bateman RJ, Blennow K, Gobom J.","Alzheimers Res Ther. 2016 Mar 7;8(1):11. doi: 10.1186/s13195-016-0178-x.","Hölttä M","Alzheimers Res Ther","2016","2016/03/08","PMC4780148","","10.1186/s13195-016-0178-x"
"9258894","Automatic and effortful processing in aging and dementia: event-related brain potentials","Ford JM, Roth WT, Isaacks BG, Tinklenberg JR, Yesavage J, Pfefferbaum A.","Neurobiol Aging. 1997 Mar-Apr;18(2):169-80. doi: 10.1016/s0197-4580(96)00072-3.","Ford JM","Neurobiol Aging","1997","1997/03/01","","","10.1016/s0197-4580(96)00072-3"
"27511740","SolCos model-based individual reminiscence for older adults with mild to moderate dementia in nursing homes: a randomized controlled intervention study","Van Bogaert P, Tolson D, Eerlingen R, Carvers D, Wouters K, Paque K, Timmermans O, Dilles T, Engelborghs S.","J Psychiatr Ment Health Nurs. 2016 Nov;23(9-10):568-575. doi: 10.1111/jpm.12336. Epub 2016 Aug 10.","Van Bogaert P","J Psychiatr Ment Health Nurs","2016","2016/08/12","","","10.1111/jpm.12336"
"33727798","Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects","Sheng L, Cao W, Lin P, Chen W, Xu H, Zhong C, Yuan F, Chen H, Li H, Liu C, Yang M, Li X.","Drug Des Devel Ther. 2021 Mar 9;15:1101-1110. doi: 10.2147/DDDT.S296197. eCollection 2021.","Sheng L","Drug Des Devel Ther","2021","2021/03/17","PMC7955752","","10.2147/DDDT.S296197"
"28432265","ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment","Guekht A, Skoog I, Edmundson S, Zakharov V, Korczyn AD.","Stroke. 2017 May;48(5):1262-1270. doi: 10.1161/STROKEAHA.116.014321.","Guekht A","Stroke","2017","2017/04/23","PMC5404405","","10.1161/STROKEAHA.116.014321"
"34527222","Higher circulating α-carotene was associated with better cognitive function: an evaluation among the MIND trial participants","Liu X, Dhana K, Furtado JD, Agarwal P, Aggarwal NT, Tangney C, Laranjo N, Carey V, Barnes LL, Sacks FM.","J Nutr Sci. 2021 Aug 16;10:e64. doi: 10.1017/jns.2021.56. eCollection 2021.","Liu X","J Nutr Sci","2021","2021/09/16","PMC8411267","","10.1017/jns.2021.56"
"33579857","One-Year Aerobic Exercise Reduced Carotid Arterial Stiffness and Increased Cerebral Blood Flow in Amnestic Mild Cognitive Impairment","Tomoto T, Liu J, Tseng BY, Pasha EP, Cardim D, Tarumi T, Hynan LS, Munro Cullum C, Zhang R.","J Alzheimers Dis. 2021;80(2):841-853. doi: 10.3233/JAD-201456.","Tomoto T","J Alzheimers Dis","2021","2021/02/13","","","10.3233/JAD-201456"
"31796677","Cerebral White Matter Integrity in Amnestic Mild Cognitive Impairment: A 1-Year Randomized Controlled Trial of Aerobic Exercise Training","Tarumi T, Thomas BP, Tseng BY, Wang C, Womack KB, Hynan L, Lu H, Cullum CM, Zhang R.","J Alzheimers Dis. 2020;73(2):489-501. doi: 10.3233/JAD-190875.","Tarumi T","J Alzheimers Dis","2020","2019/12/05","","","10.3233/JAD-190875"
"25294055","Rationale and design of a multicenter, phase 2 clinical trial to investigate the efficacy of traditional Chinese medicine SaiLuoTong in vascular dementia","Liang J, Li F, Wei C, Song H, Wu L, Tang Y, Jia J.","J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2626-2634. doi: 10.1016/j.jstrokecerebrovasdis.2014.06.005. Epub 2014 Oct 5.","Liang J","J Stroke Cerebrovasc Dis","2014","2014/10/09","","","10.1016/j.jstrokecerebrovasdis.2014.06.005"
"29660936","Associations of Angiotensin Converting Enzyme-1 and Angiotensin II Blood Levels and Cognitive Function","Yasar S, Varma VR, Harris GC, Carlson MC.","J Alzheimers Dis. 2018;63(2):655-664. doi: 10.3233/JAD-170944.","Yasar S","J Alzheimers Dis","2018","2018/04/18","PMC5998658","NIHMS967981","10.3233/JAD-170944"
"18631971","Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the Cache County Study","Fotuhi M, Zandi PP, Hayden KM, Khachaturian AS, Szekely CA, Wengreen H, Munger RG, Norton MC, Tschanz JT, Lyketsos CG, Breitner JC, Welsh-Bohmer K.","Alzheimers Dement. 2008 May;4(3):223-7. doi: 10.1016/j.jalz.2008.01.004. Epub 2008 Apr 21.","Fotuhi M","Alzheimers Dement","2008","2008/07/18","PMC2684982","NIHMS103465","10.1016/j.jalz.2008.01.004"
"31164160","Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)","Stephen R, Liu Y, Ngandu T, Antikainen R, Hulkkonen J, Koikkalainen J, Kemppainen N, Lötjönen J, Levälahti E, Parkkola R, Pippola P, Rinne J, Strandberg T, Tuomilehto J, Vanninen R, Kivipelto M, Soininen H, Solomon A; FINGER study group.","Alzheimers Res Ther. 2019 Jun 4;11(1):53. doi: 10.1186/s13195-019-0506-z.","Stephen R","Alzheimers Res Ther","2019","2019/06/06","PMC6549301","","10.1186/s13195-019-0506-z"
"30738426","Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial","Silveira CRA, MacKinley J, Coleman K, Li Z, Finger E, Bartha R, Morrow SA, Wells J, Borrie M, Tirona RG, Rupar CA, Zou G, Hegele RA, Mahuran D, MacDonald P, Jenkins ME, Jog M, Pasternak SH.","BMC Neurol. 2019 Feb 9;19(1):20. doi: 10.1186/s12883-019-1252-3.","Silveira CRA","BMC Neurol","2019","2019/02/11","PMC6368728","","10.1186/s12883-019-1252-3"
"23576128","The salience network causally influences default mode network activity during moral reasoning","Chiong W, Wilson SM, D'Esposito M, Kayser AS, Grossman SN, Poorzand P, Seeley WW, Miller BL, Rankin KP.","Brain. 2013 Jun;136(Pt 6):1929-41. doi: 10.1093/brain/awt066. Epub 2013 Apr 9.","Chiong W","Brain","2013","2013/04/12","PMC3673466","","10.1093/brain/awt066"
"12390056","Health-related quality of life and long-term therapy with pravastatin and tocopherol (vitamin E) in older adults","Carlsson CM, Papcke-Benson K, Carnes M, McBride PE, Stein JH.","Drugs Aging. 2002;19(10):793-805. doi: 10.2165/00002512-200219100-00008.","Carlsson CM","Drugs Aging","2002","2002/10/23","","","10.2165/00002512-200219100-00008"
"16151537","The Douglas Hospital Longitudinal Study of Normal and Pathological Aging: summary of findings","Lupien SJ, Schwartz G, Ng YK, Fiocco A, Wan N, Pruessner JC, Meaney MJ, Nair NP.","J Psychiatry Neurosci. 2005 Sep;30(5):328-34.","Lupien SJ","J Psychiatry Neurosci","2005","2005/09/10","PMC1197277","",""
"26890759","Impact of Omega-3 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults","Külzow N, Witte AV, Kerti L, Grittner U, Schuchardt JP, Hahn A, Flöel A.","J Alzheimers Dis. 2016;51(3):713-25. doi: 10.3233/JAD-150886.","Külzow N","J Alzheimers Dis","2016","2016/02/19","","","10.3233/JAD-150886"
"18188496","Cholinergic dysfunction in subcortical ischaemic vascular dementia: a transcranial magnetic stimulation study","Nardone R, Bergmann J, Tezzon F, Ladurner G, Golaszewski S.","J Neural Transm (Vienna). 2008 May;115(5):737-43. doi: 10.1007/s00702-007-0003-6. Epub 2008 Jan 11.","Nardone R","J Neural Transm (Vienna)","2008","2008/01/12","","","10.1007/s00702-007-0003-6"
"16581169","Efficacy of perospirone in the management of aggressive behavior associated with dementia","Sato S, Mizukami K, Moro K, Tanaka Y, Asada T.","Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jun;30(4):679-83. doi: 10.1016/j.pnpbp.2006.01.028. Epub 2006 Mar 6.","Sato S","Prog Neuropsychopharmacol Biol Psychiatry","2006","2006/04/04","","","10.1016/j.pnpbp.2006.01.028"
"23292615","Closed-loop dynamic modeling of cerebral hemodynamics","Marmarelis VZ, Shin DC, Orme ME, Zhang R.","Ann Biomed Eng. 2013 May;41(5):1029-48. doi: 10.1007/s10439-012-0736-8. Epub 2013 Jan 5.","Marmarelis VZ","Ann Biomed Eng","2013","2013/01/08","PMC3625507","NIHMS433201","10.1007/s10439-012-0736-8"
"10525983","Cerebral hemorrhage and apoE","Garcia C, Pinho e Melo T, Rocha L, Lechner MC.","J Neurol. 1999 Sep;246(9):830-4. doi: 10.1007/s004150050463.","Garcia C","J Neurol","1999","1999/10/20","","","10.1007/s004150050463"
"24606601","Self-management in early-stage dementia: a pilot randomised controlled trial of the efficacy and cost-effectiveness of a self-management group intervention (the SMART study)","Quinn C, Anderson D, Toms G, Whitaker R, Edwards RT, Jones C, Clare L.","Trials. 2014 Mar 8;15:74. doi: 10.1186/1745-6215-15-74.","Quinn C","Trials","2014","2014/03/11","PMC3974022","","10.1186/1745-6215-15-74"
"28552878","Medium-Chain Triglycerides in Combination with Leucine and Vitamin D Benefit Cognition in Frail Elderly Adults: A Randomized Controlled Trial","Abe S, Ezaki O, Suzuki M.","J Nutr Sci Vitaminol (Tokyo). 2017;63(2):133-140. doi: 10.3177/jnsv.63.133.","Abe S","J Nutr Sci Vitaminol (Tokyo)","2017","2017/05/30","","","10.3177/jnsv.63.133"
"26674087","A pilot randomized controlled trial of a self-management group intervention for people with early-stage dementia (The SMART study)","Quinn C, Toms G, Jones C, Brand A, Edwards RT, Sanders F, Clare L.","Int Psychogeriatr. 2016 May;28(5):787-800. doi: 10.1017/S1041610215002094. Epub 2015 Dec 17.","Quinn C","Int Psychogeriatr","2016","2015/12/18","","","10.1017/S1041610215002094"
"32280092","Ca:Mg Ratio, APOE Cytosine Modifications, and Cognitive Function: Results from a Randomized Trial","Zhu X, Borenstein AR, Zheng Y, Zhang W, Seidner DL, Ness R, Murff HJ, Li B, Shrubsole MJ, Yu C, Hou L, Dai Q.","J Alzheimers Dis. 2020;75(1):85-98. doi: 10.3233/JAD-191223.","Zhu X","J Alzheimers Dis","2020","2020/04/14","PMC7737669","NIHMS1648781","10.3233/JAD-191223"
"20625270","Treating neuropsychiatric symptoms in dementia with Lewy bodies: a randomized controlled-trial","Culo S, Mulsant BH, Rosen J, Mazumdar S, Blakesley RE, Houck PR, Pollock BG.","Alzheimer Dis Assoc Disord. 2010 Oct-Dec;24(4):360-4. doi: 10.1097/WAD.0b013e3181e6a4d7.","Culo S","Alzheimer Dis Assoc Disord","2010","2010/07/14","","","10.1097/WAD.0b013e3181e6a4d7"
"10867223","Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition","Maki PM, Resnick SM.","Neurobiol Aging. 2000 Mar-Apr;21(2):373-83. doi: 10.1016/s0197-4580(00)00123-8.","Maki PM","Neurobiol Aging","2000","2000/06/27","","","10.1016/s0197-4580(00)00123-8"
"9409335","Estrogen replacement therapy and longitudinal decline in visual memory. A possible protective effect?","Resnick SM, Metter EJ, Zonderman AB.","Neurology. 1997 Dec;49(6):1491-7. doi: 10.1212/wnl.49.6.1491.","Resnick SM","Neurology","1997","1997/12/31","","","10.1212/wnl.49.6.1491"
"7916916","A double FDG/PET study of the effects of scopolamine in older adults","Molchan SE, Matochik JA, Zametkin AJ, Szymanski HV, Cantillon M, Cohen RM, Sunderland T.","Neuropsychopharmacology. 1994 May;10(3):191-8. doi: 10.1038/npp.1994.21.","Molchan SE","Neuropsychopharmacology","1994","1994/05/01","","","10.1038/npp.1994.21"
"34140586","A methodology for an acute exercise clinical trial called dementia risk and dynamic response to exercise","White D, John CS, Kucera A, Truver B, Lepping RJ, Kueck PJ, Lee P, Martin L, Billinger SA, Burns JM, Morris JK, Vidoni ED.","Sci Rep. 2021 Jun 17;11(1):12776. doi: 10.1038/s41598-021-92177-0.","White D","Sci Rep","2021","2021/06/18","PMC8211849","","10.1038/s41598-021-92177-0"
"31849458","Effect of Multicomponent Exercise and Nutrition Support on the Cognitive Function of Older Adults: A Randomized Controlled Trial","Imaoka M, Nakao H, Nakamura M, Tazaki F, Maebuchi M, Ibuki M, Takeda M.","Clin Interv Aging. 2019 Dec 11;14:2145-2153. doi: 10.2147/CIA.S229034. eCollection 2019.","Imaoka M","Clin Interv Aging","2019","2019/12/19","PMC6912002","","10.2147/CIA.S229034"
"24009169","Cognitive, emotional, and social benefits of regular musical activities in early dementia: randomized controlled study","Särkämö T, Tervaniemi M, Laitinen S, Numminen A, Kurki M, Johnson JK, Rantanen P.","Gerontologist. 2014 Aug;54(4):634-50. doi: 10.1093/geront/gnt100. Epub 2013 Sep 5.","Särkämö T","Gerontologist","2014","2013/09/07","","","10.1093/geront/gnt100"
"2178676","Long-term follow up of workers exposed to solvents","Edling C, Ekberg K, Ahlborg G Jr, Alexandersson R, Barregård L, Ekenvall L, Nilsson L, Svensson BG.","Br J Ind Med. 1990 Feb;47(2):75-82. doi: 10.1136/oem.47.2.75.","Edling C","Br J Ind Med","1990","1990/02/01","PMC1035105","","10.1136/oem.47.2.75"
"33217785","Kidney Function and Cognitive Decline in Older Adults: Examining the Role of Neurodegeneration","Guerville F, De Souto Barreto P, Coley N, Andrieu S, Mangin JF, Chupin M, Payoux P, Ousset PJ, Rolland Y, Vellas B; MAPT/DSA group.","J Am Geriatr Soc. 2021 Mar;69(3):651-659. doi: 10.1111/jgs.16954. Epub 2020 Nov 20.","Guerville F","J Am Geriatr Soc","2021","2020/11/20","","","10.1111/jgs.16954"
"22122992","Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia","Larsson V, Engedal K, Aarsland D, Wattmo C, Minthon L, Londos E.","Dement Geriatr Cogn Disord. 2011;32(4):227-34. doi: 10.1159/000334523. Epub 2011 Nov 25.","Larsson V","Dement Geriatr Cogn Disord","2011","2011/11/30","","","10.1159/000334523"
"34240455","Safety, pharmacokinetics and quantitative EEG modulation of TAK-071, a novel muscarinic M1 receptor positive allosteric modulator, in healthy subjects","Yin W, Mamashli F, Buhl DL, Khudyakov P, Volfson D, Martenyi F, Gevorkyan H, Rosen L, Simen AA.","Br J Clin Pharmacol. 2022 Feb;88(2):600-612. doi: 10.1111/bcp.14975. Epub 2021 Jul 31.","Yin W","Br J Clin Pharmacol","2022","2021/07/09","PMC9291057","","10.1111/bcp.14975"
"17804954","Telephonic Remote Evaluation of Neuropsychological Deficits (TREND): longitudinal monitoring of elderly community-dwelling volunteers using touch-tone telephones","Mundt JC, Kinoshita LM, Hsu S, Yesavage JA, Greist JH.","Alzheimer Dis Assoc Disord. 2007 Jul-Sep;21(3):218-24. doi: 10.1097/WAD.0b013e31811ff2c9.","Mundt JC","Alzheimer Dis Assoc Disord","2007","2007/09/07","","","10.1097/WAD.0b013e31811ff2c9"
"10413563","Acute and long-term administration of anticholinergics in Parkinson's disease: specific effects on the subcortico-frontal syndrome","Bédard MA, Pillon B, Dubois B, Duchesne N, Masson H, Agid Y.","Brain Cogn. 1999 Jul;40(2):289-313. doi: 10.1006/brcg.1999.1083.","Bédard MA","Brain Cogn","1999","1999/07/22","","","10.1006/brcg.1999.1083"
"19571732","The relationship of plasma Abeta levels to dementia in aging individuals with Down syndrome","Matsuoka Y, Andrews HF, Becker AG, Gray AJ, Mehta PD, Sano MC, Dalton AJ, Aisen PS.","Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):315-8. doi: 10.1097/WAD.0b013e3181aba61e.","Matsuoka Y","Alzheimer Dis Assoc Disord","2009","2009/07/03","PMC2787755","NIHMS127306","10.1097/WAD.0b013e3181aba61e"
"34688369","Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial","Banerjee S, High J, Stirling S, Shepstone L, Swart AM, Telling T, Henderson C, Ballard C, Bentham P, Burns A, Farina N, Fox C, Francis P, Howard R, Knapp M, Leroi I, Livingston G, Nilforooshan R, Nurock S, O'Brien J, Price A, Thomas AJ, Tabet N.","Lancet. 2021 Oct 23;398(10310):1487-1497. doi: 10.1016/S0140-6736(21)01210-1.","Banerjee S","Lancet","2021","2021/10/24","PMC8546216","","10.1016/S0140-6736(21)01210-1"
"23653143","Factors associated with caregiver readiness to use nonpharmacologic strategies to manage dementia-related behavioral symptoms","Gitlin LN, Rose K.","Int J Geriatr Psychiatry. 2014 Jan;29(1):93-102. doi: 10.1002/gps.3979. Epub 2013 May 7.","Gitlin LN","Int J Geriatr Psychiatry","2014","2013/05/09","PMC3989482","NIHMS477090","10.1002/gps.3979"
"36341847","A randomized controlled trial to test the efficacy of a diabetes behavioral intervention to prevent memory decline in older blacks/African Americans with diabetes and mild cognitive impairment","Casten R, Leiby BE, Kelley M, Rovner BW.","Contemp Clin Trials. 2022 Dec;123:106977. doi: 10.1016/j.cct.2022.106977. Epub 2022 Oct 28.","Casten R","Contemp Clin Trials","2022","2022/11/07","PMC9787831","NIHMS1859388","10.1016/j.cct.2022.106977"
"26238226","Effects of the Minnesota Adaptation of the NYU Caregiver Intervention on Depressive Symptoms and Quality of Life for Adult Child Caregivers of Persons with Dementia","Gaugler JE, Reese M, Mittelman MS.","Am J Geriatr Psychiatry. 2015 Nov;23(11):1179-92. doi: 10.1016/j.jagp.2015.06.007. Epub 2015 Jun 25.","Gaugler JE","Am J Geriatr Psychiatry","2015","2015/08/05","PMC4663141","NIHMS705504","10.1016/j.jagp.2015.06.007"
"23644819","Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease","Zhang J, Mattison HA, Liu C, Ginghina C, Auinger P, McDermott MP, Stewart T, Kang UJ; Parkinson Study Group DATATOP Investigators; Cain KC, Shi M.","Acta Neuropathol. 2013 Nov;126(5):671-82. doi: 10.1007/s00401-013-1121-x. Epub 2013 May 4.","Zhang J","Acta Neuropathol","2013","2013/05/07","PMC3796193","NIHMS475991","10.1007/s00401-013-1121-x"
"18348597","Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence","Muhonen LH, Lönnqvist J, Juva K, Alho H.","J Clin Psychiatry. 2008 Mar;69(3):392-9. doi: 10.4088/jcp.v69n0308.","Muhonen LH","J Clin Psychiatry","2008","2008/03/20","","","10.4088/jcp.v69n0308"
"29848412","Aerobic and strength training exercise programme for cognitive impairment in people with mild to moderate dementia: the DAPA RCT","Lamb SE, Mistry D, Alleyne S, Atherton N, Brown D, Copsey B, Dosanjh S, Finnegan S, Fordham B, Griffiths F, Hennings S, Khan I, Khan K, Lall R, Lyle S, Nichols V, Petrou S, Zeh P, Sheehan B.","Health Technol Assess. 2018 May;22(28):1-202. doi: 10.3310/hta22280.","Lamb SE","Health Technol Assess","2018","2018/06/01","PMC5994643","","10.3310/hta22280"
"33980288","Factors contributing to cognitive improvement effects of acupuncture in patients with mild cognitive impairment: a pilot randomized controlled trial","Kim JH, Cho MR, Shin JC, Park GC, Lee JS.","Trials. 2021 May 12;22(1):341. doi: 10.1186/s13063-021-05296-4.","Kim JH","Trials","2021","2021/05/13","PMC8117619","","10.1186/s13063-021-05296-4"
"12970516","Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial","Black S, Román GC, Geldmacher DS, Salloway S, Hecker J, Burns A, Perdomo C, Kumar D, Pratt R; Donepezil 307 Vascular Dementia Study Group.","Stroke. 2003 Oct;34(10):2323-30. doi: 10.1161/01.STR.0000091396.95360.E1. Epub 2003 Sep 11.","Black S","Stroke","2003","2003/09/13","","","10.1161/01.STR.0000091396.95360.E1"
"16594943","Efficacy and safety of donepezil in patients with dementia with Lewy bodies: preliminary findings from an open-label study","Mori S, Mori E, Iseki E, Kosaka K.","Psychiatry Clin Neurosci. 2006 Apr;60(2):190-5. doi: 10.1111/j.1440-1819.2006.01485.x.","Mori S","Psychiatry Clin Neurosci","2006","2006/04/06","","","10.1111/j.1440-1819.2006.01485.x"
"23978008","Age-related decline of precision and binding in visual working memory","Peich MC, Husain M, Bays PM.","Psychol Aging. 2013 Sep;28(3):729-43. doi: 10.1037/a0033236. Epub 2013 Aug 26.","Peich MC","Psychol Aging","2013","2013/08/28","PMC3913749","","10.1037/a0033236"
"15760642","Anti-heparan sulphate antibodies and homocysteine in dementia: markers of vascular pathology?","Briani C, Cagnin A, Gallo L, Toffanin E, Varagnolo M, Zaninotto M, Plebani M, Ricchieri G, Battistin L, Pizzolato G.","J Neurol Sci. 2005 Mar 15;229-230:215-8. doi: 10.1016/j.jns.2004.11.031. Epub 2004 Dec 16.","Briani C","J Neurol Sci","2005","2005/03/12","","","10.1016/j.jns.2004.11.031"
"31345146","Effects of Folic Acid and Vitamin B12, Alone and in Combination on Cognitive Function and Inflammatory Factors in the Elderly with Mild Cognitive Impairment: A Single-blind Experimental Design","Ma F, Zhou X, Li Q, Zhao J, Song A, An P, Du Y, Xu W, Huang G.","Curr Alzheimer Res. 2019;16(7):622-632. doi: 10.2174/1567205016666190725144629.","Ma F","Curr Alzheimer Res","2019","2019/07/27","","","10.2174/1567205016666190725144629"
"27347792","A quasi-experimental study of a reminiscence program focused on autobiographical memory in institutionalized older adults with cognitive impairment","Lopes TS, Afonso RM, Ribeiro ÓM.","Arch Gerontol Geriatr. 2016 Sep-Oct;66:183-92. doi: 10.1016/j.archger.2016.05.007. Epub 2016 Jun 4.","Lopes TS","Arch Gerontol Geriatr","2016","2016/06/28","","","10.1016/j.archger.2016.05.007"
"11881837","Naftidrofuryl in the treatment of vascular dementia","Möller HJ, Hartmann A, Kessler C, Rainer M, Brown T, Gamand S, Lehert P.","Eur Arch Psychiatry Clin Neurosci. 2001 Dec;251(6):247-54. doi: 10.1007/pl00007541.","Möller HJ","Eur Arch Psychiatry Clin Neurosci","2001","2002/03/08","","","10.1007/pl00007541"
"10222636","A nursing intervention to decrease depression in family caregivers of persons with dementia","Buckwalter KC, Gerdner L, Kohout F, Hall GR, Kelly A, Richards B, Sime M.","Arch Psychiatr Nurs. 1999 Apr;13(2):80-8. doi: 10.1016/s0883-9417(99)80024-7.","Buckwalter KC","Arch Psychiatr Nurs","1999","1999/05/01","","","10.1016/s0883-9417(99)80024-7"
"15007119","Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study","Otto M, Cepek L, Ratzka P, Doehlinger S, Boekhoff I, Wiltfang J, Irle E, Pergande G, Ellers-Lenz B, Windl O, Kretzschmar HA, Poser S, Prange H.","Neurology. 2004 Mar 9;62(5):714-8. doi: 10.1212/01.wnl.0000113764.35026.ef.","Otto M","Neurology","2004","2004/03/10","","","10.1212/01.wnl.0000113764.35026.ef"
"17378189","The Savvy Caregiver program: the demonstrated effectiveness of a transportable dementia caregiver psychoeducation program","Hepburn K, Lewis M, Tornatore J, Sherman CW, Bremer KL.","J Gerontol Nurs. 2007 Mar;33(3):30-6. doi: 10.3928/00989134-20070301-06.","Hepburn K","J Gerontol Nurs","2007","2007/03/24","","","10.3928/00989134-20070301-06"
"16298243","Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesis","Grön G, Brandenburg I, Wunderlich AP, Riepe MW.","Neurobiol Aging. 2006 Jan;27(1):78-87. doi: 10.1016/j.neurobiolaging.2004.12.005.","Grön G","Neurobiol Aging","2006","2005/11/22","","","10.1016/j.neurobiolaging.2004.12.005"
"16086128","Olfactory screening test in mild cognitive impairment","Eibenstein A, Fioretti AB, Simaskou MN, Sucapane P, Mearelli S, Mina C, Amabile G, Fusetti M.","Neurol Sci. 2005 Jul;26(3):156-60. doi: 10.1007/s10072-005-0453-2.","Eibenstein A","Neurol Sci","2005","2005/08/09","","","10.1007/s10072-005-0453-2"
"14766981","Low acetylcholine during slow-wave sleep is critical for declarative memory consolidation","Gais S, Born J.","Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2140-4. doi: 10.1073/pnas.0305404101. Epub 2004 Feb 6.","Gais S","Proc Natl Acad Sci U S A","2004","2004/02/10","PMC357065","","10.1073/pnas.0305404101"
"9532343","A protective effect of apolipoprotein E e2 allele on dementia in Down's syndrome","Tyrrell J, Cosgrave M, Hawi Z, McPherson J, O'Brien C, McCalvert J, McLaughlin M, Lawlor B, Gill M.","Biol Psychiatry. 1998 Mar 15;43(6):397-400. doi: 10.1016/s0006-3223(97)00481-2.","Tyrrell J","Biol Psychiatry","1998","1998/04/09","","","10.1016/s0006-3223(97)00481-2"
"8994938","Cognitive predictors of dementia in elderly community residents","Dartigues JF, Commenges D, Letenneur D, Barberger-Gateau P, Gilleron V, Fabrigoule C, Mazaux JM, Orgogozo JM, Salamon R.","Neuroepidemiology. 1997;16(1):29-39. doi: 10.1159/000109668.","Dartigues JF","Neuroepidemiology","1997","1997/01/01","","","10.1159/000109668"
"8753947","Naming norms for brief environmental sounds: effects of age and dementia","Fabiani M, Kazmerski VA, Cycowicz YM, Friedman D.","Psychophysiology. 1996 Jul;33(4):462-75. doi: 10.1111/j.1469-8986.1996.tb01072.x.","Fabiani M","Psychophysiology","1996","1996/07/01","","","10.1111/j.1469-8986.1996.tb01072.x"
"23253363","Benefits of training working memory in amnestic mild cognitive impairment: specific and transfer effects","Carretti B, Borella E, Fostinelli S, Zavagnin M.","Int Psychogeriatr. 2013 Apr;25(4):617-26. doi: 10.1017/S1041610212002177. Epub 2012 Dec 20.","Carretti B","Int Psychogeriatr","2013","2012/12/21","","","10.1017/S1041610212002177"
"15882921","Establishing visual category boundaries between objects: a PET study","Saumier D, Chertkow H, Arguin M, Whatmough C.","Brain Cogn. 2005 Dec;59(3):299-302. doi: 10.1016/j.bandc.2004.02.060.","Saumier D","Brain Cogn","2005","2005/05/11","","","10.1016/j.bandc.2004.02.060"
"15375277","Effects of transcutaneous electrical nerve stimulation (TENS) on self-efficacy and mood in elderly with mild cognitive impairment","Luijpen MW, Swaab DF, Sergeant JA, Scherder EJ.","Neurorehabil Neural Repair. 2004 Sep;18(3):166-75. doi: 10.1177/0888439004268785.","Luijpen MW","Neurorehabil Neural Repair","2004","2004/09/18","","","10.1177/0888439004268785"
"12658367","Apolipoprotein E epsilon 4 is associated with hippocampal volume reduction in females with alcoholism","Bleich S, Wilhelm J, Graesel E, Degner D, Sperling W, Rössner V, Javaheripour K, Kornhuber J.","J Neural Transm (Vienna). 2003 Apr;110(4):401-11. doi: 10.1007/s00702-002-0789-1.","Bleich S","J Neural Transm (Vienna)","2003","2003/03/27","","","10.1007/s00702-002-0789-1"
"11113618","Nutraceutical interventions may delay aging and the age-related diseases","Villeponteau B, Cockrell R, Feng J.","Exp Gerontol. 2000 Dec;35(9-10):1405-17. doi: 10.1016/s0531-5565(00)00182-0.","Villeponteau B","Exp Gerontol","2000","2000/12/13","","","10.1016/s0531-5565(00)00182-0"
"10217925","Clinical utility of CERAD neuropsychological battery in elderly Jamaicans","Unverzagt FW, Morgan OS, Thesiger CH, Eldemire DA, Luseko J, Pokuri S, Hui SL, Hall KS, Hendrie HC.","J Int Neuropsychol Soc. 1999 Mar;5(3):255-9. doi: 10.1017/s1355617799003082.","Unverzagt FW","J Int Neuropsychol Soc","1999","1999/04/28","","","10.1017/s1355617799003082"
"31378968","Assessment of Transporter Polymorphisms as a Factor in a BCRP Drug Interaction Study With Lanabecestat","Willis BA, Andersen SW, Ayan-Oshodi M, James DE, Liffick E, Hillgren K, Guo Y, Monk SA.","J Clin Pharmacol. 2020 Jan;60(1):107-116. doi: 10.1002/jcph.1500. Epub 2019 Aug 5.","Willis BA","J Clin Pharmacol","2020","2019/08/06","","","10.1002/jcph.1500"
"34428306","Irisin levels in the serum and cerebrospinal fluid of patients with multiple sclerosis and the expression and distribution of irisin in experimental autoimmune encephalomyelitis","Zhang QX, Zhang SN, Zhang LJ, Zhang DQ, Yang L.","Clin Exp Immunol. 2021 Nov;206(2):208-215. doi: 10.1111/cei.13656. Epub 2021 Sep 15.","Zhang QX","Clin Exp Immunol","2021","2021/08/24","PMC8506135","","10.1111/cei.13656"
"16062097","Efficacy and tolerability of low-dose donepezil in schizophrenia","Erickson SK, Schwarzkopf SB, Palumbo D, Badgley-Fleeman J, Smirnow AM, Light GA.","Clin Neuropharmacol. 2005 Jul-Aug;28(4):179-84. doi: 10.1097/01.wnf.0000173714.61744.e6.","Erickson SK","Clin Neuropharmacol","2005","2005/08/03","","","10.1097/01.wnf.0000173714.61744.e6"
"11641045","Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopy","Lin A, Nguy CH, Shic F, Ross BD.","Toxicol Lett. 2001 Sep 15;123(2-3):169-77. doi: 10.1016/s0378-4274(01)00396-4.","Lin A","Toxicol Lett","2001","2001/10/20","","","10.1016/s0378-4274(01)00396-4"
"26823561","Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study","Seibyl J, Catafau AM, Barthel H, Ishii K, Rowe CC, Leverenz JB, Ghetti B, Ironside JW, Takao M, Akatsu H, Murayama S, Bullich S, Mueller A, Koglin N, Schulz-Schaeffer WJ, Hoffmann A, Sabbagh MN, Stephens AW, Sabri O.","J Nucl Med. 2016 Jun;57(6):900-6. doi: 10.2967/jnumed.115.161927. Epub 2016 Jan 28.","Seibyl J","J Nucl Med","2016","2016/01/30","","","10.2967/jnumed.115.161927"
"32820955","Effects of a virtual group cycling experience on people living with dementia: A mixed method pilot study","D'Cunha NM, Isbel ST, Frost J, Fearon A, McKune AJ, Naumovski N, Kellett J.","Dementia (London). 2021 Jul;20(5):1518-1535. doi: 10.1177/1471301220951328. Epub 2020 Aug 21.","D'Cunha NM","Dementia (London)","2021","2020/08/22","","","10.1177/1471301220951328"
"31866419","Effectiveness of Powerful Tools for Caregivers on Caregiver Burden and on Care Recipient Behavioral and Psychological Symptoms of Dementia: A Randomized Controlled Trial","Terracciano A, Artese A, Yeh J, Edgerton L, Granville L, Aschwanden D, Luchetti M, Glueckauf RL, Stephan Y, Sutin AR, Katz P.","J Am Med Dir Assoc. 2020 Aug;21(8):1121-1127.e1. doi: 10.1016/j.jamda.2019.11.011. Epub 2019 Dec 19.","Terracciano A","J Am Med Dir Assoc","2020","2019/12/24","PMC7302999","NIHMS1545436","10.1016/j.jamda.2019.11.011"
"32236400","Effects of a Group-Based 8-Week Multicomponent Cognitive Training on Cognition, Mood and Activities of Daily Living among Healthy Older Adults: A One-Year Follow-Up of a Randomized Controlled Trial","Srisuwan P, Nakawiro D, Chansirikarnjana S, Kuha O, Chaikongthong P, Suwannagoot T.","J Prev Alzheimers Dis. 2020;7(2):112-121. doi: 10.14283/jpad.2019.42.","Srisuwan P","J Prev Alzheimers Dis","2020","2020/04/03","","","10.14283/jpad.2019.42"
"26883281","Effects of a long-term exercise programme on functional ability in people with dementia living in nursing homes: Research protocol of the LEDEN study, a cluster randomised controlled trial","de Souto Barreto P, Denormandie P, Lepage B, Armaingaud D, Rapp T, Chauvin P, Vellas B, Rolland Y.","Contemp Clin Trials. 2016 Mar;47:289-95. doi: 10.1016/j.cct.2016.02.004. Epub 2016 Feb 13.","de Souto Barreto P","Contemp Clin Trials","2016","2016/02/18","","","10.1016/j.cct.2016.02.004"
"26474116","The impact of fall risk assessment on nurse fears, patient falls, and functional ability in long-term care","Dever Fitzgerald T, Hadjistavropoulos T, Williams J, Lix L, Zahir S, Alfano D, Scudds R.","Disabil Rehabil. 2016;38(11):1041-52. doi: 10.3109/09638288.2015.1085102. Epub 2015 Oct 16.","Dever Fitzgerald T","Disabil Rehabil","2016","2015/10/17","","","10.3109/09638288.2015.1085102"
"36227593","Effect of Exercise Training or Complex Mental and Social Activities on Cognitive Function in Adults With Chronic Stroke: A Randomized Clinical Trial","Liu-Ambrose T, Falck RS, Dao E, Best JR, Davis JC, Bennett K, Hall PA, Hsiung GR, Middleton LE, Goldsmith CH, Graf P, Eng JJ.","JAMA Netw Open. 2022 Oct 3;5(10):e2236510. doi: 10.1001/jamanetworkopen.2022.36510.","Liu-Ambrose T","JAMA Netw Open","2022","2022/10/13","PMC9561961","","10.1001/jamanetworkopen.2022.36510"
"16102903","The dardarin G 2019 S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases","Hernandez D, Paisan Ruiz C, Crawley A, Malkani R, Werner J, Gwinn-Hardy K, Dickson D, Wavrant Devrieze F, Hardy J, Singleton A.","Neurosci Lett. 2005 Dec 9;389(3):137-9. doi: 10.1016/j.neulet.2005.07.044.","Hernandez D","Neurosci Lett","2005","2005/08/17","","","10.1016/j.neulet.2005.07.044"
"32280089","Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia","Shiells H, Schelter BO, Bentham P, Baddeley TC, Rubino CM, Ganesan H, Hammel J, Vuksanovic V, Staff RT, Murray AD, Bracoud L, Wischik DJ, Riedel G, Gauthier S, Jia J, Moebius HJ, Hardlund J, Kipps CM, Kook K, Storey JMD, Harrington CR, Wischik CM.","J Alzheimers Dis. 2020;75(2):501-519. doi: 10.3233/JAD-191173.","Shiells H","J Alzheimers Dis","2020","2020/04/14","PMC7306898","","10.3233/JAD-191173"
"11435810","Correlation between cortical theta activity and hippocampal volumes in health, mild cognitive impairment, and mild dementia","Grunwald M, Busse F, Hensel A, Kruggel F, Riedel-Heller S, Wolf H, Arendt T, Gertz HJ.","J Clin Neurophysiol. 2001 Mar;18(2):178-84. doi: 10.1097/00004691-200103000-00010.","Grunwald M","J Clin Neurophysiol","2001","2001/07/04","","","10.1097/00004691-200103000-00010"
"22459264","Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg","Herrschaft H, Nacu A, Likhachev S, Sholomov I, Hoerr R, Schlaefke S.","J Psychiatr Res. 2012 Jun;46(6):716-23. doi: 10.1016/j.jpsychires.2012.03.003. Epub 2012 Mar 27.","Herrschaft H","J Psychiatr Res","2012","2012/03/31","","","10.1016/j.jpsychires.2012.03.003"
"25622185","Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density","Curtis C, Gamez JE, Singh U, Sadowsky CH, Villena T, Sabbagh MN, Beach TG, Duara R, Fleisher AS, Frey KA, Walker Z, Hunjan A, Holmes C, Escovar YM, Vera CX, Agronin ME, Ross J, Bozoki A, Akinola M, Shi J, Vandenberghe R, Ikonomovic MD, Sherwin PF, Grachev ID, Farrar G, Smith AP, Buckley CJ, McLain R, Salloway S.","JAMA Neurol. 2015 Mar;72(3):287-94. doi: 10.1001/jamaneurol.2014.4144.","Curtis C","JAMA Neurol","2015","2015/01/27","","","10.1001/jamaneurol.2014.4144"
"36639676","Theta tACS impairs episodic memory more than tDCS","Murray NWG, Graham PL, Sowman PF, Savage G.","Sci Rep. 2023 Jan 13;13(1):716. doi: 10.1038/s41598-022-27190-y.","Murray NWG","Sci Rep","2023","2023/01/13","PMC9839727","","10.1038/s41598-022-27190-y"
"23594991","A double-blind, placebo-controlled, ascending-dose, randomized study to evaluate the safety, tolerability and effects on cognition of AL-108 after 12 weeks of intranasal administration in subjects with mild cognitive impairment","Morimoto BH, Schmechel D, Hirman J, Blackwell A, Keith J, Gold M; AL-108-211 Study.","Dement Geriatr Cogn Disord. 2013;35(5-6):325-36. doi: 10.1159/000348347. Epub 2013 Apr 13.","Morimoto BH","Dement Geriatr Cogn Disord","2013","2013/04/19","","","10.1159/000348347"
"16412989","Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia","Levine J, Stahl Z, Sela BA, Ruderman V, Shumaico O, Babushkin I, Osher Y, Bersudsky Y, Belmaker RH.","Biol Psychiatry. 2006 Aug 1;60(3):265-9. doi: 10.1016/j.biopsych.2005.10.009. Epub 2006 Jan 17.","Levine J","Biol Psychiatry","2006","2006/01/18","","","10.1016/j.biopsych.2005.10.009"
"11150336","Age and gender predict volume decline in the anterior and posterior hippocampus in early adulthood","Pruessner JC, Collins DL, Pruessner M, Evans AC.","J Neurosci. 2001 Jan 1;21(1):194-200. doi: 10.1523/JNEUROSCI.21-01-00194.2001.","Pruessner JC","J Neurosci","2001","2001/01/11","PMC6762451","","10.1523/JNEUROSCI.21-01-00194.2001"
"28800895","A randomized trial of a web-based platform to help families manage dementia-related behavioral symptoms: The WeCareAdvisor™","Gitlin LN, Kales HC, Marx K, Stanislawski B, Lyketsos C.","Contemp Clin Trials. 2017 Nov;62:27-36. doi: 10.1016/j.cct.2017.08.001. Epub 2017 Aug 9.","Gitlin LN","Contemp Clin Trials","2017","2017/08/13","PMC6428066","NIHMS1013118","10.1016/j.cct.2017.08.001"
"26987723","Acute tryptophan depletion and Lewy body dementias","Mace JL, Porter RJ, Dalrymple-Alford JC, Collins C, Anderson TJ.","Int Psychogeriatr. 2016 Sep;28(9):1487-91. doi: 10.1017/S1041610216000284. Epub 2016 Mar 18.","Mace JL","Int Psychogeriatr","2016","2016/03/19","","","10.1017/S1041610216000284"
"31707469","Pharmacological Heart Failure Therapy in Children: Focus on Inotropic Support","Schranz D.","Handb Exp Pharmacol. 2020;261:177-192. doi: 10.1007/164_2019_267.","Schranz D","Handb Exp Pharmacol","2020","2019/11/11","","","10.1007/164_2019_267"
"11797074","Effects of transdermal nicotine on attention and memory in healthy elderly non-smokers","Min SK, Moon IW, Ko RW, Shin HS.","Psychopharmacology (Berl). 2001 Dec;159(1):83-8. doi: 10.1007/s002130100899. Epub 2001 Sep 15.","Min SK","Psychopharmacology (Berl)","2001","2002/01/18","","","10.1007/s002130100899"
"27622854","Exercise during pregnancy enhances cerebral maturation in the newborn: A randomized controlled trial","Labonte-Lemoyne E, Curnier D, Ellemberg D.","J Clin Exp Neuropsychol. 2017 May;39(4):347-354. doi: 10.1080/13803395.2016.1227427. Epub 2016 Sep 13.","Labonte-Lemoyne E","J Clin Exp Neuropsychol","2017","2016/09/14","","","10.1080/13803395.2016.1227427"
"26275583","Intranasal insulin influences the olfactory performance of patients with smell loss, dependent on the body mass index: A pilot study","Schöpf V, Kollndorfer K, Pollak M, Mueller CA, Freiherr J.","Rhinology. 2015 Dec;53(4):371-8. doi: 10.4193/Rhino15.065.","Schöpf V","Rhinology","2015","2015/08/16","","","10.4193/Rhino15.065"
"25889057","Cognitive testing for dementia is adversely affected by administration in a foreign location","Bechtel C, Remington R, Barton B, Barasauskas C, Shea TB.","BMC Res Notes. 2015 Mar 4;8:66. doi: 10.1186/s13104-015-1021-3.","Bechtel C","BMC Res Notes","2015","2015/04/19","PMC4359506","","10.1186/s13104-015-1021-3"
"16463821","Beneficial effect of cerebrolysin on moderate and severe head injury patients: result of a cohort study","Wong GK, Zhu XL, Poon WS.","Acta Neurochir Suppl. 2005;95:59-60. doi: 10.1007/3-211-32318-x_13.","Wong GK","Acta Neurochir Suppl","2005","2006/02/09","","","10.1007/3-211-32318-x_13"
"10559569","Dementia with leukoaraiosis: clinical differentiation by temporoparietal hypometabolism on (18)FDG-PET imaging","Mendez MF, Ottowitz W, Brown CV, Cummings JL, Perryman KM, Mandelkern MA.","Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):518-25. doi: 10.1159/000017199.","Mendez MF","Dement Geriatr Cogn Disord","1999","1999/11/24","","","10.1159/000017199"
"22435956","Prefrontal cortex rTMS enhances action naming in progressive non-fluent aphasia","Cotelli M, Manenti R, Alberici A, Brambilla M, Cosseddu M, Zanetti O, Miozzo A, Padovani A, Miniussi C, Borroni B.","Eur J Neurol. 2012 Nov;19(11):1404-12. doi: 10.1111/j.1468-1331.2012.03699.x. Epub 2012 Mar 21.","Cotelli M","Eur J Neurol","2012","2012/03/23","","","10.1111/j.1468-1331.2012.03699.x"
"14528786","Using a quasi-experimental research design to assess knowledge in continuing medical education programs","Markert RJ, O'Neill SC, Bhatia SC.","J Contin Educ Health Prof. 2003 Summer;23(3):157-61. doi: 10.1002/chp.1340230306.","Markert RJ","J Contin Educ Health Prof","2003","2003/10/08","","","10.1002/chp.1340230306"
"10971544","Automated standardized pupillometry with optical method for purposes of clinical practice and research","Fotiou F, Fountoulakis KN, Goulas A, Alexopoulos L, Palikaras A.","Clin Physiol. 2000 Sep;20(5):336-47. doi: 10.1046/j.1365-2281.2000.00259.x.","Fotiou F","Clin Physiol","2000","2000/09/06","","","10.1046/j.1365-2281.2000.00259.x"
"8930946","Use of Goal Attainment Scaling to measure treatment effects in an anti-dementia drug trial","Rockwood K, Stolee P, Howard K, Mallery L.","Neuroepidemiology. 1996;15(6):330-8. doi: 10.1159/000109923.","Rockwood K","Neuroepidemiology","1996","1996/01/01","","","10.1159/000109923"
"1615141","Hypersensitivity to scopolamine in the elderly","Flicker C, Ferris SH, Serby M.","Psychopharmacology (Berl). 1992;107(2-3):437-41. doi: 10.1007/BF02245172.","Flicker C","Psychopharmacology (Berl)","1992","1992/01/01","","","10.1007/BF02245172"
"31564448","Effect of traditional opera on older adults with dementia","Chen X, Li D, Xu H, Hu Z.","Geriatr Nurs. 2020 Mar-Apr;41(2):118-123. doi: 10.1016/j.gerinurse.2019.08.002. Epub 2019 Sep 26.","Chen X","Geriatr Nurs","2020","2019/10/01","","","10.1016/j.gerinurse.2019.08.002"
"20849673","Discontinuing cholinesterase inhibitors: results of a survey of Canadian dementia experts","Herrmann N, Black SE, Li A, Lanctôt KL.","Int Psychogeriatr. 2011 May;23(4):539-45. doi: 10.1017/S1041610210001535. Epub 2010 Sep 20.","Herrmann N","Int Psychogeriatr","2011","2010/09/21","","","10.1017/S1041610210001535"
"17113685","B-vitamins reduce plasma levels of beta amyloid","Flicker L, Martins RN, Thomas J, Acres J, Taddei K, Vasikaran SD, Norman P, Jamrozik K, Almeida OP.","Neurobiol Aging. 2008 Feb;29(2):303-5. doi: 10.1016/j.neurobiolaging.2006.10.007. Epub 2006 Nov 20.","Flicker L","Neurobiol Aging","2008","2006/11/23","","","10.1016/j.neurobiolaging.2006.10.007"
"11153720","A new method for the in vivo volumetric measurement of the human hippocampus with high neuroanatomical accuracy","Pantel J, O'Leary DS, Cretsinger K, Bockholt HJ, Keefe H, Magnotta VA, Andreasen NC.","Hippocampus. 2000;10(6):752-8. doi: 10.1002/1098-1063(2000)10:6<752::AID-HIPO1012>3.0.CO;2-Y.","Pantel J","Hippocampus","2000","2001/01/12","","","10.1002/1098-1063(2000)10:6<752::AID-HIPO1012>3.0.CO;2-Y"
"10902415","The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia","Kertesz A, Nadkarni N, Davidson W, Thomas AW.","J Int Neuropsychol Soc. 2000 May;6(4):460-8. doi: 10.1017/s1355617700644041.","Kertesz A","J Int Neuropsychol Soc","2000","2000/07/21","","","10.1017/s1355617700644041"
"9223061","Relation of age and apolipoprotein E to cognitive function in Down syndrome adults","Alexander GE, Saunders AM, Szczepanik J, Strassburger TL, Pietrini P, Dani A, Furey ML, Mentis MJ, Roses AD, Rapoport SI, Schapiro MB.","Neuroreport. 1997 May 27;8(8):1835-40. doi: 10.1097/00001756-199705260-00009.","Alexander GE","Neuroreport","1997","1997/05/27","","","10.1097/00001756-199705260-00009"
"9158880","Pharmacokinetics of MDL 26479, a novel benzodiazepine inverse agonist, in normal volunteers","Robbins DK, Hutcheson SJ, Miller TD, Green VI, Bhargava VO, Weir SJ.","Biopharm Drug Dispos. 1997 May;18(4):325-34. doi: 10.1002/(sici)1099-081x(199705)18:4<325::aid-bdd21>3.0.co;2-1.","Robbins DK","Biopharm Drug Dispos","1997","1997/05/01","","","10.1002/(sici)1099-081x(199705)18:4<325::aid-bdd21>3.0.co;2-1"
"7751410","Single-dose pharmacokinetics, safety, and tolerance of linopirdine (DuP 996) in healthy young adults and elderly volunteers","Pieniaszek HJ Jr, Fiske WD, Saxton TD, Kim YS, Garner DM, Xilinas M, Martz R.","J Clin Pharmacol. 1995 Jan;35(1):22-30. doi: 10.1002/j.1552-4604.1995.tb04741.x.","Pieniaszek HJ Jr","J Clin Pharmacol","1995","1995/01/01","","","10.1002/j.1552-4604.1995.tb04741.x"
"3211287","Modelling dementia: effects of scopolamine on memory and attention","Broks P, Preston GC, Traub M, Poppleton P, Ward C, Stahl SM.","Neuropsychologia. 1988;26(5):685-700. doi: 10.1016/0028-3932(88)90004-8.","Broks P","Neuropsychologia","1988","1988/01/01","","","10.1016/0028-3932(88)90004-8"
"18583886","Abnormal integrity of corticocortical tracts in mild cognitive impairment: a diffusion tensor imaging study","Cho H, Yang DW, Shon YM, Kim BS, Kim YI, Choi YB, Lee KS, Shim YS, Yoon B, Kim W, Ahn KJ.","J Korean Med Sci. 2008 Jun;23(3):477-83. doi: 10.3346/jkms.2008.23.3.477.","Cho H","J Korean Med Sci","2008","2008/06/28","PMC2526517","","10.3346/jkms.2008.23.3.477"
"27565651","Brief Report: Initial Trial of Alpha7-Nicotinic Receptor Stimulation in Two Adult Patients with Autism Spectrum Disorder","Olincy A, Blakeley-Smith A, Johnson L, Kem WR, Freedman R.","J Autism Dev Disord. 2016 Dec;46(12):3812-3817. doi: 10.1007/s10803-016-2890-6.","Olincy A","J Autism Dev Disord","2016","2016/08/28","PMC8086723","NIHMS1662934","10.1007/s10803-016-2890-6"
"32159519","Efficacy of a Web App for Cognitive Training (MeMo) Regarding Cognitive and Behavioral Performance in People With Neurocognitive Disorders: Randomized Controlled Trial","Robert P, Manera V, Derreumaux A, Ferrandez Y Montesino M, Leone E, Fabre R, Bourgeois J.","J Med Internet Res. 2020 Mar 11;22(3):e17167. doi: 10.2196/17167.","Robert P","J Med Internet Res","2020","2020/03/12","PMC7097721","","10.2196/17167"
"30340619","Physical exercise and cognitive engagement outcomes for mild neurocognitive disorder: a group-randomized pilot trial","De Wit L, O'Shea D, Chandler M, Bhaskar T, Tanner J, Vemuri P, Crook J, Morris M, Smith G.","Trials. 2018 Oct 19;19(1):573. doi: 10.1186/s13063-018-2865-3.","De Wit L","Trials","2018","2018/10/21","PMC6194559","","10.1186/s13063-018-2865-3"
"15707912","Memory and action: an experimental study on normal subjects and schizophrenic patients","Daprati E, Nico D, Saimpont A, Franck N, Sirigu A.","Neuropsychologia. 2005;43(2):281-93. doi: 10.1016/j.neuropsychologia.2004.11.014. Epub 2005 Jan 7.","Daprati E","Neuropsychologia","2005","2005/02/15","","","10.1016/j.neuropsychologia.2004.11.014"
"16229010","Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study","Poewe W, Wolters E, Emre M, Onofrj M, Hsu C, Tekin S, Lane R; EXPRESS Investigators.","Mov Disord. 2006 Apr;21(4):456-61. doi: 10.1002/mds.20700.","Poewe W","Mov Disord","2006","2005/10/18","","","10.1002/mds.20700"
"7839316","Slow recovery of human brain MAO B after L-deprenyl (Selegeline) withdrawal","Fowler JS, Volkow ND, Logan J, Wang GJ, MacGregor RR, Schyler D, Wolf AP, Pappas N, Alexoff D, Shea C, et al.","Synapse. 1994 Oct;18(2):86-93. doi: 10.1002/syn.890180203.","Fowler JS","Synapse","1994","1994/10/01","","","10.1002/syn.890180203"
"31205938","Assessment of the Levels of Level of Biomarkers of Bone Matrix Glycoproteins and Inflammatory Cytokines from Saudi Parkinson Patients","Alrafiah A, Al-Ofi E, Obaid MT, Alsomali N.","Biomed Res Int. 2019 May 8;2019:2690205. doi: 10.1155/2019/2690205. eCollection 2019.","Alrafiah A","Biomed Res Int","2019","2019/06/18","PMC6530158","","10.1155/2019/2690205"
"27472878","Efficacy and Safety of Crocus sativus L. in Patients with Mild Cognitive Impairment: One Year Single-Blind Randomized, with Parallel Groups, Clinical Trial","Tsolaki M, Karathanasi E, Lazarou I, Dovas K, Verykouki E, Karacostas A, Georgiadis K, Tsolaki A, Adam K, Kompatsiaris I, Sinakos Z.","J Alzheimers Dis. 2016 Jul 27;54(1):129-33. doi: 10.3233/JAD-160304.","Tsolaki M","J Alzheimers Dis","2016","2016/07/30","","","10.3233/JAD-160304"
"22922591","Pharmacokinetics and pharmacodynamics of CHF5074 after short-term administration in healthy subjects","Imbimbo BP, Frigerio E, Breda M, Fiorentini F, Fernandez M, Sivilia S, Giardino L, Calzà L, Norris D, Casula D, Shenouda M.","Alzheimer Dis Assoc Disord. 2013 Jul-Sep;27(3):278-86. doi: 10.1097/WAD.0b013e3182622ace.","Imbimbo BP","Alzheimer Dis Assoc Disord","2013","2012/08/28","","","10.1097/WAD.0b013e3182622ace"
"23604006","Object alternation: a novel probe of medial frontal function in frontotemporal dementia","Freedman M, Binns MA, Black SE, Levine B, Miller BL, Ramirez J, Szilagyi GM, Scott CJ, McNeely AA, Stuss DT.","Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):316-23. doi: 10.1097/WAD.0b013e318293b546.","Freedman M","Alzheimer Dis Assoc Disord","2013","2013/04/23","PMC5933938","NIHMS958480","10.1097/WAD.0b013e318293b546"
"30547745","Study protocol: individualized music for people with dementia - improvement of quality of life and social participation for people with dementia in institutional care","Weise L, Jakob E, Töpfer NF, Wilz G.","BMC Geriatr. 2018 Dec 14;18(1):313. doi: 10.1186/s12877-018-1000-3.","Weise L","BMC Geriatr","2018","2018/12/15","PMC6295033","","10.1186/s12877-018-1000-3"
"27608620","Cognitive change is more positively associated with an active lifestyle than with training interventions in older adults at risk of dementia: a controlled interventional clinical trial","Küster OC, Fissler P, Laptinskaya D, Thurm F, Scharpf A, Woll A, Kolassa S, Kramer AF, Elbert T, von Arnim CA, Kolassa IT.","BMC Psychiatry. 2016 Sep 8;16(1):315. doi: 10.1186/s12888-016-1018-z.","Küster OC","BMC Psychiatry","2016","2016/09/10","PMC5016950","","10.1186/s12888-016-1018-z"
"24599628","Indole and trans-chalcone attenuate amyloid β plaque accumulation in male Wistar rat: in vivo effectiveness of two anti-amyloid scaffolds","Yaghmaei P, Kheirbakhsh R, Dezfulian M, Haeri-Rohani A, Larijani B, Ebrahim-Habibi A.","Arch Ital Biol. 2013 Sep;151(3):106-13. doi: 10.4449/aib.v151i3.1479.","Yaghmaei P","Arch Ital Biol","2013","2014/03/07","","","10.4449/aib.v151i3.1479"
"26508834","Urinary kallidinogenase for the treatment of cerebral arterial stenosis","Zhao L, Zhao Y, Wan Q, Zhang H.","Drug Des Devel Ther. 2015 Oct 13;9:5595-600. doi: 10.2147/DDDT.S93150. eCollection 2015.","Zhao L","Drug Des Devel Ther","2015","2015/10/29","PMC4610775","","10.2147/DDDT.S93150"
"32977992","The effect of resistance training on sleep in Chinese older adults: A randomized controlled trial","Li Z, Li J, Yu G, Yu F, Li K, Szanton S.","Geriatr Nurs. 2021 Jan-Feb;42(1):289-294. doi: 10.1016/j.gerinurse.2020.09.002. Epub 2020 Sep 22.","Li Z","Geriatr Nurs","2021","2020/09/26","","","10.1016/j.gerinurse.2020.09.002"
"30395314","Effects of Transcranial Direct Current Stimulation on Episodic Memory in Amnestic Mild Cognitive Impairment: A Pilot Study","Manenti R, Sandrini M, Gobbi E, Binetti G, Cotelli M.","J Gerontol B Psychol Sci Soc Sci. 2020 Aug 13;75(7):1403-1413. doi: 10.1093/geronb/gby134.","Manenti R","J Gerontol B Psychol Sci Soc Sci","2020","2018/11/06","","","10.1093/geronb/gby134"
"26923418","Older adults get episodic memory boosting from noninvasive stimulation of prefrontal cortex during learning","Sandrini M, Manenti R, Brambilla M, Cobelli C, Cohen LG, Cotelli M.","Neurobiol Aging. 2016 Mar;39:210-216. doi: 10.1016/j.neurobiolaging.2015.12.010. Epub 2015 Dec 29.","Sandrini M","Neurobiol Aging","2016","2016/03/01","PMC5108058","NIHMS824055","10.1016/j.neurobiolaging.2015.12.010"
"26001567","Is rivastigmine safe as pretreatment against nerve agents poisoning? A pharmacological, physiological and cognitive assessment in healthy young adult volunteers","Lavon O, Eisenkraft A, Blanca M, Raveh L, Ramaty E, Krivoy A, Atsmon J, Grauer E, Brandeis R.","Neurotoxicology. 2015 Jul;49:36-44. doi: 10.1016/j.neuro.2015.05.003. Epub 2015 May 19.","Lavon O","Neurotoxicology","2015","2015/05/24","","","10.1016/j.neuro.2015.05.003"
"17341003","Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial","Napryeyenko O, Borzenko I; GINDEM-NP Study Group.","Arzneimittelforschung. 2007;57(1):4-11. doi: 10.1055/s-0031-1296579.","Napryeyenko O","Arzneimittelforschung","2007","2007/03/08","","","10.1055/s-0031-1296579"
"16837880","Effects of hormone therapy on brain morphology of healthy postmenopausal women: a Voxel-based morphometry study","Boccardi M, Ghidoni R, Govoni S, Testa C, Benussi L, Bonetti M, Binetti G, Frisoni GB.","Menopause. 2006 Jul-Aug;13(4):584-91. doi: 10.1097/01.gme.0000196811.88505.10.","Boccardi M","Menopause","2006","2006/07/14","","","10.1097/01.gme.0000196811.88505.10"
"16777649","Improved quality of life and cognitive stimulation therapy in dementia","Woods B, Thorgrimsen L, Spector A, Royan L, Orrell M.","Aging Ment Health. 2006 May;10(3):219-26. doi: 10.1080/13607860500431652.","Woods B","Aging Ment Health","2006","2006/06/17","","","10.1080/13607860500431652"
"8588647","Estrogen replacement therapy and postural stability in the elderly","Goebel JA, Birge SJ, Price SC, Hanson JM, Fishel DG.","Am J Otol. 1995 Jul;16(4):470-4.","Goebel JA","Am J Otol","1995","1995/07/01","","",""
"34012020","Visuospatial working memory dysfunction from tapping span test as a diagnostic tool for patients with mild posterior cortical atrophy","Funayama M, Takata T, Nakagawa Y, Sunagawa K, Nakajima A, Kawashima H, Mimura M.","Sci Rep. 2021 May 19;11(1):10580. doi: 10.1038/s41598-021-90159-w.","Funayama M","Sci Rep","2021","2021/05/20","PMC8134425","","10.1038/s41598-021-90159-w"
"23069874","Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients","Mäurer M, Ortler S, Baier M, Meergans M, Scherer P, Hofmann W, Tracik F.","Mult Scler. 2013 Apr;19(5):631-8. doi: 10.1177/1352458512463481. Epub 2012 Oct 15.","Mäurer M","Mult Scler","2013","2012/10/17","","","10.1177/1352458512463481"
"22116416","Conservative versus surgical management of idiopathic normal pressure hydrocephalus: a prospective double-blind randomized controlled trial: study protocol","Toma AK, Papadopoulos MC, Stapleton S, Kitchen ND, Watkins LD.","Acta Neurochir Suppl. 2012;113:21-3. doi: 10.1007/978-3-7091-0923-6_4.","Toma AK","Acta Neurochir Suppl","2012","2011/11/26","","","10.1007/978-3-7091-0923-6_4"
"18160652","Focusing effect of acetylcholine on neuroplasticity in the human motor cortex","Kuo MF, Grosch J, Fregni F, Paulus W, Nitsche MA.","J Neurosci. 2007 Dec 26;27(52):14442-7. doi: 10.1523/JNEUROSCI.4104-07.2007.","Kuo MF","J Neurosci","2007","2007/12/28","PMC6673455","","10.1523/JNEUROSCI.4104-07.2007"
"15717335","Cognitive intervention for community-dwelling older persons with memory problems: telemedicine versus face-to-face treatment","Poon P, Hui E, Dai D, Kwok T, Woo J.","Int J Geriatr Psychiatry. 2005 Mar;20(3):285-6. doi: 10.1002/gps.1282.","Poon P","Int J Geriatr Psychiatry","2005","2005/02/18","","","10.1002/gps.1282"
"15175977","[Donepezil therapy in patients with vascular and post-traumatic cognitive impairment: some clinical observations]","Olazarán-Rodríguez J, Cruz-Orduña I, Jiménez-Martín I.","Rev Neurol. 2004 May 16-31;38(10):938-43.","Olazarán-Rodríguez J","Rev Neurol","2004","2004/06/04","","",""
"11771747","Effects of a single transdermal nicotine dose on cognitive performance in adults with Down syndrome","Bernert G, Sustrova M, Sovcikova E, Seidl R, Lubec G.","J Neural Transm Suppl. 2001;(61):237-45. doi: 10.1007/978-3-7091-6262-0_19.","Bernert G","J Neural Transm Suppl","2001","2002/01/05","","","10.1007/978-3-7091-6262-0_19"
"9860103","Transdermal nicotine effects on attention","Levin ED, Conners CK, Silva D, Hinton SC, Meck WH, March J, Rose JE.","Psychopharmacology (Berl). 1998 Nov;140(2):135-41. doi: 10.1007/s002130050750.","Levin ED","Psychopharmacology (Berl)","1998","1998/12/22","","","10.1007/s002130050750"
"9462972","[Triflusal in the prevention of vascular dementia]","López-Pousa S, Mercadal-Dalmau J, Martí-Cuadros AM, Vilalta-Franch J, Lozano-Gallego M.","Rev Neurol. 1997 Oct;25(146):1525-8.","López-Pousa S","Rev Neurol","1997","1998/02/14","","",""
"27121662","Satisfaction With a Family-Focused Intervention for Mild Cognitive Impairment Dyads","Lu YY, Ellis J, Yang Z, Weaver MT, Bakas T, Austrom MG, Haase JE.","J Nurs Scholarsh. 2016 Jul;48(4):334-44. doi: 10.1111/jnu.12214. Epub 2016 Apr 27.","Lu YY","J Nurs Scholarsh","2016","2016/04/29","PMC4970320","NIHMS802507","10.1111/jnu.12214"
"29763451","Episodic memory and delayed recall are significantly more impaired in younger patients with deficit schizophrenia than in elderly patients with amnestic mild cognitive impairment","Kanchanatawan B, Tangwongchai S, Supasitthumrong T, Sriswasdi S, Maes M.","PLoS One. 2018 May 15;13(5):e0197004. doi: 10.1371/journal.pone.0197004. eCollection 2018.","Kanchanatawan B","PLoS One","2018","2018/05/16","PMC5953437","","10.1371/journal.pone.0197004"
"20191258","A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia","Chan A, Remington R, Kotyla E, Lepore A, Zemianek J, Shea TB.","J Nutr Health Aging. 2010 Mar;14(3):224-30. doi: 10.1007/s12603-010-0054-5.","Chan A","J Nutr Health Aging","2010","2010/03/02","","","10.1007/s12603-010-0054-5"
"18213609","A 6-month, open-label study of memantine in patients with frontotemporal dementia","Diehl-Schmid J, Förstl H, Perneczky R, Pohl C, Kurz A.","Int J Geriatr Psychiatry. 2008 Jul;23(7):754-9. doi: 10.1002/gps.1973.","Diehl-Schmid J","Int J Geriatr Psychiatry","2008","2008/01/24","","","10.1002/gps.1973"
"16351359","Scaling of visuospatial attention undergoes differential longitudinal change as a function of APOE genotype prior to old age: results from the NIMH BIOCARD study","Greenwood PM, Sunderland T, Putnam K, Levy J, Parasuraman R.","Neuropsychology. 2005 Nov;19(6):830-40. doi: 10.1037/0894-4105.19.6.830.","Greenwood PM","Neuropsychology","2005","2005/12/15","","","10.1037/0894-4105.19.6.830"
"15101567","Effects of discontinuation of long-term anticholinergic treatment in elderly schizophrenia patients","Drimer T, Shahal B, Barak Y.","Int Clin Psychopharmacol. 2004 Jan;19(1):27-9. doi: 10.1097/00004850-200401000-00005.","Drimer T","Int Clin Psychopharmacol","2004","2004/04/23","","","10.1097/00004850-200401000-00005"
"35384529","An Investigation of Instability in Dried Blood Spot Samples for Pharmacokinetic Sampling in Phase 3 Trials of Verubecestat","Anderson M, Dockendorf MF, McIntosh I, Xie I, Breidinger S, Meng D, Ren S, Zhong W, Zhang L, Roadcap B, Bateman KP, Stone J, Woolf E.","AAPS J. 2022 Apr 6;24(3):52. doi: 10.1208/s12248-022-00683-4.","Anderson M","AAPS J","2022","2022/04/06","","","10.1208/s12248-022-00683-4"
"31885287","Beneficial effect of computer-based multidomain cognitive training in patients with mild cognitive impairment","Nousia A, Martzoukou M, Siokas V, Aretouli E, Aloizou AM, Folia V, Peristeri E, Messinis L, Nasios G, Dardiotis E.","Appl Neuropsychol Adult. 2021 Nov-Dec;28(6):717-726. doi: 10.1080/23279095.2019.1692842. Epub 2019 Dec 29.","Nousia A","Appl Neuropsychol Adult","2021","2019/12/31","","","10.1080/23279095.2019.1692842"
"21809439","Dark roast coffee is more effective than light roast coffee in reducing body weight, and in restoring red blood cell vitamin E and glutathione concentrations in healthy volunteers","Kotyczka C, Boettler U, Lang R, Stiebitz H, Bytof G, Lantz I, Hofmann T, Marko D, Somoza V.","Mol Nutr Food Res. 2011 Oct;55(10):1582-6. doi: 10.1002/mnfr.201100248. Epub 2011 Aug 2.","Kotyczka C","Mol Nutr Food Res","2011","2011/08/03","","","10.1002/mnfr.201100248"
"16988797","Homocysteine but not neopterin declines in demented patients on B vitamins","Frick B, Gruber B, Schroecksnadel K, Leblhuber F, Fuchs D.","J Neural Transm (Vienna). 2006 Nov;113(11):1815-9. doi: 10.1007/s00702-006-0539-x. Epub 2006 Sep 21.","Frick B","J Neural Transm (Vienna)","2006","2006/09/22","","","10.1007/s00702-006-0539-x"
"14504417","Effects of scopolamine on matching to sample paradigm and related tests in human subjects","Koller G, Satzger W, Adam M, Wagner M, Kathmann N, Soyka M, Engel R.","Neuropsychobiology. 2003;48(2):87-94. doi: 10.1159/000072883.","Koller G","Neuropsychobiology","2003","2003/09/25","","","10.1159/000072883"
"33935094","Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment","Perła-Kaján J, Włoczkowska O, Zioła-Frankowska A, Frankowski M, Smith AD, de Jager CA, Refsum H, Jakubowski H.","J Alzheimers Dis. 2021;81(3):1211-1229. doi: 10.3233/JAD-210137.","Perła-Kaján J","J Alzheimers Dis","2021","2021/05/03","PMC8293656","","10.3233/JAD-210137"
"35196481","Sunbeam Program Reduces Rate of Falls in Long-Term Care Residents With Mild to Moderate Cognitive Impairment or Dementia: Subgroup Analysis of a Cluster Randomized Controlled Trial","Mak A, Delbaere K, Refshauge K, Henwood T, Goodall S, Clemson L, Hewitt J, Taylor ME.","J Am Med Dir Assoc. 2022 May;23(5):743-749.e1. doi: 10.1016/j.jamda.2022.01.064. Epub 2022 Feb 20.","Mak A","J Am Med Dir Assoc","2022","2022/02/23","","","10.1016/j.jamda.2022.01.064"
"33906081","The effect of a 6-month ketogenic medium-chain triglyceride supplement on plasma cardiometabolic and inflammatory markers in mild cognitive impairment","Myette-Côté É, St-Pierre V, Beaulieu S, Castellano CA, Fortier M, Plourde M, Bocti C, Fulop T, Cunnane SC.","Prostaglandins Leukot Essent Fatty Acids. 2021 Jun;169:102236. doi: 10.1016/j.plefa.2020.102236. Epub 2020 Dec 24.","Myette-Côté É","Prostaglandins Leukot Essent Fatty Acids","2021","2021/04/27","","","10.1016/j.plefa.2020.102236"
"9489527","Neuropsychological prediction of dementia in Parkinson's disease","Mahieux F, Fénelon G, Flahault A, Manifacier MJ, Michelet D, Boller F.","J Neurol Neurosurg Psychiatry. 1998 Feb;64(2):178-83. doi: 10.1136/jnnp.64.2.178.","Mahieux F","J Neurol Neurosurg Psychiatry","1998","1998/03/07","PMC2169963","","10.1136/jnnp.64.2.178"
"12767414","Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial","van Dongen M, van Rossum E, Kessels A, Sielhorst H, Knipschild P.","J Clin Epidemiol. 2003 Apr;56(4):367-76. doi: 10.1016/s0895-4356(03)00003-9.","van Dongen M","J Clin Epidemiol","2003","2003/05/28","","","10.1016/s0895-4356(03)00003-9"
"23487758","Identification of genetic variants influencing the human plasma proteome","Johansson Å, Enroth S, Palmblad M, Deelder AM, Bergquist J, Gyllensten U.","Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4673-8. doi: 10.1073/pnas.1217238110. Epub 2013 Mar 4.","Johansson Å","Proc Natl Acad Sci U S A","2013","2013/03/15","PMC3606982","","10.1073/pnas.1217238110"
"25274948","Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: a clinical cohort study","Tondelli M, Bedin R, Chiari A, Molinari MA, Bonifacio G, Lelli N, Trenti T, Nichelli P.","Clin Chem Lab Med. 2015 Feb;53(3):453-60. doi: 10.1515/cclm-2014-0414.","Tondelli M","Clin Chem Lab Med","2015","2014/10/03","","","10.1515/cclm-2014-0414"
"22936530","Treatment outcomes of a crisis intervention program for dementia with severe psychiatric complications: the Kansas bridge project","Johnson DK, Niedens M, Wilson JR, Swartzendruber L, Yeager A, Jones K.","Gerontologist. 2013 Feb;53(1):102-12. doi: 10.1093/geront/gns104. Epub 2012 Aug 30.","Johnson DK","Gerontologist","2013","2012/09/01","PMC3605939","","10.1093/geront/gns104"
"16608139","Early nutritional supplementation immediately after diagnosis of infectious disease improves body weight in psychogeriatric nursing home residents","Wouters-Wesseling W, Slump E, Kleijer CN, de Groot LC, van Staveren WA.","Aging Clin Exp Res. 2006 Feb;18(1):70-4. doi: 10.1007/BF03324643.","Wouters-Wesseling W","Aging Clin Exp Res","2006","2006/04/13","","","10.1007/BF03324643"
"12040140","Apolipoprotein E epsilon4 and risk of mortality in African American and white older community residents","Fillenbaum GG, Blazer DG, Burchett BM, Saunders AM, Taylor DH Jr.","Gerontologist. 2002 Jun;42(3):381-6. doi: 10.1093/geront/42.3.381.","Fillenbaum GG","Gerontologist","2002","2002/06/01","","","10.1093/geront/42.3.381"
"8024677","Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior","Newhouse PA, Potter A, Corwin J, Lenox R.","Neuropsychopharmacology. 1994 Apr;10(2):93-107. doi: 10.1038/npp.1994.11.","Newhouse PA","Neuropsychopharmacology","1994","1994/04/01","","","10.1038/npp.1994.11"
"33755917","Reminiscence therapy serves as an optional nursing care strategy in attenuating cognitive impairment, anxiety, and depression in acute ischemic stroke patients","Li A, Liu Y.","Ir J Med Sci. 2022 Apr;191(2):877-884. doi: 10.1007/s11845-021-02600-8. Epub 2021 Mar 23.","Li A","Ir J Med Sci","2022","2021/03/23","","","10.1007/s11845-021-02600-8"
"15554751","Rivastigmine in frontotemporal dementia: an open-label study","Moretti R, Torre P, Antonello RM, Cattaruzza T, Cazzato G, Bava A.","Drugs Aging. 2004;21(14):931-7. doi: 10.2165/00002512-200421140-00003.","Moretti R","Drugs Aging","2004","2004/11/24","","","10.2165/00002512-200421140-00003"
"27519183","Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial","Goodman PJ, Tangen CM, Darke AK, Arnold KB, Hartline J, Yee M, Anderson K, Caban-Holt A, Christen WG, Cassano PA, Lance P, Klein EA, Crowley JJ, Minasian LM, Meyskens FL.","Trials. 2016 Aug 12;17:400. doi: 10.1186/s13063-016-1524-9.","Goodman PJ","Trials","2016","2016/08/14","PMC4983010","","10.1186/s13063-016-1524-9"
"32913021","Effect of escitalopram dose and treatment duration on CSF Aβ levels in healthy older adults: A controlled clinical trial","Sheline YI, Snider BJ, Beer JC, Seok D, Fagan AM, Suckow RF, Lee JM, Waligorska T, Korecka M, Aselcioglu I, Morris JC, Shaw LM, Cirrito JR.","Neurology. 2020 Nov 10;95(19):e2658-e2665. doi: 10.1212/WNL.0000000000010725. Epub 2020 Sep 10.","Sheline YI","Neurology","2020","2020/09/11","PMC7713735","","10.1212/WNL.0000000000010725"
"25771249","A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial","Ngandu T, Lehtisalo J, Solomon A, Levälahti E, Ahtiluoto S, Antikainen R, Bäckman L, Hänninen T, Jula A, Laatikainen T, Lindström J, Mangialasche F, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M.","Lancet. 2015 Jun 6;385(9984):2255-63. doi: 10.1016/S0140-6736(15)60461-5. Epub 2015 Mar 12.","Ngandu T","Lancet","2015","2015/03/16","","","10.1016/S0140-6736(15)60461-5"
"24088092","Long-term cognitive impairment after critical illness","Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, Brummel NE, Hughes CG, Vasilevskis EE, Shintani AK, Moons KG, Geevarghese SK, Canonico A, Hopkins RO, Bernard GR, Dittus RS, Ely EW; BRAIN-ICU Study Investigators.","N Engl J Med. 2013 Oct 3;369(14):1306-16. doi: 10.1056/NEJMoa1301372.","Pandharipande PP","N Engl J Med","2013","2013/10/04","PMC3922401","NIHMS542772","10.1056/NEJMoa1301372"
"23238963","Levodopa does not change cerebral vasoreactivity in Parkinson's disease","Krainik A, Maillet A, Fleury V, Sahin M, Troprès I, Lamalle L, Thobois S, Fraix V, Villien M, Warnking J, Pollak P, Pinto S, Krack P.","Mov Disord. 2013 Apr;28(4):469-75. doi: 10.1002/mds.25267. Epub 2012 Dec 12.","Krainik A","Mov Disord","2013","2012/12/15","","","10.1002/mds.25267"
"36068621","Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial","Whitfield T, Demnitz-King H, Schlosser M, Barnhofer T, Frison E, Coll-Padros N, Dautricourt S, Requier F, Delarue M, Gonneaud J, Klimecki OM, Lutz A, Paly L, Salmon E, Schild AK, Walker Z, Jessen F, Chételat G, Collette F, Wirth M, Marchant NL; Medit-Ageing Research Group.","Alzheimers Res Ther. 2022 Sep 6;14(1):125. doi: 10.1186/s13195-022-01057-w.","Whitfield T","Alzheimers Res Ther","2022","2022/09/06","PMC9446839","","10.1186/s13195-022-01057-w"
"18543682","[The future started: nitric oxide in glaucoma]","Stefan C, Dumitrica DM, Ardeleanu C.","Oftalmologia. 2007;51(4):89-94.","Stefan C","Oftalmologia","2007","2008/06/12","","",""
"17190940","Mild cognitive impairment: long-term course of four clinical subtypes","Busse A, Hensel A, Gühne U, Angermeyer MC, Riedel-Heller SG.","Neurology. 2006 Dec 26;67(12):2176-85. doi: 10.1212/01.wnl.0000249117.23318.e1.","Busse A","Neurology","2006","2006/12/28","","","10.1212/01.wnl.0000249117.23318.e1"
"10945510","Efficacy of naftidrofuryl in patients with vascular or mixed dementia: results of a multicenter, double-blind trial","Emeriau JP, Lehert P, Mosnier M.","Clin Ther. 2000 Jul;22(7):834-44. doi: 10.1016/S0149-2918(00)80056-9.","Emeriau JP","Clin Ther","2000","2000/08/17","","","10.1016/S0149-2918(00)80056-9"
"17224716","Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial","Mowla A, Mosavinasab M, Pani A.","J Clin Psychopharmacol. 2007 Feb;27(1):67-70. doi: 10.1097/JCP.0b013e31802e0002.","Mowla A","J Clin Psychopharmacol","2007","2007/01/17","","","10.1097/JCP.0b013e31802e0002"
"34786698","Using smartphone technology to improve prospective memory functioning: A randomized controlled trial","Scullin MK, Jones WE, Phenis R, Beevers S, Rosen S, Dinh K, Kiselica A, Keefe FJ, Benge JF.","J Am Geriatr Soc. 2022 Feb;70(2):459-469. doi: 10.1111/jgs.17551. Epub 2021 Nov 17.","Scullin MK","J Am Geriatr Soc","2022","2021/11/17","PMC8821124","NIHMS1752065","10.1111/jgs.17551"
"26004290","The effects of a multi-component dyadic intervention on the psychological distress of family caregivers providing care to people with dementia: a randomized controlled trial","Prick AE, de Lange J, Twisk J, Pot AM.","Int Psychogeriatr. 2015 Dec;27(12):2031-44. doi: 10.1017/S104161021500071X. Epub 2015 May 25.","Prick AE","Int Psychogeriatr","2015","2015/05/26","","","10.1017/S104161021500071X"
"28335810","Structured relearning of activities of daily living in dementia: the randomized controlled REDALI-DEM trial on errorless learning","Voigt-Radloff S, de Werd MM, Leonhart R, Boelen DH, Olde Rikkert MG, Fliessbach K, Klöppel S, Heimbach B, Fellgiebel A, Dodel R, Eschweiler GW, Hausner L, Kessels RP, Hüll M.","Alzheimers Res Ther. 2017 Mar 23;9(1):22. doi: 10.1186/s13195-017-0247-9.","Voigt-Radloff S","Alzheimers Res Ther","2017","2017/03/25","PMC5364615","","10.1186/s13195-017-0247-9"
"18948358","Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial","Schmidt H, Kern W, Giese R, Hallschmid M, Enders A.","J Med Genet. 2009 Apr;46(4):217-22. doi: 10.1136/jmg.2008.062141. Epub 2008 Oct 23.","Schmidt H","J Med Genet","2009","2008/10/25","","","10.1136/jmg.2008.062141"
"32652024","Medium-Chain Triglycerides (8:0 and 10:0) Increase Mini-Mental State Examination (MMSE) Score in Frail Elderly Adults in a Randomized Controlled Trial","Abe S, Ezaki O, Suzuki M.","J Nutr. 2020 Sep 1;150(9):2383-2390. doi: 10.1093/jn/nxaa186.","Abe S","J Nutr","2020","2020/07/12","","","10.1093/jn/nxaa186"
"29088099","Anserine/Carnosine Supplementation Suppresses the Expression of the Inflammatory Chemokine CCL24 in Peripheral Blood Mononuclear Cells from Elderly People","Katakura Y, Totsuka M, Imabayashi E, Matsuda H, Hisatsune T.","Nutrients. 2017 Oct 31;9(11):1199. doi: 10.3390/nu9111199.","Katakura Y","Nutrients","2017","2017/11/01","PMC5707671","","10.3390/nu9111199"
"27378314","First-in-human study assessing safety, tolerability and pharmacokinetics of BI 409306, a selective phosphodiesterase 9A inhibitor, in healthy males","Moschetti V, Boland K, Feifel U, Hoch A, Zimdahl-Gelling H, Sand M.","Br J Clin Pharmacol. 2016 Nov;82(5):1315-1324. doi: 10.1111/bcp.13060. Epub 2016 Aug 22.","Moschetti V","Br J Clin Pharmacol","2016","2016/07/06","PMC5061793","","10.1111/bcp.13060"
"20523050","Rivastigmine in the treatment of dementia associated with Parkinson's disease: effects on activities of daily living","Olin JT, Aarsland D, Meng X.","Dement Geriatr Cogn Disord. 2010;29(6):510-5. doi: 10.1159/000305100. Epub 2010 Jun 5.","Olin JT","Dement Geriatr Cogn Disord","2010","2010/06/05","","","10.1159/000305100"
"29257986","Selective enrichment of n-3 fatty acids in human plasma lipid motifs following intake of marine fish","Žáček P, Bukowski M, Johnson L, Raatz SK, Picklo M.","J Nutr Biochem. 2018 Apr;54:57-65. doi: 10.1016/j.jnutbio.2017.11.002. Epub 2017 Nov 16.","Žáček P","J Nutr Biochem","2018","2017/12/20","","","10.1016/j.jnutbio.2017.11.002"
"12913197","14-3-3 protein in the CSF of patients with rapidly progressive dementia","Huang N, Marie SK, Livramento JA, Chammas R, Nitrini R.","Neurology. 2003 Aug 12;61(3):354-7. doi: 10.1212/01.wnl.0000078890.89473.ed.","Huang N","Neurology","2003","2003/08/13","","","10.1212/01.wnl.0000078890.89473.ed"
"12417358","Patient populations in clinical trials of the efficacy and tolerability of donepezil in patients with vascular dementia","Pratt RD.","J Neurol Sci. 2002 Nov 15;203-204:57-65. doi: 10.1016/s0022-510x(02)00266-6.","Pratt RD","J Neurol Sci","2002","2002/11/06","","","10.1016/s0022-510x(02)00266-6"
"30724333","CPAP Adherence May Slow 1-Year Cognitive Decline in Older Adults with Mild Cognitive Impairment and Apnea","Richards KC, Gooneratne N, Dicicco B, Hanlon A, Moelter S, Onen F, Wang Y, Sawyer A, Weaver T, Lozano A, Carter P, Johnson J.","J Am Geriatr Soc. 2019 Mar;67(3):558-564. doi: 10.1111/jgs.15758. Epub 2019 Feb 6.","Richards KC","J Am Geriatr Soc","2019","2019/02/07","PMC6402995","NIHMS1012447","10.1111/jgs.15758"
"28350796","The impact of individual Cognitive Stimulation Therapy (iCST) on cognition, quality of life, caregiver health, and family relationships in dementia: A randomised controlled trial","Orrell M, Yates L, Leung P, Kang S, Hoare Z, Whitaker C, Burns A, Knapp M, Leroi I, Moniz-Cook E, Pearson S, Simpson S, Spector A, Roberts S, Russell I, de Waal H, Woods RT, Orgeta V.","PLoS Med. 2017 Mar 28;14(3):e1002269. doi: 10.1371/journal.pmed.1002269. eCollection 2017 Mar.","Orrell M","PLoS Med","2017","2017/03/29","PMC5369684","","10.1371/journal.pmed.1002269"
"35484991","Improvement of poststroke cognitive impairment by intermittent theta bursts: A double-blind randomized controlled trial","Li W, Wen Q, Xie YH, Hu AL, Wu Q, Wang YX.","Brain Behav. 2022 Jun;12(6):e2569. doi: 10.1002/brb3.2569. Epub 2022 Apr 29.","Li W","Brain Behav","2022","2022/04/29","PMC9226849","","10.1002/brb3.2569"
"34289275","Trial of Pimavanserin in Dementia-Related Psychosis","Tariot PN, Cummings JL, Soto-Martin ME, Ballard C, Erten-Lyons D, Sultzer DL, Devanand DP, Weintraub D, McEvoy B, Youakim JM, Stankovic S, Foff EP.","N Engl J Med. 2021 Jul 22;385(4):309-319. doi: 10.1056/NEJMoa2034634.","Tariot PN","N Engl J Med","2021","2021/07/21","","","10.1056/NEJMoa2034634"
"29966193","Music and Dementia: Individual Differences in Response to Personalized Playlists","Garrido S, Stevens CJ, Chang E, Dunne L, Perz J.","J Alzheimers Dis. 2018;64(3):933-941. doi: 10.3233/JAD-180084.","Garrido S","J Alzheimers Dis","2018","2018/07/04","","","10.3233/JAD-180084"
"28891445","Patient Variables Associated with the Assignment of a Formal Dementia Diagnosis to Positively Screened Primary Care Patients","Eichler T, Thyrian JR, Hertel J, Richter S, Michalowsky B, Wucherer D, Dreier A, Kilimann I, Teipel S, Hoffmann W.","Curr Alzheimer Res. 2018;15(1):44-50. doi: 10.2174/1567205014666170908095707.","Eichler T","Curr Alzheimer Res","2018","2017/09/12","","","10.2174/1567205014666170908095707"
"36327046","Effects of long-term Wuqinxi exercise on working memory in older adults with mild cognitive impairment","Luo SS, Chen L, Wang GB, Wang YG, Su XY.","Eur Geriatr Med. 2022 Dec;13(6):1327-1333. doi: 10.1007/s41999-022-00709-2. Epub 2022 Nov 3.","Luo SS","Eur Geriatr Med","2022","2022/11/03","","","10.1007/s41999-022-00709-2"
"27440727","Imaging synaptic density in the living human brain","Finnema SJ, Nabulsi NB, Eid T, Detyniecki K, Lin SF, Chen MK, Dhaher R, Matuskey D, Baum E, Holden D, Spencer DD, Mercier J, Hannestad J, Huang Y, Carson RE.","Sci Transl Med. 2016 Jul 20;8(348):348ra96. doi: 10.1126/scitranslmed.aaf6667.","Finnema SJ","Sci Transl Med","2016","2016/07/22","","","10.1126/scitranslmed.aaf6667"
"25164906","Non-invasive vagus nerve stimulation in healthy humans reduces sympathetic nerve activity","Clancy JA, Mary DA, Witte KK, Greenwood JP, Deuchars SA, Deuchars J.","Brain Stimul. 2014 Nov-Dec;7(6):871-7. doi: 10.1016/j.brs.2014.07.031. Epub 2014 Jul 16.","Clancy JA","Brain Stimul","2014","2014/08/29","","","10.1016/j.brs.2014.07.031"
"22459434","FMRI connectivity analysis of acupuncture effects on the whole brain network in mild cognitive impairment patients","Feng Y, Bai L, Ren Y, Chen S, Wang H, Zhang W, Tian J.","Magn Reson Imaging. 2012 Jun;30(5):672-82. doi: 10.1016/j.mri.2012.01.003. Epub 2012 Mar 27.","Feng Y","Magn Reson Imaging","2012","2012/03/31","","","10.1016/j.mri.2012.01.003"
"19112722","[The effect of ibuprofen and acetylsalicylic acid on cognitive impairment, total antioxidant power and isoprostane serum]","Ibáñez-Hernández MG, Macías-Islas MA, Zavalza-Gómez AB, Pacheco-Moisés FP, Ortiz GG.","Gac Med Mex. 2008 Nov-Dec;144(6):497-502.","Ibáñez-Hernández MG","Gac Med Mex","2008","2008/12/31","","",""
"17726363","Cognitive stimulation intervention for elders with mild cognitive impairment compared with normal aged subjects: preliminary results","Wenisch E, Cantegreil-Kallen I, De Rotrou J, Garrigue P, Moulin F, Batouche F, Richard A, De Sant'Anna M, Rigaud AS.","Aging Clin Exp Res. 2007 Aug;19(4):316-22. doi: 10.1007/BF03324708.","Wenisch E","Aging Clin Exp Res","2007","2007/08/30","","","10.1007/BF03324708"
"16141274","Dissociated effects of diazepam and lorazepam on short-latency afferent inhibition","Di Lazzaro V, Pilato F, Dileone M, Tonali PA, Ziemann U.","J Physiol. 2005 Nov 15;569(Pt 1):315-23. doi: 10.1113/jphysiol.2005.092155. Epub 2005 Sep 1.","Di Lazzaro V","J Physiol","2005","2005/09/06","PMC1464195","","10.1113/jphysiol.2005.092155"
"15921933","Cholinergic modulation of preattentive auditory processing in aging","Pekkonen E, Jääskeläinen IP, Kaakkola S, Ahveninen J.","Neuroimage. 2005 Aug 15;27(2):387-92. doi: 10.1016/j.neuroimage.2005.04.018.","Pekkonen E","Neuroimage","2005","2005/06/01","","","10.1016/j.neuroimage.2005.04.018"
"15639154","Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers","Tildesley NT, Kennedy DO, Perry EK, Ballard CG, Wesnes KA, Scholey AB.","Physiol Behav. 2005 Jan 17;83(5):699-709. doi: 10.1016/j.physbeh.2004.09.010.","Tildesley NT","Physiol Behav","2005","2005/01/11","","","10.1016/j.physbeh.2004.09.010"
"9038610","The cognitive effects of recombinant interleukin-2 (rIL-2) therapy: a controlled clinical trial using computerised assessments","Walker LG, Wesnes KP, Heys SD, Walker MB, Lolley J, Eremin O.","Eur J Cancer. 1996 Dec;32A(13):2275-83. doi: 10.1016/s0959-8049(96)00300-0.","Walker LG","Eur J Cancer","1996","1996/12/01","","","10.1016/s0959-8049(96)00300-0"
"32729819","Bioequivalence study of two formulations of memantine hydrochloride tablets in healthy male Chinese subjects under fasting and fed conditions","Zheng J, Chen J, Wu J, Yang M, Mai L, Yu X, Huang M, Zhong G.","Int J Clin Pharmacol Ther. 2020 Oct;58(10):575-582. doi: 10.5414/CP203683.","Zheng J","Int J Clin Pharmacol Ther","2020","2020/07/31","","","10.5414/CP203683"
"29058588","Effect of Infla-Kine supplementation on the gene expression of inflammatory markers in peripheral mononuclear cells and on C-reactive protein in blood","Mikirova NA, Kesari S, Ichim TE, Riordan NH.","J Transl Med. 2017 Oct 20;15(1):213. doi: 10.1186/s12967-017-1315-4.","Mikirova NA","J Transl Med","2017","2017/10/24","PMC5651612","","10.1186/s12967-017-1315-4"
"24063317","Life review and life story books for people with mild to moderate dementia: a randomised controlled trial","Subramaniam P, Woods B, Whitaker C.","Aging Ment Health. 2014;18(3):363-75. doi: 10.1080/13607863.2013.837144. Epub 2013 Sep 24.","Subramaniam P","Aging Ment Health","2014","2013/09/26","PMC4017276","","10.1080/13607863.2013.837144"
"18971883","Cerebroprotective effect of piracetam in patients undergoing coronary bypass burgery","Holinski S, Claus B, Alaaraj N, Dohmen PM, Kirilova K, Neumann K, Uebelhack R, Konertz W.","Med Sci Monit. 2008 Nov;14(11):PI53-7.","Holinski S","Med Sci Monit","2008","2008/10/31","","",""
"17178419","Inefficient response inhibition in individuals with mild cognitive impairment","Wylie SA, Ridderinkhof KR, Eckerle MK, Manning CA.","Neuropsychologia. 2007 Apr 8;45(7):1408-19. doi: 10.1016/j.neuropsychologia.2006.11.003. Epub 2006 Dec 18.","Wylie SA","Neuropsychologia","2007","2006/12/21","","","10.1016/j.neuropsychologia.2006.11.003"
"17117398","Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors","Rozzini L, Costardi D, Chilovi BV, Franzoni S, Trabucchi M, Padovani A.","Int J Geriatr Psychiatry. 2007 Apr;22(4):356-60. doi: 10.1002/gps.1681.","Rozzini L","Int J Geriatr Psychiatry","2007","2006/11/23","","","10.1002/gps.1681"
"16936707","Intranasal insulin improves memory in humans: superiority of insulin aspart","Benedict C, Hallschmid M, Schmitz K, Schultes B, Ratter F, Fehm HL, Born J, Kern W.","Neuropsychopharmacology. 2007 Jan;32(1):239-43. doi: 10.1038/sj.npp.1301193. Epub 2006 Aug 16.","Benedict C","Neuropsychopharmacology","2007","2006/08/29","","","10.1038/sj.npp.1301193"
"15511602","Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women","Dunkin J, Rasgon N, Wagner-Steh K, David S, Altshuler L, Rapkin A.","Psychoneuroendocrinology. 2005 Apr;30(3):284-96. doi: 10.1016/j.psyneuen.2004.09.002.","Dunkin J","Psychoneuroendocrinology","2005","2004/10/30","","","10.1016/j.psyneuen.2004.09.002"
"14499752","Effects of scopolamine on MEG spectral power and coherence in elderly subjects","Osipova D, Ahveninen J, Kaakkola S, Jääskeläinen IP, Huttunen J, Pekkonen E.","Clin Neurophysiol. 2003 Oct;114(10):1902-7. doi: 10.1016/s1388-2457(03)00165-2.","Osipova D","Clin Neurophysiol","2003","2003/09/23","","","10.1016/s1388-2457(03)00165-2"
"11994888","A pilot, randomized, open-label trial assessing safety and pharmakokinetic parameters of co-administration of rivastigmine with risperidone in dementia patients with behavioral disturbances","Weiser M, Rotmensch HH, Korczyn AD, Hartman R, Cicin-Sain A, Anand R; Rivastigmine-Risperidone Study Group.","Int J Geriatr Psychiatry. 2002 Apr;17(4):343-6. doi: 10.1002/gps.599.","Weiser M","Int J Geriatr Psychiatry","2002","2002/05/08","","","10.1002/gps.599"
"36272055","Remember NIBS? tACS improves memory performance in elders with subjective memory complaints","Varastegan S, Kazemi R, Rostami R, Khomami S, Zandbagleh A, Hadipour AL.","Geroscience. 2023 Apr;45(2):851-869. doi: 10.1007/s11357-022-00677-2. Epub 2022 Oct 22.","Varastegan S","Geroscience","2023","2022/10/22","PMC9886712","","10.1007/s11357-022-00677-2"
"28033691","Memantine Enhances the Effect of Olanzapine in Patients With Schizophrenia: A Randomized, Placebo-Controlled Study","Fakhri A, Pakseresht S, Haghdoost MR, Hekmatkhah N, Torkashvand M, Ghorbanzadeh B.","Acta Med Iran. 2016 Nov;54(11):696-703.","Fakhri A","Acta Med Iran","2016","2016/12/31","","",""
"22950711","Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE)","Wang P, Wang Y, Feng T, Zhao X, Zhou Y, Wang Y, Shi W, Ju Y; NICE Study Investigators.","BMC Neurol. 2012 Sep 5;12:88. doi: 10.1186/1471-2377-12-88.","Wang P","BMC Neurol","2012","2012/09/07","PMC3488311","","10.1186/1471-2377-12-88"
"21357811","Translation of a dementia caregiver support program in a health care system--REACH VA","Nichols LO, Martindale-Adams J, Burns R, Graney MJ, Zuber J.","Arch Intern Med. 2011 Feb 28;171(4):353-9. doi: 10.1001/archinternmed.2010.548.","Nichols LO","Arch Intern Med","2011","2011/03/02","","","10.1001/archinternmed.2010.548"
"18590622","[Adaptation and convergent validity of a telephone-based Mini-Mental State Examination]","Garre-Olmo J, Lax-Pericall C, Turro-Garriga O, Soler-Cors O, Monserrat-Vila S, Vilalta-Franch J, Taylor JL, López-Pousa S.","Med Clin (Barc). 2008 Jun 21;131(3):89-95. doi: 10.1157/13124011.","Garre-Olmo J","Med Clin (Barc)","2008","2008/07/02","","","10.1157/13124011"
"17285318","Physical activity and mental well-being in older people participating in the Better Ageing Project","Fox KR, Stathi A, McKenna J, Davis MG.","Eur J Appl Physiol. 2007 Jul;100(5):591-602. doi: 10.1007/s00421-007-0392-0. Epub 2007 Feb 7.","Fox KR","Eur J Appl Physiol","2007","2007/02/08","","","10.1007/s00421-007-0392-0"
"16901641","Reduced short latency afferent inhibition in diffuse axonal injury patients with memory impairment","Fujiki M, Hikawa T, Abe T, Ishii K, Kobayashi H.","Neurosci Lett. 2006 Sep 25;405(3):226-30. doi: 10.1016/j.neulet.2006.07.005. Epub 2006 Aug 9.","Fujiki M","Neurosci Lett","2006","2006/08/12","","","10.1016/j.neulet.2006.07.005"
"8835881","PET study of the M1-agonists [11C]xanomeline and [11C]butylthio-TZTP in monkey and man","Farde L, Suhara T, Halldin C, Nybäck H, Nakashima Y, Swahn CG, Karlsson P, Ginovart N, Bymaster FP, Shannon HE, Foged C, Suzdak PD, Sauerberg P.","Dementia. 1996 Jul-Aug;7(4):187-95. doi: 10.1159/000106877.","Farde L","Dementia","1996","1996/07/01","","","10.1159/000106877"
"35852256","Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trial","Henderson C, Knapp M, Stirling S, Shepstone L, High J, Ballard C, Bentham P, Burns A, Farina N, Fox C, Fountain J, Francis P, Howard R, Leroi I, Livingston G, Nilforooshan R, Nurock S, O'Brien JT, Price A, Swart AM, Tabet N, Telling T, Thomas AJ, Banerjee S.","Int Psychogeriatr. 2022 Oct;34(10):905-917. doi: 10.1017/S1041610222000436. Epub 2022 Jul 19.","Henderson C","Int Psychogeriatr","2022","2022/07/19","","","10.1017/S1041610222000436"
"36615708","Probiotic Bifidobacterium longum BB68S Improves Cognitive Functions in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial","Shi S, Zhang Q, Sang Y, Ge S, Wang Q, Wang R, He J.","Nutrients. 2022 Dec 22;15(1):51. doi: 10.3390/nu15010051.","Shi S","Nutrients","2022","2023/01/08","PMC9824790","","10.3390/nu15010051"
"30982783","Breath Qigong Improves Recognition in Seniors With Vascular Cognitive Impairment","Niu Y, Wan C, Zhou B, Zhang J, Ma H, Bo Y, Zhang Y, Liu H.","Altern Ther Health Med. 2019 Jan;25(1):20-26.","Niu Y","Altern Ther Health Med","2019","2019/04/16","","",""
"22855271","The PDE5 inhibitor vardenafil does not affect auditory sensory gating in rats and humans","Reneerkens OA, Sambeth A, Van Duinen MA, Blokland A, Steinbusch HW, Prickaerts J.","Psychopharmacology (Berl). 2013 Jan;225(2):303-12. doi: 10.1007/s00213-012-2817-7. Epub 2012 Aug 2.","Reneerkens OA","Psychopharmacology (Berl)","2013","2012/08/03","","","10.1007/s00213-012-2817-7"
"22578498","Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment","Bakker A, Krauss GL, Albert MS, Speck CL, Jones LR, Stark CE, Yassa MA, Bassett SS, Shelton AL, Gallagher M.","Neuron. 2012 May 10;74(3):467-74. doi: 10.1016/j.neuron.2012.03.023.","Bakker A","Neuron","2012","2012/05/15","PMC3351697","NIHMS369300","10.1016/j.neuron.2012.03.023"
"18165936","Expectancy effect: impact of pill administration on cognitive performance in healthy seniors","Oken BS, Flegal K, Zajdel D, Kishiyama S, Haas M, Peters D.","J Clin Exp Neuropsychol. 2008 Jan;30(1):7-17. doi: 10.1080/13803390701775428. Epub 2007 Dec 12.","Oken BS","J Clin Exp Neuropsychol","2008","2008/01/01","","","10.1080/13803390701775428"
"17020396","Antihypertensive medication is associated with less cognitive impairment in the very old with apolipoprotein-E epsilon4 allele","Hestad KA, Engedal K.","Drugs Aging. 2006;23(9):723-31. doi: 10.2165/00002512-200623090-00002.","Hestad KA","Drugs Aging","2006","2006/10/06","","","10.2165/00002512-200623090-00002"
"15288712","Intranasal insulin improves memory in humans","Benedict C, Hallschmid M, Hatke A, Schultes B, Fehm HL, Born J, Kern W.","Psychoneuroendocrinology. 2004 Nov;29(10):1326-34. doi: 10.1016/j.psyneuen.2004.04.003.","Benedict C","Psychoneuroendocrinology","2004","2004/08/04","","","10.1016/j.psyneuen.2004.04.003"
"15107192","Neuropsychological test performance in healthy volunteers before and after donepezil administration","Beglinger LJ, Gaydos BL, Kareken DA, Tangphao-Daniels O, Siemers ER, Mohs RC.","J Psychopharmacol. 2004 Mar;18(1):102-8. doi: 10.1177/0269881104040248.","Beglinger LJ","J Psychopharmacol","2004","2004/04/27","","","10.1177/0269881104040248"
"15084789","Temporal lobe hypoperfusion in isolated amnesia with slow onset: a single photon emission computer tomography study","Høgh P, Madsen Sjö N, Gade A, Waldemar G.","Dement Geriatr Cogn Disord. 2004;18(1):15-23. doi: 10.1159/000077730. Epub 2004 Apr 6.","Høgh P","Dement Geriatr Cogn Disord","2004","2004/04/16","","","10.1159/000077730"
"14997272","Nicotine improves delayed recognition in schizophrenic patients","Myers CS, Robles O, Kakoyannis AN, Sherr JD, Avila MT, Blaxton TA, Thaker GK.","Psychopharmacology (Berl). 2004 Jul;174(3):334-40. doi: 10.1007/s00213-003-1764-8. Epub 2004 Mar 2.","Myers CS","Psychopharmacology (Berl)","2004","2004/03/05","","","10.1007/s00213-003-1764-8"
"9799627","Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance","Resnick SM, Maki PM, Golski S, Kraut MA, Zonderman AB.","Horm Behav. 1998 Oct;34(2):171-82. doi: 10.1006/hbeh.1998.1476.","Resnick SM","Horm Behav","1998","1998/11/04","","","10.1006/hbeh.1998.1476"
"9426878","Lack of an association between delayed memory and hippocampal and temporal lobe size in patients with schizophrenia and healthy controls","Torres IJ, Flashman LA, O'Leary DS, Swayze V 2nd, Andreasen NC.","Biol Psychiatry. 1997 Dec 15;42(12):1087-96. doi: 10.1016/s0006-3223(97)00024-3.","Torres IJ","Biol Psychiatry","1997","1998/01/14","","","10.1016/s0006-3223(97)00024-3"
"31824142","Exercise Training Induced Changes In Nuclear Magnetic Resonance-Measured Lipid Particles In Mild Cognitively Impaired Elderly African American Volunteers: A Pilot Study","Fungwe TV, Ngwa JS, Ntekim OE, Allard JS, Nadarajah S, Wolday S, Ogunlana OO, Johnson SP, Hughes K, Larbi D, Gillum RF, Obisesan TO.","Clin Interv Aging. 2019 Dec 5;14:2115-2123. doi: 10.2147/CIA.S195878. eCollection 2019.","Fungwe TV","Clin Interv Aging","2019","2019/12/12","PMC6900999","","10.2147/CIA.S195878"
"33176394","Multicentre randomised controlled trial about the effect of individual reminiscence therapy in older adults with neurocognitive disorders","Justo-Henriques SI, Pérez-Sáez E, Alves Apóstolo JL.","Int J Geriatr Psychiatry. 2021 May;36(5):704-712. doi: 10.1002/gps.5469. Epub 2020 Nov 17.","Justo-Henriques SI","Int J Geriatr Psychiatry","2021","2020/11/11","","","10.1002/gps.5469"
"25294382","Inverse associations of outdoor activity and vitamin D intake with the risk of Parkinson's disease","Zhu D, Liu GY, Lv Z, Wen SR, Bi S, Wang WZ.","J Zhejiang Univ Sci B. 2014 Oct;15(10):923-7. doi: 10.1631/jzus.B1400005.","Zhu D","J Zhejiang Univ Sci B","2014","2014/10/09","PMC4201321","","10.1631/jzus.B1400005"
"10202979","Neuritic sprouting with aberrant expression of the nitric oxide synthase III gene in neurodegenerative diseases","Sohn YK, Ganju N, Bloch KD, Wands JR, de la Monte SM.","J Neurol Sci. 1999 Jan 15;162(2):133-51. doi: 10.1016/s0022-510x(98)00297-4.","Sohn YK","J Neurol Sci","1999","1999/04/15","","","10.1016/s0022-510x(98)00297-4"
"17907276","Primary care physicians' attitudes related to cognition enhancers in early dementia: a representative eight-year follow-up study in Lower Saxony, Germany","Maeck L, Haak S, Knoblauch A, Stoppe G.","Int J Geriatr Psychiatry. 2008 Apr;23(4):415-21. doi: 10.1002/gps.1896.","Maeck L","Int J Geriatr Psychiatry","2008","2007/10/02","","","10.1002/gps.1896"
"10068803","Lack of prognostic significance of SPECT abnormalities in non-demented elderly subjects with memory loss","McKelvey R, Bergman H, Stern J, Rush C, Zahirney G, Chertkow H.","Can J Neurol Sci. 1999 Feb;26(1):23-8.","McKelvey R","Can J Neurol Sci","1999","1999/03/09","","",""
"17045170","Binding properties of the cerebral alpha4beta2 nicotinic acetylcholine receptor ligand 2-[18F]fluoro-A-85380 to plasma proteins","Sorger D, Becker GA, Hauber K, Schildan A, Patt M, Birkenmeier G, Otto A, Meyer P, Kluge M, Schliebs R, Sabri O.","Nucl Med Biol. 2006 Oct;33(7):899-906. doi: 10.1016/j.nucmedbio.2006.07.012.","Sorger D","Nucl Med Biol","2006","2006/10/19","","","10.1016/j.nucmedbio.2006.07.012"
"23044653","Inhaled sevoflurane may promote progression of amnestic mild cognitive impairment: a prospective, randomized parallel-group study","Liu Y, Pan N, Ma Y, Zhang S, Guo W, Li H, Zhou J, Liu G, Gao M.","Am J Med Sci. 2013 May;345(5):355-60. doi: 10.1097/MAJ.0b013e31825a674d.","Liu Y","Am J Med Sci","2013","2012/10/10","","","10.1097/MAJ.0b013e31825a674d"
"21709611","Effects of socially stimulating group intervention on lonely, older people's cognition: a randomized, controlled trial","Pitkala KH, Routasalo P, Kautiainen H, Sintonen H, Tilvis RS.","Am J Geriatr Psychiatry. 2011 Jul;19(7):654-63. doi: 10.1097/JGP.0b013e3181f7d8b0.","Pitkala KH","Am J Geriatr Psychiatry","2011","2011/06/29","","","10.1097/JGP.0b013e3181f7d8b0"
"11927174","Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia","Meehan KM, Wang H, David SR, Nisivoccia JR, Jones B, Beasley CM Jr, Feldman PD, Mintzer JE, Beckett LM, Breier A.","Neuropsychopharmacology. 2002 Apr;26(4):494-504. doi: 10.1016/S0893-133X(01)00365-7.","Meehan KM","Neuropsychopharmacology","2002","2002/04/03","","","10.1016/S0893-133X(01)00365-7"
"28336780","Biodistribution and Radiation Dosimetry for the Tau Tracer (18)F-THK-5351 in Healthy Human Subjects","Hsiao IT, Lin KJ, Huang KL, Huang CC, Chen HS, Wey SP, Yen TC, Okamura N, Hsu JL.","J Nucl Med. 2017 Sep;58(9):1498-1503. doi: 10.2967/jnumed.116.189126. Epub 2017 Mar 23.","Hsiao IT","J Nucl Med","2017","2017/03/25","","","10.2967/jnumed.116.189126"
"23550665","Effects of cognitive stimulation therapy Japanese version (CST-J) for people with dementia: a single-blind, controlled clinical trial","Yamanaka K, Kawano Y, Noguchi D, Nakaaki S, Watanabe N, Amano T, Spector A.","Aging Ment Health. 2013;17(5):579-86. doi: 10.1080/13607863.2013.777395. Epub 2013 Apr 4.","Yamanaka K","Aging Ment Health","2013","2013/04/05","PMC3935224","","10.1080/13607863.2013.777395"
"32279541","Effectiveness of Dementia Care Mapping™ to reduce agitation in care home residents with dementia: an open-cohort cluster randomised controlled trial","Surr CA, Holloway I, Walwyn REA, Griffiths AW, Meads D, Martin A, Kelley R, Ballard C, Fossey J, Burnley N, Chenoweth L, Creese B, Downs M, Garrod L, Graham EH, Lilley-Kelly A, McDermid J, McLellan V, Millard H, Perfect D, Robinson L, Robinson O, Shoesmith E, Siddiqi N, Stokes G, Wallace D, Farrin AJ.","Aging Ment Health. 2021 Aug;25(8):1410-1423. doi: 10.1080/13607863.2020.1745144. Epub 2020 Apr 13.","Surr CA","Aging Ment Health","2021","2020/04/14","","","10.1080/13607863.2020.1745144"
"18975103","Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial)","Litvinenko IV, Odinak MM, Mogil'naya VI, Emelin AY.","Neurosci Behav Physiol. 2008 Nov;38(9):937-45. doi: 10.1007/s11055-008-9077-3.","Litvinenko IV","Neurosci Behav Physiol","2008","2008/11/01","","","10.1007/s11055-008-9077-3"
"30037778","Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled Trial","Devanand DP, Pelton GH, D'Antonio K, Ciarleglio A, Scodes J, Andrews H, Lunsford J, Beyer JL, Petrella JR, Sneed J, Ciovacco M, Doraiswamy PM.","Am J Geriatr Psychiatry. 2018 Oct;26(10):1050-1060. doi: 10.1016/j.jagp.2018.05.008. Epub 2018 Jun 28.","Devanand DP","Am J Geriatr Psychiatry","2018","2018/07/25","PMC6396676","NIHMS1013581","10.1016/j.jagp.2018.05.008"
"21775876","Celecoxib or naproxen treatment does not benefit depressive symptoms in persons age 70 and older: findings from a randomized controlled trial","Fields C, Drye L, Vaidya V, Lyketsos C; ADAPT Research Group.","Am J Geriatr Psychiatry. 2012 Jun;20(6):505-13. doi: 10.1097/JGP.0b013e318227f4da.","Fields C","Am J Geriatr Psychiatry","2012","2011/07/22","PMC3209494","NIHMS310381","10.1097/JGP.0b013e318227f4da"
"34942135","Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial","Costa ACS, Brandão AC, Boada R, Barrionuevo VL, Taylor HG, Roth E, Stasko MR, Johnson MW, Assir FF, Roberto MP, Salmona P, Abreu-Silveira G, Bederman I, Prendergast E, Hüls A, Abrishamcar S, Mustacchi Z, Scheidemantel T, Roizen NJ, Ruedrich S.","Lancet Neurol. 2022 Jan;21(1):31-41. doi: 10.1016/S1474-4422(21)00369-0.","Costa ACS","Lancet Neurol","2022","2021/12/23","","","10.1016/S1474-4422(21)00369-0"
"18090435","Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals","Galasko DR, Graff-Radford N, May S, Hendrix S, Cottrell BA, Sagi SA, Mather G, Laughlin M, Zavitz KH, Swabb E, Golde TE, Murphy MP, Koo EH.","Alzheimer Dis Assoc Disord. 2007 Oct-Dec;21(4):292-9. doi: 10.1097/WAD.0b013e31815d1048.","Galasko DR","Alzheimer Dis Assoc Disord","2007","2007/12/20","","","10.1097/WAD.0b013e31815d1048"
"30503589","The Effects of Exercise on Falls in Older People With Dementia Living in Nursing Homes: A Randomized Controlled Trial","Toots A, Wiklund R, Littbrand H, Nordin E, Nordström P, Lundin-Olsson L, Gustafson Y, Rosendahl E.","J Am Med Dir Assoc. 2019 Jul;20(7):835-842.e1. doi: 10.1016/j.jamda.2018.10.009. Epub 2018 Nov 28.","Toots A","J Am Med Dir Assoc","2019","2018/12/04","","","10.1016/j.jamda.2018.10.009"
"32736164","The presence of a caregiver is associated with patient outcomes in patients with Parkinson's disease and atypical parkinsonisms","Prizer LP, Kluger BM, Sillau S, Katz M, Galifianakis NB, Miyasaki JM.","Parkinsonism Relat Disord. 2020 Sep;78:61-65. doi: 10.1016/j.parkreldis.2020.07.003. Epub 2020 Jul 11.","Prizer LP","Parkinsonism Relat Disord","2020","2020/08/01","","","10.1016/j.parkreldis.2020.07.003"
"20950329","Efficacy of rivastigmine on executive function in patients with Parkinson's disease dementia","Schmitt FA, Farlow MR, Meng X, Tekin S, Olin JT.","CNS Neurosci Ther. 2010 Dec;16(6):330-6. doi: 10.1111/j.1755-5949.2010.00182.x. Epub 2010 Oct 15.","Schmitt FA","CNS Neurosci Ther","2010","2010/10/19","PMC6493797","","10.1111/j.1755-5949.2010.00182.x"
"10440971","A randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long-term care","Lyketsos CG, Lindell Veiel L, Baker A, Steele C.","Int J Geriatr Psychiatry. 1999 Jul;14(7):520-5.","Lyketsos CG","Int J Geriatr Psychiatry","1999","1999/08/10","","",""
"15481065","A randomized, controlled, clinical trial of activity therapy for apathy in patients with dementia residing in long-term care","Politis AM, Vozzella S, Mayer LS, Onyike CU, Baker AS, Lyketsos CG.","Int J Geriatr Psychiatry. 2004 Nov;19(11):1087-94. doi: 10.1002/gps.1215.","Politis AM","Int J Geriatr Psychiatry","2004","2004/10/14","","","10.1002/gps.1215"
"19216653","Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury","Marklund N, Blennow K, Zetterberg H, Ronne-Engström E, Enblad P, Hillered L.","J Neurosurg. 2009 Jun;110(6):1227-37. doi: 10.3171/2008.9.JNS08584.","Marklund N","J Neurosurg","2009","2009/02/17","","","10.3171/2008.9.JNS08584"
"25735919","Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunami","Martínez-Lizana E, Carmona-Iragui M, Alcolea D, Gómez-Choco M, Vilaplana E, Sánchez-Saudinós MB, Clarimón J, Hernández-Guillamon M, Munuera J, Gelpi E, Gómez-Anson B, de Juan-Delago M, Delgado-Mederos R, Montaner J, Ois A, Amaro S, Blesa R, Martí-Fàbregas J, Lleó A, Fortea J.","J Cereb Blood Flow Metab. 2015 May;35(5):710-7. doi: 10.1038/jcbfm.2015.25. Epub 2015 Mar 4.","Martínez-Lizana E","J Cereb Blood Flow Metab","2015","2015/03/05","PMC4420868","","10.1038/jcbfm.2015.25"
"29971948","Signs indicating dementia in Down, Williams and Fragile X syndromes","Sauna-Aho O, Bjelogrlic-Laakso N, Siren A, Arvio M.","Mol Genet Genomic Med. 2018 Sep;6(5):855-860. doi: 10.1002/mgg3.430. Epub 2018 Jul 3.","Sauna-Aho O","Mol Genet Genomic Med","2018","2018/07/05","PMC6160716","","10.1002/mgg3.430"
"24089073","Association between inherited CYP2D6/2C19 phenotypes and anticholinergic measures in elderly patients using anticholinergic drugs","Kersten H, Wyller TB, Molden E.","Ther Drug Monit. 2014 Feb;36(1):125-30. doi: 10.1097/FTD.0b013e31829da990.","Kersten H","Ther Drug Monit","2014","2013/10/04","","","10.1097/FTD.0b013e31829da990"
"20090508","Carbonic anhydrase I, II, and VI, blood plasma, erythrocyte and saliva zinc and copper increase after repetitive transcranial magnetic stimulation","Henkin RI, Potolicchio SJ, Levy LM, Moharram R, Velicu I, Martin BM.","Am J Med Sci. 2010 Mar;339(3):249-57. doi: 10.1097/MAJ.0b013e3181cda0e3.","Henkin RI","Am J Med Sci","2010","2010/01/22","PMC2928063","NIHMS225951","10.1097/MAJ.0b013e3181cda0e3"
"20443170","[Clinical stabilisation in neurodegenerative diseases: clinical study in phase II]","de Font-Réaulx Rojas E, Dorazco-Barragan G.","Rev Neurol. 2010 May 1;50(9):520-8.","de Font-Réaulx Rojas E","Rev Neurol","2010","2010/05/06","","",""
"14607319","Whole-brain atrophy in multiple sclerosis measured by two segmentation processes from various MRI sequences","Horsfield MA, Rovaris M, Rocca MA, Rossi P, Benedict RH, Filippi M, Bakshi R.","J Neurol Sci. 2003 Dec 15;216(1):169-77. doi: 10.1016/j.jns.2003.07.003.","Horsfield MA","J Neurol Sci","2003","2003/11/11","","","10.1016/j.jns.2003.07.003"
"31372803","Twelve weeks of resistance training does not influence peripheral levels of neurotrophic growth factors or homocysteine in healthy adults: a randomized-controlled trial","Marston KJ, Brown BM, Rainey-Smith SR, Bird S, Wijaya L, Teo SYM, Laws SM, Martins RN, Peiffer JJ.","Eur J Appl Physiol. 2019 Oct;119(10):2167-2176. doi: 10.1007/s00421-019-04202-w. Epub 2019 Aug 1.","Marston KJ","Eur J Appl Physiol","2019","2019/08/03","","","10.1007/s00421-019-04202-w"
"22589500","Effectiveness of dementia follow-up care by memory clinics or general practitioners: randomised controlled trial","Meeuwsen EJ, Melis RJ, Van Der Aa GC, Golüke-Willemse GA, De Leest BJ, Van Raak FH, Schölzel-Dorenbos CJ, Verheijen DC, Verhey FR, Visser MC, Wolfs CA, Adang EM, Olde Rikkert MG.","BMJ. 2012 May 15;344:e3086. doi: 10.1136/bmj.e3086.","Meeuwsen EJ","BMJ","2012","2012/05/17","PMC3352696","","10.1136/bmj.e3086"
"25894843","Homotaurine in Parkinson's disease","Ricciardi L, De Nigris F, Specchia A, Fasano A.","Neurol Sci. 2015 Sep;36(9):1581-7. doi: 10.1007/s10072-015-2201-6. Epub 2015 Apr 19.","Ricciardi L","Neurol Sci","2015","2015/04/21","","","10.1007/s10072-015-2201-6"
"29959111","Web-Based Intervention for Family Carers of Persons with Dementia and Multiple Chronic Conditions (My Tools 4 Care): Pragmatic Randomized Controlled Trial","Duggleby W, Ploeg J, McAiney C, Peacock S, Fisher K, Ghosh S, Markle-Reid M, Swindle J, Williams A, Triscott JA, Forbes D, Jovel Ruiz K.","J Med Internet Res. 2018 Jun 29;20(6):e10484. doi: 10.2196/10484.","Duggleby W","J Med Internet Res","2018","2018/07/01","PMC6045794","","10.2196/10484"
"28659161","Associations between cerebral amyloid and changes in cognitive function and falls risk in subcortical ischemic vascular cognitive impairment","Dao E, Best JR, Hsiung GR, Sossi V, Jacova C, Tam R, Liu-Ambrose T.","BMC Geriatr. 2017 Jun 28;17(1):133. doi: 10.1186/s12877-017-0522-4.","Dao E","BMC Geriatr","2017","2017/06/30","PMC5490153","","10.1186/s12877-017-0522-4"
"29110615","Effects of Molecular Hydrogen Assessed by an Animal Model and a Randomized Clinical Study on Mild Cognitive Impairment","Nishimaki K, Asada T, Ohsawa I, Nakajima E, Ikejima C, Yokota T, Kamimura N, Ohta S.","Curr Alzheimer Res. 2018 Mar 14;15(5):482-492. doi: 10.2174/1567205014666171106145017.","Nishimaki K","Curr Alzheimer Res","2018","2017/11/08","PMC5872374","","10.2174/1567205014666171106145017"
"9361661","Validation of a Telephone Cognitive Assessment Battery","Debanne SM, Patterson MB, Dick R, Riedel TM, Schnell A, Rowland DY.","J Am Geriatr Soc. 1997 Nov;45(11):1352-9. doi: 10.1111/j.1532-5415.1997.tb02935.x.","Debanne SM","J Am Geriatr Soc","1997","1997/11/15","","","10.1111/j.1532-5415.1997.tb02935.x"
"29505101","Evaluating Potential QT Effects of JNJ-54861911, a BACE Inhibitor in Single- and Multiple-Ascending Dose Studies, and a Thorough QT Trial With Additional Retrospective Confirmation, Using Concentration-QTc Analysis","Timmers M, Sinha V, Darpo B, Smith B, Brown R, Xue H, Ferber G, Streffer J, Russu A, Tritsmans L, Solanki B, Bogert J, Van Nueten L, Salvadore G, Nandy P.","J Clin Pharmacol. 2018 Jul;58(7):952-964. doi: 10.1002/jcph.1087. Epub 2018 Mar 5.","Timmers M","J Clin Pharmacol","2018","2018/03/06","","","10.1002/jcph.1087"
"31353857","Acoustic enhancement of sleep slow oscillations in mild cognitive impairment","Papalambros NA, Weintraub S, Chen T, Grimaldi D, Santostasi G, Paller KA, Zee PC, Malkani RG.","Ann Clin Transl Neurol. 2019 Jul;6(7):1191-1201. doi: 10.1002/acn3.796. Epub 2019 Jul 1.","Papalambros NA","Ann Clin Transl Neurol","2019","2019/07/30","PMC6649400","","10.1002/acn3.796"
"26297124","Combined therapy of Di-Huang-Yi-Zhi with Donepezil in patients with Parkinson's disease dementia","Gu C, Shen T, An H, Yuan C, Zhou J, Ye Q, Liu T, Wang X, Zhang T.","Neurosci Lett. 2015 Oct 8;606:13-7. doi: 10.1016/j.neulet.2015.08.019. Epub 2015 Aug 18.","Gu C","Neurosci Lett","2015","2015/08/23","","","10.1016/j.neulet.2015.08.019"
"33666540","The effects of polyphenols-rich tropical fruit juice on cognitive function and metabolomics profile - a randomized controlled trial in middle-aged women","Rosli H, Shahar S, Rajab NF, Che Din N, Haron H.","Nutr Neurosci. 2022 Aug;25(8):1577-1593. doi: 10.1080/1028415X.2021.1880312. Epub 2021 Mar 5.","Rosli H","Nutr Neurosci","2022","2021/03/05","","","10.1080/1028415X.2021.1880312"
"31619653","Influence of Ultra-High Hydrostatic Pressurizing Brown Rice on Cognitive Functions and Mental Health of Elderly Japanese Individuals: A 2-Year Randomized and Controlled Trial","Kuroda Y, Matsuzaki K, Wakatsuki H, Shido O, Harauma A, Moriguchi T, Sugimoto H, Yamaguchi S, Yoshino K, Hashimoto M.","J Nutr Sci Vitaminol (Tokyo). 2019;65(Supplement):S80-S87. doi: 10.3177/jnsv.65.S80.","Kuroda Y","J Nutr Sci Vitaminol (Tokyo)","2019","2019/10/18","","","10.3177/jnsv.65.S80"
"31361175","Implementing physical exercise and music interventions for patients suffering from dementia on an acute psychogeriatric inpatient ward","Pitkänen A, Alanen HM, Kampman O, Suontaka-Jamalainen K, Leinonen E.","Nord J Psychiatry. 2019 Oct;73(7):401-408. doi: 10.1080/08039488.2019.1645205. Epub 2019 Jul 30.","Pitkänen A","Nord J Psychiatry","2019","2019/07/31","","","10.1080/08039488.2019.1645205"
"25592742","Souvenaid reduces behavioral deficits and improves social cognition skills in frontotemporal dementia: a proof-of-concept study","Pardini M, Serrati C, Guida S, Mattei C, Abate L, Massucco D, Sassos D, Amore M, Krueger F, Cocito L, Emberti Gialloreti L.","Neurodegener Dis. 2015;15(1):58-62. doi: 10.1159/000369811. Epub 2015 Jan 15.","Pardini M","Neurodegener Dis","2015","2015/01/17","","","10.1159/000369811"
"22932339","The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction","Nathan PJ, Watson J, Lund J, Davies CH, Peters G, Dodds CM, Swirski B, Lawrence P, Bentley GD, O'Neill BV, Robertson J, Watson S, Jones GA, Maruff P, Croft RJ, Laruelle M, Bullmore ET.","Int J Neuropsychopharmacol. 2013 May;16(4):721-31. doi: 10.1017/S1461145712000752. Epub 2012 Aug 29.","Nathan PJ","Int J Neuropsychopharmacol","2013","2012/08/31","","","10.1017/S1461145712000752"
"21714757","Neural correlates of donepezil-induced cognitive improvement in patients with right hemisphere stroke: a pilot study","Chang WH, Park YH, Ohn SH, Park CH, Lee PK, Kim YH.","Neuropsychol Rehabil. 2011 Aug;21(4):502-14. doi: 10.1080/09602011.2011.582708. Epub 2011 Jun 30.","Chang WH","Neuropsychol Rehabil","2011","2011/07/01","","","10.1080/09602011.2011.582708"
"16797163","Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation","Sharma T, Reed C, Aasen I, Kumari V.","Schizophr Res. 2006 Jul;85(1-3):73-83. doi: 10.1016/j.schres.2006.03.037. Epub 2006 Jun 21.","Sharma T","Schizophr Res","2006","2006/06/27","","","10.1016/j.schres.2006.03.037"
"12409683","A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)","Wilcock G, Möbius HJ, Stöffler A; MMM 500 group.","Int Clin Psychopharmacol. 2002 Nov;17(6):297-305. doi: 10.1097/00004850-200211000-00005.","Wilcock G","Int Clin Psychopharmacol","2002","2002/11/01","","","10.1097/00004850-200211000-00005"
"1841609","Is prevention of vascular dementia possible? The Syst-Eur Vascular Dementia Project","Forette F, Amery A, Staessen J, Strasser T, Thijs L, Beevers DG, Bert P, Clement D, Cox J, De Leeuw PW, et al.","Aging (Milano). 1991 Dec;3(4):373-82. doi: 10.1007/BF03324039.","Forette F","Aging (Milano)","1991","1991/12/01","","","10.1007/BF03324039"
"34507866","Challenges faced by families of critically ill patients during the first wave of the COVID-19 pandemic","Greenberg JA, Basapur S, Quinn TV, Bulger JL, Schwartz NH, Oh SK, Shah RC, Glover CM.","Patient Educ Couns. 2022 Feb;105(2):297-303. doi: 10.1016/j.pec.2021.08.029. Epub 2021 Aug 27.","Greenberg JA","Patient Educ Couns","2022","2021/09/11","PMC8393512","","10.1016/j.pec.2021.08.029"
"26211415","A pilot randomized controlled trial of mindfulness-based stress reduction for caregivers of family members with dementia","Brown KW, Coogle CL, Wegelin J.","Aging Ment Health. 2016 Nov;20(11):1157-1166. doi: 10.1080/13607863.2015.1065790. Epub 2015 Jul 27.","Brown KW","Aging Ment Health","2016","2015/07/28","PMC5070659","NIHMS811502","10.1080/13607863.2015.1065790"
"25921747","Testosterone replacement therapy in older male subjective memory complainers: double-blind randomized crossover placebo-controlled clinical trial of physiological assessment and safety","Asih PR, Wahjoepramono EJ, Aniwiyanti V, Wijaya LK, de Ruyck K, Taddei K, Fuller SJ, Sohrabi H, Dhaliwal SS, Verdile G, Carruthers M, Martins RN.","CNS Neurol Disord Drug Targets. 2015;14(5):576-86. doi: 10.2174/1871527314666150429112112.","Asih PR","CNS Neurol Disord Drug Targets","2015","2015/04/30","","","10.2174/1871527314666150429112112"
"22806212","Antagonism of NMDA receptors as a potential treatment for Down syndrome: a pilot randomized controlled trial","Boada R, Hutaff-Lee C, Schrader A, Weitzenkamp D, Benke TA, Goldson EJ, Costa AC.","Transl Psychiatry. 2012 Jul 17;2(7):e141. doi: 10.1038/tp.2012.66.","Boada R","Transl Psychiatry","2012","2012/07/19","PMC3410988","","10.1038/tp.2012.66"
"16821257","Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia","Suh GH, Greenspan AJ, Choi SK.","Int J Geriatr Psychiatry. 2006 Jul;21(7):654-60. doi: 10.1002/gps.1542.","Suh GH","Int J Geriatr Psychiatry","2006","2006/07/06","","","10.1002/gps.1542"
"16809797","Pharmacokinetics and safety profile of ispronicline (TC-1734), a new brain nicotinic receptor partial agonist, in young healthy male volunteers","Dunbar G, Demazières A, Monreal A, Cisterni C, Metzger D, Kuchibhatla R, Luthringer R.","J Clin Pharmacol. 2006 Jul;46(7):715-26. doi: 10.1177/0091270006288730.","Dunbar G","J Clin Pharmacol","2006","2006/07/01","","","10.1177/0091270006288730"
"16102979","Task-dependent posterior cingulate activation in mild cognitive impairment","Ries ML, Schmitz TW, Kawahara TN, Torgerson BM, Trivedi MA, Johnson SC.","Neuroimage. 2006 Jan 15;29(2):485-92. doi: 10.1016/j.neuroimage.2005.07.030. Epub 2005 Aug 15.","Ries ML","Neuroimage","2006","2005/08/17","PMC2627779","NIHMS72192","10.1016/j.neuroimage.2005.07.030"
"16021483","Cholinergic enhancement of episodic memory in healthy young adults","Grön G, Kirstein M, Thielscher A, Riepe MW, Spitzer M.","Psychopharmacology (Berl). 2005 Oct;182(1):170-9. doi: 10.1007/s00213-005-0043-2. Epub 2005 Sep 29.","Grön G","Psychopharmacology (Berl)","2005","2005/07/16","","","10.1007/s00213-005-0043-2"
"15451390","SGS742: the first GABA(B) receptor antagonist in clinical trials","Froestl W, Gallagher M, Jenkins H, Madrid A, Melcher T, Teichman S, Mondadori CG, Pearlman R.","Biochem Pharmacol. 2004 Oct 15;68(8):1479-87. doi: 10.1016/j.bcp.2004.07.030.","Froestl W","Biochem Pharmacol","2004","2004/09/29","","","10.1016/j.bcp.2004.07.030"
"14534771","Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment","White HK, Levin ED.","Psychopharmacology (Berl). 2004 Feb;171(4):465-71. doi: 10.1007/s00213-003-1614-8. Epub 2003 Oct 8.","White HK","Psychopharmacology (Berl)","2004","2003/10/10","","","10.1007/s00213-003-1614-8"
"9839759","Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses","Rogers SL, Cooper NM, Sukovaty R, Pederson JE, Lee JN, Friedhoff LT.","Br J Clin Pharmacol. 1998 Nov;46 Suppl 1(Suppl 1):7-12. doi: 10.1046/j.1365-2125.1998.0460s1007.x.","Rogers SL","Br J Clin Pharmacol","1998","1998/12/05","PMC1873811","","10.1046/j.1365-2125.1998.0460s1007.x"
"30689016","Cognitive changes of older adults with an equivocal amyloid load","Pothier K, Saint-Aubert L, Hooper C, Delrieu J, Payoux P, de Souto Barreto P, Vellas B; MAPT/DSA Study Group.","J Neurol. 2019 Apr;266(4):835-843. doi: 10.1007/s00415-019-09203-5. Epub 2019 Jan 28.","Pothier K","J Neurol","2019","2019/01/29","","","10.1007/s00415-019-09203-5"
"30248622","An EEG nicotinic acetylcholine index to assess the efficacy of pro-cognitive compounds","Simpraga S, Mansvelder HD, Groeneveld GJ, Prins S, Hart EP, Poil SS, Linkenkaer-Hansen K.","Clin Neurophysiol. 2018 Nov;129(11):2325-2332. doi: 10.1016/j.clinph.2018.08.014. Epub 2018 Sep 11.","Simpraga S","Clin Neurophysiol","2018","2018/09/25","","","10.1016/j.clinph.2018.08.014"
"24633858","The impact of reminiscence on the quality of life of residents with dementia in long-stay care","O'Shea E, Devane D, Cooney A, Casey D, Jordan F, Hunter A, Murphy E, Newell J, Connolly S, Murphy K.","Int J Geriatr Psychiatry. 2014 Oct;29(10):1062-70. doi: 10.1002/gps.4099. Epub 2014 Mar 14.","O'Shea E","Int J Geriatr Psychiatry","2014","2014/03/18","","","10.1002/gps.4099"
"23710796","Goal-oriented cognitive rehabilitation in early-stage dementia: study protocol for a multi-centre single-blind randomised controlled trial (GREAT)","Clare L, Bayer A, Burns A, Corbett A, Jones R, Knapp M, Kopelman M, Kudlicka A, Leroi I, Oyebode J, Pool J, Woods B, Whitaker R.","Trials. 2013 May 27;14:152. doi: 10.1186/1745-6215-14-152.","Clare L","Trials","2013","2013/05/29","PMC3680175","","10.1186/1745-6215-14-152"
"22011016","Anomia training and brain stimulation in chronic aphasia","Cotelli M, Fertonani A, Miozzo A, Rosini S, Manenti R, Padovani A, Ansaldo AI, Cappa SF, Miniussi C.","Neuropsychol Rehabil. 2011 Oct;21(5):717-41. doi: 10.1080/09602011.2011.621275.","Cotelli M","Neuropsychol Rehabil","2011","2011/10/21","","","10.1080/09602011.2011.621275"
"19424811","Improving professional practice in the disclosure of a diagnosis of dementia: a modeling experiment to evaluate a theory-based intervention","Eccles MP, Francis J, Foy R, Johnston M, Bamford C, Grimshaw JM, Hughes J, Lecouturier J, Steen N, Whitty PM.","Int J Behav Med. 2009;16(4):377-87. doi: 10.1007/s12529-008-9023-3.","Eccles MP","Int J Behav Med","2009","2009/05/09","","","10.1007/s12529-008-9023-3"
"12062586","Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm)","Kennedy DO, Scholey AB, Tildesley NT, Perry EK, Wesnes KA.","Pharmacol Biochem Behav. 2002 Jul;72(4):953-64. doi: 10.1016/s0091-3057(02)00777-3.","Kennedy DO","Pharmacol Biochem Behav","2002","2002/06/14","","","10.1016/s0091-3057(02)00777-3"
"10831773","Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial","Pantoni L, Rossi R, Inzitari D, Bianchi C, Beneke M, Erkinjuntti T, Wallin A.","J Neurol Sci. 2000 Apr 15;175(2):124-34. doi: 10.1016/s0022-510x(00)00300-2.","Pantoni L","J Neurol Sci","2000","2000/06/01","","","10.1016/s0022-510x(00)00300-2"
"10496251","A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia","De Deyn PP, Rabheru K, Rasmussen A, Bocksberger JP, Dautzenberg PL, Eriksson S, Lawlor BA.","Neurology. 1999 Sep 22;53(5):946-55. doi: 10.1212/wnl.53.5.946.","De Deyn PP","Neurology","1999","1999/09/25","","","10.1212/wnl.53.5.946"
"35002241","Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study","Zhang L, Liu X, Li T, Xu B, Fu B.","Neuropsychiatr Dis Treat. 2021 Dec 29;17:3819-3825. doi: 10.2147/NDT.S334647. eCollection 2021.","Zhang L","Neuropsychiatr Dis Treat","2021","2022/01/10","PMC8721155","","10.2147/NDT.S334647"
"18315451","Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial","Arnold LE, Amato A, Bozzolo H, Hollway J, Cook A, Ramadan Y, Crowl L, Zhang D, Thompson S, Testa G, Kliewer V, Wigal T, McBurnett K, Manos M.","J Child Adolesc Psychopharmacol. 2007 Dec;17(6):791-802. doi: 10.1089/cap.2007.018.","Arnold LE","J Child Adolesc Psychopharmacol","2007","2008/03/05","","","10.1089/cap.2007.018"
"17394129","A cluster randomised controlled trial to reduce the unmet needs of people with dementia living in residential care","Orrell M, Hancock G, Hoe J, Woods B, Livingston G, Challis D.","Int J Geriatr Psychiatry. 2007 Nov;22(11):1127-34. doi: 10.1002/gps.1801.","Orrell M","Int J Geriatr Psychiatry","2007","2007/03/31","","","10.1002/gps.1801"
"15266045","Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil","Periclou AP, Ventura D, Sherman T, Rao N, Abramowitz WT.","Ann Pharmacother. 2004 Sep;38(9):1389-94. doi: 10.1345/aph.1D638. Epub 2004 Jul 20.","Periclou AP","Ann Pharmacother","2004","2004/07/22","","","10.1345/aph.1D638"
"11838627","Vitamin B6 as add-on treatment in chronic schizophrenic and schizoaffective patients: a double-blind, placebo-controlled study","Lerner V, Miodownik C, Kaptsan A, Cohen H, Loewenthal U, Kotler M.","J Clin Psychiatry. 2002 Jan;63(1):54-8. doi: 10.4088/jcp.v63n0111.","Lerner V","J Clin Psychiatry","2002","2002/02/13","","","10.4088/jcp.v63n0111"
"16041534","Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects","Wezenberg E, Verkes RJ, Sabbe BG, Ruigt GS, Hulstijn W.","Psychopharmacology (Berl). 2005 Sep;181(3):582-94. doi: 10.1007/s00213-005-0083-7. Epub 2005 Oct 12.","Wezenberg E","Psychopharmacology (Berl)","2005","2005/07/26","","","10.1007/s00213-005-0083-7"
"23151596","Developing dementia prevention trials: baseline report of the Home-Based Assessment study","Sano M, Egelko S, Donohue M, Ferris S, Kaye J, Hayes TL, Mundt JC, Sun CK, Paparello S, Aisen PS; Alzheimer Disease Cooperative Study Investigators.","Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):356-62. doi: 10.1097/WAD.0b013e3182769c05.","Sano M","Alzheimer Dis Assoc Disord","2013","2012/11/16","PMC3943465","NIHMS418290","10.1097/WAD.0b013e3182769c05"
"24378475","Hypothyroidism and risk of mild cognitive impairment in elderly persons: a population-based study","Parsaik AK, Singh B, Roberts RO, Pankratz S, Edwards KK, Geda YE, Gharib H, Boeve BF, Knopman DS, Petersen RC.","JAMA Neurol. 2014 Feb;71(2):201-7. doi: 10.1001/jamaneurol.2013.5402.","Parsaik AK","JAMA Neurol","2014","2014/01/01","PMC4136444","NIHMS612082","10.1001/jamaneurol.2013.5402"
"29036816","Sex Difference in Aerobic Exercise Efficacy to Improve Cognition in Older Adults with Vascular Cognitive Impairment: Secondary Analysis of a Randomized Controlled Trial","Barha CK, Hsiung GR, Best JR, Davis JC, Eng JJ, Jacova C, Lee PE, Munkacsy M, Cheung W, Liu-Ambrose T.","J Alzheimers Dis. 2017;60(4):1397-1410. doi: 10.3233/JAD-170221.","Barha CK","J Alzheimers Dis","2017","2017/10/18","","","10.3233/JAD-170221"
"32077057","Double-Blind Placebo-Controlled Pilot Investigation of the Safety of a Single Dose of Rapid-Acting Intranasal Insulin in Down Syndrome","Rosenbloom M, Barclay T, Johnsen J, Erickson L, Svitak A, Pyle M, Frey W, Hanson LR.","Drugs R D. 2020 Mar;20(1):11-15. doi: 10.1007/s40268-020-00296-2.","Rosenbloom M","Drugs R D","2020","2020/02/21","PMC7067723","","10.1007/s40268-020-00296-2"
"26661784","Pro198Leu polymorphism affects the selenium status and GPx activity in response to Brazil nut intake","Cardoso BR, Busse AL, Hare DJ, Cominetti C, Horst MA, McColl G, Magaldi RM, Jacob-Filho W, Cozzolino SM.","Food Funct. 2016 Feb;7(2):825-33. doi: 10.1039/c5fo01270h.","Cardoso BR","Food Funct","2016","2015/12/15","","","10.1039/c5fo01270h"
"17355738","Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits","Chouinard S, Stip E, Poulin J, Melun JP, Godbout R, Guillem F, Cohen H.","Curr Med Res Opin. 2007 Mar;23(3):575-83. doi: 10.1185/030079906X167372.","Chouinard S","Curr Med Res Opin","2007","2007/03/16","","","10.1185/030079906X167372"
"16399214","Growth hormone releasing hormone improves the cognition of healthy older adults","Vitiello MV, Moe KE, Merriam GR, Mazzoni G, Buchner DH, Schwartz RS.","Neurobiol Aging. 2006 Feb;27(2):318-23. doi: 10.1016/j.neurobiolaging.2005.01.010. Epub 2005 Mar 23.","Vitiello MV","Neurobiol Aging","2006","2006/01/10","","","10.1016/j.neurobiolaging.2005.01.010"
"34702870","Analysis of whole exome sequencing in severe mental illness hints at selection of brain development and immune related genes","Mahadevan J, Pathak AK, Vemula A, Nadella RK, Viswanath B, Jain S; Accelerator Program for Discovery in Brain disorders using Stem cells (ADBS) Consortium; Purushottam M, Mondal M.","Sci Rep. 2021 Oct 26;11(1):21088. doi: 10.1038/s41598-021-00123-x.","Mahadevan J","Sci Rep","2021","2021/10/27","PMC8548332","","10.1038/s41598-021-00123-x"
"16385401","Effect of pravastatin on plasma sterols and oxysterols in men","Thelen KM, Lütjohann D, Vesalainen R, Janatuinen T, Knuuti J, von Bergmann K, Lehtimäki T, Laaksonen R.","Eur J Clin Pharmacol. 2006 Jan;62(1):9-14. doi: 10.1007/s00228-005-0068-9. Epub 2005 Dec 30.","Thelen KM","Eur J Clin Pharmacol","2006","2005/12/31","","","10.1007/s00228-005-0068-9"
"20016895","In vivo detection of prion amyloid plaques using [(11)C]BF-227 PET","Okamura N, Shiga Y, Furumoto S, Tashiro M, Tsuboi Y, Furukawa K, Yanai K, Iwata R, Arai H, Kudo Y, Itoyama Y, Doh-ura K.","Eur J Nucl Med Mol Imaging. 2010 May;37(5):934-41. doi: 10.1007/s00259-009-1314-7. Epub 2009 Dec 17.","Okamura N","Eur J Nucl Med Mol Imaging","2010","2009/12/18","","","10.1007/s00259-009-1314-7"
"10078715","Nursing home placement is related to dementia progression: experience from a clinical trial. Alzheimer's Disease Cooperative Study","Knopman DS, Berg JD, Thomas R, Grundman M, Thal LJ, Sano M.","Neurology. 1999 Mar 10;52(4):714-8. doi: 10.1212/wnl.52.4.714.","Knopman DS","Neurology","1999","1999/03/17","","","10.1212/wnl.52.4.714"
"26035291","Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study","Gleason CE, Dowling NM, Wharton W, Manson JE, Miller VM, Atwood CS, Brinton EA, Cedars MI, Lobo RA, Merriam GR, Neal-Perry G, Santoro NF, Taylor HS, Black DM, Budoff MJ, Hodis HN, Naftolin F, Harman SM, Asthana S.","PLoS Med. 2015 Jun 2;12(6):e1001833; discussion e1001833. doi: 10.1371/journal.pmed.1001833. eCollection 2015 Jun.","Gleason CE","PLoS Med","2015","2015/06/03","PMC4452757","","10.1371/journal.pmed.1001833"
"32663977","Combined treatment with escitalopram and memantine increases gray matter volume and cortical thickness compared to escitalopram and placebo in a pilot study of geriatric depression","Krause-Sorio B, Siddarth P, Kilpatrick L, Laird KT, Milillo MM, Ercoli L, Narr KL, Lavretsky H.","J Affect Disord. 2020 Sep 1;274:464-470. doi: 10.1016/j.jad.2020.05.092. Epub 2020 May 24.","Krause-Sorio B","J Affect Disord","2020","2020/07/16","PMC7368564","NIHMS1599554","10.1016/j.jad.2020.05.092"
"23436056","An MRI rating scale for amyloid-related imaging abnormalities with edema or effusion","Barkhof F, Daams M, Scheltens P, Brashear HR, Arrighi HM, Bechten A, Morris K, McGovern M, Wattjes MP.","AJNR Am J Neuroradiol. 2013 Aug;34(8):1550-5. doi: 10.3174/ajnr.A3475. Epub 2013 Feb 22.","Barkhof F","AJNR Am J Neuroradiol","2013","2013/02/26","PMC8051438","","10.3174/ajnr.A3475"
"20478097","Recording care time in nursing homes: development and validation of the ""RUD-FOCA"" (Resource Utilization in Dementia-Formal Care)","Luttenberger K, Graessel E.","Int Psychogeriatr. 2010 Dec;22(8):1291-300. doi: 10.1017/S1041610210000487. Epub 2010 May 18.","Luttenberger K","Int Psychogeriatr","2010","2010/05/19","","","10.1017/S1041610210000487"
"15326237","Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial","Salloway S, Ferris S, Kluger A, Goldman R, Griesing T, Kumar D, Richardson S; Donepezil 401 Study Group.","Neurology. 2004 Aug 24;63(4):651-7. doi: 10.1212/01.wnl.0000134664.80320.92.","Salloway S","Neurology","2004","2004/08/25","","","10.1212/01.wnl.0000134664.80320.92"
"19606472","The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome","Kishnani PS, Sommer BR, Handen BL, Seltzer B, Capone GT, Spiridigliozzi GA, Heller JH, Richardson S, McRae T.","Am J Med Genet A. 2009 Aug;149A(8):1641-54. doi: 10.1002/ajmg.a.32953.","Kishnani PS","Am J Med Genet A","2009","2009/07/17","","","10.1002/ajmg.a.32953"
"17117070","Diagnosis of dementia using perfusion SPECT imaging at the patient's initial visit to a cognitive disorder clinic","Uchida Y, Minoshima S, Okada S, Kawata T, Ito H.","Clin Nucl Med. 2006 Dec;31(12):764-73. doi: 10.1097/01.rlu.0000246818.24566.54.","Uchida Y","Clin Nucl Med","2006","2006/11/23","","","10.1097/01.rlu.0000246818.24566.54"
"29509552","Effects of ""Essential AD2"" Supplement on Blood Acetaldehyde Levels in Individuals Who Have Aldehyde Dehydrogenase (ALDH2) Deficiency","Fujioka K, Gordon S.","Am J Ther. 2019 Sep/Oct;26(5):583-588. doi: 10.1097/MJT.0000000000000744.","Fujioka K","Am J Ther","2019","2018/03/07","","","10.1097/MJT.0000000000000744"
"27401052","Short-Term Effects of a Gain-Focused Reappraisal Intervention for Dementia Caregivers: A Double-Blind Cluster-Randomized Controlled Trial","Cheng ST, Fung HH, Chan WC, Lam LC.","Am J Geriatr Psychiatry. 2016 Sep;24(9):740-50. doi: 10.1016/j.jagp.2016.04.012. Epub 2016 Apr 29.","Cheng ST","Am J Geriatr Psychiatry","2016","2016/07/13","","","10.1016/j.jagp.2016.04.012"
"11022076","Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: A population-based study","Dik MG, Deeg DJ, Bouter LM, Corder EH, Kok A, Jonker C.","Stroke. 2000 Oct;31(10):2431-6. doi: 10.1161/01.str.31.10.2431.","Dik MG","Stroke","2000","2000/10/07","","","10.1161/01.str.31.10.2431"
"23225274","Aβ1-15/16 as a potential diagnostic marker in neurodegenerative diseases","Nutu M, Bourgeois P, Zetterberg H, Portelius E, Andreasson U, Parent S, Lipari F, Hall S, Constantinescu R, Hansson O, Blennow K.","Neuromolecular Med. 2013 Mar;15(1):169-79. doi: 10.1007/s12017-012-8208-8. Epub 2012 Dec 7.","Nutu M","Neuromolecular Med","2013","2012/12/11","","","10.1007/s12017-012-8208-8"
"21971406","High-intensity physical activity modulates diet effects on cerebrospinal amyloid-β levels in normal aging and mild cognitive impairment","Baker LD, Bayer-Carter JL, Skinner J, Montine TJ, Cholerton BA, Callaghan M, Leverenz JB, Walter BK, Tsai E, Postupna N, Lampe J, Craft S.","J Alzheimers Dis. 2012;28(1):137-46. doi: 10.3233/JAD-2011-111076.","Baker LD","J Alzheimers Dis","2012","2011/10/06","PMC3280092","NIHMS334929","10.3233/JAD-2011-111076"
"22862741","Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies","Luk C, Compta Y, Magdalinou N, Martí MJ, Hondhamuni G, Zetterberg H, Blennow K, Constantinescu R, Pijnenburg Y, Mollenhauer B, Trenkwalder C, Van Swieten J, Chiu WZ, Borroni B, Cámara A, Cheshire P, Williams DR, Lees AJ, de Silva R.","J Neurochem. 2012 Nov;123(3):396-405. doi: 10.1111/j.1471-4159.2012.07911.x. Epub 2012 Sep 3.","Luk C","J Neurochem","2012","2012/08/07","","","10.1111/j.1471-4159.2012.07911.x"
"11844887","Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies","Cummings JL, Street J, Masterman D, Clark WS.","Dement Geriatr Cogn Disord. 2002;13(2):67-73. doi: 10.1159/000048636.","Cummings JL","Dement Geriatr Cogn Disord","2002","2002/02/15","","","10.1159/000048636"
"18836134","Cognitive deficits and reduced insight in primary progressive aphasia","Banks SJ, Weintraub S.","Am J Alzheimers Dis Other Demen. 2008 Aug-Sep;23(4):363-71. doi: 10.1177/1533317508320351.","Banks SJ","Am J Alzheimers Dis Other Demen","2008","2008/10/07","PMC2743890","NIHMS128101","10.1177/1533317508320351"
"24612097","Activation of N-methyl-D-aspartate receptor glycine site temporally ameliorates neuropsychiatric symptoms of Parkinson's disease with dementia","Tsai CH, Huang HC, Liu BL, Li CI, Lu MK, Chen X, Tsai MC, Yang YW, Lane HY.","Psychiatry Clin Neurosci. 2014 Sep;68(9):692-700. doi: 10.1111/pcn.12175. Epub 2014 Apr 14.","Tsai CH","Psychiatry Clin Neurosci","2014","2014/03/12","","","10.1111/pcn.12175"
"33331917","Assessment of Plasma Amyloid-β42/40 and Cognitive Decline Among Community-Dwelling Older Adults","Giudici KV, de Souto Barreto P, Guyonnet S, Li Y, Bateman RJ, Vellas B; MAPT/DSA Group.","JAMA Netw Open. 2020 Dec 1;3(12):e2028634. doi: 10.1001/jamanetworkopen.2020.28634.","Giudici KV","JAMA Netw Open","2020","2020/12/17","PMC7747018","","10.1001/jamanetworkopen.2020.28634"
"15965198","Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study","Ravina B, Putt M, Siderowf A, Farrar JT, Gillespie M, Crawley A, Fernandez HH, Trieschmann MM, Reichwein S, Simuni T.","J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):934-9. doi: 10.1136/jnnp.2004.050682.","Ravina B","J Neurol Neurosurg Psychiatry","2005","2005/06/21","PMC1739697","","10.1136/jnnp.2004.050682"
"22915447","Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study","Dubois B, Tolosa E, Katzenschlager R, Emre M, Lees AJ, Schumann G, Pourcher E, Gray J, Thomas G, Swartz J, Hsu T, Moline ML.","Mov Disord. 2012 Sep 1;27(10):1230-8. doi: 10.1002/mds.25098. Epub 2012 Aug 22.","Dubois B","Mov Disord","2012","2012/08/24","","","10.1002/mds.25098"
"19153374","Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial","Viswanathan A, Raj S, Greenberg SM, Stampfer M, Campbell S, Hyman BT, Irizarry MC.","Neurology. 2009 Jan 20;72(3):268-72. doi: 10.1212/01.wnl.0000339486.63862.db.","Viswanathan A","Neurology","2009","2009/01/21","PMC2677526","","10.1212/01.wnl.0000339486.63862.db"
"16998649","Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's disease","Dujardin K, Devos D, Duhem S, Destée A, Marié RM, Durif F, Lacomblez L, Touchon J, Pollak P, Péré JJ.","J Neurol. 2006 Sep;253(9):1154-9. doi: 10.1007/s00415-006-0175-2. Epub 2006 Sep 22.","Dujardin K","J Neurol","2006","2006/09/26","","","10.1007/s00415-006-0175-2"
"32925028","Real-World Treatment Patterns and Characteristics Among Patients with Agitation and Dementia in the United States: Findings from a Large, Observational, Retrospective Chart Review","Aigbogun MS, Cloutier M, Gauthier-Loiselle M, Guerin A, Ladouceur M, Baker RA, Grundman M, Duffy RA, Hartry A, Gwin K, Fillit H.","J Alzheimers Dis. 2020;77(3):1181-1194. doi: 10.3233/JAD-200127.","Aigbogun MS","J Alzheimers Dis","2020","2020/09/14","PMC7683079","","10.3233/JAD-200127"
"36414626","Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study","Sauder C, Allen LA, Baker E, Miller AC, Paul SM, Brannan SK.","Transl Psychiatry. 2022 Nov 21;12(1):491. doi: 10.1038/s41398-022-02254-9.","Sauder C","Transl Psychiatry","2022","2022/11/22","PMC9681874","","10.1038/s41398-022-02254-9"
"32300799","Probiotic Supplementation Improves Cognitive Function and Mood with Changes in Gut Microbiota in Community-Dwelling Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial","Kim CS, Cha L, Sim M, Jung S, Chun WY, Baik HW, Shin DM.","J Gerontol A Biol Sci Med Sci. 2021 Jan 1;76(1):32-40. doi: 10.1093/gerona/glaa090.","Kim CS","J Gerontol A Biol Sci Med Sci","2021","2020/04/18","PMC7861012","","10.1093/gerona/glaa090"
"26417460","Neural Plastic Effects of Cognitive Training on Aging Brain","Leung NT, Tam HM, Chu LW, Kwok TC, Chan F, Lam LC, Woo J, Lee TM.","Neural Plast. 2015;2015:535618. doi: 10.1155/2015/535618. Epub 2015 Aug 31.","Leung NT","Neural Plast","2015","2015/09/30","PMC4568366","","10.1155/2015/535618"
"26289496","Effects of leisure activities at home on perceived care burden and the endocrine system of caregivers of dementia patients: a randomized controlled study","Hirano A, Umegaki H, Suzuki Y, Hayashi T, Kuzuya M.","Int Psychogeriatr. 2016 Feb;28(2):261-8. doi: 10.1017/S1041610215001295. Epub 2015 Aug 20.","Hirano A","Int Psychogeriatr","2016","2015/08/21","","","10.1017/S1041610215001295"
"25792802","Single dose pharmacokinetics of the novel transdermal donepezil patch in healthy volunteers","Kim YH, Choi HY, Lim HS, Lee SH, Jeon HS, Hong D, Kim SS, Choi YK, Bae KS.","Drug Des Devel Ther. 2015 Mar 10;9:1419-26. doi: 10.2147/DDDT.S78555. eCollection 2015.","Kim YH","Drug Des Devel Ther","2015","2015/03/21","PMC4362658","","10.2147/DDDT.S78555"
"23176536","Activities of daily living in dementia: revalidation of the E-ADL Test and suggestions for further development","Luttenberger K, Schmiedeberg A, Gräßel E.","BMC Psychiatry. 2012 Nov 23;12:208. doi: 10.1186/1471-244X-12-208.","Luttenberger K","BMC Psychiatry","2012","2012/11/27","PMC3605268","","10.1186/1471-244X-12-208"
"22982689","Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial","Kersten H, Molden E, Tolo IK, Skovlund E, Engedal K, Wyller TB.","J Gerontol A Biol Sci Med Sci. 2013 Mar;68(3):271-8. doi: 10.1093/gerona/gls176. Epub 2012 Sep 14.","Kersten H","J Gerontol A Biol Sci Med Sci","2013","2012/09/18","","","10.1093/gerona/gls176"
"22140531","A cluster-randomised trial of staff education to improve the quality of life of people with dementia living in residential care: the DIRECT study","Beer C, Horner B, Flicker L, Scherer S, Lautenschlager NT, Bretland N, Flett P, Schaper F, Almeida OP.","PLoS One. 2011;6(11):e28155. doi: 10.1371/journal.pone.0028155. Epub 2011 Nov 30.","Beer C","PLoS One","2011","2011/12/06","PMC3227637","","10.1371/journal.pone.0028155"
"21597409","Cerebroprotective effect of piracetam in patients undergoing open heart surgery","Holinski S, Claus B, Alaaraj N, Dohmen PM, Neumann K, Uebelhack R, Konertz W.","Ann Thorac Cardiovasc Surg. 2011;17(2):137-42. doi: 10.5761/atcs.oa.10.01545.","Holinski S","Ann Thorac Cardiovasc Surg","2011","2011/05/21","","","10.5761/atcs.oa.10.01545"
"20535921","[A prospective multicenter randomized double-blinded controlled clinical trial on effects of tiantai no.1 in treating mild cognitive impairment]","Wu ZZ, Zhong Q, Sun SP.","Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010 Mar;30(3):255-8.","Wu ZZ","Zhongguo Zhong Xi Yi Jie He Za Zhi","2010","2010/06/12","","",""
"15695781","18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients","Jeong Y, Cho SS, Park JM, Kang SJ, Lee JS, Kang E, Na DL, Kim SE.","J Nucl Med. 2005 Feb;46(2):233-9.","Jeong Y","J Nucl Med","2005","2005/02/08","","",""
"12640219","Safety and efficacy of switching psychiatric patients from a delayed-release to an extended-release formulation of divalproex sodium","Horne RL, Cunanan C.","J Clin Psychopharmacol. 2003 Apr;23(2):176-81. doi: 10.1097/00004714-200304000-00010.","Horne RL","J Clin Psychopharmacol","2003","2003/03/18","","","10.1097/00004714-200304000-00010"
"10507245","The effect of food and time of administration on the pharmacokinetic and pharmacodynamic profile of metrifonate","Heinig R, Sachse R.","Int J Clin Pharmacol Ther. 1999 Sep;37(9):456-64.","Heinig R","Int J Clin Pharmacol Ther","1999","1999/10/03","","",""
"7608318","Relationship between pharmacokinetics and pharmacodynamics of eptastigmine in young healthy volunteers","Imbimbo BP, Licini M, Schettino M, Mosca A, Onelli E, Zecca L, Giustina A.","J Clin Pharmacol. 1995 Mar;35(3):285-90. doi: 10.1002/j.1552-4604.1995.tb04060.x.","Imbimbo BP","J Clin Pharmacol","1995","1995/03/01","","","10.1002/j.1552-4604.1995.tb04060.x"
"35314926","Effect of low-level laser therapy (LLLT) on cognitive impairment among patients with chronic schizophrenia: a double-blind randomized placebo-controlled clinical trial","Kheradmand A, Tabeie F, Seif P, Rezaei O, Yasamy MT.","Lasers Med Sci. 2022 Aug;37(6):2717-2725. doi: 10.1007/s10103-022-03545-9. Epub 2022 Mar 22.","Kheradmand A","Lasers Med Sci","2022","2022/03/22","","","10.1007/s10103-022-03545-9"
"32131911","Managing depressive symptoms in people with mild cognitive impairment and mild dementia with a multicomponent psychotherapy intervention: a randomized controlled trial","Tonga JB, Šaltytė Benth J, Arnevik EA, Werheid K, Korsnes MS, Ulstein ID.","Int Psychogeriatr. 2021 Mar;33(3):217-231. doi: 10.1017/S1041610220000216. Epub 2020 Mar 5.","Tonga JB","Int Psychogeriatr","2021","2020/03/06","","","10.1017/S1041610220000216"
"31112605","Personality Moderates Intervention Effects on Cognitive Function: A 6-Week Conversation-Based Intervention","Cerino ES, Hooker K, Goodrich E, Dodge HH.","Gerontologist. 2020 Jul 15;60(5):958-967. doi: 10.1093/geront/gnz063.","Cerino ES","Gerontologist","2020","2019/05/22","PMC7362618","","10.1093/geront/gnz063"
"27180987","Population pharmacokinetic modeling and simulation of huperzine A in elderly Chinese subjects","Sheng L, Qu Y, Yan J, Liu GY, Wang WL, Wang YJ, Wang HY, Zhang MQ, Lu C, Liu Y, Jia JY, Hu CY, Li XN, Yu C, Xu HR.","Acta Pharmacol Sin. 2016 Jul;37(7):994-1001. doi: 10.1038/aps.2016.24. Epub 2016 May 16.","Sheng L","Acta Pharmacol Sin","2016","2016/05/17","PMC4933756","","10.1038/aps.2016.24"
"26766905","Effects of momentum-based dumbbell training on cognitive function in older adults with mild cognitive impairment: a pilot randomized controlled trial","Lü J, Sun M, Liang L, Feng Y, Pan X, Liu Y.","Clin Interv Aging. 2015 Dec 22;11:9-16. doi: 10.2147/CIA.S96042. eCollection 2016.","Lü J","Clin Interv Aging","2015","2016/01/15","PMC4699540","","10.2147/CIA.S96042"
"23345635","Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study","Simioni S, Cavassini M, Annoni JM, Métral M, Iglesias K, Rimbault Abraham A, Jilek S, Calmy A, Müller H, Fayet-Mello A, Giacobini E, Hirschel B, Du Pasquier RA.","Neurology. 2013 Feb 5;80(6):553-60. doi: 10.1212/WNL.0b013e3182815497. Epub 2013 Jan 23.","Simioni S","Neurology","2013","2013/01/25","","","10.1212/WNL.0b013e3182815497"
"19692530","Tart cherry juice decreases oxidative stress in healthy older men and women","Traustadóttir T, Davies SS, Stock AA, Su Y, Heward CB, Roberts LJ 2nd, Harman SM.","J Nutr. 2009 Oct;139(10):1896-900. doi: 10.3945/jn.109.111716. Epub 2009 Aug 19.","Traustadóttir T","J Nutr","2009","2009/08/21","PMC3151016","","10.3945/jn.109.111716"
"15582750","Estrogen use and brain metabolic change in postmenopausal women","Rasgon NL, Silverman D, Siddarth P, Miller K, Ercoli LM, Elman S, Lavretsky H, Huang SC, Phelps ME, Small GW.","Neurobiol Aging. 2005 Feb;26(2):229-35. doi: 10.1016/j.neurobiolaging.2004.03.003.","Rasgon NL","Neurobiol Aging","2005","2004/12/08","","","10.1016/j.neurobiolaging.2004.03.003"
"12616671","Pharmacokinetic and safety assessments of concurrent administration of risperidone and donepezil","Zhao Q, Xie C, Pesco-Koplowitz L, Jia X, Parier JL.","J Clin Pharmacol. 2003 Feb;43(2):180-6. doi: 10.1177/0091270002239827.","Zhao Q","J Clin Pharmacol","2003","2003/03/06","","","10.1177/0091270002239827"
"31504554","Nocturnal Gamma-Hydroxybutyrate Reduces Cortisol-Awakening Response and Morning Kynurenine Pathway Metabolites in Healthy Volunteers","Dornbierer DA, Boxler M, Voegel CD, Stucky B, Steuer AE, Binz TM, Baumgartner MR, Baur DM, Quednow BB, Kraemer T, Seifritz E, Landolt HP, Bosch OG.","Int J Neuropsychopharmacol. 2019 Oct 1;22(10):631-639. doi: 10.1093/ijnp/pyz047.","Dornbierer DA","Int J Neuropsychopharmacol","2019","2019/09/11","PMC6822136","","10.1093/ijnp/pyz047"
"24730717","Long-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [¹⁸F]FDG-PET study","Forlenza OV, Coutinho AM, Aprahamian I, Prando S, Mendes LL, Diniz BS, Gattaz WF, Buchpiguel CA.","ACS Chem Neurosci. 2014 Jun 18;5(6):484-9. doi: 10.1021/cn5000315. Epub 2014 Apr 29.","Forlenza OV","ACS Chem Neurosci","2014","2014/04/16","PMC4063507","","10.1021/cn5000315"
"15087583","Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study","Amieva H, Letenneur L, Dartigues JF, Rouch-Leroyer I, Sourgen C, D'Alchée-Birée F, Dib M, Barberger-Gateau P, Orgogozo JM, Fabrigoule C.","Dement Geriatr Cogn Disord. 2004;18(1):87-93. doi: 10.1159/000077815. Epub 2004 Apr 14.","Amieva H","Dement Geriatr Cogn Disord","2004","2004/04/17","","","10.1159/000077815"
"11198531","Temporal changes in brain volume and cognition in a randomized treatment trial of vascular dementia","Broderick JP, Gaskill M, Dhawan A, Khoury JC.","J Neuroimaging. 2001 Jan;11(1):6-12. doi: 10.1111/j.1552-6569.2001.tb00002.x.","Broderick JP","J Neuroimaging","2001","2001/02/24","","","10.1111/j.1552-6569.2001.tb00002.x"
"30445895","Outcome of neuropsychiatric symptoms and daily functioning of patients with dementia treated on an acute psychogeriatric ward","Pitkänen A, Alanen HM, Kampman O, Leinonen E.","Nord J Psychiatry. 2018 Oct;72(7):521-525. doi: 10.1080/08039488.2018.1532021. Epub 2018 Nov 16.","Pitkänen A","Nord J Psychiatry","2018","2018/11/18","","","10.1080/08039488.2018.1532021"
"27553192","An assessment of the central disposition of intranasally administered insulin lispro in the cerebrospinal fluid of healthy volunteers and beagle dogs","Lowe S, Sher E, Wishart G, Jackson K, Yuen E, Brittain C, Fong SC, Clarke DO, Landschulz WH.","Drug Deliv Transl Res. 2017 Feb;7(1):11-15. doi: 10.1007/s13346-016-0325-8.","Lowe S","Drug Deliv Transl Res","2017","2016/08/25","","","10.1007/s13346-016-0325-8"
"25525191","Effect of memantine on cough reflex sensitivity: translational studies in guinea pigs and humans","Dicpinigaitis PV, Canning BJ, Garner R, Paterson B.","J Pharmacol Exp Ther. 2015 Mar;352(3):448-54. doi: 10.1124/jpet.114.221218. Epub 2014 Dec 18.","Dicpinigaitis PV","J Pharmacol Exp Ther","2015","2014/12/20","","","10.1124/jpet.114.221218"
"24206541","Prevention of poststroke cognitive decline: ASPIS--a multicenter, randomized, observer-blind, parallel group clinical trial to evaluate multiple lifestyle interventions--study design and baseline characteristics","Brainin M, Matz K, Nemec M, Teuschl Y, Dachenhausen A, Asenbaum-Nan S, Bancher C, Kepplinger B, Oberndorfer S, Pinter M, Schnider P, Tuomilehto J; ASPIS Study Group.","Int J Stroke. 2015 Jun;10(4):627-35. doi: 10.1111/ijs.12188. Epub 2013 Nov 10.","Brainin M","Int J Stroke","2015","2013/11/12","","","10.1111/ijs.12188"
"23786741","Cognitive change in donepezil treated patients with vascular or mixed dementia","Rockwood K, Mitnitski A, Black SE, Richard M, Defoy I, VASPECT study investigators.","Can J Neurol Sci. 2013 Jul;40(4):564-71. doi: 10.1017/s0317167100014670.","Rockwood K","Can J Neurol Sci","2013","2013/06/22","","","10.1017/s0317167100014670"
"16181792","Neural correlates of adjunctive rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind fMRI study","Kumari V, Aasen I, ffytche D, Williams SC, Sharma T.","Neuroimage. 2006 Jan 15;29(2):545-56. doi: 10.1016/j.neuroimage.2005.08.013. Epub 2005 Sep 21.","Kumari V","Neuroimage","2006","2005/09/27","","","10.1016/j.neuroimage.2005.08.013"
"15711832","Access of HTB, main metabolite of triflusal, to cerebrospinal fluid in healthy volunteers","Valle M, Barbanoj MJ, Donner A, Izquierdo I, Herranz U, Klein N, Eichler HG, Müller M, Brunner M.","Eur J Clin Pharmacol. 2005 Apr;61(2):103-11. doi: 10.1007/s00228-004-0887-0. Epub 2005 Feb 12.","Valle M","Eur J Clin Pharmacol","2005","2005/02/16","","","10.1007/s00228-004-0887-0"
"23414646","Efficacy of a cognitive intervention program in patients with mild cognitive impairment","Rojas GJ, Villar V, Iturry M, Harris P, Serrano CM, Herrera JA, Allegri RF.","Int Psychogeriatr. 2013 May;25(5):825-31. doi: 10.1017/S1041610213000045. Epub 2013 Feb 18.","Rojas GJ","Int Psychogeriatr","2013","2013/02/19","","","10.1017/S1041610213000045"
"31437302","DNL104, a Centrally Penetrant RIPK1 Inhibitor, Inhibits RIP1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunteers","Grievink HW, Heuberger JAAC, Huang F, Chaudhary R, Birkhoff WAJ, Tonn GR, Mosesova S, Erickson R, Moerland M, Haddick PCG, Scearce-Levie K, Ho C, Groeneveld GJ.","Clin Pharmacol Ther. 2020 Feb;107(2):406-414. doi: 10.1002/cpt.1615. Epub 2019 Sep 25.","Grievink HW","Clin Pharmacol Ther","2020","2019/08/23","","","10.1002/cpt.1615"
"31090457","Effects of Bifidobacterium breve A1 on the cognitive function of older adults with memory complaints: a randomised, double-blind, placebo-controlled trial","Kobayashi Y, Kuhara T, Oki M, Xiao JZ.","Benef Microbes. 2019 May 28;10(5):511-520. doi: 10.3920/BM2018.0170. Epub 2019 May 15.","Kobayashi Y","Benef Microbes","2019","2019/05/16","","","10.3920/BM2018.0170"
"28222815","Cognitive stimulation therapy as a sustainable intervention for dementia in sub-Saharan Africa: feasibility and clinical efficacy using a stepped-wedge design","Paddick SM, Mkenda S, Mbowe G, Kisoli A, Gray WK, Dotchin CL, Ternent L, Ogunniyi A, Kissima J, Olakehinde O, Mushi D, Walker RW.","Int Psychogeriatr. 2017 Jun;29(6):979-989. doi: 10.1017/S1041610217000163. Epub 2017 Feb 22.","Paddick SM","Int Psychogeriatr","2017","2017/02/23","","","10.1017/S1041610217000163"
"25455511","Association between insulin resistance and cognition in patients with depressive disorders: exploratory analyses into age-specific effects","Wroolie TE, Kenna HA, Singh MK, Rasgon NL.","J Psychiatr Res. 2015 Jan;60:65-72. doi: 10.1016/j.jpsychires.2014.10.001. Epub 2014 Oct 14.","Wroolie TE","J Psychiatr Res","2015","2014/12/03","","","10.1016/j.jpsychires.2014.10.001"
"22329473","Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial","Anand A, Gunn AD, Barkay G, Karne HS, Nurnberger JI, Mathew SJ, Ghosh S.","Bipolar Disord. 2012 Feb;14(1):64-70. doi: 10.1111/j.1399-5618.2011.00971.x.","Anand A","Bipolar Disord","2012","2012/02/15","","","10.1111/j.1399-5618.2011.00971.x"
"17119538","Acute effects of the ampakine farampator on memory and information processing in healthy elderly volunteers","Wezenberg E, Verkes RJ, Ruigt GS, Hulstijn W, Sabbe BG.","Neuropsychopharmacology. 2007 Jun;32(6):1272-83. doi: 10.1038/sj.npp.1301257. Epub 2006 Nov 22.","Wezenberg E","Neuropsychopharmacology","2007","2006/11/23","","","10.1038/sj.npp.1301257"
"16960448","Statins of different brain penetrability differentially affect CSF PLTP activity","Vuletic S, Riekse RG, Marcovina SM, Peskind ER, Hazzard WR, Albers JJ.","Dement Geriatr Cogn Disord. 2006;22(5-6):392-8. doi: 10.1159/000095679. Epub 2006 Sep 7.","Vuletic S","Dement Geriatr Cogn Disord","2006","2006/09/09","","","10.1159/000095679"
"15877932","Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans","Ellis JR, Ellis KA, Bartholomeusz CF, Harrison BJ, Wesnes KA, Erskine FF, Vitetta L, Nathan PJ.","Int J Neuropsychopharmacol. 2006 Apr;9(2):175-89. doi: 10.1017/S1461145705005407. Epub 2005 May 9.","Ellis JR","Int J Neuropsychopharmacol","2006","2005/05/10","","","10.1017/S1461145705005407"
"15712768","The effect of therapeutic touch on behavioral symptoms of persons with dementia","Woods DL, Craven RF, Whitney J.","Altern Ther Health Med. 2005 Jan-Feb;11(1):66-74.","Woods DL","Altern Ther Health Med","2005","2005/02/17","","",""
"11598383","Improving influence of insulin on cognitive functions in humans","Kern W, Peters A, Fruehwald-Schultes B, Deininger E, Born J, Fehm HL.","Neuroendocrinology. 2001 Oct;74(4):270-80. doi: 10.1159/000054694.","Kern W","Neuroendocrinology","2001","2001/10/13","","","10.1159/000054694"
"11351939","Acute dietary tryptophan depletion impairs maintenance of ""affective set"" and delayed visual recognition in healthy volunteers","Rubinsztein JS, Rogers RD, Riedel WJ, Mehta MA, Robbins TW, Sahakian BJ.","Psychopharmacology (Berl). 2001 Mar;154(3):319-26. doi: 10.1007/s002130000655.","Rubinsztein JS","Psychopharmacology (Berl)","2001","2001/05/16","","","10.1007/s002130000655"
"9839758","Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses","Rogers SL, Friedhoff LT.","Br J Clin Pharmacol. 1998 Nov;46 Suppl 1(Suppl 1):1-6. doi: 10.1046/j.1365-2125.1998.0460s1001.x.","Rogers SL","Br J Clin Pharmacol","1998","1998/12/05","PMC1873812","","10.1046/j.1365-2125.1998.0460s1001.x"
"2856549","Angiotensin converting enzyme and memory: preclinical and clinical data","Sudilovsky A, Turnbull B, Croog SH, Crook T.","Int J Neurol. 1987-1988;21-22:145-62.","Sudilovsky A","Int J Neurol","1987","1987/01/01","","",""
"15742005","A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment","Thal LJ, Ferris SH, Kirby L, Block GA, Lines CR, Yuen E, Assaid C, Nessly ML, Norman BA, Baranak CC, Reines SA; Rofecoxib Protocol 078 study group.","Neuropsychopharmacology. 2005 Jun;30(6):1204-15. doi: 10.1038/sj.npp.1300690.","Thal LJ","Neuropsychopharmacology","2005","2005/03/03","","","10.1038/sj.npp.1300690"
"22121012","Detecting MCI and dementia in primary care: effectiveness of the MMS, the FAQ and the IQCODE [corrected]","Cruz-Orduña I, Bellón JM, Torrero P, Aparicio E, Sanz A, Mula N, Marzana G, Begué C, Cabezón D, Olazarán J.","Fam Pract. 2012 Aug;29(4):401-6. doi: 10.1093/fampra/cmr114. Epub 2011 Nov 25.","Cruz-Orduña I","Fam Pract","2012","2011/11/29","","","10.1093/fampra/cmr114"
"32164678","Let's CHAT (community health approaches to) dementia in Aboriginal and Torres Strait Islander communities: protocol for a stepped wedge cluster randomised controlled trial","Bradley K, Smith R, Hughson JA, Atkinson D, Bessarab D, Flicker L, Radford K, Smith K, Strivens E, Thompson S, Blackberry I, LoGiudice D.","BMC Health Serv Res. 2020 Mar 12;20(1):208. doi: 10.1186/s12913-020-4985-1.","Bradley K","BMC Health Serv Res","2020","2020/03/14","PMC7069169","","10.1186/s12913-020-4985-1"
"30388439","The effect of spermidine on memory performance in older adults at risk for dementia: A randomized controlled trial","Wirth M, Benson G, Schwarz C, Köbe T, Grittner U, Schmitz D, Sigrist SJ, Bohlken J, Stekovic S, Madeo F, Flöel A.","Cortex. 2018 Dec;109:181-188. doi: 10.1016/j.cortex.2018.09.014. Epub 2018 Oct 4.","Wirth M","Cortex","2018","2018/11/03","","","10.1016/j.cortex.2018.09.014"
"34999335","Omega-3 fatty acid, carotenoid and vitamin E supplementation improves working memory in older adults: A randomised clinical trial","Power R, Nolan JM, Prado-Cabrero A, Roche W, Coen R, Power T, Mulcahy R.","Clin Nutr. 2022 Feb;41(2):405-414. doi: 10.1016/j.clnu.2021.12.004. Epub 2021 Dec 7.","Power R","Clin Nutr","2022","2022/01/09","","","10.1016/j.clnu.2021.12.004"
"25444575","The Study of Mental and Resistance Training (SMART) study—resistance training and/or cognitive training in mild cognitive impairment: a randomized, double-blind, double-sham controlled trial","Fiatarone Singh MA, Gates N, Saigal N, Wilson GC, Meiklejohn J, Brodaty H, Wen W, Singh N, Baune BT, Suo C, Baker MK, Foroughi N, Wang Y, Sachdev PS, Valenzuela M.","J Am Med Dir Assoc. 2014 Dec;15(12):873-80. doi: 10.1016/j.jamda.2014.09.010. Epub 2014 Oct 23.","Fiatarone Singh MA","J Am Med Dir Assoc","2014","2014/12/03","","","10.1016/j.jamda.2014.09.010"
"25914281","Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study","Mamikonyan E, Xie SX, Melvin E, Weintraub D.","Mov Disord. 2015 Jun;30(7):912-8. doi: 10.1002/mds.26236. Epub 2015 Apr 25.","Mamikonyan E","Mov Disord","2015","2015/04/28","","","10.1002/mds.26236"
"32216870","Dementia Care Mapping™ to reduce agitation in care home residents with dementia: the EPIC cluster RCT","Surr CA, Holloway I, Walwyn RE, Griffiths AW, Meads D, Kelley R, Martin A, McLellan V, Ballard C, Fossey J, Burnley N, Chenoweth L, Creese B, Downs M, Garrod L, Graham EH, Lilley-Kelley A, McDermid J, Millard H, Perfect D, Robinson L, Robinson O, Shoesmith E, Siddiqi N, Stokes G, Wallace D, Farrin AJ.","Health Technol Assess. 2020 Mar;24(16):1-172. doi: 10.3310/hta24160.","Surr CA","Health Technol Assess","2020","2020/03/29","PMC7132533","","10.3310/hta24160"
"34589083","Safety and Preliminary Efficacy of a Novel Host-Modulatory Therapy for Reducing Gingival Inflammation","Hasturk H, Schulte F, Martins M, Sherzai H, Floros C, Cugini M, Chiu CJ, Hardt M, Van Dyke T.","Front Immunol. 2021 Sep 13;12:704163. doi: 10.3389/fimmu.2021.704163. eCollection 2021.","Hasturk H","Front Immunol","2021","2021/09/30","PMC8475270","","10.3389/fimmu.2021.704163"
"17944889","A pilot study of banxia houpu tang, a traditional Chinese medicine, for reducing pneumonia risk in older adults with dementia","Iwasaki K, Kato S, Monma Y, Niu K, Ohrui T, Okitsu R, Higuchi S, Ozaki S, Kaneko N, Seki T, Nakayama K, Furukawa K, Fujii M, Arai H.","J Am Geriatr Soc. 2007 Dec;55(12):2035-40. doi: 10.1111/j.1532-5415.2007.01448.x. Epub 2007 Oct 18.","Iwasaki K","J Am Geriatr Soc","2007","2007/10/20","","","10.1111/j.1532-5415.2007.01448.x"
"23279145","Improvement in delusions and hallucinations in patients with dementia with Lewy bodies upon administration of yokukansan, a traditional Japanese medicine","Iwasaki K, Kosaka K, Mori H, Okitsu R, Furukawa K, Manabe Y, Yoshita M, Kanamori A, Ito N, Wada K, Kitayama M, Horiguchi J, Yamaguchi S, Takayama S, Fukuhara R, Ouma S, Nakano S, Hashimoto M, Kinoshita T.","Psychogeriatrics. 2012 Dec;12(4):235-41. doi: 10.1111/j.1479-8301.2012.00413.x.","Iwasaki K","Psychogeriatrics","2012","2013/01/03","","","10.1111/j.1479-8301.2012.00413.x"
"16518704","Study of the association with -330T/G IL-2 in a population of centenarians from centre and south Italy","Scola L, Candore G, Colonna-Romano G, Crivello A, Forte GI, Paolisso G, Franceschi C, Lio D, Caruso C.","Biogerontology. 2005 Dec;6(6):425-9. doi: 10.1007/s10522-005-4909-9.","Scola L","Biogerontology","2005","2006/03/07","","","10.1007/s10522-005-4909-9"
"33110037","Cognitive complaints are associated with smaller right medial temporal gray-matter volume in younger postmenopausal women","Conley AC, Albert KM, Boyd BD, Kim SG, Shokouhi S, McDonald BC, Saykin AJ, Dumas JA, Newhouse PA.","Menopause. 2020 Nov;27(11):1220-1227. doi: 10.1097/GME.0000000000001613.","Conley AC","Menopause","2020","2020/10/28","PMC9153070","NIHMS1802565","10.1097/GME.0000000000001613"
"16286549","Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community","Manly JJ, Bell-McGinty S, Tang MX, Schupf N, Stern Y, Mayeux R.","Arch Neurol. 2005 Nov;62(11):1739-46. doi: 10.1001/archneur.62.11.1739.","Manly JJ","Arch Neurol","2005","2005/11/16","","","10.1001/archneur.62.11.1739"
"9702845","Maximum tolerated dose and pharmacodynamics of eptastigmine in elderly healthy volunteers","Mant T, Troetel WM, Imbimbo BP.","J Clin Pharmacol. 1998 Jul;38(7):610-7. doi: 10.1002/j.1552-4604.1998.tb04467.x.","Mant T","J Clin Pharmacol","1998","1998/08/14","","","10.1002/j.1552-4604.1998.tb04467.x"
"11114263","Neurodegeneration is associated to changes in serum insulin-like growth factors","Busiguina S, Fernandez AM, Barrios V, Clark R, Tolbert DL, Berciano J, Torres-Aleman I.","Neurobiol Dis. 2000 Dec;7(6 Pt B):657-65. doi: 10.1006/nbdi.2000.0311.","Busiguina S","Neurobiol Dis","2000","2000/12/15","","","10.1006/nbdi.2000.0311"
"1353650","Common factors contributing to intractable pain and medical problems with insufficient drug uptake in areas to be treated, and their pathogenesis and treatment: Part I. Combined use of medication with acupuncture, (+) Qi gong energy-stored material, soft laser or electrical stimulation","Omura Y, Losco BM, Omura AK, Takeshige C, Hisamitsu T, Shimotsuura Y, Yamamoto S, Ishikawa H, Muteki T, Nakajima H, et al.","Acupunct Electrother Res. 1992;17(2):107-48. doi: 10.3727/036012992816357774.","Omura Y","Acupunct Electrother Res","1992","1992/01/01","","","10.3727/036012992816357774"
"20142523","A randomized, placebo-controlled trial of latrepirdine in Huntington disease","Kieburtz K, McDermott MP, Voss TS, Corey-Bloom J, Deuel LM, Dorsey ER, Factor S, Geschwind MD, Hodgeman K, Kayson E, Noonberg S, Pourfar M, Rabinowitz K, Ravina B, Sanchez-Ramos J, Seely L, Walker F, Feigin A; Huntington Disease Study Group DIMOND Investigators.","Arch Neurol. 2010 Feb;67(2):154-60. doi: 10.1001/archneurol.2009.334.","Kieburtz K","Arch Neurol","2010","2010/02/10","PMC4134015","NIHMS600731","10.1001/archneurol.2009.334"
"24938836","Memantine enhances recovery from stroke","López-Valdés HE, Clarkson AN, Ao Y, Charles AC, Carmichael ST, Sofroniew MV, Brennan KC.","Stroke. 2014 Jul;45(7):2093-2100. doi: 10.1161/STROKEAHA.113.004476. Epub 2014 Jun 17.","López-Valdés HE","Stroke","2014","2014/06/19","PMC4142682","NIHMS597571","10.1161/STROKEAHA.113.004476"
"33470769","Sleep quality and cortical amyloid-β deposition in postmenopausal women of the Kronos early estrogen prevention study","Zeydan B, Lowe VJ, Tosakulwong N, Lesnick TG, Senjem ML, Jack CR Jr, Fields JA, James TT, Gleason CE, Dowling NM, Miller VM, Kantarci K.","Neuroreport. 2021 Mar 3;32(4):326-331. doi: 10.1097/WNR.0000000000001592.","Zeydan B","Neuroreport","2021","2021/01/20","PMC7878341","NIHMS1657616","10.1097/WNR.0000000000001592"
"27009597","Hippocampal sub-regional shape and physical activity in older adults","Varma VR, Tang X, Carlson MC.","Hippocampus. 2016 Aug;26(8):1051-60. doi: 10.1002/hipo.22586. Epub 2016 Apr 9.","Varma VR","Hippocampus","2016","2016/03/25","PMC6681805","NIHMS1043075","10.1002/hipo.22586"
"34360799","Novel Insight in Idiopathic Normal Pressure Hydrocephalus (iNPH) Biomarker Discovery in CSF","Torretta E, Arosio B, Barbacini P, Capitanio D, Rossi PD, Moriggi M, Clerici M, Mari D, Cesari M, Gelfi C.","Int J Mol Sci. 2021 Jul 27;22(15):8034. doi: 10.3390/ijms22158034.","Torretta E","Int J Mol Sci","2021","2021/08/07","PMC8347603","","10.3390/ijms22158034"
"29098341","Acute administration of roflumilast enhances sensory gating in healthy young humans in a randomized trial","Heckman PRA, Van Duinen MA, Blokland A, Uz T, Prickaerts J, Sambeth A.","Psychopharmacology (Berl). 2018 Jan;235(1):301-308. doi: 10.1007/s00213-017-4770-y. Epub 2017 Nov 3.","Heckman PRA","Psychopharmacology (Berl)","2018","2017/11/04","PMC5748397","","10.1007/s00213-017-4770-y"
"23050829","Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: the AIBL Active trial","Cyarto EV, Lautenschlager NT, Desmond PM, Ames D, Szoeke C, Salvado O, Sharman MJ, Ellis KA, Phal PM, Masters CL, Rowe CC, Martins RN, Cox KL.","BMC Psychiatry. 2012 Oct 11;12:167. doi: 10.1186/1471-244X-12-167.","Cyarto EV","BMC Psychiatry","2012","2012/10/12","PMC3534144","","10.1186/1471-244X-12-167"
"33260151","rTMS modulates precuneus-hippocampal subregion circuit in patients with subjective cognitive decline","Chen J, Ma N, Hu G, Nousayhah A, Xue C, Qi W, Xu W, Chen S, Rao J, Liu W, Zhang F, Zhang X.","Aging (Albany NY). 2020 Nov 30;13(1):1314-1331. doi: 10.18632/aging.202313. Epub 2020 Nov 30.","Chen J","Aging (Albany NY)","2020","2020/12/01","PMC7835048","","10.18632/aging.202313"
"30035339","Clinical and radiological characteristics of early versus late mild cognitive impairment in patients with comorbid depressive disorder","Motter JN, Pelton GH, D'Antonio K, Rushia SN, Pimontel MA, Petrella JR, Garcon E, Ciovacco MW, Sneed JR, Doraiswamy PM, Devanand DP.","Int J Geriatr Psychiatry. 2018 Dec;33(12):1604-1612. doi: 10.1002/gps.4955. Epub 2018 Jul 23.","Motter JN","Int J Geriatr Psychiatry","2018","2018/07/24","PMC6246783","NIHMS978894","10.1002/gps.4955"
"22421908","Effect of endurance exercise training and curcumin intake on central arterial hemodynamics in postmenopausal women: pilot study","Sugawara J, Akazawa N, Miyaki A, Choi Y, Tanabe Y, Imai T, Maeda S.","Am J Hypertens. 2012 Jun;25(6):651-6. doi: 10.1038/ajh.2012.24. Epub 2012 Mar 15.","Sugawara J","Am J Hypertens","2012","2012/03/17","","","10.1038/ajh.2012.24"
"34126778","Implementation Science in Thailand: Design and Methods of a Geriatric Mental Health Cluster-Randomized Trial","Chen H, Levkoff S, Chuengsatiansup K, Sihapark S, Hinton L, Gallagher-Thompson D, Tongsiri S, Wisetpholchai B, Fritz S, Lamont A, Domlyn A, Wandersman A, Marques AH.","Psychiatr Serv. 2022 Jan 1;73(1):83-91. doi: 10.1176/appi.ps.202000028. Epub 2021 Jun 15.","Chen H","Psychiatr Serv","2022","2021/06/15","PMC8785231","NIHMS1706552","10.1176/appi.ps.202000028"
"30611293","First-in-human study assessing safety, tolerability, and pharmacokinetics of 2-hydroxybenzylamine acetate, a selective dicarbonyl electrophile scavenger, in healthy volunteers","Pitchford LM, Rathmacher JA, Fuller JC Jr, Daniels JS, Morrison RD, Akers WS, Abumrad NN, Amarnath V, Currey PM, Roberts LJ, Oates JA, Boutaud O.","BMC Pharmacol Toxicol. 2019 Jan 5;20(1):1. doi: 10.1186/s40360-018-0281-7.","Pitchford LM","BMC Pharmacol Toxicol","2019","2019/01/07","PMC6321651","","10.1186/s40360-018-0281-7"
"28760512","Self-rated versus Caregiver-rated Health for Patients with Mild Dementia as Predictors of Patient Mortality","Phung TKT, Siersma V, Vogel A, Waldorff FB, Waldemar G.","Am J Geriatr Psychiatry. 2018 Mar;26(3):375-385. doi: 10.1016/j.jagp.2017.06.005. Epub 2017 Jun 7.","Phung TKT","Am J Geriatr Psychiatry","2018","2017/08/02","","","10.1016/j.jagp.2017.06.005"
"27885411","Scopolamine disrupts place navigation in rats and humans: a translational validation of the Hidden Goal Task in the Morris water maze and a real maze for humans","Laczó J, Markova H, Lobellova V, Gazova I, Parizkova M, Cerman J, Nekovarova T, Vales K, Klovrzova S, Harrison J, Windisch M, Vlcek K, Svoboda J, Hort J, Stuchlik A.","Psychopharmacology (Berl). 2017 Feb;234(4):535-547. doi: 10.1007/s00213-016-4488-2. Epub 2016 Nov 24.","Laczó J","Psychopharmacology (Berl)","2017","2016/11/26","","","10.1007/s00213-016-4488-2"
"26765077","An accessible pharmacodynamic transcriptional biomarker for notch target engagement","Tanis KQ, Podtelezhnikov AA, Blackman SC, Hing J, Railkar RA, Lunceford J, Klappenbach JA, Wei B, Harman A, Camargo LM, Shah S, Finney EM, Hardwick JS, Loboda A, Watters J, Bergstrom DA, Demuth T, Herman GA, Strack PR, Iannone R.","Clin Pharmacol Ther. 2016 Apr;99(4):370-80. doi: 10.1002/cpt.335. Epub 2016 Feb 17.","Tanis KQ","Clin Pharmacol Ther","2016","2016/01/15","","","10.1002/cpt.335"
"26699666","A 15-day course of donepezil modulates spectral EEG dynamics related to target auditory stimuli in young, healthy adult volunteers","Leroy C, Bourriez JL, Dujardin K, Molaee-Ardekani B, Babiloni C, Deplanque D, Ponchel A, Hennion S, Plomhause L, Devanne H, Deguil J, Payoux P, Blin O, Méligne D, Micallef J, Chauveau N, Lanteaume L, Vervueren C, Guimont F, Thalamas C, Cassé-Perrot C, Rouby F, Bordet R, Derambure P; PharmaCog Consortium.","Clin Neurophysiol. 2019 May;130(5):863-875. doi: 10.1016/j.clinph.2015.11.018. Epub 2015 Nov 27.","Leroy C","Clin Neurophysiol","2019","2015/12/25","","","10.1016/j.clinph.2015.11.018"
"26644115","Does targeted cognitive training reduce educational disparities in cognitive function among cognitively normal older adults?","Clark DO, Xu H, Unverzagt FW, Hendrie H.","Int J Geriatr Psychiatry. 2016 Jul;31(7):809-17. doi: 10.1002/gps.4395. Epub 2015 Dec 7.","Clark DO","Int J Geriatr Psychiatry","2016","2015/12/09","PMC5300706","NIHMS846633","10.1002/gps.4395"
"24061691","Prediction of outcomes in MCI with (123)I-IMP-CBF SPECT: a multicenter prospective cohort study","Ito K, Mori E, Fukuyama H, Ishii K, Washimi Y, Asada T, Mori S, Meguro K, Kitamura S, Hanyu H, Nakano S, Matsuda H, Kuwabara Y, Hashikawa K, Momose T, Uchida Y, Hatazawa J, Minoshima S, Kosaka K, Yamada T, Yonekura Y; J-COSMIC Study Group.","Ann Nucl Med. 2013 Dec;27(10):898-906. doi: 10.1007/s12149-013-0768-7. Epub 2013 Sep 6.","Ito K","Ann Nucl Med","2013","2013/09/25","PMC4328132","","10.1007/s12149-013-0768-7"
"23554879","PINCH in the cellular stress response to tau-hyperphosphorylation","Ozdemir AY, Rom I, Kovalevich J, Yen W, Adiga R, Dave RS, Langford D.","PLoS One. 2013;8(3):e58232. doi: 10.1371/journal.pone.0058232. Epub 2013 Mar 12.","Ozdemir AY","PLoS One","2013","2013/04/05","PMC3595241","","10.1371/journal.pone.0058232"
"21341919","Galantamine improves sustained attention in chronic cocaine users","Sofuoglu M, Waters AJ, Poling J, Carroll KM.","Exp Clin Psychopharmacol. 2011 Feb;19(1):11-9. doi: 10.1037/a0022213.","Sofuoglu M","Exp Clin Psychopharmacol","2011","2011/02/24","PMC3350372","NIHMS375127","10.1037/a0022213"
"21048483","Effects of a creative expression intervention on emotions, communication, and quality of life in persons with dementia","Phillips LJ, Reid-Arndt SA, Pak Y.","Nurs Res. 2010 Nov-Dec;59(6):417-25. doi: 10.1097/NNR.0b013e3181faff52.","Phillips LJ","Nurs Res","2010","2010/11/05","PMC3010410","NIHMS252969","10.1097/NNR.0b013e3181faff52"
"20826875","Cortical and frontal atrophy are associated with cognitive impairment in age-related confluent white-matter lesion","Mok V, Wong KK, Xiong Y, Wong A, Schmidt R, Chu W, Hu X, Leung EY, Chen S, Chen Y, Tang WK, Chen X, Ho CL, Wong KS, Wong ST.","J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):52-7. doi: 10.1136/jnnp.2009.201665. Epub 2010 Sep 8.","Mok V","J Neurol Neurosurg Psychiatry","2011","2010/09/10","","","10.1136/jnnp.2009.201665"
"20495134","Single- and multiple-dose pharmacokinetics, safety, and tolerability of the selective alpha7 neuronal nicotinic receptor agonist, ABT-107, in healthy human volunteers","Othman AA, Lenz RA, Zhang J, Li J, Awni WM, Dutta S.","J Clin Pharmacol. 2011 Apr;51(4):512-26. doi: 10.1177/0091270010370460. Epub 2010 May 21.","Othman AA","J Clin Pharmacol","2011","2010/05/25","","","10.1177/0091270010370460"
"19812865","The effect of a nutrient dense drink on mental and physical function in institutionalized elderly people","Manders M, De Groot LC, Hoefnagels WH, Dhonukshe-Rutten RA, Wouters-Wesseling W, Mulders AJ, Van Staveren WA.","J Nutr Health Aging. 2009 Nov;13(9):760-7. doi: 10.1007/s12603-009-0211-x.","Manders M","J Nutr Health Aging","2009","2009/10/09","","","10.1007/s12603-009-0211-x"
"26553159","The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men","Wahjoepramono EJ, Asih PR, Aniwiyanti V, Taddei K, Dhaliwal SS, Fuller SJ, Foster J, Carruthers M, Verdile G, Sohrabi HR, Martins RN.","CNS Neurol Disord Drug Targets. 2016;15(3):337-43. doi: 10.2174/1871527315666151110125704.","Wahjoepramono EJ","CNS Neurol Disord Drug Targets","2016","2015/11/11","PMC5078598","","10.2174/1871527315666151110125704"
"26138674","Dementia care mapping: effects on residents' quality of life and challenging behavior in German nursing homes. A quasi-experimental trial","Dichter MN, Quasdorf T, Schwab CG, Trutschel D, Haastert B, Riesner C, Bartholomeyczik S, Halek M.","Int Psychogeriatr. 2015 Nov;27(11):1875-92. doi: 10.1017/S1041610215000927. Epub 2015 Jul 3.","Dichter MN","Int Psychogeriatr","2015","2015/07/04","","","10.1017/S1041610215000927"
"25344629","Enhancing dentate gyrus function with dietary flavanols improves cognition in older adults","Brickman AM, Khan UA, Provenzano FA, Yeung LK, Suzuki W, Schroeter H, Wall M, Sloan RP, Small SA.","Nat Neurosci. 2014 Dec;17(12):1798-803. doi: 10.1038/nn.3850. Epub 2014 Oct 26.","Brickman AM","Nat Neurosci","2014","2014/10/27","PMC4940121","NIHMS695554","10.1038/nn.3850"
"23563930","Association between chemotherapy and cognitive impairments in a large cohort of patients with colorectal cancer","Du XL, Cai Y, Symanski E.","Int J Oncol. 2013 Jun;42(6):2123-33. doi: 10.3892/ijo.2013.1882. Epub 2013 Apr 4.","Du XL","Int J Oncol","2013","2013/04/09","","","10.3892/ijo.2013.1882"
"22932777","Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial","Lee LK, Shahar S, Chin AV, Yusoff NA.","Psychopharmacology (Berl). 2013 Feb;225(3):605-12. doi: 10.1007/s00213-012-2848-0. Epub 2012 Aug 30.","Lee LK","Psychopharmacology (Berl)","2013","2012/08/31","","","10.1007/s00213-012-2848-0"
"22169248","Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia","Javitt DC, Buchanan RW, Keefe RS, Kern R, McMahon RP, Green MF, Lieberman J, Goff DC, Csernansky JG, McEvoy JP, Jarskog F, Seidman LJ, Gold JM, Kimhy D, Nolan KS, Barch DS, Ball MP, Robinson J, Marder SR.","Schizophr Res. 2012 Apr;136(1-3):25-31. doi: 10.1016/j.schres.2011.11.001. Epub 2011 Dec 12.","Javitt DC","Schizophr Res","2012","2011/12/16","","","10.1016/j.schres.2011.11.001"
"19005465","A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia","Lieberman JA, Papadakis K, Csernansky J, Litman R, Volavka J, Jia XD, Gage A; MEM-MD-29 Study Group.","Neuropsychopharmacology. 2009 Apr;34(5):1322-9. doi: 10.1038/npp.2008.200. Epub 2008 Nov 12.","Lieberman JA","Neuropsychopharmacology","2009","2008/11/14","","","10.1038/npp.2008.200"
"17320833","Cholinesterase inhibitors affect brain potentials in amnestic mild cognitive impairment","Irimajiri R, Michalewski HJ, Golob EJ, Starr A.","Brain Res. 2007 May 11;1145:108-16. doi: 10.1016/j.brainres.2007.01.120. Epub 2007 Feb 2.","Irimajiri R","Brain Res","2007","2007/02/27","PMC1933386","NIHMS21735","10.1016/j.brainres.2007.01.120"
"10484245","Improving morning care routines of nursing home residents with dementia","Rogers JC, Holm MB, Burgio LD, Granieri E, Hsu C, Hardin JM, McDowell BJ.","J Am Geriatr Soc. 1999 Sep;47(9):1049-57. doi: 10.1111/j.1532-5415.1999.tb05226.x.","Rogers JC","J Am Geriatr Soc","1999","1999/09/14","","","10.1111/j.1532-5415.1999.tb05226.x"
"29453681","(18)F-FPYBF-2, a new F-18 labelled amyloid imaging PET tracer: biodistribution and radiation dosimetry assessment of first-in-man (18)F-FPYBF-2 PET imaging","Nishii R, Higashi T, Kagawa S, Okuyama C, Kishibe Y, Takahashi M, Okina T, Suzuki N, Hasegawa H, Nagahama Y, Ishizu K, Oishi N, Kimura H, Watanabe H, Ono M, Saji H, Yamauchi H.","Ann Nucl Med. 2018 May;32(4):256-263. doi: 10.1007/s12149-018-1240-5. Epub 2018 Feb 16.","Nishii R","Ann Nucl Med","2018","2018/02/18","","","10.1007/s12149-018-1240-5"
"24622517","Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia","Rasgon NL, Geist CL, Kenna HA, Wroolie TE, Williams KE, Silverman DH.","PLoS One. 2014 Mar 12;9(3):e89095. doi: 10.1371/journal.pone.0089095. eCollection 2014.","Rasgon NL","PLoS One","2014","2014/03/14","PMC3951184","","10.1371/journal.pone.0089095"
"23018531","A placebo-controlled, multiple ascending dose study to evaluate the safety, pharmacokinetics and pharmacodynamics of avagacestat (BMS-708163) in healthy young and elderly subjects","Dockens R, Wang JS, Castaneda L, Sverdlov O, Huang SP, Slemmon R, Gu H, Wong O, Li H, Berman RM, Smith C, Albright CF, Tong G.","Clin Pharmacokinet. 2012 Oct 1;51(10):681-93. doi: 10.1007/s40262-012-0005-x.","Dockens R","Clin Pharmacokinet","2012","2012/09/29","","","10.1007/s40262-012-0005-x"
"21644059","Additive effects of a cholinesterase inhibitor and a histamine inverse agonist on scopolamine deficits in humans","Cho W, Maruff P, Connell J, Gargano C, Calder N, Doran S, Fox-Bosetti S, Hassan A, Renger J, Herman G, Lines C, Verma A.","Psychopharmacology (Berl). 2011 Dec;218(3):513-24. doi: 10.1007/s00213-011-2344-y. Epub 2011 Jun 7.","Cho W","Psychopharmacology (Berl)","2011","2011/06/07","","","10.1007/s00213-011-2344-y"
"19079814","A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia","Mizukami K, Asada T, Kinoshita T, Tanaka K, Sonohara K, Nakai R, Yamaguchi K, Hanyu H, Kanaya K, Takao T, Okada M, Kudo S, Kotoku H, Iwakiri M, Kurita H, Miyamura T, Kawasaki Y, Omori K, Shiozaki K, Odawara T, Suzuki T, Yamada S, Nakamura Y, Toba K.","Int J Neuropsychopharmacol. 2009 Mar;12(2):191-9. doi: 10.1017/S146114570800970X. Epub 2008 Dec 11.","Mizukami K","Int J Neuropsychopharmacol","2009","2008/12/17","","","10.1017/S146114570800970X"
"16417614","Influence and interactions of cathepsin D, HLA-DRB1 and APOE on cognitive abilities in an older non-demented population","Payton A, van den Boogerd E, Davidson Y, Gibbons L, Ollier W, Rabbitt P, Worthington J, Horan M, Pendleton N.","Genes Brain Behav. 2006;5 Suppl 1:23-31. doi: 10.1111/j.1601-183X.2006.00191.x.","Payton A","Genes Brain Behav","2006","2006/01/19","","","10.1111/j.1601-183X.2006.00191.x"
"12939421","Donepezil in vascular dementia: a randomized, placebo-controlled study","Wilkinson D, Doody R, Helme R, Taubman K, Mintzer J, Kertesz A, Pratt RD; Donepezil 308 Study Group.","Neurology. 2003 Aug 26;61(4):479-86. doi: 10.1212/01.wnl.0000078943.50032.fc.","Wilkinson D","Neurology","2003","2003/08/27","","","10.1212/01.wnl.0000078943.50032.fc"
"11022397","Probing peripheral and central cholinergic system responses","Naranjo CA, Fourie J, Herrmann N, Lanctôt KL, Birt C, Yau KK.","J Psychiatry Neurosci. 2000 Sep;25(4):325-36.","Naranjo CA","J Psychiatry Neurosci","2000","2000/10/07","PMC1407737","",""
"35801957","Demographic and clinical profile of residents living with dementia and depressive symptoms in Australian private residential aged care: Data from the Music Interventions for Dementia and Depression in ELderly care (MIDDEL) cluster-randomised controlled trial","Lee YC, Sousa TV, Stretton-Smith PA, Gold C, Geretsegger M, Baker FA.","Australas J Ageing. 2022 Dec;41(4):e387-e396. doi: 10.1111/ajag.13104. Epub 2022 Jul 8.","Lee YC","Australas J Ageing","2022","2022/07/08","PMC10084363","","10.1111/ajag.13104"
"28094873","Effects of adding whole-body vibration to routine day activity program on physical functioning in elderly with mild or moderate dementia: a randomized controlled trial","Lam FMH, Liao LR, Kwok TCY, Pang MYC.","Int J Geriatr Psychiatry. 2018 Jan;33(1):21-30. doi: 10.1002/gps.4662. Epub 2017 Jan 17.","Lam FMH","Int J Geriatr Psychiatry","2018","2017/01/18","","","10.1002/gps.4662"
"26116933","Memory improvement via slow-oscillatory stimulation during sleep in older adults","Westerberg CE, Florczak SM, Weintraub S, Mesulam MM, Marshall L, Zee PC, Paller KA.","Neurobiol Aging. 2015 Sep;36(9):2577-86. doi: 10.1016/j.neurobiolaging.2015.05.014. Epub 2015 Jun 3.","Westerberg CE","Neurobiol Aging","2015","2015/06/29","PMC4523433","NIHMS696779","10.1016/j.neurobiolaging.2015.05.014"
"27129013","Population pharmacokinetic and pharmacodynamic analysis of plasma Aβ40 and Aβ42 following single oral doses of the BACE1 inhibitor AZD3839 to healthy volunteers","Quartino A, Huledal G, Sparve E, Lüttgen M, Bueters T, Karlsson P, Olsson T, Paraskos J, Maltby J, Claeson-Bohnstedt K, Lee CM, Alexander R, Fälting J, Paulsson B.","Clin Pharmacol Drug Dev. 2014 Sep;3(5):396-405. doi: 10.1002/cpdd.130. Epub 2014 May 26.","Quartino A","Clin Pharmacol Drug Dev","2014","2016/04/30","","","10.1002/cpdd.130"
"22495093","Effectiveness of Physio Acoustic Sound (PAS) therapy in demented nursing home residents with nocturnal restlessness: study protocol for a randomized controlled trial","van Os AJ, Aziz L, Schalkwijk D, Schols JM, de Bie RA.","Trials. 2012 Apr 11;13:34. doi: 10.1186/1745-6215-13-34.","van Os AJ","Trials","2012","2012/04/13","PMC3349520","","10.1186/1745-6215-13-34"
"22281004","Beneficial effect of donepezil on obstructive sleep apnea: a double-blind, placebo-controlled clinical trial","Sukys-Claudino L, Moraes W, Guilleminault C, Tufik S, Poyares D.","Sleep Med. 2012 Mar;13(3):290-6. doi: 10.1016/j.sleep.2011.09.014. Epub 2012 Jan 26.","Sukys-Claudino L","Sleep Med","2012","2012/01/28","","","10.1016/j.sleep.2011.09.014"
"20483885","Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial","Lovera JF, Frohman E, Brown TR, Bandari D, Nguyen L, Yadav V, Stuve O, Karman J, Bogardus K, Heimburger G, Cua L, Remingon G, Fowler J, Monahan T, Kilcup S, Courtney Y, McAleenan J, Butler K, Wild K, Whitham R, Bourdette D.","Mult Scler. 2010 Jun;16(6):715-23. doi: 10.1177/1352458510367662. Epub 2010 May 18.","Lovera JF","Mult Scler","2010","2010/05/21","","","10.1177/1352458510367662"
"16626752","Effects of donepezil on memory and cognition in multiple sclerosis","Christodoulou C, Melville P, Scherl WF, Macallister WS, Elkins LE, Krupp LB.","J Neurol Sci. 2006 Jun 15;245(1-2):127-36. doi: 10.1016/j.jns.2005.08.021. Epub 2006 Apr 19.","Christodoulou C","J Neurol Sci","2006","2006/04/22","","","10.1016/j.jns.2005.08.021"
"12590626","Randomized controlled trial of different models of care for nursing home residents with dementia complicated by depression or psychosis","Brodaty H, Draper BM, Millar J, Low LF, Lie D, Sharah S, Paton H.","J Clin Psychiatry. 2003 Jan;64(1):63-72. doi: 10.4088/jcp.v64n0113.","Brodaty H","J Clin Psychiatry","2003","2003/02/20","","","10.4088/jcp.v64n0113"
"9322135","Withdrawal of neuroleptic medications from institutionalized dementia patients: results of a double-blind, baseline-treatment-controlled pilot study","Bridges-Parlet S, Knopman D, Steffes S.","J Geriatr Psychiatry Neurol. 1997 Jul;10(3):119-26. doi: 10.1177/089198879701000306.","Bridges-Parlet S","J Geriatr Psychiatry Neurol","1997","1997/07/01","","","10.1177/089198879701000306"
"23968157","CHF5074 reduces biomarkers of neuroinflammation in patients with mild cognitive impairment: a 12-week, double-blind, placebo-controlled study","Ross J, Sharma S, Winston J, Nunez M, Bottini G, Franceschi M, Scarpini E, Frigerio E, Fiorentini F, Fernandez M, Sivilia S, Giardino L, Calza L, Norris D, Cicirello H, Casula D, Imbimbo BP.","Curr Alzheimer Res. 2013 Sep;10(7):742-53. doi: 10.2174/13892037113149990144.","Ross J","Curr Alzheimer Res","2013","2013/08/24","","","10.2174/13892037113149990144"
"27823800","A randomized placebo controlled trial of vitamin B(12) supplementation to prevent cognitive decline in older diabetic people with borderline low serum vitamin B(12)","Kwok T, Lee J, Ma RC, Wong SY, Kung K, Lam A, Ho CS, Lee V, Harrison J, Lam L.","Clin Nutr. 2017 Dec;36(6):1509-1515. doi: 10.1016/j.clnu.2016.10.018. Epub 2016 Oct 27.","Kwok T","Clin Nutr","2017","2016/11/09","","","10.1016/j.clnu.2016.10.018"
"27030249","Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial","Weintraub D, Hauser RA, Elm JJ, Pagan F, Davis MD, Choudhry A; MODERATO Investigators.","Mov Disord. 2016 May;31(5):709-14. doi: 10.1002/mds.26617. Epub 2016 Mar 31.","Weintraub D","Mov Disord","2016","2016/04/01","","","10.1002/mds.26617"
"17545740","Diabetes and parkinsonian signs in older persons","Arvanitakis Z, Wilson RS, Bienias JL, Bennett DA.","Alzheimer Dis Assoc Disord. 2007 Apr-Jun;21(2):144-9. doi: 10.1097/WAD.0b013e31805ba768.","Arvanitakis Z","Alzheimer Dis Assoc Disord","2007","2007/06/05","","","10.1097/WAD.0b013e31805ba768"
"31255494","Blood amyloid levels and risk of dementia in the Ginkgo Evaluation of Memory Study (GEMS): A longitudinal analysis","Lopez OL, Chang Y, Ives DG, Snitz BE, Fitzpatrick AL, Carlson MC, Rapp SR, Williamson JD, Tracy RP, DeKosky ST, Kuller LH.","Alzheimers Dement. 2019 Aug;15(8):1029-1038. doi: 10.1016/j.jalz.2019.04.008. Epub 2019 Jun 27.","Lopez OL","Alzheimers Dement","2019","2019/07/01","PMC7325728","NIHMS1598919","10.1016/j.jalz.2019.04.008"
"11936711","Descriptive study and pharmacotherapeutic intervention in patients with epilepsy or Parkinson's disease at nursing homes in southern Sweden","Midlöv P, Bondesson A, Eriksson T, Petersson J, Minthon L, Höglund P.","Eur J Clin Pharmacol. 2002 Feb;57(12):903-10. doi: 10.1007/s00228-001-0408-3.","Midlöv P","Eur J Clin Pharmacol","2002","2002/04/09","","","10.1007/s00228-001-0408-3"
"10436098","Increased thromboxane biosynthesis is associated with poststroke dementia","van Kooten F, Ciabattoni G, Koudstaal PJ, Grobbee DE, Kluft C, Patrono C.","Stroke. 1999 Aug;30(8):1542-7. doi: 10.1161/01.str.30.8.1542.","van Kooten F","Stroke","1999","1999/08/06","","","10.1161/01.str.30.8.1542"
"25622286","Domain identification moderates the effect of positive stereotypes on Chinese American women's math performance","Saad CS, Meyer OL, Dhindsa M, Zane N.","Cultur Divers Ethnic Minor Psychol. 2015 Jan;21(1):162-7. doi: 10.1037/a0038428.","Saad CS","Cultur Divers Ethnic Minor Psychol","2015","2015/01/27","","","10.1037/a0038428"
"14520164","The effects of a cholinesterase inhibitor are prominent in patients with fluctuating cognition: a part 3 study of the main mechanism of cholinesterase inhibitors in dementia","Onofrj M, Thomas A, Iacono D, Luciano AL, Di Iorio A.","Clin Neuropharmacol. 2003 Sep-Oct;26(5):239-51. doi: 10.1097/00002826-200309000-00008.","Onofrj M","Clin Neuropharmacol","2003","2003/10/02","","","10.1097/00002826-200309000-00008"
"29059120","Change in Depression, Confidence, and Physical Function Among Older Adults With Mild Cognitive Impairment","Ellis JL, Altenburger P, Lu Y.","J Geriatr Phys Ther. 2019 Jul/Sep;42(3):E108-E115. doi: 10.1519/JPT.0000000000000143.","Ellis JL","J Geriatr Phys Ther","2019","2017/10/24","PMC5910300","NIHMS880785","10.1519/JPT.0000000000000143"
"30334942","A cluster randomized controlled trial to test the feasibility and preliminary effectiveness of a family dementia caregiver intervention in Vietnam: The REACH VN study protocol","Nguyen TA, Nguyen H, Pham T, Nguyen TH, Hinton L.","Medicine (Baltimore). 2018 Oct;97(42):e12553. doi: 10.1097/MD.0000000000012553.","Nguyen TA","Medicine (Baltimore)","2018","2018/10/19","PMC6211867","","10.1097/MD.0000000000012553"
"23567399","The peaceful mind program: a pilot test of a cognitive-behavioral therapy-based intervention for anxious patients with dementia","Stanley MA, Calleo J, Bush AL, Wilson N, Snow AL, Kraus-Schuman C, Paukert AL, Petersen NJ, Brenes GA, Schulz PE, Williams SP, Kunik ME.","Am J Geriatr Psychiatry. 2013 Jul;21(7):696-708. doi: 10.1016/j.jagp.2013.01.007. Epub 2013 Feb 6.","Stanley MA","Am J Geriatr Psychiatry","2013","2013/04/10","PMC3411894","NIHMS367657","10.1016/j.jagp.2013.01.007"
"12810485","Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele","Diaz-Arrastia R, Gong Y, Fair S, Scott KD, Garcia MC, Carlile MC, Agostini MA, Van Ness PC.","Arch Neurol. 2003 Jun;60(6):818-22. doi: 10.1001/archneur.60.6.818.","Diaz-Arrastia R","Arch Neurol","2003","2003/06/18","","","10.1001/archneur.60.6.818"
"25972490","Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial","van den Elsen GA, Ahmed AI, Verkes RJ, Kramers C, Feuth T, Rosenberg PB, van der Marck MA, Olde Rikkert MG.","Neurology. 2015 Jun 9;84(23):2338-46. doi: 10.1212/WNL.0000000000001675. Epub 2015 May 13.","van den Elsen GA","Neurology","2015","2015/05/15","PMC4464746","","10.1212/WNL.0000000000001675"
"27000036","Cognitive rehabilitation for Parkinson’s disease dementia: a study protocol for a pilot randomised controlled trial","Hindle JV, Watermeyer TJ, Roberts J, Martyr A, Lloyd-Williams H, Brand A, Gutting P, Hoare Z, Edwards RT, Clare L.","Trials. 2016 Mar 22;17:152. doi: 10.1186/s13063-016-1253-0.","Hindle JV","Trials","2016","2016/03/23","PMC4802850","","10.1186/s13063-016-1253-0"
"36395695","Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy","Kling JM, Dowling NM, Bimonte-Nelson H, Gleason CE, Kantarci K, Stonnington CM, Harman SM, Naftolin F, Pal L, Cedars M, Manson JE, James TT, Brinton EA, Miller VM.","Maturitas. 2023 Jan;167:113-122. doi: 10.1016/j.maturitas.2022.10.002. Epub 2022 Oct 27.","Kling JM","Maturitas","2023","2022/11/17","PMC10077876","NIHMS1883649","10.1016/j.maturitas.2022.10.002"
"31663769","Impact of menopausal hormone formulations on pituitary-ovarian regulatory feedback","Kling JM, Dowling NM, Bimonte-Nelson HA, Gleason CE, Kantarci K, Manson JE, Taylor HS, Brinton EA, Lobo RA, Cedars MI, Pal L, Neal-Perry G, Naftolin F, Harman SM, Miller VM.","Am J Physiol Regul Integr Comp Physiol. 2019 Dec 1;317(6):R912-R920. doi: 10.1152/ajpregu.00234.2019. Epub 2019 Oct 30.","Kling JM","Am J Physiol Regul Integr Comp Physiol","2019","2019/10/31","PMC6957372","","10.1152/ajpregu.00234.2019"
"24434526","Long-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized study","Emre M, Poewe W, De Deyn PP, Barone P, Kulisevsky J, Pourcher E, van Laar T, Storch A, Micheli F, Burn D, Durif F, Pahwa R, Callegari F, Tenenbaum N, Strohmaier C.","Clin Neuropharmacol. 2014 Jan-Feb;37(1):9-16. doi: 10.1097/WNF.0000000000000010.","Emre M","Clin Neuropharmacol","2014","2014/01/18","","","10.1097/WNF.0000000000000010"
"34207701","Multi-Component Intervention Program on Habitual Physical Activity Parameters and Cognitive Function in Patients with Mild Cognitive Impairment: A Randomized Controlled Trial","Jeong MK, Park KW, Ryu JK, Kim GM, Jung HH, Park H.","Int J Environ Res Public Health. 2021 Jun 9;18(12):6240. doi: 10.3390/ijerph18126240.","Jeong MK","Int J Environ Res Public Health","2021","2021/07/02","PMC8296099","","10.3390/ijerph18126240"
"16492072","A substudy protocol of the hypertension in the Very Elderly Trial assessing cognitive decline and dementia incidence (HYVET-COG) : An ongoing randomised, double-blind, placebo-controlled trial","Peters R, Beckett N, Nunes M, Fletcher A, Forette F, Bulpitt C.","Drugs Aging. 2006;23(1):83-92. doi: 10.2165/00002512-200623010-00008.","Peters R","Drugs Aging","2006","2006/02/24","","","10.2165/00002512-200623010-00008"
"20542923","A randomized double-blind study comparing 25 and 50 mg TC-1734 (AZD3480) with placebo, in older subjects with age-associated memory impairment","Dunbar GC, Kuchibhatla RV, Lee G; TC-1734 (AZD3480) AAMI Clinical Study Group (USA).","J Psychopharmacol. 2011 Aug;25(8):1020-9. doi: 10.1177/0269881110367727. Epub 2010 Jun 11.","Dunbar GC","J Psychopharmacol","2011","2010/06/15","","","10.1177/0269881110367727"
"28954877","Disparate effects of training on brain activation in Parkinson disease","Maidan I, Rosenberg-Katz K, Jacob Y, Giladi N, Hausdorff JM, Mirelman A.","Neurology. 2017 Oct 24;89(17):1804-1810. doi: 10.1212/WNL.0000000000004576. Epub 2017 Sep 27.","Maidan I","Neurology","2017","2017/09/29","","","10.1212/WNL.0000000000004576"
"19906345","Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine","de Lucena D, Fernandes BS, Berk M, Dodd S, Medeiros DW, Pedrini M, Kunz M, Gomes FA, Giglio LF, Lobato MI, Belmonte-de-Abreu PS, Gama CS.","J Clin Psychiatry. 2009 Oct;70(10):1416-23. doi: 10.4088/JCP.08m04935gry.","de Lucena D","J Clin Psychiatry","2009","2009/11/13","","","10.4088/JCP.08m04935gry"
"1538042","Pentoxifylline in cerebrovascular dementia","Black RS, Barclay LL, Nolan KA, Thaler HT, Hardiman ST, Blass JP.","J Am Geriatr Soc. 1992 Mar;40(3):237-44. doi: 10.1111/j.1532-5415.1992.tb02075.x.","Black RS","J Am Geriatr Soc","1992","1992/03/01","","","10.1111/j.1532-5415.1992.tb02075.x"
"34491646","[Effect of early acupuncture on cognitive function in patients with vascular dementia after cerebral infarction]","Han H, Li X, Jiang HN, Xu K, Wang Y.","Zhongguo Zhen Jiu. 2021 Sep 12;41(9):979-83. doi: 10.13703/j.0255-2930.20210117-k0008.","Han H","Zhongguo Zhen Jiu","2021","2021/09/07","","","10.13703/j.0255-2930.20210117-k0008"
"31907026","Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial","Pitchford LM, Driver PM, Fuller JC Jr, Akers WS, Abumrad NN, Amarnath V, Milne GL, Chen SC, Ye F, Roberts LJ 2nd, Shoemaker MB, Oates JA, Rathmacher JA, Boutaud O.","BMC Pharmacol Toxicol. 2020 Jan 6;21(1):3. doi: 10.1186/s40360-020-0382-y.","Pitchford LM","BMC Pharmacol Toxicol","2020","2020/01/08","PMC6945443","","10.1186/s40360-020-0382-y"
"31319809","A multicenter cohort study to investigate the factors associated with functional autonomy change in patients with cognitive complaint or neurocognitive disorders: the MEMORA study protocol","Dauphinot V, Moutet C, Rouch I, Verdurand M, Mouchoux C, Delphin-Combe F, Gaujard S, Krolak-Salmon P; MEMORA group.","BMC Geriatr. 2019 Jul 18;19(1):191. doi: 10.1186/s12877-019-1204-1.","Dauphinot V","BMC Geriatr","2019","2019/07/20","PMC6637582","","10.1186/s12877-019-1204-1"
"29846283","Menopausal hormone therapy and mild cognitive impairment: a randomized, placebo-controlled trial","Yoon BK, Chin J, Kim JW, Shin MH, Ahn S, Lee DY, Seo SW, Na DL.","Menopause. 2018 Aug;25(8):870-876. doi: 10.1097/GME.0000000000001140.","Yoon BK","Menopause","2018","2018/05/31","","","10.1097/GME.0000000000001140"
"29501470","Changes in cognitive function after a 12-week exercise intervention in adults with Down syndrome","Ptomey LT, Szabo AN, Willis EA, Gorczyca AM, Greene JL, Danon JC, Donnelly JE.","Disabil Health J. 2018 Jul;11(3):486-490. doi: 10.1016/j.dhjo.2018.02.003. Epub 2018 Feb 26.","Ptomey LT","Disabil Health J","2018","2018/03/05","PMC6005720","NIHMS946237","10.1016/j.dhjo.2018.02.003"
"28898959","Cognitive Training Using a Novel Memory Game on an iPad in Patients with Amnestic Mild Cognitive Impairment (aMCI)","Savulich G, Piercy T, Fox C, Suckling J, Rowe JB, O'Brien JT, Sahakian BJ.","Int J Neuropsychopharmacol. 2017 Aug 1;20(8):624-633. doi: 10.1093/ijnp/pyx040.","Savulich G","Int J Neuropsychopharmacol","2017","2017/09/14","PMC5569993","","10.1093/ijnp/pyx040"
"28012176","Selection and early clinical evaluation of the brain-penetrant 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor UE2343 (Xanamem™)","Webster SP, McBride A, Binnie M, Sooy K, Seckl JR, Andrew R, Pallin TD, Hunt HJ, Perrior TR, Ruffles VS, Ketelbey JW, Boyd A, Walker BR.","Br J Pharmacol. 2017 Mar;174(5):396-408. doi: 10.1111/bph.13699. Epub 2017 Jan 25.","Webster SP","Br J Pharmacol","2017","2016/12/25","PMC5301048","","10.1111/bph.13699"
"23217188","Are the effects of a non-drug multimodal activation therapy of dementia sustainable? Follow-up study 10 months after completion of a randomised controlled trial","Luttenberger K, Hofner B, Graessel E.","BMC Neurol. 2012 Dec 5;12:151. doi: 10.1186/1471-2377-12-151.","Luttenberger K","BMC Neurol","2012","2012/12/11","PMC3527171","","10.1186/1471-2377-12-151"
"36986229","Supplementation with Flaxseed Oil Rich in Alpha-Linolenic Acid Improves Verbal Fluency in Healthy Older Adults","Ogawa T, Sawane K, Ookoshi K, Kawashima R.","Nutrients. 2023 Mar 21;15(6):1499. doi: 10.3390/nu15061499.","Ogawa T","Nutrients","2023","2023/03/29","PMC10056498","","10.3390/nu15061499"
"35696054","Bioavailability Study of a Transdermal Patch Formulation of Rivastigmine Compared with Exelon in Healthy Subjects","Morte A, Vaqué A, Iniesta M, Schug B, Koch C, De la Torre R, Schurad B.","Eur J Drug Metab Pharmacokinet. 2022 Jul;47(4):567-578. doi: 10.1007/s13318-022-00778-5. Epub 2022 Jun 13.","Morte A","Eur J Drug Metab Pharmacokinet","2022","2022/06/13","","","10.1007/s13318-022-00778-5"
"34174392","White matter plasticity in healthy older adults: The effects of aerobic exercise","Mendez Colmenares A, Voss MW, Fanning J, Salerno EA, Gothe NP, Thomas ML, McAuley E, Kramer AF, Burzynska AZ.","Neuroimage. 2021 Oct 1;239:118305. doi: 10.1016/j.neuroimage.2021.118305. Epub 2021 Jun 24.","Mendez Colmenares A","Neuroimage","2021","2021/06/26","","","10.1016/j.neuroimage.2021.118305"
"32713772","Effects of a Humanoid Companion Robot on Dementia Symptoms and Caregiver Distress for Residents in Long-Term Care","Chen K, Lou VW, Tan KC, Wai MY, Chan LL.","J Am Med Dir Assoc. 2020 Nov;21(11):1724-1728.e3. doi: 10.1016/j.jamda.2020.05.036. Epub 2020 Jul 23.","Chen K","J Am Med Dir Assoc","2020","2020/07/28","","","10.1016/j.jamda.2020.05.036"
"27230861","Group- and Home-Based Cognitive Intervention for Patients with Mild Cognitive Impairment: A Randomized Controlled Trial","Jeong JH, Na HR, Choi SH, Kim J, Na DL, Seo SW, Chin J, Park SA, Kim EJ, Han HJ, Han SH, Yoon SJ, Lee JH, Park KW, Moon SY, Park MH, Choi MS, Han IW, Lee JH, Lee JS, Shim YS, Kim JY.","Psychother Psychosom. 2016;85(4):198-207. doi: 10.1159/000442261. Epub 2016 May 27.","Jeong JH","Psychother Psychosom","2016","2016/05/28","","","10.1159/000442261"
"26158265","Dose-Response of Aerobic Exercise on Cognition: A Community-Based, Pilot Randomized Controlled Trial","Vidoni ED, Johnson DK, Morris JK, Van Sciver A, Greer CS, Billinger SA, Donnelly JE, Burns JM.","PLoS One. 2015 Jul 9;10(7):e0131647. doi: 10.1371/journal.pone.0131647. eCollection 2015.","Vidoni ED","PLoS One","2015","2015/07/10","PMC4497726","","10.1371/journal.pone.0131647"
"25056981","RAndomised controlled trial to imProve depressIon and the quality of life of people with Dementia using cognitive bias modification: RAPID study protocol","Almeida OP, MacLeod C, Flicker L, Ford A, Grafton B, Etherton-Beer C.","BMJ Open. 2014 Jul 23;4(7):e005623. doi: 10.1136/bmjopen-2014-005623.","Almeida OP","BMJ Open","2014","2014/07/25","PMC4120303","","10.1136/bmjopen-2014-005623"
"23018285","Effects of single doses of avagacestat (BMS-708163) on cerebrospinal fluid Aβ levels in healthy young men","Tong G, Castaneda L, Wang JS, Sverdlov O, Huang SP, Slemmon R, Gu H, Wong O, Li H, Berman RM, Smith C, Albright C, Dockens RC.","Clin Drug Investig. 2012 Nov;32(11):761-9. doi: 10.1007/s40261-012-0006-4.","Tong G","Clin Drug Investig","2012","2012/09/29","","","10.1007/s40261-012-0006-4"
"22540849","Parallel but not equivalent: challenges and solutions for repeated assessment of cognition over time","Gross AL, Inouye SK, Rebok GW, Brandt J, Crane PK, Parisi JM, Tommet D, Bandeen-Roche K, Carlson MC, Jones RN.","J Clin Exp Neuropsychol. 2012;34(7):758-72. doi: 10.1080/13803395.2012.681628. Epub 2012 Apr 30.","Gross AL","J Clin Exp Neuropsychol","2012","2012/05/01","PMC3574868","NIHMS438890","10.1080/13803395.2012.681628"
"22176583","Mobility of Vulnerable Elders (MOVE): study protocol to evaluate the implementation and outcomes of a mobility intervention in long-term care facilities","Slaughter SE, Estabrooks CA, Jones CA, Wagg AS.","BMC Geriatr. 2011 Dec 16;11:84. doi: 10.1186/1471-2318-11-84.","Slaughter SE","BMC Geriatr","2011","2011/12/20","PMC3264506","","10.1186/1471-2318-11-84"
"15641877","Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine","Mulsant BH, Gharabawi GM, Bossie CA, Mao L, Martinez RA, Tune LE, Greenspan AJ, Bastean JN, Pollock BG.","J Clin Psychiatry. 2004 Dec;65(12):1708-14. doi: 10.4088/jcp.v65n1217.","Mulsant BH","J Clin Psychiatry","2004","2005/01/12","","","10.4088/jcp.v65n1217"
"29936419","Effects of golf training on cognition in older adults: a randomised controlled trial","Shimada H, Lee S, Akishita M, Kozaki K, Iijima K, Nagai K, Ishii S, Tanaka M, Koshiba H, Tanaka T, Toba K.","J Epidemiol Community Health. 2018 Oct;72(10):944-950. doi: 10.1136/jech-2017-210052. Epub 2018 Jun 23.","Shimada H","J Epidemiol Community Health","2018","2018/06/25","","","10.1136/jech-2017-210052"
"28630492","Towards affordable biomarkers of frontotemporal dementia: A classification study via network's information sharing","Dottori M, Sedeño L, Martorell Caro M, Alifano F, Hesse E, Mikulan E, García AM, Ruiz-Tagle A, Lillo P, Slachevsky A, Serrano C, Fraiman D, Ibanez A.","Sci Rep. 2017 Jun 19;7(1):3822. doi: 10.1038/s41598-017-04204-8.","Dottori M","Sci Rep","2017","2017/06/21","PMC5476568","","10.1038/s41598-017-04204-8"
"26396135","Pharmacokinetic comparisons of two acetyl-L-carnitine formulations in healthy Korean volunteers","Baek SM, Zheng R, Seo EJ, Hwang DY, Kim BH.","Int J Clin Pharmacol Ther. 2015 Nov;53(11):980-6. doi: 10.5414/CP202381.","Baek SM","Int J Clin Pharmacol Ther","2015","2015/09/24","","","10.5414/CP202381"
"25363835","AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation","Feuerbach D, Pezous N, Weiss M, Shakeri-Nejad K, Lingenhoehl K, Hoyer D, Hurth K, Bilbe G, Pryce CR, McAllister K, Chaperon F, Kucher K, Johns D, Blaettler T, Lopez Lopez C.","Br J Pharmacol. 2015 Mar;172(5):1292-304. doi: 10.1111/bph.13001. Epub 2015 Jan 12.","Feuerbach D","Br J Pharmacol","2015","2014/11/04","PMC4337702","","10.1111/bph.13001"
"23656173","Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study","Chen CC, Wei ST, Tsaia SC, Chen XX, Cho DY.","Br J Neurosurg. 2013 Dec;27(6):803-7. doi: 10.3109/02688697.2013.793287. Epub 2013 May 8.","Chen CC","Br J Neurosurg","2013","2013/05/10","","","10.3109/02688697.2013.793287"
"20178604","Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light--a randomized clinical trial","Most EI, Scheltens P, Van Someren EJ.","Trials. 2010 Feb 23;11:19. doi: 10.1186/1745-6215-11-19.","Most EI","Trials","2010","2010/02/25","PMC2841161","","10.1186/1745-6215-11-19"
"35445687","BAILA: A Randomized Controlled Trial of Latin Dancing to Increase Physical Activity in Spanish-Speaking Older Latinos","Marquez DX, Wilbur J, Hughes S, Wilson R, Buchner DM, Berbaum ML, McAuley E, Aguiñaga S, Balbim GM, Vásquez PM, Marques IG, Wang T, Kaushal N.","Ann Behav Med. 2022 Nov 18;56(12):1231-1243. doi: 10.1093/abm/kaac009.","Marquez DX","Ann Behav Med","2022","2022/04/21","PMC9672351","","10.1093/abm/kaac009"
"34627672","Effects of 12-Week Supervised Early Resistance Training (SEcReT) Versus Aerobic-Based Rehabilitation on Cognitive Recovery Following Cardiac Surgery via Median Sternotomy: A Pilot Randomised Controlled Trial","Pengelly J, Royse C, Williams G, Bryant A, Clarke-Errey S, Royse A, El-Ansary D.","Heart Lung Circ. 2022 Mar;31(3):395-406. doi: 10.1016/j.hlc.2021.08.023. Epub 2021 Oct 7.","Pengelly J","Heart Lung Circ","2022","2021/10/10","","","10.1016/j.hlc.2021.08.023"
"33491811","Feasibility and preliminary effectiveness of an online training and support program for caregivers of people with dementia in India: a randomized controlled trial","Baruah U, Varghese M, Loganathan S, Mehta KM, Gallagher-Thompson D, Zandi D, Dua T, Pot AM.","Int J Geriatr Psychiatry. 2021 Apr;36(4):606-617. doi: 10.1002/gps.5502. Epub 2021 Feb 8.","Baruah U","Int J Geriatr Psychiatry","2021","2021/01/25","","","10.1002/gps.5502"
"22210566","Circulating brain-derived neurotrophic factor concentration is downregulated by intralipid/heparin infusion or high-fat meal in young healthy male subjects","Karczewska-Kupczewska M, Kowalska I, Nikołajuk A, Adamska A, Zielińska M, Kamińska N, Otziomek E, Górska M, Strączkowski M.","Diabetes Care. 2012 Feb;35(2):358-62. doi: 10.2337/dc11-1295. Epub 2011 Dec 30.","Karczewska-Kupczewska M","Diabetes Care","2012","2012/01/03","PMC3263867","","10.2337/dc11-1295"
"22173933","Memantine for late-life depression and apathy after a disabling medical event: a 12-week, double-blind placebo-controlled pilot study","Lenze EJ, Skidmore ER, Begley AE, Newcomer JW, Butters MA, Whyte EM.","Int J Geriatr Psychiatry. 2012 Sep;27(9):974-80. doi: 10.1002/gps.2813. Epub 2011 Dec 16.","Lenze EJ","Int J Geriatr Psychiatry","2012","2011/12/17","PMC3601891","NIHMS372168","10.1002/gps.2813"
"16413248","Pharmacokinetic study of memantine in healthy and renally impaired subjects","Periclou A, Ventura D, Rao N, Abramowitz W.","Clin Pharmacol Ther. 2006 Jan;79(1):134-43. doi: 10.1016/j.clpt.2005.10.005.","Periclou A","Clin Pharmacol Ther","2006","2006/01/18","","","10.1016/j.clpt.2005.10.005"
"27510902","Insights into neuroepigenetics through human histone deacetylase PET imaging","Wey HY, Gilbert TM, Zürcher NR, She A, Bhanot A, Taillon BD, Schroeder FA, Wang C, Haggarty SJ, Hooker JM.","Sci Transl Med. 2016 Aug 10;8(351):351ra106. doi: 10.1126/scitranslmed.aaf7551.","Wey HY","Sci Transl Med","2016","2016/08/12","PMC5784409","NIHMS931986","10.1126/scitranslmed.aaf7551"
"17452062","Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI","Jack CR Jr, Petersen RC, Grundman M, Jin S, Gamst A, Ward CP, Sencakova D, Doody RS, Thal LJ; Members of the Alzheimer's Disease Cooperative Study (ADCS).","Neurobiol Aging. 2008 Sep;29(9):1285-95. doi: 10.1016/j.neurobiolaging.2007.03.004. Epub 2007 Apr 23.","Jack CR Jr","Neurobiol Aging","2008","2007/04/25","PMC2768818","NIHMS136214","10.1016/j.neurobiolaging.2007.03.004"
"18296124","Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL","Dichgans M, Markus HS, Salloway S, Verkkoniemi A, Moline M, Wang Q, Posner H, Chabriat HS.","Lancet Neurol. 2008 Apr;7(4):310-8. doi: 10.1016/S1474-4422(08)70046-2. Epub 2008 Feb 28.","Dichgans M","Lancet Neurol","2008","2008/02/26","","","10.1016/S1474-4422(08)70046-2"
"26374482","Multidomain Lifestyle Interventions for the Prevention of Cognitive Decline After Ischemic Stroke: Randomized Trial","Matz K, Teuschl Y, Firlinger B, Dachenhausen A, Keindl M, Seyfang L, Tuomilehto J, Brainin M; ASPIS Study Group.","Stroke. 2015 Oct;46(10):2874-80. doi: 10.1161/STROKEAHA.115.009992. Epub 2015 Sep 15.","Matz K","Stroke","2015","2015/09/17","","","10.1161/STROKEAHA.115.009992"
"31915189","Effects of acute sleep loss on diurnal plasma dynamics of CNS health biomarkers in young men","Benedict C, Blennow K, Zetterberg H, Cedernaes J.","Neurology. 2020 Mar 17;94(11):e1181-e1189. doi: 10.1212/WNL.0000000000008866. Epub 2020 Jan 8.","Benedict C","Neurology","2020","2020/01/10","PMC7220231","","10.1212/WNL.0000000000008866"
"33742194","Exercise, diet, and cognition in a 4-year randomized controlled trial: Dose-Responses to Exercise Training (DR's EXTRA)","Komulainen P, Tuomilehto J, Savonen K, Männikkö R, Hassinen M, Lakka TA, Hänninen T, Kiviniemi V, Jacobs DR, Kivipelto M, Rauramaa R.","Am J Clin Nutr. 2021 Jun 1;113(6):1428-1439. doi: 10.1093/ajcn/nqab018.","Komulainen P","Am J Clin Nutr","2021","2021/03/20","PMC8244125","","10.1093/ajcn/nqab018"
"9892049","Normative data for equivalent, parallel forms of the Judgment of Line Orientation Test","Woodard JL, Benedict RH, Salthouse TA, Toth JP, Zgaljardic DJ, Hancock HE.","J Clin Exp Neuropsychol. 1998 Aug;20(4):457-62. doi: 10.1076/jcen.20.4.457.1473.","Woodard JL","J Clin Exp Neuropsychol","1998","1999/01/19","","","10.1076/jcen.20.4.457.1473"
"34664858","Investigation of combined treatment of acupuncture and neurofeedback for improving cognitive function in mild neurocognitive disorder: A randomized, assessor-blind, pilot study","Jeong JH, Jung C, Kim J, Kim JY, Kim HS, Park YC, Lee JH, Jung IC.","Medicine (Baltimore). 2021 Sep 17;100(37):e27218. doi: 10.1097/MD.0000000000027218.","Jeong JH","Medicine (Baltimore)","2021","2021/10/19","PMC8448021","","10.1097/MD.0000000000027218"
"18090456","Safety, tolerability, and effects on plasma and cerebrospinal fluid amyloid-beta after inhibition of gamma-secretase","Siemers ER, Dean RA, Friedrich S, Ferguson-Sells L, Gonzales C, Farlow MR, May PC.","Clin Neuropharmacol. 2007 Nov-Dec;30(6):317-25. doi: 10.1097/WNF.0b013e31805b7660.","Siemers ER","Clin Neuropharmacol","2007","2007/12/20","","","10.1097/WNF.0b013e31805b7660"
"34542418","The Effect of Reminiscence Therapy Using Virtual Reality on Apathy in Residential Aged Care: Multisite Nonrandomized Controlled Trial","Saredakis D, Keage HA, Corlis M, Ghezzi ES, Loffler H, Loetscher T.","J Med Internet Res. 2021 Sep 20;23(9):e29210. doi: 10.2196/29210.","Saredakis D","J Med Internet Res","2021","2021/09/20","PMC8491119","","10.2196/29210"
"28359749","Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial","Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S, Bories L, Cufi MN, Dantoine T, Dartigues JF, Desclaux F, Gabelle A, Gasnier Y, Pesce A, Sudres K, Touchon J, Robert P, Rouaud O, Legrand P, Payoux P, Caubere JP, Weiner M, Carrié I, Ousset PJ, Vellas B; MAPT Study Group.","Lancet Neurol. 2017 May;16(5):377-389. doi: 10.1016/S1474-4422(17)30040-6. Epub 2017 Mar 27.","Andrieu S","Lancet Neurol","2017","2017/04/01","","","10.1016/S1474-4422(17)30040-6"
"26239690","Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis","Ballard C, Isaacson S, Mills R, Williams H, Corbett A, Coate B, Pahwa R, Rascol O, Burn DJ.","J Am Med Dir Assoc. 2015 Oct 1;16(10):898.e1-7. doi: 10.1016/j.jamda.2015.06.021. Epub 2015 Aug 1.","Ballard C","J Am Med Dir Assoc","2015","2015/08/05","","","10.1016/j.jamda.2015.06.021"
"25483019","Low-intensity daily walking activity is associated with hippocampal volume in older adults","Varma VR, Chuang YF, Harris GC, Tan EJ, Carlson MC.","Hippocampus. 2015 May;25(5):605-15. doi: 10.1002/hipo.22397. Epub 2014 Dec 26.","Varma VR","Hippocampus","2015","2014/12/09","PMC4425252","NIHMS647844","10.1002/hipo.22397"
"28869176","(11)C-PIB retention patterns in white and grey cerebral matter in idiopathic normal pressure hydrocephalus patients. A visual analysis","Jiménez-Bonilla JF, Quirce R, de Arcocha-Torres M, Martínez-Rodríguez I, Martínez-Amador N, Sánchez-Juan P, Pozueta A, Martín-Láez R, Banzo I, Rodríguez-Rodríguez E.","Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018 Mar-Apr;37(2):87-93. doi: 10.1016/j.remn.2017.07.006. Epub 2017 Aug 30.","Jiménez-Bonilla JF","Rev Esp Med Nucl Imagen Mol (Engl Ed)","2018","2017/09/05","","","10.1016/j.remn.2017.07.006"
"19922631","The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: role of the renin angiotensin system inhibition","Hajjar I, Hart M, Milberg W, Novak V, Lipsitz L.","BMC Geriatr. 2009 Nov 18;9:48. doi: 10.1186/1471-2318-9-48.","Hajjar I","BMC Geriatr","2009","2009/11/20","PMC2784465","","10.1186/1471-2318-9-48"
"3898228","A clinical trial with desglycinamide arginine vasopressin for the treatment of memory disorders in man","Jennekens-Schinkel A, Wintzen AR, Lanser JB.","Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(3):273-84. doi: 10.1016/0278-5846(85)90091-0.","Jennekens-Schinkel A","Prog Neuropsychopharmacol Biol Psychiatry","1985","1985/01/01","","","10.1016/0278-5846(85)90091-0"
"19812461","An open-label study of memantine treatment in 3 subtypes of frontotemporal lobar degeneration","Boxer AL, Lipton AM, Womack K, Merrilees J, Neuhaus J, Pavlic D, Gandhi A, Red D, Martin-Cook K, Svetlik D, Miller BL.","Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):211-7. doi: 10.1097/WAD.0b013e318197852f.","Boxer AL","Alzheimer Dis Assoc Disord","2009","2009/10/09","PMC2760056","NIHMS117953","10.1097/WAD.0b013e318197852f"
"29433682","A randomised double-blind placebo-controlled pilot trial of a combined extract of sage, rosemary and melissa, traditional herbal medicines, on the enhancement of memory in normal healthy subjects, including influence of age","Perry NSL, Menzies R, Hodgson F, Wedgewood P, Howes MR, Brooker HJ, Wesnes KA, Perry EK.","Phytomedicine. 2018 Jan 15;39:42-48. doi: 10.1016/j.phymed.2017.08.015. Epub 2017 Aug 18.","Perry NSL","Phytomedicine","2018","2018/02/14","","","10.1016/j.phymed.2017.08.015"
"22791904","Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humans","Maccecchini ML, Chang MY, Pan C, John V, Zetterberg H, Greig NH.","J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):894-902. doi: 10.1136/jnnp-2012-302589. Epub 2012 Jul 11.","Maccecchini ML","J Neurol Neurosurg Psychiatry","2012","2012/07/14","PMC3415310","","10.1136/jnnp-2012-302589"
"21780182","Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial","de Jager CA, Oulhaj A, Jacoby R, Refsum H, Smith AD.","Int J Geriatr Psychiatry. 2012 Jun;27(6):592-600. doi: 10.1002/gps.2758. Epub 2011 Jul 21.","de Jager CA","Int J Geriatr Psychiatry","2012","2011/07/23","","","10.1002/gps.2758"
"20861451","Vitamins B(12), B(6), and folic acid for cognition in older men","Ford AH, Flicker L, Alfonso H, Thomas J, Clarnette R, Martins R, Almeida OP.","Neurology. 2010 Oct 26;75(17):1540-7. doi: 10.1212/WNL.0b013e3181f962c4. Epub 2010 Sep 22.","Ford AH","Neurology","2010","2010/09/24","","","10.1212/WNL.0b013e3181f962c4"
"12888775","Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties","Kennedy DO, Wake G, Savelev S, Tildesley NT, Perry EK, Wesnes KA, Scholey AB.","Neuropsychopharmacology. 2003 Oct;28(10):1871-81. doi: 10.1038/sj.npp.1300230.","Kennedy DO","Neuropsychopharmacology","2003","2003/07/31","","","10.1038/sj.npp.1300230"
"34995992","Serum amyloid P component level is associated with clinical response to escitalopram treatment in patients with major depressive disorder","Yang J, Zhou J, Zhou J, Wang H, Sun Z, Zhu X, He Y, Wong AHC, Liu F, Wang G.","J Psychiatr Res. 2022 Feb;146:172-178. doi: 10.1016/j.jpsychires.2021.12.051. Epub 2021 Dec 30.","Yang J","J Psychiatr Res","2022","2022/01/07","","","10.1016/j.jpsychires.2021.12.051"
"26006738","Evaluation of a hospital-based day-structuring exercise programme on exacerbated behavioural and psychological symptoms in dementia--the exercise carrousel: study protocol for a randomised controlled trial","Fleiner T, Zijlstra W, Dauth H, Haussermann P.","Trials. 2015 May 26;16:228. doi: 10.1186/s13063-015-0758-2.","Fleiner T","Trials","2015","2015/05/27","PMC4465726","","10.1186/s13063-015-0758-2"
"22959954","Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans","Ramsden CE, Ringel A, Feldstein AE, Taha AY, MacIntosh BA, Hibbeln JR, Majchrzak-Hong SF, Faurot KR, Rapoport SI, Cheon Y, Chung YM, Berk M, Mann JD.","Prostaglandins Leukot Essent Fatty Acids. 2012 Oct-Nov;87(4-5):135-41. doi: 10.1016/j.plefa.2012.08.004. Epub 2012 Sep 5.","Ramsden CE","Prostaglandins Leukot Essent Fatty Acids","2012","2012/09/11","PMC3467319","NIHMS404053","10.1016/j.plefa.2012.08.004"
"18668226","The apolipoprotein E epsilon4 allele and memory performance in HIV-1 seropositive subjects: differences at baseline but not after acute oral lorazepam challenge","Pomara N, Belzer KD, Silva R, Cooper TB, Sidtis JJ.","Psychopharmacology (Berl). 2008 Nov;201(1):125-35. doi: 10.1007/s00213-008-1253-1. Epub 2008 Jul 31.","Pomara N","Psychopharmacology (Berl)","2008","2008/08/01","","","10.1007/s00213-008-1253-1"
"36445170","Effects of telehealth on functional capacity, mental health and quality of life among older people with dementia: LAPESI telehealth protocol for a randomized controlled trial","Tsen C, Andreatto CAA, Aily JB, Pelicioni PHS, Neto DB, Mattiello SM, Gomes GAO, de Andrade LP.","Physiother Res Int. 2023 Apr;28(2):e1981. doi: 10.1002/pri.1981. Epub 2022 Nov 29.","Tsen C","Physiother Res Int","2023","2022/11/29","","","10.1002/pri.1981"
"34762845","Multicomponent Staff Training Intervention to Improve Residential Dementia Care (PROCUIDA-Demencia): A Mixed-Methods 2-Arm Cluster Randomized Controlled Pilot and Clinical Outcomes Study","Torres-Castro S, Rabaneda-Bueno R, López-Ortega M, Gutiérrez-Robledo LM, Guzmán A.","J Am Med Dir Assoc. 2022 Mar;23(3):350-358.e5. doi: 10.1016/j.jamda.2021.09.035. Epub 2021 Nov 8.","Torres-Castro S","J Am Med Dir Assoc","2022","2021/11/11","","","10.1016/j.jamda.2021.09.035"
"34183087","A tablet-based intervention for activating nursing home residents with dementia: results from a cluster-randomized controlled trial","O'Sullivan JL, Lech S, Gellert P, Grittner U, Voigt-Antons JN, Möller S, Kuhlmey A, Nordheim J.","Int Psychogeriatr. 2022 Feb;34(2):129-141. doi: 10.1017/S1041610221000818. Epub 2021 Jun 29.","O'Sullivan JL","Int Psychogeriatr","2022","2021/06/29","","","10.1017/S1041610221000818"
"30007160","Guanfacine treatment for prefrontal cognitive dysfunction in older participants: a randomized clinical trial","Barcelos NM, Van Ness PH, Wagner AF, MacAvoy MG, Mecca AP, Anderson GM, Trentalange M, Hawkins KA, Sano M, Arnsten AFT, van Dyck CH.","Neurobiol Aging. 2018 Oct;70:117-124. doi: 10.1016/j.neurobiolaging.2018.05.033. Epub 2018 May 31.","Barcelos NM","Neurobiol Aging","2018","2018/07/15","PMC6503670","NIHMS1025793","10.1016/j.neurobiolaging.2018.05.033"
"29370756","Centre- versus home-based exercise among people with mci and mild dementia: study protocol for a randomized parallel-group trial","Middleton LE, Black SE, Herrmann N, Oh PI, Regan K, Lanctot KL.","BMC Geriatr. 2018 Jan 25;18(1):27. doi: 10.1186/s12877-017-0684-0.","Middleton LE","BMC Geriatr","2018","2018/01/27","PMC5785893","","10.1186/s12877-017-0684-0"
"27272332","Increased Risk of Dementia in Patients with Tension-Type Headache: A Nationwide Retrospective Population-Based Cohort Study","Yang FC, Lin TY, Chen HJ, Lee JT, Lin CC, Kao CH.","PLoS One. 2016 Jun 7;11(6):e0156097. doi: 10.1371/journal.pone.0156097. eCollection 2016.","Yang FC","PLoS One","2016","2016/06/09","PMC4896423","","10.1371/journal.pone.0156097"
"25826620","Would older adults with mild cognitive impairment adhere to and benefit from a structured lifestyle activity intervention to enhance cognition?: a cluster randomized controlled trial","Lam LC, Chan WC, Leung T, Fung AW, Leung EM.","PLoS One. 2015 Mar 31;10(3):e0118173. doi: 10.1371/journal.pone.0118173. eCollection 2015.","Lam LC","PLoS One","2015","2015/04/01","PMC4380493","","10.1371/journal.pone.0118173"
"24853403","Human whole-body biodistribution and dosimetry of a new PET tracer, [(11)C]ketoprofen methyl ester, for imagings of neuroinflammation","Ohnishi A, Senda M, Yamane T, Sasaki M, Mikami T, Nishio T, Ikari Y, Nishida H, Shukuri M, Takashima T, Mawatari A, Doi H, Watanabe Y, Onoe H.","Nucl Med Biol. 2014 Aug;41(7):594-9. doi: 10.1016/j.nucmedbio.2014.04.008. Epub 2014 Apr 13.","Ohnishi A","Nucl Med Biol","2014","2014/05/24","","","10.1016/j.nucmedbio.2014.04.008"
"24676963","Maintenance cognitive stimulation therapy for dementia: single-blind, multicentre, pragmatic randomised controlled trial","Orrell M, Aguirre E, Spector A, Hoare Z, Woods RT, Streater A, Donovan H, Hoe J, Knapp M, Whitaker C, Russell I.","Br J Psychiatry. 2014 Jun;204(6):454-61. doi: 10.1192/bjp.bp.113.137414. Epub 2014 Mar 27.","Orrell M","Br J Psychiatry","2014","2014/03/29","","","10.1192/bjp.bp.113.137414"
"34013755","One-year aerobic exercise altered cerebral vasomotor reactivity in mild cognitive impairment","Tomoto T, Tarumi T, Chen JN, Hynan LS, Cullum CM, Zhang R.","J Appl Physiol (1985). 2021 Jul 1;131(1):119-130. doi: 10.1152/japplphysiol.00158.2021. Epub 2021 May 20.","Tomoto T","J Appl Physiol (1985)","2021","2021/05/20","PMC8325610","","10.1152/japplphysiol.00158.2021"
"31082417","Feasibility and effects of galantamine on cognition in humans with cannabis use disorder","Sugarman DE, De Aquino JP, Poling J, Sofuoglu M.","Pharmacol Biochem Behav. 2019 Jun;181:86-92. doi: 10.1016/j.pbb.2019.05.004. Epub 2019 May 10.","Sugarman DE","Pharmacol Biochem Behav","2019","2019/05/15","PMC6545124","NIHMS1529397","10.1016/j.pbb.2019.05.004"
"26003546","A randomised controlled trial investigating the effects of Mediterranean diet and aerobic exercise on cognition in cognitively healthy older people living independently within aged care facilities: the Lifestyle Intervention in Independent Living Aged Care (LIILAC) study protocol [ACTRN12614001133628]","Hardman RJ, Kennedy G, Macpherson H, Scholey AB, Pipingas A.","Nutr J. 2015 May 24;14:53. doi: 10.1186/s12937-015-0042-z.","Hardman RJ","Nutr J","2015","2015/05/25","PMC4449609","","10.1186/s12937-015-0042-z"
"22700031","Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood","Attia A, Rapp SR, Case LD, D'Agostino R, Lesser G, Naughton M, McMullen K, Rosdhal R, Shaw EG.","J Neurooncol. 2012 Sep;109(2):357-63. doi: 10.1007/s11060-012-0901-9. Epub 2012 Jun 15.","Attia A","J Neurooncol","2012","2012/06/16","PMC3752650","NIHMS487885","10.1007/s11060-012-0901-9"
"19262961","Cost-effectiveness of post-diagnosis treatment in dementia coordinated by Multidisciplinary Memory Clinics in comparison to treatment coordinated by general practitioners: an example of a pragmatic trial","Meeuwsen EJ, German P, Melis RJ, Adang EM, Golüke-Willemse GA, Krabbe PF, de Leest BJ, van Raak FH, Schölzel-Dorenbos CJ, Visser MC, Wolfs CA, Vliek S, Rikkert MG.","J Nutr Health Aging. 2009 Mar;13(3):242-8. doi: 10.1007/s12603-009-0066-1.","Meeuwsen EJ","J Nutr Health Aging","2009","2009/03/06","","","10.1007/s12603-009-0066-1"
"32080123","Safety and efficacy of Jujadokseo-hwan for memory deficit (amnesia) in mild neurocognitive disorder: A protocol for randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial","Jeong JH, Lee JY, Kim JY, Seo YK, Kang WC, Kang HW, Park SJ, Jang HK, Park YC, Jung IC.","Medicine (Baltimore). 2020 Feb;99(8):e19231. doi: 10.1097/MD.0000000000019231.","Jeong JH","Medicine (Baltimore)","2020","2020/02/22","PMC7034695","","10.1097/MD.0000000000019231"
"30261917","Adaptive crossover designs for assessment of symptomatic treatments targeting behaviour in neurodegenerative disease: a phase 2 clinical trial of intranasal oxytocin for frontotemporal dementia (FOXY)","Finger E, Berry S, Cummings J, Coleman K, Hsiung R, Feldman HH, Boxer A.","Alzheimers Res Ther. 2018 Sep 27;10(1):102. doi: 10.1186/s13195-018-0427-2.","Finger E","Alzheimers Res Ther","2018","2018/09/29","PMC6161323","","10.1186/s13195-018-0427-2"
"31256092","A computer-based cognitive training in Mild Cognitive Impairment in Parkinson's Disease","Bernini S, Alloni A, Panzarasa S, Picascia M, Quaglini S, Tassorelli C, Sinforiani E.","NeuroRehabilitation. 2019;44(4):555-567. doi: 10.3233/NRE-192714.","Bernini S","NeuroRehabilitation","2019","2019/07/01","","","10.3233/NRE-192714"
"32969833","An Internet-Based Intervention Augmented With a Diet and Physical Activity Consultation to Decrease the Risk of Dementia in At-Risk Adults in a Primary Care Setting: Pragmatic Randomized Controlled Trial","Anstey KJ, Cherbuin N, Kim S, McMaster M, D'Este C, Lautenschlager N, Rebok G, McRae I, Torres SJ, Cox KL, Pond CD.","J Med Internet Res. 2020 Sep 24;22(9):e19431. doi: 10.2196/19431.","Anstey KJ","J Med Internet Res","2020","2020/09/24","PMC7545332","","10.2196/19431"
"21106918","Adherence to nutritional recommendations and subsequent cognitive performance: findings from the prospective Supplementation with Antioxidant Vitamins and Minerals 2 (SU.VI.MAX 2) study","Kesse-Guyot E, Amieva H, Castetbon K, Henegar A, Ferry M, Jeandel C, Hercberg S, Galan P; SU.VI.MAX 2 Research Group.","Am J Clin Nutr. 2011 Jan;93(1):200-10. doi: 10.3945/ajcn.2010.29761. Epub 2010 Nov 24.","Kesse-Guyot E","Am J Clin Nutr","2011","2010/11/26","","","10.3945/ajcn.2010.29761"
"31973997","Adjunctive sapropterin dihydrochloride treatment in schizophrenia: A positive proof-of-concept, rater-blind, randomized, multivitamin-controlled study","Clelland CL, Kantrowitz JT, Choo T, Clelland JD, Lieberman JA.","Schizophr Res. 2020 Apr;218:321-323. doi: 10.1016/j.schres.2019.12.039. Epub 2020 Jan 21.","Clelland CL","Schizophr Res","2020","2020/01/25","","","10.1016/j.schres.2019.12.039"
"20110592","Complex antioxidant blend improves memory in community-dwelling seniors","Summers WK, Martin RL, Cunningham M, DeBoynton VL, Marsh GM.","J Alzheimers Dis. 2010;19(2):429-39. doi: 10.3233/JAD-2010-1229.","Summers WK","J Alzheimers Dis","2010","2010/01/30","","","10.3233/JAD-2010-1229"
"30862889","Cerebrospinal Fluid Spermidine, Glutamine and Putrescine Predict Postoperative Delirium Following Elective Orthopaedic Surgery","Pan X, Cunningham EL, Passmore AP, McGuinness B, McAuley DF, Beverland D, O'Brien S, Mawhinney T, Schott JM, Zetterberg H, Green BD.","Sci Rep. 2019 Mar 12;9(1):4191. doi: 10.1038/s41598-019-40544-3.","Pan X","Sci Rep","2019","2019/03/14","PMC6414730","","10.1038/s41598-019-40544-3"
"11048905","Long-Term use of quetiapine in elderly patients with psychotic disorders","Tariot PN, Salzman C, Yeung PP, Pultz J, Rak IW.","Clin Ther. 2000 Sep;22(9):1068-84. doi: 10.1016/s0149-2918(00)80085-5.","Tariot PN","Clin Ther","2000","2000/10/26","","","10.1016/s0149-2918(00)80085-5"
"24816641","Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusion","Nudelman KN, Wang Y, McDonald BC, Conroy SK, Smith DJ, West JD, O'Neill DP, Schneider BP, Saykin AJ.","PLoS One. 2014 May 9;9(5):e96713. doi: 10.1371/journal.pone.0096713. eCollection 2014.","Nudelman KN","PLoS One","2014","2014/05/13","PMC4016018","","10.1371/journal.pone.0096713"
"27521509","Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial","Houghton D, Thoma C, Hallsworth K, Cassidy S, Hardy T, Burt AD, Tiniakos D, Hollingsworth KG, Taylor R, Day CP, McPherson S, Anstee QM, Trenell MI.","Clin Gastroenterol Hepatol. 2017 Jan;15(1):96-102.e3. doi: 10.1016/j.cgh.2016.07.031. Epub 2016 Aug 10.","Houghton D","Clin Gastroenterol Hepatol","2017","2016/08/14","PMC5196006","","10.1016/j.cgh.2016.07.031"
"32920022","Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease","Wolfe R, Wetmore JB, Woods RL, McNeil JJ, Gallagher H, Roderick P, Walker R, Nelson MR, Reid CM, Shah RC, Ernst ME, Lockery JE, Tonkin AM, Abhayaratna WP, Gibbs P, Wood EM, Mahady SE, Williamson JD, Donnan GA, Cloud GC, Murray AM, Polkinghorne KR.","Kidney Int. 2021 Feb;99(2):466-474. doi: 10.1016/j.kint.2020.08.011. Epub 2020 Sep 10.","Wolfe R","Kidney Int","2021","2020/09/13","PMC7957958","NIHMS1676962","10.1016/j.kint.2020.08.011"
"27439593","Exercise-induced improvements in liver fat and endothelial function are not sustained 12 months following cessation of exercise supervision in nonalcoholic fatty liver disease","Pugh CJ, Sprung VS, Jones H, Richardson P, Shojaee-Moradie F, Umpleby AM, Green DJ, Cable NT, Trenell MI, Kemp GJ, Cuthbertson DJ.","Int J Obes (Lond). 2016 Dec;40(12):1927-1930. doi: 10.1038/ijo.2016.123. Epub 2016 Jul 21.","Pugh CJ","Int J Obes (Lond)","2016","2016/07/22","","","10.1038/ijo.2016.123"
"31471436","Cognitive training and neuroplasticity in mild cognitive impairment (COG-IT): protocol for a two-site, blinded, randomised, controlled treatment trial","D'Antonio J, Simon-Pearson L, Goldberg T, Sneed JR, Rushia S, Kerner N, Andrews H, Hellegers C, Tolbert S, Perea E, Petrella J, Doraiswamy PM, Devanand D.","BMJ Open. 2019 Aug 30;9(8):e028536. doi: 10.1136/bmjopen-2018-028536.","D'Antonio J","BMJ Open","2019","2019/09/01","PMC6720324","","10.1136/bmjopen-2018-028536"
"15860944","[The effect of lavender aromatherapy on cognitive function, emotion, and aggressive behavior of elderly with dementia]","Lee SY.","Taehan Kanho Hakhoe Chi. 2005 Apr;35(2):303-12. doi: 10.4040/jkan.2005.35.2.303.","Lee SY","Taehan Kanho Hakhoe Chi","2005","2005/04/30","","","10.4040/jkan.2005.35.2.303"
"27511183","Evolution of clinical features in possible DLB depending on FP-CIT SPECT result","Walker Z, Moreno E, Thomas A, Inglis F, Tabet N, Stevens T, Whitfield T, Aarsland D, Rainer M, Padovani A; DaTSCAN DLB Phase 4 Study Group.","Neurology. 2016 Sep 6;87(10):1045-51. doi: 10.1212/WNL.0000000000003076. Epub 2016 Aug 10.","Walker Z","Neurology","2016","2016/08/12","PMC5027811","","10.1212/WNL.0000000000003076"
"9077496","Close relationship between spongiform change and ubiquitin-positive granular structures in diffuse Lewy body disease","Iseki E, Li F, Kosaka K.","J Neurol Sci. 1997 Feb 27;146(1):53-7. doi: 10.1016/s0022-510x(96)00282-1.","Iseki E","J Neurol Sci","1997","1997/02/27","","","10.1016/s0022-510x(96)00282-1"
"1496187","[Use of 99mTc-HMPAO SPECT in the study of AIDS-correlated dementia]","Garavelli PL, Zoccola R, Villa G, Scopinaro G.","Recenti Prog Med. 1992 Jun;83(6):358-60.","Garavelli PL","Recenti Prog Med","1992","1992/06/01","","",""
"35212023","Estradiol treatment in young postmenopausal women with self-reported cognitive complaints: Effects on cholinergic-mediated cognitive performance","Conley AC, Albert KM, McDonald BC, Saykin AJ, Dumas JA, Newhouse PA.","Hum Psychopharmacol. 2022 Sep;37(5):e2838. doi: 10.1002/hup.2838. Epub 2022 Feb 24.","Conley AC","Hum Psychopharmacol","2022","2022/02/25","PMC9399322","NIHMS1807338","10.1002/hup.2838"
"27856335","Examining the impact of grape consumption on brain metabolism and cognitive function in patients with mild decline in cognition: A double-blinded placebo controlled pilot study","Lee J, Torosyan N, Silverman DH.","Exp Gerontol. 2017 Jan;87(Pt A):121-128. doi: 10.1016/j.exger.2016.10.004. Epub 2016 Nov 14.","Lee J","Exp Gerontol","2017","2016/11/19","","","10.1016/j.exger.2016.10.004"
"25438724","Pharmacodynamics, pharmacokinetics, safety, and tolerability of encenicline, a selective α7 nicotinic receptor partial agonist, in single ascending-dose and bioavailability studies","Barbier AJ, Hilhorst M, Van Vliet A, Snyder P, Palfreyman MG, Gawryl M, Dgetluck N, Massaro M, Tiessen R, Timmerman W, Hilt DC.","Clin Ther. 2015 Feb 1;37(2):311-24. doi: 10.1016/j.clinthera.2014.09.013. Epub 2014 Oct 14.","Barbier AJ","Clin Ther","2015","2014/12/03","","","10.1016/j.clinthera.2014.09.013"
"31959733","An Altered Relationship between Soluble TREM2 and Inflammatory Markers in Young Adults with Down Syndrome: A Preliminary Report","Weber GE, Koenig KA, Khrestian M, Shao Y, Tuason ED, Gramm M, Lal D, Leverenz JB, Bekris LM.","J Immunol. 2020 Mar 1;204(5):1111-1118. doi: 10.4049/jimmunol.1901166. Epub 2020 Jan 20.","Weber GE","J Immunol","2020","2020/01/22","PMC7033027","NIHMS1547076","10.4049/jimmunol.1901166"
"24448401","Novel pathophysiological markers are revealed by iTRAQ-based quantitative clinical proteomics approach in vascular dementia","Datta A, Qian J, Chong R, Kalaria RN, Francis P, Lai MK, Chen CP, Sze SK.","J Proteomics. 2014 Mar 17;99(100):54-67. doi: 10.1016/j.jprot.2014.01.011. Epub 2014 Jan 19.","Datta A","J Proteomics","2014","2014/01/23","PMC4024194","","10.1016/j.jprot.2014.01.011"
"30672317","Effectiveness of acupuncture for vascular cognitive impairment no dementia: a randomized controlled trial","Yang JW, Shi GX, Zhang S, Tu JF, Wang LQ, Yan CQ, Lin LL, Liu BZ, Wang J, Sun SF, Yang BF, Wu LY, Tan C, Chen S, Zhang ZJ, Fisher M, Liu CZ.","Clin Rehabil. 2019 Apr;33(4):642-652. doi: 10.1177/0269215518819050. Epub 2019 Jan 23.","Yang JW","Clin Rehabil","2019","2019/01/24","","","10.1177/0269215518819050"
"26089183","Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia","Keefe RS, Meltzer HA, Dgetluck N, Gawryl M, Koenig G, Moebius HJ, Lombardo I, Hilt DC.","Neuropsychopharmacology. 2015 Dec;40(13):3053-60. doi: 10.1038/npp.2015.176. Epub 2015 Jun 19.","Keefe RS","Neuropsychopharmacology","2015","2015/06/20","PMC4864641","","10.1038/npp.2015.176"
"24735588","The effect of a pre- and postoperative orthogeriatric service on cognitive function in patients with hip fracture: randomized controlled trial (Oslo Orthogeriatric Trial)","Watne LO, Torbergsen AC, Conroy S, Engedal K, Frihagen F, Hjorthaug GA, Juliebo V, Raeder J, Saltvedt I, Skovlund E, Wyller TB.","BMC Med. 2014 Apr 15;12:63. doi: 10.1186/1741-7015-12-63.","Watne LO","BMC Med","2014","2014/04/17","PMC4022270","","10.1186/1741-7015-12-63"
"33227157","Mindfulness in Motion and Dietary Approaches to Stop Hypertension (DASH) in Hypertensive African Americans","Wright KD, Klatt MD, Adams IR, Nguyen CM, Mion LC, Tan A, Monroe TB, Rose KM, Scharre DW.","J Am Geriatr Soc. 2021 Mar;69(3):773-778. doi: 10.1111/jgs.16947. Epub 2020 Nov 23.","Wright KD","J Am Geriatr Soc","2021","2020/11/23","PMC8329944","NIHMS1721445","10.1111/jgs.16947"
"30565793","Donepezil for gait and falls in mild cognitive impairment: a randomized controlled trial","Montero-Odasso M, Speechley M, Chertkow H, Sarquis-Adamson Y, Wells J, Borrie M, Vanderhaeghe L, Zou GY, Fraser S, Bherer L, Muir-Hunter SW.","Eur J Neurol. 2019 Apr;26(4):651-659. doi: 10.1111/ene.13872. Epub 2018 Dec 26.","Montero-Odasso M","Eur J Neurol","2019","2018/12/20","","","10.1111/ene.13872"
"29345724","Effects of Cognitive Training on Cognition and Quality of Life of Older Persons with Dementia","Kallio EL, Öhman H, Hietanen M, Soini H, Strandberg TE, Kautiainen H, Pitkälä KH.","J Am Geriatr Soc. 2018 Apr;66(4):664-670. doi: 10.1111/jgs.15196. Epub 2018 Jan 18.","Kallio EL","J Am Geriatr Soc","2018","2018/01/19","","","10.1111/jgs.15196"
"29076028","Safety, Tolerability and Pharmacokinetics of Oral BI 425809, a Glycine Transporter 1 Inhibitor, in Healthy Male Volunteers: A Partially Randomised, Single-Blind, Placebo-Controlled, First-in-Human Study","Moschetti V, Desch M, Goetz S, Liesenfeld KH, Rosenbrock H, Kammerer KP, Wunderlich G, Wind S.","Eur J Drug Metab Pharmacokinet. 2018 Apr;43(2):239-249. doi: 10.1007/s13318-017-0440-z.","Moschetti V","Eur J Drug Metab Pharmacokinet","2018","2017/10/28","PMC5854750","","10.1007/s13318-017-0440-z"
"28270574","Mild Cognitive Impairment Is Characterized by Deficient Brainstem and Cortical Representations of Speech","Bidelman GM, Lowther JE, Tak SH, Alain C.","J Neurosci. 2017 Mar 29;37(13):3610-3620. doi: 10.1523/JNEUROSCI.3700-16.2017. Epub 2017 Mar 7.","Bidelman GM","J Neurosci","2017","2017/03/09","PMC6596919","","10.1523/JNEUROSCI.3700-16.2017"
"23982627","Peripheral and central nervous system inhibition of 11β-hydroxysteroid dehydrogenase type 1 in man by the novel inhibitor ABT-384","Katz DA, Liu W, Locke C, Jacobson P, Barnes DM, Basu R, An G, Rieser MJ, Daszkowski D, Groves F, Heneghan G, Shah A, Gevorkyan H, Jhee SS, Ereshefsky L, Marek GJ.","Transl Psychiatry. 2013 Aug 27;3(8):e295. doi: 10.1038/tp.2013.67.","Katz DA","Transl Psychiatry","2013","2013/08/29","PMC3756293","","10.1038/tp.2013.67"
"35118644","Serum biomarkers of brain injury after uncomplicated cardiac surgery: Secondary analysis from a randomized trial","Barbu M, Jónsson K, Zetterberg H, Blennow K, Kolsrud O, Ricksten SE, Dellgren G, Björk K, Jeppsson A.","Acta Anaesthesiol Scand. 2022 Apr;66(4):447-453. doi: 10.1111/aas.14033. Epub 2022 Feb 19.","Barbu M","Acta Anaesthesiol Scand","2022","2022/02/04","PMC9302991","","10.1111/aas.14033"
"27377542","Effects of long-term testosterone administration on cognition in older men with low or low-to-normal testosterone concentrations: a prespecified secondary analysis of data from the randomised, double-blind, placebo-controlled TEAAM trial","Huang G, Wharton W, Bhasin S, Harman SM, Pencina KM, Tsitouras P, Li Z, Hally KA, Asthana S, Storer TW, Basaria S.","Lancet Diabetes Endocrinol. 2016 Aug;4(8):657-665. doi: 10.1016/S2213-8587(16)30102-4. Epub 2016 Jul 1.","Huang G","Lancet Diabetes Endocrinol","2016","2016/07/06","","","10.1016/S2213-8587(16)30102-4"
"26940919","Subclinical Cardiovascular Disease and Death, Dementia, and Coronary Heart Disease in Patients 80+ Years","Kuller LH, Lopez OL, Mackey RH, Rosano C, Edmundowicz D, Becker JT, Newman AB.","J Am Coll Cardiol. 2016 Mar 8;67(9):1013-1022. doi: 10.1016/j.jacc.2015.12.034.","Kuller LH","J Am Coll Cardiol","2016","2016/03/05","PMC5502352","NIHMS840511","10.1016/j.jacc.2015.12.034"
"12815501","Assessment of lifetime participation in cognitively stimulating activities","Wilson R, Barnes L, Bennett D.","J Clin Exp Neuropsychol. 2003 Aug;25(5):634-42. doi: 10.1076/jcen.25.5.634.14572.","Wilson R","J Clin Exp Neuropsychol","2003","2003/06/20","","","10.1076/jcen.25.5.634.14572"
"20104071","Improving depression and enhancing resilience in family dementia caregivers: a pilot randomized placebo-controlled trial of escitalopram","Lavretsky H, Siddarth P, Irwin MR.","Am J Geriatr Psychiatry. 2010 Feb;18(2):154-62. doi: 10.1097/JGP.0b013e3181beab1e.","Lavretsky H","Am J Geriatr Psychiatry","2010","2010/01/28","PMC2813456","NIHMS153831","10.1097/JGP.0b013e3181beab1e"
"24490265","Long-term multivitamin supplementation and cognitive function in men: a randomized trial","Grodstein F, O'Brien J, Kang JH, Dushkes R, Cook NR, Okereke O, Manson JE, Glynn RJ, Buring JE, Gaziano M, Sesso HD.","Ann Intern Med. 2013 Dec 17;159(12):806-14. doi: 10.7326/0003-4819-159-12-201312170-00006.","Grodstein F","Ann Intern Med","2013","2014/02/04","PMC3858850","NIHMS529498","10.7326/0003-4819-159-12-201312170-00006"
"15965311","Safety, tolerability, and changes in amyloid beta concentrations after administration of a gamma-secretase inhibitor in volunteers","Siemers E, Skinner M, Dean RA, Gonzales C, Satterwhite J, Farlow M, Ness D, May PC.","Clin Neuropharmacol. 2005 May-Jun;28(3):126-32. doi: 10.1097/01.wnf.0000167360.27670.29.","Siemers E","Clin Neuropharmacol","2005","2005/06/21","","","10.1097/01.wnf.0000167360.27670.29"
"32444540","Tolcapone Treatment for Cognitive and Behavioral Symptoms in Behavioral Variant Frontotemporal Dementia: A Placebo-Controlled Crossover Study","Fremont R, Manoochehri M, Armstrong NM, Mattay VS, Apud JA, Tierney MC, Devanand DP, Gazes Y, Habeck C, Wassermann EM, Grafman J, Huey ED.","J Alzheimers Dis. 2020;75(4):1391-1403. doi: 10.3233/JAD-191265.","Fremont R","J Alzheimers Dis","2020","2020/05/24","PMC10131251","NIHMS1890177","10.3233/JAD-191265"
"12374512","The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study","Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, Bossini A, Fagard R, Gil-Extremera B, Laks T, Kobalava Z, Sarti C, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Birkenhäger WH; Systolic Hypertension in Europe Investigators.","Arch Intern Med. 2002 Oct 14;162(18):2046-52. doi: 10.1001/archinte.162.18.2046.","Forette F","Arch Intern Med","2002","2002/10/11","","","10.1001/archinte.162.18.2046"
"33970268","Change in CAIDE Dementia Risk Score and Neuroimaging Biomarkers During a 2-Year Multidomain Lifestyle Randomized Controlled Trial: Results of a Post-Hoc Subgroup Analysis","Stephen R, Ngandu T, Liu Y, Peltonen M, Antikainen R, Kemppainen N, Laatikainen T, Lötjönen J, Rinne J, Strandberg T, Tuomilehto J, Vanninen R, Soininen H, Kivipelto M, Solomon A; FINGER Study Group.","J Gerontol A Biol Sci Med Sci. 2021 Jul 13;76(8):1407-1414. doi: 10.1093/gerona/glab130.","Stephen R","J Gerontol A Biol Sci Med Sci","2021","2021/05/10","PMC8277089","","10.1093/gerona/glab130"
"25805891","The Effect of a Personalized Dementia Care Intervention for Caregivers From Australian Minority Groups","Xiao LD, De Bellis A, Kyriazopoulos H, Draper B, Ullah S.","Am J Alzheimers Dis Other Demen. 2016 Feb;31(1):57-67. doi: 10.1177/1533317515578256. Epub 2015 Mar 24.","Xiao LD","Am J Alzheimers Dis Other Demen","2016","2015/03/26","","","10.1177/1533317515578256"
"16682542","Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study","Okun MS, Fernandez HH, Rodriguez RL, Romrell J, Suelter M, Munson S, Louis ED, Mulligan T, Foster PS, Shenal BV, Armaghani SJ, Jacobson C, Wu S, Crucian G.","Arch Neurol. 2006 May;63(5):729-35. doi: 10.1001/archneur.63.5.729.","Okun MS","Arch Neurol","2006","2006/05/10","","","10.1001/archneur.63.5.729"
"17409748","Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study","Edwards K, Royall D, Hershey L, Lichter D, Hake A, Farlow M, Pasquier F, Johnson S.","Dement Geriatr Cogn Disord. 2007;23(6):401-5. doi: 10.1159/000101512. Epub 2007 Apr 3.","Edwards K","Dement Geriatr Cogn Disord","2007","2007/04/06","","","10.1159/000101512"
"31883703","A Phase I Study to Assess the Effect of Speed of Injection on Pain, Tolerability, and Pharmacokinetics After High-volume Subcutaneous Administration of Gantenerumab in Healthy Volunteers","Portron A, Jordan P, Draper K, Muenzer C, Dickerson D, van Iersel T, Hofmann C.","Clin Ther. 2020 Jan;42(1):108-120.e1. doi: 10.1016/j.clinthera.2019.11.015. Epub 2019 Dec 26.","Portron A","Clin Ther","2020","2019/12/30","","","10.1016/j.clinthera.2019.11.015"
"29846887","Multiple Rising Doses of Oral BI 425809, a GlyT1 Inhibitor, in Young and Elderly Healthy Volunteers: A Randomised, Double-Blind, Phase I Study Investigating Safety and Pharmacokinetics","Moschetti V, Schlecker C, Wind S, Goetz S, Schmitt H, Schultz A, Liesenfeld KH, Wunderlich G, Desch M.","Clin Drug Investig. 2018 Aug;38(8):737-750. doi: 10.1007/s40261-018-0660-2.","Moschetti V","Clin Drug Investig","2018","2018/05/31","PMC6061410","","10.1007/s40261-018-0660-2"
"23403474","Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study","Cotroneo AM, Castagna A, Putignano S, Lacava R, Fantò F, Monteleone F, Rocca F, Malara A, Gareri P.","Clin Interv Aging. 2013;8:131-7. doi: 10.2147/CIA.S38420. Epub 2013 Feb 5.","Cotroneo AM","Clin Interv Aging","2013","2013/02/14","PMC3569046","","10.2147/CIA.S38420"
"21223356","Central nervous system effects of the interaction between risperidone (single dose) and the 5-HT6 antagonist SB742457 (repeated doses) in healthy men","Liem-Moolenaar M, Rad M, Zamuner S, Cohen AF, Lemme F, Franson KL, van Gerven JM, Pich EM.","Br J Clin Pharmacol. 2011 Jun;71(6):907-16. doi: 10.1111/j.1365-2125.2011.03902.x.","Liem-Moolenaar M","Br J Clin Pharmacol","2011","2011/01/13","PMC3099377","","10.1111/j.1365-2125.2011.03902.x"
"20656516","Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial","Guekht AB, Moessler H, Novak PH, Gusev EI; Cerebrolysin Investigators.","J Stroke Cerebrovasc Dis. 2011 Jul-Aug;20(4):310-8. doi: 10.1016/j.jstrokecerebrovasdis.2010.01.012. Epub 2010 Jul 24.","Guekht AB","J Stroke Cerebrovasc Dis","2011","2010/07/27","","","10.1016/j.jstrokecerebrovasdis.2010.01.012"
"34347883","Safety, Tolerability, and Pharmacokinetics of High-Volume Subcutaneous Crenezumab, With and Without Recombinant Human Hyaluronidase in Healthy Volunteers","Dolton MJ, Chesterman A, Moein A, Sink KM, Waitz A, Blondeau K, Kerchner GA, Hu N, Brooks L, Wetzel-Smith MK, Roden A, Deshmukh A, Peng K, Carrasco-Triguero M, Smith J, Ostrowitzki S, Quartino A.","Clin Pharmacol Ther. 2021 Nov;110(5):1337-1348. doi: 10.1002/cpt.2385. Epub 2021 Aug 27.","Dolton MJ","Clin Pharmacol Ther","2021","2021/08/04","","","10.1002/cpt.2385"
"34188459","Effects of ICT-Based Multicomponent Program on Body Composition and Cognitive Function in Older Adults: A Randomized Controlled Clinical Study","Kim DR, Song S, Kim GM, Chang JH, Tak YJ, Huh U, Cho JS, Liao Y, Han KS, Ko MH, Park JH.","Clin Interv Aging. 2021 Jun 21;16:1161-1171. doi: 10.2147/CIA.S306894. eCollection 2021.","Kim DR","Clin Interv Aging","2021","2021/06/30","PMC8232840","","10.2147/CIA.S306894"
"32761337","Efficacy and Safety of Guilingji Capsules () for Treating Mild-to-Moderate Cognitive Impairment: Study Protocol for A Randomized, Double-Blind, Positive-Controlled, Multicenter and Noninferiority Trial","Liu NY, Pei H, Liu MX, Liu LT, Fu CG, Li H, Chen KJ.","Chin J Integr Med. 2020 Aug;26(8):577-582. doi: 10.1007/s11655-020-2723-5. Epub 2020 Aug 5.","Liu NY","Chin J Integr Med","2020","2020/08/08","","","10.1007/s11655-020-2723-5"
"20927401","Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling","Salinthone S, Yadav V, Schillace RV, Bourdette DN, Carr DW.","PLoS One. 2010 Sep 28;5(9):e13058. doi: 10.1371/journal.pone.0013058.","Salinthone S","PLoS One","2010","2010/10/08","PMC2946928","","10.1371/journal.pone.0013058"
"32244028","Network topology and machine learning analyses reveal microstructural white matter changes underlying Chinese medicine Dengzhan Shengmai treatment on patients with vascular cognitive impairment","Lu H, Zhang J, Liang Y, Qiao Y, Yang C, He X, Wang W, Zhao S, Wei D, Li H, Cheng W, Zhang Z.","Pharmacol Res. 2020 Jun;156:104773. doi: 10.1016/j.phrs.2020.104773. Epub 2020 Mar 31.","Lu H","Pharmacol Res","2020","2020/04/04","","","10.1016/j.phrs.2020.104773"
"31979283","Combined Treatment with Two Water Extracts of Eleutherococcus senticosus Leaf and Rhizome of Drynaria fortunei Enhances Cognitive Function: A Placebo-Controlled, Randomized, Double-Blind Study in Healthy Adults","Tohda C, Matsui M, Inada Y, Yang X, Kuboyama T, Kimbara Y, Watari H.","Nutrients. 2020 Jan 23;12(2):303. doi: 10.3390/nu12020303.","Tohda C","Nutrients","2020","2020/01/26","PMC7070741","","10.3390/nu12020303"
"31567873","Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy","Wang Y, Hernandez G, Mack WJ, Schneider LS, Yin F, Brinton RD.","Menopause. 2020 Jan;27(1):57-65. doi: 10.1097/GME.0000000000001418.","Wang Y","Menopause","2020","2019/10/01","PMC7100617","NIHMS1535157","10.1097/GME.0000000000001418"
"29772028","Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1","Borthwick NJ, Lane T, Moyo N, Crook A, Shim JM, Baines I, Wee EG, Hawkins PN, Gillmore JD, Hanke T, Pepys MB.","PLoS One. 2018 May 17;13(5):e0197299. doi: 10.1371/journal.pone.0197299. eCollection 2018.","Borthwick NJ","PLoS One","2018","2018/05/18","PMC5957335","","10.1371/journal.pone.0197299"
"26289681","Prescription Opioids and Risk of Dementia or Cognitive Decline: A Prospective Cohort Study","Dublin S, Walker RL, Gray SL, Hubbard RA, Anderson ML, Yu O, Crane PK, Larson EB.","J Am Geriatr Soc. 2015 Aug;63(8):1519-26. doi: 10.1111/jgs.13562.","Dublin S","J Am Geriatr Soc","2015","2015/08/21","PMC4776316","NIHMS722604","10.1111/jgs.13562"
"36041414","Intranasal Insulin Attenuates the Long-Term Adverse Effects of Neonatal Hyperglycemia on the Hippocampus in Rats","McClure Yauch L, Ennis-Czerniak K, Frey Ii WH, Tkac I, Rao RB.","Dev Neurosci. 2022;44(6):590-602. doi: 10.1159/000526627. Epub 2022 Aug 30.","McClure Yauch L","Dev Neurosci","2022","2022/08/30","PMC9928603","NIHMS1835423","10.1159/000526627"
"33194354","A pilot feasibility randomized controlled trial on combining mind-body physical exercise, cognitive training, and nurse-led risk factor modification to reduce cognitive decline among older adults with mild cognitive impairment in primary care","Xu Z, Zhang D, Lee ATC, Sit RWS, Wong C, Lee EKP, Yip BHK, Tiu JYS, Lam LCW, Wong SYS.","PeerJ. 2020 Sep 7;8:e9845. doi: 10.7717/peerj.9845. eCollection 2020.","Xu Z","PeerJ","2020","2020/11/16","PMC7482623","","10.7717/peerj.9845"
"30901716","Effects of a moderate-intensity aerobic exercise programme on the cognitive function and quality of life of community-dwelling elderly people with mild cognitive impairment: A randomised controlled trial","Song D, Yu DSF.","Int J Nurs Stud. 2019 May;93:97-105. doi: 10.1016/j.ijnurstu.2019.02.019. Epub 2019 Mar 5.","Song D","Int J Nurs Stud","2019","2019/03/23","","","10.1016/j.ijnurstu.2019.02.019"
"28903738","A randomized controlled trial of physical activity with individual goal-setting and volunteer mentors to overcome sedentary lifestyle in older adults at risk of cognitive decline: the INDIGO trial protocol","Cox KL, Cyarto EV, Etherton-Beer C, Ellis KA, Alfonso H, Clare L, Liew D, Ames D, Flicker L, Almeida OP, LoGiudice D, Lautenschlager NT.","BMC Geriatr. 2017 Sep 13;17(1):215. doi: 10.1186/s12877-017-0617-y.","Cox KL","BMC Geriatr","2017","2017/09/15","PMC5597988","","10.1186/s12877-017-0617-y"
"28304092","Mediation of Cognitive Function Improvements by Strength Gains After Resistance Training in Older Adults with Mild Cognitive Impairment: Outcomes of the Study of Mental and Resistance Training","Mavros Y, Gates N, Wilson GC, Jain N, Meiklejohn J, Brodaty H, Wen W, Singh N, Baune BT, Suo C, Baker MK, Foroughi N, Wang Y, Sachdev PS, Valenzuela M, Fiatarone Singh MA.","J Am Geriatr Soc. 2017 Mar;65(3):550-559. doi: 10.1111/jgs.14542. Epub 2016 Oct 24.","Mavros Y","J Am Geriatr Soc","2017","2017/03/18","","","10.1111/jgs.14542"
"27989253","Montmorency Tart cherries (Prunus cerasus L.) modulate vascular function acutely, in the absence of improvement in cognitive performance","Keane KM, Haskell-Ramsay CF, Veasey RC, Howatson G.","Br J Nutr. 2016 Dec;116(11):1935-1944. doi: 10.1017/S0007114516004177. Epub 2016 Dec 19.","Keane KM","Br J Nutr","2016","2016/12/20","","","10.1017/S0007114516004177"
"26237116","External locus of control contributes to racial disparities in memory and reasoning training gains in ACTIVE","Zahodne LB, Meyer OL, Choi E, Thomas ML, Willis SL, Marsiske M, Gross AL, Rebok GW, Parisi JM.","Psychol Aging. 2015 Sep;30(3):561-72. doi: 10.1037/pag0000042. Epub 2015 Aug 3.","Zahodne LB","Psychol Aging","2015","2015/08/04","PMC4556562","NIHMS704794","10.1037/pag0000042"
"15219659","One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men","Almeida OP, Waterreus A, Spry N, Flicker L, Martins RN.","Psychoneuroendocrinology. 2004 Sep;29(8):1071-81. doi: 10.1016/j.psyneuen.2003.11.002.","Almeida OP","Psychoneuroendocrinology","2004","2004/06/29","","","10.1016/j.psyneuen.2003.11.002"
"30894299","The effects of 7-week cognitive training in patients with vascular cognitive impairment, no dementia (the Cog-VACCINE study): A randomized controlled trial","Tang Y, Xing Y, Zhu Z, He Y, Li F, Yang J, Liu Q, Li F, Teipel SJ, Zhao G, Jia J.","Alzheimers Dement. 2019 May;15(5):605-614. doi: 10.1016/j.jalz.2019.01.009. Epub 2019 Mar 17.","Tang Y","Alzheimers Dement","2019","2019/03/22","","","10.1016/j.jalz.2019.01.009"
"33904966","Memory enhancement by multidomain group cognitive training in patients with Parkinson's disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trial","Schmidt N, Tödt I, Berg D, Schlenstedt C, Folkerts AK, Ophey A, Dimenshteyn K, Elben S, Wojtecki L, Liepelt-Scarfone I, Schulte C, Sulzer P, Eggers C, Kalbe E, Witt K.","J Neurol. 2021 Dec;268(12):4655-4666. doi: 10.1007/s00415-021-10568-9. Epub 2021 Apr 27.","Schmidt N","J Neurol","2021","2021/04/27","PMC8563628","","10.1007/s00415-021-10568-9"
"32040141","Comparison of Integrated Outpatient Palliative Care With Standard Care in Patients With Parkinson Disease and Related Disorders: A Randomized Clinical Trial","Kluger BM, Miyasaki J, Katz M, Galifianakis N, Hall K, Pantilat S, Khan R, Friedman C, Cernik W, Goto Y, Long J, Fairclough D, Sillau S, Kutner JS.","JAMA Neurol. 2020 May 1;77(5):551-560. doi: 10.1001/jamaneurol.2019.4992.","Kluger BM","JAMA Neurol","2020","2020/02/11","PMC7042842","","10.1001/jamaneurol.2019.4992"
"24162942","Clinical effectiveness of a manual based coping strategy programme (START, STrAtegies for RelaTives) in promoting the mental health of carers of family members with dementia: pragmatic randomised controlled trial","Livingston G, Barber J, Rapaport P, Knapp M, Griffin M, King D, Livingston D, Mummery C, Walker Z, Hoe J, Sampson EL, Cooper C.","BMJ. 2013 Oct 25;347:f6276. doi: 10.1136/bmj.f6276.","Livingston G","BMJ","2013","2013/10/29","PMC3808082","","10.1136/bmj.f6276"
"28532471","Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease (PASTIS): study protocol for a randomised controlled trial","Pauls MMH, Clarke N, Trippier S, Betteridge S, Howe FA, Khan U, Kruuse C, Madigan JB, Moynihan B, Pereira AC, Rolfe D, Rostrup E, Haig CE, Barrick TR, Isaacs JD, Hainsworth AH.","Trials. 2017 May 22;18(1):229. doi: 10.1186/s13063-017-1973-9.","Pauls MMH","Trials","2017","2017/05/24","PMC5440904","","10.1186/s13063-017-1973-9"
"33776997","The Cholinergic Drug Galantamine Alleviates Oxidative Stress Alongside Anti-inflammatory and Cardio-Metabolic Effects in Subjects With the Metabolic Syndrome in a Randomized Trial","Sangaleti CT, Katayama KY, De Angelis K, Lemos de Moraes T, Araújo AA, Lopes HF, Camacho C, Bortolotto LA, Michelini LC, Irigoyen MC, Olofsson PS, Barnaby DP, Tracey KJ, Pavlov VA, Consolim Colombo FM.","Front Immunol. 2021 Mar 11;12:613979. doi: 10.3389/fimmu.2021.613979. eCollection 2021.","Sangaleti CT","Front Immunol","2021","2021/03/29","PMC7991724","","10.3389/fimmu.2021.613979"
"26967225","Formal Psychiatric Disorders are not Overrepresented in Behavioral Variant Frontotemporal Dementia","Gossink FT, Dols A, Krudop WA, Sikkes SA, Kerssens CJ, Prins ND, Scheltens P, Stek ML, Pijnenburg YA.","J Alzheimers Dis. 2016;51(4):1249-56. doi: 10.3233/JAD-151198.","Gossink FT","J Alzheimers Dis","2016","2016/03/12","","","10.3233/JAD-151198"
"25459912","Associations of advanced glycation end-products with cognitive functions in individuals with and without type 2 diabetes: the maastricht study","Spauwen PJ, van Eupen MG, Köhler S, Stehouwer CD, Verhey FR, van der Kallen CJ, Sep SJ, Koster A, Schaper NC, Dagnelie PC, Schalkwijk CG, Schram MT, van Boxtel MP.","J Clin Endocrinol Metab. 2015 Mar;100(3):951-60. doi: 10.1210/jc.2014-2754. Epub 2014 Dec 2.","Spauwen PJ","J Clin Endocrinol Metab","2015","2014/12/03","","","10.1210/jc.2014-2754"
"15496222","Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses","Okereke CS, Kirby L, Kumar D, Cullen EI, Pratt RD, Hahne WA.","Br J Clin Pharmacol. 2004 Nov;58 Suppl 1(Suppl 1):41-9. doi: 10.1111/j.1365-2125.2004.01799.x.","Okereke CS","Br J Clin Pharmacol","2004","2004/10/22","PMC1884553","","10.1111/j.1365-2125.2004.01799.x"
"3183305","In vivo probe of central cholinergic systems","Meador KJ, Loring DW, Lee GP, Taylor HS, Hughes DR, Feldman DS.","J Gerontol. 1988 Nov;43(6):M158-62. doi: 10.1093/geronj/43.6.m158.","Meador KJ","J Gerontol","1988","1988/11/01","","","10.1093/geronj/43.6.m158"
"35946107","Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial","Williams T, Tur C, Eshaghi A, Doshi A, Chan D, Binks S, Wellington H, Heslegrave A, Zetterberg H, Chataway J.","Mult Scler. 2022 Oct;28(12):1913-1926. doi: 10.1177/13524585221114441. Epub 2022 Aug 9.","Williams T","Mult Scler","2022","2022/08/10","PMC9493411","","10.1177/13524585221114441"
"27881145","Evaluation of efficacy and efficiency of a pragmatic intervention by a social worker to support informal caregivers of elderly patients (The ICE Study): study protocol for a randomized controlled trial","Pozet A, Lejeune C, Bonnet M, Dabakuyo S, Dion M, Fagnoni P, Gaimard M, Imbert G, Nerich V, Foubert A, Chotard M, Bonin M, Anota A, Bonnetain F.","Trials. 2016 Nov 3;17(1):531. doi: 10.1186/s13063-016-1622-8.","Pozet A","Trials","2016","2016/11/25","PMC5122007","","10.1186/s13063-016-1622-8"
"20429751","Diffusion tensor imaging (DTI) in dementia patients with frontal lobe symptoms","Naik M, Lundervold A, Nygaard H, Geitung JT.","Acta Radiol. 2010 Jul;51(6):662-8. doi: 10.3109/02841851003709870.","Naik M","Acta Radiol","2010","2010/05/01","","","10.3109/02841851003709870"
"31981370","Prospective Associations Between Diffusion Tensor Imaging Parameters and Frailty in Older Adults","Maltais M, de Souto Barreto P, Perus L, Mangin JF, Grigis A, Chupin M, Bouyahia A, Gabelle A, Delrieux J, Rolland Y, Vellas B; Multidomain Alzheimer Preventive Trial/Data Sharing Alzheimer (MAPT/DSA) Study Group.","J Am Geriatr Soc. 2020 May;68(5):1050-1055. doi: 10.1111/jgs.16343. Epub 2020 Jan 25.","Maltais M","J Am Geriatr Soc","2020","2020/01/26","","","10.1111/jgs.16343"
"29282336","CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP","Rojas JC, Bang J, Lobach IV, Tsai RM, Rabinovici GD, Miller BL, Boxer AL; AL-108-231 Investigators.","Neurology. 2018 Jan 23;90(4):e273-e281. doi: 10.1212/WNL.0000000000004859. Epub 2017 Dec 27.","Rojas JC","Neurology","2018","2017/12/29","PMC5798651","","10.1212/WNL.0000000000004859"
"30705390","Screening and brief intervention for obesity in primary care: cost-effectiveness analysis in the BWeL trial","Retat L, Pimpin L, Webber L, Jaccard A, Lewis A, Tearne S, Hood K, Christian-Brown A, Adab P, Begh R, Jolly K, Daley A, Farley A, Lycett D, Nickless A, Yu LM, Jebb S, Aveyard P.","Int J Obes (Lond). 2019 Oct;43(10):2066-2075. doi: 10.1038/s41366-018-0295-7. Epub 2019 Jan 31.","Retat L","Int J Obes (Lond)","2019","2019/02/02","PMC6776469","EMS80737","10.1038/s41366-018-0295-7"
"27150035","Compartmental modeling of [(11)C]MENET binding to the norepinephrine transporter in the healthy human brain","Adhikarla V, Zeng F, Votaw JR, Goodman MM, Nye JA.","Nucl Med Biol. 2016 May;43(5):318-23. doi: 10.1016/j.nucmedbio.2016.02.008. Epub 2016 Feb 28.","Adhikarla V","Nucl Med Biol","2016","2016/05/07","PMC4860207","NIHMS764498","10.1016/j.nucmedbio.2016.02.008"
"34275209","Effects of simvastatin on white matter integrity in healthy middle-aged adults","Vogt NM, Hunt JFV, Ma Y, Van Hulle CA, Adluru N, Chappell RJ, Lazar KK, Jacobson LE, Austin BP, Asthana S, Johnson SC, Bendlin BB, Carlsson CM.","Ann Clin Transl Neurol. 2021 Aug;8(8):1656-1667. doi: 10.1002/acn3.51421. Epub 2021 Jul 18.","Vogt NM","Ann Clin Transl Neurol","2021","2021/07/18","PMC8351379","","10.1002/acn3.51421"
"35430328","Effect of Aspirin on CKD Progression in Older Adults: Secondary Analysis From the ASPREE Randomized Clinical Trial","Polkinghorne KR, Wetmore JB, Thao LTP, Wolfe R, Woods RL, Ernst ME, Nelson MR, Reid CM, Shah RC, McNeil JJ, Murray AM.","Am J Kidney Dis. 2022 Dec;80(6):810-813. doi: 10.1053/j.ajkd.2022.02.019. Epub 2022 Apr 14.","Polkinghorne KR","Am J Kidney Dis","2022","2022/04/17","PMC9562592","NIHMS1816152","10.1053/j.ajkd.2022.02.019"
"14561111","Effects of donepezil on cognitive functioning in Down syndrome","Johnson N, Fahey C, Chicoine B, Chong G, Gitelman D.","Am J Ment Retard. 2003 Nov;108(6):367-72. doi: 10.1352/0895-8017(2003)108<367:EODOCF>2.0.CO;2.","Johnson N","Am J Ment Retard","2003","2003/10/17","","","10.1352/0895-8017(2003)108<367:EODOCF>2.0.CO;2"
"25877495","Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial","Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD.","Am J Clin Nutr. 2015 Jul;102(1):215-21. doi: 10.3945/ajcn.114.103283. Epub 2015 Apr 15.","Jernerén F","Am J Clin Nutr","2015","2015/04/17","","","10.3945/ajcn.114.103283"
"29632101","Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study","Bruno RM, Stea F, Sicari R, Ghiadoni L, Taddei S, Ungar A, Bonuccelli U, Tognoni G, Cintoli S, Del Turco S, Sbrana S, Gargani L, D'Angelo G, Pratali L, Berardi N, Maffei L, Picano E; Train the Brain Consortium.","Hypertension. 2018 Jun;71(6):1218-1225. doi: 10.1161/HYPERTENSIONAHA.117.10066. Epub 2018 Apr 9.","Bruno RM","Hypertension","2018","2018/04/11","","","10.1161/HYPERTENSIONAHA.117.10066"
"22381714","Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral γ-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markers","Tong G, Wang JS, Sverdlov O, Huang SP, Slemmon R, Croop R, Castaneda L, Gu H, Wong O, Li H, Berman RM, Smith C, Albright CF, Dockens RC.","Clin Ther. 2012 Mar;34(3):654-67. doi: 10.1016/j.clinthera.2012.01.022. Epub 2012 Feb 28.","Tong G","Clin Ther","2012","2012/03/03","","","10.1016/j.clinthera.2012.01.022"
"34566409","Effect of Psychoeducational Intervention on Donepezil Retention Rate and Analysis of Reasons for the Discontinuation in Patients with Alzheimer's Dementia: A Randomized Study","Kamei T, Kobayashi H, Nishida M, Muramoto K, Nishimoto S.","Patient Prefer Adherence. 2021 Sep 18;15:2103-2111. doi: 10.2147/PPA.S330372. eCollection 2021.","Kamei T","Patient Prefer Adherence","2021","2021/09/27","PMC8457860","","10.2147/PPA.S330372"
"14518801","The Resources for Enhancing Alzheimer's Caregiver Health (REACH): project design and baseline characteristics","Wisniewski SR, Belle SH, Coon DW, Marcus SM, Ory MG, Burgio LD, Burns R, Schulz R; REACH Investigators.","Psychol Aging. 2003 Sep;18(3):375-84. doi: 10.1037/0882-7974.18.3.375.","Wisniewski SR","Psychol Aging","2003","2003/10/02","PMC2577188","NIHMS72034","10.1037/0882-7974.18.3.375"
"20729148","Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial","Emre M, Tsolaki M, Bonuccelli U, Destée A, Tolosa E, Kutzelnigg A, Ceballos-Baumann A, Zdravkovic S, Bladström A, Jones R; 11018 Study Investigators.","Lancet Neurol. 2010 Oct;9(10):969-77. doi: 10.1016/S1474-4422(10)70194-0. Epub 2010 Aug 20.","Emre M","Lancet Neurol","2010","2010/08/24","","","10.1016/S1474-4422(10)70194-0"
"10454944","Improving adherence to dementia guidelines through education and opinion leaders. A randomized, controlled trial","Gifford DR, Holloway RG, Frankel MR, Albright CL, Meyerson R, Griggs RC, Vickrey BG.","Ann Intern Med. 1999 Aug 17;131(4):237-46. doi: 10.7326/0003-4819-131-4-199908170-00002.","Gifford DR","Ann Intern Med","1999","1999/08/24","","","10.7326/0003-4819-131-4-199908170-00002"
"15358438","Distress proneness and cognitive decline in a population of older persons","Wilson RS, Bennett DA, Mendes de Leon CF, Bienias JL, Morris MC, Evans DA.","Psychoneuroendocrinology. 2005 Jan;30(1):11-7. doi: 10.1016/j.psyneuen.2004.04.005.","Wilson RS","Psychoneuroendocrinology","2005","2004/09/11","","","10.1016/j.psyneuen.2004.04.005"
"36751940","Baseline characteristics of the North American prodromal Synucleinopathy cohort","Elliott JE, Lim MM, Keil AT, Postuma RB, Pelletier A, Gagnon JF, St Louis EK, Forsberg LK, Fields JA, Huddleston DE, Bliwise DL, Avidan AY, Howell MJ, Schenck CH, McLeland J, Criswell SR, Videnovic A, During EH, Miglis MG, Shprecher DR, Lee-Iannotti JK, Boeve BF, Ju YS; North American Prodromal Synucleinopathy (NAPS) Consortium.","Ann Clin Transl Neurol. 2023 Apr;10(4):520-535. doi: 10.1002/acn3.51738. Epub 2023 Feb 8.","Elliott JE","Ann Clin Transl Neurol","2023","2023/02/08","PMC10109527","","10.1002/acn3.51738"
"34847709","Effects of Cilostazol and Isosorbide Mononitrate on Cerebral Hemodynamics in the LACI-1 Randomized Controlled Trial","Blair GW, Janssen E, Stringer MS, Thrippleton MJ, Chappell F, Shi Y, Hamilton I, Flaherty K, Appleton JP, Doubal FN, Bath PM, Wardlaw JM.","Stroke. 2022 Jan;53(1):29-33. doi: 10.1161/STROKEAHA.121.034866. Epub 2021 Dec 1.","Blair GW","Stroke","2022","2021/12/01","PMC8700302","EMS138069","10.1161/STROKEAHA.121.034866"
"33755924","First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat","Antonijoan RM, Ferrero-Cafiero JM, Coimbra J, Puntes M, Martínez-Colomer J, Arévalo MI, Mascaró C, Molinero C, Buesa C, Maes T.","CNS Drugs. 2021 Mar;35(3):331-344. doi: 10.1007/s40263-021-00797-x. Epub 2021 Mar 23.","Antonijoan RM","CNS Drugs","2021","2021/03/23","PMC7985749","","10.1007/s40263-021-00797-x"
"29784589","Tolerability and blinding of 4x1 high-definition transcranial direct current stimulation (HD-tDCS) at two and three milliamps","Reckow J, Rahman-Filipiak A, Garcia S, Schlaefflin S, Calhoun O, DaSilva AF, Bikson M, Hampstead BM.","Brain Stimul. 2018 Sep-Oct;11(5):991-997. doi: 10.1016/j.brs.2018.04.022. Epub 2018 May 4.","Reckow J","Brain Stimul","2018","2018/05/23","PMC6512313","NIHMS1016810","10.1016/j.brs.2018.04.022"
"22789530","The effects on metabolic clearance when administering a potent CYP3A autoinducer with the prototypic CYP3A inhibitor, ketoconazole","Ayan-Oshodi MA, Willis BA, Annes WF, Lowe SL, Friedrich S, de la Peña A, Zhang W, Brown T, Wise SD, Hall SD.","Drug Metab Dispos. 2012 Oct;40(10):1945-52. doi: 10.1124/dmd.112.046060. Epub 2012 Jul 12.","Ayan-Oshodi MA","Drug Metab Dispos","2012","2012/07/14","","","10.1124/dmd.112.046060"
"21723605","Pharmacokinetic comparison of orally disintegrating and conventional donepezil formulations in healthy Korean male subjects: a single-dose, randomized, open-label, 2-sequence, 2-period crossover study","Kim KA, Lim JL, Kim C, Park JY.","Clin Ther. 2011 Jul;33(7):965-72. doi: 10.1016/j.clinthera.2011.06.003. Epub 2011 Jul 2.","Kim KA","Clin Ther","2011","2011/07/05","","","10.1016/j.clinthera.2011.06.003"
"34620151","Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial","Shin HY, Kim HR, Jahng GH, Jin C, Kwon S, Cho SY, Park SU, Jung WS, Moon SK, Ko CN, Park JM.","BMC Complement Med Ther. 2021 Oct 7;21(1):251. doi: 10.1186/s12906-021-03428-6.","Shin HY","BMC Complement Med Ther","2021","2021/10/08","PMC8495912","","10.1186/s12906-021-03428-6"
"3771502","Opiate antagonism fails to reverse post-ECT cognitive deficits","Nasrallah HA, Varney N, Coffman JA, Bayless J, Chapman S.","J Clin Psychiatry. 1986 Nov;47(11):555-6.","Nasrallah HA","J Clin Psychiatry","1986","1986/11/01","","",""
"26433119","Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment","Köbe T, Witte AV, Schnelle A, Lesemann A, Fabian S, Tesky VA, Pantel J, Flöel A.","Neuroimage. 2016 May 1;131:226-38. doi: 10.1016/j.neuroimage.2015.09.050. Epub 2015 Oct 1.","Köbe T","Neuroimage","2016","2015/10/04","","","10.1016/j.neuroimage.2015.09.050"
"25536218","A randomized, placebo controlled pilot trial of botulinum toxin for paratonic rigidity in people with advanced cognitive impairment","Kleiner-Fisman G, Khoo E, Moncrieffe N, Forbell T, Gryfe P, Fisman D.","PLoS One. 2014 Dec 23;9(12):e114733. doi: 10.1371/journal.pone.0114733. eCollection 2014.","Kleiner-Fisman G","PLoS One","2014","2014/12/24","PMC4275182","","10.1371/journal.pone.0114733"
"8872421","The enhancing effect of pyridostigmine on the GH response to GHRH undergoes an accelerated age-related reduction in Down syndrome","Arvat E, Gianotti L, Ragusa L, Valetto MR, Cappa M, Aimaretti G, Ramunni J, Grottoli S, Camanni F, Ghigo E.","Dementia. 1996 Sep-Oct;7(5):288-92. doi: 10.1159/000106894.","Arvat E","Dementia","1996","1996/09/01","","","10.1159/000106894"
"29614659","Cardiorespiratory Fitness and Cognitive Function are Positively Related Among Participants with Mild and Subjective Cognitive Impairment","Stuckenschneider T, Askew CD, Rüdiger S, Polidori MC, Abeln V, Vogt T, Krome A, Olde Rikkert M, Lawlor B, Schneider S; NeuroExercise Study Group.","J Alzheimers Dis. 2018;62(4):1865-1875. doi: 10.3233/JAD-170996.","Stuckenschneider T","J Alzheimers Dis","2018","2018/04/05","","","10.3233/JAD-170996"
"23563246","Predictors of progression from mild cognitive impairment to dementia in the placebo-arm of a clinical trial population","Prins ND, van der Flier WM, Brashear HR, Knol DL, van de Pol LA, Barkhof F, Scheltens P.","J Alzheimers Dis. 2013;36(1):79-85. doi: 10.3233/JAD-122233.","Prins ND","J Alzheimers Dis","2013","2013/04/09","","","10.3233/JAD-122233"
"24345444","Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial","Seritan AL, Nguyen DV, Mu Y, Tassone F, Bourgeois JA, Schneider A, Cogswell JB, Cook KR, Leehey MA, Grigsby J, Olichney JM, Adams PE, Legg W, Zhang L, Hagerman PJ, Hagerman RJ.","J Clin Psychiatry. 2014 Mar;75(3):264-71. doi: 10.4088/JCP.13m08546.","Seritan AL","J Clin Psychiatry","2014","2013/12/19","PMC4296896","NIHMS654109","10.4088/JCP.13m08546"
"15054065","Identification and differential vulnerability of a neural network in sleep deprivation","Bell-McGinty S, Habeck C, Hilton HJ, Rakitin B, Scarmeas N, Zarahn E, Flynn J, DeLaPaz R, Basner R, Stern Y.","Cereb Cortex. 2004 May;14(5):496-502. doi: 10.1093/cercor/bhh011. Epub 2004 Mar 28.","Bell-McGinty S","Cereb Cortex","2004","2004/04/01","","","10.1093/cercor/bhh011"
"9818867","Dopamine agonists reorient visual exploration away from the neglected hemispace","Grujic Z, Mapstone M, Gitelman DR, Johnson N, Weintraub S, Hays A, Kwasnica C, Harvey R, Mesulam MM.","Neurology. 1998 Nov;51(5):1395-8. doi: 10.1212/wnl.51.5.1395.","Grujic Z","Neurology","1998","1998/11/18","","","10.1212/wnl.51.5.1395"
"7963203","A nutritional index predicting mortality in the nursing home","Frisoni GB, Franzoni S, Rozzini R, Ferrucci L, Boffelli S, Trabucchi M.","J Am Geriatr Soc. 1994 Nov;42(11):1167-72. doi: 10.1111/j.1532-5415.1994.tb06983.x.","Frisoni GB","J Am Geriatr Soc","1994","1994/11/01","","","10.1111/j.1532-5415.1994.tb06983.x"
"29020806","Transcranial static magnetic field stimulation (tSMS) of the visual cortex decreases experimental photophobia","Lozano-Soto E, Soto-León V, Sabbarese S, Ruiz-Alvarez L, Sanchez-Del-Rio M, Aguilar J, Strange BA, Foffani G, Oliviero A.","Cephalalgia. 2018 Jul;38(8):1493-1497. doi: 10.1177/0333102417736899. Epub 2017 Oct 11.","Lozano-Soto E","Cephalalgia","2018","2017/10/13","","","10.1177/0333102417736899"
"16417422","Menopausal Vasomotor Symptoms (MVS) survey for assessment of hot flashes","Ratka A, Miller V, Brown K, Raut A, Cipher D, Meczekalski B, Simpkins JW.","J Womens Health (Larchmt). 2006 Jan-Feb;15(1):77-89. doi: 10.1089/jwh.2006.15.77.","Ratka A","J Womens Health (Larchmt)","2006","2006/01/19","","","10.1089/jwh.2006.15.77"
"12578932","Ecological implications of ideomotor apraxia: evidence from physical activities of daily living","Hanna-Pladdy B, Heilman KM, Foundas AL.","Neurology. 2003 Feb 11;60(3):487-90. doi: 10.1212/wnl.60.3.487.","Hanna-Pladdy B","Neurology","2003","2003/02/13","","","10.1212/wnl.60.3.487"
"15893473","Language network specializations: an analysis with parallel task designs and functional magnetic resonance imaging","Gitelman DR, Nobre AC, Sonty S, Parrish TB, Mesulam MM.","Neuroimage. 2005 Jul 15;26(4):975-85. doi: 10.1016/j.neuroimage.2005.03.014.","Gitelman DR","Neuroimage","2005","2005/05/17","","","10.1016/j.neuroimage.2005.03.014"
"14642482","Relation of cognitive reserve and task performance to expression of regional covariance networks in an event-related fMRI study of nonverbal memory","Habeck C, Hilton HJ, Zarahn E, Flynn J, Moeller J, Stern Y.","Neuroimage. 2003 Nov;20(3):1723-33. doi: 10.1016/j.neuroimage.2003.07.032.","Habeck C","Neuroimage","2003","2003/12/04","","","10.1016/j.neuroimage.2003.07.032"
"24993765","Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study","Stubendorff K, Larsson V, Ballard C, Minthon L, Aarsland D, Londos E.","BMJ Open. 2014 Jul 3;4(7):e005158. doi: 10.1136/bmjopen-2014-005158.","Stubendorff K","BMJ Open","2014","2014/07/05","PMC4091277","","10.1136/bmjopen-2014-005158"
"31598893","Methods for Gait Analysis During Obstacle Avoidance Task","Patashov D, Menahem Y, Ben-Haim O, Gazit E, Maidan I, Mirelman A, Sosnik R, Goldstein D, Hausdorff JM.","Ann Biomed Eng. 2020 Feb;48(2):634-643. doi: 10.1007/s10439-019-02380-4. Epub 2019 Oct 9.","Patashov D","Ann Biomed Eng","2020","2019/10/11","","","10.1007/s10439-019-02380-4"
"14766439","Cortical gray matter volumes are associated with subjective responses to cocaine infusion","Bartzokis G, Beckson M, Lu PH, Edwards N, Rapoport R, Bridge P, Mintz J.","Am J Addict. 2004 Jan-Feb;13(1):64-73. doi: 10.1080/10550490490265352.","Bartzokis G","Am J Addict","2004","2004/02/10","","","10.1080/10550490490265352"
"11163257","Imaging physiologic dysfunction of individual hippocampal subregions in humans and genetically modified mice","Small SA, Wu EX, Bartsch D, Perera GM, Lacefield CO, DeLaPaz R, Mayeux R, Stern Y, Kandel ER.","Neuron. 2000 Dec;28(3):653-64. doi: 10.1016/s0896-6273(00)00144-6.","Small SA","Neuron","2000","2001/02/13","","","10.1016/s0896-6273(00)00144-6"
"35854137","Comparison of Botulinum neurotoxin efficiency in dystonia associated with Parkinson's disease and atypical parkinsonism: a retrospective study with a self-reported improvement scale","Lapostolle A, Houot M, Mongin M, Degos B.","J Neurol. 2022 Nov;269(11):6021-6028. doi: 10.1007/s00415-022-11280-y. Epub 2022 Jul 19.","Lapostolle A","J Neurol","2022","2022/07/19","","","10.1007/s00415-022-11280-y"
"32732104","A Randomized Controlled Trial of High-Intensity Exercise and Executive Functioning in Cognitively Normal Older Adults","Frost NJ, Weinborn M, Gignac GE, Rainey-Smith SR, Markovic S, Gordon N, Sohrabi HR, Laws SM, Martins RN, Peiffer JJ, Brown BM.","Am J Geriatr Psychiatry. 2021 Feb;29(2):129-140. doi: 10.1016/j.jagp.2020.06.015. Epub 2020 Jun 21.","Frost NJ","Am J Geriatr Psychiatry","2021","2020/08/01","","","10.1016/j.jagp.2020.06.015"
"32250301","Increased Cerebrospinal Fluid Amyloid-β During Sleep Deprivation in Healthy Middle-Aged Adults Is Not Due to Stress or Circadian Disruption","Blattner MS, Panigrahi SK, Toedebusch CD, Hicks TJ, McLeland JS, Banks IR, Schaibley C, Ovod V, Mawuenyega KG, Bateman RJ, Wardlaw SL, Lucey BP.","J Alzheimers Dis. 2020;75(2):471-482. doi: 10.3233/JAD-191122.","Blattner MS","J Alzheimers Dis","2020","2020/04/07","PMC7246155","NIHMS1580393","10.3233/JAD-191122"
"22869065","Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial","Baker LD, Barsness SM, Borson S, Merriam GR, Friedman SD, Craft S, Vitiello MV.","Arch Neurol. 2012 Nov;69(11):1420-9. doi: 10.1001/archneurol.2012.1970.","Baker LD","Arch Neurol","2012","2012/08/08","PMC3764914","NIHMS508242","10.1001/archneurol.2012.1970"
"20040554","Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial","Snitz BE, O'Meara ES, Carlson MC, Arnold AM, Ives DG, Rapp SR, Saxton J, Lopez OL, Dunn LO, Sink KM, DeKosky ST; Ginkgo Evaluation of Memory (GEM) Study Investigators.","JAMA. 2009 Dec 23;302(24):2663-70. doi: 10.1001/jama.2009.1913.","Snitz BE","JAMA","2009","2009/12/31","PMC2832285","NIHMS168866","10.1001/jama.2009.1913"
"23689947","Growth hormone-releasing hormone effects on brain γ-aminobutyric acid levels in mild cognitive impairment and healthy aging","Friedman SD, Baker LD, Borson S, Jensen JE, Barsness SM, Craft S, Merriam GR, Otto RK, Novotny EJ, Vitiello MV.","JAMA Neurol. 2013 Jul;70(7):883-90. doi: 10.1001/jamaneurol.2013.1425.","Friedman SD","JAMA Neurol","2013","2013/05/22","PMC3764915","NIHMS508241","10.1001/jamaneurol.2013.1425"
"10536645","Life stress, mood disturbance, and elevated interleukin-6 in healthy older women","Lutgendorf SK, Garand L, Buckwalter KC, Reimer TT, Hong SY, Lubaroff DM.","J Gerontol A Biol Sci Med Sci. 1999 Sep;54(9):M434-9. doi: 10.1093/gerona/54.9.m434.","Lutgendorf SK","J Gerontol A Biol Sci Med Sci","1999","1999/10/28","PMC6642656","NIHMS1041332","10.1093/gerona/54.9.m434"
"33522961","High-intensity exercise and cognitive function in cognitively normal older adults: a pilot randomised clinical trial","Brown BM, Frost N, Rainey-Smith SR, Doecke J, Markovic S, Gordon N, Weinborn M, Sohrabi HR, Laws SM, Martins RN, Erickson KI, Peiffer JJ.","Alzheimers Res Ther. 2021 Feb 1;13(1):33. doi: 10.1186/s13195-021-00774-y.","Brown BM","Alzheimers Res Ther","2021","2021/02/01","PMC7849126","","10.1186/s13195-021-00774-y"
"26018225","The effect of cognitive-motor dual-task training on cognitive function and plasma amyloid β peptide 42/40 ratio in healthy elderly persons: a randomized controlled trial","Yokoyama H, Okazaki K, Imai D, Yamashina Y, Takeda R, Naghavi N, Ota A, Hirasawa Y, Miyagawa T.","BMC Geriatr. 2015 May 28;15:60. doi: 10.1186/s12877-015-0058-4.","Yokoyama H","BMC Geriatr","2015","2015/05/29","PMC4446802","","10.1186/s12877-015-0058-4"
"23438937","Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine","Banerjee S, Hellier J, Romeo R, Dewey M, Knapp M, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A.","Health Technol Assess. 2013 Feb;17(7):1-166. doi: 10.3310/hta17070.","Banerjee S","Health Technol Assess","2013","2013/02/27","PMC4782811","","10.3310/hta17070"
"28442236","Red blood cell membrane omega-3 fatty acid levels and physical performance: Cross-sectional data from the MAPT study","Fougère B, de Souto Barreto P, Goisser S, Soriano G, Guyonnet S, Andrieu S, Vellas B; MAPT Study Group.","Clin Nutr. 2018 Aug;37(4):1141-1144. doi: 10.1016/j.clnu.2017.04.005. Epub 2017 Apr 12.","Fougère B","Clin Nutr","2018","2017/04/27","","","10.1016/j.clnu.2017.04.005"
"28501537","Effects of Exercise on Liver Fat and Metabolism in Alcohol Drinkers","Houghton D, Hallsworth K, Thoma C, Cassidy S, Hardy T, Heaps S, Hollingsworth KG, Taylor R, Day CP, Masson S, McPherson S, Anstee QM, Trenell MI.","Clin Gastroenterol Hepatol. 2017 Oct;15(10):1596-1603.e3. doi: 10.1016/j.cgh.2017.05.001. Epub 2017 May 10.","Houghton D","Clin Gastroenterol Hepatol","2017","2017/05/15","","","10.1016/j.cgh.2017.05.001"
"23211271","REMCARE: reminiscence groups for people with dementia and their family caregivers - effectiveness and cost-effectiveness pragmatic multicentre randomised trial","Woods RT, Bruce E, Edwards RT, Elvish R, Hoare Z, Hounsome B, Keady J, Moniz-Cook ED, Orgeta V, Orrell M, Rees J, Russell IT.","Health Technol Assess. 2012;16(48):v-xv, 1-116. doi: 10.3310/hta16480.","Woods RT","Health Technol Assess","2012","2012/12/06","","","10.3310/hta16480"
"27091813","BRIGHTEN Heart: Design and baseline characteristics of a randomized controlled trial for minority older adults with depression and cardiometabolic syndrome","Rothschild SK, Emery-Tiburcio EE, Mack LJ, Wang Y, Avery EF, Li H, Golden RL, Powell LH.","Contemp Clin Trials. 2016 May;48:99-109. doi: 10.1016/j.cct.2016.04.008. Epub 2016 Apr 16.","Rothschild SK","Contemp Clin Trials","2016","2016/04/20","PMC5975636","NIHMS968015","10.1016/j.cct.2016.04.008"
"35340008","Therapeutic Touch in the Management of Responsive Behaviors in Patients with Dementia","Senderovich H, Gardner S, Berall A, Shultz R, Grant B, Santaguida V.","Dement Geriatr Cogn Disord. 2022;51(2):142-149. doi: 10.1159/000523752. Epub 2022 Mar 25.","Senderovich H","Dement Geriatr Cogn Disord","2022","2022/03/27","","","10.1159/000523752"
"34847159","Bacterial variation in the oral microbiota in multiple sclerosis patients","Zangeneh Z, Abdi-Ali A, Khamooshian K, Alvandi A, Abiri R.","PLoS One. 2021 Nov 30;16(11):e0260384. doi: 10.1371/journal.pone.0260384. eCollection 2021.","Zangeneh Z","PLoS One","2021","2021/11/30","PMC8631616","","10.1371/journal.pone.0260384"
"30604204","Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sjögren's syndrome: a randomized-controlled trial","Miyamoto ST, Valim V, Carletti L, Ng WF, Perez AJ, Lendrem DW, Trennel M, Giovelli RA, Dias LH, Serrano ÉV, Subtil AM, Abreu VC, Natour J.","Rheumatol Int. 2019 Feb;39(2):227-238. doi: 10.1007/s00296-018-4213-z. Epub 2019 Jan 2.","Miyamoto ST","Rheumatol Int","2019","2019/01/04","","","10.1007/s00296-018-4213-z"
"27000224","Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study","Peyro Saint Paul L, Creveuil C, Heinzlef O, De Seze J, Vermersch P, Castelnovo G, Cabre P, Debouverie M, Brochet B, Dupuy B, Lebiez P, Sartori É, Clavelou P, Brassat D, Lebrun-Frenay C, Daplaud D, Pelletier J, Coman I, Hautecoeur P, Tourbah A, Defer G.","J Neurol Sci. 2016 Apr 15;363:69-76. doi: 10.1016/j.jns.2016.02.012. Epub 2016 Feb 6.","Peyro Saint Paul L","J Neurol Sci","2016","2016/03/23","","","10.1016/j.jns.2016.02.012"
"35104057","Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkers","Berger M, Browndyke JN, Cooter Wright M, Nobuhara C, Reese M, Acker L, Bullock WM, Colin BJ, Devinney MJ, Moretti EW, Moul JW, Ohlendorf B, Laskowitz DT, Waligorska T, Shaw LM, Whitson HE, Cohen HJ, Mathew JP; MADCO-PC Investigators.","Ann Clin Transl Neurol. 2022 Feb;9(2):155-170. doi: 10.1002/acn3.51499. Epub 2022 Feb 1.","Berger M","Ann Clin Transl Neurol","2022","2022/02/01","PMC8862419","","10.1002/acn3.51499"
"26305649","Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial","Chew EY, Clemons TE, Agrón E, Launer LJ, Grodstein F, Bernstein PS; Age-Related Eye Disease Study 2 (AREDS2) Research Group.","JAMA. 2015 Aug 25;314(8):791-801. doi: 10.1001/jama.2015.9677.","Chew EY","JAMA","2015","2015/08/26","PMC5369607","NIHMS850016","10.1001/jama.2015.9677"
"15718046","1H MRS in stroke patients with and without cognitive impairment","Ross AJ, Sachdev PS, Wen W, Valenzuela MJ, Brodaty H.","Neurobiol Aging. 2005 Jun;26(6):873-82. doi: 10.1016/j.neurobiolaging.2004.07.008.","Ross AJ","Neurobiol Aging","2005","2005/02/19","","","10.1016/j.neurobiolaging.2004.07.008"
"31395425","The Effect of Continuous Theta-Burst Transcranial Magnetic Stimulation Combined with Prism Adaptation on the Neglect Recovery in Stroke Patients","Vatanparasti S, Kazemnejad A, Yoonessi A, Oveisgharan S.","J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104296. doi: 10.1016/j.jstrokecerebrovasdis.2019.07.012. Epub 2019 Aug 6.","Vatanparasti S","J Stroke Cerebrovasc Dis","2019","2019/08/10","","","10.1016/j.jstrokecerebrovasdis.2019.07.012"
"22179158","Acute exercise improves cognition in the depressed elderly: the effect of dual-tasks","Vasques PE, Moraes H, Silveira H, Deslandes AC, Laks J.","Clinics (Sao Paulo). 2011;66(9):1553-7. doi: 10.1590/s1807-59322011000900008.","Vasques PE","Clinics (Sao Paulo)","2011","2011/12/20","PMC3164403","","10.1590/s1807-59322011000900008"
"12815506","Exploring the neural basis of cognitive reserve","Stern Y, Zarahn E, Hilton HJ, Flynn J, DeLaPaz R, Rakitin B.","J Clin Exp Neuropsychol. 2003 Aug;25(5):691-701. doi: 10.1076/jcen.25.5.691.14573.","Stern Y","J Clin Exp Neuropsychol","2003","2003/06/20","","","10.1076/jcen.25.5.691.14573"
"36905632","Driving practice effects for older drivers with mild cognitive impairment: A preliminary study","Cheng YH, Pai MC, Shih BH, Jan SS, Lin CY, Chang LH.","Scand J Occup Ther. 2023 May;30(4):550-558. doi: 10.1080/11038128.2023.2184420. Epub 2023 Mar 11.","Cheng YH","Scand J Occup Ther","2023","2023/03/11","","","10.1080/11038128.2023.2184420"
"30460747","Results from a person-centered music intervention for individuals living with dementia","Ihara ES, Tompkins CJ, Inoue M, Sonneman S.","Geriatr Gerontol Int. 2019 Jan;19(1):30-34. doi: 10.1111/ggi.13563. Epub 2018 Nov 20.","Ihara ES","Geriatr Gerontol Int","2019","2018/11/22","","","10.1111/ggi.13563"
"12932433","Glucose enhancement of face recognition is unaffected by alterations of face features","Metzger MM, Flint RW.","Neurobiol Learn Mem. 2003 Sep;80(2):172-5. doi: 10.1016/s1074-7427(03)00058-3.","Metzger MM","Neurobiol Learn Mem","2003","2003/08/23","","","10.1016/s1074-7427(03)00058-3"
"20798612","Pilot trial of memantine in primary progressive aphasia","Johnson NA, Rademaker A, Weintraub S, Gitelman D, Wienecke C, Mesulam M.","Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):308. doi: 10.1097/WAD.0b013e3181cf468d.","Johnson NA","Alzheimer Dis Assoc Disord","2010","2010/08/28","PMC2952417","NIHMS239828","10.1097/WAD.0b013e3181cf468d"
"25656074","Dementia Care Management in an Underserved Community: The Comparative Effectiveness of Two Different Approaches","Chodosh J, Colaiaco BA, Connor KI, Cope DW, Liu H, Ganz DA, Richman MJ, Cherry DL, Blank JM, Carbone Rdel P, Wolf SM, Vickrey BG.","J Aging Health. 2015 Aug;27(5):864-93. doi: 10.1177/0898264315569454. Epub 2015 Feb 4.","Chodosh J","J Aging Health","2015","2015/02/07","","","10.1177/0898264315569454"
"26782852","Effects of a High-Intensity Functional Exercise Program on Dependence in Activities of Daily Living and Balance in Older Adults with Dementia","Toots A, Littbrand H, Lindelöf N, Wiklund R, Holmberg H, Nordström P, Lundin-Olsson L, Gustafson Y, Rosendahl E.","J Am Geriatr Soc. 2016 Jan;64(1):55-64. doi: 10.1111/jgs.13880.","Toots A","J Am Geriatr Soc","2016","2016/01/20","PMC4722852","","10.1111/jgs.13880"
"29671901","Using dolls for therapeutic purposes: A study on nursing home residents with severe dementia","Cantarella A, Borella E, Faggian S, Navuzzi A, De Beni R.","Int J Geriatr Psychiatry. 2018 Jul;33(7):915-925. doi: 10.1002/gps.4872. Epub 2018 Apr 19.","Cantarella A","Int J Geriatr Psychiatry","2018","2018/04/20","","","10.1002/gps.4872"
"3080461","Hyponatremia in tube-fed elderly men","Rudman D, Racette D, Rudman IW, Mattson DE, Erve PR.","J Chronic Dis. 1986;39(2):73-80. doi: 10.1016/0021-9681(86)90063-9.","Rudman D","J Chronic Dis","1986","1986/01/01","","","10.1016/0021-9681(86)90063-9"
"25609935","Comparison of strength training, aerobic training, and additional physical therapy as supplementary treatments for Parkinson's disease: pilot study","Carvalho A, Barbirato D, Araujo N, Martins JV, Cavalcanti JL, Santos TM, Coutinho ES, Laks J, Deslandes AC.","Clin Interv Aging. 2015 Jan 7;10:183-91. doi: 10.2147/CIA.S68779. eCollection 2015.","Carvalho A","Clin Interv Aging","2015","2015/01/23","PMC4293290","","10.2147/CIA.S68779"
"33557254","Benefits of Dog-Assisted Therapy in Patients with Dementia Residing in Aged Care Centers in Spain","Vegue Parra E, Hernández Garre JM, Echevarría Pérez P.","Int J Environ Res Public Health. 2021 Feb 4;18(4):1471. doi: 10.3390/ijerph18041471.","Vegue Parra E","Int J Environ Res Public Health","2021","2021/02/09","PMC7914582","","10.3390/ijerph18041471"
"29460337","A pilot study to evaluate the effectiveness of an individualized and cognitive behavioural communication intervention for informal carers of people with dementia: The Talking Sense programme","Barnes CJ, Markham C.","Int J Lang Commun Disord. 2018 May;53(3):615-627. doi: 10.1111/1460-6984.12375. Epub 2018 Feb 20.","Barnes CJ","Int J Lang Commun Disord","2018","2018/02/21","","","10.1111/1460-6984.12375"
"31401841","Impact of Zumba on Cognition and Quality of Life is Independent of APOE4 Carrier Status in Cognitively Unimpaired Older Women: A 6-Month Randomized Controlled Pilot Study","Stonnington CM, Krell-Roesch J, Locke DEC, Hentz JG, Dueck AC, Geda YE, Tariot PN, Caselli RJ.","Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317519868370. doi: 10.1177/1533317519868370. Epub 2019 Aug 11.","Stonnington CM","Am J Alzheimers Dis Other Demen","2020","2019/08/13","","","10.1177/1533317519868370"
"29914518","SPARC: a new approach to quantifying gait smoothness in patients with Parkinson's disease","Beck Y, Herman T, Brozgol M, Giladi N, Mirelman A, Hausdorff JM.","J Neuroeng Rehabil. 2018 Jun 18;15(1):49. doi: 10.1186/s12984-018-0398-3.","Beck Y","J Neuroeng Rehabil","2018","2018/06/20","PMC6006701","","10.1186/s12984-018-0398-3"
"9667603","The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia","Geschwind D, Karrim J, Nelson SF, Miller B.","Ann Neurol. 1998 Jul;44(1):134-8. doi: 10.1002/ana.410440122.","Geschwind D","Ann Neurol","1998","1998/07/17","","","10.1002/ana.410440122"
"30616998","Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study","Justice JN, Nambiar AM, Tchkonia T, LeBrasseur NK, Pascual R, Hashmi SK, Prata L, Masternak MM, Kritchevsky SB, Musi N, Kirkland JL.","EBioMedicine. 2019 Feb;40:554-563. doi: 10.1016/j.ebiom.2018.12.052. Epub 2019 Jan 5.","Justice JN","EBioMedicine","2019","2019/01/09","PMC6412088","","10.1016/j.ebiom.2018.12.052"
"30874799","A Multimodal Training Modulates Short Afferent Inhibition and Improves Complex Walking in a Cohort of Faller Older Adults With an Increased Prevalence of Parkinson's Disease","Pelosin E, Cerulli C, Ogliastro C, Lagravinese G, Mori L, Bonassi G, Mirelman A, Hausdorff JM, Abbruzzese G, Marchese R, Avanzino L.","J Gerontol A Biol Sci Med Sci. 2020 Mar 9;75(4):722-728. doi: 10.1093/gerona/glz072.","Pelosin E","J Gerontol A Biol Sci Med Sci","2020","2019/03/16","","","10.1093/gerona/glz072"
"35639376","Association of Dual Decline in Cognition and Gait Speed With Risk of Dementia in Older Adults","Collyer TA, Murray AM, Woods RL, Storey E, Chong TT, Ryan J, Orchard SG, Brodtmann A, Srikanth VK, Shah RC, Callisaya ML.","JAMA Netw Open. 2022 May 2;5(5):e2214647. doi: 10.1001/jamanetworkopen.2022.14647.","Collyer TA","JAMA Netw Open","2022","2022/05/31","PMC9157262","","10.1001/jamanetworkopen.2022.14647"
"34103345","Diffusion-weighted imaging lesions and risk of recurrent stroke after intracerebral haemorrhage","Wiegertjes K, Dinsmore L, Drever J, Hutchison A, Stephen J, Valdés Hernández MC, Bhatnagar P, Minks DP, Rodrigues MA, Werring DJ, de Leeuw FE, Klijn CJ, Al-Shahi Salman R, White PM, Wardlaw JM.","J Neurol Neurosurg Psychiatry. 2021 Sep;92(9):950-955. doi: 10.1136/jnnp-2021-326116. Epub 2021 Jun 8.","Wiegertjes K","J Neurol Neurosurg Psychiatry","2021","2021/06/09","","","10.1136/jnnp-2021-326116"
"33323224","Healthy ageing through internet counselling in the elderly (HATICE): a multinational, randomised controlled trial","Richard E, Moll van Charante EP, Hoevenaar-Blom MP, Coley N, Barbera M, van der Groep A, Meiller Y, Mangialasche F, Beishuizen CB, Jongstra S, van Middelaar T, Van Wanrooij LL, Ngandu T, Guillemont J, Andrieu S, Brayne C, Kivipelto M, Soininen H, Van Gool WA.","Lancet Digit Health. 2019 Dec;1(8):e424-e434. doi: 10.1016/S2589-7500(19)30153-0. Epub 2019 Nov 14.","Richard E","Lancet Digit Health","2019","2020/12/16","","","10.1016/S2589-7500(19)30153-0"
"29448219","Gait & Posture Special Issue: Gait adaptations in response to obstacle type in fallers with Parkinson's disease","Alcock L, Galna B, Hausdorff JM, Lord S, Rochester L.","Gait Posture. 2018 Mar;61:368-374. doi: 10.1016/j.gaitpost.2018.01.030. Epub 2018 Jan 31.","Alcock L","Gait Posture","2018","2018/02/16","","","10.1016/j.gaitpost.2018.01.030"
"12442883","A double-blind, randomised comparative trial of amisulpride versus olanzapine in the treatment of schizophrenia: short-term results at two months","Martin S, Lĵo H, Peuskens J, Thirumalai S, Giudicelli A, Fleurot O, Rein W; SOLIANOL Study Group.","Curr Med Res Opin. 2002;18(6):355-62. doi: 10.1185/030079902125001128.","Martin S","Curr Med Res Opin","2002","2002/11/22","","","10.1185/030079902125001128"
"28670911","Bioequivalence Study of Rivastigmine 6 mg Capsules (Single Dose) in Healthy Volunteers","Abhyankar D, Shedage A, Gole M, Raut P.","Am J Alzheimers Dis Other Demen. 2017 Sep;32(6):360-366. doi: 10.1177/1533317517712890. Epub 2017 Jul 3.","Abhyankar D","Am J Alzheimers Dis Other Demen","2017","2017/07/04","","","10.1177/1533317517712890"
"24411709","Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial","Haïk S, Marcon G, Mallet A, Tettamanti M, Welaratne A, Giaccone G, Azimi S, Pietrini V, Fabreguettes JR, Imperiale D, Cesaro P, Buffa C, Aucan C, Lucca U, Peckeu L, Suardi S, Tranchant C, Zerr I, Houillier C, Redaelli V, Vespignani H, Campanella A, Sellal F, Krasnianski A, Seilhean D, Heinemann U, Sedel F, Canovi M, Gobbi M, Di Fede G, Laplanche JL, Pocchiari M, Salmona M, Forloni G, Brandel JP, Tagliavini F.","Lancet Neurol. 2014 Feb;13(2):150-8. doi: 10.1016/S1474-4422(13)70307-7. Epub 2014 Jan 8.","Haïk S","Lancet Neurol","2014","2014/01/14","","","10.1016/S1474-4422(13)70307-7"
"29436740","Multitarget transcranial direct current stimulation for freezing of gait in Parkinson's disease","Dagan M, Herman T, Harrison R, Zhou J, Giladi N, Ruffini G, Manor B, Hausdorff JM.","Mov Disord. 2018 Apr;33(4):642-646. doi: 10.1002/mds.27300. Epub 2018 Feb 13.","Dagan M","Mov Disord","2018","2018/02/14","PMC5964604","NIHMS966765","10.1002/mds.27300"
"12794387","Interchanging scores between clinical dementia rating scale and global deterioration scale","Choi SH, Lee BH, Kim S, Hahm DS, Jeong JH, Yoon SJ, Jeong Y, Ha CK, Nab DL.","Alzheimer Dis Assoc Disord. 2003 Apr-Jun;17(2):98-105. doi: 10.1097/00002093-200304000-00008.","Choi SH","Alzheimer Dis Assoc Disord","2003","2003/06/10","","","10.1097/00002093-200304000-00008"
"34656952","Consumption of peanut products improves memory and stress response in healthy adults from the ARISTOTLE study: A 6-month randomized controlled trial","Parilli-Moser I, Domínguez-López I, Trius-Soler M, Castellví M, Bosch B, Castro-Barquero S, Estruch R, Hurtado-Barroso S, Lamuela-Raventós RM.","Clin Nutr. 2021 Nov;40(11):5556-5567. doi: 10.1016/j.clnu.2021.09.020. Epub 2021 Sep 20.","Parilli-Moser I","Clin Nutr","2021","2021/10/17","","","10.1016/j.clnu.2021.09.020"
"29580209","Physical activity and fitness are associated with verbal memory, quality of life and depression among nursing home residents: preliminary data of a randomized controlled trial","Arrieta H, Rezola-Pardo C, Echeverria I, Iturburu M, Gil SM, Yanguas JJ, Irazusta J, Rodriguez-Larrad A.","BMC Geriatr. 2018 Mar 27;18(1):80. doi: 10.1186/s12877-018-0770-y.","Arrieta H","BMC Geriatr","2018","2018/03/28","PMC5869769","","10.1186/s12877-018-0770-y"
"24871547","Memantine effects on verbal memory in fragile X-associated tremor/ataxia syndrome (FXTAS): a double-blind brain potential study","Yang JC, Niu YQ, Simon C, Seritan AL, Chen L, Schneider A, Moghaddam ST, Hagerman PJ, Hagerman RJ, Olichney JM.","Neuropsychopharmacology. 2014 Nov;39(12):2760-8. doi: 10.1038/npp.2014.122. Epub 2014 May 29.","Yang JC","Neuropsychopharmacology","2014","2014/05/30","PMC4200486","","10.1038/npp.2014.122"
"20850878","Influence of regular exercise on subjective sense of burden and physical symptoms in community-dwelling caregivers of dementia patients: a randomized controlled trial","Hirano A, Suzuki Y, Kuzuya M, Onishi J, Ban N, Umegaki H.","Arch Gerontol Geriatr. 2011 Sep-Oct;53(2):e158-63. doi: 10.1016/j.archger.2010.08.004. Epub 2010 Sep 17.","Hirano A","Arch Gerontol Geriatr","2011","2010/09/21","","","10.1016/j.archger.2010.08.004"
"31654268","Biomarkers of leaky gut are related to inflammation and reduced physical function in older adults with cardiometabolic disease and mobility limitations","Kavanagh K, Hsu FC, Davis AT, Kritchevsky SB, Rejeski WJ, Kim S.","Geroscience. 2019 Dec;41(6):923-933. doi: 10.1007/s11357-019-00112-z. Epub 2019 Oct 25.","Kavanagh K","Geroscience","2019","2019/10/27","PMC6925090","","10.1007/s11357-019-00112-z"
"10634129","The O-demethylation of the antidementia drug galanthamine is catalysed by cytochrome P450 2D6","Bachus R, Bickel U, Thomsen T, Roots I, Kewitz H.","Pharmacogenetics. 1999 Dec;9(6):661-8.","Bachus R","Pharmacogenetics","1999","2000/01/14","","",""
"2201659","Acetyl-L-carnitine in the treatment of mildly demented elderly patients","Passeri M, Cucinotta D, Bonati PA, Iannuccelli M, Parnetti L, Senin U.","Int J Clin Pharmacol Res. 1990;10(1-2):75-9.","Passeri M","Int J Clin Pharmacol Res","1990","1990/01/01","","",""
"16856579","Necessity of a uniform start for scanning after FDG injection in brain PET study","Ishii K, Higashi Y, Tabata M, Miyaishi M, Mizutani T, Sasaki M.","Ann Nucl Med. 2006 May;20(4):329-31. doi: 10.1007/BF02984652.","Ishii K","Ann Nucl Med","2006","2006/07/22","","","10.1007/BF02984652"
"24697702","Effect of the bathing without a battle training intervention on bathing-associated physical and verbal outcomes in nursing home residents with dementia: a randomized crossover diffusion study","Gozalo P, Prakash S, Qato DM, Sloane PD, Mor V.","J Am Geriatr Soc. 2014 May;62(5):797-804. doi: 10.1111/jgs.12777. Epub 2014 Apr 2.","Gozalo P","J Am Geriatr Soc","2014","2014/04/05","PMC5584541","NIHMS895085","10.1111/jgs.12777"
"31738191","Local Health Jurisdiction Staff Deliver Health Promotion to Small Worksites, Washington","Harris JR, Hammerback K, Brown M, Ryan DE, Coe NB, Pike KJ, Santiago PM, Hannon PA.","J Public Health Manag Pract. 2021 Mar-Apr 01;27(2):117-124. doi: 10.1097/PHH.0000000000001105.","Harris JR","J Public Health Manag Pract","2021","2019/11/19","PMC7220816","NIHMS1540878","10.1097/PHH.0000000000001105"
"34786992","Preventive effect of greater occipital nerve block on patients with episodic migraine: A randomized double-blind placebo-controlled clinical trial","Malekian N, Bastani PB, Oveisgharan S, Nabaei G, Abdi S.","Cephalalgia. 2022 May;42(6):481-489. doi: 10.1177/03331024211058182. Epub 2021 Nov 17.","Malekian N","Cephalalgia","2022","2021/11/17","","","10.1177/03331024211058182"
"23358884","Cardiac disease associated with increased risk of nonamnestic cognitive impairment: stronger effect on women","Roberts RO, Geda YE, Knopman DS, Cha RH, Pankratz VS, Boeve BF, Tangalos EG, Ivnik RJ, Mielke MM, Petersen RC.","JAMA Neurol. 2013 Mar 1;70(3):374-82. doi: 10.1001/jamaneurol.2013.607.","Roberts RO","JAMA Neurol","2013","2013/01/30","PMC3734560","NIHMS372708","10.1001/jamaneurol.2013.607"
"28956706","Comparing the Effect of a Moderate Physical Activity Intervention on the Mental Health Outcomes of African American and Caucasian Dementia Family Caregivers: A Secondary Data Analysis","Cothran FA, Paun O, Barnes LL, Epps F, Schoeny M, Farran CJ.","Issues Ment Health Nurs. 2017 Dec;38(12):996-1004. doi: 10.1080/01612840.2017.1364807. Epub 2017 Sep 28.","Cothran FA","Issues Ment Health Nurs","2017","2017/09/29","","","10.1080/01612840.2017.1364807"
"27587328","ASPREE-D: Aspirin for the prevention of depression in the elderly","Berk M, Woods RL, Nelson MR, Shah RC, Reid CM, Storey E, Fitzgerald SM, Lockery JE, Wolfe R, Mohebbi M, Murray AM, Kirpach B, Grimm R, McNeil JJ.","Int Psychogeriatr. 2016 Oct;28(10):1741-8. doi: 10.1017/S104161021600079X. Epub 2016 May 31.","Berk M","Int Psychogeriatr","2016","2016/09/03","PMC6719794","NIHMS1048110","10.1017/S104161021600079X"
"19697298","Evaluating cognition in an elderly cohort via telephone assessment","Mitsis EM, Jacobs D, Luo X, Andrews H, Andrews K, Sano M.","Int J Geriatr Psychiatry. 2010 May;25(5):531-9. doi: 10.1002/gps.2373.","Mitsis EM","Int J Geriatr Psychiatry","2010","2009/08/22","PMC3526377","NIHMS342343","10.1002/gps.2373"
"35254390","Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial","Dolui S, Detre JA, Gaussoin SA, Herrick JS, Wang DJJ, Tamura MK, Cho ME, Haley WE, Launer LJ, Punzi HA, Rastogi A, Still CH, Weiner DE, Wright JT Jr, Williamson JD, Wright CB, Bryan RN, Bress AP, Pajewski NM, Nasrallah IM.","JAMA Neurol. 2022 Apr 1;79(4):380-389. doi: 10.1001/jamaneurol.2022.0074.","Dolui S","JAMA Neurol","2022","2022/03/07","PMC8902686","","10.1001/jamaneurol.2022.0074"
"35926332","Associations between cognitive function and endogenous levels of estradiol and testosterone in adults with type 2 diabetes","Espeland MA, Howard M, Bennett W, Robusto BA, Yasar S, Hugenschmidt CE, Luchsinger JA, Bahnson J, Yassine H, Johnson KC, Cook D, Hayden KM; Action for Health in Diabetes (Look AHEAD) MIND Ancillary Study Group.","J Diabetes Complications. 2022 Sep;36(9):108268. doi: 10.1016/j.jdiacomp.2022.108268. Epub 2022 Jul 26.","Espeland MA","J Diabetes Complications","2022","2022/08/04","","","10.1016/j.jdiacomp.2022.108268"
"28509934","The role of the prefrontal cortex in freezing of gait in Parkinson's disease: insights from a deep repetitive transcranial magnetic stimulation exploratory study","Dagan M, Herman T, Mirelman A, Giladi N, Hausdorff JM.","Exp Brain Res. 2017 Aug;235(8):2463-2472. doi: 10.1007/s00221-017-4981-9. Epub 2017 May 16.","Dagan M","Exp Brain Res","2017","2017/05/17","","","10.1007/s00221-017-4981-9"
"18454094","[Noben (idebenone) in the treatment of dementia and memory impairment without dementia]","Voronkova KV, Meleshkov MN.","Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):27-32.","Voronkova KV","Zh Nevrol Psikhiatr Im S S Korsakova","2008","2008/05/06","","",""
"27060939","Changes in Neural Connectivity and Memory Following a Yoga Intervention for Older Adults: A Pilot Study","Eyre HA, Acevedo B, Yang H, Siddarth P, Van Dyk K, Ercoli L, Leaver AM, Cyr NS, Narr K, Baune BT, Khalsa DS, Lavretsky H.","J Alzheimers Dis. 2016;52(2):673-84. doi: 10.3233/JAD-150653.","Eyre HA","J Alzheimers Dis","2016","2016/04/11","PMC4927889","","10.3233/JAD-150653"
"19935406","Safety, tolerability, and cerebrospinal fluid penetration of ursodeoxycholic Acid in patients with amyotrophic lateral sclerosis","Parry GJ, Rodrigues CM, Aranha MM, Hilbert SJ, Davey C, Kelkar P, Low WC, Steer CJ.","Clin Neuropharmacol. 2010 Jan-Feb;33(1):17-21. doi: 10.1097/WNF.0b013e3181c47569.","Parry GJ","Clin Neuropharmacol","2010","2009/11/26","","","10.1097/WNF.0b013e3181c47569"
"30201421","Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations","Brittain C, McCarthy A, Irizarry MC, McDermott D, Biglan K, Höglinger GU, Lorenzl S, Del Ser T, Boxer AL; AL-108-231 Study Group; PROPSPERA investigators; 4RNTI-1authors; Tau Restoration on PSP (TAUROS) Investigators.","Parkinsonism Relat Disord. 2019 Mar;60:138-145. doi: 10.1016/j.parkreldis.2018.08.025. Epub 2018 Sep 4.","Brittain C","Parkinsonism Relat Disord","2019","2018/09/12","PMC6399076","NIHMS1002251","10.1016/j.parkreldis.2018.08.025"
"30470592","Improving the quality of life of care home residents with dementia: Cost-effectiveness of an optimized intervention for residents with clinically significant agitation in dementia","Romeo R, Zala D, Knapp M, Orrell M, Fossey J, Ballard C.","Alzheimers Dement. 2019 Feb;15(2):282-291. doi: 10.1016/j.jalz.2018.08.010. Epub 2018 Nov 20.","Romeo R","Alzheimers Dement","2019","2018/11/25","","","10.1016/j.jalz.2018.08.010"
"35080016","Attention control in a trial of an online psychoeducational intervention for caregivers","Kovaleva M, Nocera JR, Hepburn K, Higgins M, Nash R, Epps F, Brewster G, Bilsborough E, Blumling AA, Griffiths PC.","Res Nurs Health. 2022 Jun;45(3):337-349. doi: 10.1002/nur.22208. Epub 2022 Jan 25.","Kovaleva M","Res Nurs Health","2022","2022/01/26","PMC9064916","NIHMS1771162","10.1002/nur.22208"
"29319935","Clinical Bioavailability of the Novel BACE1 Inhibitor Lanabecestat (AZD3293): Assessment of Tablet Formulations Versus an Oral Solution and the Impact of Gastric pH on Pharmacokinetics","Ye N, Monk SA, Daga P, Bender DM, Rosen LB, Mullen J, Minkwitz MC, Kugler AR.","Clin Pharmacol Drug Dev. 2018 Mar;7(3):233-243. doi: 10.1002/cpdd.422. Epub 2018 Jan 10.","Ye N","Clin Pharmacol Drug Dev","2018","2018/01/11","PMC5947295","","10.1002/cpdd.422"
"31075314","The Role of S100B in Aerobic Training Efficacy in Older Adults with Mild Vascular Cognitive Impairment: Secondary Analysis of a Randomized Controlled Trial","Barha CK, Hsiung GYR, Liu-Ambrose T.","Neuroscience. 2019 Jul 1;410:176-182. doi: 10.1016/j.neuroscience.2019.04.052. Epub 2019 May 7.","Barha CK","Neuroscience","2019","2019/05/11","","","10.1016/j.neuroscience.2019.04.052"
"30531382","A High-Intensity Exercise Boot Camp for Persons With Parkinson Disease: A Phase II, Pragmatic, Randomized Clinical Trial of Feasibility, Safety, Signal of Efficacy, and Disease Mechanisms","Landers MR, Navalta JW, Murtishaw AS, Kinney JW, Pirio Richardson S.","J Neurol Phys Ther. 2019 Jan;43(1):12-25. doi: 10.1097/NPT.0000000000000249.","Landers MR","J Neurol Phys Ther","2019","2018/12/12","","","10.1097/NPT.0000000000000249"
"10713296","Glucose enhancement of a facial recognition task in young adults","Metzger MM.","Physiol Behav. 2000 Feb;68(4):549-53. doi: 10.1016/s0031-9384(99)00215-2.","Metzger MM","Physiol Behav","2000","2000/03/14","","","10.1016/s0031-9384(99)00215-2"
"31526767","Dopamine replacement improves motor learning of an upper extremity task in people with Parkinson disease","Paul SS, Dibble LE, Olivier GN, Walter C, Duff K, Schaefer SY.","Behav Brain Res. 2020 Jan 13;377:112213. doi: 10.1016/j.bbr.2019.112213. Epub 2019 Sep 14.","Paul SS","Behav Brain Res","2020","2019/09/19","PMC7398159","NIHMS1606856","10.1016/j.bbr.2019.112213"
"35112661","Appetite and energy intake following a bout of circuit resistance training in chronic hemiparetic stroke patients: a preliminary randomized controlled trial","Dos Santos TR, Billinger SA, Midgley AW, Michalski AC, Costa VAB, Fonseca GF, Cunha FA.","Top Stroke Rehabil. 2023 May;30(4):309-322. doi: 10.1080/10749357.2022.2035577. Epub 2022 Feb 3.","Dos Santos TR","Top Stroke Rehabil","2023","2022/02/03","","","10.1080/10749357.2022.2035577"
"30670359","Personalized striatal targets for deep brain stimulation in obsessive-compulsive disorder","Barcia JA, Avecillas-Chasín JM, Nombela C, Arza R, García-Albea J, Pineda-Pardo JA, Reneses B, Strange BA.","Brain Stimul. 2019 May-Jun;12(3):724-734. doi: 10.1016/j.brs.2018.12.226. Epub 2018 Dec 20.","Barcia JA","Brain Stimul","2019","2019/01/24","","","10.1016/j.brs.2018.12.226"
"29356339","Caregiver active participation in psychoeducational intervention improved caregiving skills and competency","Tang SH, Chio OI, Chang LH, Mao HF, Chen LH, Yip PK, Hwang JP.","Geriatr Gerontol Int. 2018 May;18(5):750-757. doi: 10.1111/ggi.13246. Epub 2018 Jan 22.","Tang SH","Geriatr Gerontol Int","2018","2018/01/23","","","10.1111/ggi.13246"
"32183672","The Effects of Exposure to Recent Autobiographical Events on Declarative Memory in Amnestic Mild Cognitive Impairment: A Preliminary Pilot Study","Gelonch O, Cano N, Vancells M, Bolaños M, Farràs-Permanyer L, Garolera M.","Curr Alzheimer Res. 2020;17(2):158-167. doi: 10.2174/1567205017666200317093341.","Gelonch O","Curr Alzheimer Res","2020","2020/03/19","","","10.2174/1567205017666200317093341"
"25329433","Resistance training does not have an effect on cognition or related serum biomarkers in nonagenarians: a randomized controlled trial","Ruiz JR, Gil-Bea F, Bustamante-Ara N, Rodríguez-Romo G, Fiuza-Luces C, Serra-Rexach JA, Cedazo-Minguez A, Lucia A.","Int J Sports Med. 2015 Jan;36(1):54-60. doi: 10.1055/s-0034-1375693. Epub 2014 Oct 20.","Ruiz JR","Int J Sports Med","2015","2014/10/21","","","10.1055/s-0034-1375693"
"34817445","A Randomized Controlled Trial of the Effect of Repetitive Transcranial Magnetic Stimulation of the Motor Cortex on Lower Extremity Spasticity in Hereditary Spastic Paraplegia","Bastani PB, Kordjazi M, Oveisgharan S, Abdi S.","J Clin Neurophysiol. 2023 Feb 1;40(2):173-179. doi: 10.1097/WNP.0000000000000874. Epub 2021 Nov 23.","Bastani PB","J Clin Neurophysiol","2023","2021/11/24","","","10.1097/WNP.0000000000000874"
"29504666","A randomized trial using telehealth technology to link caregivers with dementia care experts for in-home caregiving support: FamTechCare protocol","Williams K, Blyler D, Vidoni ED, Shaw C, Wurth J, Seabold D, Perkhounkova Y, Van Sciver A.","Res Nurs Health. 2018 Jun;41(3):219-227. doi: 10.1002/nur.21869. Epub 2018 Mar 5.","Williams K","Res Nurs Health","2018","2018/03/06","PMC6003850","NIHMS947980","10.1002/nur.21869"
"28893574","Enhancement of Motor Recovery through Left Dorsolateral Prefrontal Cortex Stimulation after Acute Ischemic Stroke","Oveisgharan S, Organji H, Ghorbani A.","J Stroke Cerebrovasc Dis. 2018 Jan;27(1):185-191. doi: 10.1016/j.jstrokecerebrovasdis.2017.08.026. Epub 2017 Sep 8.","Oveisgharan S","J Stroke Cerebrovasc Dis","2018","2017/09/13","","","10.1016/j.jstrokecerebrovasdis.2017.08.026"
"31701026","Static magnetic field stimulation of the supplementary motor area modulates resting-state activity and motor behavior","Pineda-Pardo JA, Obeso I, Guida P, Dileone M, Strange BA, Obeso JA, Oliviero A, Foffani G.","Commun Biol. 2019 Oct 31;2:397. doi: 10.1038/s42003-019-0643-8. eCollection 2019.","Pineda-Pardo JA","Commun Biol","2019","2019/11/09","PMC6823375","","10.1038/s42003-019-0643-8"
"12880846","Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects","Scarmeas N, Zarahn E, Anderson KE, Hilton J, Flynn J, Van Heertum RL, Sackeim HA, Stern Y.","Neuroimage. 2003 Jul;19(3):1215-27. doi: 10.1016/s1053-8119(03)00074-0.","Scarmeas N","Neuroimage","2003","2003/07/26","PMC3026568","NIHMS262611","10.1016/s1053-8119(03)00074-0"
"30297210","Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial","Corvol JC, Durif F, Meissner WG, Azulay JP, Haddad R, Guimarães-Costa R, Mariani LL, Cormier-Dequaire F, Thalamas C, Galitzky M, Boraud T, Debilly B, Eusebio A, Houot M, Dellapina E, Chaigneau V, Salis A, Lacomblez L, Benel L, Rascol O; French NS-Park/F-CRIN Network.","Parkinsonism Relat Disord. 2019 Mar;60:51-56. doi: 10.1016/j.parkreldis.2018.10.005. Epub 2018 Oct 4.","Corvol JC","Parkinsonism Relat Disord","2019","2018/10/10","","","10.1016/j.parkreldis.2018.10.005"
"27321596","Inflammatory Biomarkers and Cognitive Decline: The Ginkgo Evaluation of Memory Study","Sharma M, Fitzpatrick AL, Arnold AM, Chi G, Lopez OL, Jenny NS, DeKosky ST.","J Am Geriatr Soc. 2016 Jun;64(6):1171-7. doi: 10.1111/jgs.14140.","Sharma M","J Am Geriatr Soc","2016","2016/06/21","PMC6218168","NIHMS971265","10.1111/jgs.14140"
"16768378","Combined blockade of cholinergic receptors shifts the brain from stimulus encoding to memory consolidation","Rasch BH, Born J, Gais S.","J Cogn Neurosci. 2006 May;18(5):793-802. doi: 10.1162/jocn.2006.18.5.793.","Rasch BH","J Cogn Neurosci","2006","2006/06/14","","","10.1162/jocn.2006.18.5.793"
"15370048","Well-being, appraisal, and coping in African-American and Caucasian dementia caregivers: findings from the REACH study","Haley WE, Gitlin LN, Wisniewski SR, Mahoney DF, Coon DW, Winter L, Corcoran M, Schinfeld S, Ory M.","Aging Ment Health. 2004 Jul;8(4):316-29. doi: 10.1080/13607860410001728998.","Haley WE","Aging Ment Health","2004","2004/09/17","","","10.1080/13607860410001728998"
"10416734","Glucose-induced increase in memory performance in patients with schizophrenia","Newcomer JW, Craft S, Fucetola R, Moldin SO, Selke G, Paras L, Miller R.","Schizophr Bull. 1999;25(2):321-35. doi: 10.1093/oxfordjournals.schbul.a033381.","Newcomer JW","Schizophr Bull","1999","1999/07/23","","","10.1093/oxfordjournals.schbul.a033381"
"8030850","Superiority of antagonic-stress composition versus nicergoline in gerontopsychiatry","Schneider F, Popa R, Mihalas G, Stefanigă P, Mihalas IG, Măties R, Mateescu R.","Ann N Y Acad Sci. 1994 Jun 30;717:332-42. doi: 10.1111/j.1749-6632.1994.tb12102.x.","Schneider F","Ann N Y Acad Sci","1994","1994/06/30","","","10.1111/j.1749-6632.1994.tb12102.x"
"8030848","Antagonic-stress. A new treatment in gerontopsychiatry and for a healthy productive life","Predescu V, Riga D, Riga S, Turlea J, Bărbat IM, Botezat-Antonescu L.","Ann N Y Acad Sci. 1994 Jun 30;717:315-31. doi: 10.1111/j.1749-6632.1994.tb12101.x.","Predescu V","Ann N Y Acad Sci","1994","1994/06/30","","","10.1111/j.1749-6632.1994.tb12101.x"
"16806095","Galantamine improves cognition in schizophrenic patients stabilized on risperidone","Schubert MH, Young KA, Hicks PB.","Biol Psychiatry. 2006 Sep 15;60(6):530-3. doi: 10.1016/j.biopsych.2006.04.006. Epub 2006 Jun 27.","Schubert MH","Biol Psychiatry","2006","2006/06/30","","","10.1016/j.biopsych.2006.04.006"
"9549592","Clinical experience with risperidone, haloperidol, and thioridazine for dementia-associated behavioral disturbances","Frenchman IB, Prince T.","Int Psychogeriatr. 1997 Dec;9(4):431-5. doi: 10.1017/s1041610297004560.","Frenchman IB","Int Psychogeriatr","1997","1998/04/29","","","10.1017/s1041610297004560"
"26631687","Multisensory Stimulation as an Intervention Strategy for Elderly Patients With Severe Dementia: A Pilot Randomized Controlled Trial","Sánchez A, Marante-Moar MP, Sarabia C, de Labra C, Lorenzo T, Maseda A, Millán-Calenti JC.","Am J Alzheimers Dis Other Demen. 2016 Jun;31(4):341-50. doi: 10.1177/1533317515618801. Epub 2015 Dec 1.","Sánchez A","Am J Alzheimers Dis Other Demen","2016","2015/12/04","","","10.1177/1533317515618801"
"32591439","Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial","Kurella Tamura M, Gaussoin SA, Pajewski NM, Chelune GJ, Freedman BI, Gure TR, Haley WE, Killeen AA, Oparil S, Rapp SR, Rifkin DE, Supiano M, Williamson JD, Weiner DE; SPRINT Research Group*.","J Am Soc Nephrol. 2020 Sep;31(9):2122-2132. doi: 10.1681/ASN.2020010038. Epub 2020 Jun 26.","Kurella Tamura M","J Am Soc Nephrol","2020","2020/06/28","PMC7461687","","10.1681/ASN.2020010038"
"1781976","Efficacy and clinical relevance of cognition enhancers","Herrmann WM, Stephan K.","Alzheimer Dis Assoc Disord. 1991;5 Suppl 1:S7-12. doi: 10.1097/00002093-199100051-00003.","Herrmann WM","Alzheimer Dis Assoc Disord","1991","1991/01/01","","","10.1097/00002093-199100051-00003"
"30084133","Comparative Effectiveness of 2 Interventions for Hispanic Caregivers of Persons with Dementia","Luchsinger JA, Burgio L, Mittelman M, Dunner I, Levine JA, Hoyos C, Tipiani D, Henriquez Y, Kong J, Silver S, Ramirez M, Teresi JA.","J Am Geriatr Soc. 2018 Sep;66(9):1708-1715. doi: 10.1111/jgs.15450. Epub 2018 Aug 7.","Luchsinger JA","J Am Geriatr Soc","2018","2018/08/08","PMC6157000","NIHMS964037","10.1111/jgs.15450"
"35867966","In Individuals With Subjective Cognitive Decline, Age, Memory and Speed Scores at Baseline Predict Progression to Cognitive Impairment","Perron A, Roussel M, Wannepain-Despretz S, Barbay M, Devendeville A, Godefroy O, Andriuta D.","Alzheimer Dis Assoc Disord. 2022 Oct-Dec 01;36(4):359-361. doi: 10.1097/WAD.0000000000000520. Epub 2022 Jul 19.","Perron A","Alzheimer Dis Assoc Disord","2022","2022/07/22","","","10.1097/WAD.0000000000000520"
"34406695","Multitarget Transcranial Electrical Stimulation for Freezing of Gait: A Randomized Controlled Trial","Manor B, Dagan M, Herman T, Gouskova NA, Vanderhorst VG, Giladi N, Travison TG, Pascual-Leone A, Lipsitz LA, Hausdorff JM.","Mov Disord. 2021 Nov;36(11):2693-2698. doi: 10.1002/mds.28759. Epub 2021 Aug 18.","Manor B","Mov Disord","2021","2021/08/18","","","10.1002/mds.28759"
"31566651","Effect of Collaborative Dementia Care via Telephone and Internet on Quality of Life, Caregiver Well-being, and Health Care Use: The Care Ecosystem Randomized Clinical Trial","Possin KL, Merrilees JJ, Dulaney S, Bonasera SJ, Chiong W, Lee K, Hooper SM, Allen IE, Braley T, Bernstein A, Rosa TD, Harrison K, Begert-Hellings H, Kornak J, Kahn JG, Naasan G, Lanata S, Clark AM, Chodos A, Gearhart R, Ritchie C, Miller BL.","JAMA Intern Med. 2019 Dec 1;179(12):1658-1667. doi: 10.1001/jamainternmed.2019.4101.","Possin KL","JAMA Intern Med","2019","2019/10/01","PMC6777227","","10.1001/jamainternmed.2019.4101"
"31978826","Hippocampal plasticity underpins long-term cognitive gains from resistance exercise in MCI","Broadhouse KM, Singh MF, Suo C, Gates N, Wen W, Brodaty H, Jain N, Wilson GC, Meiklejohn J, Singh N, Baune BT, Baker M, Foroughi N, Wang Y, Kochan N, Ashton K, Brown M, Li Z, Mavros Y, Sachdev PS, Valenzuela MJ.","Neuroimage Clin. 2020;25:102182. doi: 10.1016/j.nicl.2020.102182. Epub 2020 Jan 14.","Broadhouse KM","Neuroimage Clin","2020","2020/01/25","PMC6974789","","10.1016/j.nicl.2020.102182"
"34836179","APOE ɛ4 Is Associated with Postprandial Inflammation in Older Adults with Metabolic Syndrome Traits","Schönknecht YB, Crommen S, Stoffel-Wagner B, Coenen M, Fimmers R, Stehle P, Ramirez A, Egert S.","Nutrients. 2021 Nov 2;13(11):3924. doi: 10.3390/nu13113924.","Schönknecht YB","Nutrients","2021","2021/11/27","PMC8624753","","10.3390/nu13113924"
"36266559","Pre-frail older adults show improved cognition with StayFitLonger computerized home-based training: a randomized controlled trial","Belleville S, Cuesta M, Bieler-Aeschlimann M, Giacomino K, Widmer A, Mittaz Hager AG, Perez-Marcos D, Cardin S, Boller B, Bier N, Aubertin-Leheudre M, Bherer L, Berryman N, Agrigoroaei S, Demonet JF.","Geroscience. 2023 Apr;45(2):811-822. doi: 10.1007/s11357-022-00674-5. Epub 2022 Oct 21.","Belleville S","Geroscience","2023","2022/10/20","PMC9589849","","10.1007/s11357-022-00674-5"
"25491305","An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome","Grieco JC, Ciarlone SL, Gieron-Korthals M, Schoenberg MR, Smith AG, Philpot RM, Heussler HS, Banko JL, Weeber EJ.","BMC Neurol. 2014 Dec 10;14:232. doi: 10.1186/s12883-014-0232-x.","Grieco JC","BMC Neurol","2014","2014/12/11","PMC4276108","","10.1186/s12883-014-0232-x"
"27888180","Northern Manhattan Hispanic Caregiver Intervention Effectiveness Study: protocol of a pragmatic randomised trial comparing the effectiveness of two established interventions for informal caregivers of persons with dementia","Luchsinger JA, Burgio L, Mittelman M, Dunner I, Levine JA, Kong J, Silver S, Ramirez M, Teresi JA.","BMJ Open. 2016 Nov 25;6(11):e014082. doi: 10.1136/bmjopen-2016-014082.","Luchsinger JA","BMJ Open","2016","2016/11/27","PMC5168522","","10.1136/bmjopen-2016-014082"
"16201486","Sustaining a best-care practice in a nursing home","Beck C, Heacock P, Mercer SO, Doan R, O'Sullivan PS, Stevenson JG, Schnelle JF, Hoskins JG.","J Healthc Qual. 2005 Jul-Aug;27(4):5-16. doi: 10.1111/j.1945-1474.2005.tb00563.x.","Beck C","J Healthc Qual","2005","2005/10/06","","","10.1111/j.1945-1474.2005.tb00563.x"
"29762043","Effects of Fish Oil on HIV-Related Inflammation and Markers of Immunosenescence: A Randomized Clinical Trial","Swanson B, Keithley J, Baum L, Leurgans S, Adeyemi O, Barnes LL, Mata M, Rosdil A.","J Altern Complement Med. 2018 Jul;24(7):709-716. doi: 10.1089/acm.2017.0222. Epub 2018 May 15.","Swanson B","J Altern Complement Med","2018","2018/05/16","PMC6065520","","10.1089/acm.2017.0222"
"10532588","Differential expression of individual complement regulators in the brain and choroid plexus","Singhrao SK, Neal JW, Rushmere NK, Morgan BP, Gasque P.","Lab Invest. 1999 Oct;79(10):1247-59.","Singhrao SK","Lab Invest","1999","1999/10/26","","",""
"31942969","Falls Risk in Relation to Activity Exposure in High-Risk Older Adults","Del Din S, Galna B, Lord S, Nieuwboer A, Bekkers EMJ, Pelosin E, Avanzino L, Bloem BR, Olde Rikkert MGM, Nieuwhof F, Cereatti A, Della Croce U, Mirelman A, Hausdorff JM, Rochester L.","J Gerontol A Biol Sci Med Sci. 2020 May 22;75(6):1198-1205. doi: 10.1093/gerona/glaa007.","Del Din S","J Gerontol A Biol Sci Med Sci","2020","2020/01/17","PMC7243591","","10.1093/gerona/glaa007"
"35286146","Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial","Nelson MR, Polekhina G, Woods RL, Reid CM, Tonkin AM, Wolfe R, Murray AM, Kirpach B, Ernst ME, Lockery JE, Shah RC, Stocks N, Orchard SG, Zhou Z.","Ann Intern Med. 2022 May;175(5):761-764. doi: 10.7326/M21-3823. Epub 2022 Mar 15.","Nelson MR","Ann Intern Med","2022","2022/03/14","PMC9434500","NIHMS1831758","10.7326/M21-3823"
"33840227","Late-Life Vascular Risk Score in Association With Postmortem Cerebrovascular Disease Brain Pathologies","Oveisgharan S, Yu L, Capuano A, Arvanitakis Z, Barnes LL, Schneider JA, Bennett DA, Buchman AS.","Stroke. 2021 Jun;52(6):2060-2067. doi: 10.1161/STROKEAHA.120.030226. Epub 2021 Apr 12.","Oveisgharan S","Stroke","2021","2021/04/12","PMC9069859","NIHMS1685903","10.1161/STROKEAHA.120.030226"
"29938480","Improvement in mood, oxidative stress, fatigue, and insomnia following supplementary management with Robuvit®","Belcaro G, Saggino A, Cornelli U, Luzzi R, Dugall M, Hosoi M, Feragalli B, Cesarone MR.","J Neurosurg Sci. 2018 Aug;62(4):423-427. doi: 10.23736/S0390-5616.18.04384-9.","Belcaro G","J Neurosurg Sci","2018","2018/06/26","","","10.23736/S0390-5616.18.04384-9"
"34709529","Cognitive Functioning and Health in Hispanic/Latina Breast Cancer Survivors","Marín-Chollom AM, Hale C, Koch P, Gaffney AO, Contento I, Shen H, Hershman DL, Brickman AM, Greenlee H.","J Immigr Minor Health. 2022 Jun;24(3):597-604. doi: 10.1007/s10903-021-01300-w. Epub 2021 Oct 28.","Marín-Chollom AM","J Immigr Minor Health","2022","2021/10/28","PMC9046461","NIHMS1759371","10.1007/s10903-021-01300-w"
"34271944","Adapting to the COVID-19 pandemic on Building Research in Diet and Cognition (BRIDGE) trial","Fitzgibbon M, Blumstein L, Schiffer L, Antonic MA, McLeod A, Dakers R, Restrepo L, Boots EA, Sanchez-Flack JC, Tussing-Humphreys L, Lamar M.","Trials. 2021 Jul 16;22(1):459. doi: 10.1186/s13063-021-05383-6.","Fitzgibbon M","Trials","2021","2021/07/17","PMC8284687","","10.1186/s13063-021-05383-6"
"17955941","Ampakine (CX717) effects on performance and alertness during simulated night shift work","Wesensten NJ, Reichardt RM, Balkin TJ.","Aviat Space Environ Med. 2007 Oct;78(10):937-43. doi: 10.3357/asem.2055.2007.","Wesensten NJ","Aviat Space Environ Med","2007","2007/10/25","","","10.3357/asem.2055.2007"
"15283472","HPLC determination and pharmacokinetics of endogenous acetyl-L-carnitine (ALC) in human volunteers orally administered a single dose of ALC","Kwon OS, Chung YB.","Arch Pharm Res. 2004 Jun;27(6):676-81. doi: 10.1007/BF02980169.","Kwon OS","Arch Pharm Res","2004","2004/07/31","","","10.1007/BF02980169"
"12461760","Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia","Serfaty M, Kennell-Webb S, Warner J, Blizard R, Raven P.","Int J Geriatr Psychiatry. 2002 Dec;17(12):1120-7. doi: 10.1002/gps.760.","Serfaty M","Int J Geriatr Psychiatry","2002","2002/12/04","","","10.1002/gps.760"
"35920161","Association of cognition with leptin and vascular endothelial growth factor in individuals with type 2 diabetes mellitus","Espeland MA, Evans JK, Carmichael O, Luchsinger JA, Marcovina SM, Neiberg R, Johnson KC, Kahn SE, Hayden KM; Action for Health in Diabetes (Look AHEAD) MIND Ancillary Study Group.","Obesity (Silver Spring). 2022 Sep;30(9):1863-1874. doi: 10.1002/oby.23495. Epub 2022 Aug 3.","Espeland MA","Obesity (Silver Spring)","2022","2022/08/03","PMC9420754","NIHMS1808919","10.1002/oby.23495"
"31841599","Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial","Pagan FL, Hebron ML, Wilmarth B, Torres-Yaghi Y, Lawler A, Mundel EE, Yusuf N, Starr NJ, Anjum M, Arellano J, Howard HH, Shi W, Mulki S, Kurd-Misto T, Matar S, Liu X, Ahn J, Moussa C.","JAMA Neurol. 2020 Mar 1;77(3):309-317. doi: 10.1001/jamaneurol.2019.4200.","Pagan FL","JAMA Neurol","2020","2019/12/17","PMC6990742","","10.1001/jamaneurol.2019.4200"
"30538021","A manual-based intervention for carers of people with dementia and sleep disturbances: an acceptability and feasibility RCT","Kinnunen KM, Rapaport P, Webster L, Barber J, Kyle SD, Hallam B, Cooper C, Horsley R, Pickett JA, Vikhanova A, Espie CA, Livingston G.","Health Technol Assess. 2018 Dec;22(71):1-408. doi: 10.3310/hta22710.","Kinnunen KM","Health Technol Assess","2018","2018/12/13","PMC6307368","","10.3310/hta22710"
"29480202","Real World Recruiting of Older Subjects with Mild Cognitive Impairment for Exercise Trials: Community Readiness is Pivotal","Sanders ML, Stuckenschneider T, Devenney KE, Lawlor B, Schneider S, Olde Rikkert MGM; NeuroExercise Study Group.","J Alzheimers Dis. 2018;62(2):579-581. doi: 10.3233/JAD-171083.","Sanders ML","J Alzheimers Dis","2018","2018/02/27","","","10.3233/JAD-171083"
"36857053","Association of Intensive vs Standard Blood Pressure Control With Regional Changes in Cerebral Small Vessel Disease Biomarkers: Post Hoc Secondary Analysis of the SPRINT MIND Randomized Clinical Trial","Rashid T, Li K, Toledo JB, Nasrallah I, Pajewski NM, Dolui S, Detre J, Wolk DA, Liu H, Heckbert SR, Bryan RN, Williamson J, Davatzikos C, Seshadri S, Launer LJ, Habes M.","JAMA Netw Open. 2023 Mar 1;6(3):e231055. doi: 10.1001/jamanetworkopen.2023.1055.","Rashid T","JAMA Netw Open","2023","2023/03/01","PMC9978954","","10.1001/jamanetworkopen.2023.1055"
"34857029","Clinical and cost-effectiveness of a New psychosocial intervention to support Independence in Dementia (NIDUS-family) for family carers and people living with dementia in their own homes: a randomised controlled trial","Burton A, Rapaport P, Palomo M, Lord K, Budgett J, Barber J, Hunter R, Butler L, Vickerstaff J, Rockwood K, Ogden M, Smith D, Lang I, Livingston G, Dow B, Kales H, Manthorpe J, Walters K, Hoe J, Orgeta V, Samus Q, Cooper C; NIDUS study team.","Trials. 2021 Dec 2;22(1):865. doi: 10.1186/s13063-021-05851-z.","Burton A","Trials","2021","2021/12/03","PMC8637036","","10.1186/s13063-021-05851-z"
"29111960","The aspirin in reducing events in the elderly trial: Statistical analysis plan","Wolfe R, Murray AM, Woods RL, Kirpach B, Gilbertson D, Shah RC, Nelson MR, Reid CM, Ernst ME, Lockery J, Donnan GA, Williamson J, McNeil JJ.","Int J Stroke. 2018 Apr;13(3):335-338. doi: 10.1177/1747493017741383. Epub 2017 Nov 7.","Wolfe R","Int J Stroke","2018","2017/11/08","PMC6380180","NIHMS1007938","10.1177/1747493017741383"
"28944718","Obesity is associated with altered mid-insula functional connectivity to limbic regions underlying appetitive responses to foods","Avery JA, Powell JN, Breslin FJ, Lepping RJ, Martin LE, Patrician TM, Donnelly JE, Savage CR, Simmons WK.","J Psychopharmacol. 2017 Nov;31(11):1475-1484. doi: 10.1177/0269881117728429. Epub 2017 Sep 25.","Avery JA","J Psychopharmacol","2017","2017/09/26","PMC6527420","NIHMS1020944","10.1177/0269881117728429"
"34338761","Validation of a Deficit-Accumulation Frailty Index in the ASPirin in Reducing Events in the Elderly Study and Its Predictive Capacity for Disability-Free Survival","Ryan J, Espinoza S, Ernst ME, Ekram ARMS, Wolfe R, Murray AM, Shah RC, Orchard SG, Fitzgerald S, Beilin LJ, Ward SA, Williamson JD, Newman AB, McNeil JJ, Woods RL.","J Gerontol A Biol Sci Med Sci. 2022 Jan 7;77(1):19-26. doi: 10.1093/gerona/glab225.","Ryan J","J Gerontol A Biol Sci Med Sci","2022","2021/08/02","PMC8751791","","10.1093/gerona/glab225"
"28291781","Effectiveness of an intervention to facilitate prompt referral to memory clinics in the United Kingdom: Cluster randomised controlled trial","Livingston G, Baio G, Sommerlad A, de Lusignan S, Poulimenos S, Morris S, Rait G, Hoe J.","PLoS Med. 2017 Mar 14;14(3):e1002252. doi: 10.1371/journal.pmed.1002252. eCollection 2017 Mar.","Livingston G","PLoS Med","2017","2017/03/15","PMC5349651","","10.1371/journal.pmed.1002252"
"28436694","Acculturation level and caregiver outcomes from a randomized intervention trial to enhance caregivers' health: evidence from REACH II","Meyer OL, Liu XL, Tancredi D, Ramirez AS, Schulz R, Hinton L.","Aging Ment Health. 2018 Jun;22(6):730-737. doi: 10.1080/13607863.2017.1317330. Epub 2017 Apr 24.","Meyer OL","Aging Ment Health","2018","2017/04/25","PMC5654701","NIHMS866351","10.1080/13607863.2017.1317330"
"23983230","Subjective stressors moderate effectiveness of a multi-component, multi-site intervention on caregiver depression and burden","Hatch DJ, DeHart WB, Norton MC.","Int J Geriatr Psychiatry. 2014 Apr;29(4):406-13. doi: 10.1002/gps.4019. Epub 2013 Aug 27.","Hatch DJ","Int J Geriatr Psychiatry","2014","2013/08/29","","","10.1002/gps.4019"
"17595426","Predictors of adherence to a skill-building intervention in dementia caregivers","Chee YK, Gitlin LN, Dennis MP, Hauck WW.","J Gerontol A Biol Sci Med Sci. 2007 Jun;62(6):673-8. doi: 10.1093/gerona/62.6.673.","Chee YK","J Gerontol A Biol Sci Med Sci","2007","2007/06/28","","","10.1093/gerona/62.6.673"
"30233154","The interactive Physical and Cognitive Exercise System (iPACES™): effects of a 3-month in-home pilot clinical trial for mild cognitive impairment and caregivers","Anderson-Hanley C, Stark J, Wall KM, VanBrakle M, Michel M, Maloney M, Barcelos N, Striegnitz K, Cohen BD, Kramer AF.","Clin Interv Aging. 2018 Sep 4;13:1565-1577. doi: 10.2147/CIA.S160756. eCollection 2018.","Anderson-Hanley C","Clin Interv Aging","2018","2018/09/21","PMC6130272","","10.2147/CIA.S160756"
"23000875","Effects of DHA-phospholipids, melatonin and tryptophan supplementation on erythrocyte membrane physico-chemical properties in elderly patients suffering from mild cognitive impairment","Cazzola R, Rondanelli M, Faliva M, Cestaro B.","Exp Gerontol. 2012 Dec;47(12):974-8. doi: 10.1016/j.exger.2012.09.004. Epub 2012 Sep 20.","Cazzola R","Exp Gerontol","2012","2012/09/25","","","10.1016/j.exger.2012.09.004"
"34673821","Mortality in association with antipsychotic medication use and clinical outcomes among geriatric psychiatry outpatients with COVID-19","Austria B, Haque R, Mittal S, Scott J, Vengassery A, Maltz D, Li W, Greenwald B, Freudenberg-Hua Y.","PLoS One. 2021 Oct 21;16(10):e0258916. doi: 10.1371/journal.pone.0258916. eCollection 2021.","Austria B","PLoS One","2021","2021/10/21","PMC8530340","","10.1371/journal.pone.0258916"
"35607975","Daily Written Care Summaries for Families of Critically Ill Patients: A Randomized Controlled Trial","Greenberg JA, Basapur S, Quinn TV, Bulger JL, Schwartz NH, Oh SK, Ritz EM, Glover CM, Shah RC.","Crit Care Med. 2022 Sep 1;50(9):1296-1305. doi: 10.1097/CCM.0000000000005583. Epub 2022 May 23.","Greenberg JA","Crit Care Med","2022","2022/05/24","","","10.1097/CCM.0000000000005583"
"32291802","A pilot randomized controlled trial of hearing aids to improve mood and cognition in older adults","Brewster KK, Pavlicova M, Stein A, Chen M, Chen C, Brown PJ, Roose SP, Kim AH, Golub JS, Brickman A, Galatioto J, Kuhlmey M, Rutherford BR.","Int J Geriatr Psychiatry. 2020 Aug;35(8):842-850. doi: 10.1002/gps.5311. Epub 2020 Apr 23.","Brewster KK","Int J Geriatr Psychiatry","2020","2020/04/16","PMC7656495","NIHMS1642434","10.1002/gps.5311"
"31558719","First-in-human trial of blood-brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound","Abrahao A, Meng Y, Llinas M, Huang Y, Hamani C, Mainprize T, Aubert I, Heyn C, Black SE, Hynynen K, Lipsman N, Zinman L.","Nat Commun. 2019 Sep 26;10(1):4373. doi: 10.1038/s41467-019-12426-9.","Abrahao A","Nat Commun","2019","2019/09/28","PMC6763482","","10.1038/s41467-019-12426-9"
"31753521","Impact of the mental health and dynamic referral for oncology (MHADRO) program on oncology patient outcomes, health care utilization, and health provider behaviors: A multi-site randomized control trial","O'Hea E, Kroll-Desrosiers A, Cutillo AS, Michalak HR, Barton BA, Harralson T, Carmack C, McMahon C, Boudreaux ED.","Patient Educ Couns. 2020 Mar;103(3):607-616. doi: 10.1016/j.pec.2019.10.006. Epub 2019 Nov 5.","O'Hea E","Patient Educ Couns","2020","2019/11/23","PMC7061075","NIHMS1545324","10.1016/j.pec.2019.10.006"
"30890197","Neuropsychological Function Response to Nocturnal Blue Light Blockage in Individuals With Symptoms of Insomnia: A Pilot Randomized Controlled Study","Zimmerman ME, Kim MB, Hale C, Westwood AJ, Brickman AM, Shechter A.","J Int Neuropsychol Soc. 2019 Aug;25(7):668-677. doi: 10.1017/S1355617719000055.","Zimmerman ME","J Int Neuropsychol Soc","2019","2019/03/21","PMC7045510","NIHMS1557081","10.1017/S1355617719000055"
"29078839","Association of Bone Metabolic Markers With Diabetic Retinopathy and Diabetic Macular Edema in Elderly Chinese Individuals With Type 2 Diabetes Mellitus","Zhang X, Yang J, Zhong Y, Xu L, Wang O, Huang P, Li C, Qu B, Wang J, Zheng C, Niu M, Yu W.","Am J Med Sci. 2017 Oct;354(4):355-361. doi: 10.1016/j.amjms.2017.07.003. Epub 2017 Jul 10.","Zhang X","Am J Med Sci","2017","2017/10/29","PMC5666572","NIHMS910146","10.1016/j.amjms.2017.07.003"
"28600159","Building research in diet and cognition: The BRIDGE randomized controlled trial","Tussing-Humphreys L, Lamar M, Blumenthal JA, Babyak M, Fantuzzi G, Blumstein L, Schiffer L, Fitzgibbon ML.","Contemp Clin Trials. 2017 Aug;59:87-97. doi: 10.1016/j.cct.2017.06.003. Epub 2017 Jun 7.","Tussing-Humphreys L","Contemp Clin Trials","2017","2017/06/11","PMC7289155","NIHMS1589031","10.1016/j.cct.2017.06.003"
"35124321","Functional Abilities of an International Post-Stroke Population: Standard Assessment of Global Everyday Activities (SAGEA) Scale","Bosch J, Pearce LA, Sharma M, Mikulík R, Whiteley WN, Canavan M, Hart RG, O'Donnell MJ.","J Stroke Cerebrovasc Dis. 2022 Apr;31(4):106329. doi: 10.1016/j.jstrokecerebrovasdis.2022.106329. Epub 2022 Feb 3.","Bosch J","J Stroke Cerebrovasc Dis","2022","2022/02/06","","","10.1016/j.jstrokecerebrovasdis.2022.106329"
"35010526","The Role of Executive Function in the Effectiveness of Multi-Component Interventions Targeting Physical Activity Behavior in Office Workers","Wang R, Blom V, Nooijen CFJ, Kallings LV, Ekblom Ö, Ekblom MM.","Int J Environ Res Public Health. 2021 Dec 27;19(1):266. doi: 10.3390/ijerph19010266.","Wang R","Int J Environ Res Public Health","2021","2022/01/11","PMC8751160","","10.3390/ijerph19010266"
"34342879","Utility of the iPad NIH Toolbox Cognition Battery in a clinical trial of older adults","Parsey CM, Bagger JE, Trittschuh EH, Hanson AJ.","J Am Geriatr Soc. 2021 Dec;69(12):3519-3528. doi: 10.1111/jgs.17382. Epub 2021 Aug 3.","Parsey CM","J Am Geriatr Soc","2021","2021/08/03","PMC8648969","NIHMS1725722","10.1111/jgs.17382"
"32293314","The ResidentialCare Transition Module: a single-blinded randomized controlled evaluation of a telehealth support intervention for family caregivers of persons with dementia living in residential long-term care","Gaugler JE, Statz TL, Birkeland RW, Louwagie KW, Peterson CM, Zmora R, Emery A, McCarron HR, Hepburn K, Whitlatch CJ, Mittelman MS, Roth DL.","BMC Geriatr. 2020 Apr 15;20(1):133. doi: 10.1186/s12877-020-01542-7.","Gaugler JE","BMC Geriatr","2020","2020/04/16","PMC7158110","","10.1186/s12877-020-01542-7"
"34763080","Randomized Controlled Trial of a Cognitive Intervention to Improve Memory in Heart Failure","Pressler SJ, Jung M, Gradus-Pizlo I, Titler MG, Smith DG, Gao S, Lake KR, Burney H, Clark DG, Wierenga KL, Dorsey SG, Giordani B.","J Card Fail. 2022 Apr;28(4):519-530. doi: 10.1016/j.cardfail.2021.10.008. Epub 2021 Nov 8.","Pressler SJ","J Card Fail","2022","2021/11/11","PMC9018491","NIHMS1764230","10.1016/j.cardfail.2021.10.008"
"25211775","Recruitment and baseline characteristics of participants in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)-a randomized controlled lifestyle trial","Ngandu T, Lehtisalo J, Levälahti E, Laatikainen T, Lindström J, Peltonen M, Solomon A, Ahtiluoto S, Antikainen R, Hänninen T, Jula A, Mangialasche F, Paajanen T, Pajala S, Rauramaa R, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M.","Int J Environ Res Public Health. 2014 Sep 10;11(9):9345-60. doi: 10.3390/ijerph110909345.","Ngandu T","Int J Environ Res Public Health","2014","2014/09/12","PMC4199023","","10.3390/ijerph110909345"
"27060958","Comparing the Effects of Multisensory Stimulation and Individualized Music Sessions on Elderly People with Severe Dementia: A Randomized Controlled Trial","Sánchez A, Maseda A, Marante-Moar MP, de Labra C, Lorenzo-López L, Millán-Calenti JC.","J Alzheimers Dis. 2016 Mar 8;52(1):303-15. doi: 10.3233/JAD-151150.","Sánchez A","J Alzheimers Dis","2016","2016/04/11","","","10.3233/JAD-151150"
"33827960","Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration","Rojas JC, Wang P, Staffaroni AM, Heller C, Cobigo Y, Wolf A, Goh SM, Ljubenkov PA, Heuer HW, Fong JC, Taylor JB, Veras E, Song L, Jeromin A, Hanlon D, Yu L, Khinikar A, Sivasankaran R, Kieloch A, Valentin MA, Karydas AM, Mitic LL, Pearlman R, Kornak J, Kramer JH, Miller BL, Kantarci K, Knopman DS, Graff-Radford N, Petrucelli L, Rademakers R, Irwin DJ, Grossman M, Ramos EM, Coppola G, Mendez MF, Bordelon Y, Dickerson BC, Ghoshal N, Huey ED, Mackenzie IR, Appleby BS, Domoto-Reilly K, Hsiung GR, Toga AW, Weintraub S, Kaufer DI, Kerwin D, Litvan I, Onyike CU, Pantelyat A, Roberson ED, Tartaglia MC, Foroud T, Chen W, Czerkowicz J, Graham DL, van Swieten JC, Borroni B, Sanchez-Valle R, Moreno F, Laforce R, Graff C, Synofzik M, Galimberti D, Rowe JB, Masellis M, Finger E, Vandenberghe R, de Mendonça A, Tagliavini F, Santana I, Ducharme S, Butler CR, Gerhard A, Levin J, Danek A, Otto M, Sorbi S, Cash DM, Convery RS, Bocchetta M, Foiani M, Greaves CV, Peakman G, Russell L, Swift I, Todd E, Rohrer JD, Boeve BF, Rosen HJ, Boxer AL; ALLFTD and GENFI consortia.","Neurology. 2021 May 4;96(18):e2296-e2312. doi: 10.1212/WNL.0000000000011848. Epub 2021 Apr 7.","Rojas JC","Neurology","2021","2021/04/08","PMC8166434","","10.1212/WNL.0000000000011848"
"28327083","The effect of an interactive cycling training on cognitive functioning in older adults with mild dementia: study protocol for a randomized controlled trial","Karssemeijer EG, Bossers WJ, Aaronson JA, Kessels RP, Olde Rikkert MG.","BMC Geriatr. 2017 Mar 21;17(1):73. doi: 10.1186/s12877-017-0464-x.","Karssemeijer EG","BMC Geriatr","2017","2017/03/23","PMC5361710","","10.1186/s12877-017-0464-x"
"31403944","Exercise Training in Amnestic Mild Cognitive Impairment: A One-Year Randomized Controlled Trial","Tarumi T, Rossetti H, Thomas BP, Harris T, Tseng BY, Turner M, Wang C, German Z, Martin-Cook K, Stowe AM, Womack KB, Mathews D, Kerwin DR, Hynan L, Diaz-Arrastia R, Lu H, Cullum CM, Zhang R.","J Alzheimers Dis. 2019;71(2):421-433. doi: 10.3233/JAD-181175.","Tarumi T","J Alzheimers Dis","2019","2019/08/13","","","10.3233/JAD-181175"
"34516308","World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial","Norgren L, North R, Baumgartner I, Berger JS, Blomster JI, Hiatt WR, Jones WS, Katona BG, Mahaffey KW, Mulder H, Patel MR, Rockhold FW, Fowkes FGR.","Vasc Med. 2022 Feb;27(1):21-29. doi: 10.1177/1358863X211038620. Epub 2021 Sep 13.","Norgren L","Vasc Med","2022","2021/09/13","PMC8808360","NIHMS1733385","10.1177/1358863X211038620"
"24119856","Effects of problem solving therapy on mental health outcomes in family caregivers of persons with a new diagnosis of mild cognitive impairment or early dementia: a randomized controlled trial","Garand L, Rinaldo DE, Alberth MM, Delany J, Beasock SL, Lopez OL, Reynolds CF 3rd, Dew MA.","Am J Geriatr Psychiatry. 2014 Aug;22(8):771-81. doi: 10.1016/j.jagp.2013.07.007. Epub 2013 Oct 8.","Garand L","Am J Geriatr Psychiatry","2014","2013/10/15","PMC4021000","NIHMS575044","10.1016/j.jagp.2013.07.007"
"17225162","Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers","Dunbar G, Boeijinga PH, Demazières A, Cisterni C, Kuchibhatla R, Wesnes K, Luthringer R.","Psychopharmacology (Berl). 2007 May;191(4):919-29. doi: 10.1007/s00213-006-0675-x. Epub 2007 Jan 16.","Dunbar G","Psychopharmacology (Berl)","2007","2007/01/17","","","10.1007/s00213-006-0675-x"
"16192980","Differential effects of the muscarinic M1 receptor agonist RS-86 and the acetylcholine-esterase inhibitor donepezil on REM sleep regulation in healthy volunteers","Nissen C, Nofzinger EA, Feige B, Waldheim B, Radosa MP, Riemann D, Berger M.","Neuropsychopharmacology. 2006 Jun;31(6):1294-300. doi: 10.1038/sj.npp.1300906.","Nissen C","Neuropsychopharmacology","2006","2005/09/30","","","10.1038/sj.npp.1300906"
"14614169","End-of-life care and the effects of bereavement on family caregivers of persons with dementia","Schulz R, Mendelsohn AB, Haley WE, Mahoney D, Allen RS, Zhang S, Thompson L, Belle SH; Resources for Enhancing Alzheimer's Caregiver Health Investigators.","N Engl J Med. 2003 Nov 13;349(20):1936-42. doi: 10.1056/NEJMsa035373.","Schulz R","N Engl J Med","2003","2003/11/14","","","10.1056/NEJMsa035373"
"26543007","The Effect of an Online Cognitive Training Package in Healthy Older Adults: An Online Randomized Controlled Trial","Corbett A, Owen A, Hampshire A, Grahn J, Stenton R, Dajani S, Burns A, Howard R, Williams N, Williams G, Ballard C.","J Am Med Dir Assoc. 2015 Nov 1;16(11):990-7. doi: 10.1016/j.jamda.2015.06.014.","Corbett A","J Am Med Dir Assoc","2015","2015/11/07","","","10.1016/j.jamda.2015.06.014"
"24943996","Maintaining the potential of a psycho-educational program: efficacy of a booster session after an intervention offered family caregivers at disclosure of a relative's dementia diagnosis","Ducharme F, Lachance L, Lévesque L, Zarit SH, Kergoat MJ.","Aging Ment Health. 2015;19(3):207-16. doi: 10.1080/13607863.2014.922527. Epub 2014 Jun 19.","Ducharme F","Aging Ment Health","2015","2014/06/20","","","10.1080/13607863.2014.922527"
"34365016","¡Mi Vida Saludable! A randomized, controlled, 2 × 2 factorial trial of a diet and physical activity intervention among Latina breast cancer survivors: Study design and methods","Santiago-Torres M, Contento I, Koch P, Tsai WY, Brickman AM, Gaffney AO, Thomson CA, Crane TE, Dominguez N, Sepulveda J, Marín-Chollom AM, Paul R, Shi Z, Ulanday KT, Hale C, Hershman D, Greenlee H.","Contemp Clin Trials. 2021 Nov;110:106524. doi: 10.1016/j.cct.2021.106524. Epub 2021 Aug 6.","Santiago-Torres M","Contemp Clin Trials","2021","2021/08/08","PMC8595705","NIHMS1740661","10.1016/j.cct.2021.106524"
"32839527","Minocycline differentially modulates human spatial memory systems","Berens SC, Bird CM, Harrison NA.","Neuropsychopharmacology. 2020 Dec;45(13):2162-2169. doi: 10.1038/s41386-020-00811-8. Epub 2020 Aug 24.","Berens SC","Neuropsychopharmacology","2020","2020/08/26","PMC7784680","","10.1038/s41386-020-00811-8"
"31279613","Telephone-based behavioral activation intervention for dementia family caregivers: Outcomes and mediation effect of a randomized controlled trial","Au A, Yip HM, Lai S, Ngai S, Cheng ST, Losada A, Thompson L, Gallagher-Thompson D.","Patient Educ Couns. 2019 Nov;102(11):2049-2059. doi: 10.1016/j.pec.2019.06.009. Epub 2019 Jun 26.","Au A","Patient Educ Couns","2019","2019/07/08","","","10.1016/j.pec.2019.06.009"
"29439085","IDEA intervention to prevent depressive symptoms and promote well-being in early-stage dementia: protocol for a randomised controlled feasibility study","Tuijt R, Livingston G, Gould RL, Jones R, Verdaguer ES, Orgeta V.","BMJ Open. 2018 Feb 8;8(2):e021074. doi: 10.1136/bmjopen-2017-021074.","Tuijt R","BMJ Open","2018","2018/02/14","PMC5879789","","10.1136/bmjopen-2017-021074"
"34216034","Targeted tDCS Mitigates Dual-Task Costs to Gait and Balance in Older Adults","Zhou J, Manor B, Yu W, Lo OY, Gouskova N, Salvador R, Katz R, Cornejo Thumm P, Brozgol M, Ruffini G, Pascual-Leone A, Lipsitz LA, Hausdorff JM.","Ann Neurol. 2021 Sep;90(3):428-439. doi: 10.1002/ana.26156. Epub 2021 Jul 17.","Zhou J","Ann Neurol","2021","2021/07/03","PMC8434977","NIHMS1721328","10.1002/ana.26156"
"32880220","Lessons from KEEPS: the Kronos Early Estrogen Prevention Study","Miller VM, Taylor HS, Naftolin F, Manson JE, Gleason CE, Brinton EA, Kling JM, Cedars MI, Dowling NM, Kantarci K, Harman SM.","Climacteric. 2021 Apr;24(2):139-145. doi: 10.1080/13697137.2020.1804545. Epub 2020 Sep 3.","Miller VM","Climacteric","2021","2020/09/04","PMC8108428","NIHMS1679136","10.1080/13697137.2020.1804545"
"20693265","Early-stage memory loss support groups: outcomes from a randomized controlled clinical trial","Logsdon RG, Pike KC, McCurry SM, Hunter P, Maher J, Snyder L, Teri L.","J Gerontol B Psychol Sci Soc Sci. 2010 Nov;65(6):691-7. doi: 10.1093/geronb/gbq054. Epub 2010 Aug 6.","Logsdon RG","J Gerontol B Psychol Sci Soc Sci","2010","2010/08/10","PMC2954328","","10.1093/geronb/gbq054"
"20056684","The moderating influence of demographic characteristics, social support, and religious coping on the effectiveness of a multicomponent psychosocial caregiver intervention in three racial ethnic groups","Lee CC, Czaja SJ, Schulz R.","J Gerontol B Psychol Sci Soc Sci. 2010 Mar;65B(2):185-94. doi: 10.1093/geronb/gbp131. Epub 2010 Jan 7.","Lee CC","J Gerontol B Psychol Sci Soc Sci","2010","2010/01/09","PMC2821943","","10.1093/geronb/gbp131"
"16413604","A comprehensive assessment of the safety of intravenous methamphetamine administration during treatment with selegiline","Newton TF, De La Garza R 2nd, Fong T, Chiang N, Holmes TH, Bloch DA, Anderson A, Elkashef A.","Pharmacol Biochem Behav. 2005 Dec;82(4):704-11. doi: 10.1016/j.pbb.2005.11.012. Epub 2006 Jan 18.","Newton TF","Pharmacol Biochem Behav","2005","2006/01/18","","","10.1016/j.pbb.2005.11.012"
"31097732","Complexity-Based Measures of Heart Rate Dynamics in Older Adults Following Long- and Short-Term Tai Chi Training: Cross-sectional and Randomized Trial Studies","Ma Y, Wu CW, Peng CK, Ahn A, Bertisch SM, Lipsitz LA, Yeh GY, Manor B, Novak V, Hausdorff JM, Gow B, Wayne PM.","Sci Rep. 2019 May 16;9(1):7500. doi: 10.1038/s41598-019-43602-y.","Ma Y","Sci Rep","2019","2019/05/18","PMC6522618","","10.1038/s41598-019-43602-y"
"24632987","Angina pectoris severity among coronary heart disease patients is associated with subsequent cognitive impairment","Weinstein G, Goldbourt U, Tanne D.","Alzheimer Dis Assoc Disord. 2015 Jan-Mar;29(1):6-11. doi: 10.1097/WAD.0000000000000038.","Weinstein G","Alzheimer Dis Assoc Disord","2015","2014/03/18","","","10.1097/WAD.0000000000000038"
"28095412","Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) Randomised Controlled Trial","Bath PM, Scutt P, Blackburn DJ, Ankolekar S, Krishnan K, Ballard C, Burns A, Mant J, Passmore P, Pocock S, Reckless J, Sprigg N, Stewart R, Wardlaw JM, Ford GA; PODCAST Trial Investigators.","PLoS One. 2017 Jan 17;12(1):e0164608. doi: 10.1371/journal.pone.0164608. eCollection 2017.","Bath PM","PLoS One","2017","2017/01/18","PMC5240987","","10.1371/journal.pone.0164608"
"36470231","The Potential of Transcranial Alternating Current Stimulation to Alleviate Dual-Task Gait Costs in Older Adults: Insights from a Double-Blinded Pilot Study","Sayig-Keren RM, Dagan M, Cornejo Thumm P, Brozgol M, Gazit E, Manor B, Hausdorff JM.","Gerontology. 2023;69(4):513-518. doi: 10.1159/000527171. Epub 2022 Dec 5.","Sayig-Keren RM","Gerontology","2023","2022/12/05","PMC10073237","NIHMS1848161","10.1159/000527171"
"25430996","Effects of testosterone administration on cognitive function in hysterectomized women with low testosterone levels: a dose-response randomized trial","Huang G, Wharton W, Travison TG, Ho MH, Gleason C, Asthana S, Bhasin S, Basaria S.","J Endocrinol Invest. 2015 Apr;38(4):455-61. doi: 10.1007/s40618-014-0213-3. Epub 2014 Nov 28.","Huang G","J Endocrinol Invest","2015","2014/11/29","PMC4716804","NIHMS748368","10.1007/s40618-014-0213-3"
"32887591","Cost-effectiveness of the Namaste care family program for nursing home residents with advanced dementia in comparison with usual care: a cluster-randomized controlled trial","El Alili M, Smaling HJA, Joling KJ, Achterberg WP, Francke AL, Bosmans JE, van der Steen JT.","BMC Health Serv Res. 2020 Sep 4;20(1):831. doi: 10.1186/s12913-020-05570-2.","El Alili M","BMC Health Serv Res","2020","2020/09/05","PMC7473814","","10.1186/s12913-020-05570-2"
"33551234","Association of White Matter Integrity With Executive Function and Antidepressant Treatment Outcome in Patients With Late-Life Depression","He X, Pueraro E, Kim Y, Garcia CM, Maas B, Choi J, Egglefield DA, Schiff S, Sneed JR, Brown PJ, Brickman AM, Roose SP, Rutherford BR.","Am J Geriatr Psychiatry. 2021 Dec;29(12):1188-1198. doi: 10.1016/j.jagp.2021.01.004. Epub 2021 Jan 23.","He X","Am J Geriatr Psychiatry","2021","2021/02/08","PMC8298620","NIHMS1670680","10.1016/j.jagp.2021.01.004"
"31484587","Post-diagnostic allied health interventions for people with dementia in Australia: a spotlight on current practice","Cations M, Radisic G, de la Perrelle L, Laver KE; Agents of Change Collaborative Group.","BMC Res Notes. 2019 Sep 4;12(1):559. doi: 10.1186/s13104-019-4588-2.","Cations M","BMC Res Notes","2019","2019/09/06","PMC6727518","","10.1186/s13104-019-4588-2"
"26409223","Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders","Trampush JW, Lencz T, DeRosse P, John M, Gallego JA, Petrides G, Hassoun Y, Zhang JP, Addington J, Kellner CH, Tohen M, Burdick KE, Goldberg TE, Kane JM, Robinson DG, Malhotra AK.","Schizophr Bull. 2015 Nov;41(6):1237-47. doi: 10.1093/schbul/sbv120. Epub 2015 Sep 25.","Trampush JW","Schizophr Bull","2015","2015/09/27","PMC4601719","","10.1093/schbul/sbv120"
"24969395","B.A.I.L.A. - a Latin dance randomized controlled trial for older Spanish-speaking Latinos: rationale, design, and methods","Marquez DX, Wilbur J, Hughes SL, Berbaum ML, Wilson RS, Buchner DM, McAuley E.","Contemp Clin Trials. 2014 Jul;38(2):397-408. doi: 10.1016/j.cct.2014.06.012. Epub 2014 Jun 24.","Marquez DX","Contemp Clin Trials","2014","2014/06/28","PMC4123962","NIHMS608507","10.1016/j.cct.2014.06.012"
"29108888","The Effect of a 2-Year Intervention Consisting of Diet, Physical Exercise, Cognitive Training, and Monitoring of Vascular Risk on Chronic Morbidity-the FINGER Randomized Controlled Trial","Marengoni A, Rizzuto D, Fratiglioni L, Antikainen R, Laatikainen T, Lehtisalo J, Peltonen M, Soininen H, Strandberg T, Tuomilehto J, Kivipelto M, Ngandu T.","J Am Med Dir Assoc. 2018 Apr;19(4):355-360.e1. doi: 10.1016/j.jamda.2017.09.020. Epub 2017 Nov 3.","Marengoni A","J Am Med Dir Assoc","2018","2017/11/08","","","10.1016/j.jamda.2017.09.020"
"28329340","Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study","McNeil JJ, Woods RL, Nelson MR, Murray AM, Reid CM, Kirpach B, Storey E, Shah RC, Wolfe RS, Tonkin AM, Newman AB, Williamson JD, Lockery JE, Margolis KL, Ernst ME, Abhayaratna WP, Stocks N, Fitzgerald SM, Trevaks RE, Orchard SG, Beilin LJ, Donnan GA, Gibbs P, Johnston CI, Grimm RH; ASPREE Investigator Group.","J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1586-1593. doi: 10.1093/gerona/glw342.","McNeil JJ","J Gerontol A Biol Sci Med Sci","2017","2017/03/23","PMC5861878","","10.1093/gerona/glw342"
"24957311","Relationship between poststroke cognition, baseline factors, and functional outcome: data from ""efficacy of nitric oxide in stroke"" trial","Ankolekar S, Renton C, Sare G, Ellender S, Sprigg N, Wardlaw JM, Bath PM; ENOS Trial Investigators.","J Stroke Cerebrovasc Dis. 2014 Aug;23(7):1821-9. doi: 10.1016/j.jstrokecerebrovasdis.2014.04.022. Epub 2014 Jun 21.","Ankolekar S","J Stroke Cerebrovasc Dis","2014","2014/06/25","","","10.1016/j.jstrokecerebrovasdis.2014.04.022"
"25848237","Behavioral activation for dementia caregivers: scheduling pleasant events and enhancing communications","Au A, Gallagher-Thompson D, Wong MK, Leung J, Chan WC, Chan CC, Lu HJ, Lai MK, Chan K.","Clin Interv Aging. 2015 Mar 26;10:611-9. doi: 10.2147/CIA.S72348. eCollection 2015.","Au A","Clin Interv Aging","2015","2015/04/08","PMC4381894","","10.2147/CIA.S72348"
"16549835","Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life","Shaw EG, Rosdhal R, D'Agostino RB Jr, Lovato J, Naughton MJ, Robbins ME, Rapp SR.","J Clin Oncol. 2006 Mar 20;24(9):1415-20. doi: 10.1200/JCO.2005.03.3001.","Shaw EG","J Clin Oncol","2006","2006/03/22","","","10.1200/JCO.2005.03.3001"
"12523876","Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis","Sajatovic M, Mullen JA, Sweitzer DE.","J Clin Psychiatry. 2002 Dec;63(12):1156-63. doi: 10.4088/jcp.v63n1211.","Sajatovic M","J Clin Psychiatry","2002","2003/01/14","","","10.4088/jcp.v63n1211"
"32122325","Effects of simultaneous cognitive and aerobic exercise training on dual-task walking performance in healthy older adults: results from a pilot randomized controlled trial","Raichlen DA, Bharadwaj PK, Nguyen LA, Franchetti MK, Zigman EK, Solorio AR, Alexander GE.","BMC Geriatr. 2020 Mar 2;20(1):83. doi: 10.1186/s12877-020-1484-5.","Raichlen DA","BMC Geriatr","2020","2020/03/04","PMC7052975","","10.1186/s12877-020-1484-5"
"26031760","Olfactory identification deficits and increased mortality in the community","Devanand DP, Lee S, Manly J, Andrews H, Schupf N, Masurkar A, Stern Y, Mayeux R, Doty RL.","Ann Neurol. 2015 Sep;78(3):401-11. doi: 10.1002/ana.24447. Epub 2015 Jul 3.","Devanand DP","Ann Neurol","2015","2015/06/03","PMC4546561","NIHMS696315","10.1002/ana.24447"
"27640872","Impact of antipsychotic review and non-pharmacological intervention on health-related quality of life in people with dementia living in care homes: WHELD-a factorial cluster randomised controlled trial","Ballard C, Orrell M, Sun Y, Moniz-Cook E, Stafford J, Whitaker R, Woods B, Corbett A, Banerjee S, Testad I, Garrod L, Khan Z, Woodward-Carlton B, Wenborn J, Fossey J.","Int J Geriatr Psychiatry. 2017 Oct;32(10):1094-1103. doi: 10.1002/gps.4572. Epub 2016 Sep 19.","Ballard C","Int J Geriatr Psychiatry","2017","2016/09/20","","","10.1002/gps.4572"
"24266960","Prevention of Decline in Cognition after Stroke Trial (PODCAST): a study protocol for a factorial randomised controlled trial of intensive versus guideline lowering of blood pressure and lipids","Blackburn DJ, Krishnan K, Fox L, Ballard C, Burns A, Ford GA, Mant J, Passmore P, Pocock S, Reckless J, Sprigg N, Stewart R, Wardlaw J, Bath PM.","Trials. 2013 Nov 22;14:401. doi: 10.1186/1745-6215-14-401.","Blackburn DJ","Trials","2013","2013/11/26","PMC4222827","","10.1186/1745-6215-14-401"
"23611363","The response of agitated behavior to pain management in persons with dementia","Husebo BS, Ballard C, Cohen-Mansfield J, Seifert R, Aarsland D.","Am J Geriatr Psychiatry. 2014 Jul;22(7):708-17. doi: 10.1016/j.jagp.2012.12.006. Epub 2013 Apr 20.","Husebo BS","Am J Geriatr Psychiatry","2014","2013/04/25","","","10.1016/j.jagp.2012.12.006"
"34724257","Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson's Disease: A Placebo-Controlled Trial of Rasagiline","Arpin DJ, Mitchell T, Archer DB, Burciu RG, Chu WT, Gao H, Guttuso T, Hess CW, Lai S, Malaty IA, McFarland NR, Pasternak O, Price CC, Shukla AW, Wu SS, Okun MS, Vaillancourt DE.","Mov Disord. 2022 Feb;37(2):325-333. doi: 10.1002/mds.28838. Epub 2021 Nov 1.","Arpin DJ","Mov Disord","2022","2021/11/01","PMC9019575","NIHMS1795149","10.1002/mds.28838"
"18096841","Neurological signs in relation to type of cerebrovascular disease in vascular dementia","Staekenborg SS, van der Flier WM, van Straaten EC, Lane R, Barkhof F, Scheltens P.","Stroke. 2008 Feb;39(2):317-22. doi: 10.1161/STROKEAHA.107.493353. Epub 2007 Dec 20.","Staekenborg SS","Stroke","2008","2007/12/22","","","10.1161/STROKEAHA.107.493353"
"36535116","Predictors of relapse of psychotic depression: Findings from the STOP-PD II randomized clinical trial","Flint AJ, Bingham KS, Alexopoulos GS, Marino P, Mulsant BH, Neufeld NH, Rothschild AJ, Voineskos AN, Whyte EM, Meyers BS; STOP-PD II Study Group.","J Psychiatr Res. 2023 Jan;157:285-290. doi: 10.1016/j.jpsychires.2022.12.011. Epub 2022 Dec 12.","Flint AJ","J Psychiatr Res","2023","2022/12/19","","","10.1016/j.jpsychires.2022.12.011"
"31912155","Effect of a 2-year diet intervention with walnuts on cognitive decline. The Walnuts And Healthy Aging (WAHA) study: a randomized controlled trial","Sala-Vila A, Valls-Pedret C, Rajaram S, Coll-Padrós N, Cofán M, Serra-Mir M, Pérez-Heras AM, Roth I, Freitas-Simoes TM, Doménech M, Calvo C, López-Illamola A, Bitok E, Buxton NK, Huey L, Arechiga A, Oda K, Lee GJ, Corella D, Vaqué-Alcázar L, Sala-Llonch R, Bartrés-Faz D, Sabaté J, Ros E.","Am J Clin Nutr. 2020 Mar 1;111(3):590-600. doi: 10.1093/ajcn/nqz328.","Sala-Vila A","Am J Clin Nutr","2020","2020/01/09","","","10.1093/ajcn/nqz328"
"23566344","Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: a population based CAIDE study","Rusanen M, Ngandu T, Laatikainen T, Tuomilehto J, Soininen H, Kivipelto M.","Curr Alzheimer Res. 2013 Jun;10(5):549-55. doi: 10.2174/1567205011310050011.","Rusanen M","Curr Alzheimer Res","2013","2013/04/10","","","10.2174/1567205011310050011"
"31910895","Methylphenidate and galantamine in patients with vascular cognitive impairment-the proof-of-principle study STREAM-VCI","Leijenaar JF, Groeneveld GJ, Klaassen ES, Leeuwis AE, Scheltens P, Weinstein HC, van Gerven JMA, Barkhof F, van der Flier WM, Prins ND.","Alzheimers Res Ther. 2020 Jan 7;12(1):10. doi: 10.1186/s13195-019-0567-z.","Leijenaar JF","Alzheimers Res Ther","2020","2020/01/09","PMC6947990","","10.1186/s13195-019-0567-z"
"36736039","Cognitive rehabilitation and mindfulness reduce cognitive complaints in multiple sclerosis (REMIND-MS): A randomized controlled trial","Nauta IM, Bertens D, Fasotti L, Fieldhouse J, Uitdehaag BMJ, Kessels RPC, Speckens AEM, de Jong BA.","Mult Scler Relat Disord. 2023 Mar;71:104529. doi: 10.1016/j.msard.2023.104529. Epub 2023 Jan 20.","Nauta IM","Mult Scler Relat Disord","2023","2023/02/03","","","10.1016/j.msard.2023.104529"
"30543172","Outcomes of Perilla Seed Oil as an Additional Neuroprotective Therapy in Patients with Mild to Moderate Dementia: A Randomized Control Trial","Kamalashiran C, Sriyakul K, Pattaraarchachai J, Muengtaweepongsa S.","Curr Alzheimer Res. 2019;16(2):146-155. doi: 10.2174/1567205016666181212153720.","Kamalashiran C","Curr Alzheimer Res","2019","2018/12/14","","","10.2174/1567205016666181212153720"
"34151805","Effect of a Multidomain Lifestyle Intervention on Estimated Dementia Risk","Solomon A, Handels R, Wimo A, Antikainen R, Laatikainen T, Levälahti E, Peltonen M, Soininen H, Strandberg T, Tuomilehto J, Kivipelto M, Ngandu T.","J Alzheimers Dis. 2021;82(4):1461-1466. doi: 10.3233/JAD-210331.","Solomon A","J Alzheimers Dis","2021","2021/06/21","PMC8461663","","10.3233/JAD-210331"
"32564066","Does the Impact of Intensive Lifestyle Intervention on Cardiovascular Disease Risk Vary According to Frailty as Measured via Deficit Accumulation?","Simpson FR, Pajewski NM, Beavers KM, Kritchevsky S, McCaffery J, Nicklas BJ, Wing RR, Bertoni A, Ingram F, Ojeranti D, Espeland MA.","J Gerontol A Biol Sci Med Sci. 2021 Jan 18;76(2):339-345. doi: 10.1093/gerona/glaa153.","Simpson FR","J Gerontol A Biol Sci Med Sci","2021","2020/06/22","PMC8444302","","10.1093/gerona/glaa153"
"30518237","A Comparative Single-Blind Randomized Controlled Trial With Language Training in People With Mild Cognitive Impairment","Poptsi E, Lazarou I, Markou N, Vassiloglou M, Nikolaidou E, Diamantidou A, Siatra V, Karathanassi E, Karakostas A, Zafeiropoulou FK, Tsiatsos T, Tsolaki M.","Am J Alzheimers Dis Other Demen. 2019 May;34(3):176-187. doi: 10.1177/1533317518813554. Epub 2018 Dec 5.","Poptsi E","Am J Alzheimers Dis Other Demen","2019","2018/12/07","","","10.1177/1533317518813554"
"25300037","START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of carers of people with dementia","Livingston G, Barber J, Rapaport P, Knapp M, Griffin M, Romeo R, King D, Livingston D, Lewis-Holmes E, Mummery C, Walker Z, Hoe J, Cooper C.","Health Technol Assess. 2014 Oct;18(61):1-242. doi: 10.3310/hta18610.","Livingston G","Health Technol Assess","2014","2014/10/10","PMC4781467","","10.3310/hta18610"
"35349875","The association between polypharmacy, frailty and disability-free survival in community-dwelling healthy older individuals","Ekram ARMS, Woods RL, Ryan J, Espinoza SE, Gilmartin-Thomas JFM, Shah RC, Mehta R, Kochar B, Lowthian JA, Lockery J, Orchard S, Nelson M, Fravel MA, Liew D, Ernst ME.","Arch Gerontol Geriatr. 2022 Jul-Aug;101:104694. doi: 10.1016/j.archger.2022.104694. Epub 2022 Mar 23.","Ekram ARMS","Arch Gerontol Geriatr","2022","2022/03/29","PMC9437977","NIHMS1831767","10.1016/j.archger.2022.104694"
"32859156","Rationale and protocol of the StayFitLonger study: a multicentre trial to measure efficacy and adherence of a home-based computerised multidomain intervention in healthy older adults","Belleville S, Cuesta M, Bieler-Aeschlimann M, Giacomino K, Widmer A, Mittaz Hager AG, Perez-Marcos D, Cardin S, Boller B, Bier N, Aubertin-Leheudre M, Bherer L, Berryman N, Agrigoroaei S, Demonet JF.","BMC Geriatr. 2020 Aug 28;20(1):315. doi: 10.1186/s12877-020-01709-2.","Belleville S","BMC Geriatr","2020","2020/08/30","PMC7453698","","10.1186/s12877-020-01709-2"
"27645761","Neurologic Complications of Unprotected Transcatheter Aortic Valve Implantation (from the Neuro-TAVI Trial)","Lansky AJ, Brown D, Pena C, Pietras CG, Parise H, Ng VG, Meller S, Abrams KJ, Cleman M, Margolis P, Petrossian G, Brickman AM, Voros S, Moses J, Forrest JK.","Am J Cardiol. 2016 Nov 15;118(10):1519-1526. doi: 10.1016/j.amjcard.2016.08.013. Epub 2016 Aug 23.","Lansky AJ","Am J Cardiol","2016","2016/09/21","","","10.1016/j.amjcard.2016.08.013"
"25539637","Characteristics associated with willingness to participate in a randomized controlled behavioral clinical trial using home-based personal computers and a webcam","Dodge HH, Katsumata Y, Zhu J, Mattek N, Bowman M, Gregor M, Wild K, Kaye JA.","Trials. 2014 Dec 23;15:508. doi: 10.1186/1745-6215-15-508.","Dodge HH","Trials","2014","2014/12/26","PMC4307639","","10.1186/1745-6215-15-508"
"24150105","Metabolic correlates of Rey auditory verbal learning test in elderly subjects with memory complaints","Brugnolo A, Morbelli S, Arnaldi D, De Carli F, Accardo J, Bossert I, Dessi B, Famà F, Ferrara M, Girtler N, Picco A, Rodriguez G, Sambuceti G, Nobili F.","J Alzheimers Dis. 2014;39(1):103-13. doi: 10.3233/JAD-121684.","Brugnolo A","J Alzheimers Dis","2014","2013/10/24","","","10.3233/JAD-121684"
"30221615","DREAMS-START (Dementia RElAted Manual for Sleep; STrAtegies for RelaTives) for people with dementia and sleep disturbances: a single-blind feasibility and acceptability randomized controlled trial","Livingston G, Barber JA, Kinnunen KM, Webster L, Kyle SD, Cooper C, Espie CA, Hallam B, Horsley R, Pickett J, Rapaport P.","Int Psychogeriatr. 2019 Feb;31(2):251-265. doi: 10.1017/S1041610218000753. Epub 2018 Sep 17.","Livingston G","Int Psychogeriatr","2019","2018/09/18","PMC6474714","","10.1017/S1041610218000753"
"25657183","Effects of blood pressure-lowering treatment in different subtypes of acute ischemic stroke","Sandset EC, Jusufovic M, Sandset PM, Bath PM, Berge E; SCAST Study Group.","Stroke. 2015 Mar;46(3):877-9. doi: 10.1161/STROKEAHA.114.008512. Epub 2015 Feb 5.","Sandset EC","Stroke","2015","2015/02/07","","","10.1161/STROKEAHA.114.008512"
"34702730","Implementation processes in a cognitive rehabilitation intervention for people with dementia: a complexity-informed qualitative analysis","Morgan-Trimmer S, Kudlicka A, Warmoth K, Leroi I, Oyebode JR, Pool J, Woods R, Clare L.","BMJ Open. 2021 Oct 26;11(10):e051255. doi: 10.1136/bmjopen-2021-051255.","Morgan-Trimmer S","BMJ Open","2021","2021/10/27","PMC8549661","","10.1136/bmjopen-2021-051255"
"22700039","Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report","Sofuoglu M, Herman AI, Li Y, Waters AJ.","Psychopharmacology (Berl). 2012 Dec;224(3):413-20. doi: 10.1007/s00213-012-2763-4. Epub 2012 Jun 15.","Sofuoglu M","Psychopharmacology (Berl)","2012","2012/06/16","PMC3636552","NIHMS460449","10.1007/s00213-012-2763-4"
"32466776","Effect of baseline cognitive impairment on association between predicted propofol effect site concentration and Bispectral index or sedation score","Sieber F, Neufeld K, Oh ES, Gottschalk A, Wang NY.","BMC Anesthesiol. 2020 May 28;20(1):129. doi: 10.1186/s12871-020-01043-5.","Sieber F","BMC Anesthesiol","2020","2020/05/30","PMC7254641","","10.1186/s12871-020-01043-5"
"22725836","Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers","Volak LP, Hanley MJ, Masse G, Hazarika S, Harmatz JS, Badmaev V, Majeed M, Greenblatt DJ, Court MH.","Br J Clin Pharmacol. 2013 Feb;75(2):450-62. doi: 10.1111/j.1365-2125.2012.04364.x.","Volak LP","Br J Clin Pharmacol","2013","2012/06/26","PMC3579260","","10.1111/j.1365-2125.2012.04364.x"
"19536421","Health and nutritional promotion program for patients with dementia (NutriAlz Study): design and baseline data","Salva A, Andrieu S, Fernandez E, Schiffrin EJ, Moulin J, Decarli B, Guigoz Y, Vellas B; NutriAlz Group.","J Nutr Health Aging. 2009 Jun;13(6):529-37. doi: 10.1007/s12603-009-0103-0.","Salva A","J Nutr Health Aging","2009","2009/06/19","","","10.1007/s12603-009-0103-0"
"34853363","Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial","Kang JH, Vyas CM, Okereke OI, Ogata S, Albert M, Lee IM, D'Agostino D, Buring JE, Cook NR, Grodstein F, Manson JE.","Sci Rep. 2021 Dec 1;11(1):23253. doi: 10.1038/s41598-021-02485-8.","Kang JH","Sci Rep","2021","2021/12/02","PMC8636504","","10.1038/s41598-021-02485-8"
"32975632","Biomarkers of neuronal damage in saturation diving-a controlled observational study","Rosén A, Gennser M, Oscarsson N, Kvarnström A, Sandström G, Blennow K, Seeman-Lodding H, Zetterberg H.","Eur J Appl Physiol. 2020 Dec;120(12):2773-2784. doi: 10.1007/s00421-020-04499-y. Epub 2020 Sep 25.","Rosén A","Eur J Appl Physiol","2020","2020/09/25","PMC7674315","","10.1007/s00421-020-04499-y"
"28596452","Effect of Long-Term Vascular Care on Progression of Cerebrovascular Lesions: Magnetic Resonance Imaging Substudy of the PreDIVA Trial (Prevention of Dementia by Intensive Vascular Care)","van Dalen JW, Moll van Charante EP, Caan MWA, Scheltens P, Majoie CBLM, Nederveen AJ, van Gool WA, Richard E.","Stroke. 2017 Jul;48(7):1842-1848. doi: 10.1161/STROKEAHA.117.017207. Epub 2017 Jun 8.","van Dalen JW","Stroke","2017","2017/06/10","","","10.1161/STROKEAHA.117.017207"
"32924754","Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial","Rymer JA, Mulder H, Smolderen KG, Hiatt WR, Conte MS, Berger JS, Norgren L, Mahaffey KW, Baumgartner I, Fowkes FG, Katona BG, Rockhold F, Jones WS, Patel MR.","J Am Heart Assoc. 2020 Oct 20;9(19):e016573. doi: 10.1161/JAHA.120.016573. Epub 2020 Sep 13.","Rymer JA","J Am Heart Assoc","2020","2020/09/14","PMC7792388","","10.1161/JAHA.120.016573"
"29287521","Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?","Moreau C, Danel V, Devedjian JC, Grolez G, Timmerman K, Laloux C, Petrault M, Gouel F, Jonneaux A, Dutheil M, Lachaud C, Lopes R, Kuchcinski G, Auger F, Kyheng M, Duhamel A, Pérez T, Pradat PF, Blasco H, Veyrat-Durebex C, Corcia P, Oeckl P, Otto M, Dupuis L, Garçon G, Defebvre L, Cabantchik ZI, Duce J, Bordet R, Devos D.","Antioxid Redox Signal. 2018 Sep 10;29(8):742-748. doi: 10.1089/ars.2017.7493. Epub 2018 Feb 8.","Moreau C","Antioxid Redox Signal","2018","2017/12/31","PMC6067092","","10.1089/ars.2017.7493"
"35292423","Rivaroxaban versus aspirin on functional and cognitive outcomes after embolic stroke of undetermined source: NAVIGATE ESUS trial","Bosch J, Pearce LA, Sharma M, Canavan M, Whiteley WN, Mikulík R, Mundl H, Yusuf S, Hart RG, O'Donnell MJ.","J Stroke Cerebrovasc Dis. 2022 May;31(5):106404. doi: 10.1016/j.jstrokecerebrovasdis.2022.106404. Epub 2022 Mar 12.","Bosch J","J Stroke Cerebrovasc Dis","2022","2022/03/16","","","10.1016/j.jstrokecerebrovasdis.2022.106404"
"33920971","Effects of Two Randomized and Controlled Multi-Component Interventions Focusing On 24-Hour Movement Behavior among Office Workers: A Compositional Data Analysis","Larisch LM, Bojsen-Møller E, Nooijen CFJ, Blom V, Ekblom M, Ekblom Ö, Arvidsson D, Fridolfsson J, Hallman DM, Mathiassen SE, Wang R, Kallings LV.","Int J Environ Res Public Health. 2021 Apr 15;18(8):4191. doi: 10.3390/ijerph18084191.","Larisch LM","Int J Environ Res Public Health","2021","2021/04/30","PMC8071247","","10.3390/ijerph18084191"
"21680159","Quantitative approaches for assessment of white matter hyperintensities in elderly populations","Brickman AM, Sneed JR, Provenzano FA, Garcon E, Johnert L, Muraskin J, Yeung LK, Zimmerman ME, Roose SP.","Psychiatry Res. 2011 Aug 30;193(2):101-6. doi: 10.1016/j.pscychresns.2011.03.007. Epub 2011 Jun 16.","Brickman AM","Psychiatry Res","2011","2011/06/18","PMC3164869","NIHMS304476","10.1016/j.pscychresns.2011.03.007"
"35258771","Proximal improvement and higher-order resting state network change after multidomain cognitive training intervention in healthy older adults","Hardcastle C, Hausman HK, Kraft JN, Albizu A, O'Shea A, Boutzoukas EM, Evangelista ND, Langer K, Van Etten EJ, Bharadwaj PK, Song H, Smith SG, Porges E, DeKosky ST, Hishaw GA, Wu SS, Marsiske M, Cohen R, Alexander GE, Woods AJ.","Geroscience. 2022 Apr;44(2):1011-1027. doi: 10.1007/s11357-022-00535-1. Epub 2022 Mar 8.","Hardcastle C","Geroscience","2022","2022/03/08","PMC9135928","","10.1007/s11357-022-00535-1"
"36805256","Evaluating depressive symptoms, BDNF Val66Met, and APOE-ε4 as moderators of response to computerized cognitive training in heart failure","Pressler SJ, Jung M, Giordani B, Titler MG, Gradus-Pizlo I, Lake KR, Wierenga KL, Clark DG, Perkins SM, Smith DG, Mocci E, Dorsey SG.","Heart Lung. 2023 May-Jun;59:146-156. doi: 10.1016/j.hrtlng.2023.02.002. Epub 2023 Feb 18.","Pressler SJ","Heart Lung","2023","2023/02/22","PMC10065971","NIHMS1877969","10.1016/j.hrtlng.2023.02.002"
"35278154","Higher white matter hyperintensity load adversely affects pre-post proximal cognitive training performance in healthy older adults","Boutzoukas EM, O'Shea A, Kraft JN, Hardcastle C, Evangelista ND, Hausman HK, Albizu A, Van Etten EJ, Bharadwaj PK, Smith SG, Song H, Porges EC, Hishaw A, DeKosky ST, Wu SS, Marsiske M, Alexander GE, Cohen R, Woods AJ.","Geroscience. 2022 Jun;44(3):1441-1455. doi: 10.1007/s11357-022-00538-y. Epub 2022 Mar 12.","Boutzoukas EM","Geroscience","2022","2022/03/12","PMC9213634","","10.1007/s11357-022-00538-y"
"34559230","Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial","Ljubenkov PA, Edwards L, Iaccarino L, La Joie R, Rojas JC, Koestler M, Harris B, Boeve BF, Borroni B, van Swieten JC, Grossman M, Pasquier F, Frisoni GB, Mummery CJ, Vandenberghe R, Le Ber I, Hannequin D, McGinnis SM, Auriacombe S, Onofrj M, Goodman IJ, Riordan HJ, Wisniewski G, Hesterman J, Marek K, Haynes BA, Patzke H, Koenig G, Hilt D, Moebius H, Boxer AL.","JAMA Netw Open. 2021 Sep 1;4(9):e2125584. doi: 10.1001/jamanetworkopen.2021.25584.","Ljubenkov PA","JAMA Netw Open","2021","2021/09/24","PMC8463943","","10.1001/jamanetworkopen.2021.25584"
"32383964","Delirium Severity Trajectories and Outcomes in ICU Patients. Defining a Dynamic Symptom Phenotype","Lindroth H, Khan BA, Carpenter JS, Gao S, Perkins AJ, Khan SH, Wang S, Jones RN, Boustani MA.","Ann Am Thorac Soc. 2020 Sep;17(9):1094-1103. doi: 10.1513/AnnalsATS.201910-764OC.","Lindroth H","Ann Am Thorac Soc","2020","2020/05/09","PMC7462321","","10.1513/AnnalsATS.201910-764OC"
"36067369","Effect of Vitamin D Supplementation on Overactive Bladder and Urinary Incontinence Symptoms in Older Men: Ancillary Findings From a Randomized Trial","Markland AD, Vaughan CP, Huang AJ, Kim E, Bubes VY, Tangpricha V, Buring JR, Lee IM, Cook NR, Manson JE, Grodstein F.","J Urol. 2023 Jan;209(1):243-252. doi: 10.1097/JU.0000000000002942. Epub 2022 Sep 6.","Markland AD","J Urol","2023","2022/09/06","PMC9742141","NIHMS1829992","10.1097/JU.0000000000002942"
"28840742","International Ballroom Dancing Against Neurodegeneration: A Randomized Controlled Trial in Greek Community-Dwelling Elders With Mild Cognitive impairment","Lazarou I, Parastatidis T, Tsolaki A, Gkioka M, Karakostas A, Douka S, Tsolaki M.","Am J Alzheimers Dis Other Demen. 2017 Dec;32(8):489-499. doi: 10.1177/1533317517725813. Epub 2017 Aug 25.","Lazarou I","Am J Alzheimers Dis Other Demen","2017","2017/08/26","","","10.1177/1533317517725813"
"33288467","Online Education and Cognitive Behavior Therapy Improve Dementia Caregivers' Mental Health: A Randomized Trial","Fossey J, Charlesworth G, Fowler JA, Frangou E, Pimm TJ, Dent J, Ryder J, Robinson A, Kahn R, Aarsland D, Pickett J, Ballard C.","J Am Med Dir Assoc. 2021 Jul;22(7):1403-1409.e1. doi: 10.1016/j.jamda.2020.10.009. Epub 2020 Dec 5.","Fossey J","J Am Med Dir Assoc","2021","2020/12/08","","","10.1016/j.jamda.2020.10.009"
"29233097","Individualized support for informal caregivers of people with dementia - effectiveness of the German adaptation of REACH II","Berwig M, Heinrich S, Spahlholz J, Hallensleben N, Brähler E, Gertz HJ.","BMC Geriatr. 2017 Dec 12;17(1):286. doi: 10.1186/s12877-017-0678-y.","Berwig M","BMC Geriatr","2017","2017/12/14","PMC5728045","","10.1186/s12877-017-0678-y"
"26975720","Contacting authors to retrieve individual patient data: study protocol for a randomized controlled trial","Veroniki AA, Straus SE, Ashoor H, Stewart LA, Clarke M, Tricco AC.","Trials. 2016 Mar 15;17(1):138. doi: 10.1186/s13063-016-1238-z.","Veroniki AA","Trials","2016","2016/03/16","PMC4791799","","10.1186/s13063-016-1238-z"
"22683399","The impact of family caregivers on potentially inappropriate medication use in noninstitutionalized older adults with dementia","Thorpe JM, Thorpe CT, Kennelty KA, Gellad WF, Schulz R.","Am J Geriatr Pharmacother. 2012 Aug;10(4):230-41. doi: 10.1016/j.amjopharm.2012.05.001. Epub 2012 Jun 9.","Thorpe JM","Am J Geriatr Pharmacother","2012","2012/06/12","PMC3413778","NIHMS386507","10.1016/j.amjopharm.2012.05.001"
"19368900","Serotonin modulation of cerebral glucose metabolism in depressed older adults","Smith GS, Kramer E, Hermann C, Ma Y, Dhawan V, Chaly T, Eidelberg D.","Biol Psychiatry. 2009 Aug 1;66(3):259-66. doi: 10.1016/j.biopsych.2009.02.012. Epub 2009 Apr 15.","Smith GS","Biol Psychiatry","2009","2009/04/17","PMC2706292","NIHMS100330","10.1016/j.biopsych.2009.02.012"
"30527596","Dietary changes and cognition over 2 years within a multidomain intervention trial-The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)","Lehtisalo J, Levälahti E, Lindström J, Hänninen T, Paajanen T, Peltonen M, Antikainen R, Laatikainen T, Strandberg T, Soininen H, Tuomilehto J, Kivipelto M, Ngandu T.","Alzheimers Dement. 2019 Mar;15(3):410-417. doi: 10.1016/j.jalz.2018.10.001. Epub 2018 Dec 4.","Lehtisalo J","Alzheimers Dement","2019","2018/12/12","","","10.1016/j.jalz.2018.10.001"
"35700341","Phase 1 Single Ascending and Multiple Ascending Dose Studies of Phosphodiesterase-9 Inhibitor E2027: Confirmation of Target Engagement and Selection of Phase 2 Dose in Dementia With Lewy Bodies Trial","Landry IS, Aluri J, Schuck E, Ino M, Horie K, Boyd P, Reyderman L, Lai R.","Alzheimer Dis Assoc Disord. 2022 Jul-Sep 01;36(3):200-207. doi: 10.1097/WAD.0000000000000515. Epub 2022 Jun 9.","Landry IS","Alzheimer Dis Assoc Disord","2022","2022/06/14","","","10.1097/WAD.0000000000000515"
"25811797","Determinants of Activity Levels in African Americans With Mild Cognitive Impairment","Rovner BW, Casten RJ, Leiby BE.","Alzheimer Dis Assoc Disord. 2016 Jan-Mar;30(1):41-6. doi: 10.1097/WAD.0000000000000096.","Rovner BW","Alzheimer Dis Assoc Disord","2016","2015/03/27","PMC5911368","NIHMS959446","10.1097/WAD.0000000000000096"
"23906000","Quality of education and memory test performance in older men: the New York University Paragraph Recall Test normative data","Mathews M, Abner E, Caban-Holt A, Dennis BC, Kryscio R, Schmitt F.","Curr Alzheimer Res. 2013 Sep;10(7):776-83. doi: 10.2174/15672050113109990140.","Mathews M","Curr Alzheimer Res","2013","2013/08/03","PMC4030724","NIHMS573348","10.2174/15672050113109990140"
"19965852","Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease","Staekenborg SS, Su T, van Straaten EC, Lane R, Scheltens P, Barkhof F, van der Flier WM.","J Neurol Neurosurg Psychiatry. 2010 May;81(5):547-51. doi: 10.1136/jnnp.2009.187500. Epub 2009 Dec 3.","Staekenborg SS","J Neurol Neurosurg Psychiatry","2010","2009/12/08","","","10.1136/jnnp.2009.187500"
"35224525","A multistate model of health transitions in older people: a secondary analysis of ASPREE clinical trial data","Neumann JT, Thao LTP, Callander E, Carr PR, Qaderi V, Nelson MR, Reid CM, Woods RL, Orchard SG, Wolfe R, Polekhina G, Williamson JD, Trauer JM, Newman AB, Murray AM, Ernst ME, Tonkin AM, McNeil JJ.","Lancet Healthy Longev. 2022 Feb;3(2):e89-e97. doi: 10.1016/s2666-7568(21)00308-1. Epub 2022 Feb 7.","Neumann JT","Lancet Healthy Longev","2022","2022/02/28","PMC8880962","NIHMS1778473","10.1016/s2666-7568(21)00308-1"
"30478131","Namaste Care in nursing care homes for people with advanced dementia: protocol for a feasibility randomised controlled trial","Froggatt K, Patel S, Perez Algorta G, Bunn F, Burnside G, Coast J, Dunleavy L, Goodman C, Hardwick B, Kinley J, Preston NJ, Walshe C.","BMJ Open. 2018 Nov 25;8(11):e026531. doi: 10.1136/bmjopen-2018-026531.","Froggatt K","BMJ Open","2018","2018/11/28","PMC6254402","","10.1136/bmjopen-2018-026531"
"36253765","Cognitive and biological effects of citrus phytochemicals in subjective cognitive decline: a 36-week, randomized, placebo-controlled trial","Galluzzi S, Zanardini R, Ferrari C, Gipponi S, Passeggia I, Rampini M, Sgrò G, Genovese S, Fiorito S, Palumbo L, Pievani M, Frisoni GB, Epifano F.","Nutr J. 2022 Oct 17;21(1):64. doi: 10.1186/s12937-022-00817-6.","Galluzzi S","Nutr J","2022","2022/10/17","PMC9575277","","10.1186/s12937-022-00817-6"
"36905757","The application of a continuous partnership-based birth plan in China: A randomized controlled trial","Guo H, Li T, Zhou R, Li M, Feng C, Cai X, Zhang C.","Midwifery. 2023 May;120:103625. doi: 10.1016/j.midw.2023.103625. Epub 2023 Feb 11.","Guo H","Midwifery","2023","2023/03/11","","","10.1016/j.midw.2023.103625"
"25472578","Effects of blood pressure lowering in patients with acute ischemic stroke and carotid artery stenosis","Jusufovic M, Sandset EC, Bath PM, Karlson BW, Berge E; Scandinavian Candesartan Acute Stroke Trial Study Group.","Int J Stroke. 2015 Apr;10(3):354-9. doi: 10.1111/ijs.12418. Epub 2014 Dec 3.","Jusufovic M","Int J Stroke","2015","2014/12/05","","","10.1111/ijs.12418"
"34758073","The Effect of Low-Dose Aspirin on Frailty Phenotype and Frailty Index in Community-Dwelling Older Adults in the ASPirin in Reducing Events in the Elderly Study","Espinoza SE, Woods RL, Ekram ARMS, Ernst ME, Polekhina G, Wolfe R, Shah RC, Ward SA, Storey E, Nelson MR, Reid CM, Lockery JE, Orchard SG, Trevaks R, Fitzgerald SM, Stocks NP, Chan A, McNeil JJ, Murray AM, Newman AB, Ryan J.","J Gerontol A Biol Sci Med Sci. 2022 Oct 6;77(10):2007-2014. doi: 10.1093/gerona/glab340.","Espinoza SE","J Gerontol A Biol Sci Med Sci","2022","2021/11/10","PMC9536436","","10.1093/gerona/glab340"
"31934946","Menopausal hormone therapy, blood thrombogenicity, and development of white matter hyperintensities in women of the Kronos Early Estrogen Prevention Study","Jayachandran M, Lahr BD, Bailey KR, Miller VM, Kantarci K.","Menopause. 2020 Mar;27(3):305-310. doi: 10.1097/GME.0000000000001465.","Jayachandran M","Menopause","2020","2020/01/15","PMC7050795","NIHMS1577934","10.1097/GME.0000000000001465"
"31099860","Comparative Effectiveness of Behavioral Interventions on Quality of Life for Older Adults With Mild Cognitive Impairment: A Randomized Clinical Trial","Chandler MJ, Locke DE, Crook JE, Fields JA, Ball CT, Phatak VS, Dean PM, Morris M, Smith GE.","JAMA Netw Open. 2019 May 3;2(5):e193016. doi: 10.1001/jamanetworkopen.2019.3016.","Chandler MJ","JAMA Netw Open","2019","2019/05/18","PMC6537922","","10.1001/jamanetworkopen.2019.3016"
"27890482","Dietary nitrate does not affect physical activity or outcomes in healthy older adults in a randomized, cross-over trial","Siervo M, Oggioni C, Jakovljevic DG, Trenell M, Mathers JC, Houghton D, Celis-Morales C, Ashor AW, Ruddock A, Ranchordas M, Klonizakis M, Williams EA.","Nutr Res. 2016 Dec;36(12):1361-1369. doi: 10.1016/j.nutres.2016.11.004. Epub 2016 Nov 14.","Siervo M","Nutr Res","2016","2016/11/29","","","10.1016/j.nutres.2016.11.004"
"27089522","Combining clinical variables to optimize prediction of antidepressant treatment outcomes","Iniesta R, Malki K, Maier W, Rietschel M, Mors O, Hauser J, Henigsberg N, Dernovsek MZ, Souery D, Stahl D, Dobson R, Aitchison KJ, Farmer A, Lewis CM, McGuffin P, Uher R.","J Psychiatr Res. 2016 Jul;78:94-102. doi: 10.1016/j.jpsychires.2016.03.016. Epub 2016 Apr 1.","Iniesta R","J Psychiatr Res","2016","2016/04/19","","","10.1016/j.jpsychires.2016.03.016"
"22922507","Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke","Böhm M, Cotton D, Foster L, Custodis F, Laufs U, Sacco R, Bath PM, Yusuf S, Diener HC.","Eur Heart J. 2012 Nov;33(22):2804-12. doi: 10.1093/eurheartj/ehs250. Epub 2012 Aug 26.","Böhm M","Eur Heart J","2012","2012/08/28","","","10.1093/eurheartj/ehs250"
"35232389","Feasibility of an online training and support program for dementia carers: results from a mixed-methods pilot randomized controlled trial","Teles S, Ferreira A, Paúl C.","BMC Geriatr. 2022 Mar 1;22(1):173. doi: 10.1186/s12877-022-02831-z.","Teles S","BMC Geriatr","2022","2022/03/02","PMC8887647","","10.1186/s12877-022-02831-z"
"33873195","Effects of a Mindfulness-Based Intervention versus Health Self-Management on Subclinical Anxiety in Older Adults with Subjective Cognitive Decline: The SCD-Well Randomized Superiority Trial","Marchant NL, Barnhofer T, Coueron R, Wirth M, Lutz A, Arenaza-Urquijo EM, Collette F, Poisnel G, Demnitz-King H, Schild AK, Coll-Padros N, Delphin-Combe F, Whitfield T, Schlosser M, Gonneaud J, Asselineau J, Walker Z, Krolak-Salmon P, Molinuevo JL, Frison E, Chételat G, Jessen F, Klimecki OM; The Medit-Ageing Research Group.","Psychother Psychosom. 2021;90(5):341-350. doi: 10.1159/000515669. Epub 2021 Apr 19.","Marchant NL","Psychother Psychosom","2021","2021/04/19","","","10.1159/000515669"
"30540355","Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial","Olivier CB, Mulder H, Hiatt WR, Jones WS, Fowkes FGR, Rockhold FW, Berger JS, Baumgartner I, Held P, Katona BG, Norgren L, Blomster J, Patel MR, Mahaffey KW.","JAMA Cardiol. 2019 Jan 1;4(1):7-15. doi: 10.1001/jamacardio.2018.4171.","Olivier CB","JAMA Cardiol","2019","2018/12/13","PMC6439683","","10.1001/jamacardio.2018.4171"
"36357586","Treadmill training with virtual reality to enhance gait and cognitive function among people with multiple sclerosis: a randomized controlled trial","Galperin I, Mirelman A, Schmitz-Hübsch T, Hsieh KL, Regev K, Karni A, Brozgol M, Cornejo Thumm P, Lynch SG, Paul F, Devos H, Sosnoff J, Hausdorff JM.","J Neurol. 2023 Mar;270(3):1388-1401. doi: 10.1007/s00415-022-11469-1. Epub 2022 Nov 11.","Galperin I","J Neurol","2023","2022/11/10","PMC9649393","","10.1007/s00415-022-11469-1"
"33526043","Combining transcranial direct current stimulation with a motor-cognitive task: the impact on dual-task walking costs in older adults","Schneider N, Dagan M, Katz R, Thumm PC, Brozgol M, Giladi N, Manor B, Mirelman A, Hausdorff JM.","J Neuroeng Rehabil. 2021 Feb 1;18(1):23. doi: 10.1186/s12984-021-00826-2.","Schneider N","J Neuroeng Rehabil","2021","2021/02/02","PMC7852224","","10.1186/s12984-021-00826-2"
"24938504","Does an interdisciplinary network improve dementia care? Results from the IDemUck-study","Köhler L, Meinke-Franze C, Hein J, Fendrich K, Heymann R, Thyrian JR, Hoffmann W.","Curr Alzheimer Res. 2014;11(6):538-48. doi: 10.2174/1567205011666140618100727.","Köhler L","Curr Alzheimer Res","2014","2014/06/19","PMC4150489","","10.2174/1567205011666140618100727"
"33504953","Effects of aspirin on the long-term management of depression in older people: a double-blind randomised placebo-controlled trial","Berk M, Agustini B, Woods RL, Nelson MR, Shah RC, Reid CM, Storey E, Fitzgerald SM, Lockery JE, Wolfe R, Mohebbi M, Dodd S, Murray AM, Stocks N, Fitzgerald PB, Mazza C, McNeil JJ.","Mol Psychiatry. 2021 Sep;26(9):5161-5170. doi: 10.1038/s41380-021-01020-5. Epub 2021 Jan 27.","Berk M","Mol Psychiatry","2021","2021/01/28","PMC8313623","NIHMS1661143","10.1038/s41380-021-01020-5"
"24290367","Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: a longitudinal study","Diniz BS, Reynolds CF 3rd, Begley A, Dew MA, Anderson SJ, Lotrich F, Erickson KI, Lopez O, Aizenstein H, Sibille EL, Butters MA.","J Psychiatr Res. 2014 Feb;49:96-101. doi: 10.1016/j.jpsychires.2013.11.004. Epub 2013 Nov 20.","Diniz BS","J Psychiatr Res","2014","2013/12/03","PMC3921964","NIHMS542571","10.1016/j.jpsychires.2013.11.004"
"18482298","Decisional capacity for research participation in individuals with mild cognitive impairment","Jefferson AL, Lambe S, Moser DJ, Byerly LK, Ozonoff A, Karlawish JH.","J Am Geriatr Soc. 2008 Jul;56(7):1236-43. doi: 10.1111/j.1532-5415.2008.01752.x. Epub 2008 May 12.","Jefferson AL","J Am Geriatr Soc","2008","2008/05/17","PMC2724182","NIHMS112627","10.1111/j.1532-5415.2008.01752.x"
"35994031","Implementing a home-based virtual hypertension programme-a pilot feasibility study","Gupta A, Ellis SD, Burkhardt C, Young K, Mazzotti DR, Mahnken J, Abu-El-Rub N, Chandaka S, Comfort B, Shanks D, Woodward J, Unrein A, Anderson H, Loucks J, Song X, Waitman LR, Burns JM.","Fam Pract. 2023 Mar 28;40(2):414-422. doi: 10.1093/fampra/cmac084.","Gupta A","Fam Pract","2023","2022/08/22","PMC10047620","","10.1093/fampra/cmac084"
"36342703","Daily Low-Dose Aspirin and Risk of Serious Falls and Fractures in Healthy Older People: A Substudy of the ASPREE Randomized Clinical Trial","Barker AL, Morello R, Thao LTP, Seeman E, Ward SA, Sanders KM, Cumming RG, Pasco JA, Ebeling PR, Woods RL, Wolfe R, Khosla S, Hussain SM, Ronaldson K, Newman AB, Williamson JD, McNeil JJ.","JAMA Intern Med. 2022 Dec 1;182(12):1289-1297. doi: 10.1001/jamainternmed.2022.5028.","Barker AL","JAMA Intern Med","2022","2022/11/07","PMC9641595","","10.1001/jamainternmed.2022.5028"
"17132972","A phase 2 study of tramiprosate for cerebral amyloid angiopathy","Greenberg SM, Rosand J, Schneider AT, Creed Pettigrew L, Gandy SE, Rovner B, Fitzsimmons BF, Smith EE, Edip Gurol M, Schwab K, Laurin J, Garceau D.","Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):269-74. doi: 10.1097/01.wad.0000213845.28624.f4.","Greenberg SM","Alzheimer Dis Assoc Disord","2006","2006/11/30","","","10.1097/01.wad.0000213845.28624.f4"
"36215061","Effect of an 18-Month Meditation Training on Regional Brain Volume and Perfusion in Older Adults: The Age-Well Randomized Clinical Trial","Chételat G, Lutz A, Klimecki O, Frison E, Asselineau J, Schlosser M, Arenaza-Urquijo EM, Mézenge F, Kuhn E, Moulinet I, Touron E, Dautricourt S, André C, Palix C, Ourry V, Felisatti F, Gonneaud J, Landeau B, Rauchs G, Chocat A, Quillard A, Devouge EF, Vuilleumier P, de La Sayette V, Vivien D, Collette F, Poisnel G, Marchant NL; Medit-Ageing Research Group.","JAMA Neurol. 2022 Nov 1;79(11):1165-1174. doi: 10.1001/jamaneurol.2022.3185.","Chételat G","JAMA Neurol","2022","2022/10/10","PMC9552046","","10.1001/jamaneurol.2022.3185"
"32186653","Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial","Marquis-Gravel G, Roe MT, Robertson HR, Harrington RA, Pencina MJ, Berdan LG, Hammill BG, Faulkner M, Muñoz D, Fonarow GC, Nallamothu BK, Fintel DJ, Ford DE, Zhou L, Daugherty SE, Nauman E, Kraschnewski J, Ahmad FS, Benziger CP, Haynes K, Merritt JG, Metkus T, Kripalani S, Gupta K, Shah RC, McClay JC, Re RN, Geary C, Lampert BC, Bradley SM, Jain SK, Seifein H, Whittle J, Roger VL, Effron MB, Alvarado G, Goldberg YH, VanWormer JL, Girotra S, Farrehi P, McTigue KM, Rothman R, Hernandez AF, Jones WS.","JAMA Cardiol. 2020 May 1;5(5):598-607. doi: 10.1001/jamacardio.2020.0116.","Marquis-Gravel G","JAMA Cardiol","2020","2020/03/19","","","10.1001/jamacardio.2020.0116"
"27288376","Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment","Richard E, Jongstra S, Soininen H, Brayne C, Moll van Charante EP, Meiller Y, van der Groep B, Beishuizen CR, Mangialasche F, Barbera M, Ngandu T, Coley N, Guillemont J, Savy S, Dijkgraaf MG, Peters RJ, van Gool WA, Kivipelto M, Andrieu S.","BMJ Open. 2016 Jun 10;6(6):e010806. doi: 10.1136/bmjopen-2015-010806.","Richard E","BMJ Open","2016","2016/06/12","PMC4908903","","10.1136/bmjopen-2015-010806"
"17174572","Improved reliability of hippocampal atrophy rate measurement in mild cognitive impairment using fluid registration","van de Pol LA, Barnes J, Scahill RI, Frost C, Lewis EB, Boyes RG, van Schijndel RA, Scheltens P, Fox NC, Barkhof F.","Neuroimage. 2007 Feb 1;34(3):1036-41. doi: 10.1016/j.neuroimage.2006.10.033. Epub 2006 Dec 15.","van de Pol LA","Neuroimage","2007","2006/12/19","","","10.1016/j.neuroimage.2006.10.033"
"26374231","COSMOS--improving the quality of life in nursing home patients: protocol for an effectiveness-implementation cluster randomized clinical hybrid trial","Husebo BS, Flo E, Aarsland D, Selbaek G, Testad I, Gulla C, Aasmul I, Ballard C.","Implement Sci. 2015 Sep 15;10:131. doi: 10.1186/s13012-015-0310-5.","Husebo BS","Implement Sci","2015","2015/09/17","PMC4572450","","10.1186/s13012-015-0310-5"
"35684987","Assessing the feasibility of a web-based outcome measurement system in child and adolescent mental health services - myHealthE a randomised controlled feasibility pilot study","Morris AC, Ibrahim Z, Heslin M, Moghraby OS, Stringaris A, Grant IM, Zalewski L, Pritchard M, Stewart R, Hotopf M, Pickles A, Dobson RJB, Simonoff E, Downs J.","Child Adolesc Ment Health. 2023 Feb;28(1):128-147. doi: 10.1111/camh.12571. Epub 2022 Jun 9.","Morris AC","Child Adolesc Ment Health","2023","2022/06/10","PMC10083915","","10.1111/camh.12571"
"29615645","Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables","Iniesta R, Hodgson K, Stahl D, Malki K, Maier W, Rietschel M, Mors O, Hauser J, Henigsberg N, Dernovsek MZ, Souery D, Dobson R, Aitchison KJ, Farmer A, McGuffin P, Lewis CM, Uher R.","Sci Rep. 2018 Apr 3;8(1):5530. doi: 10.1038/s41598-018-23584-z.","Iniesta R","Sci Rep","2018","2018/04/05","PMC5882876","","10.1038/s41598-018-23584-z"
"31930364","Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults: A Randomized Clinical Trial","Isaacson SH, Ondo W, Jackson CE, Trosch RM, Molho E, Pagan F, Lew M, Dashtipour K, Clinch T, Espay AJ; MYSTICOL Study Group.","JAMA Neurol. 2020 Apr 1;77(4):461-469. doi: 10.1001/jamaneurol.2019.4565.","Isaacson SH","JAMA Neurol","2020","2020/01/14","PMC6990829","","10.1001/jamaneurol.2019.4565"
"9529819","Quantitative analysis of hemispatial neglect in the intracarotid sodium amobarbital (ISA) test","Ahern GL, Herring AM, Labiner DM, Weinand ME.","J Int Neuropsychol Soc. 1998 Mar;4(2):99-105. doi: 10.1017/s135561779800099x.","Ahern GL","J Int Neuropsychol Soc","1998","1998/04/08","","","10.1017/s135561779800099x"
"34131267","Omega-3 polyunsaturated fatty acids protect against inflammation through production of LOX and CYP450 lipid mediators: relevance for major depression and for human hippocampal neurogenesis","Borsini A, Nicolaou A, Camacho-Muñoz D, Kendall AC, Di Benedetto MG, Giacobbe J, Su KP, Pariante CM.","Mol Psychiatry. 2021 Nov;26(11):6773-6788. doi: 10.1038/s41380-021-01160-8. Epub 2021 Jun 16.","Borsini A","Mol Psychiatry","2021","2021/06/16","PMC8760043","","10.1038/s41380-021-01160-8"
"31062260","Association Between Statin Use and Depressive Symptoms in a Large Community-Dwelling Older Population Living in Australia and the USA: A Cross-Sectional Study","Agustini B, Mohebbi M, Woods RL, McNeil JJ, Nelson MR, Shah RC, Murray AM, Ernst ME, Reid CM, Tonkin A, Lockery JE, Berk M; ASPREE Investigator Group.","CNS Drugs. 2019 Jul;33(7):685-694. doi: 10.1007/s40263-019-00633-3.","Agustini B","CNS Drugs","2019","2019/05/08","PMC6719539","NIHMS1048053","10.1007/s40263-019-00633-3"
"30103334","Is Computerized Working Memory Training Effective in Healthy Older Adults? Evidence from a Multi-Site, Randomized Controlled Trial","Simon SS, Tusch ES, Feng NC, Håkansson K, Mohammed AH, Daffner KR.","J Alzheimers Dis. 2018;65(3):931-949. doi: 10.3233/JAD-180455.","Simon SS","J Alzheimers Dis","2018","2018/08/15","","","10.3233/JAD-180455"
"25663218","Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI","Verhaaren BF, Debette S, Bis JC, Smith JA, Ikram MK, Adams HH, Beecham AH, Rajan KB, Lopez LM, Barral S, van Buchem MA, van der Grond J, Smith AV, Hegenscheid K, Aggarwal NT, de Andrade M, Atkinson EJ, Beekman M, Beiser AS, Blanton SH, Boerwinkle E, Brickman AM, Bryan RN, Chauhan G, Chen CP, Chouraki V, de Craen AJ, Crivello F, Deary IJ, Deelen J, De Jager PL, Dufouil C, Elkind MS, Evans DA, Freudenberger P, Gottesman RF, Guðnason V, Habes M, Heckbert SR, Heiss G, Hilal S, Hofer E, Hofman A, Ibrahim-Verbaas CA, Knopman DS, Lewis CE, Liao J, Liewald DC, Luciano M, van der Lugt A, Martinez OO, Mayeux R, Mazoyer B, Nalls M, Nauck M, Niessen WJ, Oostra BA, Psaty BM, Rice KM, Rotter JI, von Sarnowski B, Schmidt H, Schreiner PJ, Schuur M, Sidney SS, Sigurdsson S, Slagboom PE, Stott DJ, van Swieten JC, Teumer A, Töglhofer AM, Traylor M, Trompet S, Turner ST, Tzourio C, Uh HW, Uitterlinden AG, Vernooij MW, Wang JJ, Wong TY, Wardlaw JM, Windham BG, Wittfeld K, Wolf C, Wright CB, Yang Q, Zhao W, Zijdenbos A, Jukema JW, Sacco RL, Kardia SL, Amouyel P, Mosley TH, Longstreth WT Jr, DeCarli CC, van Duijn CM, Schmidt R, Launer LJ, Grabe HJ, Seshadri SS, et al.","Circ Cardiovasc Genet. 2015 Apr;8(2):398-409. doi: 10.1161/CIRCGENETICS.114.000858. Epub 2015 Feb 7.","Verhaaren BF","Circ Cardiovasc Genet","2015","2015/02/10","PMC4427240","NIHMS675137","10.1161/CIRCGENETICS.114.000858"
"31424391","Self and Informant Memory Reports in FINGER: Associations with Two-Year Cognitive Change","Vaskivuo L, Hokkanen L, Hänninen T, Antikainen R, Bäckman L, Laatikainen T, Paajanen T, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M, Ngandu T.","J Alzheimers Dis. 2019;71(3):785-795. doi: 10.3233/JAD-190133.","Vaskivuo L","J Alzheimers Dis","2019","2019/08/20","","","10.3233/JAD-190133"
"9226739","Executive function and uptake of 99mTc-exametazime shown by single photon emission tomography after oral idazoxan in probable Alzheimer-type dementia","Goodwin GM, Conway SC, Peyro-Saint-Paul H, Glabus MF, O'Carroll RE, Ebmeier KP.","Psychopharmacology (Berl). 1997 Jun;131(4):371-8. doi: 10.1007/s002130050305.","Goodwin GM","Psychopharmacology (Berl)","1997","1997/06/01","","","10.1007/s002130050305"
"31004095","Retinal microvasculature and cerebral small vessel disease in the Lothian Birth Cohort 1936 and Mild Stroke Study","McGrory S, Ballerini L, Doubal FN, Staals J, Allerhand M, Valdes-Hernandez MDC, Wang X, MacGillivray T, Doney ASF, Dhillon B, Starr JM, Bastin ME, Trucco E, Deary IJ, Wardlaw JM.","Sci Rep. 2019 Apr 19;9(1):6320. doi: 10.1038/s41598-019-42534-x.","McGrory S","Sci Rep","2019","2019/04/21","PMC6474900","","10.1038/s41598-019-42534-x"
"24637951","A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment","Singh B, Mielke MM, Parsaik AK, Cha RH, Roberts RO, Scanlon PD, Geda YE, Christianson TJ, Pankratz VS, Petersen RC.","JAMA Neurol. 2014 May;71(5):581-8. doi: 10.1001/jamaneurol.2014.94.","Singh B","JAMA Neurol","2014","2014/03/19","PMC4020948","NIHMS559149","10.1001/jamaneurol.2014.94"
"31825466","Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial","Coffin PO, Santos GM, Hern J, Vittinghoff E, Walker JE, Matheson T, Santos D, Colfax G, Batki SL.","JAMA Psychiatry. 2020 Mar 1;77(3):246-255. doi: 10.1001/jamapsychiatry.2019.3655.","Coffin PO","JAMA Psychiatry","2020","2019/12/12","PMC6990973","","10.1001/jamapsychiatry.2019.3655"
"36205814","Mixed circuit training acutely reduces arterial stiffness in patients with chronic stroke: a crossover randomized controlled trial","Michalski AC, Ferreira AS, Midgley AW, Costa VAB, Fonseca GF, da Silva NSL, Borges J, Billinger SA, Cunha FA.","Eur J Appl Physiol. 2023 Jan;123(1):121-134. doi: 10.1007/s00421-022-05061-8. Epub 2022 Oct 7.","Michalski AC","Eur J Appl Physiol","2023","2022/10/07","","","10.1007/s00421-022-05061-8"
"26983548","Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial","Häge A, Banaschewski T, Buitelaar JK, Dijkhuizen RM, Franke B, Lythgoe DJ, Mechler K, Williams SC, Dittmann RW; TACTICS Consortium.","Trials. 2016 Mar 17;17(1):141. doi: 10.1186/s13063-016-1266-8.","Häge A","Trials","2016","2016/03/18","PMC4794817","","10.1186/s13063-016-1266-8"
"26621261","Transcriptomics and the mechanisms of antidepressant efficacy","Hodgson K, Tansey KE, Powell TR, Coppola G, Uher R, Zvezdana Dernovšek M, Mors O, Hauser J, Souery D, Maier W, Henigsberg N, Rietschel M, Placentino A, Aitchison KJ, Craig IW, Farmer AE, Breen G, McGuffin P, Dobson R.","Eur Neuropsychopharmacol. 2016 Jan;26(1):105-112. doi: 10.1016/j.euroneuro.2015.10.009. Epub 2015 Nov 12.","Hodgson K","Eur Neuropsychopharmacol","2016","2015/12/02","","","10.1016/j.euroneuro.2015.10.009"
"27380342","Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial","Huntington Study Group; Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, Whaley J, Wong C, Suter G, Jankovic J, Jimenez-Shahed J, Hunter C, Claassen DO, Roman OC, Sung V, Smith J, Janicki S, Clouse R, Saint-Hilaire M, Hohler A, Turpin D, James RC, Rodriguez R, Rizer K, Anderson KE, Heller H, Carlson A, Criswell S, Racette BA, Revilla FJ, Nucifora F Jr, Margolis RL, Ong M, Mendis T, Mendis N, Singer C, Quesada M, Paulsen JS, Brashers-Krug T, Miller A, Kerr J, Dubinsky RM, Gray C, Factor SA, Sperin E, Molho E, Eglow M, Evans S, Kumar R, Reeves C, Samii A, Chouinard S, Beland M, Scott BL, Hickey PT, Esmail S, Fung WL, Gibbons C, Qi L, Colcher A, Hackmyer C, McGarry A, Klos K, Gudesblatt M, Fafard L, Graffitti L, Schneider DP, Dhall R, Wojcieszek JM, LaFaver K, Duker A, Neefus E, Wilson-Perez H, Shprecher D, Wall P, Blindauer KA, Wheeler L, Boyd JT, Houston E, Farbman ES, Agarwal P, Eberly SW, Watts A, Tariot PN, Feigin A, Evans S, Beck C, Orme C, Edicola J, Christopher E.","JAMA. 2016 Jul 5;316(1):40-50. doi: 10.1001/jama.2016.8655.","Huntington Study Group","JAMA","2016","2016/07/06","","","10.1001/jama.2016.8655"
"35761496","Effect of Simultaneous Dual-Task Training on Regional Cerebral Blood Flow in Older Adults with Amnestic Mild Cognitive Impairment","Kunieda Y, Arakawa C, Yamada T, Koyama S, Suzuki M, Ishiyama D, Yamada M, Hirokawa R, Matsuda T, Nio S, Adachi T, Hoshino H, Fujiwara T.","Curr Alzheimer Res. 2022;19(6):458-468. doi: 10.2174/1567205019666220627091246.","Kunieda Y","Curr Alzheimer Res","2022","2022/06/28","","","10.2174/1567205019666220627091246"
"26085640","Static Magnetic Field Stimulation over the Visual Cortex Increases Alpha Oscillations and Slows Visual Search in Humans","Gonzalez-Rosa JJ, Soto-Leon V, Real P, Carrasco-Lopez C, Foffani G, Strange BA, Oliviero A.","J Neurosci. 2015 Jun 17;35(24):9182-93. doi: 10.1523/JNEUROSCI.4232-14.2015.","Gonzalez-Rosa JJ","J Neurosci","2015","2015/06/19","PMC6605156","","10.1523/JNEUROSCI.4232-14.2015"
"28280254","Static Magnetic Field Stimulation over Parietal Cortex Enhances Somatosensory Detection in Humans","Carrasco-López C, Soto-León V, Céspedes V, Profice P, Strange BA, Foffani G, Oliviero A.","J Neurosci. 2017 Apr 5;37(14):3840-3847. doi: 10.1523/JNEUROSCI.2123-16.2017. Epub 2017 Mar 9.","Carrasco-López C","J Neurosci","2017","2017/03/11","PMC6596712","","10.1523/JNEUROSCI.2123-16.2017"
"33522444","Improving Prospective Memory Performance in Community-dwelling Older Adults: Goal Management Training and Implementation Intentions","Fine L, Loft S, Bucks RS, Parker D, Laws M, Olaithe M, Pushpanathan M, Rainey Smith SR, Sohrabi HR, Martins RN, Weinborn M.","Exp Aging Res. 2021 Oct-Dec;47(5):414-435. doi: 10.1080/0361073X.2021.1876409. Epub 2021 Jan 31.","Fine L","Exp Aging Res","2021","2021/02/01","","","10.1080/0361073X.2021.1876409"
"15795167","Reliable manual segmentation of the frontal, parietal, temporal, and occipital lobes on magnetic resonance images of healthy subjects","Bokde AL, Teipel SJ, Schwarz R, Leinsinger G, Buerger K, Moeller T, Möller HJ, Hampel H.","Brain Res Brain Res Protoc. 2005 Apr;14(3):135-45. doi: 10.1016/j.brainresprot.2004.10.001.","Bokde AL","Brain Res Brain Res Protoc","2005","2005/03/30","","","10.1016/j.brainresprot.2004.10.001"
"33658371","Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder","Farmen K, Nissen SK, Stokholm MG, Iranzo A, Østergaard K, Serradell M, Otto M, Svendsen KB, Garrido A, Vilas D, Borghammer P, Santamaria J, Møller A, Gaig C, Brooks DJ, Tolosa E, Pavese N, Romero-Ramos M.","Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):e2020858118. doi: 10.1073/pnas.2020858118.","Farmen K","Proc Natl Acad Sci U S A","2021","2021/03/04","PMC7958435","","10.1073/pnas.2020858118"
"30809801","The Effect of Multidomain Lifestyle Intervention on Daily Functioning in Older People","Kulmala J, Ngandu T, Havulinna S, Levälahti E, Lehtisalo J, Solomon A, Antikainen R, Laatikainen T, Pippola P, Peltonen M, Rauramaa R, Soininen H, Strandberg T, Tuomilehto J, Kivipelto M.","J Am Geriatr Soc. 2019 Jun;67(6):1138-1144. doi: 10.1111/jgs.15837. Epub 2019 Feb 26.","Kulmala J","J Am Geriatr Soc","2019","2019/02/28","","","10.1111/jgs.15837"
"28330458","The effects of an extensive exercise programme on the progression of Mild Cognitive Impairment (MCI): study protocol for a randomised controlled trial","Devenney KE, Sanders ML, Lawlor B, Olde Rikkert MGM, Schneider S; NeuroExercise Study Group.","BMC Geriatr. 2017 Mar 22;17(1):75. doi: 10.1186/s12877-017-0457-9.","Devenney KE","BMC Geriatr","2017","2017/03/24","PMC5361785","","10.1186/s12877-017-0457-9"
"33033851","Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm","Panoskaltsis N, McCarthy NE, Stagg AJ, Mummery CJ, Husni M, Arebi N, Greenstein D, Price CL, Al-Hassi HO, Koutinas M, Mantalaris A, Knight SC.","Cancer Immunol Immunother. 2021 Apr;70(4):1127-1142. doi: 10.1007/s00262-020-02725-2. Epub 2020 Oct 8.","Panoskaltsis N","Cancer Immunol Immunother","2021","2020/10/09","PMC7543968","","10.1007/s00262-020-02725-2"
"29063244","Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)","Comi G, Patti F, Rocca MA, Mattioli FC, Amato MP, Gallo P, Centonze D, Pozzilli C, Saccà F, Bergh FT, Bartezaghi M, Turrini R, Filippi M; Golden Study Group.","J Neurol. 2017 Dec;264(12):2436-2449. doi: 10.1007/s00415-017-8642-5. Epub 2017 Oct 23.","Comi G","J Neurol","2017","2017/10/25","PMC5688215","","10.1007/s00415-017-8642-5"
"30735234","Effect of Financial Bonus Size, Loss Aversion, and Increased Social Pressure on Physician Pay-for-Performance: A Randomized Clinical Trial and Cohort Study","Navathe AS, Volpp KG, Caldarella KL, Bond A, Troxel AB, Zhu J, Matloubieh S, Lyon Z, Mishra A, Sacks L, Nelson C, Patel P, Shea J, Calcagno D, Vittore S, Sokol K, Weng K, McDowald N, Crawford P, Small D, Emanuel EJ.","JAMA Netw Open. 2019 Feb 1;2(2):e187950. doi: 10.1001/jamanetworkopen.2018.7950.","Navathe AS","JAMA Netw Open","2019","2019/02/09","PMC6484616","","10.1001/jamanetworkopen.2018.7950"
"31521532","Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial","van der Kolk NM, de Vries NM, Kessels RPC, Joosten H, Zwinderman AH, Post B, Bloem BR.","Lancet Neurol. 2019 Nov;18(11):998-1008. doi: 10.1016/S1474-4422(19)30285-6. Epub 2019 Sep 11.","van der Kolk NM","Lancet Neurol","2019","2019/09/16","","","10.1016/S1474-4422(19)30285-6"
"27834742","Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2)","Lyden P, Hemmen T, Grotta J, Rapp K, Ernstrom K, Rzesiewicz T, Parker S, Concha M, Hussain S, Agarwal S, Meyer B, Jurf J, Altafullah I, Raman R; Collaborators.","Stroke. 2016 Dec;47(12):2888-2895. doi: 10.1161/STROKEAHA.116.014200. Epub 2016 Nov 10.","Lyden P","Stroke","2016","2016/11/12","PMC5134910","NIHMS824615","10.1161/STROKEAHA.116.014200"
"22397614","Ageing in general practice (AGP) trial: a cluster randomised trial to examine the effectiveness of peer education on GP diagnostic assessment and management of dementia","Pond CD, Brodaty H, Stocks NP, Gunn J, Marley J, Disler P, Magin P, Paterson N, Horton G, Goode S, Paine B, Mate KE.","BMC Fam Pract. 2012 Mar 7;13:12. doi: 10.1186/1471-2296-13-12.","Pond CD","BMC Fam Pract","2012","2012/03/09","PMC3323889","","10.1186/1471-2296-13-12"
"31185042","High rates of health care utilization in pediatric multiple sclerosis: A Canadian population-based study","Marrie RA, O'Mahony J, Maxwell CJ, Ling V, Yeh EA, Arnold DL, Bar-Or A, Banwell B; Canadian Pediatric Demyelinating Disease Network.","PLoS One. 2019 Jun 11;14(6):e0218215. doi: 10.1371/journal.pone.0218215. eCollection 2019.","Marrie RA","PLoS One","2019","2019/06/12","PMC6559708","","10.1371/journal.pone.0218215"
"29916140","Statin Use is Not Associated with Future Long-Term Care Admission: Extended Follow-Up of Two Randomised Controlled Trials","Burton JK, Papworth R, Haig C, McCowan C, Ford I, Stott DJ, Quinn TJ.","Drugs Aging. 2018 Jul;35(7):657-663. doi: 10.1007/s40266-018-0560-4.","Burton JK","Drugs Aging","2018","2018/06/20","","","10.1007/s40266-018-0560-4"
"23009579","Validation study of the prototype of a disease-specific index measure for health-related quality of life in dementia","Schölzel-Dorenbos CJ, Arons AM, Wammes JJ, Rikkert MG, Krabbe PF.","Health Qual Life Outcomes. 2012 Sep 25;10:118. doi: 10.1186/1477-7525-10-118.","Schölzel-Dorenbos CJ","Health Qual Life Outcomes","2012","2012/09/27","PMC3503596","","10.1186/1477-7525-10-118"
"25615434","Evaluation of a problem-solving (PS) techniques-based intervention for informal carers of patients with dementia receiving in-home care","Chiu M, Pauley T, Wesson V, Pushpakumar D, Sadavoy J.","Int Psychogeriatr. 2015 Jun;27(6):937-48. doi: 10.1017/S1041610214002798. Epub 2015 Jan 23.","Chiu M","Int Psychogeriatr","2015","2015/01/24","","","10.1017/S1041610214002798"
"28088925","A randomized controlled trial of Kundalini yoga in mild cognitive impairment","Eyre HA, Siddarth P, Acevedo B, Van Dyk K, Paholpak P, Ercoli L, St Cyr N, Yang H, Khalsa DS, Lavretsky H.","Int Psychogeriatr. 2017 Apr;29(4):557-567. doi: 10.1017/S1041610216002155. Epub 2017 Jan 16.","Eyre HA","Int Psychogeriatr","2017","2017/01/17","PMC5540331","NIHMS886967","10.1017/S1041610216002155"
"34543687","Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure","Kurella Tamura M, Gaussoin S, Pajewski NM, Zaharchuk G, Freedman BI, Rapp SR, Auchus AP, Haley WE, Oparil S, Kendrick J, Roumie CL, Beddhu S, Cheung AK, Williamson JD, Detre JA, Dolui S, Bryan RN, Nasrallah IM; SPRINT Research Group.","Am J Kidney Dis. 2022 May;79(5):677-687.e1. doi: 10.1053/j.ajkd.2021.07.024. Epub 2021 Sep 17.","Kurella Tamura M","Am J Kidney Dis","2022","2021/09/20","PMC8926938","NIHMS1766773","10.1053/j.ajkd.2021.07.024"
"33783254","Computerized Cognitive Training in Amnestic Mild Cognitive Impairment: A Randomized Clinical Trial","Duff K, Ying J, Suhrie KR, Dalley BCA, Atkinson TJ, Porter SM, Dixon AM, Hammers DB, Wolinsky FD.","J Geriatr Psychiatry Neurol. 2022 May;35(3):400-409. doi: 10.1177/08919887211006472. Epub 2021 Mar 30.","Duff K","J Geriatr Psychiatry Neurol","2022","2021/03/30","","","10.1177/08919887211006472"
"33271636","A quasi-experimental study of the effectiveness of the Reitman Centre CARERS group intervention on family caregivers of persons with dementia","Sadavoy J, Sajedinejad S, Chiu M.","Int J Geriatr Psychiatry. 2021 Jun;36(6):811-821. doi: 10.1002/gps.5481. Epub 2020 Dec 19.","Sadavoy J","Int J Geriatr Psychiatry","2021","2020/12/03","","","10.1002/gps.5481"
"15106392","Therapeutic robocat for nursing home residents with dementia: preliminary inquiry","Libin A, Cohen-Mansfield J.","Am J Alzheimers Dis Other Demen. 2004 Mar-Apr;19(2):111-6. doi: 10.1177/153331750401900209.","Libin A","Am J Alzheimers Dis Other Demen","2004","2004/04/27","","","10.1177/153331750401900209"
"24130124","Subtle gait changes in patients with REM sleep behavior disorder","McDade EM, Boot BP, Christianson TJ, Pankratz VS, Boeve BF, Ferman TJ, Bieniek K, Hollman JH, Roberts RO, Mielke MM, Knopman DS, Petersen RC.","Mov Disord. 2013 Nov;28(13):1847-53. doi: 10.1002/mds.25653. Epub 2013 Oct 15.","McDade EM","Mov Disord","2013","2013/10/17","PMC3952497","NIHMS516682","10.1002/mds.25653"
"32877582","Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis","Paganoni S, Macklin EA, Hendrix S, Berry JD, Elliott MA, Maiser S, Karam C, Caress JB, Owegi MA, Quick A, Wymer J, Goutman SA, Heitzman D, Heiman-Patterson T, Jackson CE, Quinn C, Rothstein JD, Kasarskis EJ, Katz J, Jenkins L, Ladha S, Miller TM, Scelsa SN, Vu TH, Fournier CN, Glass JD, Johnson KM, Swenson A, Goyal NA, Pattee GL, Andres PL, Babu S, Chase M, Dagostino D, Dickson SP, Ellison N, Hall M, Hendrix K, Kittle G, McGovern M, Ostrow J, Pothier L, Randall R, Shefner JM, Sherman AV, Tustison E, Vigneswaran P, Walker J, Yu H, Chan J, Wittes J, Cohen J, Klee J, Leslie K, Tanzi RE, Gilbert W, Yeramian PD, Schoenfeld D, Cudkowicz ME.","N Engl J Med. 2020 Sep 3;383(10):919-930. doi: 10.1056/NEJMoa1916945.","Paganoni S","N Engl J Med","2020","2020/09/03","PMC9134321","NIHMS1805149","10.1056/NEJMoa1916945"
"9659818","Spontaneity in dementia: an analysis of 696 institutionalized elderly patients","Katayama T.","Keio J Med. 1998 Jun;47(2):85-91. doi: 10.2302/kjm.47.85.","Katayama T","Keio J Med","1998","1998/07/11","","","10.2302/kjm.47.85"
"24244428","CLU genetic variants and cognitive decline among elderly and oldest old","Mengel-From J, Thinggaard M, Lindahl-Jacobsen R, McGue M, Christensen K, Christiansen L.","PLoS One. 2013 Nov 14;8(11):e79105. doi: 10.1371/journal.pone.0079105. eCollection 2013.","Mengel-From J","PLoS One","2013","2013/11/19","PMC3828341","","10.1371/journal.pone.0079105"
"7893774","Diagnosis of dementia in primary care: results of a representative survey in lower Saxony, Germany","Stoppe G, Sandholzer H, Staedt J, Winter S, Kiefer J, Kochen MM, Rüther E.","Eur Arch Psychiatry Clin Neurosci. 1994;244(5):278-83. doi: 10.1007/BF02190381.","Stoppe G","Eur Arch Psychiatry Clin Neurosci","1994","1994/01/01","","","10.1007/BF02190381"
"33175128","Telomere Length Change in a Multidomain Lifestyle Intervention to Prevent Cognitive Decline: A Randomized Clinical Trial","Sindi S, Solomon A, Kåreholt I, Hovatta I, Antikainen R, Hänninen T, Levälahti E, Laatikainen T, Lehtisalo J, Lindström J, Paajanen T, Peltonen M, Singh Khalsa D, Wolozin B, Strandberg T, Tuomilehto J, Soininen H, Ngandu T, Kivipelto M; FINGER Study Group.","J Gerontol A Biol Sci Med Sci. 2021 Feb 25;76(3):491-498. doi: 10.1093/gerona/glaa279.","Sindi S","J Gerontol A Biol Sci Med Sci","2021","2020/11/11","PMC7907495","","10.1093/gerona/glaa279"
"12105362","Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300)","Orgogozo JM, Rigaud AS, Stöffler A, Möbius HJ, Forette F.","Stroke. 2002 Jul;33(7):1834-9. doi: 10.1161/01.str.0000020094.08790.49.","Orgogozo JM","Stroke","2002","2002/07/10","","","10.1161/01.str.0000020094.08790.49"
"34702069","Axonal Injury Partially Mediates Associations Between Increased Left Ventricular Mass Index and White Matter Damage","Moore EE, Khan OA, Shashikumar N, Pechman KR, Liu D, Bell SP, Nair S, Terry JG, Gifford KA, Anderson AW, Landman BA, Blennow K, Zetterberg H, Hohman TJ, Carr JJ, Jefferson AL.","Stroke. 2022 Mar;53(3):808-816. doi: 10.1161/STROKEAHA.121.034349. Epub 2021 Oct 27.","Moore EE","Stroke","2022","2021/10/27","PMC8885768","NIHMS1745390","10.1161/STROKEAHA.121.034349"
"15633941","Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients","Moretti R, Torre P, Antonello RM, Cattaruzza T, Cazzato G.","Am J Alzheimers Dis Other Demen. 2004 Nov-Dec;19(6):333-9. doi: 10.1177/153331750401900607.","Moretti R","Am J Alzheimers Dis Other Demen","2004","2005/01/07","","","10.1177/153331750401900607"
"23032410","Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy","Du Pasquier RA, Jilek S, Kalubi M, Yerly S, Fux CA, Gutmann C, Cusini A, Günthard HF, Cavassini M, Vernazza PL; Swiss HIV Cohort Study.","AIDS. 2013 Jan 14;27(2):203-10. doi: 10.1097/QAD.0b013e32835a9a4a.","Du Pasquier RA","AIDS","2013","2012/10/04","","","10.1097/QAD.0b013e32835a9a4a"
"27373556","A Two-Year Treatment of Amnestic Mild Cognitive Impairment using a Compound Chinese Medicine: A Placebo Controlled Randomized Trial","Zhang J, Liu Z, Zhang H, Yang C, Li H, Li X, Chen K, Zhang Z.","Sci Rep. 2016 Jul 4;6:28982. doi: 10.1038/srep28982.","Zhang J","Sci Rep","2016","2016/07/05","PMC4931444","","10.1038/srep28982"
"36410013","A natural history study to track brain and spinal cord changes in individuals with Friedreich's ataxia: TRACK-FA study protocol","Georgiou-Karistianis N, Corben LA, Reetz K, Adanyeguh IM, Corti M, Deelchand DK, Delatycki MB, Dogan I, Evans R, Farmer J, França MC, Gaetz W, Harding IH, Harris KS, Hersch S, Joules R, Joers JJ, Krishnan ML, Lax M, Lock EF, Lynch D, Mareci T, Muthuhetti Gamage S, Pandolfo M, Papoutsi M, Rezende TJR, Roberts TPL, Rosenberg JT, Romanzetti S, Schulz JB, Schilling T, Schwarz AJ, Subramony S, Yao B, Zicha S, Lenglet C, Henry PG.","PLoS One. 2022 Nov 21;17(11):e0269649. doi: 10.1371/journal.pone.0269649. eCollection 2022.","Georgiou-Karistianis N","PLoS One","2022","2022/11/21","PMC9678384","","10.1371/journal.pone.0269649"
"31296586","Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia","Fernandez HH, Stamler D, Davis MD, Factor SA, Hauser RA, Jimenez-Shahed J, Ondo WG, Jarskog LF, Woods SW, Bega D, LeDoux MS, Shprecher DR, Anderson KE.","J Neurol Neurosurg Psychiatry. 2019 Dec;90(12):1317-1323. doi: 10.1136/jnnp-2018-319918. Epub 2019 Jul 10.","Fernandez HH","J Neurol Neurosurg Psychiatry","2019","2019/07/13","PMC6902058","","10.1136/jnnp-2018-319918"
"32039852","A Structured Physical Exercise Program Reduces Professional Caregiver's Burden Caused by Neuropsychiatric Symptoms in Acute Dementia Care: Randomized Controlled Trial Results","Fleiner T, Dauth H, Zijlstra W, Haussermann P.","J Alzheimers Dis. 2020;74(2):429-433. doi: 10.3233/JAD-191102.","Fleiner T","J Alzheimers Dis","2020","2020/02/11","","","10.3233/JAD-191102"
"17267375","Structured practice: a memory intervention for persons with dementia","Hochhalter AK, Stevens AB, Okonkwo O.","Am J Alzheimers Dis Other Demen. 2006 Dec-2007 Jan;21(6):424-30. doi: 10.1177/1533317506292328.","Hochhalter AK","Am J Alzheimers Dis Other Demen","2006","2007/02/03","","","10.1177/1533317506292328"
"30612511","The Effect of Reminiscence Therapy With Internet-Based Videos on Cognitive Status and Apathy of Older People With Mild Dementia","İnel Manav A, Simsek N.","J Geriatr Psychiatry Neurol. 2019 Mar;32(2):104-113. doi: 10.1177/0891988718819864. Epub 2019 Jan 6.","İnel Manav A","J Geriatr Psychiatry Neurol","2019","2019/01/08","","","10.1177/0891988718819864"
"32492080","Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial","Berk M, Woods RL, Nelson MR, Shah RC, Reid CM, Storey E, Fitzgerald S, Lockery JE, Wolfe R, Mohebbi M, Dodd S, Murray AM, Stocks N, Fitzgerald PB, Mazza C, Agustini B, McNeil JJ.","JAMA Psychiatry. 2020 Oct 1;77(10):1012-1020. doi: 10.1001/jamapsychiatry.2020.1214.","Berk M","JAMA Psychiatry","2020","2020/06/04","PMC7271558","","10.1001/jamapsychiatry.2020.1214"
"34519802","Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial","Parkinson Study Group SURE-PD3 Investigators; Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, Scott B, Gauger L, Aldred J, Bixby M, Ciccarello J, Gunzler SA, Henchcliffe C, Brodsky M, Keith K, Hauser RA, Goetz C, LeDoux MS, Hinson V, Kumar R, Espay AJ, Jimenez-Shahed J, Hunter C, Christine C, Daley A, Leehey M, de Marcaida JA, Friedman JH, Hung A, Bwala G, Litvan I, Simon DK, Simuni T, Poon C, Schiess MC, Chou K, Park A, Bhatti D, Peterson C, Criswell SR, Rosenthal L, Durphy J, Shill HA, Mehta SH, Ahmed A, Deik AF, Fang JY, Stover N, Zhang L, Dewey RB Jr, Gerald A, Boyd JT, Houston E, Suski V, Mosovsky S, Cloud L, Shah BB, Saint-Hilaire M, James R, Zauber SE, Reich S, Shprecher D, Pahwa R, Langhammer A, LaFaver K, LeWitt PA, Kaminski P, Goudreau J, Russell D, Houghton DJ, Laroche A, Thomas K, McGraw M, Mari Z, Serrano C, Blindauer K, Rabin M, Kurlan R, Morgan JC, Soileau M, Ainslie M, Bodis-Wollner I, Schneider RB, Waters C, Ratel AS, Beck CA, Bolger P, Callahan KF, Crotty GF, Klements D, Kostrzebski M, et al.","JAMA. 2021 Sep 14;326(10):926-939. doi: 10.1001/jama.2021.10207.","Parkinson Study Group SURE-PD3 Investigators","JAMA","2021","2021/09/14","PMC8441591","","10.1001/jama.2021.10207"
"1391670","Moving from the question of efficacy to the question of therapeutic relevance: an exploratory reanalysis of a controlled clinical study of 130 inpatients with dementia syndrome taking piracetam","Herrmann WM, Stephan K.","Int Psychogeriatr. 1992 Summer;4(1):25-44. doi: 10.1017/s1041610292000887.","Herrmann WM","Int Psychogeriatr","1992","1992/01/01","","","10.1017/s1041610292000887"
"33186735","Personalized Blood Pressure Management During Cardiac Surgery With Cerebral Autoregulation Monitoring: A Randomized Trial","Hogue CW, Brown CH 4th, Hori D, Ono M, Nomura Y, Balmert LC, Srdanovic N, Grafman J, Brady K; Cerebral Autoregulation Study Group.","Semin Thorac Cardiovasc Surg. 2021 Summer;33(2):429-438. doi: 10.1053/j.semtcvs.2020.09.032. Epub 2020 Nov 10.","Hogue CW","Semin Thorac Cardiovasc Surg","2021","2020/11/13","","","10.1053/j.semtcvs.2020.09.032"
"34935176","A randomized clinical trial to investigate the effect of dietary protein sources on periodontal health","Eberhard J, Ruiz K, Tan J, Jayasinghe TN, Khan S, Eroglu E, Adler C, Simpson SJ, Le Couteur DG, Raubenheimer D, Macia L, Gosby AK, Ribeiro RV.","J Clin Periodontol. 2022 Apr;49(4):388-400. doi: 10.1111/jcpe.13587. Epub 2022 Jan 24.","Eberhard J","J Clin Periodontol","2022","2021/12/22","","","10.1111/jcpe.13587"
"34919838","Pragmatic Trials in Long-Term Care: Implementation and Dissemination Challenges and Opportunities","Levy C, Zimmerman S, Mor V, Gifford D, Greenberg SA, Klinger JH, Lieblich C, Linnebur S, McAllister A, Nazir A, Pace D, Stone R, Resnick B, Sloane PD, Ouslander J, Gaugler JE.","J Am Med Dir Assoc. 2022 Mar;23(3):339-344. doi: 10.1016/j.jamda.2021.11.024. Epub 2021 Dec 14.","Levy C","J Am Med Dir Assoc","2022","2021/12/17","PMC8919424","NIHMS1783458","10.1016/j.jamda.2021.11.024"
"29424447","Behavioural intervention to reduce resistance in those attending adult day care centres: PROCENDIAS study protocol for a randomized clinical trial","Rodriguez-Sánchez E, Tamayo-Morales O, González-Sanchez J, Mora-Simón S, Losada-Baltar A, Unzueta-Arce J, Patino-Alonso MC, De Dios-Rodríguez E, Gómez-Marcos MA, García-Ortiz L.","J Adv Nurs. 2018 Jun;74(6):1402-1411. doi: 10.1111/jan.13537. Epub 2018 Feb 28.","Rodriguez-Sánchez E","J Adv Nurs","2018","2018/02/10","","","10.1111/jan.13537"
"24833646","Sonas: a pilot study investigating the effectiveness of an intervention for people with moderate to severe dementia","Hutson C, Orrell M, Dugmore O, Spector A.","Am J Alzheimers Dis Other Demen. 2014 Dec;29(8):696-703. doi: 10.1177/1533317514534756. Epub 2014 May 14.","Hutson C","Am J Alzheimers Dis Other Demen","2014","2014/05/17","","","10.1177/1533317514534756"
"16526585","Factors that relate to activity engagement in nursing home residents","Kolanowski A, Buettner L, Litaker M, Yu F.","Am J Alzheimers Dis Other Demen. 2006 Jan-Feb;21(1):15-22. doi: 10.1177/153331750602100109.","Kolanowski A","Am J Alzheimers Dis Other Demen","2006","2006/03/11","","","10.1177/153331750602100109"
"26836161","Cognitive Stimulation Modulates Platelet Total Phospholipases A2 Activity in Subjects with Mild Cognitive Impairment","Balietti M, Giuli C, Fattoretti P, Fabbietti P, Postacchini D, Conti F.","J Alzheimers Dis. 2016;50(4):957-62. doi: 10.3233/JAD-150714.","Balietti M","J Alzheimers Dis","2016","2016/02/03","PMC4927922","","10.3233/JAD-150714"
"18955726","Multidyad memory notebook intervention for very mild dementia: a pilot study","Schmitter-Edgecombe M, Howard JT, Pavawalla SP, Howell L, Rueda A.","Am J Alzheimers Dis Other Demen. 2008 Oct-Nov;23(5):477-87. doi: 10.1177/1533317508320794.","Schmitter-Edgecombe M","Am J Alzheimers Dis Other Demen","2008","2008/10/29","","","10.1177/1533317508320794"
"17545139","Comparative outcomes of two distance-based interventions for male caregivers of family members with dementia","Gant JR, Steffen AM, Lauderdale SA.","Am J Alzheimers Dis Other Demen. 2007 Apr-May;22(2):120-8. doi: 10.1177/1533317506298880.","Gant JR","Am J Alzheimers Dis Other Demen","2007","2007/06/05","","","10.1177/1533317506298880"
"15214204","Effect of design interventions on a dementia care setting","Schwarz B, Chaudhury H, Tofle RB.","Am J Alzheimers Dis Other Demen. 2004 May-Jun;19(3):172-6. doi: 10.1177/153331750401900304.","Schwarz B","Am J Alzheimers Dis Other Demen","2004","2004/06/25","","","10.1177/153331750401900304"
"21131677","Multisensory stimulation to improve functional performance in moderate to severe dementia--interim results","Collier L, McPherson K, Ellis-Hill C, Staal J, Bucks R.","Am J Alzheimers Dis Other Demen. 2010 Dec;25(8):698-703. doi: 10.1177/1533317510387582.","Collier L","Am J Alzheimers Dis Other Demen","2010","2010/12/07","","","10.1177/1533317510387582"
"19346501","Preserving cognition through an integrated cognitive stimulation and training program","Eckroth-Bucher M, Siberski J.","Am J Alzheimers Dis Other Demen. 2009 Jun-Jul;24(3):234-45. doi: 10.1177/1533317509332624. Epub 2009 Apr 3.","Eckroth-Bucher M","Am J Alzheimers Dis Other Demen","2009","2009/04/07","","","10.1177/1533317509332624"
"22495340","Cognitive stimulation in a-MCI: an experimental study","Moro V, Condoleo MT, Sala F, Pernigo S, Moretto G, Gambina G.","Am J Alzheimers Dis Other Demen. 2012 Mar;27(2):121-30. doi: 10.1177/1533317512441386.","Moro V","Am J Alzheimers Dis Other Demen","2012","2012/04/13","","","10.1177/1533317512441386"
"16869334","Effects of the Serial Trial Intervention on discomfort and behavior of nursing home residents with dementia","Kovach CR, Logan BR, Noonan PE, Schlidt AM, Smerz J, Simpson M, Wells T.","Am J Alzheimers Dis Other Demen. 2006 Jun-Jul;21(3):147-55. doi: 10.1177/1533317506288949.","Kovach CR","Am J Alzheimers Dis Other Demen","2006","2006/07/28","","","10.1177/1533317506288949"
"32748261","Aerobic endurance training to improve cognition and enhance recovery in schizophrenia: design and methodology of a multicenter randomized controlled trial","Maurus I, Hasan A, Schmitt A, Roeh A, Keeser D, Malchow B, Schneider-Axmann T, Hellmich M, Schmied S, Lembeck M, Keller-Varady K, Papazova I, Hirjak D, Topor CE, Walter H, Mohnke S, Vogel BO, Wölwer W, Schneider F, Henkel K, Meyer-Lindenberg A, Falkai P.","Eur Arch Psychiatry Clin Neurosci. 2021 Mar;271(2):315-324. doi: 10.1007/s00406-020-01175-2. Epub 2020 Aug 3.","Maurus I","Eur Arch Psychiatry Clin Neurosci","2021","2020/08/05","PMC8257533","","10.1007/s00406-020-01175-2"
"7049291","Anti-cholinergic drugs and memory: the effects of benzhexol on memory in a group of geriatric patients","Potamianos G, Kellett JM.","Br J Psychiatry. 1982 May;140:470-2. doi: 10.1192/bjp.140.5.470.","Potamianos G","Br J Psychiatry","1982","1982/05/01","","","10.1192/bjp.140.5.470"
"24113564","Life enhancing activities for family caregivers of people with frontotemporal dementia","Dowling GA, Merrilees J, Mastick J, Chang VY, Hubbard E, Moskowitz JT.","Alzheimer Dis Assoc Disord. 2014 Apr-Jun;28(2):175-81. doi: 10.1097/WAD.0b013e3182a6b905.","Dowling GA","Alzheimer Dis Assoc Disord","2014","2013/10/12","","","10.1097/WAD.0b013e3182a6b905"
"27273350","Genetic Variants of the FADS Gene Cluster Are Associated with Erythrocyte Membrane LC PUFA Levels in Patients with Mild Cognitive Impairment","Schuchardt JP, Köbe T, Witte V, Willers J, Gingrich A, Tesky V, Pantel J, Rujescu D, Illig T, Flöel A, Hahn A.","J Nutr Health Aging. 2016;20(6):611-20. doi: 10.1007/s12603-016-0720-3.","Schuchardt JP","J Nutr Health Aging","2016","2016/06/09","","","10.1007/s12603-016-0720-3"
"30799167","Effects of a Multidisciplinary Intervention on the Presence of Neuropsychiatric Symptoms and Psychotropic Drug Use in Nursing Home Residents WithYoung-Onset Dementia: Behavior and Evolution of Young-Onset Dementia Part 2 (BEYOND-II) Study","Appelhof B, Bakker C, de Vugt ME, van Duinen-van den IJssel JCL, Zwijsen SA, Smalbrugge M, Teerenstra S, Verhey FRJ, Zuidema SU, Koopmans RTCM.","Am J Geriatr Psychiatry. 2019 Jun;27(6):581-589. doi: 10.1016/j.jagp.2018.12.032. Epub 2019 Jan 4.","Appelhof B","Am J Geriatr Psychiatry","2019","2019/02/26","","","10.1016/j.jagp.2018.12.032"
"29221645","Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, Rodrigues AM, Rehackova L, Adamson AJ, Sniehotta FF, Mathers JC, Ross HM, McIlvenna Y, Stefanetti R, Trenell M, Welsh P, Kean S, Ford I, McConnachie A, Sattar N, Taylor R.","Lancet. 2018 Feb 10;391(10120):541-551. doi: 10.1016/S0140-6736(17)33102-1. Epub 2017 Dec 5.","Lean ME","Lancet","2018","2017/12/10","","","10.1016/S0140-6736(17)33102-1"
"32815394","High School Students' Knowledge, Attitude and Preventive Practice of Dementia Care in Macao","Lo IL, Zeng W, Lei CI, Lam C, Lou HL.","Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317520948341. doi: 10.1177/1533317520948341.","Lo IL","Am J Alzheimers Dis Other Demen","2020","2020/08/21","","","10.1177/1533317520948341"
"14569643","Rivastigmine in subcortical vascular dementia: a randomized, controlled, open 12-month study in 208 patients","Moretti R, Torre P, Antonello RM, Cazzato G, Bava A.","Am J Alzheimers Dis Other Demen. 2003 Sep-Oct;18(5):265-72. doi: 10.1177/153331750301800508.","Moretti R","Am J Alzheimers Dis Other Demen","2003","2003/10/23","","","10.1177/153331750301800508"
"12955786","Activity calendars for older adults with dementia: what you see is not what you get","Buettner LL, Fitzsimmons S.","Am J Alzheimers Dis Other Demen. 2003 Jul-Aug;18(4):215-26. doi: 10.1177/153331750301800405.","Buettner LL","Am J Alzheimers Dis Other Demen","2003","2003/09/06","","","10.1177/153331750301800405"
"22002790","Neurofeedback in healthy elderly human subjects with electroencephalographic risk for cognitive disorder","Becerra J, Fernández T, Roca-Stappung M, Díaz-Comas L, Galán L, Bosch J, Espino M, Moreno AJ, Harmony T.","J Alzheimers Dis. 2012;28(2):357-67. doi: 10.3233/JAD-2011-111055.","Becerra J","J Alzheimers Dis","2012","2011/10/18","","","10.3233/JAD-2011-111055"
"26285025","The Healthy Mind, Healthy Mobility Trial: A Novel Exercise Program for Older Adults","Gill DP, Gregory MA, Zou G, Liu-Ambrose T, Shigematsu R, Hachinski V, Fitzgerald C, Petrella RJ.","Med Sci Sports Exerc. 2016 Feb;48(2):297-306. doi: 10.1249/MSS.0000000000000758.","Gill DP","Med Sci Sports Exerc","2016","2015/08/19","","","10.1249/MSS.0000000000000758"
"25679228","Effectiveness of an Internet intervention for family caregivers of people with dementia: results of a randomized controlled trial","Blom MM, Zarit SH, Groot Zwaaftink RB, Cuijpers P, Pot AM.","PLoS One. 2015 Feb 13;10(2):e0116622. doi: 10.1371/journal.pone.0116622. eCollection 2015.","Blom MM","PLoS One","2015","2015/02/14","PMC4334515","","10.1371/journal.pone.0116622"
"30221597","Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly","McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR, Reid CM, Lockery JE, Kirpach B, Storey E, Shah RC, Williamson JD, Margolis KL, Ernst ME, Abhayaratna WP, Stocks N, Fitzgerald SM, Orchard SG, Trevaks RE, Beilin LJ, Johnston CI, Ryan J, Radziszewska B, Jelinek M, Malik M, Eaton CB, Brauer D, Cloud G, Wood EM, Mahady SE, Satterfield S, Grimm R, Murray AM; ASPREE Investigator Group.","N Engl J Med. 2018 Oct 18;379(16):1509-1518. doi: 10.1056/NEJMoa1805819. Epub 2018 Sep 16.","McNeil JJ","N Engl J Med","2018","2018/09/18","PMC6289056","NIHMS1512090","10.1056/NEJMoa1805819"
"8181206","[Effect of the chronic treatment with L-acetylcarnitine in Down's syndrome]","De Falco FA, D'Angelo E, Grimaldi G, Scafuro F, Sachez F, Caruso G.","Clin Ter. 1994 Feb;144(2):123-7.","De Falco FA","Clin Ter","1994","1994/02/01","","",""
"36148821","Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial","Beghi E, Pupillo E, Bianchi E, Bonetto V, Luotti S, Pasetto L, Bendotti C, Tortarolo M, Sironi F, Camporeale L, Sherman AV, Paganoni S, Scognamiglio A, De Marchi F, Bongioanni P, Del Carratore R, Caponnetto C, Diamanti L, Martinelli D, Calvo A, Filosto M, Padovani A, Piccinelli SC, Ricci C, Dalla Giacoma S, De Angelis N, Inghilleri M, Spataro R, La Bella V, Logroscino G, Lunetta C, Tarlarini C, Mandrioli J, Martinelli I, Simonini C, Zucchi E, Monsurrò MR, Ricciardi D, Trojsi F, Riva N, Filippi M, Simone IL, Sorarù G, Spera C, Florio L, Messina S, Russo M, Siciliano G, Conte A, Saddi MV, Carboni N, Mazzini L; RNS60-ALS Study Group.","Eur J Neurol. 2023 Jan;30(1):69-86. doi: 10.1111/ene.15573. Epub 2022 Oct 7.","Beghi E","Eur J Neurol","2023","2022/09/23","PMC10092300","","10.1111/ene.15573"
"30979401","Effects on staff outcomes from an intervention for management of neuropsychiatric symptoms in residents of young-onset dementia care units: A cluster randomised controlled trial","van Duinen-van den IJssel JCL, Bakker C, Smalbrugge M, Zwijsen SA, Appelhof B, Teerenstra S, Zuidema SU, de Vugt ME, Verhey FRJ, Koopmans RTCM.","Int J Nurs Stud. 2019 Aug;96:35-43. doi: 10.1016/j.ijnurstu.2019.03.006. Epub 2019 Mar 15.","van Duinen-van den IJssel JCL","Int J Nurs Stud","2019","2019/04/14","","","10.1016/j.ijnurstu.2019.03.006"
"22815078","STAM protocol in dementia: a multicenter, single-blind, randomized, and controlled trial","Ceccato E, Vigato G, Bonetto C, Bevilacqua A, Pizziolo P, Crociani S, Zanfretta E, Pollini L, Caneva PA, Baldin L, Frongillo C, Signorini A, Demoro S, Barchi E.","Am J Alzheimers Dis Other Demen. 2012 Aug;27(5):301-10. doi: 10.1177/1533317512452038.","Ceccato E","Am J Alzheimers Dis Other Demen","2012","2012/07/21","","","10.1177/1533317512452038"
"19001352","Group, individual, and staff therapy: an efficient and effective cognitive behavioral therapy in long-term care","Hyer L, Yeager CA, Hilton N, Sacks A.","Am J Alzheimers Dis Other Demen. 2008 Dec-2009 Jan;23(6):528-39. doi: 10.1177/1533317508323571. Epub 2008 Nov 10.","Hyer L","Am J Alzheimers Dis Other Demen","2008","2008/11/13","","","10.1177/1533317508323571"
"18182471","Effects of a goal-oriented rehabilitation program in mild cognitive impairment: a pilot study","Londos E, Boschian K, Lindén A, Persson C, Minthon L, Lexell J.","Am J Alzheimers Dis Other Demen. 2008 Apr-May;23(2):177-83. doi: 10.1177/1533317507312622. Epub 2008 Jan 8.","Londos E","Am J Alzheimers Dis Other Demen","2008","2008/01/10","","","10.1177/1533317507312622"
"21282276","Dementia caregivers' responses to 2 Internet-based intervention programs","Marziali E, Garcia LJ.","Am J Alzheimers Dis Other Demen. 2011 Feb;26(1):36-43. doi: 10.1177/1533317510387586.","Marziali E","Am J Alzheimers Dis Other Demen","2011","2011/02/02","","","10.1177/1533317510387586"
"20129321","Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis","Liepelt I, Gaenslen A, Godau J, Di Santo A, Schweitzer KJ, Gasser T, Berg D.","Alzheimers Dement. 2010 Jan;6(1):70-4. doi: 10.1016/j.jalz.2009.04.1231.","Liepelt I","Alzheimers Dement","2010","2010/02/05","","","10.1016/j.jalz.2009.04.1231"
"17267370","Evaluation of a telephone-based support group intervention for female caregivers of community-dwelling individuals with dementia","Winter L, Gitlin LN.","Am J Alzheimers Dis Other Demen. 2006 Dec-2007 Jan;21(6):391-7. doi: 10.1177/1533317506291371.","Winter L","Am J Alzheimers Dis Other Demen","2006","2007/02/03","","","10.1177/1533317506291371"
"15115576","Effect of high climate temperature on the behavioral and psychological symptoms of dementia","Cornali C, Franzoni S, Riello R, Ghianda D, Frisoni GB, Trabucchi M.","J Am Med Dir Assoc. 2004 May-Jun;5(3):161-6. doi: 10.1097/01.JAM.0000126422.82173.87.","Cornali C","J Am Med Dir Assoc","2004","2004/04/30","","","10.1097/01.JAM.0000126422.82173.87"
"36542537","An Examination of Whether Diabetes Control and Treatments Are Associated With Change in Frailty Index Across 8 Years: An Ancillary Exploratory Study From the Action for Health in Diabetes (Look AHEAD) Trial","Simpson FR, Justice JN, Pilla SJ, Kritchevsky SB, Boyko EJ, Munshi MN, Ferris CK, Espeland MA; Look AHEAD Research Group.","Diabetes Care. 2023 Mar 1;46(3):519-525. doi: 10.2337/dc22-1728.","Simpson FR","Diabetes Care","2023","2022/12/21","PMC10020016","","10.2337/dc22-1728"
"29546320","Relationship of Physical Function to Single Muscle Fiber Contractility in Older Adults: Effects of Resistance Training With and Without Caloric Restriction","Wang ZM, Leng X, Messi ML, Choi SJ, Marsh AP, Nicklas B, Delbono O.","J Gerontol A Biol Sci Med Sci. 2019 Feb 15;74(3):412-419. doi: 10.1093/gerona/gly047.","Wang ZM","J Gerontol A Biol Sci Med Sci","2019","2018/03/17","PMC6376083","","10.1093/gerona/gly047"
"29127417","The positive effects of Xueshuan Xinmai tablets on brain functional connectivity in acute ischemic stroke: a placebo controlled randomized trial","Wei D, Xie D, Li H, Chen Y, Qi D, Wang Y, Zhang Y, Chen K, Li C, Zhang Z.","Sci Rep. 2017 Nov 10;7(1):15244. doi: 10.1038/s41598-017-15456-9.","Wei D","Sci Rep","2017","2017/11/12","PMC5681502","","10.1038/s41598-017-15456-9"
"31234864","Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial","Magni LR, Carcione A, Ferrari C, Semerari A, Riccardi I, Nicolo' G, Lanfredi M, Pedrini L, Cotelli M, Bocchio L, Pievani M, Gasparotti R, Rossi R; CLIMAMITHE Study group.","BMC Psychiatry. 2019 Jun 24;19(1):195. doi: 10.1186/s12888-019-2127-2.","Magni LR","BMC Psychiatry","2019","2019/06/26","PMC6591903","","10.1186/s12888-019-2127-2"
"31211691","Task-related fMRI BOLD response to hyperinsulinemia in healthy older adults","Williams VJ, Trombetta BA, Jafri RZ, Koenig AM, Wennick CD, Carlyle BC, Ekhlaspour L, Ahima RS, Russell SJ, Salat DH, Arnold SE.","JCI Insight. 2019 Jun 18;5(14):e129700. doi: 10.1172/jci.insight.129700.","Williams VJ","JCI Insight","2019","2019/06/19","PMC6675560","","10.1172/jci.insight.129700"
"28731266","A randomized, double-blind, placebo-controlled crossover study of the effects of levetiracetam on cognition, mood, and balance in healthy older adults","Schoenberg MR, Rum RS, Osborn KE, Werz MA.","Epilepsia. 2017 Sep;58(9):1566-1574. doi: 10.1111/epi.13849. Epub 2017 Jul 21.","Schoenberg MR","Epilepsia","2017","2017/07/22","","","10.1111/epi.13849"
"22354158","Improving burden and coping skills in frontotemporal dementia caregivers: a pilot study","Mioshi E, McKinnon C, Savage S, O'Connor CM, Hodges JR.","Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):84-6. doi: 10.1097/WAD.0b013e31824a7f5b.","Mioshi E","Alzheimer Dis Assoc Disord","2013","2012/02/23","","","10.1097/WAD.0b013e31824a7f5b"
"34028358","Internet-Based Cognitive Behavioral Therapy for Patients Reporting Symptoms of Anxiety and Depression After Myocardial Infarction: U-CARE Heart Randomized Controlled Trial Twelve-Month Follow-up","Humphries SM, Wallert J, Norlund F, Wallin E, Burell G, von Essen L, Held C, Olsson EMG.","J Med Internet Res. 2021 May 24;23(5):e25465. doi: 10.2196/25465.","Humphries SM","J Med Internet Res","2021","2021/05/24","PMC8185614","","10.2196/25465"
"30219032","Promoting safe walking among older people: the effects of a physical and cognitive training intervention vs. physical training alone on mobility and falls among older community-dwelling men and women (the PASSWORD study): design and methods of a randomized controlled trial","Sipilä S, Tirkkonen A, Hänninen T, Laukkanen P, Alen M, Fielding RA, Kivipelto M, Kokko K, Kulmala J, Rantanen T, Sihvonen SE, Sillanpää E, Stigsdotter-Neely A, Törmäkangas T.","BMC Geriatr. 2018 Sep 15;18(1):215. doi: 10.1186/s12877-018-0906-0.","Sipilä S","BMC Geriatr","2018","2018/09/17","PMC6139154","","10.1186/s12877-018-0906-0"
"21131675","Physical and psychological effects of 6-week tactile massage on elderly patients with severe dementia","Suzuki M, Tatsumi A, Otsuka T, Kikuchi K, Mizuta A, Makino K, Kimoto A, Fujiwara K, Abe T, Nakagomi T, Hayashi T, Saruhara T.","Am J Alzheimers Dis Other Demen. 2010 Dec;25(8):680-6. doi: 10.1177/1533317510386215.","Suzuki M","Am J Alzheimers Dis Other Demen","2010","2010/12/07","","","10.1177/1533317510386215"
"29345144","Pilot Randomized Controlled Trial of the GO Game Intervention on Cognitive Function","Iizuka A, Suzuki H, Ogawa S, Kobayashi-Cuya KE, Kobayashi M, Takebayashi T, Fujiwara Y.","Am J Alzheimers Dis Other Demen. 2018 May;33(3):192-198. doi: 10.1177/1533317517753362. Epub 2018 Jan 18.","Iizuka A","Am J Alzheimers Dis Other Demen","2018","2018/01/19","","","10.1177/1533317517753362"
"27659392","An Education Intervention to Enhance Staff Self-Efficacy to Provide Dementia Care in an Acute Care Hospital in Canada: A Nonrandomized Controlled Study","Schindel Martin L, Gillies L, Coker E, Pizzacalla A, Montemuro M, Suva G, McLelland V.","Am J Alzheimers Dis Other Demen. 2016 Dec;31(8):664-677. doi: 10.1177/1533317516668574. Epub 2016 Sep 22.","Schindel Martin L","Am J Alzheimers Dis Other Demen","2016","2016/09/24","PMC5336139","","10.1177/1533317516668574"
"16024406","Follow-up of an intervention program for caregivers of a relative with dementia living in a long-term care setting: Are there any persistent and delayed effects?","Ducharme F, Lévesque L, Giroux F, Lachance L.","Aging Ment Health. 2005 Sep;9(5):461-9. doi: 10.1080/13607860500142812.","Ducharme F","Aging Ment Health","2005","2005/07/19","","","10.1080/13607860500142812"
"8424849","Effects of the novel acetylcholinesterase inhibitor SDZ ENA 713 on sleep in man","Holsboer-Trachsler E, Hatzinger M, Stohler R, Hemmeter U, Gray J, Müller J, Kocher R, Spiegel R.","Neuropsychopharmacology. 1993 Jan;8(1):87-92. doi: 10.1038/npp.1993.10.","Holsboer-Trachsler E","Neuropsychopharmacology","1993","1993/01/01","","","10.1038/npp.1993.10"
"24792708","Multisensory stimulation on mood, behavior, and biomedical parameters in people with dementia: is it more effective than conventional one-to-one stimulation?","Maseda A, Sánchez A, Marante MP, González-Abraldes I, de Labra C, Millán-Calenti JC.","Am J Alzheimers Dis Other Demen. 2014 Nov;29(7):637-47. doi: 10.1177/1533317514532823. Epub 2014 May 1.","Maseda A","Am J Alzheimers Dis Other Demen","2014","2014/05/06","","","10.1177/1533317514532823"
"24604894","Effects of Multisensory Stimulation on a Sample of Institutionalized Elderly People With Dementia Diagnosis: A Controlled Longitudinal Trial","Maseda A, Sánchez A, Marante MP, González-Abraldes I, Buján A, Millán-Calenti JC.","Am J Alzheimers Dis Other Demen. 2014 Aug;29(5):463-73. doi: 10.1177/1533317514522540. Epub 2014 Mar 6.","Maseda A","Am J Alzheimers Dis Other Demen","2014","2014/03/08","","","10.1177/1533317514522540"
"23528880","Learning to live with a loved one with mild cognitive impairment: effectiveness of a waiting list controlled trial of a group intervention on significant others' sense of competence and well-being","Banningh LW, Vernooij-Dassen MJ, Vullings M, Prins JB, Rikkert MG, Kessels RP.","Am J Alzheimers Dis Other Demen. 2013 May;28(3):228-38. doi: 10.1177/1533317513481093. Epub 2013 Mar 25.","Banningh LW","Am J Alzheimers Dis Other Demen","2013","2013/03/27","","","10.1177/1533317513481093"
"23221028","Motor and multisensory care-based approach in dementia: long-term effects of a pilot study","Marques A, Cruz J, Barbosa A, Figueiredo D, Sousa LX.","Am J Alzheimers Dis Other Demen. 2013 Feb;28(1):24-34. doi: 10.1177/1533317512466691. Epub 2012 Dec 7.","Marques A","Am J Alzheimers Dis Other Demen","2013","2012/12/11","","","10.1177/1533317512466691"
"23677733","Safe home program: a suite of technologies to support extended home care of persons with dementia","McKenzie B, Bowen ME, Keys K, Bulat T.","Am J Alzheimers Dis Other Demen. 2013 Jun;28(4):348-54. doi: 10.1177/1533317513488917. Epub 2013 May 15.","McKenzie B","Am J Alzheimers Dis Other Demen","2013","2013/05/17","","","10.1177/1533317513488917"
"22914593","Exercise-induced noradrenergic activation enhances memory consolidation in both normal aging and patients with amnestic mild cognitive impairment","Segal SK, Cotman CW, Cahill LF.","J Alzheimers Dis. 2012;32(4):1011-8. doi: 10.3233/JAD-2012-121078.","Segal SK","J Alzheimers Dis","2012","2012/08/24","PMC3951984","NIHMS498587","10.3233/JAD-2012-121078"
"18955724","A behavioral rehabilitation intervention for amnestic mild cognitive impairment","Greenaway MC, Hanna SM, Lepore SW, Smith GE.","Am J Alzheimers Dis Other Demen. 2008 Oct-Nov;23(5):451-61. doi: 10.1177/1533317508320352.","Greenaway MC","Am J Alzheimers Dis Other Demen","2008","2008/10/29","PMC2845519","NIHMS90216","10.1177/1533317508320352"
"33279344","Effects of an educational peer-group intervention on knowledge about dementia among family caregivers with a Turkish or Moroccan immigrant background: A cluster randomised controlled trial","van Wezel N, van der Heide I, Devillé WL, Kayan Acun E, Meerveld JHCM, Spreeuwenberg P, Blom MM, Francke AL.","Patient Educ Couns. 2021 Jul;104(7):1726-1735. doi: 10.1016/j.pec.2020.11.008. Epub 2020 Nov 17.","van Wezel N","Patient Educ Couns","2021","2020/12/06","","","10.1016/j.pec.2020.11.008"
"34171518","Effects on staff outcomes and process evaluation of the educating nursing staff effectively (TENSE) program for managing challenging behavior in nursing home residents with dementia: A cluster-randomized controlled trial","Bielderman A, Nieuwenhuis A, Hazelhof TJGM, van Gaal BGI, Schoonhoven L, Akkermans RP, Spijker A, Koopmans RTCM, Gerritsen DL.","Int J Nurs Stud. 2021 Aug;120:103982. doi: 10.1016/j.ijnurstu.2021.103982. Epub 2021 May 26.","Bielderman A","Int J Nurs Stud","2021","2021/06/25","","","10.1016/j.ijnurstu.2021.103982"
"25547113","Effectiveness of a training package for implementing a community-based occupational therapy program in dementia: a cluster randomized controlled trial","Döpp CM, Graff MJ, Teerenstra S, Olde Rikkert MG, Nijhuis-van der Sanden MW, Vernooij-Dassen MJ.","Clin Rehabil. 2015 Oct;29(10):974-86. doi: 10.1177/0269215514564699. Epub 2014 Dec 28.","Döpp CM","Clin Rehabil","2015","2014/12/31","","","10.1177/0269215514564699"
"35137699","Relapse in Dementia-related Psychosis and Clinical Decisions","Soto-Martin M, Foff EP, Devanand DP.","Alzheimer Dis Assoc Disord. 2022 Apr-Jun 01;36(2):180-184. doi: 10.1097/WAD.0000000000000480. Epub 2022 Feb 9.","Soto-Martin M","Alzheimer Dis Assoc Disord","2022","2022/02/09","PMC9132239","","10.1097/WAD.0000000000000480"
"15999906","EEG mapping and low-resolution brain electromagnetic tomography (LORETA) in diagnosis and therapy of psychiatric disorders: evidence for a key-lock principle","Saletu B, Anderer P, Saletu-Zyhlarz GM, Pascual-Marqui RD.","Clin EEG Neurosci. 2005 Apr;36(2):108-15. doi: 10.1177/155005940503600210.","Saletu B","Clin EEG Neurosci","2005","2005/07/08","","","10.1177/155005940503600210"
"3370078","Randomized placebo-controlled double-blind cross-over study on antihypoxidotic effects of piracetam using psychophysiological measures in healthy volunteers","Schaffler K, Klausnitzer W.","Arzneimittelforschung. 1988 Feb;38(2):288-91.","Schaffler K","Arzneimittelforschung","1988","1988/02/01","","",""
"35871331","go4cognition: Combined Physiological and Cognitive Intervention in Mild Cognitive Impairment","Lissek VJ, Ben Abdallah H, Praetorius A, Ohmann T, Suchan B.","J Alzheimers Dis. 2022;89(2):449-462. doi: 10.3233/JAD-220145.","Lissek VJ","J Alzheimers Dis","2022","2022/07/24","","","10.3233/JAD-220145"
"34797188","Exploring Effects of Aerobic Exercise and Mindfulness Training on Cognitive Function in Older Adults at Risk of Dementia: A Feasibility, Proof-of-Concept Study","Salmoirago-Blotcher E, Trivedi D, Dunsiger S, Harris K, Breault C, Yang Santos C, Walaska K, Snyder P, Cohen R.","Am J Alzheimers Dis Other Demen. 2021 Jan-Dec;36:15333175211039094. doi: 10.1177/15333175211039094.","Salmoirago-Blotcher E","Am J Alzheimers Dis Other Demen","2021","2021/11/19","","","10.1177/15333175211039094"
"18453647","Multisensory stimulation for elderly with dementia: a 24-week single-blind randomized controlled pilot study","Milev RV, Kellar T, McLean M, Mileva V, Luthra V, Thompson S, Peever L.","Am J Alzheimers Dis Other Demen. 2008 Aug-Sep;23(4):372-6. doi: 10.1177/1533317508316681. Epub 2008 May 4.","Milev RV","Am J Alzheimers Dis Other Demen","2008","2008/05/06","","","10.1177/1533317508316681"
"28683560","Feasibility of a Latin Dance Program for Older Latinos With Mild Cognitive Impairment","Aguiñaga S, Marquez DX.","Am J Alzheimers Dis Other Demen. 2017 Dec;32(8):479-488. doi: 10.1177/1533317517719500. Epub 2017 Jul 6.","Aguiñaga S","Am J Alzheimers Dis Other Demen","2017","2017/07/08","","","10.1177/1533317517719500"
"27650383","Reducing sample size by combining superiority and non-inferiority for two primary endpoints in the Social Fitness study","Donkers H, Graff M, Vernooij-Dassen M, Nijhuis-van der Sanden M, Teerenstra S.","J Clin Epidemiol. 2017 Jan;81:86-95. doi: 10.1016/j.jclinepi.2016.09.007. Epub 2016 Sep 17.","Donkers H","J Clin Epidemiol","2017","2016/09/22","","","10.1016/j.jclinepi.2016.09.007"
"35662124","Cognitive Stimulation Program Presented Through New Technologies in a Group of People with Moderate Cognitive Impairment","Gonzalez-Moreno J, Satorres E, Soria-Urios G, Meléndez JC.","J Alzheimers Dis. 2022;88(2):513-519. doi: 10.3233/JAD-220245.","Gonzalez-Moreno J","J Alzheimers Dis","2022","2022/06/06","","","10.3233/JAD-220245"
"25118333","Evaluation of a pet-assisted living intervention for improving functional status in assisted living residents with mild to moderate cognitive impairment: a pilot study","Friedmann E, Galik E, Thomas SA, Hall PS, Chung SY, McCune S.","Am J Alzheimers Dis Other Demen. 2015 May;30(3):276-89. doi: 10.1177/1533317514545477. Epub 2014 Aug 11.","Friedmann E","Am J Alzheimers Dis Other Demen","2015","2014/08/14","","","10.1177/1533317514545477"
"24963079","Computer-based cognitive training for individuals with intellectual and developmental disabilities: pilot study","Siberski J, Shatil E, Siberski C, Eckroth-Bucher M, French A, Horton S, Loefflad RF, Rouse P.","Am J Alzheimers Dis Other Demen. 2015 Feb;30(1):41-8. doi: 10.1177/1533317514539376. Epub 2014 Jun 24.","Siberski J","Am J Alzheimers Dis Other Demen","2015","2014/06/26","","","10.1177/1533317514539376"
"20164557","Meditation effects on cognitive function and cerebral blood flow in subjects with memory loss: a preliminary study","Newberg AB, Wintering N, Khalsa DS, Roggenkamp H, Waldman MR.","J Alzheimers Dis. 2010;20(2):517-26. doi: 10.3233/JAD-2010-1391.","Newberg AB","J Alzheimers Dis","2010","2010/02/19","","","10.3233/JAD-2010-1391"
"14569644","Teaching staff to respond effectively to cognitively impaired residents who display self-protective behaviors","Schindel-Martin L, Morden P, Cetinski G, Lasky N, McDowell C, Roberts J.","Am J Alzheimers Dis Other Demen. 2003 Sep-Oct;18(5):273-81. doi: 10.1177/153331750301800510.","Schindel-Martin L","Am J Alzheimers Dis Other Demen","2003","2003/10/23","","","10.1177/153331750301800510"
"27303064","A Quasi-Randomized Controlled Trial of Brain-Activating Rehabilitation in an Acute Hospital","Tsuchiya K, Yamaguchi T, Fujita T, Taguchi M, Honda A, Satou Y, Sekiguchi H, Kimura N, Osawa T, Terauchi M.","Am J Alzheimers Dis Other Demen. 2016 Dec;31(8):612-617. doi: 10.1177/1533317516653822. Epub 2016 Jun 14.","Tsuchiya K","Am J Alzheimers Dis Other Demen","2016","2016/06/16","","","10.1177/1533317516653822"
"31638902","A four-stage process for intervention description and guide development of a practice-based intervention: refining the Namaste Care intervention implementation specification for people with advanced dementia prior to a feasibility cluster randomised trial","Walshe C, Kinley J, Patel S, Goodman C, Bunn F, Lynch J, Scott D, Lund AD, Stacpoole M, Preston N, Froggatt K.","BMC Geriatr. 2019 Oct 21;19(1):275. doi: 10.1186/s12877-019-1275-z.","Walshe C","BMC Geriatr","2019","2019/10/23","PMC6802319","","10.1186/s12877-019-1275-z"
"30137218","Effect of Intentional Weight Loss on Mortality Biomarkers in Older Adults With Obesity","Shaver LN, Beavers DP, Kiel J, Kritchevsky SB, Beavers KM.","J Gerontol A Biol Sci Med Sci. 2019 Jul 12;74(8):1303-1309. doi: 10.1093/gerona/gly192.","Shaver LN","J Gerontol A Biol Sci Med Sci","2019","2018/08/24","PMC7179512","","10.1093/gerona/gly192"
"26585409","Impact of Antipsychotic Review and Nonpharmacological Intervention on Antipsychotic Use, Neuropsychiatric Symptoms, and Mortality in People With Dementia Living in Nursing Homes: A Factorial Cluster-Randomized Controlled Trial by the Well-Being and Health for People With Dementia (WHELD) Program","Ballard C, Orrell M, YongZhong S, Moniz-Cook E, Stafford J, Whittaker R, Woods B, Corbett A, Garrod L, Khan Z, Woodward-Carlton B, Wenborn J, Fossey J.","Am J Psychiatry. 2016 Mar 1;173(3):252-62. doi: 10.1176/appi.ajp.2015.15010130. Epub 2015 Nov 20.","Ballard C","Am J Psychiatry","2016","2015/11/21","","","10.1176/appi.ajp.2015.15010130"
"23158959","Poor health-related quality of life prior to ECT in depressed patients normalizes with sustained remission after ECT","McCall WV, Reboussin D, Prudic J, Haskett RF, Isenberg K, Olfson M, Rosenquist PB, Sackeim HA.","J Affect Disord. 2013 May;147(1-3):107-11. doi: 10.1016/j.jad.2012.10.018. Epub 2012 Nov 15.","McCall WV","J Affect Disord","2013","2012/11/20","PMC3606673","NIHMS423593","10.1016/j.jad.2012.10.018"
"10547980","[Assessment of brain cell function using 123I-IMP SPECT of cerebral blood flow and visual evoked potential by photic stimulation in normal and demented elderly subjects]","Ogawa K, Katsunuma H, Ishida H, Takasaki M.","Kaku Igaku. 1999 Sep;36(7):705-13.","Ogawa K","Kaku Igaku","1999","1999/11/05","","",""
"8579810","Disturbances of cerebrospinal fluid (CSF) circulation--neuropsychiatric symptoms and neuroradiological contribution","Hofmann E, Becker T, Meixensberger J, Jackel M, Schneider M, Reichmann H.","J Neural Transm Gen Sect. 1995;99(1-3):79-88. doi: 10.1007/BF01271471.","Hofmann E","J Neural Transm Gen Sect","1995","1995/01/01","","","10.1007/BF01271471"
"1492861","[Dihydroergocristine in the treatment of organic brain psychosyndrome. Dose-finding study against placebo]","Milvio C.","Arzneimittelforschung. 1992 Nov;42(11A):1399-402.","Milvio C","Arzneimittelforschung","1992","1992/11/01","","",""
"28971360","Respond, don't react: The influence of mindfulness training on performance monitoring in older adults","Smart CM, Segalowitz SJ.","Cogn Affect Behav Neurosci. 2017 Dec;17(6):1151-1163. doi: 10.3758/s13415-017-0539-3.","Smart CM","Cogn Affect Behav Neurosci","2017","2017/10/04","","","10.3758/s13415-017-0539-3"
"22484523","Intake of alcohol-free red wine modulates antioxidant enzyme activities in a human intervention study","Noguer MA, Cerezo AB, Donoso Navarro E, Garcia-Parrilla MC.","Pharmacol Res. 2012 Jun;65(6):609-14. doi: 10.1016/j.phrs.2012.03.003. Epub 2012 Mar 30.","Noguer MA","Pharmacol Res","2012","2012/04/10","","","10.1016/j.phrs.2012.03.003"
"12955293","Separate and combined effects of scopolamine and nicotine on retrieval-induced forgetting","Edginton T, Rusted JM.","Psychopharmacology (Berl). 2003 Dec;170(4):351-7. doi: 10.1007/s00213-003-1563-2. Epub 2003 Aug 29.","Edginton T","Psychopharmacology (Berl)","2003","2003/09/05","","","10.1007/s00213-003-1563-2"
"29356827","Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial","Solomon A, Turunen H, Ngandu T, Peltonen M, Levälahti E, Helisalmi S, Antikainen R, Bäckman L, Hänninen T, Jula A, Laatikainen T, Lehtisalo J, Lindström J, Paajanen T, Pajala S, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M.","JAMA Neurol. 2018 Apr 1;75(4):462-470. doi: 10.1001/jamaneurol.2017.4365.","Solomon A","JAMA Neurol","2018","2018/01/23","PMC5885273","","10.1001/jamaneurol.2017.4365"
"35606688","Postoperative but not preoperative depression is associated with cognitive impairment after cardiac surgery: exploratory analysis of data from a randomized trial","Lewis C, Dokucu ME, Brown CH, Balmert L, Srdanovic N, Madhan AS, Samra SS, Csernansky J, Grafman J, Hogue CW.","BMC Anesthesiol. 2022 May 23;22(1):157. doi: 10.1186/s12871-022-01672-y.","Lewis C","BMC Anesthesiol","2022","2022/05/23","PMC9125857","","10.1186/s12871-022-01672-y"
"35090363","The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation","Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J, Lennard-Jones M, Mistry S, Saldarini F, Stansfield S, Tai SJ, Williams S, Weston N, Malievskaia E, Young AH.","J Psychopharmacol. 2022 Jan;36(1):114-125. doi: 10.1177/02698811211064720. Epub 2022 Jan 4.","Rucker JJ","J Psychopharmacol","2022","2022/01/29","PMC8801675","","10.1177/02698811211064720"
"34549700","The Effect of Self-Paced Exercise Intensity and Cardiorespiratory Fitness on Frontal Grey Matter Volume in Cognitively Normal Older Adults: A Randomised Controlled Trial","Frost NJ, Weinborn M, Gignac GE, Xia Y, Doré V, Rainey-Smith SR, Markovic S, Gordon N, Sohrabi HR, Laws SM, Martins RN, Peiffer JJ, Brown BM.","J Int Neuropsychol Soc. 2022 Oct;28(9):902-915. doi: 10.1017/S1355617721001132. Epub 2021 Sep 22.","Frost NJ","J Int Neuropsychol Soc","2022","2021/09/22","","","10.1017/S1355617721001132"
"31688650","Association of Fish Oil and Physical Activity on Mobility Disability in Older Adults","Balachandran A, Gundermann DM, Walkup MP, King AC, Ambrosius WT, Kritchevsky SB, Pahor M, Newman AB, Manini TM.","Med Sci Sports Exerc. 2020 Apr;52(4):859-867. doi: 10.1249/MSS.0000000000002195.","Balachandran A","Med Sci Sports Exerc","2020","2019/11/06","PMC7123515","NIHMS1549951","10.1249/MSS.0000000000002195"
"31084341","Temporal Trends in Ischemic Stroke Incidence in Younger Adults in the Framingham Study","Aparicio HJ, Himali JJ, Satizabal CL, Pase MP, Romero JR, Kase CS, Beiser AS, Seshadri S.","Stroke. 2019 Jun;50(6):1558-1560. doi: 10.1161/STROKEAHA.119.025171. Epub 2019 May 14.","Aparicio HJ","Stroke","2019","2019/05/16","PMC6538454","NIHMS1527433","10.1161/STROKEAHA.119.025171"
"31221697","Olfactory Dysfunction Mediates Adiposity in Cognitive Impairment of Type 2 Diabetes: Insights From Clinical and Functional Neuroimaging Studies","Zhang Z, Zhang B, Wang X, Zhang X, Yang QX, Qing Z, Zhang W, Zhu D, Bi Y.","Diabetes Care. 2019 Jul;42(7):1274-1283. doi: 10.2337/dc18-2584. Epub 2019 May 21.","Zhang Z","Diabetes Care","2019","2019/06/22","","","10.2337/dc18-2584"
"33967049","A Novel Cognitive Function Scale Using Functional Near-Infrared Spectroscopy for Evaluating Cognitive Dysfunction","Nakamura S, Yomota S, Ito H, Akinaga N, Hori A, Chinomi K, Suzuki H, Uchida K, Asada T.","J Alzheimers Dis. 2021;81(4):1579-1588. doi: 10.3233/JAD-210072.","Nakamura S","J Alzheimers Dis","2021","2021/05/10","PMC8293658","","10.3233/JAD-210072"
"26399485","Effects of a Psychoeducational Intervention for Direct Care Workers Caring for People With Dementia: Results From a 6-Month Follow-Up Study","Barbosa A, Nolan M, Sousa L, Marques A, Figueiredo D.","Am J Alzheimers Dis Other Demen. 2016 Mar;31(2):144-55. doi: 10.1177/1533317515603500. Epub 2015 Sep 22.","Barbosa A","Am J Alzheimers Dis Other Demen","2016","2015/09/25","","","10.1177/1533317515603500"
"25392187","Testosterone treatment of men with mild cognitive impairment and low testosterone levels","Cherrier MM, Anderson K, Shofer J, Millard S, Matsumoto AM.","Am J Alzheimers Dis Other Demen. 2015 Jun;30(4):421-30. doi: 10.1177/1533317514556874. Epub 2014 Nov 11.","Cherrier MM","Am J Alzheimers Dis Other Demen","2015","2014/11/14","","","10.1177/1533317514556874"
"25074341","Psychosocial telephone intervention for dementia caregivers: A randomized, controlled trial","Tremont G, Davis JD, Papandonatos GD, Ott BR, Fortinsky RH, Gozalo P, Yue MS, Bryant K, Grover C, Bishop DS.","Alzheimers Dement. 2015 May;11(5):541-8. doi: 10.1016/j.jalz.2014.05.1752. Epub 2014 Jul 26.","Tremont G","Alzheimers Dement","2015","2014/07/31","PMC4306648","NIHMS601731","10.1016/j.jalz.2014.05.1752"
"24643137","A randomized controlled pilot study to evaluate a technology platform for the assisted living of people with dementia and their carers","Torkamani M, McDonald L, Saez Aguayo I, Kanios C, Katsanou MN, Madeley L, Limousin PD, Lees AJ, Haritou M, Jahanshahi M; ALADDIN Collaborative Group.","J Alzheimers Dis. 2014;41(2):515-23. doi: 10.3233/JAD-132156.","Torkamani M","J Alzheimers Dis","2014","2014/03/20","","","10.3233/JAD-132156"
"26560511","Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled Trial","van den Elsen GAH, Ahmed AIA, Verkes RJ, Feuth T, van der Marck MA, Olde Rikkert MGM.","Am J Geriatr Psychiatry. 2015 Dec;23(12):1214-1224. doi: 10.1016/j.jagp.2015.07.011. Epub 2015 Jul 30.","van den Elsen GAH","Am J Geriatr Psychiatry","2015","2015/11/13","","","10.1016/j.jagp.2015.07.011"
"25237132","Supporting direct care workers in dementia care: effects of a psychoeducational intervention","Barbosa A, Nolan M, Sousa L, Figueiredo D.","Am J Alzheimers Dis Other Demen. 2015 Mar;30(2):130-8. doi: 10.1177/1533317514550331. Epub 2014 Sep 18.","Barbosa A","Am J Alzheimers Dis Other Demen","2015","2014/09/20","","","10.1177/1533317514550331"
"18453642","The effects of a multimodal intervention on outcomes of persons with early-stage dementia","Burgener SC, Yang Y, Gilbert R, Marsh-Yant S.","Am J Alzheimers Dis Other Demen. 2008 Aug-Sep;23(4):382-94. doi: 10.1177/1533317508317527. Epub 2008 May 4.","Burgener SC","Am J Alzheimers Dis Other Demen","2008","2008/05/06","PMC3014218","NIHMS255006","10.1177/1533317508317527"
"29083439","Cognitive Changes with Omega-3 Polyunsaturated Fatty Acids in Non-Demented Older Adults with Low Omega-3 Index","Hooper C, De Souto Barreto P, Coley N, Cantet C, Cesari M, Andrieu S, Vellas B.","J Nutr Health Aging. 2017;21(9):988-993. doi: 10.1007/s12603-017-0957-5.","Hooper C","J Nutr Health Aging","2017","2017/10/31","","","10.1007/s12603-017-0957-5"
"31056923","The Implementation of Dementia Care Mapping in a Randomized Controlled Trial in Long-Term Care: Results of a Process Evaluation","Surr CA, Griffiths AW, Kelley R, Holloway I, Walwyn REA, Martin A, McDermid J, Chenoweth L, Farrin AJ.","Am J Alzheimers Dis Other Demen. 2019 Sep;34(6):390-398. doi: 10.1177/1533317519845725. Epub 2019 May 5.","Surr CA","Am J Alzheimers Dis Other Demen","2019","2019/05/07","PMC6676338","","10.1177/1533317519845725"
"30775982","Psychosocial Intervention in Couples Coping with Dementia Led by a Psychotherapist and a Social Worker: The DYADEM Trial","Nordheim J, Häusler A, Yasar S, Suhr R, Kuhlmey A, Rapp M, Gellert P.","J Alzheimers Dis. 2019;68(2):745-755. doi: 10.3233/JAD-180812.","Nordheim J","J Alzheimers Dis","2019","2019/02/19","","","10.3233/JAD-180812"
"27716673","The Utilization of Robotic Pets in Dementia Care","Petersen S, Houston S, Qin H, Tague C, Studley J.","J Alzheimers Dis. 2017;55(2):569-574. doi: 10.3233/JAD-160703.","Petersen S","J Alzheimers Dis","2017","2016/10/08","PMC5181659","","10.3233/JAD-160703"
"25408218","Randomized controlled trial of a healthy brain ageing cognitive training program: effects on memory, mood, and sleep","Diamond K, Mowszowski L, Cockayne N, Norrie L, Paradise M, Hermens DF, Lewis SJ, Hickie IB, Naismith SL.","J Alzheimers Dis. 2015;44(4):1181-91. doi: 10.3233/JAD-142061.","Diamond K","J Alzheimers Dis","2015","2014/11/20","","","10.3233/JAD-142061"
"24526760","Cognitive stimulation for Portuguese older adults with cognitive impairment: a randomized controlled trial of efficacy, comparative duration, feasibility, and experiential relevance","Alves J, Alves-Costa F, Magalhães R, Gonçalves OF, Sampaio A.","Am J Alzheimers Dis Other Demen. 2014 Sep;29(6):503-12. doi: 10.1177/1533317514522541. Epub 2014 Feb 13.","Alves J","Am J Alzheimers Dis Other Demen","2014","2014/02/15","","","10.1177/1533317514522541"
"23118201","Clock drawing test in elderly individuals with different education levels: correlation with clinical dementia rating","Cecato JF, Fiorese B, Montiel JM, Bartholomeu D, Martinelli JE.","Am J Alzheimers Dis Other Demen. 2012 Dec;27(8):620-4. doi: 10.1177/1533317512463954. Epub 2012 Nov 1.","Cecato JF","Am J Alzheimers Dis Other Demen","2012","2012/11/03","","","10.1177/1533317512463954"
"31315417","Age-Related Effect of Antihypertensive Treatment on Cognitive Performance: Is it Better Preventing Dementia in Older Age?","Vazirinejad R, Mirmotalebi M, Bageri M, Kounis NG, Koniari I, Lilley JM, Gommnami N.","Am J Alzheimers Dis Other Demen. 2019 Nov-Dec;34(7-8):486-491. doi: 10.1177/1533317519859197. Epub 2019 Jul 17.","Vazirinejad R","Am J Alzheimers Dis Other Demen","2019","2019/07/19","","","10.1177/1533317519859197"
"27886013","Is Salivary Chromogranin A a Valid Psychological Stress Biomarker During Sensory Stimulation in People with Advanced Dementia?","Valdiglesias V, Maseda A, Lorenzo-López L, Pásaro E, Millán-Calenti JC, Laffon B.","J Alzheimers Dis. 2017;55(4):1509-1517. doi: 10.3233/JAD-160893.","Valdiglesias V","J Alzheimers Dis","2017","2016/11/26","","","10.3233/JAD-160893"
"27497474","Cognitive Stimulation for People with Dementia in Long-Term Care Facilities: Baseline Cognitive Level Predicts Cognitive Gains, Moderated by Depression","Middelstädt J, Folkerts AK, Blawath S, Kalbe E.","J Alzheimers Dis. 2016 Aug 4;54(1):253-68. doi: 10.3233/JAD-160181.","Middelstädt J","J Alzheimers Dis","2016","2016/08/07","","","10.3233/JAD-160181"
"23246919","Lifelong estrogen exposure and memory in older postmenopausal women","Tierney MC, Ryan J, Ancelin ML, Moineddin R, Rankin S, Yao C, MacLusky NJ.","J Alzheimers Dis. 2013;34(3):601-8. doi: 10.3233/JAD-122062.","Tierney MC","J Alzheimers Dis","2013","2012/12/19","","","10.3233/JAD-122062"
"27515720","Improving comfort in people with dementia and pneumonia: a cluster randomized trial","van der Maaden T, de Vet HC, Achterberg WP, Boersma F, Schols JM, Mehr DR, Galindo-Garre F, Hertogh CM, Koopmans RT, van der Steen JT.","BMC Med. 2016 Aug 11;14(1):116. doi: 10.1186/s12916-016-0663-x.","van der Maaden T","BMC Med","2016","2016/08/13","PMC4981997","","10.1186/s12916-016-0663-x"
"27653887","At-home tDCS of the left dorsolateral prefrontal cortex improves visual short-term memory in mild vascular dementia","André S, Heinrich S, Kayser F, Menzler K, Kesselring J, Khader PH, Lefaucheur JP, Mylius V.","J Neurol Sci. 2016 Oct 15;369:185-190. doi: 10.1016/j.jns.2016.07.065. Epub 2016 Jul 30.","André S","J Neurol Sci","2016","2016/09/23","","","10.1016/j.jns.2016.07.065"
"21601315","Prolonged coenzyme Q10 treatment in Down syndrome patients: effect on DNA oxidation","Tiano L, Padella L, Santoro L, Carnevali P, Principi F, Brugè F, Gabrielli O, Littarru GP.","Neurobiol Aging. 2012 Mar;33(3):626.e1-8. doi: 10.1016/j.neurobiolaging.2011.03.025. Epub 2011 May 23.","Tiano L","Neurobiol Aging","2012","2011/05/24","","","10.1016/j.neurobiolaging.2011.03.025"
"8752533","[The long-term effect of day care rehabilitation on individuals with dementia]","Watanabe Y.","Hokkaido Igaku Zasshi. 1996 May;71(3):391-402.","Watanabe Y","Hokkaido Igaku Zasshi","1996","1996/05/01","","",""
"31409559","Exergaming as a Physical Exercise Strategy Reduces Frailty in People With Dementia: A Randomized Controlled Trial","Karssemeijer EGA, Bossers WJR, Aaronson JA, Sanders LMJ, Kessels RPC, Olde Rikkert MGM.","J Am Med Dir Assoc. 2019 Dec;20(12):1502-1508.e1. doi: 10.1016/j.jamda.2019.06.026. Epub 2019 Aug 10.","Karssemeijer EGA","J Am Med Dir Assoc","2019","2019/08/15","","","10.1016/j.jamda.2019.06.026"
"27524393","Addition of a non-immersive virtual reality component to treadmill training to reduce fall risk in older adults (V-TIME): a randomised controlled trial","Mirelman A, Rochester L, Maidan I, Del Din S, Alcock L, Nieuwhof F, Rikkert MO, Bloem BR, Pelosin E, Avanzino L, Abbruzzese G, Dockx K, Bekkers E, Giladi N, Nieuwboer A, Hausdorff JM.","Lancet. 2016 Sep 17;388(10050):1170-82. doi: 10.1016/S0140-6736(16)31325-3. Epub 2016 Aug 11.","Mirelman A","Lancet","2016","2016/08/16","","","10.1016/S0140-6736(16)31325-3"
"36093705","Acupuncture Treatment Modulate Regional Homogeneity of Dorsal Lateral Prefrontal Cortex in Patients with Amnesic Mild Cognitive Impairment","Zhang J, Hu S, Liu Y, Lyu H, Huang X, Li X, Chen J, Hu Q, Xu J, Yu H.","J Alzheimers Dis. 2022;90(1):173-184. doi: 10.3233/JAD-220592.","Zhang J","J Alzheimers Dis","2022","2022/09/12","","","10.3233/JAD-220592"
"34542079","Mindfulness-Based Training Does Not Improve Neuropsychological Outcomes in Mild Cognitive Impairment More Than Spontaneous Reversion Rates: A Randomized Controlled Trial","Doshi K, Henderson SL, Fan Q, Wong KF, Lim J.","J Alzheimers Dis. 2021;84(1):449-458. doi: 10.3233/JAD-215035.","Doshi K","J Alzheimers Dis","2021","2021/09/20","","","10.3233/JAD-215035"
"33579842","Mixed-Methods Study on Caregiver Strain, Quality of Life, and Perceived Health","Di Lorito C, Bosco A, Godfrey M, Dunlop M, Lock J, Pollock K, Harwood RH, van der Wardt V.","J Alzheimers Dis. 2021;80(2):799-811. doi: 10.3233/JAD-201257.","Di Lorito C","J Alzheimers Dis","2021","2021/02/13","PMC8075381","","10.3233/JAD-201257"
"32236395","Exploring Factors that Contribute to Joining and Regularly Practicing in Cognitive Training among Healthy Older Adults: A One-Year Follow-Up Qualitative Study","Srisuwan P, Nakawiro D, Chansirikarnjana S, Kuha O, Kengpanich S, Gesakomol K.","J Prev Alzheimers Dis. 2020;7(2):75-81. doi: 10.14283/jpad.2020.14.","Srisuwan P","J Prev Alzheimers Dis","2020","2020/04/03","","","10.14283/jpad.2020.14"
"34308903","Depressive and Anxious Comorbidity and Treatment Response in Family Caregivers of People with Dementia","Romero-Moreno R, Márquez-González M, Barrera-Caballero S, Vara-García C, Olazarán J, Pedroso-Chaparro MDS, Jiménez-Gonzalo L, Losada-Baltar A.","J Alzheimers Dis. 2021;83(1):395-405. doi: 10.3233/JAD-210348.","Romero-Moreno R","J Alzheimers Dis","2021","2021/07/26","","","10.3233/JAD-210348"
"26444773","Strategies for improving memory: a randomized trial of memory groups for older people, including those with mild cognitive impairment","Kinsella GJ, Ames D, Storey E, Ong B, Pike KE, Saling MM, Clare L, Mullaly E, Rand E.","J Alzheimers Dis. 2016;49(1):31-43. doi: 10.3233/JAD-150378.","Kinsella GJ","J Alzheimers Dis","2016","2015/10/08","","","10.3233/JAD-150378"
"23202438","Sustainability of motor training effects in older people with dementia","Zieschang T, Schwenk M, Oster P, Hauer K.","J Alzheimers Dis. 2013;34(1):191-202. doi: 10.3233/JAD-120814.","Zieschang T","J Alzheimers Dis","2013","2012/12/04","","","10.3233/JAD-120814"
"36502317","Effects of Remote Expressive Arts Program in Older Adults with Mild Cognitive Impairment: A Randomized Controlled Trial","Luo Y, Lin R, Yan Y, Su J, Lin S, Ma M, Li H.","J Alzheimers Dis. 2023;91(2):815-831. doi: 10.3233/JAD-215685.","Luo Y","J Alzheimers Dis","2023","2022/12/11","PMC9912742","","10.3233/JAD-215685"
"30370782","Cognitive Stimulating Play Intervention for Dementia: A Feasibility Randomized Controlled Trial","Cheung DSK, Li B, Lai DWL, Leung AYM, Yu CTK, Tsang KT.","Am J Alzheimers Dis Other Demen. 2019 Feb;34(1):63-71. doi: 10.1177/1533317518808036. Epub 2018 Oct 28.","Cheung DSK","Am J Alzheimers Dis Other Demen","2019","2018/10/30","","","10.1177/1533317518808036"
"29188854","Short-Term Impact of a Combined Nutraceutical on Cognitive Function, Perceived Stress and Depression in Young Elderly with Cognitive Impairment: A Pilot, Double-Blind, Randomized Clinical Trial","Cicero AF, Bove M, Colletti A, Rizzo M, Fogacci F, Giovannini M, Borghi C.","J Prev Alzheimers Dis. 2017;4(1):12-15. doi: 10.14283/jpad.2016.10.","Cicero AF","J Prev Alzheimers Dis","2017","2017/12/01","","","10.14283/jpad.2016.10"
"28527220","Quantitative Erythrocyte Omega-3 EPA Plus DHA Levels are Related to Higher Regional Cerebral Blood Flow on Brain SPECT","Amen DG, Harris WS, Kidd PM, Meysami S, Raji CA.","J Alzheimers Dis. 2017;58(4):1189-1199. doi: 10.3233/JAD-170281.","Amen DG","J Alzheimers Dis","2017","2017/05/21","","","10.3233/JAD-170281"
"27911313","Challenges in Screening and Recruitment for a Neuroimaging Study in Cognitively Impaired Geriatric Inpatients","Apostolova I, Lange C, Roberts A, Igel HJ, Mäurer A, Liese S, Estrella M, Prasad V, Stechl E, Lämmler G, Steinhagen-Thiessen E, Buchert R.","J Alzheimers Dis. 2017;56(1):197-204. doi: 10.3233/JAD-160797.","Apostolova I","J Alzheimers Dis","2017","2016/12/03","","","10.3233/JAD-160797"
"27031480","Living Alone with Dementia: Prevalence, Correlates and the Utilization of Health and Nursing Care Services","Eichler T, Hoffmann W, Hertel J, Richter S, Wucherer D, Michalowsky B, Dreier A, Thyrian JR.","J Alzheimers Dis. 2016;52(2):619-29. doi: 10.3233/JAD-151058.","Eichler T","J Alzheimers Dis","2016","2016/04/01","PMC4927920","","10.3233/JAD-151058"
"25765916","Burden of Behavioral and Psychiatric Symptoms in People Screened Positive for Dementia in Primary Care: Results of the DelpHi-Study","Thyrian JR, Eichler T, Hertel J, Wucherer D, Dreier A, Michalowsky B, Killimann I, Teipel S, Hoffmann W.","J Alzheimers Dis. 2015;46(2):451-9. doi: 10.3233/JAD-143114.","Thyrian JR","J Alzheimers Dis","2015","2015/03/14","","","10.3233/JAD-143114"
"23587747","The impact of human-computer interaction-based comprehensive training on the cognitive functions of cognitive impairment elderly individuals in a nursing home","Zhuang JP, Fang R, Feng X, Xu XH, Liu LH, Bai QK, Tang HD, Zhao ZG, Chen SD.","J Alzheimers Dis. 2013;36(2):245-51. doi: 10.3233/JAD-130158.","Zhuang JP","J Alzheimers Dis","2013","2013/04/17","","","10.3233/JAD-130158"
"35213366","Short Term Economic Evaluation of the Digital Platform ""Support, Monitoring and Reminder Technology for Mild Dementia"" (SMART4MD) for People with Mild Cognitive Impairment and their Informal Caregivers","Ghani Z, Saha S, Jarl J, Andersson M, Berglund JS, Anderberg P.","J Alzheimers Dis. 2022;86(4):1629-1641. doi: 10.3233/JAD-215013.","Ghani Z","J Alzheimers Dis","2022","2022/02/25","PMC9108554","","10.3233/JAD-215013"
"33782667","Online Personalised Training in Memory Strategies for Everyday (OPTIMiSE) Program for Older Adults with Cognitive Concerns: Pilot Study Protocol","Pike KE, Moller CI, Bryant C, Farrow M, Dao DP, Ellis KA.","J Alzheimers Dis Rep. 2021 Feb 24;5(1):143-152. doi: 10.3233/ADR-200251.","Pike KE","J Alzheimers Dis Rep","2021","2021/03/30","PMC7990456","","10.3233/ADR-200251"
"33336222","Comparative Effectiveness of Behavioral Interventions to Prevent or Delay Dementia: One-Year Partner Outcomes","Amofa PA, Locke DEC, Chandler M, Crook JE, Ball CT, Phatak V, Smith GE.","J Prev Alzheimers Dis. 2021;8(1):33-40. doi: 10.14283/jpad.2020.59.","Amofa PA","J Prev Alzheimers Dis","2021","2020/12/18","","","10.14283/jpad.2020.59"
"28482639","Chinese Calligraphy Writing for Augmenting Attentional Control and Working Memory of Older Adults at Risk of Mild Cognitive Impairment: A Randomized Controlled Trial","Chan SCC, Chan CCH, Derbie AY, Hui I, Tan DGH, Pang MYC, Lau SCL, Fong KNK.","J Alzheimers Dis. 2017;58(3):735-746. doi: 10.3233/JAD-170024.","Chan SCC","J Alzheimers Dis","2017","2017/05/10","","","10.3233/JAD-170024"
"27903289","Changes in cerebral glucose metabolism after 3 weeks of noninvasive electrical stimulation of mild cognitive impairment patients","Yun K, Song IU, Chung YA.","Alzheimers Res Ther. 2016 Dec 1;8(1):49. doi: 10.1186/s13195-016-0218-6.","Yun K","Alzheimers Res Ther","2016","2016/12/02","PMC5131431","","10.1186/s13195-016-0218-6"
"26401946","Cognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent Carotenoids","Kelly D, Coen RF, Akuffo KO, Beatty S, Dennison J, Moran R, Stack J, Howard AN, Mulcahy R, Nolan JM.","J Alzheimers Dis. 2015;48(1):261-77. doi: 10.3233/JAD-150199.","Kelly D","J Alzheimers Dis","2015","2015/09/25","PMC4923753","","10.3233/JAD-150199"
"25391382","Antidementia drug treatment in people screened positive for dementia in primary care","Wucherer D, Eichler T, Kilimann I, Hertel J, Michalowsky B, Thyrian JR, Teipel S, Hoffmann W.","J Alzheimers Dis. 2015;44(3):1015-21. doi: 10.3233/JAD-142064.","Wucherer D","J Alzheimers Dis","2015","2014/11/14","","","10.3233/JAD-142064"
"19118805","Activity loss is associated with cognitive decline in age-related macular degeneration","Rovner BW, Casten RJ, Leiby BE, Tasman WS.","Alzheimers Dement. 2009 Jan;5(1):12-7. doi: 10.1016/j.jalz.2008.06.001.","Rovner BW","Alzheimers Dement","2009","2009/01/03","PMC3586705","NIHMS445153","10.1016/j.jalz.2008.06.001"
"30126766","An Experience Sampling Method Intervention for Dementia Caregivers: Results of a Randomized Controlled Trial","van Knippenberg RJM, de Vugt ME, Ponds RW, Myin-Germeys I, Verhey FRJ.","Am J Geriatr Psychiatry. 2018 Dec;26(12):1231-1243. doi: 10.1016/j.jagp.2018.06.004. Epub 2018 Jun 21.","van Knippenberg RJM","Am J Geriatr Psychiatry","2018","2018/08/22","","","10.1016/j.jagp.2018.06.004"
"15799079","The effect of integrated emotion-oriented care versus usual care on elderly persons with dementia in the nursing home and on nursing assistants: a randomized clinical trial","Finnema E, Dröes RM, Ettema T, Ooms M, Adèr H, Ribbe M, van Tilburg W.","Int J Geriatr Psychiatry. 2005 Apr;20(4):330-43. doi: 10.1002/gps.1286.","Finnema E","Int J Geriatr Psychiatry","2005","2005/03/31","","","10.1002/gps.1286"
"10427634","Pathological changes in cobalt-supplemented and non-supplemented twin lambs in relation to blood concentrations of methylmalonic acid and homocysteine","Vellema P, van den Ingh TS, Wouda W.","Vet Q. 1999 Jun;21(3):93-8. doi: 10.1080/01652176.1999.9695001.","Vellema P","Vet Q","1999","1999/07/31","","","10.1080/01652176.1999.9695001"
"36592671","Residual or re-emergent impaired insight into delusions following remission is unrelated to later relapse during a randomized clinical trial of continuation pharmacotherapy for psychotic depression - The STOP-PD II Study","Song J, Mulsant BH, Sanches M, Alexopoulos GS, Marino P, Meyers BS, Rothschild AJ, Voineskos AN, Whyte EM, Flint AJ, Gerretsen P; STOP-PD II Study Group.","J Affect Disord. 2023 Mar 15;325:29-34. doi: 10.1016/j.jad.2022.12.078. Epub 2022 Dec 30.","Song J","J Affect Disord","2023","2023/01/02","","","10.1016/j.jad.2022.12.078"
"25733639","Cocoa flavanol consumption improves cognitive function, blood pressure control, and metabolic profile in elderly subjects: the Cocoa, Cognition, and Aging (CoCoA) Study--a randomized controlled trial","Mastroiacovo D, Kwik-Uribe C, Grassi D, Necozione S, Raffaele A, Pistacchio L, Righetti R, Bocale R, Lechiara MC, Marini C, Ferri C, Desideri G.","Am J Clin Nutr. 2015 Mar;101(3):538-48. doi: 10.3945/ajcn.114.092189. Epub 2014 Dec 17.","Mastroiacovo D","Am J Clin Nutr","2015","2015/03/04","PMC4340060","","10.3945/ajcn.114.092189"
"36410799","Time intervals and distances travelled for prehospital ambulance stroke care: data from the randomised-controlled ambulance-based Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2)","Dixon M, Appleton JP, Scutt P, Woodhouse LJ, Haywood LJ, Havard D, Williams J, Siriwardena AN, Bath PM; RIGHT-2 Investigators.","BMJ Open. 2022 Nov 21;12(11):e060211. doi: 10.1136/bmjopen-2021-060211.","Dixon M","BMJ Open","2022","2022/11/21","PMC9680177","","10.1136/bmjopen-2021-060211"
"32385134","Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial","Sharpe C, Reiner GE, Davis SL, Nespeca M, Gold JJ, Rasmussen M, Kuperman R, Harbert MJ, Michelson D, Joe P, Wang S, Rismanchi N, Le NM, Mower A, Kim J, Battin MR, Lane B, Honold J, Knodel E, Arnell K, Bridge R, Lee L, Ernstrom K, Raman R, Haas RH; NEOLEV2 INVESTIGATORS.","Pediatrics. 2020 Jun;145(6):e20193182. doi: 10.1542/peds.2019-3182. Epub 2020 May 8.","Sharpe C","Pediatrics","2020","2020/05/10","PMC7263056","","10.1542/peds.2019-3182"
"25065855","A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL","Price E, Artz AS, Barnhart H, Sapp S, Chelune G, Ershler WB, Walston JD, Gordeuk VR, Berger NA, Reuben D, Prchal J, Rao SV, Roy CN, Supiano MA, Schrier SL, Cohen HJ.","Blood Cells Mol Dis. 2014 Dec;53(4):221-30. doi: 10.1016/j.bcmd.2014.06.003. Epub 2014 Jul 25.","Price E","Blood Cells Mol Dis","2014","2014/07/29","PMC4198614","NIHMS616481","10.1016/j.bcmd.2014.06.003"
"31070702","Comparative Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Response to a Physical Activity Intervention in Older Adults: Results From the Lifestyle Interventions and Independence for Elders Study","Brown JD, Smith SM, Strotmeyer ES, Kritchevsky SB, Gill TM, Blair SN, Fielding RA, Buford TW, Pahor M, Manini TM.","J Gerontol A Biol Sci Med Sci. 2020 Apr 17;75(5):1010-1016. doi: 10.1093/gerona/glz120.","Brown JD","J Gerontol A Biol Sci Med Sci","2020","2019/05/10","PMC7164526","","10.1093/gerona/glz120"
"30221595","Effect of Aspirin on All-Cause Mortality in the Healthy Elderly","McNeil JJ, Nelson MR, Woods RL, Lockery JE, Wolfe R, Reid CM, Kirpach B, Shah RC, Ives DG, Storey E, Ryan J, Tonkin AM, Newman AB, Williamson JD, Margolis KL, Ernst ME, Abhayaratna WP, Stocks N, Fitzgerald SM, Orchard SG, Trevaks RE, Beilin LJ, Donnan GA, Gibbs P, Johnston CI, Radziszewska B, Grimm R, Murray AM; ASPREE Investigator Group.","N Engl J Med. 2018 Oct 18;379(16):1519-1528. doi: 10.1056/NEJMoa1803955. Epub 2018 Sep 16.","McNeil JJ","N Engl J Med","2018","2018/09/18","PMC6433466","NIHMS1512091","10.1056/NEJMoa1803955"
"35420334","Prediction of disability-free survival in healthy older people","Neumann JT, Thao LTP, Murray AM, Callander E, Carr PR, Nelson MR, Wolfe R, Woods RL, Reid CM, Shah RC, Newman AB, Williamson JD, Tonkin AM, McNeil JJ; ASPREE investigators.","Geroscience. 2022 Jun;44(3):1641-1655. doi: 10.1007/s11357-022-00547-x. Epub 2022 Apr 14.","Neumann JT","Geroscience","2022","2022/04/14","PMC9213595","","10.1007/s11357-022-00547-x"
"19657199","Safety and effectiveness of a traditional ginkgo fresh plant extract - results from a clinical trial","Bäurle P, Suter A, Wormstall H.","Forsch Komplementmed. 2009 Jun;16(3):156-61. doi: 10.1159/000213167. Epub 2009 May 14.","Bäurle P","Forsch Komplementmed","2009","2009/08/07","","","10.1159/000213167"
"17565435","Actigraphy in agitated patients with dementia. Monitoring treatment outcomes","Mahlberg R, Walther S.","Z Gerontol Geriatr. 2007 Jun;40(3):178-84. doi: 10.1007/s00391-007-0420-z.","Mahlberg R","Z Gerontol Geriatr","2007","2007/06/15","","","10.1007/s00391-007-0420-z"
"15117063","[The effect of ginkgo biloba on healthy elderly subjects]","Cieza A, Maier P, Pöppel E.","Fortschr Med Orig. 2003;121(1):5-10.","Cieza A","Fortschr Med Orig","2003","2004/05/01","","",""
"33098800","Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial","Rapp SR, Gaussoin SA, Sachs BC, Chelune G, Supiano MA, Lerner AJ, Wadley VG, Wilson VM, Fine LJ, Whittle JC, Auchus AP, Beddhu S, Berlowitz DR, Bress AP, Johnson KC, Krousel-Wood M, Martindale-Adams J, Miller EC, Rifkin DE, Snyder JK, Tamariz L, Wolfgram DF, Cleveland ML, Yang M, Nichols LO, Bryan RN, Reboussin DM, Williamson JD, Pajewski NM; SPRINT Research Group.","Lancet Neurol. 2020 Nov;19(11):899-907. doi: 10.1016/S1474-4422(20)30319-7.","Rapp SR","Lancet Neurol","2020","2020/10/25","PMC7714000","NIHMS1642572","10.1016/S1474-4422(20)30319-7"
"12555375","[Antihypertensive treatment and prevention of dementia]","Seux ML.","Ann Cardiol Angeiol (Paris). 1999 Sep;48(7):512-7.","Seux ML","Ann Cardiol Angeiol (Paris)","1999","2003/01/31","","",""
"27169811","Dealing with daily challenges in dementia (deal-id study): effectiveness of the experience sampling method intervention 'Partner in Sight' for spousal caregivers of people with dementia: design of a randomized controlled trial","van Knippenberg RJ, de Vugt ME, Ponds RW, Myin-Germeys I, Verhey FR.","BMC Psychiatry. 2016 May 11;16:136. doi: 10.1186/s12888-016-0834-5.","van Knippenberg RJ","BMC Psychiatry","2016","2016/05/13","PMC4865019","","10.1186/s12888-016-0834-5"
"31519517","A Randomized Double-Blind Placebo-Controlled Trial of Combined Escitalopram and Memantine for Older Adults With Major Depression and Subjective Memory Complaints","Lavretsky H, Laird KT, Krause-Sorio B, Heimberg BF, Yeargin J, Grzenda A, Wu P, Thana-Udom K, Ercoli LM, Siddarth P.","Am J Geriatr Psychiatry. 2020 Feb;28(2):178-190. doi: 10.1016/j.jagp.2019.08.011. Epub 2019 Aug 22.","Lavretsky H","Am J Geriatr Psychiatry","2020","2019/09/15","PMC6997044","NIHMS1538111","10.1016/j.jagp.2019.08.011"
"34420958","Preventing Delirium and Promoting Long-Term Brain Health: A Clinical Trial Design for the Perioperative Cognitive Enhancement (PROTECT) Trial","Atkins KJ, Scott DA, Silbert B, Pike KE, Evered L.","J Alzheimers Dis. 2021;83(4):1637-1649. doi: 10.3233/JAD-210438.","Atkins KJ","J Alzheimers Dis","2021","2021/08/23","","","10.3233/JAD-210438"
"32236398","Effects of Rice Wine Lees on Cognitive Function in Community-Dwelling Physically Active Older Adults: A Pilot Randomized Controlled Trial","Nagai N, Shindo N, Wada A, Izu H, Fujii T, Matsubara K, Wada Y, Sakane N.","J Prev Alzheimers Dis. 2020;7(2):95-103. doi: 10.14283/jpad.2019.45.","Nagai N","J Prev Alzheimers Dis","2020","2020/04/03","","","10.14283/jpad.2019.45"
"29480185","Designing an Internet-Based Multidomain Intervention for the Prevention of Cardiovascular Disease and Cognitive Impairment in Older Adults: The HATICE Trial","Barbera M, Mangialasche F, Jongstra S, Guillemont J, Ngandu T, Beishuizen C, Coley N, Brayne C, Andrieu S, Richard E, Soininen H, Kivipelto M; HATICE study group.","J Alzheimers Dis. 2018;62(2):649-663. doi: 10.3233/JAD-170858.","Barbera M","J Alzheimers Dis","2018","2018/02/27","","","10.3233/JAD-170858"
"29188859","Cognitive Performance Does not Limit Physical Activity Participation in the Lifestyle Interventions and Independence for Elders Pilot Study (LIFE-P)","Reid KF, Walkup MP, Katula JA, Sink KM, Anton S, Axtell R, Kerwin DR, King AC, Kramer F, Miller ME, Myers V, Rosano C, Studenski SA, Lopez OL, Verghese J, Fielding RA, Williamson J.","J Prev Alzheimers Dis. 2017;4(1):44-50. doi: 10.14283/jpad.2016.107.","Reid KF","J Prev Alzheimers Dis","2017","2017/12/01","PMC5778912","NIHMS882307","10.14283/jpad.2016.107"
"28922158","Tailored and Adaptive Computerized Cognitive Training in Older Adults at Risk for Dementia: A Randomized Controlled Trial","Bahar-Fuchs A, Webb S, Bartsch L, Clare L, Rebok G, Cherbuin N, Anstey KJ.","J Alzheimers Dis. 2017;60(3):889-911. doi: 10.3233/JAD-170404.","Bahar-Fuchs A","J Alzheimers Dis","2017","2017/09/19","","","10.3233/JAD-170404"
"28157096","Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study","Molad J, Kliper E, Korczyn AD, Ben Assayag E, Ben Bashat D, Shenhar-Tsarfaty S, Aizenstein O, Shopin L, Bornstein NM, Auriel E.","J Alzheimers Dis. 2017;56(4):1293-1299. doi: 10.3233/JAD-160939.","Molad J","J Alzheimers Dis","2017","2017/02/04","","","10.3233/JAD-160939"
"26402009","Depression and Suicidal Ideation During Two Psychosocial Treatments in Older Adults with Major Depression and Dementia","Kiosses DN, Rosenberg PB, McGovern A, Fonzetti P, Zaydens H, Alexopoulos GS.","J Alzheimers Dis. 2015;48(2):453-62. doi: 10.3233/JAD-150200.","Kiosses DN","J Alzheimers Dis","2015","2015/09/25","PMC5822689","NIHMS882215","10.3233/JAD-150200"
"22954669","Recognition of facial emotional expression in amnestic mild cognitive impairment","Varjassyová A, Hořínek D, Andel R, Amlerova J, Laczó J, Sheardová K, Magerová H, Holmerová I, Vyhnálek M, Bradáč O, Geda YE, Hort J.","J Alzheimers Dis. 2013;33(1):273-80. doi: 10.3233/JAD-2012-120148.","Varjassyová A","J Alzheimers Dis","2013","2012/09/08","PMC3918473","NIHMS547725","10.3233/JAD-2012-120148"
"21157021","Memantine in behavioral variant frontotemporal dementia: negative results","Vercelletto M, Boutoleau-Bretonnière C, Volteau C, Puel M, Auriacombe S, Sarazin M, Michel BF, Couratier P, Thomas-Antérion C, Verpillat P, Gabelle A, Golfier V, Cerato E, Lacomblez L; French research network on Frontotemporal dementia.","J Alzheimers Dis. 2011;23(4):749-59. doi: 10.3233/JAD-2010-101632.","Vercelletto M","J Alzheimers Dis","2011","2010/12/16","","","10.3233/JAD-2010-101632"
"34806608","Caregiver Tele-Assistance for Reduction of Emotional Distress During the COVID-19 Pandemic. Psychological Support to Caregivers of People with Dementia: The Italian Experience","Rotondo E, Galimberti D, Mercurio M, Giardinieri G, Forti S, Vimercati R, Borracci V, Fumagalli GG, Pietroboni AM, Carandini T, Nobili A, Scarpini E, Arighi A.","J Alzheimers Dis. 2022;85(3):1045-1052. doi: 10.3233/JAD-215185.","Rotondo E","J Alzheimers Dis","2022","2021/11/22","","","10.3233/JAD-215185"
"34668644","The effect of adherence on cognition in a multidomain lifestyle intervention (FINGER)","Ngandu T, Lehtisalo J, Korkki S, Solomon A, Coley N, Antikainen R, Bäckman L, Hänninen T, Lindström J, Laatikainen T, Paajanen T, Havulinna S, Peltonen M, Neely AS, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M.","Alzheimers Dement. 2022 Jul;18(7):1325-1334. doi: 10.1002/alz.12492. Epub 2021 Oct 20.","Ngandu T","Alzheimers Dement","2022","2021/10/20","","","10.1002/alz.12492"
"34420956","Effects of Photobiomodulation on Changes in Cognitive Function and Regional Cerebral Blood Flow in Patients with Mild Cognitive Impairment: A Pilot Uncontrolled Trial","Baik JS, Lee TY, Kim NG, Pak K, Ko SH, Min JH, Shin YI.","J Alzheimers Dis. 2021;83(4):1513-1519. doi: 10.3233/JAD-210386.","Baik JS","J Alzheimers Dis","2021","2021/08/23","","","10.3233/JAD-210386"
"22451320","Changes in brain volume and cognition in a randomized trial of exercise and social interaction in a community-based sample of non-demented Chinese elders","Mortimer JA, Ding D, Borenstein AR, DeCarli C, Guo Q, Wu Y, Zhao Q, Chu S.","J Alzheimers Dis. 2012;30(4):757-66. doi: 10.3233/JAD-2012-120079.","Mortimer JA","J Alzheimers Dis","2012","2012/03/28","PMC3788823","NIHMS509822","10.3233/JAD-2012-120079"
"21971474","Cognitive training changes hippocampal function in mild cognitive impairment: a pilot study","Rosen AC, Sugiura L, Kramer JH, Whitfield-Gabrieli S, Gabrieli JD.","J Alzheimers Dis. 2011;26 Suppl 3(Suppl 3):349-57. doi: 10.3233/JAD-2011-0009.","Rosen AC","J Alzheimers Dis","2011","2011/10/06","PMC3277842","NIHMS352344","10.3233/JAD-2011-0009"
"35275531","Physical Activity Self-Report Is Not Reliable Among Subjects with Mild Vascular Cognitive Impairment: The AFIVASC Study","Verdelho A, Correia M, Ferro JM, Madureira S, Vilela P, Rodrigues M, Borges M, Oliveira V, Santos AC, Gonçalves-Pereira M, Santa-Clara H.","J Alzheimers Dis. 2022;87(1):405-414. doi: 10.3233/JAD-215381.","Verdelho A","J Alzheimers Dis","2022","2022/03/11","","","10.3233/JAD-215381"
"34334394","Adjunctive Therapy to Manage Neuropsychiatric Symptoms in Moderate and Severe Dementia: Randomized Clinical Trial Using an Outpatient Version of Tailored Activity Program","Oliveira AM, Radanovic M, Mello PCH, Buchain PC, Vizzotto ADB, Harder J, Stella F, Gitlin LN, Piersol CV, Valiengo LLC, Forlenza OV.","J Alzheimers Dis. 2021;83(1):475-486. doi: 10.3233/JAD-210142.","Oliveira AM","J Alzheimers Dis","2021","2021/08/02","","","10.3233/JAD-210142"
"32623402","Probiotic Bifidobacterium breve in Improving Cognitive Functions of Older Adults with Suspected Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial","Xiao J, Katsumata N, Bernier F, Ohno K, Yamauchi Y, Odamaki T, Yoshikawa K, Ito K, Kaneko T.","J Alzheimers Dis. 2020;77(1):139-147. doi: 10.3233/JAD-200488.","Xiao J","J Alzheimers Dis","2020","2020/07/06","PMC7592675","","10.3233/JAD-200488"
"31533443","Feasibility of Conducting Nonpharmacological Interventions to Manage Dementia Symptoms in Community-Dwelling Older Adults: A Cluster Randomized Controlled Trial","Park J, Tolea MI, Sherman D, Rosenfeld A, Arcay V, Lopes Y, Galvin JE.","Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317519872635. doi: 10.1177/1533317519872635. Epub 2019 Sep 18.","Park J","Am J Alzheimers Dis Other Demen","2020","2019/09/20","","","10.1177/1533317519872635"
"29843244","Multisensory Stimulation and Individualized Music Sessions on Older Adults with Severe Dementia: Effects on Mood, Behavior, and Biomedical Parameters","Maseda A, Cibeira N, Lorenzo-López L, González-Abraldes I, Buján A, de Labra C, Millán-Calenti JC.","J Alzheimers Dis. 2018;63(4):1415-1425. doi: 10.3233/JAD-180109.","Maseda A","J Alzheimers Dis","2018","2018/05/31","","","10.3233/JAD-180109"
"28759967","People with Dementia Can Learn Compensatory Movement Maneuvers for the Sit-to-Stand Task: A Randomized Controlled Trial","Werner C, Wiloth S, Lemke NC, Kronbach F, Jansen CP, Oster P, Bauer JM, Hauer K.","J Alzheimers Dis. 2017;60(1):107-120. doi: 10.3233/JAD-170258.","Werner C","J Alzheimers Dis","2017","2017/08/02","","","10.3233/JAD-170258"
"24787916","Cognitive training enhances pre-attentive neurophysiological responses in older adults 'at risk' of dementia","Mowszowski L, Hermens DF, Diamond K, Norrie L, Cockayne N, Ward PB, Hickie IB, Lewis SJ, Batchelor J, Naismith SL.","J Alzheimers Dis. 2014;41(4):1095-108. doi: 10.3233/JAD-131985.","Mowszowski L","J Alzheimers Dis","2014","2014/05/03","","","10.3233/JAD-131985"
"24296814","Treatment of primary progressive aphasias by transcranial direct current stimulation combined with language training","Cotelli M, Manenti R, Petesi M, Brambilla M, Cosseddu M, Zanetti O, Miniussi C, Padovani A, Borroni B.","J Alzheimers Dis. 2014;39(4):799-808. doi: 10.3233/JAD-131427.","Cotelli M","J Alzheimers Dis","2014","2013/12/04","","","10.3233/JAD-131427"
"36631905","The effects of a moderate physical activity intervention on physical fitness and cognition in healthy elderly with low levels of physical activity: a randomized controlled trial","Galle SA, Deijen JB, Milders MV, De Greef MHG, Scherder EJA, van Duijn CM, Drent ML.","Alzheimers Res Ther. 2023 Jan 11;15(1):12. doi: 10.1186/s13195-022-01123-3.","Galle SA","Alzheimers Res Ther","2023","2023/01/11","PMC9832427","","10.1186/s13195-022-01123-3"
"35431237","Biomarkers of Prevalent and Incident Cognitive Dysfunction in People with Dysglycemia: Data from the ORIGIN Trial","Cukierman-Yaffe T, Lee SF, Pare G, McQueen M, Hess S, Gerstein HC.","J Alzheimers Dis. 2022;87(3):1143-1150. doi: 10.3233/JAD-215195.","Cukierman-Yaffe T","J Alzheimers Dis","2022","2022/04/18","","","10.3233/JAD-215195"
"33337365","Efficacy and Safety of Zonisamide in Dementia with Lewy Bodies Patients with Parkinsonism: A Post Hoc Analysis of Two Randomized, Double-Blind, Placebo-Controlled Trials","Hasegawa K, Kochi K, Maruyama H, Konishi O, Toya S, Odawara T.","J Alzheimers Dis. 2021;79(2):627-637. doi: 10.3233/JAD-200893.","Hasegawa K","J Alzheimers Dis","2021","2020/12/18","PMC7902955","","10.3233/JAD-200893"
"31743998","Effects of a Modified Tai Chi Program on Older People with Mild Dementia: A Randomized Controlled Trial","Huang N, Li W, Rong X, Champ M, Wei L, Li M, Mu H, Hu Y, Ma Z, Lyu J.","J Alzheimers Dis. 2019;72(3):947-956. doi: 10.3233/JAD-190487.","Huang N","J Alzheimers Dis","2019","2019/11/21","","","10.3233/JAD-190487"
"31609689","Behavioral Activation for Promoting Well-Being in Mild Dementia: Feasibility and Outcomes of a Pilot Randomized Controlled Trial","Orgeta V, Tuijt R, Leung P, Verdaguer ES, Gould RL, Jones R, Livingston G.","J Alzheimers Dis. 2019;72(2):563-574. doi: 10.3233/JAD-190696.","Orgeta V","J Alzheimers Dis","2019","2019/10/15","","","10.3233/JAD-190696"
"31498125","Differential Effects of Physical Exercise, Cognitive Training, and Mindfulness Practice on Serum BDNF Levels in Healthy Older Adults: A Randomized Controlled Intervention Study","Ledreux A, Håkansson K, Carlsson R, Kidane M, Columbo L, Terjestam Y, Ryan E, Tusch E, Winblad B, Daffner K, Granholm AC, Mohammed AKH.","J Alzheimers Dis. 2019;71(4):1245-1261. doi: 10.3233/JAD-190756.","Ledreux A","J Alzheimers Dis","2019","2019/09/10","","","10.3233/JAD-190756"
"29972213","Auraptene in the Peels of Citrus Kawachiensis (Kawachibankan) Contributes to the Preservation of Cognitive Function: A Randomized, Placebo-Controlled, Double-Blind Study in Healthy Volunteers","Igase M, Okada Y, Ochi M, Igase K, Ochi H, Okuyama S, Furukawa Y, Ohyagi Y.","J Prev Alzheimers Dis. 2018;5(3):197-201. doi: 10.14283/jpad.2017.47.","Igase M","J Prev Alzheimers Dis","2018","2018/07/05","","","10.14283/jpad.2017.47"
"26890767","Unmet Needs of Community-Dwelling Primary Care Patients with Dementia in Germany: Prevalence and Correlates","Eichler T, Thyrian JR, Hertel J, Richter S, Wucherer D, Michalowsky B, Teipel S, Kilimann I, Dreier A, Hoffmann W.","J Alzheimers Dis. 2016;51(3):847-55. doi: 10.3233/JAD-150935.","Eichler T","J Alzheimers Dis","2016","2016/02/19","","","10.3233/JAD-150935"
"24217275","An intensive exercise program improves motor performances in patients with dementia: translational model of geriatric rehabilitation","Schwenk M, Dutzi I, Englert S, Micol W, Najafi B, Mohler J, Hauer K.","J Alzheimers Dis. 2014;39(3):487-98. doi: 10.3233/JAD-130470.","Schwenk M","J Alzheimers Dis","2014","2013/11/13","","","10.3233/JAD-130470"
"9647683","Stimulus characteristics determine processing approach on random array letter-cancellation tasks","Geldmacher DS.","Brain Cogn. 1998 Apr;36(3):346-54. doi: 10.1006/brcg.1997.0978.","Geldmacher DS","Brain Cogn","1998","1998/07/02","","","10.1006/brcg.1997.0978"
"29432518","The effect of biannual medication reviews on the appropriateness of psychotropic drug use for neuropsychiatric symptoms in patients with dementia: a randomised controlled trial","van der Spek K, Koopmans RTCM, Smalbrugge M, Nelissen-Vrancken MHJMG, Wetzels RB, Smeets CHW, de Vries E, Teerenstra S, Zuidema SU, Gerritsen DL.","Age Ageing. 2018 May 1;47(3):430-437. doi: 10.1093/ageing/afy001.","van der Spek K","Age Ageing","2018","2018/02/13","","","10.1093/ageing/afy001"
"23305463","Effectiveness and cost-effectiveness of an internet intervention for family caregivers of people with dementia: design of a randomized controlled trial","Blom MM, Bosmans JE, Cuijpers P, Zarit SH, Pot AM.","BMC Psychiatry. 2013 Jan 10;13:17. doi: 10.1186/1471-244X-13-17.","Blom MM","BMC Psychiatry","2013","2013/01/12","PMC3557221","","10.1186/1471-244X-13-17"
"15507054","Effect of person-centered showering and the towel bath on bathing-associated aggression, agitation, and discomfort in nursing home residents with dementia: a randomized, controlled trial","Sloane PD, Hoeffer B, Mitchell CM, McKenzie DA, Barrick AL, Rader J, Stewart BJ, Talerico KA, Rasin JH, Zink RC, Koch GG.","J Am Geriatr Soc. 2004 Nov;52(11):1795-804. doi: 10.1111/j.1532-5415.2004.52501.x.","Sloane PD","J Am Geriatr Soc","2004","2004/10/28","","","10.1111/j.1532-5415.2004.52501.x"
"35718871","Omega-3 Supplementation for the Prevention of Cognitive Decline in Older Adults: Does It Depend on Homocysteine Levels?","Maltais M, de Souto Barreto P, Bowman GL, Smith AD, Cantet C, Andrieu S, Rolland Y.","J Nutr Health Aging. 2022;26(6):615-620. doi: 10.1007/s12603-022-1809-5.","Maltais M","J Nutr Health Aging","2022","2022/06/19","","","10.1007/s12603-022-1809-5"
"34788804","Eight-Year Changes in Multimorbidity and Frailty in Adults With Type 2 Diabetes Mellitus: Associations With Cognitive and Physical Function and Mortality","Espeland MA, Justice JN, Bahnson J, Evans JK, Munshi M, Hayden KM, Simpson FR, Johnson KC, Johnston C, Kritchevsky SR.","J Gerontol A Biol Sci Med Sci. 2022 Aug 12;77(8):1691-1698. doi: 10.1093/gerona/glab342.","Espeland MA","J Gerontol A Biol Sci Med Sci","2022","2021/11/17","PMC9373968","","10.1093/gerona/glab342"
"33006763","Promoting Active Aging: Lessons Learned in an Implementation Pilot in Primary Care","Callahan KE, Willard J, Foley KL, Miller ME, Houston DK, Kritchevsky SB, Williamson JD, Applegate WB, Girma F, Whitehead SE, Rejeski WJ.","J Am Geriatr Soc. 2021 Feb;69(2):373-380. doi: 10.1111/jgs.16838. Epub 2020 Oct 2.","Callahan KE","J Am Geriatr Soc","2021","2020/10/02","PMC7902351","NIHMS1641207","10.1111/jgs.16838"
"27538352","Impact of Prior Treatment on Remission of Late-Life Depression with Venlafaxine and Subsequent Aripiprazole or Placebo Augmentation","Hsu JH, Mulsant BH, Lenze EJ, Karp JF, Lavretsky H, Roose SP, Reynolds CF 3rd, Blumberger DM.","Am J Geriatr Psychiatry. 2016 Oct;24(10):918-22. doi: 10.1016/j.jagp.2016.04.015. Epub 2016 May 6.","Hsu JH","Am J Geriatr Psychiatry","2016","2016/08/20","PMC5026879","NIHMS782719","10.1016/j.jagp.2016.04.015"
"27430267","A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocol","Greenan C, Murphy L, Yu LM, Kehoe PG, Coulthard E, Bath P, Stewart R, Jones R, Corbett A, Thomas A, Connelly P, Arrojo F, Canning R, Wallach S, Henderson C, McGuinness B, O'Sullivan M, Holmes C, Knapp M, Ballard C, Passmore P; AFFECT Investigators.","Trials. 2016 Jul 18;17(1):324. doi: 10.1186/s13063-016-1449-3.","Greenan C","Trials","2016","2016/07/20","PMC4950108","","10.1186/s13063-016-1449-3"
"30286230","Identification of Baseline Characteristics Associated With Development of Depression Among Patients With Head and Neck Cancer: A Secondary Analysis of a Randomized Clinical Trial","Panwar A, Rieke K, Burke WJ, Sayles H, Lydiatt WM; Prevention of Depression in Patients Being Treated for Head and Neck Cancer Trial (PROTECT) study group.","JAMA Otolaryngol Head Neck Surg. 2018 Nov 1;144(11):1004-1010. doi: 10.1001/jamaoto.2018.2228.","Panwar A","JAMA Otolaryngol Head Neck Surg","2018","2018/10/05","PMC6248189","","10.1001/jamaoto.2018.2228"
"33874747","Autonomic Imbalance and Risk of Dementia and Stroke: The Framingham Study","Weinstein G, Davis-Plourde K, Beiser AS, Seshadri S.","Stroke. 2021 Jun;52(6):2068-2076. doi: 10.1161/STROKEAHA.120.030601. Epub 2021 Apr 20.","Weinstein G","Stroke","2021","2021/04/20","PMC8154675","NIHMS1686094","10.1161/STROKEAHA.120.030601"
"30221596","Effect of Aspirin on Disability-free Survival in the Healthy Elderly","McNeil JJ, Woods RL, Nelson MR, Reid CM, Kirpach B, Wolfe R, Storey E, Shah RC, Lockery JE, Tonkin AM, Newman AB, Williamson JD, Margolis KL, Ernst ME, Abhayaratna WP, Stocks N, Fitzgerald SM, Orchard SG, Trevaks RE, Beilin LJ, Donnan GA, Gibbs P, Johnston CI, Ryan J, Radziszewska B, Grimm R, Murray AM; ASPREE Investigator Group.","N Engl J Med. 2018 Oct 18;379(16):1499-1508. doi: 10.1056/NEJMoa1800722. Epub 2018 Sep 16.","McNeil JJ","N Engl J Med","2018","2018/09/18","PMC6426126","NIHMS1512092","10.1056/NEJMoa1800722"
"36155502","Weight for It: Resistance Training Mitigates White Matter Hyperintensity-Related Disruption to Functional Networks in Older Females","Crockett RA, Hsu CL, Dao E, Tam R, Eng JJ, Handy TC, Liu-Ambrose T.","J Alzheimers Dis. 2022;90(2):553-563. doi: 10.3233/JAD-220142.","Crockett RA","J Alzheimers Dis","2022","2022/09/26","","","10.3233/JAD-220142"
"34092640","Exploring the Effect of Combined Transcranial and Intra-Oral Photobiomodulation Therapy Over a Four-Week Period on Physical and Cognitive Outcome Measures for People with Parkinson's Disease: A Randomized Double-Blind Placebo-Controlled Pilot Study","Bullock-Saxton J, Lehn A, Laakso EL.","J Alzheimers Dis. 2021;83(4):1499-1512. doi: 10.3233/JAD-210170.","Bullock-Saxton J","J Alzheimers Dis","2021","2021/06/07","","","10.3233/JAD-210170"
"33104028","Randomized Controlled Trial of Multi-Component Cognitive Stimulation Therapy (SADEM) in Community-Dwelling Demented Adults","Juárez-Cedillo T, Gutiérrez-Gutiérrez L, Sánchez-Hurtado LA, Martínez-Rodríguez N, Juarez-Cedillo E.","J Alzheimers Dis. 2020;78(3):1033-1045. doi: 10.3233/JAD-200574.","Juárez-Cedillo T","J Alzheimers Dis","2020","2020/10/26","","","10.3233/JAD-200574"
"31476159","Association Between Insulin Resistance, Plasma Leptin, and Neurocognition in Vascular Cognitive Impairment","Smith PJ, Mabe S, Sherwood A, Babyak MA, Doraiswamy PM, Welsh-Bohmer KA, Kraus W, Burke J, Hinderliter A, Blumenthal JA.","J Alzheimers Dis. 2019;71(3):921-929. doi: 10.3233/JAD-190569.","Smith PJ","J Alzheimers Dis","2019","2019/09/03","","","10.3233/JAD-190569"
"31256137","Feasibility of Three Novel Forms of Passive Exercise in a Multisensory Environment in Vulnerable Institutionalized Older Adults with Dementia","Heesterbeek M, van der Zee EA, van Heuvelen MJG.","J Alzheimers Dis. 2019;70(3):681-690. doi: 10.3233/JAD-190309.","Heesterbeek M","J Alzheimers Dis","2019","2019/07/01","PMC6700638","","10.3233/JAD-190309"
"30584136","Identifying Unmet Needs of Family Dementia Caregivers: Results of the Baseline Assessment of a Cluster-Randomized Controlled Intervention Trial","Zwingmann I, Michalowsky B, Esser A, Kaczynski A, Monsees J, Keller A, Hertel J, Wucherer D, Thyrian JR, Eichler T, Kilimann I, Teipel S, Dreier Wolfgramm A, Hoffmann W.","J Alzheimers Dis. 2019;67(2):527-539. doi: 10.3233/JAD-180244.","Zwingmann I","J Alzheimers Dis","2019","2018/12/26","PMC6398541","","10.3233/JAD-180244"
"29186280","FACEHBI: A Prospective Study of Risk Factors, Biomarkers and Cognition in a Cohort of Individuals with Subjective Cognitive Decline. Study Rationale and Research Protocols","Rodriguez-Gomez O, Sanabria A, Perez-Cordon A, Sanchez-Ruiz D, Abdelnour C, Valero S, Hernandez I, Rosende-Roca M, Mauleon A, Vargas L, Alegret M, Espinosa A, Ortega G, Guitart M, Gailhajanet A, Sotolongo-Grau O, Moreno-Grau S, Ruiz S, Tarragona M, Serra J, Martin E, Peleja E, Lomeña F, Campos F, Vivas A, Gomez-Chiari M, Tejero MA, Giménez J, Pesini P, Sarasa M, Martinez G, Ruiz A, Tarraga L, Boada M.","J Prev Alzheimers Dis. 2017;4(2):100-108. doi: 10.14283/jpad.2016.122.","Rodriguez-Gomez O","J Prev Alzheimers Dis","2017","2017/11/30","","","10.14283/jpad.2016.122"
"33569560","A Web-Based Multidomain Lifestyle Intervention for Older Adults: The eMIND Randomized Controlled Trial","de Souto Barreto P, Pothier K, Soriano G, Lussier M, Bherer L, Guyonnet S, Piau A, Ousset PJ, Vellas B.","J Prev Alzheimers Dis. 2021;8(2):142-150. doi: 10.14283/jpad.2020.70.","de Souto Barreto P","J Prev Alzheimers Dis","2021","2021/02/11","PMC7754697","","10.14283/jpad.2020.70"
"32474473","Supplementation with Matured Hop Bitter Acids Improves Cognitive Performance and Mood State in Healthy Older Adults with Subjective Cognitive Decline","Fukuda T, Ohnuma T, Obara K, Kondo S, Arai H, Ano Y.","J Alzheimers Dis. 2020;76(1):387-398. doi: 10.3233/JAD-200229.","Fukuda T","J Alzheimers Dis","2020","2020/06/01","PMC7369117","","10.3233/JAD-200229"
"31424410","A Pilot Double-Blind Randomized Controlled Trial of Cognitive Training Combined with Transcranial Direct Current Stimulation for Amnestic Mild Cognitive Impairment","Martin DM, Mohan A, Alonzo A, Gates N, Gbadeyan O, Meinzer M, Sachdev P, Brodaty H, Loo C.","J Alzheimers Dis. 2019 Aug 12;71(2):503-512. doi: 10.3233/JAD-190306.","Martin DM","J Alzheimers Dis","2019","2019/08/20","","","10.3233/JAD-190306"
"31256116","The Effectiveness of a Web-Based Health Education Tool, WESIHAT 2.0, among Older Adults: A Randomized Controlled Trial","Vanoh D, Shahar S, Razali R, Ali NM, Manaf ZA, Mohd Noah SA, Nur AM.","J Alzheimers Dis. 2019;70(s1):S255-S270. doi: 10.3233/JAD-180464.","Vanoh D","J Alzheimers Dis","2019","2019/07/01","PMC6700644","","10.3233/JAD-180464"
"35098980","Effects of Mindfulness-Based Tai Chi Chuan on Physical Performance and Cognitive Function among Cognitive Frailty Older Adults: A Six-Month Follow-Up of a Randomized Controlled Trial","Jiayuan Z, Xiang-Zi J, Li-Na M, Jin-Wei Y, Xue Y.","J Prev Alzheimers Dis. 2022;9(1):104-112. doi: 10.14283/jpad.2021.40.","Jiayuan Z","J Prev Alzheimers Dis","2022","2022/01/31","","","10.14283/jpad.2021.40"
"34585222","The Japan-Multimodal Intervention Trial for Prevention of Dementia (J-MINT): The Study Protocol for an 18-Month, Multicenter, Randomized, Controlled Trial","Sugimoto T, Sakurai T, Akatsu H, Doi T, Fujiwara Y, Hirakawa A, Kinoshita F, Kuzuya M, Lee S, Matsuo K, Michikawa M, Ogawa S, Otsuka R, Sato K, Shimada H, Suzuki H, Suzuki H, Takechi H, Takeda S, Umegaki H, Wakayama S, Arai H.","J Prev Alzheimers Dis. 2021;8(4):465-476. doi: 10.14283/jpad.2021.29.","Sugimoto T","J Prev Alzheimers Dis","2021","2021/09/29","PMC8187136","","10.14283/jpad.2021.29"
"34487043","Personalized Repetitive Transcranial Magnetic Stimulation for Primary Progressive Aphasia","Pytel V, Cabrera-Martín MN, Delgado-Álvarez A, Ayala JL, Balugo P, Delgado-Alonso C, Yus M, Carreras MT, Carreras JL, Matías-Guiu J, Matías-Guiu JA.","J Alzheimers Dis. 2021;84(1):151-167. doi: 10.3233/JAD-210566.","Pytel V","J Alzheimers Dis","2021","2021/09/06","","","10.3233/JAD-210566"
"33935074","Effects of Acupuncture on Vascular Cognitive Impairment with No Dementia: A Randomized Controlled Trial","Huang L, Yin X, Li W, Cao Y, Chen Y, Lao L, Zhang Z, Mi Y, Xu S.","J Alzheimers Dis. 2021;81(4):1391-1401. doi: 10.3233/JAD-201353.","Huang L","J Alzheimers Dis","2021","2021/05/03","PMC8293636","","10.3233/JAD-201353"
"29332050","Supplemental Retinal Carotenoids Enhance Memory in Healthy Individuals with Low Levels of Macular Pigment in A Randomized, Double-Blind, Placebo-Controlled Clinical Trial","Power R, Coen RF, Beatty S, Mulcahy R, Moran R, Stack J, Howard AN, Nolan JM.","J Alzheimers Dis. 2018;61(3):947-961. doi: 10.3233/JAD-170713.","Power R","J Alzheimers Dis","2018","2018/01/15","","","10.3233/JAD-170713"
"31524161","ReadClear: An Assistive Reading Tool for People Living with Posterior Cortical Atrophy","Suarez-Gonzalez A, Ocal D, Pavisic I, Peacock A, Naessens M, Ahmed S, Butler CR, Leff AP, Yong KXX, Crutch SJ.","J Alzheimers Dis. 2019;71(4):1285-1295. doi: 10.3233/JAD-190335.","Suarez-Gonzalez A","J Alzheimers Dis","2019","2019/09/17","","","10.3233/JAD-190335"
"23422357","Caffeine and cognitive decline in elderly women at high vascular risk","Vercambre MN, Berr C, Ritchie K, Kang JH.","J Alzheimers Dis. 2013;35(2):413-21. doi: 10.3233/JAD-122371.","Vercambre MN","J Alzheimers Dis","2013","2013/02/21","PMC3807252","NIHMS500162","10.3233/JAD-122371"
"21297276","Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin","Hsu CC, Wahlqvist ML, Lee MS, Tsai HN.","J Alzheimers Dis. 2011;24(3):485-93. doi: 10.3233/JAD-2011-101524.","Hsu CC","J Alzheimers Dis","2011","2011/02/08","","","10.3233/JAD-2011-101524"
"31759901","Educating Dutch General Practitioners in Dementia Advance Care Planning: A Cluster Randomized Controlled Trial","Tilburgs B, Koopmans R, Vernooij-Dassen M, Adang E, Schers H, Teerenstra S, van de Pol M, Smits C, Engels Y, Perry M.","J Am Med Dir Assoc. 2020 Jun;21(6):837-842.e4. doi: 10.1016/j.jamda.2019.09.010. Epub 2019 Nov 20.","Tilburgs B","J Am Med Dir Assoc","2020","2019/11/25","","","10.1016/j.jamda.2019.09.010"
"24489762","The economics of dementia-care mapping in nursing homes: a cluster-randomised controlled trial","van de Ven G, Draskovic I, van Herpen E, Koopmans RT, Donders R, Zuidema SU, Adang EM, Vernooij-Dassen MJ.","PLoS One. 2014 Jan 28;9(1):e86662. doi: 10.1371/journal.pone.0086662. eCollection 2014.","van de Ven G","PLoS One","2014","2014/02/04","PMC3904939","","10.1371/journal.pone.0086662"
"33115484","Permeability of the windows of the brain: feasibility of dynamic contrast-enhanced MRI of the circumventricular organs","Verheggen ICM, de Jong JJA, van Boxtel MPJ, Postma AA, Verhey FRJ, Jansen JFA, Backes WH.","Fluids Barriers CNS. 2020 Oct 28;17(1):66. doi: 10.1186/s12987-020-00228-x.","Verheggen ICM","Fluids Barriers CNS","2020","2020/10/29","PMC7594295","","10.1186/s12987-020-00228-x"
"30106321","Potentially Inappropriate Prescribing in Australian Nursing Home Residents with Advanced Dementia: A Substudy of the IDEAL Study","Disalvo D, Luckett T, Luscombe G, Bennett A, Davidson P, Chenoweth L, Mitchell G, Pond D, Phillips J, Beattie E, Goodall S, Agar M.","J Palliat Med. 2018 Oct;21(10):1472-1479. doi: 10.1089/jpm.2018.0070. Epub 2018 Aug 14.","Disalvo D","J Palliat Med","2018","2018/08/15","","","10.1089/jpm.2018.0070"
"28851406","Effectiveness of an online social support intervention for caregivers of people with dementia: the study protocol of a randomised controlled trial","Dam AEH, de Vugt ME, van Boxtel MPJ, Verhey FRJ.","Trials. 2017 Aug 29;18(1):395. doi: 10.1186/s13063-017-2097-y.","Dam AEH","Trials","2017","2017/08/31","PMC5575867","","10.1186/s13063-017-2097-y"
"25035121","Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: a randomized controlled trial","Ahmed AI, van den Elsen GA, Colbers A, van der Marck MA, Burger DM, Feuth TB, Rikkert MG, Kramers C.","Eur Neuropsychopharmacol. 2014 Sep;24(9):1475-82. doi: 10.1016/j.euroneuro.2014.06.007. Epub 2014 Jun 28.","Ahmed AI","Eur Neuropsychopharmacol","2014","2014/07/19","","","10.1016/j.euroneuro.2014.06.007"
"19799779","WHEDA study: effectiveness of occupational therapy at home for older people with dementia and their caregivers--the design of a pragmatic randomised controlled trial evaluating a Dutch programme in seven German centres","Voigt-Radloff S, Graff M, Leonhart R, Schornstein K, Vernooij-Dassen M, Olde-Rikkert M, Huell M.","BMC Geriatr. 2009 Oct 2;9:44. doi: 10.1186/1471-2318-9-44.","Voigt-Radloff S","BMC Geriatr","2009","2009/10/06","PMC2761388","","10.1186/1471-2318-9-44"
"26527417","The ileal bile acid transporter inhibitor A4250 decreases serum bile acids by interrupting the enterohepatic circulation","Graffner H, Gillberg PG, Rikner L, Marschall HU.","Aliment Pharmacol Ther. 2016 Jan;43(2):303-10. doi: 10.1111/apt.13457. Epub 2015 Nov 2.","Graffner H","Aliment Pharmacol Ther","2016","2015/11/04","","","10.1111/apt.13457"
"27142676","Effectiveness of the blended care self-management program ""Partner in Balance"" for early-stage dementia caregivers: study protocol for a randomized controlled trial","Boots LM, de Vugt ME, Kempen GI, Verhey FR.","Trials. 2016 May 4;17(1):231. doi: 10.1186/s13063-016-1351-z.","Boots LM","Trials","2016","2016/05/05","PMC4855318","","10.1186/s13063-016-1351-z"
"29889067","Patients with Dementia in Primary Care: Who Is Referred to a Neurologist/Psychiatrist and What Patient-Oriented Factors Are Associated with the Visit?","Strohmaier U, Keller F, Kilimann I, Michalowsky B, Wucherer D, Zwingmann I, Teipel S, Hoffmann W, Thyrian JR.","J Alzheimers Dis. 2018;64(3):925-932. doi: 10.3233/JAD-180196.","Strohmaier U","J Alzheimers Dis","2018","2018/06/12","","","10.3233/JAD-180196"
"25720410","Impaired Cerebral Hemodynamics and Cognitive Performance in Patients with Atherothrombotic Disease","Haratz S, Weinstein G, Molshazki N, Beeri MS, Ravona-Springer R, Marzeliak O, Goldbourt U, Tanne D.","J Alzheimers Dis. 2015;46(1):137-44. doi: 10.3233/JAD-150052.","Haratz S","J Alzheimers Dis","2015","2015/02/28","PMC5753416","NIHMS931089","10.3233/JAD-150052"
"36057827","B Vitamin Supplementation Slows Cognitive Decline in Mild Cognitive Impairment Patients with Frontal Lobe Atrophy","Gong X, Shi L, Wu Y, Luo Y, Kwok T.","J Alzheimers Dis. 2022;89(4):1453-1461. doi: 10.3233/JAD-220685.","Gong X","J Alzheimers Dis","2022","2022/09/04","","","10.3233/JAD-220685"
"30248056","Effectiveness of a Personalized Brain-Computer Interface System for Cognitive Training in Healthy Elderly: A Randomized Controlled Trial","Yeo SN, Lee TS, Sng WT, Heo MQ, Bautista D, Cheung YB, Zhang HH, Wang C, Chin ZY, Feng L, Zhou J, Chong MS, Ng TP, Krishnan KR, Guan C.","J Alzheimers Dis. 2018;66(1):127-138. doi: 10.3233/JAD-180450.","Yeo SN","J Alzheimers Dis","2018","2018/09/25","","","10.3233/JAD-180450"
"29480175","Visit-To-Visit Blood Pressure Variability and the Risk of Dementia in Older People","van Middelaar T, van Dalen JW, van Gool WA, van den Born BH, van Vught LA, Moll van Charante EP, Richard E.","J Alzheimers Dis. 2018;62(2):727-735. doi: 10.3233/JAD-170757.","van Middelaar T","J Alzheimers Dis","2018","2018/02/27","","","10.3233/JAD-170757"
"28587629","Efficacy of the Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training (USMART) program among patients with mild cognitive impairment: a randomized controlled crossover trial","Han JW, Son KL, Byun HJ, Ko JW, Kim K, Hong JW, Kim TH, Kim KW.","Alzheimers Res Ther. 2017 Jun 6;9(1):39. doi: 10.1186/s13195-017-0264-8.","Han JW","Alzheimers Res Ther","2017","2017/06/08","PMC5461696","","10.1186/s13195-017-0264-8"
"25854932","The Effects of Bushen Capsule on Episodic Memory in Amnestic Mild Cognitive Impairment Patients: A Pilot Placebo Controlled fMRI Study","Zhang J, Xu K, Wei D, Guo R, Li H, Wang Y, Zhang Z.","J Alzheimers Dis. 2015;46(3):665-76. doi: 10.3233/JAD-150004.","Zhang J","J Alzheimers Dis","2015","2015/04/10","","","10.3233/JAD-150004"
"34602464","Effects of High Definition-Transcranial Direct Current Stimulation on Local GABA and Glutamate Levels Among Older Adults with and without Mild Cognitive Impairment: An Exploratory Study","Lengu K, Ryan S, Peltier SJ, Tyszkowski T, Kairys A, Giordani B, Hampstead BM.","J Alzheimers Dis. 2021;84(3):1091-1102. doi: 10.3233/JAD-201091.","Lengu K","J Alzheimers Dis","2021","2021/10/04","PMC8925725","NIHMS1783047","10.3233/JAD-201091"
"33720882","Functional Connectivity and Response Inhibition: A Secondary Analysis of an 8-Week Randomized Controlled Trial of Computerized Cognitive Training","Ten Brinke LF, Hsu CL, Erickson KI, Handy TC, Liu-Ambrose T.","J Alzheimers Dis. 2021;80(4):1525-1537. doi: 10.3233/JAD-200844.","Ten Brinke LF","J Alzheimers Dis","2021","2021/03/15","","","10.3233/JAD-200844"
"19383979","A multicenter, open-label, 24-week follow-up study for efficacy on cognitive function of donepezil in Binswanger-type subcortical vascular dementia","Kwon JC, Kim EG, Kim JW, Kwon OD, Yoo BG, Yi HA, Choi NC, Ahn SY, Lee BH, Kang MJ, Choi DS; BKVD Study Group.","Am J Alzheimers Dis Other Demen. 2009 Aug-Sep;24(4):293-301. doi: 10.1177/1533317509334960. Epub 2009 Apr 21.","Kwon JC","Am J Alzheimers Dis Other Demen","2009","2009/04/23","","","10.1177/1533317509334960"
"32130142","Online Self-Management Support for Family Caregivers Dealing With Behavior Changes in Relatives With Dementia (Part 2): Randomized Controlled Trial","Huis In Het Veld JG, Willemse BM, van Asch IF, Groot Zwaaftink RB, Verkade PJ, Twisk JW, Verkaik R, Blom MM, van Meijel B, Francke AL.","J Med Internet Res. 2020 Feb 25;22(2):e13001. doi: 10.2196/13001.","Huis In Het Veld JG","J Med Internet Res","2020","2020/03/05","PMC7064946","","10.2196/13001"
"25210447","The LIFE Cognition Study: design and baseline characteristics","Sink KM, Espeland MA, Rushing J, Castro CM, Church TS, Cohen R, Gill TM, Henkin L, Jennings JM, Kerwin DR, Manini TM, Myers V, Pahor M, Reid KF, Woolard N, Rapp SR, Williamson JD; LIFE Investigators.","Clin Interv Aging. 2014 Aug 27;9:1425-36. doi: 10.2147/CIA.S65381. eCollection 2014.","Sink KM","Clin Interv Aging","2014","2014/09/12","PMC4154884","","10.2147/CIA.S65381"
"27766347","ACCORDION MIND: results of the observational extension of the ACCORD MIND randomised trial","Murray AM, Hsu FC, Williamson JD, Bryan RN, Gerstein HC, Sullivan MD, Miller ME, Leng I, Lovato LL, Launer LJ; Action to Control Cardiovascular Risk in Diabetes Follow-On Memory in Diabetes (ACCORDION MIND) Investigators.","Diabetologia. 2017 Jan;60(1):69-80. doi: 10.1007/s00125-016-4118-x. Epub 2016 Oct 20.","Murray AM","Diabetologia","2017","2016/10/22","PMC5633725","NIHMS821276","10.1007/s00125-016-4118-x"
"26398910","Olfactory Deficits Predict Cognitive Improvement on Donepezil in Patients With Depression and Cognitive Impairment: A Randomized Controlled Pilot Study","Pelton GH, Soleimani L, Roose SP, Tabert MH, Devanand DP.","Alzheimer Dis Assoc Disord. 2016 Jan-Mar;30(1):67-9. doi: 10.1097/WAD.0000000000000107.","Pelton GH","Alzheimer Dis Assoc Disord","2016","2015/09/24","PMC4764438","NIHMS716342","10.1097/WAD.0000000000000107"
"9651140","Bromocriptine treatment for perseveration in demented patients","Imamura T, Takanashi M, Hattori N, Fujimori M, Yamashita H, Ishii K, Yamadori A.","Alzheimer Dis Assoc Disord. 1998 Jun;12(2):109-13. doi: 10.1097/00002093-199806000-00009.","Imamura T","Alzheimer Dis Assoc Disord","1998","1998/07/03","","","10.1097/00002093-199806000-00009"
"36767702","Effects of Transcranial Pulse Stimulation (TPS) on Adults with Symptoms of Depression-A Pilot Randomized Controlled Trial","Cheung T, Li TMH, Ho YS, Kranz G, Fong KNK, Leung SF, Lam SC, Yeung WF, Lam JYT, Fong KH, Beisteiner R, Xiang YT, Cheng CPW.","Int J Environ Res Public Health. 2023 Jan 28;20(3):2333. doi: 10.3390/ijerph20032333.","Cheung T","Int J Environ Res Public Health","2023","2023/02/11","PMC9915638","","10.3390/ijerph20032333"
"32014029","Doll therapy intervention for women with dementia living in nursing homes: a randomized single-blind controlled trial protocol","Vaccaro R, Ballabio R, Molteni V, Ceppi L, Ferrari B, Cantù M, Zaccaria D, Vandoni C, Ardito RB, Adenzato M, Poletti B, Guaita A, Pezzati R.","Trials. 2020 Feb 3;21(1):133. doi: 10.1186/s13063-020-4050-8.","Vaccaro R","Trials","2020","2020/02/05","PMC6998291","","10.1186/s13063-020-4050-8"
"31657080","Cost-consequence analysis of an intervention for the management of neuropsychiatric symptoms in young-onset dementia: Results from the BEYOND-II study","van Duinen-van den IJssel JCL, Bakker C, Smalbrugge M, Zwijsen SA, Adang E, Appelhof B, Zuidema SU, de Vugt ME, Verhey FRJ, Koopmans RTCM.","Int J Geriatr Psychiatry. 2020 Jan;35(1):131-137. doi: 10.1002/gps.5229. Epub 2019 Nov 7.","van Duinen-van den IJssel JCL","Int J Geriatr Psychiatry","2020","2019/10/29","PMC6916543","","10.1002/gps.5229"
"25019974","Sex-specific associations between Neutrophil Gelatinase-Associated Lipocalin (NGAL) and cognitive domains in late-life depression","Naudé PJ, den Boer JA, Comijs HC, Bosker FJ, Zuidersma M, Groenewold NA, De Deyn PP, Luiten PG, Eisel UL, Oude Voshaar RC.","Psychoneuroendocrinology. 2014 Oct;48:169-77. doi: 10.1016/j.psyneuen.2014.06.016. Epub 2014 Jun 27.","Naudé PJ","Psychoneuroendocrinology","2014","2014/07/15","","","10.1016/j.psyneuen.2014.06.016"
"11144994","Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effects of scopolamine in healthy volunteers","Ebert U, Grossmann M, Oertel R, Gramatté T, Kirch W.","J Clin Pharmacol. 2001 Jan;41(1):51-60. doi: 10.1177/00912700122009836.","Ebert U","J Clin Pharmacol","2001","2001/01/06","","","10.1177/00912700122009836"
"35135037","The PASTIS trial: Testing tadalafil for possible use in vascular cognitive impairment","Pauls MMH, Binnie LR, Benjamin P, Betteridge S, Clarke B, Dhillon MK, Ghatala R, Hainsworth FAH, Howe FA, Khan U, Kruuse C, Madigan JB, Moynihan B, Patel B, Pereira AC, Rostrup E, Shtaya ABY, Spilling CA, Trippier S, Williams R, Young R, Barrick TR, Isaacs JD, Hainsworth AH.","Alzheimers Dement. 2022 Dec;18(12):2393-2402. doi: 10.1002/alz.12559. Epub 2022 Feb 8.","Pauls MMH","Alzheimers Dement","2022","2022/02/08","PMC10078742","","10.1002/alz.12559"
"35124649","The Effectiveness of GRADIOR: A Neuropsychological Rehabilitation Program for People with Mild Cognitive Impairment and Mild Dementia. Results of a Randomized Controlled Trial After 4 and 12 Months of Treatment","Diaz Baquero AA, Franco-Martín MA, Parra Vidales E, Toribio-Guzmán JM, Bueno-Aguado Y, Martínez Abad F, Perea Bartolomé MV, Asl AM, van der Roest HG.","J Alzheimers Dis. 2022;86(2):711-727. doi: 10.3233/JAD-215350.","Diaz Baquero AA","J Alzheimers Dis","2022","2022/02/06","PMC9028667","","10.3233/JAD-215350"
"32651322","The Effects of Propofol and Sevoflurane on Postoperative Delirium in Older Patients: A Randomized Clinical Trial Study","Mei X, Zheng HL, Li C, Ma X, Zheng H, Marcantonio E, Xie Z, Shen Y.","J Alzheimers Dis. 2020;76(4):1627-1636. doi: 10.3233/JAD-200322.","Mei X","J Alzheimers Dis","2020","2020/07/12","PMC7844419","NIHMS1663035","10.3233/JAD-200322"
"24577471","Acute caffeine administration effect on brain activation patterns in mild cognitive impairment","Haller S, Montandon ML, Rodriguez C, Moser D, Toma S, Hofmeister J, Sinanaj I, Lovblad KO, Giannakopoulos P.","J Alzheimers Dis. 2014;41(1):101-12. doi: 10.3233/JAD-132360.","Haller S","J Alzheimers Dis","2014","2014/03/01","","","10.3233/JAD-132360"
"34511499","A Randomized Controlled Trial on the Effects of a 6-Month Home-Based Physical Activity Program with Individual Goal-Setting and Volunteer Mentors on Physical Activity, Adherence, and Physical Fitness in Inactive Older Adults at Risk of Cognitive Decline: The INDIGO Study","Cox KL, Clare L, Cyarto EV, Ellis KA, Etherton-Beer C, Southam J, Ames D, Flicker L, Almeida OP, LoGiudice D, Liew D, Vlaskovsky P, Lautenschlager NT.","J Alzheimers Dis. 2021;84(1):207-226. doi: 10.3233/JAD-210479.","Cox KL","J Alzheimers Dis","2021","2021/09/13","","","10.3233/JAD-210479"
"28655351","Digitally translated Self-Administered Gerocognitive Examination (eSAGE): relationship with its validated paper version, neuropsychological evaluations, and clinical assessments","Scharre DW, Chang SI, Nagaraja HN, Vrettos NE, Bornstein RA.","Alzheimers Res Ther. 2017 Jun 27;9(1):44. doi: 10.1186/s13195-017-0269-3.","Scharre DW","Alzheimers Res Ther","2017","2017/06/29","PMC5488440","","10.1186/s13195-017-0269-3"
"35871338","Effects of a 6-Month Multifaceted Diet and Exercise Intervention on Cognition in Older Adults at Risk of Cognitive Decline: The PONDER Double-Blind, Placebo-Controlled Randomized Trial","Macpherson H, Brownell S, Harris E, Duckham RL, O'Connell S, Meyer BJ, Mirzaee S, Daly RM.","J Alzheimers Dis. 2022;89(1):247-263. doi: 10.3233/JAD-220234.","Macpherson H","J Alzheimers Dis","2022","2022/07/24","","","10.3233/JAD-220234"
"34092635","Effects of Aerobic, Resistance, or Combined Exercise Training Among Older Adults with Subjective Memory Complaints: A Randomized Controlled Trial","Makino T, Umegaki H, Ando M, Cheng XW, Ishida K, Akima H, Oshida Y, Yoshida Y, Uemura K, Shimada H, Kuzuya M.","J Alzheimers Dis. 2021;82(2):701-717. doi: 10.3233/JAD-210047.","Makino T","J Alzheimers Dis","2021","2021/06/07","","","10.3233/JAD-210047"
"28304291","Insulin Resistance and Future Cognitive Performance and Cognitive Decline in Elderly Patients with Cardiovascular Disease","Lutski M, Weinstein G, Goldbourt U, Tanne D.","J Alzheimers Dis. 2017;57(2):633-643. doi: 10.3233/JAD-161016.","Lutski M","J Alzheimers Dis","2017","2017/03/18","","","10.3233/JAD-161016"
"22976075","MRI signatures of brain macrostructural atrophy and microstructural degradation in frontotemporal lobar degeneration subtypes","Zhang Y, Tartaglia MC, Schuff N, Chiang GC, Ching C, Rosen HJ, Gorno-Tempini ML, Miller BL, Weiner MW.","J Alzheimers Dis. 2013;33(2):431-44. doi: 10.3233/JAD-2012-121156.","Zhang Y","J Alzheimers Dis","2013","2012/09/15","PMC3738303","NIHMS484100","10.3233/JAD-2012-121156"
"33164936","Vitamin D Supplementation Improves Cognitive Function Through Reducing Oxidative Stress Regulated by Telomere Length in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized Controlled Trial","Yang T, Wang H, Xiong Y, Chen C, Duan K, Jia J, Ma F.","J Alzheimers Dis. 2020;78(4):1509-1518. doi: 10.3233/JAD-200926.","Yang T","J Alzheimers Dis","2020","2020/11/09","","","10.3233/JAD-200926"
"32804132","Effects of Resistance Exercise with Instability on Cognitive Function (REI Study): A Proof-Of-Concept Randomized Controlled Trial in Older Adults with Cognitive Complaints","Cavalcante BR, de Souza MF, Falck RS, Liu-Ambrose T, Behm DG, Pitangui ACR, de Araújo RC.","J Alzheimers Dis. 2020;77(1):227-239. doi: 10.3233/JAD-200349.","Cavalcante BR","J Alzheimers Dis","2020","2020/08/18","","","10.3233/JAD-200349"
"30281796","Self-Reported Physical Function As a Predictor of Hospitalization in the Lifestyle Interventions and Independence for Elders Study","Callahan KE, Lovato L, Miller ME, Marsh AP, Fielding RA, Gill TM, Groessl EJ, Guralnik J, King AC, Kritchevsky SB, McDermott MM, Manini T, Newman AB, Rejeski WJ.","J Am Geriatr Soc. 2018 Oct;66(10):1927-1933. doi: 10.1111/jgs.15468. Epub 2018 Oct 3.","Callahan KE","J Am Geriatr Soc","2018","2018/10/04","PMC6277208","NIHMS970079","10.1111/jgs.15468"
"35696263","Does the Effect of a 3-Year Lifestyle Intervention on Body Weight and Cardiometabolic Health Differ by Prediabetes Metabolic Phenotype? A Post Hoc Analysis of the PREVIEW Study","Zhu R, Jalo E, Silvestre MP, Poppitt SD, Handjieva-Darlenska T, Handjiev S, Huttunen-Lenz M, Mackintosh K, Stratton G, Navas-Carretero S, Pietiläinen KH, Simpson E, Macdonald IA, Muirhead R, Brand-Miller J, Fogelholm M, Færch K, Martinez JA, Westerterp-Plantenga MS, Adam TC, Raben A.","Diabetes Care. 2022 Nov 1;45(11):2698-2708. doi: 10.2337/dc22-0549.","Zhu R","Diabetes Care","2022","2022/06/13","","","10.2337/dc22-0549"
"22594383","The effects of cognitive speed of processing training among older adults with psychometrically- defined mild cognitive impairment","Valdes EG, O'Connor ML, Edwards JD.","Curr Alzheimer Res. 2012 Nov;9(9):999-1009. doi: 10.2174/156720512803568984.","Valdes EG","Curr Alzheimer Res","2012","2012/05/19","","","10.2174/156720512803568984"
"21995966","Dementelcoach: effect of telephone coaching on carers of community-dwelling people with dementia","van Mierlo LD, Meiland FJ, Dröes RM.","Int Psychogeriatr. 2012 Feb;24(2):212-22. doi: 10.1017/S1041610211001827.","van Mierlo LD","Int Psychogeriatr","2012","2011/10/15","","","10.1017/S1041610211001827"
"10994660","Responsiveness of outcome measures used in an antidementia drug trial","Rockwood K, Stolee P.","Alzheimer Dis Assoc Disord. 2000 Jul-Sep;14(3):182-5. doi: 10.1097/00002093-200007000-00010.","Rockwood K","Alzheimer Dis Assoc Disord","2000","2000/09/20","","","10.1097/00002093-200007000-00010"
"10609696","Nimodipine in subcortical vascular dementia trial","Rossi R, Inzitari D, Pantoni L, del Ser T, Erkinjuntti T, Wallin A, Bianchi C, Badenas JM, Beneke M.","Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13 Suppl 3:S159-65.","Rossi R","Alzheimer Dis Assoc Disord","1999","1999/12/28","","",""
"18378994","Integrated multidisciplinary diagnostic approach for dementia care: randomised controlled trial","Wolfs CA, Kessels A, Dirksen CD, Severens JL, Verhey FR.","Br J Psychiatry. 2008 Apr;192(4):300-5. doi: 10.1192/bjp.bp.107.035204.","Wolfs CA","Br J Psychiatry","2008","2008/04/02","","","10.1192/bjp.bp.107.035204"
"34250935","Effect of Advanced Glycation End Products on Cognition in Older Adults with Type 2 Diabetes: Results from a Pilot Clinical Trial","Lotan R, Ganmore I, Livny A, Itzhaki N, Waserman M, Shelly S, Zacharia M, Moshier E, Uribarri J, Beisswenger P, Cai W, Troen AM, Beeri MS.","J Alzheimers Dis. 2021;82(4):1785-1795. doi: 10.3233/JAD-210131.","Lotan R","J Alzheimers Dis","2021","2021/07/12","","","10.3233/JAD-210131"
"32192537","Effects of low- and high-intensity physical exercise on physical and cognitive function in older persons with dementia: a randomized controlled trial","Sanders LMJ, Hortobágyi T, Karssemeijer EGA, Van der Zee EA, Scherder EJA, van Heuvelen MJG.","Alzheimers Res Ther. 2020 Mar 19;12(1):28. doi: 10.1186/s13195-020-00597-3.","Sanders LMJ","Alzheimers Res Ther","2020","2020/03/21","PMC7082953","","10.1186/s13195-020-00597-3"
"29972210","Effects of a Six-Month Multi-Ingredient Nutrition Supplement Intervention of Omega-3 Polyunsaturated Fatty Acids, vitamin D, Resveratrol, and Whey Protein on Cognitive Function in Older Adults: A Randomised, Double-Blind, Controlled Trial","Moran C, Scotto di Palumbo A, Bramham J, Moran A, Rooney B, De Vito G, Egan B.","J Prev Alzheimers Dis. 2018;5(3):175-183. doi: 10.14283/jpad.2018.11.","Moran C","J Prev Alzheimers Dis","2018","2018/07/05","","","10.14283/jpad.2018.11"
"28869475","Effect of Attention Training in Mild Cognitive Impairment Patients with Subcortical Vascular Changes: The RehAtt Study","Pantoni L, Poggesi A, Diciotti S, Valenti R, Orsolini S, Della Rocca E, Inzitari D, Mascalchi M, Salvadori E.","J Alzheimers Dis. 2017;60(2):615-624. doi: 10.3233/JAD-170428.","Pantoni L","J Alzheimers Dis","2017","2017/09/05","PMC5611829","","10.3233/JAD-170428"
"21967845","Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients","Geleijnse JM, Giltay EJ, Kromhout D.","Alzheimers Dement. 2012 Jul;8(4):278-87. doi: 10.1016/j.jalz.2011.06.002. Epub 2011 Oct 2.","Geleijnse JM","Alzheimers Dement","2012","2011/10/05","","","10.1016/j.jalz.2011.06.002"
"32925039","Metabolic and Neurocognitive Changes Following Lifestyle Modification: Examination of Biomarkers from the ENLIGHTEN Randomized Clinical Trial","Smith PJ, Mabe SM, Sherwood A, Doraiswamy PM, Welsh-Bohmer KA, Burke JR, Kraus WE, Lin PH, Browndyke JN, Babyak MA, Hinderliter AL, Blumenthal JA.","J Alzheimers Dis. 2020;77(4):1793-1803. doi: 10.3233/JAD-200374.","Smith PJ","J Alzheimers Dis","2020","2020/09/14","PMC9999371","NIHMS1878263","10.3233/JAD-200374"
"33443874","Psychometric Properties of the ICECAP-O Quality of Life Measurement Tool When Self-reported by Community-dwelling Older People With Mild and Moderate Dementia","Nyman SR, Casey C, Polman R.","Alzheimer Dis Assoc Disord. 2021 Oct-Dec 01;35(4):356-359. doi: 10.1097/WAD.0000000000000430.","Nyman SR","Alzheimer Dis Assoc Disord","2021","2021/01/14","PMC7612012","EMS114159","10.1097/WAD.0000000000000430"
"34844129","A pragmatic trial testing a tailored non pharmacologic therapies on nocturnal behavioral and psychological symptoms associated with dementia","Bautrant T, Franqui C, Clément H, Rabault M, Masseboeuf F, Pastore M, Pardo M, Brandi Y, Drouin N, Brice AD, Grino M.","Geriatr Nurs. 2022 Jan-Feb;43:85-90. doi: 10.1016/j.gerinurse.2021.11.002. Epub 2021 Nov 26.","Bautrant T","Geriatr Nurs","2022","2021/11/29","","","10.1016/j.gerinurse.2021.11.002"
"17545742","The diagnosis and course of frontotemporal dementia","Kertesz A, Blair M, McMonagle P, Munoz DG.","Alzheimer Dis Assoc Disord. 2007 Apr-Jun;21(2):155-63. doi: 10.1097/WAD.0b013e31806547eb.","Kertesz A","Alzheimer Dis Assoc Disord","2007","2007/06/05","","","10.1097/WAD.0b013e31806547eb"
"35226732","Development and Validation of a Cutoff for the Chair Stand Test as a Screening for Mobility Impairment in the Context of the Integrated Care for Older People Program","Gonzalez-Bautista E, de Souto Barreto P, Salinas-Rodriguez A, Manrique-Espinoza B, Sourdet S, Rolland Y, Rodríguez-Mañas L, Andrieu S, Vellas B; MAPT/DSA Group.","J Gerontol A Biol Sci Med Sci. 2023 Jan 26;78(1):104-110. doi: 10.1093/gerona/glac055.","Gonzalez-Bautista E","J Gerontol A Biol Sci Med Sci","2023","2022/02/28","","","10.1093/gerona/glac055"
"31367958","Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial","Nilsson M, Jensen N, Gejl M, Bergmann ML, Storgaard H, Zander M, Miskowiak K, Rungby J.","Diabetologia. 2019 Oct;62(10):1948-1958. doi: 10.1007/s00125-019-4964-4. Epub 2019 Jul 31.","Nilsson M","Diabetologia","2019","2019/08/02","","","10.1007/s00125-019-4964-4"
"32101271","Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial","Voineskos AN, Mulsant BH, Dickie EW, Neufeld NH, Rothschild AJ, Whyte EM, Meyers BS, Alexopoulos GS, Hoptman MJ, Lerch JP, Flint AJ.","JAMA Psychiatry. 2020 Jul 1;77(7):674-683. doi: 10.1001/jamapsychiatry.2020.0036.","Voineskos AN","JAMA Psychiatry","2020","2020/02/27","PMC7330722","","10.1001/jamapsychiatry.2020.0036"
"31429896","Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial","Flint AJ, Meyers BS, Rothschild AJ, Whyte EM, Alexopoulos GS, Rudorfer MV, Marino P, Banerjee S, Pollari CD, Wu Y, Voineskos AN, Mulsant BH; STOP-PD II Study Group.","JAMA. 2019 Aug 20;322(7):622-631. doi: 10.1001/jama.2019.10517.","Flint AJ","JAMA","2019","2019/08/21","PMC6704758","","10.1001/jama.2019.10517"
"30658705","Consecutive sessions of transcranial direct current stimulation do not remediate visual hallucinations in Lewy body dementia: a randomised controlled trial","Elder GJ, Colloby SJ, Firbank MJ, McKeith IG, Taylor JP.","Alzheimers Res Ther. 2019 Jan 18;11(1):9. doi: 10.1186/s13195-018-0465-9.","Elder GJ","Alzheimers Res Ther","2019","2019/01/20","PMC6339360","","10.1186/s13195-018-0465-9"
"36585689","Paroxysmal slow wave events are associated with cognitive impairment in patients with obstructive sleep apnea","Li M, Sun Z, Sun H, Zhao G, Leng B, Shen T, Xue S, Hou H, Li Z, Zhang J.","Alzheimers Res Ther. 2022 Dec 30;14(1):200. doi: 10.1186/s13195-022-01153-x.","Li M","Alzheimers Res Ther","2022","2022/12/30","PMC9801625","","10.1186/s13195-022-01153-x"
"33749643","Effects of Folic Acid Combined with DHA Supplementation on Cognitive Function and Amyloid-β-Related Biomarkers in Older Adults with Mild Cognitive Impairment by a Randomized, Double Blind, Placebo-Controlled Trial","Bai D, Fan J, Li M, Dong C, Gao Y, Fu M, Huang G, Liu H.","J Alzheimers Dis. 2021;81(1):155-167. doi: 10.3233/JAD-200997.","Bai D","J Alzheimers Dis","2021","2021/03/22","","","10.3233/JAD-200997"
"22465175","Diuretic use is associated with better learning and memory in older adults in the Ginkgo Evaluation of Memory Study","Yasar S, Lin FM, Fried LP, Kawas CH, Sink KM, DeKosky ST, Carlson MC; Ginkgo Evaluation of Memory (GEM) Study Investigators.","Alzheimers Dement. 2012 May;8(3):188-95. doi: 10.1016/j.jalz.2011.03.010. Epub 2012 Mar 30.","Yasar S","Alzheimers Dement","2012","2012/04/03","PMC3341535","NIHMS285740","10.1016/j.jalz.2011.03.010"
"32444553","Effect of a Multimodal Lifestyle Intervention on Sleep and Cognitive Function in Older Adults with Probable Mild Cognitive Impairment and Poor Sleep: A Randomized Clinical Trial","Falck RS, Davis JC, Best JR, Chan PCY, Li LC, Wyrough AB, Bennett KJ, Backhouse D, Liu-Ambrose T.","J Alzheimers Dis. 2020;76(1):179-193. doi: 10.3233/JAD-200383.","Falck RS","J Alzheimers Dis","2020","2020/05/24","","","10.3233/JAD-200383"
"31801630","Effects of functional tasks exercise on cognitive functions of older adults with mild cognitive impairment: a randomized controlled pilot trial","Law LLF, Mok VCT, Yau MMK.","Alzheimers Res Ther. 2019 Dec 4;11(1):98. doi: 10.1186/s13195-019-0548-2.","Law LLF","Alzheimers Res Ther","2019","2019/12/06","PMC6894271","","10.1186/s13195-019-0548-2"
"29182708","B-Vitamin Therapy for Kidney Transplant Recipients Lowers Homocysteine and Improves Selective Cognitive Outcomes in the Randomized FAVORIT Ancillary Cognitive Trial","Scott TM, Rogers G, Weiner DE, Livingston K, Selhub J, Jacques PF, Rosenberg IH, Troen AM.","J Prev Alzheimers Dis. 2017;4(3):174-182. doi: 10.14283/jpad.2017.15.","Scott TM","J Prev Alzheimers Dis","2017","2017/11/29","PMC5724781","NIHMS893455","10.14283/jpad.2017.15"
"28628488","Falls and Physical Activity in Persons With Mild to Moderate Dementia Participating in an Intensive Motor Training: Randomized Controlled Trial","Zieschang T, Schwenk M, Becker C, Uhlmann L, Oster P, Hauer K.","Alzheimer Dis Assoc Disord. 2017 Oct-Dec;31(4):307-314. doi: 10.1097/WAD.0000000000000201.","Zieschang T","Alzheimer Dis Assoc Disord","2017","2017/06/20","","","10.1097/WAD.0000000000000201"
"24632986","The effects of spaced retrieval combined with errorless learning in institutionalized elders with dementia: recall performance, cognitive status, and food intake","Wu HS, Lin LC, Su SC, Wu SC.","Alzheimer Dis Assoc Disord. 2014 Oct-Dec;28(4):333-9. doi: 10.1097/WAD.0000000000000028.","Wu HS","Alzheimer Dis Assoc Disord","2014","2014/03/18","","","10.1097/WAD.0000000000000028"
"21898324","[The costs and benefits of an integrated approach to dementia]","Wolfs CA, Dirksen CD, Severens JL, Kessels A, Verkaaik M, Verhey FR.","Tijdschr Psychiatr. 2011;53(9):657-65.","Wolfs CA","Tijdschr Psychiatr","2011","2011/09/08","","",""
"15494620","Comparison of clinic-based home assessment to a home visit in demented elderly patients","Ramsdell JW, Jackson JE, Guy HJ, Renvall MJ.","Alzheimer Dis Assoc Disord. 2004 Jul-Sep;18(3):145-53. doi: 10.1097/01.wad.0000137863.90007.ec.","Ramsdell JW","Alzheimer Dis Assoc Disord","2004","2004/10/21","","","10.1097/01.wad.0000137863.90007.ec"
"21135531","Effectiveness of nonpharmacological approaches in patients with mild cognitive impairment","Tsolaki M, Kounti F, Agogiatou C, Poptsi E, Bakoglidou E, Zafeiropoulou M, Soumbourou A, Nikolaidou E, Batsila G, Siambani A, Nakou S, Mouzakidis C, Tsiakiri A, Zafeiropoulos S, Karagiozi K, Messini C, Diamantidou A, Vasiloglou M.","Neurodegener Dis. 2011;8(3):138-45. doi: 10.1159/000320575. Epub 2010 Dec 3.","Tsolaki M","Neurodegener Dis","2011","2010/12/08","","","10.1159/000320575"
"18525288","Efficacy of music therapy in the treatment of behavioral and psychiatric symptoms of dementia","Raglio A, Bellelli G, Traficante D, Gianotti M, Ubezio MC, Villani D, Trabucchi M.","Alzheimer Dis Assoc Disord. 2008 Apr-Jun;22(2):158-62. doi: 10.1097/WAD.0b013e3181630b6f.","Raglio A","Alzheimer Dis Assoc Disord","2008","2008/06/06","","","10.1097/WAD.0b013e3181630b6f"
"18196898","Galantamine in frontotemporal dementia and primary progressive aphasia","Kertesz A, Morlog D, Light M, Blair M, Davidson W, Jesso S, Brashear R.","Dement Geriatr Cogn Disord. 2008;25(2):178-85. doi: 10.1159/000113034. Epub 2008 Jan 14.","Kertesz A","Dement Geriatr Cogn Disord","2008","2008/01/17","","","10.1159/000113034"
"35916848","Effect of Graded Sensorimotor Retraining on Pain Intensity in Patients With Chronic Low Back Pain: A Randomized Clinical Trial","Bagg MK, Wand BM, Cashin AG, Lee H, Hübscher M, Stanton TR, O'Connell NE, O'Hagan ET, Rizzo RRN, Wewege MA, Rabey M, Goodall S, Saing S, Lo SN, Luomajoki H, Herbert RD, Maher CG, Moseley GL, McAuley JH.","JAMA. 2022 Aug 2;328(5):430-439. doi: 10.1001/jama.2022.9930.","Bagg MK","JAMA","2022","2022/08/02","PMC9346551","","10.1001/jama.2022.9930"
"29408901","Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial","Ballard C, Corbett A, Orrell M, Williams G, Moniz-Cook E, Romeo R, Woods B, Garrod L, Testad I, Woodward-Carlton B, Wenborn J, Knapp M, Fossey J.","PLoS Med. 2018 Feb 6;15(2):e1002500. doi: 10.1371/journal.pmed.1002500. eCollection 2018 Feb.","Ballard C","PLoS Med","2018","2018/02/07","PMC5800565","","10.1371/journal.pmed.1002500"
"34010531","Final Report of a Trial of Intensive versus Standard Blood-Pressure Control","SPRINT Research Group; Lewis CE, Fine LJ, Beddhu S, Cheung AK, Cushman WC, Cutler JA, Evans GW, Johnson KC, Kitzman DW, Oparil S, Rahman M, Reboussin DM, Rocco MV, Sink KM, Snyder JK, Whelton PK, Williamson JD, Wright JT Jr, Ambrosius WT.","N Engl J Med. 2021 May 20;384(20):1921-1930. doi: 10.1056/NEJMoa1901281.","SPRINT Research Group","N Engl J Med","2021","2021/05/19","PMC9907774","NIHMS1709331","10.1056/NEJMoa1901281"
"35570513","Tele-Mindfulness for Dementia's Family Caregivers: A Randomized Trial with a Usual Care Control Group","Zarei S, Lakhanpal G, Sadavoy J.","Curr Alzheimer Res. 2022;19(5):364-372. doi: 10.2174/1567205019666220514131015.","Zarei S","Curr Alzheimer Res","2022","2022/05/16","","","10.2174/1567205019666220514131015"
"34747132","Communicating the diagnosis of cancer or depression: Results of a randomized controlled online study using video vignettes","Kühne F, Fauth H, Ay-Bryson DS, Visser LNC, Weck F.","Cancer Med. 2021 Dec;10(24):9012-9021. doi: 10.1002/cam4.4396. Epub 2021 Nov 8.","Kühne F","Cancer Med","2021","2021/11/08","PMC8683534","","10.1002/cam4.4396"
"34686382","Methodological choices in experimental research on medical communication using vignettes: The impact of gender congruence and vignette modality","Visser LNC, van der Velden NCA, Smets EMA, van der Lelie S, Nieuwenbroek E, van Vliet LM, Hillen MA.","Patient Educ Couns. 2022 Jun;105(6):1634-1641. doi: 10.1016/j.pec.2021.10.015. Epub 2021 Oct 13.","Visser LNC","Patient Educ Couns","2022","2021/10/23","","","10.1016/j.pec.2021.10.015"
"19255381","Economic evaluation of an integrated diagnostic approach for psychogeriatric patients: results of a randomized controlled trial","Wolfs CA, Dirksen CD, Kessels A, Severens JL, Verhey FR.","Arch Gen Psychiatry. 2009 Mar;66(3):313-23. doi: 10.1001/archgenpsychiatry.2008.544.","Wolfs CA","Arch Gen Psychiatry","2009","2009/03/04","","","10.1001/archgenpsychiatry.2008.544"
"12854296","Effects of a relationship-enhancing program of care on outcomes","McGilton KS, O'Brien-Pallas LL, Darlington G, Evans M, Wynn F, Pringle DM.","J Nurs Scholarsh. 2003;35(2):151-6. doi: 10.1111/j.1547-5069.2003.00151.x.","McGilton KS","J Nurs Scholarsh","2003","2003/07/12","","","10.1111/j.1547-5069.2003.00151.x"
"16248851","Anticholinesterase and pharmacokinetic profile of phenserine in healthy elderly human subjects","Greig NH, Ruckle J, Comer P, Brownell L, Holloway HW, Flanagan DR Jr, Canfield CJ, Burford RG.","Curr Alzheimer Res. 2005 Oct;2(4):483-92. doi: 10.2174/156720505774330564.","Greig NH","Curr Alzheimer Res","2005","2005/10/27","","","10.2174/156720505774330564"
"36001764","Factors Associated With Sleep Quality in Hospitalized Persons With Dementia","Kuzmik A, Boltz M, BeLue R, Galvin JE, Arendacs R, Resnick B.","Alzheimer Dis Assoc Disord. 2022 Jul-Sep 01;36(3):253-258. doi: 10.1097/WAD.0000000000000502. Epub 2022 Mar 25.","Kuzmik A","Alzheimer Dis Assoc Disord","2022","2022/08/24","PMC9426998","NIHMS1782432","10.1097/WAD.0000000000000502"
"24282511","Cost-effectiveness of one year dementia follow-up care by memory clinics or general practitioners: economic evaluation of a randomised controlled trial","Meeuwsen E, Melis R, van der Aa G, Golüke-Willemse G, de Leest B, van Raak F, Schölzel-Dorenbos C, Verheijen D, Verhey F, Visser M, Wolfs C, Adang E, Olde Rikkert M.","PLoS One. 2013 Nov 25;8(11):e79797. doi: 10.1371/journal.pone.0079797. eCollection 2013.","Meeuwsen E","PLoS One","2013","2013/11/28","PMC3839971","","10.1371/journal.pone.0079797"
"19812459","Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress","Richard E, Van den Heuvel E, Moll van Charante EP, Achthoven L, Vermeulen M, Bindels PJ, Van Gool WA.","Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):198-204. doi: 10.1097/WAD.0b013e31819783a4.","Richard E","Alzheimer Dis Assoc Disord","2009","2009/10/09","","","10.1097/WAD.0b013e31819783a4"
"18978600","Effect of exercise on negative affect in residents in special care units with moderate to severe dementia","Edwards N, Gardiner M, Ritchie DM, Baldwin K, Sands L.","Alzheimer Dis Assoc Disord. 2008 Oct-Dec;22(4):362-8. doi: 10.1097/WAD.0b013e31818ecbbc.","Edwards N","Alzheimer Dis Assoc Disord","2008","2008/11/04","","","10.1097/WAD.0b013e31818ecbbc"
"30455075","The effect of minocycline on symptoms in schizophrenia: Results from a randomized controlled trial","Weiser M, Levi L, Burshtein S, Chiriță R, Cirjaliu D, Gonen I, Yolken R, Davidson M, Zamora D, Davis JM.","Schizophr Res. 2019 Apr;206:325-332. doi: 10.1016/j.schres.2018.10.023. Epub 2018 Nov 16.","Weiser M","Schizophr Res","2019","2018/11/21","","","10.1016/j.schres.2018.10.023"
"30066463","An intervention programme for caregivers of dementia patients with frontal behavioural changes: an explorative study with controlled effect on sense of competence","Gossink F, Pijnenburg Y, Scheltens P, Pera A, Kleverwal R, Korten N, Stek M, Dröes RM, Dols A.","Psychogeriatrics. 2018 Nov;18(6):451-459. doi: 10.1111/psyg.12351. Epub 2018 Jul 31.","Gossink F","Psychogeriatrics","2018","2018/08/02","","","10.1111/psyg.12351"
"21346517","The efficacy of nonpharmacological treatment for dementia-related apathy","Ferrero-Arias J, Goñi-Imízcoz M, González-Bernal J, Lara-Ortega F, da Silva-González A, Díez-Lopez M.","Alzheimer Dis Assoc Disord. 2011 Jul-Sep;25(3):213-9. doi: 10.1097/WAD.0b013e3182087dbc.","Ferrero-Arias J","Alzheimer Dis Assoc Disord","2011","2011/02/25","","","10.1097/WAD.0b013e3182087dbc"
"34477823","Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage: Extended Follow-up of the RESTART Randomized Clinical Trial","Al-Shahi Salman R, Dennis MS, Sandercock PAG, Sudlow CLM, Wardlaw JM, Whiteley WN, Murray GD, Stephen J, Rodriguez A, Lewis S, Werring DJ, White PM; RESTART Collaboration.","JAMA Neurol. 2021 Oct 1;78(10):1179-1186. doi: 10.1001/jamaneurol.2021.2956.","Al-Shahi Salman R","JAMA Neurol","2021","2021/09/03","PMC8417806","","10.1001/jamaneurol.2021.2956"
"36102337","Effects of cocoa extract and a multivitamin on cognitive function: A randomized clinical trial","Baker LD, Manson JE, Rapp SR, Sesso HD, Gaussoin SA, Shumaker SA, Espeland MA.","Alzheimers Dement. 2023 Apr;19(4):1308-1319. doi: 10.1002/alz.12767. Epub 2022 Sep 14.","Baker LD","Alzheimers Dement","2023","2022/09/14","PMC10011015","NIHMS1826714","10.1002/alz.12767"
"33785077","The efficacy of exergaming in people with major neurocognitive disorder residing in long-term care facilities: a pilot randomized controlled trial","Swinnen N, Vandenbulcke M, de Bruin ED, Akkerman R, Stubbs B, Firth J, Vancampfort D.","Alzheimers Res Ther. 2021 Mar 30;13(1):70. doi: 10.1186/s13195-021-00806-7.","Swinnen N","Alzheimers Res Ther","2021","2021/03/31","PMC8008333","","10.1186/s13195-021-00806-7"
"26086180","Sleep duration, cognitive decline, and dementia risk in older women","Chen JC, Espeland MA, Brunner RL, Lovato LC, Wallace RB, Leng X, Phillips LS, Robinson JG, Kotchen JM, Johnson KC, Manson JE, Stefanick ML, Sarto GE, Mysiw WJ.","Alzheimers Dement. 2016 Jan;12(1):21-33. doi: 10.1016/j.jalz.2015.03.004. Epub 2015 Jun 15.","Chen JC","Alzheimers Dement","2016","2015/06/19","PMC4679723","NIHMS693724","10.1016/j.jalz.2015.03.004"
"25835516","Impact of the Baltimore Experience Corps Trial on cortical and hippocampal volumes","Carlson MC, Kuo JH, Chuang YF, Varma VR, Harris G, Albert MS, Erickson KI, Kramer AF, Parisi JM, Xue QL, Tan EJ, Tanner EK, Gross AL, Seeman TE, Gruenewald TL, McGill S, Rebok GW, Fried LP.","Alzheimers Dement. 2015 Nov;11(11):1340-8. doi: 10.1016/j.jalz.2014.12.005. Epub 2015 Mar 31.","Carlson MC","Alzheimers Dement","2015","2015/04/04","PMC5179033","NIHMS683779","10.1016/j.jalz.2014.12.005"
"30507375","Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT","Howard R, Cort E, Bradley R, Harper E, Kelly L, Bentham P, Ritchie C, Reeves S, Fawzi W, Livingston G, Sommerlad A, Oomman S, Nazir E, Nilforooshan R, Barber R, Fox C, Macharouthu A, Ramachandra P, Pattan V, Sykes J, Curran V, Katona C, Dening T, Knapp M, Romeo R, Gray R.","Health Technol Assess. 2018 Nov;22(67):1-62. doi: 10.3310/hta22670.","Howard R","Health Technol Assess","2018","2018/12/04","PMC6304731","","10.3310/hta22670"
"34551696","Decreased Plasma Level of Lipoprotein Lipase Predicted Verbal Disfluency in Chinese Type 2 Diabetes Mellitus Patients with Early Cognitive Deficits","An K, Guo P, Zhang H, Zhu W, Cao W, Shi J, Wang S.","Curr Alzheimer Res. 2021;18(8):656-666. doi: 10.2174/1567205018666210922105850.","An K","Curr Alzheimer Res","2021","2021/09/23","","","10.2174/1567205018666210922105850"
"25590939","Effectiveness of a fotonovela for reducing depression and stress in Latino dementia family caregivers","Gallagher-Thompson D, Tzuang M, Hinton L, Alvarez P, Rengifo J, Valverde I, Chen N, Emrani T, Thompson LW.","Alzheimer Dis Assoc Disord. 2015 Apr-Jun;29(2):146-53. doi: 10.1097/WAD.0000000000000077.","Gallagher-Thompson D","Alzheimer Dis Assoc Disord","2015","2015/01/16","PMC4437891","NIHMS644204","10.1097/WAD.0000000000000077"
"24801219","The effects of CCRC on cognition and brain activity in aMCI patients: a pilot placebo controlled BOLD fMRI study","Zhang J, Wang Z, Xu S, Chen Y, Chen K, Liu L, Wang Y, Guo R, Zhang Z.","Curr Alzheimer Res. 2014;11(5):484-93. doi: 10.2174/1567205011666140505095939.","Zhang J","Curr Alzheimer Res","2014","2014/05/08","","","10.2174/1567205011666140505095939"
"33657852","Quantitative Assessment of Motor Neglect","Toba MN, Pagliari C, Rabuffetti M, Nighoghossian N, Rode G, Cotton F, Spinazzola L, Baglio F, Migliaccio R, Bartolomeo P.","Stroke. 2021 May;52(5):1618-1627. doi: 10.1161/STROKEAHA.120.031949. Epub 2021 Mar 4.","Toba MN","Stroke","2021","2021/03/04","","","10.1161/STROKEAHA.120.031949"
"32802364","A qualitative study-Patient experience of tactile massage after stroke","Seiger Cronfalk B, Åkesson E, Nygren J, Nyström A, Strandell AM, Ruas J, von Euler M.","Nurs Open. 2020 May 29;7(5):1446-1452. doi: 10.1002/nop2.515. eCollection 2020 Sep.","Seiger Cronfalk B","Nurs Open","2020","2020/08/18","PMC7424438","","10.1002/nop2.515"
"31452471","Implementing a multidisciplinary psychotropic medication review among nursing home residents with dementia: a process evaluation","Gerritsen DL, de Vries E, Smalbrugge M, Smeets CHW, van der Spek K, Zuidema SU, Koopmans RTCM.","Int Psychogeriatr. 2021 Sep;33(9):933-945. doi: 10.1017/S1041610219000577. Epub 2019 Aug 27.","Gerritsen DL","Int Psychogeriatr","2021","2019/08/28","","","10.1017/S1041610219000577"
"16325382","Task difficulty in a simultaneous face matching task modulates activity in face fusiform area","Bokde AL, Dong W, Born C, Leinsinger G, Meindl T, Teipel SJ, Reiser M, Hampel H.","Brain Res Cogn Brain Res. 2005 Dec;25(3):701-10. doi: 10.1016/j.cogbrainres.2005.09.016. Epub 2005 Dec 1.","Bokde AL","Brain Res Cogn Brain Res","2005","2005/12/06","","","10.1016/j.cogbrainres.2005.09.016"
"30201101","Sex-related differences in the prevalence of cognitive impairment among overweight and obese adults with type 2 diabetes","Espeland MA, Carmichael O, Yasar S, Hugenschmidt C, Hazzard W, Hayden KM, Rapp SR, Neiberg R, Johnson KC, Hoscheidt S, Mielke MM; Action for Health in Diabetes (Look AHEAD) Research Group.","Alzheimers Dement. 2018 Sep;14(9):1184-1192. doi: 10.1016/j.jalz.2018.05.015. Epub 2018 Jul 5.","Espeland MA","Alzheimers Dement","2018","2018/09/12","PMC6338071","NIHMS997127","10.1016/j.jalz.2018.05.015"
"19812460","Computer-based cognitive training for mild cognitive impairment: results from a pilot randomized, controlled trial","Barnes DE, Yaffe K, Belfor N, Jagust WJ, DeCarli C, Reed BR, Kramer JH.","Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):205-10. doi: 10.1097/WAD.0b013e31819c6137.","Barnes DE","Alzheimer Dis Assoc Disord","2009","2009/10/09","PMC2760033","NIHMS127293","10.1097/WAD.0b013e31819c6137"
"35921506","Add-On Pramipexole for the Treatment of Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial","Levi L, Zamora D, Nastas I, Gonen I, Radu P, Matei V, Ciobanu AM, Nacu A, Boronin L, Karakrah L, Davidson M, Davis JM, Weiser M.","J Clin Psychiatry. 2022 Aug 1;83(5):21m14233. doi: 10.4088/JCP.21m14233.","Levi L","J Clin Psychiatry","2022","2022/08/03","","","10.4088/JCP.21m14233"
"35148419","Randomized trial of individual reminiscence therapy for older adults with cognitive impairment: a 3-month responder analysis","Justo-Henriques SI, Carvalho JO, Pérez-Sáez E, Neves H, Parola V, Alves-Apóstolo JL.","Rev Neurol. 2022 Feb 16;74(4):107-116. doi: 10.33588/rn.7404.2021322.","Justo-Henriques SI","Rev Neurol","2022","2022/02/11","","","10.33588/rn.7404.2021322"
"33728336","Plasma Resolvin D2 to Leukotriene B(4) Ratio Is Reduced in Diabetic Patients with Ischemic Stroke and Related to Prognosis","Miao Z, Tang X, Schultzberg M, Zhao Y, Wang X.","Biomed Res Int. 2021 Feb 26;2021:6657646. doi: 10.1155/2021/6657646. eCollection 2021.","Miao Z","Biomed Res Int","2021","2021/03/17","PMC7935571","","10.1155/2021/6657646"
"33143906","Effects of an educational intervention on health-related quality of life among family caregivers of people with dementia with a Turkish or Moroccan immigrant background: Insights from a cluster randomised controlled trial","van der Heide I, van Wezel N, Blom M, Spreeuwenberg P, Devillé WLJM, Francke AL.","Patient Educ Couns. 2021 May;104(5):1168-1175. doi: 10.1016/j.pec.2020.10.029. Epub 2020 Oct 22.","van der Heide I","Patient Educ Couns","2021","2020/11/04","","","10.1016/j.pec.2020.10.029"
"28714738","Dealing with daily challenges in dementia (deal-id study): process evaluation of the experience sampling method intervention 'Partner in Sight' for spousal caregivers of people with dementia","van Knippenberg RJM, de Vugt ME, Smeets CMJ, Myin-Germeys I, Verhey FRJ, Ponds RW.","Aging Ment Health. 2018 Sep;22(9):1199-1206. doi: 10.1080/13607863.2017.1348466. Epub 2017 Jul 17.","van Knippenberg RJM","Aging Ment Health","2018","2017/07/18","","","10.1080/13607863.2017.1348466"
"32967619","Advance care planning with people with dementia: a process evaluation of an educational intervention for general practitioners","Tilburgs B, Koopmans R, Schers H, Smits C, Vernooij-Dassen M, Perry M, Engels Y.","BMC Fam Pract. 2020 Sep 23;21(1):199. doi: 10.1186/s12875-020-01265-z.","Tilburgs B","BMC Fam Pract","2020","2020/09/24","PMC7513545","","10.1186/s12875-020-01265-z"
"31948507","Specific components of a complex depression care program can affect staff outcomes differently: post-hoc analyses of a stepped-wedge cluster-randomized trial in nursing homes","Leontjevas R, Hooijschuur L, Smalbrugge M, Koopmans RTCM, Gerritsen DL.","Int Psychogeriatr. 2020 Mar;32(3):371-380. doi: 10.1017/S1041610219002151.","Leontjevas R","Int Psychogeriatr","2020","2020/01/18","","","10.1017/S1041610219002151"
"29168741","Dose-Dependent Effects of Oral Tyrosine Administration on Plasma Tyrosine Levels and Cognition in Aging","van de Rest O, Bloemendaal M, de Heus R, Aarts E.","Nutrients. 2017 Nov 23;9(12):1279. doi: 10.3390/nu9121279.","van de Rest O","Nutrients","2017","2017/11/24","PMC5748730","","10.3390/nu9121279"
"28891446","The Clock Drawing Test: A Reasonable Instrument to Assess Probable Dementia in Primary Care?","Reiner K, Eichler T, Hertel J, Hoffmann W, Thyrian JR.","Curr Alzheimer Res. 2018;15(1):38-43. doi: 10.2174/1567205014666170908101822.","Reiner K","Curr Alzheimer Res","2018","2017/09/12","","","10.2174/1567205014666170908101822"
"28595523","Blue-Enriched Lighting for Older People Living in Care Homes: Effect on Activity, Actigraphic Sleep, Mood and Alertness","Hopkins S, Morgan PL, Schlangen LJM, Williams P, Skene DJ, Middleton B.","Curr Alzheimer Res. 2017;14(10):1053-1062. doi: 10.2174/1567205014666170608091119.","Hopkins S","Curr Alzheimer Res","2017","2017/06/10","","","10.2174/1567205014666170608091119"
"18171718","Community occupational therapy for older patients with dementia and their care givers: cost effectiveness study","Graff MJ, Adang EM, Vernooij-Dassen MJ, Dekker J, Jönsson L, Thijssen M, Hoefnagels WH, Rikkert MG.","BMJ. 2008 Jan 19;336(7636):134-8. doi: 10.1136/bmj.39408.481898.BE. Epub 2008 Jan 2.","Graff MJ","BMJ","2008","2008/01/04","PMC2206302","","10.1136/bmj.39408.481898.BE"
"17316169","Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study","Zhong KX, Tariot PN, Mintzer J, Minkwitz MC, Devine NA.","Curr Alzheimer Res. 2007 Feb;4(1):81-93. doi: 10.2174/156720507779939805.","Zhong KX","Curr Alzheimer Res","2007","2007/02/24","","","10.2174/156720507779939805"
"25862600","Slow-oscillatory Transcranial Direct Current Stimulation Modulates Memory in Temporal Lobe Epilepsy by Altering Sleep Spindle Generators: A Possible Rehabilitation Tool","Del Felice A, Magalini A, Masiero S.","Brain Stimul. 2015 May-Jun;8(3):567-73. doi: 10.1016/j.brs.2015.01.410. Epub 2015 Jan 30.","Del Felice A","Brain Stimul","2015","2015/04/12","","","10.1016/j.brs.2015.01.410"
"20664181","Group therapy for patients with mild cognitive impairment and their significant others: results of a waiting-list controlled trial","Joosten-Weyn Banningh LW, Prins JB, Vernooij-Dassen MJ, Wijnen HH, Olde Rikkert MG, Kessels RP.","Gerontology. 2011;57(5):444-54. doi: 10.1159/000315933. Epub 2010 Jul 20.","Joosten-Weyn Banningh LW","Gerontology","2011","2010/07/29","","","10.1159/000315933"
"25391305","Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT","van der Zwaluw NL, Dhonukshe-Rutten RA, van Wijngaarden JP, Brouwer-Brolsma EM, van de Rest O, In 't Veld PH, Enneman AW, van Dijk SC, Ham AC, Swart KM, van der Velde N, van Schoor NM, van der Cammen TJ, Uitterlinden AG, Lips P, Kessels RP, de Groot LC.","Neurology. 2014 Dec 2;83(23):2158-66. doi: 10.1212/WNL.0000000000001050. Epub 2014 Nov 12.","van der Zwaluw NL","Neurology","2014","2014/11/14","","","10.1212/WNL.0000000000001050"
"29698251","Effects of the Tailored Activity Program in Brazil (TAP-BR) for Persons With Dementia: A Randomized Pilot Trial","Novelli MMPC, Machado SCB, Lima GB, Cantatore L, Sena BP, Rodrigues RS, Rodrigues CIB, Canon MBF, Piersol CV, Nitrini R, Yassuda MS, Gitlin LN.","Alzheimer Dis Assoc Disord. 2018 Oct-Dec;32(4):339-345. doi: 10.1097/WAD.0000000000000256.","Novelli MMPC","Alzheimer Dis Assoc Disord","2018","2018/04/27","","","10.1097/WAD.0000000000000256"
"27624148","Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A randomised controlled crossover trial","van den Elsen GA, Tobben L, Ahmed AI, Verkes RJ, Kramers C, Marijnissen RM, Olde Rikkert MG, van der Marck MA.","J Psychopharmacol. 2017 Feb;31(2):184-191. doi: 10.1177/0269881116665357. Epub 2016 Sep 27.","van den Elsen GA","J Psychopharmacol","2017","2016/09/15","","","10.1177/0269881116665357"
"22878163","Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals","Sperling RA, Johnson KA, Doraiswamy PM, Reiman EM, Fleisher AS, Sabbagh MN, Sadowsky CH, Carpenter A, Davis MD, Lu M, Flitter M, Joshi AD, Clark CM, Grundman M, Mintun MA, Skovronsky DM, Pontecorvo MJ; AV45-A05 Study Group.","Neurobiol Aging. 2013 Mar;34(3):822-31. doi: 10.1016/j.neurobiolaging.2012.06.014. Epub 2012 Aug 9.","Sperling RA","Neurobiol Aging","2013","2012/08/11","PMC3518678","NIHMS400694","10.1016/j.neurobiolaging.2012.06.014"
"34448856","Facilitators and barriers to implementing lifestyle intervention programme to prevent cognitive decline","Kulmala J, Rosenberg A, Ngandu T, Hemiö K, Tenkula T, Hyytiä A, Vienola M, Huhtamäki-Kuoppala M, Saarinen A, Korkki S, Laatikainen T, Solomon A, Kivipelto M.","Eur J Public Health. 2021 Oct 11;31(4):816-822. doi: 10.1093/eurpub/ckab087.","Kulmala J","Eur J Public Health","2021","2021/08/27","PMC8505000","","10.1093/eurpub/ckab087"
"30587151","A group study on the effects of a short multi-domain cognitive training in healthy elderly Italian people","Tagliabue CF, Guzzetti S, Gualco G, Boccolieri G, Boccolieri A, Smith S, Daini R.","BMC Geriatr. 2018 Dec 27;18(1):321. doi: 10.1186/s12877-018-1014-x.","Tagliabue CF","BMC Geriatr","2018","2018/12/28","PMC6307149","","10.1186/s12877-018-1014-x"
"22005105","Ghrelin-attenuated cognitive dysfunction in streptozotocin-induced diabetic rats","Ma LY, Zhang DM, Tang Y, Lu Y, Zhang Y, Gao Y, Xia L, Zhao KX, Chai LY, Xiao Q.","Alzheimer Dis Assoc Disord. 2011 Oct-Dec;25(4):352-63. doi: 10.1097/WAD.0b013e31820ce536.","Ma LY","Alzheimer Dis Assoc Disord","2011","2011/10/19","","","10.1097/WAD.0b013e31820ce536"
"34217230","Process evaluation of a tailored intervention to Reduce Inappropriate psychotropic Drug use in nursing home residents with dementia","Groot Kormelinck CM, van Teunenbroek CF, Zuidema SU, Smalbrugge M, Gerritsen DL.","BMC Geriatr. 2021 Jul 3;21(1):414. doi: 10.1186/s12877-021-02357-w.","Groot Kormelinck CM","BMC Geriatr","2021","2021/07/04","PMC8254904","","10.1186/s12877-021-02357-w"
"28829005","Does working with the Veder Contact Method influence the job satisfaction of caregivers? A non-randomized controlled trial in nursing homes for people with dementia","Boersma P, Dröes RM, Lissenberg-Witte BI, van Meijel B, van Weert JCM.","Int Psychogeriatr. 2017 Dec;29(12):2017-2032. doi: 10.1017/S1041610217001582. Epub 2017 Aug 22.","Boersma P","Int Psychogeriatr","2017","2017/08/23","","","10.1017/S1041610217001582"
"33437034","A randomized experimental study to test the effects of discussing uncertainty during cancer genetic counseling: different strategies, different outcomes?","Medendorp NM, Hillen MA, Visser LNC, Aalfs CM, Duijkers FAM, van Engelen K, Ausems MGEM, Verhoef S, Stiggelbout AM, Smets EMA.","Eur J Hum Genet. 2021 May;29(5):789-799. doi: 10.1038/s41431-020-00799-1. Epub 2021 Jan 12.","Medendorp NM","Eur J Hum Genet","2021","2021/01/13","PMC8110589","","10.1038/s41431-020-00799-1"
"36827951","Double blind, nonrandomized crossover study of active recharge biphasic deep brain stimulation for primary dystonia","Wong JK, Lopes JMLJ, Hu W, Wang A, Au KLK, Stiep T, Frey J, Toledo JB, Raike RS, Okun MS, Almeida L.","Parkinsonism Relat Disord. 2023 Apr;109:105328. doi: 10.1016/j.parkreldis.2023.105328. Epub 2023 Feb 18.","Wong JK","Parkinsonism Relat Disord","2023","2023/02/24","","","10.1016/j.parkreldis.2023.105328"
"32431251","Can the PROPER intervention reduce psychotropic drug prescription in nursing home residents with dementia? Results of a cluster-randomized controlled trial","Smeets CHW, Smalbrugge M, Koopmans RTCM, Nelissen-Vrancken MHJMG, van der Spek K, Teerenstra S, Gerritsen DL, Zuidema SU.","Int Psychogeriatr. 2021 Jun;33(6):577-586. doi: 10.1017/S1041610220000629. Epub 2020 May 20.","Smeets CHW","Int Psychogeriatr","2021","2020/05/21","","","10.1017/S1041610220000629"
"18580590","Factors associated with skilled nursing facility transfers in dementia-specific assisted living","Kenny AM, Bellantonio S, Fortinsky RH, Dauser D, Kleppinger A, Robison J, Gruman C, Trella P, Walsh SJ.","Alzheimer Dis Assoc Disord. 2008 Jul-Sep;22(3):255-60. doi: 10.1097/WAD.0b013e31816c92d5.","Kenny AM","Alzheimer Dis Assoc Disord","2008","2008/06/27","","","10.1097/WAD.0b013e31816c92d5"
"31781732","Is the Effect of a High-Intensity Functional Exercise Program on Functional Balance Influenced by Applicability and Motivation among Older People with Dementia in Nursing Homes?","Sondell A, Littbrand H, Holmberg H, Lindelöf N, Rosendahl E.","J Nutr Health Aging. 2019;23(10):1011-1020. doi: 10.1007/s12603-019-1269-8.","Sondell A","J Nutr Health Aging","2019","2019/11/30","PMC6874619","","10.1007/s12603-019-1269-8"
"28791690","Apathy: Risk Factor for Mortality in Nursing Home Patients","Nijsten JMH, Leontjevas R, Pat-El R, Smalbrugge M, Koopmans RTCM, Gerritsen DL.","J Am Geriatr Soc. 2017 Oct;65(10):2182-2189. doi: 10.1111/jgs.15007. Epub 2017 Aug 9.","Nijsten JMH","J Am Geriatr Soc","2017","2017/08/10","","","10.1111/jgs.15007"
"31291337","Computer-based cognitive training for older adults: Determinants of adherence","Turunen M, Hokkanen L, Bäckman L, Stigsdotter-Neely A, Hänninen T, Paajanen T, Soininen H, Kivipelto M, Ngandu T.","PLoS One. 2019 Jul 10;14(7):e0219541. doi: 10.1371/journal.pone.0219541. eCollection 2019.","Turunen M","PLoS One","2019","2019/07/11","PMC6620011","","10.1371/journal.pone.0219541"
"26876762","Longitudinal telomere length shortening and cognitive and physical decline in later life: The Lothian Birth Cohorts 1936 and 1921","Harris SE, Marioni RE, Martin-Ruiz C, Pattie A, Gow AJ, Cox SR, Corley J, von Zglinicki T, Starr JM, Deary IJ.","Mech Ageing Dev. 2016 Mar;154:43-8. doi: 10.1016/j.mad.2016.02.004. Epub 2016 Feb 10.","Harris SE","Mech Ageing Dev","2016","2016/02/16","PMC4798845","","10.1016/j.mad.2016.02.004"
"31141104","P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes","Povsic TJ, Ohman EM, Roe MT, White J, Rockhold FW, Montalescot G, Cornel JH, Nicolau JC, Steg PG, James S, Bode C, Welsh RC, Plotnikov AN, Mundl H, Gibson CM.","JAMA Cardiol. 2019 Jul 1;4(7):680-684. doi: 10.1001/jamacardio.2019.1510.","Povsic TJ","JAMA Cardiol","2019","2019/05/30","PMC6547088","","10.1001/jamacardio.2019.1510"
"29258980","Implementation of the Blended Care Self-Management Program for Caregivers of People With Early-Stage Dementia (Partner in Balance): Process Evaluation of a Randomized Controlled Trial","Boots LM, de Vugt ME, Smeets CM, Kempen GI, Verhey FR.","J Med Internet Res. 2017 Dec 19;19(12):e423. doi: 10.2196/jmir.7666.","Boots LM","J Med Internet Res","2017","2017/12/21","PMC5750419","","10.2196/jmir.7666"
"24113563","Effectiveness of a psychoeducational intervention group program in the reduction of the burden experienced by caregivers of patients with dementia: the EDUCA-II randomized trial","Martín-Carrasco M, Domínguez-Panchón AI, González-Fraile E, Muñoz-Hermoso P, Ballesteros J; EDUCA Group.","Alzheimer Dis Assoc Disord. 2014 Jan-Mar;28(1):79-87. doi: 10.1097/WAD.0000000000000003.","Martín-Carrasco M","Alzheimer Dis Assoc Disord","2014","2013/10/12","","","10.1097/WAD.0000000000000003"
"32552074","Randomized controlled feasibility study of FindMyApps: first evaluation of a tablet-based intervention to promote self-management and meaningful activities in people with mild dementia","Kerkhof Y, Kohl G, Veijer M, Mangiaracina F, Bergsma A, Graff M, Dröes RM.","Disabil Rehabil Assist Technol. 2022 Jan;17(1):85-99. doi: 10.1080/17483107.2020.1765420. Epub 2020 Jun 19.","Kerkhof Y","Disabil Rehabil Assist Technol","2022","2020/06/20","","","10.1080/17483107.2020.1765420"
"33479775","Adjunctive Aspirin vs Placebo in Patients With Schizophrenia: Results of Two Randomized Controlled Trials","Weiser M, Zamora D, Levi L, Nastas I, Gonen I, Radu P, Matei V, Nacu A, Boronin L, Davidson M, Davis JM.","Schizophr Bull. 2021 Jul 8;47(4):1077-1087. doi: 10.1093/schbul/sbaa198.","Weiser M","Schizophr Bull","2021","2021/01/22","PMC8266648","","10.1093/schbul/sbaa198"
"30088298","Stability, reliability, and validity of the THINC-it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteers","Harrison JE, Barry H, Baune BT, Best MW, Bowie CR, Cha DS, Culpepper L, Fossati P, Greer TL, Harmer C, Klag E, Lam RW, Lee Y, Mansur RB, Wittchen HU, McIntyre RS.","Int J Methods Psychiatr Res. 2018 Sep;27(3):e1736. doi: 10.1002/mpr.1736. Epub 2018 Aug 7.","Harrison JE","Int J Methods Psychiatr Res","2018","2018/08/09","PMC6174931","","10.1002/mpr.1736"
"25458804","Coming to grips with challenging behaviour: a cluster randomised controlled trial on the effects of a new care programme for challenging behaviour on burnout, job satisfaction and job demands of care staff on dementia special care units","Zwijsen SA, Gerritsen DL, Eefsting JA, Smalbrugge M, Hertogh CM, Pot AM.","Int J Nurs Stud. 2015 Jan;52(1):68-74. doi: 10.1016/j.ijnurstu.2014.10.003. Epub 2014 Oct 13.","Zwijsen SA","Int J Nurs Stud","2015","2014/12/03","","","10.1016/j.ijnurstu.2014.10.003"
"26170035","Community-dwelling patients with dementia and their informal caregivers with and without case management: 2-year outcomes of a pragmatic trial","MacNeil Vroomen J, Bosmans JE, van de Ven PM, Joling KJ, van Mierlo LD, Meiland FJ, Moll van Charante EP, van Hout HP, de Rooij SE.","J Am Med Dir Assoc. 2015 Sep 1;16(9):800.e1-8. doi: 10.1016/j.jamda.2015.06.011. Epub 2015 Jul 10.","MacNeil Vroomen J","J Am Med Dir Assoc","2015","2015/07/15","","","10.1016/j.jamda.2015.06.011"
"22978421","Sea-anemone toxin ATX-II elicits A-fiber-dependent pain and enhances resurgent and persistent sodium currents in large sensory neurons","Klinger AB, Eberhardt M, Link AS, Namer B, Kutsche LK, Schuy ET, Sittl R, Hoffmann T, Alzheimer C, Huth T, Carr RW, Lampert A.","Mol Pain. 2012 Sep 15;8:69. doi: 10.1186/1744-8069-8-69.","Klinger AB","Mol Pain","2012","2012/09/18","PMC3495684","","10.1186/1744-8069-8-69"
"33772877","Effects of physical and cognitive training on gait speed and cognition in older adults: A randomized controlled trial","Sipilä S, Tirkkonen A, Savikangas T, Hänninen T, Laukkanen P, Alen M, Fielding RA, Kivipelto M, Kulmala J, Rantanen T, Sihvonen SE, Sillanpää E, Stigsdotter Neely A, Törmäkangas T.","Scand J Med Sci Sports. 2021 Jul;31(7):1518-1533. doi: 10.1111/sms.13960. Epub 2021 Apr 6.","Sipilä S","Scand J Med Sci Sports","2021","2021/03/27","","","10.1111/sms.13960"
"34910809","Effects of Physical and Cognitive Training on Falls and Concern About Falling in Older Adults: Results From a Randomized Controlled Trial","Turunen KM, Tirkkonen A, Savikangas T, Hänninen T, Alen M, Fielding RA, Kivipelto M, Stigsdotter Neely A, Törmäkangas T, Sipilä S.","J Gerontol A Biol Sci Med Sci. 2022 Jul 5;77(7):1430-1437. doi: 10.1093/gerona/glab375.","Turunen KM","J Gerontol A Biol Sci Med Sci","2022","2021/12/15","PMC9255687","","10.1093/gerona/glab375"
"35182352","Psychosocial determinants for adherence to a healthy lifestyle and intervention participation in the FINGER trial: an exploratory analysis of a randomised clinical trial","Neuvonen E, Lehtisalo J, Solomon A, Antikainen R, Havulinna S, Hänninen T, Laatikainen T, Lindström J, Rautio N, Soininen H, Strandberg T, Tuomilehto J, Kivipelto M, Ngandu T.","Aging Clin Exp Res. 2022 Aug;34(8):1793-1805. doi: 10.1007/s40520-022-02088-x. Epub 2022 Feb 19.","Neuvonen E","Aging Clin Exp Res","2022","2022/02/19","PMC9283154","","10.1007/s40520-022-02088-x"
"33245000","Impact of the FindMyApps program on people with mild cognitive impairment or dementia and their caregivers; an exploratory pilot randomised controlled trial","Beentjes KM, Neal DP, Kerkhof YJF, Broeder C, Moeridjan ZDJ, Ettema TP, Pelkmans W, Muller MM, Graff MJL, Dröes RM.","Disabil Rehabil Assist Technol. 2023 Apr;18(3):253-265. doi: 10.1080/17483107.2020.1842918. Epub 2020 Nov 27.","Beentjes KM","Disabil Rehabil Assist Technol","2023","2020/11/27","","","10.1080/17483107.2020.1842918"
"34896069","An Electronic Health Record Integrated Decision Tool and Supportive Interventions to Improve Antibiotic Prescribing for Urinary Tract Infections in Nursing Homes: A Cluster Randomized Controlled Trial","Rutten JJS, van Buul LW, Smalbrugge M, Geerlings SE, Gerritsen DL, Natsch S, Sloane PD, van der Wouden JC, Twisk JWR, Hertogh CMPM.","J Am Med Dir Assoc. 2022 Mar;23(3):387-393. doi: 10.1016/j.jamda.2021.11.010. Epub 2021 Dec 10.","Rutten JJS","J Am Med Dir Assoc","2022","2021/12/13","","","10.1016/j.jamda.2021.11.010"
"33496902","Development of an EORTC questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumours: phase I-III","Oort Q, Dirven L, Sikkes SAM, Aaronson N, Boele F, Brannan C, Egeter J, Grant R, Klein M, Lips I, Narita Y, Sato H, Sztankay M, Stockhammer G, Talacchi A, Uitdehaag BMJ, Reijneveld JC, Taphoorn MJB; EORTC Quality of Life Group.","Qual Life Res. 2021 May;30(5):1491-1502. doi: 10.1007/s11136-020-02738-5. Epub 2021 Jan 26.","Oort Q","Qual Life Res","2021","2021/01/26","PMC8068708","","10.1007/s11136-020-02738-5"
"30821829","Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical Trials","Offer A, Arnold M, Clarke R, Bennett D, Bowman L, Bulbulia R, Haynes R, Li J, Hopewell JC, Landray M, Armitage J, Collins R, Parish S; Heart Protection Study (HPS), Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH), and Treatment of HDL (High-Density Lipoprotein) to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Collaborative Grou.","JAMA Netw Open. 2019 Mar 1;2(3):e190223. doi: 10.1001/jamanetworkopen.2019.0223.","Offer A","JAMA Netw Open","2019","2019/03/02","PMC6484650","","10.1001/jamanetworkopen.2019.0223"
"34644357","The effects of a physical and cognitive training intervention vs. physical training alone on older adults' physical activity: A randomized controlled trial with extended follow-up during COVID-19","Savikangas T, Törmäkangas T, Tirkkonen A, Alen M, Fielding RA, Kivipelto M, Rantalainen T, Stigsdotter Neely A, Sipilä S.","PLoS One. 2021 Oct 13;16(10):e0258559. doi: 10.1371/journal.pone.0258559. eCollection 2021.","Savikangas T","PLoS One","2021","2021/10/13","PMC8513828","","10.1371/journal.pone.0258559"
"32059724","Why do family dementia caregivers reject caregiver support services? Analyzing types of rejection and associated health-impairments in a cluster-randomized controlled intervention trial","Zwingmann I, Dreier-Wolfgramm A, Esser A, Wucherer D, Thyrian JR, Eichler T, Kaczynski A, Monsees J, Keller A, Hertel J, Kilimann I, Teipel S, Michalowsky B, Hoffmann W.","BMC Health Serv Res. 2020 Feb 14;20(1):121. doi: 10.1186/s12913-020-4970-8.","Zwingmann I","BMC Health Serv Res","2020","2020/02/16","PMC7023728","","10.1186/s12913-020-4970-8"
"30006327","Effectiveness of a Blended Care Self-Management Program for Caregivers of People With Early-Stage Dementia (Partner in Balance): Randomized Controlled Trial","Boots LM, de Vugt ME, Kempen GI, Verhey FR.","J Med Internet Res. 2018 Jul 13;20(7):e10017. doi: 10.2196/10017.","Boots LM","J Med Internet Res","2018","2018/07/15","PMC6064039","","10.2196/10017"
"31787369","A randomized placebo-controlled trial of using B vitamins to prevent cognitive decline in older mild cognitive impairment patients","Kwok T, Wu Y, Lee J, Lee R, Yung CY, Choi G, Lee V, Harrison J, Lam L, Mok V.","Clin Nutr. 2020 Aug;39(8):2399-2405. doi: 10.1016/j.clnu.2019.11.005. Epub 2019 Nov 20.","Kwok T","Clin Nutr","2020","2019/12/03","","","10.1016/j.clnu.2019.11.005"
"28125977","Supporting clinical rules engine in the adjustment of medication (SCREAM): protocol of a multicentre, prospective, randomised study","Mestres Gonzalvo C, de Wit HA, van Oijen BP, Hurkens KP, Janknegt R, Schols JM, Mulder WJ, Verhey FR, Winkens B, van der Kuy PM.","BMC Geriatr. 2017 Jan 26;17(1):35. doi: 10.1186/s12877-017-0426-3.","Mestres Gonzalvo C","BMC Geriatr","2017","2017/01/28","PMC5270253","","10.1186/s12877-017-0426-3"
"26841799","Community occupational therapy for people with dementia and family carers (COTiD-UK) versus treatment as usual (Valuing Active Life in Dementia [VALID] programme): study protocol for a randomised controlled trial","Wenborn J, Hynes S, Moniz-Cook E, Mountain G, Poland F, King M, Omar R, Morris S, Vernooij-Dassen M, Challis D, Michie S, Russell I, Sackley C, Graff M, O'Keeffe A, Crellin N, Orrell M.","Trials. 2016 Feb 3;17:65. doi: 10.1186/s13063-015-1150-y.","Wenborn J","Trials","2016","2016/02/05","PMC4739339","","10.1186/s13063-015-1150-y"
"31365044","Effect of Adjunctive Estradiol on Schizophrenia Among Women of Childbearing Age: A Randomized Clinical Trial","Weiser M, Levi L, Zamora D, Biegon A, SanGiovanni JP, Davidson M, Burshtein S, Gonen I, Radu P, Slobozean Pavalache K, Nastas I, Hemi R, Ryan T, Davis JM.","JAMA Psychiatry. 2019 Oct 1;76(10):1009-1017. doi: 10.1001/jamapsychiatry.2019.1842.","Weiser M","JAMA Psychiatry","2019","2019/08/01","PMC6669788","","10.1001/jamapsychiatry.2019.1842"
"28029114","Folate and Vitamin B(12)-Related Biomarkers in Relation to Brain Volumes","van der Zwaluw NL, Brouwer-Brolsma EM, van de Rest O, van Wijngaarden JP, In 't Veld PH, Kourie DI, Swart KM, Enneman AW, van Dijk SC, van der Velde N, Kessels RP, Smeets PA, Kok FJ, Dhonukshe-Rutten RA, de Groot LC.","Nutrients. 2016 Dec 24;9(1):8. doi: 10.3390/nu9010008.","van der Zwaluw NL","Nutrients","2016","2016/12/29","PMC5295052","","10.3390/nu9010008"
"30579407","Delirium detection using relative delta power based on 1-minute single-channel EEG: a multicentre study","Numan T, van den Boogaard M, Kamper AM, Rood PJT, Peelen LM, Slooter AJC; Dutch Delirium Detection Study Group.","Br J Anaesth. 2019 Jan;122(1):60-68. doi: 10.1016/j.bja.2018.08.021. Epub 2018 Oct 2.","Numan T","Br J Anaesth","2019","2018/12/24","","","10.1016/j.bja.2018.08.021"
"35385395","Factors Predicting Engagement of Older Adults With a Coach-Supported eHealth Intervention Promoting Lifestyle Change and Associations Between Engagement and Changes in Cardiovascular and Dementia Risk: Secondary Analysis of an 18-Month Multinational Randomized Controlled Trial","Coley N, Andre L, Hoevenaar-Blom MP, Ngandu T, Beishuizen C, Barbera M, van Wanrooij L, Kivipelto M, Soininen H, van Gool W, Brayne C, Moll van Charante E, Richard E, Andrieu S; HATICE study group; PRODEMOS study group.","J Med Internet Res. 2022 May 9;24(5):e32006. doi: 10.2196/32006.","Coley N","J Med Internet Res","2022","2022/04/06","PMC9127655","","10.2196/32006"